Citrus Sinensis ID: 002509
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 914 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGI2 | 929 | Probable LRR receptor-lik | no | no | 0.926 | 0.911 | 0.482 | 0.0 | |
| Q9FZB8 | 871 | Probable LRR receptor-lik | no | no | 0.892 | 0.936 | 0.346 | 1e-135 | |
| Q9FZB1 | 872 | Probable LRR receptor-lik | no | no | 0.878 | 0.920 | 0.338 | 1e-130 | |
| Q9ZQR3 | 868 | Leucine-rich repeat recep | no | no | 0.877 | 0.923 | 0.362 | 1e-129 | |
| C0LGG4 | 890 | Probable LRR receptor-lik | no | no | 0.904 | 0.929 | 0.336 | 1e-128 | |
| O64556 | 877 | Putative leucine-rich rep | no | no | 0.887 | 0.924 | 0.343 | 1e-128 | |
| O65924 | 881 | Putative leucine-rich rep | no | no | 0.901 | 0.935 | 0.333 | 1e-127 | |
| Q9ZQQ7 | 886 | Putative leucine-rich rep | no | no | 0.903 | 0.932 | 0.352 | 1e-127 | |
| Q9LIG2 | 899 | Receptor-like protein kin | no | no | 0.881 | 0.896 | 0.345 | 1e-126 | |
| O81069 | 884 | Probable leucine-rich rep | no | no | 0.885 | 0.915 | 0.346 | 1e-125 |
| >sp|C0LGI2|Y1677_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g67720 OS=Arabidopsis thaliana GN=At1g67720 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 830 bits (2144), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 426/883 (48%), Positives = 572/883 (64%), Gaps = 36/883 (4%)
Query: 15 SVLILLLLDSSSAQMPGFVSLNCGGNENFTD-EIGLQWIADDHLI-YGEISNISVANETR 72
+V L L+ +Q+ FVS++CG + N+TD GL W++D +I G+ ++ N
Sbjct: 9 AVTCLFLVPFVLSQVTEFVSIDCGCSSNYTDPRTGLGWVSDSEIIKQGKPVTLANTNWNS 68
Query: 73 KQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTI 132
QY R FP D++KYCY+L R RY++R TFLYG + YPKF + L T W+T+
Sbjct: 69 MQYRRRRDFPTDNKKYCYRLSTKERRRYIVRTTFLYGGLGSEEAYPKFQLYLDATKWATV 128
Query: 133 VISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLS 192
I + + + V ELI A+S +DVC+ A TG PF+STLELR N S+Y T +ED ++L
Sbjct: 129 TIQEVSRVYVEELIVRATSSYVDVCVCCAITGSPFMSTLELRPLNLSMYATDYEDNFFLK 188
Query: 193 VSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDEL 252
V+AR+NFGA + +RYPDDP+DRIWESD K+ NYLV VA GT +++T I+ + E
Sbjct: 189 VAARVNFGAPNMDALRYPDDPYDRIWESDINKRPNYLVGVAPGTTRINTSKTINTLTREY 248
Query: 253 PPQKVMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDV 312
PP KVMQTAVVGT G ++YRLNL+ FP A YFAEIE+L +E+RKF+LV P PD
Sbjct: 249 PPMKVMQTAVVGTQGLISYRLNLEDFPANARAYAYFAEIEELGANETRKFKLVQPYFPDY 308
Query: 313 SKAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYL---- 368
S A+VNI ENA G Y +YEP Y N++L FVL+F FGKT DS++GPLLNA+EI+KYL
Sbjct: 309 SNAVVNIAENANGSYTLYEPSYMNVTLDFVLTFSFGKTKDSTQGPLLNAIEISKYLPISV 368
Query: 369 --ERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSK 426
+R+D S+ + ++ S+ +DWA EGGDPC+PV WSW+ C+S P +T I LS K
Sbjct: 369 KTDRSDVSV----LDAIRSMSPDSDWASEGGDPCIPVLWSWVNCSSTSPPRVTKIALSRK 424
Query: 427 NLTGNIPSDLTKLSSLVEFGCPD---------------LRIIHLEDNQLTGPLPSSLMNL 471
NL G IP + + +L E D L+I+HLE+NQL+G LP L +L
Sbjct: 425 NLRGEIPPGINYMEALTELWLDDNELTGTLPDMSKLVNLKIMHLENNQLSGSLPPYLAHL 484
Query: 472 PNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVL- 530
PNL+EL ++NN G +PS+LL V+ Y N L + KH I+G S+ A +
Sbjct: 485 PNLQELSIENNSFKGKIPSALLKGKVLFKYNNNPELQNEAQ-RKHFWQILGISIAAVAIL 543
Query: 531 ----LLATVVSCLFMHKGKKNNYDK-EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIED 585
+ V+ C + + D E + L V + A+ +L +E+
Sbjct: 544 LLLVGGSLVLLCALRKTKRADKGDSTETKKKGLVAYSAVRGGHLLDEGVAYFISLPVLEE 603
Query: 586 ATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV 645
AT KK+G G FG VYYG++KDGKE+AVK+ S R+F EV LLSRIHHRNLV
Sbjct: 604 ATDNFSKKVGRGSFGSVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVALLSRIHHRNLV 663
Query: 646 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 705
+GYC+E R +LVYE+MHNG+L +HL+G+ ++ ++W+ RL+IA+DAAKG+EYLHTG
Sbjct: 664 PLIGYCEEADRRILVYEYMHNGSLGDHLHGSSDYKP-LDWLTRLQIAQDAAKGLEYLHTG 722
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 765
C P+IIHRD+KSSNILLD +MRAKVSDFGLS+ + +HVSS+ +GTVGYLDPEYY SQ
Sbjct: 723 CNPSIIHRDVKSSNILLDINMRAKVSDFGLSRQTEEDLTHVSSVAKGTVGYLDPEYYASQ 782
Query: 766 QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 825
QLT+KSDVYSFGV+L EL+SG++ +S E FG NIV WA+ I GD+ GIIDP +
Sbjct: 783 QLTEKSDVYSFGVVLFELLSGKKPVSAEDFGPEL-NIVHWARSLIRKGDVCGIIDPCIAS 841
Query: 826 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIER 868
I+S+W++ E A CV GH RP + EV+ IQDAI IER
Sbjct: 842 NVKIESVWRVAEVANQCVEQRGHNRPRMQEVIVAIQDAIRIER 884
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FZB8|Y5181_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51810 OS=Arabidopsis thaliana GN=At1g51810 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 483 bits (1243), Expect = e-135, Method: Compositional matrix adjust.
Identities = 325/938 (34%), Positives = 505/938 (53%), Gaps = 122/938 (13%)
Query: 1 MERRRRLLLPFSVASVLILLLLDSSSAQMP-GFVSLNCG----GNENFTDEIGLQWIADD 55
MER + FS L+L AQ P GF++L+CG G+ GL + +DD
Sbjct: 1 MERHCLFFVIFS-------LILHLVQAQDPIGFINLDCGLSIQGSPYKESSTGLTYTSDD 53
Query: 56 HLIY-GEISNISVANET--RKQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFD 112
+ G+I I+ E+ +K TLR+FP D + C+ L+V T+YLI+ TFLYGN+D
Sbjct: 54 GFVQSGKIGKITKELESLYKKPERTLRYFP-DGVRNCFSLNVTRGTKYLIKPTFLYGNYD 112
Query: 113 NNNVYPKFDISLGPTHWSTIVISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLE 172
NV P FD+ +GP W T+ + ++E++ ++ S + VCL T P+I+TLE
Sbjct: 113 GRNVIPDFDLYIGPNMWITVNTDNT----IKEILHVSKSNTLQVCLVKTGTSIPYINTLE 168
Query: 173 LRQFNGSVYLTPFEDRYYLSVSARINF-----GADSEAPVRYPDDPFDRIWESDSLKKAN 227
LR P D Y + S +N+ ++ + + YPDD DRIW+ L +
Sbjct: 169 LR---------PLADDIYTNESGSLNYLFRVYYSNLKGYIEYPDDVHDRIWK-QILPYQD 218
Query: 228 YLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNGSLT---YRLNLDGFPGFGWA 284
+ + ++T L I++ +D PQ+VM+TAV S T + NL+ +
Sbjct: 219 WQI--------LTTNLQINVSNDYDLPQRVMKTAVTPIKASTTTMEFPWNLEPPTSQFYL 270
Query: 285 VTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPFVLS 344
+FAE++ L +E+R+F +VL N ++ Y P + + + +
Sbjct: 271 FLHFAELQSLQANETREFNVVL---------------NGNVTFKSYSPKFLEMQTVYSTA 315
Query: 345 ----------FKFGKTYDSSRGPLLNAMEINKYLE--RNDGSIDGV-AIVSVISLY--SS 389
+ KT S+ PL+NAME L+ + + ++D V AI ++ S Y S
Sbjct: 316 PKQCDGGKCLLQLVKTSRSTLPPLINAMEAYTVLDFPQIETNVDEVIAIKNIQSTYGLSK 375
Query: 390 ADWAQEGGDPCLPVPWSW--LQCN----SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLV 443
W GDPC+P + W L CN S P P IT ++LSS LTG I + L++L
Sbjct: 376 TTWQ---GDPCVPKKFLWDGLNCNNSDDSTP-PIITSLNLSSSGLTGIIVLTIQNLANLQ 431
Query: 444 EFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVV-LNYA 502
E + L +N L+G +P L ++ +L + + N LSG VP L+ K ++ LN
Sbjct: 432 E--------LDLSNNNLSGGVPEFLADMKSLLVINLSGNNLSGVVPQKLIEKKMLKLNIE 483
Query: 503 GNINLH-----------EGGRGAKHLNIIIGSSVGAAV-LLLATVVSCLFMHKGKKNNYD 550
GN L+ EGGR K + I I +S+G+ V +A ++ C+ +KNN
Sbjct: 484 GNPKLNCTVESCVNKDEEGGRQIKSMTIPIVASIGSVVAFTVALMIFCVV----RKNNPS 539
Query: 551 KEQHRHSLPVQRPVSSLNDAPAEAAHC--FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK 608
++ S P S + P FT +++ T +K +G GGFG+VYYG +
Sbjct: 540 NDEAPTS--CMLPADSRSSEPTIVTKNKKFTYAEVLTMTNNFQKILGKGGFGIVYYGSVN 597
Query: 609 DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 668
+++AVK+L+ +S QG ++F EV LL R+HH+NLV +GYC+E + L+YE+M NG
Sbjct: 598 GTEQVAVKMLSHSSAQGYKQFKAEVELLLRVHHKNLVGLVGYCEEGDKLALIYEYMANGD 657
Query: 669 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA 728
L EH+ G +NW RL+IA +AA+G+EYLH GC P ++HRD+K++NILL++H
Sbjct: 658 LDEHMSGK-RGGSILNWGTRLKIALEAAQGLEYLHNGCKPLMVHRDVKTTNILLNEHFDT 716
Query: 729 KVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 787
K++DFGLS+ F ++G +HVS++V GT+GYLDPEYY + LT+KSDVYSFGV+LL +I+ Q
Sbjct: 717 KLADFGLSRSFPIEGETHVSTVVAGTIGYLDPEYYRTNWLTEKSDVYSFGVVLLVMITNQ 776
Query: 788 EAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHG 847
I + R+I +W + GDI+ I DP+LL +Y+ S+WK E A+ C+ P
Sbjct: 777 PVIDQNR---EKRHIAEWVGGMLTKGDIKSITDPNLLGDYNSGSVWKAVELAMSCMNPSS 833
Query: 848 HMRPSISEVLKDIQDAIVIE--REAAAARDGNSDDMSR 883
RP++S+V+ ++++ + E RE + M+R
Sbjct: 834 MTRPTMSQVVFELKECLASESSREVSMTFGTEVAPMAR 871
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZB1|Y5188_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51880 OS=Arabidopsis thaliana GN=At1g51880 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 465 bits (1196), Expect = e-130, Method: Compositional matrix adjust.
Identities = 307/906 (33%), Positives = 482/906 (53%), Gaps = 103/906 (11%)
Query: 20 LLLDSSSAQ-MPGFVSLNCG---GNENFTDEI-GLQWIADDHLI-YGEISNISV--ANET 71
++L+S AQ GF+SL+CG N +T++ + + +D + I G + IS +
Sbjct: 16 VILESVQAQDQLGFISLDCGLVPKNATYTEKTTNITYKSDANYIDSGLVGRISAEYKAQL 75
Query: 72 RKQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWST 131
++Q T+R FP R CY ++ ++RYLIRATF YGN+D PKFDI +GP+ W++
Sbjct: 76 QQQTWTVRSFPEGERN-CYNFNLTAKSRYLIRATFTYGNYDGLRQVPKFDIHIGPSKWTS 134
Query: 132 IVISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYL 191
+ + V E+I + + ++ +CL G PFIS+LELR N + YLT L
Sbjct: 135 VKLDGVGNGAVLEMIHVLTQDRLQICLVKTGKGIPFISSLELRPLNNNTYLT---QSGSL 191
Query: 192 SVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDE 251
AR+ F A + +RY +D DR+W + G + +ST L +D +
Sbjct: 192 IGFARVFFSA-TPTFIRYDEDIHDRVW----------VRQFGNGLKSISTDLLVDTSNPY 240
Query: 252 LPPQKVMQTAVVGTNGS--LTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQ 309
PQ V +TA V +N S L + LD + +FAEI+ L ++ R+F + G
Sbjct: 241 DVPQAVAKTACVPSNASQPLIFDWTLDNITSQSYVYMHFAEIQTLKDNDIREFNITYNG- 299
Query: 310 PDVSKAIVNIQENAQGKYRVYEPGYTNLSLPF----------VLSFKFGKTYDSSRGPLL 359
Q Y P +S F S F KT +S+ PL+
Sbjct: 300 -------------GQNVYSYLRPEKFEISTLFDSKPLSSPDGSFSLSFTKTGNSTLPPLI 346
Query: 360 NAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQE---GGDPCLPVPWSW--LQC---N 411
N +EI K L+ + D + ++I++ ++ D +++ GDPC P + W L C N
Sbjct: 347 NGLEIYKVLDLLELETDQDEVSAMINIKATYDLSKKVSWQGDPCAPKSYQWEGLNCSYPN 406
Query: 412 SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNL 471
SD QP I ++L+ LTG I +++KL+ L+E + L N L+G +P ++
Sbjct: 407 SD-QPRIISLNLAENKLTGTITPEISKLTQLIE--------LDLSKNDLSGEIPEFFADM 457
Query: 472 PNLRELYVQNNM-LSGTVPSS----LLSKNVVLNYAGNI--NLHEGGRGAKHLNIIIGSS 524
L+ + + N+ L+ T+P S L SK+++L + + + G+ K I I +S
Sbjct: 458 KLLKLINLSGNLGLNSTIPDSIQQRLDSKSLILILSKTVTKTVTLKGKSKKVPMIPIVAS 517
Query: 525 VGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIE 584
V A V L +++ F+ + K +K + + +R + T ++
Sbjct: 518 V-AGVFALLVILAIFFVVRRKNGESNKGTNPSIITKERRI--------------TYPEVL 562
Query: 585 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL 644
T E+ +G GGFG VY+G L+D ++AVK+L+ +S QG +EF EV LL R+HHRNL
Sbjct: 563 KMTNNFERVLGKGGFGTVYHGNLED-TQVAVKMLSHSSAQGYKEFKAEVELLLRVHHRNL 621
Query: 645 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 704
V +GYC + L+YE+M NG LKE++ G + W R++IA +AA+G+EYLH
Sbjct: 622 VGLVGYCDDGDNLALIYEYMANGDLKENMSGK-RGGNVLTWENRMQIAVEAAQGLEYLHN 680
Query: 705 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 763
GC P ++HRD+K++NILL++ AK++DFGLS+ F VDG SHVS++V GT GYLDPEYY
Sbjct: 681 GCTPPMVHRDVKTTNILLNERYGAKLADFGLSRSFPVDGESHVSTVVAGTPGYLDPEYYR 740
Query: 764 SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 823
+ L++KSDVYSFGV+LLE+++ Q + +I +W + GDI+ I+DP L
Sbjct: 741 TNWLSEKSDVYSFGVVLLEIVTNQPVTDKTR---ERTHINEWVGSMLTKGDIKSILDPKL 797
Query: 824 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSR 883
+ +YD WKI E AL CV P + RP+++ V+ ++ + + +E A R G R
Sbjct: 798 MGDYDTNGAWKIVELALACVNPSSNRRPTMAHVVTELNECVALEN---ARRQG------R 848
Query: 884 NSLHSS 889
+H+S
Sbjct: 849 EEMHTS 854
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZQR3|Y2451_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At2g14510 OS=Arabidopsis thaliana GN=At2g14510 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 463 bits (1191), Expect = e-129, Method: Compositional matrix adjust.
Identities = 327/901 (36%), Positives = 480/901 (53%), Gaps = 99/901 (10%)
Query: 1 MERRRRLLLPFSVASVLILLLLDSSSAQMPGFVSLNCG--GNENFTD-EIGLQWIADDHL 57
ME R + +L + A+ I+ L+ S + Q GF+SL+CG E++ + L +I+D +
Sbjct: 1 METRNKFML-LACATFSIMSLVKSQNQQ--GFISLDCGLPSKESYIEPSSNLTFISDVNF 57
Query: 58 I----YGEISNISVANETRKQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDN 113
I G I N S N K + LR+FP D + CY L V T+YLIR F YGN+D
Sbjct: 58 IRGGKTGNIQNNSRTNFIFKPFKVLRYFP-DGIRNCYSLSVKQGTKYLIRTLFYYGNYDG 116
Query: 114 NNVYPKFDISLGPTHWSTI--VISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTL 171
N P+FD+ LGP W+++ +I+D V E++ + S +D+CL T P IS +
Sbjct: 117 LNTSPRFDLFLGPNIWTSVDVLIADVGDGVVEEIVHVTRSNILDICLVKTGTSTPMISAI 176
Query: 172 ELRQFNGSVYLTPFEDRYYLSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVD 231
ELR Y L A F EA +RYP+D +DR+W S +
Sbjct: 177 ELRPLRYDTYTARTGS---LKSMAHFYFTNSDEA-IRYPEDVYDRVWMPYSQPEWT---- 228
Query: 232 VAAGTEKVSTKLPIDLRSDEL-PPQKVMQTAVVGTNGS--LTYRLNLDGFPGFGWAVTYF 288
+++T + SD PPQ V+QTA + TNGS LT+ NL+ +A +F
Sbjct: 229 ------QINTTRNVSGFSDGYNPPQGVIQTASIPTNGSEPLTFTWNLESSDDETYAYLFF 282
Query: 289 AEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPF------- 341
AEI+ L +E+R+F+++ G + Y ++ LS P
Sbjct: 283 AEIQQLKVNETREFKILANGVDYID-------------YTPWKFEARTLSNPAPLKCEGG 329
Query: 342 VLSFKFGKTYDSSRGPLLNAMEINKYLE--RNDGSIDGV-AIVSVISLY--SSADWAQEG 396
V + KT S+ PL+NA+EI ++ ++D + D V AI + S Y S W
Sbjct: 330 VCRVQLSKTPKSTLPPLMNAIEIFSVIQFPQSDTNTDEVIAIKKIQSTYQLSRISWQ--- 386
Query: 397 GDPCLPVPWSWL--QCN----SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDL 450
GDPC+P +SW+ CN S P P I + LS LTG I + L+ L E
Sbjct: 387 GDPCVPKQFSWMGVSCNVIDISTP-PRIISLDLSLSGLTGVISPSIQNLTMLRE------ 439
Query: 451 RIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL--SKNVVLNYAGNINLH 508
+ L +N LTG +P L + L ++++ N L G+VP +L KN L + N+
Sbjct: 440 --LDLSNNNLTGEVPEFLATIKPLLVIHLRGNNLRGSVPQALQDREKNDGLKLFVDPNIT 497
Query: 509 EGGRGAKH--LNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSS 566
G+ L I+ S AV ++ V+ +F+ + +K++ K V RP
Sbjct: 498 RRGKHQPKSWLVAIVASISCVAVTIIVLVL--IFIFRRRKSSTRK--------VIRPSLE 547
Query: 567 LNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK 626
+ + F S++++ T E +G GGFGVVY+G L + +++AVKVL+ +S QG
Sbjct: 548 MKN------RRFKYSEVKEMTNNFEVVLGKGGFGVVYHGFLNN-EQVAVKVLSQSSTQGY 600
Query: 627 REFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI 686
+EF EV LL R+HH NLV +GYC E L+YEFM NG LKEHL G +NW
Sbjct: 601 KEFKTEVELLLRVHHVNLVSLVGYCDEGIDLALIYEFMENGNLKEHLSGK-RGGSVLNWS 659
Query: 687 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASH 745
RL+IA ++A GIEYLH GC P ++HRD+KS+NILL AK++DFGLS+ F V +H
Sbjct: 660 SRLKIAIESALGIEYLHIGCQPPMVHRDVKSTNILLGLRFEAKLADFGLSRSFLVGSQAH 719
Query: 746 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW 805
VS+ V GT+GYLDPEYY+ LT+KSDVYSFG++LLE I+GQ I + + IV+W
Sbjct: 720 VSTNVAGTLGYLDPEYYLKNWLTEKSDVYSFGIVLLESITGQPVIEQSR---DKSYIVEW 776
Query: 806 AKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865
AK + +GDI+ I+DP+L +YD S WK E A++C+ P RP+++ V ++ + +
Sbjct: 777 AKSMLANGDIESIMDPNLHQDYDSSSSWKALELAMLCINPSSTQRPNMTRVAHELNECLE 836
Query: 866 I 866
I
Sbjct: 837 I 837
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG4|Y1518_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51860 OS=Arabidopsis thaliana GN=At1g51860 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 461 bits (1186), Expect = e-128, Method: Compositional matrix adjust.
Identities = 311/924 (33%), Positives = 486/924 (52%), Gaps = 97/924 (10%)
Query: 16 VLILLLLDSSSAQ-MPGFVSLNCG---GNENFTDE-IGLQWIAD-DHLIYGEISNISVAN 69
++ +L S AQ GF+SL+CG +T++ + + +D D++ G + I+ A
Sbjct: 12 IIAFTVLRSVEAQNQAGFISLDCGLVPKETTYTEKSTNITYKSDVDYIDSGLVGKINDAY 71
Query: 70 ETR--KQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPT 127
+T+ +Q +R FP R CY +++ +YLIR TF+YGN+D N +P FD+ +GP
Sbjct: 72 KTQFQQQVWAVRSFPVGQRN-CYNVNLTANNKYLIRGTFVYGNYDGLNQFPSFDLHIGPN 130
Query: 128 HWSTIVISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFED 187
WS++ I + E+I + ++VCL PFIS+LE+R N YLT
Sbjct: 131 KWSSVKILGVTNTSMHEIIHVVPQDSLEVCLVKTGPTTPFISSLEVRPLNNESYLT---Q 187
Query: 188 RYYLSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDL 247
L + AR+ F + S + +RY +D DR+W S + + T +ST LPID
Sbjct: 188 SGSLMLFARVYFPSSSSSFIRYDEDIHDRVWNSFTDDE----------TVWISTDLPIDT 237
Query: 248 RSDELPPQKVMQTAVVGTNGSLTYRL--NLDGFPGFGWAVTYFAEIEDLDPDESRKFRLV 305
+ PQ VM+TA V N S + L LD + +FAE+++L +E+R+F
Sbjct: 238 SNSYDMPQSVMKTAAVPKNASEPWLLWWTLDENTAQSYVYMHFAEVQNLTANETREF--- 294
Query: 306 LPGQPDVSKAIVNIQENAQGKYRVY-EPGYTNLSLPF----------VLSFKFGKTYDSS 354
NI N ++ Y P ++S F + +F F T +S+
Sbjct: 295 ------------NITYNGGLRWFSYLRPPNLSISTIFNPRAVSSSNGIFNFTFAMTGNST 342
Query: 355 RGPLLNAMEINKY-----LERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSW-- 407
PLLNA+EI LE N + A++++ Y + GDPC P + W
Sbjct: 343 LPPLLNALEIYTVVDILQLETNKDEVS--AMMNIKETYGLSKKISWQGDPCAPQLYRWEG 400
Query: 408 LQCN-SDPQPS-ITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLP 465
L C+ D + S I ++L+ LTG+I SD++KL+ L ++ L +N L+G +P
Sbjct: 401 LNCSYPDSEGSRIISLNLNGSELTGSITSDISKLTLLT--------VLDLSNNDLSGDIP 452
Query: 466 SSLMNLPNLRELYVQN--NMLSGTVPSSLL----SKNVVLNYAGNINLHEGGRGAKHLNI 519
+ + +L+ + + N+ +P SL SK++ L N+ L K +
Sbjct: 453 TFFAEMKSLKLINLSGNPNLNLTAIPDSLQQRVNSKSLTLILGENLTLTPKKESKKVPMV 512
Query: 520 IIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLP--------VQRPVSSLNDAP 571
I +SV A V L +++ F+ K K + + H+ P V+ S N +
Sbjct: 513 AIAASV-AGVFALLVILAIFFVIKRK----NVKAHKSPGPPPLVTPGIVKSETRSSNPSI 567
Query: 572 AEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTN 631
T ++ T E+ +G GGFG VY+G L DG E+AVK+L+ +S QG +EF
Sbjct: 568 ITRERKITYPEVLKMTNNFERVLGKGGFGTVYHGNL-DGAEVAVKMLSHSSAQGYKEFKA 626
Query: 632 EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI 691
EV LL R+HHR+LV +GYC + L+YE+M NG L+E++ G + W R++I
Sbjct: 627 EVELLLRVHHRHLVGLVGYCDDGDNLALIYEYMANGDLRENMSGK-RGGNVLTWENRMQI 685
Query: 692 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIV 750
A +AA+G+EYLH GC P ++HRD+K++NILL++ AK++DFGLS+ F +DG HVS++V
Sbjct: 686 AVEAAQGLEYLHNGCRPPMVHRDVKTTNILLNERCGAKLADFGLSRSFPIDGECHVSTVV 745
Query: 751 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 810
GT GYLDPEYY + L++KSDVYSFGV+LLE+++ Q I + +I W +
Sbjct: 746 AGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVIDKTR---ERPHINDWVGFML 802
Query: 811 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREA 870
GDI+ I+DP L+ +YD WKI E AL CV P + RP+++ V+ ++ D + +E
Sbjct: 803 TKGDIKSIVDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHVVMELNDCVALEN-- 860
Query: 871 AAARDGNSDDMSRNSLHSSLNVGS 894
A R G+ + S S+ SL+ S
Sbjct: 861 -ARRQGSEEMYSMGSVDYSLSSTS 883
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64556|Y2923_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g19230 OS=Arabidopsis thaliana GN=At2g19230 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 459 bits (1181), Expect = e-128, Method: Compositional matrix adjust.
Identities = 314/914 (34%), Positives = 495/914 (54%), Gaps = 103/914 (11%)
Query: 8 LLPF-SVASVLILLLLDSSSAQMPGFVSLNCGGNEN---FTDEIGLQWIADDHLI-YGEI 62
LP S AS +++L+L + Q GFVS++CG E+ + ++ +++I+D + G I
Sbjct: 6 FLPLVSFASFVVVLVLVCAQDQ-SGFVSIDCGIPEDSSYYDEKTDIKYISDAAFVESGTI 64
Query: 63 SNISVANETR---KQYMTLRHFPADSRKYCYKLDVITRT--RYLIRATFLYGNFDNNNVY 117
+I + + KQ+ +R FP + +K CY + +YLIR F+YGN+DN
Sbjct: 65 HSIDSKFQKKNLEKQFQKVRSFP-EGKKNCYDVQPPQGKGFKYLIRTRFMYGNYDNLGKA 123
Query: 118 PKFDISLGPTHWSTIVISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFN 177
P FD+ LG W ++ + ++ TI +E+I+ S K+ VCL + G PF+S LELR
Sbjct: 124 PDFDLYLGVNLWDSVTLENSTTIVTKEIIYTLRSDKVHVCLVDKERGTPFLSVLELRLLK 183
Query: 178 GSVYLTPFEDRYYLSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTE 237
++Y T + L + R + GA + P RY DD FDR W L N+L+
Sbjct: 184 NNIYETASDS---LMLYRRWDLGATGDLPARYKDDIFDRFWMP--LMFPNFLI------- 231
Query: 238 KVSTKLPIDLRSDE--LPPQKVMQTAVVGTNGS----LTYRLNLDGFPGFGWAV-TYFAE 290
++T L ID S LPP VM TAV N S + Y D P + + + +FAE
Sbjct: 232 -LNTSLMIDPTSSNGFLPPSVVMSTAVAPMNSSIEQIMVYWEPRD--PNWKFYIYIHFAE 288
Query: 291 IEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTN--LSLPFVLSFKFG 348
+E L +E+R+F + L +K ++ + Y + Y +S PF L F
Sbjct: 289 VEKLPSNETREFSVFL------NKEQIDTTSVFRPSYLYTDTLYVQNPVSGPF-LEFVLR 341
Query: 349 KTYDSSRGPLLNAMEI---NKYLERNDGSIDGVAIVSVISLYSSA-DWAQEGGDPCLPV- 403
+ S+R P++NA+E N++L+ D AI+ + + Y +W GDPC P
Sbjct: 342 QGVKSTRPPIMNAIETYRTNEFLDLPTDQNDVDAIMKIKTKYKVKKNWL---GDPCAPFG 398
Query: 404 -PWSWLQCN--SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQL 460
PW + C+ ++ P I ++LS LTG I L+ L + + L +N+L
Sbjct: 399 YPWQGINCSYTANNPPRIISVNLSFSGLTGQIDPVFITLTPLQK--------LDLSNNRL 450
Query: 461 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN----VVLNYAGNINL--HEGGRGA 514
TG +P L NLP+L EL ++ N L+G +P LL ++ + L GN +L + R
Sbjct: 451 TGTVPDFLANLPDLTELNLEENKLTGILPEKLLERSKDGSLSLRVGGNPDLCVSDSCRNK 510
Query: 515 K-----HLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLND 569
K ++ + S G LLLA + F + + S+
Sbjct: 511 KTERKEYIIPSVASVTGLFFLLLALISFWQFKKRQQ--------------------SVKT 550
Query: 570 APAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREF 629
P + + S+I + T E+ +G GGFG VYYG L+ G+++A+K+L+ +S QG +EF
Sbjct: 551 GPLDTKRYYKYSEIVEITNNFERVLGQGGFGKVYYGVLR-GEQVAIKMLSKSSAQGYKEF 609
Query: 630 TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL 689
EV LL R+HH+NL+ +GYC E + L+YE++ NGTL ++L G + ++W +RL
Sbjct: 610 RAEVELLLRVHHKNLIALIGYCHEGDQMALIYEYIGNGTLGDYLSGK--NSSILSWEERL 667
Query: 690 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSS 748
+I+ DAA+G+EYLH GC P I+HRD+K +NIL+++ ++AK++DFGLS+ F ++G S VS+
Sbjct: 668 QISLDAAQGLEYLHNGCKPPIVHRDVKPTNILINEKLQAKIADFGLSRSFTLEGDSQVST 727
Query: 749 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL 808
V GT+GYLDPE+Y QQ ++KSDVYSFGV+LLE+I+GQ IS + N R+I L
Sbjct: 728 EVAGTIGYLDPEHYSMQQFSEKSDVYSFGVVLLEVITGQPVISRSRTEEN-RHISDRVSL 786
Query: 809 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIER 868
+ GDI+ I+DP L + ++ WKI E AL C R ++S+V+ ++++++ R
Sbjct: 787 MLSKGDIKSIVDPKLGERFNAGLAWKITEVALACASESTKTRLTMSQVVAELKESLCRAR 846
Query: 869 EAAAARDGNSDDMS 882
+ G+S D+S
Sbjct: 847 TS-----GDSGDIS 855
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65924|Y2921_ARATH Putative leucine-rich repeat receptor-like protein kinase At2g19210 OS=Arabidopsis thaliana GN=At2g19210 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 457 bits (1175), Expect = e-127, Method: Compositional matrix adjust.
Identities = 309/927 (33%), Positives = 494/927 (53%), Gaps = 103/927 (11%)
Query: 8 LLPFSVASVLILLLLDSSSAQMPGFVSLNCGGNEN--FTDEI-GLQWIADDHLI-YGEIS 63
L+ F+ + +LL+ + GFVS++CG E+ + DE +++++D + G I
Sbjct: 9 LIIFACFFAVFVLLV--RAQDQSGFVSIDCGIPEDSSYNDETTDIKYVSDAAFVESGTIH 66
Query: 64 NISVANET---RKQYMTLRHFPADSRKYCYKLDVITRT--RYLIRATFLYGNFDNNNVYP 118
+I +T KQ+ +R FP +R CY + +YLIR F+YGN+DN P
Sbjct: 67 SIDPEFQTSSLEKQFQNVRSFPEGNRN-CYDVKPPQGKGFKYLIRTRFMYGNYDNLGKAP 125
Query: 119 KFDISLGPTHWSTIVISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNG 178
FD+ LG W ++ I +A TI +E+I S + VCL + G PF+S LE+R
Sbjct: 126 DFDLYLGFNIWDSVTIDNATTIVTKEIIHTLRSDHVHVCLVDKNRGTPFLSALEIRLLKS 185
Query: 179 SVYLTPFEDRYYLSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEK 238
+ Y TP++ L + R + G PVRY DD FDRIW L+ Y +
Sbjct: 186 NTYETPYDS---LILFKRWDLGGLGALPVRYKDDVFDRIWIP--LRFPKYTI-------- 232
Query: 239 VSTKLPIDLRSDE--LPPQKVMQTAVVGTNGSLTYRLNLD-GFPGFGWAV-TYFAEIEDL 294
+ L ID ++E P + VM TA + S + + P + + V +FAE+ +L
Sbjct: 233 FNASLTIDSNNNEGFQPARFVMNTATSPEDLSQDIIFSWEPKDPTWKYFVYMHFAEVVEL 292
Query: 295 DPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPFV--------LSFK 346
+E+R+F+++L ++ +N+ + P Y FV L F+
Sbjct: 293 PSNETREFKVLL------NEKEINMSS--------FSPRYLYTDTLFVQNPVSGPKLEFR 338
Query: 347 FGKTYDSSRGPLLNAME---INKYLERNDGSIDGVAIVSVISLYS-SADWAQEGGDPCLP 402
+T S+ P++NA+E +N++L+ D AI+ + S Y W GDPC P
Sbjct: 339 LQQTPRSTLPPIINAIETYRVNEFLQSPTDQQDVDAIMRIKSKYGVKKSWL---GDPCAP 395
Query: 403 V--PWSWLQCN--SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDN 458
V PW + C+ + P I ++LSS LTG I + + L+ L I+ L +N
Sbjct: 396 VKYPWKDINCSYVDNESPRIISVNLSSSGLTGEIDAAFSNLTLL--------HILDLSNN 447
Query: 459 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN----VVLNYAGNINLHEGG--- 511
LTG +P L NL NL EL ++ N LSG +P LL ++ ++L GN +L
Sbjct: 448 SLTGKIPDFLGNLHNLTELNLEGNKLSGAIPVKLLERSNKKLILLRIDGNPDLCVSASCQ 507
Query: 512 ----RGAKHLNII--IGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVS 565
+ K++ II + S VG L+LA + L+ K++HR
Sbjct: 508 ISDEKTKKNVYIIPLVASVVGVLGLVLAIALFLLY----------KKRHRRG-----GSG 552
Query: 566 SLNDAPAEAA-HCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ 624
+ P + + S++ T E+ +G GGFG VY+G L D ++AVK+L+ +S Q
Sbjct: 553 GVRAGPLDTTKRYYKYSEVVKVTNNFERVLGQGGFGKVYHGVLND-DQVAVKILSESSAQ 611
Query: 625 GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRIN 684
G +EF EV LL R+HH+NL +GYC E + L+YEFM NGTL ++L G ++ ++
Sbjct: 612 GYKEFRAEVELLLRVHHKNLTALIGYCHEGKKMALIYEFMANGTLGDYLSGEKSYV--LS 669
Query: 685 WIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGA 743
W +RL+I+ DAA+G+EYLH GC P I+ RD+K +NIL+++ ++AK++DFGLS+ A+DG
Sbjct: 670 WEERLQISLDAAQGLEYLHNGCKPPIVQRDVKPANILINEKLQAKIADFGLSRSVALDGN 729
Query: 744 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 803
+ ++ V GT+GYLDPEY+++Q+L++KSD+YSFGV+LLE++SGQ I+ + A +I
Sbjct: 730 NQDTTAVAGTIGYLDPEYHLTQKLSEKSDIYSFGVVLLEVVSGQPVIARSRTTAENIHIT 789
Query: 804 QWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 863
L + +GDI+GI+DP L + +D S WKI E A+ C RP++S V+ +++++
Sbjct: 790 DRVDLMLSTGDIRGIVDPKLGERFDAGSAWKITEVAMACASSSSKNRPTMSHVVAELKES 849
Query: 864 IVIEREAAAARDGNSDDMSRNSLHSSL 890
+ R + + D + + S +
Sbjct: 850 VSRARAGGGSGASSVTDPAMTNFDSGM 876
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZQQ7|Y2144_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g14440 OS=Arabidopsis thaliana GN=At2g14440 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 456 bits (1174), Expect = e-127, Method: Compositional matrix adjust.
Identities = 330/937 (35%), Positives = 491/937 (52%), Gaps = 111/937 (11%)
Query: 1 MERRRRLLLPFSVASVLILLLLDSSSAQMPGFVSLNCGGNENFTDEI----GLQWIADDH 56
ME R +L+L + A+ I+ L+ S + Q GF+SL CG N + I L +I+D +
Sbjct: 1 METRSKLML-LACATFSIISLVKSQNQQ--GFISLYCGLPSNESPYIEPLTNLTYISDVN 57
Query: 57 LI----YGEISNISVANETRKQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFD 112
+ G I N S + T + Y LR+FP R CY L V T+YLIR F YGN+D
Sbjct: 58 FVRGGKTGNIKNNSDIDFTSRPYKVLRYFPEGIRN-CYSLSVKQGTKYLIRTLFFYGNYD 116
Query: 113 NNNVYPKFDISLGPTHWSTIVIS--DAATIEVRELIFLASSPKIDVCLSNATTGQPFIST 170
N P+FD+ LGP W+++ + D + E+I + +D+CL T P IS
Sbjct: 117 GLNTSPRFDLFLGPNIWTSVDVQKVDGGDGVIEEIIHVTRCNILDICLVKTGTTTPMISA 176
Query: 171 LELRQFNGSVYLTPFEDRYYLSVSARINF-GADSEAPVRYPDDPFDRIWESDSLKKANYL 229
+ELR Y S+ ++F +S VRYP+D +DR+W S +
Sbjct: 177 IELRPLRYDTYTARTG-----SLKKILHFYFTNSGKEVRYPEDVYDRVWIPHSQPEWT-- 229
Query: 230 VDVAAGTEKVSTKLPIDLRSDEL-PPQKVMQTAVVGTNGS--LTYRLNLDGFPGFGWAVT 286
+++T + SD PPQ V++TA + TN S LT+ + +A
Sbjct: 230 --------QINTTRNVSGFSDGYNPPQDVIKTASIPTNVSEPLTFTWMSESSDDETYAYL 281
Query: 287 YFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPF---VL 343
YFAEI+ L +E+R+F++++ G V + K+ E T +L V
Sbjct: 282 YFAEIQQLKANETRQFKILVNG--------VYYIDYIPRKFEA-ETLITPAALKCGGGVC 332
Query: 344 SFKFGKTYDSSRGPLLNAMEINKYLE--RNDGSIDGV-AIVSVISLY--SSADWAQEGGD 398
+ KT S+ P +NA+EI ++ ++D + D V AI ++ S Y S W GD
Sbjct: 333 RVQLSKTPKSTLPPQMNAIEIFSVIQFPQSDTNTDEVIAIKNIQSTYKVSRISWQ---GD 389
Query: 399 PCLPVPWSWL--QCN----SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRI 452
PC+P+ +SW+ CN S P P I + LSS LTG I + L+ L E
Sbjct: 390 PCVPIQFSWMGVSCNVIDISTP-PRIISLDLSSSGLTGVITPSIQNLTMLRE-------- 440
Query: 453 IHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN--VVLNYAGN------ 504
+ L +N LTG +P SL NL LREL + NN L+G VP L + +V++ GN
Sbjct: 441 LDLSNNNLTGVIPPSLQNLTMLRELDLSNNNLTGEVPEFLATIKPLLVIHLRGNNLRGSV 500
Query: 505 ------------INLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKE 552
+ L G K + I +S+ + + +V +F+ + +K++ K
Sbjct: 501 PQALQDRENNDGLKLLRGKHQPKSWLVAIVASISCVAVTIIVLV-LIFIFRRRKSSTRK- 558
Query: 553 QHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE 612
V RP + + F S++++ T E +G GGFGVVY+G L + ++
Sbjct: 559 -------VIRPSLEMKN------RRFKYSEVKEMTNNFEVVLGKGGFGVVYHGFL-NNEQ 604
Query: 613 IAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEH 672
+AVKVL+ +S QG +EF EV LL R+HH NLV +GYC + L+YEFM NG LKEH
Sbjct: 605 VAVKVLSQSSTQGYKEFKTEVELLLRVHHVNLVSLVGYCDKGNDLALIYEFMENGNLKEH 664
Query: 673 LYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 732
L G +NW RL+IA ++A GIEYLH GC P ++HRD+KS+NILL AK++D
Sbjct: 665 LSGK-RGGPVLNWPGRLKIAIESALGIEYLHIGCKPPMVHRDVKSTNILLGLRFEAKLAD 723
Query: 733 FGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS 791
FGLS+ F V +HVS+ V GT+GYLDPEYY LT+KSDVYSFG++LLE+I+GQ I
Sbjct: 724 FGLSRSFLVGSQTHVSTNVAGTLGYLDPEYYQKNWLTEKSDVYSFGIVLLEIITGQPVIE 783
Query: 792 NEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP 851
+ + IV+WAK + +GDI+ I+D +L +YD S WK E A++C+ P +RP
Sbjct: 784 QSR---DKSYIVEWAKSMLANGDIESIMDRNLHQDYDTSSSWKALELAMLCINPSSTLRP 840
Query: 852 SISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHS 888
+++ V ++ + + I R + S++S H+
Sbjct: 841 NMTRVAHELNECLEIYN--LTKRRSQDQNSSKSSGHT 875
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LIG2|RLK6_ARATH Receptor-like protein kinase At3g21340 OS=Arabidopsis thaliana GN=At3g21340 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 454 bits (1169), Expect = e-126, Method: Compositional matrix adjust.
Identities = 315/913 (34%), Positives = 470/913 (51%), Gaps = 107/913 (11%)
Query: 31 GFVSLNCGGNEN---FTD-EIGLQWIADDHLIY-GEISNISVANET--RKQYMTLRHFPA 83
GF+SL+CG N + D GL + DD + G+ I A E+ K + LR+FP
Sbjct: 32 GFISLDCGSLPNEPPYNDPSTGLTYSTDDGFVQSGKTGRIQKAFESIFSKPSLKLRYFP- 90
Query: 84 DSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVR 143
D + CY L+V T YLI+A F+YGN+D N P FD+ LGP W T+ ++ ++
Sbjct: 91 DGFRNCYTLNVTQDTNYLIKAVFVYGNYDGLNNPPSFDLYLGPNLWVTVDMNGRTNGTIQ 150
Query: 144 ELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLT-----PFEDRYYLSVSARIN 198
E+I S + VCL T P I+TLELR + Y T + RYY S S +
Sbjct: 151 EIIHKTISKSLQVCLVKTGTSSPMINTLELRPLKNNTYNTQSGSLKYFFRYYFSGSGQ-- 208
Query: 199 FGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVM 258
+RYPDD DR W D TE ++T L I+ + PP+ VM
Sbjct: 209 -------NIRYPDDVNDRKWYP--------FFDAKEWTE-LTTNLNINSSNGYAPPEVVM 252
Query: 259 QTAV--VGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAI 316
+A + T G+ + L + +FAEI+ L ++R+F++ L
Sbjct: 253 ASASTPISTFGTWNFSWLLPSSTTQFYVYMHFAEIQTLRSLDTREFKVTL---------- 302
Query: 317 VNIQENAQGKYRVYEPGYTNLSLPFVLS----------FKFGKTYDSSRGPLLNAMEINK 366
N + Y Y P F + + KT S+ PL+NA+E+
Sbjct: 303 -----NGKLAYERYSPKTLATETIFYSTPQQCEDGTCLLELTKTPKSTLPPLMNALEVFT 357
Query: 367 YL---ERNDGSIDGVAIVSVISLY--SSADWAQEGGDPCLPVPWSW--LQCN----SDPQ 415
+ + D AI S+ S Y S W GDPC+P + W L CN S P
Sbjct: 358 VIDFPQMETNPDDVAAIKSIQSTYGLSKISWQ---GDPCVPKQFLWEGLNCNNLDNSTP- 413
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
P +T ++LSS +LTG I + L+ L E + L +N LTG +P L ++ +L
Sbjct: 414 PIVTSLNLSSSHLTGIIAQGIQNLTHLQE--------LDLSNNNLTGGIPEFLADIKSLL 465
Query: 476 ELYVQNNMLSGTVPSSLLSKN-VVLNYAGNINL---------HEGGRGAKHLNIIIG--S 523
+ + N +G++P LL K + L GN NL G GAK +N++I +
Sbjct: 466 VINLSGNNFNGSIPQILLQKKGLKLILEGNANLICPDGLCVNKAGNGGAKKMNVVIPIVA 525
Query: 524 SVGAAVLL---LATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTL 580
SV V+L LA + + V R + S A FT
Sbjct: 526 SVAFVVVLGSALAFFFIFKKKKTSNSQDLGPSSYTQVSEV-RTIRSSESAIMTKNRRFTY 584
Query: 581 SDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 640
S++ T E+ +G GGFG+VY+G + + +++AVK+L+ +S QG +EF EV LL R+H
Sbjct: 585 SEVVTMTNNFERVLGKGGFGMVYHGTVNNTEQVAVKMLSHSSSQGYKEFKAEVELLLRVH 644
Query: 641 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 700
H+NLV +GYC E L+YE+M NG L+EH+ G +NW RL+I ++A+G+E
Sbjct: 645 HKNLVGLVGYCDEGENLALIYEYMANGDLREHMSGK-RGGSILNWETRLKIVVESAQGLE 703
Query: 701 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDP 759
YLH GC P ++HRD+K++NILL++H+ AK++DFGLS+ F ++G +HVS++V GT GYLDP
Sbjct: 704 YLHNGCKPPMVHRDVKTTNILLNEHLHAKLADFGLSRSFPIEGETHVSTVVAGTPGYLDP 763
Query: 760 EYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 819
EYY + L +KSDVYSFG++LLE+I+ Q I+ + +I +W L + GDIQ I+
Sbjct: 764 EYYRTNWLNEKSDVYSFGIVLLEIITNQLVINQSR---EKPHIAEWVGLMLTKGDIQNIM 820
Query: 820 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAAAARDGNSD 879
DP L +YD S+W+ E A+ C+ P RP++S+V+ ++ + + E AR G S
Sbjct: 821 DPKLYGDYDSGSVWRAVELAMSCLNPSSARRPTMSQVVIELNECLSYEN----ARGGTSQ 876
Query: 880 DM-SRNSLHSSLN 891
+M S +S+ S+N
Sbjct: 877 NMNSESSIEVSMN 889
|
Probable receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81069|Y2899_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g28990 OS=Arabidopsis thaliana GN=At2g28990 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 451 bits (1161), Expect = e-125, Method: Compositional matrix adjust.
Identities = 314/905 (34%), Positives = 484/905 (53%), Gaps = 96/905 (10%)
Query: 31 GFVSLNCG--GNENFTDEI--GLQWIADDHLIY-GEISNIS--VANETRKQYMTLRHFPA 83
GF+SL+CG +E+ D+ GL + +D I G+I ++ + KQY+TLR+FP
Sbjct: 24 GFISLDCGLPSDESPYDDSFNGLTFTSDSTFIQTGKIDSVDKDLNINLSKQYLTLRYFP- 82
Query: 84 DSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVR 143
+ ++ CY LDV T YLI +F+YGN+D N P FDI LGP W I +
Sbjct: 83 EGKRNCYSLDVKRGTTYLIVVSFVYGNYDGLNRDPNFDIHLGPNKWKRIDLDGEKEGTRE 142
Query: 144 ELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGADS 203
E+I A S +D+CL P IS +E+R + Y+T L +S R+ + ++S
Sbjct: 143 EIIHKARSNSLDICLVKTGETLPIISAIEIRPLRNNTYVT---QSGSLMMSFRV-YLSNS 198
Query: 204 EAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVV 263
+A +RY DD DRIW + + ++T L I+ + P+ ++QTA +
Sbjct: 199 DASIRYADDVHDRIWSPFN----------GSSHTHITTDLNINNSNAYEIPKNILQTAAI 248
Query: 264 GTNGSLTYRLNLDGFPGFGWAVTY--FAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQE 321
N S + D P Y FAEI+ L+ +E+R+F ++L G N
Sbjct: 249 PRNASAPLIITWDPLPINAEVYLYMHFAEIQTLEANETRQFDVILRGN-------FNHSG 301
Query: 322 NAQGKYRVY-----EP---GYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKY-----L 368
+ K +V+ EP G L V KT +S+ PL+NA+E L
Sbjct: 302 FSPTKLKVFTLYTEEPMKCGSEGCYLQLV------KTPNSTLPPLINAIEAYSVIEFSQL 355
Query: 369 ERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSW--LQC---NSDPQPSITVIHL 423
E + +D + + + W GDPCLP SW ++C + P+I + L
Sbjct: 356 ETSLSDVDAIKNIKNTYKLNKITWQ---GDPCLPQDLSWESIRCTYVDGSTSPTIISLDL 412
Query: 424 SSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 483
S L G+IP L + L E + L +N LTGP+P L N+ L + + N
Sbjct: 413 SKSGLNGSIPQILQNFTQLQE--------LDLSNNSLTGPVPIFLANMKTLSLINLSGNN 464
Query: 484 LSGTVPSSLLSKN---VVLNYAGNINLHEGG-----RGAKHLNIIIGSSVGAAVLLLATV 535
LSG+VP +LL K +VL GN +L + + K L +I S+ ++++
Sbjct: 465 LSGSVPQALLDKEKEGLVLKLEGNPDLCKSSFCNTEKKNKFLLPVIASAASLVIVVVVVA 524
Query: 536 VSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHC-----FTLSDIEDATKML 590
+ F+ + KK + S+PV P +++ +E++ FT S++++ T
Sbjct: 525 LF--FVFRKKKASPSNLHAPPSMPVSNPG---HNSQSESSFTSKKIRFTYSEVQEMTNNF 579
Query: 591 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 650
+K +G GGFGVVY+G + +++AVK+L+ +S QG + F EV LL R+HH NLV +GY
Sbjct: 580 DKALGEGGFGVVYHGFVNVIEQVAVKLLSQSSSQGYKHFKAEVELLMRVHHINLVSLVGY 639
Query: 651 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHTGCVPA 709
C E L+YE+M NG LK+HL G H + +W RL+I DAA G+EYLHTGCVP
Sbjct: 640 CDEGEHLALIYEYMPNGDLKQHLSG--KHGGFVLSWESRLKIVLDAALGLEYLHTGCVPP 697
Query: 710 IIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLT 768
++HRD+K++NILLD+H++AK++DFGLS+ F + +VS++V GT GYLDPEYY + LT
Sbjct: 698 MVHRDIKTTNILLDQHLQAKLADFGLSRSFPIGNEKNVSTVVAGTPGYLDPEYYQTNWLT 757
Query: 769 DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 828
+KSD+YSFG++LLE+IS + I + +IV+W I GD++ I+DP+L +YD
Sbjct: 758 EKSDIYSFGIVLLEIISNRPIIQQSREKP---HIVEWVSFMITKGDLRSIMDPNLHQDYD 814
Query: 829 IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAAAARDGNSDDM-SRNSLH 887
I S+WK E A+ CV RP++S V+ ++++ ++ E +R G DM S+ S+
Sbjct: 815 IGSVWKAIELAMSCVSLSSARRPNMSRVVNELKECLISE----TSRIGEGRDMESKGSME 870
Query: 888 SSLNV 892
S ++
Sbjct: 871 FSRDI 875
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 914 | ||||||
| 255568426 | 900 | Nodulation receptor kinase precursor, pu | 0.961 | 0.976 | 0.824 | 0.0 | |
| 356570730 | 936 | PREDICTED: probable LRR receptor-like se | 0.967 | 0.944 | 0.789 | 0.0 | |
| 224068652 | 924 | predicted protein [Populus trichocarpa] | 0.972 | 0.962 | 0.796 | 0.0 | |
| 356503698 | 937 | PREDICTED: probable LRR receptor-like se | 0.986 | 0.962 | 0.771 | 0.0 | |
| 224138590 | 921 | predicted protein [Populus trichocarpa] | 0.971 | 0.964 | 0.794 | 0.0 | |
| 449440057 | 897 | PREDICTED: probable LRR receptor-like se | 0.963 | 0.982 | 0.789 | 0.0 | |
| 297741494 | 924 | unnamed protein product [Vitis vinifera] | 0.990 | 0.979 | 0.776 | 0.0 | |
| 225439769 | 927 | PREDICTED: probable LRR receptor-like se | 0.975 | 0.962 | 0.779 | 0.0 | |
| 357510569 | 932 | Leucine-rich repeat receptor-like protei | 0.969 | 0.950 | 0.767 | 0.0 | |
| 356545961 | 902 | PREDICTED: probable LRR receptor-like se | 0.955 | 0.967 | 0.788 | 0.0 |
| >gi|255568426|ref|XP_002525187.1| Nodulation receptor kinase precursor, putative [Ricinus communis] gi|223535484|gb|EEF37153.1| Nodulation receptor kinase precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1528 bits (3955), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 736/893 (82%), Positives = 805/893 (90%), Gaps = 14/893 (1%)
Query: 25 SSAQMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFPAD 84
SSAQMPGFVSLNCGG ENFTDE+GL W +DD LIYGE + ISVANETRKQY TLRHFPAD
Sbjct: 19 SSAQMPGFVSLNCGGKENFTDELGLVWTSDDSLIYGEPATISVANETRKQYKTLRHFPAD 78
Query: 85 SRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVRE 144
SRKYCY LDVI+RTRYL+RATFLYGNFDNNNVYPKFDIS+G THWSTIVISDA TIE E
Sbjct: 79 SRKYCYTLDVISRTRYLLRATFLYGNFDNNNVYPKFDISVGATHWSTIVISDANTIESIE 138
Query: 145 LIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGADSE 204
LIFLASSP I VCLSNATTGQPFISTLELRQFNGSVY T FE+++YLS+SARINFGADSE
Sbjct: 139 LIFLASSPTISVCLSNATTGQPFISTLELRQFNGSVYYTSFENQFYLSISARINFGADSE 198
Query: 205 APVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVG 264
APVRYPDDPFDRIWESDS+KKANYLVDVAAGTEK+ST + ID+ +DE PP+KVMQTAVVG
Sbjct: 199 APVRYPDDPFDRIWESDSVKKANYLVDVAAGTEKISTNMSIDVSNDERPPEKVMQTAVVG 258
Query: 265 TNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQ 324
TNGSLTYRLNLDGFPGFGWAVTYFAEIEDL PDESRKFRL+LPG PD+SK IVNIQENAQ
Sbjct: 259 TNGSLTYRLNLDGFPGFGWAVTYFAEIEDLAPDESRKFRLILPGFPDMSKPIVNIQENAQ 318
Query: 325 GKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVI 384
GKYR+Y+PGY N+SLPFVLSF+FGKT DSSRGPLLNAMEINKYLE+NDGS+DG I SVI
Sbjct: 319 GKYRLYQPGYPNISLPFVLSFRFGKTSDSSRGPLLNAMEINKYLEKNDGSLDGEVIASVI 378
Query: 385 SLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVE 444
SLY+S DWAQEGGDPCLPVPWSWLQCNSD +P I I LSSKNLTGNIPSDL KL L E
Sbjct: 379 SLYTSTDWAQEGGDPCLPVPWSWLQCNSDARPRIIKISLSSKNLTGNIPSDLPKLKGLAE 438
Query: 445 FGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 504
F HLE+NQLTG LPSSLMNLP+LRELYVQNN+LSGTVPS LL KN+ LNY+GN
Sbjct: 439 F--------HLENNQLTGGLPSSLMNLPHLRELYVQNNLLSGTVPSGLLDKNLFLNYSGN 490
Query: 505 INLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPV 564
+++HEGGR KH IIIGSSVGAAVLL+AT+ SC F+ +GKK+N+D E HR PVQR V
Sbjct: 491 LHVHEGGRREKHTGIIIGSSVGAAVLLIATIASCFFIRRGKKSNHDYEHHRVPPPVQRLV 550
Query: 565 SSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ 624
S+LND PAE A+CFT S+IEDAT+ LEKKIGSGGFG+VYYGKLK+GKEIAVKVLT+NS+Q
Sbjct: 551 STLNDNPAEGAYCFTFSEIEDATRKLEKKIGSGGFGIVYYGKLKNGKEIAVKVLTNNSFQ 610
Query: 625 GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRIN 684
GKREF+NEVTLLSRIHHRNLVQFLG+CQE+GRS+LVYE+MHNGTLKEHLYG + + IN
Sbjct: 611 GKREFSNEVTLLSRIHHRNLVQFLGFCQEDGRSMLVYEYMHNGTLKEHLYG--SRGRSIN 668
Query: 685 WIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744
WIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK+SNILLDKHMRAKVSDFGLSK A+DGAS
Sbjct: 669 WIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKTSNILLDKHMRAKVSDFGLSKLALDGAS 728
Query: 745 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 804
HVSS+VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLEL+SG+EAISNE FG NCRNIVQ
Sbjct: 729 HVSSVVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELMSGKEAISNE-FGTNCRNIVQ 787
Query: 805 WAKLHIESGDIQGIIDPSL-LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 863
WAKLHIESGDIQG+ID S DEYDIQSMWKI EKALMCV PHGHMRPSISEVLK+IQDA
Sbjct: 788 WAKLHIESGDIQGVIDSSFDDDEYDIQSMWKIAEKALMCVQPHGHMRPSISEVLKEIQDA 847
Query: 864 IVIEREAAAARDGNSDDMSRNSLHSSLNVGS--FGGTENFLSLDESIVRPSAR 914
I IERE+ A R+GNSDDMSRNS+HSSLN+GS GGTEN+LSLDES+ RP+AR
Sbjct: 848 IAIERESVAVREGNSDDMSRNSVHSSLNLGSLELGGTENYLSLDESVARPTAR 900
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356570730|ref|XP_003553538.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1498 bits (3877), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 718/909 (78%), Positives = 796/909 (87%), Gaps = 25/909 (2%)
Query: 29 MPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFPADSRKY 88
M GFVSL+CGG E FTDE+GL W DD L YG+IS ISVANETRKQY TLRHFPADSRKY
Sbjct: 30 MQGFVSLDCGGTEKFTDELGLHWTPDDKLTYGQISTISVANETRKQYTTLRHFPADSRKY 89
Query: 89 CYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVRELIFL 148
CY L+V++RTRYL+RA+FLYGNFDNNNVYPKFDIS+G THWSTIVISDA +IE+RELIFL
Sbjct: 90 CYTLEVVSRTRYLLRASFLYGNFDNNNVYPKFDISVGATHWSTIVISDANSIEMRELIFL 149
Query: 149 ASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGADSEAPVR 208
ASSP + VCLSNATTGQPFISTLELRQFNGSVY T FE +YLSVSARINFGA+S+AP+R
Sbjct: 150 ASSPTVSVCLSNATTGQPFISTLELRQFNGSVYYTQFEQHFYLSVSARINFGAESDAPIR 209
Query: 209 YPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNGS 268
YPDDPFDRIWESDS+KKANYLVDVAAGTEK+ST +PID+ DE+PP KVMQTAVVGTNGS
Sbjct: 210 YPDDPFDRIWESDSVKKANYLVDVAAGTEKISTTVPIDVNRDEMPPVKVMQTAVVGTNGS 269
Query: 269 LTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYR 328
LTYRLNLDGFPG GWA TYFAEIEDLDPDESRKFRLVLPGQPD+SKA+VNI+ENAQGKYR
Sbjct: 270 LTYRLNLDGFPGTGWAFTYFAEIEDLDPDESRKFRLVLPGQPDISKAVVNIEENAQGKYR 329
Query: 329 VYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYS 388
+YEPG+TN+SLPFVLSF+FGKTYDSSRGPLLNAMEIN YLE+NDGS+DG I +++S YS
Sbjct: 330 LYEPGFTNISLPFVLSFRFGKTYDSSRGPLLNAMEINMYLEKNDGSLDGATISNILSHYS 389
Query: 389 SADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEF--- 445
+ADW QEGGDPCLPVPWSW++CNSDPQP I I LS+KNLTGNIP D+TKL LVE
Sbjct: 390 AADWLQEGGDPCLPVPWSWVRCNSDPQPRIVSILLSNKNLTGNIPLDITKLVGLVELWLD 449
Query: 446 ------------GCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL 493
GC DL+IIHLE+NQLTG LP+SL NLP+LRELYVQNNMLSGT+PS LL
Sbjct: 450 GNMLTGPFPDFTGCMDLKIIHLENNQLTGVLPTSLTNLPSLRELYVQNNMLSGTIPSELL 509
Query: 494 SKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQ 553
SK++VLNY+GNINLH R H+ +IIGSSVGA+VLLLAT++SCL+MHKGK+ + EQ
Sbjct: 510 SKDLVLNYSGNINLHRESRIKGHMYVIIGSSVGASVLLLATIISCLYMHKGKRRYH--EQ 567
Query: 554 HR------HSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKL 607
R SLP QR S +D PAEAAHCF+ S+IE+AT EKKIGSGGFGVVYYGKL
Sbjct: 568 GRILNSCIDSLPTQRLASWKSDDPAEAAHCFSYSEIENATNNFEKKIGSGGFGVVYYGKL 627
Query: 608 KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 667
KDGKEIAVKVLTSNSYQGKREF+NEVTLLSRIHHRNLVQ LGYC++E S+LVYEFMHNG
Sbjct: 628 KDGKEIAVKVLTSNSYQGKREFSNEVTLLSRIHHRNLVQLLGYCRDEENSMLVYEFMHNG 687
Query: 668 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR 727
TLKEHLYG L H + INWIKRLEIAEDAAKGIEYLHTGCVP +IHRDLKSSNILLDKHMR
Sbjct: 688 TLKEHLYGPLVHGRSINWIKRLEIAEDAAKGIEYLHTGCVPVVIHRDLKSSNILLDKHMR 747
Query: 728 AKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 787
AKVSDFGLSK AVDG SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ
Sbjct: 748 AKVSDFGLSKLAVDGVSHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 807
Query: 788 EAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHG 847
EAISNE FG NCRNIVQWAKLHIESGDIQGIIDP L ++YD+QSMWKI EKALMCV PHG
Sbjct: 808 EAISNESFGVNCRNIVQWAKLHIESGDIQGIIDPLLRNDYDLQSMWKIAEKALMCVQPHG 867
Query: 848 HMRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGS--FGGTENFLSLD 905
HMRPSISE LK+IQDAI IER+A A R+GNSDDMS+NS HSS+N+GS GG E++LS+D
Sbjct: 868 HMRPSISEALKEIQDAISIERQAEALREGNSDDMSKNSFHSSMNMGSMDLGGAESYLSID 927
Query: 906 ESIVRPSAR 914
ESI +P+AR
Sbjct: 928 ESIAQPTAR 936
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224068652|ref|XP_002326166.1| predicted protein [Populus trichocarpa] gi|222833359|gb|EEE71836.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1495 bits (3870), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 723/908 (79%), Positives = 806/908 (88%), Gaps = 19/908 (2%)
Query: 24 SSSAQMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFPA 83
+SSAQ PGF+SL+CGG NFTD++GL W +D + YG ++ISVANETRKQY T+RHFPA
Sbjct: 19 ASSAQ-PGFLSLDCGGPVNFTDDLGLSWTSDFNFSYGAAASISVANETRKQYTTVRHFPA 77
Query: 84 DSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVR 143
DSRKYCY+LDV +RTRYL+RATFLYGNFD+NNVYPKFDIS+GPTHWSTIVISDA TIE
Sbjct: 78 DSRKYCYRLDVTSRTRYLLRATFLYGNFDSNNVYPKFDISVGPTHWSTIVISDANTIEST 137
Query: 144 ELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGADS 203
ELIFLASS + VCLSNATTGQPFISTLELRQFNGSVY T FE+++YLS+SARINFGAD+
Sbjct: 138 ELIFLASSSSMSVCLSNATTGQPFISTLELRQFNGSVYYTEFENQFYLSMSARINFGADN 197
Query: 204 EAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVV 263
EAP+RYPDDP+DRIWESDS+KKANYLVDVAAGT+KVST +PID+ DE PP++VMQTAVV
Sbjct: 198 EAPIRYPDDPYDRIWESDSVKKANYLVDVAAGTKKVSTDMPIDVNIDERPPERVMQTAVV 257
Query: 264 GTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENA 323
GTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDP+ESRKFRLVLPG PD+SKAIVNI+ENA
Sbjct: 258 GTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPEESRKFRLVLPGYPDMSKAIVNIEENA 317
Query: 324 QGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSV 383
QGKYR+YEPGYTNLSLPFVLSF+FGKT DSSRGPL+NAMEI+KYLE+NDG++DG I V
Sbjct: 318 QGKYRLYEPGYTNLSLPFVLSFRFGKTSDSSRGPLVNAMEIHKYLEKNDGTLDGYVISRV 377
Query: 384 ISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLV 443
I +S+ DWAQEGGDPCLPVPWSW+QCNSD +P I + LSSKNL+GN+PS LT L+ LV
Sbjct: 378 ILSHSTEDWAQEGGDPCLPVPWSWVQCNSDARPRIVKLSLSSKNLSGNVPSGLTMLTGLV 437
Query: 444 EF---------------GCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTV 488
E GC L IIHLE+NQLTG LPSSL+NLPNLRELYVQNN+LSGT+
Sbjct: 438 ELWLDGNSLTGPIPDFTGCTGLEIIHLENNQLTGELPSSLLNLPNLRELYVQNNLLSGTI 497
Query: 489 PSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNN 548
PS LS+ V LNY+GNINL EG R +H++IIIGSSVGAAVLL+AT+VSCLFMHKGKK +
Sbjct: 498 PSG-LSRKVALNYSGNINLREGARRGRHMDIIIGSSVGAAVLLIATIVSCLFMHKGKKRH 556
Query: 549 YDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK 608
D+EQ R SLP+Q VSSL +AP EAAHCFT +IEDATK EKKIGSGGFGVVYYGK+K
Sbjct: 557 PDQEQLRDSLPMQMVVSSLRNAPGEAAHCFTTFEIEDATKKFEKKIGSGGFGVVYYGKMK 616
Query: 609 DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 668
DG+EIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE+G+S+LVYEFMHNGT
Sbjct: 617 DGREIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEDGKSMLVYEFMHNGT 676
Query: 669 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA 728
LKEHLYG L + INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL+DK+MRA
Sbjct: 677 LKEHLYGPLKRGKSINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILVDKNMRA 736
Query: 729 KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 788
KV+DFGLSK AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLEL+SGQE
Sbjct: 737 KVADFGLSKLAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELMSGQE 796
Query: 789 AISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGH 848
AISNE FG NCRNIVQWAKLHIESGDIQGIIDPSL EYDIQSMWKI EKALMCV PHGH
Sbjct: 797 AISNESFGVNCRNIVQWAKLHIESGDIQGIIDPSLCGEYDIQSMWKIAEKALMCVQPHGH 856
Query: 849 MRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGS--FGGTENFLSLDE 906
MRPSISEVLK+IQDAI+IERE AAR+ SD+MSRNS+HSSLN+GS GG EN+L+LDE
Sbjct: 857 MRPSISEVLKEIQDAILIEREVTAAREDISDEMSRNSVHSSLNLGSLDLGGAENYLALDE 916
Query: 907 SIVRPSAR 914
SI +P+AR
Sbjct: 917 SIAQPTAR 924
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356503698|ref|XP_003520642.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1490 bits (3858), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 715/927 (77%), Positives = 804/927 (86%), Gaps = 25/927 (2%)
Query: 11 FSVASVLILLLLDSSSAQMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANE 70
F+++ LIL SS+ M GFVSL+CGG E F DEIGL W DD L YG+IS ISV NE
Sbjct: 13 FALSLSLILHSPFSSAQIMQGFVSLDCGGTEKFADEIGLHWTPDDKLTYGQISTISVVNE 72
Query: 71 TRKQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWS 130
TRKQY TLRHFPADSRKYCY L+V++RTRYL+RA+FLYGNFD+NNVYPKFDIS+GPTHWS
Sbjct: 73 TRKQYTTLRHFPADSRKYCYTLEVVSRTRYLLRASFLYGNFDDNNVYPKFDISIGPTHWS 132
Query: 131 TIVISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYY 190
TIVISDA +IE+RELIFLASSP + VCLSNATTGQPFISTLELRQFNGSVY T FE+ +Y
Sbjct: 133 TIVISDANSIEMRELIFLASSPTVSVCLSNATTGQPFISTLELRQFNGSVYYTQFEEHFY 192
Query: 191 LSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSD 250
LSVSARINFGA+S+AP+RYPDDPFDRIWESDS+KKANYLVDVAAGTEK+ST +PID+ D
Sbjct: 193 LSVSARINFGAESDAPIRYPDDPFDRIWESDSVKKANYLVDVAAGTEKISTTVPIDVNRD 252
Query: 251 ELPPQKVMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQP 310
E+PP KVMQTAVVGTNGSLTYRLNLDGFPG GWA TYFAEIEDLDP+ESRKFRLVLPGQP
Sbjct: 253 EMPPVKVMQTAVVGTNGSLTYRLNLDGFPGTGWAFTYFAEIEDLDPNESRKFRLVLPGQP 312
Query: 311 DVSKAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLER 370
D+SKA+VNI+ENAQGKYR+YEPG+TN+SLPFVLSF+FGKTYDSSRGPLLNAMEIN YLE+
Sbjct: 313 DISKAVVNIEENAQGKYRLYEPGFTNISLPFVLSFRFGKTYDSSRGPLLNAMEINMYLEK 372
Query: 371 NDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTG 430
NDGS+DG I +++S YS+ DWAQEGGDPCLPVPWSW++CNSDPQP I I LS+KNLTG
Sbjct: 373 NDGSLDGATISNILSHYSAEDWAQEGGDPCLPVPWSWVRCNSDPQPRIVSILLSNKNLTG 432
Query: 431 NIPSDLTKLSSLVEF---------------GCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
NIP D+TKL LVE GC DL+IIHLE+NQLTG LP+SL NLP+LR
Sbjct: 433 NIPMDITKLVGLVELWLDGNMLTGPFPDFTGCMDLKIIHLENNQLTGVLPTSLTNLPSLR 492
Query: 476 ELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATV 535
ELYVQNNMLSGT+PS LLSK++VLNY+GNINLH R H+ +IIGSSVGA+VLLLAT+
Sbjct: 493 ELYVQNNMLSGTIPSELLSKDLVLNYSGNINLHRESRIKGHMYVIIGSSVGASVLLLATI 552
Query: 536 VSCLFMHKGKKNNYDKEQHR------HSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKM 589
+SCL+M KGK+ + EQ R SLP QR S +D PAEAAHCF+ +IE+AT
Sbjct: 553 ISCLYMRKGKRRYH--EQGRILNNRIDSLPTQRLASWKSDDPAEAAHCFSFPEIENATNN 610
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 649
E KIGSGGFG+VYYGKLKDGKEIAVKVLTSNSYQGKREF+NEVTLLSRIHHRNLVQ LG
Sbjct: 611 FETKIGSGGFGIVYYGKLKDGKEIAVKVLTSNSYQGKREFSNEVTLLSRIHHRNLVQLLG 670
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 709
YC++E S+LVYEFMHNGTLKEHLYG L H + INWIKRLEIAEDAAKGIEYLHTGC+P
Sbjct: 671 YCRDEESSMLVYEFMHNGTLKEHLYGPLVHGRSINWIKRLEIAEDAAKGIEYLHTGCIPV 730
Query: 710 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 769
+IHRDLKSSNILLDKHMRAKVSDFGLSK AVDG SHVSSIVRGTVGYLDPEYYISQQLTD
Sbjct: 731 VIHRDLKSSNILLDKHMRAKVSDFGLSKLAVDGVSHVSSIVRGTVGYLDPEYYISQQLTD 790
Query: 770 KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 829
KSDVYSFGVILLELISGQEAISNE FG NCRNIVQWAKLHIESGDIQGIIDP L ++YD+
Sbjct: 791 KSDVYSFGVILLELISGQEAISNESFGVNCRNIVQWAKLHIESGDIQGIIDPLLRNDYDL 850
Query: 830 QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSS 889
QSMWKI EKALMCV PHGHMRP+ISEV+K+IQDAI IER+A A R+GNSDDMS++S HSS
Sbjct: 851 QSMWKIAEKALMCVQPHGHMRPTISEVIKEIQDAISIERQAEALREGNSDDMSKHSFHSS 910
Query: 890 LNVGS--FGGTENFLSLDESIVRPSAR 914
+N+GS GG E++LS+DESI +P+AR
Sbjct: 911 MNMGSMDLGGAESYLSIDESIAQPTAR 937
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224138590|ref|XP_002322852.1| predicted protein [Populus trichocarpa] gi|222867482|gb|EEF04613.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1486 bits (3846), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 721/908 (79%), Positives = 804/908 (88%), Gaps = 20/908 (2%)
Query: 24 SSSAQMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFPA 83
+SSAQ PGF+SL+CGG NFTD +GL W +D + IYGE ++ISVANETRKQY T+RHFPA
Sbjct: 17 ASSAQ-PGFLSLDCGGPANFTDALGLSWTSDVNFIYGEAASISVANETRKQYTTVRHFPA 75
Query: 84 DSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVR 143
D+RKYCY+LDV +RTRYL+RATFLYG+FDNNNVYPKFDIS+GPTHWSTIVISDA TIE
Sbjct: 76 DTRKYCYRLDVTSRTRYLLRATFLYGDFDNNNVYPKFDISVGPTHWSTIVISDANTIESI 135
Query: 144 ELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGADS 203
ELIFLASS I VCLSNATTGQPFISTLELRQFNGSVY T FE++++LSVSARINFGADS
Sbjct: 136 ELIFLASSSSISVCLSNATTGQPFISTLELRQFNGSVYFTAFENQFFLSVSARINFGADS 195
Query: 204 EAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVV 263
PVRYPDDP+DRIWESDS+KKANYLVDVAAGT+KVST +PI++ DE PP+KVMQTAVV
Sbjct: 196 VDPVRYPDDPYDRIWESDSVKKANYLVDVAAGTKKVSTDMPINVNIDERPPEKVMQTAVV 255
Query: 264 GTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENA 323
GTNGSLTYRLNLDGFPGFGWA TYFAEIEDLDP ESRKFRLVLPG PD+SKA+VNI+ENA
Sbjct: 256 GTNGSLTYRLNLDGFPGFGWACTYFAEIEDLDPTESRKFRLVLPGNPDMSKAVVNIEENA 315
Query: 324 QGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSV 383
QGKYR+YEPGYTNLSLPFVLSF+FGKT DSSRGPLLNAMEINKYLE+NDGS+DG I V
Sbjct: 316 QGKYRLYEPGYTNLSLPFVLSFRFGKTSDSSRGPLLNAMEINKYLEKNDGSLDGDVISGV 375
Query: 384 ISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLV 443
I LYS+ADWAQEGGDPC+PVPWSW+QCNS+ +P I + LSSKNL+G++PSDLTKL+ LV
Sbjct: 376 ILLYSTADWAQEGGDPCMPVPWSWVQCNSEARPRIVKLSLSSKNLSGSVPSDLTKLTGLV 435
Query: 444 EF---------------GCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTV 488
E GC DL IIHLE+NQLTG LPSSL+NLPNLRELYVQNNMLSGT+
Sbjct: 436 ELWLDGNSLTGPIPDFTGCTDLEIIHLENNQLTGELPSSLLNLPNLRELYVQNNMLSGTI 495
Query: 489 PSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNN 548
PS L + VVLNY+GNINLHEG R +H+ IIIGSSVGAAVLL+ T+VSC+FM KGKK +
Sbjct: 496 PSG-LGRKVVLNYSGNINLHEGARRGRHMGIIIGSSVGAAVLLITTLVSCMFMQKGKKRH 554
Query: 549 YDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK 608
D+EQ R SLPVQR VS+L++AP EAAH FT +IEDATK EKKIGSGGFGVVYYGK+K
Sbjct: 555 PDQEQLRDSLPVQRVVSTLSNAPGEAAHRFTSFEIEDATKKFEKKIGSGGFGVVYYGKMK 614
Query: 609 DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 668
DG+EIAVKVLTSNS+QGKREF+NEV+LLSRIHHRNLVQFLG+CQE G+S+LVYEFMHNGT
Sbjct: 615 DGREIAVKVLTSNSFQGKREFSNEVSLLSRIHHRNLVQFLGFCQEVGKSMLVYEFMHNGT 674
Query: 669 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA 728
LKEHLYG L + I+WIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK+SNILLDK+MRA
Sbjct: 675 LKEHLYGPLKQGRSISWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKTSNILLDKNMRA 734
Query: 729 KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 788
KV+DFGLSK AVDGASHVSSIVRGTVGYLDPEYYISQQLT+KSDVYSFGVILLEL+SGQE
Sbjct: 735 KVADFGLSKLAVDGASHVSSIVRGTVGYLDPEYYISQQLTNKSDVYSFGVILLELMSGQE 794
Query: 789 AISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGH 848
AISNE FG NCRNIVQWAKLHIESGDIQGIIDPSL +E+DIQSMWKI EKAL CV PHGH
Sbjct: 795 AISNESFGVNCRNIVQWAKLHIESGDIQGIIDPSLCNEFDIQSMWKIAEKALTCVQPHGH 854
Query: 849 MRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGS--FGGTENFLSLDE 906
MRPSISEVLK+IQDAI+IERE AAR G SD+MSRNS+ SS N+GS GGTEN L+LDE
Sbjct: 855 MRPSISEVLKEIQDAILIEREVTAAR-GFSDEMSRNSVQSSFNLGSLDLGGTENCLALDE 913
Query: 907 SIVRPSAR 914
SI RP+AR
Sbjct: 914 SIARPTAR 921
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440057|ref|XP_004137801.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Cucumis sativus] gi|449524194|ref|XP_004169108.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1476 bits (3822), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 706/894 (78%), Positives = 793/894 (88%), Gaps = 13/894 (1%)
Query: 23 DSSSAQMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFP 82
D S AQMPGFVSL+CGG E+FTD+IGL+W D + +GE NISVANETRKQYMTLRHFP
Sbjct: 15 DVSFAQMPGFVSLDCGGQESFTDDIGLEWDPDTQVRFGEAVNISVANETRKQYMTLRHFP 74
Query: 83 ADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEV 142
ADSRKYCY L+V +RTRYL+RATFLYGNFDNNNVYPKFDISLG THWSTIVISDA TIEV
Sbjct: 75 ADSRKYCYSLNVTSRTRYLLRATFLYGNFDNNNVYPKFDISLGATHWSTIVISDANTIEV 134
Query: 143 RELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGAD 202
RELIFLAS+P + VCLSNATTGQPFISTLELRQFNGS Y T FED++YLSVSARINFGAD
Sbjct: 135 RELIFLASTPTVSVCLSNATTGQPFISTLELRQFNGSAYYTQFEDQFYLSVSARINFGAD 194
Query: 203 SEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAV 262
SEAPVRYPDDPFDR+WESDS++KANYLVDVAAGTEKVSTKLPID+ DE PPQKVMQTAV
Sbjct: 195 SEAPVRYPDDPFDRMWESDSVRKANYLVDVAAGTEKVSTKLPIDVDRDERPPQKVMQTAV 254
Query: 263 VGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQEN 322
VG NGSLTYRLNLDGFPGFGWAVTYFAEIEDL P ++RKFRLVLPG P++SKA+VNI+EN
Sbjct: 255 VGRNGSLTYRLNLDGFPGFGWAVTYFAEIEDLGPTDTRKFRLVLPGMPEISKAVVNIEEN 314
Query: 323 AQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVS 382
AQGKYR+YEPG+TN++LPFVLSF+FGKT DSS GPLLNAMEINKYLE++DGS+DG + S
Sbjct: 315 AQGKYRLYEPGFTNITLPFVLSFRFGKTQDSSLGPLLNAMEINKYLEKSDGSLDGAVVAS 374
Query: 383 VISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSL 442
VIS + S+DW EGGDPC+PVPWSWLQCNSDPQP I I LS +NL+GNIP+D+ KLS L
Sbjct: 375 VISKFPSSDW-DEGGDPCMPVPWSWLQCNSDPQPRIIKISLSKQNLSGNIPTDIAKLSGL 433
Query: 443 VEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYA 502
VEF HLE+NQLTG LPSSL +LPNLRELYVQNNMLSGTVPS LLSKN+V++Y+
Sbjct: 434 VEF--------HLENNQLTGELPSSLASLPNLRELYVQNNMLSGTVPSGLLSKNLVVDYS 485
Query: 503 GNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQR 562
GNINLHEGG+ H+ II+GS +GA VLLLATVVSC F+HKG++ ++++ SL VQR
Sbjct: 486 GNINLHEGGK-KNHVYIIVGSVIGAVVLLLATVVSCYFLHKGRRRYHEQDLPEESLAVQR 544
Query: 563 PVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS 622
VSS DA E AHCF++++I ATK E+KIGSGGFGVVYYGKL DGKEIAVKVLTSNS
Sbjct: 545 FVSSKGDASKETAHCFSVNEIVQATKDFERKIGSGGFGVVYYGKLNDGKEIAVKVLTSNS 604
Query: 623 YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR 682
+QG+REF NEVTLLSRIHHRNLVQFLGYCQE+ RS+L+YEFMHNGTLKEHLYG LT E+
Sbjct: 605 FQGRREFANEVTLLSRIHHRNLVQFLGYCQEQDRSMLIYEFMHNGTLKEHLYGPLTREKT 664
Query: 683 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 742
I+WIKRLEIAEDAA+G+EYLHTGC+PAIIHRDLKSSNILLD+HM+AKVSDFGLSK AVDG
Sbjct: 665 ISWIKRLEIAEDAARGVEYLHTGCIPAIIHRDLKSSNILLDRHMKAKVSDFGLSKLAVDG 724
Query: 743 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 802
SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN FGANCRNI
Sbjct: 725 VSHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNVNFGANCRNI 784
Query: 803 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862
VQWAKLHIESGDIQGIIDPSL +EYDIQSMWKI EKALMCV +GH+RPSISEVLK+IQD
Sbjct: 785 VQWAKLHIESGDIQGIIDPSLRNEYDIQSMWKIAEKALMCVQANGHLRPSISEVLKEIQD 844
Query: 863 AIVIEREAAAARDGNSDDMSRNSLHSSLNVGSFG--GTENFLSLDESIVRPSAR 914
+I+IERE+ A ++GNSDDMSRNS+H SLN+GS G EN++S DESI RP+AR
Sbjct: 845 SILIERESTATKEGNSDDMSRNSVH-SLNMGSLDLCGNENYVSFDESIARPTAR 897
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297741494|emb|CBI32626.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1472 bits (3810), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 718/925 (77%), Positives = 803/925 (86%), Gaps = 20/925 (2%)
Query: 6 RLLLPFSVASVLILLLLDSSSAQMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNI 65
RLLL F +VL L+D+++AQMPGFVS +CGG+ENFTD++GL W +DD L+YGEI+ I
Sbjct: 4 RLLLLFLSVTVL---LMDAANAQMPGFVSFDCGGSENFTDDLGLWWTSDDQLMYGEIATI 60
Query: 66 SVANETRKQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLG 125
SVANETRKQY TLRHFPAD+RKYCY LDVI+RTRYL+RATFLYGNFDNN VYPKFDISLG
Sbjct: 61 SVANETRKQYTTLRHFPADNRKYCYTLDVISRTRYLVRATFLYGNFDNNKVYPKFDISLG 120
Query: 126 PTHWSTIVISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPF 185
T WSTIVISDA TIE ELIFLAS P I VCLSNATTGQPFISTLELRQFNGS+Y T +
Sbjct: 121 ATPWSTIVISDANTIESSELIFLASDPTISVCLSNATTGQPFISTLELRQFNGSIYYTEY 180
Query: 186 EDRYYLSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPI 245
E+ ++LSVSAR+NFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVA GTEKVST++PI
Sbjct: 181 EEDFFLSVSARVNFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAPGTEKVSTQMPI 240
Query: 246 DLRSDELPPQKVMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLV 305
D+ D PP+KVMQTAVVG NG+L+YRLNLDGFPGFGWA TY AEIEDL P+E+RKFRL+
Sbjct: 241 DVNKDSRPPEKVMQTAVVGRNGTLSYRLNLDGFPGFGWAFTYLAEIEDLGPEETRKFRLI 300
Query: 306 LPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEIN 365
LP PD+SK VNIQENAQGKYR+YEPGY N+SLPFVLSFKFGKT DSS+GPLLNAMEIN
Sbjct: 301 LPNMPDLSKPAVNIQENAQGKYRLYEPGYPNISLPFVLSFKFGKTSDSSQGPLLNAMEIN 360
Query: 366 KYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSS 425
KYLE+ DG +DG AI S++ YSS DWA+EGGDPCLPVPWSW+ CNSDPQP I IHLS
Sbjct: 361 KYLEKRDGCLDGSAIASIVLQYSSEDWAKEGGDPCLPVPWSWVACNSDPQPRIVSIHLSG 420
Query: 426 KNLTGNIPSDLTKLSSLVEF---------------GCPDLRIIHLEDNQLTGPLPSSLMN 470
KNLTGNIP+DLTKLS LVE G +L+ IHLE+NQL+G LPSSL++
Sbjct: 421 KNLTGNIPTDLTKLSGLVELWLDGNALAGPIPDFTGLINLKTIHLENNQLSGELPSSLVD 480
Query: 471 LPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVL 530
L +L+ELYVQNNMLSG VPS LL++N+ NY+GN NLH+G G +H+ IIIGSSVGA VL
Sbjct: 481 LQSLKELYVQNNMLSGKVPSGLLNENLDFNYSGNDNLHKGSTGGRHIGIIIGSSVGAVVL 540
Query: 531 LLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKML 590
L+AT+ SCLFMHKGKK Y+++Q H LP QR VSSLNDA EAA+CF+LS+IEDAT+
Sbjct: 541 LIATIASCLFMHKGKKRYYEQDQLGHGLPAQRIVSSLNDAATEAANCFSLSEIEDATRKF 600
Query: 591 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 650
EKKIGSGGFGVVYYGK+KDGKEIAVKVL +NSYQG REF+NEVTLLSRIHHRNLVQFLGY
Sbjct: 601 EKKIGSGGFGVVYYGKMKDGKEIAVKVLINNSYQGNREFSNEVTLLSRIHHRNLVQFLGY 660
Query: 651 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 710
CQEEGRS+LVYEFMHNGTLKEHLYG LT E+ I+WIKRLEIAEDAAKGIEYLHTGCVP+I
Sbjct: 661 CQEEGRSMLVYEFMHNGTLKEHLYGPLTRERAISWIKRLEIAEDAAKGIEYLHTGCVPSI 720
Query: 711 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 770
IHRDLKSSNILLDK+M+AKVSDFGLSK AVDG+SHVSS+VRGTVGYLDPEYYISQQLTDK
Sbjct: 721 IHRDLKSSNILLDKYMKAKVSDFGLSKLAVDGSSHVSSVVRGTVGYLDPEYYISQQLTDK 780
Query: 771 SDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQ 830
SDVYSFGVILLELISGQEAISNE FG NCRNIVQWAKLHIESGDIQGIIDPSL DEYDIQ
Sbjct: 781 SDVYSFGVILLELISGQEAISNESFGVNCRNIVQWAKLHIESGDIQGIIDPSLRDEYDIQ 840
Query: 831 SMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSL 890
SMWKI EKALMCV PHG MRP ISEV+K+IQ+AI IER A AAR+GNS D SRNS+HSS+
Sbjct: 841 SMWKIAEKALMCVQPHGSMRPPISEVIKEIQEAISIERGAEAAREGNS-DASRNSIHSSI 899
Query: 891 NVG-SFGGTENFLSLDESIVRPSAR 914
N+G G TEN+LS DESI RP+ R
Sbjct: 900 NMGIDVGPTENYLSFDESIARPTPR 924
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225439769|ref|XP_002275389.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1463 bits (3788), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 710/911 (77%), Positives = 794/911 (87%), Gaps = 19/911 (2%)
Query: 22 LDSSSAQMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHF 81
+D+++AQMPGFVS +CGG+ENFTD++GL W +DD L+YGEI+ ISVANETRKQY TLRHF
Sbjct: 18 MDAANAQMPGFVSFDCGGSENFTDDLGLWWTSDDQLMYGEIATISVANETRKQYTTLRHF 77
Query: 82 PADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIE 141
PAD+RKYCY LDVI+RTRYL+RATFLYGNFDNN VYPKFDISLG T WSTIVISDA TIE
Sbjct: 78 PADNRKYCYTLDVISRTRYLVRATFLYGNFDNNKVYPKFDISLGATPWSTIVISDANTIE 137
Query: 142 VRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGA 201
ELIFLAS P I VCLSNATTGQPFISTLELRQFNGS+Y T +E+ ++LSVSAR+NFGA
Sbjct: 138 SSELIFLASDPTISVCLSNATTGQPFISTLELRQFNGSIYYTEYEEDFFLSVSARVNFGA 197
Query: 202 DSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTA 261
DSEAPVRYPDDPFDRIWESDSLKKANYLVDVA GTEKVST++PID+ D PP+KVMQTA
Sbjct: 198 DSEAPVRYPDDPFDRIWESDSLKKANYLVDVAPGTEKVSTQMPIDVNKDSRPPEKVMQTA 257
Query: 262 VVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQE 321
VVG NG+L+YRLNLDGFPGFGWA TY AEIEDL P+E+RKFRL+LP PD+SK VNIQE
Sbjct: 258 VVGRNGTLSYRLNLDGFPGFGWAFTYLAEIEDLGPEETRKFRLILPNMPDLSKPAVNIQE 317
Query: 322 NAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIV 381
NAQGKYR+YEPGY N+SLPFVLSFKFGKT DSS+GPLLNAMEINKYLE+ DG +DG AI
Sbjct: 318 NAQGKYRLYEPGYPNISLPFVLSFKFGKTSDSSQGPLLNAMEINKYLEKRDGCLDGSAIA 377
Query: 382 SVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSS 441
S++ YSS DWA+EGGDPCLPVPWSW+ CNSDPQP I IHLS KNLTGNIP+DLTKLS
Sbjct: 378 SIVLQYSSEDWAKEGGDPCLPVPWSWVACNSDPQPRIVSIHLSGKNLTGNIPTDLTKLSG 437
Query: 442 LVEF---------------GCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 486
LVE G +L+ IHLE+NQL+G LPSSL++L +L+ELYVQNNMLSG
Sbjct: 438 LVELWLDGNALAGPIPDFTGLINLKTIHLENNQLSGELPSSLVDLQSLKELYVQNNMLSG 497
Query: 487 TVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKK 546
VPS LL++N+ NY+GN NLH+G G +H+ IIIGSSVGA VLL+AT+ SCLFMHKGKK
Sbjct: 498 KVPSGLLNENLDFNYSGNDNLHKGSTGGRHIGIIIGSSVGAVVLLIATIASCLFMHKGKK 557
Query: 547 NNYDKEQHR--HSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYY 604
Y++ H+ H LP QR VSSLNDA EAA+CF+LS+IEDAT+ EKKIGSGGFGVVYY
Sbjct: 558 RYYEQGMHQLGHGLPAQRIVSSLNDAATEAANCFSLSEIEDATRKFEKKIGSGGFGVVYY 617
Query: 605 GKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 664
GK+KDGKEIAVKVL +NSYQG REF+NEVTLLSRIHHRNLVQFLGYCQEEGRS+LVYEFM
Sbjct: 618 GKMKDGKEIAVKVLINNSYQGNREFSNEVTLLSRIHHRNLVQFLGYCQEEGRSMLVYEFM 677
Query: 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 724
HNGTLKEHLYG LT E+ I+WIKRLEIAEDAAKGIEYLHTGCVP+IIHRDLKSSNILLDK
Sbjct: 678 HNGTLKEHLYGPLTRERAISWIKRLEIAEDAAKGIEYLHTGCVPSIIHRDLKSSNILLDK 737
Query: 725 HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELI 784
+M+AKVSDFGLSK AVDG+SHVSS+VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELI
Sbjct: 738 YMKAKVSDFGLSKLAVDGSSHVSSVVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELI 797
Query: 785 SGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVL 844
SGQEAISNE FG NCRNIVQWAKLHIESGDIQGIIDPSL DEYDIQSMWKI EKALMCV
Sbjct: 798 SGQEAISNESFGVNCRNIVQWAKLHIESGDIQGIIDPSLRDEYDIQSMWKIAEKALMCVQ 857
Query: 845 PHGHMRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVG-SFGGTENFLS 903
PHG MRP ISEV+K+IQ+AI IER A AAR+GNS D SRNS+HSS+N+G G TEN+LS
Sbjct: 858 PHGSMRPPISEVIKEIQEAISIERGAEAAREGNS-DASRNSIHSSINMGIDVGPTENYLS 916
Query: 904 LDESIVRPSAR 914
DESI RP+ R
Sbjct: 917 FDESIARPTPR 927
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357510569|ref|XP_003625573.1| Leucine-rich repeat receptor-like protein kinase [Medicago truncatula] gi|355500588|gb|AES81791.1| Leucine-rich repeat receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1443 bits (3735), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 693/903 (76%), Positives = 778/903 (86%), Gaps = 17/903 (1%)
Query: 29 MPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFPADSRKY 88
M GFVSL+CGG+E+FTD+IGL W D+ L YGEIS ISV NETRKQY TLRHFPADSRKY
Sbjct: 30 MQGFVSLDCGGSESFTDDIGLDWTPDNKLTYGEISTISVVNETRKQYTTLRHFPADSRKY 89
Query: 89 CYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVRELIFL 148
CY LDVI+RTRYL+RA+FLYGNFDNNNVYPKFDIS+G THWSTIVISDA IE+RELIFL
Sbjct: 90 CYTLDVISRTRYLLRASFLYGNFDNNNVYPKFDISVGATHWSTIVISDANIIEMRELIFL 149
Query: 149 ASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGADSEAPVR 208
ASS + VCLSNATTGQPFISTLELRQFNGS+Y T FE ++YLSVSARINFGA+++AP+R
Sbjct: 150 ASSSTVSVCLSNATTGQPFISTLELRQFNGSIYYTQFEQQFYLSVSARINFGAETDAPIR 209
Query: 209 YPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNGS 268
YPDDPFDRIWESDS+KKANYLVDVA GTEKVST +PI + D++PP KVMQTAVVGTNGS
Sbjct: 210 YPDDPFDRIWESDSVKKANYLVDVAVGTEKVSTNVPILVNRDDVPPVKVMQTAVVGTNGS 269
Query: 269 LTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYR 328
LTYRLNLDGFPG WAVTYFAEIEDL P+ESRKFRLVLPGQP++SKAIVNI+ENA GKYR
Sbjct: 270 LTYRLNLDGFPGNAWAVTYFAEIEDLSPNESRKFRLVLPGQPEISKAIVNIEENAFGKYR 329
Query: 329 VYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYS 388
+YEPG+TNLSLPFVLSFKF KT DSS+GPL+NAMEINKYLE+NDGS D AI V+S YS
Sbjct: 330 LYEPGFTNLSLPFVLSFKFAKTPDSSKGPLVNAMEINKYLEKNDGSPDVEAISGVLSHYS 389
Query: 389 SADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEF--- 445
SA+W QEGGDPCLPVPWSW++C+SDPQP I I LS KNLTGNIPSD+TKL LVE
Sbjct: 390 SANWTQEGGDPCLPVPWSWIRCSSDPQPRIISILLSGKNLTGNIPSDITKLVGLVELWLD 449
Query: 446 ------------GCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL 493
GC DL+IIHLE+NQ G LP+SL NLP+LRELYVQNNMLSG VP LL
Sbjct: 450 GNMLTGPIPDFTGCMDLKIIHLENNQFNGVLPASLANLPSLRELYVQNNMLSGEVPPHLL 509
Query: 494 SKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQ 553
SK+++LNY+GN NLH+ R H+ IIIGS+VGA+VLLLATV+SCL +HKGK+ Y+K+
Sbjct: 510 SKDLILNYSGNTNLHKQSRIKSHMYIIIGSAVGASVLLLATVISCLVIHKGKRRYYEKDH 569
Query: 554 HRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI 613
++P QRP S +D PAEAAHCF+L++IE AT EK+IGSGGFG+VYYGKLK+GKEI
Sbjct: 570 IVSAVPTQRPDSWKSDDPAEAAHCFSLAEIETATNNFEKRIGSGGFGIVYYGKLKEGKEI 629
Query: 614 AVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL 673
AVKVL +NSYQGKREF+NEVTLLSRIHHRNLVQ +GYC+EE S+LVYEFMHNGTLKEHL
Sbjct: 630 AVKVLRNNSYQGKREFSNEVTLLSRIHHRNLVQLIGYCREEENSILVYEFMHNGTLKEHL 689
Query: 674 YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 733
YGTL H + INWIKRLEIAEDAAKGIEYLHTGCVP +IHRDLK+SNILLD+ MRAKVSDF
Sbjct: 690 YGTLEHGRSINWIKRLEIAEDAAKGIEYLHTGCVPVVIHRDLKTSNILLDRQMRAKVSDF 749
Query: 734 GLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 793
GLSK AVDG SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE
Sbjct: 750 GLSKLAVDGVSHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 809
Query: 794 KFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSI 853
FG +CRNIVQWAKLHIESGDIQGIIDP L YD+QSMWKI EKALMCV PHG MRPSI
Sbjct: 810 SFGLHCRNIVQWAKLHIESGDIQGIIDPLLGSNYDLQSMWKIAEKALMCVQPHGDMRPSI 869
Query: 854 SEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGS--FGGTENFLSLDESIVRP 911
SEVLK+IQDAI IE+EA R+GNSD+ SRNS SS+N+GS G E+FLS+DESI +P
Sbjct: 870 SEVLKEIQDAISIEKEAETLREGNSDEASRNSFQSSMNIGSMDLGRAESFLSIDESIAQP 929
Query: 912 SAR 914
+AR
Sbjct: 930 TAR 932
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356545961|ref|XP_003541401.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1439 bits (3726), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 702/890 (78%), Positives = 773/890 (86%), Gaps = 17/890 (1%)
Query: 27 AQMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFPADSR 86
AQMPGFVSL+CGG ENFTDEIGL W D L YGEISNISVANETRKQY LRHFPADSR
Sbjct: 28 AQMPGFVSLDCGGKENFTDEIGLNWTPDK-LRYGEISNISVANETRKQYTALRHFPADSR 86
Query: 87 KYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVRELI 146
KYCY LDV++RTRYL+RA+FLYGNFD NNVYPKFDI +G THWSTIVISDA TIE+RELI
Sbjct: 87 KYCYTLDVVSRTRYLLRASFLYGNFDANNVYPKFDIFIGATHWSTIVISDANTIEMRELI 146
Query: 147 FLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGADSEAP 206
FLA SP + VCLSNATTG+PFISTLELRQFNGSVY T E+ +YLSVSARINFGADS+AP
Sbjct: 147 FLALSPTVSVCLSNATTGKPFISTLELRQFNGSVYYTYTEEHFYLSVSARINFGADSDAP 206
Query: 207 VRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTN 266
+RYPDDPFDRIWESDS+KKANYLVDVAAGT K+ST ID+ SDE+PP KVMQTAVVGTN
Sbjct: 207 IRYPDDPFDRIWESDSVKKANYLVDVAAGTRKISTNKSIDVNSDEMPPMKVMQTAVVGTN 266
Query: 267 GSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGK 326
GSLTYRLNLDGFPGF WA TYFAEIEDL +ESRKFRLVLPG D+SKA+VNI+ENA GK
Sbjct: 267 GSLTYRLNLDGFPGFAWAFTYFAEIEDLAENESRKFRLVLPGHSDISKAVVNIEENAPGK 326
Query: 327 YRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISL 386
YR+YEPGYTNLSLPFVLSF+FGKT DSSRGPLLNAMEIN+YLE+NDGS DG I SV+S
Sbjct: 327 YRLYEPGYTNLSLPFVLSFRFGKTSDSSRGPLLNAMEINEYLEKNDGSPDGEVISSVLSH 386
Query: 387 YSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFG 446
Y SADWAQEGGDPCLPVPWSW++C+SD QP I I LSSKNLTGNIP D+TKL+ LVE
Sbjct: 387 YFSADWAQEGGDPCLPVPWSWVRCSSDQQPKIISILLSSKNLTGNIPLDITKLTGLVE-- 444
Query: 447 CPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 506
+HLE+NQLTG L +SL NLPNLRELYVQNNMLSGTVPS LLSK++ LNY GN N
Sbjct: 445 ------LHLENNQLTGALSTSLANLPNLRELYVQNNMLSGTVPSDLLSKDLDLNYTGNTN 498
Query: 507 LHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSS 566
LH+G R HL +IIGS+VGAAVLL+AT++SCL M KGK Y+ + S P Q SS
Sbjct: 499 LHKGSRKKSHLYVIIGSAVGAAVLLVATIISCLVMRKGKTKYYE-QNSLVSHPSQSMDSS 557
Query: 567 LNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK 626
+ P+E AHCF+ S+IE++T EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK
Sbjct: 558 KSIGPSEVAHCFSFSEIENSTNNFEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK 617
Query: 627 REFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI 686
REF+NEVTLLSRIHHRNLVQ LGYC+EEG S+L+YEFMHNGTLKEHLYG LTH + INW+
Sbjct: 618 REFSNEVTLLSRIHHRNLVQLLGYCREEGNSMLIYEFMHNGTLKEHLYGPLTHGRSINWM 677
Query: 687 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746
KRLEIAED+AKGIEYLHTGCVPA+IHRDLKSSNILLDKHMRAKVSDFGLSK AVDGASHV
Sbjct: 678 KRLEIAEDSAKGIEYLHTGCVPAVIHRDLKSSNILLDKHMRAKVSDFGLSKLAVDGASHV 737
Query: 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA 806
SSIVRGTVGYLDPEYYISQQLTDKSD+YSFGVILLELISGQEAISN+ FGANCRNIVQWA
Sbjct: 738 SSIVRGTVGYLDPEYYISQQLTDKSDIYSFGVILLELISGQEAISNDSFGANCRNIVQWA 797
Query: 807 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 866
KLHIESGDIQGIIDP L + YD+QSMWKI EKALMCV PHGHMRPSISEVLK+IQDAI I
Sbjct: 798 KLHIESGDIQGIIDPVLQNNYDLQSMWKIAEKALMCVQPHGHMRPSISEVLKEIQDAIAI 857
Query: 867 EREAAAARDGNSDDMSRNSLHSSLNVGS--FGGTENFLSLDESIVRPSAR 914
EREA +GNSD+ RNS+HSS+N+GS TEN+LS+DESI +P AR
Sbjct: 858 EREA----EGNSDE-PRNSVHSSINMGSMDLAATENYLSIDESIAQPIAR 902
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 914 | ||||||
| TAIR|locus:2008565 | 929 | AT1G67720 [Arabidopsis thalian | 0.496 | 0.488 | 0.477 | 1.2e-214 | |
| TAIR|locus:2057991 | 934 | AT2G37050 [Arabidopsis thalian | 0.568 | 0.556 | 0.665 | 2e-191 | |
| TAIR|locus:2066163 | 872 | AT2G29000 [Arabidopsis thalian | 0.656 | 0.688 | 0.351 | 1.5e-121 | |
| TAIR|locus:2066158 | 884 | AT2G28990 [Arabidopsis thalian | 0.864 | 0.893 | 0.350 | 6.2e-117 | |
| TAIR|locus:2078186 | 889 | AT3G46340 [Arabidopsis thalian | 0.857 | 0.881 | 0.353 | 3.4e-116 | |
| TAIR|locus:2055160 | 886 | AT2G14440 [Arabidopsis thalian | 0.304 | 0.313 | 0.485 | 1.3e-115 | |
| TAIR|locus:2824870 | 884 | AT1G51805 [Arabidopsis thalian | 0.892 | 0.923 | 0.348 | 1.5e-115 | |
| TAIR|locus:2078191 | 838 | AT3G46420 [Arabidopsis thalian | 0.298 | 0.325 | 0.467 | 2e-115 | |
| TAIR|locus:2195850 | 890 | AT1G51860 [Arabidopsis thalian | 0.873 | 0.896 | 0.336 | 3.1e-115 | |
| TAIR|locus:2028446 | 888 | AT1G49100 [Arabidopsis thalian | 0.859 | 0.885 | 0.348 | 1.7e-114 |
| TAIR|locus:2008565 AT1G67720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1129 (402.5 bits), Expect = 1.2e-214, Sum P(2) = 1.2e-214
Identities = 225/471 (47%), Positives = 306/471 (64%)
Query: 28 QMPGFVSLNCGGNENFTD-EIGLQWIADDHLI-YGEISNISVANETRKQYMTLRHFPADS 85
Q+ FVS++CG + N+TD GL W++D +I G+ ++ N QY R FP D+
Sbjct: 22 QVTEFVSIDCGCSSNYTDPRTGLGWVSDSEIIKQGKPVTLANTNWNSMQYRRRRDFPTDN 81
Query: 86 RKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVREL 145
+KYCY+L R RY++R TFLYG + YPKF + L T W+T+ I + + + V EL
Sbjct: 82 KKYCYRLSTKERRRYIVRTTFLYGGLGSEEAYPKFQLYLDATKWATVTIQEVSRVYVEEL 141
Query: 146 IFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGADSEA 205
I A+S +DVC+ A TG PF+STLELR N S+Y T +ED ++L V+AR+NFGA +
Sbjct: 142 IVRATSSYVDVCVCCAITGSPFMSTLELRPLNLSMYATDYEDNFFLKVAARVNFGAPNMD 201
Query: 206 PVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGT 265
+RYPDDP+DRIWESD K+ NYLV VA GT +++T I+ + E PP KVMQTAVVGT
Sbjct: 202 ALRYPDDPYDRIWESDINKRPNYLVGVAPGTTRINTSKTINTLTREYPPMKVMQTAVVGT 261
Query: 266 NGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQG 325
G ++YRLNL+ FP A YFAEIE+L +E+RKF+LV P PD S A+VNI ENA G
Sbjct: 262 QGLISYRLNLEDFPANARAYAYFAEIEELGANETRKFKLVQPYFPDYSNAVVNIAENANG 321
Query: 326 KYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLE---RNDGSIDGVAIVS 382
Y +YEP Y N++L FVL+F FGKT DS++GPLLNA+EI+KYL + D S V+++
Sbjct: 322 SYTLYEPSYMNVTLDFVLTFSFGKTKDSTQGPLLNAIEISKYLPISVKTDRS--DVSVLD 379
Query: 383 VI-SLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSS 441
I S+ +DWA EGGDPC+PV WSW+ C+S P +T I LS KNL G IP + + +
Sbjct: 380 AIRSMSPDSDWASEGGDPCIPVLWSWVNCSSTSPPRVTKIALSRKNLRGEIPPGINYMEA 439
Query: 442 LVEFGCPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYVQNNMLSGTVPSSL 492
L E + L+DN+LTG + ++++NN LSG++P L
Sbjct: 440 LTE--------LWLDDNELTGTLPDMSKLVNL-KIMHLENNQLSGSLPPYL 481
|
|
| TAIR|locus:2057991 AT2G37050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1855 (658.1 bits), Expect = 2.0e-191, P = 2.0e-191
Identities = 358/538 (66%), Positives = 416/538 (77%)
Query: 28 QMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFPADSRK 87
Q PGFVSL+CGG E FTDE+GL+W D+HLIYGE +NIS NETR QY TLRHFPADSRK
Sbjct: 24 QAPGFVSLDCGGAEPFTDELGLKWSPDNHLIYGETANISSVNETRTQYTTLRHFPADSRK 83
Query: 88 YCYKLDVITRTRYLIRATFLYGNFDN-NNVYPKFDISLGPTHWSTIVISDAATIEVRELI 146
YCY L+V +R RYLIRATFLYGNFDN NNVYPKFDISLG THW+TIVIS+ IE EL+
Sbjct: 84 YCYTLNVTSRNRYLIRATFLYGNFDNSNNVYPKFDISLGATHWATIVISETYIIETAELV 143
Query: 147 FLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPF-EDRYYLSVSARINFGADSEA 205
FLASSP + VCLSNATTGQPFISTLELRQ +GS+Y + EDR+YLSV+ARINFGA+SEA
Sbjct: 144 FLASSPTVSVCLSNATTGQPFISTLELRQLSGSMYGSMLSEDRFYLSVAARINFGAESEA 203
Query: 206 PVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGT 265
VRYPDDP+DRIWESD KK NYLVDVAAGT +VST LPI+ R D+ PPQKVMQTAVVGT
Sbjct: 204 SVRYPDDPYDRIWESDLQKKPNYLVDVAAGTVRVSTTLPIESRVDDRPPQKVMQTAVVGT 263
Query: 266 NGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQG 325
NGSLTYR+NLDGFPGFGWA TYFAEIEDL DESRKFRLVLP QP+ SK++VNI+EN Q
Sbjct: 264 NGSLTYRMNLDGFPGFGWAFTYFAEIEDLAEDESRKFRLVLPEQPEYSKSVVNIKENTQR 323
Query: 326 KYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVIS 385
YRVY PGY N++LPFVL+F+F KT DSSRGP+LNAMEI+KYL ++DGS+D + +V S
Sbjct: 324 PYRVYAPGYPNITLPFVLNFRFAKTADSSRGPILNAMEISKYLRKSDGSVDATVMANVAS 383
Query: 386 LYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEF 445
LYSS +WAQEGGDPC P PWSW+QCNSDPQP + I LSS NLTGNIPSDL KL+ LVE
Sbjct: 384 LYSSTEWAQEGGDPCSPSPWSWVQCNSDPQPRVVAIKLSSMNLTGNIPSDLVKLTGLVEL 443
Query: 446 ---G------------CPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYVQNNMLSGTVPS 490
G CP+L IIHLE+N+LTG +ELY+QNN+L+GT+PS
Sbjct: 444 WLDGNSFTGPIPDFSRCPNLEIIHLENNRLTGKIPSSLTKLPNLKELYLQNNVLTGTIPS 503
Query: 491 SLLSKNVVLNYAGNINLHEGGRGAKHLNIIIXXXXXXXXXXXXXXXXCLFMHKGKKNN 548
L +K+V+ N++GN+NL + G K L +II C+ M K KKNN
Sbjct: 504 DL-AKDVISNFSGNLNLEKSGDKGKKLGVIIGASVGAFVLLIATIISCIVMCKSKKNN 560
|
|
| TAIR|locus:2066163 AT2G29000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 862 (308.5 bits), Expect = 1.5e-121, Sum P(2) = 1.5e-121
Identities = 225/640 (35%), Positives = 330/640 (51%)
Query: 236 TEKVSTKLPIDLRSDELPPQKVMQTAVVGTNGSLTYRLNLDGFPGFGWAVTY--FAEIED 293
T+ V T L ++ + PQ ++++A N S + G+ Y FAEI+
Sbjct: 222 TKAVKTALSVNSTNPFELPQVIIRSAATPVNSSEPITVEYGGYSSGDQVYLYLHFAEIQT 281
Query: 294 LDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDS 353
L ++R+F +V ++ K + + P + + F +F +T S
Sbjct: 282 LKASDNREFDIVWAN--NIKKLAYKPKVSQIDTLLNTSPNKCDNT--FCKAFLV-RTQRS 336
Query: 354 SRGPLLNAMEINKYLE---RNDGSIDGVAIVSVISLYSSADWAQEGGDPCLP--VPWSWL 408
+ PLLNA E+ +E D VAI + + Y + +G DPCLP W ++
Sbjct: 337 TLPPLLNAYEVYILVEFPYSETHPDDVVAIKKIKAAYGLKIISWQG-DPCLPREYKWEYI 395
Query: 409 QC---NSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGXXX 465
+C N+ P I + LS++ L G I L L+ L + DL I N+L+G
Sbjct: 396 ECSYTNNSIPPRIISLDLSNRGLKGIIEPVLQNLTQLEKL---DLSI-----NRLSGEVP 447
Query: 466 XXXXXXXXXRELYVQNNMLSGTVPSSLLSKN---VVLNYAGNINLHEGGRGAKHLNIIIX 522
+ + N L G +P +L K + LN GN NL G + +
Sbjct: 448 EFLANMKSLSNINLSWNNLKGLIPPALEEKRKNGLKLNTQGNQNLCPGDECKRSIPKFPV 507
Query: 523 XXXXXXXXXXXXXXXCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSD 582
L + KK K +HR LP+ + S + FT S+
Sbjct: 508 TTVVSISAILLTVVVLLIVFIYKKKKTSKVRHR--LPITK--SEILTKKRR----FTYSE 559
Query: 583 IEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR 642
+E T E+ IG GGFG+VY+G L D +++AVK+L+ +S QG ++F EV LL R+HH
Sbjct: 560 VEAVTNKFERVIGEGGFGIVYHGHLNDTEQVAVKLLSHSSTQGYKQFKAEVELLLRVHHT 619
Query: 643 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 702
NLV +GYC EE LVYE+ NG LK+HL G + +NW RL IA + A+G+EYL
Sbjct: 620 NLVNLVGYCNEEDHLALVYEYAANGDLKQHLSGE-SSSAALNWASRLGIATETAQGLEYL 678
Query: 703 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEY 761
H GC P +IHRD+K++NILLD+H AK++DFGLS+ F V SHVS+ V GT GYLDPEY
Sbjct: 679 HIGCEPPMIHRDVKTTNILLDEHFHAKLADFGLSRSFPVGVESHVSTNVAGTPGYLDPEY 738
Query: 762 YISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 821
Y + LT+KSDVYS G++LLE+I+ Q I + +I +W L + GDI+ I+DP
Sbjct: 739 YRTNWLTEKSDVYSMGIVLLEIITNQPVIQQVR---EKPHIAEWVGLMLTKGDIKSIMDP 795
Query: 822 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861
L EYD S+WK E A+ CV P RP++S+V+ +++
Sbjct: 796 KLNGEYDSSSVWKALELAMSCVNPSSGGRPTMSQVISELK 835
|
|
| TAIR|locus:2066158 AT2G28990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1152 (410.6 bits), Expect = 6.2e-117, P = 6.2e-117
Identities = 303/865 (35%), Positives = 455/865 (52%)
Query: 31 GFVSLNCG--GNEN-FTDEI-GLQWIADDHLIY-GEISNISV-AN-ETRKQYMTLRHFPA 83
GF+SL+CG +E+ + D GL + +D I G+I ++ N KQY+TLR+FP
Sbjct: 24 GFISLDCGLPSDESPYDDSFNGLTFTSDSTFIQTGKIDSVDKDLNINLSKQYLTLRYFP- 82
Query: 84 DSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVR 143
+ ++ CY LDV T YLI +F+YGN+D N P FDI LGP W I +
Sbjct: 83 EGKRNCYSLDVKRGTTYLIVVSFVYGNYDGLNRDPNFDIHLGPNKWKRIDLDGEKEGTRE 142
Query: 144 ELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGADS 203
E+I A S +D+CL P IS +E+R + Y+T L +S R+ + ++S
Sbjct: 143 EIIHKARSNSLDICLVKTGETLPIISAIEIRPLRNNTYVTQSGS---LMMSFRV-YLSNS 198
Query: 204 EAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVV 263
+A +RY DD DRIW + + ++T L I+ + P+ ++QTA +
Sbjct: 199 DASIRYADDVHDRIWSPFN----------GSSHTHITTDLNINNSNAYEIPKNILQTAAI 248
Query: 264 GTNGSLTYRLNLDGFPGFGWAVTY--FAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQE 321
N S + D P Y FAEI+ L+ +E+R+F ++L G + S
Sbjct: 249 PRNASAPLIITWDPLPINAEVYLYMHFAEIQTLEANETRQFDVILRGNFNHS----GFSP 304
Query: 322 NAQGKYRVY--EP---GYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERN--DGS 374
+ +Y EP G L V KT +S+ PL+NA+E +E + + S
Sbjct: 305 TKLKVFTLYTEEPMKCGSEGCYLQLV------KTPNSTLPPLINAIEAYSVIEFSQLETS 358
Query: 375 IDGV-AIVSVISLY--SSADWAQEGGDPCLPVPWSW--LQC---NSDPQPSITVIHLSSK 426
+ V AI ++ + Y + W GDPCLP SW ++C + P+I + LS
Sbjct: 359 LSDVDAIKNIKNTYKLNKITWQ---GDPCLPQDLSWESIRCTYVDGSTSPTIISLDLSKS 415
Query: 427 NLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYVQNNMLSG 486
L G+IP L + L E + L +N LTG + + N LSG
Sbjct: 416 GLNGSIPQILQNFTQLQE--------LDLSNNSLTGPVPIFLANMKTLSLINLSGNNLSG 467
Query: 487 TVPSSLLSKN---VVLNYAGNINLHEGG--RGAKHLNIIIXXXXXXXXXXXXXXXXCLFM 541
+VP +LL K +VL GN +L + K ++ LF
Sbjct: 468 SVPQALLDKEKEGLVLKLEGNPDLCKSSFCNTEKKNKFLLPVIASAASLVIVVVVVALFF 527
Query: 542 HKGKKNNYDKEQHRH-SLPVQRPV-SSLNDAPAEAAHC-FTLSDIEDATKMLEKKIGSGG 598
KK H S+PV P +S +++ + FT S++++ T +K +G GG
Sbjct: 528 VFRKKKASPSNLHAPPSMPVSNPGHNSQSESSFTSKKIRFTYSEVQEMTNNFDKALGEGG 587
Query: 599 FGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 658
FGVVY+G + +++AVK+L+ +S QG + F EV LL R+HH NLV +GYC E
Sbjct: 588 FGVVYHGFVNVIEQVAVKLLSQSSSQGYKHFKAEVELLMRVHHINLVSLVGYCDEGEHLA 647
Query: 659 LVYEFMHNGTLKEHLYGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKS 717
L+YE+M NG LK+HL G H + +W RL+I DAA G+EYLHTGCVP ++HRD+K+
Sbjct: 648 LIYEYMPNGDLKQHLSGK--HGGFVLSWESRLKIVLDAALGLEYLHTGCVPPMVHRDIKT 705
Query: 718 SNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSF 776
+NILLD+H++AK++DFGLS+ F + +VS++V GT GYLDPEYY + LT+KSD+YSF
Sbjct: 706 TNILLDQHLQAKLADFGLSRSFPIGNEKNVSTVVAGTPGYLDPEYYQTNWLTEKSDIYSF 765
Query: 777 GVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIE 836
G++LLE+IS + I + +IV+W I GD++ I+DP+L +YDI S+WK
Sbjct: 766 GIVLLEIISNRPIIQQSR---EKPHIVEWVSFMITKGDLRSIMDPNLHQDYDIGSVWKAI 822
Query: 837 EKALMCVLPHGHMRPSISEVLKDIQ 861
E A+ CV RP++S V+ +++
Sbjct: 823 ELAMSCVSLSSARRPNMSRVVNELK 847
|
|
| TAIR|locus:2078186 AT3G46340 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1145 (408.1 bits), Expect = 3.4e-116, P = 3.4e-116
Identities = 309/873 (35%), Positives = 461/873 (52%)
Query: 31 GFVSLNCG--GNE--NFTDEI-GLQWIADDHLIY-GEISNISVANE--TRKQYMTLRHFP 82
GF+SL+CG NE + + GL++ +D I G+I + + E T K YMTLR+FP
Sbjct: 31 GFISLDCGLPPNEVSPYIEPFTGLRFSSDSSFIQSGKIGKVDKSFEATTLKSYMTLRYFP 90
Query: 83 ADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEV 142
D ++ CY L V Y+IRAT LYGN+D N+ PKFD+ +G W+T+ + + V
Sbjct: 91 -DGKRNCYNLIVKQGKTYMIRATALYGNYDGLNISPKFDLYIGANFWTTLDAGEYLSGVV 149
Query: 143 RELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFED-----RYYLSVSARI 197
E+ ++ S +DVCL T PF+S LELR + YLT RYYLS
Sbjct: 150 EEVNYIPRSNSLDVCLVKTDTSTPFLSLLELRPLDNDSYLTGSGSLKTFRRYYLS----- 204
Query: 198 NFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKV 257
+SE+ + YP+D DRIWE D + +++ T L + + L P+ V
Sbjct: 205 ----NSESVIAYPEDVKDRIWEPT--------FD--SEWKQIWTTLKPNNSNGYLVPKNV 250
Query: 258 MQTAVVGTNGSLTYRLN--LDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKA 315
+ TA + N S +R LD + +F+E++ L +ESR+F ++ G+
Sbjct: 251 LMTAAIPANDSAPFRFTEELDSPTDELYVYLHFSEVQSLQANESREFDILWSGEVAYEAF 310
Query: 316 I---VNIQENAQGKYRVYEPG-YTNLSLPFVLSFKFGKTYDSSRGPLLNAME----IN-K 366
I +NI Q V PG NL L +T +S+ PL+NA+E +N
Sbjct: 311 IPEYLNIT-TIQTNTPVTCPGGKCNLELK--------RTKNSTHPPLINAIEFYTVVNFP 361
Query: 367 YLERNDGSIDGVAIVSVISLY--SSADWAQEGGDPCLPVPWSW--LQCNSDPQ---PSIT 419
LE N+ D VAI + + Y + W GDPC+P + W L CNS P IT
Sbjct: 362 QLETNE--TDVVAIKDIKATYELNRITWQ---GDPCVPQKFIWEGLDCNSKDALTLPRIT 416
Query: 420 VIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYV 479
++LSS LTGNI + + L+ L + + L +N LTG + +
Sbjct: 417 SLNLSSTGLTGNIAAGIQNLTHLDK--------LDLSNNNLTGGVPEFLASMKSLSFINL 468
Query: 480 QNNMLSGTVPSSLLSKN---VVLNYAGNINLHEGGR--GAKHLNIIIXXXXXXXXXXXXX 534
N L+G++P +LL + + L+ I G K ++I
Sbjct: 469 SKNNLNGSIPQALLKREKDGLKLSVDEQIRCFPGSCVITKKKFPVMIVALVSSAVVVILV 528
Query: 535 XXXCLFMHKGKK-NNYDKEQHRHSLPVQRPVS-SLNDAPAEAAHC-FTLSDIEDATKMLE 591
+F+ K KK +N + + P + S S++D E F+ S++ + TK L+
Sbjct: 529 VLVLIFVFKKKKPSNLEDLPPSSNTPRENITSTSISDTSIETKRKRFSYSEVMEMTKNLQ 588
Query: 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 650
+ +G GGFGVVY+G + +++AVK+L+ +S QG +EF EV LL R+HH NLV +GY
Sbjct: 589 RPLGEGGFGVVYHGDINGSSQQVAVKLLSQSSTQGYKEFKAEVELLLRVHHINLVSLVGY 648
Query: 651 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHTGCVPA 709
C E L+YE+M N LK HL G H + W RL+IA DAA G+EYLH GC P+
Sbjct: 649 CDERDHLALIYEYMSNKDLKHHLSGK--HGGSVLKWNTRLQIAVDAALGLEYLHIGCRPS 706
Query: 710 IIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLT 768
++HRD+KS+NILLD AK++DFGLS+ F + S VS++V GT GYLDPEYY + +L
Sbjct: 707 MVHRDVKSTNILLDDQFTAKMADFGLSRSFQLGDESQVSTVVAGTPGYLDPEYYRTGRLA 766
Query: 769 DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 828
+ SDVYSFG++LLE+I+ Q I + ++ I +W + GDI I+DP+L +Y+
Sbjct: 767 EMSDVYSFGIVLLEIITNQRVIDPAREKSH---ITEWTAFMLNRGDITRIMDPNLQGDYN 823
Query: 829 IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861
+S+W+ E A+MC P RPS+S+V+ +++
Sbjct: 824 SRSVWRALELAMMCANPSSEKRPSMSQVVIELK 856
|
|
| TAIR|locus:2055160 AT2G14440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 695 (249.7 bits), Expect = 1.3e-115, Sum P(2) = 1.3e-115
Identities = 138/284 (48%), Positives = 192/284 (67%)
Query: 578 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLS 637
F S++++ T E +G GGFGVVY+G L + +++AVKVL+ +S QG +EF EV LL
Sbjct: 571 FKYSEVKEMTNNFEVVLGKGGFGVVYHGFLNN-EQVAVKVLSQSSTQGYKEFKTEVELLL 629
Query: 638 RIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK 697
R+HH NLV +GYC + L+YEFM NG LKEHL G +NW RL+IA ++A
Sbjct: 630 RVHHVNLVSLVGYCDKGNDLALIYEFMENGNLKEHLSGKRGGPV-LNWPGRLKIAIESAL 688
Query: 698 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGY 756
GIEYLH GC P ++HRD+KS+NILL AK++DFGLS+ F V +HVS+ V GT+GY
Sbjct: 689 GIEYLHIGCKPPMVHRDVKSTNILLGLRFEAKLADFGLSRSFLVGSQTHVSTNVAGTLGY 748
Query: 757 LDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 816
LDPEYY LT+KSDVYSFG++LLE+I+GQ I + + IV+WAK + +GDI+
Sbjct: 749 LDPEYYQKNWLTEKSDVYSFGIVLLEIITGQPVIEQSR---DKSYIVEWAKSMLANGDIE 805
Query: 817 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 860
I+D +L +YD S WK E A++C+ P +RP+++ V ++
Sbjct: 806 SIMDRNLHQDYDTSSSWKALELAMLCINPSSTLRPNMTRVAHEL 849
|
|
| TAIR|locus:2824870 AT1G51805 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1139 (406.0 bits), Expect = 1.5e-115, P = 1.5e-115
Identities = 312/895 (34%), Positives = 471/895 (52%)
Query: 30 PGFVSLNCG--GNENFTDEIG--LQWIADDHLIY-GEISNISVANETRKQY--MTLRHFP 82
PGF++++CG ++ + +G L + +D L+ G+ I+ E +TLR+FP
Sbjct: 24 PGFINVDCGLLPRDSPYNALGTGLVYTSDVGLVSSGKTGKIAKEFEENNSTPNLTLRYFP 83
Query: 83 ADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEV 142
D + CY L+V T Y+I+ATF+YGN+D + P FD+ LGP W+T+ S + T+E
Sbjct: 84 -DGARNCYNLNVSRDTNYMIKATFVYGNYDGHKDEPNFDLYLGPNLWATV--SRSETVE- 139
Query: 143 RELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGAD 202
E+I + S + VCL+ PFI+ LELR +VY+T + L + R F +D
Sbjct: 140 -EIIHVTKSDSLQVCLAKTGDFIPFINILELRPLKKNVYVT---ESGSLKLLFRKYF-SD 194
Query: 203 SEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAV 262
S +RYPDD +DR+W + L+ N+ +VST L +++ + Q VM T
Sbjct: 195 SGQTIRYPDDIYDRVWHASFLEN-NWA--------QVSTTLGVNVTDNYDLSQDVMATGA 245
Query: 263 VGTNGSLTYRLNLDGFPGFGWAVTY--FAEIEDLDPDESRKFRLVLPGQP---DVSKAIV 317
N S T + + P +Y FAE+E L +++R+F ++L G S +
Sbjct: 246 TPLNDSETLNITWNVEPPTTKVYSYMHFAELETLRANDTREFNVMLNGNDLFGPYSPIPL 305
Query: 318 NIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAME---INKYLERNDGS 374
+ K E G L L KT S+ PLLNA+E + +L+
Sbjct: 306 KTETETNLKPEECEDGACILQLV--------KTSKSTLPPLLNAIEAFTVIDFLQVETDE 357
Query: 375 IDGVAIVSVISLYSSADWAQEGGDPCLPVPWSW--LQCN-SDPQPSI-TVIHLSSKNLTG 430
D AI +V + Y + + GDPC+P +SW L+C+ SD P I + LS+ LTG
Sbjct: 358 DDAAAIKNVQNAYGLINRSSWQGDPCVPKQYSWDGLKCSYSDSTPPIINFLDLSASGLTG 417
Query: 431 NIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYVQNNMLSGTVPS 490
I + L+ L I+ L +N LTG + ++ N LSG VP+
Sbjct: 418 IIAPAIQNLTHL--------EILALSNNNLTGEVPEFLADLKSIMVIDLRGNNLSGPVPA 469
Query: 491 SLLSKN-VVLNYAGNINL--------HEGGRGAKHLNIIIXXXXXXXXXXXXXXXXCLFM 541
SLL K ++L+ N ++ H+G G K +II+ LF+
Sbjct: 470 SLLQKKGLMLHLDDNPHILCTTGSCMHKG-EGEKK-SIIVPVVASIVSLAVIIGALILFL 527
Query: 542 HKGKKNNYDKE----QHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSG 597
KK E + + + P SS A FT S + T ++ +G G
Sbjct: 528 VFRKKKASKVEGTLPSYMQASDGRSPRSS-EPAIVTKNKRFTYSQVVIMTNNFQRILGKG 586
Query: 598 GFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 657
GFG+VY+G + +++AVK+L+ +S QG ++F EV LL R+HH+NLV +GYC E
Sbjct: 587 GFGIVYHGFVNGVEQVAVKILSHSSSQGYKQFKAEVELLLRVHHKNLVGLVGYCDEGENM 646
Query: 658 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKS 717
L+YE+M NG LKEH+ GT + +NW RL+I D+A+G+EYLH GC P ++HRD+K+
Sbjct: 647 ALIYEYMANGDLKEHMSGT-RNRFILNWETRLKIVIDSAQGLEYLHNGCKPLMVHRDVKT 705
Query: 718 SNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSF 776
+NILL++H AK++DFGLS+ F + G +HVS++V GT GYLDPEYY + +LT+KSDVYSF
Sbjct: 706 TNILLNEHFEAKLADFGLSRSFPIGGETHVSTVVAGTPGYLDPEYYKTNRLTEKSDVYSF 765
Query: 777 GVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIE 836
G++LLE+I+ + I + I +W + + GDI I+DPSL +YD S+WK
Sbjct: 766 GIVLLEMITNRPVIDQSR---EKPYISEWVGIMLTKGDIISIMDPSLNGDYDSGSVWKAV 822
Query: 837 EKALMCVLPHGHMRPSISEVLKDIQXXXXXXXXXXXXXXGNSDDM-SRNSLHSSL 890
E A+ C+ P RP++S+VL + G S DM S++SL SL
Sbjct: 823 ELAMSCLNPSSTRRPTMSQVLIALNECLVSENSRG----GASRDMDSKSSLEVSL 873
|
|
| TAIR|locus:2078191 AT3G46420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 679 (244.1 bits), Expect = 2.0e-115, Sum P(2) = 2.0e-115
Identities = 130/278 (46%), Positives = 186/278 (66%)
Query: 585 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL 644
D T ++ +G GGFGVVY+G L +++AVK+L+ +S QG +EF EV LL R+HH NL
Sbjct: 528 DMTNNFQRALGEGGFGVVYHGYLNGSEQVAVKLLSQSSVQGYKEFKAEVELLLRVHHINL 587
Query: 645 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 704
V +GYC + LVYE+M NG LK HL G + ++W RL+IA DAA G+EYLH
Sbjct: 588 VSLVGYCDDRNHLALVYEYMSNGDLKHHLSGR-NNGFVLSWSTRLQIAVDAALGLEYLHI 646
Query: 705 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 763
GC P+++HRD+KS+NILL + AK++DFGLS+ F + +H+S++V GT GYLDPEYY
Sbjct: 647 GCRPSMVHRDVKSTNILLGEQFTAKMADFGLSRSFQIGDENHISTVVAGTPGYLDPEYYR 706
Query: 764 SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 823
+ +L +KSD+YSFG++LLE+I+ Q AI + +I W I GDI IIDP+L
Sbjct: 707 TSRLAEKSDIYSFGIVLLEMITSQHAIDRTRVK---HHITDWVVSLISRGDITRIIDPNL 763
Query: 824 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861
Y+ +S+W+ E A+ C P RP++S+V+ D++
Sbjct: 764 QGNYNSRSVWRALELAMSCANPTSEKRPNMSQVVIDLK 801
|
|
| TAIR|locus:2195850 AT1G51860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1136 (405.0 bits), Expect = 3.1e-115, P = 3.1e-115
Identities = 288/857 (33%), Positives = 453/857 (52%)
Query: 31 GFVSLNCG---GNENFTDE-IGLQWIAD-DHLIYGEISNISVANETR--KQYMTLRHFPA 83
GF+SL+CG +T++ + + +D D++ G + I+ A +T+ +Q +R FP
Sbjct: 28 GFISLDCGLVPKETTYTEKSTNITYKSDVDYIDSGLVGKINDAYKTQFQQQVWAVRSFPV 87
Query: 84 DSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVR 143
R CY +++ +YLIR TF+YGN+D N +P FD+ +GP WS++ I +
Sbjct: 88 GQRN-CYNVNLTANNKYLIRGTFVYGNYDGLNQFPSFDLHIGPNKWSSVKILGVTNTSMH 146
Query: 144 ELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGADS 203
E+I + ++VCL PFIS+LE+R N YLT L + AR+ F + S
Sbjct: 147 EIIHVVPQDSLEVCLVKTGPTTPFISSLEVRPLNNESYLTQSGS---LMLFARVYFPSSS 203
Query: 204 EAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVV 263
+ +RY +D DR+W S + D T +ST LPID + PQ VM+TA V
Sbjct: 204 SSFIRYDEDIHDRVWNS-------FTDDE---TVWISTDLPIDTSNSYDMPQSVMKTAAV 253
Query: 264 GTNGSLTYRL--NLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQE 321
N S + L LD + +FAE+++L +E+R+F + G + ++
Sbjct: 254 PKNASEPWLLWWTLDENTAQSYVYMHFAEVQNLTANETREFNITYNGG---LRWFSYLRP 310
Query: 322 NAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLE--RNDGSIDGV- 378
++ P + S + +F F T +S+ PLLNA+EI ++ + + + D V
Sbjct: 311 PNLSISTIFNPRAVSSSNG-IFNFTFAMTGNSTLPPLLNALEIYTVVDILQLETNKDEVS 369
Query: 379 AIVSVISLYSSADWAQEGGDPCLPVPWSW--LQCN-SDPQPS-ITVIHLSSKNLTGNIPS 434
A++++ Y + GDPC P + W L C+ D + S I ++L+ LTG+I S
Sbjct: 370 AMMNIKETYGLSKKISWQGDPCAPQLYRWEGLNCSYPDSEGSRIISLNLNGSELTGSITS 429
Query: 435 DLTKLSSLVEFGCPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYVQNNM-LSGT-VPSSL 492
D++KL+ L ++ L +N L+G + + + N L+ T +P SL
Sbjct: 430 DISKLTLLT--------VLDLSNNDLSGDIPTFFAEMKSLKLINLSGNPNLNLTAIPDSL 481
Query: 493 L----SKNVVLNYAGNINLHEGGRGAKHLNIIIXXXXXXXXXXXXXXXXCLFMHKGKKNN 548
SK++ L N+ L + +K + ++ F+ K K
Sbjct: 482 QQRVNSKSLTLILGENLTLTPK-KESKKVPMVAIAASVAGVFALLVILAIFFVIKRKNVK 540
Query: 549 YDKEQHRHSL--P--VQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYY 604
K L P V+ S N + T ++ T E+ +G GGFG VY+
Sbjct: 541 AHKSPGPPPLVTPGIVKSETRSSNPSIITRERKITYPEVLKMTNNFERVLGKGGFGTVYH 600
Query: 605 GKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 664
G L DG E+AVK+L+ +S QG +EF EV LL R+HHR+LV +GYC + L+YE+M
Sbjct: 601 GNL-DGAEVAVKMLSHSSAQGYKEFKAEVELLLRVHHRHLVGLVGYCDDGDNLALIYEYM 659
Query: 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 724
NG L+E++ G + W R++IA +AA+G+EYLH GC P ++HRD+K++NILL++
Sbjct: 660 ANGDLRENMSGKRGGNV-LTWENRMQIAVEAAQGLEYLHNGCRPPMVHRDVKTTNILLNE 718
Query: 725 HMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLEL 783
AK++DFGLS+ F +DG HVS++V GT GYLDPEYY + L++KSDVYSFGV+LLE+
Sbjct: 719 RCGAKLADFGLSRSFPIDGECHVSTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEI 778
Query: 784 ISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCV 843
++ Q I + +I W + GDI+ I+DP L+ +YD WKI E AL CV
Sbjct: 779 VTNQPVIDKTR---ERPHINDWVGFMLTKGDIKSIVDPKLMGDYDTNGAWKIVELALACV 835
Query: 844 LPHGHMRPSISEVLKDI 860
P + RP+++ V+ ++
Sbjct: 836 NPSSNRRPTMAHVVMEL 852
|
|
| TAIR|locus:2028446 AT1G49100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1129 (402.5 bits), Expect = 1.7e-114, P = 1.7e-114
Identities = 302/866 (34%), Positives = 445/866 (51%)
Query: 31 GFVSLNCG----GNENFTDEIGLQWIADDHLIY-GEISNISVANETR--KQYMTLRHFPA 83
GF++L+CG G+ GL + +D I G+ +S +E K ++TLR+FP
Sbjct: 29 GFITLDCGLLPDGSPYTNPSTGLTFTSDSSFIESGKNGRVSKDSERNFEKAFVTLRYFP- 87
Query: 84 DSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVR 143
D + CY L+V T YLIRA FLYGN+D N P FD+ +GP +T+ +
Sbjct: 88 DGERNCYNLNVTQGTNYLIRAAFLYGNYDGLNTVPNFDLFIGPNKVTTVNFNATGGGVFV 147
Query: 144 ELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGADS 203
E+I ++ S +D+CL T P ISTLELR Y++ L +N DS
Sbjct: 148 EIIHMSRSTPLDICLVKTGTTTPMISTLELRPLRSDTYISAIGSSLLLYFRGYLN---DS 204
Query: 204 EAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAV- 262
+RYPDD DR W S K+ + T V+T DL PQ M +A
Sbjct: 205 GVVLRYPDDVNDRRWFPFSYKEWK----IVTTTLNVNTSNGFDL------PQGAMASAAT 254
Query: 263 -VGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQP---DVSKAIVN 318
V NG+ + +L+ +FAE++ L +E+R+F ++L G+ S +++
Sbjct: 255 RVNDNGTWEFPWSLEDSTTRFHIYLHFAELQTLLANETREFNVLLNGKVYYGPYSPKMLS 314
Query: 319 IQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLE--RNDGSID 376
I + +P T + KT S+ PL+NA+E+ +E +++ + D
Sbjct: 315 IDTMSP------QPDSTLTCKGGSCLLQLVKTTKSTLPPLINAIELFTVVEFPQSETNQD 368
Query: 377 GVAIVSVISL-Y--SSADWAQEGGDPCLPVPWSW--LQC---NSDPQPSITVIHLSSKNL 428
V + I L Y S +W GDPC+P + W L+C NS P+IT ++LSS L
Sbjct: 369 EVIAIKKIQLTYGLSRINWQ---GDPCVPEQFLWAGLKCSNINSSTPPTITFLNLSSSGL 425
Query: 429 TGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYVQNNMLSGTV 488
TG I + L+ L E + L +N LTG + + N SG +
Sbjct: 426 TGIISPSIQNLTHLQE--------LDLSNNDLTGDVPEFLADIKSLLIINLSGNNFSGQL 477
Query: 489 PSSLLSKN-VVLNYAGNINL-----------HEGGRGAKHLNIIIXXXXXXXXXXXXXXX 536
P L+ K + LN GN L EGG K +II+
Sbjct: 478 PQKLIDKKRLKLNVEGNPKLLCTKGPCGNKPGEGGHPKK--SIIVPVVSSVALIAILIAA 535
Query: 537 XCLFMHKGKKN-NYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIG 595
LF+ KKN + KE R S + P + FT ++ + T +G
Sbjct: 536 LVLFLVLRKKNPSRSKENGRTSRSSEPPRITKKKK-------FTYVEVTEMTNNFRSVLG 588
Query: 596 SGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG 655
GGFG+VY+G + +++AVKVL+ S G ++F EV LL R+HH+NLV +GYC++
Sbjct: 589 KGGFGMVYHGYVNGREQVAVKVLSHASKHGHKQFKAEVELLLRVHHKNLVSLVGYCEKGK 648
Query: 656 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDL 715
LVYE+M NG LKE G + + W RL+IA +AA+G+EYLH GC P I+HRD+
Sbjct: 649 ELALVYEYMANGDLKEFFSGK-RGDDVLRWETRLQIAVEAAQGLEYLHKGCRPPIVHRDV 707
Query: 716 KSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVY 774
K++NILLD+H +AK++DFGLS+ F +G SHVS++V GT+GYLDPEYY + LT+KSDVY
Sbjct: 708 KTANILLDEHFQAKLADFGLSRSFLNEGESHVSTVVAGTIGYLDPEYYRTNWLTEKSDVY 767
Query: 775 SFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWK 834
SFGV+LLE+I+ Q I + +I +W L I GDI+ I+DP+L +Y S+WK
Sbjct: 768 SFGVVLLEIITNQRVIERTR---EKPHIAEWVNLMITKGDIRKIVDPNLKGDYHSDSVWK 824
Query: 835 IEEKALMCVLPHGHMRPSISEVLKDI 860
E A+ CV RP++++V+ ++
Sbjct: 825 FVELAMTCVNDSSATRPTMTQVVTEL 850
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 914 | |||
| pfam12819 | 335 | pfam12819, Malectin_like, Carbohydrate-binding pro | 2e-89 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-50 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-50 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-44 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-44 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-44 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-35 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-32 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-31 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-30 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-28 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-28 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-27 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-26 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-23 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-23 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-23 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-22 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-22 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-21 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-20 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-19 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-19 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-18 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-18 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-16 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-15 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-14 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-12 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 9e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-07 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 6e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 8e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.002 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.002 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER | Back alignment and domain information |
|---|
Score = 287 bits (737), Expect = 2e-89
Identities = 126/352 (35%), Positives = 180/352 (51%), Gaps = 36/352 (10%)
Query: 35 LNCG--GNENFTDEI-GLQWIADDHLIY-GEISNISVANETR---KQYMTLRHFPADSRK 87
++CG NE++TD G+ W++D I G+ NIS N + K Y TLR FP D ++
Sbjct: 1 IDCGLPSNESYTDPSTGITWVSDAGFIDTGKSGNISKENSSSFLSKPYKTLRSFP-DGKR 59
Query: 88 YCYKLDVIT--RTRYLIRATFLYGNFDNNN---VYPKFDISLGPTHWSTIVISDAA--TI 140
CY L V T+YLIRATFLYGN+D N P FD+ LG W+T+ +S+ + ++
Sbjct: 60 NCYTLPVTPGKGTKYLIRATFLYGNYDGLNSVSSPPSFDLYLGVNLWTTVNLSNDSGDSV 119
Query: 141 EVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFG 200
+I + S + VCL N TG PFIS LELR S+Y + L + AR+NFG
Sbjct: 120 VKEYIIHVTKSDTLSVCLVNTGTGTPFISALELRPLPDSLYPSSGGS-QALKLVARLNFG 178
Query: 201 ADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSD---ELPPQKV 257
+RYPDD +DRIWE + G ++ST L +D+ S+ +PP V
Sbjct: 179 GSEGT-IRYPDDVYDRIWEPFF---------SSPGWSQISTSLSVDISSNNAPYIPPSAV 228
Query: 258 MQTAVVGTNGSLTYRLNLD-GFPGFG-WAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKA 315
+QTAV TN S D P F + +FAEI+ L E+R+F + + G+
Sbjct: 229 LQTAVTPTNASAPLNFTWDLVDPNFEYYVYLHFAEIQSL---ETREFDIYINGKTVYGD- 284
Query: 316 IVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKY 367
V+ + +Y N+S +L+ T S+ PLLNA+EI K
Sbjct: 285 -VSPKYLGTDTGALYLDFPVNVSGGGLLNISLVPTSGSTLPPLLNALEIFKV 335
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 3e-50
Identities = 73/206 (35%), Positives = 111/206 (53%), Gaps = 13/206 (6%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGK-----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRN 643
L KK+G G FG VY GKLK E+AVK L + S Q EF E ++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 644 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 703
+V+ LG C EE +V E+M G L +L + +++ L A A+G+EYL
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 704 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 763
+ IHRDL + N L+ +++ K+SDFGLS+ D + + + ++ PE
Sbjct: 120 SKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLK 176
Query: 764 SQQLTDKSDVYSFGVILLELIS-GQE 788
+ T KSDV+SFGV+L E+ + G++
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQ 202
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 6e-50
Identities = 73/206 (35%), Positives = 111/206 (53%), Gaps = 12/206 (5%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGK-----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRN 643
L KK+G G FG VY G LK E+AVK L + S Q EF E ++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 644 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 703
+V+ LG C EE ++V E+M G L ++L + ++ L A A+G+EYL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 704 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 763
+ IHRDL + N L+ +++ K+SDFGLS+ D + + + ++ PE
Sbjct: 121 SKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 764 SQQLTDKSDVYSFGVILLELIS-GQE 788
+ T KSDV+SFGV+L E+ + G+E
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEE 203
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 2e-48
Identities = 75/204 (36%), Positives = 117/204 (57%), Gaps = 13/204 (6%)
Query: 594 IGSGGFGVVYYGK-LKDGKEIAVKVLT-SNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 651
+G GGFG VY + K GK++A+K++ +S E E+ +L +++H N+V+ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 652 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH-TGCVPAI 710
++E LV E+ G+LK+ L +E +++ + L I +G+EYLH G I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLHSNG----I 113
Query: 711 IHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ-LT 768
IHRDLK NILLD + + K++DFGLSK S + +IV GT Y+ PE + + +
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYS 172
Query: 769 DKSDVYSFGVILLELISGQEAISN 792
+KSD++S GVIL EL ++ I
Sbjct: 173 EKSDIWSLGVILYELPELKDLIRK 196
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 1e-45
Identities = 66/202 (32%), Positives = 112/202 (55%), Gaps = 15/202 (7%)
Query: 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 647
+ +K+G G FG VY + K GK +A+KV+ + RE E+ +L ++ H N+V+
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 705
++E + LV E+ G L + L G L+ ++ +++ +I +EYLH+
Sbjct: 63 YDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLR--QILS----ALEYLHSK 116
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 765
I+HRDLK NILLD+ K++DFGL++ +D +++ V GT Y+ PE + +
Sbjct: 117 G---IVHRDLKPENILLDEDGHVKLADFGLARQ-LDPGEKLTTFV-GTPEYMAPEVLLGK 171
Query: 766 QLTDKSDVYSFGVILLELISGQ 787
D++S GVIL EL++G+
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 2e-44
Identities = 73/204 (35%), Positives = 114/204 (55%), Gaps = 16/204 (7%)
Query: 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 646
L +K+GSG FG VY K K GK +AVK+L S + + E+ +L R+ H N+V+
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62
Query: 647 FLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 704
+ +++ LV E+ G L ++L G L+ ++ ++ +G+EYLH
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQI------LRGLEYLH- 115
Query: 705 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 764
IIHRDLK NILLD++ K++DFGL+K + +S +++ V GT Y+ PE +
Sbjct: 116 --SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLG 172
Query: 765 QQL-TDKSDVYSFGVILLELISGQ 787
K DV+S GVIL EL++G+
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 4e-44
Identities = 71/209 (33%), Positives = 107/209 (51%), Gaps = 22/209 (10%)
Query: 592 KKIGSGGFGVVYYGKLKDGK----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQ 646
KK+G G FG VY GKLK E+AVK L + S + +++F E ++ ++ H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 647 FLGYCQEEGRSVLVYEFMHNGTLKEHL-----YGTLTHEQRINWIKRLEIAEDAAKGIEY 701
LG C EE LV E+M G L ++L + ++ L A AKG+EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 702 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS-----IVRGTVGY 756
L + +HRDL + N L+ + + K+SDFGLS+ D + +R +
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173
Query: 757 LDPEYYISQQLTDKSDVYSFGVILLELIS 785
+ PE T KSDV+SFGV+L E+ +
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 6e-44
Identities = 69/204 (33%), Positives = 108/204 (52%), Gaps = 13/204 (6%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKE-----IAVKVLT-SNSYQGKREFTNEVTLLSRIHHRN 643
L KK+G G FG VY G LK E +AVK L S + + EF E +++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 644 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 703
+V+ LG C + +V E+M G L + L H +++ L++A AKG+EYL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFL---RKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 704 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYY 762
+ +HRDL + N L+ +++ K+SDFGLS+ D + + ++ PE
Sbjct: 120 SKN---FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 763 ISQQLTDKSDVYSFGVILLELISG 786
+ T KSDV+SFGV+L E+ +
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 60/204 (29%), Positives = 106/204 (51%), Gaps = 17/204 (8%)
Query: 592 KKIGSGGFGVVYYGKLKD-GKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
+ +G G FG VY KD G+ +AVK L+ +S + E+ +LS + H N+V++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 649 G-YCQEEGRSVLVY-EFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 704
G EE ++ ++ E++ G+L L +G L I++ +G+ YLH+
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV----IRKY--TRQILEGLAYLHS 119
Query: 705 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-SHVSSIVRGTVGYLDPEYYI 763
I+HRD+K +NIL+D K++DFG +K D + VRGT ++ PE
Sbjct: 120 NG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 764 SQQLTDKSDVYSFGVILLELISGQ 787
++ +D++S G ++E+ +G+
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 8e-35
Identities = 69/200 (34%), Positives = 111/200 (55%), Gaps = 15/200 (7%)
Query: 592 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 650
+KIG GGFG VY + + GKE+A+KV+ S + K + NE+ +L + H N+V++ G
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 651 CQEEGRSVLVYEFMHNGTLKE---HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
++ +V EF G+LK+ TLT E +I ++ + + KG+EYLH+
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLLKSTNQTLT-ESQIAYVCK-----ELLKGLEYLHSN-- 117
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 767
IIHRD+K++NILL K+ DFGLS D + + + GT ++ PE +
Sbjct: 118 -GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVINGKPY 174
Query: 768 TDKSDVYSFGVILLELISGQ 787
K+D++S G+ +EL G+
Sbjct: 175 DYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 62/198 (31%), Positives = 107/198 (54%), Gaps = 7/198 (3%)
Query: 589 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
K++GSG FGVV+ GK + ++A+K++ + + +F E ++ ++ H NLVQ
Sbjct: 7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLY 65
Query: 649 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 708
G C ++ +V E+M NG L +L + ++ L++ D + +EYL +
Sbjct: 66 GVCTKQRPIFIVTEYMANGCLLNYLR---ERKGKLGTEWLLDMCSDVCEAMEYLESNGF- 121
Query: 709 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 768
IHRDL + N L+ + KVSDFGL+++ +D S + V + PE + + +
Sbjct: 122 --IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179
Query: 769 DKSDVYSFGVILLELISG 786
KSDV+SFGV++ E+ S
Sbjct: 180 SKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-31
Identities = 68/195 (34%), Positives = 111/195 (56%), Gaps = 9/195 (4%)
Query: 592 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 651
K++G+G FGVV YGK + ++A+K++ S + EF E ++ ++ H LVQ G C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 652 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 711
++ +V E+M NG L +L H +R + LE+ +D +G+ YL + I
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLR---EHGKRFQPSQLLEMCKDVCEGMAYLES---KQFI 122
Query: 712 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-VRGTVGYLDPEYYISQQLTDK 770
HRDL + N L+D KVSDFGLS++ +D + SS+ + V + PE + + + K
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLLYSKFSSK 181
Query: 771 SDVYSFGVILLELIS 785
SDV++FGV++ E+ S
Sbjct: 182 SDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 3e-31
Identities = 63/204 (30%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 592 KKIGSGGFGVVYYGKL-----KDGKEIAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLV 645
K++G G FG V + G+++AVK L S Q + +F E+ +L + H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 646 QFLGYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 703
++ G C++ G L+ E++ +G+L+++L H +IN + L + KG++YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLG 126
Query: 704 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV--DGASHVSSIVRGTVGYLDPEY 761
+ IHRDL + NIL++ K+SDFGL+K +V + + PE
Sbjct: 127 S---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183
Query: 762 YISQQLTDKSDVYSFGVILLELIS 785
+ + + SDV+SFGV L EL +
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 3e-31
Identities = 131/492 (26%), Positives = 222/492 (45%), Gaps = 83/492 (16%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
+ + LS L+G IP +L+ LV + L NQL+G +P+S +P L
Sbjct: 499 SELMQLKLSENKLSGEIPDELSSCKKLVS--------LDLSHNQLSGQIPASFSEMPVLS 550
Query: 476 ELYVQNNMLSGTVPS------SLLSKNVVLNY-------------------AGNINLHEG 510
+L + N LSG +P SL+ N+ N+ AGNI+L G
Sbjct: 551 QLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGG 610
Query: 511 G-----------RGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDK--EQHRHS 557
R I ++GA L+LA V +G+ N K E +
Sbjct: 611 DTTSGLPPCKRVRKTPSWWFYITCTLGA-FLVLALVAFGFVFIRGRNNLELKRVENEDGT 669
Query: 558 LPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVK 616
+Q S + + T++DI + K E I G G Y GK +K+G + VK
Sbjct: 670 WELQFFDS-------KVSKSITINDILSSLKE-ENVISRGKKGASYKGKSIKNGMQFVVK 721
Query: 617 -VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG 675
+ NS ++E+ + ++ H N+V+ +G C+ E + L++E++ L E L
Sbjct: 722 EINDVNSIP-----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN 776
Query: 676 TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD--KHMRAKVSDF 733
++W +R +IA AK + +LH C PA++ +L I++D ++S
Sbjct: 777 -------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLP 829
Query: 734 GLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 793
GL D +SS Y+ PE ++ +T+KSD+Y FG+IL+EL++G+ ++
Sbjct: 830 GL--LCTDTKCFISS------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSP-ADA 880
Query: 794 KFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI--QSMWKIEEKALMCVLPHGHMRP 851
+FG + +IV+WA+ + IDPS+ + + + ++ AL C RP
Sbjct: 881 EFGVH-GSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP 939
Query: 852 SISEVLKDIQDA 863
++VLK ++ A
Sbjct: 940 CANDVLKTLESA 951
|
Length = 968 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 4e-30
Identities = 78/284 (27%), Positives = 131/284 (46%), Gaps = 48/284 (16%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-TSNSYQGKREFT-NEVTLLSRIHHRNLVQ 646
+ K+IG G FG VY + DGK +K + SN + +RE NEV +L +++H N+++
Sbjct: 4 IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK 63
Query: 647 FLGYCQEEGRSVLVYEFMHNGTLKEHL------YGTLTHEQRINWIKRLEIAEDAAKGIE 700
+ +E+G+ +V E+ G L + + EQ ++W +L ++
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL------CLALK 117
Query: 701 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 760
YLH+ I+HRD+K NI L + K+ DFG+SK ++V GT YL PE
Sbjct: 118 YLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE 173
Query: 761 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE------SGD 814
++ KSD++S G +L EL + + E I+ K S +
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL---KGQYPPIPSQYSSE 230
Query: 815 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 858
++ ++ SLL K E+ RPSI+++L+
Sbjct: 231 LRNLVS-SLL--------QKDPEE-----------RPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 65/199 (32%), Positives = 108/199 (54%), Gaps = 13/199 (6%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 649
L ++IGSG FG+V+ G + +++A+K + + +F E ++ ++ H LVQ G
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 706
C E LV+EFM +G L ++L G + E L + D +G+ YL +
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQE------TLLGMCLDVCEGMAYLESSN 120
Query: 707 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 766
V IHRDL + N L+ ++ KVSDFG+++F +D S+ + V + PE + +
Sbjct: 121 V---IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSK 177
Query: 767 LTDKSDVYSFGVILLELIS 785
+ KSDV+SFGV++ E+ S
Sbjct: 178 YSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 74/202 (36%), Positives = 103/202 (50%), Gaps = 20/202 (9%)
Query: 594 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 649
+G G FG V + KD GK A+KVL ++E E +LSRI+H +V+ L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK-LH 59
Query: 650 YC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHT-G 705
Y Q E + LV E+ G L HL G + E+R R AE +EYLH+ G
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFS-EERA----RFYAAE-IVLALEYLHSLG 113
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 765
II+RDLK NILLD K++DFGL+K S ++ GT YL PE + +
Sbjct: 114 ----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGK 168
Query: 766 QLTDKSDVYSFGVILLELISGQ 787
D +S GV+L E+++G+
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 9e-29
Identities = 66/192 (34%), Positives = 103/192 (53%), Gaps = 11/192 (5%)
Query: 594 IGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE 653
IG G FG V G + G+++AVK L +S + F E ++++ + H NLVQ LG +
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 654 EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHR 713
+V E+M G+L ++L I ++L A D +G+EYL +HR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEE---KNFVHR 126
Query: 714 DLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDV 773
DL + N+L+ + + AKVSDFGL+K AS + V + PE ++ + KSDV
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKKFSTKSDV 182
Query: 774 YSFGVILLELIS 785
+SFG++L E+ S
Sbjct: 183 WSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 119 bits (297), Expect = 1e-28
Identities = 70/212 (33%), Positives = 110/212 (51%), Gaps = 19/212 (8%)
Query: 589 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVL---TSNSYQGKREFTNEVTLLSRI-HHRNL 644
+ +K+G G FG VY + D K +A+KVL + + F E+ +L+ + H N+
Sbjct: 3 RILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 645 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 704
V+ + Q+EG LV E++ G+L++ L + + ++ + L I +EYLH+
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILAQILSALEYLHS 119
Query: 705 GCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVS-----SIVRGTVGYLD 758
IIHRD+K NILLD+ K+ DFGL+K D S S S GT GY+
Sbjct: 120 KG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 759 PEYYISQQL---TDKSDVYSFGVILLELISGQ 787
PE + L + SD++S G+ L EL++G
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 61/196 (31%), Positives = 103/196 (52%), Gaps = 6/196 (3%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 649
LE+K+GSG FG V+ G K+ +A+K+L S+ +++F EV L R+ H++L+
Sbjct: 10 LERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFA 69
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 709
C ++ E M G+L L Q + +++A A+G+ YL
Sbjct: 70 VCSVGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLEE---QN 124
Query: 710 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 769
IHRDL + NIL+ + + KV+DFGL++ + ++SS + + PE +
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-YLSSDKKIPYKWTAPEAASHGTFST 183
Query: 770 KSDVYSFGVILLELIS 785
KSDV+SFG++L E+ +
Sbjct: 184 KSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 7/203 (3%)
Query: 582 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 640
++E ++ K+G G +G VY G K +AVK L ++ + + EF E ++ I
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 60
Query: 641 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 700
H NLVQ LG C E ++ EFM G L ++L + Q +N + L +A + +E
Sbjct: 61 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAME 118
Query: 701 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 760
YL IHRDL + N L+ ++ KV+DFGLS+ + + + + PE
Sbjct: 119 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 175
Query: 761 YYISQQLTDKSDVYSFGVILLEL 783
+ + KSDV++FGV+L E+
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 68/197 (34%), Positives = 105/197 (53%), Gaps = 8/197 (4%)
Query: 592 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGY 650
+KIG G FG VY G LK E+AVK S KR+F E +L + H N+V+ +G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 651 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 710
C ++ +V E + G+L L + R+ K L+++ DAA G+EYL +
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESKNC--- 114
Query: 711 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT-VGYLDPEYYISQQLTD 769
IHRDL + N L+ ++ K+SDFG+S+ G VS ++ + + PE + T
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 770 KSDVYSFGVILLELISG 786
+SDV+S+G++L E S
Sbjct: 175 ESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 57/204 (27%), Positives = 103/204 (50%), Gaps = 15/204 (7%)
Query: 589 MLEKKIGSGGFGVVYYG-KLKDGKEIAVK--VLTSNSYQGKREFTNEVTLLSRIHHRNLV 645
L IG G FGVVY G L+ G +A+K L + + E+ LL + H N+V
Sbjct: 3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIV 62
Query: 646 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 703
+++G + ++ E+ NG+L++ + +G ++ ++ +G+ YLH
Sbjct: 63 KYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQV------LQGLAYLH 116
Query: 704 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 763
+IHRD+K++NIL K K++DFG++ ++ S + V GT ++ PE
Sbjct: 117 E---QGVIHRDIKAANILTTKDGVVKLADFGVAT-KLNDVSKDDASVVGTPYWMAPEVIE 172
Query: 764 SQQLTDKSDVYSFGVILLELISGQ 787
+ SD++S G ++EL++G
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 592 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 650
+KIG G G VY GKE+A+K + Q K NE+ ++ H N+V +
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYD- 82
Query: 651 CQEEGRSV-LVYEFMHNGTLKEHLYGTLT--HEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
G + +V E+M G+L + + +E +I ++ R E+ + G+EYLH+
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCR-EVLQ----GLEYLHSQ-- 135
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD---GASHVSSIVRGTVGYLDPEYYIS 764
+IHRD+KS NILL K K++DFG FA S +S+V GT ++ PE
Sbjct: 136 -NVIHRDIKSDNILLSKDGSVKLADFG---FAAQLTKEKSKRNSVV-GTPYWMAPEVIKR 190
Query: 765 QQLTDKSDVYSFGVILLELISGQ 787
+ K D++S G++ +E+ G+
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 64/197 (32%), Positives = 107/197 (54%), Gaps = 13/197 (6%)
Query: 592 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 651
K++GSG FGVV+ GK + ++A+K + + + +F E ++ ++ H LVQ G C
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 652 QEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 708
++ +V EFM NG L +L G L+ + L + +D +G+EYL
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML------LSMCQDVCEGMEYLERN--- 119
Query: 709 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 768
+ IHRDL + N L+ KVSDFG++++ +D SS + V + PE + + +
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS 179
Query: 769 DKSDVYSFGVILLELIS 785
KSDV+SFGV++ E+ +
Sbjct: 180 SKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 64/203 (31%), Positives = 107/203 (52%), Gaps = 20/203 (9%)
Query: 594 IGSGGFGVVYYG-KLKDGKEIAVKV--LTSNSYQGK---REFTNEVTLLSRIHHRNLVQF 647
+GSG FG VY G L DG AVK L + G+ ++ E+ LLS++ H N+VQ+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 705
LG +EE + E + G+L + L YG+ + +++ G+EYLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQI------LLGLEYLHDR 121
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 765
+HRD+K +NIL+D + K++DFG++K V+ + S +G+ ++ PE Q
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVIAQQ 176
Query: 766 QLTD-KSDVYSFGVILLELISGQ 787
+D++S G +LE+ +G+
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 59/205 (28%), Positives = 108/205 (52%), Gaps = 16/205 (7%)
Query: 589 MLEKKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRN 643
+EK IG G FG V G+L K ++A+K L + S +R +F E +++ + H N
Sbjct: 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 644 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 703
+++ G + +++ E+M NG+L + L ++ + + + + A G++YL
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLR---ENDGKFTVGQLVGMLRGIASGMKYLS 123
Query: 704 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG---TVGYLDPE 760
+HRDL + NIL++ ++ KVSDFGLS+ S + +G + + PE
Sbjct: 124 EMNY---VHRDLAARNILVNSNLVCKVSDFGLSR--RLEDSEATYTTKGGKIPIRWTAPE 178
Query: 761 YYISQQLTDKSDVYSFGVILLELIS 785
++ T SDV+SFG+++ E++S
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 14/208 (6%)
Query: 582 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 641
+I+ + L +K+G+G FG V+ G + +AVK L + K +F E ++ ++ H
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRH 60
Query: 642 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG----TLTHEQRINWIKRLEIAEDAAK 697
L+Q C E +V E M G+L E+L G L Q I ++A A
Sbjct: 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI------DMAAQVAS 114
Query: 698 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 757
G+ YL IHRDL + N+L+ ++ KV+DFGL++ + + + +
Sbjct: 115 GMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT 171
Query: 758 DPEYYISQQLTDKSDVYSFGVILLELIS 785
PE + + + KSDV+SFG++L E+++
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 27/217 (12%)
Query: 590 LEKKIGSGGFGVVYYGKL-----KDGKEI-AVKVLT-SNSYQGKREFTNEVTLLSRIHHR 642
L++++G G FG V+ G+ ++ KE+ AVK L + S +++F E LL+ H
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 643 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL----------YGTLTHEQRINWIKRLEIA 692
N+V+F G C E ++V+E+M +G L + L + + + L+IA
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 693 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG 752
A G+ YL + +HRDL + N L+ + K+ DFG+S+ D + V G
Sbjct: 129 VQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVVKIGDFGMSR---DVYTTDYYRVGG 182
Query: 753 T----VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
+ ++ PE + ++ T +SDV+SFGV+L E+ +
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 62/201 (30%), Positives = 102/201 (50%), Gaps = 15/201 (7%)
Query: 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLG 649
K +G G GVVY + K GK A+K + + + +++ E+ L +V+ G
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL---EIAEDAAKGIEYLHTGC 706
+EG +V E+M G+L + L +++ I IA KG++YLHT
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLL-------KKVGKIPEPVLAYIARQILKGLDYLHT-- 117
Query: 707 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 766
IIHRD+K SN+L++ K++DFG+SK + ++ V GTV Y+ PE +
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGES 176
Query: 767 LTDKSDVYSFGVILLELISGQ 787
+ +D++S G+ LLE G+
Sbjct: 177 YSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 60/196 (30%), Positives = 103/196 (52%), Gaps = 6/196 (3%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 649
LE+K+G+G FG V+ G ++AVK L + F E ++ ++ H LVQ
Sbjct: 10 LERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQLYA 68
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 709
C EE +V E+M G+L + L + R+ + +++A A+G+ YL +
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLP--QLVDMAAQIAEGMAYLES---RN 123
Query: 710 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 769
IHRDL + NIL+ +++ K++DFGL++ D + + + PE + T
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTI 183
Query: 770 KSDVYSFGVILLELIS 785
KSDV+SFG++L E+++
Sbjct: 184 KSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-25
Identities = 145/593 (24%), Positives = 242/593 (40%), Gaps = 83/593 (13%)
Query: 13 VASVLILLLLDSSSAQMPGFVSLNCGGNENF-TDEIGLQWIADDHLIYGEISNISVANET 71
+A+ +L +L S ++ P + ++CG N T W D G +N + +
Sbjct: 6 LAASALLAVLASLASPEPFTMRISCGARVNVRTAPTNTLWYKDFAYTGGIPANATRPSFI 65
Query: 72 RKQYMTLRHFP-ADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWS 130
TLR+FP +D + CY ++ + + Y +R F N + P FD+S+ T S
Sbjct: 66 APPLKTLRYFPLSDGPENCYNINRVPKGHYSVRVFFGLVAEPNFDSEPLFDVSVEGTQIS 125
Query: 131 TIVI---SDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYL--TPF 185
++ S + L+FL +C + G P I ++E+ Q + Y +
Sbjct: 126 SLKSGWSSHDEQVFAEALVFLTDG-SASICFHSTGHGDPAILSIEILQVDDKAYNFGPSW 184
Query: 186 EDRYYLSVSARINFGA-DSEAPVRYPDDPF--DRIWESDSLKKANYLVDVAAGTEKVSTK 242
L + R++ GA S+ Y D + DR W + D A TE V K
Sbjct: 185 GQGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSG--SDQAISTENVIKK 242
Query: 243 LPIDLRSDELPPQKVMQTAVVGTNG--SLTYRLNLDGFPGFGWAV-TYFAEIED-LDPDE 298
+ P+ + Q+A+V T+ L+Y +++D P ++V +FAEI++ + +
Sbjct: 243 A---SNAPNFYPESLYQSALVSTDTQPDLSYTMDVD--PNRNYSVWLHFAEIDNSITAEG 297
Query: 299 SRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLP---FVLSFKFGKTYDSSR 355
R F +++ G D + V+I + + + YT L L V +
Sbjct: 298 KRVFDVLING--DTAFKDVDIVKMSGER-------YTALVLNKTVAVSGRTLTIVLQPKK 348
Query: 356 GP--LLNAMEINKYLERNDGSIDGVA-----IVSVISLYSSADWAQEGGDPCLPV--PWS 406
G ++NA+E+ + + ++ + S + L W GDPC+P PWS
Sbjct: 349 GTHAIINAIEVFEIITAESKTLLEEVSALQTLKSSLGLPLRFGW---NGDPCVPQQHPWS 405
Query: 407 WLQCNSDPQPS---ITVIHLSSKNLTGNIPSDLTKLSSL---------------VEFG-C 447
C D I + L ++ L G IP+D++KL L G
Sbjct: 406 GADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSI 465
Query: 448 PDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGN 504
L ++ L N G +P SL L +LR L + N LSG VP++L L N+ N
Sbjct: 466 TSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
Query: 505 INL------HEGGR----GAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKN 547
L G GAK IG + G +V L V+ + K ++N
Sbjct: 526 AGLCGIPGLRACGPHLSVGAK-----IGIAFGVSVAFLFLVICAMCWWKRRQN 573
|
Length = 623 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 47/219 (21%)
Query: 592 KKIGSGGFGVV---YYGKLKD--GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 646
+++G G FG V Y L+D G+ +AVK L ++ + R+F E+ +L + H N+V+
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 647 FLGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 704
+ G C GR LV E++ G+L+++L H +R++ K L A KG+EYL +
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYLGS 126
Query: 705 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 764
+HRDL + NIL++ R K+ DFGL+K V D EYY
Sbjct: 127 ---KRYVHRDLATRNILVESENRVKIGDFGLTK----------------VLPQDKEYYKV 167
Query: 765 QQ-------------LTD-----KSDVYSFGVILLELIS 785
++ LT+ SDV+SFGV+L EL +
Sbjct: 168 REPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 69/231 (29%), Positives = 111/231 (48%), Gaps = 34/231 (14%)
Query: 578 FTLSDIEDATKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLT-SNSYQGKREFT 630
LS + +++G G FG VY G+L +A+K L + + ++EF
Sbjct: 2 IPLSAVR-----FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR 56
Query: 631 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE---------- 680
E L+S + H N+V LG C +E + +++E++ +G L E L H
Sbjct: 57 QEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDET 116
Query: 681 --QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 738
++ L IA A G+EYL + +HRDL + N L+ + + K+SDFGLS+
Sbjct: 117 VKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSR- 172
Query: 739 AVDGASH----VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
D S V S V ++ PE + + T +SD++SFGV+L E+ S
Sbjct: 173 --DIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 68/227 (29%), Positives = 105/227 (46%), Gaps = 39/227 (17%)
Query: 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREF-TNEVTLLSRI-HHR 642
K IG G F V K K KE A+K+L + K ++ E +L+R+ H
Sbjct: 4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKIL-DKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 643 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 700
+++ Q+E V E+ NG L +++ YG+L E+ + AE +E
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLD-EKCTRFY----AAE-ILLALE 116
Query: 701 YLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF----------AVDGASHVSSI 749
YLH+ G IIHRDLK NILLDK M K++DFG +K D + S I
Sbjct: 117 YLHSKG----IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 750 VR---------GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 787
+ GT Y+ PE + SD+++ G I+ ++++G+
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 15/217 (6%)
Query: 594 IGSGGFG-VVYYGKLKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 650
+G G FG Y + +D + K LT S + +R+ NE+ +LS + H N++ + +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 651 CQEEGRSVLVYEFMHNGTLKE---HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
++ ++ E+ + GTL + G L E+ + W + Y+H
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY-----LFQIVSAVSYIHKA-- 120
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 767
I+HRD+K+ NI L K K+ DFG+SK S ++V GT Y+ PE +
Sbjct: 121 -GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKY 178
Query: 768 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 804
KSD+++ G +L EL++ + IVQ
Sbjct: 179 NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 66/196 (33%), Positives = 106/196 (54%), Gaps = 13/196 (6%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 649
L + IG G FG V G+ G+++AVK + + + F E +++++HH+NLV+ LG
Sbjct: 10 LGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLG 66
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 709
G + V E M G L L ++ I+ L+ + D A+G+EYL +
Sbjct: 67 VILHNGLYI-VMELMSKGNLVNFL--RTRGRALVSVIQLLQFSLDVAEGMEYLES---KK 120
Query: 710 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 769
++HRDL + NIL+ + AKVSDFGL++ G + V+ T PE ++ +
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTA----PEALKHKKFSS 176
Query: 770 KSDVYSFGVILLELIS 785
KSDV+S+GV+L E+ S
Sbjct: 177 KSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 67/200 (33%), Positives = 107/200 (53%), Gaps = 18/200 (9%)
Query: 592 KKIGSGGFGVVYYGKLK-DGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
KKIG G FG +Y K K D + +K LT + K EV LL+++ H N+V F
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 649 GYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHT 704
QE GR +V E+ G L + + G L E +I +W ++ + G++++H
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIHD 119
Query: 705 GCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 763
I+HRD+KS NI L K+ M AK+ DFG+++ ++ + ++ GT YL PE
Sbjct: 120 ---RKILHRDIKSQNIFLSKNGMVAKLGDFGIAR-QLNDSMELAYTCVGTPYYLSPEICQ 175
Query: 764 SQQLTDKSDVYSFGVILLEL 783
++ +K+D++S G +L EL
Sbjct: 176 NRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 4e-23
Identities = 64/197 (32%), Positives = 105/197 (53%), Gaps = 13/197 (6%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 649
L + IG G FG V G + G ++AVK + +++ + F E ++++++ H NLVQ LG
Sbjct: 10 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLG 66
Query: 650 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 708
EE + +V E+M G+L ++L + L+ + D + +EYL
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN--- 121
Query: 709 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 768
+HRDL + N+L+ + AKVSDFGL+K AS + V + PE ++ +
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFS 177
Query: 769 DKSDVYSFGVILLELIS 785
KSDV+SFG++L E+ S
Sbjct: 178 TKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 4e-23
Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 21/205 (10%)
Query: 592 KKIGSGGFGVVYYGKLKD-GKEIAVKVLT--SNSYQGKRE---FTNEVTLLSRIHHRNLV 645
K +G G FG VY D G+E+AVK + +S + K+E E+ LL + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 646 QFLGYCQEEGRSVLVY-EFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYL 702
Q+ G C + ++ ++ E+M G++K+ L YG LT + + +I E G+EYL
Sbjct: 68 QYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR--QILE----GVEYL 120
Query: 703 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI--VRGTVGYLDPE 760
H+ I+HRD+K +NIL D K+ DFG SK S + + V GT ++ PE
Sbjct: 121 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177
Query: 761 YYISQQLTDKSDVYSFGVILLELIS 785
+ K+DV+S G ++E+++
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 8e-23
Identities = 67/203 (33%), Positives = 105/203 (51%), Gaps = 19/203 (9%)
Query: 592 KKIGSGGFGVVYYG--KLKDGKEI--AVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQ 646
K++G G FG V G +K GKE+ AVK L GK+EF E ++++++ H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 647 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 706
+G C+ E +LV E G L ++L + I E+A A G+ YL +
Sbjct: 61 LIGVCKGEP-LMLVMELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLES-- 113
Query: 707 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPE--YY 762
+HRDL + N+LL +AK+SDFG+S+ G+ + + G + + PE Y
Sbjct: 114 -KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 763 ISQQLTDKSDVYSFGVILLELIS 785
+ + KSDV+S+GV L E S
Sbjct: 173 --GKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 66/209 (31%), Positives = 114/209 (54%), Gaps = 23/209 (11%)
Query: 590 LEKKIGSGGFGVVYYGKLK-DGKE---IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNL 644
+E+ IG+G FG V G+LK GK +A+K L S + + +R+F +E +++ + H N+
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 645 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 704
+ G + +++ EFM NG L L ++ + I+ + + A G++YL
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLSE 124
Query: 705 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS---HVSSI-----VRGTVGY 756
+HRDL + NIL++ ++ KVSDFGLS+F D S + SS+ +R T
Sbjct: 125 ---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA-- 179
Query: 757 LDPEYYISQQLTDKSDVYSFGVILLELIS 785
PE ++ T SDV+S+G+++ E++S
Sbjct: 180 --PEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 3e-22
Identities = 62/210 (29%), Positives = 114/210 (54%), Gaps = 13/210 (6%)
Query: 583 IEDATKMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLT---SNSYQGKREFTNEVTLLS 637
I+ + +EK IG+G FG V G+LK +EI V + T + + +R+F +E +++
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMG 60
Query: 638 RIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK 697
+ H N++ G + ++V E+M NG+L L H+ + I+ + + A
Sbjct: 61 QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLR---KHDGQFTVIQLVGMLRGIAS 117
Query: 698 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--ASHVSSIVRGTVG 755
G++YL +HRDL + NIL++ ++ KVSDFGLS+ D A++ + + +
Sbjct: 118 GMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 174
Query: 756 YLDPEYYISQQLTDKSDVYSFGVILLELIS 785
+ PE ++ T SDV+S+G+++ E++S
Sbjct: 175 WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 5e-22
Identities = 58/196 (29%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 649
L KK+G+G FG V+ G ++A+K L S F E L+ ++ H LV+
Sbjct: 10 LVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYA 68
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 709
+E ++ E+M NG+L + L + IN K +++A A+G+ ++
Sbjct: 69 VVTQE-PIYIITEYMENGSLVDFLKTPEGIKLTIN--KLIDMAAQIAEGMAFIE---RKN 122
Query: 710 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 769
IHRDL+++NIL+ + + K++DFGL++ D + + + PE T
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 182
Query: 770 KSDVYSFGVILLELIS 785
KSDV+SFG++L E+++
Sbjct: 183 KSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 62/218 (28%), Positives = 109/218 (50%), Gaps = 9/218 (4%)
Query: 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQ 646
+ KIG G FGVV+ K D + A+K L+ + + + E +E +L+++ +++
Sbjct: 4 ILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIR 63
Query: 647 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 706
+ ++G+ +V E+ NG L + L + + R I G+ +LH+
Sbjct: 64 YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI--QILLGLAHLHSK- 120
Query: 707 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 766
I+HRD+KS N+ LD + K+ D G++K D + ++IV GT YL PE +
Sbjct: 121 --KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPELCEDKP 177
Query: 767 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 804
+KSDV++ GV+L E +G+ GA I++
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 5e-22
Identities = 77/278 (27%), Positives = 131/278 (47%), Gaps = 37/278 (13%)
Query: 594 IGSGGFGVVYYGKLKDGKEIAVKVL---TSNSYQGKREFTN---EVTLLSRIHHRNLVQF 647
+G G +G VY G G+ IAVK + TSN ++E+ EV LL + H N+VQ+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 705
LG C ++ + EF+ G++ L +G L + K++ G+ YLH
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI------LDGVAYLHNN 121
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSS----IVRGTVGYLDPE 760
CV +HRD+K +N++L + K+ DFG + + A G S + GT ++ PE
Sbjct: 122 CV---VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 761 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 820
KSD++S G + E+ +G+ +++ A A +I G +G++
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--------AMFYI--GAHRGLM- 227
Query: 821 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 858
P L D + ++ + C+ H RPS ++L+
Sbjct: 228 PRLPDSFSAAAI----DFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 6e-22
Identities = 59/196 (30%), Positives = 100/196 (51%), Gaps = 7/196 (3%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 649
LE K+G G FG V+ G +A+K L + F E ++ ++ H LVQ
Sbjct: 10 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA 68
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 709
EE +V E+M G+L + L G + R+ + +++A A G+ Y+
Sbjct: 69 VVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVER---MN 122
Query: 710 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 769
+HRDL+++NIL+ +++ KV+DFGL++ D + + + PE + + T
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 770 KSDVYSFGVILLELIS 785
KSDV+SFG++L EL +
Sbjct: 183 KSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 8e-22
Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 593 KIGSGGFGVVYYGKLKDGKEI-AVK-VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 650
++G G G V +LK+ I A+K + T + +++ E+ + +V++ G
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 651 CQEEGRSVL--VYEFMHNGTLKEHLYG-TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
+E S + E+ G+L + +Y RI +IAE KG+ YLH+
Sbjct: 68 FLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS--- 123
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 767
IIHRD+K SNILL + + K+ DFG+S V + ++ GT Y+ PE +
Sbjct: 124 RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV---NSLAGTFTGTSFYMAPERIQGKPY 180
Query: 768 TDKSDVYSFGVILLELISG 786
+ SDV+S G+ LLE+
Sbjct: 181 SITSDVWSLGLTLLEVAQN 199
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 73/252 (28%), Positives = 106/252 (42%), Gaps = 40/252 (15%)
Query: 594 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQFLG 649
I G +G V+ K K +I A+KV+ K + E +LS+ +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 650 YCQEEGRSVLVYEFMHNGTLKE--HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
Q + LV E++ G L G+L + + R+ IAE +EYLH+
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDED-----VARIYIAE-IVLALEYLHSN-- 112
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV--------DGASHVSSIVRGTVGYLDP 759
IIHRDLK NIL+D + K++DFGLSK + D IV GT Y+ P
Sbjct: 113 -GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV-GTPDYIAP 170
Query: 760 EYYISQQLTDKSDVYSFGVILLELISG----QEAISNEKFGANCRNIVQWAKLHIESGDI 815
E + Q + D +S G IL E + G E F +I +G I
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQ------------NILNGKI 218
Query: 816 QGIIDPSLLDEY 827
+ D + DE
Sbjct: 219 EWPEDVEVSDEA 230
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 77/278 (27%), Positives = 125/278 (44%), Gaps = 40/278 (14%)
Query: 592 KKIGSGGFGVVYYGKLKDG------KEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV 645
+ +G G FG+V+ + K K+I V+ +T + + NE +L + H N++
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNII 62
Query: 646 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 705
++ E+ ++V E+ GTL E++ ++ + + I + + LH
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYI-----QKRCNSLLDEDTILHFFVQILLALHHV 117
Query: 706 CVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 764
I+HRDLK+ NILLDKH M K+ DFG+SK + + + V GT Y+ PE
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISK--ILSSKSKAYTVVGTPCYISPELCEG 175
Query: 765 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID---P 821
+ KSD+++ G +L EL S + A AN +V L I SG I D P
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAFE----AANLPALV----LKIMSGTFAPISDRYSP 227
Query: 822 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859
L I SM + RP +S+++
Sbjct: 228 DL--RQLILSMLNL----------DPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 20/206 (9%)
Query: 592 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQFL 648
KIG G FG VY L G+ +AVK + K +E +E+ +L + H NLV++
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 649 GYCQEEGRSVLVYEFMHNGTLKEHL-YGTLTHEQRIN-WIKRLEIAEDAAKGIEYLHTGC 706
G + + E+ GTL+E L +G + E I + +L +G+ YLH+
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL------LEGLAYLHSH- 118
Query: 707 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG---YLDPEYYI 763
I+HRD+K +NI LD + K+ DFG + + + + V+ G Y+ PE
Sbjct: 119 --GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 764 SQQLTDK---SDVYSFGVILLELISG 786
+ +D++S G ++LE+ +G
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATG 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 3e-21
Identities = 68/295 (23%), Positives = 128/295 (43%), Gaps = 58/295 (19%)
Query: 594 IGSGGFGVVYYGKLK----DGKE--IAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQ 646
+G G FG V+ K K +G E + VK L + + EF E+ + ++ H+N+V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 647 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE-----QRINWIKRLEIAEDAAKGIEY 701
LG C+E ++ E+ G LK+ L T + + ++ +++ + A G+++
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 702 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGASHVSSIVRGTVGYLDP 759
L +HRDL + N L+ KVS LSK + + ++++ + +L P
Sbjct: 133 LSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI--PLRWLAP 187
Query: 760 EYYISQQLTDKSDVYSFGVILLELISGQE----AISNEKFGANCRNIVQWAKLHIESGDI 815
E + KSDV+SFGV++ E+ + E +S+E+ +++G +
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR-----------LQAGKL 236
Query: 816 QGIIDPSLLDEYDIQSMWKIEEKA------LM--CVLPHGHMRPSISEVLKDIQD 862
+ + E LM C + RPS SE++ + +
Sbjct: 237 E----------------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 59/202 (29%), Positives = 113/202 (55%), Gaps = 13/202 (6%)
Query: 591 EKKIGSGGFGVVYYGKLK-DGKE---IAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLV 645
+K IG+G FG V+ G LK G++ +A+K L + +R +F +E +++ + H N++
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 646 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 705
+ G + ++++ E+M NG L ++L H+ + + + + A G++YL
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLR---DHDGEFSSYQLVGMLRGIAAGMKYLSD- 125
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--ASHVSSIVRGTVGYLDPEYYI 763
+HRDL + NIL++ ++ KVSDFGLS+ D ++ +S + + + PE
Sbjct: 126 --MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA 183
Query: 764 SQQLTDKSDVYSFGVILLELIS 785
++ T SDV+SFG+++ E++S
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 68/202 (33%), Positives = 104/202 (51%), Gaps = 17/202 (8%)
Query: 594 IGSGGFGVVYYGKL--KDGKEI--AVKVLTS-NSYQGKREFTNEVTLLSRIHHRNLVQFL 648
IG G FG VY+G L DG++I AVK L + +F E ++ H N++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 649 GYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL-EIAEDAAKGIEYLHTGC 706
G C EG ++V +M +G L+ + E +K L AKG+EYL +
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFI----RSETHNPTVKDLIGFGLQVAKGMEYLAS-- 116
Query: 707 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSIVRGTVGYLDPEYYI 763
+HRDL + N +LD+ KV+DFGL++ D + H + + V ++ E
Sbjct: 117 -KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 764 SQQLTDKSDVYSFGVILLELIS 785
+Q+ T KSDV+SFGV+L EL++
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 4e-21
Identities = 58/204 (28%), Positives = 102/204 (50%), Gaps = 20/204 (9%)
Query: 592 KKIGSGGFGVVYYGKLKDGKE-----IAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLV 645
K +GSG FG VY G E +A+KVL S + +E +E +++ + H ++V
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 646 QFLGYCQEEGRSVLVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEYL 702
+ LG C + L+ + M G L +++ + + +NW AKG+ YL
Sbjct: 73 RLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYL 125
Query: 703 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEY 761
++HRDL + N+L+ K++DFGL+K VD + + + + ++ E
Sbjct: 126 EE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 762 YISQQLTDKSDVYSFGVILLELIS 785
+ + T KSDV+S+GV + EL++
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 4e-21
Identities = 61/214 (28%), Positives = 111/214 (51%), Gaps = 21/214 (9%)
Query: 589 MLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR 642
+L++++G G FG V+ + +D +AVK L S +++F E LL+ + H
Sbjct: 8 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHE 67
Query: 643 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY-----GTLTHE----QRINWIKRLEIAE 693
++V+F G C E ++V+E+M +G L + L L E + + L IA+
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 694 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGASHVSSIVR 751
A G+ YL + +HRDL + N L+ +++ K+ DFG+S+ ++ D V
Sbjct: 128 QIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD-YYRVGGHTM 183
Query: 752 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
+ ++ PE + ++ T +SDV+S GV+L E+ +
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 64/221 (28%), Positives = 110/221 (49%), Gaps = 26/221 (11%)
Query: 594 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKRE----------FTNEVTLLSRIHHR 642
IG G +G VY + G+ +AVK + + R +E+ L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 643 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 700
N+VQ+LG+ E + E++ G++ L YG EQ + + E +G+
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRF-EEQLVRFF-----TEQVLEGLA 122
Query: 701 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-VRGTVGYLDP 759
YLH+ I+HRDLK+ N+L+D K+SDFG+SK + D + ++ ++G+V ++ P
Sbjct: 123 YLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 760 EYYISQQ--LTDKSDVYSFGVILLELISGQEAISN-EKFGA 797
E S + K D++S G ++LE+ +G+ S+ E A
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA 220
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 18/213 (8%)
Query: 592 KKIGSGGFGVVYYGKLK-DGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
++G+G GVV + GK +AVK L N K+ E+ +L + + +V F
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQ-ILRELDILHKCNSPYIVGFY 65
Query: 649 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL---EIAEDAAKGIEYLHTG 705
G G + E+M G+L + L ++ I +IA KG+ YLH
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKIL------KEVQGRIPERILGKIAVAVLKGLTYLHE- 118
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 765
IIHRD+K SNIL++ + K+ DFG+S V+ + GT Y+ PE
Sbjct: 119 -KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV---GTSSYMAPERIQGN 174
Query: 766 QLTDKSDVYSFGVILLELISGQEAISNEKFGAN 798
+ KSD++S G+ L+EL +G+ E +
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPD 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 5e-21
Identities = 61/197 (30%), Positives = 101/197 (51%), Gaps = 9/197 (4%)
Query: 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLG 649
++IG G FG V+ G+L+ D +AVK K +F E +L + H N+V+ +G
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 709
C ++ +V E + G L T R+ + +++ E+AA G+EYL +
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLR---TEGPRLKVKELIQMVENAAAGMEYLESKHC-- 115
Query: 710 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT-VGYLDPEYYISQQLT 768
IHRDL + N L+ + K+SDFG+S+ DG + ++ V + PE + +
Sbjct: 116 -IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 769 DKSDVYSFGVILLELIS 785
+SDV+SFG++L E S
Sbjct: 175 SESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 7e-21
Identities = 62/222 (27%), Positives = 110/222 (49%), Gaps = 34/222 (15%)
Query: 589 MLEKKIGSGGFGVVYYGK------LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR 642
+L++++G G FG V+ + KD +AVK L + +++F E LL+ + H
Sbjct: 8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 67
Query: 643 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWIKRLE 690
++V+F G C + ++V+E+M +G L + L + + + L
Sbjct: 68 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 691 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-------FAVDGA 743
IA A G+ YL + +HRDL + N L+ ++ K+ DFG+S+ + V G
Sbjct: 128 IASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG- 183
Query: 744 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
H +R ++ PE + ++ T +SDV+SFGVIL E+ +
Sbjct: 184 -HTMLPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 7e-21
Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 28/211 (13%)
Query: 594 IGSGGFGVVYYG-KLKDGKEIAVK--VLTSNSYQGKRE-------FTNEVTLLSRIHHRN 643
IGSG FG VY G G+ +AVK L S S K E+ LL + H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 644 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEY 701
+VQ+LG + + E++ G++ L YG N+++++ KG+ Y
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQI------LKGLNY 121
Query: 702 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK------FAVDGASHVSSIVRGTVG 755
LH IIHRD+K +NIL+D K+SDFG+SK + S+ +G+V
Sbjct: 122 LHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSL-QGSVF 177
Query: 756 YLDPEYYISQQLTDKSDVYSFGVILLELISG 786
++ PE T K+D++S G +++E+++G
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 7e-21
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 18/204 (8%)
Query: 592 KKIGSGGFGVVY---YGKLKD--GKEIAVKVLTS-NSYQGKREFTNEVTLLSRIHHRNLV 645
+ +G G FG V Y D G+ +AVK L Q + E+ +L ++H N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 646 QFLGYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 703
++ G C E+G L+ E++ G+L+++L + ++N + L A+ +G+ YLH
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQQICEGMAYLH 124
Query: 704 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH--VSSIVRGTVGYLDPEY 761
+ IHRDL + N+LLD K+ DFGL+K +G + V V + E
Sbjct: 125 S---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC 181
Query: 762 YISQQLTDKSDVYSFGVILLELIS 785
+ + SDV+SFGV L EL++
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 1e-20
Identities = 64/224 (28%), Positives = 106/224 (47%), Gaps = 35/224 (15%)
Query: 591 EKKIGSGGFGVVYYGK---LKDGKE---IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRN 643
+ IG G FG V+ + L + +AVK+L S + +F E L++ H N
Sbjct: 10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPN 69
Query: 644 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQ------------------RINW 685
+V+ LG C L++E+M G L E L Q ++
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 686 IKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVD-- 741
++L IA+ A G+ YL +HRDL + N L+ ++M K++DFGLS+ ++ D
Sbjct: 130 TEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 742 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
AS +I + ++ PE + T +SDV+++GV+L E+ S
Sbjct: 187 KASENDAI---PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 1e-20
Identities = 81/293 (27%), Positives = 126/293 (43%), Gaps = 60/293 (20%)
Query: 589 MLEKKIGSGGFGVVYYGK---------LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI 639
+L++++G G FG VY K LK KEI V L N + E LLS++
Sbjct: 3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNE---TVQANQEAQLLSKL 59
Query: 640 HHRNLVQFLG-------------YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI 686
H +V+F YC+ + E H G TL+ Q W
Sbjct: 60 DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGK-------TLSENQVCEWF 112
Query: 687 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746
+L + G+ Y+H I+HRDLK+ NI L ++ K+ DFG+S+ + G+ +
Sbjct: 113 IQLLL------GVHYMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM-GSCDL 161
Query: 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA 806
++ GT Y+ PE Q KSD++S G IL E+ A + F + IV+
Sbjct: 162 ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE-- 219
Query: 807 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859
G PSL + Y + + I + L +RPS +E+L++
Sbjct: 220 ------GPT-----PSLPETYS-RQLNSIMQSMLN---KDPSLRPSAAEILRN 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 30/209 (14%)
Query: 592 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN--EVTLLSRIHHRNLVQFL 648
KIG G +GVVY + K EI A+K + T E+ LL ++H N+++ L
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 649 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 700
+ +G LV+EFM LY + QR + E K G+
Sbjct: 65 DVFRHKGDLYLVFEFMD-----TDLYKLIKDRQR-------GLPESLIKSYLYQLLQGLA 112
Query: 701 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDP 759
+ H+ I+HRDLK N+L++ K++DFGL++ F + +V T Y P
Sbjct: 113 FCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV--TRWYRAP 167
Query: 760 E-YYISQQLTDKSDVYSFGVILLELISGQ 787
E + + D++S G I EL+S +
Sbjct: 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 59/202 (29%), Positives = 86/202 (42%), Gaps = 23/202 (11%)
Query: 594 IGSGGFGVVYYGKLKDGKEI-------AVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 646
IG G FG V + +D K++ K + S + NE +L ++H LV
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVL---NERRILQELNHPFLVN 64
Query: 647 FLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 704
Q+E LV + + G L+ HL + EQ + I E +EYLH+
Sbjct: 65 LWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQ-----VKFWICE-IVLALEYLHS 118
Query: 705 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 764
IIHRD+K NILLD+ ++DF ++ S GT GY+ PE
Sbjct: 119 ---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS--TSGTPGYMAPEVLCR 173
Query: 765 QQLTDKSDVYSFGVILLELISG 786
Q + D +S GV E + G
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRG 195
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 7/196 (3%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 649
L KK+G+G FG V+ G ++AVK L + F E ++ ++ H LVQ
Sbjct: 10 LIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYA 68
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 709
EE +V E+M G+L + L + + +++A A G+ Y+
Sbjct: 69 VVSEE-PIYIVTEYMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIER---MN 122
Query: 710 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 769
IHRDL+S+NIL+ + K++DFGL++ D + + + PE + + T
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 770 KSDVYSFGVILLELIS 785
KSDV+SFG++L EL++
Sbjct: 183 KSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 30/214 (14%)
Query: 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-----QGKREFTNEVTLLSRIHHRNLV 645
+ IG G FG V + K DGK + K + Y + K++ +EV +L + H N+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEI---DYGNMTEKEKQQLVSEVNILRELKHPNIV 62
Query: 646 QFLGYCQEEGRSVL--VYEFMHNGTL--------KEHLYGTLTHEQRINWIKRLEIAEDA 695
++ + L V E+ G L KE Y + E + +L +A
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY--IEEEFIWRILTQLLLA--- 117
Query: 696 AKGIEYLHTGCVP--AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 753
+ H P ++HRDLK +NI LD + K+ DFGL+K +S + V GT
Sbjct: 118 ---LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GT 173
Query: 754 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 787
Y+ PE +KSD++S G ++ EL +
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 67/211 (31%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 590 LEKKIGSGGFGVVYYGKLK----DGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHR 642
L + +G G FG VY G + D E+ V V T S S Q + +F E ++S+ +H+
Sbjct: 10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQ 69
Query: 643 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR---INWIKRLEIAEDAAKGI 699
N+V+ +G E ++ E M G LK L +R + L A D AKG
Sbjct: 70 NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 700 EYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFAVDGASHVSSIVRGT--V 754
+YL IHRD+ + N LL AK++DFG+++ + AS+ R +
Sbjct: 130 KYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-DIYRASYYRKGGRAMLPI 185
Query: 755 GYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
++ PE ++ T K+DV+SFGV+L E+ S
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 60/216 (27%), Positives = 109/216 (50%), Gaps = 23/216 (10%)
Query: 589 MLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR 642
+L+ ++G G FG V+ + +D +AVK L S +++F E LL+ + H+
Sbjct: 8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQ 67
Query: 643 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY-----------GTLTHEQRINWIKRLEI 691
++V+F G C E ++V+E+M +G L L G ++ + L I
Sbjct: 68 HIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 692 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGASHVSSI 749
A A G+ YL + +HRDL + N L+ + + K+ DFG+S+ ++ D V
Sbjct: 128 ASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD-YYRVGGR 183
Query: 750 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
+ ++ PE + ++ T +SD++SFGV+L E+ +
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 6e-20
Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 29/209 (13%)
Query: 592 KKIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQG-----KREFTNEVTLLSRIHHRNL 644
+IG G +G VY + K G+ +A+K + N +G RE + LL ++ H N+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIRE----IKLLQKLRHPNI 60
Query: 645 VQFLGYCQEEGR-SV-LVYEFM-H--NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 699
V+ +G+ S+ +V+E+M H G L T Q ++K+L +G+
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEV-KFTESQIKCYMKQL------LEGL 113
Query: 700 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLD 758
+YLH+ I+HRD+K SNIL++ K++DFGL+ + ++ ++ V T+ Y
Sbjct: 114 QYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRP 169
Query: 759 PEYYI-SQQLTDKSDVYSFGVILLELISG 786
PE + + + + D++S G IL EL G
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 6e-20
Identities = 60/222 (27%), Positives = 102/222 (45%), Gaps = 41/222 (18%)
Query: 590 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQGKR-EFTNEVTLLSRIHHR 642
L +++G G FG+VY G K +A+K + N+ +R EF NE +++ +
Sbjct: 10 LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH 69
Query: 643 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIKRLE 690
++V+ LG +++V E M G LK +L G T ++ I
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM----- 124
Query: 691 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-------FAVDGA 743
A + A G+ YL +HRDL + N ++ + + K+ DFG+++ + G
Sbjct: 125 -AAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 744 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
+ VR ++ PE T KSDV+SFGV+L E+ +
Sbjct: 181 GLLP--VR----WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 6e-20
Identities = 60/194 (30%), Positives = 99/194 (51%), Gaps = 9/194 (4%)
Query: 594 IGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGYCQ 652
+G G FG V+ G LKD +AVK + Q K +F +E +L + H N+V+ +G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 653 EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAII 711
+ +V E + G L + + + ++ A DAA G+ YL + C I
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLR---KKKDELKTKQLVKFALDAAAGMAYLESKNC----I 115
Query: 712 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 771
HRDL + N L+ ++ K+SDFG+S+ DG S + + + + PE + + +S
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 772 DVYSFGVILLELIS 785
DV+S+G++L E S
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 8e-20
Identities = 65/204 (31%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 592 KKIGSGGFGVV---YYGKLKD--GKEIAVKVLTSNSYQGK-REFTNEVTLLSRIHHRNLV 645
+ +G G FG V Y D G+++AVK L S + E+ +L ++H N+V
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 646 QFLGYCQEEG-RSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 703
++ G C E+G + L+ EF+ +G+LKE+L IN ++L+ A KG++YL
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK---INLKQQLKYAVQICKGMDYLG 126
Query: 704 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH--VSSIVRGTVGYLDPEY 761
+ +HRDL + N+L++ + K+ DFGL+K + V + V + PE
Sbjct: 127 S---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183
Query: 762 YISQQLTDKSDVYSFGVILLELIS 785
I + SDV+SFGV L EL++
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (225), Expect = 8e-20
Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 34/211 (16%)
Query: 592 KKIGSGGFGVVYYGK-LKDGKEIAVKV---------LTSNSYQGKREFTNEVTLLSRIHH 641
+K+G G +GVVY + K G+ +A+K + S + + E++LL + H
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-------EISLLKELKH 57
Query: 642 RNLVQFLGYCQEEGRSVLVYEFMHNGTLK---EHLYGTLTHEQRINWIKRLEIAEDAAKG 698
N+V+ L E + LV+E+ LK + G L+ N IK I +G
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLS----PNLIKS--IMYQLLRG 110
Query: 699 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYL 757
+ Y H+ I+HRDLK NIL+++ K++DFGL++ F + ++ +V T+ Y
Sbjct: 111 LAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYR 165
Query: 758 DPEYYISQQLTDKS-DVYSFGVILLELISGQ 787
PE + + + D++S G I E+I+G+
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 54/201 (26%), Positives = 103/201 (51%), Gaps = 7/201 (3%)
Query: 585 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL 644
++ K++ KK+G+G FG V+ G + ++AVK L + + F E L+ + H L
Sbjct: 6 ESIKLV-KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKL 63
Query: 645 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 704
V+ +E ++ E+M G+L + L ++ K ++ + A+G+ Y+
Sbjct: 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIER 121
Query: 705 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 764
IHRDL+++N+L+ + + K++DFGL++ D + + + PE
Sbjct: 122 ---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF 178
Query: 765 QQLTDKSDVYSFGVILLELIS 785
T KSDV+SFG++L E+++
Sbjct: 179 GSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 7/204 (3%)
Query: 582 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 641
+I + LEKK+G+G FG V+ ++AVK + S F E ++ + H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQH 60
Query: 642 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 701
LV+ +E ++ EFM G+L + L +Q + K ++ + A+G+ +
Sbjct: 61 DKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAF 117
Query: 702 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 761
+ IHRDL+++NIL+ + K++DFGL++ D + + + PE
Sbjct: 118 IEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 174
Query: 762 YISQQLTDKSDVYSFGVILLELIS 785
T KSDV+SFG++L+E+++
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 63/206 (30%), Positives = 91/206 (44%), Gaps = 16/206 (7%)
Query: 592 KKIGSGGFGVVYYGKLKD--GKEI--AVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQ 646
KK+G G FGVV G+ GK I AVK L S+ +F E ++ + H NL++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 647 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL-EIAEDAAKGIEYLHTG 705
G ++V E G+L + L I L + A A G+ YL +
Sbjct: 61 LYGVVLTH-PLMMVTELAPLGSLLDRLR---KDALGHFLISTLCDYAVQIANGMRYLES- 115
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV--GYLDPEYYI 763
IHRDL + NILL + K+ DFGL + H V + PE
Sbjct: 116 --KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173
Query: 764 SQQLTDKSDVYSFGVILLELIS-GQE 788
++ + SDV+ FGV L E+ + G+E
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEE 199
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 3e-19
Identities = 66/214 (30%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 590 LEKKIGSGGFGVVYYGKLK--DGK--EIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRN 643
L K +G G FG V G+L DG ++AVK L ++Y EF +E + H N
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPN 62
Query: 644 LVQFLGYC------QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI--KRLEIAEDA 695
+++ +G C Q+ + +++ FM +G L L + L+ D
Sbjct: 63 VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122
Query: 696 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS-IVRGTV 754
A G+EYL IHRDL + N +L + M V+DFGLSK G + I + V
Sbjct: 123 ALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 755 GYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQ 787
++ E + T KSDV++FGV + E+ + GQ
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 75/278 (26%), Positives = 128/278 (46%), Gaps = 44/278 (15%)
Query: 592 KKIGSGGFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
KK+G G +G VY K L D + A+K L S S + + + NE+ +L+ ++H N++ +
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK 65
Query: 649 GYCQEEGRSVLVYEFMHNGTL-----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 703
+ + +V E+ G L K L EQ I W +++ +G++ LH
Sbjct: 66 EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEI-WRIFIQLL----RGLQALH 120
Query: 704 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 763
I+HRDLKS+NILL + K+ D G+SK +++ GT Y+ PE +
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPHYMAPEVWK 174
Query: 764 SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL----HIESGDIQGII 819
+ + KSD++S G +L E+ + + + R VQ K I S D+Q I
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPF-EARSMQDLRYKVQRGKYPPIPPIYSQDLQNFI 233
Query: 820 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVL 857
++++ V P +RP+ ++L
Sbjct: 234 ------------------RSMLQVKP--KLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 4e-19
Identities = 65/206 (31%), Positives = 106/206 (51%), Gaps = 24/206 (11%)
Query: 592 KKIGSGGFGVVYYGKLKDGKE----IAVKVLTSNSYQGKREF--TNEVTLLSRIHHRNLV 645
K +G G FG V+ + G + A+KVL + + + E +L+ ++H +V
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 646 QFLGYCQEEGRSVLVYEFMHNGTL-----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 700
+ Q EG+ L+ +F+ G L KE ++ T E + +AE A ++
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF---TEED-----VKFYLAE-LALALD 112
Query: 701 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 760
+LH+ II+RDLK NILLD+ K++DFGLSK ++D S GTV Y+ PE
Sbjct: 113 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPE 168
Query: 761 YYISQQLTDKSDVYSFGVILLELISG 786
+ T +D +SFGV++ E+++G
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-19
Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 28/222 (12%)
Query: 589 MLEKKIGSGGFGVVYYGKLKDGKE---------------IAVKVLTSNSYQGKR-EFTNE 632
L++K+G G FG V+ + + E +AVK+L ++ + R +F E
Sbjct: 8 RLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKE 67
Query: 633 VTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL-----YGTLTHEQRINWIK 687
+ ++SR+ + N+++ LG C + ++ E+M NG L + L T TH I +
Sbjct: 68 IKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127
Query: 688 R---LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744
L +A A G++YL + +HRDL + N L+ H K++DFG+S+ G
Sbjct: 128 IANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184
Query: 745 H-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
+ + + ++ E + + T SDV++FGV L E+ +
Sbjct: 185 YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 5e-19
Identities = 63/221 (28%), Positives = 109/221 (49%), Gaps = 26/221 (11%)
Query: 586 ATKMLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTS-NSYQGKREFTNEVTLLSRI 639
A + +E+ +G FG +Y G L + +A+K L N+ Q EF E +L++ +
Sbjct: 6 AVRFMEE-LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL 64
Query: 640 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH-------------EQRINWI 686
HH N+V LG +E +++E+++ G L E L H + ++
Sbjct: 65 HHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 687 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGAS 744
L IA A G+EYL + +H+DL + NIL+ + + K+SD GLS+ ++ D
Sbjct: 125 DFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSAD-YY 180
Query: 745 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
V + ++ PE + + + SD++SFGV+L E+ S
Sbjct: 181 RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 5e-19
Identities = 74/230 (32%), Positives = 111/230 (48%), Gaps = 46/230 (20%)
Query: 584 EDATKMLEKKIGSGGFGVVYYGKLK-DGKEI--AVKVLTS-NSYQGKREFTNEVTLLSRI 639
ED E IG G FG V +K DG ++ A+K+L S R+F E+ +L ++
Sbjct: 2 EDIK--FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKL 59
Query: 640 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTL-----------------KEH-LYGTLTHE 680
HH N++ LG C+ G + E+ G L KEH TLT +
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 681 QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 740
Q L+ A D A G++YL IHRDL + N+L+ +++ +K++DFGLS+
Sbjct: 120 QL------LQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSRGE- 169
Query: 741 DGASHVSSIVRGTVGYLDPEYYISQQL-----TDKSDVYSFGVILLELIS 785
V+ T+G L + + L T KSDV+SFGV+L E++S
Sbjct: 170 ------EVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 9e-19
Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 29/208 (13%)
Query: 594 IGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ 652
+G G +G+VY + L IA+K + + + E+ L S + HRN+VQ+LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 653 EEGRSVLVYEFMHNGTLKEHL---YGTLT-HEQRINWIKRLEIAEDAAKGIEYLHTGCVP 708
E G + E + G+L L +G L +EQ I + + +I E G++YLH
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-QILE----GLKYLHDN--- 127
Query: 709 AIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 767
I+HRD+K N+L++ + K+SDFG SK + G + + GT+ Y+ PE +
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSK-RLAGINPCTETFTGTLQYMAPE------V 180
Query: 768 TDK--------SDVYSFGVILLELISGQ 787
DK +D++S G ++E+ +G+
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 9e-19
Identities = 71/223 (31%), Positives = 104/223 (46%), Gaps = 30/223 (13%)
Query: 594 IGSGGFGVVYYGKLKD----GKE---IAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLV 645
+GSG FG VY G D G +AVK L + Q K+EF E L+S +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 646 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYG---TLTHEQRINWIKRLEIAEDAAKGIEYL 702
+ LG C ++ E M G L +L + + L+I D AKG YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 703 HTGCVPAIIHRDLKSSNILL-----DKHMRAKVSDFGLSKFAVDGASHVSSIVRG----T 753
IHRDL + N L+ D K+ DFGL++ D G
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR---DIYKSDYYRKEGEGLLP 176
Query: 754 VGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQE---AISN 792
V ++ PE + + T +SDV+SFGV++ E+++ GQ+ A++N
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN 219
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 78/275 (28%), Positives = 133/275 (48%), Gaps = 36/275 (13%)
Query: 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQFL 648
KKIG G FG K K DGK+ +K + + K E EV +LS + H N+VQ+
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 649 GYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHT 704
+E G +V ++ G L + + G L E +I +W ++ +A ++++H
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVHD 119
Query: 705 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 764
I+HRD+KS NI L K K+ DFG+++ ++ ++ GT YL PE +
Sbjct: 120 ---RKILHRDIKSQNIFLTKDGTIKLGDFGIAR-VLNSTVELARTCIGTPYYLSPEICEN 175
Query: 765 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP-SL 823
+ +KSD+++ G +L E+ + + A N +N+V L I I+G P S
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLKHAFE----AGNMKNLV----LKI----IRGSYPPVSS 223
Query: 824 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 858
YD++++ K + RPS++ +L+
Sbjct: 224 HYSYDLRNLVSQLFKR------NPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 1e-18
Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 32/214 (14%)
Query: 594 IGSGGFGVVYYGKLK-DGKEI--AVKVLTS-NSYQGKREFTNEVTLLSRI-HHRNLVQFL 648
IG G FG V ++K DG + A+K + S R+F E+ +L ++ HH N++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 649 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR------------LEIAEDAA 696
G C+ G L E+ +G L + L + E + L A D A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 697 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 756
+G++YL IHRDL + NIL+ ++ AK++DFGLS+ V+ T+G
Sbjct: 123 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ-------EVYVKKTMGR 172
Query: 757 LDPEYYISQQL-----TDKSDVYSFGVILLELIS 785
L + + L T SDV+S+GV+L E++S
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 61/225 (27%), Positives = 110/225 (48%), Gaps = 31/225 (13%)
Query: 589 MLEKKIGSGGFGVVYYGKLKDGK------EIAVKVLTSNSYQGK-REFTNEVTLLSRIHH 641
+L K +G G FG V K +AVK+L N+ + R+ +E LL +++H
Sbjct: 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNH 62
Query: 642 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------------YGTLTH--EQ 681
++++ G C ++G +L+ E+ G+L+ L L + E+
Sbjct: 63 PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 682 RINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 741
+ + A ++G++YL ++HRDL + N+L+ + + K+SDFGLS+ +
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179
Query: 742 GASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
S+V S R V ++ E T +SDV+SFGV+L E+++
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 2e-18
Identities = 67/253 (26%), Positives = 95/253 (37%), Gaps = 49/253 (19%)
Query: 592 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT----NEVTLLSRIHHRNLVQ 646
K IG G FG V+ + KD ++ A+KVL S KR E +L+ +V+
Sbjct: 7 KVIGRGAFGEVWLVRDKDTGQVYAMKVL-RKSDMIKRNQIAHVRAERDILADADSPWIVK 65
Query: 647 FLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 704
Q+E LV E+M G L L E R IAE ++ +H
Sbjct: 66 LYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE-----TARFYIAELVL-ALDSVHK 119
Query: 705 -GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGAS------------------ 744
G IHRD+K NIL+D K++DFGL K
Sbjct: 120 LGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 745 ----------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 794
+S V GT Y+ PE + D +S GVIL E++ G ++
Sbjct: 176 RRRDHKQRRVRANSTV-GTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234
Query: 795 FGANCRNIVQWAK 807
I+ W +
Sbjct: 235 LQETYNKIINWKE 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-18
Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 32/214 (14%)
Query: 594 IGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGK---REFTNEVTLLSRI-HHRNLVQFL 648
IG G FG V ++ KDG + + Y K R+F E+ +L ++ HH N++ L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 649 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE------------QRINWIKRLEIAEDAA 696
G C+ G L E+ +G L + L + E ++ + L A D A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 697 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 756
+G++YL IHRDL + NIL+ ++ AK++DFGLS+ V+ T+G
Sbjct: 135 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ-------EVYVKKTMGR 184
Query: 757 LDPEYYISQQL-----TDKSDVYSFGVILLELIS 785
L + + L T SDV+S+GV+L E++S
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 57/197 (28%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 649
L+ K+G G FG V+ G ++A+K L + F E ++ ++ H LV
Sbjct: 10 LDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYA 68
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHLY-GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 708
EE +V EFM G+L + L G + + + +++A A G+ Y+
Sbjct: 69 VVSEE-PIYIVTEFMGKGSLLDFLKEGDGKY---LKLPQLVDMAAQIADGMAYIER---M 121
Query: 709 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 768
IHRDL+++NIL+ ++ K++DFGL++ D + + + PE + + T
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 769 DKSDVYSFGVILLELIS 785
KSDV+SFG++L EL++
Sbjct: 182 IKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 3e-18
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLG 649
+IGSG G VY + G+ A+KV+ N +R+ E+ +L ++H N+V+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 709
G ++ EFM G+L+ + EQ + ++A GI YLH
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGT---HIADEQFLA-----DVARQILSGIAYLHR---RH 188
Query: 710 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 769
I+HRD+K SN+L++ K++DFG+S+ +S V GT+ Y+ PE I+ L
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPE-RINTDLNH 246
Query: 770 ------KSDVYSFGVILLELISGQ 787
D++S GV +LE G+
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 61/200 (30%), Positives = 90/200 (45%), Gaps = 15/200 (7%)
Query: 594 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 649
+G GGFG V ++K GK A K L + ++ NE +L ++ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVS-LA 59
Query: 650 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI-AEDAAKGIEYLHTGCV 707
Y E + LV M+ G LK H+Y + R A G+E+LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIY---NVGEPGFPEARAIFYAAQIICGLEHLHQ--- 113
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 767
I++RDLK N+LLD H ++SD GL+ G GT GY+ PE +
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA--GTPGYMAPEVLQGEVY 171
Query: 768 TDKSDVYSFGVILLELISGQ 787
D ++ G L E+I+G+
Sbjct: 172 DFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 67/208 (32%), Positives = 104/208 (50%), Gaps = 17/208 (8%)
Query: 594 IGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLG 649
+G GGFG V +++ GK A K L +G+ NE +L +++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVS-LA 66
Query: 650 YCQEEGRSV-LVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 706
Y E ++ LV M+ G LK H+Y G E+ + + A + G+E LH
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEG----RAVFYAAEICCGLEDLHQ-- 120
Query: 707 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 766
I++RDLK NILLD H ++SD GL+ +G + + GTVGY+ PE +++
Sbjct: 121 -ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKNER 177
Query: 767 LTDKSDVYSFGVILLELISGQEAISNEK 794
T D ++ G +L E+I+GQ K
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQSPFQQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-18
Identities = 62/219 (28%), Positives = 112/219 (51%), Gaps = 27/219 (12%)
Query: 592 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT----SNSYQGK--REFTNEVTLLSRIHHRNL 644
+++G+G F Y + +K G +AVK +T ++S Q + E+ L++R++H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 645 VQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYL 702
++ LG E+ L E+M G++ L YG IN+ ++L +G+ YL
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL------LRGLSYL 119
Query: 703 HTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLS-KFAVD--GASHVSSIVRGTVGYLD 758
H IIHRD+K +N+L+D R +++DFG + + A GA + GT+ ++
Sbjct: 120 HEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 759 PEYYISQQLTDKSDVYSFGVILLELISGQ-----EAISN 792
PE +Q DV+S G +++E+ + + E SN
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 4e-18
Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 12/204 (5%)
Query: 592 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 650
KIG G G+V G+++AVK + Q + NEV ++ H N+V+
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84
Query: 651 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 710
+V EF+ G L + + T +E++I + K + +LH +
Sbjct: 85 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLAVLKALSFLHA---QGV 136
Query: 711 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD- 769
IHRD+KS +ILL R K+SDFG S+V GT ++ PE IS+
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPE-VISRLPYGT 194
Query: 770 KSDVYSFGVILLELISGQEAISNE 793
+ D++S G++++E++ G+ NE
Sbjct: 195 EVDIWSLGIMVIEMVDGEPPYFNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 5e-18
Identities = 64/224 (28%), Positives = 112/224 (50%), Gaps = 34/224 (15%)
Query: 589 MLEKKIGSGGFGVVY----YGKLKDGKE----IAVKVLTSN-SYQGKREFTNEVTLLSRI 639
+L K +G G FG V YG K + +AVK+L N + + + +E+ L+ I
Sbjct: 15 VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLI 74
Query: 640 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY------------GTLTHEQRINWI 686
H+N++ LG C +EG ++ E+ G L+E L T E+++++
Sbjct: 75 GKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK 134
Query: 687 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746
+ A A+G+EYL + IHRDL + N+L+ + K++DFGL++ G +
Sbjct: 135 DLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLAR----GVHDI 187
Query: 747 -----SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
+S R V ++ PE + T +SDV+SFG+++ E+ +
Sbjct: 188 DYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 74/291 (25%), Positives = 132/291 (45%), Gaps = 45/291 (15%)
Query: 592 KKIGSGGFGVVY----YGKLKDGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNL 644
+++G G FG+VY G +KD E V + T N RE F NE +++ + ++
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 645 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI------KRLEIAEDAAKG 698
V+ LG + ++++ E M G LK +L + K +++A + A G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 699 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--TVGY 756
+ YL+ +HRDL + N ++ + K+ DFG+++ + + +G V +
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYRKGGKGLLPVRW 187
Query: 757 LDPEYYISQQLTDKSDVYSFGVILLELISGQE----AISNEKFGANCRNIVQWAKLHIES 812
+ PE T SDV+SFGV+L E+ + E +SNE+
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV----------------- 230
Query: 813 GDIQGIIDPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862
++ +++ LLD+ D M + E MC + MRPS E++ I++
Sbjct: 231 --LRFVMEGGLLDKPDNCPDM--LFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 9e-18
Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 32/277 (11%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIA---VKVLTSNSYQGKREFTNEVTLLSRIHHRNLV 645
+EKKIG G F VVY L DG+ +A V++ + +++ E+ LL ++ H N++
Sbjct: 6 IEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVI 65
Query: 646 QFLGYCQEEGRSVLVYEFMHNGTLKEHL-----YGTLTHEQRINWIKRLEIAEDAAKGIE 700
++L E +V E G L + L E+ I W +++ +E
Sbjct: 66 KYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI-WKYFVQLCS----ALE 120
Query: 701 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 760
++H+ I+HRD+K +N+ + K+ D GL +F + S+V GT Y+ PE
Sbjct: 121 HMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 761 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 820
KSD++S G +L E+ + Q +K N ++ + IE D
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK--MNLYSLCK----KIEKCDYP---- 226
Query: 821 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVL 857
P D Y + + + C+ P RP IS VL
Sbjct: 227 PLPADHYSEE----LRDLVSRCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 57/201 (28%), Positives = 105/201 (52%), Gaps = 16/201 (7%)
Query: 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
+ +K+G G +G VY K+ G+ +A+KV+ +E E+++L + +V++
Sbjct: 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYY 64
Query: 649 GYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 705
G + +V E+ G+ + + TLT E+ I I KG+EYLH+
Sbjct: 65 GSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLT-EEEIAAILY-----QTLKGLEYLHSN 118
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 765
IHRD+K+ NILL++ +AK++DFG+S D + ++++ GT ++ PE
Sbjct: 119 ---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEI 174
Query: 766 QLTDKSDVYSFGVILLELISG 786
+K+D++S G+ +E+ G
Sbjct: 175 GYNNKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-17
Identities = 65/229 (28%), Positives = 102/229 (44%), Gaps = 53/229 (23%)
Query: 580 LSDIEDATKMLE--KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKR------EFT 630
L +D K+ ++IG G FG VY+ + E+ A+K + SY GK+ +
Sbjct: 7 LFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKM---SYSGKQSNEKWQDII 63
Query: 631 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF----------MHNGTLKEHLYGTLTHE 680
EV L ++ H N +++ G E + LV E+ +H L+E
Sbjct: 64 KEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQE--------- 114
Query: 681 QRINWIKRLEIA---EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 737
+EIA A +G+ YLH+ IHRD+K+ NILL + K++DFG +
Sbjct: 115 --------VEIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSAS 163
Query: 738 FAVDGASHVSSIVRGTVGYLDPEYYISQ---QLTDKSDVYSFGVILLEL 783
S V GT ++ PE ++ Q K DV+S G+ +EL
Sbjct: 164 LVSPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 68/240 (28%), Positives = 107/240 (44%), Gaps = 15/240 (6%)
Query: 593 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 651
KIG G G+V K GK++AVK + Q + NEV ++ HH N+V
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 652 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 711
+V EF+ G L + + T +E++I + + + YLH +I
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLHN---QGVI 140
Query: 712 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 771
HRD+KS +ILL R K+SDFG S+V GT ++ PE +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEV 199
Query: 772 DVYSFGVILLELISGQEAISNEKFGANCRNI-----VQWAKLHIESGDIQGIIDPSLLDE 826
D++S G++++E+I G+ NE R I + H S ++G +D L+ E
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVRE 259
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 2e-17
Identities = 60/218 (27%), Positives = 104/218 (47%), Gaps = 12/218 (5%)
Query: 579 TLSDIEDATKMLEK--KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTL 635
T+ I D K + KIG G G V+ + G+E+A+K + K NE+ +
Sbjct: 10 TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILV 69
Query: 636 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 695
+ + + N+V FL +V E++ G+L + + T E +I + R +
Sbjct: 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCR-----EC 124
Query: 696 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 755
+ +E+LH +IHRD+KS N+LL K++DFG S S++V GT
Sbjct: 125 LQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPY 180
Query: 756 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 793
++ PE + K D++S G++ +E++ G+ NE
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 585 DATKMLEKKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGK-REFTNEVTLLSRIHHR 642
D +++E IG G VVY E +A+K + Q E EV +S+ +H
Sbjct: 1 DDYELIEV-IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 643 NLVQFLGYCQ-EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA---EDAAK 697
N+V++ Y G + LV ++ G+L + + IA ++ K
Sbjct: 60 NVVKY--YTSFVVGDELWLVMPYLSGGSL----LDIMKSSYPRGGLDEAIIATVLKEVLK 113
Query: 698 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR----GT 753
G+EYLH+ IHRD+K+ NILL + K++DFG+S DG + VR GT
Sbjct: 114 GLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD-RTRKVRKTFVGT 169
Query: 754 VGYLDPEYYISQQ--LTDKSDVYSFGVILLELISG 786
++ PE + Q K+D++SFG+ +EL +G
Sbjct: 170 PCWMAPE-VMEQVHGYDFKADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 593 KIGSGGFGVVYYGKLKDGKEI-AVK-VLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLG 649
+G G +GVV + K EI A+K S + ++ EV +L ++ H N+V
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHL----YGTLTHE-QRINWIKRLEIAEDAAKGIEYLHT 704
+ +GR LV+E++ TL E L G + W + I Y H+
Sbjct: 68 AFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIW--------QLLQAIAYCHS 118
Query: 705 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYI 763
IIHRD+K NIL+ + K+ DFG ++ AS ++ V T Y PE +
Sbjct: 119 H---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLV 174
Query: 764 SQQLTDKS-DVYSFGVILLELISGQ 787
K DV++ G I+ EL+ G+
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 31/212 (14%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
L ++IGSG +G VY + + G+ +A+KV+ E+++L H N+V +
Sbjct: 7 LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYF 66
Query: 649 GYCQEEGRSVLVYEFMHNGTLKEHLY----GTLTHEQRINWIKRLEIAEDAAKGIEYLHT 704
G + +V E+ G+L++ +Y G L+ E +I ++ R + KG+ YLH
Sbjct: 67 GSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLS-ELQIAYVCR-----ETLKGLAYLHE 119
Query: 705 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR-----GTVGYLDP 759
IHRD+K +NILL + K++DFG+S A ++I + GT ++ P
Sbjct: 120 TGK---IHRDIKGANILLTEDGDVKLADFGVS------AQLTATIAKRKSFIGTPYWMAP 170
Query: 760 EYYISQQLTD----KSDVYSFGVILLELISGQ 787
E + + K D+++ G+ +EL Q
Sbjct: 171 E-VAAVERKGGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 3e-17
Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 14/219 (6%)
Query: 579 TLSDIEDATKMLEK--KIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTL 635
T+ + D K + KIG G G VY + G+E+A+K + K NE+ +
Sbjct: 10 TIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILV 69
Query: 636 LSRIHHRNLVQFL-GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 694
+ H N+V +L Y + V V E++ G+L + + T E +I + R +
Sbjct: 70 MRENKHPNIVNYLDSYLVGDELWV-VMEYLAGGSLTDVVTETCMDEGQIAAVCR-----E 123
Query: 695 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 754
+ +E+LH+ V IHRD+KS NILL K++DFG S S++V GT
Sbjct: 124 CLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTP 179
Query: 755 GYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 793
++ PE + K D++S G++ +E++ G+ NE
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 16/205 (7%)
Query: 592 KKIGSGGFGVV---YYGKLKDGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLVQ 646
++GSG FG V Y K K +AVK+L +N K E E ++ ++ + +V+
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 647 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 706
+G C+ E +LV E G L + L + + E+ + G++YL
Sbjct: 61 MIGICEAESW-MLVMELAELGPLNKFL----QKNKHVTEKNITELVHQVSMGMKYLEET- 114
Query: 707 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPEYYIS 764
+HRDL + N+LL AK+SDFGLSK ++ + G V + PE
Sbjct: 115 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 765 QQLTDKSDVYSFGVILLELIS-GQE 788
+ + KSDV+SFGV++ E S GQ+
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 72/278 (25%), Positives = 125/278 (44%), Gaps = 30/278 (10%)
Query: 589 MLEKKIGSGGFGVVYYGK-LKDGKEIAVK---VLTSNSYQGKREFTNEVTLLSRIHHRNL 644
+EKKIG G F VY L D K +A+K + + +++ E+ LL +++H N+
Sbjct: 5 QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNV 64
Query: 645 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE----QRINWIKRLEIAEDAAKGIE 700
+++L E+ +V E G L + + + +R W +++ +E
Sbjct: 65 IKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS----AVE 120
Query: 701 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 760
++H+ ++HRD+K +N+ + K+ D GL +F + S+V GT Y+ PE
Sbjct: 121 HMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 761 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 820
KSD++S G +L E+ + Q +K N ++ Q IE D
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLFSLCQ----KIEQCDY----- 225
Query: 821 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 858
P L E+ + K+ E MC+ P RP I V +
Sbjct: 226 PPLPTEHYSE---KLRELVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 25/208 (12%)
Query: 592 KKIGSGGFGVVYYG-KLKDGKEIAVKVLT--SNSYQGKREFTN---EVTLLSRIHHRNLV 645
K +G G FG VY + G+E+A K + S + +E + E+ LL + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 646 QFLGYCQEEGRSVLV--YEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEY 701
Q+ G ++ L E+M G++K+ L YG LT + +++ +G+ Y
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI------LEGMSY 121
Query: 702 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK----FAVDGASHVSSIVRGTVGYL 757
LH+ I+HRD+K +NIL D K+ DFG SK + G S V GT ++
Sbjct: 122 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS--VTGTPYWM 176
Query: 758 DPEYYISQQLTDKSDVYSFGVILLELIS 785
PE + K+DV+S G ++E+++
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 25/210 (11%)
Query: 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSN--SYQGKREFTN---EVTLLSRIHHRN 643
L K +G G FG VY D G+E+AVK + + S + +E E+ LL + H
Sbjct: 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHER 65
Query: 644 LVQFLGYCQEEGRSVL--VYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGI 699
+VQ+ G ++ L E M G++K+ L YG LT + +++ +G+
Sbjct: 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI------LEGV 119
Query: 700 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK----FAVDGASHVSSIVRGTVG 755
YLH+ I+HRD+K +NIL D K+ DFG SK + G S V GT
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS--VTGTPY 174
Query: 756 YLDPEYYISQQLTDKSDVYSFGVILLELIS 785
++ PE + K+D++S G ++E+++
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 14/210 (6%)
Query: 582 DIEDATKMLEK--KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSR 638
D D +LE KIG G G+V + K G+++AVK++ Q + NEV ++
Sbjct: 15 DQGDPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD 74
Query: 639 IHHRNLVQ-FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK 697
H+N+V+ + Y E VL+ EF+ G L + + + R+N + + E +
Sbjct: 75 YQHQNVVEMYKSYLVGEELWVLM-EFLQGGALTD-----IVSQTRLNEEQIATVCESVLQ 128
Query: 698 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 757
+ YLH+ +IHRD+KS +ILL R K+SDFG S+V GT ++
Sbjct: 129 ALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWM 184
Query: 758 DPEYYISQQLTDKSDVYSFGVILLELISGQ 787
PE + D++S G++++E++ G+
Sbjct: 185 APEVISRTPYGTEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 59/202 (29%), Positives = 106/202 (52%), Gaps = 17/202 (8%)
Query: 597 GGFGVVYYGKLKDGK-----EIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQFLGY 650
G FG ++YG L D K E+ VK + ++ + + E LL + H+N++ L
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 651 CQEEGRSVLV-YEFMHNGTLKEHL----YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 705
C E+G V Y +M+ G LK L G + Q ++ + + +A A G+ YLH
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK- 135
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGASHVSSIVRGTVGYLDPEYYI 763
+IH+D+ + N ++D+ ++ K++D LS+ F +D + R V ++ E +
Sbjct: 136 --RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR-PVKWMALESLV 192
Query: 764 SQQLTDKSDVYSFGVILLELIS 785
+++ + SDV+SFGV+L EL++
Sbjct: 193 NKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 6e-17
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 33/208 (15%)
Query: 592 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSY--QGKREFT-NEVTLLSRIHHRNLVQF 647
K +G+G FG V + K + A+K+L+ + E NE +L I H LV
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GI 699
G Q++ LV E++ G L HL R E A+ +
Sbjct: 67 YGSFQDDSNLYLVMEYVPGGELFSHL----------RKSGRFP--EPVARFYAAQVVLAL 114
Query: 700 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 759
EYLH+ I++RDLK N+LLD K++DFG +K + GT YL P
Sbjct: 115 EYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC----GTPEYLAP 167
Query: 760 EYYISQQLTDKS-DVYSFGVILLELISG 786
E I + K+ D ++ G+++ E+++G
Sbjct: 168 E-IILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 8e-17
Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 22/207 (10%)
Query: 592 KKIGSGGFGVVY----YGKLKDGK--EIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HHRN 643
K +G+G FG V YG K ++AVK+L ++ +RE +E+ ++S + +H N
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 644 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 703
+V LG C G +++ E+ G L L E + L + AKG+ +L
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLA 158
Query: 704 T-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT----VGYLD 758
+ C IHRDL + N+LL K+ DFGL++ D + + +V+G V ++
Sbjct: 159 SKNC----IHRDLAARNVLLTHGKIVKICDFGLAR---DIMNDSNYVVKGNARLPVKWMA 211
Query: 759 PEYYISQQLTDKSDVYSFGVILLELIS 785
PE + T +SDV+S+G++L E+ S
Sbjct: 212 PESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 1e-16
Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 25/220 (11%)
Query: 584 EDATKMLE--KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKR------EFTNEVTL 635
ED K+ ++IG G FG VY+ + D + V + SY GK+ + EV
Sbjct: 21 EDPEKLFTDLREIGHGSFGAVYFAR--DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKF 78
Query: 636 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 695
L RI H N +++ G E + LV E+ G+ + L H++ + ++ I A
Sbjct: 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLE---VHKKPLQEVEIAAITHGA 134
Query: 696 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 755
+G+ YLH+ +IHRD+K+ NILL + + K++DFG + A S V GT
Sbjct: 135 LQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPY 186
Query: 756 YLDPEYYISQ---QLTDKSDVYSFGVILLELISGQEAISN 792
++ PE ++ Q K DV+S G+ +EL + + N
Sbjct: 187 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 10/202 (4%)
Query: 593 KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 651
KIG G G+V +K GK +AVK + Q + NEV ++ H N+V+
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 652 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 711
+V EF+ G L + + T +E++I + K + LH +I
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHA---QGVI 138
Query: 712 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 771
HRD+KS +ILL R K+SDFG S+V GT ++ PE +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEV 197
Query: 772 DVYSFGVILLELISGQEAISNE 793
D++S G++++E++ G+ NE
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNE 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 56/199 (28%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 592 KKIGSGGFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
+KIG G +GVVY + G+ +A+K L + + E++LL ++H N+V+ L
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 649 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 708
E + LV+EF+H LK+ + + + IK +G+ + H+ V
Sbjct: 66 DVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIK--SYLFQLLQGLAFCHSHRV- 121
Query: 709 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 766
+HRDLK N+L++ K++DFGL++ F V ++ +V T+ Y PE + +
Sbjct: 122 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKY 177
Query: 767 LTDKSDVYSFGVILLELIS 785
+ D++S G I E+++
Sbjct: 178 YSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVL--TSNSYQGKREFTN---EVTLLSRIHHRN 643
L K +G G FG VY D G+E+AVK + +S + +E E+ LL + H
Sbjct: 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDR 65
Query: 644 LVQFLGYCQ--EEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGI 699
+VQ+ G + EE + + E+M G++K+ L YG LT + +++ +G+
Sbjct: 66 IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI------LQGV 119
Query: 700 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK----FAVDGASHVSSIVRGTVG 755
YLH+ I+HRD+K +NIL D K+ DFG SK + G S V GT
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS--VTGTPY 174
Query: 756 YLDPEYYISQQLTDKSDVYSFGVILLELIS 785
++ PE + K+DV+S ++E+++
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 14/203 (6%)
Query: 593 KIGSGGFGVVYYGKLKDGK---EIAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLVQFL 648
++GSG FG V G K K ++A+KVL + + + R E E ++ ++ + +V+ +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 649 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 708
G C+ E +LV E G L + L G + I +E+ + G++YL
Sbjct: 62 GVCEAEAL-MLVMEMASGGPLNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEG---K 114
Query: 709 AIIHRDLKSSNILLDKHMRAKVSDFGLSKF--AVDGASHVSSIVRGTVGYLDPEYYISQQ 766
+HRDL + N+LL AK+SDFGLSK A D S + + + PE ++
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174
Query: 767 LTDKSDVYSFGVILLELIS-GQE 788
+ +SDV+S+G+ + E S GQ+
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 19/209 (9%)
Query: 594 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 649
+G GGFG V +++ GK A K L + ++ NE +L +++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS-LA 66
Query: 650 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTG 705
Y E ++ LV M+ G LK H+Y E+R + A + G+E LH
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFY-----AAEITCGLEDLHR- 120
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 765
I++RDLK NILLD + ++SD GL+ +G + + GTVGY+ PE ++
Sbjct: 121 --ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV--GTVGYMAPEVVKNE 176
Query: 766 QLTDKSDVYSFGVILLELISGQEAISNEK 794
+ T D + G ++ E+I G+ K
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 23/205 (11%)
Query: 591 EKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTN-----EVTLLSRIHHRNL 644
KK+G G + VVY + + G+ +A+K + + ++ N E+ LL + H N+
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNI 64
Query: 645 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG----TLTHEQRINWIKRLEIAEDAAKGIE 700
+ L + LV+EFM T E + LT +++ +G+E
Sbjct: 65 IGLLDVFGHKSNINLVFEFME--TDLEKVIKDKSIVLTPADIKSYMLMT------LRGLE 116
Query: 701 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 760
YLH+ I+HRDLK +N+L+ K++DFGL++ ++ V T Y PE
Sbjct: 117 YLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPE 172
Query: 761 -YYISQQLTDKSDVYSFGVILLELI 784
+ ++ D++S G I EL+
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 10/203 (4%)
Query: 592 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 650
+KIG G G VY + G+E+A++ + K NE+ ++ + N+V +L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 651 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 710
+V E++ G+L + + T E +I + R + + +E+LH+ +
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSN---QV 137
Query: 711 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 770
IHRD+KS NILL K++DFG S S++V GT ++ PE + K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 196
Query: 771 SDVYSFGVILLELISGQEAISNE 793
D++S G++ +E+I G+ NE
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNE 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 64/225 (28%), Positives = 100/225 (44%), Gaps = 27/225 (12%)
Query: 593 KIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGK---REFTNEVTLLSRIHHRNLVQFL 648
++G GG+G V+ K KD EI A+K + + R E +L+ LV+ L
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 649 GYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 706
Q++ L E++ G + L G L+ + R +AE ++ LH
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH-----ARFYMAEMFE-AVDALHE-- 119
Query: 707 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 766
IHRDLK N L+D K++DFGLSK V ++ +S+V G+ Y+ PE +
Sbjct: 120 -LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV---TYANSVV-GSPDYMAPEVLRGKG 174
Query: 767 LTDKSDVYSFGVILLELISGQEAIS----NEKFGANCRNIVQWAK 807
D +S G +L E + G S NE + N+ W +
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW----ENLKYWKE 215
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 10/203 (4%)
Query: 592 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 650
+KIG G G VY + G+E+A+K + K NE+ ++ + N+V +L
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 651 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 710
+V E++ G+L + + T E +I + R + + +++LH+ +
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALDFLHSN---QV 136
Query: 711 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 770
IHRD+KS NILL K++DFG S S++V GT ++ PE + K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 195
Query: 771 SDVYSFGVILLELISGQEAISNE 793
D++S G++ +E++ G+ NE
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 590 LEKKIGSGGFGVVY---YGKLKDGK-EIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNL 644
L + IG G FG VY Y ++ K +AVK + + RE F E ++ + H ++
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHI 69
Query: 645 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI---AEDAAKGIEY 701
V+ +G E +V E G L+ +L + + + + + + Y
Sbjct: 70 VKLIGVI-TENPVWIVMELAPLGELRSYL------QVNKYSLDLASLILYSYQLSTALAY 122
Query: 702 LH-TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 760
L V HRD+ + N+L+ K+ DFGLS++ D + + +S + + ++ PE
Sbjct: 123 LESKRFV----HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178
Query: 761 YYISQQLTDKSDVYSFGVILLELIS 785
++ T SDV+ FGV + E++
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 3e-16
Identities = 62/224 (27%), Positives = 113/224 (50%), Gaps = 34/224 (15%)
Query: 589 MLEKKIGSGGFGVVYYG------KLKDGK--EIAVKVLTSNSYQGK-REFTNEVTLLSRI 639
+L K +G G FG V K K + ++AVK+L S++ + + +E+ ++ I
Sbjct: 21 VLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 80
Query: 640 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWI 686
H+N++ LG C ++G ++ E+ G L+E+L T E+++++
Sbjct: 81 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 687 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746
+ A A+G+EYL + IHRDL + N+L+ + K++DFGL++ H+
Sbjct: 141 DLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHI 193
Query: 747 SSIVRGTVG-----YLDPEYYISQQLTDKSDVYSFGVILLELIS 785
+ T G ++ PE + T +SDV+SFGV+L E+ +
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 57/220 (25%), Positives = 108/220 (49%), Gaps = 28/220 (12%)
Query: 590 LEKKIGSGGFGVVYYG--------KLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI- 639
L K +G G FG V K K+ +AVK+L ++ + + +E+ ++ I
Sbjct: 19 LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 78
Query: 640 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWIK 687
H+N++ LG C ++G ++ E+ G L+E+L ++++ +
Sbjct: 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 688 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 747
+ A+G+EYL + IHRDL + N+L+ ++ K++DFGL++ V+ +
Sbjct: 139 LVSCTYQVARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLAR-DVNNIDYYK 194
Query: 748 SIVRG--TVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
G V ++ PE + T +SDV+SFGV++ E+ +
Sbjct: 195 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQF 647
L + IG G +G VY + K G+ +A+K++ + E E +L + +H N+ F
Sbjct: 10 LVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATF 68
Query: 648 LG-YCQEEGRSV-----LVYEFMHNGTLKEHLYGTLTHEQRI--NWIKRLEIAEDAAKGI 699
G + ++ LV E G++ + + G +R+ WI I + +G+
Sbjct: 69 YGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--ILRETLRGL 126
Query: 700 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 759
YLH V IHRD+K NILL K+ K+ DFG+S +D + GT ++ P
Sbjct: 127 AYLHENKV---IHRDIKGQNILLTKNAEVKLVDFGVSA-QLDSTLGRRNTFIGTPYWMAP 182
Query: 760 EYYISQQLTD-----KSDVYSFGVILLELISGQ 787
E + D +SDV+S G+ +EL G+
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 4e-16
Identities = 66/209 (31%), Positives = 100/209 (47%), Gaps = 19/209 (9%)
Query: 594 IGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLG 649
+G GGFG V +++ GK A K L +G+ NE +L +++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVN-LA 66
Query: 650 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTG 705
Y E ++ LV M+ G LK H+Y E+R L A + G+E LH
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERA-----LFYAAEILCGLEDLHR- 120
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 765
++RDLK NILLD + ++SD GL+ +G S + GTVGY+ PE +Q
Sbjct: 121 --ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV--GTVGYMAPEVLNNQ 176
Query: 766 QLTDKSDVYSFGVILLELISGQEAISNEK 794
+ T D + G ++ E+I GQ K
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 4e-16
Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 40/225 (17%)
Query: 590 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQGK-REFTNEVTLLSRI-HH 641
L K +G G FG V + +AVK+L ++ + + +E+ ++ I H
Sbjct: 16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 75
Query: 642 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIKRL 689
+N++ LG C +EG +V E+ +G L++ L E+ + +
Sbjct: 76 KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135
Query: 690 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS---------KFAV 740
A A+G+E+L + IHRDL + N+L+ + K++DFGL+ +
Sbjct: 136 SFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192
Query: 741 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
+G R V ++ PE + T +SDV+SFGV+L E+ +
Sbjct: 193 NG--------RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 5e-16
Identities = 66/201 (32%), Positives = 94/201 (46%), Gaps = 15/201 (7%)
Query: 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQ 646
K IG G FG V K K DGK AVKVL + K+E LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 647 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 706
Q + V ++++ G L HL E+ + A + A + YLH+
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHL----QRERSFPEPRARFYAAEIASALGYLHS-- 114
Query: 707 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 766
II+RDLK NILLD ++DFGL K ++ + S+ GT YL PE + +Q
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC-GTPEYLAPE-VLRKQ 171
Query: 767 LTDKS-DVYSFGVILLELISG 786
D++ D + G +L E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 54/207 (26%), Positives = 105/207 (50%), Gaps = 17/207 (8%)
Query: 594 IGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRIHH---RNLVQFL 648
IG G +G VY GK + G+ +A+K++ ++ + EV LLS++ N+ ++
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 649 GYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
G +G + ++ E+ G+++ + E+ I+ I R + ++Y+H
Sbjct: 69 G-SYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR-----EVLVALKYIHKV-- 120
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 767
+IHRD+K++NIL+ K+ DFG++ +S S+ V GT ++ PE +
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKY 178
Query: 768 TD-KSDVYSFGVILLELISGQEAISNE 793
D K+D++S G+ + E+ +G S+
Sbjct: 179 YDTKADIWSLGITIYEMATGNPPYSDV 205
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 7e-16
Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTN-EVTLLSRIHHRNLVQF 647
L + IG G FG VY K + +A+KV+ + + E E+ LS+ + ++
Sbjct: 5 LLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKY 64
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHL-YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 706
G + + ++ E+ G+ + L G L E I +I R + G+EYLH
Sbjct: 65 YGSFLKGSKLWIIMEYCGGGSCLDLLKPGKL-DETYIAFILR-----EVLLGLEYLHEEG 118
Query: 707 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 766
IHRD+K++NILL + K++DFG+S S ++ V GT ++ PE I Q
Sbjct: 119 K---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPE-VIKQS 173
Query: 767 LTD-KSDVYSFGVILLELISG 786
D K+D++S G+ +EL G
Sbjct: 174 GYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 7e-16
Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 19/214 (8%)
Query: 590 LEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTS--NSYQGKREFTNEVTLLSRIHHRN 643
L + +G G FG V +LK +++AVK+L + S EF E + H N
Sbjct: 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPN 62
Query: 644 LVQFLG---YCQEEGR---SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR--LEIAEDA 695
+++ +G + +GR +++ FM +G L L + E+ + + D
Sbjct: 63 VIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI 122
Query: 696 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTV 754
A G+EYL + IHRDL + N +L+++M V+DFGLSK G + + V
Sbjct: 123 ASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV 179
Query: 755 GYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQ 787
+L E T SDV++FGV + E+++ GQ
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 9e-16
Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 25/210 (11%)
Query: 593 KIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKR------EFTNEVTLLSRIHHRNLV 645
+IG G FG VY+ E+ AVK + SY GK+ + EV L ++ H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKM---SYSGKQTNEKWQDIIKEVKFLQQLKHPNTI 84
Query: 646 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 705
++ G +E + LV E+ G+ + L H++ + ++ I A +G+ YLH+
Sbjct: 85 EYKGCYLKEHTAWLVMEYCL-GSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSH 140
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 765
+IHRD+K+ NILL + + K++DFG + + S V GT ++ PE ++
Sbjct: 141 N---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAM 192
Query: 766 ---QLTDKSDVYSFGVILLELISGQEAISN 792
Q K DV+S G+ +EL + + N
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPPLFN 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 9e-16
Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEI---AVKVLTSN--SYQGKREFTNEVTLLSRIHHRNL 644
L K +G G FG V G+L I AVK + + +F +E + H N+
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62
Query: 645 VQFLGYC----QEEG--RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL--EIAEDAA 696
++ +G C + EG V++ FM +G L L + + ++ + D A
Sbjct: 63 MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122
Query: 697 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS-IVRGTVG 755
G+EYL + + IHRDL + N +L+++M V+DFGLSK +G + I + V
Sbjct: 123 SGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179
Query: 756 YLDPEYYISQQLTDKSDVYSFGVILLELIS-GQ 787
++ E + T KSDV+SFGV + E+ + GQ
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQ 212
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 53/201 (26%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 589 MLEKKIGSGGFG--VVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 646
+ + +G G FG ++ D K ++ S + E LL+++ H N+V
Sbjct: 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVA 62
Query: 647 FLGYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRI-NWIKRLEIAEDAAKGIEYL 702
F + +G +V E+ G L + + G L E I W ++ + G++++
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHI 116
Query: 703 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 762
H ++HRD+KS NI L ++ + K+ DFG ++ ++ + V GT Y+ PE +
Sbjct: 117 HE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIW 172
Query: 763 ISQQLTDKSDVYSFGVILLEL 783
+ +KSD++S G IL EL
Sbjct: 173 ENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 68/275 (24%), Positives = 127/275 (46%), Gaps = 35/275 (12%)
Query: 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
+ +G G +G V + + DGK+ +K L + S + ++ E LLS++ H N+V +
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 649 GYCQ-EEGRSVLVYEFMHNG----TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 703
+ E+G +V F G LKE L Q + W ++ +A ++YLH
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA------LQYLH 119
Query: 704 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 763
I+HRDLK+ N+ L + KV D G+++ ++ ++S + GT Y+ PE +
Sbjct: 120 E---KHILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCDMASTLIGTPYYMSPELFS 175
Query: 764 SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 823
++ KSDV++ G + E+ + + A + + + I++ KL P +
Sbjct: 176 NKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE-GKL------------PPM 222
Query: 824 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 858
+Y + I ++ P RPS+ +L+
Sbjct: 223 PKDYSPELGELI--ATMLSKRP--EKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 17/202 (8%)
Query: 593 KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQFLG 649
+IG G G+V+ K + G+ +A+K + +G + E+ L H +V+ L
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR---INWIKRLEIAEDAAKGIEYLHTGC 706
VLV E+M + L L E+R +K KG+ Y+H
Sbjct: 67 VFPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQVKSY--MRMLLKGVAYMHAN- 118
Query: 707 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE-YYISQ 765
I+HRDLK +N+L+ K++DFGL++ + + S T Y PE Y ++
Sbjct: 119 --GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR 176
Query: 766 QLTDKSDVYSFGVILLELISGQ 787
+ D+++ G I EL++G
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 23/203 (11%)
Query: 594 IGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQGKREFT-NEVTLLSRI---HHRNLVQF 647
IG G +G VY + L G+ +A+K V S +G T E+ LL ++ H N+V+
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 648 LGYCQ----EEGRSV-LVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 700
L C + + LV+E + T + I + R ++ +G++
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMR-QLL----RGVD 121
Query: 701 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 760
+LH+ I+HRDLK NIL+ + K++DFGL++ + S +V T+ Y PE
Sbjct: 122 FLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV--TLWYRAPE 176
Query: 761 YYISQQLTDKSDVYSFGVILLEL 783
+ D++S G I EL
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 592 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLG 649
+G+G G V K + G +A KV+ + +++ E+ ++ +V F G
Sbjct: 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG 70
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
E + EFM G+L G + E +IA +G+ YL+ V
Sbjct: 71 AFLNENNICMCMEFMDCGSLDRIYKKGGPIPVE------ILGKIAVAVVEGLTYLYN--V 122
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 767
I+HRD+K SNIL++ + K+ DFG+S ++ ++ GT Y+ PE +
Sbjct: 123 HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---IADTFVGTSTYMSPERIQGGKY 179
Query: 768 TDKSDVYSFGVILLELISGQ 787
T KSDV+S G+ ++EL G+
Sbjct: 180 TVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 591 EK--KIGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQG-KREFTNEVTLLSRIHHRNLV 645
EK +IG G +G+VY + EI KV N G E+TLL + H N+V
Sbjct: 10 EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIV 69
Query: 646 QFLGYCQEEGRSV----LVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 699
+ G+ + LV E+ +L +++ + Q +K L + +G+
Sbjct: 70 ELKEVVV--GKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQ----VKCLML--QLLRGL 121
Query: 700 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 759
+YLH IIHRDLK SN+LL K++DFGL++ A ++ V T+ Y P
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAP 177
Query: 760 EYYI-SQQLTDKSDVYSFGVILLELISGQ 787
E + T D+++ G IL EL++ +
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 27/214 (12%)
Query: 592 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT-----NEVTLLSR------I 639
K +G G FG V +LK E A+K L K++ E T++ R
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKAL-------KKDVVLEDDDVECTMVERRVLALAW 53
Query: 640 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 699
H L Q + V E+++ G L H+ + ++ EI G+
Sbjct: 54 EHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEII----CGL 109
Query: 700 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 759
++LH II+RDLK N+LLDK K++DFG+ K ++G S+ GT Y+ P
Sbjct: 110 QFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAP 165
Query: 760 EYYISQQLTDKSDVYSFGVILLELISGQEAISNE 793
E Q+ + D +SFGV+L E++ GQ E
Sbjct: 166 EILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 62/206 (30%), Positives = 107/206 (51%), Gaps = 14/206 (6%)
Query: 585 DATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHH 641
D TK+ +KIG G +GVVY G+ K G+ +A+K + S + T E++LL + H
Sbjct: 1 DYTKI--EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQH 58
Query: 642 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 701
N+V +E R L++EF+ + LK++L +L Q ++ +GI +
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFL-SMDLKKYL-DSLPKGQYMDAELVKSYLYQILQGILF 116
Query: 702 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPE 760
H+ ++HRDLK N+L+D K++DFGL++ F + + +V T+ Y PE
Sbjct: 117 CHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPE 171
Query: 761 YYI-SQQLTDKSDVYSFGVILLELIS 785
+ S + + D++S G I E+ +
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-15
Identities = 63/221 (28%), Positives = 107/221 (48%), Gaps = 26/221 (11%)
Query: 573 EAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKR---- 627
+ A F D E L ++IG G FG VY+ + +++ + +A+K + SY GK+
Sbjct: 3 DVAELFFKDDPEKLFSDL-REIGHGSFGAVYFARDVRNSEVVAIKKM---SYSGKQSNEK 58
Query: 628 --EFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINW 685
+ EV L ++ H N +Q+ G E + LV E+ G+ + L H++ +
Sbjct: 59 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLE---VHKKPLQE 114
Query: 686 IKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745
++ + A +G+ YLH+ +IHRD+K+ NILL + K+ DFG +
Sbjct: 115 VEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF 171
Query: 746 VSSIVRGTVGYLDPEYYISQ---QLTDKSDVYSFGVILLEL 783
V GT ++ PE ++ Q K DV+S G+ +EL
Sbjct: 172 V-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 3e-15
Identities = 59/208 (28%), Positives = 107/208 (51%), Gaps = 12/208 (5%)
Query: 582 DIEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI 639
D E+ LEK IG G FG V+ G + K +A+K++ + + E E+T+LS+
Sbjct: 1 DPEELFTKLEK-IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59
Query: 640 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 699
+ ++ G ++ + ++ E++ G+ + L E +I I R + KG+
Sbjct: 60 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGL 114
Query: 700 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 759
+YLH+ IHRD+K++N+LL +H K++DFG++ D ++ V GT ++ P
Sbjct: 115 DYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAP 170
Query: 760 EYYISQQLTDKSDVYSFGVILLELISGQ 787
E K+D++S G+ +EL G+
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 60/237 (25%), Positives = 99/237 (41%), Gaps = 30/237 (12%)
Query: 594 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQFLG 649
+G GGFG V +++ GK A K L + ++ + E +L+++H R +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 709
Q + LV M+ G L+ H+Y + G+E+LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117
Query: 710 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 769
II+RDLK N+LLD ++SD GL+ DG S GT G++ PE ++
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-GTPGFMAPELLQGEEYDF 176
Query: 770 KSDVYSFGVILLELISGQ-------EAISN---------------EKFGANCRNIVQ 804
D ++ GV L E+I+ + E + N +KF ++ +
Sbjct: 177 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCE 233
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 67/216 (31%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 582 DIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--TSNSYQGKREFTN-EVTLLS 637
D+ D + E IGSG G VY + K G +AVK + T N + KR + +V L S
Sbjct: 13 DLNDLENLGE--IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS 70
Query: 638 RIHHR--NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 695
H +V+ GY + + E M T + L + + + ++ +A
Sbjct: 71 ---HDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVA--I 123
Query: 696 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 755
K + YL +IHRD+K SNILLD K+ DFG+S VD + S G
Sbjct: 124 VKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS--AGCAA 179
Query: 756 YLDPEYYISQQLTDK----SDVYSFGVILLELISGQ 787
Y+ PE K +DV+S G+ L+EL +GQ
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 22/205 (10%)
Query: 592 KKIGSGGFGVVYYGK-LKDGKEI----AVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLV 645
K +GSG FG V+ G + +G I A+K + S Q +E T+ + + + H +V
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 646 QFLGYCQEEGRSV-LVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEY 701
+ LG C G S+ LV + G+L +H+ +L ++ +NW ++ AKG+ Y
Sbjct: 73 RLLGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYY 124
Query: 702 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPE 760
L ++HR+L + NILL +++DFG++ D + S + + ++ E
Sbjct: 125 LEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181
Query: 761 YYISQQLTDKSDVYSFGVILLELIS 785
+ + T +SDV+S+GV + E++S
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-15
Identities = 69/234 (29%), Positives = 99/234 (42%), Gaps = 33/234 (14%)
Query: 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR-----NLV 645
K I G FG VY K + G A+KVL + K + TN V I +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTN-VKAERAIMMIQGESPYVA 60
Query: 646 QFLGYCQEEGRSVLVYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 702
+ Q + LV E+++ G +L + L G L + W K+ IAE G+E L
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTL-GGLPED----WAKQY-IAE-VVLGVEDL 113
Query: 703 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 762
H IIHRD+K N+L+D+ K++DFGLS+ + GT YL PE
Sbjct: 114 HQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDYLAPETI 165
Query: 763 ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 816
+ SD +S G ++ E + G F A + V + I S I
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYPP-----FHAETPDAV-FDN--ILSRRIN 211
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 7e-15
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 17/203 (8%)
Query: 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSR------IHHRNL 644
K +G G FG V+ +LK + A+K L + + E T++ + H L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDV--ECTMVEKRVLSLAWEHPFL 58
Query: 645 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 704
Q + V E+++ G L H+ + + + A + G+++LH+
Sbjct: 59 THLYCTFQTKENLFFVMEYLNGGDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHS 114
Query: 705 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 764
I++RDLK NILLD K++DFG+ K + G + + GT Y+ PE +
Sbjct: 115 ---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLG 170
Query: 765 QQLTDKSDVYSFGVILLELISGQ 787
Q+ D +SFGV+L E++ GQ
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 8e-15
Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 14/201 (6%)
Query: 592 KKIGSGGFGVVYYGK-LKDGKEI----AVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLV 645
K +GSG FG VY G + +G+ + A+K+L + + EF +E +++ + H +LV
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 646 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 705
+ LG C LV + M +G L ++++ H+ I L AKG+ YL
Sbjct: 73 RLLGVCLSPTIQ-LVTQLMPHGCLLDYVH---EHKDNIGSQLLLNWCVQIAKGMMYLEE- 127
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYYIS 764
++HRDL + N+L+ K++DFGL++ D + + + + ++ E
Sbjct: 128 --RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 185
Query: 765 QQLTDKSDVYSFGVILLELIS 785
++ T +SDV+S+GV + EL++
Sbjct: 186 RKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 9e-15
Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 19/209 (9%)
Query: 594 IGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLG 649
+G GGFG V +++ GK A K L +G+ NE +L +++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVS-LA 66
Query: 650 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTG 705
Y E ++ LV M+ G LK H+Y EQR + A + G+E L
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRA-----IFYAAELCCGLEDLQR- 120
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 765
I++RDLK NILLD ++SD GL+ +G + + GTVGY+ PE ++
Sbjct: 121 --ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV--GTVGYMAPEVINNE 176
Query: 766 QLTDKSDVYSFGVILLELISGQEAISNEK 794
+ T D + G ++ E+I GQ K
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-14
Identities = 65/206 (31%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV----- 645
K +G G FG V +LK G+ AVK L + + E T++ + R L
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDV--ECTMVEK---RVLALAWEN 55
Query: 646 QFLG--YC--QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 701
FL YC Q + V EF++ G L H+ + R + + A + G+++
Sbjct: 56 PFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHI----QDKGRFDLYRATFYAAEIVCGLQF 111
Query: 702 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 761
LH+ II+RDLK N++LD+ K++DFG+ K V G + S+ GT Y+ PE
Sbjct: 112 LHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEI 167
Query: 762 YISQQLTDKSDVYSFGVILLELISGQ 787
+ T D +SFGV+L E++ GQ
Sbjct: 168 LQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 56/204 (27%), Positives = 105/204 (51%), Gaps = 20/204 (9%)
Query: 592 KKIGSGGFGVVYYGK-LKDGKEI----AVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLV 645
K +GSG FG VY G + DG+ + A+KVL N S + +E +E +++ + +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 646 QFLGYCQEEGRSVLVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEYL 702
+ LG C LV + M G L +++ + + +NW ++ AKG+ YL
Sbjct: 73 RLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYL 125
Query: 703 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA-VDGASHVSSIVRGTVGYLDPEY 761
++HRDL + N+L+ K++DFGL++ +D + + + + ++ E
Sbjct: 126 EE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182
Query: 762 YISQQLTDKSDVYSFGVILLELIS 785
+ ++ T +SDV+S+GV + EL++
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 19/199 (9%)
Query: 594 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ 652
+G G FG VY + K+ A K++ S + +F E+ +LS H N+V
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 653 EEGRSVLVYEFMHNGTLK---EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 709
E + ++ EF G L L LT E +I ++ R + + +LH+
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLT-EPQIRYVCR-----QMLEALNFLHSH---K 123
Query: 710 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 769
+IHRDLK+ NILL K++DFG+S + + GT ++ PE + D
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKD 182
Query: 770 -----KSDVYSFGVILLEL 783
K+D++S G+ L+EL
Sbjct: 183 NPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 59/208 (28%), Positives = 109/208 (52%), Gaps = 22/208 (10%)
Query: 588 KMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLV 645
K LEK +G G + VY G+ + EI A+K + ++ +G E++L+ + H N+V
Sbjct: 3 KQLEK-LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 646 QFLGYCQEEGRSVLVYEFMHNGTLKEHL-----YGTLTHEQRINWIKRLEIAEDAAKGIE 700
+ E + +LV+E+M + LK+++ G L ++ +L KGI
Sbjct: 62 RLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQL------LKGIA 114
Query: 701 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDP 759
+ H ++HRDLK N+L++K K++DFGL++ F + + + +V T+ Y P
Sbjct: 115 FCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAP 169
Query: 760 EYYI-SQQLTDKSDVYSFGVILLELISG 786
+ + S+ + D++S G I+ E+I+G
Sbjct: 170 DVLLGSRTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 67/271 (24%), Positives = 118/271 (43%), Gaps = 22/271 (8%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVK---VLTSNSYQGKREFTNEVTLLSRIHHRNLV 645
+EKKIG G F VY L DG +A+K + + + + E+ LL +++H N++
Sbjct: 6 IEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVI 65
Query: 646 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 705
++ E+ +V E G L + ++ I + +E++H+
Sbjct: 66 KYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS- 124
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 765
++HRD+K +N+ + K+ D GL +F + S+V GT Y+ PE
Sbjct: 125 --RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHEN 181
Query: 766 QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 825
KSD++S G +L E+ + Q +K N+ K IE D P L
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCK-KIEQCDY-----PPLPS 230
Query: 826 EYDIQSMWKIEEKALMCVLPHGHMRPSISEV 856
++ + + ++ MC+ P RP I+ V
Sbjct: 231 DHYSEELRQLVN---MCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 74/225 (32%), Positives = 109/225 (48%), Gaps = 28/225 (12%)
Query: 579 TLSDIEDATKMLEKKIGSGGFGVVY-YGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLS 637
+L D D +++E IG G +G VY KDG AVK+L S E E +L
Sbjct: 16 SLGDPTDTWEIIET-IGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQ 73
Query: 638 RI-HHRNLVQFLG--YCQEE---GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI 691
+ +H N+V+F G Y ++ G+ LV E + G++ E + G L QR++ I
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYI 133
Query: 692 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 751
A G+++LH IIHRD+K +NILL K+ DFG+S A S+ +R
Sbjct: 134 LYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVS------AQLTSTRLR 184
Query: 752 -----GTVGYLDPEYYISQQLTDKS-----DVYSFGVILLELISG 786
GT ++ PE +Q D S DV+S G+ +EL G
Sbjct: 185 RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 13/197 (6%)
Query: 593 KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 651
++G G FG VY K K+ G A KV+ + S + ++ E+ +L+ +H +V+ LG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 652 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 711
+G+ ++ EF G + + L ++ + + I + ++YLH+ II
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIM---LELDRGLTEPQIQVICRQMLEALQYLHS---MKII 132
Query: 712 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-- 769
HRDLK+ N+LL K++DFG+S V S + GT ++ PE + + + D
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCETMKDTP 191
Query: 770 ---KSDVYSFGVILLEL 783
K+D++S G+ L+E+
Sbjct: 192 YDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 57/231 (24%), Positives = 112/231 (48%), Gaps = 37/231 (16%)
Query: 589 MLEKKIGSGGFGVVYYGKLKDGKE-----------------IAVKVLTSNSYQGKR-EFT 630
+ ++K+G G FG V+ ++ + ++ +AVK+L ++ + R +F
Sbjct: 8 LFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFL 67
Query: 631 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR-------- 682
EV +LSR+ N+++ LG C +E ++ E+M NG L + L ++
Sbjct: 68 KEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127
Query: 683 -------INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 735
I++ L +A A G++YL + +HRDL + N L+ +++ K++DFG+
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGM 184
Query: 736 SKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
S+ G + + + ++ E + + T SDV++FGV L E++
Sbjct: 185 SRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 28/202 (13%)
Query: 594 IGSGGFGVVYYG-KLKDGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYC 651
+G G G VY L + +AVKV+ + + + +++ +E+ +L + ++ F G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 652 QEEGRSVLVYEFMHNGTLK------EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 705
E R + EFM G+L EH+ G IA KG+ YL +
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIPEHVLG--------------RIAVAVVKGLTYLWS- 113
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 765
I+HRD+K SN+L++ + K+ DFG+S V+ ++ GT Y+ PE +
Sbjct: 114 --LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPERISGE 168
Query: 766 QLTDKSDVYSFGVILLELISGQ 787
Q SDV+S G+ +EL G+
Sbjct: 169 QYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 2e-14
Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 20/206 (9%)
Query: 594 IGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYC 651
+G+G +G VY G+ +K G+ A+KV+ + + E E+ +L + HHRN+ + G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 652 QEEG------RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 705
++ + LV EF G++ + + T + + WI I + +G+ +LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQH 130
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 765
+IHRD+K N+LL ++ K+ DFG+S +D + GT ++ PE
Sbjct: 131 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNTFIGTPYWMAPEVIACD 186
Query: 766 QLTD-----KSDVYSFGVILLELISG 786
+ D KSD++S G+ +E+ G
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 65/200 (32%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT----LLSRIHHRNLVQ 646
K IG G FG V K K DG AVKVL + K+E + + LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 647 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 706
Q + V ++++ G L HL E+ + A + A I YLH+
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHL----QRERCFLEPRARFYAAEVASAIGYLHS-- 114
Query: 707 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 766
II+RDLK NILLD ++DFGL K V+ S+ GT YL PE +
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC-GTPEYLAPEVLRKEP 172
Query: 767 LTDKSDVYSFGVILLELISG 786
D + G +L E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-14
Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 26/200 (13%)
Query: 610 GKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQFL--GYCQEEGRSVLVYEFM 664
G E+A+K+L +++ + + + F E L +R++H N+V L G G V+E++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 665 HNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 722
TL+E L G L + + ++ A A H I+HRDLK NI++
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACA------HNQ---GIVHRDLKPQNIMV 112
Query: 723 ---DKHMRAKVSDFGLSKFAVD-GASHVSSIVR-----GTVGYLDPEYYISQQLTDKSDV 773
AKV DFG+ + V+++ R GT Y PE + +T SD+
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172
Query: 774 YSFGVILLELISGQEAISNE 793
Y++G+I LE ++GQ +
Sbjct: 173 YAWGLIFLECLTGQRVVQGA 192
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 65/224 (29%), Positives = 96/224 (42%), Gaps = 33/224 (14%)
Query: 578 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTN----- 631
FT D++D +IG G FG V K G +AVK + S ++E
Sbjct: 1 FTAEDLKD-----LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV--DEKEQKRLLMDL 53
Query: 632 EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL-- 689
+V + S +V+F G EG + E M + Y + + + +
Sbjct: 54 DVVMRSS-DCPYIVKFYGALFREGDCWICMELMD--ISLDKFYKYVYEVLKSVIPEEILG 110
Query: 690 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 749
+IA K + YL IIHRD+K SNILLD++ K+ DFG+S VD SI
Sbjct: 111 KIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD------SI 162
Query: 750 VR----GTVGYLDPEYYISQQLTD---KSDVYSFGVILLELISG 786
+ G Y+ PE +SDV+S G+ L E+ +G
Sbjct: 163 AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 592 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQFLG 649
++IG G FG VY G KE+ A+K++ + + E E+T+LS+ + ++ G
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 709
+ + ++ E++ G+ + L E I I R + KG++YLH+
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR-----EILKGLDYLHS---ER 121
Query: 710 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 769
IHRD+K++N+LL + K++DFG++ D ++ V GT ++ PE I Q D
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPE-VIKQSAYD 179
Query: 770 -KSDVYSFGVILLELISGQEAISN 792
K+D++S G+ +EL G+ S+
Sbjct: 180 FKADIWSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 63/236 (26%), Positives = 104/236 (44%), Gaps = 61/236 (25%)
Query: 592 KKIGSGGFGVVYYGK--------LKDGKE---------IAVKVLTSN-SYQGKREFTNEV 633
+K+G G FG V+ + K E +AVKVL + S + +F EV
Sbjct: 11 EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEV 70
Query: 634 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR----- 688
+LSR+ N+ + LG C + ++ E+M NG L + L H + +
Sbjct: 71 KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQ---KHVAETSGLACNSKSL 127
Query: 689 -----LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK------ 737
L +A A G+ YL + +HRDL + N L+ K+ K++DFG+S+
Sbjct: 128 SFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184
Query: 738 -FAVDGASHV-------SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
+ V G + + S++ G + T KSDV++FGV L E+++
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLG-------------KFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-14
Identities = 66/201 (32%), Positives = 89/201 (44%), Gaps = 15/201 (7%)
Query: 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQ 646
K IG G FG V K K DGK AVKVL ++E LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 647 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH-EQRINWIKRLEIAEDAAKGIEYLHTG 705
Q + V +F++ G L HL + E R R AE A + YLH+
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPR----ARFYAAE-IASALGYLHS- 114
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 765
I++RDLK NILLD ++DFGL K + + ++ GT YL PE Q
Sbjct: 115 --INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC-GTPEYLAPEVIRKQ 171
Query: 766 QLTDKSDVYSFGVILLELISG 786
+ D + G +L E++ G
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 74/293 (25%), Positives = 136/293 (46%), Gaps = 45/293 (15%)
Query: 590 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLT-SNSYQGKREFTNEVTLLSRIHHR 642
L +++G G FG+VY G +D +AVK + S S + + EF NE +++
Sbjct: 10 LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 69
Query: 643 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRIN-------WIKRLEIAEDA 695
++V+ LG + +++V E M +G LK +L +L E N + +++A +
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLR-SLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 696 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--T 753
A G+ YL+ +HRDL + N ++ K+ DFG+++ + + +G
Sbjct: 129 ADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR-DIYETDYYRKGGKGLLP 184
Query: 754 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE----AISNEKFGANCRNIVQWAKLH 809
V ++ PE T SD++SFGV+L E+ S E +SNE+
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV-------------- 230
Query: 810 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862
++ ++D LD+ D ++ + MC + MRP+ E++ ++D
Sbjct: 231 -----LKFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 60/222 (27%), Positives = 109/222 (49%), Gaps = 22/222 (9%)
Query: 580 LSDIEDATKMLE--KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLL 636
LS + D + E + +G+G +G VY G+ +K G+ A+KV+ + + E E+ +L
Sbjct: 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINML 66
Query: 637 SRI-HHRNLVQFLGY------CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL 689
+ HHRN+ + G + + LV EF G++ + + T + + +WI
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY- 125
Query: 690 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 749
I + +G+ +LH +IHRD+K N+LL ++ K+ DFG+S +D +
Sbjct: 126 -ICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNT 180
Query: 750 VRGTVGYLDPEYYISQQLTD-----KSDVYSFGVILLELISG 786
GT ++ PE + D +SD++S G+ +E+ G
Sbjct: 181 FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 6e-14
Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 28/220 (12%)
Query: 590 LEKKIGSGGFGVVYYG------KLKDGK--EIAVKVLTSNSY-QGKREFTNEVTLLSRI- 639
L K +G G FG V K K K +AVK+L ++ + + +E+ ++ I
Sbjct: 16 LGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG 75
Query: 640 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL---------YGTLT---HEQRINWIK 687
H+N++ LG C ++G ++ E+ G L+E+L Y T E+++ +
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 688 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 747
+ A A+G+EYL + IHRDL + N+L+ + K++DFGL++ V +
Sbjct: 136 LVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVTEDNVMKIADFGLAR-DVHNIDYYK 191
Query: 748 SIVRG--TVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
G V ++ PE + T +SDV+SFGV+L E+ +
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 7e-14
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 647
K +G G FG V + K GK A+K+L K E + +T +L H L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
Q + R V E+++ G L HL + E+ + + + ++YLH+G
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHL----SRERVFSEDRTRFYGAEIVSALDYLHSG-- 114
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 767
I++RDLK N++LDK K++DFGL K + A+ + + GT YL PE
Sbjct: 115 -KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTPEYLAPEVLEDNDY 172
Query: 768 TDKSDVYSFGVILLELISGQEAISNE 793
D + GV++ E++ G+ N+
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 7e-14
Identities = 70/225 (31%), Positives = 95/225 (42%), Gaps = 48/225 (21%)
Query: 580 LSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREF--------- 629
LSD E + + +G+G FG V K K G+ A+K L KRE
Sbjct: 17 LSDFE-----MGETLGTGSFGRVRIAKHKGTGEYYAIKCLK------KREILKMKQVQHV 65
Query: 630 TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL 689
E ++L + H +V + Q+E R + EF+ G L HL K
Sbjct: 66 AQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR------------KAG 113
Query: 690 EIAEDAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 741
D AK EYLH+ II+RDLK N+LLD KV+DFG +K D
Sbjct: 114 RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170
Query: 742 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 786
+ GT YL PE S+ D ++ GV+L E I+G
Sbjct: 171 RTFTLC----GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 7e-14
Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 38/218 (17%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEI-AVKVLT---SNSYQGKREFTNEVTLLSRI-HHRNL 644
+ +K+G G +G+V+ + KE+ A+K + N+ +R F E+ L + H N+
Sbjct: 11 ILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF-REIMFLQELGDHPNI 69
Query: 645 VQFLG-YCQEEGRSV-LVYEFM----HN----GTLKEHLYGTLTHEQRINWIKRLEIAED 694
V+ L E + + LV+E+M H L++ H++ I +
Sbjct: 70 VKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILED------VHKRYIMY--------Q 115
Query: 695 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGT 753
K ++Y+H+G +IHRDLK SNILL+ R K++DFGL++ + + + ++
Sbjct: 116 LLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDY 172
Query: 754 VG---YLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 787
V Y PE + S + T D++S G IL E++ G+
Sbjct: 173 VATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-14
Identities = 54/201 (26%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 592 KKIGSGGFGVVYYGK-LKDGKEI----AVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLV 645
K +GSG FG VY G + +G+++ A+K L + S + +E +E +++ + + ++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 646 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 705
+ LG C L+ + M G L +++ H+ I L AKG+ YL
Sbjct: 73 RLLGICLTSTVQ-LITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEE- 127
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYIS 764
++HRDL + N+L+ K++DFGL+K D + + + + ++ E +
Sbjct: 128 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH 185
Query: 765 QQLTDKSDVYSFGVILLELIS 785
+ T +SDV+S+GV + EL++
Sbjct: 186 RIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 9e-14
Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 14/201 (6%)
Query: 591 EKKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQF 647
+KIG G +GVVY + + E IA+K + T E++LL + H N+V+
Sbjct: 7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
E R LV+E++ + LK+H+ + + IK +GI Y H+
Sbjct: 67 QDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTY--LYQILRGIAYCHSH-- 121
Query: 708 PAIIHRDLKSSNILLDKHMRA-KVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-S 764
++HRDLK N+L+D+ A K++DFGL++ F + + +V T+ Y PE + S
Sbjct: 122 -RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRAPEILLGS 178
Query: 765 QQLTDKSDVYSFGVILLELIS 785
+ + D++S G I E+++
Sbjct: 179 RHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 21/205 (10%)
Query: 594 IGSGGFGVVYYGKLKDG-------KEIAVKVLTSNSYQGKRE-------FTNEVTLL-SR 638
+GSG FG VY + K+ KEI V + KRE +EVT++ +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNP--AFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 639 IHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 698
+ H N+V++ E R +V + + L EH +QR + I
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 699 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 758
+ YLH I+HRDL +NI+L + + ++DFGL+K S ++S+V GT+ Y
Sbjct: 126 LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVV-GTILYSC 181
Query: 759 PEYYISQQLTDKSDVYSFGVILLEL 783
PE ++ +K+DV++FG IL ++
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 62/204 (30%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 594 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRN--LVQF 647
IG GGFG VY + D GK A+K L QG+ NE +LS + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 648 LGYC-QEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 704
+ Y + + + M+ G L HL +G + + + A + G+E++H
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFY------AAEIILGLEHMHN 115
Query: 705 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 764
V ++RDLK +NILLD+H ++SD GL+ H S GT GY+ PE
Sbjct: 116 RFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQK 169
Query: 765 QQLTDKS-DVYSFGVILLELISGQ 787
D S D +S G +L +L+ G
Sbjct: 170 GVAYDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 594 IGSGGFGVVYYGKLK---DGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
+G G +GVV K++ G +AVK + T NS + KR + + + V F
Sbjct: 9 LGRGAYGVVD--KMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 649 GYCQEEGRSVLVYEFMHNGTLKEHLY-GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
G EG + E M T + Y I +IA K +EYLH+
Sbjct: 67 GALFREGDVWICMEVMD--TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL- 123
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY---IS 764
++IHRD+K SN+L++++ + K+ DFG+S + VD S +I G Y+ PE ++
Sbjct: 124 -SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD--SVAKTIDAGCKPYMAPERINPELN 180
Query: 765 QQLTD-KSDVYSFGVILLELISG 786
Q+ D KSDV+S G+ ++EL +G
Sbjct: 181 QKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 15/211 (7%)
Query: 582 DIEDATKMLEKKIGSGGFGVVYYG--KLKDGKEIAVKVLT---SNSYQGKREFTNEVTLL 636
++++ + +E+ +G+G FG + G KL +E+ V + T S + +R F E L
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 637 SRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 696
+ H N+V+ G ++V E+M NG L L HE ++ + + + A
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR---KHEGQLVAGQLMGMLPGLA 117
Query: 697 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--TV 754
G++YL +H+ L + +L++ + K+S F + D + + + + G V
Sbjct: 118 SGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPV 172
Query: 755 GYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
+ PE + SDV+SFG+++ E++S
Sbjct: 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 3e-13
Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 39/219 (17%)
Query: 589 MLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNL 644
L K IGSG +GVV + G+++A+K ++ + KR E+ LL + H N+
Sbjct: 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL-REIKLLRHLRHENI 61
Query: 645 VQ----FLGYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIK-RLEIAEDAAK- 697
+ E+ V +V E M T H IK + +D +
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELME----------TDLH----KVIKSPQPLTDDHIQY 107
Query: 698 -------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 750
G++YLH+ +IHRDLK SNIL++ + K+ DFGL++ +
Sbjct: 108 FLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164
Query: 751 RGTVG--YLDPEYYISQQLTDKS-DVYSFGVILLELISG 786
V Y PE +S K+ D++S G I EL++
Sbjct: 165 EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 4e-13
Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 31/210 (14%)
Query: 592 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN-----EVTLLS-RI----- 639
K +G G FG V +LK E+ AVKVL K++ E T+ R+
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVL-------KKDVILQDDDVECTMTEKRVLALAG 53
Query: 640 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAK 697
H L Q Q + R V E+++ G L H+ G + + A +
Sbjct: 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFY------AAEIVL 107
Query: 698 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 757
G+++LH II+RDLK N+LLD K++DFG+ K + G S+ GT Y+
Sbjct: 108 GLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC-GTPDYI 163
Query: 758 DPEYYISQQLTDKSDVYSFGVILLELISGQ 787
PE Q D ++ GV+L E+++GQ
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 594 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRN--LVQF 647
IG GGFG VY + D GK A+K L QG+ NE +LS + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 648 LGYC-QEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 704
+ Y + + + M+ G L HL +G + ++ + A + G+E++H
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFY------ATEIILGLEHMHN 115
Query: 705 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 764
V ++RDLK +NILLD+H ++SD GL+ H S GT GY+ PE
Sbjct: 116 RFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQK 169
Query: 765 QQLTDKS-DVYSFGVILLELISGQEAISNEK 794
D S D +S G +L +L+ G K
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 5e-13
Identities = 40/154 (25%), Positives = 71/154 (46%), Gaps = 19/154 (12%)
Query: 592 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN--EVTLLSRI-HHRNLVQF 647
K++G G FG VY + K+ E+ A+K + + E N EV L ++ H N+V+
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMK-KKFYSWEECMNLREVKSLRKLNEHPNIVKL 63
Query: 648 LGYCQEEGRSVLVYEFMHN---GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 704
+E V+E+M +K+ + + I ++ +G+ ++H
Sbjct: 64 KEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQI------LQGLAHIHK 117
Query: 705 -GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 737
G HRDLK N+L+ K++DFGL++
Sbjct: 118 HG----FFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 590 LEKKIGSGGFGVVYY----GKLKDGKEIAVKVLTSNSYQGKR---EFT-NEVTLLSRIHH 641
L + +G+G +G V+ G GK A+KVL + K E T E +L +
Sbjct: 4 LLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRR 63
Query: 642 RNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK---RLEIAEDAAK 697
+ L Y Q + + L+ ++++ G L HLY QR ++ + R+ IAE
Sbjct: 64 CPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY------QREHFTESEVRVYIAE-IVL 116
Query: 698 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 757
+++LH II+RD+K NILLD ++DFGLSK + + GT+ Y+
Sbjct: 117 ALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173
Query: 758 DPEYYISQQL--TDKSDVYSFGVILLELISG 786
PE D +S GV+ EL++G
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 54/208 (25%), Positives = 105/208 (50%), Gaps = 12/208 (5%)
Query: 582 DIEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI 639
D E+ LE+ IG G FG V+ G + + +A+K++ + + E E+T+LS+
Sbjct: 1 DPEELFTKLER-IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59
Query: 640 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 699
+ ++ G + + ++ E++ G+ + L E +I + ++ KG+
Sbjct: 60 DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQI-----ATMLKEILKGL 114
Query: 700 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 759
+YLH+ IHRD+K++N+LL + K++DFG++ D ++ V GT ++ P
Sbjct: 115 DYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAP 170
Query: 760 EYYISQQLTDKSDVYSFGVILLELISGQ 787
E K+D++S G+ +EL G+
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 8e-13
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 593 KIGSGGFGVVYYGKLKD-GKEIAVK--VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 649
KIG G +GVV+ + ++ G+ +A+K V + + K+ E+ +L ++ H NLV +
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 650 YCQEEGRSVLVYEFMHNGTLKE---HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-G 705
+ + + LV+E+ + L E + G H IK+ I + + + H
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHL-----IKK--IIWQTLQAVNFCHKHN 120
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 765
C IHRD+K NIL+ K + K+ DFG ++ + V T Y PE +
Sbjct: 121 C----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGD 175
Query: 766 -QLTDKSDVYSFGVILLELISGQ 787
Q DV++ G + EL++GQ
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 8e-13
Identities = 65/216 (30%), Positives = 98/216 (45%), Gaps = 14/216 (6%)
Query: 594 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQFLG 649
IG G FG V + +D + I A+K + + E T+ E T+L++++ +V
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK-RLEIAEDAAKGIEYLHTGCVP 708
Q + LV F++ G L HL E R + + R AE +E LH V
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHL----QREGRFDLSRARFYTAE-LLCALENLHKFNV- 114
Query: 709 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 768
I+RDLK NILLD + DFGL K + ++ GT YL PE + T
Sbjct: 115 --IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLAPELLLGHGYT 171
Query: 769 DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 804
D ++ GV+L E+++G +E R I+Q
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ 207
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 9e-13
Identities = 59/210 (28%), Positives = 90/210 (42%), Gaps = 26/210 (12%)
Query: 592 KKIGSGGFGVVYYGKLKDGKEIA---VKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 647
+IG+G FG V G+ G A VK L S + + F EV ++H N++Q
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLE-IAEDAAKGIEYLHTGC 706
LG C E +LV EF G LK +L ++ L+ +A + A G+ +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA- 119
Query: 707 VPAIIHRDLKSSNILLDKHMRAKVSDFGLS------KFAVDGASHVSSIVRGTVGYLDPE 760
IH DL N L + K+ D+GL+ + + H + +L PE
Sbjct: 120 --DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPL-----RWLAPE 172
Query: 761 YYISQQ-------LTDKSDVYSFGVILLEL 783
+ T KS+++S GV + EL
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 15/206 (7%)
Query: 594 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQFLG 649
+G G FG V +LK G+ AVKVL + + +T +LS + + L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 650 YC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 708
C Q R V EF++ G L H+ + +R + + A + + +LH
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEITSALMFLHD---K 115
Query: 709 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYYISQQL 767
II+RDLK N+LLD K++DFG+ K + +G + +S GT Y+ PE
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAPEILQEMLY 173
Query: 768 TDKSDVYSFGVILLELISGQEAISNE 793
D ++ GV+L E++ G E
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPFEAE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 62/231 (26%), Positives = 100/231 (43%), Gaps = 58/231 (25%)
Query: 590 LEKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGK-------REFTNEVTLLSRI 639
+E IG G +G VY K K DGKE A+K + Q RE + LL +
Sbjct: 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACRE----IALLREL 59
Query: 640 HHRNLVQFLGYCQEEG-RSV-LVYEFMHNGTLKEH-LYGTLTHEQRINWIKRLEIAEDAA 696
H N+V + E +SV L++++ EH L+ + ++ KR+ I
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDY------AEHDLWQIIKFHRQA---KRVSIPPSMV 110
Query: 697 K--------GIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSK------- 737
K G+ YLH+ ++HRDLK +NIL+ + K+ D GL++
Sbjct: 111 KSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK 167
Query: 738 --FAVDGASHVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELIS 785
+D V T+ Y PE + ++ T D+++ G I EL++
Sbjct: 168 PLADLDP-------VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 585 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHH 641
D+ + LEK +G G + VY GK K +GK +A+KV+ +G FT E +LL + H
Sbjct: 5 DSYEKLEK-LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKGLKH 62
Query: 642 RNLVQFLGYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAKG 698
N+V + LV+E++H + +H G ++ + L +G
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLL-------RG 115
Query: 699 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 758
+ Y+H I+HRDLK N+L+ K++DFGL++ A SH S T+ Y
Sbjct: 116 LSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRP 171
Query: 759 PEYYI-SQQLTDKSDVYSFGVILLELISGQEAISNEK 794
P+ + S + + D++ G I +E+I G A K
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 53/201 (26%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 593 KIGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLG 649
KIG G +G V+ K ++ EI +V + +G E+ LL + H+N+V+
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 650 YCQEEGRSVLVYEFMHNGTLK--EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
+ + LV+E+ K + G + E +++ +L KG+ + H+
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQL------LKGLAFCHS--- 117
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 766
++HRDLK N+L++K+ K++DFGL++ F + + + +V T+ Y P+ +
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAK 175
Query: 767 LTDKS-DVYSFGVILLELISG 786
L S D++S G I EL +
Sbjct: 176 LYSTSIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 577 CFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK---REFTNEV 633
C DI+ T +L I +Y G + KE+ ++ K NE+
Sbjct: 14 CIESDDIDKYTSVL---IKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEI 69
Query: 634 TLLSRIHHRNLVQFLGY----CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL 689
L RI N+++ G+ + R L+ E+ G L+E L E+ +++ +L
Sbjct: 70 KNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD----KEKDLSFKTKL 125
Query: 690 EIAEDAAKGIEYLHTGC-VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVS 747
++A D KG+ L+ P +++L S + L+ ++ + K+ GL K + +V+
Sbjct: 126 DMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVN 182
Query: 748 SIVRGTVGYLDPEYY--ISQQLTDKSDVYSFGVILLELISG 786
+V Y + I + T K D+YS GV+L E+ +G
Sbjct: 183 FMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTG 218
|
Length = 283 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 61/212 (28%), Positives = 107/212 (50%), Gaps = 37/212 (17%)
Query: 594 IGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQGKREF----TNEVTLLSRIHHRNLVQF 647
IG G +G VY + KD E+ KV N +G F E+ +L +++HRN+V
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG---FPITAIREIKILRQLNHRNIVNL 71
Query: 648 ----------LGYCQEEGRSVLVYEFM-HN--GTLKEHLYGTLTHEQRINWIKRLEIAED 694
L + +++G LV+E+M H+ G L+ L + + +++K+L
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV-HFSEDHIKSFMKQL----- 125
Query: 695 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF--AVDGASHVSSIVRG 752
+G+ Y H +HRD+K SNILL+ + K++DFGL++ + + + + ++
Sbjct: 126 -LEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-- 179
Query: 753 TVGYLDPEYYISQQLTDKS-DVYSFGVILLEL 783
T+ Y PE + ++ + DV+S G IL EL
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 60/203 (29%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 647
K +G G FG V + K GK A+K+L K E + +T +L H L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 705
Q R V E+ + G L HL + ++ R AE + YLH+
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAE-IVSALGYLHSC 114
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYYIS 764
+++RDLK N++LDK K++DFGL K + DGA+ GT YL PE
Sbjct: 115 ---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLED 169
Query: 765 QQLTDKSDVYSFGVILLELISGQ 787
D + GV++ E++ G+
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 29/205 (14%)
Query: 593 KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFLG 649
KIG G +GVVY + G+ +A+K + + T E++LL ++H N+V+ L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIEY 701
E + LV+EF+ LK+++ + + K GI Y
Sbjct: 66 VVHSENKLYLVFEFLDL-DLKKYM----------DSSPLTGLDPPLIKSYLYQLLQGIAY 114
Query: 702 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPE 760
H+ ++HRDLK N+L+D+ K++DFGL++ F V ++ +V T+ Y PE
Sbjct: 115 CHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPE 169
Query: 761 YYI-SQQLTDKSDVYSFGVILLELI 784
+ S+Q + D++S G I E++
Sbjct: 170 ILLGSRQYSTPVDIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 70/218 (32%), Positives = 99/218 (45%), Gaps = 18/218 (8%)
Query: 594 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRN---LVQ 646
IG G FG VY + KD + I A+KVL+ K+E + E +L R +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 647 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK-RLEIAEDAAKGIEYLHTG 705
Q + LV ++M G L HL E R + + + IAE +E+LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHL----QKEGRFSEDRAKFYIAE-LVLALEHLHKY 115
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 765
I++RDLK NILLD + DFGLSK A + ++ GT YL PE + +
Sbjct: 116 ---DIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLLDE 171
Query: 766 Q-LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 802
+ T D +S GV++ E+ G E RNI
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI 209
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 58/208 (27%), Positives = 86/208 (41%), Gaps = 30/208 (14%)
Query: 594 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEVTLL----------SRI 639
+G G FG V + K E+ A+K L K+ +EV L +
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKAL-------KKGDIIARDEVESLMCEKRIFETANSE 59
Query: 640 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 699
H LV Q E V E+ G L H+ H + + + A G+
Sbjct: 60 RHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI-----HTDVFSEPRAVFYAACVVLGL 114
Query: 700 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 759
+YLH I++RDLK N+LLD K++DFGL K + G +S GT +L P
Sbjct: 115 QYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM-GFGDRTSTFCGTPEFLAP 170
Query: 760 EYYISQQLTDKSDVYSFGVILLELISGQ 787
E T D + GV++ E++ G+
Sbjct: 171 EVLTETSYTRAVDWWGLGVLIYEMLVGE 198
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 593 KIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQGKREFT-NEVTLLSRIH---HRNLVQ 646
+IG G +G VY + G +A+K V + G T EV LL R+ H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 647 FLGYC-----QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 701
+ C E + LV+E + + L+ +L IK ++ +G+++
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIK--DLMRQFLRGLDF 123
Query: 702 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 761
LH C I+HRDLK NIL+ + K++DFGL++ + +V T+ Y PE
Sbjct: 124 LHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWYRAPEV 178
Query: 762 YISQQLTDKSDVYSFGVILLEL 783
+ D++S G I E+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 51/204 (25%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 593 KIGSGGFGVVYYGKLKD-GKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 649
+G G +G+V K K+ G+ +A+K + + K+ E+ +L ++ H NLV +
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 650 YCQEEGRSVLVYEFMHNGTLK--EHLYGTLTHE--QRINWIKRLEIAEDAAKGIEYLHTG 705
+ + R LV+EF+ + L E L ++ + +GIE+ H+
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLF--------QILRGIEFCHSH 119
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYIS 764
IIHRD+K NIL+ + K+ DFG ++ A G + + T Y PE +
Sbjct: 120 ---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV--ATRWYRAPELLVG 174
Query: 765 QQLTDKS-DVYSFGVILLELISGQ 787
++ D+++ G ++ E+++G+
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 39/180 (21%)
Query: 577 CFTLSDIEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFT--NEV 633
C L D E + K+G G FG VY ++K G+ +A+K + ++ + T E+
Sbjct: 4 CSKLRDYE-----ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREI 58
Query: 634 TLLSRIHHRNLVQFLGYCQEEGRSV--------LVYEFM--------HNGTLKEHLYGTL 677
+L ++ H N+V + E +V +M N ++K L
Sbjct: 59 KILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK------L 112
Query: 678 THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 737
T Q ++ +L +GI YLH I+HRD+K++NIL+D K++DFGL++
Sbjct: 113 TESQIKCYMLQL------LEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 13/197 (6%)
Query: 593 KIGSGGFGVVYYGKLKDGKEIAV-KVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 651
++G G FG VY + K+ +A KV+ + S + ++ E+ +L+ H N+V+ L
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 652 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 711
E ++ EF G + + L E+ + + + + + + YLH II
Sbjct: 72 YYENNLWILIEFCAGGAVDAVM---LELERPLTEPQIRVVCKQTLEALNYLHEN---KII 125
Query: 712 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-- 769
HRDLK+ NIL K++DFG+S S + GT ++ PE + + D
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRP 184
Query: 770 ---KSDVYSFGVILLEL 783
K+DV+S G+ L+E+
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 55/206 (26%), Positives = 103/206 (50%), Gaps = 21/206 (10%)
Query: 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 648
+K+G G + VY G + +G+ +A+KV++ + +G FT E +LL + H N+V
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLH 69
Query: 649 GYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 705
+ V+E+MH + +H G + R+ + L +G+ Y+H
Sbjct: 70 DIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLL-------RGLAYIHG- 121
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYI- 763
I+HRDLK N+L+ K++DFGL++ ++ ++ S +V T+ Y P+ +
Sbjct: 122 --QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLG 177
Query: 764 SQQLTDKSDVYSFGVILLELISGQEA 789
+ + D++ G I +E++ GQ A
Sbjct: 178 ATDYSSALDIWGAGCIFIEMLQGQPA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 62/201 (30%), Positives = 88/201 (43%), Gaps = 15/201 (7%)
Query: 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQ 646
K IG G FG V + K + K AVKVL + K+E + LL + H LV
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 647 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI-AEDAAKGIEYLHTG 705
Q + V ++++ G L HL +R R A + A + YLH+
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHL-----QRERCFLEPRARFYAAEIASALGYLHS- 114
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 765
I++RDLK NILLD ++DFGL K ++ S+ GT YL PE Q
Sbjct: 115 --LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC-GTPEYLAPEVLHKQ 171
Query: 766 QLTDKSDVYSFGVILLELISG 786
D + G +L E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 63/210 (30%), Positives = 93/210 (44%), Gaps = 26/210 (12%)
Query: 592 KKIGSGGFGVVYYGKLKDG---KEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQF 647
K+IG+G FG V G++ G ++ VK L + S Q + +F E + H NL+Q
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLE-IAEDAAKGIEYLHTGC 706
LG C E +LV EF G LK +L E L+ +A + A G+ +LH
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN- 119
Query: 707 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 766
IH DL N LL + K+ D+GLS +V+ P +I+ +
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV-----PLRWIAPE 172
Query: 767 LTDK-------------SDVYSFGVILLEL 783
L D+ S+V+S GV + EL
Sbjct: 173 LVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 4e-12
Identities = 55/222 (24%), Positives = 104/222 (46%), Gaps = 29/222 (13%)
Query: 590 LEKKIGSGGFGVVYY----GKLKDGKE-------------IAVKVLTSNSYQGKR-EFTN 631
++K+G G FG V+ G K + +AVK+L ++ + R +F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 632 EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY-------GTLTHEQRIN 684
E+ ++SR+ N+++ L C ++ E+M NG L + L I+
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 685 WIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744
+ + +A A G++YL + +HRDL + N L+ K+ K++DFG+S+ G
Sbjct: 129 YSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 745 H-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
+ + + ++ E + + T SDV++FGV L E+++
Sbjct: 186 YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 5e-12
Identities = 62/234 (26%), Positives = 98/234 (41%), Gaps = 60/234 (25%)
Query: 582 DIEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVK-------VLTSNSYQGKREFTNEV 633
D+ K +E IGSG +GVV + GK++A+K V T KR E+
Sbjct: 2 DVGSRYKPIEN-IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTL----AKRTL-REL 55
Query: 634 TLLSRIHHRNLV---QFLGYCQEEGRSV-LVYEFM----H-----NGTLKEH-----LYG 675
+L H N++ L + + V +V + M H + L E LY
Sbjct: 56 KILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQ 115
Query: 676 TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG- 734
L +G++Y+H+ V IHRDLK SN+L+++ ++ DFG
Sbjct: 116 LL-------------------RGLKYIHSANV---IHRDLKPSNLLVNEDCELRIGDFGM 153
Query: 735 ---LSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELI 784
LS + ++ V T Y PE +S + T D++S G I E++
Sbjct: 154 ARGLSSSPTEHKYFMTEYV-ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 53/200 (26%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
L ++IGSG +G VY + + G+ A+KV+ + E+ ++ H N+V +
Sbjct: 13 LIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYF 72
Query: 649 GYCQEEGRSVLVYEFMHNGTLKE--HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 706
G + + EF G+L++ H+ G L+ E +I ++ R + +G+ YLH+
Sbjct: 73 GSYLRRDKLWICMEFCGGGSLQDIYHVTGPLS-ESQIAYVSR-----ETLQGLYYLHS-- 124
Query: 707 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 766
+HRD+K +NILL + K++DFG+S + S + GT ++ PE ++
Sbjct: 125 -KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVER 182
Query: 767 ---LTDKSDVYSFGVILLEL 783
D+++ G+ +EL
Sbjct: 183 KGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 7e-12
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 23/205 (11%)
Query: 592 KKIGSGGFGVVYYG-KLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 647
K IGSG G+V G +AVK L+ N KR + E+ LL ++H+N++
Sbjct: 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISL 85
Query: 648 LGY-----CQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 701
L EE + V LV E M + L + ++ L HE R++++ + GI++
Sbjct: 86 LNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHE-RMSYLLYQMLC-----GIKH 138
Query: 702 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 761
LH+ IIHRDLK SNI++ K+ DFGL++ A +V T Y PE
Sbjct: 139 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEV 193
Query: 762 YISQQLTDKSDVYSFGVILLELISG 786
+ + D++S G I+ EL+ G
Sbjct: 194 ILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 9e-12
Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 592 KKIGSGGFGVV---YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLV 645
K IGSG G+V Y G+ +A+K L+ N KR + E+ L+ ++H+N++
Sbjct: 22 KPIGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAY-RELVLMKLVNHKNII 78
Query: 646 QFLGYCQ-----EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 699
L EE + V LV E M + L + + L HE R++++ + GI
Sbjct: 79 GLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHE-RMSYLLYQMLC-----GI 131
Query: 700 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 759
++LH+ IIHRDLK SNI++ K+ DFGL++ A +V T Y P
Sbjct: 132 KHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAP 186
Query: 760 EYYISQQLTDKSDVYSFGVILLELISGQ 787
E + + D++S G I+ E+I G
Sbjct: 187 EVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 63/226 (27%), Positives = 109/226 (48%), Gaps = 18/226 (7%)
Query: 579 TLSDIEDATKMLEKKIGSGGFGVVY-YGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLS 637
+ D D +++E IG G +G V+ K+G + AVK+L + E E +L
Sbjct: 12 SFPDPSDTWEIIET-IGKGTYGKVFKVLNKKNGSKAAVKILDP-IHDIDEEIEAEYNILK 69
Query: 638 RIH-HRNLVQFLG-YCQEEGRS----VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI 691
+ H N+V+F G Y +++ ++ LV E + G++ + + G L +R+ I
Sbjct: 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYI 129
Query: 692 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 751
+A G+++LH V IHRD+K +NILL K+ DFG+S + +
Sbjct: 130 LHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSA-QLTSTRLRRNTSV 185
Query: 752 GTVGYLDPEYYISQQLTDKS-----DVYSFGVILLELISGQEAISN 792
GT ++ PE +Q D + DV+S G+ +EL G +++
Sbjct: 186 GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD 231
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 56/225 (24%), Positives = 105/225 (46%), Gaps = 25/225 (11%)
Query: 582 DIEDATKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSYQGKRE-FTNEVT 634
+I +T +++G FG VY G L + + +A+K L + RE F +E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 635 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH------------EQR 682
+ SR+ H N+V LG +E +++ + + L E L H +
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 683 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAV 740
+ + I A G+E+L + V +H+DL + N+L+ + K+SD GL + +A
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHHV---VHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 741 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
D + + + + ++ PE + + + SD++S+GV+L E+ S
Sbjct: 178 DYYKLMGNSLL-PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 34/219 (15%)
Query: 592 KKIGSGGFGVVYYGKLKDGKE----IAVKVLTSNSYQGKREFTN----EVTLLSRIHHRN 643
K +G GG+G V+ + G + A+KVL + ++ T E +L + H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 644 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI-AEDAAK----- 697
+V + Q G+ L+ E++ G L HL +R I ED A
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHL-------------EREGIFMEDTACFYLSE 108
Query: 698 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 754
+E+LH II+RDLK NILLD K++DFGL K ++ + V+ GT+
Sbjct: 109 ISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTI 164
Query: 755 GYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 793
Y+ PE + D +S G ++ ++++G + E
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE 203
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 2e-11
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 25/204 (12%)
Query: 592 KKIGSGGFGVV--YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQ 646
K IGSG G+V Y + D + +A+K L+ N KR + E+ L+ ++H+N++
Sbjct: 23 KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIS 80
Query: 647 FLGY-----CQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 700
L EE + V LV E M + L + + L HE R++++ + GI+
Sbjct: 81 LLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDHE-RMSYLLYQMLC-----GIK 133
Query: 701 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 760
+LH+ IIHRDLK SNI++ K+ DFGL++ A G S + + T Y PE
Sbjct: 134 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE 188
Query: 761 YYISQQLTDKSDVYSFGVILLELI 784
+ + D++S G I+ E++
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 33/209 (15%)
Query: 594 IGSGGFGVVYYGKLKDGKEI-AVKVLTSN----------SYQGKREFTNEVTLLSRIHHR 642
+G G FG V + K E+ A+K+L + + KR + L +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRV----LALPGKPPF- 62
Query: 643 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK---GI 699
L Q Q R V E+++ G L H+ Q++ K AA+ G+
Sbjct: 63 -LTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-------QQVGKFKEPHAVFYAAEIAIGL 114
Query: 700 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 759
+LH+ II+RDLK N++LD K++DFG+ K + G + GT Y+ P
Sbjct: 115 FFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC-GTPDYIAP 170
Query: 760 EYYISQQLTDKS-DVYSFGVILLELISGQ 787
E I+ Q KS D ++FGV+L E+++GQ
Sbjct: 171 E-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 590 LEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
L +++GSG +G VY L G+ AVK++ E+ ++ H N+V +
Sbjct: 13 LIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYF 72
Query: 649 GYCQEEGRSVLVYEFMHNGTLKE--HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 706
G + + E+ G+L++ H+ G L+ E +I ++ R + +G+ YLH+
Sbjct: 73 GSYLSREKLWICMEYCGGGSLQDIYHVTGPLS-ELQIAYVCR-----ETLQGLAYLHS-- 124
Query: 707 VPAIIHRDLKSSNILLDKHMRAKVSDFGL-SKFAVDGASHVSSIVRGTVGYLDPEYYISQ 765
+HRD+K +NILL + K++DFG+ +K A S I GT ++ PE +
Sbjct: 125 -KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI--GTPYWMAPEVAAVE 181
Query: 766 Q---LTDKSDVYSFGVILLEL 783
+ D+++ G+ +EL
Sbjct: 182 KNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 52/199 (26%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 592 KKIGSGGFGVVYYGKLKDGKE-IAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQF 647
K +G+G FG V+ + + + A+KV+ + ++ NE +L + H +++
Sbjct: 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
++ ++ E++ G L+ L + R + L A + +EYLH+
Sbjct: 67 FWTEHDQRFLYMLMEYVPGG----ELFSYLRNSGRFSNSTGLFYASEIVCALEYLHS--- 119
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 767
I++RDLK NILLDK K++DFG +K D + GT YL PE S+
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC----GTPEYLAPEVIQSKGH 175
Query: 768 TDKSDVYSFGVILLELISG 786
D ++ G+++ E++ G
Sbjct: 176 NKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 3e-11
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 28/207 (13%)
Query: 593 KIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLVQ 646
+I G +GVVY + K EI A+K L + ++E T+ E+ +L ++ H N+V
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKL---KMEKEKEGFPITSLREINILLKLQHPNIVT 68
Query: 647 F----LGYCQEEGRSVLVYEFMHNG--TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 700
+G + + +V E++ + +L E + + + +L G+
Sbjct: 69 VKEVVVGSNLD--KIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQL------LSGVA 120
Query: 701 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 760
+LH I+HRDLK+SN+LL+ K+ DFGL++ + +V T+ Y PE
Sbjct: 121 HLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPE 176
Query: 761 YYISQQL-TDKSDVYSFGVILLELISG 786
+ + + D++S G I EL++
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 3e-11
Identities = 65/227 (28%), Positives = 110/227 (48%), Gaps = 31/227 (13%)
Query: 578 FTLSDIEDATKMLEKK------IGSGGFGVV---YYGKLKDGKEIAVKVLT---SNSYQG 625
F +I D+T + K+ IGSG G+V Y L+ + +A+K L+ N
Sbjct: 10 FYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHA 67
Query: 626 KREFTNEVTLLSRIHHRNLVQFLGY-----CQEEGRSVLVYEFMHNGTLKEHLYGTLTHE 680
KR + E+ L+ ++H+N++ L EE + V + + + L + + L HE
Sbjct: 68 KRAY-RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE 126
Query: 681 QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 740
R++++ + GI++LH+ IIHRDLK SNI++ K+ DFGL++ A
Sbjct: 127 -RMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA- 176
Query: 741 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 787
G S + + T Y PE + + D++S G I+ E+I G
Sbjct: 177 -GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 5e-11
Identities = 67/260 (25%), Positives = 101/260 (38%), Gaps = 58/260 (22%)
Query: 592 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEV----TLLSRIHHRNLVQ 646
K IG G FG V + KD G A+K L S ++E V +L+ + +V+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKL-RKSEMLEKEQVAHVRAERDILAEADNPWVVK 65
Query: 647 FLGYC--QEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYL 702
Y Q+E L+ E++ G + L T T E+ R IAE I+ +
Sbjct: 66 L--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE-----TRFYIAE-TILAIDSI 117
Query: 703 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK---------------------FAVD 741
H IHRD+K N+LLD K+SDFGL F
Sbjct: 118 HK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174
Query: 742 GASHVSSIVR----------------GTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
+ +SS + GT Y+ PE ++ + D +S GVI+ E++
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234
Query: 786 GQEAISNEKFGANCRNIVQW 805
G ++ R I+ W
Sbjct: 235 GYPPFCSDNPQETYRKIINW 254
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 6e-11
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 35/215 (16%)
Query: 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQF 647
IG G +G+V K G ++A+K ++ +Q + T E+ +L R H N++
Sbjct: 9 NLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGI 68
Query: 648 LGYCQ----EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK----- 697
L + E V +V E M + LY IK ++ D +
Sbjct: 69 LDIIRPPSFESFNDVYIVQELM-----ETDLYKL---------IKTQHLSNDHIQYFLYQ 114
Query: 698 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--G 752
G++Y+H+ V +HRDLK SN+LL+ + K+ DFGL++ A H +
Sbjct: 115 ILRGLKYIHSANV---LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 753 TVGYLDPEYYISQQLTDKS-DVYSFGVILLELISG 786
T Y PE ++ + K+ D++S G IL E++S
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-11
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 13/207 (6%)
Query: 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 647
K +G G FG V K K G+ A+K+L K E + +T +L H L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
Q R V E+ + G L HL + E+ + + + ++YLH+
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSE-- 114
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYYISQQ 766
+++RDLK N++LDK K++DFGL K + DGA+ + GT YL PE
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC--GTPEYLAPEVLEDND 172
Query: 767 LTDKSDVYSFGVILLELISGQEAISNE 793
D + GV++ E++ G+ N+
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPFYNQ 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 9e-11
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 52/217 (23%)
Query: 593 KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTN--EVTLLSRI-HHRNLVQFL 648
KIG G F V + K GK A+K + ++ + N E+ L R+ H N+++ +
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64
Query: 649 G--YCQEEGRSVLVYEFMHNGTLKEHLYGTLTH--EQRI-NWIKRLEIAEDAAKGIEYLH 703
+ ++ GR LV+E M + L E + G E+R+ +++ +L K ++++H
Sbjct: 65 EVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQL------LKSLDHMH 117
Query: 704 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY-- 761
I HRD+K NIL+ K++DFG S RG Y P Y
Sbjct: 118 RN---GIFHRDIKPENILIKDD-ILKLADFG-------------SC-RGI--YSKPPYTE 157
Query: 762 YISQQ--------LTD-----KSDVYSFGVILLELIS 785
YIS + LTD K D+++ G + E++S
Sbjct: 158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 594 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLG 649
+G GGFG V ++K+ GK A K L + G++ E +L +++ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVN-LA 59
Query: 650 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 708
Y E + LV M+ G LK H+Y + + + + GI +LH+
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERV--IHYSAQITCGILHLHS---M 114
Query: 709 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 768
I++RD+K N+LLD ++SD GL+ DG + GT GY+ PE + +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA--GTNGYMAPEILKEEPYS 172
Query: 769 DKSDVYSFGVILLELISGQEAISNEK 794
D ++ G + E+++G+ + K
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTPFKDHK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 12/206 (5%)
Query: 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 647
K +G G FG V + K G+ A+K+L K E + VT +L H L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
Q R V E+ + G L HL + E+ + + +EYLH+ V
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSRDV 116
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 767
++RD+K N++LDK K++DFGL K + + + + GT YL PE
Sbjct: 117 ---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDY 172
Query: 768 TDKSDVYSFGVILLELISGQEAISNE 793
D + GV++ E++ G+ N+
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 51/229 (22%), Positives = 89/229 (38%), Gaps = 41/229 (17%)
Query: 590 LEKKIGSGGFGVVY-YGKLKDGKEIAVKVLTSNSYQGKRE------------FT--NEVT 634
+G G +G V GK +A+K + FT E+
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 635 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 694
+++ I H N++ + E LV + M + K E ++ I L+I
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCI-LLQIL-- 129
Query: 695 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGAS--------- 744
G+ LH +HRDL +NI ++ K++DFGL+ ++ S
Sbjct: 130 --NGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 745 -----HVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 787
S +V T+ Y PE + +++ D++S G I EL++G+
Sbjct: 185 QRREEMTSKVV--TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 53/205 (25%), Positives = 86/205 (41%), Gaps = 29/205 (14%)
Query: 594 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 649
+G GGFG V K+K + A+K + + +E +L +H +V+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIEY 701
+++ ++ E+ G L L R E A+ EY
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILR------------DRGLFDEYTARFYIACVVLAFEY 108
Query: 702 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 761
LH II+RDLK N+LLD + K+ DFG +K G + GT Y+ PE
Sbjct: 109 LHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC--GTPEYVAPEI 163
Query: 762 YISQQLTDKSDVYSFGVILLELISG 786
+++ D +S G++L EL++G
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQG----KREFTNEVTLLSRIHHRNL 644
++ IG G FGVV+ +DGK +A+K + N +Q KR F E+ +L H N+
Sbjct: 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMP-NVFQNLVSCKRVF-RELKMLCFFKHDNV 61
Query: 645 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK------- 697
+ L Q ++ ++ L+ + Q + + D K
Sbjct: 62 LSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPL--------SSDHVKVFLYQIL 113
Query: 698 -GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVG 755
G++YLH+ I+HRD+K N+L++ + K+ DFGL++ D + H++ V T
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQY 169
Query: 756 YLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 787
Y PE + S+ T D++S G I EL+ +
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 49/149 (32%), Positives = 75/149 (50%), Gaps = 13/149 (8%)
Query: 644 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI--NWIKRLEIAEDAAKGIEY 701
+V F G +G + E M G+L + L RI N + ++ IA +G+ Y
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQ----VLKKAGRIPENILGKISIA--VLRGLTY 114
Query: 702 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 761
L I+HRD+K SNIL++ K+ DFG+S +D S +S V GT Y+ PE
Sbjct: 115 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPER 169
Query: 762 YISQQLTDKSDVYSFGVILLELISGQEAI 790
T +SD++S G+ L+E+ G+ I
Sbjct: 170 LQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 15/202 (7%)
Query: 593 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--KREFTNEVTLLSRIHHRNLVQFLGY 650
++G+G GVV + K I + L + + + E+ +L + +V F G
Sbjct: 12 ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 651 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI--NWIKRLEIAEDAAKGIEYLHTGCVP 708
+G + E M G+L + L +RI + ++ IA +G+ YL
Sbjct: 72 FYSDGEISICMEHMDGGSLDQ----VLKEAKRIPEEILGKVSIA--VLRGLAYLREK--H 123
Query: 709 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 768
I+HRD+K SNIL++ K+ DFG+S +D S +S V GT Y+ PE +
Sbjct: 124 QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPERLQGTHYS 180
Query: 769 DKSDVYSFGVILLELISGQEAI 790
+SD++S G+ L+EL G+ I
Sbjct: 181 VQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-10
Identities = 44/167 (26%), Positives = 74/167 (44%), Gaps = 9/167 (5%)
Query: 625 GKREFT-NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI 683
G+R T E +L I+H +++Q G + L+ K LY L ++ I
Sbjct: 125 GQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP-----RYKTDLYCYLAAKRNI 179
Query: 684 NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 743
L I + I+YLH IIHRD+K+ NI ++ + DFG + F VD
Sbjct: 180 AICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236
Query: 744 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI 790
++ GT+ PE D++S G++L E+ + +++
Sbjct: 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.4 bits (156), Expect = 2e-10
Identities = 64/227 (28%), Positives = 101/227 (44%), Gaps = 36/227 (15%)
Query: 592 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-----KREFTNEVTLLSRIHHRNLVQ 646
KKIG+G FG V+ K K +E + SY+G K + EV ++ + H+N+V+
Sbjct: 19 KKIGNGRFGEVFLVKHKRTQEFFC--WKAISYRGLKEREKSQLVIEVNVMRELKHKNIVR 76
Query: 647 FLGYCQEEGRSVL--VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 704
++ + L + EF G L ++ +I ++I + Y H
Sbjct: 77 YIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHN 136
Query: 705 ----GCVPAIIHRDLKSSNILLDKHMR-----------------AKVSDFGLSK-FAVDG 742
++HRDLK NI L +R AK+ DFGLSK ++
Sbjct: 137 LKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES 196
Query: 743 ASHVSSIVRGTVGYLDPEYYI--SQQLTDKSDVYSFGVILLELISGQ 787
+H S V GT Y PE + ++ DKSD+++ G I+ EL SG+
Sbjct: 197 MAH--SCV-GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 585 DATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQGKREFT-NEVTLLSRIHH 641
DA + LEK IG G +G VY + GK +A+K +G E++LL +
Sbjct: 1 DAYEKLEK-IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSE 59
Query: 642 RN-LVQFLGYCQEEGRS-----VLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIA 692
+V+ L E ++ LV+E++ + LK+ + IK
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMY- 117
Query: 693 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSK-FAVDGASHVSSIV 750
KG+ + H ++HRDLK N+L+DK K++D GL + F++ S+ IV
Sbjct: 118 -QLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173
Query: 751 RGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 787
T+ Y PE + S + D++S G I E+ Q
Sbjct: 174 --TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 594 IGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLGY 650
+G G +GVV + K+ KEI K S + +E T E+ +L + N+V+
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 651 CQEEGRSVLVYEFMHNGTLK---EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
+ G+ LV+E++ L+ E G + R ++I +L K I + H
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVR-SYIYQL------IKAIHWCHKN-- 119
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 767
I+HRD+K N+L+ + K+ DFG ++ +G++ + T Y PE +
Sbjct: 120 -DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPY 178
Query: 768 TDKSDVYSFGVILLELISGQEAISNE 793
D++S G IL EL GQ E
Sbjct: 179 GKAVDMWSVGCILGELSDGQPLFPGE 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 594 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVTLLSR--IHHRN----LVQ 646
+G G FG V + K E+ A+K+L + + E T++ + + ++ L Q
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDV--ECTMVEKRVLALQDKPPFLTQ 65
Query: 647 FLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 704
Q R V E+++ G L H+ G Q + + A + + G+ +LH
Sbjct: 66 LHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY------AAEISVGLFFLHR 119
Query: 705 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 763
II+RDLK N++LD K++DFG+ K VDG + + GT Y+ PE
Sbjct: 120 ---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT--TRTFCGTPDYIAPEIIA 174
Query: 764 SQQLTDKSDVYSFGVILLELISGQEAISNE 793
Q D +++GV+L E+++GQ E
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 35/216 (16%)
Query: 590 LEKKIGSGGFGVVYY----GKLKDGKEIAVKVLTSNSYQGKREFTNEVT-----LLSRIH 640
L K +G+G +G V+ GK A+KVL + ++ T E T +L +
Sbjct: 4 LLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALV-QKAKTVEHTRTERNVLEHVR 62
Query: 641 HRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 697
+ L Y Q E + L+ +++ G + HLY QR N+ +ED +
Sbjct: 63 QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY------QRDNF------SEDEVRFY 110
Query: 698 ------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 751
+E+LH I++RD+K NILLD ++DFGLSK + +
Sbjct: 111 SGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC 167
Query: 752 GTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISG 786
GT+ Y+ PE + K+ D +S G+++ EL++G
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 28/208 (13%)
Query: 592 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQ 646
K++GSG +G V + G+++A+K L S +Q KR + E+TLL + H N++
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKL-SRPFQSEIFAKRAY-RELTLLKHMQHENVIG 78
Query: 647 FLGY--CQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 700
L G LV +M K + G E ++ ++ G++
Sbjct: 79 LLDVFTSAVSGDEFQDFYLVMPYMQTDLQK--IMGHPLSEDKVQYL-----VYQMLCGLK 131
Query: 701 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 760
Y+H+ IIHRDLK N+ +++ K+ DFGL++ A A +V T Y PE
Sbjct: 132 YIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHA--DAEMTGYVV--TRWYRAPE 184
Query: 761 YYIS-QQLTDKSDVYSFGVILLELISGQ 787
++ D++S G I+ E+++G+
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 4e-10
Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 13/201 (6%)
Query: 592 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQ 646
K +G G FG V +LK E+ A+KVL + + T + L H L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 647 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 706
Q + R V E+++ G L + ++ + + A + + +LH
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQI----QRSRKFDEPRSRFYAAEVTLALMFLHRH- 115
Query: 707 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 766
+I+RDLK NILLD K++DFG+ K + ++ GT Y+ PE +
Sbjct: 116 --GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC-GTPDYIAPEILQELE 172
Query: 767 LTDKSDVYSFGVILLELISGQ 787
D ++ GV++ E+++GQ
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-10
Identities = 48/164 (29%), Positives = 81/164 (49%), Gaps = 20/164 (12%)
Query: 631 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLE 690
+E+ L+ H +V+ + + + +L+ E+ G L + + +QR+ + L
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI------KQRLK--EHLP 165
Query: 691 IAEDAAKGIEY--------LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 742
E + Y +H+ ++HRDLKS+NI L K+ DFG SK D
Sbjct: 166 FQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222
Query: 743 AS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
S V+S GT YL PE + ++ + K+D++S GVIL EL++
Sbjct: 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-10
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 25/211 (11%)
Query: 594 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVTLLS-RIHHRN-----LVQ 646
+G G FG V + K E+ A+K+L + + E T++ R+ + L Q
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDV--ECTMVEKRVLALSGKPPFLTQ 65
Query: 647 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR---LEIAEDAAKGIEYLH 703
Q R V E+++ G L + Q++ K + A + A G+ +LH
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYQI-------QQVGRFKEPHAVFYAAEIAIGLFFLH 118
Query: 704 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYY 762
+ II+RDLK N++LD K++DFG+ K + DG + + GT Y+ PE
Sbjct: 119 S---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTFCGTPDYIAPEII 173
Query: 763 ISQQLTDKSDVYSFGVILLELISGQEAISNE 793
Q D ++FGV+L E+++GQ E
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 593 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--KREFTNEVTLLSRIHHRNLVQFLGY 650
++G+G GVV+ K I + L + + + E+ +L + +V F G
Sbjct: 12 ELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 651 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 710
+G + E M G+L + L ++I + ++ IA KG+ YL I
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI--LGKVSIA--VIKGLTYLREK--HKI 125
Query: 711 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 770
+HRD+K SNIL++ K+ DFG+S +D S +S V GT Y+ PE + +
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPERLQGTHYSVQ 182
Query: 771 SDVYSFGVILLELISGQEAI 790
SD++S G+ L+E+ G+ I
Sbjct: 183 SDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 51/163 (31%), Positives = 82/163 (50%), Gaps = 32/163 (19%)
Query: 593 KIGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQGKREFT----NEVTLLSRIHHRNLVQ 646
KIG G FG V+ + K K+I KVL N +G F E+ +L + H N+V
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG---FPITALREIKILQLLKHENVVN 75
Query: 647 FLGYCQEE--------GRSVLVYEFMHNGTLKEH-LYGTLTHEQ---RINWIKRLEIAED 694
+ C+ + G LV+EF EH L G L+++ ++ IK+ + +
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFC------EHDLAGLLSNKNVKFTLSEIKK--VMKM 127
Query: 695 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 737
G+ Y+H I+HRD+K++NIL+ K K++DFGL++
Sbjct: 128 LLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 8e-10
Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQ 646
+ + +GSG G V K + DG+ AVKV+ K EV L ++V+
Sbjct: 36 ISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK 95
Query: 647 FLGYCQEE------------GRSVLVYEFMHNGTLKEHLYGT-------LTHEQRINWIK 687
C E+ LV ++ + G L++ + HE + +I+
Sbjct: 96 ----CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ 151
Query: 688 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHV 746
L + ++H+ +IHRD+KS+NILL + K+ DFG SK +A + V
Sbjct: 152 VL-------LAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDV 201
Query: 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
GT Y+ PE + + + K+D++S GV+L EL++
Sbjct: 202 GRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLT 240
|
Length = 496 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 9e-10
Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 34/212 (16%)
Query: 592 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQF 647
K IG G FG V + K +++ L S KR F E +++ + +VQ
Sbjct: 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GI 699
Q++ +V E+M G L +N + ++ E AK +
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDL-------------VNLMSNYDVPEKWAKFYTAEVVLAL 155
Query: 700 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLD 758
+ +H+ +IHRD+K N+LLDKH K++DFG K G + V GT Y+
Sbjct: 156 DAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYIS 211
Query: 759 PEYYISQ----QLTDKSDVYSFGVILLELISG 786
PE SQ + D +S GV L E++ G
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-09
Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 34/212 (16%)
Query: 592 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 647
K IG G FG V + K K++ A+K+L+ + + F E +++ + +VQ
Sbjct: 49 KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL 108
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GI 699
Q++ +V E+M G L +N + +I E A+ +
Sbjct: 109 HYAFQDDKYLYMVMEYMPGGDL-------------VNLMSNYDIPEKWARFYTAEVVLAL 155
Query: 700 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLD 758
+ +H+ IHRD+K N+LLDK K++DFG K +G + V GT Y+
Sbjct: 156 DAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYIS 211
Query: 759 PEYYISQ----QLTDKSDVYSFGVILLELISG 786
PE SQ + D +S GV L E++ G
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 590 LEKKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNSYQGKREFT----NEVTLLSRIHH 641
L K +G+G +G V+ + GK A+KVL + K + T E +L I
Sbjct: 4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 63
Query: 642 RNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK---RLEIAEDAAK 697
+ L Y Q + + L+ ++++ G L HL QR + + ++ E
Sbjct: 64 SPFLVTLHYAFQTDTKLHLILDYINGGELFTHL------SQRERFKEQEVQIYSGE-IVL 116
Query: 698 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGY 756
+E+LH II+RD+K NILLD + ++DFGLSK F D S GT+ Y
Sbjct: 117 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC-GTIEY 172
Query: 757 LDPEYYISQQLT-DKS-DVYSFGVILLELISG 786
+ P+ DK+ D +S GV++ EL++G
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 49/205 (23%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 594 IGSGGFGVVYYGKLKDGK--------EIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV 645
+G G F ++ G ++ E+ +KVL + F +++S++ H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 646 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 705
G C S++V E++ G+L +L ++ IN +LE+A+ A + +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLK---KNKNLINISWKLEVAKQLAWALHFLED- 118
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV---SSIVRGTVGYLDPE-Y 761
+ H ++ + N+LL + K + K + G S I+ + ++ PE
Sbjct: 119 --KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECI 176
Query: 762 YISQQLTDKSDVYSFGVILLELISG 786
Q L+ +D +SFG L E+ SG
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 43/214 (20%)
Query: 594 IGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 648
+GSG +G V +A+K L S +Q KR + E+ LL + H N++ L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKL-SRPFQSAIHAKRTY-RELRLLKHMDHENVIGLL 80
Query: 649 -----GYCQEEGRSV-LVYEFMH---NGTLKEHLYGTLTHEQRINWIKRL--EIAEDAAK 697
E+ + V LV M N +K L+ + I+ L +I +
Sbjct: 81 DVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQ---KLSDDH----IQFLVYQIL----R 129
Query: 698 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG-- 755
G++Y+H+ IIHRDLK SNI +++ K+ DFGL A H + G V
Sbjct: 130 GLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGL-------ARHTDDEMTGYVATR 179
Query: 756 -YLDPEYYIS-QQLTDKSDVYSFGVILLELISGQ 787
Y PE ++ D++S G I+ EL++G+
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 37/213 (17%)
Query: 592 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQ 646
K++GSG +G V + G ++A+K L +Q KR + E+ LL + H N++
Sbjct: 21 KQVGSGAYGTVCSALDRRTGAKVAIKKL-YRPFQSELFAKRAY-RELRLLKHMKHENVIG 78
Query: 647 FLG-YCQEEGRS-----VLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 698
L + + LV FM G L +H E RI ++ KG
Sbjct: 79 LLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH---EKLSEDRIQFL-----VYQMLKG 130
Query: 699 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV---G 755
++Y+H IIHRDLK N+ +++ K+ DFGL A S + G V
Sbjct: 131 LKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL-------ARQTDSEMTGYVVTRW 180
Query: 756 YLDPEYYIS-QQLTDKSDVYSFGVILLELISGQ 787
Y PE ++ T D++S G I+ E+++G+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 26/208 (12%)
Query: 593 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK-REFTNEVTLLSRIHHRNLVQFLGY 650
++G G +G VY + G +A+K + + K + E+ +L + +V F G
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 651 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL---HTGCV 707
EG + E+M G+L + LY + I I KG+++L H
Sbjct: 68 FFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--- 123
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG---YLDPEYYIS 764
IIHRD+K +N+L++ + + K+ DFG+S + V+S+ + +G Y+ PE S
Sbjct: 124 --IIHRDVKPTNVLVNGNGQVKLCDFGVS------GNLVASLAKTNIGCQSYMAPERIKS 175
Query: 765 QQLTD------KSDVYSFGVILLELISG 786
+SDV+S G+ +LE+ G
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 30/207 (14%)
Query: 592 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 647
+ +G G FG+V + G+ +A+K + S KR + E+ LL + H N++
Sbjct: 16 QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLRHENII-- 72
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLE------IAEDAAKGIEY 701
S + + + L GT H R+ + LE +G++Y
Sbjct: 73 -------SLSDIFISPLEDIYFVTELLGTDLH--RLLTSRPLEKQFIQYFLYQILRGLKY 123
Query: 702 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 761
+H+ V +HRDLK SNIL++++ K+ DFGL++ ++ V T Y PE
Sbjct: 124 VHSAGV---VHRDLKPSNILINENCDLKICDFGLARIQ---DPQMTGYV-STRYYRAPEI 176
Query: 762 YISQQLTD-KSDVYSFGVILLELISGQ 787
++ Q D + D++S G I E++ G+
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-09
Identities = 54/171 (31%), Positives = 79/171 (46%), Gaps = 29/171 (16%)
Query: 583 IEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 641
IE+ + K I G FG VY G K + K AVKV+ K + N+ +
Sbjct: 3 IEEFV--IVKPISRGAFGKVYLGRKKNNSKLYAVKVVK------KADMINKNMVHQVQAE 54
Query: 642 RNLV-----QF---LGYCQEEGRSV-LVYEFMHNGTLKE--HLYGTLTHEQRINWIKRLE 690
R+ + F L Y + +V LV E++ G +K H+YG E + +I +
Sbjct: 55 RDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVA 114
Query: 691 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 741
+A D YLH IIHRDLK N+L+ K++DFGLSK ++
Sbjct: 115 LALD------YLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 46/191 (24%), Positives = 86/191 (45%), Gaps = 21/191 (10%)
Query: 632 EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR-INWIKRLE 690
E LL ++H ++++ + +V LY LT R + + L
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLP-----HYSSDLYTYLTKRSRPLPIDQALI 161
Query: 691 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 750
I + +G+ YLH IIHRD+K+ NI ++ + + D G ++F V + + +
Sbjct: 162 IEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--L 216
Query: 751 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI------SNEKFGANCRN--- 801
GTV PE + K+D++S G++L E+++ I + E++ +C +
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLL 276
Query: 802 -IVQWAKLHIE 811
I+ K+H E
Sbjct: 277 KIISTLKVHPE 287
|
Length = 357 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 593 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLVQFLGY 650
K+G G + V+ G+ K +A+K + +G EV+LL + H N+V
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 651 CQEEGRSVLVYEFMHNGTLKEHL--YGTL--THEQRINWIKRLEIAEDAAKGIEYLHTGC 706
E LV+E++ + LK++L G L H +I + L +G+ Y H
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLL-------RGLSYCHK-- 121
Query: 707 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYI-S 764
I+HRDLK N+L+++ K++DFGL++ +V ++ + +V T+ Y P+ + S
Sbjct: 122 -RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGS 178
Query: 765 QQLTDKSDVYSFGVILLELISGQ 787
+ + D++ G IL E+ +G+
Sbjct: 179 TEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 66/264 (25%), Positives = 105/264 (39%), Gaps = 71/264 (26%)
Query: 590 LEKKIGSGGFGVVY------YGKLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI-HH 641
L K +G G FG V K +AVK+L + + + +E+ +L I +H
Sbjct: 11 LGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNH 70
Query: 642 RNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHL---------YGTLTHEQRINWIKRLEI 691
N+V LG C + G +++ EF G L L Y + +QR + +E
Sbjct: 71 LNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQ 130
Query: 692 A------------------------------------------ED-------AAKGIEYL 702
+ ED A+G+E+L
Sbjct: 131 SRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL 190
Query: 703 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEY 761
+ IHRDL + NILL ++ K+ DFGL++ +V R + ++ PE
Sbjct: 191 AS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPES 247
Query: 762 YISQQLTDKSDVYSFGVILLELIS 785
+ T +SDV+SFGV+L E+ S
Sbjct: 248 IFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 37/219 (16%)
Query: 592 KKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSY----QGKREFTNEVTLLSRIHHRNLVQ 646
K I +G +G VY + K+ ++ A+K + + Q ++ F E +L+ + +V
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-ERDILTFAENPFVVS 65
Query: 647 FLGYCQEEGRSVL--VYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 701
+C E + L V E++ G TL +++ G L + + R+ AE +EY
Sbjct: 66 M--FCSFETKRHLCMVMEYVEGGDCATLLKNI-GALPVD-----MARMYFAE-TVLALEY 116
Query: 702 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF--------------AVDGASHVS 747
LH I+HRDLK N+L+ K++DFGLSK D +
Sbjct: 117 LHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173
Query: 748 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 786
V GT Y+ PE + Q D ++ G+IL E + G
Sbjct: 174 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 6/92 (6%)
Query: 696 AKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGT 753
A+G+E+L + C IHRDL + NILL ++ K+ DFGL++ +V R
Sbjct: 183 ARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 754 VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
+ ++ PE + T +SDV+SFGV+L E+ S
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 37/211 (17%)
Query: 594 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 648
+GSG +G V K G +AVK L S +Q KR + E+ LL + H N++ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 82
Query: 649 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 700
RS E ++ L HL G + N +K ++ +D +G++
Sbjct: 83 DVFTP-ARS---LEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 134
Query: 701 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG---YL 757
Y+H+ IIHRDLK SN+ +++ K+ DFGL A H + G V Y
Sbjct: 135 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL-------ARHTDDEMTGYVATRWYR 184
Query: 758 DPEYYISQQLTDKS-DVYSFGVILLELISGQ 787
PE ++ +++ D++S G I+ EL++G+
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 51/202 (25%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 593 KIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLVQFLGY 650
K+G G + VY G+ K +A+K + +G EV+LL + H N+V
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 651 CQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRIN-WIKRLEIAEDAAKGIEYLHTGCV 707
E LV+E++ + LK++L G + + ++ +L +G+ Y H
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQL------LRGLNYCHR--- 122
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYI-SQ 765
++HRDLK N+L+++ K++DFGL++ ++ ++ + +V T+ Y P+ + S
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGST 180
Query: 766 QLTDKSDVYSFGVILLELISGQ 787
+ + D++ G I E+ +G+
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-08
Identities = 36/90 (40%), Positives = 52/90 (57%), Gaps = 10/90 (11%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 476
S+ I+L NL+G IP ++ L+SL + L N LTGP+PSSL NL NL+
Sbjct: 213 SLKWIYLGYNNLSGEIPYEIGGLTSLNH--------LDLVYNNLTGPIPSSLGNLKNLQY 264
Query: 477 LYVQNNMLSGTVPSSL--LSKNVVLNYAGN 504
L++ N LSG +P S+ L K + L+ + N
Sbjct: 265 LFLYQNKLSGPIPPSIFSLQKLISLDLSDN 294
|
Length = 968 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 56/226 (24%), Positives = 95/226 (42%), Gaps = 54/226 (23%)
Query: 592 KKIGSGGFGVV---YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIH-HRNL 644
K++G G +G+V + + + +A+K +T S KR E+ LL H+N+
Sbjct: 6 KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL-RELKLLRHFRGHKNI 64
Query: 645 V-----------QFLG-YCQEEGRSVLVYEFMHNGT------LKEHLYGTLTHEQRINWI 686
F Y EE +++ + +G + +Y L
Sbjct: 65 TCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILC-------- 116
Query: 687 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK----FAVDG 742
G++Y+H+ V +HRDLK N+L++ K+ DFGL++ +
Sbjct: 117 -----------GLKYIHSANV---LHRDLKPGNLLVNADCELKICDFGLARGFSENPGEN 162
Query: 743 ASHVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 787
A ++ V T Y PE +S Q K+ DV+S G IL EL+ +
Sbjct: 163 AGFMTEYV-ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 29/207 (14%)
Query: 594 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREF---TNEVTLLSRIHHRNLVQFLG 649
IG G + V +LK +I A+KV+ + E + + + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 650 YC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 700
C Q R LV E+++ G L H+ QR ++ E+ A+ +
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHM-----QRQR-------KLPEEHARFYAAEICIALN 110
Query: 701 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 760
+LH II+RDLK N+LLD K++D+G+ K + G +S GT Y+ PE
Sbjct: 111 FLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL-GPGDTTSTFCGTPNYIAPE 166
Query: 761 YYISQQLTDKSDVYSFGVILLELISGQ 787
++ D ++ GV++ E+++G+
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 25/218 (11%)
Query: 592 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 647
K IG G FG V KLK+ ++ A+K+L + E F E +L ++ +
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66
Query: 648 LGYCQEEGRSVLVYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 704
Q+E LV ++ G TL L + ++ + IA D+ + Y
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY--- 123
Query: 705 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 764
+HRD+K NIL+D + +++DFG ++ + SS+ GT Y+ PE I
Sbjct: 124 ------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE--IL 175
Query: 765 QQLTD-------KSDVYSFGVILLELISGQEAISNEKF 795
Q + D + D +S GV + E++ G+ E
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 4e-08
Identities = 30/102 (29%), Positives = 52/102 (50%), Gaps = 11/102 (10%)
Query: 405 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPL 464
W + CN+ + + I LS KN++G I S F P ++ I+L +NQL+GP+
Sbjct: 60 WQGITCNNSSR--VVSIDLSGKNISGKI--------SSAIFRLPYIQTINLSNNQLSGPI 109
Query: 465 PSSLMNLP-NLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNI 505
P + +LR L + NN +G++P + L+ + N+
Sbjct: 110 PDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNM 151
|
Length = 968 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 15/204 (7%)
Query: 592 KKIGSGGFGVVYYGKLKDGKEIA---VKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQF 647
++IG+G FG V ++ +A VK L +N S + + EF + + H N++Q
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
LG C E +LV+E+ G LK +L H + + +A + A G+ ++H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK--- 117
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGL--SKFAVD---GASHVSSIVRGTVGYLDPEYY 762
+H DL N L + KV D+G+ S++ D +R L E++
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177
Query: 763 ---ISQQLTDKSDVYSFGVILLEL 783
I+ + T S+V++ GV L EL
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 696 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTV 754
AKG+E+L + IHRDL + NILL ++ K+ DFGL++ +V R +
Sbjct: 189 AKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 755 GYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
++ PE + T +SDV+SFGV+L E+ S
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 52/204 (25%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 592 KKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLVQFLG 649
+K+G G + V+ G+ K + +A+K + +G EV+LL + H N+V
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHL--YGTLT--HEQRINWIKRLEIAEDAAKGIEYLHTG 705
+ LV+E++ + LK+++ G + H +I + L +G+ Y H
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQIL-------RGLAYCHR- 122
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYI- 763
++HRDLK N+L+++ K++DFGL++ +V ++ + +V T+ Y P+ +
Sbjct: 123 --RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLG 178
Query: 764 SQQLTDKSDVYSFGVILLELISGQ 787
S + + + D++ G I E+ SG+
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-08
Identities = 57/237 (24%), Positives = 92/237 (38%), Gaps = 41/237 (17%)
Query: 592 KKIGSGGFGVVYYG-KLKDGKEIAVKV----LTSNSYQGKREFTNEVTLLSRIHHRNLVQ 646
+ IG GG G VY + +A+K L+ N KR F E + + + H +V
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKR-FLREAKIAADLIHPGIVP 66
Query: 647 FLGYCQEEGRSVLVY---EFMHNGTLKEHLYGTLT-------HEQRINWIKRLEIAEDAA 696
C + VY ++ TLK L ++ + L I
Sbjct: 67 VYSICSD---GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 697 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-------------AVDGA 743
IEY+H+ ++HRDLK NILL + D+G + F
Sbjct: 124 ATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 744 SHVS-----SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF 795
+ S IV GT Y+ PE + ++ +D+Y+ GVIL ++++ +K
Sbjct: 181 CYSSMTIPGKIV-GTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236
|
Length = 932 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 593 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFLG 649
K+G G + VY G+ K G+ +A+K + +G FT E +LL + H N+V
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTLHD 70
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
+ LV+E++ LK+++ G + RL + + +G+ Y H
Sbjct: 71 IIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNV----RLFLFQ-LLRGLAYCHQ--- 121
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 766
++HRDLK N+L+ + K++DFGL++ A S S T+ Y P+ + S +
Sbjct: 122 RRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVVTLWYRPPDVLLGSTE 180
Query: 767 LTDKSDVYSFGVILLELISGQ 787
+ D++ G I E+ +G+
Sbjct: 181 YSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 6e-08
Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 592 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTS---NSYQGKREFTNEVTLLSRIHHRNLVQF 647
K IG G +G+V K + +++A+K + + N KR E+ LL + H N++
Sbjct: 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL-REIKLLRHLDHENVIAI 69
Query: 648 LGYCQEEGRSV-----LVYEFMHNGTLKEHLYG--TLTHEQRINWIKRLEIAEDAAKGIE 700
R +VYE M + L + + TL+ + ++ +L +G++
Sbjct: 70 KDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQL------LRGLK 122
Query: 701 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 760
Y+H+ ++HRDLK SN+LL+ + K+ DFGL++ + ++ V T Y PE
Sbjct: 123 YIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPE 178
Query: 761 YYIS-QQLTDKSDVYSFGVILLELISGQ 787
++ + T DV+S G I EL+ +
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 7e-08
Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 29/207 (14%)
Query: 594 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREF----TNEVTLLSRIHHRNLVQFL 648
IG G + V +LK + I A+KV+ + T + +H LV
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 649 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 700
Q E R V E+++ G L H+ QR ++ E+ A+ +
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHM-----QRQR-------KLPEEHARFYSAEISLALN 110
Query: 701 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 760
YLH II+RDLK N+LLD K++D+G+ K + S+ GT Y+ PE
Sbjct: 111 YLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPE 166
Query: 761 YYISQQLTDKSDVYSFGVILLELISGQ 787
+ D ++ GV++ E+++G+
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 9e-08
Identities = 67/274 (24%), Positives = 98/274 (35%), Gaps = 77/274 (28%)
Query: 592 KKIGSGGFGVV-YYGKLKDGKEIAVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQF 647
K IG G FG V K GK A+K L + K + + E +L+ +V
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 705
Q+ L+ EF+ G L L Y T + + + R +AE
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED-----VTRFYMAE------------ 109
Query: 706 CVPAI--------IHRDLKSSNILLDKHMRAKVSDFGLS------------------KFA 739
CV AI IHRD+K NIL+D+ K+SDFGLS K
Sbjct: 110 CVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSN 169
Query: 740 VDGASHVSSIV----------------------------RGTVGYLDPEYYISQQLTDKS 771
+ + +S+ GT Y+ PE ++ Q +
Sbjct: 170 KNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC 229
Query: 772 DVYSFGVILLELISGQEAISNEKFGANCRNIVQW 805
D +S G I+ E + G +E R I+ W
Sbjct: 230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIINW 263
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 35/102 (34%), Positives = 56/102 (54%), Gaps = 12/102 (11%)
Query: 689 LEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 747
L + AKG+ +L + C IHRDL + NILL K+ DFGL++ D + +
Sbjct: 217 LSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLAR---DIRNDSN 269
Query: 748 SIVRGT----VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
+V+G V ++ PE + T +SDV+S+G++L E+ S
Sbjct: 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 62/254 (24%), Positives = 97/254 (38%), Gaps = 49/254 (19%)
Query: 592 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQF 647
K IG G FG V + KD I A+K+L K + + E +L +V+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 705
Q++ L+ EF+ G + L TL+ E +I +A DA + +
Sbjct: 67 FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF---- 122
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGL---------------------SKFAVDGAS 744
IHRD+K N+LLD K+SDFGL S F+ +
Sbjct: 123 -----IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 745 -------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS 791
++ GT Y+ PE ++ D +S GVI+ E++ G
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 792 NEKFGANCRNIVQW 805
+E R ++ W
Sbjct: 238 SETPQETYRKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 29/207 (14%)
Query: 594 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREF----TNEVTLLSRIHHRNLVQFL 648
IG G + V +LK + I A+KV+ + T + + +H LV
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 649 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 700
Q E R V EF+ G L H+ QR ++ E+ A+ +
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHM-----QRQR-------KLPEEHARFYSAEISLALN 110
Query: 701 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 760
+LH II+RDLK N+LLD K++D+G+ K + +S GT Y+ PE
Sbjct: 111 FLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI-RPGDTTSTFCGTPNYIAPE 166
Query: 761 YYISQQLTDKSDVYSFGVILLELISGQ 787
+ D ++ GV++ E+++G+
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 16/200 (8%)
Query: 592 KKIGSGGFGVVYYGKLKDGK--EIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQ 646
+ +G+G FG V K+ +A+K + +++ +E +L+ I+H V
Sbjct: 36 RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95
Query: 647 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 706
G ++E LV EF+ G + L +R A EYL +
Sbjct: 96 LYGSFKDESYLYLVLEFVIGG----EFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS-- 149
Query: 707 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 766
I++RDLK N+LLDK K++DFG +K VD ++ + GT Y+ PE ++
Sbjct: 150 -LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-VDTRTYT---LCGTPEYIAPEILLNVG 204
Query: 767 LTDKSDVYSFGVILLELISG 786
+D ++ G+ + E++ G
Sbjct: 205 HGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 63/236 (26%), Positives = 90/236 (38%), Gaps = 55/236 (23%)
Query: 592 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQG----KREFTNEVTLLSRIHHRNLVQ 646
K +G G G V+ +LK GK A+KVL KR T E +L+ + H L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLT-EQEILATLDHPFLPT 65
Query: 647 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------G 698
Q E LV ++ G L+ L + K L E+ A+
Sbjct: 66 LYASFQTETYLCLVMDYCPGG----ELFRLLQRQPG----KCLS--EEVARFYAAEVLLA 115
Query: 699 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR------- 751
+EYLH I++RDLK NILL + +SDF LSK + VS +R
Sbjct: 116 LEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172
Query: 752 ---------------------GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 786
GT Y+ PE D ++ G++L E++ G
Sbjct: 173 VNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 12/102 (11%)
Query: 689 LEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 747
L A+G+E+L + CV HRDL + N+LL + K+ DFGL++ + +++VS
Sbjct: 240 LSFTYQVARGMEFLASKNCV----HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS 295
Query: 748 SIVRGT----VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
+G+ V ++ PE T SDV+S+G++L E+ S
Sbjct: 296 ---KGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 61/254 (24%), Positives = 97/254 (38%), Gaps = 49/254 (19%)
Query: 592 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQF 647
K IG G FG V + KD G A+K+L K + + E +L +V+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 705
Q++ L+ EF+ G + L TLT E+ +I +A D+ + +
Sbjct: 67 FYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF---- 122
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGL---------------------SKFAVDGAS 744
IHRD+K N+LLD K+SDFGL S F +
Sbjct: 123 -----IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 745 -------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS 791
++ GT Y+ PE ++ D +S GVI+ E++ G
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 792 NEKFGANCRNIVQW 805
+E + ++ W
Sbjct: 238 SETPQETYKKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 5e-07
Identities = 53/222 (23%), Positives = 101/222 (45%), Gaps = 42/222 (18%)
Query: 592 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 650
+ +G G G+V+ D K +AVK + Q + E+ ++ R+ H N+V+
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK---- 66
Query: 651 CQEEGRSVLVYEFM-HNGTLKEHLYGTLTHEQRI------------NWIKRLEIAEDAAK 697
VYE + +G+ G+LT + N +++ ++E+ A+
Sbjct: 67 ---------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHAR 117
Query: 698 --------GIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDGASHVSS 748
G++Y+H+ V +HRDLK +N+ ++ + + K+ DFGL++ SH
Sbjct: 118 LFMYQLLRGLKYIHSANV---LHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 749 IVRGTVG--YLDPEYYIS-QQLTDKSDVYSFGVILLELISGQ 787
+ G V Y P +S T D+++ G I E+++G+
Sbjct: 175 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 5e-07
Identities = 55/213 (25%), Positives = 102/213 (47%), Gaps = 41/213 (19%)
Query: 594 IGSGGFGVV---YYGKLKDGKEIAVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 647
+GSG +G V Y +L+ +++AVK L S +Q R E+ LL + H N++
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKL-SRPFQSLIHARRTYRELRLLKHMKHENVIGL 79
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKE----HLYGTLTHEQRINWIKRLEIAEDAA------- 696
L F +++ +L L N +K +++++
Sbjct: 80 LDV------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQL 127
Query: 697 -KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 755
+G++Y+H+ IIHRDLK SN+ +++ ++ DFGL++ A D ++ V T
Sbjct: 128 LRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADD---EMTGYV-ATRW 180
Query: 756 YLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 787
Y PE ++ +++ D++S G I+ EL+ G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 20/203 (9%)
Query: 593 KIGSGGFGVVYYGK-LKDG-KEIAVK-VLTSNSYQGKREFT-NEVTLLSRIH---HRNLV 645
+IG G +G V+ + LK+G + +A+K V +G T EV +L + H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 646 QFLGYC-----QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 700
+ C E + LV+E + + L +L IK ++ +G++
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK--DMMFQLLRGLD 124
Query: 701 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 760
+LH+ ++HRDLK NIL+ + K++DFGL++ + S +V T+ Y PE
Sbjct: 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPE 179
Query: 761 YYISQQLTDKSDVYSFGVILLEL 783
+ D++S G I E+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-07
Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 34/212 (16%)
Query: 592 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQF 647
K IG G FG V + K +++ L S KR F E +++ + +VQ
Sbjct: 49 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GI 699
Q++ +V E+M G L +N + ++ E A+ +
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDL-------------VNLMSNYDVPEKWARFYTAEVVLAL 155
Query: 700 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLD 758
+ +H+ IHRD+K N+LLDK K++DFG K +G + V GT Y+
Sbjct: 156 DAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYIS 211
Query: 759 PEYYISQ----QLTDKSDVYSFGVILLELISG 786
PE SQ + D +S GV L E++ G
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 6e-07
Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 27/211 (12%)
Query: 592 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 647
K IG G FG V K+K+ ++ A+K+L + E F E +L R +
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66
Query: 648 LGYCQEEGRSVLVYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 704
Q+E LV ++ G TL L + ++ + +A D+ + Y
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGY--- 123
Query: 705 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLDPEYYI 763
+HRD+K N+LLDK+ +++DFG + DG S++ GT Y+ PE I
Sbjct: 124 ------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ-SNVAVGTPDYISPE--I 174
Query: 764 SQQLTD-------KSDVYSFGVILLELISGQ 787
Q + D + D +S GV + E++ G+
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 6e-07
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 594 IGSGGFGVVYYGKLKDGKE-IAVK-VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 651
IG+G FGVVY D E +A+K VL Y+ + E+ ++ ++H N++ Y
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR-----ELLIMKNLNHINIIFLKDYY 128
Query: 652 QEEG-----RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE----DAAKGIEYL 702
E +++ + M H Y + H R N L + + + + Y+
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKY--MKHYARNNHALPLFLVKLYSYQLCRALAYI 186
Query: 703 HTGCVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 761
H+ I HRDLK N+L+D + K+ DFG +K + G VS I + Y PE
Sbjct: 187 HS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC--SRFYRAPEL 241
Query: 762 YI-SQQLTDKSDVYSFGVILLELISGQEAISNE 793
+ + T D++S G I+ E+I G S +
Sbjct: 242 MLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ 274
|
Length = 440 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 8e-07
Identities = 50/181 (27%), Positives = 66/181 (36%), Gaps = 50/181 (27%)
Query: 688 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL---------SKF 738
R IAE IE +H IHRD+K NIL+D+ K++DFGL SK+
Sbjct: 104 RFYIAE-LTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159
Query: 739 AVDGASH----------VSSIVR-----------------------GTVGYLDPEYYISQ 765
G H S I R GT Y+ PE +
Sbjct: 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT 219
Query: 766 QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK-LHIESGDIQGIIDPSLL 824
T D +S GVIL E++ GQ + ++ W LHI S Q +
Sbjct: 220 GYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPS---QAKLSREAS 276
Query: 825 D 825
D
Sbjct: 277 D 277
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 8e-07
Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 25/210 (11%)
Query: 592 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 647
K IG G FG V K+K + I A+K+L + E F E +L + +
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTL 66
Query: 648 LGYCQEEGRSVLVYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 704
Q+E LV ++ G TL L + +I + +A + + Y
Sbjct: 67 HYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHY--- 123
Query: 705 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 764
+HRD+K N+LLD + +++DFG + SS+ GT Y+ PE I
Sbjct: 124 ------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE--IL 175
Query: 765 QQLTD-------KSDVYSFGVILLELISGQ 787
Q + D + D +S GV + E++ G+
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 58/233 (24%), Positives = 98/233 (42%), Gaps = 43/233 (18%)
Query: 580 LSDIEDATKMLEKKIGSGGFGVVYYGKLK----------------DGKEIAVKVLTSNSY 623
L DI ++K IG GGFG VY + + + I ++ L N+
Sbjct: 6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNI 65
Query: 624 QGKREFTNEVTLLSRIH---HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE 680
+++ L IH H + ++ G C R + Y F+ L E L T E
Sbjct: 66 YDI----DKIALWKNIHNIDHLGIPKYYG-CGSFKRCRMYYRFI----LLEKLVEN-TKE 115
Query: 681 --QRI-NWIKRL--EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 735
+RI K+L I +D +EY+H I H D+K NI++D + R + D+G+
Sbjct: 116 IFKRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGI 172
Query: 736 SKFAVDGASHVS------SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLE 782
+ + H+ + RGT+ Y + + +T + D+ S G +L+
Sbjct: 173 ASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 33/102 (32%), Positives = 59/102 (57%), Gaps = 12/102 (11%)
Query: 689 LEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 747
L + A+G+++L + C IHRD+ + N+LL AK+ DFGL++ ++ +++V
Sbjct: 215 LRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV- 269
Query: 748 SIVRGT----VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
V+G V ++ PE T +SDV+S+G++L E+ S
Sbjct: 270 --VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-06
Identities = 36/115 (31%), Positives = 50/115 (43%), Gaps = 35/115 (30%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
P I I+LS+ L+G IP D+ SS LR ++L +N TG +P ++PNL
Sbjct: 93 PYIQTINLSNNQLSGPIPDDIFTTSS-------SLRYLNLSNNNFTGSIPRG--SIPNLE 143
Query: 476 ELYVQNNMLSGT------------------------VPSSL--LSKNVVLNYAGN 504
L + NNMLSG +P+SL L+ L A N
Sbjct: 144 TLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASN 198
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-06
Identities = 31/99 (31%), Positives = 44/99 (44%), Gaps = 16/99 (16%)
Query: 416 PSITVIHLSSKNLTGNIPS---DLTKLSSLV------------EFGCPDLRIIHLEDNQL 460
P + + +S+ NL G I S D+ L L FG L + L NQ
Sbjct: 428 PLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQF 487
Query: 461 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS-KNVV 498
+G +P L +L L +L + N LSG +P L S K +V
Sbjct: 488 SGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLV 526
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 5e-06
Identities = 27/78 (34%), Positives = 41/78 (52%), Gaps = 8/78 (10%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 476
++ ++HL S N TG IP LT L P L+++ L N+ +G +P +L NL
Sbjct: 309 NLEILHLFSNNFTGKIPVALTSL--------PRLQVLQLWSNKFSGEIPKNLGKHNNLTV 360
Query: 477 LYVQNNMLSGTVPSSLLS 494
L + N L+G +P L S
Sbjct: 361 LDLSTNNLTGEIPEGLCS 378
|
Length = 968 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-06
Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 593 KIGSGGFGVVYYGKLKDG---KEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLV-- 645
K+G G +G VY K KDG KE A+K + T S R E+ LL + H N++
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR----EIALLRELKHPNVIAL 63
Query: 646 QFLGYCQEEGRSVLVYEFMHNGTLKEH-LYGTLT-HEQRINWIKRLEIAEDAAK------ 697
Q + + + L++++ EH L+ + H K +++ K
Sbjct: 64 QKVFLSHSDRKVWLLFDY------AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI 117
Query: 698 --GIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSI-- 749
GI YLH V +HRDLK +NIL+ + R K++D G ++ ++ +
Sbjct: 118 LDGIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174
Query: 750 VRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 787
V T Y PE + ++ T D+++ G I EL++ +
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 6e-06
Identities = 56/228 (24%), Positives = 98/228 (42%), Gaps = 26/228 (11%)
Query: 567 LNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK 626
++D PA A + + +T+ E G GK K + IA +V +
Sbjct: 153 IDDLPAGAFGKIFICALRASTEEAEA---RRGVNSTNQGKPKCERLIAKRV--KAGSRAA 207
Query: 627 REFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV--------YEFMHNGTLKEHLYGTLT 678
+ NE+ L R++H N+++ + E + ++ Y FM++ L
Sbjct: 208 IQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLK 267
Query: 679 HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG-LSK 737
+ I +K+L A +EY+H +IHRD+K NI L+ + + DFG
Sbjct: 268 QTRAI--MKQLLCA------VEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMP 316
Query: 738 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
F + + V GTV PE + +D++S G+ILL+++S
Sbjct: 317 FEKEREAFDYGWV-GTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 37/150 (24%), Positives = 63/150 (42%), Gaps = 16/150 (10%)
Query: 592 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV--QFLG 649
K + G VY KD +K+ S RE EV +L + + L + L
Sbjct: 4 KLLKGGLTNRVYLLGTKDED-YVLKINPSREKGADRE--REVAILQLLARKGLPVPKVLA 60
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 709
+ +G S L+ E++ TL E ++ E++ + IAE A+ + LH +
Sbjct: 61 SGESDGWSYLLMEWIEGETLDE-----VSEEEKED------IAEQLAELLAKLHQLPLLV 109
Query: 710 IIHRDLKSSNILLDKHMRAKVSDFGLSKFA 739
+ H DL NIL+D + D+ + +
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 7e-06
Identities = 27/73 (36%), Positives = 40/73 (54%), Gaps = 8/73 (10%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 476
S+ + L NLTG IPS L L +L+ + L N+L+GP+P S+ +L L
Sbjct: 237 SLNHLDLVYNNLTGPIPSSLGNLK--------NLQYLFLYQNKLSGPIPPSIFSLQKLIS 288
Query: 477 LYVQNNMLSGTVP 489
L + +N LSG +P
Sbjct: 289 LDLSDNSLSGEIP 301
|
Length = 968 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 7e-06
Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLV 645
+++ IG G +GVV G+++A+K + + ++ + T E+ LL + H ++V
Sbjct: 4 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIV 62
Query: 646 Q----FLGYCQEEGRSV-LVYEFMH---------NGTL-KEH----LYGTLTHEQRINWI 686
+ L + E + + +V+E M N L EH LY L
Sbjct: 63 EIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLL--------- 113
Query: 687 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASH 745
+ ++Y+HT V HRDLK NIL + + K+ DFGL++ A D +
Sbjct: 114 ----------RALKYIHTANV---FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 160
Query: 746 V--SSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQ 787
+ + V T Y PE S + T D++S G I E+++G+
Sbjct: 161 IFWTDYV-ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 7e-06
Identities = 28/80 (35%), Positives = 40/80 (50%), Gaps = 8/80 (10%)
Query: 710 IIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 768
IIH D+K N+L D+ R + D+GL K S GT+ Y PE I
Sbjct: 130 IIHNDIKLENVLYDRAKDRIYLCDYGLCK-----IIGTPSCYDGTLDYFSPE-KIKGHNY 183
Query: 769 DKS-DVYSFGVILLELISGQ 787
D S D ++ GV+ EL++G+
Sbjct: 184 DVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 593 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLG-Y 650
K+G G +G VY K KDGK+ L G E+ LL + H N++ +
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 651 CQEEGRSV-LVYEFMHNG---TLKEHLYGTLTHEQRINWIKRL--EIAEDAAKGIEYLHT 704
R V L++++ + +K H + +++ + + + + GI YLH
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFH-RASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 705 GCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSI--VRGTVGYLD 758
V +HRDLK +NIL+ + R K++D G ++ ++ + V T Y
Sbjct: 127 NWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 759 PEYYI-SQQLTDKSDVYSFGVILLELISGQ 787
PE + ++ T D+++ G I EL++ +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 8e-06
Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 22/207 (10%)
Query: 594 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQFLG 649
+G G FG V + K +I A+KV+ + + F E +LS + + Q
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
Q++ LV E+ G L L Y E + +AE + +H+
Sbjct: 69 AFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMA----QFYLAEL----VLAIHSVHQ 120
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR-GTVGYLDPEYYISQQ 766
+HRD+K N+L+D+ K++DFG S + V+S + GT Y+ PE +
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFG-SAARLTANKMVNSKLPVGTPDYIAPEVLTTMN 179
Query: 767 LTDKS------DVYSFGVILLELISGQ 787
K D +S GVI E+I G+
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-05
Identities = 32/92 (34%), Positives = 43/92 (46%), Gaps = 16/92 (17%)
Query: 415 QPSITVIHLSSKNLTGNIPSDLT---KLSSLVEFG-------------CPDLRIIHLEDN 458
++TV+ LS+ NLTG IP L L L+ F C LR + L+DN
Sbjct: 355 HNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDN 414
Query: 459 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPS 490
+G LPS LP + L + NN L G + S
Sbjct: 415 SFSGELPSEFTKLPLVYFLDISNNNLQGRINS 446
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-05
Identities = 26/77 (33%), Positives = 40/77 (51%), Gaps = 8/77 (10%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
P + V+ L S +G IP +L K ++L ++ L N LTG +P L + NL
Sbjct: 332 PRLQVLQLWSNKFSGEIPKNLGKHNNLT--------VLDLSTNNLTGEIPEGLCSSGNLF 383
Query: 476 ELYVQNNMLSGTVPSSL 492
+L + +N L G +P SL
Sbjct: 384 KLILFSNSLEGEIPKSL 400
|
Length = 968 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 30/95 (31%), Positives = 56/95 (58%), Gaps = 12/95 (12%)
Query: 696 AKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT- 753
A G+E+L + CV HRDL + N+L+ + K+ DFGL++ + ++++S +G+
Sbjct: 249 ANGMEFLASKNCV----HRDLAARNVLICEGKLVKICDFGLARDIMRDSNYIS---KGST 301
Query: 754 ---VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
+ ++ PE + T SDV+SFG++L E+ +
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 1e-05
Identities = 48/211 (22%), Positives = 82/211 (38%), Gaps = 30/211 (14%)
Query: 595 GSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLGY 650
+V+ K K +AVK + K + E+ ++ H N++ ++
Sbjct: 9 CFEDLMIVHLAKHKPTNTLVAVKK-INLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 651 CQEEGRSVLVYEFMHNGT----LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-G 705
+ +V M G+ LK H L E I +I + D ++Y+H+ G
Sbjct: 68 FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-ELAIAFILK-----DVLNALDYIHSKG 121
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG------YLDP 759
IHR +K+S+ILL + +S S + + +L P
Sbjct: 122 F----IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177
Query: 760 EYYISQQL---TDKSDVYSFGVILLELISGQ 787
E + Q L +KSD+YS G+ EL +G
Sbjct: 178 EV-LQQNLQGYNEKSDIYSVGITACELANGH 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-05
Identities = 29/84 (34%), Positives = 45/84 (53%), Gaps = 10/84 (11%)
Query: 423 LSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 482
LS +L+G IP + +L +L I+HL N TG +P +L +LP L+ L + +N
Sbjct: 291 LSDNSLSGEIPELVIQLQNL--------EILHLFSNNFTGKIPVALTSLPRLQVLQLWSN 342
Query: 483 MLSGTVPSSLLSKN--VVLNYAGN 504
SG +P +L N VL+ + N
Sbjct: 343 KFSGEIPKNLGKHNNLTVLDLSTN 366
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-05
Identities = 26/76 (34%), Positives = 39/76 (51%), Gaps = 8/76 (10%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 476
S+ V+ L L G IP+ LT L+SL + L NQL G +P L + +L+
Sbjct: 165 SLKVLDLGGNVLVGKIPNSLTNLTSL--------EFLTLASNQLVGQIPRELGQMKSLKW 216
Query: 477 LYVQNNMLSGTVPSSL 492
+Y+ N LSG +P +
Sbjct: 217 IYLGYNNLSGEIPYEI 232
|
Length = 968 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 594 IGSGGFGVVYYGKLKD---------GKEIAV--KVLTSNSYQGKREFTNEVTLLSRIHHR 642
+G G F +Y G L+ G+E++V KVL S+ ++ F +L+S++ H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD-HRDSLAFFETASLMSQLSHK 61
Query: 643 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRIN----WIKRLEIAEDAAKG 698
+LV+ G C + +++V E++ G L L H ++ N W +L++A+ A
Sbjct: 62 HLVKLYGVCVRDE-NIMVEEYVKFGPLDVFL-----HREKNNVSLHW--KLDVAKQLASA 113
Query: 699 IEYLHTGCVPAIIHRDLKSSNILLDKH-------MRAKVSDFGLSKFAVDGASHVSSIVR 751
+ YL ++H ++ NIL+ ++ K+SD G+ + V I
Sbjct: 114 LHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI-- 168
Query: 752 GTVGYLDPEYY--ISQQLTDKSDVYSFGVILLELISGQEA 789
++ PE LT +D +SFG LLE+ S E
Sbjct: 169 ---PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEE 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 6e-05
Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
P++ + LS+ L+G IP+D+ SS L+++ L N L G +P+SL NL +L
Sbjct: 140 PNLETLDLSNNMLSGEIPNDIGSFSS--------LKVLDLGGNVLVGKIPNSLTNLTSLE 191
Query: 476 ELYVQNNMLSGTVPSSL-LSKNVVLNYAGNINL 507
L + +N L G +P L K++ Y G NL
Sbjct: 192 FLTLASNQLVGQIPRELGQMKSLKWIYLGYNNL 224
|
Length = 968 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 6e-05
Identities = 21/63 (33%), Positives = 32/63 (50%), Gaps = 3/63 (4%)
Query: 422 HLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 481
+L S +L+ N LT + G P+L+++ L N LT P + LP+LR L +
Sbjct: 1 NLKSLDLSNN---RLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSG 57
Query: 482 NML 484
N L
Sbjct: 58 NNL 60
|
Length = 60 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 6e-05
Identities = 47/195 (24%), Positives = 81/195 (41%), Gaps = 25/195 (12%)
Query: 630 TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL 689
+E LL R+ H ++ L G + LV + LY L R+ +
Sbjct: 208 VHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS-----DLYTYLG--ARLRPLGLA 260
Query: 690 EIAEDAAK---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746
++ A + I+Y+H IIHRD+K+ N+L++ + DFG + FA S
Sbjct: 261 QVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFA--RGSWS 315
Query: 747 SSIVRGTVGYLD---PEYYISQQLTDKSDVYSFGVILLE-------LISGQEAISNEKFG 796
+ G G +D PE T D++S G+++ E L S +
Sbjct: 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYD 375
Query: 797 ANCRNIVQWAKLHIE 811
A I++ A++H++
Sbjct: 376 AQILRIIRQAQVHVD 390
|
Length = 461 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 8e-05
Identities = 27/88 (30%), Positives = 47/88 (53%), Gaps = 8/88 (9%)
Query: 590 LEKKIGSGGFGVVY------YGKLKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HH 641
K +G+G FG V GK + +AVK+L ++++ +RE +E+ +LS + H
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101
Query: 642 RNLVQFLGYCQEEGRSVLVYEFMHNGTL 669
+N+V LG C G +++ E+ G L
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDL 129
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 8e-05
Identities = 58/230 (25%), Positives = 96/230 (41%), Gaps = 28/230 (12%)
Query: 565 SSLNDAPAEAAHCFTLSDIEDATKM---LEKKIGSGGFGVVY----YGKLKDGKEIAVKV 617
S D E + SD +M + + G G V+ +G + K++ VK
Sbjct: 68 SPQTDVCQEPCETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCTKHGD-EQRKKVIVKA 126
Query: 618 LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL-GYCQEEGRSVLVYEFMHNGTLKEHLYGT 676
+T G + E+ +L I HR ++ + Y + +++ ++ + G
Sbjct: 127 VT-----GGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGP 181
Query: 677 LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 736
L EQ I +RL A + YLH IIHRD+K+ NI LD+ A + DFG +
Sbjct: 182 LPLEQAITIQRRLLEA------LAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAA 232
Query: 737 KFAVDGASHVSSIVRGTVGYLD---PEYYISQQLTDKSDVYSFGVILLEL 783
A + G G L+ PE K+D++S G++L E+
Sbjct: 233 --CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 39/146 (26%), Positives = 60/146 (41%), Gaps = 15/146 (10%)
Query: 643 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 700
N+V Y E LV + G L H+ + + E W + +A DA
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 701 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 760
LH I+ RDL +NILLD +++ F V+ + ++ Y PE
Sbjct: 101 -LHR---EGIVCRDLNPNNILLDDRGHIQLTYFS-RWSEVEDSCDGEAVENM---YCAPE 152
Query: 761 YYISQQLTDKSDVYSFGVILLELISG 786
+ T+ D +S G IL EL++G
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-04
Identities = 73/296 (24%), Positives = 103/296 (34%), Gaps = 105/296 (35%)
Query: 590 LEKKIGSGGFGVVYYG-----KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN- 643
L KK+G G FGVVY + K + +K + Y + NE R N
Sbjct: 136 LGKKLGEGAFGVVYKASLVNKQSKKEGKYVLK--KATEYGAVEIWMNERV---RRACPNS 190
Query: 644 ----LVQFLGYCQEEGRSV--LVYEFMHNGTL------KEHLYGTLTHEQRINWIKRLEI 691
+ FL + LV+ + TL KE Y E + L
Sbjct: 191 CADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNV---EPYL-----LGK 242
Query: 692 AEDAAKGIEY------------------LH-TGCVPAIIHRDLKSSNILLDKHMRA-KVS 731
+D KG+E LH TG I+HRD+K NI+ + + K+
Sbjct: 243 VQDLPKGLERENKIIQTIMRQILFALDGLHSTG----IVHRDVKPQNIIFSEGSGSFKII 298
Query: 732 DFGLSKFAVDGASHVSSIVRGTVGY------LDP------EYYISQQ------------- 766
D G A D +R + Y LDP +Y +S Q
Sbjct: 299 DLGA---AAD--------LRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATAL 347
Query: 767 --------LTDKSDVYSFGVILLE-----LISGQEAIS-NEKFGANCRNIVQWAKL 808
L D+ D+YS G+I L+ L S I N + N ++V W KL
Sbjct: 348 SPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKL 403
|
Length = 566 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 6e-04
Identities = 60/248 (24%), Positives = 93/248 (37%), Gaps = 61/248 (24%)
Query: 592 KKIGSGGFG-VVYYGKLKDGKEIAVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQF 647
K +G G FG V K+ A+K L + + + E +L+ + +V+
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
Q++ V +++ G + L + + R IAE IE +H
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVL---ARFYIAE-LTLAIESVHK--- 119
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGL---------SKFAVDGASHVS----------- 747
IHRD+K NIL+D K++DFGL SK+ G SH+
Sbjct: 120 MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKG-SHIRQDSMEPSDLWD 178
Query: 748 ----------------------------SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVI 779
S+V GT Y+ PE + + T D +S GVI
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLV-GTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 780 LLELISGQ 787
L E++ GQ
Sbjct: 238 LFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 49/191 (25%), Positives = 84/191 (43%), Gaps = 21/191 (10%)
Query: 609 DGKEIAV--KVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666
+G+E+ V KVL + F +L+S++ H +L G C +++V EF+ +
Sbjct: 41 NGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEH 100
Query: 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 726
G L L + W ++ +A+ A + YL ++H ++ + NILL +
Sbjct: 101 GPLDVCLRKEKGR-VPVAW--KITVAQQLASALSYLED---KNLVHGNVCAKNILLARLG 154
Query: 727 RA-------KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGV 778
A K+SD G+S A+ V I ++ PE L+ +D +SFG
Sbjct: 155 LAEGTSPFIKLSDPGVSFTALSREERVERI-----PWIAPECVPGGNSLSTAADKWSFGT 209
Query: 779 ILLELISGQEA 789
LLE+ E
Sbjct: 210 TLLEICFDGEV 220
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 35/114 (30%), Positives = 58/114 (50%), Gaps = 15/114 (13%)
Query: 592 KKIGSGGFGVVY----YGKLKDGK--EIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HHRN 643
K +G+G FG V YG K +AVK+L +++ +RE +E+ +LS + +H N
Sbjct: 41 KTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHIN 100
Query: 644 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI--KRLEIAEDA 695
+V LG C G ++++ E+ G L L +R ++I K + AE A
Sbjct: 101 IVNLLGACTVGGPTLVITEYCCYGDLLNFL-----RRKRDSFICPKHEDHAEAA 149
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 36/112 (32%), Positives = 54/112 (48%), Gaps = 33/112 (29%)
Query: 695 AAKGIEYLH-TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV--- 750
A +G+ YLH G IHR++K+S+IL +S GL ++ G SH+ S+V
Sbjct: 110 ALRGLNYLHQNGY----IHRNIKASHIL--------ISGDGL--VSLSGLSHLYSLVRNG 155
Query: 751 -RGTVGYLDPEYYIS-----------QQLTD---KSDVYSFGVILLELISGQ 787
+ V Y P++ S Q L KSD+YS G+ EL +G+
Sbjct: 156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.004
Identities = 40/149 (26%), Positives = 55/149 (36%), Gaps = 51/149 (34%)
Query: 711 IHRDLKSSNILLDKHMRAKVSDFGL---------SKFAVDGASHVS-------------- 747
IHRD+K NIL+D+ K++DFGL SK+ G HV
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSG-DHVRQDSMDFSNEWGDPA 181
Query: 748 -------------------------SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLE 782
S+V GT Y+ PE + T D +S GVIL E
Sbjct: 182 NCRCGDRLKPLERRAARQHQRCLAHSLV-GTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240
Query: 783 LISGQEAISNEKFGANCRNIVQW-AKLHI 810
++ GQ + ++ W LHI
Sbjct: 241 MLVGQPPFLAQTPLETQMKVINWQTSLHI 269
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 914 | |||
| PLN03150 | 623 | hypothetical protein; Provisional | 100.0 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.98 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.98 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.98 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.98 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.98 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.95 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.78 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.77 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.77 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.76 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.73 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.71 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.69 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.69 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.69 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.68 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.67 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.66 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.64 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.63 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.62 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.6 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.58 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.53 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.53 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.52 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.48 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.48 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.36 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.34 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.34 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.19 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.12 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.08 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.07 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.04 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.03 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.03 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.0 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.99 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.92 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 98.83 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.8 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.76 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.75 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.71 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.67 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.67 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.45 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.45 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.41 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.38 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 98.36 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.34 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.32 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.32 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.31 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.31 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.31 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.26 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.2 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 98.18 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.08 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.03 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.95 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.95 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 97.92 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.92 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.9 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.9 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.86 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 97.84 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 97.8 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.76 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 97.75 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 97.74 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 97.71 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.67 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.62 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 97.62 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.61 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.57 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.55 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 97.53 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.51 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 97.51 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.47 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 97.47 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 97.39 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.34 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.3 |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-84 Score=773.00 Aligned_cols=494 Identities=24% Similarity=0.364 Sum_probs=390.7
Q ss_pred ccccCCCCcEEEecCCCCCc-ccCCCeEEecCCccccCcceeeecCccccccccccccccCCC-CCceeeeeccCCceEE
Q 002509 24 SSSAQMPGFVSLNCGGNENF-TDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFPADS-RKYCYKLDVITRTRYL 101 (914)
Q Consensus 24 ~~~~~~~~~~~idCG~~~~~-~~~~~~~~~~D~~~~~g~~~~~~~~~~~~~~~~tlR~Fp~~~-~~~cY~~~~~~~~~yl 101 (914)
.++.+++++++||||+++++ +|.+|++|++|..|+.|.....+.+....++|+|+|+||... ++|||+||++++||||
T Consensus 17 ~~~~~~~~~~~I~CGs~~~~~~d~~~~~w~~D~~~~~~~~~~~~~~~~~~~~~~t~R~F~~~~g~~~cY~~~~~~~g~yl 96 (623)
T PLN03150 17 SLASPEPFTMRISCGARVNVRTAPTNTLWYKDFAYTGGIPANATRPSFIAPPLKTLRYFPLSDGPENCYNINRVPKGHYS 96 (623)
T ss_pred ccccCCCccEEEeCCCCCCcccCCCCCEEcCCcccccCccccccCcccccchhhccccCCcccccccceEeeecCCCcEE
Confidence 34555889999999998887 778999999998887655555555555678999999999643 6889999999999999
Q ss_pred EEEEeecccCCCCCCCCceeEEeCCcccceeeec--CCCceEEEEEEEecCCCCeeEEEecCCCCCceeeeeeeeecCCc
Q 002509 102 IRATFLYGNFDNNNVYPKFDISLGPTHWSTIVIS--DAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGS 179 (914)
Q Consensus 102 vR~~f~ygnyd~~~~~p~Fd~~~~~~~w~~v~~~--~~~~~~~~e~i~~~~~~~~~vcl~~~~~~~pfis~lEl~~l~~~ 179 (914)
||++|+|||||+.+++|.|||++|||.|.+|+.. .....+++|+|+++++++++|||+++++|.||||+||||||+++
T Consensus 97 VRl~F~~~~y~~~~~~~~Fdv~~~~~~~~tv~~~~~~~~~~v~~E~i~~~~~~~l~vcf~~~~~~~pFIs~iEv~~l~~~ 176 (623)
T PLN03150 97 VRVFFGLVAEPNFDSEPLFDVSVEGTQISSLKSGWSSHDEQVFAEALVFLTDGSASICFHSTGHGDPAILSIEILQVDDK 176 (623)
T ss_pred EEEEeecCCcCCCCCCCceEEEECcEEEEEEecCcccCCCcEEEEEEEEecCCcEEEEEecCCCCCCceeEEEEEEcCcc
Confidence 9999999999999999999999999999999863 34456889999999999999999999999999999999999999
Q ss_pred cccccc--cCceeEEEEeeeccCCCCCC-CccCCCCCC--CCcccCCccccccccccccCCccccccccccCC--CCCCC
Q 002509 180 VYLTPF--EDRYYLSVSARINFGADSEA-PVRYPDDPF--DRIWESDSLKKANYLVDVAAGTEKVSTKLPIDL--RSDEL 252 (914)
Q Consensus 180 ~y~~~~--~~~~~l~~~~R~~~G~~~~~-~~rypdD~~--dR~W~~~~~~~~~~~~~~~~~~~~~st~~~~~~--~~~~~ 252 (914)
+|.... +.+.+|++++|+|||+.+.. .+|||||+| ||+|.+|+.|..+. |..+++...|.. ..++.
T Consensus 177 ~y~~~~~~~~~~~L~~~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~~~-------~~~~st~~~I~~~~~~~~~ 249 (623)
T PLN03150 177 AYNFGPSWGQGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSGS-------DQAISTENVIKKASNAPNF 249 (623)
T ss_pred cccccccccCceEEEEEEEEEecCcccccccCCCCCcccCccccCcCcccCCCc-------ccccccccccccccCCCcc
Confidence 996442 44678999999999986543 489999999 99999988776332 445555555542 34588
Q ss_pred ChHHHHhhceeccCCCeeEEEecCCCCC-ccceeeeehhccc-CCCCcceEEEEEeCCCCCcccceeccccccCCceeee
Q 002509 253 PPQKVMQTAVVGTNGSLTYRLNLDGFPG-FGWAVTYFAEIED-LDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVY 330 (914)
Q Consensus 253 ~P~~v~~tA~t~~~~~~~~~~~~~~~~~-~~~v~lhFae~~~-~~~~~~R~F~i~ing~~~~~~~~~~~~~~~~~~~~~~ 330 (914)
+|++|||||.++.++..++.|.|+..+. .++|+|||||++. ....++|+|||||||+.+.++ +++....++.+.++
T Consensus 250 ~P~~VyqTA~~~~~~~~~lty~~~v~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~~~--~di~~~~g~~~~~~ 327 (623)
T PLN03150 250 YPESLYQSALVSTDTQPDLSYTMDVDPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKD--VDIVKMSGERYTAL 327 (623)
T ss_pred ChHHHhhhhccccCCCCceEEEeecCCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEeecc--cChhhhcCCcccce
Confidence 8999999998877655556666665443 2389999999984 667789999999999987665 34444333333333
Q ss_pred cccccccccceEEEEEEeecCCCCCCcchhhhhhhhhccCC--CCCccHHHHHHHHhhcCC---CCCcCCCCCCCCCC--
Q 002509 331 EPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERN--DGSIDGVAIVSVISLYSS---ADWAQEGGDPCLPV-- 403 (914)
Q Consensus 331 ~~~~~~~~~~~~~~l~l~~~~~s~lpp~ln~le~l~~l~~~--~~~~d~~al~~l~~~~~~---~~~~~~~~dpc~~~-- 403 (914)
...+........+++.+.+...+ ||+|||+|++++.... +.+.|+.||+++|+.... .+| .+|||.|.
T Consensus 328 ~~~~~v~~~~g~l~isl~p~~~s--~pilNaiEI~~~~~~~~~t~~~~~~aL~~~k~~~~~~~~~~W---~g~~C~p~~~ 402 (623)
T PLN03150 328 VLNKTVAVSGRTLTIVLQPKKGT--HAIINAIEVFEIITAESKTLLEEVSALQTLKSSLGLPLRFGW---NGDPCVPQQH 402 (623)
T ss_pred EEEeEEeecCCeEEEEEeeCCCC--cceeeeeeeeeccccccccCchHHHHHHHHHHhcCCcccCCC---CCCCCCCccc
Confidence 33333222224477888876544 7999999999998877 799999999999883322 256 47899876
Q ss_pred CCceEEeCCCC---CCCeEEEEccCCCCcccCCchhhcccccccc----------------CCCCCcEEEcCCCcCCCCC
Q 002509 404 PWSWLQCNSDP---QPSITVIHLSSKNLTGNIPSDLTKLSSLVEF----------------GCPDLRIIHLEDNQLTGPL 464 (914)
Q Consensus 404 ~w~gv~c~~~~---~~~l~~L~L~~n~l~G~ip~~~~~l~~L~~l----------------~l~~L~~L~Ls~N~l~G~i 464 (914)
+|.||.|..+. ...++.|+|++|+|+|.+|..|++|++|+.| .|++|+.|||++|+|+|.+
T Consensus 403 ~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~i 482 (623)
T PLN03150 403 PWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482 (623)
T ss_pred ccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCC
Confidence 89999996422 2358999999999999999999999999887 4678999999999999999
Q ss_pred CccCcCCCCCceeeecCccccCCCCccccc---cccccccccCCCccCCCc-----CccccceeeceehhhhhHH
Q 002509 465 PSSLMNLPNLRELYVQNNMLSGTVPSSLLS---KNVVLNYAGNINLHEGGR-----GAKHLNIIIGSSVGAAVLL 531 (914)
Q Consensus 465 P~~l~~l~~L~~l~l~~N~l~G~iP~~~~~---~~~~l~~~~N~~~~~~~~-----~~~~~~iii~i~v~~~vl~ 531 (914)
|..+++|++|+.|+|++|+|+|.+|..+.. .+..+++.+|+.+|+.+. .......++++++++++++
T Consensus 483 P~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~~~~~~~~~i~~~~~~~~~~ 557 (623)
T PLN03150 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPHLSVGAKIGIAFGVSVAF 557 (623)
T ss_pred chHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCCCCCCCcccCCCceEEEEEhHHHHHH
Confidence 999999999999999999999999998743 345788999999998642 1122334455555544433
|
|
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-64 Score=561.87 Aligned_cols=320 Identities=35% Similarity=0.573 Sum_probs=251.5
Q ss_pred EecCCCCC---ccc-CCCeEEecCCccc-cCcceeeecC-----ccccccccccccccCCCCCceeeeecc--CCceEEE
Q 002509 35 LNCGGNEN---FTD-EIGLQWIADDHLI-YGEISNISVA-----NETRKQYMTLRHFPADSRKYCYKLDVI--TRTRYLI 102 (914)
Q Consensus 35 idCG~~~~---~~~-~~~~~~~~D~~~~-~g~~~~~~~~-----~~~~~~~~tlR~Fp~~~~~~cY~~~~~--~~~~ylv 102 (914)
||||++.+ |+| .+||+|++|++|+ +|..++++.. ....++|+|+|+||+|. ++||+||+. +|+||||
T Consensus 1 IdCG~~~~~s~y~D~~tg~~~~~D~~~~~~g~~~~i~~~~~~~~~~~~~~y~taR~F~~g~-r~cY~l~~~~~~~~~yli 79 (347)
T PF12819_consen 1 IDCGSSSNSSSYVDDSTGRTWVSDDDFIDTGKSGNISSQPDSSSSDSSPPYQTARIFPEGS-RNCYTLPVTPPGGGKYLI 79 (347)
T ss_pred CcCCCCCCCcccccCCCCcEEeCCCCcccCCCccccccccCCcCCccccccceEEEcCCCC-ccEEEeeccCCCCceEEE
Confidence 89998755 666 4899999999999 6777877322 34568999999999884 589999998 5679999
Q ss_pred EEEeecccCCCCC-----CCCceeEEeCCcccceeeecCC-CceEEEEEEE-ecCCCCeeEEEecCCCCC-ceeeeeeee
Q 002509 103 RATFLYGNFDNNN-----VYPKFDISLGPTHWSTIVISDA-ATIEVRELIF-LASSPKIDVCLSNATTGQ-PFISTLELR 174 (914)
Q Consensus 103 R~~f~ygnyd~~~-----~~p~Fd~~~~~~~w~~v~~~~~-~~~~~~e~i~-~~~~~~~~vcl~~~~~~~-pfis~lEl~ 174 (914)
|++|+|||||+++ ++|.|||++|+|.|.+|+.++. ...+++|+|+ +.++++++|||+++++|+ ||||+||||
T Consensus 80 Rl~F~~gnyd~~~fs~~~~~~~FdL~~~~n~~~tV~~~~~~~~~~~~E~ii~v~~~~~l~vclv~~~~g~~pFIsaiEl~ 159 (347)
T PF12819_consen 80 RLHFYYGNYDGLNFSVSSSPPTFDLLLGFNFWSTVNLSNSPSSPVVKEFIINVTWSDTLSVCLVPTGSGTFPFISAIELR 159 (347)
T ss_pred EEEeccccccccccccccCCcceEEEECCceeEEEEecCCCcceEEEEEEEEEcCCCcEEEEEEeCCCCCCCceeEEEEE
Confidence 9999999999874 3678999999999999999872 2468899555 555899999999999999 999999999
Q ss_pred ecCCcccccc-ccCceeEEEEeeeccCCCCCCCccCCCCCCCCcccCCccccccccccccCCccccccccccC-C--CCC
Q 002509 175 QFNGSVYLTP-FEDRYYLSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPID-L--RSD 250 (914)
Q Consensus 175 ~l~~~~y~~~-~~~~~~l~~~~R~~~G~~~~~~~rypdD~~dR~W~~~~~~~~~~~~~~~~~~~~~st~~~~~-~--~~~ 250 (914)
||++++|+.. ...+.+|++++|+|||+... .||||||+|||+|+| |.. ...|.+++++.+++ . ...
T Consensus 160 ~lp~~ly~~~~~~~s~~L~~~~R~n~G~~~~-~iryp~D~~dR~W~~---~~~------~~~~~~ist~~~i~~~~~~~~ 229 (347)
T PF12819_consen 160 PLPDSLYPDTDANSSQALETVYRLNVGGSSS-FIRYPDDTYDRIWQP---YSS------SPGWSNISTTSNININSSNNP 229 (347)
T ss_pred ECCccceeccccCCCceeEEEEeecCCCccc-ccCCCCCcceeeccc---ccc------CccccccccceeeecccCCcc
Confidence 9999999532 35678999999999998654 399999999999997 321 23578888876665 2 234
Q ss_pred CCChHHHHhhceeccCCCeeEEEecCCCC-Cc-cceeeeehhcccCC-CCcceEEEEEeCCCCCcccceeccccccCCce
Q 002509 251 ELPPQKVMQTAVVGTNGSLTYRLNLDGFP-GF-GWAVTYFAEIEDLD-PDESRKFRLVLPGQPDVSKAIVNIQENAQGKY 327 (914)
Q Consensus 251 ~~~P~~v~~tA~t~~~~~~~~~~~~~~~~-~~-~~v~lhFae~~~~~-~~~~R~F~i~ing~~~~~~~~~~~~~~~~~~~ 327 (914)
|.||++|||||+++.+.+.+++++|.... .. .||+||||||+.+. ..++|+|||||||+.+++ ++.+........
T Consensus 230 ~~~P~~V~~TA~~~~~~s~~~nltw~~~~~~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~--~~~~~~~~~~~~ 307 (347)
T PF12819_consen 230 YDAPSAVYQTARTPSNSSDPLNLTWSFVDPGFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYS--DVSPPYLGADTV 307 (347)
T ss_pred CcChHHHHHhhhcccccccceEEEeccCCCCccEEEEEEEeecccccCCCCeEEEEEEECCeEccC--ccCcccccCcce
Confidence 99999999999999888777888887622 22 39999999999865 445899999999999875 343322222112
Q ss_pred eeecccccccccceEEEEEEeecCCCCCCcchhhhhhhhh
Q 002509 328 RVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKY 367 (914)
Q Consensus 328 ~~~~~~~~~~~~~~~~~l~l~~~~~s~lpp~ln~le~l~~ 367 (914)
..|..............++|.++..+++||+|||+|+|++
T Consensus 308 ~~~~d~~~~~~~~~~~~isL~~t~~S~lppiLNalEIy~v 347 (347)
T PF12819_consen 308 PYYSDYVVNVPDSGFLNISLGPTPDSTLPPILNALEIYKV 347 (347)
T ss_pred EeecceEEEecCCCEEEEEEEeCCCCCcCceeEeeeeEeC
Confidence 1222222222222347889999999999999999999975
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-54 Score=481.45 Aligned_cols=288 Identities=49% Similarity=0.859 Sum_probs=254.2
Q ss_pred cccccCHHHHHHHHHHHh--ccccccCcEEEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeee
Q 002509 574 AAHCFTLSDIEDATKMLE--KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 651 (914)
Q Consensus 574 ~~~~~~~~ei~~~~~~~~--~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~ 651 (914)
....|++.|+..+|.+|. ++||+|+||.||+|.+.+|+.||||++........++|..|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 456799999999999998 699999999999999999999999988765433155699999999999999999999999
Q ss_pred eecC-ceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEE
Q 002509 652 QEEG-RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 730 (914)
Q Consensus 652 ~~~~-~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 730 (914)
.+.+ +.+||||||++|+|.++|++.... .++|.+|++||.++|+||+|||+.+.++|+||||||+|||||+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9998 599999999999999999876433 8899999999999999999999999999999999999999999999999
Q ss_pred eeccccccccCCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhh
Q 002509 731 SDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 810 (914)
Q Consensus 731 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~ 810 (914)
+|||+|+.......+......||.+|+|||++..+..++|+|||||||+|+||+||+++.+... ......+++|++..+
T Consensus 219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~-~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR-PRGELSLVEWAKPLL 297 (361)
T ss_pred cCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC-CcccccHHHHHHHHH
Confidence 9999997654312222221179999999999999999999999999999999999999887544 233456999999999
Q ss_pred hcCCcccccCCccC-CccCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhH
Q 002509 811 ESGDIQGIIDPSLL-DEYDI-QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 864 (914)
Q Consensus 811 ~~~~~~~i~d~~l~-~~~~~-~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 864 (914)
.++++.+++|+++. ..+.. +++.++.++|++|++.+|++||+|.||+++|+.+.
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 99999999999997 56664 78999999999999999999999999999996554
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-51 Score=518.16 Aligned_cols=424 Identities=27% Similarity=0.454 Sum_probs=305.1
Q ss_pred CCeEEEEccCCCCcccCCchhhcccccccc----------------CCCCCcEEEcCCCcCCCCCCccCcCCCCCceeee
Q 002509 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEF----------------GCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 479 (914)
Q Consensus 416 ~~l~~L~L~~n~l~G~ip~~~~~l~~L~~l----------------~l~~L~~L~Ls~N~l~G~iP~~l~~l~~L~~l~l 479 (914)
++|+.|+|++|+++|.+|..+++|++|+.| ++++|+.|||++|+++|.+|..+.++++|+.|+|
T Consensus 499 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l 578 (968)
T PLN00113 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNI 578 (968)
T ss_pred hccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEec
Confidence 456666666666666666666666666655 3456779999999999999999999999999999
Q ss_pred cCccccCCCCccc-cccccccccccCCCccCCCcC--------c-cc--cceeeceehhhhhHHhhhhheeeeeecCCCC
Q 002509 480 QNNMLSGTVPSSL-LSKNVVLNYAGNINLHEGGRG--------A-KH--LNIIIGSSVGAAVLLLATVVSCLFMHKGKKN 547 (914)
Q Consensus 480 ~~N~l~G~iP~~~-~~~~~~l~~~~N~~~~~~~~~--------~-~~--~~iii~i~v~~~vl~l~~~~~~~~~~~rrk~ 547 (914)
++|+++|.+|..- +.......+.||+.+|+.... . +. ..++++++++++++++++++++ ++.++|+.
T Consensus 579 s~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 657 (968)
T PLN00113 579 SHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGF-VFIRGRNN 657 (968)
T ss_pred cCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHH-HHHHhhhc
Confidence 9999999999753 334455678999999975420 0 11 1122233333322222222222 22222221
Q ss_pred cccccccccCCCccCCCCCCCCCCcccccccCHHHHHHHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccc
Q 002509 548 NYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK 626 (914)
Q Consensus 548 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ei~~~~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~ 626 (914)
...+ +.... ................+++.++.... ...+.||+|+||.||+|+.. +++.||||.++....
T Consensus 658 ~~~~-~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--- 728 (968)
T PLN00113 658 LELK-RVENE----DGTWELQFFDSKVSKSITINDILSSL-KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--- 728 (968)
T ss_pred cccc-ccccc----cccccccccccccchhhhHHHHHhhC-CcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---
Confidence 1100 00000 00000000000111224455544332 23468999999999999874 789999999864322
Q ss_pred hhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCC
Q 002509 627 REFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 706 (914)
Q Consensus 627 ~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~ 706 (914)
....|++.+++++|||||+++|+|.+++..++||||+++|+|.++++ .++|.++.+++.|+|+||+|||..+
T Consensus 729 -~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~ 800 (968)
T PLN00113 729 -IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRC 800 (968)
T ss_pred -ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCC
Confidence 22456889999999999999999999999999999999999999984 2789999999999999999999776
Q ss_pred CCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhC
Q 002509 707 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 786 (914)
Q Consensus 707 ~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG 786 (914)
.++|+||||||+||+++.++.+++. ||.+...... ....||..|+|||++.+..++.|+|||||||++|||++|
T Consensus 801 ~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg 874 (968)
T PLN00113 801 SPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTG 874 (968)
T ss_pred CCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhC
Confidence 7799999999999999999988876 6665433211 123578999999999999999999999999999999999
Q ss_pred CCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCc--cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhH
Q 002509 787 QEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE--YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 864 (914)
Q Consensus 787 ~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~--~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 864 (914)
+.|++... .....+.+|++...........+|+.+... .+.+++.++.+++.+|++.+|++||+|+||++.|+++.
T Consensus 875 ~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 875 KSPADAEF--GVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred CCCCCccc--CCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 99985432 223567888877766666677778777543 34567778999999999999999999999999999775
Q ss_pred h
Q 002509 865 V 865 (914)
Q Consensus 865 ~ 865 (914)
+
T Consensus 953 ~ 953 (968)
T PLN00113 953 R 953 (968)
T ss_pred c
Confidence 4
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=395.29 Aligned_cols=254 Identities=34% Similarity=0.552 Sum_probs=209.7
Q ss_pred HhccccccCcEEEEEEEECCCcEEEEEEEecCCccc--chhhhHHHHHHhhcccCceeEEEeeeeecC-ceEEEEEeccC
Q 002509 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--KREFTNEVTLLSRIHHRNLVQFLGYCQEEG-RSVLVYEFMHN 666 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~--~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~LV~E~~~~ 666 (914)
+.+.||+|+||+||+|.++....||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 445699999999999999844449999998654332 458999999999999999999999999987 79999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCC-ccccCCCCCceEeCCCC-cEEEeeccccccccCCCC
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA-IIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~-ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~ 744 (914)
|+|.++++.. ....+++..++++|.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++......
T Consensus 125 GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 125 GSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 9999999764 467899999999999999999999998 6 99999999999999997 99999999998764432
Q ss_pred ceeeccccCCcccCccccc--cCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCc
Q 002509 745 HVSSIVRGTVGYLDPEYYI--SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 822 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~--~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 822 (914)
...+...||+.|||||++. ...++.|+||||||++||||+||+.||..... ..+... ....+.
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~----~~~~~~---v~~~~~-------- 263 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP----VQVASA---VVVGGL-------- 263 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH----HHHHHH---HHhcCC--------
Confidence 2223367999999999999 66999999999999999999999999976542 122221 111111
Q ss_pred cCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHh
Q 002509 823 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 823 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 865 (914)
+...+..+...+..++.+||+.||++||++.|++..|+.+..
T Consensus 264 -Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 264 -RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred -CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 111222244568888889999999999999999999998765
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=387.97 Aligned_cols=261 Identities=28% Similarity=0.447 Sum_probs=219.9
Q ss_pred HHHHHHHHHhccccccCcEEEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEE
Q 002509 582 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 661 (914)
Q Consensus 582 ei~~~~~~~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 661 (914)
++......+.+.||+|-||.||.|.++....||+|.++... .....|.+|+++|++++|+|||+++|+|..++..+|||
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 44555566788999999999999999988899999998763 34578999999999999999999999999999999999
Q ss_pred EeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccC
Q 002509 662 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 741 (914)
Q Consensus 662 E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 741 (914)
|||+.|+|.++|+. ..+..+...+.+.++.|||+|++||+++ ++|||||.++||||+++..+||+|||||+...+
T Consensus 281 E~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCC
Confidence 99999999999976 2467788999999999999999999999 999999999999999999999999999996555
Q ss_pred CCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccC
Q 002509 742 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 820 (914)
Q Consensus 742 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 820 (914)
+.........-+..|.|||.+..+.++.|||||||||+||||+| |+.|+.+.... .+++ .++.|
T Consensus 356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~----ev~~----~le~G------- 420 (468)
T KOG0197|consen 356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE----EVLE----LLERG------- 420 (468)
T ss_pred CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH----HHHH----HHhcc-------
Confidence 55445555556789999999999999999999999999999999 88887765432 2222 22222
Q ss_pred CccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHh
Q 002509 821 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 821 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 865 (914)
.+-..+..+...+.+++..||+.+|++|||++.+...|+++..
T Consensus 421 --yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 421 --YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred --CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 1112233345578899999999999999999999999987754
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=362.47 Aligned_cols=257 Identities=29% Similarity=0.429 Sum_probs=209.9
Q ss_pred cCHHHHHHHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecC-CcccchhhhHHHHHHhhcccCceeEEEeeeeecC
Q 002509 578 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG 655 (914)
Q Consensus 578 ~~~~ei~~~~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~ 655 (914)
++.+|++. .+.||+|..|+|||++++ +++-+|+|++..+ .....+++.+|++++++++||+||+++|.|...+
T Consensus 76 i~~~dle~-----~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 76 ISLSDLER-----LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG 150 (364)
T ss_pred cCHHHhhh-----hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence 56666653 357999999999999988 6788999999654 3445788999999999999999999999999998
Q ss_pred -ceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecc
Q 002509 656 -RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 734 (914)
Q Consensus 656 -~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 734 (914)
...++||||++|+|++.+.. .+++++...-+|+.+|++||.|||+. .+||||||||+|||++..|++||+|||
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEecccc
Confidence 49999999999999999853 36689999999999999999999973 299999999999999999999999999
Q ss_pred ccccccCCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCC
Q 002509 735 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 814 (914)
Q Consensus 735 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 814 (914)
.++..... ......||..|||||.+.+..|+.++||||||+.++|+.+|+.|+.... +....+.+-......+ .
T Consensus 225 VS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~--~~~~~~~~Ll~~Iv~~-p 298 (364)
T KOG0581|consen 225 VSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN--PPYLDIFELLCAIVDE-P 298 (364)
T ss_pred ccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC--CCCCCHHHHHHHHhcC-C
Confidence 99887654 4456779999999999999999999999999999999999999987541 1111222222111111 0
Q ss_pred cccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 815 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 815 ~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
-|++..+ ..-.++..++-.|++.||.+||+++|++++
T Consensus 299 -----pP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 299 -----PPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -----CCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1222222 233468899999999999999999999976
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=353.08 Aligned_cols=259 Identities=27% Similarity=0.420 Sum_probs=211.2
Q ss_pred HHHHHhccccccCcEEEEEEEE-CCCcEEEEEEEecC--CcccchhhhHHHHHHhhcccCceeEEEe-eeeecCc-eEEE
Q 002509 586 ATKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLG-YCQEEGR-SVLV 660 (914)
Q Consensus 586 ~~~~~~~~lG~G~~G~Vy~~~~-~~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g-~~~~~~~-~~LV 660 (914)
+.+.+.++||+|.||+|||+.. .+|..||.|.++-. .....+....|+.+|++++|||||++++ -+.++.+ ..||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 3456778999999999999965 48999999988733 3344567889999999999999999998 4445555 7899
Q ss_pred EEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCC--ccccCCCCCceEeCCCCcEEEeecccccc
Q 002509 661 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA--IIHRDLKSSNILLDKHMRAKVSDFGLSKF 738 (914)
Q Consensus 661 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~--ivHrDlkp~NILl~~~~~~kl~DFGla~~ 738 (914)
||+|..|+|...+...+...+.+++..++++..|++.||.++|+.. ++ |+||||||.||+|+.+|.+||+|||++++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999999877778889999999999999999999999932 24 89999999999999999999999999998
Q ss_pred ccCCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccc
Q 002509 739 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 818 (914)
Q Consensus 739 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i 818 (914)
+..... .....+|||.||+||.+.+.+|+.|+||||+||++|||+.-+.||.+...-+.+ ..++.+++..+
T Consensus 178 l~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~--------~KI~qgd~~~~ 248 (375)
T KOG0591|consen 178 LSSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLC--------KKIEQGDYPPL 248 (375)
T ss_pred hcchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHH--------HHHHcCCCCCC
Confidence 765443 334567999999999999999999999999999999999999999875433222 23444444332
Q ss_pred cCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002509 819 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862 (914)
Q Consensus 819 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 862 (914)
-|. -....+.+|+..|+..||+.||+...+++.++.
T Consensus 249 p~~--------~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 249 PDE--------HYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred cHH--------HhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 221 222357888999999999999996666655544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=361.18 Aligned_cols=253 Identities=26% Similarity=0.408 Sum_probs=202.6
Q ss_pred HHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcc-------cchhhhHHHHHHhhcccCceeEEEeeeeecCc
Q 002509 585 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR 656 (914)
Q Consensus 585 ~~~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~-------~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~ 656 (914)
...+.+.+.||+|+||.|-+|.-+ +|+.||||++++.... ......+|+++|++++|||||++++++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 345556789999999999999654 8999999999764221 12234699999999999999999999999999
Q ss_pred eEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCC---CcEEEeec
Q 002509 657 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDF 733 (914)
Q Consensus 657 ~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DF 733 (914)
.|+|||||+||.|.+.+-. ...+.+..-..++.|++.|+.|||+. ||+||||||+|||+..+ ..+||+||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred eEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999853 34455666678999999999999999 99999999999999866 78999999
Q ss_pred cccccccCCCCceeeccccCCcccCccccccCCC---CccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhh
Q 002509 734 GLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL---TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 810 (914)
Q Consensus 734 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~---s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~ 810 (914)
|+|+... ........+||+.|.|||++.+..+ ..|.|+||+|||||-+++|.+||.+...... +.+ .+
T Consensus 324 GlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s---l~e----QI 394 (475)
T KOG0615|consen 324 GLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS---LKE----QI 394 (475)
T ss_pred chhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc---HHH----HH
Confidence 9999875 4456677899999999999987543 3477999999999999999999987654331 111 12
Q ss_pred hcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 811 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 811 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
..|++.. - .....+.-++..+++.+++..||++||++.|++++
T Consensus 395 ~~G~y~f--~----p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 395 LKGRYAF--G----PLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred hcCcccc--c----ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 2232221 0 11122344578899999999999999999999976
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=359.57 Aligned_cols=196 Identities=32% Similarity=0.571 Sum_probs=176.5
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecC--CcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
+.+.||+|+||+||+|+++ ++.+||||.+... .....+.+..|+.+|+.++|||||.+++++..++..+||||||.+
T Consensus 14 ~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~g 93 (429)
T KOG0595|consen 14 LSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNG 93 (429)
T ss_pred ehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCC
Confidence 4467999999999999887 6899999998766 444566788999999999999999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCC------CcEEEeecccccccc
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH------MRAKVSDFGLSKFAV 740 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~------~~~kl~DFGla~~~~ 740 (914)
|+|.++|+. .+++++.....++.|+|.||++||++ +||||||||+||||+.. -.+||+|||+|+.+.
T Consensus 94 GDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 94 GDLSDYIRR----RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 999999964 34789999999999999999999999 99999999999999865 568999999999886
Q ss_pred CCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCccccc
Q 002509 741 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 794 (914)
Q Consensus 741 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~ 794 (914)
++ ......+|++-|||||+++.++|+.|+|+||.|++|||+++|+.||+...
T Consensus 167 ~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 167 PG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred ch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 43 34456789999999999999999999999999999999999999998554
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=372.18 Aligned_cols=248 Identities=25% Similarity=0.437 Sum_probs=209.5
Q ss_pred HHHHHhccccccCcEEEEEEEE-CCCcEEEEEEEecC---CcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEE
Q 002509 586 ATKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 661 (914)
Q Consensus 586 ~~~~~~~~lG~G~~G~Vy~~~~-~~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 661 (914)
.+|...+.||+|||+.+|.++. ..|+.||+|++.+. .....+...+|+++.+.|+|||||+++++|++.+..++|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4556678999999999999988 78999999999864 2334567889999999999999999999999999999999
Q ss_pred EeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccC
Q 002509 662 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 741 (914)
Q Consensus 662 E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 741 (914)
|+|++++|.+++. ....+++.++..++.||+.||.|||++ +|+|||||..|+||++++++||+|||||.....
T Consensus 98 ELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999985 356799999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCC
Q 002509 742 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 821 (914)
Q Consensus 742 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 821 (914)
.. ......+||+.|+|||++.....+..+||||+||+||-|+.|++||+.....+....|.. .++. + |
T Consensus 171 ~~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~--------~~Y~--~-P 238 (592)
T KOG0575|consen 171 DG-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL--------NEYS--M-P 238 (592)
T ss_pred cc-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh--------cCcc--c-c
Confidence 32 333457899999999999999999999999999999999999999987654443333322 1110 1 1
Q ss_pred ccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 822 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 822 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
. ....+..+|+..+++++|.+|||+++|+.+
T Consensus 239 ~-------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 239 S-------HLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred c-------ccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1 111246688999999999999999999974
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=390.61 Aligned_cols=258 Identities=28% Similarity=0.478 Sum_probs=216.5
Q ss_pred HHHhccccccCcEEEEEEEEC------CCcEEEEEEEecCCcc-cchhhhHHHHHHhhcccCceeEEEeeeeecCceEEE
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 660 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~------~g~~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV 660 (914)
..+.+.||+|+||.||+|+.. +...||||.++..... ..++|++|++++..++|||||+|+|.|.+++..++|
T Consensus 488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~Mv 567 (774)
T KOG1026|consen 488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMV 567 (774)
T ss_pred eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEE
Confidence 345678999999999999764 3456999999987655 688999999999999999999999999999999999
Q ss_pred EEeccCCChHHHhhcccC------c----cccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEE
Q 002509 661 YEFMHNGTLKEHLYGTLT------H----EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 730 (914)
Q Consensus 661 ~E~~~~gsL~~~L~~~~~------~----~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 730 (914)
+|||..|+|.++|+.... . ...|+..+.+.||.|||.||+||-++ .+|||||..+|+||.++..|||
T Consensus 568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEe
Confidence 999999999999965322 2 22388999999999999999999998 9999999999999999999999
Q ss_pred eeccccccccCCCCceee-ccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHH
Q 002509 731 SDFGLSKFAVDGASHVSS-IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKL 808 (914)
Q Consensus 731 ~DFGla~~~~~~~~~~~~-~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~ 808 (914)
+||||++.....+.+... ...-+.+|||||.+..+++|.+||||||||||||+++ |+.|+.+... +.+++
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn----~EVIe---- 716 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN----QEVIE---- 716 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch----HHHHH----
Confidence 999999877665544332 2334789999999999999999999999999999999 9999876543 23333
Q ss_pred hhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHh
Q 002509 809 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 809 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 865 (914)
.++.+++. +.+..+..++.+|+..||+..|++||+++||-..|+...+
T Consensus 717 ~i~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 717 CIRAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 33444432 2334556679999999999999999999999999987654
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=380.46 Aligned_cols=261 Identities=25% Similarity=0.454 Sum_probs=219.2
Q ss_pred HHHHHHHHhccccccCcEEEEEEEEC-C---CcEEEEEEEecCC-cccchhhhHHHHHHhhcccCceeEEEeeeeecCce
Q 002509 583 IEDATKMLEKKIGSGGFGVVYYGKLK-D---GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 657 (914)
Q Consensus 583 i~~~~~~~~~~lG~G~~G~Vy~~~~~-~---g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 657 (914)
|......++++||.|.||.||+|+++ . ...||||.++... .+.+++|..|+.+|.+..||||++|.|........
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv 705 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV 705 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence 33344445678999999999999987 2 3569999998764 34567899999999999999999999999999999
Q ss_pred EEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccc
Q 002509 658 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 737 (914)
Q Consensus 658 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 737 (914)
++|.|||+||+|+.+|+.. ..++.+.+...+..+||.|+.||-+. ++|||||.++|||++.+..+||+|||+++
T Consensus 706 MIiTEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSR 779 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 779 (996)
T ss_pred EEEhhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEecccccee
Confidence 9999999999999999865 35599999999999999999999998 99999999999999999999999999999
Q ss_pred cccCCCCceeecc--ccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCC
Q 002509 738 FAVDGASHVSSIV--RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGD 814 (914)
Q Consensus 738 ~~~~~~~~~~~~~--~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 814 (914)
...++.....+.. .-+.+|.|||.+..++++.++||||||+||||+++ |++|+.++... +++.-
T Consensus 780 vledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ----dVIka--------- 846 (996)
T KOG0196|consen 780 VLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ----DVIKA--------- 846 (996)
T ss_pred ecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH----HHHHH---------
Confidence 8765542222222 22578999999999999999999999999999988 99998766532 22221
Q ss_pred cccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHhH
Q 002509 815 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 866 (914)
Q Consensus 815 ~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 866 (914)
++...+-..++++...|.+|++.||++|-.+||++.||+..|+.++..
T Consensus 847 ----Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 847 ----IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred ----HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 222233345667788999999999999999999999999999988764
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=329.97 Aligned_cols=261 Identities=21% Similarity=0.269 Sum_probs=199.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCC
Q 002509 591 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 667 (914)
Q Consensus 591 ~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 667 (914)
..++|+|+||.|||++.+ +|+-||||++.... +.-++-.++|+++|++++|+|+|.++..|..+...+||+|||+.-
T Consensus 7 LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhT 86 (396)
T KOG0593|consen 7 LGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHT 86 (396)
T ss_pred hhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchH
Confidence 347999999999999988 69999999986543 334566789999999999999999999999999999999999985
Q ss_pred ChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCcee
Q 002509 668 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 747 (914)
Q Consensus 668 sL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 747 (914)
-|.+.- . ....++.....+++.|+++|+.|+|++ +++||||||+||||+.++.+||+|||+|+.... .....
T Consensus 87 vL~eLe-~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~Y 158 (396)
T KOG0593|consen 87 VLHELE-R---YPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNY 158 (396)
T ss_pred HHHHHH-h---ccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Ccchh
Confidence 454433 2 244577888899999999999999999 999999999999999999999999999998763 23334
Q ss_pred eccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHH-------HhhhcCC-cccc
Q 002509 748 SIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK-------LHIESGD-IQGI 818 (914)
Q Consensus 748 ~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~-------~~~~~~~-~~~i 818 (914)
+..+.|.+|+|||.+.+ .+|....||||.||++.||++|++-|.+.+.-+-...|..-.. ..+.... ...+
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 55668999999999987 6899999999999999999999998876542211111111111 1111111 1111
Q ss_pred cCCccCCccC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 819 IDPSLLDEYD-----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 819 ~d~~l~~~~~-----~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.=|......+ +.....+++++..|++.||.+|++-+|++.+
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 1111111001 1122367899999999999999999999865
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=350.79 Aligned_cols=262 Identities=28% Similarity=0.501 Sum_probs=207.7
Q ss_pred HHHHHHHHHhccccccCcEEEEEEEECCCcEEEEEEEecCCc--ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEE
Q 002509 582 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 659 (914)
Q Consensus 582 ei~~~~~~~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~L 659 (914)
||......+.+.||+|.||+||+|+|. .+||||+++.... ...+.|.+|+..+++-||.||+-+.|||..+.. .+
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI 464 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI 464 (678)
T ss_pred ccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence 444444456789999999999999997 5799999987643 346789999999999999999999999999887 99
Q ss_pred EEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccc
Q 002509 660 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 739 (914)
Q Consensus 660 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 739 (914)
|..+|++.+|..+||.. +.+++..+.+.||.|+|+|+.|||.+ +|||||||+.||+|.++++|||+||||+..-
T Consensus 465 iTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred eehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeee
Confidence 99999999999999865 46788899999999999999999999 9999999999999999999999999998542
Q ss_pred cCC-CCceeeccccCCcccCcccccc---CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCc
Q 002509 740 VDG-ASHVSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 815 (914)
Q Consensus 740 ~~~-~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 815 (914)
..- .........|...|||||+++. .+|++.+||||||+|+|||++|..|+.....+ +|+ | .+..|-
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d----qIi-f---mVGrG~- 609 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD----QII-F---MVGRGY- 609 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh----heE-E---Eecccc-
Confidence 211 1111222347789999999974 57999999999999999999999999743321 111 0 111111
Q ss_pred ccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHh
Q 002509 816 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 816 ~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 865 (914)
-..|... ....+..++.+|...|+..++++||.+.+|+..|++++.
T Consensus 610 -l~pd~s~---~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 610 -LMPDLSK---IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred -cCccchh---hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 1111111 112344578889999999999999999999999998765
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=377.07 Aligned_cols=267 Identities=28% Similarity=0.432 Sum_probs=216.8
Q ss_pred HHHHHHHHHHhccccccCcEEEEEEEEC--CCc----EEEEEEEecC-CcccchhhhHHHHHHhhcccCceeEEEeeeee
Q 002509 581 SDIEDATKMLEKKIGSGGFGVVYYGKLK--DGK----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE 653 (914)
Q Consensus 581 ~ei~~~~~~~~~~lG~G~~G~Vy~~~~~--~g~----~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~ 653 (914)
.++....-.+.+.||+|+||.||+|... +|. .||||.++.. +.+...+|.+|..+|++++|||||+++|+|.+
T Consensus 687 p~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 687 PEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred ccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 3344555556789999999999999876 343 3889988766 44567889999999999999999999999999
Q ss_pred cCceEEEEEeccCCChHHHhhcccC---ccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEE
Q 002509 654 EGRSVLVYEFMHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 730 (914)
Q Consensus 654 ~~~~~LV~E~~~~gsL~~~L~~~~~---~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 730 (914)
.+..++++|||++|+|..+|++... ....++....+.++.|||+|+.||+++ ++|||||.++|+||++...|||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKI 843 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKI 843 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEE
Confidence 9999999999999999999976522 355688899999999999999999999 9999999999999999999999
Q ss_pred eeccccccccCCCCceeecc-ccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHH
Q 002509 731 SDFGLSKFAVDGASHVSSIV-RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKL 808 (914)
Q Consensus 731 ~DFGla~~~~~~~~~~~~~~-~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~ 808 (914)
+|||+|+...+......... .-...|||||.+..+.++.|+|||||||+|||++| |..|+...... ++.. .
T Consensus 844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~----~v~~---~ 916 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF----EVLL---D 916 (1025)
T ss_pred cccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH----HHHH---H
Confidence 99999996655444333222 23568999999999999999999999999999999 88888654421 2222 1
Q ss_pred hhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHhHh
Q 002509 809 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 867 (914)
Q Consensus 809 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~~ 867 (914)
..+.+++ +.+..+..++.+++..||+.+|++||++..+++.++.+....
T Consensus 917 ~~~ggRL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 917 VLEGGRL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred HHhCCcc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 1222321 123344557889999999999999999999999998887643
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=350.73 Aligned_cols=261 Identities=26% Similarity=0.431 Sum_probs=202.5
Q ss_pred HHHHHhccccccCcEEEEEEEE------CCCcEEEEEEEecCCc-ccchhhhHHHHHHhhc-ccCceeEEEeeeeec-Cc
Q 002509 586 ATKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE-GR 656 (914)
Q Consensus 586 ~~~~~~~~lG~G~~G~Vy~~~~------~~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~-~~ 656 (914)
..+.+.++||+|+||.||+|.. .+++.||||+++.... .....+.+|+.++.++ +||||++++++|... +.
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 3456778999999999999974 2356799999875432 2345788999999999 899999999988765 45
Q ss_pred eEEEEEeccCCChHHHhhcccC----------------------------------------------------------
Q 002509 657 SVLVYEFMHNGTLKEHLYGTLT---------------------------------------------------------- 678 (914)
Q Consensus 657 ~~LV~E~~~~gsL~~~L~~~~~---------------------------------------------------------- 678 (914)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 7899999999999999864311
Q ss_pred ccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce-eeccccCCccc
Q 002509 679 HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYL 757 (914)
Q Consensus 679 ~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~Y~ 757 (914)
....+++.+++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++......... .....++..|+
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 023478889999999999999999998 99999999999999999999999999997654332221 12234578899
Q ss_pred CccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccCHHHHHHHH
Q 002509 758 DPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIE 836 (914)
Q Consensus 758 aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~ 836 (914)
|||++.+..++.++|||||||++|||++ |+.||......+ .+.+ ....+... .... .....+.
T Consensus 244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~---~~~~----~~~~~~~~-----~~~~----~~~~~l~ 307 (338)
T cd05102 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE---EFCQ----RLKDGTRM-----RAPE----NATPEIY 307 (338)
T ss_pred CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH---HHHH----HHhcCCCC-----CCCC----CCCHHHH
Confidence 9999999999999999999999999997 999987543211 1111 11111111 1111 1223578
Q ss_pred HHHHHccCCCCCCCCCHHHHHHHHhhhHh
Q 002509 837 EKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 837 ~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 865 (914)
+++.+|++.+|++||+|.||++.|++++.
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=340.38 Aligned_cols=260 Identities=24% Similarity=0.344 Sum_probs=200.8
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeeec--CceEEEEEecc
Q 002509 591 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVYEFMH 665 (914)
Q Consensus 591 ~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~LV~E~~~ 665 (914)
.++||+|.||.||+|+.. +|+.||+|+++... ........+|+.+|++++||||++|.+...+. ...+||+|||+
T Consensus 122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd 201 (560)
T KOG0600|consen 122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD 201 (560)
T ss_pred HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc
Confidence 458999999999999754 89999999987654 33345567899999999999999999998877 68899999998
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+ +|..++.. ..-.++..++..++.|++.||+|+|++ +|+|||||.+|||||.+|.+||+|||||+++......
T Consensus 202 h-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~ 274 (560)
T KOG0600|consen 202 H-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA 274 (560)
T ss_pred c-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCCCc
Confidence 8 78777753 245789999999999999999999999 9999999999999999999999999999988766655
Q ss_pred eeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcC----Ccc--cc
Q 002509 746 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG----DIQ--GI 818 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~----~~~--~i 818 (914)
..+..+-|.+|+|||++.+ ..|+.+.|+||.||||.||+.|++.|.+...-+-...|.+......+.- ++. ..
T Consensus 275 ~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~ 354 (560)
T KOG0600|consen 275 PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATI 354 (560)
T ss_pred ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccc
Confidence 5666677999999999987 5799999999999999999999998876542211112211110000000 111 11
Q ss_pred cCCccCCccC--HH-----HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 819 IDPSLLDEYD--IQ-----SMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 819 ~d~~l~~~~~--~~-----~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+.+. ..+. .. .....++|+..++..||.+|.|+.++++.
T Consensus 355 ~kp~--~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 355 FKPQ--QPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cCCC--CcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 1111 0111 11 12346788889999999999999999864
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=335.50 Aligned_cols=252 Identities=25% Similarity=0.380 Sum_probs=198.5
Q ss_pred HHhccccccCcEEEEEEEECC-CcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecC--ceEEEEEecc
Q 002509 589 MLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG--RSVLVYEFMH 665 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~--~~~LV~E~~~ 665 (914)
...+.||+|+||+||.+...+ |...|||..........+.+.+|+.+|.+++|||||+.+|...... .+.+.|||++
T Consensus 20 ~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~ 99 (313)
T KOG0198|consen 20 SKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAP 99 (313)
T ss_pred hhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccC
Confidence 345789999999999998874 8999999987654333567899999999999999999999855544 6899999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCC-CCcEEEeeccccccccC--C
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVD--G 742 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~--~ 742 (914)
+|+|.+++.... . .+++..+..++.|+++||+|||++ +|+||||||+|||++. ++.+||+|||+++.... .
T Consensus 100 ~GsL~~~~~~~g--~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 100 GGSLSDLIKRYG--G-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred CCcHHHHHHHcC--C-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 999999996542 2 699999999999999999999998 9999999999999999 79999999999976653 2
Q ss_pred CCceeeccccCCcccCccccccCC-CCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCC
Q 002509 743 ASHVSSIVRGTVGYLDPEYYISQQ-LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 821 (914)
Q Consensus 743 ~~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 821 (914)
.........||+.|||||++..+. ...++|||||||++.||+||+.||... .....+.-.....+...
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~------~~~~~~~~~ig~~~~~P----- 242 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF------FEEAEALLLIGREDSLP----- 242 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh------cchHHHHHHHhccCCCC-----
Confidence 222234567999999999998643 335999999999999999999999753 01112222222222111
Q ss_pred ccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002509 822 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861 (914)
Q Consensus 822 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 861 (914)
.+... ......+++..|+..+|++|||+++++++.-
T Consensus 243 ~ip~~----ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 243 EIPDS----LSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred CCCcc----cCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 11111 2224678888999999999999999998754
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=332.75 Aligned_cols=245 Identities=28% Similarity=0.405 Sum_probs=199.1
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcc---cchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~---~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
+.++||+|+||.||.++.+ +++-+|+|++++.... ..+...+|..+|.+++||.||+++-.+++.+.++||+||+.
T Consensus 29 ~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~ 108 (357)
T KOG0598|consen 29 ILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLN 108 (357)
T ss_pred eeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccC
Confidence 5689999999999999766 6888999999876432 34567889999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
||.|..+|. .+..+++....-++.+|+.||.|||+. +||||||||+|||||++|+++|+||||++..... ..
T Consensus 109 GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-~~ 180 (357)
T KOG0598|consen 109 GGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-GD 180 (357)
T ss_pred CccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccC-CC
Confidence 999999994 456788888888999999999999999 9999999999999999999999999999854332 23
Q ss_pred eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCC
Q 002509 746 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 825 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 825 (914)
.+..++||+.|||||++.+..++..+|.||+|+++|||++|.+||...+.....+.+. +. +.. ...
T Consensus 181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~-------~~-k~~------~~p 246 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKIL-------KG-KLP------LPP 246 (357)
T ss_pred ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHh-------cC-cCC------CCC
Confidence 3455789999999999999999999999999999999999999998655332222222 21 100 011
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCC----CHHHHHHH
Q 002509 826 EYDIQSMWKIEEKALMCVLPHGHMRP----SISEVLKD 859 (914)
Q Consensus 826 ~~~~~~~~~l~~l~~~C~~~~P~~RP----sm~eVl~~ 859 (914)
.+-. .+..+++...+..+|++|- ...+|-++
T Consensus 247 ~~ls---~~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 247 GYLS---EEARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred ccCC---HHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 1111 2356778889999999995 45555443
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=352.87 Aligned_cols=254 Identities=30% Similarity=0.450 Sum_probs=204.5
Q ss_pred HhccccccCcEEEEEEEECC--C--cE-EEEEEEecC---CcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEE
Q 002509 590 LEKKIGSGGFGVVYYGKLKD--G--KE-IAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 661 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~~--g--~~-vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 661 (914)
+.++||+|+||.||+|+++. + .. ||||..+.. ......+|.+|+++|++++|||||+++|++..+...++||
T Consensus 161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivm 240 (474)
T KOG0194|consen 161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVM 240 (474)
T ss_pred ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEE
Confidence 45799999999999998763 2 23 899998853 2445678999999999999999999999999999999999
Q ss_pred EeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccC
Q 002509 662 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 741 (914)
Q Consensus 662 E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 741 (914)
|+|.||+|.++|... ...++..+++.++.++|.||+|||++ +++||||.++|||++.++.+||+|||+++....
T Consensus 241 El~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 241 ELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ 314 (474)
T ss_pred EecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence 999999999999754 23689999999999999999999999 999999999999999999999999999876431
Q ss_pred CCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccC
Q 002509 742 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 820 (914)
Q Consensus 742 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 820 (914)
..... ....-+..|+|||.+..+.++.++|||||||++||+++ |..|+.+.... .+.+++. ..+ ...
T Consensus 315 ~~~~~-~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~----~v~~kI~---~~~-~r~--- 382 (474)
T KOG0194|consen 315 YVMKK-FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY----EVKAKIV---KNG-YRM--- 382 (474)
T ss_pred eeecc-ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH----HHHHHHH---hcC-ccC---
Confidence 11111 11234689999999999999999999999999999999 88898765532 3333321 111 111
Q ss_pred CccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHhH
Q 002509 821 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 866 (914)
Q Consensus 821 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 866 (914)
..+......+..+..+|+..+|++||+|.+|.+.|+.+...
T Consensus 383 -----~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 383 -----PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred -----CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 11112334566777799999999999999999999987654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=341.07 Aligned_cols=266 Identities=20% Similarity=0.247 Sum_probs=207.9
Q ss_pred HHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC-cccchhhhHHHHHHhhcc-cCceeEEEeeeeecC-ceEEE
Q 002509 585 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEG-RSVLV 660 (914)
Q Consensus 585 ~~~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~-~~~LV 660 (914)
..+|.+.++||.|.||.||+|+.+ +|+.||||.++..- ...+..=.+|+..|++++ |||||++.+.+.+.+ .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 346677789999999999999766 79999999987653 233334468999999998 999999999998887 89999
Q ss_pred EEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccccc
Q 002509 661 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 740 (914)
Q Consensus 661 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 740 (914)
||||+. +|.++++++ .+.+++..+..|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+|+...
T Consensus 89 fE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred HHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence 999976 899999755 67799999999999999999999999 99999999999999999999999999999775
Q ss_pred CCCCceeeccccCCcccCccccc-cCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCC-----
Q 002509 741 DGASHVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD----- 814 (914)
Q Consensus 741 ~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~----- 814 (914)
... ..+..+.|.+|+|||++. .+-|+.+.||||+|||++|+.+-++-|.+...-+..-.|.+......++.+
T Consensus 162 Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 162 SKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred cCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 433 334566899999999986 567899999999999999999999988776543323333332221111111
Q ss_pred cccccCCccCC-------ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 815 IQGIIDPSLLD-------EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 815 ~~~i~d~~l~~-------~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+...+.=++.. ..-.....+.++++.+|++-||.+|||++|.+++
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 11111111100 0111244578899999999999999999999986
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=338.45 Aligned_cols=246 Identities=26% Similarity=0.362 Sum_probs=203.7
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecC---CcccchhhhHHHHHHhhc-ccCceeEEEeeeeecCceEEEEEe
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEF 663 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~ 663 (914)
.|++.||+|+|++|++|+.+ .++++|||++.+. .....+-...|-++|.+| .||.|++|+-.|+++..+|+|+||
T Consensus 76 ~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~ 155 (604)
T KOG0592|consen 76 KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEY 155 (604)
T ss_pred chhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEe
Confidence 47789999999999999766 6899999998754 222344567888999999 899999999999999999999999
Q ss_pred ccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCC
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 743 (914)
Q Consensus 664 ~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 743 (914)
+++|+|.++|+. .+.+++.....++.+|+.||+|||++ |||||||||+|||||+||++||+|||.|+.+.+..
T Consensus 156 A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 156 APNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred cCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 999999999964 46788888899999999999999999 99999999999999999999999999998775432
Q ss_pred Cc----------ee--eccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhh
Q 002509 744 SH----------VS--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE 811 (914)
Q Consensus 744 ~~----------~~--~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~ 811 (914)
.. .+ ..++||..|.+||++.....+..+|+|+|||+||+|+.|++||...+.-...+.|..
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~------- 301 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA------- 301 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH-------
Confidence 11 11 447899999999999999999999999999999999999999976552222222221
Q ss_pred cCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 812 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 812 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+|-.+...++ +.+.+|+.+.+..||.+|++.+||.++
T Consensus 302 -------l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 302 -------LDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -------hcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhC
Confidence 1112222222 457788999999999999999999887
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=341.92 Aligned_cols=244 Identities=27% Similarity=0.440 Sum_probs=204.6
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCChH
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK 670 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~ 670 (914)
++||+|+.|.||.++.. +++.||||++.......++-+.+|+.+|+..+|+|||.++..+..+++.++|||||++|+|.
T Consensus 279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT 358 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT 358 (550)
T ss_pred hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence 57999999999999654 78999999998887777888999999999999999999999998889999999999999999
Q ss_pred HHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCceeecc
Q 002509 671 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 750 (914)
Q Consensus 671 ~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 750 (914)
|.+. ...+++.++..|+.++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+....... ...
T Consensus 359 DvVt-----~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR-~Tm 429 (550)
T KOG0578|consen 359 DVVT-----KTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR-STM 429 (550)
T ss_pred hhhh-----cccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc-ccc
Confidence 9984 34589999999999999999999999 99999999999999999999999999998776554433 445
Q ss_pred ccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccCHH
Q 002509 751 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQ 830 (914)
Q Consensus 751 ~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 830 (914)
.||+.|||||+.....|..|.||||||++++||+-|++||-.+.. .+.+.. ....|. .++-.+. .
T Consensus 430 VGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P---lrAlyL----Ia~ng~-P~lk~~~-------k 494 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP---LRALYL----IATNGT-PKLKNPE-------K 494 (550)
T ss_pred cCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh---HHHHHH----HhhcCC-CCcCCcc-------c
Confidence 699999999999999999999999999999999999999975432 111111 111121 1111111 1
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 831 SMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 831 ~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.-..+.++..+|++.|+++||+++|++++
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 12357788999999999999999999986
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=329.58 Aligned_cols=260 Identities=24% Similarity=0.359 Sum_probs=206.2
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCccc-chhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEec
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~-~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
.|++.+.||.|..++||+|+.. .++.||||++.-..... ...+.+|+..|+.++||||++++..|..+..+++||.||
T Consensus 27 ~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfM 106 (516)
T KOG0582|consen 27 DYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFM 106 (516)
T ss_pred ceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhh
Confidence 4567789999999999999765 68999999998665443 478899999999999999999999999999999999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 744 (914)
.+|++.+.+..... ..+++..+..|..++++||.|||.+ |.||||||+.||||+.+|.+||+|||.+..+.+...
T Consensus 107 a~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 107 AGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred cCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999977653 3489999999999999999999999 999999999999999999999999999865544321
Q ss_pred c--ee-eccccCCcccCcccccc--CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCccccc
Q 002509 745 H--VS-SIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 819 (914)
Q Consensus 745 ~--~~-~~~~gt~~Y~aPE~~~~--~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 819 (914)
. .. ....||+.|||||+++. ..|+.|+||||||+..+||.+|..||.....- +.+..-....+..-. ....
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm---kvLl~tLqn~pp~~~-t~~~ 257 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM---KVLLLTLQNDPPTLL-TSGL 257 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH---HHHHHHhcCCCCCcc-cccC
Confidence 1 11 44579999999999653 57999999999999999999999999765421 122221111111000 0011
Q ss_pred CCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 820 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 820 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
|. +.....-..+.+++-.|++.||++|||+++++++
T Consensus 258 ~~----d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 258 DK----DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred Ch----HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 11 1111222368889999999999999999999865
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=340.45 Aligned_cols=271 Identities=25% Similarity=0.384 Sum_probs=224.2
Q ss_pred cCHHHHHHHHHHHhccccccCcEEEEEEEECCCcEEEEEEEecCCccc-chhhhHHHHHHhhcccCceeEEEeeeeecCc
Q 002509 578 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGYCQEEGR 656 (914)
Q Consensus 578 ~~~~ei~~~~~~~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~-~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~ 656 (914)
-.+.|+.+....|.++||+|.||.|.......+..||||+++.....+ ..+|.+|+++|.+++|||||.++|.|..++.
T Consensus 530 ~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP 609 (807)
T KOG1094|consen 530 PALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP 609 (807)
T ss_pred cchhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc
Confidence 356677777778889999999999999999888999999999876554 4899999999999999999999999999999
Q ss_pred eEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccc
Q 002509 657 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 736 (914)
Q Consensus 657 ~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 736 (914)
.++|+|||++|+|.+++...... .+.-....+|+.|||.||+||.+. ++|||||.++|||++.++++||+|||++
T Consensus 610 icmI~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgms 684 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMS 684 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccc
Confidence 99999999999999999655322 244556678999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceee-ccccCCcccCccccccCCCCccCceeehHHHHHHHHh--CCCCcccccccccchhHHHHHHHhhhcC
Q 002509 737 KFAVDGASHVSS-IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS--GQEAISNEKFGANCRNIVQWAKLHIESG 813 (914)
Q Consensus 737 ~~~~~~~~~~~~-~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt--G~~p~~~~~~~~~~~~l~~~~~~~~~~~ 813 (914)
+.+..++.+... ..+-+.+|||+|.+.-++++.++|||+||+.+||+++ .+.|+.... .+++++-....+..+
T Consensus 685 R~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt----~e~vven~~~~~~~~ 760 (807)
T KOG1094|consen 685 RNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT----DEQVVENAGEFFRDQ 760 (807)
T ss_pred cccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh----HHHHHHhhhhhcCCC
Confidence 987776665543 3345789999999999999999999999999999876 677886544 244555444444433
Q ss_pred CcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 002509 814 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 863 (914)
Q Consensus 814 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 863 (914)
....+ ...+.-+..++.+++++|+..+.++||+++++...|++.
T Consensus 761 ~~~~~------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 761 GRQVV------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred Cccee------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 22211 122334556788999999999999999999999998864
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=333.30 Aligned_cols=246 Identities=22% Similarity=0.321 Sum_probs=197.7
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEEecCCccc---chhhhHHHHHHhhcccCceeEEEeeeee----cCceEEEEEec
Q 002509 592 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVLVYEFM 664 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~---~~~f~~E~~~l~~l~HpnIv~l~g~~~~----~~~~~LV~E~~ 664 (914)
..||+|++|.||+|.+ +|+.||||+++...... .+.|.+|+.+|.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 4699999999999998 58999999997653332 3567899999999999999999999877 34678999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 744 (914)
++|+|.+++.. .+.++|...+.++.|++.||+|||+.. +++||||||+|||+++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999964 346889999999999999999999742 67899999999999999999999999987653321
Q ss_pred ceeeccccCCcccCcccccc--CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCc
Q 002509 745 HVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 822 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 822 (914)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... ..+...+ ...+. . +.
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~----~~~~~~i---~~~~~-~----~~ 242 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT----KEIYDLI---INKNN-S----LK 242 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH----HHHHHHH---HhcCC-C----CC
Confidence 12347899999999976 6889999999999999999999999975432 1222211 11110 0 11
Q ss_pred cCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhH
Q 002509 823 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 864 (914)
Q Consensus 823 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 864 (914)
+ +......+.+++.+|++.+|++||+|+||++.|+...
T Consensus 243 ~----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 243 L----PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred C----CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1 1122345889999999999999999999999998764
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=336.96 Aligned_cols=263 Identities=25% Similarity=0.405 Sum_probs=201.2
Q ss_pred HHHHhccccccCcEEEEEEEECC-----------------CcEEEEEEEecCCc-ccchhhhHHHHHHhhcccCceeEEE
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLKD-----------------GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFL 648 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~~-----------------g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~ 648 (914)
.+.+.++||+|+||.||++.+++ +..||+|+++.... .....|.+|++++.+++||||++++
T Consensus 6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 85 (304)
T cd05096 6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLL 85 (304)
T ss_pred hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence 44566889999999999997642 34699999876432 2345789999999999999999999
Q ss_pred eeeeecCceEEEEEeccCCChHHHhhcccC---------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCCcccc
Q 002509 649 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLT---------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHR 713 (914)
Q Consensus 649 g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~---------------~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHr 713 (914)
+++...+..++||||+++|+|.+++..... ....++|..+++++.|++.||+|||+. +|+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~ 162 (304)
T cd05096 86 GVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHR 162 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccccc
Confidence 999999999999999999999999854311 123578889999999999999999998 99999
Q ss_pred CCCCCceEeCCCCcEEEeeccccccccCCCCc-eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh--CCCCc
Q 002509 714 DLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS--GQEAI 790 (914)
Q Consensus 714 Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt--G~~p~ 790 (914)
||||+|||++.++.+||+|||+++........ ......++..|+|||++..+.++.++|||||||++|||++ +..||
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence 99999999999999999999999765433221 1222345789999999988899999999999999999987 45666
Q ss_pred ccccccccchhHHHHHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002509 791 SNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862 (914)
Q Consensus 791 ~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 862 (914)
..... ..+...+............. ..+......+.+++.+|++.+|++||+|.||.+.|++
T Consensus 243 ~~~~~----~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 243 GELTD----EQVIENAGEFFRDQGRQVYL------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CcCCH----HHHHHHHHHHhhhccccccc------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 54332 22333322222211100000 0011223468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=307.34 Aligned_cols=262 Identities=22% Similarity=0.286 Sum_probs=202.5
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcc--cchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEe
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 663 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~ 663 (914)
+|.-.++||+|.||.||+|+.. +|+.||||.++..... -.....+|++.|+.++|+||+.+++++...+...||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 3455678999999999999765 7999999999765332 356788999999999999999999999999999999999
Q ss_pred ccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCC
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 743 (914)
Q Consensus 664 ~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 743 (914)
|+. +|+..++.. ...++-.++..++.++++||+|||.+ .|+||||||.|+|++.+|.+||+|||+|+.+....
T Consensus 83 m~t-dLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 83 MPT-DLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ccc-cHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 987 899888643 55688889999999999999999999 99999999999999999999999999999886554
Q ss_pred CceeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHH--hhhcCCcc---c
Q 002509 744 SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL--HIESGDIQ---G 817 (914)
Q Consensus 744 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~--~~~~~~~~---~ 817 (914)
..... .+-|.+|+|||.+.+ ++|+...||||.|||+.||+-|.+-|.+.+.- +++....+. ...+..+. .
T Consensus 156 ~~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi---dQL~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 156 RIQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI---DQLSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred ccccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH---HHHHHHHHHcCCCCcccCccccc
Confidence 33322 256999999999986 57999999999999999999998777654421 222221111 11111111 1
Q ss_pred ccCC---c-----cCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 818 IIDP---S-----LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 818 i~d~---~-----l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+-|- . .....-..+....+++...++..||.+|.+++|++++
T Consensus 232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1110 0 0000111223356899999999999999999999875
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=331.75 Aligned_cols=256 Identities=22% Similarity=0.344 Sum_probs=203.0
Q ss_pred HHHHHHhccccccCcEEEEEEEEC----CCcEEEEEEEecCCc-ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEE
Q 002509 585 DATKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 659 (914)
Q Consensus 585 ~~~~~~~~~lG~G~~G~Vy~~~~~----~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~L 659 (914)
...+.+.+.||+|+||.||+|.++ .+..||+|+++.... .....|.+|+..+.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 345567789999999999999764 356899999876532 234578899999999999999999999999999999
Q ss_pred EEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccc
Q 002509 660 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 739 (914)
Q Consensus 660 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 739 (914)
||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +++||||||+|||++.++.+|++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999998643 34689999999999999999999998 9999999999999999999999999987653
Q ss_pred cCCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccc
Q 002509 740 VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 818 (914)
Q Consensus 740 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i 818 (914)
............++..|+|||.+.+..++.++|||||||++||+++ |+.||..... ..+.+.. ..+...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~----~~~~~~~----~~~~~~-- 227 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG----QDVIKAV----EDGFRL-- 227 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH----HHHHHHH----HCCCCC--
Confidence 2222111122335678999999999999999999999999999875 9999965432 1222221 111110
Q ss_pred cCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 002509 819 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 863 (914)
Q Consensus 819 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 863 (914)
.. +......+.+++.+|++.+|++||+++|+.+.|+.+
T Consensus 228 ---~~----~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 ---PA----PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---CC----CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 01 112234588899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=335.93 Aligned_cols=239 Identities=30% Similarity=0.464 Sum_probs=198.6
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCChHH
Q 002509 592 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKE 671 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~ 671 (914)
+-||+|+.|.||.|+++ ++.||||+++... +.+++-|++|+|+||+.+.|+|.....+|||||||..|-|.+
T Consensus 130 eWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 46999999999999998 7999999875322 357888999999999999999999999999999999999999
Q ss_pred HhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCceeeccc
Q 002509 672 HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 751 (914)
Q Consensus 672 ~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 751 (914)
.|+. ++.+.-.....+..+||.|+.|||.+ .|||||||+-||||+.+..+||+|||-++...+. .....++
T Consensus 202 VLka----~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFa 272 (904)
T KOG4721|consen 202 VLKA----GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFA 272 (904)
T ss_pred HHhc----cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhh
Confidence 9963 45566677788999999999999999 9999999999999999999999999999876543 2334478
Q ss_pred cCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccCHHH
Q 002509 752 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQS 831 (914)
Q Consensus 752 gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 831 (914)
||..|||||++...+.++|.||||||||||||+||..|+.+-... .| =|- +. .-.|.-..+..+
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AI-IwG---VG--------sNsL~LpvPstc 336 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AI-IWG---VG--------SNSLHLPVPSTC 336 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----ee-EEe---cc--------CCcccccCcccC
Confidence 999999999999999999999999999999999999998542210 00 010 00 111222234455
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 002509 832 MWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 863 (914)
Q Consensus 832 ~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 863 (914)
...+.-|+..||+..|..||++++++.+|+.+
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 66788899999999999999999999999754
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=345.99 Aligned_cols=259 Identities=25% Similarity=0.404 Sum_probs=202.4
Q ss_pred HHHHHhccccccCcEEEEEEEE------CCCcEEEEEEEecCC-cccchhhhHHHHHHhhc-ccCceeEEEeeeeecCce
Q 002509 586 ATKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRS 657 (914)
Q Consensus 586 ~~~~~~~~lG~G~~G~Vy~~~~------~~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~ 657 (914)
..+.+.+.||+|+||.||+|++ .++..||||+++... ....+.+.+|++++..+ +||||++++++|...+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 3456778999999999999964 246689999987543 23345688999999999 899999999999999999
Q ss_pred EEEEEeccCCChHHHhhcccC-----------------------------------------------------------
Q 002509 658 VLVYEFMHNGTLKEHLYGTLT----------------------------------------------------------- 678 (914)
Q Consensus 658 ~LV~E~~~~gsL~~~L~~~~~----------------------------------------------------------- 678 (914)
++||||+++|+|.++++....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 999999999999999864311
Q ss_pred ------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 679 ------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 679 ------------~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
....++|..++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 112578899999999999999999998 99999999999999999999999999997654332211
Q ss_pred -eeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCCccC
Q 002509 747 -SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824 (914)
Q Consensus 747 -~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 824 (914)
.....++..|+|||.+.+..++.++|||||||++|||++ |..||...... ..+.++... +... ..+.
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~---~~~~~~~~~----~~~~--~~~~-- 340 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD---SKFYKMIKE----GYRM--LSPE-- 340 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch---HHHHHHHHh----CccC--CCCC--
Confidence 112335678999999999999999999999999999998 88888654321 122232221 1100 0011
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 002509 825 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 863 (914)
Q Consensus 825 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 863 (914)
....++.+++.+|++.+|++||+|.||++.|++.
T Consensus 341 -----~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 341 -----CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred -----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1123578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=329.36 Aligned_cols=249 Identities=26% Similarity=0.368 Sum_probs=198.2
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc---ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
..+.||+|+||.||++... +|+.||+|.+..... .....+.+|++++.+++|+||+++.+++.+.+..++||||++
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05631 4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecC
Confidence 4578999999999999875 789999999875422 223467889999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+|+|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++.......
T Consensus 84 ~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05631 84 GGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-- 156 (285)
T ss_pred CCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence 99999888543 234588999999999999999999998 99999999999999999999999999997653322
Q ss_pred eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCC
Q 002509 746 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 825 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 825 (914)
......||..|+|||++.+..++.++|||||||++|||++|+.||...........+... ......
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~----~~~~~~---------- 222 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR----VKEDQE---------- 222 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH----hhcccc----------
Confidence 123346899999999999999999999999999999999999999754422111111111 111100
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 002509 826 EYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 859 (914)
Q Consensus 826 ~~~~~~~~~l~~l~~~C~~~~P~~RPs-----m~eVl~~ 859 (914)
.+.......+.+++.+|++.+|++||+ ++|++++
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 011112235788999999999999997 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=325.41 Aligned_cols=255 Identities=25% Similarity=0.431 Sum_probs=205.6
Q ss_pred HHHHHHhccccccCcEEEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEec
Q 002509 585 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 585 ~~~~~~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
...+.+.+.||+|++|.||+|..++++.||+|.++... ...+++.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 34556678999999999999998888899999987543 33567899999999999999999999999999999999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 744 (914)
++++|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 84 KYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 9999999986542 45689999999999999999999998 999999999999999999999999999987653322
Q ss_pred ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCCcc
Q 002509 745 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 823 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 823 (914)
........+..|+|||++.+..++.++||||||++++||++ |+.||..... ..+.... ......
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~----~~~~~~------- 223 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN----AEVLQQV----DQGYRM------- 223 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHH----HcCCCC-------
Confidence 22222223468999999998899999999999999999999 9999865331 1122111 111000
Q ss_pred CCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002509 824 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862 (914)
Q Consensus 824 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 862 (914)
..+......+.+++.+|++.+|++||+|+++++.|++
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 --PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred --CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0111123468899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=335.79 Aligned_cols=247 Identities=26% Similarity=0.451 Sum_probs=201.2
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecC----Cc-ccchhhhHHHHHHhhcc-cCceeEEEeeeeecCceEE
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN----SY-QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVL 659 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~----~~-~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~L 659 (914)
.+.+.+.||+|.||.|+.|+.. ++..||+|++... .. ...+.+.+|+.++++++ ||||++++.++......++
T Consensus 18 ~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~i 97 (370)
T KOG0583|consen 18 KYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYI 97 (370)
T ss_pred ceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEE
Confidence 4556789999999999999765 7899999977653 11 23455668999999998 9999999999999999999
Q ss_pred EEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCC-CcEEEeecccccc
Q 002509 660 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKF 738 (914)
Q Consensus 660 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~ 738 (914)
||||+.+|+|.+++.. ..++.+.+...++.|++.|++|+|++ +|+||||||+|||++.+ +++||+|||++..
T Consensus 98 vmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 98 VMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred EEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 9999999999999953 45678889999999999999999999 99999999999999999 9999999999987
Q ss_pred ccCCCCceeeccccCCcccCccccccCC-CC-ccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcc
Q 002509 739 AVDGASHVSSIVRGTVGYLDPEYYISQQ-LT-DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 816 (914)
Q Consensus 739 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s-~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 816 (914)
.. .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+...... +.. .+..++..
T Consensus 171 ~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~----l~~----ki~~~~~~ 241 (370)
T KOG0583|consen 171 SP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN----LYR----KIRKGEFK 241 (370)
T ss_pred cC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH----HHH----HHhcCCcc
Confidence 64 3334456678999999999999877 76 67999999999999999999998643221 111 12222110
Q ss_pred cccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002509 817 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 858 (914)
Q Consensus 817 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 858 (914)
+ |.. .. -.++..++.+|+..+|.+|+++.||++
T Consensus 242 --~-p~~---~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 242 --I-PSY---LL---SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred --C-CCC---cC---CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 0 111 10 235788999999999999999999993
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=322.43 Aligned_cols=248 Identities=30% Similarity=0.515 Sum_probs=200.7
Q ss_pred HHhccccccCcEEEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCC
Q 002509 589 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 668 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gs 668 (914)
.+.+.||+|+||.||+++++++..+|+|.+.... .....+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~ 85 (256)
T cd05114 7 TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGC 85 (256)
T ss_pred EEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCc
Confidence 3557899999999999999888899999876432 335678899999999999999999999999999999999999999
Q ss_pred hHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCceee
Q 002509 669 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 748 (914)
Q Consensus 669 L~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 748 (914)
|.++++.. ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++...........
T Consensus 86 L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 86 LLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred HHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence 99998643 23588999999999999999999998 9999999999999999999999999998765433222222
Q ss_pred ccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCcc
Q 002509 749 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 827 (914)
Q Consensus 749 ~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 827 (914)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+...... +.. ...+..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~----~~~~~~i~~----~~~--~~~~~~---- 225 (256)
T cd05114 160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN----YEVVEMISR----GFR--LYRPKL---- 225 (256)
T ss_pred CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHC----CCC--CCCCCC----
Confidence 2335678999999988889999999999999999999 8999865432 222222211 110 111111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002509 828 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 860 (914)
Q Consensus 828 ~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L 860 (914)
....+.+++.+|++.+|++||+|+|+++.|
T Consensus 226 ---~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 226 ---ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ---CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 123588999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=322.91 Aligned_cols=252 Identities=24% Similarity=0.440 Sum_probs=203.7
Q ss_pred HHHhccccccCcEEEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCC
Q 002509 588 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 667 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 667 (914)
+.+.++||+|++|.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+..+++|||+++|
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (261)
T cd05072 8 IKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKG 86 (261)
T ss_pred eEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCC
Confidence 44567899999999999998888999999876533 23567889999999999999999999999999999999999999
Q ss_pred ChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCcee
Q 002509 668 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 747 (914)
Q Consensus 668 sL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 747 (914)
+|.++++.. ....+++.+++.++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++..........
T Consensus 87 ~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 87 SLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred cHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 999998653 244678889999999999999999998 999999999999999999999999999976544322222
Q ss_pred eccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCc
Q 002509 748 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826 (914)
Q Consensus 748 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 826 (914)
....++..|+|||++....++.++|||||||++|||++ |+.||..... ..+..... .+... +. ...
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~----~~~~~~~~----~~~~~----~~-~~~ 228 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN----SDVMSALQ----RGYRM----PR-MEN 228 (261)
T ss_pred CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH----HHHHHHHH----cCCCC----CC-CCC
Confidence 23345678999999988889999999999999999998 9999864321 12222221 11100 00 111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002509 827 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862 (914)
Q Consensus 827 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 862 (914)
...++.+++.+|++.+|++||+++++.+.|++
T Consensus 229 ----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 229 ----CPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ----CCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 12357889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=340.93 Aligned_cols=261 Identities=25% Similarity=0.420 Sum_probs=202.5
Q ss_pred HHHHHHhccccccCcEEEEEEEEC------CCcEEEEEEEecCCc-ccchhhhHHHHHHhhc-ccCceeEEEeeeeecCc
Q 002509 585 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGR 656 (914)
Q Consensus 585 ~~~~~~~~~lG~G~~G~Vy~~~~~------~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~ 656 (914)
...+.+.+.||+|+||.||+++.. +++.||||+++.... .....+.+|+++++.+ +|+||++++++|...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 334557789999999999998742 345799999975432 2345688999999999 89999999999999999
Q ss_pred eEEEEEeccCCChHHHhhcccC----------------------------------------------------------
Q 002509 657 SVLVYEFMHNGTLKEHLYGTLT---------------------------------------------------------- 678 (914)
Q Consensus 657 ~~LV~E~~~~gsL~~~L~~~~~---------------------------------------------------------- 678 (914)
.++||||+++|+|.++++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999999854210
Q ss_pred --------ccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce-eec
Q 002509 679 --------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SSI 749 (914)
Q Consensus 679 --------~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~ 749 (914)
....+++.++++++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++......... ...
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 113478889999999999999999998 99999999999999999999999999997654332211 122
Q ss_pred cccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccC
Q 002509 750 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 828 (914)
Q Consensus 750 ~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 828 (914)
..++..|+|||++....++.++|||||||++|||++ |+.||....... .+.... ..+ . ....+. .
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---~~~~~~----~~~-~-~~~~~~---~-- 339 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---KFYKMV----KRG-Y-QMSRPD---F-- 339 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH---HHHHHH----Hcc-c-CccCCC---C--
Confidence 235678999999998899999999999999999997 999986543211 111111 111 0 000111 1
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhH
Q 002509 829 IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 864 (914)
Q Consensus 829 ~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 864 (914)
...++.+++.+|++.+|++||++.||++.|++++
T Consensus 340 --~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 340 --APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred --CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1235788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=327.62 Aligned_cols=248 Identities=34% Similarity=0.545 Sum_probs=192.8
Q ss_pred hccccccCcEEEEEEEEC-----CCcEEEEEEEecCCc-ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEec
Q 002509 591 EKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 591 ~~~lG~G~~G~Vy~~~~~-----~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
.+.||.|.||.||+|.+. .+..|+||+++.... .....|.+|++.+++++||||++++|+|...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 468999999999999887 367799999965432 33678999999999999999999999999888899999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 744 (914)
++|+|.++|+.. ....+++..++.|+.|+++||+|||++ +++|+||+++|||+++++.+||+|||+++.......
T Consensus 84 ~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 84 PGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 999999999754 245689999999999999999999998 999999999999999999999999999976632222
Q ss_pred -ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCCc
Q 002509 745 -HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 822 (914)
Q Consensus 745 -~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 822 (914)
...........|+|||.+....++.++||||||+++|||++ |+.|+..... ..+...+ .++.....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~----~~~~~~~----~~~~~~~~---- 226 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN----EEIIEKL----KQGQRLPI---- 226 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH----HHHHHHH----HTTEETTS----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc----ccccccc----ccccccee----
Confidence 22233446789999999999999999999999999999999 6788754321 2222222 21111110
Q ss_pred cCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002509 823 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 860 (914)
Q Consensus 823 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L 860 (914)
+......+.+++.+|++.+|++||+|+|+++.|
T Consensus 227 -----~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 -----PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -----BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -----ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111223577899999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=324.56 Aligned_cols=253 Identities=29% Similarity=0.444 Sum_probs=202.9
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
..+.+.||+|++|.||+|..+ .++.||+|++.... ....++.+|++++++++|+||+++++++..++..++||||+++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (263)
T cd05052 8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 86 (263)
T ss_pred eEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCC
Confidence 345678999999999999876 58899999987542 3356788999999999999999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
++|.+++... ....+++..++.++.|+++||+|||++ +++||||||+||++++++.+||+|||++..........
T Consensus 87 ~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 87 GNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 9999998643 234689999999999999999999998 99999999999999999999999999987654432222
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCC
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 825 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 825 (914)
.....++..|+|||.+.+..++.++|||||||++|||++ |..|+...... .+.+.. ..+ ..+....
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~----~~~~~~----~~~-----~~~~~~~ 228 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYELL----EKG-----YRMERPE 228 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHH----HCC-----CCCCCCC
Confidence 222234678999999998899999999999999999998 89998643321 111111 111 0011111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 002509 826 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 863 (914)
Q Consensus 826 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 863 (914)
.....+.+++.+|++.+|++||+|.|+++.|+.+
T Consensus 229 ----~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 229 ----GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ----CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1224588899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=331.09 Aligned_cols=245 Identities=27% Similarity=0.370 Sum_probs=205.9
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEec
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
|.+-+.||+|+||.||||+.+ +.+.||+|.+.+.. .+..+.+.+|++++++++|||||.++++++...+.++|.||+
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a 83 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA 83 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence 344568999999999999877 68889999986543 233456889999999999999999999999999999999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 744 (914)
.+ +|..+|. ....+++..+..|+.++..||.|||++ +|+|||+||+|||++..+.+|++|||+|+.+... .
T Consensus 84 ~g-~L~~il~----~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t 154 (808)
T KOG0597|consen 84 VG-DLFTILE----QDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-T 154 (808)
T ss_pred hh-hHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC-c
Confidence 88 9999984 456799999999999999999999999 9999999999999999999999999999977553 4
Q ss_pred ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccC
Q 002509 745 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 824 (914)
...+...||+-|||||+..+.+|+..+|+||+||++||+++|++||... .+.+.++....+.- .
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-------si~~Lv~~I~~d~v--------~- 218 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-------SITQLVKSILKDPV--------K- 218 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-------HHHHHHHHHhcCCC--------C-
Confidence 4556678999999999999999999999999999999999999999643 34444443333221 1
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 825 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 825 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
++...-..+..+....+..||.+|-+-.+++.+
T Consensus 219 --~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 219 --PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred --CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 111233457788888999999999999999865
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=318.71 Aligned_cols=255 Identities=27% Similarity=0.376 Sum_probs=198.2
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecC-----ceEEEEEecc
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-----RSVLVYEFMH 665 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~-----~~~LV~E~~~ 665 (914)
+++|.|+||.||+|.+. +++.||||..-.+ .+--..|+++|++++|||||+++-++.... ...+|||||+
T Consensus 30 ~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d----~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP 105 (364)
T KOG0658|consen 30 RLIGSGSFGVVYQAKLRETEEEVAIKKVLQD----KRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP 105 (364)
T ss_pred EEEeecccceEEEEEEcCCCceeEEEEecCC----CCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch
Confidence 68999999999999877 5799999987543 223357899999999999999999886543 2358999998
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCC-CcEEEeeccccccccCCCC
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~~~~ 744 (914)
. +|.+.++.....+++++...+.-+..|+.+||+|||+. +|+||||||+|+|+|.+ |.+||+|||.|+....+..
T Consensus 106 ~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep 181 (364)
T KOG0658|consen 106 E-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP 181 (364)
T ss_pred H-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence 7 89999976555567788888889999999999999997 99999999999999987 8999999999999887766
Q ss_pred ceeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHh--hhcC-------C
Q 002509 745 HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH--IESG-------D 814 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~--~~~~-------~ 814 (914)
..+.. -|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+++.. .+++..++-. .... .
T Consensus 182 niSYi--cSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~---dQL~eIik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 182 NISYI--CSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV---DQLVEIIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred ceeEE--EeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH---HHHHHHHHHhCCCCHHHHhhcCcc
Confidence 65544 3889999999986 57999999999999999999999999775432 2333332211 0000 0
Q ss_pred cccccCCccCCc-----cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 815 IQGIIDPSLLDE-----YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 815 ~~~i~d~~l~~~-----~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
..+.-.|.+... .......+.++++.++++.+|.+|.++.|++++
T Consensus 257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 111111222111 112334468899999999999999999999875
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=331.85 Aligned_cols=242 Identities=23% Similarity=0.312 Sum_probs=195.6
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCC
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 667 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 667 (914)
+.||+|+||.||+++.+ +|+.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999875 78999999997542 222346778999999999999999999999999999999999999
Q ss_pred ChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCcee
Q 002509 668 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 747 (914)
Q Consensus 668 sL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 747 (914)
+|.+++.. ...+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~ 152 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccc
Confidence 99998853 34678999999999999999999998 99999999999999999999999999987532221 122
Q ss_pred eccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCcc
Q 002509 748 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 827 (914)
Q Consensus 748 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 827 (914)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ..+.... ..+. ..+...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~----~~~~~~~----~~~~------~~~p~~- 217 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKLFELI----LMEE------IRFPRT- 217 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH----HHHHHHH----HcCC------CCCCCC-
Confidence 345699999999999999999999999999999999999999965332 1122211 1111 111111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002509 828 DIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 859 (914)
Q Consensus 828 ~~~~~~~l~~l~~~C~~~~P~~RP-----sm~eVl~~ 859 (914)
...++.+++.+|++.||++|| ++.|++++
T Consensus 218 ---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 218 ---LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred ---CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 123577899999999999999 79999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=334.07 Aligned_cols=250 Identities=23% Similarity=0.315 Sum_probs=200.4
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEec
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
.+.+.||+|+||.||+|+.. +++.||+|+++... ......+..|++++.+++||||+++++++...+..++||||+
T Consensus 4 ~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (333)
T cd05600 4 QILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYV 83 (333)
T ss_pred EEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCC
Confidence 34578999999999999887 58999999997542 223456888999999999999999999999999999999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 744 (914)
++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 84 PGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 99999999853 34578889999999999999999998 999999999999999999999999999876533
Q ss_pred ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccC
Q 002509 745 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 824 (914)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+..|.... . .....++.
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~---~~~~~~~~-- 226 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL-Q---RPVYDDPR-- 226 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccc-c---CCCCCccc--
Confidence 2233468999999999999899999999999999999999999997654322222222221100 0 00000100
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 825 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 825 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.....++.+++.+|+..+|++||+++|++++
T Consensus 227 ----~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 227 ----FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ----cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1122357788899999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=321.38 Aligned_cols=253 Identities=27% Similarity=0.442 Sum_probs=208.0
Q ss_pred HHHHhccccccCcEEEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
.+.+.++||+|+||.||+|...+++.+|+|++..........+..|+++++.++|+||+++++++......++||||+++
T Consensus 7 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (261)
T cd05148 7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEK 86 (261)
T ss_pred HHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeeccc
Confidence 45667899999999999999988999999999876655567789999999999999999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
|+|.+++... ....+++.+++.++.|+++||+|||+. +++||||||+||++++++.+||+|||++.........
T Consensus 87 ~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~- 160 (261)
T cd05148 87 GSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL- 160 (261)
T ss_pred CCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcccc-
Confidence 9999999654 245689999999999999999999998 9999999999999999999999999999765432211
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCC
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 825 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 825 (914)
.....++..|+|||.+....++.++||||||++++||++ |+.||..... ..+.+...... . +
T Consensus 161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~----~~~~~~~~~~~---~------~---- 223 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN----HEVYDQITAGY---R------M---- 223 (261)
T ss_pred ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH----HHHHHHHHhCC---c------C----
Confidence 123345778999999988889999999999999999998 8999865431 12222221110 0 0
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002509 826 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862 (914)
Q Consensus 826 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 862 (914)
..+......+.+++.+|++.+|++||+++++++.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 0111223457899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=327.26 Aligned_cols=265 Identities=21% Similarity=0.239 Sum_probs=199.4
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEec
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
+.+.+.||+|+||.||+++.+ +++.||||+++... ....+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 345678999999999999987 67889999987542 223456789999999999999999999999999999999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 744 (914)
+++.+..... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 83 EKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred CCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 9987765442 134588889999999999999999998 999999999999999999999999999987644333
Q ss_pred ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHH--------HHhhhcCCcc
Q 002509 745 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA--------KLHIESGDIQ 816 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~--------~~~~~~~~~~ 816 (914)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||......+....+.... ..........
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 23334568999999999998889999999999999999999999997543211111111110 0000011111
Q ss_pred cccCCccCCcc------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 817 GIIDPSLLDEY------DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 817 ~i~d~~l~~~~------~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
....+...... .......+.+++.+|++.+|++||+++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 11111110000 00122358899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=319.38 Aligned_cols=253 Identities=26% Similarity=0.459 Sum_probs=202.7
Q ss_pred HHHhccccccCcEEEEEEEECC----CcEEEEEEEecCCc-ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEE
Q 002509 588 KMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 662 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~~----g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 662 (914)
+.+.+.||+|+||.||+|+++. ...||||.++.... .....|.+|+.++++++||||+++++++...+..++|||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 85 (266)
T cd05033 6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE 85 (266)
T ss_pred ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEE
Confidence 4466899999999999998752 45799999875432 334678899999999999999999999999999999999
Q ss_pred eccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCC
Q 002509 663 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 742 (914)
Q Consensus 663 ~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 742 (914)
|+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 86 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 86 YMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred cCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999998643 23689999999999999999999998 9999999999999999999999999999876422
Q ss_pred CCc-eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccC
Q 002509 743 ASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 820 (914)
Q Consensus 743 ~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 820 (914)
... ......++..|+|||.+.+..++.++||||||++++||++ |..||..... ..+.+... .+...
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~----~~~~~~~~----~~~~~---- 227 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN----QDVIKAVE----DGYRL---- 227 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH----HHHHHHHH----cCCCC----
Confidence 221 2222335678999999998899999999999999999998 9999864331 12222221 11000
Q ss_pred CccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 002509 821 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 863 (914)
Q Consensus 821 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 863 (914)
+ .+......+.+++.+|++.+|++||+++||+++|+++
T Consensus 228 ~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 P-----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred C-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 0111234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=322.59 Aligned_cols=257 Identities=26% Similarity=0.472 Sum_probs=205.6
Q ss_pred HHHHHHhccccccCcEEEEEEEECC------CcEEEEEEEecCCcc-cchhhhHHHHHHhhcccCceeEEEeeeeecCce
Q 002509 585 DATKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 657 (914)
Q Consensus 585 ~~~~~~~~~lG~G~~G~Vy~~~~~~------g~~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 657 (914)
...+.+.+.||+|+||.||+|+..+ ++.||||.++..... ..+.+.+|++++++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3456677899999999999998643 478999998765433 456899999999999999999999999999999
Q ss_pred EEEEEeccCCChHHHhhccc----------CccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCc
Q 002509 658 VLVYEFMHNGTLKEHLYGTL----------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR 727 (914)
Q Consensus 658 ~LV~E~~~~gsL~~~L~~~~----------~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~ 727 (914)
++||||+++|+|.+++.... .....+++..+..++.|++.||+|||++ +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 99999999999999996532 2235588999999999999999999998 9999999999999999999
Q ss_pred EEEeeccccccccCCCCc-eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHH
Q 002509 728 AKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQW 805 (914)
Q Consensus 728 ~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~ 805 (914)
+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+.+.
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~----~~~~~~ 236 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN----EEVIEC 236 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHH
Confidence 999999998754332211 1222335788999999999999999999999999999998 9999864332 122222
Q ss_pred HHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002509 806 AKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861 (914)
Q Consensus 806 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 861 (914)
.. .+..... +......+.+++.+|++.+|++||++.||++.|+
T Consensus 237 ~~----~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 237 IT----QGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HH----cCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 21 1211110 1112245889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=322.01 Aligned_cols=259 Identities=28% Similarity=0.432 Sum_probs=196.8
Q ss_pred HhccccccCcEEEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhh--cccCceeEEEeeeeecC----ceEEEEEe
Q 002509 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSR--IHHRNLVQFLGYCQEEG----RSVLVYEF 663 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~--l~HpnIv~l~g~~~~~~----~~~LV~E~ 663 (914)
+.+.||+|.||.||||+++ ++.||||++.. ..++.|.+|-++.+. ++|+||++++++-.... +++||+||
T Consensus 214 l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 4468999999999999997 59999999864 446778888877665 58999999999876655 88999999
Q ss_pred ccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCC------CCCccccCCCCCceEeCCCCcEEEeeccccc
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC------VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 737 (914)
Q Consensus 664 ~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~------~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 737 (914)
.++|+|.++|. ...++|....+|+.-+++||+|||+.. .|+|+|||||++||||..|+++.|+|||+|.
T Consensus 290 h~kGsL~dyL~-----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 290 HPKGSLCDYLK-----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred ccCCcHHHHHH-----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 99999999995 456899999999999999999999743 4799999999999999999999999999998
Q ss_pred cccCCCCce-eeccccCCcccCccccccCC-CC-----ccCceeehHHHHHHHHhCCCCcccccccc-------------
Q 002509 738 FAVDGASHV-SSIVRGTVGYLDPEYYISQQ-LT-----DKSDVYSFGVILLELISGQEAISNEKFGA------------- 797 (914)
Q Consensus 738 ~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~-~s-----~ksDV~S~Gvvl~ElltG~~p~~~~~~~~------------- 797 (914)
.+..+.... ....+||.+|||||++.+.- +. .+.||||+|.|||||++....+.....++
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 776544322 23367999999999997632 22 36799999999999999876543111100
Q ss_pred cchhHHHHHHHhhhcCCcccccCCccCCcc-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHh
Q 002509 798 NCRNIVQWAKLHIESGDIQGIIDPSLLDEY-DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 798 ~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~-~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 865 (914)
....+...+ ++++ ..|.+.... .-..+..+.+.+..||..||+.|-|+.=|.+.+.++..
T Consensus 445 t~e~mq~~V---V~kK-----~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 445 TLEEMQELV---VRKK-----QRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred CHHHHHHHH---Hhhc-----cCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 011111111 1111 111111110 01334567789999999999999999999998887654
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=323.74 Aligned_cols=254 Identities=28% Similarity=0.478 Sum_probs=202.5
Q ss_pred HHhccccccCcEEEEEEEECC------CcEEEEEEEecCCc-ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEE
Q 002509 589 MLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 661 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~~------g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 661 (914)
.+.+.||+|+||.||+|.... ...||+|.++.... .....|.+|++++.+++||||+++++++...+..+++|
T Consensus 8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 87 (283)
T cd05048 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLF 87 (283)
T ss_pred chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEE
Confidence 456789999999999998653 25799999875432 23456889999999999999999999999999999999
Q ss_pred EeccCCChHHHhhcccC------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEE
Q 002509 662 EFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAK 729 (914)
Q Consensus 662 E~~~~gsL~~~L~~~~~------------~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 729 (914)
||+++|+|.+++..... ....+++...+.++.|++.||+|||+. +++||||||+||++++++.+|
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 164 (283)
T cd05048 88 EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVK 164 (283)
T ss_pred ecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcEE
Confidence 99999999999964321 114688899999999999999999998 999999999999999999999
Q ss_pred EeeccccccccCCCC-ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHH
Q 002509 730 VSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAK 807 (914)
Q Consensus 730 l~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~ 807 (914)
|+|||+++....... .......+++.|+|||.+....++.++|||||||++|||++ |..||..... ..+.+.+.
T Consensus 165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~----~~~~~~i~ 240 (283)
T cd05048 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN----QEVIEMIR 240 (283)
T ss_pred ECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHH
Confidence 999999976533322 12223346788999999988899999999999999999998 9999865432 22333221
Q ss_pred HhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002509 808 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862 (914)
Q Consensus 808 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 862 (914)
.+.... .+.....++.+++.+|++.+|.+||+++||+++|+.
T Consensus 241 ----~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 241 ----SRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ----cCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111111 111233568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=327.84 Aligned_cols=264 Identities=25% Similarity=0.397 Sum_probs=218.0
Q ss_pred HHHHHHHHhccccccCcEEEEEEEECC---Cc--EEEEEEEecC-CcccchhhhHHHHHHhhcccCceeEEEeeeeecCc
Q 002509 583 IEDATKMLEKKIGSGGFGVVYYGKLKD---GK--EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR 656 (914)
Q Consensus 583 i~~~~~~~~~~lG~G~~G~Vy~~~~~~---g~--~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~ 656 (914)
+.++...+.++||+|-||.||+|.+.+ |+ .||||..+.+ .....+.|..|.-+|+.++|||||+++|.|.+. .
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-P 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-c
Confidence 334444556899999999999997642 33 4788988775 445577899999999999999999999999864 5
Q ss_pred eEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccc
Q 002509 657 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 736 (914)
Q Consensus 657 ~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 736 (914)
.++|||.++-|.|.++|... ...|+......++.||+.||+|||+. ++|||||..+|||+.....+||+|||++
T Consensus 465 ~WivmEL~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred eeEEEecccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchh
Confidence 78999999999999999654 56788889999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCc
Q 002509 737 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDI 815 (914)
Q Consensus 737 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 815 (914)
+...+...+..+...-+..|||||.+.-++++.++|||.|||.+||++. |..||.+....+... .++.|+
T Consensus 539 R~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~--------~iEnGe- 609 (974)
T KOG4257|consen 539 RYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG--------HIENGE- 609 (974)
T ss_pred hhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE--------EecCCC-
Confidence 9988877666665556789999999999999999999999999999987 999997654332211 122221
Q ss_pred ccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHhHhhHH
Q 002509 816 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREA 870 (914)
Q Consensus 816 ~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~~~~~ 870 (914)
+...+..+...+..+.-+||+.+|.+||.+.|+...|+++++.++..
T Consensus 610 --------RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~ 656 (974)
T KOG4257|consen 610 --------RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKIN 656 (974)
T ss_pred --------CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhh
Confidence 12234455667889999999999999999999999999998765443
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=324.88 Aligned_cols=240 Identities=24% Similarity=0.330 Sum_probs=192.5
Q ss_pred ccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCCh
Q 002509 594 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 669 (914)
Q Consensus 594 lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 669 (914)
||+|+||.||+++.. +++.||+|+++... ......+..|++++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999876 58899999987532 23345678899999999999999999999999999999999999999
Q ss_pred HHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCceeec
Q 002509 670 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 749 (914)
Q Consensus 670 ~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 749 (914)
.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 999853 34588999999999999999999998 99999999999999999999999999987543222 22334
Q ss_pred cccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccCH
Q 002509 750 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 829 (914)
Q Consensus 750 ~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 829 (914)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||...... +....... +.. .+...
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~-------~~~~~~~~-~~~------~~~~~--- 215 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-------EMYRKILQ-EPL------RFPDG--- 215 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH-------HHHHHHHc-CCC------CCCCc---
Confidence 56899999999999999999999999999999999999999754321 11111111 110 11111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 002509 830 QSMWKIEEKALMCVLPHGHMRPS---ISEVLKD 859 (914)
Q Consensus 830 ~~~~~l~~l~~~C~~~~P~~RPs---m~eVl~~ 859 (914)
....+.+++.+|++.+|++||+ +.|++++
T Consensus 216 -~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 216 -FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred -CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 1235778899999999999985 5666554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=329.69 Aligned_cols=255 Identities=24% Similarity=0.395 Sum_probs=200.1
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCc----EEEEEEEecCC-cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEE
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 660 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~----~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV 660 (914)
.+...+.||+|+||.||+|++. +++ .||+|+++... ....+.+.+|+.+++.++||||++++|+|... ...+|
T Consensus 8 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v 86 (316)
T cd05108 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 86 (316)
T ss_pred hceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceee
Confidence 3455678999999999999865 333 38999987543 23456788999999999999999999999865 56799
Q ss_pred EEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccccc
Q 002509 661 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 740 (914)
Q Consensus 661 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 740 (914)
+||+++|+|.+++... ...+++..++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 87 ~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 87 TQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccccc
Confidence 9999999999998643 34588899999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCce-eeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccc
Q 002509 741 DGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 818 (914)
Q Consensus 741 ~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i 818 (914)
...... .....++..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+.+.. ..+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~----~~~~~~~----~~~~~~-- 230 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SEISSIL----EKGERL-- 230 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHH----hCCCCC--
Confidence 433222 122234678999999999999999999999999999998 9999865331 1222211 111100
Q ss_pred cCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHh
Q 002509 819 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 819 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 865 (914)
..+ ......+.+++.+|++.+|.+||++.++++.|..+..
T Consensus 231 ~~~-------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 231 PQP-------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CCC-------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 000 1112357889999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=324.22 Aligned_cols=264 Identities=21% Similarity=0.281 Sum_probs=196.8
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc-ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
+.+.++||+|+||.||+|+.+ +++.||+|+++.... .....+.+|++++++++||||+++++++..++..++||||++
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD 86 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence 445578999999999999876 689999999875432 234567899999999999999999999999999999999998
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+ +|.+++... ...+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 87 ~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 87 S-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred c-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 5 898888533 33578889999999999999999998 999999999999999999999999999875432221
Q ss_pred eeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhh--------cCCcc
Q 002509 746 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE--------SGDIQ 816 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~--------~~~~~ 816 (914)
......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+.+....... .....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 1223457899999999875 56889999999999999999999999754432222222111100000 00011
Q ss_pred cccCCccCCccC----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 817 GIIDPSLLDEYD----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 817 ~i~d~~l~~~~~----~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
....+....... .....+..+++.+|++.||.+|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 111111100000 0112356789999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=315.98 Aligned_cols=253 Identities=26% Similarity=0.449 Sum_probs=202.4
Q ss_pred HHHHHhccccccCcEEEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 586 ATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 586 ~~~~~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
..+.+.++||+|+||.||+|..+++..+|+|.++.... ....+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 34567789999999999999988888999999875433 3467899999999999999999999885 456789999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+++|.++++.. ....+++.+++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++.........
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 84 KGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 99999998653 234588999999999999999999998 9999999999999999999999999999765433222
Q ss_pred eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCCccC
Q 002509 746 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 824 (914)
......++..|+|||.+.+..++.++||||||++++||++ |+.||..... ..+.+... .+.. ..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~----~~~~~~~~----~~~~-----~~-- 223 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN----REVLEQVE----RGYR-----MP-- 223 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHH----cCCC-----CC--
Confidence 2222335678999999988889999999999999999999 8888865331 12222211 1100 00
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002509 825 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862 (914)
Q Consensus 825 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 862 (914)
.+......+.+++.+|++.+|++||++.++.+.|++
T Consensus 224 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 --CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111223468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=318.09 Aligned_cols=249 Identities=31% Similarity=0.502 Sum_probs=200.4
Q ss_pred HHhccccccCcEEEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCC
Q 002509 589 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 668 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gs 668 (914)
.+.+.||+|+||.||+|+.+++..+|+|.+.... .....|.+|++++++++||||+++++++......++||||+++|+
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05113 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGC 85 (256)
T ss_pred EEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCc
Confidence 4557899999999999998877789999887543 234678999999999999999999999999889999999999999
Q ss_pred hHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCceee
Q 002509 669 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 748 (914)
Q Consensus 669 L~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 748 (914)
|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++...........
T Consensus 86 l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05113 86 LLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159 (256)
T ss_pred HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence 99998643 23689999999999999999999998 9999999999999999999999999998765443322222
Q ss_pred ccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCcc
Q 002509 749 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 827 (914)
Q Consensus 749 ~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 827 (914)
...++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .+.... ..+.... .+.
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~----~~~~~~----~~~~~~~--~~~----- 224 (256)
T cd05113 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS----ETVEKV----SQGLRLY--RPH----- 224 (256)
T ss_pred CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----HHHHHH----hcCCCCC--CCC-----
Confidence 2345678999999988889999999999999999998 99998643321 122211 1111100 001
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002509 828 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861 (914)
Q Consensus 828 ~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 861 (914)
.....+.+++.+|++.+|++||++.++++.|+
T Consensus 225 --~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 225 --LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11246889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=331.24 Aligned_cols=262 Identities=26% Similarity=0.417 Sum_probs=203.2
Q ss_pred HHHHHHhccccccCcEEEEEEEEC------CCcEEEEEEEecCCc-ccchhhhHHHHHHhhc-ccCceeEEEeeeeec-C
Q 002509 585 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE-G 655 (914)
Q Consensus 585 ~~~~~~~~~lG~G~~G~Vy~~~~~------~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~-~ 655 (914)
...+.+.+.||+|+||.||+|... .++.||+|+++.... ...+.+..|++++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 345677899999999999999643 357899999875422 2245677899999999 899999999988654 5
Q ss_pred ceEEEEEeccCCChHHHhhcccC---------------------------------------------------------
Q 002509 656 RSVLVYEFMHNGTLKEHLYGTLT--------------------------------------------------------- 678 (914)
Q Consensus 656 ~~~LV~E~~~~gsL~~~L~~~~~--------------------------------------------------------- 678 (914)
..++++||+++|+|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999999854211
Q ss_pred ccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce-eeccccCCccc
Q 002509 679 HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYL 757 (914)
Q Consensus 679 ~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~Y~ 757 (914)
....++|..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++......... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 023689999999999999999999998 99999999999999999999999999998654332222 22234677899
Q ss_pred CccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccCHHHHHHHH
Q 002509 758 DPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIE 836 (914)
Q Consensus 758 aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~ 836 (914)
|||++.+..++.++|||||||+++||++ |+.||......+ .+.. ....+... .. +.....++.
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~---~~~~----~~~~~~~~--~~-------~~~~~~~~~ 306 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE---EFCR----RLKEGTRM--RA-------PEYATPEIY 306 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH---HHHH----HHhccCCC--CC-------CccCCHHHH
Confidence 9999999999999999999999999998 999986432211 1111 11111110 00 111234688
Q ss_pred HHHHHccCCCCCCCCCHHHHHHHHhhhHh
Q 002509 837 EKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 837 ~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 865 (914)
+++.+|++.+|++||++.||+++|+++++
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=316.79 Aligned_cols=249 Identities=28% Similarity=0.463 Sum_probs=199.5
Q ss_pred HHHhccccccCcEEEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCC
Q 002509 588 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 667 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 667 (914)
..+.+.||+|+||.||+++.+++..+|+|++.... .....+.+|++++++++||||+++++++...+..++||||++++
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred cchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 44678899999999999998877889999986432 23456888999999999999999999999999999999999999
Q ss_pred ChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCcee
Q 002509 668 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 747 (914)
Q Consensus 668 sL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 747 (914)
+|.+++... ...+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|||+++...+......
T Consensus 85 ~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 85 CLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 999998643 23689999999999999999999998 999999999999999999999999999876543222221
Q ss_pred eccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCc
Q 002509 748 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826 (914)
Q Consensus 748 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 826 (914)
....++..|+|||.+.+..++.++||||||+++||+++ |+.||...... .+.... ..+. ....
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~~----~~~~-----~~~~--- 222 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS----EVVESV----SAGY-----RLYR--- 222 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH----HHHHHH----HcCC-----cCCC---
Confidence 22224568999999998899999999999999999999 88888643321 111111 1110 0000
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002509 827 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 860 (914)
Q Consensus 827 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L 860 (914)
+.....++.+++.+|++.+|++||+|.|+++.|
T Consensus 223 -~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 -PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 111234688999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=331.60 Aligned_cols=254 Identities=27% Similarity=0.413 Sum_probs=211.4
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCC
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 667 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 667 (914)
...++||-|.||.||.|.|+ -.-.||||.++.+. ...++|..|+.+|+.++|||+|+|+|+|..+...|||.|||..|
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yG 348 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYG 348 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCc
Confidence 34579999999999999998 46779999998664 34678999999999999999999999999999999999999999
Q ss_pred ChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCcee
Q 002509 668 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 747 (914)
Q Consensus 668 sL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 747 (914)
+|.++|++. ....++-.-.+.+|.||+.|++||..+ .+|||||.++|+|+.++..+||+||||++++.......-
T Consensus 349 NLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAH 423 (1157)
T KOG4278|consen 349 NLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAH 423 (1157)
T ss_pred cHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCceecc
Confidence 999999865 345567777889999999999999998 999999999999999999999999999998865433222
Q ss_pred eccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCc
Q 002509 748 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826 (914)
Q Consensus 748 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 826 (914)
....-...|.|||.+....++.|+|||+|||+||||.| |..|+.+-... ++. . +++...+-+
T Consensus 424 AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS----qVY----~---------LLEkgyRM~ 486 (1157)
T KOG4278|consen 424 AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVY----G---------LLEKGYRMD 486 (1157)
T ss_pred cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH----HHH----H---------HHhcccccc
Confidence 23334678999999999999999999999999999998 88887643311 111 1 222222333
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHh
Q 002509 827 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 827 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 865 (914)
.+..+..++.+|+..||+-+|.+||++.|+.+.+|.++.
T Consensus 487 ~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 487 GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 344566789999999999999999999999999887653
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=336.82 Aligned_cols=259 Identities=24% Similarity=0.393 Sum_probs=202.2
Q ss_pred HHHHhccccccCcEEEEEEEEC------CCcEEEEEEEecCCc-ccchhhhHHHHHHhhcc-cCceeEEEeeeeecCceE
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSV 658 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~------~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~ 658 (914)
.+.+.++||+|+||.||+|+.. .+..||||+++.... ...+.+.+|+++++++. ||||++++++|.+.+..+
T Consensus 38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~ 117 (400)
T cd05105 38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIY 117 (400)
T ss_pred ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceE
Confidence 4456689999999999999753 234799999975432 23457899999999996 999999999999999999
Q ss_pred EEEEeccCCChHHHhhcccC------------------------------------------------------------
Q 002509 659 LVYEFMHNGTLKEHLYGTLT------------------------------------------------------------ 678 (914)
Q Consensus 659 LV~E~~~~gsL~~~L~~~~~------------------------------------------------------------ 678 (914)
+||||+++|+|.++|+....
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (400)
T cd05105 118 IITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEA 197 (400)
T ss_pred EEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhh
Confidence 99999999999999864310
Q ss_pred --------------------------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCC
Q 002509 679 --------------------------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 726 (914)
Q Consensus 679 --------------------------------~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~ 726 (914)
....+++..++.++.|+++||+|||+. +|+||||||+|||++.++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~ 274 (400)
T cd05105 198 SKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGK 274 (400)
T ss_pred hhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCCC
Confidence 013478888999999999999999998 999999999999999999
Q ss_pred cEEEeeccccccccCCCCce-eeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHH
Q 002509 727 RAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQ 804 (914)
Q Consensus 727 ~~kl~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~ 804 (914)
.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||....... .+..
T Consensus 275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~---~~~~ 351 (400)
T cd05105 275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS---TFYN 351 (400)
T ss_pred EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH---HHHH
Confidence 99999999997654332221 122346788999999998899999999999999999997 888986432111 1111
Q ss_pred HHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhH
Q 002509 805 WAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 864 (914)
Q Consensus 805 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 864 (914)
. ...+.. .. .+......+.+++.+|++.+|++||++.+|.+.|++++
T Consensus 352 ~----~~~~~~-----~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 352 K----IKSGYR-----MA----KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred H----HhcCCC-----CC----CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 1 111100 00 01122346889999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=317.76 Aligned_cols=255 Identities=25% Similarity=0.429 Sum_probs=203.0
Q ss_pred HHHHHhccccccCcEEEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 586 ATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 586 ~~~~~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
..+.+.++||+|+||.||+|+.+++..||+|+++... .....+.+|++++++++|+||+++++++. ....++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 4466778999999999999998877789999987533 23457899999999999999999999875 456789999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+|+|.+++... ....+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|||.++........
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 84 KGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 99999999643 234578999999999999999999998 9999999999999999999999999999765443322
Q ss_pred eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCCccC
Q 002509 746 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 824 (914)
......++..|+|||+..+..++.++|||||||++|||++ |+.||...... .+.. ....+. ..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~----~~~~----~~~~~~-----~~--- 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLD----QVERGY-----RM--- 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH----HHHH----HHhcCC-----CC---
Confidence 2223346778999999988889999999999999999999 88888643311 1111 111110 00
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhH
Q 002509 825 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 864 (914)
Q Consensus 825 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 864 (914)
....+....+.+++.+|++.+|++||++.++++.|++..
T Consensus 223 -~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 223 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred -CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 011223456889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=347.43 Aligned_cols=252 Identities=22% Similarity=0.307 Sum_probs=202.2
Q ss_pred HHHhccccccCcEEEEEEEEC-C-CcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-D-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~-g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
+.+.+.||+|++|.||+|... + ++.||+|.+..........+..|++++++++||||+++++++...+..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 456689999999999999765 3 67788887755544445567889999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC-
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS- 744 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~- 744 (914)
+|+|.++++........+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 9999999875544455688899999999999999999998 999999999999999999999999999986543322
Q ss_pred ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccC
Q 002509 745 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 824 (914)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.+.. ..+.... .
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~----~~~~~~~----~~~~~~~-----~- 291 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ----REIMQQV----LYGKYDP-----F- 291 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH----HhCCCCC-----C-
Confidence 123345699999999999999999999999999999999999999965332 1122211 1111110 0
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 825 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 825 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+......+.+++.+|++.+|++||+++|++++
T Consensus 292 ---~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 292 ---PCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ---CccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 11112357889999999999999999999753
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=320.35 Aligned_cols=248 Identities=25% Similarity=0.336 Sum_probs=196.3
Q ss_pred ccccCcEEEEEEEEC-CCcEEEEEEEecCCcc---cchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCCh
Q 002509 594 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 669 (914)
Q Consensus 594 lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~---~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 669 (914)
||+|+||+||++... +++.+|+|.+...... ..+.+..|++++++++|+||+++.+++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999876 7889999998754222 234577899999999999999999999999999999999999999
Q ss_pred HHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCceeec
Q 002509 670 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 749 (914)
Q Consensus 670 ~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 749 (914)
.+++.........+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988865444456789999999999999999999998 999999999999999999999999999876543322 2233
Q ss_pred cccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccCH
Q 002509 750 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 829 (914)
Q Consensus 750 ~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 829 (914)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+... ... + .. ..+.
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~---~~~-~--------~~--~~~~ 222 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR---ILN-D--------SV--TYPD 222 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHh---hcc-c--------CC--CCcc
Confidence 46899999999999999999999999999999999999999653321111111111 100 0 00 0111
Q ss_pred HHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002509 830 QSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 859 (914)
Q Consensus 830 ~~~~~l~~l~~~C~~~~P~~RP-----sm~eVl~~ 859 (914)
.....+.+++.+|++.+|++|| +++|++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 1223578899999999999999 67777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=327.93 Aligned_cols=242 Identities=25% Similarity=0.355 Sum_probs=195.2
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCC
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 667 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 667 (914)
+.||+|+||.||+++.+ +++.||+|++.... ......+.+|+++++.++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999876 68999999997542 223456788999999999999999999999999999999999999
Q ss_pred ChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCcee
Q 002509 668 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 747 (914)
Q Consensus 668 sL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 747 (914)
+|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 152 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATM 152 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccc
Confidence 99988853 34688999999999999999999998 99999999999999999999999999987533221 122
Q ss_pred eccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCcc
Q 002509 748 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 827 (914)
Q Consensus 748 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 827 (914)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+. ... +. ..+....
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~----~~~~~---~~~-~~------~~~p~~~ 218 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFEL---ILM-ED------IKFPRTL 218 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH----HHHHH---hcc-CC------ccCCCCC
Confidence 3356899999999999889999999999999999999999999653321 11111 100 10 1111111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002509 828 DIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 859 (914)
Q Consensus 828 ~~~~~~~l~~l~~~C~~~~P~~RP-----sm~eVl~~ 859 (914)
...+.+++.+|++.+|++|| ++.|++++
T Consensus 219 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 219 ----SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ----CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 23577889999999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=297.10 Aligned_cols=253 Identities=26% Similarity=0.410 Sum_probs=210.5
Q ss_pred cccCHHHHHHHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhcccCceeEEEeee
Q 002509 576 HCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYC 651 (914)
Q Consensus 576 ~~~~~~ei~~~~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~ 651 (914)
..+++.+++ +++.||+|.||.||.|+.+ ++--||+|++.+.. ....+++.+|+++-..++||||+++++++
T Consensus 17 ~~~~l~dfe-----igr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f 91 (281)
T KOG0580|consen 17 KTWTLDDFE-----IGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF 91 (281)
T ss_pred cccchhhcc-----ccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence 456666654 6789999999999999877 57789999986542 33467899999999999999999999999
Q ss_pred eecCceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEe
Q 002509 652 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 731 (914)
Q Consensus 652 ~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 731 (914)
.++...||++||..+|.+...|.+. ...+++......++.|+|.||.|+|.. +++||||||+|+|++.++..||+
T Consensus 92 hd~~riyLilEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiA 166 (281)
T KOG0580|consen 92 HDSKRIYLILEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIA 166 (281)
T ss_pred eccceeEEEEEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeecc
Confidence 9999999999999999999999754 245577777888999999999999998 99999999999999999999999
Q ss_pred eccccccccCCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhh
Q 002509 732 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE 811 (914)
Q Consensus 732 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~ 811 (914)
|||-+.... .......+||..|.+||+..+...+.+.|+|++|++.+|++.|.+||.....++..+.|.+
T Consensus 167 dfGwsV~~p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k------- 236 (281)
T KOG0580|consen 167 DFGWSVHAP---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK------- 236 (281)
T ss_pred CCCceeecC---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH-------
Confidence 999986543 3344567899999999999999999999999999999999999999987664444433332
Q ss_pred cCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 812 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 812 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.++.+|. .......+++.+|+..+|.+|.+..||+.+
T Consensus 237 ----~~~~~p~-------~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 237 ----VDLKFPS-------TISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ----ccccCCc-------ccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1122221 112357889999999999999999999875
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=321.30 Aligned_cols=248 Identities=23% Similarity=0.317 Sum_probs=203.9
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcc---cchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~---~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
+.+.||+|+||.||.++-+ +|..+|+|++++.... ..+....|-.+|....+|.||+|+-.|++.+.+||||||++
T Consensus 145 ~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylP 224 (550)
T KOG0605|consen 145 LLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLP 224 (550)
T ss_pred hheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecC
Confidence 3468999999999999766 6899999999876433 33456789999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccC----
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD---- 741 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~---- 741 (914)
||++..+|. ..+.|+......++.+++-|++-||.. |+|||||||+|+|||..|++||+||||+.-...
T Consensus 225 GGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 225 GGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred CccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 999999985 356788888889999999999999999 999999999999999999999999999842211
Q ss_pred ------------------CCCc-----e-------------------eeccccCCcccCccccccCCCCccCceeehHHH
Q 002509 742 ------------------GASH-----V-------------------SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVI 779 (914)
Q Consensus 742 ------------------~~~~-----~-------------------~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvv 779 (914)
.... . ....+|||.|||||++.+..|+..+|.||+|||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI 377 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence 0000 0 011459999999999999999999999999999
Q ss_pred HHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCC---HHHH
Q 002509 780 LLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS---ISEV 856 (914)
Q Consensus 780 l~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPs---m~eV 856 (914)
+|||+.|-+||..+...+.++.|+.|........+. . .-.+..+|+.+|+. ||++|-. ++||
T Consensus 378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~------~--------~s~eA~DLI~rll~-d~~~RLG~~G~~EI 442 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEV------D--------LSDEAKDLITRLLC-DPENRLGSKGAEEI 442 (550)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcC------c--------ccHHHHHHHHHHhc-CHHHhcCcccHHHH
Confidence 999999999999999899999999997543222110 0 11356788888888 9999964 6666
Q ss_pred HHH
Q 002509 857 LKD 859 (914)
Q Consensus 857 l~~ 859 (914)
.++
T Consensus 443 K~H 445 (550)
T KOG0605|consen 443 KKH 445 (550)
T ss_pred hcC
Confidence 544
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=321.75 Aligned_cols=264 Identities=21% Similarity=0.277 Sum_probs=193.5
Q ss_pred HHHhccccccCcEEEEEEEEC--CCcEEEEEEEecCCcc--cchhhhHHHHHHhhc---ccCceeEEEeeeee-----cC
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRI---HHRNLVQFLGYCQE-----EG 655 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~--~g~~vAVK~l~~~~~~--~~~~f~~E~~~l~~l---~HpnIv~l~g~~~~-----~~ 655 (914)
|.+.+.||+|+||.||+|+.. +++.||+|+++..... ....+.+|+++++++ +||||++++++|.. ..
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 445678999999999999863 4688999998754322 234566777777766 69999999999852 35
Q ss_pred ceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccc
Q 002509 656 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 735 (914)
Q Consensus 656 ~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 735 (914)
..++||||++ ++|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 6799999997 5899988643 234588999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCc
Q 002509 736 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 815 (914)
Q Consensus 736 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 815 (914)
++..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+.+...........
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 9765432 22334568999999999988889999999999999999999999997644322222222211100000000
Q ss_pred c------cccCCccCC---ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 816 Q------GIIDPSLLD---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 816 ~------~i~d~~l~~---~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
. ....+.-.. .........+.+++.+|++.+|++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0 000000000 0001122356789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=327.51 Aligned_cols=242 Identities=23% Similarity=0.327 Sum_probs=194.4
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCC
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 667 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 667 (914)
+.||+|+||.||+++.+ +|+.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999875 68999999997542 223345678999999999999999999999999999999999999
Q ss_pred ChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCcee
Q 002509 668 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 747 (914)
Q Consensus 668 sL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 747 (914)
+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~ 152 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccc
Confidence 99988853 34688999999999999999999998 99999999999999999999999999987532221 122
Q ss_pred eccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCcc
Q 002509 748 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 827 (914)
Q Consensus 748 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 827 (914)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+.. . ... ..+....
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~----~~~~~~---~-~~~------~~~p~~~ 218 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELI---L-MEE------IRFPRTL 218 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHH---h-cCC------CCCCCCC
Confidence 3356899999999999989999999999999999999999999653321 111111 0 000 0111111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002509 828 DIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 859 (914)
Q Consensus 828 ~~~~~~~l~~l~~~C~~~~P~~RP-----sm~eVl~~ 859 (914)
...+.+++.+|++.+|++|| ++.+++++
T Consensus 219 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 219 ----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred ----CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 23577899999999999998 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=315.82 Aligned_cols=256 Identities=25% Similarity=0.427 Sum_probs=205.3
Q ss_pred HHHHHHHHhccccccCcEEEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEE
Q 002509 583 IEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 662 (914)
Q Consensus 583 i~~~~~~~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 662 (914)
+....+++.++||+|+||.||+|..++++.||+|.+..... ....+.+|++++++++|+||+++++++. .+..+++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 44566777889999999999999998999999999875432 3467899999999999999999999864 456899999
Q ss_pred eccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCC
Q 002509 663 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 742 (914)
Q Consensus 663 ~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 742 (914)
|+++++|.+++... ....+++.+++.++.|++.||+|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 81 YMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred cCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 99999999998643 245688999999999999999999998 9999999999999999999999999998765433
Q ss_pred CCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCC
Q 002509 743 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 821 (914)
Q Consensus 743 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 821 (914)
.........++..|+|||++....++.++||||||++++|+++ |+.||..... ..+.+... .+...
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~----~~~~~----- 222 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN----PEVIQNLE----RGYRM----- 222 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh----HHHHHHHH----cCCCC-----
Confidence 2222223345778999999988889999999999999999999 9999965432 12222211 11000
Q ss_pred ccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002509 822 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862 (914)
Q Consensus 822 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 862 (914)
.... ....++.+++.+|++.+|++||+++++++.|+.
T Consensus 223 ~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 PRPD----NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0111 112358899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=324.03 Aligned_cols=250 Identities=25% Similarity=0.364 Sum_probs=209.6
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeeecCc-eEEEEE
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR-SVLVYE 662 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~-~~LV~E 662 (914)
.|...+++|+|+||.++..+.+ +++.+++|.+.... ....+...+|+.++++++|||||.+.+.+.+++. .+|||+
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence 3556689999999999988776 68899999987553 3345578899999999999999999999999988 899999
Q ss_pred eccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCC
Q 002509 663 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 742 (914)
Q Consensus 663 ~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 742 (914)
|++||++.+.+.... +.-+++.+++.++.|++.|+.|||++ +|+|||||+.||+++.+..+||+|||+|+.....
T Consensus 85 Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred ecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 999999999997653 56688899999999999999999988 9999999999999999999999999999988765
Q ss_pred CCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCc
Q 002509 743 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 822 (914)
Q Consensus 743 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 822 (914)
.. ....+.||+.|+.||.+.+.+|..|+|||||||++|||++-+++|...+.......+.+- .+
T Consensus 160 ~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~------------~~--- 223 (426)
T KOG0589|consen 160 DS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRG------------LY--- 223 (426)
T ss_pred hh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhc------------cC---
Confidence 43 334566999999999999999999999999999999999999999866543322222221 01
Q ss_pred cCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 823 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 823 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
...+.....++..++..|++.+|+.||++.+++.+
T Consensus 224 --~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 --SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11222333468889999999999999999999987
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=328.61 Aligned_cols=243 Identities=27% Similarity=0.377 Sum_probs=197.0
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEe
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 663 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~ 663 (914)
+.+.+.||+|+||.||+|+.+ +++.||+|+++... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 99 (329)
T PTZ00263 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEF 99 (329)
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcC
Confidence 345678999999999999886 68999999987542 22345688999999999999999999999999999999999
Q ss_pred ccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCC
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 743 (914)
Q Consensus 664 ~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 743 (914)
+++|+|.+++.. ...+++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 100 VVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred CCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 999999999853 34578888889999999999999998 99999999999999999999999999997653321
Q ss_pred CceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCcc
Q 002509 744 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 823 (914)
Q Consensus 744 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 823 (914)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ..+.+ .+..+... +
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----~~~~~----~i~~~~~~------~ 234 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP----FRIYE----KILAGRLK------F 234 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH----HHHHH----HHhcCCcC------C
Confidence 234689999999999998899999999999999999999999965331 11111 11111110 0
Q ss_pred CCccCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 002509 824 LDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 859 (914)
Q Consensus 824 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPs-----m~eVl~~ 859 (914)
.... ..++.+++.+|++.||++||+ ++|++++
T Consensus 235 p~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 235 PNWF----DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCCC----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1111 124778999999999999986 6888765
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=321.19 Aligned_cols=260 Identities=26% Similarity=0.462 Sum_probs=205.7
Q ss_pred HHHHHhccccccCcEEEEEEEEC------CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEE
Q 002509 586 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 659 (914)
Q Consensus 586 ~~~~~~~~lG~G~~G~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~L 659 (914)
..+.+.+.||+|+||.||++... ++..+|+|.+..........+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 33456688999999999999752 345689999876555556678999999999999999999999999999999
Q ss_pred EEEeccCCChHHHhhccc---------CccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEE
Q 002509 660 VYEFMHNGTLKEHLYGTL---------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 730 (914)
Q Consensus 660 V~E~~~~gsL~~~L~~~~---------~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 730 (914)
||||+++++|.+++.... .....+++..++.++.|++.||+|||++ +++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence 999999999999986432 1223589999999999999999999998 9999999999999999999999
Q ss_pred eeccccccccCCCCc-eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHH
Q 002509 731 SDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKL 808 (914)
Q Consensus 731 ~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~ 808 (914)
+|||+++........ ......++..|+|||.+.+..++.++|||||||+++||++ |+.||..... ..+....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~----~~~~~~i-- 235 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN----NEVIECI-- 235 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHH--
Confidence 999998755332211 1122335778999999998889999999999999999998 8998864432 1122211
Q ss_pred hhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHh
Q 002509 809 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 809 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 865 (914)
..+.... .... ....+.+++.+|++.+|.+||+++||.+.|+.+..
T Consensus 236 --~~~~~~~-----~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 236 --TQGRVLQ-----RPRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred --HcCCcCC-----CCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 1121111 0111 12358999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=322.88 Aligned_cols=257 Identities=26% Similarity=0.467 Sum_probs=205.6
Q ss_pred HHhccccccCcEEEEEEEEC------CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEE
Q 002509 589 MLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 662 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 662 (914)
.+.+.||+|+||.||+++.. ++..+++|.+........+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (291)
T cd05094 8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFE 87 (291)
T ss_pred EEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEe
Confidence 34578999999999999753 356689999876655555779999999999999999999999999999999999
Q ss_pred eccCCChHHHhhcccC------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEE
Q 002509 663 FMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 730 (914)
Q Consensus 663 ~~~~gsL~~~L~~~~~------------~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 730 (914)
|+++++|.+++..... ....++|..++.++.|++.||+|||++ +|+||||||+|||++.++.+||
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l 164 (291)
T cd05094 88 YMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKI 164 (291)
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEE
Confidence 9999999999965321 224589999999999999999999998 9999999999999999999999
Q ss_pred eeccccccccCCCC-ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHH
Q 002509 731 SDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKL 808 (914)
Q Consensus 731 ~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~ 808 (914)
+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+.+.
T Consensus 165 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~----~~~~~~--- 237 (291)
T cd05094 165 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN----TEVIEC--- 237 (291)
T ss_pred CCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHH---
Confidence 99999976543221 11223346788999999998899999999999999999999 9999864332 112221
Q ss_pred hhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHh
Q 002509 809 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 809 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 865 (914)
...+..... .......+.+++.+|++.+|++||++++|++.|+++..
T Consensus 238 -~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 238 -ITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred -HhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 122211111 11123458899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=327.75 Aligned_cols=196 Identities=28% Similarity=0.403 Sum_probs=170.3
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC-cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
+.+.+.||+|+||.||+++.+ ++..+|+|++.... ......+.+|++++++++||||+++++++...+..++||||++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 86 (331)
T cd06649 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 86 (331)
T ss_pred ceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCC
Confidence 345578999999999999877 68889999987542 2334578999999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+|+|.+++.. ...+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 87 ~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 157 (331)
T cd06649 87 GGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (331)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence 9999999854 345788899999999999999999852 6999999999999999999999999998755332
Q ss_pred eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCccc
Q 002509 746 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 792 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~ 792 (914)
......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 12234589999999999998999999999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=320.02 Aligned_cols=266 Identities=24% Similarity=0.372 Sum_probs=200.1
Q ss_pred HHhccccccCcEEEEEEEE-----CCCcEEEEEEEecCCc-ccchhhhHHHHHHhhcccCceeEEEeeeeec--CceEEE
Q 002509 589 MLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLV 660 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~-----~~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~LV 660 (914)
.+.+.||+|+||+||.+.. .+++.||+|+++.... .....+.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 4567899999999988653 3678899999875432 3456788999999999999999999988654 357899
Q ss_pred EEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccccc
Q 002509 661 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 740 (914)
Q Consensus 661 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 740 (914)
|||+++|+|.+++.. ..+++.+++.++.|+++||+|||++ +++||||||+|||+++++.+||+|||+++...
T Consensus 87 ~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 87 MEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred ecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccC
Confidence 999999999999853 3589999999999999999999998 99999999999999999999999999997654
Q ss_pred CCCCc--eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccc
Q 002509 741 DGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 818 (914)
Q Consensus 741 ~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i 818 (914)
..... ......++..|+|||.+....++.++||||||++++||++|+.|+...... ...+..+.........+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhhhh
Confidence 33221 112223566799999998888999999999999999999999997532210 01111111100000111111
Q ss_pred cCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhH
Q 002509 819 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 864 (914)
Q Consensus 819 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 864 (914)
++.......+.....++.+++..|++.+|++||+|++|++.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1211111112223357889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=325.82 Aligned_cols=242 Identities=23% Similarity=0.322 Sum_probs=196.5
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEec
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
.+.+.||+|+||.||+++.+ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 83 (291)
T cd05612 4 ERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYV 83 (291)
T ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCC
Confidence 35578999999999999876 68999999986532 123456889999999999999999999999999999999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 744 (914)
++|+|.+++.. ...+++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 84 PGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence 99999999853 34578889999999999999999998 9999999999999999999999999998765432
Q ss_pred ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccC
Q 002509 745 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 824 (914)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .+.+.+ ..+.. .+.
T Consensus 155 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~----~~~~~i----~~~~~------~~~ 218 (291)
T cd05612 155 --TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF----GIYEKI----LAGKL------EFP 218 (291)
T ss_pred --cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH----HhCCc------CCC
Confidence 12345899999999999888999999999999999999999999754321 111111 11111 011
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 002509 825 DEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 859 (914)
Q Consensus 825 ~~~~~~~~~~l~~l~~~C~~~~P~~RPs-----m~eVl~~ 859 (914)
... ...+.+++.+|++.||.+||+ ++|++++
T Consensus 219 ~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 219 RHL----DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ccC----CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 111 235778999999999999995 8888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=313.65 Aligned_cols=247 Identities=29% Similarity=0.437 Sum_probs=195.3
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCC-cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCCh
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 669 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 669 (914)
+.||+|+||.||+|+.. +++.+|+|.+.... ......+.+|++++++++||||++++++|......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999876 78999999876442 23346789999999999999999999999999999999999999999
Q ss_pred HHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCcee-e
Q 002509 670 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS-S 748 (914)
Q Consensus 670 ~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~ 748 (914)
.+++... ...+++..++.++.|+++||+|||+. +++||||||+||+++.++.+||+|||++........... .
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9998542 34578999999999999999999998 999999999999999999999999999875432211111 1
Q ss_pred ccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCcc
Q 002509 749 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 827 (914)
Q Consensus 749 ~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 827 (914)
....+..|+|||.+.++.++.++|||||||++|||++ |..|+..... ...... ....... ..
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~----~~~~~~----~~~~~~~---------~~ 217 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN----QQTREA----IEQGVRL---------PC 217 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH----HHHHHH----HHcCCCC---------CC
Confidence 1123457999999998889999999999999999998 8888864321 111111 1111000 01
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002509 828 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861 (914)
Q Consensus 828 ~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 861 (914)
+......+.+++.+|++.+|++||++.||.+.|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1112346889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=319.73 Aligned_cols=258 Identities=25% Similarity=0.426 Sum_probs=203.3
Q ss_pred HHHHhccccccCcEEEEEEEEC------CCcEEEEEEEecCC-cccchhhhHHHHHHhhc-ccCceeEEEeeeeecCceE
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSV 658 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~ 658 (914)
.+.+.+.||+|+||.||++... ....+|+|++.... ......+.+|++++.++ +|+||+++++++..++..+
T Consensus 13 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (293)
T cd05053 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLY 92 (293)
T ss_pred HeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeE
Confidence 3445678999999999999864 23679999987542 23345688999999999 8999999999999999999
Q ss_pred EEEEeccCCChHHHhhccc------------CccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCC
Q 002509 659 LVYEFMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 726 (914)
Q Consensus 659 LV~E~~~~gsL~~~L~~~~------------~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~ 726 (914)
++|||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+|||+++++
T Consensus 93 li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~ 169 (293)
T cd05053 93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDH 169 (293)
T ss_pred EEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCC
Confidence 9999999999999986431 2345689999999999999999999998 999999999999999999
Q ss_pred cEEEeeccccccccCCCCce-eeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHH
Q 002509 727 RAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQ 804 (914)
Q Consensus 727 ~~kl~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~ 804 (914)
.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||...... .+.+
T Consensus 170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~~ 245 (293)
T cd05053 170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE----ELFK 245 (293)
T ss_pred eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH----HHHH
Confidence 99999999998654432211 122235678999999988889999999999999999998 88888644321 1212
Q ss_pred HHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhH
Q 002509 805 WAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 864 (914)
Q Consensus 805 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 864 (914)
.. ..+... ..+......+.+++.+|++.+|++||||+|+++.|++++
T Consensus 246 ~~----~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 246 LL----KEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HH----HcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11 111100 011122346889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=327.40 Aligned_cols=243 Identities=25% Similarity=0.391 Sum_probs=204.4
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
+++.||+|+.|.|-.|++. +|+.+|||++.+.. ......+++|+-+|+.+.|||++++++.+....++++|.||++
T Consensus 16 LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~ 95 (786)
T KOG0588|consen 16 LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVP 95 (786)
T ss_pred ccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecC
Confidence 5678999999999999865 89999999997652 2234568899999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+|-|.+++. ..+.+.+.+..+++.||..|+.|+|.. +|+||||||+|+|||..+++||+|||+|....++ .
T Consensus 96 gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g--k 166 (786)
T KOG0588|consen 96 GGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG--K 166 (786)
T ss_pred CchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC--c
Confidence 999999995 456788899999999999999999998 9999999999999999999999999999765443 3
Q ss_pred eeeccccCCcccCccccccCCCC-ccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccC
Q 002509 746 VSSIVRGTVGYLDPEYYISQQLT-DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~~~~s-~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 824 (914)
.-...||++.|.+||++.+.+|. .++||||+||||+.|++|+.||++.+ .+.+.. .++.|.++-
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN----ir~LLl----KV~~G~f~M------- 231 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN----IRVLLL----KVQRGVFEM------- 231 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc----HHHHHH----HHHcCcccC-------
Confidence 44567899999999999999885 68999999999999999999998543 233333 334443321
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 825 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 825 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+.....+..+|+.+|+..||++|-|++||.+|
T Consensus 232 ---Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 232 ---PSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ---CCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 11112246788999999999999999999987
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=330.69 Aligned_cols=245 Identities=25% Similarity=0.401 Sum_probs=199.8
Q ss_pred cccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCChHH
Q 002509 593 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKE 671 (914)
Q Consensus 593 ~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~ 671 (914)
+||+|.||+||.|+.. +...+|||-+........+.+.+|+.+.++++|+|||+++|.|.+.+..-+.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999876 467799999988777777889999999999999999999999999999999999999999999
Q ss_pred HhhcccCccccc--cHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCC-CCcEEEeeccccccccCCCCceee
Q 002509 672 HLYGTLTHEQRI--NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGASHVSS 748 (914)
Q Consensus 672 ~L~~~~~~~~~l--~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~ 748 (914)
+|+..- +++ ++.+.-.+.+||++||.|||++ .|||||||-+|||++. .|.+||+|||-++.... -...+.
T Consensus 662 LLrskW---GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TE 734 (1226)
T KOG4279|consen 662 LLRSKW---GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTE 734 (1226)
T ss_pred HHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-CCcccc
Confidence 997542 223 5666777889999999999999 9999999999999975 68999999999986543 334456
Q ss_pred ccccCCcccCccccccC--CCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCc
Q 002509 749 IVRGTVGYLDPEYYISQ--QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826 (914)
Q Consensus 749 ~~~gt~~Y~aPE~~~~~--~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 826 (914)
.+.||..|||||++..+ .|..++|||||||.+.||.||++||........ .. ++-|-+ +....
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA----AM-----FkVGmy------KvHP~ 799 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA----AM-----FKVGMY------KVHPP 799 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH----hh-----hhhcce------ecCCC
Confidence 67799999999999864 588999999999999999999999975432211 11 111100 01122
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 827 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 827 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.+.+.-.+...++++|+.++|.+||+++++++.
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 333444567789999999999999999999864
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=312.16 Aligned_cols=247 Identities=28% Similarity=0.412 Sum_probs=198.1
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEEecCCc-ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCChH
Q 002509 592 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK 670 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~ 670 (914)
++||+|+||.||+|..++++.+|+|.++.... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988899999999875432 22446889999999999999999999999999999999999999999
Q ss_pred HHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCceeecc
Q 002509 671 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 750 (914)
Q Consensus 671 ~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 750 (914)
+++... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 988543 34578999999999999999999998 999999999999999999999999999875433222222222
Q ss_pred ccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccCH
Q 002509 751 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 829 (914)
Q Consensus 751 ~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 829 (914)
.++..|+|||++.+..++.++||||||+++||+++ |..||...... ..... ...+... . ...
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~----~~~~~----~~~~~~~-----~----~~~ 217 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ----QAREQ----VEKGYRM-----S----CPQ 217 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH----HHHHH----HHcCCCC-----C----CCC
Confidence 34678999999998889999999999999999998 99998643311 11111 1111100 0 011
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002509 830 QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861 (914)
Q Consensus 830 ~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 861 (914)
.....+.+++.+|++.+|++||++.|+++.|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 12346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.26 Aligned_cols=268 Identities=22% Similarity=0.236 Sum_probs=201.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEEecCCc--ccchhhhHHHHHHhhcccCc-eeEEEeeeeecC------ceEEE
Q 002509 591 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRN-LVQFLGYCQEEG------RSVLV 660 (914)
Q Consensus 591 ~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~Hpn-Iv~l~g~~~~~~------~~~LV 660 (914)
.++||+|+||+||+|+.+ +|+.||+|+++.... .......+|+.+|++++|+| ||.+.+++...+ ..++|
T Consensus 16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lv 95 (323)
T KOG0594|consen 16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLV 95 (323)
T ss_pred HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEE
Confidence 356999999999999876 789999999986643 23455689999999999999 999999999877 78899
Q ss_pred EEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccccc
Q 002509 661 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 740 (914)
Q Consensus 661 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 740 (914)
+||++. +|..++.........++-..+..++.|+++||+|||++ +|+||||||+||||+++|.+||+|||+|+...
T Consensus 96 fe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ 171 (323)
T KOG0594|consen 96 FEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARAFS 171 (323)
T ss_pred EEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHHHhc
Confidence 999976 89999865432224566678899999999999999999 99999999999999999999999999998654
Q ss_pred CCCCceeeccccCCcccCccccccC-CCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccc-
Q 002509 741 DGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI- 818 (914)
Q Consensus 741 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i- 818 (914)
-+.. ..+...+|.+|+|||++.+. .|+...||||+||++.||++++.-|.+....+....|.+-....-++.+....
T Consensus 172 ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~ 250 (323)
T KOG0594|consen 172 IPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSS 250 (323)
T ss_pred CCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccc
Confidence 2222 23344589999999999876 78999999999999999999998887655322222222222111111111111
Q ss_pred -cCCc--cCCcc-----CHHH---HHHHHHHHHHccCCCCCCCCCHHHHHHH--Hhhh
Q 002509 819 -IDPS--LLDEY-----DIQS---MWKIEEKALMCVLPHGHMRPSISEVLKD--IQDA 863 (914)
Q Consensus 819 -~d~~--l~~~~-----~~~~---~~~l~~l~~~C~~~~P~~RPsm~eVl~~--L~~~ 863 (914)
.|-. ..... .... .....+++.+|++.+|.+|.+++.++++ +.+.
T Consensus 251 ~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 251 LPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred cccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 0111 00000 0000 1357889999999999999999999987 5543
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=332.81 Aligned_cols=249 Identities=24% Similarity=0.311 Sum_probs=199.5
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEec
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
.+.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|++++..++||||+++++++.+++..++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (350)
T cd05573 4 EVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYM 83 (350)
T ss_pred eEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCC
Confidence 35578999999999999877 78999999997542 133456889999999999999999999999999999999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCC-
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA- 743 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~- 743 (914)
++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 84 PGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred CCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999998643 5688899999999999999999998 99999999999999999999999999997654332
Q ss_pred ---------------------------CceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCccccccc
Q 002509 744 ---------------------------SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG 796 (914)
Q Consensus 744 ---------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~ 796 (914)
........||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 11223346899999999999999999999999999999999999999754422
Q ss_pred ccchhHHHHHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 002509 797 ANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS-ISEVLKD 859 (914)
Q Consensus 797 ~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPs-m~eVl~~ 859 (914)
.....+..|.. ... -+.. .. ....+.+++.+|++ +|++||+ ++|++++
T Consensus 237 ~~~~~i~~~~~------~~~---~p~~-~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 ETYNKIINWKE------SLR---FPPD-PP----VSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHHhccCC------ccc---CCCC-CC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 21122222110 000 0000 00 12357788889997 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=318.01 Aligned_cols=256 Identities=24% Similarity=0.422 Sum_probs=200.0
Q ss_pred HHHHhccccccCcEEEEEEEEC------CCcEEEEEEEecCCc-ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEE
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 659 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~------~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~L 659 (914)
.+.+.+.||+|+||.||+|..+ .+..||+|++..... ....++.+|+.+++.++||||+++++++......++
T Consensus 7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l 86 (277)
T cd05062 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 86 (277)
T ss_pred HceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEE
Confidence 4556689999999999999753 356799999864322 234568899999999999999999999999999999
Q ss_pred EEEeccCCChHHHhhcccCc------cccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeec
Q 002509 660 VYEFMHNGTLKEHLYGTLTH------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 733 (914)
Q Consensus 660 V~E~~~~gsL~~~L~~~~~~------~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 733 (914)
||||+++|+|.+++...... ...+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+||
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~df 163 (277)
T cd05062 87 IMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF 163 (277)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECCC
Confidence 99999999999998643211 23467889999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCCce-eeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhh
Q 002509 734 GLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIE 811 (914)
Q Consensus 734 Gla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~ 811 (914)
|+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ....+.+ .
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~----~~~~~~~----~ 235 (277)
T cd05062 164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN----EQVLRFV----M 235 (277)
T ss_pred CCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHH----H
Confidence 9987554322211 112235778999999998889999999999999999999 6888864332 1222221 1
Q ss_pred cCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002509 812 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862 (914)
Q Consensus 812 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 862 (914)
.+..... +......+.+++.+|++.+|++||++.|++++|++
T Consensus 236 ~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 236 EGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred cCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111110 11123468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=311.26 Aligned_cols=258 Identities=26% Similarity=0.400 Sum_probs=204.4
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEe
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 663 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~ 663 (914)
+.+.+.||+|+||.||+|+.. +++.||||.++... ......+.+|++++++++||||+++++++...+..++|+||
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence 345678999999999999876 78999999876432 22345688999999999999999999999999999999999
Q ss_pred ccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCC
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 743 (914)
Q Consensus 664 ~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 743 (914)
+++|+|.+++.........+++..++.++.|+++||+|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999998864433345578889999999999999999998 99999999999999999999999999987654322
Q ss_pred CceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCcc
Q 002509 744 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 823 (914)
Q Consensus 744 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 823 (914)
. ......|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ....+... +..... +..
T Consensus 161 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-----~~~~~~~~-~~~~~~-----~~~ 228 (267)
T cd08228 161 T-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLFSLCQK-IEQCDY-----PPL 228 (267)
T ss_pred H-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-----cHHHHHHH-HhcCCC-----CCC
Confidence 1 11234578899999999888899999999999999999999999854321 11121111 111111 111
Q ss_pred CCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 002509 824 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 863 (914)
Q Consensus 824 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 863 (914)
. .......+.+++.+|++.+|++||++.||++.|+++
T Consensus 229 ~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 229 P---TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred C---hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1 112234588999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=325.46 Aligned_cols=265 Identities=24% Similarity=0.425 Sum_probs=206.0
Q ss_pred HHHHHHHHhccccccCcEEEEEEEEC--------CCcEEEEEEEecCC-cccchhhhHHHHHHhhc-ccCceeEEEeeee
Q 002509 583 IEDATKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQ 652 (914)
Q Consensus 583 i~~~~~~~~~~lG~G~~G~Vy~~~~~--------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~ 652 (914)
+...++.+.+.||+|+||.||+++.. .+..||+|.++... ....+++.+|+++++++ +||||++++++|.
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 34455677889999999999999752 12368999887542 23356788999999999 8999999999999
Q ss_pred ecCceEEEEEeccCCChHHHhhccc------------CccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCce
Q 002509 653 EEGRSVLVYEFMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 720 (914)
Q Consensus 653 ~~~~~~LV~E~~~~gsL~~~L~~~~------------~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NI 720 (914)
..+..++++||+++|+|.+++.... .....++|.+++.++.|+++||+|||++ +++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceE
Confidence 9999999999999999999986432 1234688999999999999999999998 999999999999
Q ss_pred EeCCCCcEEEeeccccccccCCCCce-eeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCccccccccc
Q 002509 721 LLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGAN 798 (914)
Q Consensus 721 Ll~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~ 798 (914)
|++.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-- 243 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-- 243 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH--
Confidence 99999999999999987654322111 112234567999999999899999999999999999998 88888643321
Q ss_pred chhHHHHHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHhHh
Q 002509 799 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 867 (914)
Q Consensus 799 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~~ 867 (914)
.+.... ..+...+ .......++.+++.+|++.+|++||+|.|+++.|+++....
T Consensus 244 --~~~~~~----~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 244 --ELFKLL----KEGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred --HHHHHH----HcCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 121111 1111111 01112236889999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=339.96 Aligned_cols=257 Identities=23% Similarity=0.328 Sum_probs=207.5
Q ss_pred HHHhccccccCcEEEEEEEECCC-cEEEEEEEecCCcccchhhhHHHHHHhhcc-cCceeEEEee-eee------cCceE
Q 002509 588 KMLEKKIGSGGFGVVYYGKLKDG-KEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGY-CQE------EGRSV 658 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~~g-~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~-~~~------~~~~~ 658 (914)
..+.+.|.+|||+.||.|+...+ .++|+|++-.......+...+|+++|++|+ |+|||.+++. ... .-+.+
T Consensus 39 v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evl 118 (738)
T KOG1989|consen 39 VTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVL 118 (738)
T ss_pred EEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEE
Confidence 34568999999999999988765 999999987777777788999999999996 9999999993 221 23678
Q ss_pred EEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccc
Q 002509 659 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 738 (914)
Q Consensus 659 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 738 (914)
|.||||.+|.|-|++..+. ..+|++.++++|+.|+++|+++||.. .++|||||||-+||||+.+++.||||||.+.-
T Consensus 119 lLmEyC~gg~Lvd~mn~Rl--q~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 119 LLMEYCKGGSLVDFMNTRL--QTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred eehhhccCCcHHHHHHHHH--hccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 9999999999999997665 33499999999999999999999985 67899999999999999999999999999854
Q ss_pred ccCCCCcee--------eccccCCcccCccccc---cCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHH
Q 002509 739 AVDGASHVS--------SIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK 807 (914)
Q Consensus 739 ~~~~~~~~~--------~~~~gt~~Y~aPE~~~---~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~ 807 (914)
......... -...-|+.|+|||++. +..+++|+|||+|||+||-|+....||+...
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------------- 262 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------------- 262 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-------------
Confidence 322221100 0123689999999984 6789999999999999999999999997532
Q ss_pred HhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHhHh
Q 002509 808 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 867 (914)
Q Consensus 808 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~~ 867 (914)
-..|++....-.........+.+||..|++++|.+||++-||+..+-++...+
T Consensus 263 -------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 263 -------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred -------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 12233333322222345567999999999999999999999999988876553
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=318.92 Aligned_cols=255 Identities=24% Similarity=0.429 Sum_probs=200.4
Q ss_pred HHHhccccccCcEEEEEEEE-----CCCcEEEEEEEecCC-cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEE
Q 002509 588 KMLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 661 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~-----~~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 661 (914)
..+.+.||+|+||.||+|+. ..+..+++|.+.... ......+.+|++++++++||||+++++++..++..++||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 86 (283)
T cd05090 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLF 86 (283)
T ss_pred ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEE
Confidence 34668899999999999975 246789999987533 233457889999999999999999999999999999999
Q ss_pred EeccCCChHHHhhcccC-------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcE
Q 002509 662 EFMHNGTLKEHLYGTLT-------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA 728 (914)
Q Consensus 662 E~~~~gsL~~~L~~~~~-------------~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~ 728 (914)
||+++++|.+++..... ....+++.+.+.++.|++.||+|||++ +++||||||+|||+++++.+
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (283)
T cd05090 87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHV 163 (283)
T ss_pred EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcE
Confidence 99999999999853211 123578999999999999999999998 99999999999999999999
Q ss_pred EEeeccccccccCCCC-ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHH
Q 002509 729 KVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWA 806 (914)
Q Consensus 729 kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~ 806 (914)
||+|||+++....... .......++..|+|||++.+..++.++|||||||+++||++ |..||..... ..+.+.+
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~----~~~~~~~ 239 (283)
T cd05090 164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN----QEVIEMV 239 (283)
T ss_pred EeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHH
Confidence 9999999976543221 12223345778999999988889999999999999999998 8888864321 2222222
Q ss_pred HHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002509 807 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862 (914)
Q Consensus 807 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 862 (914)
. ...... ... ....++.+++.+|++.+|++||++.+|.++|+.
T Consensus 240 ~----~~~~~~-----~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 R----KRQLLP-----CSE----DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred H----cCCcCC-----CCC----CCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1 111110 111 122357889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=318.40 Aligned_cols=257 Identities=22% Similarity=0.373 Sum_probs=201.5
Q ss_pred HHHHHhccccccCcEEEEEEEEC------CCcEEEEEEEecCCcc-cchhhhHHHHHHhhcccCceeEEEeeeeecCceE
Q 002509 586 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 658 (914)
Q Consensus 586 ~~~~~~~~lG~G~~G~Vy~~~~~------~g~~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 658 (914)
..+.+.+.||+|+||.||+|+.. +++.||+|+++..... ....+.+|+.++.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 34667789999999999999864 3578999998754322 2456889999999999999999999999999999
Q ss_pred EEEEeccCCChHHHhhccc------------CccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCC
Q 002509 659 LVYEFMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 726 (914)
Q Consensus 659 LV~E~~~~gsL~~~L~~~~------------~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~ 726 (914)
+++||+.+++|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 9999999999999985321 1123588889999999999999999998 999999999999999999
Q ss_pred cEEEeeccccccccCCCC-ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHH
Q 002509 727 RAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQ 804 (914)
Q Consensus 727 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~ 804 (914)
.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||..... ..+.+
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~~~~ 237 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN----QDVIE 237 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHH
Confidence 999999999876543221 11222345789999999988889999999999999999998 8888764321 12222
Q ss_pred HHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002509 805 WAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862 (914)
Q Consensus 805 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 862 (914)
.. ..+.... .+......+.+++..|++.+|++||+++||++.|+.
T Consensus 238 ~i----~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 MI----RNRQVLP---------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HH----HcCCcCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 21 1111111 111223357899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=327.97 Aligned_cols=244 Identities=25% Similarity=0.378 Sum_probs=189.1
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc-ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCC
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 667 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 667 (914)
+.++||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++|+||+++++++...+..++||||+++|
T Consensus 78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 157 (353)
T PLN00034 78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG 157 (353)
T ss_pred hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence 4578999999999999876 689999999865432 23467889999999999999999999999999999999999999
Q ss_pred ChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCcee
Q 002509 668 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 747 (914)
Q Consensus 668 sL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 747 (914)
+|.+.. ...+..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 158 ~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~ 225 (353)
T PLN00034 158 SLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PC 225 (353)
T ss_pred cccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-cc
Confidence 986532 245567788999999999999998 999999999999999999999999999976543221 12
Q ss_pred eccccCCcccCcccccc-----CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCc
Q 002509 748 SIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 822 (914)
Q Consensus 748 ~~~~gt~~Y~aPE~~~~-----~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 822 (914)
....||..|+|||++.. ...+.++|||||||++|||++|+.||......+. ..+.... ..... +.
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~----~~~~~-----~~ 295 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW-ASLMCAI----CMSQP-----PE 295 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHHHH----hccCC-----CC
Confidence 33468999999998743 2344689999999999999999999973322111 1111110 00000 01
Q ss_pred cCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 823 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 823 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
. ......++.+++.+|++.+|++||+++|++++
T Consensus 296 ~----~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 296 A----PATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred C----CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 11122358899999999999999999999985
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=325.75 Aligned_cols=250 Identities=23% Similarity=0.311 Sum_probs=196.0
Q ss_pred HHhccccccCcEEEEEEEEC----CCcEEEEEEEecCC----cccchhhhHHHHHHhhc-ccCceeEEEeeeeecCceEE
Q 002509 589 MLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS----YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVL 659 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~----~g~~vAVK~l~~~~----~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~L 659 (914)
.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+..|++++.++ +|+||+++++++...+..++
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (332)
T cd05614 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL 82 (332)
T ss_pred eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence 35678999999999998753 58899999987532 12234577899999999 59999999999999999999
Q ss_pred EEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccc
Q 002509 660 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 739 (914)
Q Consensus 660 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 739 (914)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 83 v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 83 ILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 9999999999999853 34588899999999999999999998 9999999999999999999999999999765
Q ss_pred cCCCCceeeccccCCcccCccccccC-CCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccc
Q 002509 740 VDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 818 (914)
Q Consensus 740 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i 818 (914)
............||..|+|||.+.+. .++.++|||||||++|||++|+.||...........+... ...
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~---~~~------- 225 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR---ILK------- 225 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH---Hhc-------
Confidence 44333333345699999999999865 4788999999999999999999999643322211112111 111
Q ss_pred cCCccCCccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002509 819 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 859 (914)
Q Consensus 819 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----sm~eVl~~ 859 (914)
.++.+.... ...+.+++.+|++.||++|| +++|++++
T Consensus 226 ~~~~~~~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 CDPPFPSFI----GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCCCCCCC----CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 111121111 23477899999999999999 77788765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=323.04 Aligned_cols=199 Identities=28% Similarity=0.409 Sum_probs=171.7
Q ss_pred HHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC-cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEE
Q 002509 585 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 662 (914)
Q Consensus 585 ~~~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 662 (914)
...+.+.++||+|+||.||+++.+ ++..+|+|++.... ......+.+|++++++++||||++++++|...+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 445667789999999999999887 68889999887542 2334568899999999999999999999999999999999
Q ss_pred eccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCC
Q 002509 663 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 742 (914)
Q Consensus 663 ~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 742 (914)
|+++|+|.+++.. ...+++.....++.|++.||+|||+.+ +++||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999853 345788888999999999999999742 6999999999999999999999999998755322
Q ss_pred CCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCccc
Q 002509 743 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 792 (914)
Q Consensus 743 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~ 792 (914)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 12234589999999999988899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=323.42 Aligned_cols=250 Identities=22% Similarity=0.301 Sum_probs=194.9
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhc-ccCceeEEEeeeeecCceEEEEEeccC
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
+.||+|+||.||+++.+ +++.+|+|+++... ......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 67899999997542 22234577888888776 899999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~ 152 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT 152 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cc
Confidence 999988753 34688999999999999999999998 99999999999999999999999999987532221 12
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccc-cchhHHHHHHHhhhcCCcccccCCccCC
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA-NCRNIVQWAKLHIESGDIQGIIDPSLLD 825 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~-~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 825 (914)
.....||..|+|||++.+..++.++|||||||++|||++|+.||....... .......+.......... .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~-- 224 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RI-- 224 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CC--
Confidence 234568999999999999999999999999999999999999996322111 111222232222222211 11
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 002509 826 EYDIQSMWKIEEKALMCVLPHGHMRPS------ISEVLKD 859 (914)
Q Consensus 826 ~~~~~~~~~l~~l~~~C~~~~P~~RPs------m~eVl~~ 859 (914)
+.....++.+++.+|++.+|++||+ +.|++++
T Consensus 225 --p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 225 --PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred --CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1112235778999999999999998 5677655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=321.39 Aligned_cols=243 Identities=25% Similarity=0.390 Sum_probs=200.9
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCCcc-cchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCCh
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 669 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 669 (914)
++||+|.||.||||... .++.||+|++...... ...+.++|+.+|..++++||.+++|.+..+..++++||||.+|++
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv 98 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV 98 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence 68999999999999766 6889999999866433 356788999999999999999999999999999999999999999
Q ss_pred HHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCceeec
Q 002509 670 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 749 (914)
Q Consensus 670 ~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 749 (914)
.+.|... ..+++....-|+.++..||.|||.+ +.+|||||+.|||+..+|.+||+|||.+.......... ..
T Consensus 99 ~~lL~~~----~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~t 170 (467)
T KOG0201|consen 99 LDLLKSG----NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-KT 170 (467)
T ss_pred hhhhccC----CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc-cc
Confidence 9998532 2336666677889999999999999 99999999999999999999999999997765544333 56
Q ss_pred cccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccCH
Q 002509 750 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 829 (914)
Q Consensus 750 ~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 829 (914)
++||+.|||||++.+..|+.|+||||||+..+||.+|.+|+........... +..--.|.+.+.+.
T Consensus 171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl-------------Ipk~~PP~L~~~~S- 236 (467)
T KOG0201|consen 171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL-------------IPKSAPPRLDGDFS- 236 (467)
T ss_pred ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe-------------ccCCCCCccccccC-
Confidence 7799999999999988999999999999999999999999875442111111 11112233433333
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 830 QSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 830 ~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
..+.+++..|+..+|+.||++.+++++
T Consensus 237 ---~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 237 ---PPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ---HHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 347788999999999999999999976
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=318.71 Aligned_cols=256 Identities=26% Similarity=0.434 Sum_probs=202.1
Q ss_pred HhccccccCcEEEEEEEEC------CCcEEEEEEEecCCc-ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEE
Q 002509 590 LEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 662 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~------~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 662 (914)
+.+.||+|+||.||+|+.. ....+++|.+..... .....+..|+++++.++||||+++++.+...+..++++|
T Consensus 4 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (290)
T cd05045 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE 83 (290)
T ss_pred ccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEE
Confidence 4578999999999999753 235789998865432 234578899999999999999999999999999999999
Q ss_pred eccCCChHHHhhccc--------------------CccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEe
Q 002509 663 FMHNGTLKEHLYGTL--------------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 722 (914)
Q Consensus 663 ~~~~gsL~~~L~~~~--------------------~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl 722 (914)
|+.+|+|.+++.... .....+++..++.++.|++.||+|||+. +++||||||+|||+
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nill 160 (290)
T cd05045 84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLV 160 (290)
T ss_pred ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEEE
Confidence 999999999986421 1124588999999999999999999998 99999999999999
Q ss_pred CCCCcEEEeeccccccccCCCCce-eeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccch
Q 002509 723 DKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCR 800 (914)
Q Consensus 723 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~ 800 (914)
++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||++++||++ |+.||..... .
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~ 236 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP----E 236 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH----H
Confidence 999999999999987653332211 222345778999999988889999999999999999998 9999864331 2
Q ss_pred hHHHHHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHh
Q 002509 801 NIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 801 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 865 (914)
.+.++...... ... +......+.+++.+|++.+|++||+++|+++.|++++.
T Consensus 237 ~~~~~~~~~~~---------~~~----~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 237 RLFNLLKTGYR---------MER----PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHHhCCCC---------CCC----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 23332211100 001 11122358899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=323.64 Aligned_cols=242 Identities=25% Similarity=0.365 Sum_probs=193.1
Q ss_pred ccccccCcEEEEEEEE----CCCcEEEEEEEecCC----cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEe
Q 002509 592 KKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNS----YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 663 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~----~~g~~vAVK~l~~~~----~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~ 663 (914)
+.||+|+||.||+++. ..++.||||+++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 357899999987532 12234577899999999999999999999999999999999
Q ss_pred ccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCC
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 743 (914)
Q Consensus 664 ~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 743 (914)
+++|+|.+++.. ...+.+..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999998853 34567788888999999999999998 99999999999999999999999999987543222
Q ss_pred CceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCcc
Q 002509 744 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 823 (914)
Q Consensus 744 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 823 (914)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+ .. ..+.. .+
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~----~~~~---~~-~~~~~------~~ 219 (323)
T cd05584 155 T-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK----KTID---KI-LKGKL------NL 219 (323)
T ss_pred C-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH----HHHH---HH-HcCCC------CC
Confidence 1 223356899999999999888999999999999999999999999754321 1111 11 11111 01
Q ss_pred CCccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002509 824 LDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 859 (914)
Q Consensus 824 ~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----sm~eVl~~ 859 (914)
... ....+.+++.+|++.+|++|| ++++++++
T Consensus 220 ~~~----~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 220 PPY----LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCC----CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 111 123577899999999999999 88888775
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=296.50 Aligned_cols=264 Identities=21% Similarity=0.314 Sum_probs=210.2
Q ss_pred HHHHHHhccccccCcEEEEEEE-ECCCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeec-----CceE
Q 002509 585 DATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSV 658 (914)
Q Consensus 585 ~~~~~~~~~lG~G~~G~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~-----~~~~ 658 (914)
..+|.+.+.||+|||+-||.++ ..+++.+|+|++.....++.+..++|++..++++|||++++++++..+ .+.+
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 3456778899999999999997 457889999999877767778899999999999999999999988544 3589
Q ss_pred EEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccc
Q 002509 659 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 738 (914)
Q Consensus 659 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 738 (914)
|+++|...|+|.+.+...+.++..+++.+.+.|+.++++||++||+. .+++.||||||.|||+.+.+.+++.|||.++.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 99999999999999988777777899999999999999999999997 34699999999999999999999999999865
Q ss_pred ccC---CCCce-----eeccccCCcccCccccc---cCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHH
Q 002509 739 AVD---GASHV-----SSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK 807 (914)
Q Consensus 739 ~~~---~~~~~-----~~~~~gt~~Y~aPE~~~---~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~ 807 (914)
..- +.... .....-|..|+|||.+. +...++++|||||||+||+|+.|..||+.....+
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G---------- 248 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG---------- 248 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC----------
Confidence 421 11111 11123588999999996 4567899999999999999999999997432111
Q ss_pred HhhhcCCc-ccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhH
Q 002509 808 LHIESGDI-QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 864 (914)
Q Consensus 808 ~~~~~~~~-~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 864 (914)
+.+ ..+..+.+.-.-+....+.+.+++.+|++.||.+||++.|++.+++..+
T Consensus 249 -----gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 249 -----GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -----CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111 1122222211111123457899999999999999999999999998653
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=302.20 Aligned_cols=260 Identities=21% Similarity=0.240 Sum_probs=197.3
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEEecCCccc--chhhhHHHHHHhhcccCceeEEEeeeeec--CceEEEEEecc
Q 002509 591 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG--KREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVYEFMH 665 (914)
Q Consensus 591 ~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~--~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~LV~E~~~ 665 (914)
.++|++|.||.||+|+.+ +++.||+|+++...... .-.-.+|+.+|.+++|||||.+..+.... +..++|||||+
T Consensus 81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E 160 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE 160 (419)
T ss_pred HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence 468999999999999877 68889999997653221 23457899999999999999999887654 57899999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+ +|...+... .+++...+...++.|+++|++|||.+ -|+|||||++|+|+++.|.+||+|||+|+.+......
T Consensus 161 h-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~ 233 (419)
T KOG0663|consen 161 H-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP 233 (419)
T ss_pred h-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCccc
Confidence 8 898888765 36788889999999999999999999 9999999999999999999999999999988665333
Q ss_pred eeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCc--
Q 002509 746 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS-- 822 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~-- 822 (914)
.+..+-|.+|+|||.+.+ ..|++..|+||+|||+.|++++++-|.+....+-...|.+-.... .+..+...-+..
T Consensus 234 -~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtP-te~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 234 -YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTP-SEAIWPGYSELPAV 311 (419)
T ss_pred -CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCC-ccccCCCccccchh
Confidence 334456999999999986 468999999999999999999999887655332222332221111 111111111110
Q ss_pred ------------cCCccCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 823 ------------LLDEYDIQ-SMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 823 ------------l~~~~~~~-~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
++..+... .-..-.++....+..||++|-|++|.+++
T Consensus 312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 11111111 11334567778899999999999999875
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=311.45 Aligned_cols=252 Identities=25% Similarity=0.422 Sum_probs=200.4
Q ss_pred HHHHhccccccCcEEEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
.+.+.+.||+|++|.||++..+.+..+|+|.+.... ...+.+.+|++++++++|+|++++++++. .+..+++|||+++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 355667899999999999998877789999876543 23457889999999999999999999875 4567899999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
|+|.++++.. ....+++..+..++.|+++||+|||+. +++|+||||+||++++++.+||+|||+++.........
T Consensus 85 ~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 85 GSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 9999999653 234578999999999999999999998 99999999999999999999999999997654332222
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCC
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 825 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 825 (914)
.....++..|+|||...+..++.++|||||||++|||++ |+.||..... ....++... +.. +..
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~~~----~~~-----~~~-- 224 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN----REVLEQVER----GYR-----MPC-- 224 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHc----CCC-----CCC--
Confidence 222346778999999988889999999999999999999 8889865331 122222111 100 000
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002509 826 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862 (914)
Q Consensus 826 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 862 (914)
+......+.+++.+|++.+|++||++++|++.|++
T Consensus 225 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 --PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11223468889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=325.24 Aligned_cols=242 Identities=23% Similarity=0.320 Sum_probs=194.1
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCC
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 667 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 667 (914)
+.||+|+||.||+++.. +|+.||+|+++... ......+..|++++..++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999865 78999999997542 222356678999999999999999999999999999999999999
Q ss_pred ChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHh-CCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 668 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 668 sL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
+|.+++.. ...+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T 152 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence 99988853 3468899999999999999999997 5 899999999999999999999999999875432221 2
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCc
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 826 (914)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.+... .+. ..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~----~~~~~~i~----~~~------~~~p~~ 218 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKLFELIL----MEE------IRFPRT 218 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH----HHHHHHHh----cCC------CCCCCC
Confidence 2334689999999999998999999999999999999999999965332 11111111 000 011111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002509 827 YDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 859 (914)
Q Consensus 827 ~~~~~~~~l~~l~~~C~~~~P~~RP-----sm~eVl~~ 859 (914)
. ...+.+++.+|++.||++|+ ++.|++++
T Consensus 219 ~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 219 L----SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred C----CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1 23577899999999999996 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=318.57 Aligned_cols=261 Identities=26% Similarity=0.397 Sum_probs=197.8
Q ss_pred HHHhccccccCcEEEEEEEEC-----CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeec--CceEEE
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLV 660 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-----~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~LV 660 (914)
+.+.+.||+|+||.||++..+ +++.||+|.+........+.+.+|++++++++||||+++++++... ...++|
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 85 (284)
T cd05081 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLV 85 (284)
T ss_pred ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEE
Confidence 345578999999999999753 5789999998766555566889999999999999999999987543 467899
Q ss_pred EEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccccc
Q 002509 661 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 740 (914)
Q Consensus 661 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 740 (914)
+||+++|+|.+++... ...+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||+++...
T Consensus 86 ~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 86 MEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999998543 34589999999999999999999998 99999999999999999999999999998664
Q ss_pred CCCCcee--eccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCccccccc------cc-c-hhHHHHHHHhh
Q 002509 741 DGASHVS--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG------AN-C-RNIVQWAKLHI 810 (914)
Q Consensus 741 ~~~~~~~--~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~------~~-~-~~l~~~~~~~~ 810 (914)
....... ....++..|+|||++.+..++.++|||||||+++||++|..++...... .. . ..+........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 4322211 1122345699999998888999999999999999999987765322100 00 0 00000000111
Q ss_pred hcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 002509 811 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 863 (914)
Q Consensus 811 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 863 (914)
..+. ...........+.+++.+|++.+|++||||+||++.|+.+
T Consensus 240 ~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 240 KNNG---------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hcCC---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1110 0001111234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=321.77 Aligned_cols=242 Identities=22% Similarity=0.323 Sum_probs=193.6
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhc-ccCceeEEEeeeeecCceEEEEEeccC
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
++||+|+||.||+|+.+ +++.||+|+++... ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 57899999987542 22334577888888876 799999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
|+|.+.+.. ...+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VT 152 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cc
Confidence 999988853 34588899999999999999999998 99999999999999999999999999987543222 22
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCc
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 826 (914)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+.. ..+.. ..+. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~----~~~~~i----~~~~~---~~p~---~ 218 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED----DLFESI----LHDDV---LYPV---W 218 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH----HHHHHH----HcCCC---CCCC---C
Confidence 23456899999999999889999999999999999999999999754321 222211 11110 0111 1
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCC-------CHHHHHHH
Q 002509 827 YDIQSMWKIEEKALMCVLPHGHMRP-------SISEVLKD 859 (914)
Q Consensus 827 ~~~~~~~~l~~l~~~C~~~~P~~RP-------sm~eVl~~ 859 (914)
...++.+++.+|++.+|++|| ++++++++
T Consensus 219 ----~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 219 ----LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred ----CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 113577899999999999999 88888765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=310.97 Aligned_cols=258 Identities=24% Similarity=0.365 Sum_probs=205.5
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc---ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEe
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 663 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~ 663 (914)
+.+.+.||+|++|.||+++.. +++.+|||.+..... .....+.+|+++++.++|+||+++++++..++..+++|||
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 83 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence 456678999999999999865 789999998865322 2345788999999999999999999999999999999999
Q ss_pred ccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCC
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 743 (914)
Q Consensus 664 ~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 743 (914)
+++++|.+++.........+++..++.++.|+++||+|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 999999999865433455689999999999999999999998 99999999999999999999999999987654322
Q ss_pred CceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCcc
Q 002509 744 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 823 (914)
Q Consensus 744 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 823 (914)
. ......|+..|+|||.+.+..++.++||||||+++|||++|..||...... ..+..... ... ..+.+
T Consensus 161 ~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~-~~~-----~~~~~ 228 (267)
T cd08229 161 T-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LYSLCKKI-EQC-----DYPPL 228 (267)
T ss_pred c-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-----HHHHhhhh-hcC-----CCCCC
Confidence 2 122345889999999998888999999999999999999999998643211 11111111 111 11111
Q ss_pred CCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 002509 824 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 863 (914)
Q Consensus 824 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 863 (914)
.. ......+.+++.+|++.+|++||||.+|++.++++
T Consensus 229 ~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 229 PS---DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred Cc---ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 11 12234688899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=330.57 Aligned_cols=251 Identities=22% Similarity=0.270 Sum_probs=195.8
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEE
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 662 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 662 (914)
.+.+.+.||+|+||.||+++.+ +++.||+|++.... ......+.+|+.+++.++||||+++++++..++..++|||
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05596 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVME 123 (370)
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEc
Confidence 3445678999999999999876 68899999997532 2233457789999999999999999999999999999999
Q ss_pred eccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCC
Q 002509 663 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 742 (914)
Q Consensus 663 ~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 742 (914)
|+++|+|.+++.. ..++......++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 124 y~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 124 YMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred CCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999998853 2467777888999999999999998 9999999999999999999999999999765433
Q ss_pred CCceeeccccCCcccCccccccC----CCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccc
Q 002509 743 ASHVSSIVRGTVGYLDPEYYISQ----QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 818 (914)
Q Consensus 743 ~~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i 818 (914)
.........||+.|+|||.+.+. .++.++|||||||++|||++|+.||....... ... ..........
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----~~~---~i~~~~~~~~- 267 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----TYS---KIMDHKNSLT- 267 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH----HHH---HHHcCCCcCC-
Confidence 22223345699999999998653 47889999999999999999999997544211 111 1111100000
Q ss_pred cCCccCCccCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 002509 819 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHM--RPSISEVLKD 859 (914)
Q Consensus 819 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~--RPsm~eVl~~ 859 (914)
... .......+.+++.+|++.+|++ ||+++|++++
T Consensus 268 ----~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 268 ----FPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ----CCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 000 0011235778899999999987 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=331.03 Aligned_cols=260 Identities=24% Similarity=0.407 Sum_probs=202.0
Q ss_pred HHHHHhccccccCcEEEEEEEEC------CCcEEEEEEEecCCc-ccchhhhHHHHHHhhcc-cCceeEEEeeeeecCce
Q 002509 586 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRS 657 (914)
Q Consensus 586 ~~~~~~~~lG~G~~G~Vy~~~~~------~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~ 657 (914)
....+.++||+|+||.||+|++. .++.||||+++.... ...+.+..|+++|.++. ||||++++++|...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 34446689999999999999864 346899999975432 22346889999999997 99999999999999999
Q ss_pred EEEEEeccCCChHHHhhcccC-----------------------------------------------------------
Q 002509 658 VLVYEFMHNGTLKEHLYGTLT----------------------------------------------------------- 678 (914)
Q Consensus 658 ~LV~E~~~~gsL~~~L~~~~~----------------------------------------------------------- 678 (914)
++|+||+++|+|.++++....
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 999999999999999964321
Q ss_pred -----------------------------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeC
Q 002509 679 -----------------------------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 723 (914)
Q Consensus 679 -----------------------------------~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~ 723 (914)
....++|...+.++.|++.||+|||+. +++||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEe
Confidence 112467888899999999999999998 999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCc-eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchh
Q 002509 724 KHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRN 801 (914)
Q Consensus 724 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~ 801 (914)
+++.+||+|||+++........ ......++..|+|||.+....++.++|||||||++|||++ |+.||......+ .
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~---~ 350 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE---Q 350 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH---H
Confidence 9999999999999765332211 1122346788999999998889999999999999999998 888886433111 1
Q ss_pred HHHHHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhH
Q 002509 802 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 864 (914)
Q Consensus 802 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 864 (914)
+.. .+..+... . .+.....++.+++.+|++.+|.+||+++||++.|++++
T Consensus 351 ~~~----~~~~~~~~-----~----~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 FYN----AIKRGYRM-----A----KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHH----HHHcCCCC-----C----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 111 11111100 0 01112246889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=318.13 Aligned_cols=261 Identities=23% Similarity=0.320 Sum_probs=193.8
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc-ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
+.+.+.||+|+||.||+|+.. +++.||||+++.... .....+.+|++++++++||||+++++++..+...++||||++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (303)
T cd07869 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH 86 (303)
T ss_pred ceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC
Confidence 445678999999999999887 689999999875432 223467789999999999999999999999999999999996
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 87 -~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 158 (303)
T cd07869 87 -TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-H 158 (303)
T ss_pred -cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-c
Confidence 5787777532 34578888999999999999999998 99999999999999999999999999987543221 1
Q ss_pred eeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhc---CCccc----
Q 002509 746 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES---GDIQG---- 817 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~---~~~~~---- 817 (914)
......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...... ....+........ .....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI---QDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH---HHHHHHHHHHhCCCChhhccchhhc
Confidence 2233457999999999865 45788999999999999999999999753211 1111111100000 00000
Q ss_pred -ccCCc-cC--CccCHH-------HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 818 -IIDPS-LL--DEYDIQ-------SMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 818 -i~d~~-l~--~~~~~~-------~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
..++. .. ...... ....+.+++.+|++.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00000 00 000000 11346789999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=319.13 Aligned_cols=264 Identities=22% Similarity=0.360 Sum_probs=199.9
Q ss_pred HHHHHHhccccccCcEEEEEEEECC---------------CcEEEEEEEecCC-cccchhhhHHHHHHhhcccCceeEEE
Q 002509 585 DATKMLEKKIGSGGFGVVYYGKLKD---------------GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFL 648 (914)
Q Consensus 585 ~~~~~~~~~lG~G~~G~Vy~~~~~~---------------g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~ 648 (914)
...+.+.+.||+|+||.||+++... ...||+|.++... ......|.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3455667899999999999987642 2348999987542 22345688999999999999999999
Q ss_pred eeeeecCceEEEEEeccCCChHHHhhcccC--------ccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCce
Q 002509 649 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLT--------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 720 (914)
Q Consensus 649 g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~--------~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NI 720 (914)
+++...+..++||||+++++|.+++..... ....+++..++.++.|+++||+|||+. +++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 999999999999999999999999854311 112478899999999999999999998 999999999999
Q ss_pred EeCCCCcEEEeeccccccccCCCCce-eeccccCCcccCccccccCCCCccCceeehHHHHHHHHh--CCCCcccccccc
Q 002509 721 LLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS--GQEAISNEKFGA 797 (914)
Q Consensus 721 Ll~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt--G~~p~~~~~~~~ 797 (914)
++++++.+||+|||++.......... .....++..|+|||.+..+.++.++|||||||+++||++ |..||.....
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~-- 238 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD-- 238 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh--
Confidence 99999999999999987654332111 122335678999999998889999999999999999998 5567654332
Q ss_pred cchhHHHHHHHhhhcCCc-ccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002509 798 NCRNIVQWAKLHIESGDI-QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862 (914)
Q Consensus 798 ~~~~l~~~~~~~~~~~~~-~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 862 (914)
..+.+........... .....+. .....+.+++.+|++.+|++||+|++|++.|++
T Consensus 239 --~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 239 --EQVIENTGEFFRNQGRQIYLSQTP-------LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred --HHHHHHHHHhhhhccccccCCCCC-------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1222221111111100 0000011 112468999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=316.60 Aligned_cols=250 Identities=26% Similarity=0.369 Sum_probs=198.5
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc---ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEec
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
+..++||+|+||.||++... +++.||+|++..... .....+.+|++++++++||||+++++.+..++..++||||+
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05605 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 82 (285)
T ss_pred eEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEecc
Confidence 34578999999999999875 689999999875422 22345778999999999999999999999999999999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 744 (914)
++|+|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||+++.......
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 83 NGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred CCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 999999988643 234689999999999999999999998 999999999999999999999999999876533221
Q ss_pred ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccC
Q 002509 745 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 824 (914)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||...........+.. .+....
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~----~~~~~~---------- 221 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER----RVKEDQ---------- 221 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHH----Hhhhcc----------
Confidence 1234589999999999988899999999999999999999999975432111111111 111110
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002509 825 DEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 859 (914)
Q Consensus 825 ~~~~~~~~~~l~~l~~~C~~~~P~~RP-----sm~eVl~~ 859 (914)
..+.......+.+++.+|++.||++|| ++++++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 011112233578899999999999999 88888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=311.59 Aligned_cols=254 Identities=26% Similarity=0.451 Sum_probs=204.2
Q ss_pred HHHHHhccccccCcEEEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 586 ATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 586 ~~~~~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
..+.+.++||+|+||.||+|..++++.+|||.+.... ....++.+|++++++++|+||+++++++......++||||++
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 3455678999999999999998888899999987543 235678999999999999999999999999899999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+++|.+++... ....+++..+..++.|++.||+|||++ +++|+||||+||+++.++.+||+|||+++........
T Consensus 85 ~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 85 KGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred CCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 99999999654 235689999999999999999999998 9999999999999999999999999998765432222
Q ss_pred eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCCccC
Q 002509 746 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 824 (914)
......++..|+|||.+.+..++.++|||||||+++|+++ |+.||..... ....+....... ...
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~----~~~~~~~~~~~~---------~~~- 225 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN----REVLEQVERGYR---------MPR- 225 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcCCC---------CCC-
Confidence 2222234678999999998889999999999999999998 9999864331 122222111100 000
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002509 825 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862 (914)
Q Consensus 825 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 862 (914)
+......+.+++.+|++.+|++||+++|+.+.|+.
T Consensus 226 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 ---PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 01113358899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=329.01 Aligned_cols=250 Identities=21% Similarity=0.226 Sum_probs=197.3
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc---ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEec
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
.+.+.||+|+||.||+++.. +++.||+|+++.... .....+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (330)
T cd05601 4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQ 83 (330)
T ss_pred eEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCC
Confidence 34578999999999999876 789999999975422 23456889999999999999999999999999999999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 744 (914)
++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 84 ~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 84 PGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999998643 24688899999999999999999998 999999999999999999999999999986654433
Q ss_pred ceeeccccCCcccCccccc------cCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccc
Q 002509 745 HVSSIVRGTVGYLDPEYYI------SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 818 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~------~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i 818 (914)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||......... ............
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~-------~~i~~~~~~~~~ 230 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY-------NNIMNFQRFLKF 230 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHH-------HHHHcCCCccCC
Confidence 3334456899999999986 456788999999999999999999999754321111 111111111100
Q ss_pred cCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 819 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 819 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.+ .......+.+++..|++ +|++||++++++++
T Consensus 231 ~~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 231 PE-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CC-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 00 00112346778888997 99999999999865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.21 Aligned_cols=254 Identities=26% Similarity=0.430 Sum_probs=199.8
Q ss_pred HhccccccCcEEEEEEEECC----CcEEEEEEEecCCc--ccchhhhHHHHHHhhcccCceeEEEeeeeecCc------e
Q 002509 590 LEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR------S 657 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~~----g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~------~ 657 (914)
+.+.||+|+||.||+|.... +..||+|+++.... .....+..|++.++.++||||+++++++..... .
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence 56789999999999998752 36799999875422 224578899999999999999999998876554 6
Q ss_pred EEEEEeccCCChHHHhhcccC--ccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccc
Q 002509 658 VLVYEFMHNGTLKEHLYGTLT--HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 735 (914)
Q Consensus 658 ~LV~E~~~~gsL~~~L~~~~~--~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 735 (914)
++++||+++|+|.+++..... ....+++...+.++.|++.||+|||+. +++||||||+||++++++.+||+|||+
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCccc
Confidence 899999999999999854321 234689999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCce-eeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcC
Q 002509 736 SKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESG 813 (914)
Q Consensus 736 a~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~ 813 (914)
++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||..... ..+.++... +
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~----~~~~~~~~~----~ 231 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN----HEIYDYLRH----G 231 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHc----C
Confidence 98654433221 122335678999999988889999999999999999999 8888864331 223332221 1
Q ss_pred CcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 002509 814 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 863 (914)
Q Consensus 814 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 863 (914)
... .. +......+.+++.+|++.+|++||++.||++.|+++
T Consensus 232 ~~~-----~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 NRL-----KQ----PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCC-----CC----CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111 11 112234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=310.87 Aligned_cols=247 Identities=26% Similarity=0.434 Sum_probs=194.8
Q ss_pred cccccCcEEEEEEEEC---CCcEEEEEEEecCCc-ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCC
Q 002509 593 KIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 668 (914)
Q Consensus 593 ~lG~G~~G~Vy~~~~~---~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gs 668 (914)
.||+|+||.||+|.+. .+..||+|++..... ...+.+.+|++++++++||||+++++++. ....++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999764 456799999875532 23456889999999999999999999885 456799999999999
Q ss_pred hHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCcee-
Q 002509 669 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS- 747 (914)
Q Consensus 669 L~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~- 747 (914)
|.+++... ...+++..++.++.|+++||+|||++ +++||||||+|||++.++.+||+|||+++..........
T Consensus 81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99998643 34688999999999999999999998 999999999999999999999999999975543322211
Q ss_pred -eccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCC
Q 002509 748 -SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 825 (914)
Q Consensus 748 -~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 825 (914)
....++..|+|||.+....++.++|||||||++||+++ |+.||..... ..+...+ ..+...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~----~~~~~~--------- 217 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG----PEVMSFI----EQGKRL--------- 217 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH----HHHHHHH----HCCCCC---------
Confidence 11223578999999988889999999999999999996 9999865432 1222211 111111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 002509 826 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 863 (914)
Q Consensus 826 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 863 (914)
..+.....++.+++.+|++.+|++||++.+|.+.|+..
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 11112234678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=314.11 Aligned_cols=252 Identities=25% Similarity=0.440 Sum_probs=200.0
Q ss_pred HHhccccccCcEEEEEEEEC-CC---cEEEEEEEecCC-cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEe
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DG---KEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 663 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g---~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~ 663 (914)
...+.||+|+||.||+|+.. ++ ..+|+|.++... ....+.+..|++++++++|+|++++.+++...+..++||||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (268)
T cd05063 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEY 87 (268)
T ss_pred eEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEc
Confidence 34578999999999999875 33 368999886542 23356788999999999999999999999999999999999
Q ss_pred ccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCC
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 743 (914)
Q Consensus 664 ~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 743 (914)
+++++|.+++... ...+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 88 MENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred CCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 9999999998643 34689999999999999999999998 99999999999999999999999999987654332
Q ss_pred Ccee--eccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccC
Q 002509 744 SHVS--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 820 (914)
Q Consensus 744 ~~~~--~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 820 (914)
.... .....+..|+|||++....++.++|||||||++||+++ |+.||..... ..+..... ......
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~----~~~~~~i~---~~~~~~---- 230 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN----HEVMKAIN---DGFRLP---- 230 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH----HHHHHHHh---cCCCCC----
Confidence 2211 11223457999999988889999999999999999997 9999864332 12222111 110000
Q ss_pred CccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 002509 821 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 863 (914)
Q Consensus 821 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 863 (914)
...+...++.+++.+|++.+|++||+|.+|++.|+++
T Consensus 231 ------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 231 ------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0112234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=316.43 Aligned_cols=261 Identities=25% Similarity=0.366 Sum_probs=206.2
Q ss_pred HHHHHHhccccccCcEEEEEEEECC-----CcEEEEEEEecCC-cccchhhhHHHHHHhhcccCceeEEEeeeee-cCce
Q 002509 585 DATKMLEKKIGSGGFGVVYYGKLKD-----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRS 657 (914)
Q Consensus 585 ~~~~~~~~~lG~G~~G~Vy~~~~~~-----g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~-~~~~ 657 (914)
...+.+.+.||+|+||.||+|...+ +..|++|++.... ......+.+|+.++++++|+||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 3445567899999999999998875 7889999987543 2335668899999999999999999998876 4678
Q ss_pred EEEEEeccCCChHHHhhcccCc----cccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeec
Q 002509 658 VLVYEFMHNGTLKEHLYGTLTH----EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 733 (914)
Q Consensus 658 ~LV~E~~~~gsL~~~L~~~~~~----~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 733 (914)
++++||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998654221 25689999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCCce-eeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhh
Q 002509 734 GLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIE 811 (914)
Q Consensus 734 Gla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~ 811 (914)
|+++.+....... .....++..|+|||++....++.++|||||||++||+++ |+.||..... ..+..+....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~~~-- 235 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP----FEMAAYLKDG-- 235 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH----HHHHHHHHcC--
Confidence 9998654433221 122346778999999988889999999999999999999 9999865331 2233322211
Q ss_pred cCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHh
Q 002509 812 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 812 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 865 (914)
.... . .......+.+++.+|++.+|++||++.||++.|+++..
T Consensus 236 -~~~~------~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 236 -YRLA------Q----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred -CCCC------C----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0100 0 01122357899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=309.21 Aligned_cols=258 Identities=26% Similarity=0.391 Sum_probs=206.5
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEe
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 663 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~ 663 (914)
+.+.+.||+|++|.||+|... +|+.||+|.++... ......+.+|++++++++|+|++++++++...+..++||||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence 345678999999999999887 89999999886432 22356788999999999999999999999999999999999
Q ss_pred ccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCC
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 743 (914)
Q Consensus 664 ~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 743 (914)
+++|+|.+++.........+++.+++.++.|+++||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 999999999865444456689999999999999999999998 99999999999999999999999999987654322
Q ss_pred CceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCcc
Q 002509 744 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 823 (914)
Q Consensus 744 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 823 (914)
.. .....++..|+|||.+.+..++.++|||||||++|||++|+.||..... .+.+.... ...+.... +
T Consensus 161 ~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~-~~~~~~~~-----~ 228 (267)
T cd08224 161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKK-IEKCDYPP-----L 228 (267)
T ss_pred cc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-----cHHHHHhh-hhcCCCCC-----C
Confidence 21 2234578899999999988899999999999999999999999854321 12221111 11111111 1
Q ss_pred CCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 002509 824 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 863 (914)
Q Consensus 824 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 863 (914)
. .......+.+++.+|+..+|++||++.+|++.|+++
T Consensus 229 ~---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 229 P---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred C---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 0 112234578999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=322.11 Aligned_cols=250 Identities=22% Similarity=0.304 Sum_probs=196.1
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCCc---ccchhhhHHHHHHhhc-ccCceeEEEeeeeecCceEEEEEeccC
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
+.||+|+||.||+++.+ +++.||+|+++.... .....+..|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999876 688999999975422 2234577899999888 799999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DT 152 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cc
Confidence 999988843 34689999999999999999999998 99999999999999999999999999987432211 22
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccc-cchhHHHHHHHhhhcCCcccccCCccCC
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA-NCRNIVQWAKLHIESGDIQGIIDPSLLD 825 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~-~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 825 (914)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||+.....+ ......++.......+.. .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~p~ 226 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RIPR 226 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CCCC
Confidence 234568999999999999999999999999999999999999996432111 011122222222222211 1111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 002509 826 EYDIQSMWKIEEKALMCVLPHGHMRPS------ISEVLKD 859 (914)
Q Consensus 826 ~~~~~~~~~l~~l~~~C~~~~P~~RPs------m~eVl~~ 859 (914)
.. ..++.+++.+|++.+|.+||+ ++|++++
T Consensus 227 ~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 227 SL----SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CC----CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 11 235788999999999999997 6788765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=314.94 Aligned_cols=251 Identities=25% Similarity=0.346 Sum_probs=195.2
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcc--------------cchhhhHHHHHHhhcccCceeEEEeee
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--------------GKREFTNEVTLLSRIHHRNLVQFLGYC 651 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~--------------~~~~f~~E~~~l~~l~HpnIv~l~g~~ 651 (914)
.|.+.+.||+|.||.|-+|+.. +++.||||++.+.... ..+...+|+.+|++++|||||+|+.+.
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL 177 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL 177 (576)
T ss_pred heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence 4556678999999999999876 7999999999654211 113677899999999999999999998
Q ss_pred eec--CceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEE
Q 002509 652 QEE--GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAK 729 (914)
Q Consensus 652 ~~~--~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~k 729 (914)
.+. +..|||+|||..|.+...= .....++..+..+++.++..||+|||.+ +|+||||||+|+||+++|++|
T Consensus 178 DDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 178 DDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred cCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEE
Confidence 764 5789999999999876532 1222389999999999999999999999 999999999999999999999
Q ss_pred EeeccccccccCCCCc----eeeccccCCcccCccccccCC----CCccCceeehHHHHHHHHhCCCCcccccccccchh
Q 002509 730 VSDFGLSKFAVDGASH----VSSIVRGTVGYLDPEYYISQQ----LTDKSDVYSFGVILLELISGQEAISNEKFGANCRN 801 (914)
Q Consensus 730 l~DFGla~~~~~~~~~----~~~~~~gt~~Y~aPE~~~~~~----~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~ 801 (914)
|+|||.+..+..+... ......||+.|+|||...++. .+.+.||||+||.||.|+.|+.||.+...-+....
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K 330 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK 330 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence 9999999766333211 112357999999999998743 34578999999999999999999975442221111
Q ss_pred HHHHHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002509 802 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 860 (914)
Q Consensus 802 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L 860 (914)
| +...+.-....+.-..+.+|++++++.||++|-+..+|..+.
T Consensus 331 I----------------vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 331 I----------------VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred H----------------hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 1 122221111223445688999999999999999999998763
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=297.63 Aligned_cols=202 Identities=30% Similarity=0.446 Sum_probs=178.9
Q ss_pred cCHHHHHHHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCccc---chhhhHHHHHHhhcccCceeEEEeeeee
Q 002509 578 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQFLGYCQE 653 (914)
Q Consensus 578 ~~~~ei~~~~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~---~~~f~~E~~~l~~l~HpnIv~l~g~~~~ 653 (914)
+++.|.+ +.+.||.|+||.|...+.+ +|..+|+|+++...... .+...+|..+|+.+.||.++++.+.+.+
T Consensus 41 ~~l~dfe-----~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d 115 (355)
T KOG0616|consen 41 YSLQDFE-----RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD 115 (355)
T ss_pred cchhhhh-----heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence 4555543 4568999999999999987 68889999998664332 3446789999999999999999999999
Q ss_pred cCceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeec
Q 002509 654 EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 733 (914)
Q Consensus 654 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 733 (914)
.+..++||||+++|.|..+|+ ..++++......+|.||+.||+|||+. .|++|||||+|||||++|.+||.||
T Consensus 116 ~~~lymvmeyv~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDF 188 (355)
T KOG0616|consen 116 NSNLYMVMEYVPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDF 188 (355)
T ss_pred CCeEEEEEeccCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEec
Confidence 999999999999999999996 356789999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccc
Q 002509 734 GLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF 795 (914)
Q Consensus 734 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~ 795 (914)
|+|+..... +...+||+.|+|||.+....+..++|-|||||++|||+.|..||.....
T Consensus 189 GFAK~v~~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 189 GFAKRVSGR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred cceEEecCc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 999876432 4567899999999999999999999999999999999999999976553
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=327.78 Aligned_cols=249 Identities=21% Similarity=0.294 Sum_probs=191.1
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc---ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
+.+.||+|+||+||+|+.. +++.||+|+++.... .....+..|++++.+++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~ 84 (381)
T cd05626 5 KIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP 84 (381)
T ss_pred EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCC
Confidence 4468999999999999875 688999999975422 234568899999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC-
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS- 744 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~- 744 (914)
+|+|.+++.. ...+++.....++.|++.||+|||+. +|+||||||+|||++.++++||+|||+++.......
T Consensus 85 gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 85 GGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 9999999853 34578888889999999999999998 999999999999999999999999999753311000
Q ss_pred ---------------------------------------------ceeeccccCCcccCccccccCCCCccCceeehHHH
Q 002509 745 ---------------------------------------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVI 779 (914)
Q Consensus 745 ---------------------------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvv 779 (914)
.......||+.|+|||.+.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 00123469999999999998889999999999999
Q ss_pred HHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHH--ccCCCCCCCCCHHHHH
Q 002509 780 LLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALM--CVLPHGHMRPSISEVL 857 (914)
Q Consensus 780 l~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~--C~~~~P~~RPsm~eVl 857 (914)
+|||++|+.||......+....+..|. .... +.+ ....+. ++.+++.+ |...+|..||+++|++
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~------~~~~--~~~--~~~~s~----~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWE------NTLH--IPP--QVKLSP----EAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHccc------cccC--CCC--CCCCCH----HHHHHHHHHccCcccccCCCCHHHHh
Confidence 999999999997543221111111110 0000 000 001122 34455544 6677777899999999
Q ss_pred HH
Q 002509 858 KD 859 (914)
Q Consensus 858 ~~ 859 (914)
++
T Consensus 304 ~h 305 (381)
T cd05626 304 AH 305 (381)
T ss_pred cC
Confidence 86
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=318.82 Aligned_cols=241 Identities=26% Similarity=0.372 Sum_probs=189.0
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhc-ccCceeEEEeeeeecCceEEEEEeccC
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
+.||+|+||.||+|+.+ +++.||+|+++... ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999876 57889999997542 22234455666666654 899999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
|+|.+++.. ...+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 999998853 34578888999999999999999998 99999999999999999999999999997543322 22
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCc
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 826 (914)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+..-+ .... +.+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~----~~~~~~i----~~~~------~~~~~- 217 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE----DELFDSI----LNDR------PHFPR- 217 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH----HHHHHHH----HcCC------CCCCC-
Confidence 2345689999999999988999999999999999999999999975432 1121111 1100 11111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 002509 827 YDIQSMWKIEEKALMCVLPHGHMRPSIS-EVLK 858 (914)
Q Consensus 827 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~-eVl~ 858 (914)
.....+.+++.+|++.+|++||++. ++.+
T Consensus 218 ---~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 218 ---WISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred ---CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1123467889999999999999975 4544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=341.51 Aligned_cols=253 Identities=25% Similarity=0.346 Sum_probs=200.6
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeeecC--------
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-------- 655 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~-------- 655 (914)
.|.+.+.||+|+||+||+++.. +|+.||||++.... ......+.+|+..+..++|+|++++...+...+
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~ 112 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL 112 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence 4556789999999999999765 78999999987542 233456788999999999999999988765432
Q ss_pred ceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccc
Q 002509 656 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 735 (914)
Q Consensus 656 ~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 735 (914)
..++||||+++|+|.+++.........+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 35799999999999999976544456788999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCC-ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCC
Q 002509 736 SKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 814 (914)
Q Consensus 736 a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 814 (914)
++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. .... .+.
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~----~~~---~~~~-~~~ 261 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME----EVM---HKTL-AGR 261 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH----HHH---HHHh-cCC
Confidence 976543221 2223456999999999999999999999999999999999999999754321 111 1111 111
Q ss_pred cccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 815 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 815 ~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
... +.. ....++.+++.+|++.+|++||++.+++++
T Consensus 262 ~~~-----~~~----~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 262 YDP-----LPP----SISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCC-----CCC----CCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 110 111 122358889999999999999999999864
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=325.69 Aligned_cols=263 Identities=20% Similarity=0.293 Sum_probs=192.2
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecC--CcccchhhhHHHHHHhhcccCceeEEEeeeeecC-----ceEEE
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-----RSVLV 660 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~-----~~~LV 660 (914)
.+.++||+|+||.||+|+.+ +++.||||+++.. .......+.+|++++++++||||+++++++.... ..++|
T Consensus 3 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv 82 (338)
T cd07859 3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 82 (338)
T ss_pred EEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEE
Confidence 45678999999999999876 6899999998743 2223456889999999999999999999886432 47999
Q ss_pred EEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccccc
Q 002509 661 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 740 (914)
Q Consensus 661 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 740 (914)
|||+. ++|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 83 FELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 99996 688888753 34588999999999999999999998 99999999999999999999999999997543
Q ss_pred CCCC--ceeeccccCCcccCcccccc--CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHH-------Hh
Q 002509 741 DGAS--HVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK-------LH 809 (914)
Q Consensus 741 ~~~~--~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~-------~~ 809 (914)
.... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||...........+..... ..
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2211 11233468999999999875 6789999999999999999999999965432110000000000 00
Q ss_pred hhcCCcccc---cCCccCCccC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 810 IESGDIQGI---IDPSLLDEYD---IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 810 ~~~~~~~~i---~d~~l~~~~~---~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+......+. +.+....... ......+.+++.+|++.+|++||+++|++++
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000 0000000000 0112356789999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=328.18 Aligned_cols=250 Identities=22% Similarity=0.287 Sum_probs=192.3
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEe
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 663 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~ 663 (914)
+.+.+.||+|+||.||+++.+ +++.+|+|++.... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 45 y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey 124 (370)
T cd05621 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEY 124 (370)
T ss_pred CeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcC
Confidence 445578999999999999887 58899999986432 22345578899999999999999999999999999999999
Q ss_pred ccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCC
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 743 (914)
Q Consensus 664 ~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 743 (914)
+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 125 ~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 125 MPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred CCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 999999999853 3477888899999999999999998 99999999999999999999999999998654332
Q ss_pred CceeeccccCCcccCccccccC----CCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCccccc
Q 002509 744 SHVSSIVRGTVGYLDPEYYISQ----QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 819 (914)
Q Consensus 744 ~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 819 (914)
........||+.|+|||++.+. .++.++|||||||++|||++|+.||......+. + ...........
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~---~----~~i~~~~~~~~-- 267 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT---Y----SKIMDHKNSLN-- 267 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH---H----HHHHhCCcccC--
Confidence 2223345699999999999754 378899999999999999999999975432111 1 11111110000
Q ss_pred CCccCCccCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 002509 820 DPSLLDEYDIQSMWKIEEKALMCVLPHGHM--RPSISEVLKD 859 (914)
Q Consensus 820 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~--RPsm~eVl~~ 859 (914)
... .......+.+++..|+..++.+ ||++.|++++
T Consensus 268 ---~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 268 ---FPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ---CCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 000 0111234567777888755543 8999999886
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=314.80 Aligned_cols=251 Identities=24% Similarity=0.412 Sum_probs=195.6
Q ss_pred HhccccccCcEEEEEEEEC-CCc----EEEEEEEecCCc-ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEe
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 663 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~----~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~ 663 (914)
+.+.||+|+||.||+|.+. +++ .+++|.+..... ....++..|+..+++++||||+++++++.. ...++++||
T Consensus 11 ~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~ 89 (279)
T cd05111 11 KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQL 89 (279)
T ss_pred eccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEe
Confidence 4578999999999999875 344 477777754322 223567788889999999999999998864 456789999
Q ss_pred ccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCC
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 743 (914)
Q Consensus 664 ~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 743 (914)
+++|+|.+++... ...++|..++.++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++......
T Consensus 90 ~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 90 SPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred CCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 9999999999643 34689999999999999999999998 89999999999999999999999999998654332
Q ss_pred C-ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCC
Q 002509 744 S-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 821 (914)
Q Consensus 744 ~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 821 (914)
. .......++..|+|||.+.++.++.++|||||||++||+++ |+.||..... ..+.+.. ..+... ..+
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~----~~~~~~~----~~~~~~--~~~ 233 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP----HEVPDLL----EKGERL--AQP 233 (279)
T ss_pred cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHH----HCCCcC--CCC
Confidence 2 22233457789999999998899999999999999999998 9999865431 1222222 112111 111
Q ss_pred ccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhH
Q 002509 822 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 864 (914)
Q Consensus 822 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 864 (914)
.. ....+.+++.+|+..+|++||++.|+++.|+.+.
T Consensus 234 ~~-------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 234 QI-------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred CC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 11 1124677889999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=316.35 Aligned_cols=263 Identities=23% Similarity=0.378 Sum_probs=200.1
Q ss_pred HHHHhccccccCcEEEEEEEEC-----------------CCcEEEEEEEecCC-cccchhhhHHHHHHhhcccCceeEEE
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-----------------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFL 648 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-----------------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~ 648 (914)
.+.+.++||+|+||.||++... ++..+|+|+++... ......+.+|++++++++|+||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~ 85 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL 85 (296)
T ss_pred hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 3556789999999999998543 24468999987543 23346789999999999999999999
Q ss_pred eeeeecCceEEEEEeccCCChHHHhhcccC-------ccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceE
Q 002509 649 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLT-------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 721 (914)
Q Consensus 649 g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~-------~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NIL 721 (914)
+++...+..++||||+++|+|.+++..... ....+++.+++.++.|++.||+|||+. +++||||||+|||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nil 162 (296)
T cd05095 86 AVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCL 162 (296)
T ss_pred EEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEE
Confidence 999999999999999999999999865322 123578889999999999999999998 9999999999999
Q ss_pred eCCCCcEEEeeccccccccCCCCce-eeccccCCcccCccccccCCCCccCceeehHHHHHHHHh--CCCCccccccccc
Q 002509 722 LDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS--GQEAISNEKFGAN 798 (914)
Q Consensus 722 l~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt--G~~p~~~~~~~~~ 798 (914)
++.++.+||+|||+++......... .....++..|++||....+.++.++|||||||++|||++ |..||......
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~-- 240 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE-- 240 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH--
Confidence 9999999999999987654332211 112234678999999888889999999999999999998 66777543322
Q ss_pred chhHHHHHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002509 799 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862 (914)
Q Consensus 799 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 862 (914)
.+............... ..+. +..+...+.+++.+|++.+|++||+|.||++.|++
T Consensus 241 --~~~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 --QVIENTGEFFRDQGRQV-YLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred --HHHHHHHHHHhhccccc-cCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 12211111111111000 0000 11122468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=312.48 Aligned_cols=254 Identities=28% Similarity=0.441 Sum_probs=196.8
Q ss_pred HhccccccCcEEEEEEEECCC-c--EEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeeec------CceE
Q 002509 590 LEKKIGSGGFGVVYYGKLKDG-K--EIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSV 658 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~~g-~--~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~------~~~~ 658 (914)
+.+.||+|+||.||+|+..+. . .+|+|.++... ....+.+..|++++++++|+||++++++|... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 457899999999999987643 2 58999886542 23356788999999999999999999988532 2468
Q ss_pred EEEEeccCCChHHHhhccc--CccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccc
Q 002509 659 LVYEFMHNGTLKEHLYGTL--THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 736 (914)
Q Consensus 659 LV~E~~~~gsL~~~L~~~~--~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 736 (914)
+++||+++|+|.+++.... .....+++.....++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence 9999999999999874221 1234589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCce-eeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCC
Q 002509 737 KFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGD 814 (914)
Q Consensus 737 ~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 814 (914)
+......... .....++..|+|||+..+..++.++|||||||++|||++ |+.||..... ..+.+. ...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~~~~~----~~~~~ 231 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN----SEIYDY----LRQGN 231 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHH----HHcCC
Confidence 8654332211 122345778999999998899999999999999999999 7888864321 122221 12221
Q ss_pred cccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 002509 815 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 863 (914)
Q Consensus 815 ~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 863 (914)
... . .......+.+++.+|++.+|++||++.|+++.|+++
T Consensus 232 ~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RLK-----Q----PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC-----C----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111 0 111223578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=319.16 Aligned_cols=261 Identities=25% Similarity=0.433 Sum_probs=203.9
Q ss_pred HHHHHhccccccCcEEEEEEEEC--------CCcEEEEEEEecCC-cccchhhhHHHHHHhhc-ccCceeEEEeeeeecC
Q 002509 586 ATKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG 655 (914)
Q Consensus 586 ~~~~~~~~lG~G~~G~Vy~~~~~--------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~ 655 (914)
..+.+.+.||+|+||.||+++.. ++..+|+|.++... ......+..|++++.++ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 45567789999999999999753 23569999987542 23345688899999999 7999999999999999
Q ss_pred ceEEEEEeccCCChHHHhhcccC------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeC
Q 002509 656 RSVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 723 (914)
Q Consensus 656 ~~~LV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~ 723 (914)
..++||||+++|+|.+++..... ....++|.+++.++.|++.||+|||+. +++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence 99999999999999999965421 224589999999999999999999998 999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCce-eeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchh
Q 002509 724 KHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRN 801 (914)
Q Consensus 724 ~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~ 801 (914)
.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ..
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~----~~ 250 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----EE 250 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH----HH
Confidence 99999999999987553221111 111224568999999988889999999999999999998 8888864331 12
Q ss_pred HHHHHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHhH
Q 002509 802 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 866 (914)
Q Consensus 802 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 866 (914)
+.+. ...+...+ .+.....++.+++.+|++.+|++||+|.||++.|++++..
T Consensus 251 ~~~~----~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 251 LFKL----LKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHH----HHcCCCCC---------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 2221 11111110 1112234677899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=327.87 Aligned_cols=259 Identities=20% Similarity=0.261 Sum_probs=193.9
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
.|.+.+.||+|+||.||++... .++.||+|... ...+.+|++++++++||||+++++++......++|+|++.
T Consensus 93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 3555678999999999999875 68899999743 2356789999999999999999999999999999999985
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
++|.+++.. ...+++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 167 -~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 167 -TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred -CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 688888743 34588999999999999999999998 9999999999999999999999999999754333222
Q ss_pred eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccc-cc---cchhHHHHHHHh---hhc------
Q 002509 746 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF-GA---NCRNIVQWAKLH---IES------ 812 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~-~~---~~~~l~~~~~~~---~~~------ 812 (914)
......||+.|+|||++.+..++.++|||||||++|||++|+.|+..... .. ....+....... ..+
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 33345699999999999998999999999999999999999988643211 10 011111111000 000
Q ss_pred CCccccc---------CCccCCcc--CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 813 GDIQGII---------DPSLLDEY--DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 813 ~~~~~i~---------d~~l~~~~--~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
..+.+.. .+...... .......+.+++.+|++.||++|||++|++++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000 00000000 01223467889999999999999999999863
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=316.33 Aligned_cols=263 Identities=25% Similarity=0.399 Sum_probs=203.3
Q ss_pred HHHHhccccccCcEEEEEEEECC-----------------CcEEEEEEEecCCc-ccchhhhHHHHHHhhcccCceeEEE
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLKD-----------------GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFL 648 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~~-----------------g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~ 648 (914)
.+.+.+.||+|+||.||+++..+ +..||+|++..... .....+.+|++++++++||||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 85 (296)
T cd05051 6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLL 85 (296)
T ss_pred hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 34566899999999999987652 24589999875532 3456788999999999999999999
Q ss_pred eeeeecCceEEEEEeccCCChHHHhhcccC-------ccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceE
Q 002509 649 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLT-------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 721 (914)
Q Consensus 649 g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~-------~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NIL 721 (914)
+++..++..++++||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nil 162 (296)
T cd05051 86 GVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCL 162 (296)
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhcee
Confidence 999999999999999999999999965431 123689999999999999999999998 9999999999999
Q ss_pred eCCCCcEEEeeccccccccCCCC-ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh--CCCCccccccccc
Q 002509 722 LDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS--GQEAISNEKFGAN 798 (914)
Q Consensus 722 l~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt--G~~p~~~~~~~~~ 798 (914)
++.++.++|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..|+.....
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~--- 239 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD--- 239 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh---
Confidence 99999999999999876543321 12223346788999999988889999999999999999998 6677754332
Q ss_pred chhHHHHHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002509 799 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862 (914)
Q Consensus 799 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 862 (914)
..+.+...............+ .......++.+++.+|++.+|++||+|.||++.|++
T Consensus 240 -~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 -QQVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred -HHHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 223333322222211111111 111122468999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=310.41 Aligned_cols=246 Identities=28% Similarity=0.420 Sum_probs=194.6
Q ss_pred cccccCcEEEEEEEEC---CCcEEEEEEEecCCc--ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCC
Q 002509 593 KIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 667 (914)
Q Consensus 593 ~lG~G~~G~Vy~~~~~---~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 667 (914)
.||+|+||.||+|.++ +++.+|+|+++.... ...+++.+|+.++++++||||+++++++.. +..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 5899999999999653 578899999864432 234678899999999999999999998864 5678999999999
Q ss_pred ChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCcee
Q 002509 668 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 747 (914)
Q Consensus 668 sL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 747 (914)
+|.+++.. ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++..........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999853 34588999999999999999999998 999999999999999999999999999976544332211
Q ss_pred --eccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCCccC
Q 002509 748 --SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824 (914)
Q Consensus 748 --~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 824 (914)
....++..|+|||.+....++.++|||||||++|||++ |+.||..... ..+.+.. +.+.... ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~i----~~~~~~~-----~~ 220 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG----NEVTQMI----ESGERME-----CP 220 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHH----HCCCCCC-----CC
Confidence 12234578999999988888999999999999999998 9999865432 1222222 1111111 11
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 002509 825 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 863 (914)
Q Consensus 825 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 863 (914)
. ....++.+++.+|++.+|++||+|.+|++.|++.
T Consensus 221 ~----~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 221 Q----RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred C----CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1 1223578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=310.64 Aligned_cols=254 Identities=23% Similarity=0.402 Sum_probs=203.2
Q ss_pred HHHHHHhccccccCcEEEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEec
Q 002509 585 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 585 ~~~~~~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
...+.+.++||+|+||.||++...++..+|+|.+.... .....+.+|++++++++|+||+++.+++.. ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 34456778999999999999998888889999886542 234678899999999999999999999887 7789999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 744 (914)
++|+|.+++... ....+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 83 AKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 999999999654 244678899999999999999999998 999999999999999999999999999876543322
Q ss_pred ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCCcc
Q 002509 745 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 823 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 823 (914)
.......++..|+|||++....++.++|+|||||+++|+++ |+.||..... ..+.++.. .+.... .
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~----~~~~~~~~----~~~~~~-----~ 224 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN----PEVIRALE----RGYRMP-----R 224 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHh----CCCCCC-----C
Confidence 22223345678999999998889999999999999999999 8989864331 12222221 111100 0
Q ss_pred CCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002509 824 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862 (914)
Q Consensus 824 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 862 (914)
.. .....+.+++.+|++.+|++||++.++.+.|+.
T Consensus 225 ~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 PE----NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred cc----cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01 122358899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=325.93 Aligned_cols=243 Identities=24% Similarity=0.286 Sum_probs=195.8
Q ss_pred HHHhccccccCcEEEEEEEECC--CcEEEEEEEecCC---cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEE
Q 002509 588 KMLEKKIGSGGFGVVYYGKLKD--GKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 662 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~~--g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 662 (914)
+.+.+.||+|+||.||+|+.+. +..||+|++.... ......+.+|++++..++||||+++++++.+.+..++|||
T Consensus 32 y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~E 111 (340)
T PTZ00426 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLE 111 (340)
T ss_pred cEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEe
Confidence 4566899999999999998653 3689999986532 2234567889999999999999999999999999999999
Q ss_pred eccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCC
Q 002509 663 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 742 (914)
Q Consensus 663 ~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 742 (914)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 112 y~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 112 FVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 9999999999853 34588889999999999999999998 9999999999999999999999999999765322
Q ss_pred CCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCc
Q 002509 743 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 822 (914)
Q Consensus 743 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 822 (914)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+ .+..+.. .+.
T Consensus 185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~----~~~~----~i~~~~~--~~p-- 248 (340)
T PTZ00426 185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL----LIYQ----KILEGII--YFP-- 248 (340)
T ss_pred ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH----HHHH----HHhcCCC--CCC--
Confidence 12346899999999999888999999999999999999999999754311 1111 1111111 011
Q ss_pred cCCccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002509 823 LLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 859 (914)
Q Consensus 823 l~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----sm~eVl~~ 859 (914)
...+ ..+.+++.+|++.+|++|+ +++|++++
T Consensus 249 --~~~~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 249 --KFLD----NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred --CCCC----HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1111 2467899999999999995 89998876
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=330.81 Aligned_cols=248 Identities=22% Similarity=0.332 Sum_probs=193.8
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
+.+.||+|+||.||+++.. +++.||||++.... ......+.+|++++..++||||+++++++..++..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (364)
T cd05599 5 SIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLP 84 (364)
T ss_pred EEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCC
Confidence 4578999999999999876 68999999997542 2233557889999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 85 ~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 85 GGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 9999999853 34588999999999999999999998 9999999999999999999999999998654221100
Q ss_pred -------------------------------------eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCC
Q 002509 746 -------------------------------------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 788 (914)
Q Consensus 746 -------------------------------------~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~ 788 (914)
......||+.|+|||++....++.++|||||||++|||++|+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0112358999999999999899999999999999999999999
Q ss_pred CcccccccccchhHHHHHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 002509 789 AISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS---ISEVLKD 859 (914)
Q Consensus 789 p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPs---m~eVl~~ 859 (914)
||......+....+..|.. .+ . ..... .. ...+.+++.+|+. +|.+|++ ++|++++
T Consensus 238 Pf~~~~~~~~~~~i~~~~~------~~-~-~~~~~--~~----s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 238 PFCSDNPQETYRKIINWKE------TL-Q-FPDEV--PL----SPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCHHHHHHHHHcCCC------cc-C-CCCCC--CC----CHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9975442221122221110 00 0 00000 11 1245677777886 8999997 9998875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=311.08 Aligned_cols=248 Identities=23% Similarity=0.365 Sum_probs=193.9
Q ss_pred ccccCcEEEEEEEEC-CCcEEEEEEEecCCc---ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCCh
Q 002509 594 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 669 (914)
Q Consensus 594 lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 669 (914)
||+|+||.||+++.+ +|+.+|+|.+..... .....+..|++++++++||||+++++++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999876 689999999864321 2234556799999999999999999999999999999999999999
Q ss_pred HHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCceeec
Q 002509 670 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 749 (914)
Q Consensus 670 ~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 749 (914)
.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 9888543 234588999999999999999999998 99999999999999999999999999987654322 2233
Q ss_pred cccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccCH
Q 002509 750 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 829 (914)
Q Consensus 750 ~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 829 (914)
..|+..|+|||++.+..++.++|||||||++|||++|+.||...........+ ...... ... .. ....+
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~---~~~~~~-~~~----~~-~~~~~-- 222 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL---KRRTLE-DEV----KF-EHQNF-- 222 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH---HHHhhc-ccc----cc-ccccC--
Confidence 45899999999999888999999999999999999999998643211111111 111111 111 00 00111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002509 830 QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861 (914)
Q Consensus 830 ~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 861 (914)
..++.+++..|++.+|++||+++|+++.+.
T Consensus 223 --~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 223 --TEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred --CHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 234788999999999999999987765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=318.28 Aligned_cols=258 Identities=27% Similarity=0.430 Sum_probs=199.5
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcE--EEEEEEecCC-cccchhhhHHHHHHhhc-ccCceeEEEeeeeecCceEEEEE
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKE--IAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 662 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~--vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E 662 (914)
+.+.+.||+|+||.||+|..+ ++.. +++|.++... ......+.+|++++.++ +|+||+++++++...+..++|||
T Consensus 9 ~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 88 (303)
T cd05088 9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 88 (303)
T ss_pred ceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEE
Confidence 346688999999999999875 4544 5777765432 23345788999999999 89999999999999999999999
Q ss_pred eccCCChHHHhhcccC------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEE
Q 002509 663 FMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 730 (914)
Q Consensus 663 ~~~~gsL~~~L~~~~~------------~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 730 (914)
|+++|+|.++++.... ....+++.+++.++.|+++||+|||++ +++||||||+|||+++++.+||
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl 165 (303)
T cd05088 89 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI 165 (303)
T ss_pred eCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEEe
Confidence 9999999999964321 123588999999999999999999998 9999999999999999999999
Q ss_pred eeccccccccCCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHh
Q 002509 731 SDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH 809 (914)
Q Consensus 731 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 809 (914)
+|||+++...... ......++..|+|||++.+..++.++|||||||+++||++ |..||..... ..+.+..
T Consensus 166 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~~~~~--- 236 (303)
T cd05088 166 ADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----AELYEKL--- 236 (303)
T ss_pred CccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh----HHHHHHH---
Confidence 9999986322111 1111224668999999988889999999999999999998 9999864332 1222211
Q ss_pred hhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHhHh
Q 002509 810 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 867 (914)
Q Consensus 810 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~~ 867 (914)
..+.. ... .......+.+++.+|++.+|++||+++++++.|++++..+
T Consensus 237 -~~~~~-----~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 237 -PQGYR-----LEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred -hcCCc-----CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11100 000 1111235788999999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=307.46 Aligned_cols=247 Identities=24% Similarity=0.395 Sum_probs=200.9
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecC--CcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
+.+.||+|++|.||+++.+ +++.|++|.+... .......+.+|++++++++||||+++++++...+..++||||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08529 4 ILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAEN 83 (256)
T ss_pred EeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCC
Confidence 4578999999999999876 6899999998643 233456788999999999999999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
++|.++++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++........
T Consensus 84 ~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~- 157 (256)
T cd08529 84 GDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF- 157 (256)
T ss_pred CcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccch-
Confidence 9999999753 245688999999999999999999998 9999999999999999999999999998765443222
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCc
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 826 (914)
.....|+..|+|||+..+..++.++|||||||+++||++|+.||..... ..+.... ..+.... +..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~----~~~~~~~-----~~~- 223 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ----GALILKI----IRGVFPP-----VSQ- 223 (256)
T ss_pred hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH----HcCCCCC-----Ccc-
Confidence 2334588999999999998899999999999999999999999965431 1111111 1111111 111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 827 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 827 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.....+.+++.+|++.+|++||+|.|++++
T Consensus 224 ---~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 224 ---MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ---ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 223468899999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=313.28 Aligned_cols=256 Identities=26% Similarity=0.436 Sum_probs=202.6
Q ss_pred HHHHhccccccCcEEEEEEEECC------CcEEEEEEEecCC-cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEE
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 659 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~~------g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~L 659 (914)
.+.+.+.||+|+||.||+|..++ +..||+|.+.... ......+.+|+++++.++||||+++++++......++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~ 86 (277)
T cd05032 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLV 86 (277)
T ss_pred HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEE
Confidence 44456789999999999998652 4689999986543 2334578899999999999999999999999999999
Q ss_pred EEEeccCCChHHHhhcccCc------cccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeec
Q 002509 660 VYEFMHNGTLKEHLYGTLTH------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 733 (914)
Q Consensus 660 V~E~~~~gsL~~~L~~~~~~------~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 733 (914)
||||+++|+|.+++...... ...++|..++.++.|++.||.|||+. +++||||||+||+++.++.+||+||
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~df 163 (277)
T cd05032 87 VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDF 163 (277)
T ss_pred EEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECCc
Confidence 99999999999999654321 23478999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCCc-eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhh
Q 002509 734 GLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIE 811 (914)
Q Consensus 734 Gla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~ 811 (914)
|+++........ ......++..|+|||.+.+..++.++|||||||++||+++ |+.||..... ..+.++..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~----~~~~~~~~---- 235 (277)
T cd05032 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN----EEVLKFVI---- 235 (277)
T ss_pred ccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH----HHHHHHHh----
Confidence 998765433221 1223346789999999988889999999999999999998 8888864332 22223221
Q ss_pred cCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002509 812 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862 (914)
Q Consensus 812 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 862 (914)
.+.... ... .....+.+++.+|++.+|++|||+.|+++.|++
T Consensus 236 ~~~~~~-----~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 DGGHLD-----LPE----NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred cCCCCC-----CCC----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111111 111 113468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=320.65 Aligned_cols=242 Identities=26% Similarity=0.381 Sum_probs=192.4
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhc-ccCceeEEEeeeeecCceEEEEEeccC
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
+.||+|+||.||+++.+ +++.||||+++... ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999876 68899999987542 22345567788888876 699999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~ 152 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT 152 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence 999998853 34588899999999999999999998 99999999999999999999999999987532221 22
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCc
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 826 (914)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ..+.+.. ..+.. ..+ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~----~~~~~~i----~~~~~---~~~---~~ 218 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE----DDLFEAI----LNDEV---VYP---TW 218 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH----HHHHHHH----hcCCC---CCC---CC
Confidence 2345689999999999988999999999999999999999999975432 1222211 11111 011 11
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 002509 827 YDIQSMWKIEEKALMCVLPHGHMRPSI------SEVLKD 859 (914)
Q Consensus 827 ~~~~~~~~l~~l~~~C~~~~P~~RPsm------~eVl~~ 859 (914)
....+.+++.+|++.||++||++ ++++++
T Consensus 219 ----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 219 ----LSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred ----CCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 12357789999999999999998 666554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=317.53 Aligned_cols=263 Identities=23% Similarity=0.429 Sum_probs=205.7
Q ss_pred HHHHHHhccccccCcEEEEEEEEC--------CCcEEEEEEEecCC-cccchhhhHHHHHHhhc-ccCceeEEEeeeeec
Q 002509 585 DATKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE 654 (914)
Q Consensus 585 ~~~~~~~~~lG~G~~G~Vy~~~~~--------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~ 654 (914)
...+.+.+.||+|+||.||+++.. ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 344456789999999999999742 34579999987542 23356788999999999 899999999999999
Q ss_pred CceEEEEEeccCCChHHHhhcccC------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEe
Q 002509 655 GRSVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 722 (914)
Q Consensus 655 ~~~~LV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl 722 (914)
+..++||||+++|+|.+++..... ....++|.+++.++.|+++||+|||++ +++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 999999999999999999965321 134688999999999999999999998 99999999999999
Q ss_pred CCCCcEEEeeccccccccCCCCc-eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccch
Q 002509 723 DKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCR 800 (914)
Q Consensus 723 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~ 800 (914)
++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||..... .
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~ 246 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----E 246 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH----H
Confidence 99999999999999765432222 1222345678999999988889999999999999999998 7788764332 1
Q ss_pred hHHHHHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHhHh
Q 002509 801 NIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 867 (914)
Q Consensus 801 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~~ 867 (914)
.+.+. ...+.... ........+.+++.+|++.+|++||+|.||++.|++++...
T Consensus 247 ~~~~~----~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 247 ELFKL----LKEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred HHHHH----HHcCCcCC---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 22221 11111100 01122345788999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=313.09 Aligned_cols=254 Identities=26% Similarity=0.485 Sum_probs=201.0
Q ss_pred HHHHhccccccCcEEEEEEEEC-CC---cEEEEEEEecC-CcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEE
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DG---KEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 661 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g---~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 661 (914)
.+.+.+.||+|+||.||+|+.. ++ ..||||++... .......|..|++++++++||||+++++++..+...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 3456789999999999999876 33 35999998754 2333567999999999999999999999999999999999
Q ss_pred EeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccC
Q 002509 662 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 741 (914)
Q Consensus 662 E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 741 (914)
||+++|+|.+++... ...+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 85 EFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999998643 34588999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCcee--eccc--cCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcc
Q 002509 742 GASHVS--SIVR--GTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQ 816 (914)
Q Consensus 742 ~~~~~~--~~~~--gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 816 (914)
...... .... .+..|+|||++.+..++.++|||||||++||+++ |..||..... ..+..++.... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~----~~~~~~i~~~~---~~~ 231 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN----QDVINAIEQDY---RLP 231 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH----HHHHHHHHcCC---cCC
Confidence 322111 1111 2457999999998899999999999999999886 9999864331 23333321110 000
Q ss_pred cccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 002509 817 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 863 (914)
Q Consensus 817 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 863 (914)
...+....+.+++.+|++.+|.+||+|++|++.|+.+
T Consensus 232 ----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 232 ----------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0112234578899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=310.78 Aligned_cols=251 Identities=27% Similarity=0.441 Sum_probs=195.6
Q ss_pred ccccccCcEEEEEEEECC-Cc--EEEEEEEecCC-cccchhhhHHHHHHhhc-ccCceeEEEeeeeecCceEEEEEeccC
Q 002509 592 KKIGSGGFGVVYYGKLKD-GK--EIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~~-g~--~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
+.||+|+||.||+|+.++ +. .+++|.++... ......+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998863 43 46888877432 23345788999999999 899999999999999999999999999
Q ss_pred CChHHHhhcccC------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecc
Q 002509 667 GTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 734 (914)
Q Consensus 667 gsL~~~L~~~~~------------~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 734 (914)
|+|.+++..... ....+++.+++.++.|++.||+|||+. +++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999865321 123578999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcC
Q 002509 735 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESG 813 (914)
Q Consensus 735 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~ 813 (914)
++...... ........+..|+|||++....++.++|||||||+++||++ |..||..... ..+.+.. ..+
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~----~~~~~~~----~~~ 227 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----AELYEKL----PQG 227 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH----HHHHHHH----hCC
Confidence 98532111 01111223567999999988889999999999999999997 9999865332 1222211 111
Q ss_pred CcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhH
Q 002509 814 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 864 (914)
Q Consensus 814 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 864 (914)
...+ . .......+.+++.+|++.+|.+||++.|+++.|++++
T Consensus 228 ~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 YRLE-----K----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCC-----C----CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1000 0 1112235789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=320.43 Aligned_cols=243 Identities=23% Similarity=0.319 Sum_probs=190.8
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHH---hhcccCceeEEEeeeeecCceEEEEE
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLL---SRIHHRNLVQFLGYCQEEGRSVLVYE 662 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l---~~l~HpnIv~l~g~~~~~~~~~LV~E 662 (914)
+.+.||+|+||.||+|..+ +++.||||+++... ....+.+..|++++ ++++||||+++++++...+..++|||
T Consensus 3 i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E 82 (324)
T cd05589 3 CLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVME 82 (324)
T ss_pred EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEc
Confidence 4578999999999999876 68999999997542 12234566666554 56689999999999999999999999
Q ss_pred eccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCC
Q 002509 663 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 742 (914)
Q Consensus 663 ~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 742 (914)
|+++|+|...++ ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 83 ~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 83 YAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred CCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999998874 34689999999999999999999998 9999999999999999999999999998653222
Q ss_pred CCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCc
Q 002509 743 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 822 (914)
Q Consensus 743 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 822 (914)
. .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .+... . ..+.. .
T Consensus 155 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~----~~~~~---i-~~~~~------~ 219 (324)
T cd05589 155 G-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE----EVFDS---I-VNDEV------R 219 (324)
T ss_pred C-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH----HHHHH---H-HhCCC------C
Confidence 1 2223456899999999999989999999999999999999999999754321 11111 1 11110 1
Q ss_pred cCCccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002509 823 LLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 859 (914)
Q Consensus 823 l~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----sm~eVl~~ 859 (914)
..... ...+.+++.+|++.+|++|| ++.+++++
T Consensus 220 ~p~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 220 YPRFL----SREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CCCCC----CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 11111 23477899999999999999 56666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=316.75 Aligned_cols=258 Identities=27% Similarity=0.423 Sum_probs=200.0
Q ss_pred HHhccccccCcEEEEEEEECC-Cc--EEEEEEEecC-CcccchhhhHHHHHHhhc-ccCceeEEEeeeeecCceEEEEEe
Q 002509 589 MLEKKIGSGGFGVVYYGKLKD-GK--EIAVKVLTSN-SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEF 663 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~~-g~--~vAVK~l~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~ 663 (914)
.+.+.||+|+||.||+|..++ +. .+++|.++.. .....+.+..|++++.++ +||||+++++++...+..++|+||
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 84 (297)
T cd05089 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEY 84 (297)
T ss_pred eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEe
Confidence 456789999999999998763 33 4788887743 223346788999999999 799999999999999999999999
Q ss_pred ccCCChHHHhhcccC------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEe
Q 002509 664 MHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 731 (914)
Q Consensus 664 ~~~gsL~~~L~~~~~------------~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 731 (914)
+++|+|.++++.... ....+++..++.++.|++.||+|||++ +++||||||+|||+++++.+||+
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEEC
Confidence 999999999965321 123588999999999999999999998 99999999999999999999999
Q ss_pred eccccccccCCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhh
Q 002509 732 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHI 810 (914)
Q Consensus 732 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~ 810 (914)
|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||..... ..+.+..
T Consensus 162 dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~----~~~~~~~---- 231 (297)
T cd05089 162 DFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC----AELYEKL---- 231 (297)
T ss_pred CcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHH----
Confidence 999986422110 1111123567999999988889999999999999999997 9999865432 1222211
Q ss_pred hcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHhHhh
Q 002509 811 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIER 868 (914)
Q Consensus 811 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~~~ 868 (914)
..+. .+.... .....+.+++.+|++.+|.+||+++++++.|++++...+
T Consensus 232 ~~~~-----~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 232 PQGY-----RMEKPR----NCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred hcCC-----CCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 1110 001111 122357889999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=318.06 Aligned_cols=241 Identities=25% Similarity=0.389 Sum_probs=190.9
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhc-ccCceeEEEeeeeecCceEEEEEeccC
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
+.||+|+||.||+|+.. +++.||||+++... ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999876 57899999997642 22234566777788764 899999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
|+|.+++.. ...+++.+...++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-K 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-c
Confidence 999999853 34578889999999999999999998 999999999999999999999999999875322221 2
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCc
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 826 (914)
.....||..|+|||++.+..++.++|||||||++|||++|+.||..... ..+.+.+. ... +.....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~----~~~~~~i~----~~~------~~~~~~ 218 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE----EELFQSIR----MDN------PCYPRW 218 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH----HHHHHHHH----hCC------CCCCcc
Confidence 2335689999999999988999999999999999999999999975432 12222211 110 111111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 002509 827 YDIQSMWKIEEKALMCVLPHGHMRPSIS-EVLK 858 (914)
Q Consensus 827 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~-eVl~ 858 (914)
....+.+++.+|++.+|++||++. ++.+
T Consensus 219 ----~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 219 ----LTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ----CCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 113467889999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=306.90 Aligned_cols=248 Identities=22% Similarity=0.398 Sum_probs=209.6
Q ss_pred HHHHHHHhccccccCcEEEEEEEE-CCCcEEEEEEEecCCcccch---hhhHHHHHHhhcccCceeEEEeeeeecCceEE
Q 002509 584 EDATKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGKR---EFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 659 (914)
Q Consensus 584 ~~~~~~~~~~lG~G~~G~Vy~~~~-~~g~~vAVK~l~~~~~~~~~---~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~L 659 (914)
.+.+++|.+.||+|.||.|-+|.- ..|+.||||.+++....+++ .+.+|+++|..++||||+.++.+|..++...+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 456788899999999999999965 68999999999877655544 46789999999999999999999999999999
Q ss_pred EEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccc
Q 002509 660 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 739 (914)
Q Consensus 660 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 739 (914)
||||..+|.|.|++. ..+.|++.+...++.||..|+.|+|.+ +++|||||.+|||||+++++||+|||++..+
T Consensus 131 vMEYaS~GeLYDYiS----er~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 131 VMEYASGGELYDYIS----ERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEEecCCccHHHHHH----HhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhh
Confidence 999999999999995 457799999999999999999999999 9999999999999999999999999999877
Q ss_pred cCCCCceeeccccCCcccCccccccCCCC-ccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccc
Q 002509 740 VDGASHVSSIVRGTVGYLDPEYYISQQLT-DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 818 (914)
Q Consensus 740 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i 818 (914)
.+. ...+.++|++-|.+||.+.+.+|. +..|-|||||+||-|+.|..||++.+. ..+++. +..|.+.+
T Consensus 204 ~~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh----k~lvrQ----Is~GaYrE- 272 (668)
T KOG0611|consen 204 ADK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH----KRLVRQ----ISRGAYRE- 272 (668)
T ss_pred ccc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH----HHHHHH----hhcccccC-
Confidence 543 344668899999999999998885 579999999999999999999987543 233332 23333322
Q ss_pred cCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 819 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 819 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
|.- .....-|+.+|+..+|++|.|+.+|..+
T Consensus 273 --P~~--------PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 273 --PET--------PSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred --CCC--------CchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 111 1124567889999999999999999876
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=306.69 Aligned_cols=248 Identities=26% Similarity=0.401 Sum_probs=198.9
Q ss_pred ccccccCcEEEEEEEECC--C--cEEEEEEEecCCc-ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 592 KKIGSGGFGVVYYGKLKD--G--KEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~~--g--~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
+.||+|++|.||+|.+.+ + ..||+|.++.... ...+.+..|++++++++||||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998753 3 3689999987655 456688999999999999999999999988 888999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
|+|.+++..... ..++|...+.++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999965421 5689999999999999999999998 99999999999999999999999999998764432221
Q ss_pred --eeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCCcc
Q 002509 747 --SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 823 (914)
Q Consensus 747 --~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 823 (914)
.....++..|+|||++.+..++.++|||||||+++||++ |+.||..... ..+...... ...... .
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~~~---~~~~~~--~--- 222 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG----SQILKKIDK---EGERLE--R--- 222 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHh---cCCcCC--C---
Confidence 122446789999999998899999999999999999999 9999864332 122222111 110000 0
Q ss_pred CCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002509 824 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861 (914)
Q Consensus 824 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 861 (914)
+......+.+++.+|++.+|++||++.||++.|.
T Consensus 223 ----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 ----PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ----CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0112245888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=310.95 Aligned_cols=254 Identities=25% Similarity=0.447 Sum_probs=201.1
Q ss_pred HHHHhccccccCcEEEEEEEEC----CCcEEEEEEEecCC-cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEE
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 661 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~----~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 661 (914)
.+.+.+.||+|+||.||+|+.. .+..+|+|.++... ....+.+..|+.++++++||||+++++++..++..++||
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (267)
T cd05066 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVT 84 (267)
T ss_pred HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence 3456789999999999999864 23479999886542 223467899999999999999999999999999999999
Q ss_pred EeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccC
Q 002509 662 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 741 (914)
Q Consensus 662 E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 741 (914)
||+++++|.+++... ...+++.+++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||++.....
T Consensus 85 e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 85 EYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999643 34589999999999999999999998 999999999999999999999999999986654
Q ss_pred CCCceee--ccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccc
Q 002509 742 GASHVSS--IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 818 (914)
Q Consensus 742 ~~~~~~~--~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i 818 (914)
....... ...++..|+|||++.+..++.++|||||||+++|+++ |+.||..... ..+..... ++..
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~----~~~~~~~~----~~~~--- 227 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN----QDVIKAIE----EGYR--- 227 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH----HHHHHHHh----CCCc---
Confidence 3322221 1223568999999998889999999999999999887 9999865432 12222221 1100
Q ss_pred cCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 002509 819 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 863 (914)
Q Consensus 819 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 863 (914)
... .......+.+++.+|++.+|++||+|.++++.|+++
T Consensus 228 --~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 --LPA----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --CCC----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 000 111234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=314.06 Aligned_cols=264 Identities=26% Similarity=0.392 Sum_probs=201.3
Q ss_pred HHHHHHhccccccCcEEEEEEEE-----CCCcEEEEEEEecCC-cccchhhhHHHHHHhhcccCceeEEEeeeeec--Cc
Q 002509 585 DATKMLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GR 656 (914)
Q Consensus 585 ~~~~~~~~~lG~G~~G~Vy~~~~-----~~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~ 656 (914)
..++.+.+.||+|+||.||.++. .+++.||+|.++... ......+.+|++++++++|||++++.+++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 34556678899999999999974 257889999987543 23346789999999999999999999998775 56
Q ss_pred eEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccc
Q 002509 657 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 736 (914)
Q Consensus 657 ~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 736 (914)
.++||||+++++|.+++... ...++|..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred eEEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccc
Confidence 78999999999999998543 23589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCc--eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccc-------cccchhHHHHHH
Q 002509 737 KFAVDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF-------GANCRNIVQWAK 807 (914)
Q Consensus 737 ~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~-------~~~~~~l~~~~~ 807 (914)
+........ ......++..|+|||++.+..++.++|||||||+++||++++.|...... ............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 765433221 11234467789999999888899999999999999999998766432110 000000111111
Q ss_pred HhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 002509 808 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 863 (914)
Q Consensus 808 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 863 (914)
.....+.... ........+.+++.+|++.+|++||+++|+++.|+++
T Consensus 237 ~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVLEEGKRLP---------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHcCccCC---------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111111110 0111234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=308.01 Aligned_cols=248 Identities=29% Similarity=0.464 Sum_probs=202.0
Q ss_pred HHHHhccccccCcEEEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
.+.+.+.||+|++|.||+|... |+.||+|.++.... ..+.+.+|+.++++++|+||+++++++...+..++||||+++
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 3456689999999999999876 88999999976543 456789999999999999999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
++|.+++... ....+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||.++.......
T Consensus 85 ~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 85 GSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999998643 223689999999999999999999998 999999999999999999999999999976532221
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCC
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 825 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 825 (914)
...++..|+|||++....++.++||||||++++|+++ |..||..... ..+..... .+... ..
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~~~----~~~~~-----~~-- 220 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPHVE----KGYRM-----EA-- 220 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHh----cCCCC-----CC--
Confidence 2234678999999998889999999999999999997 9999864331 22222211 11000 00
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002509 826 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862 (914)
Q Consensus 826 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 862 (914)
+......+.+++.+|+..+|++||+++|++++|+.
T Consensus 221 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 --PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred --ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11123468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=313.71 Aligned_cols=253 Identities=26% Similarity=0.440 Sum_probs=200.1
Q ss_pred HHhccccccCcEEEEEEEEC------CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEE
Q 002509 589 MLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 662 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 662 (914)
.+.++||+|+||.||++... ++..+|+|.+..........+.+|++++++++|+||+++++++...+..++++|
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (280)
T cd05092 8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFE 87 (280)
T ss_pred eeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEe
Confidence 34578999999999999642 466799998876655556789999999999999999999999999999999999
Q ss_pred eccCCChHHHhhcccC-----------ccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEe
Q 002509 663 FMHNGTLKEHLYGTLT-----------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 731 (914)
Q Consensus 663 ~~~~gsL~~~L~~~~~-----------~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 731 (914)
|+++|+|.++++.... ....+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||+
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~ 164 (280)
T cd05092 88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIG 164 (280)
T ss_pred cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEEC
Confidence 9999999999865421 113588999999999999999999998 99999999999999999999999
Q ss_pred eccccccccCCCCc-eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHh
Q 002509 732 DFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH 809 (914)
Q Consensus 732 DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 809 (914)
|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |+.||...... ...+..
T Consensus 165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~~~~--- 237 (280)
T cd05092 165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT----EAIECI--- 237 (280)
T ss_pred CCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH----HHHHHH---
Confidence 99998755332211 1122335678999999998899999999999999999998 89998643321 111111
Q ss_pred hhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002509 810 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861 (914)
Q Consensus 810 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 861 (914)
..+.... .+ . .....+.+++.+|++.+|.+||+++||++.|+
T Consensus 238 -~~~~~~~--~~---~----~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 238 -TQGRELE--RP---R----TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -HcCccCC--CC---C----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1111000 00 1 11235789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=324.91 Aligned_cols=237 Identities=26% Similarity=0.363 Sum_probs=196.8
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc---ccchhhhHHHHHHhhc-ccCceeEEEeeeeecCceEEEEEec
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
+.++||+|.||.|+.+..+ +++.+|||++++... .+.+..+.|..++... +||.++.++.+++.+++.++||||+
T Consensus 372 ~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~ 451 (694)
T KOG0694|consen 372 LLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYV 451 (694)
T ss_pred EEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEec
Confidence 5679999999999999887 678899999988743 3345677888888777 5999999999999999999999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 744 (914)
.||++..+. ..+.+++.....+|..|+.||.|||++ +||+||||.+|||||.+|++||+|||+++.... ..
T Consensus 452 ~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~-~g 522 (694)
T KOG0694|consen 452 AGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG-QG 522 (694)
T ss_pred CCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCC-CC
Confidence 999954433 356789999999999999999999999 999999999999999999999999999986432 23
Q ss_pred ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccC
Q 002509 745 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 824 (914)
..+...+||+.|||||++.+..|+...|-|||||+||||+.|+.||.+.+.++....|+. .|+
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~--------------d~~--- 585 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN--------------DEV--- 585 (694)
T ss_pred CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc--------------CCC---
Confidence 356678999999999999999999999999999999999999999986654333322221 011
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCH
Q 002509 825 DEYDIQSMWKIEEKALMCVLPHGHMRPSI 853 (914)
Q Consensus 825 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm 853 (914)
.|+.-...+.+.+..+.+..+|++|-.+
T Consensus 586 -~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 -RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1233333457788889999999999776
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=318.20 Aligned_cols=241 Identities=26% Similarity=0.360 Sum_probs=190.7
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhc-ccCceeEEEeeeeecCceEEEEEeccC
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
+.||+|+||.||+|+.+ +|+.||+|+++... ......+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999887 68899999997542 22334566777777764 899999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
|+|.+++.. ...+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence 999998853 34578889999999999999999998 99999999999999999999999999987432222 22
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCc
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 826 (914)
.....||..|+|||++.+..++.++|||||||++|||++|+.||..... ..+.+... .+ .+.+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~----~~~~~~~~----~~------~~~~~~~ 218 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE----DELFESIR----VD------TPHYPRW 218 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHH----hC------CCCCCCC
Confidence 2345689999999999999999999999999999999999999975432 12222111 11 0111111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 002509 827 YDIQSMWKIEEKALMCVLPHGHMRPSIS-EVLK 858 (914)
Q Consensus 827 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~-eVl~ 858 (914)
...++.+++.+|++.||++||++. ++.+
T Consensus 219 ----~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 219 ----ITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred ----CCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 123477899999999999999984 5653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=313.86 Aligned_cols=254 Identities=27% Similarity=0.424 Sum_probs=198.0
Q ss_pred HHHhccccccCcEEEEEEEECC------CcEEEEEEEecCCc-ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEE
Q 002509 588 KMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 660 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~~------g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV 660 (914)
+.+.+.||+|++|.||+|...+ +..||+|.+..... .....|..|+.++++++|+||+++++++.+.+..++|
T Consensus 8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 87 (277)
T cd05036 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFIL 87 (277)
T ss_pred cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEE
Confidence 3455789999999999998753 56789998765432 2345689999999999999999999999999999999
Q ss_pred EEeccCCChHHHhhcccC---ccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCC---cEEEeecc
Q 002509 661 YEFMHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDFG 734 (914)
Q Consensus 661 ~E~~~~gsL~~~L~~~~~---~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFG 734 (914)
|||+++++|.+++..... ....++|..++.++.|++.||+|||+. +++||||||+||+++.++ .+||+|||
T Consensus 88 ~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg 164 (277)
T cd05036 88 LELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFG 164 (277)
T ss_pred EecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCc
Confidence 999999999999865421 223589999999999999999999998 999999999999998754 59999999
Q ss_pred ccccccCCCCce-eeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhc
Q 002509 735 LSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIES 812 (914)
Q Consensus 735 la~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~ 812 (914)
+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||...... .+.+.+. ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~----~~~~~~~---~~ 237 (277)
T cd05036 165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ----EVMEFVT---GG 237 (277)
T ss_pred cccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHH---cC
Confidence 997653222111 111223568999999998899999999999999999997 99998754321 2222111 11
Q ss_pred CCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002509 813 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861 (914)
Q Consensus 813 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 861 (914)
... ..+......+.+++.+|++.+|++||++.||+++|+
T Consensus 238 ~~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 238 GRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 110 011112246888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=328.33 Aligned_cols=249 Identities=22% Similarity=0.280 Sum_probs=190.6
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEec
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
.+.+.||+|+||.||+++.. +++.||||++.... ......+.+|++++.+++|+||+++++.+.+++..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (376)
T cd05598 4 VKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI 83 (376)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCC
Confidence 34578999999999999876 68999999986532 123456788999999999999999999999999999999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCC--
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG-- 742 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~-- 742 (914)
++|+|.+++.. ...++......++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 84 ~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 84 PGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 99999999854 33577788888999999999999998 9999999999999999999999999997532100
Q ss_pred ----------------------------------------CCceeeccccCCcccCccccccCCCCccCceeehHHHHHH
Q 002509 743 ----------------------------------------ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLE 782 (914)
Q Consensus 743 ----------------------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~E 782 (914)
.........||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 0000113469999999999999999999999999999999
Q ss_pred HHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCC---CHHHHHHH
Q 002509 783 LISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP---SISEVLKD 859 (914)
Q Consensus 783 lltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RP---sm~eVl~~ 859 (914)
|++|+.||......+....+..|.. . .. .+. ....+ ..+.+++.+|+ .+|.+|+ ++.|++++
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i~~~~~------~-~~--~~~-~~~~s----~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKVINWET------T-LH--IPS-QAKLS----REASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHHhccCc------c-cc--CCC-CCCCC----HHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999975442211111111110 0 00 000 01112 23455566655 4999999 89999876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=316.53 Aligned_cols=242 Identities=26% Similarity=0.351 Sum_probs=193.6
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhc-ccCceeEEEeeeeecCceEEEEEeccC
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
+.||+|+||.||+++.+ +++.||||+++... ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 57899999997542 22344567888888887 799999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VT 152 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cc
Confidence 999988853 34689999999999999999999998 99999999999999999999999999986532221 12
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCc
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 826 (914)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||..... ..+.... ..... ....
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~----~~~~~~i----~~~~~------~~~~- 217 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE----DELFQSI----LEDEV------RYPR- 217 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH----HHHHHHH----HcCCC------CCCC-
Confidence 2334689999999999999999999999999999999999999965432 1111111 11111 0111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 002509 827 YDIQSMWKIEEKALMCVLPHGHMRPSI-----SEVLKD 859 (914)
Q Consensus 827 ~~~~~~~~l~~l~~~C~~~~P~~RPsm-----~eVl~~ 859 (914)
.....+.+++.+|++.+|++||++ .+++++
T Consensus 218 ---~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 218 ---WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred ---cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 112357889999999999999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=320.83 Aligned_cols=238 Identities=26% Similarity=0.346 Sum_probs=190.6
Q ss_pred ccccccCcEEEEEEEE----CCCcEEEEEEEecCCc--ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 592 KKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~----~~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
+.||+|+||.||+++. .+|+.+|+|+++.... .....+..|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4799999999999875 3688999999975422 233457789999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+|+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 9999998853 34588999999999999999999998 999999999999999999999999999876543322
Q ss_pred eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCC
Q 002509 746 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 825 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 825 (914)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ...... ..... .+..
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~----~~~~~i----~~~~~------~~p~ 219 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK----ETMTMI----LKAKL------GMPQ 219 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH----HHHHHH----HcCCC------CCCC
Confidence 223356899999999999888999999999999999999999999754321 111111 11111 0111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 002509 826 EYDIQSMWKIEEKALMCVLPHGHMRPSISE 855 (914)
Q Consensus 826 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~e 855 (914)
.. ...+.+++.+|++.+|++||++.+
T Consensus 220 ~~----~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FL----SPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CC----CHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11 234778899999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=319.37 Aligned_cols=237 Identities=28% Similarity=0.362 Sum_probs=186.8
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCCc---ccchhhhHHHH-HHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVT-LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~-~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
+.||+|+||.||+|+.. +|+.||+|++..... .....+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999886 789999999875421 12234444544 56788999999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
|+|.+++.. ...+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT 152 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence 999998853 34678888999999999999999998 99999999999999999999999999987543222 22
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCc
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 826 (914)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+ .... +.. .+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~----~~~~---~i~~-~~~------~~~~~ 218 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA----EMYD---NILN-KPL------RLKPN 218 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH----HHHH---HHHc-CCC------CCCCC
Confidence 23456899999999999989999999999999999999999999754321 1111 1111 110 11111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 002509 827 YDIQSMWKIEEKALMCVLPHGHMRPSIS 854 (914)
Q Consensus 827 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~ 854 (914)
. ...+.+++.+|++.+|++||++.
T Consensus 219 ~----~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 219 I----SVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred C----CHHHHHHHHHHhhcCHHhCCCCC
Confidence 1 23578899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=307.50 Aligned_cols=254 Identities=27% Similarity=0.354 Sum_probs=191.5
Q ss_pred ccccccCcEEEEEEEECC---CcEEEEEEEecCCc-ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCC
Q 002509 592 KKIGSGGFGVVYYGKLKD---GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 667 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~~---g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 667 (914)
+.||+|+||.||+|...+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998653 45789998875532 23457888999999999999999999999999999999999999
Q ss_pred ChHHHhhcccC-ccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 668 TLKEHLYGTLT-HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 668 sL~~~L~~~~~-~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
+|.++++.... .....++..+..++.|++.||+|||+. +++||||||+||+++.++++||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999965422 233567778889999999999999998 99999999999999999999999999987543322211
Q ss_pred -eeccccCCcccCccccccC-------CCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCccc
Q 002509 747 -SSIVRGTVGYLDPEYYISQ-------QLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQG 817 (914)
Q Consensus 747 -~~~~~gt~~Y~aPE~~~~~-------~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 817 (914)
.....++..|+|||++... .++.++|||||||++|||++ |+.||...... ...... .. +....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~----~~~~~~---~~-~~~~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE----QVLTYT---VR-EQQLK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH----HHHHHH---hh-cccCC
Confidence 2234577889999998642 35789999999999999996 99999643321 111111 11 11111
Q ss_pred ccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002509 818 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861 (914)
Q Consensus 818 i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 861 (914)
..++.+.... ...+.+++.+|+ .+|++||+++||++.|+
T Consensus 230 ~~~~~~~~~~----~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLKLPL----SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccCCCC----ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2222222111 123566778898 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=325.75 Aligned_cols=198 Identities=26% Similarity=0.373 Sum_probs=170.4
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
+.+.||+|+||+||+++.. +++.||+|+++... ......+..|++++.+++|+||+++++.+.+....++||||++
T Consensus 5 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (363)
T cd05628 5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLP 84 (363)
T ss_pred EeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCC
Confidence 4578999999999999876 68999999997542 2223567889999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC-
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS- 744 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~- 744 (914)
+|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 85 GGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 9999999853 34688999999999999999999998 999999999999999999999999999875432110
Q ss_pred ---------------------------------ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcc
Q 002509 745 ---------------------------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS 791 (914)
Q Consensus 745 ---------------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~ 791 (914)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 00123469999999999999999999999999999999999999997
Q ss_pred ccc
Q 002509 792 NEK 794 (914)
Q Consensus 792 ~~~ 794 (914)
...
T Consensus 238 ~~~ 240 (363)
T cd05628 238 SET 240 (363)
T ss_pred CCC
Confidence 544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=304.41 Aligned_cols=250 Identities=31% Similarity=0.502 Sum_probs=202.9
Q ss_pred ccccccCcEEEEEEEECC----CcEEEEEEEecCCccc-chhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 592 KKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~~----g~~vAVK~l~~~~~~~-~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
+.||+|+||.||+|.... +..+++|+++...... .+.+.+|++.+..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998764 7889999997654333 57788999999999999999999999999999999999999
Q ss_pred CChHHHhhcccCc-----cccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccC
Q 002509 667 GTLKEHLYGTLTH-----EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 741 (914)
Q Consensus 667 gsL~~~L~~~~~~-----~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 741 (914)
++|.+++...... ...+++..++.++.|+++||+|||++ +++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999654221 46789999999999999999999998 999999999999999999999999999987654
Q ss_pred CCC-ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCccccc
Q 002509 742 GAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 819 (914)
Q Consensus 742 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 819 (914)
... .......++..|+|||.+....++.++|||||||+++||++ |+.||..... ..+.+.... +...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~~~~----~~~~--- 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN----EEVLEYLRK----GYRL--- 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHHc----CCCC---
Confidence 321 11233457889999999988889999999999999999999 6999875432 222222211 1100
Q ss_pred CCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002509 820 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861 (914)
Q Consensus 820 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 861 (914)
.. +.....++.+++.+|++.+|++||++.|++++|+
T Consensus 227 --~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 --PK----PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --CC----CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 00 1111346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=321.37 Aligned_cols=262 Identities=27% Similarity=0.435 Sum_probs=201.0
Q ss_pred HHHHHHhccccccCcEEEEEEEE------CCCcEEEEEEEecCCc-ccchhhhHHHHHHhhc-ccCceeEEEeeeeec-C
Q 002509 585 DATKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE-G 655 (914)
Q Consensus 585 ~~~~~~~~~lG~G~~G~Vy~~~~------~~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~-~ 655 (914)
...+.+.+.||+|+||.||+|.. .+++.||||+++.... .....+.+|++++.++ +||||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 34567788999999999999973 3578899999975432 2345688899999999 789999999988654 4
Q ss_pred ceEEEEEeccCCChHHHhhcccC---------------------------------------------------------
Q 002509 656 RSVLVYEFMHNGTLKEHLYGTLT--------------------------------------------------------- 678 (914)
Q Consensus 656 ~~~LV~E~~~~gsL~~~L~~~~~--------------------------------------------------------- 678 (914)
..++||||+++|+|.++++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999999864211
Q ss_pred ------ccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce-eeccc
Q 002509 679 ------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVR 751 (914)
Q Consensus 679 ------~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~ 751 (914)
....+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++......... .....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 012478888999999999999999998 99999999999999999999999999987653322211 11233
Q ss_pred cCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccCHH
Q 002509 752 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQ 830 (914)
Q Consensus 752 gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 830 (914)
++..|+|||.+.+..++.++||||||+++|||++ |..|+...... ..+.. ....+..... +. ..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~----~~~~~~~~~~--~~---~~--- 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---EEFCR----RLKEGTRMRA--PD---YT--- 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc---HHHHH----HHhccCCCCC--CC---CC---
Confidence 5678999999988889999999999999999997 88888643211 11111 1111111100 11 11
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHh
Q 002509 831 SMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 831 ~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 865 (914)
..++.+++..|++.+|++||++.||+++|+.+++
T Consensus 308 -~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 -TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred -CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1357899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=309.07 Aligned_cols=251 Identities=31% Similarity=0.477 Sum_probs=198.7
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccc--hhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~--~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
+.+.||+|+||+||+++.. +++.+|+|++........ .....|+.++++++||||+++++++......++||||+++
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~ 82 (260)
T PF00069_consen 3 LVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPG 82 (260)
T ss_dssp EEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETT
T ss_pred EeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccc
Confidence 4578999999999999887 567899999987644332 2345699999999999999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
++|.+++. ....+++..++.++.|+++||++||+. +++|+||||+||++++++.++|+|||.+.... .....
T Consensus 83 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~ 154 (260)
T PF00069_consen 83 GSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNEN 154 (260)
T ss_dssp EBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSE
T ss_pred cccccccc----ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccccc
Confidence 99999996 356689999999999999999999998 99999999999999999999999999987542 22223
Q ss_pred eeccccCCcccCccccc-cCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCC
Q 002509 747 SSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 825 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~-~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 825 (914)
.....++..|+|||.+. +..++.++||||+|+++++|++|..|+......+....+.+-....... ....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~ 225 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPS---------SSQQ 225 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHH---------HTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccc---------cccc
Confidence 34456899999999998 7889999999999999999999999997652111111111111100000 0000
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 826 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 826 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.......+.+++..|++.+|++||++.|++++
T Consensus 226 --~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 226 --SREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp --HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred --cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00011578999999999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=307.18 Aligned_cols=249 Identities=30% Similarity=0.535 Sum_probs=200.0
Q ss_pred HHhccccccCcEEEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCC
Q 002509 589 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 668 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gs 668 (914)
.+.+.||+|+||.||++.+.+++.+|+|.++... .....|.+|++++++++|||++++++++......++|+||+++++
T Consensus 7 ~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (256)
T cd05112 7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGC 85 (256)
T ss_pred EEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCc
Confidence 3557899999999999998878899999886443 234578999999999999999999999999999999999999999
Q ss_pred hHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCceee
Q 002509 669 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 748 (914)
Q Consensus 669 L~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 748 (914)
|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...........
T Consensus 86 L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 86 LSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred HHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 99998643 24578999999999999999999998 9999999999999999999999999998765433221122
Q ss_pred ccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCcc
Q 002509 749 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 827 (914)
Q Consensus 749 ~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 827 (914)
...++.+|+|||.+.++.++.++||||||+++|||++ |+.||..... ..+.+.. ..+ .....+...
T Consensus 160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~~~~~~----~~~--~~~~~~~~~--- 226 (256)
T cd05112 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN----SEVVETI----NAG--FRLYKPRLA--- 226 (256)
T ss_pred CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH----HHHHHHH----hCC--CCCCCCCCC---
Confidence 2235678999999998889999999999999999998 9999864331 1222211 111 011122221
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002509 828 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861 (914)
Q Consensus 828 ~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 861 (914)
...+.+++.+|++.+|++||+|.||+++|.
T Consensus 227 ----~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 227 ----SQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ----CHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 246889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=334.63 Aligned_cols=262 Identities=22% Similarity=0.275 Sum_probs=190.9
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeec--------CceE
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--------GRSV 658 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--------~~~~ 658 (914)
+.+.++||+|+||.||+|... +++.||||++... .....+|+.++++++||||+++++++... ...+
T Consensus 68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~ 143 (440)
T PTZ00036 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143 (440)
T ss_pred EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence 455678999999999999875 6889999988543 22345799999999999999999876432 1356
Q ss_pred EEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCC-cEEEeeccccc
Q 002509 659 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSK 737 (914)
Q Consensus 659 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~ 737 (914)
+||||+++ +|.+++.........+++.....++.|+++||+|||+. +|+||||||+|||++.++ .+||+|||+++
T Consensus 144 lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 89999985 77777754433456789999999999999999999998 999999999999999765 79999999998
Q ss_pred cccCCCCceeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhh-----
Q 002509 738 FAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE----- 811 (914)
Q Consensus 738 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~----- 811 (914)
....... .....||+.|+|||++.+ ..++.++|||||||++|||++|..||.+....+....+.+.......
T Consensus 220 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 297 (440)
T PTZ00036 220 NLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE 297 (440)
T ss_pred hccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 6543322 223457999999999875 46899999999999999999999999764422211122111100000
Q ss_pred -cCCccc-----ccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 812 -SGDIQG-----IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 812 -~~~~~~-----i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.....+ +....+...++.....++.+++.+|++.+|++||++.|++++
T Consensus 298 ~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 298 MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred hchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000000 000011111111122468899999999999999999999865
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=315.01 Aligned_cols=256 Identities=25% Similarity=0.391 Sum_probs=201.3
Q ss_pred HHHHhccccccCcEEEEEEEEC------CCcEEEEEEEecCCc-ccchhhhHHHHHHhhc-ccCceeEEEeeeeecCceE
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSV 658 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~------~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~ 658 (914)
.+.+.+.||+|+||.||++... .+..||||+++.... ...+.+.+|+++++++ +||||+++++++...+..+
T Consensus 36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 115 (302)
T cd05055 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPIL 115 (302)
T ss_pred HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceE
Confidence 3456689999999999999742 356799999875432 2345688999999999 7999999999999999999
Q ss_pred EEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccc
Q 002509 659 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 738 (914)
Q Consensus 659 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 738 (914)
+||||+.+|+|.++++... ...+++.+++.++.|++.||+|||++ +++|+||||+|||++.++.+|++|||+++.
T Consensus 116 lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 116 VITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred EEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccccc
Confidence 9999999999999986432 23389999999999999999999998 999999999999999999999999999976
Q ss_pred ccCCCCc-eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcc
Q 002509 739 AVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQ 816 (914)
Q Consensus 739 ~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 816 (914)
....... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||......+ .+.... ..+..
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~---~~~~~~----~~~~~- 262 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS---KFYKLI----KEGYR- 262 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH---HHHHHH----HcCCc-
Confidence 5433221 1122335778999999998889999999999999999998 999986543211 111111 11100
Q ss_pred cccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 002509 817 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 863 (914)
Q Consensus 817 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 863 (914)
+.. ......++.+++.+|++.+|++||++.||++.|++.
T Consensus 263 ----~~~----~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 ----MAQ----PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----CCC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 000 011123688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=306.10 Aligned_cols=247 Identities=29% Similarity=0.432 Sum_probs=196.7
Q ss_pred ccccccCcEEEEEEEECC----CcEEEEEEEecCCc-ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 592 KKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~~----g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
++||+|+||.||+|++.. +..+|+|.+..... ...+.+.+|+++++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997642 26899999876543 24567889999999999999999999876 4567999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
|+|.+++... ..+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999643 3688999999999999999999998 99999999999999999999999999997664433222
Q ss_pred e--eccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCCcc
Q 002509 747 S--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 823 (914)
Q Consensus 747 ~--~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 823 (914)
. ....++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ..+..+... +....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~----~~~~~~~~~----~~~~~------ 218 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG----AEVIAMLES----GERLP------ 218 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH----HHHHHHHHc----CCcCC------
Confidence 1 11223568999999998899999999999999999998 9999865431 233333221 11110
Q ss_pred CCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 002509 824 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 863 (914)
Q Consensus 824 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 863 (914)
........+.+++.+|++.+|++||++.+|++.|+++
T Consensus 219 ---~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 ---RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred ---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 0111224678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=309.60 Aligned_cols=256 Identities=22% Similarity=0.357 Sum_probs=201.5
Q ss_pred HHHHHhccccccCcEEEEEEEECC----CcEEEEEEEecCC-cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEE
Q 002509 586 ATKMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 660 (914)
Q Consensus 586 ~~~~~~~~lG~G~~G~Vy~~~~~~----g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV 660 (914)
..+.+.+.||+|+||.||+|...+ ...|++|...... ....+.+.+|+.++++++||||+++++++.. +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 344567899999999999998653 2468999886554 3345678999999999999999999998875 456899
Q ss_pred EEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccccc
Q 002509 661 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 740 (914)
Q Consensus 661 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 740 (914)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999999643 33589999999999999999999998 99999999999999999999999999987664
Q ss_pred CCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCccccc
Q 002509 741 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 819 (914)
Q Consensus 741 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 819 (914)
...........++..|+|||.+....++.++|||||||+++|+++ |+.||...... ....+. ..+....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----~~~~~~----~~~~~~~-- 228 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN----DVIGRI----ENGERLP-- 228 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHH----HcCCcCC--
Confidence 433222223334578999999988889999999999999999986 99999654321 122211 1111110
Q ss_pred CCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHh
Q 002509 820 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 820 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 865 (914)
... .....+.+++.+|+..+|++||++.|+++.|+++..
T Consensus 229 ---~~~----~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 229 ---MPP----NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ---CCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 111 122358889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=305.23 Aligned_cols=261 Identities=23% Similarity=0.352 Sum_probs=198.2
Q ss_pred HhccccccCcEEEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhhc--ccCceeEEEeeeeecC----ceEEEEEe
Q 002509 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI--HHRNLVQFLGYCQEEG----RSVLVYEF 663 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l--~HpnIv~l~g~~~~~~----~~~LV~E~ 663 (914)
+.+.||+|.||.||+|+|+ |+.||||++.. .+++.+.+|.++.+.+ +|+||+.+++.-..++ +++||.+|
T Consensus 215 L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdY 290 (513)
T KOG2052|consen 215 LQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDY 290 (513)
T ss_pred EEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeec
Confidence 4578999999999999998 99999999864 3456778888888765 9999999998775543 67899999
Q ss_pred ccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHh-----CCCCCccccCCCCCceEeCCCCcEEEeecccccc
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-----GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 738 (914)
Q Consensus 664 ~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~-----~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 738 (914)
.++|||.|+|. ...++-...++++.-+|.||+|||. ++.|.|.|||||+.|||+..++.+.|+|+|||..
T Consensus 291 He~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~ 365 (513)
T KOG2052|consen 291 HEHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 365 (513)
T ss_pred ccCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEE
Confidence 99999999994 4568888999999999999999996 4568999999999999999999999999999966
Q ss_pred ccCCCCc---eeeccccCCcccCccccccCC------CCccCceeehHHHHHHHHhCC----------CCcccccccccc
Q 002509 739 AVDGASH---VSSIVRGTVGYLDPEYYISQQ------LTDKSDVYSFGVILLELISGQ----------EAISNEKFGANC 799 (914)
Q Consensus 739 ~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~------~s~ksDV~S~Gvvl~ElltG~----------~p~~~~~~~~~~ 799 (914)
....... .....+||.+|||||++...- .-..+||||||.|+||+.... .||.+.-..+.
T Consensus 366 h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP- 444 (513)
T KOG2052|consen 366 HDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP- 444 (513)
T ss_pred ecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC-
Confidence 5443222 234467999999999996431 123589999999999998643 34432111000
Q ss_pred hhHHHHHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHh
Q 002509 800 RNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 800 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 865 (914)
++ +-++..+-..++...++.+. .+.+.+..+.+++..||..+|..|-|+=.+-+.|.++.+
T Consensus 445 -s~-eeMrkVVCv~~~RP~ipnrW---~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 445 -SF-EEMRKVVCVQKLRPNIPNRW---KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred -CH-HHHhcceeecccCCCCCccc---ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 00 11112222222222222222 234678889999999999999999999999888887764
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=313.07 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=199.3
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
+.+.+.||+|++|.||+|... +++.||+|.+..........+.+|+.+++.++|+||+++++.+..+...++||||+++
T Consensus 22 y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~ 101 (296)
T cd06654 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (296)
T ss_pred eeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCC
Confidence 344568999999999999865 6899999998866555567788999999999999999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
++|.+++.. ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 102 ~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~- 172 (296)
T cd06654 102 GSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (296)
T ss_pred CCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccc-
Confidence 999999853 3478889999999999999999998 9999999999999999999999999998754332211
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCc
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 826 (914)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||...... ..+..+. ..+. . .+.
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~---~~~~~~~----~~~~-~-----~~~-- 237 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---RALYLIA----TNGT-P-----ELQ-- 237 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH---HhHHHHh----cCCC-C-----CCC--
Confidence 22345889999999999888899999999999999999999999653311 1111111 1110 0 000
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 827 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 827 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
........+.+++.+|+..+|++||+++|++++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 011122357789999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=312.49 Aligned_cols=260 Identities=23% Similarity=0.417 Sum_probs=200.9
Q ss_pred HHHHHHhccccccCcEEEEEEEEC------CCcEEEEEEEecCC-cccchhhhHHHHHHhhcccCceeEEEeeeeecCce
Q 002509 585 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 657 (914)
Q Consensus 585 ~~~~~~~~~lG~G~~G~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 657 (914)
...+.+.++||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.++++++||||+++++++...+..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 345566789999999999999754 24579999876443 22344678899999999999999999999999999
Q ss_pred EEEEEeccCCChHHHhhcccC------ccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEe
Q 002509 658 VLVYEFMHNGTLKEHLYGTLT------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 731 (914)
Q Consensus 658 ~LV~E~~~~gsL~~~L~~~~~------~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 731 (914)
++||||+++|+|.+++..... ....+.+..+..++.|++.||+|||++ +|+||||||+||++++++.+||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEEC
Confidence 999999999999999964321 123456778889999999999999998 99999999999999999999999
Q ss_pred eccccccccCCCCce-eeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHh
Q 002509 732 DFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH 809 (914)
Q Consensus 732 DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 809 (914)
|||+++......... .....++..|+|||.+.+..++.++|||||||+++||++ |+.||..... ..+.+..
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~----~~~~~~~--- 234 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN----EQVLKFV--- 234 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHH---
Confidence 999987553322111 122235678999999998899999999999999999998 7888864321 1222211
Q ss_pred hhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhH
Q 002509 810 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 864 (914)
Q Consensus 810 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 864 (914)
. .+.... . +......+.+++.+|++.+|++||+|.|+++.|++.+
T Consensus 235 ~-~~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 235 M-DGGYLD-----Q----PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred H-cCCCCC-----C----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1 111110 0 0111246889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=307.13 Aligned_cols=240 Identities=20% Similarity=0.375 Sum_probs=188.4
Q ss_pred ccccccCcEEEEEEEECC-------------CcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceE
Q 002509 592 KKIGSGGFGVVYYGKLKD-------------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 658 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~~-------------g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 658 (914)
+.||+|+||.||+|++.+ ...|++|.+..........|.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998642 2358899877654444567889999999999999999999999999999
Q ss_pred EEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCc-------EEEe
Q 002509 659 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR-------AKVS 731 (914)
Q Consensus 659 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~-------~kl~ 731 (914)
+||||+++|+|..+++.. ...+++..++.++.|+++||+|||+. +|+||||||+|||++.++. +|++
T Consensus 81 lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 999999999999888543 34588999999999999999999998 9999999999999987654 8999
Q ss_pred eccccccccCCCCceeeccccCCcccCccccc-cCCCCccCceeehHHHHHHHH-hCCCCcccccccccchhHHHHHHHh
Q 002509 732 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELI-SGQEAISNEKFGANCRNIVQWAKLH 809 (914)
Q Consensus 732 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDV~S~Gvvl~Ell-tG~~p~~~~~~~~~~~~l~~~~~~~ 809 (914)
|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ .|+.|+......+ ...
T Consensus 155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~----~~~----- 220 (262)
T cd05077 155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE----KER----- 220 (262)
T ss_pred CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH----HHH-----
Confidence 99998654321 2234788999999887 467889999999999999997 5888875432111 111
Q ss_pred hhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002509 810 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861 (914)
Q Consensus 810 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 861 (914)
...+.. .. .. .....+.+++.+|++.+|++||++.|+++.|+
T Consensus 221 ~~~~~~-~~-----~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 221 FYEGQC-ML-----VT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HHhcCc-cC-----CC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 011110 00 01 11235788999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=317.97 Aligned_cols=245 Identities=24% Similarity=0.311 Sum_probs=192.5
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhccc-CceeEEEeeeeecCceEEEEEe
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHH-RNLVQFLGYCQEEGRSVLVYEF 663 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H-pnIv~l~g~~~~~~~~~LV~E~ 663 (914)
.+.+.||+|+||.||+|+.+ +++.||||+++... ....+.+..|.+++..++| ++|+++++++...+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 82 (324)
T ss_pred eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence 35578999999999999876 57889999987542 2334567789999999976 4688899999999999999999
Q ss_pred ccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCC
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 743 (914)
Q Consensus 664 ~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 743 (914)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 83 VNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 999999998853 34578889999999999999999998 99999999999999999999999999986432221
Q ss_pred CceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCcc
Q 002509 744 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 823 (914)
Q Consensus 744 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 823 (914)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+..... ... ..+
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~----~~~~~~i~----~~~------~~~ 220 (324)
T cd05587 156 -KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE----DELFQSIM----EHN------VSY 220 (324)
T ss_pred -CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHH----cCC------CCC
Confidence 122345689999999999999999999999999999999999999975432 12222111 111 011
Q ss_pred CCccCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 002509 824 LDEYDIQSMWKIEEKALMCVLPHGHMRPSI-----SEVLKD 859 (914)
Q Consensus 824 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm-----~eVl~~ 859 (914)
.... ..++.+++.+|++.+|++|++. +++.++
T Consensus 221 ~~~~----~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 221 PKSL----SKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred CCCC----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1111 2357789999999999999976 565544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=322.37 Aligned_cols=248 Identities=25% Similarity=0.386 Sum_probs=204.5
Q ss_pred HhccccccCcEEEEEEEEC--CCc--EEEEEEEecCCcc-cchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEec
Q 002509 590 LEKKIGSGGFGVVYYGKLK--DGK--EIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~--~g~--~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
+.++||+|.||.|++|.|. .|+ .||||+++..... .-.+|.+|+.+|.+|+|||+++|+|...+ ....+|+|.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 5578999999999999887 344 4799999877544 45789999999999999999999999988 6778999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 744 (914)
+.|+|.+.|+.. ....|-......++.|||.||.||.++ ++|||||.++|+||-..-.+||+||||.+-+...+.
T Consensus 193 plGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 193 PLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred ccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 999999999873 455677788899999999999999999 999999999999999999999999999988765544
Q ss_pred cee--eccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCC
Q 002509 745 HVS--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 821 (914)
Q Consensus 745 ~~~--~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 821 (914)
+.. ....-...|+|||.+..+.++.++|||+|||.+|||+| |+.||.+... .+|++- +|.
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g----~qIL~~-------------iD~ 330 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG----IQILKN-------------IDA 330 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH----HHHHHh-------------ccc
Confidence 431 22334678999999999999999999999999999999 8889875442 223321 222
Q ss_pred ccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002509 822 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 860 (914)
Q Consensus 822 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L 860 (914)
.-+-..+..+.+.+.++++.||..+|++||++.++.+.+
T Consensus 331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 222223445667899999999999999999999998543
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=308.31 Aligned_cols=253 Identities=20% Similarity=0.324 Sum_probs=197.9
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
.+.+.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++++..++..++|+||++
T Consensus 10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~ 89 (267)
T cd06646 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCG 89 (267)
T ss_pred hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCC
Confidence 4556789999999999999875 688999999876544445568889999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+++|.++++. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 90 ~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06646 90 GGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA- 161 (267)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence 9999998853 34578889999999999999999998 999999999999999999999999999876532211
Q ss_pred eeeccccCCcccCccccc---cCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCc
Q 002509 746 VSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 822 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~---~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 822 (914)
......|+..|+|||.+. ...++.++|||||||+++||++|+.|+......+. ...+. .... ..+.
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~---~~~~~-----~~~~---~~~~ 230 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---LFLMS-----KSNF---QPPK 230 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh---heeee-----cCCC---CCCC
Confidence 112345789999999884 34577899999999999999999999854321110 00000 0000 0011
Q ss_pred cCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002509 823 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 860 (914)
Q Consensus 823 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L 860 (914)
... .......+.+++.+|++.+|++||++++++++|
T Consensus 231 ~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 LKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred Ccc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 110 011224678999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=327.40 Aligned_cols=248 Identities=25% Similarity=0.339 Sum_probs=191.3
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
+.++||+|+||.||+++.. +++.||||++.... ......+.+|++++.+++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 84 (377)
T cd05629 5 TVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLP 84 (377)
T ss_pred EeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCC
Confidence 4578999999999999876 78999999986532 2223567889999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC-
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS- 744 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~- 744 (914)
+|+|.+++.. ...+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 85 GGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 9999999853 34578888889999999999999998 999999999999999999999999999863221000
Q ss_pred -----------c----------------------------------eeeccccCCcccCccccccCCCCccCceeehHHH
Q 002509 745 -----------H----------------------------------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVI 779 (914)
Q Consensus 745 -----------~----------------------------------~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvv 779 (914)
. ......||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0 0012459999999999998899999999999999
Q ss_pred HHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCC---CCHHHH
Q 002509 780 LLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMR---PSISEV 856 (914)
Q Consensus 780 l~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~R---Psm~eV 856 (914)
+|||++|+.||......+....+..|.. .+ .. +. . ......+.+++.+|+. +|.+| |++.|+
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~------~~-~~--p~---~--~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRE------TL-YF--PD---D--IHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCC------cc-CC--CC---C--CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 9999999999975432221122222110 00 00 00 0 0011346778888887 66654 699999
Q ss_pred HHH
Q 002509 857 LKD 859 (914)
Q Consensus 857 l~~ 859 (914)
+++
T Consensus 303 l~h 305 (377)
T cd05629 303 KSH 305 (377)
T ss_pred hcC
Confidence 876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=311.80 Aligned_cols=253 Identities=25% Similarity=0.413 Sum_probs=198.5
Q ss_pred HHhccccccCcEEEEEEEEC-CCc----EEEEEEEecCCc-ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEE
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 662 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~----~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 662 (914)
.+.++||+|+||+||+|++. +++ .||+|+++.... ...+.+.+|+.++..++|+||+++++++... ..++++|
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~ 88 (279)
T cd05109 10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQ 88 (279)
T ss_pred eeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEE
Confidence 44578999999999999864 444 489999875432 3356788999999999999999999999754 4679999
Q ss_pred eccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCC
Q 002509 663 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 742 (914)
Q Consensus 663 ~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 742 (914)
|+++|+|.++++.. ...+++..++.++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 89 ~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 89 LMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred cCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 99999999998643 34688999999999999999999998 9999999999999999999999999999866433
Q ss_pred CCce-eeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccC
Q 002509 743 ASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 820 (914)
Q Consensus 743 ~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 820 (914)
.... .....++..|+|||...+..++.++|||||||++|||++ |..||..... ..+..+... +....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~~~----~~~~~--- 231 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA----REIPDLLEK----GERLP--- 231 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHC----CCcCC---
Confidence 2221 112235678999999998889999999999999999998 8899864331 223332221 11100
Q ss_pred CccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHh
Q 002509 821 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 821 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 865 (914)
.+......+.+++.+|++.+|++||++.|+++.|+++..
T Consensus 232 ------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 232 ------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred ------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 011123357889999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=310.90 Aligned_cols=261 Identities=25% Similarity=0.407 Sum_probs=202.0
Q ss_pred HHHhccccccCcEEEEEEEEC-----CCcEEEEEEEecCCcc-cchhhhHHHHHHhhcccCceeEEEeeeee--cCceEE
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVL 659 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-----~g~~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~L 659 (914)
+.+.+.||+|+||.||++++. +++.+|||+++..... ....|.+|++++++++|+||+++++++.. ....++
T Consensus 6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05038 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRL 85 (284)
T ss_pred chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEE
Confidence 445678999999999999864 3688999999765443 45679999999999999999999999987 557899
Q ss_pred EEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccc
Q 002509 660 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 739 (914)
Q Consensus 660 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 739 (914)
||||+++++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 86 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 86 IMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 99999999999999643 23589999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCce--eeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccc-------hhHHHHHHHhh
Q 002509 740 VDGASHV--SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANC-------RNIVQWAKLHI 810 (914)
Q Consensus 740 ~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~-------~~l~~~~~~~~ 810 (914)
....... .....++..|+|||...+..++.++||||||++++||++|+.|+......... ...........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 5322211 11223566799999998889999999999999999999999987543211100 00011111111
Q ss_pred hcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 002509 811 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 863 (914)
Q Consensus 811 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 863 (914)
..+. ....+.....++.+++.+|++.+|++||+|.||+++|+.+
T Consensus 240 ~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 240 KEGE---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HcCC---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1110 0001112224688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=318.48 Aligned_cols=237 Identities=28% Similarity=0.342 Sum_probs=185.7
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCCc---ccchhhhHHH-HHHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEV-TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~-~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
+.||+|+||.||+|+.. +++.||+|++..... .....+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999886 688999999875421 2233444554 467889999999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
|+|.+++.. ...+.+.....++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET 152 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence 999888743 34577888889999999999999998 99999999999999999999999999987532222 12
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCc
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 826 (914)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .+.+.+ ..+.. .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~i----~~~~~------~~--- 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS----QMYDNI----LHKPL------QL--- 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH----HHHHHH----hcCCC------CC---
Confidence 23456899999999999889999999999999999999999999754321 111111 11110 01
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 002509 827 YDIQSMWKIEEKALMCVLPHGHMRPSIS 854 (914)
Q Consensus 827 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~ 854 (914)
+......+.+++.+|++.+|.+||+..
T Consensus 216 -~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 -PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 111223578899999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=326.90 Aligned_cols=198 Identities=24% Similarity=0.317 Sum_probs=167.9
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
+.++||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++.+.+++..++||||++
T Consensus 5 ~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (382)
T cd05625 5 KIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIP 84 (382)
T ss_pred EEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCC
Confidence 4578999999999999875 68899999987542 1224568889999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCC--
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-- 743 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 743 (914)
+|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 85 gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 85 GGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 99999998532 3577888888999999999999998 99999999999999999999999999975321000
Q ss_pred --------------------------------------------CceeeccccCCcccCccccccCCCCccCceeehHHH
Q 002509 744 --------------------------------------------SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVI 779 (914)
Q Consensus 744 --------------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvv 779 (914)
........||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000122468999999999999999999999999999
Q ss_pred HHHHHhCCCCccccc
Q 002509 780 LLELISGQEAISNEK 794 (914)
Q Consensus 780 l~ElltG~~p~~~~~ 794 (914)
+|||++|+.||....
T Consensus 238 l~elltG~~Pf~~~~ 252 (382)
T cd05625 238 LYEMLVGQPPFLAQT 252 (382)
T ss_pred HHHHHhCCCCCCCCC
Confidence 999999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=303.52 Aligned_cols=247 Identities=32% Similarity=0.468 Sum_probs=197.9
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEEecCCcc-cchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCChH
Q 002509 592 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK 670 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~ 670 (914)
++||+|++|.||++..++++.||+|.++..... ....+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999998765433 4567899999999999999999999999999999999999999999
Q ss_pred HHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCcee-ec
Q 002509 671 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS-SI 749 (914)
Q Consensus 671 ~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~~ 749 (914)
+++... ...+++..++.++.+++.||+|||++ +++||||||+||+++.++.+||+|||+++.......... ..
T Consensus 81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 998643 33578889999999999999999998 999999999999999999999999999875532221111 11
Q ss_pred cccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccC
Q 002509 750 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 828 (914)
Q Consensus 750 ~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 828 (914)
..++..|+|||.+.+..++.++|||||||+++||++ |..||...... ....... .+. ... .+
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~----~~~~~~~----~~~--~~~-------~~ 217 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ----QTRERIE----SGY--RMP-------AP 217 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH----HHHHHHh----cCC--CCC-------CC
Confidence 224567999999988889999999999999999999 88888643321 1111111 100 000 01
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002509 829 IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861 (914)
Q Consensus 829 ~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 861 (914)
......+.+++.+|++.+|++||++.||++.|+
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 112236889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=309.91 Aligned_cols=239 Identities=23% Similarity=0.373 Sum_probs=186.8
Q ss_pred cccccCcEEEEEEEECC-------------------------CcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEE
Q 002509 593 KIGSGGFGVVYYGKLKD-------------------------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQF 647 (914)
Q Consensus 593 ~lG~G~~G~Vy~~~~~~-------------------------g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l 647 (914)
+||+|+||.||+|.+.. ...|++|++..........|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997521 23588998865544445678889999999999999999
Q ss_pred EeeeeecCceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCC-
Q 002509 648 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM- 726 (914)
Q Consensus 648 ~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~- 726 (914)
+++|.+....++||||+++|+|..++... ...+++..++.++.|+++||+|||+. +|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence 99999999999999999999999988542 34678899999999999999999998 999999999999997643
Q ss_pred ------cEEEeeccccccccCCCCceeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHH-hCCCCccccccccc
Q 002509 727 ------RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELI-SGQEAISNEKFGAN 798 (914)
Q Consensus 727 ------~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~Ell-tG~~p~~~~~~~~~ 798 (914)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++||++ +|+.||......
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-- 228 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS-- 228 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH--
Confidence 4899999987543221 12346788999998875 56889999999999999995 689888653321
Q ss_pred chhHHHHHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002509 799 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861 (914)
Q Consensus 799 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 861 (914)
....+... .. .+.... ...+.+++.+|++.+|++||+|++|++.|+
T Consensus 229 --~~~~~~~~---~~--------~~~~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 229 --EKERFYEK---KH--------RLPEPS----CKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred --HHHHHHHh---cc--------CCCCCC----ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11111110 00 000111 125788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=325.44 Aligned_cols=261 Identities=24% Similarity=0.313 Sum_probs=194.2
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeeecC-----ceEEEE
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-----RSVLVY 661 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~-----~~~LV~ 661 (914)
+.+.||+|+||.||++... +++.||||++.... ....+.+.+|+++++.++|+||+++++++...+ ..++|+
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 83 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT 83 (372)
T ss_pred ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence 4578999999999999875 78999999986432 223456889999999999999999999998776 789999
Q ss_pred EeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccC
Q 002509 662 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 741 (914)
Q Consensus 662 E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 741 (914)
||+. ++|.+.+.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 84 e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 84 ELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred eccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9997 578777742 35688999999999999999999998 999999999999999999999999999976543
Q ss_pred CCCceeeccccCCcccCccccccC-CCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHH---------------
Q 002509 742 GASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW--------------- 805 (914)
Q Consensus 742 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~--------------- 805 (914)
..........++..|+|||.+.+. .++.++|||||||+++||++|+.||......+....+.+.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 333333334578999999998764 5789999999999999999999999754322111111110
Q ss_pred HHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 806 AKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 806 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
...............+.+. ....+...++.+++.+|++.||++||+++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLY-TLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHhCCCCCCchHHhc-ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000000000000 0001113457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=315.51 Aligned_cols=249 Identities=22% Similarity=0.288 Sum_probs=193.7
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCCc---ccchhhhHHHHHHhhc-ccCceeEEEeeeeecCceEEEEEeccC
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
+.||+|+||.||+++.. +++.+|+|+++.... .....+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999876 678999999976422 2234577899999888 699999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
|+|.+++.. ...+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DT 152 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cc
Confidence 999988743 34689999999999999999999998 99999999999999999999999999987532221 22
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCc
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 826 (914)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....++.......... .+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~------~~p~~ 225 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD-MNTEDYLFQVILEKPI------RIPRF 225 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcc-cccHHHHHHHHHhCCC------CCCCC
Confidence 2345689999999999999999999999999999999999999964321111 1111222222221111 01111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 002509 827 YDIQSMWKIEEKALMCVLPHGHMRPSI------SEVLKD 859 (914)
Q Consensus 827 ~~~~~~~~l~~l~~~C~~~~P~~RPsm------~eVl~~ 859 (914)
....+.+++.+|++.||++||++ +++.++
T Consensus 226 ----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 226 ----LSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred ----CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 11346789999999999999984 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=318.70 Aligned_cols=239 Identities=27% Similarity=0.355 Sum_probs=187.5
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHH-HHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVT-LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~-~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
+.||+|+||.||+++.. +|+.+|+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999876 78999999987542 122344555554 56778999999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
|+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 152 (325)
T cd05604 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DT 152 (325)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CC
Confidence 999988853 34688899999999999999999998 99999999999999999999999999987532221 12
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCc
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 826 (914)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+ .... +.. .+. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~----~~~~---~~~~-~~~--~~~----~~ 218 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA----EMYD---NILH-KPL--VLR----PG 218 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH----HHHH---HHHc-CCc--cCC----CC
Confidence 23456899999999999999999999999999999999999999754321 1111 1111 111 011 11
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 002509 827 YDIQSMWKIEEKALMCVLPHGHMRPSISEV 856 (914)
Q Consensus 827 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eV 856 (914)
....+.+++.+|++.+|++||++++.
T Consensus 219 ----~~~~~~~ll~~ll~~~p~~R~~~~~~ 244 (325)
T cd05604 219 ----ASLTAWSILEELLEKDRQRRLGAKED 244 (325)
T ss_pred ----CCHHHHHHHHHHhccCHHhcCCCCCC
Confidence 12346788999999999999988643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=317.80 Aligned_cols=244 Identities=24% Similarity=0.313 Sum_probs=192.3
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc---ccchhhhHHHHHHhhc-ccCceeEEEeeeeecCceEEEEEec
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
+.+.||+|+||.||+|+.+ +++.||+|+++.... .....+..|..++..+ +|++|+++++++...+..++||||+
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 83 (323)
T cd05616 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYV 83 (323)
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCC
Confidence 4578999999999999877 578999999875422 2234466777888777 5899999999999999999999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 744 (914)
++|+|.+.+.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~- 155 (323)
T cd05616 84 NGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG- 155 (323)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-
Confidence 99999988853 34578899999999999999999998 99999999999999999999999999987543221
Q ss_pred ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccC
Q 002509 745 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 824 (914)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.+... .... .
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~~~~i~----~~~~------~-- 219 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSIM----EHNV------A-- 219 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH----HHHHHHHH----hCCC------C--
Confidence 122345689999999999999999999999999999999999999975432 12222111 1110 0
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 002509 825 DEYDIQSMWKIEEKALMCVLPHGHMRPSI-----SEVLKD 859 (914)
Q Consensus 825 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm-----~eVl~~ 859 (914)
++.....++.+++.+|++.+|++|++. +++.++
T Consensus 220 --~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 220 --YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred --CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 111122357889999999999999984 566543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=310.24 Aligned_cols=263 Identities=23% Similarity=0.314 Sum_probs=192.7
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc--ccchhhhHHHHHHhhc---ccCceeEEEeeeee-----cCce
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRI---HHRNLVQFLGYCQE-----EGRS 657 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l---~HpnIv~l~g~~~~-----~~~~ 657 (914)
.+.+.||+|+||.||+|+.+ +++.||+|.++.... .....+.+|+++++++ +||||+++++++.. ....
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~ 82 (288)
T cd07863 3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKV 82 (288)
T ss_pred eEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceE
Confidence 34578999999999999876 688999999875422 2234566788777766 69999999998864 2457
Q ss_pred EEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccc
Q 002509 658 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 737 (914)
Q Consensus 658 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 737 (914)
++||||+.+ +|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 83 ~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 83 TLVFEHVDQ-DLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred EEEEccccc-CHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence 899999985 888888543 234588999999999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcc-
Q 002509 738 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ- 816 (914)
Q Consensus 738 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~- 816 (914)
...... ......||..|+|||++.+..++.++|||||||+++||++|+.||......+....+..............
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 654321 12234578999999999988999999999999999999999999865432222222222211000000000
Q ss_pred -----cccCCccC---CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 817 -----GIIDPSLL---DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 817 -----~i~d~~l~---~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
....+... .....+...++.+++.+|++.||++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 00111223457899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=314.02 Aligned_cols=260 Identities=25% Similarity=0.434 Sum_probs=202.1
Q ss_pred HHHHHhccccccCcEEEEEEEEC--------CCcEEEEEEEecCC-cccchhhhHHHHHHhhc-ccCceeEEEeeeeecC
Q 002509 586 ATKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG 655 (914)
Q Consensus 586 ~~~~~~~~lG~G~~G~Vy~~~~~--------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~ 655 (914)
..+.+.++||+|+||.||+++.. ....+|+|+++... ......+..|+++++++ +||||++++++|...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 34456789999999999999752 34578999987542 22345688999999999 6999999999999999
Q ss_pred ceEEEEEeccCCChHHHhhcccC------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeC
Q 002509 656 RSVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 723 (914)
Q Consensus 656 ~~~LV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~ 723 (914)
..++||||+++|+|.+++..... ....++|.+++.++.|++.||+|||++ +++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence 99999999999999999965321 234689999999999999999999998 999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCce-eeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchh
Q 002509 724 KHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRN 801 (914)
Q Consensus 724 ~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~ 801 (914)
+++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..... ..
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~----~~ 244 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV----EE 244 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH----HH
Confidence 99999999999997654322111 111224567999999998889999999999999999999 8888864332 12
Q ss_pred HHHHHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHh
Q 002509 802 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 802 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 865 (914)
+.+.. ..+...+ . +.....++.+++.+|++.+|++||++.|+++.|+++..
T Consensus 245 ~~~~~----~~~~~~~-----~----~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 245 LFKLL----REGHRMD-----K----PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHHHH----HcCCCCC-----C----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 22211 1111111 0 11122357789999999999999999999999997754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=305.35 Aligned_cols=253 Identities=25% Similarity=0.352 Sum_probs=189.5
Q ss_pred cccccCcEEEEEEEECCCc---EEEEEEEecCC-cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCC
Q 002509 593 KIGSGGFGVVYYGKLKDGK---EIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 668 (914)
Q Consensus 593 ~lG~G~~G~Vy~~~~~~g~---~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gs 668 (914)
.||+|+||.||+|+..++. .+++|.++... ....+.|.+|+.+++.++||||+++++.|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 6999999999999765433 45666665443 2345678999999999999999999999999999999999999999
Q ss_pred hHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCC-Ccee
Q 002509 669 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-SHVS 747 (914)
Q Consensus 669 L~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-~~~~ 747 (914)
|.++++.........++.....++.|+++||+|||+. +++||||||+|||++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999976433344567777889999999999999998 99999999999999999999999999986432211 1112
Q ss_pred eccccCCcccCcccccc-------CCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCccccc
Q 002509 748 SIVRGTVGYLDPEYYIS-------QQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 819 (914)
Q Consensus 748 ~~~~gt~~Y~aPE~~~~-------~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 819 (914)
....++..|+|||++.. ..++.++|||||||++|||++ |..||..... ..+.. .... +......
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~----~~~~~---~~~~-~~~~~~~ 230 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD----REVLN---HVIK-DQQVKLF 230 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH----HHHHH---HHHh-hcccccC
Confidence 23457889999999853 245789999999999999997 5667754321 11111 1111 1222334
Q ss_pred CCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002509 820 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861 (914)
Q Consensus 820 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 861 (914)
++.+...++ ..+.+++..|+ .+|++||+|+||++.|.
T Consensus 231 ~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 444433333 24666778898 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=323.48 Aligned_cols=253 Identities=21% Similarity=0.247 Sum_probs=193.9
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEE
Q 002509 586 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 661 (914)
Q Consensus 586 ~~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 661 (914)
..+.+.+.||+|+||.||+++.+ +++.+|+|++.... ......+.+|+.+++.++||||+++++.+..++..++||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 34455688999999999999887 68899999986432 222345778999999999999999999999999999999
Q ss_pred EeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccC
Q 002509 662 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 741 (914)
Q Consensus 662 E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 741 (914)
||+++|+|.+++.. ..++...+..++.|++.||+|||+. +|+||||||+|||++.++++||+|||+++....
T Consensus 123 Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 123 EYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred cCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 99999999999853 3467778888999999999999998 999999999999999999999999999976543
Q ss_pred CCCceeeccccCCcccCccccccC----CCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCccc
Q 002509 742 GASHVSSIVRGTVGYLDPEYYISQ----QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 817 (914)
Q Consensus 742 ~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 817 (914)
..........||+.|+|||++... .++.++|||||||++|||++|+.||....... .............
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~~~~ 267 (371)
T cd05622 195 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-------TYSKIMNHKNSLT 267 (371)
T ss_pred CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCccc
Confidence 332233445699999999998753 37889999999999999999999997543211 1111111111111
Q ss_pred ccCCccCCccCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHH
Q 002509 818 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHM--RPSISEVLKDI 860 (914)
Q Consensus 818 i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~--RPsm~eVl~~L 860 (914)
..+. ......+.+++..|+...+.+ ||+++|++++.
T Consensus 268 ~~~~-------~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 268 FPDD-------NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCc-------CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 1110 011234667888899744433 78999998864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=306.35 Aligned_cols=248 Identities=26% Similarity=0.353 Sum_probs=194.0
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC-cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 83 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG 83 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence 34578999999999999865 78899999986542 23346788999999999999999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
++|..+. .+++.....++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||++...... .
T Consensus 84 ~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~ 149 (279)
T cd06619 84 GSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---I 149 (279)
T ss_pred CChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---c
Confidence 9986542 356778889999999999999998 9999999999999999999999999998755332 1
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCc
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 826 (914)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||.............++....... . .+.+..
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~-----~~~~~~- 222 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-D-----PPVLPV- 222 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc-C-----CCCCCC-
Confidence 223468999999999998889999999999999999999999986432111111111111111110 0 111111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 827 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 827 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.....++.+++.+|++.+|++||+++|++++
T Consensus 223 --~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 223 --GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred --CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0112357889999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=326.34 Aligned_cols=258 Identities=21% Similarity=0.269 Sum_probs=192.0
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCC
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 667 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 667 (914)
.+.+.||+|+||.||++... .++.||||... ...+.+|+++|++++|+|||++++++..++..++|||++. +
T Consensus 172 ~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~ 244 (461)
T PHA03211 172 AIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-S 244 (461)
T ss_pred EEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-C
Confidence 34578999999999999876 57889999632 2346789999999999999999999999999999999995 6
Q ss_pred ChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc-e
Q 002509 668 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-V 746 (914)
Q Consensus 668 sL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~ 746 (914)
+|.+++... ...++|.+++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++........ .
T Consensus 245 ~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 245 DLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 888887532 34689999999999999999999998 9999999999999999999999999999765432221 2
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCccccccc----ccchhHHHHHHHhhh-cCCcccccCC
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG----ANCRNIVQWAKLHIE-SGDIQGIIDP 821 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~----~~~~~l~~~~~~~~~-~~~~~~i~d~ 821 (914)
.....||..|+|||++.+..++.++|||||||++|||++|..++-..... .....+.+.+..... ..........
T Consensus 319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~ 398 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS 398 (461)
T ss_pred ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence 23356999999999999999999999999999999999988765322111 111122222111100 0000000000
Q ss_pred cc------------CCccCH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 822 SL------------LDEYDI-------QSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 822 ~l------------~~~~~~-------~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
++ ...... ..-..+.+++.+|++.||++|||+.|++++
T Consensus 399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 000000 011257789999999999999999999985
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=303.45 Aligned_cols=248 Identities=26% Similarity=0.388 Sum_probs=196.2
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcc-----cchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEE
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-----GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 662 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~-----~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 662 (914)
.+.+.||+|++|.||++... +++.+|+|.+...... ....+.+|++++++++||||+++++++..++..++|+|
T Consensus 5 ~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 84 (263)
T cd06625 5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFME 84 (263)
T ss_pred cccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEE
Confidence 34678999999999999865 6899999998644211 23468889999999999999999999999999999999
Q ss_pred eccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCC
Q 002509 663 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 742 (914)
Q Consensus 663 ~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 742 (914)
|+++++|.+.+.. ...+++.....++.|++.||+|||+. +++||||||+||+++++++++|+|||+++.....
T Consensus 85 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 85 YMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred ECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 9999999998853 23577888899999999999999998 9999999999999999999999999998755332
Q ss_pred CCcee--eccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccC
Q 002509 743 ASHVS--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 820 (914)
Q Consensus 743 ~~~~~--~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 820 (914)
..... ....|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ..+.. . ... ...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~-~---~~~-~~~---- 225 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM---AAIFK-I---ATQ-PTN---- 225 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH---HHHHH-H---hcc-CCC----
Confidence 21111 2345788999999999988999999999999999999999998643211 11111 1 011 000
Q ss_pred CccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 821 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 821 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+.+ +......+.+++.+|+..+|++||++.|++++
T Consensus 226 ~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 PQL----PSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCC----CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111 11122357889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=305.66 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=197.5
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
+++.+.||+|+||.||+|... ++..+++|.+..........+.+|+++++.++|||++++++++..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 456678999999999999887 5778899998765555556788999999999999999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
++|.+++... ...+++..+..++.|+++||+|||+. +++||||||+||+++.++++||+|||++....... ..
T Consensus 87 ~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~ 159 (282)
T cd06643 87 GAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 159 (282)
T ss_pred CcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-cc
Confidence 9999887542 34689999999999999999999998 99999999999999999999999999986543322 12
Q ss_pred eeccccCCcccCccccc-----cCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCC
Q 002509 747 SSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 821 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 821 (914)
.....++..|+|||++. ...++.++|||||||++|||++|+.||...... ..+..... ........+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~~~~~-----~~~~~~~~~ 231 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM---RVLLKIAK-----SEPPTLAQP 231 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH---HHHHHHhh-----cCCCCCCCc
Confidence 23345899999999984 345778999999999999999999998643311 11111111 000011111
Q ss_pred ccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 822 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 822 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
. .....+.+++.+|++.+|.+||++.+++++
T Consensus 232 ~-------~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 232 S-------RWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred c-------ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 112357889999999999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=304.34 Aligned_cols=247 Identities=29% Similarity=0.455 Sum_probs=196.8
Q ss_pred HHHhccccccCcEEEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeee-ecCceEEEEEeccC
Q 002509 588 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ-EEGRSVLVYEFMHN 666 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~-~~~~~~LV~E~~~~ 666 (914)
+.+.+.||+|+||.||++... |+.+|+|.++... ..+.+.+|+.++++++|+|++++++++. ..+..++|+||+++
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 8 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred CeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 445678999999999999876 7889999986432 3457889999999999999999999765 45678999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
++|.+++... ....+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||+++......
T Consensus 85 ~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 85 GSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 9999998643 234588999999999999999999998 99999999999999999999999999987543221
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCC
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 825 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 825 (914)
....++..|+|||++....++.++|||||||++|||++ |+.||..... ..+..... .+.. +....
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~----~~~~~~~~----~~~~-----~~~~~ 222 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPRVE----KGYK-----MDAPD 222 (256)
T ss_pred -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHh----cCCC-----CCCCC
Confidence 12234678999999988889999999999999999998 9988864321 22222221 1110 11111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 002509 826 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 863 (914)
Q Consensus 826 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 863 (914)
.....+.+++.+|++.+|++||++.++++.|+++
T Consensus 223 ----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 223 ----GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1234578899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=316.68 Aligned_cols=241 Identities=26% Similarity=0.335 Sum_probs=187.3
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCCc---ccchhhhHHH-HHHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEV-TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~-~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
+.||+|+||.||+++.+ +++.||+|++..... .....+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999876 678899999875421 2223344444 456778999999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
|+|.+++.. ...+.......++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~ 152 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GT 152 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CC
Confidence 999998853 34567778888999999999999998 99999999999999999999999999987543222 12
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCc
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 826 (914)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+... . ... .+.+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~i~---~-~~~--~~~~~---- 218 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA----EMYDNIL---N-KPL--QLKPN---- 218 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH----HHHHHHH---h-CCc--CCCCC----
Confidence 23456999999999999999999999999999999999999999754321 1111111 1 110 01111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002509 827 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 858 (914)
Q Consensus 827 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 858 (914)
....+.+++.+|++.+|.+||++.+.+.
T Consensus 219 ----~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 219 ----ITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred ----CCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 1235778899999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=312.58 Aligned_cols=255 Identities=25% Similarity=0.441 Sum_probs=200.1
Q ss_pred HHHhccccccCcEEEEEEEEC------CCcEEEEEEEecCC-cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEE
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 660 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV 660 (914)
+.+.+.||+|+||.||+++.+ ++..||+|++.... ......+.+|++++++++||||+++++++......++|
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv 86 (288)
T cd05050 7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLL 86 (288)
T ss_pred ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEE
Confidence 345578999999999999864 46789999987543 23346788999999999999999999999999999999
Q ss_pred EEeccCCChHHHhhcccC------------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEe
Q 002509 661 YEFMHNGTLKEHLYGTLT------------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 722 (914)
Q Consensus 661 ~E~~~~gsL~~~L~~~~~------------------~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl 722 (914)
+||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||++
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~ 163 (288)
T cd05050 87 FEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLV 163 (288)
T ss_pred EecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheEe
Confidence 999999999999964321 123578899999999999999999998 99999999999999
Q ss_pred CCCCcEEEeeccccccccCCCC-ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccch
Q 002509 723 DKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCR 800 (914)
Q Consensus 723 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~ 800 (914)
+.++.+||+|||+++....... ........+..|+|||.+.+..++.++|||||||++|||++ |..||..... .
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~----~ 239 (288)
T cd05050 164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH----E 239 (288)
T ss_pred cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH----H
Confidence 9999999999999875433221 11122234678999999988899999999999999999998 8888754321 1
Q ss_pred hHHHHHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002509 801 NIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862 (914)
Q Consensus 801 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 862 (914)
.+... ...++.... +.....++.+++.+|++.+|++||++.|+++.|++
T Consensus 240 ~~~~~----~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 EVIYY----VRDGNVLSC---------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHH----HhcCCCCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 22221 122221110 11123468889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=304.28 Aligned_cols=250 Identities=30% Similarity=0.473 Sum_probs=192.0
Q ss_pred ccccccCcEEEEEEEEC----CCcEEEEEEEecCC-cccchhhhHHHHHHhhcccCceeEEEeeeee-cCceEEEEEecc
Q 002509 592 KKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSVLVYEFMH 665 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~----~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~LV~E~~~ 665 (914)
+.||+|+||.||+|... +...+|+|.+.... ......+.+|+.+++.++||||+++++++.. ++..++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999864 24579999875432 2334678889999999999999999998764 556789999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+|+|.+++... ...+++..++.++.|+++||+|||+. +++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999998643 23467778899999999999999998 9999999999999999999999999998754332111
Q ss_pred ---eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhC-CCCcccccccccchhHHHHHHHhhhcCCcccccCC
Q 002509 746 ---VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG-QEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 821 (914)
Q Consensus 746 ---~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG-~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 821 (914)
......++..|+|||.+.+..++.++|||||||++|||++| ..|+..... ..+..... .+.... .+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~----~~~~~~--~~ 224 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS----FDITVYLL----QGRRLL--QP 224 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHh----cCCCCC--CC
Confidence 11123457789999999888899999999999999999995 555543221 12222211 111000 00
Q ss_pred ccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhH
Q 002509 822 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 864 (914)
Q Consensus 822 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 864 (914)
. .....+.+++..|++.+|++||++.||++.|+++.
T Consensus 225 ---~----~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 225 ---E----YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred ---C----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 0 11235889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=307.10 Aligned_cols=251 Identities=29% Similarity=0.433 Sum_probs=197.0
Q ss_pred ccccccCcEEEEEEEECC-------CcEEEEEEEecCC-cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEe
Q 002509 592 KKIGSGGFGVVYYGKLKD-------GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 663 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~~-------g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~ 663 (914)
+.||+|+||.||+|+..+ ++.+|+|.+.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998753 2579999876543 23456788999999999999999999999999999999999
Q ss_pred ccCCChHHHhhcccC---ccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCC-----cEEEeeccc
Q 002509 664 MHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-----RAKVSDFGL 735 (914)
Q Consensus 664 ~~~gsL~~~L~~~~~---~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-----~~kl~DFGl 735 (914)
+++++|.+++..... ....+++.+++.++.|+++||+|||+. +++|+||||+||+++.+. .+|++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999965322 224578999999999999999999998 899999999999999877 899999999
Q ss_pred cccccCCCCc-eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcC
Q 002509 736 SKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESG 813 (914)
Q Consensus 736 a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~ 813 (914)
++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+..... .+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~----~~~~~~~~----~~ 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN----QEVLQHVT----AG 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH----HHHHHHHh----cC
Confidence 8755332211 1112235678999999999999999999999999999998 9999864321 12222211 11
Q ss_pred CcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002509 814 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862 (914)
Q Consensus 814 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 862 (914)
... .........+.+++.+|++.+|++||++++|++.|++
T Consensus 230 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 GRL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred Ccc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 100 0011123467899999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=307.36 Aligned_cols=247 Identities=24% Similarity=0.376 Sum_probs=198.7
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC-cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEec
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
.+...+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4445578999999999999875 57889999987543 233457889999999999999999999999999999999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 744 (914)
++++|.+++. ...+++..+..++.|+++||.|||++ +++|+||+|+||++++++.++|+|||++........
T Consensus 85 ~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 9999999884 24578899999999999999999998 999999999999999999999999999876543221
Q ss_pred ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccC
Q 002509 745 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 824 (914)
......|+..|+|||++.+..++.++|||||||+++||++|+.|+...... ....+ ...+. .+.+.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~~~----~~~~~-----~~~~~ 222 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM----RVLFL----IPKNS-----PPTLE 222 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh----hHHhh----hhcCC-----CCCCC
Confidence 122245788999999999888999999999999999999999998643211 11111 11110 11111
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 825 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 825 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
......+.+++.+|++.+|++||+|.||+++
T Consensus 223 ----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 223 ----GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ----cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1223458899999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=305.19 Aligned_cols=253 Identities=25% Similarity=0.330 Sum_probs=187.8
Q ss_pred cccccCcEEEEEEEECC---CcEEEEEEEecCCc-ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCC
Q 002509 593 KIGSGGFGVVYYGKLKD---GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 668 (914)
Q Consensus 593 ~lG~G~~G~Vy~~~~~~---g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gs 668 (914)
.||+|+||.||+|+..+ ...+++|.+..... .....|.+|++.++.++|+||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997653 34678887754432 234568899999999999999999999999999999999999999
Q ss_pred hHHHhhcccC-ccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc-e
Q 002509 669 LKEHLYGTLT-HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-V 746 (914)
Q Consensus 669 L~~~L~~~~~-~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~ 746 (914)
|.+++..... .....++...+.++.|++.||+|||+. +|+||||||+|||++.++++||+|||++......... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999965432 223456788889999999999999998 9999999999999999999999999998654332211 1
Q ss_pred eeccccCCcccCcccccc-------CCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccc
Q 002509 747 SSIVRGTVGYLDPEYYIS-------QQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 818 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~-------~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i 818 (914)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||...... ..... ....+ ....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~----~~~~~---~~~~~-~~~~ 230 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE----QVLKQ---VVREQ-DIKL 230 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH----HHHHH---Hhhcc-CccC
Confidence 122345778999998753 356789999999999999999 77787543211 11111 11111 1112
Q ss_pred cCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002509 819 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861 (914)
Q Consensus 819 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 861 (914)
.++.+.... ...+.++...|+ .+|++||+++||++.|.
T Consensus 231 ~~~~~~~~~----~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLDLKY----SDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcccccC----CHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 222222222 234556777787 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=330.33 Aligned_cols=252 Identities=27% Similarity=0.419 Sum_probs=204.7
Q ss_pred HHhccccccCcEEEEEEEEC-CC----cEEEEEEEecC-CcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEE
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DG----KEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 662 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g----~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 662 (914)
.-.++||+|+||+||||.+- .| -+||+|++... ..+...++.+|+-+|.+++|||+++++|+|.... ..||.+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 34578999999999999764 34 35899998765 3455788999999999999999999999998876 789999
Q ss_pred eccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCC
Q 002509 663 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 742 (914)
Q Consensus 663 ~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 742 (914)
||+.|+|.++++.. +..+--...+.++.|||+||.|||.+ +++||||.++||||.+-..+||.|||+++.....
T Consensus 778 ~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred hcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999999764 55677788899999999999999998 9999999999999999999999999999987654
Q ss_pred CCc-eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccC
Q 002509 743 ASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 820 (914)
Q Consensus 743 ~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 820 (914)
... ......-.+.|||-|.+....++.++|||||||.+||++| |..|+++....+ |.+ .++.++
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e----I~d----lle~ge------ 917 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE----IPD----LLEKGE------ 917 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH----hhH----HHhccc------
Confidence 333 2233344678999999999999999999999999999999 999987655322 221 222221
Q ss_pred CccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhH
Q 002509 821 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 864 (914)
Q Consensus 821 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 864 (914)
+| .-+.-+...+..++.+||..|+..||+++++...+.+..
T Consensus 918 -RL--sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 918 -RL--SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred -cC--CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 11 122234456888899999999999999999998876654
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=314.69 Aligned_cols=264 Identities=20% Similarity=0.290 Sum_probs=194.8
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc-ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
+.+.+.||+|+||.||+|+.+ +++.||+|.++.... .....+.+|++++++++||||+++++++..++..++||||++
T Consensus 8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 87 (309)
T cd07872 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD 87 (309)
T ss_pred eEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC
Confidence 345578999999999999876 678899999875432 234467889999999999999999999999999999999998
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+ +|.+++... ...+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 88 ~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 88 K-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred C-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 5 888877543 34578888999999999999999998 999999999999999999999999999875432221
Q ss_pred eeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHH-------hhhc-CCcc
Q 002509 746 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL-------HIES-GDIQ 816 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~-------~~~~-~~~~ 816 (914)
......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+...... .... ....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 1223357899999999865 46788999999999999999999999754432211111110000 0000 0000
Q ss_pred cccCCccCCc----cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 817 GIIDPSLLDE----YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 817 ~i~d~~l~~~----~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
..-.+..... .......++.+++.+|++.||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000000000 000112356789999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=309.00 Aligned_cols=248 Identities=26% Similarity=0.350 Sum_probs=195.2
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEEecCCcc---cchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 591 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 591 ~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~---~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
.+.||+|+||+||++... +++.+|+|.+...... ....+.+|++++++++|+||+++.+++..++..++||||+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05632 5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccC
Confidence 468999999999999876 6889999998754322 234577899999999999999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 85 ~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-- 157 (285)
T cd05632 85 GDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-- 157 (285)
T ss_pred ccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc--
Confidence 9999988643 234689999999999999999999998 999999999999999999999999999865433221
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCc
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 826 (914)
.....|+..|+|||++.+..++.++|+|||||++|||++|+.||........ .+.......... . ....
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~----~~~~~~~~~~~~--~----~~~~- 226 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK----REEVDRRVLETE--E----VYSA- 226 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHhhhccc--c----ccCc-
Confidence 1234689999999999988899999999999999999999999975432111 111111111110 0 1111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 002509 827 YDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 859 (914)
Q Consensus 827 ~~~~~~~~l~~l~~~C~~~~P~~RPs-----m~eVl~~ 859 (914)
.....+.+++..|++.+|++||+ ++|++++
T Consensus 227 ---~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 227 ---KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ---cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 11235778999999999999999 5566553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=306.01 Aligned_cols=258 Identities=24% Similarity=0.319 Sum_probs=204.1
Q ss_pred HHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC-cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEE
Q 002509 585 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 662 (914)
Q Consensus 585 ~~~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 662 (914)
...+.+.+.||+|+||+||++... +++.+|+|++.... ....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 345667789999999999999876 68899999886543 2335678899999999999999999999999999999999
Q ss_pred eccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCC
Q 002509 663 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 742 (914)
Q Consensus 663 ~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 742 (914)
|+++++|.+++.. ...+++.....++.+++.||.|||+. .+++||||||+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 9999999998853 34588999999999999999999974 27999999999999999999999999998654322
Q ss_pred CCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCccccccc----ccchhHHHHHHHhhhcCCcccc
Q 002509 743 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG----ANCRNIVQWAKLHIESGDIQGI 818 (914)
Q Consensus 743 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~----~~~~~l~~~~~~~~~~~~~~~i 818 (914)
. .....|+..|+|||++.+..++.++|||||||+++|+++|+.||...... .....+..+........
T Consensus 158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 229 (284)
T cd06620 158 I---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP----- 229 (284)
T ss_pred c---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-----
Confidence 1 12345899999999998888999999999999999999999999754321 11222333333222211
Q ss_pred cCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002509 819 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 860 (914)
Q Consensus 819 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L 860 (914)
.+.+.. .+....+.+++.+|++.+|++||+++||+++.
T Consensus 230 -~~~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 -PPRLPS---SDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred -CCCCCc---hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 011111 11234578899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=304.71 Aligned_cols=254 Identities=25% Similarity=0.399 Sum_probs=198.5
Q ss_pred HHhccccccCcEEEEEEEECC--CcEEEEEEEecCCc----------ccchhhhHHHHHHhh-cccCceeEEEeeeeecC
Q 002509 589 MLEKKIGSGGFGVVYYGKLKD--GKEIAVKVLTSNSY----------QGKREFTNEVTLLSR-IHHRNLVQFLGYCQEEG 655 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~~--g~~vAVK~l~~~~~----------~~~~~f~~E~~~l~~-l~HpnIv~l~g~~~~~~ 655 (914)
.+.+.||+|+||.||+|..+. ++.+|+|.+..... .....+..|+.++.+ ++||||+++++++...+
T Consensus 3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 82 (269)
T cd08528 3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND 82 (269)
T ss_pred hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence 355789999999999999875 68899998754321 112346678887765 79999999999999999
Q ss_pred ceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccc
Q 002509 656 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 735 (914)
Q Consensus 656 ~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 735 (914)
..+++|||+++++|.+++.........+++..++.++.|++.||.|||+.. +++|+||||+||+++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 83 RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecccc
Confidence 999999999999999988654334567899999999999999999999631 799999999999999999999999999
Q ss_pred cccccCCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCc
Q 002509 736 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 815 (914)
Q Consensus 736 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 815 (914)
+....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... .... .. ..+..
T Consensus 161 ~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~----~~~~---~~-~~~~~ 230 (269)
T cd08528 161 AKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML----SLAT---KI-VEAVY 230 (269)
T ss_pred eeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH----HHHH---HH-hhccC
Confidence 97654332 223445889999999999888999999999999999999999998643211 1111 11 11111
Q ss_pred ccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002509 816 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862 (914)
Q Consensus 816 ~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 862 (914)
....+ . .....+.+++.+|++.+|++||++.||.+++++
T Consensus 231 ~~~~~----~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 231 EPLPE----G----MYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred CcCCc----c----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 11100 0 112357889999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=308.85 Aligned_cols=249 Identities=27% Similarity=0.396 Sum_probs=196.6
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcc---cchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~---~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
..+.||+|+||.||++... +++.+|||.+...... ....+..|+.++++++|+|++++++.+...+..++||||++
T Consensus 4 ~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05630 4 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 83 (285)
T ss_pred eeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecC
Confidence 3468999999999999876 6889999998754322 23457789999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+++|.+++... ....+++..++.++.|++.||.|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 84 g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 84 GGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred CCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 99999988543 234588999999999999999999998 999999999999999999999999999875533222
Q ss_pred eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCC
Q 002509 746 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 825 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 825 (914)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||................ .. .. .....
T Consensus 158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~----~~--~~----~~~~~ 226 (285)
T cd05630 158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV----KE--VQ----EEYSE 226 (285)
T ss_pred -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh----hh--hh----hhcCc
Confidence 123468999999999998899999999999999999999999997533211111111110 00 00 01111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 002509 826 EYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 859 (914)
Q Consensus 826 ~~~~~~~~~l~~l~~~C~~~~P~~RPs-----m~eVl~~ 859 (914)
.+ ...+.+++..|++.+|++||+ ++|++++
T Consensus 227 ~~----~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 227 KF----SPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred cC----CHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 11 234778999999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=305.45 Aligned_cols=246 Identities=25% Similarity=0.395 Sum_probs=193.3
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCChH
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK 670 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~ 670 (914)
..||+|+||.||+|+.. ++..||+|.+........+.+.+|++++++++|+||+++++++..++..++|+||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 47999999999999865 67889999987665555678999999999999999999999999999999999999999999
Q ss_pred HHhhcccCccccc--cHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCC-CCcEEEeeccccccccCCCCcee
Q 002509 671 EHLYGTLTHEQRI--NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGASHVS 747 (914)
Q Consensus 671 ~~L~~~~~~~~~l--~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~ 747 (914)
+++.... ..+ ++..+..++.|+++||+|||+. +|+||||||+||+++. ++.+||+|||++........ ..
T Consensus 94 ~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~ 166 (268)
T cd06624 94 ALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CT 166 (268)
T ss_pred HHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-cc
Confidence 9986431 223 7788889999999999999998 9999999999999986 67999999999875533221 12
Q ss_pred eccccCCcccCccccccCC--CCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCC
Q 002509 748 SIVRGTVGYLDPEYYISQQ--LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 825 (914)
Q Consensus 748 ~~~~gt~~Y~aPE~~~~~~--~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 825 (914)
....|+..|+|||++.... ++.++||||||+++|||++|+.||...... ....+...... ..+.+
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~----~~~~~~~~~~~-------~~~~~-- 233 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP----QAAMFKVGMFK-------IHPEI-- 233 (268)
T ss_pred ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh----hhhHhhhhhhc-------cCCCC--
Confidence 2335789999999986543 788999999999999999999998642211 11111111000 01111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 826 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 826 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+.....++.+++.+|++.+|++||++.|++++
T Consensus 234 --~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 234 --PESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred --CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 11222357788999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=315.61 Aligned_cols=252 Identities=21% Similarity=0.249 Sum_probs=192.2
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEec
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
.+.+.||+|+||.||+++.+ +++.||+|++.... ......+.+|..++..++|+||+++++++.+.+..++||||+
T Consensus 4 ~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~ 83 (331)
T cd05624 4 EIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYY 83 (331)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence 35578999999999999876 67889999986532 222345788999999999999999999999999999999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 744 (914)
++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 84 VGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred CCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999999642 34578888899999999999999998 999999999999999999999999999976544333
Q ss_pred ceeeccccCCcccCcccccc-----CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCccccc
Q 002509 745 HVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 819 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 819 (914)
.......||+.|+|||++.+ +.++.++|||||||++|||++|+.||......+ ... ......... .+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~----~~~---~i~~~~~~~-~~ 229 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE----TYG---KIMNHEERF-QF 229 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH----HHH---HHHcCCCcc-cC
Confidence 33334569999999999875 467889999999999999999999997543211 111 111110000 01
Q ss_pred CCccCCccCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 002509 820 DPSLLDEYDIQSMWKIEEKALMCVLPHGHM--RPSISEVLKD 859 (914)
Q Consensus 820 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~--RPsm~eVl~~ 859 (914)
.+.. . ....++.+++.+|+...+++ |+++++++++
T Consensus 230 p~~~-~----~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 230 PSHI-T----DVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCcc-c----cCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 1111 1 11234667777777765543 5688888875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=303.09 Aligned_cols=250 Identities=24% Similarity=0.381 Sum_probs=193.9
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhc-ccCceeEEEeeeeec------CceE
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE------GRSV 658 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~------~~~~ 658 (914)
.+.+.+.||+|+||.||+|... +++.||+|++.... .....+..|+.++.++ +|+||+++++++... ...+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 85 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence 3455678999999999999876 68889999986543 3345788899999998 799999999998753 4578
Q ss_pred EEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccc
Q 002509 659 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 738 (914)
Q Consensus 659 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 738 (914)
+||||+.+|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 86 iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 86 LVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 999999999999998643 235688999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCceeeccccCCcccCccccc-----cCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcC
Q 002509 739 AVDGASHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 813 (914)
Q Consensus 739 ~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 813 (914)
...... ......|+..|+|||++. ...++.++|||||||++|||++|+.||...... ..... ....
T Consensus 161 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~------~~~~~--~~~~ 231 (272)
T cd06637 161 LDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RALFL--IPRN 231 (272)
T ss_pred cccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH------HHHHH--HhcC
Confidence 433221 223345899999999986 345788999999999999999999998643211 11110 0111
Q ss_pred CcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 814 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 814 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
......+. .....+.+++.+|++.+|.+||++.|++++
T Consensus 232 ~~~~~~~~--------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 232 PAPRLKSK--------KWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCCCCCCC--------CcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 11111111 112357889999999999999999999863
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=302.24 Aligned_cols=238 Identities=24% Similarity=0.413 Sum_probs=188.8
Q ss_pred ccccccCcEEEEEEEECCCc-----------EEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEE
Q 002509 592 KKIGSGGFGVVYYGKLKDGK-----------EIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 660 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~~g~-----------~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV 660 (914)
+.||+|+||.||+|...+.. .+++|++...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999887433 5788877654333 6788999999999999999999999988 778999
Q ss_pred EEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCC-------cEEEeec
Q 002509 661 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-------RAKVSDF 733 (914)
Q Consensus 661 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-------~~kl~DF 733 (914)
|||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+||
T Consensus 79 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence 9999999999998643 22688899999999999999999998 999999999999999887 7999999
Q ss_pred cccccccCCCCceeeccccCCcccCccccccC--CCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhh
Q 002509 734 GLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ--QLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHI 810 (914)
Q Consensus 734 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~ 810 (914)
|++..... .....++..|+|||++... .++.++|||||||++|||++ |..|+...... ....+..
T Consensus 153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~----~~~~~~~--- 220 (259)
T cd05037 153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS----EKERFYQ--- 220 (259)
T ss_pred Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch----hHHHHHh---
Confidence 99876533 1223467789999999876 78899999999999999999 56676543211 1111110
Q ss_pred hcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002509 811 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861 (914)
Q Consensus 811 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 861 (914)
...... .+ ....+.+++.+|+..+|.+||++.||++.|+
T Consensus 221 -~~~~~~--~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 -DQHRLP--MP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -cCCCCC--CC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000000 00 0146889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=339.52 Aligned_cols=260 Identities=22% Similarity=0.311 Sum_probs=201.5
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc---ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEec
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
.+.++||+|+||.||+|+.. +|+.||+|+++.... ...+.|.+|++++++++||||+++++++.+.+..++||||+
T Consensus 5 eIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~ 84 (932)
T PRK13184 5 DIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYI 84 (932)
T ss_pred EEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcC
Confidence 45578999999999999876 689999999875422 22456889999999999999999999999999999999999
Q ss_pred cCCChHHHhhcccC-------ccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccc
Q 002509 665 HNGTLKEHLYGTLT-------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 737 (914)
Q Consensus 665 ~~gsL~~~L~~~~~-------~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 737 (914)
++|+|.+++..... ....+++..++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 85 eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 85 EGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred CCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcce
Confidence 99999999864211 123467788899999999999999998 99999999999999999999999999997
Q ss_pred cccCCCC-----------------ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccch
Q 002509 738 FAVDGAS-----------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR 800 (914)
Q Consensus 738 ~~~~~~~-----------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~ 800 (914)
....... .......||+.|+|||.+.+..++.++|||||||+++||++|+.||......
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~---- 237 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR---- 237 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh----
Confidence 6521110 0011245899999999999999999999999999999999999999653211
Q ss_pred hHHHHHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhhhHhH
Q 002509 801 NIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-SISEVLKDIQDAIVI 866 (914)
Q Consensus 801 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RP-sm~eVl~~L~~~~~~ 866 (914)
.+... .. +.++.-.. ...+....+.+++.+|++.+|++|| +++++++.|+..+..
T Consensus 238 ki~~~--~~--------i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 238 KISYR--DV--------ILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhhhh--hh--------ccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 11110 00 00000000 0011223577899999999999995 688888888877653
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=316.06 Aligned_cols=200 Identities=27% Similarity=0.359 Sum_probs=170.5
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEec
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|..++..++|+||+++++++.+.+..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (331)
T cd05597 4 EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYY 83 (331)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecC
Confidence 45678999999999999876 68999999987531 223456888999999999999999999999999999999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 744 (914)
++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 84 ~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 84 VGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred CCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 999999998532 34578888999999999999999998 999999999999999999999999999876544333
Q ss_pred ceeeccccCCcccCcccccc-----CCCCccCceeehHHHHHHHHhCCCCccccc
Q 002509 745 HVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEK 794 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~ 794 (914)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||....
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~ 212 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence 33334568999999999863 457889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=300.45 Aligned_cols=248 Identities=25% Similarity=0.392 Sum_probs=200.0
Q ss_pred HHHhccccccCcEEEEEEEECC-CcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 588 KMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
+.+.+.||+|++|.||+|+..+ ++.+++|.++.... ..++.+|++++++++|+||+++++++......++++||+++
T Consensus 5 y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 82 (256)
T cd06612 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82 (256)
T ss_pred chhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence 4566789999999999999874 78999999875533 67899999999999999999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
++|.+++... ...+++..+..++.|+++||.|||+. +++||||+|+||+++.++.+||+|||++........ .
T Consensus 83 ~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (256)
T cd06612 83 GSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K 155 (256)
T ss_pred CcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence 9999998543 35689999999999999999999998 999999999999999999999999999876543321 2
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCc
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 826 (914)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||....... ..... ... ..+.+.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~---~~~~~-----~~~-----~~~~~~-- 220 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR---AIFMI-----PNK-----PPPTLS-- 220 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh---hhhhh-----ccC-----CCCCCC--
Confidence 233447889999999998899999999999999999999999986533211 11110 000 000110
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 827 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 827 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.+......+.+++.+|++.+|++||+++||+++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 011122357889999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=314.74 Aligned_cols=262 Identities=19% Similarity=0.279 Sum_probs=193.0
Q ss_pred Hhcccccc--CcEEEEEEEEC-CCcEEEEEEEecCCc--ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEec
Q 002509 590 LEKKIGSG--GFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 590 ~~~~lG~G--~~G~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
+.++||+| +|++||+++.+ +|+.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45689999 77899999775 789999999875432 22356778999999999999999999999999999999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 744 (914)
++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999985432 33588999999999999999999998 999999999999999999999999986543221111
Q ss_pred c------eeeccccCCcccCcccccc--CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhh-----
Q 002509 745 H------VSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE----- 811 (914)
Q Consensus 745 ~------~~~~~~gt~~Y~aPE~~~~--~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~----- 811 (914)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... .+.........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~ 233 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ---MLLEKLNGTVPCLLDT 233 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH---HHHHHhcCCccccccc
Confidence 0 1112346778999999976 458899999999999999999999996433211 01110000000
Q ss_pred ----cCCc-----ccccCCcc-----------------CCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 812 ----SGDI-----QGIIDPSL-----------------LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 812 ----~~~~-----~~i~d~~l-----------------~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.... ....+... ...........+.+++.+|++.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0000 00000000 000111223468899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=302.19 Aligned_cols=247 Identities=22% Similarity=0.356 Sum_probs=200.0
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC-cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEec
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
.+...+.||+|+||.||+|..+ +++.||+|++.... ......+.+|++++++++|+||+++++++.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 3445578999999999999876 58899999987543 233567889999999999999999999999999999999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 744 (914)
++|+|.+++.. ..+++.+...++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 85 GGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999998853 3578888999999999999999998 999999999999999999999999999976543321
Q ss_pred ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccC
Q 002509 745 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 824 (914)
......++..|+|||++.+..++.++|||||||++|||++|+.||....... ... ....+ ..
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~~----~~~~~---------~~ 218 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR----VLF----LIPKN---------NP 218 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh----Hhh----hhhcC---------CC
Confidence 2223457889999999988889999999999999999999999986543211 111 00101 01
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 825 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 825 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
..........+.+++.+|++.+|++||+++|++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 11222344568899999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=315.65 Aligned_cols=239 Identities=23% Similarity=0.300 Sum_probs=189.4
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhcc-cCceeEEEeeeeecCceEEEEEe
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEF 663 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~LV~E~ 663 (914)
++.+.||+|+||.||+++.+ +|+.||+|+++... ....+.+..|..++..+. |++|+++.+++...+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey 82 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEY 82 (323)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcC
Confidence 35578999999999999876 68999999987542 223345778888888885 57788899999999999999999
Q ss_pred ccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCC
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 743 (914)
Q Consensus 664 ~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 743 (914)
+++|+|.+++.. ...+++.+++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 83 VNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999998853 34588999999999999999999998 99999999999999999999999999987543221
Q ss_pred CceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCcc
Q 002509 744 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 823 (914)
Q Consensus 744 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 823 (914)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.+... .... ..
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~----~~~~~~i~----~~~~------~~ 220 (323)
T cd05615 156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE----DELFQSIM----EHNV------SY 220 (323)
T ss_pred -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHH----hCCC------CC
Confidence 122335689999999999988899999999999999999999999975432 22222211 1111 01
Q ss_pred CCccCHHHHHHHHHHHHHccCCCCCCCCCH
Q 002509 824 LDEYDIQSMWKIEEKALMCVLPHGHMRPSI 853 (914)
Q Consensus 824 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm 853 (914)
... ....+.+++.+|++.+|++|++.
T Consensus 221 p~~----~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 221 PKS----LSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred Ccc----CCHHHHHHHHHHcccCHhhCCCC
Confidence 111 12357789999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=316.91 Aligned_cols=189 Identities=22% Similarity=0.342 Sum_probs=161.3
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
.+.+.+.||+|+||.||+|+.. +++.||+|+... .....|+.++++++||||+++++++......++|+|++.
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 140 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS 140 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence 3556689999999999999876 577899997432 234579999999999999999999999999999999995
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 141 -~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~ 211 (357)
T PHA03209 141 -SDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--P 211 (357)
T ss_pred -CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC--c
Confidence 5888887532 45689999999999999999999998 9999999999999999999999999998753322 1
Q ss_pred eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCc
Q 002509 746 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI 790 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~ 790 (914)
......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 223345899999999999999999999999999999999865554
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=308.14 Aligned_cols=249 Identities=23% Similarity=0.342 Sum_probs=199.5
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
.+.+.+.||+|++|.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||++
T Consensus 20 ~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (297)
T cd06656 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 99 (297)
T ss_pred hceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccC
Confidence 4445678999999999999864 799999999976655556678899999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+++|.+++.. ..+++.++..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++.........
T Consensus 100 ~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 100 GGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 9999999843 3478889999999999999999998 9999999999999999999999999998765433221
Q ss_pred eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCC
Q 002509 746 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 825 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 825 (914)
.....+++.|+|||.+.+..++.++|||||||++|++++|+.||....... .+... ...+ ......
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~---~~~~~----~~~~-~~~~~~----- 237 (297)
T cd06656 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---ALYLI----ATNG-TPELQN----- 237 (297)
T ss_pred -cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch---heeee----ccCC-CCCCCC-----
Confidence 223457899999999998889999999999999999999999996533111 00000 0000 000000
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 826 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 826 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.......+.+++.+|++.+|++||++++|+++
T Consensus 238 --~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 238 --PERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred --ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122346789999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=306.72 Aligned_cols=240 Identities=25% Similarity=0.407 Sum_probs=188.2
Q ss_pred ccccccCcEEEEEEEECC--------CcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEe
Q 002509 592 KKIGSGGFGVVYYGKLKD--------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 663 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~~--------g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~ 663 (914)
+.||+|+||.||+|..+. ...+++|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999997642 234888887655444456788999999999999999999999999999999999
Q ss_pred ccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCc--------EEEeeccc
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR--------AKVSDFGL 735 (914)
Q Consensus 664 ~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~--------~kl~DFGl 735 (914)
+++|+|.++++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999999643 23678999999999999999999998 9999999999999987765 69999998
Q ss_pred cccccCCCCceeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCC-CCcccccccccchhHHHHHHHhhhcC
Q 002509 736 SKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQ-EAISNEKFGANCRNIVQWAKLHIESG 813 (914)
Q Consensus 736 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~-~p~~~~~~~~~~~~l~~~~~~~~~~~ 813 (914)
+...... ....++..|+|||++.+ ..++.++|||||||++|||++|. .|+...... ...... ..
T Consensus 155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~----~~~~~~----~~- 220 (258)
T cd05078 155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ----KKLQFY----ED- 220 (258)
T ss_pred ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH----HHHHHH----Hc-
Confidence 8654321 22457889999999986 45789999999999999999995 554432211 111110 00
Q ss_pred CcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002509 814 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861 (914)
Q Consensus 814 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 861 (914)
. ..+ +.....++.+++.+|++.+|++||+++|+++.|+
T Consensus 221 ~------~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 R------HQL----PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred c------ccC----CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 001 1111235789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=301.19 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=197.4
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
.+.+.+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||++
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG 89 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence 4556788999999999999875 688999999876544445567889999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+++|.+++.. ...+++.+.+.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++....... .
T Consensus 90 ~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~ 161 (267)
T cd06645 90 GGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-A 161 (267)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-c
Confidence 9999998853 34688999999999999999999998 99999999999999999999999999987553321 1
Q ss_pred eeeccccCCcccCccccc---cCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCc
Q 002509 746 VSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 822 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~---~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 822 (914)
......|+..|+|||++. ...++.++|||||||++|||++|+.||...... ..+..... .... .+.
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~---~~~~~~~~-----~~~~---~~~ 230 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM---RALFLMTK-----SNFQ---PPK 230 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch---hhHHhhhc-----cCCC---CCc
Confidence 123345899999999974 456888999999999999999999998543211 11111100 0000 011
Q ss_pred cCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 823 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 823 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
..... .....+.+++.+|++.+|++||++++|+++
T Consensus 231 ~~~~~--~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 231 LKDKM--KWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ccccC--CCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 11000 111247789999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=300.78 Aligned_cols=248 Identities=21% Similarity=0.365 Sum_probs=198.8
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC-cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
.+.+.||+|+||.||+++.. +++.+|+|.++... ....+.+..|+.++++++|+||+++++.+..++..++||||+++
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDG 82 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence 34578999999999999876 68999999986432 33456788899999999999999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
|+|.+++... ....+++...+.++.|++.||.|||++ +++|+||||+||++++++.++++|||++........ .
T Consensus 83 ~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 83 GDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 9999988543 234578888999999999999999998 999999999999999999999999999876543221 2
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCc
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 826 (914)
.....|+..|+|||++.+..++.++||||||+++++|++|+.||...... .... ....+.... + ..
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~----~~~~----~~~~~~~~~-~----~~- 222 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK----NLIL----KVCQGSYKP-L----PS- 222 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH----HHHH----HHhcCCCCC-C----Cc-
Confidence 23345889999999999888999999999999999999999999753321 1111 111121111 1 11
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 827 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 827 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.....+.+++.+|++.+|++||++.|++..
T Consensus 223 ---~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 223 ---HYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 112357789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=312.31 Aligned_cols=250 Identities=28% Similarity=0.411 Sum_probs=206.9
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCccc---chhhhHHHHHHhhcc-cCceeEEEeeeeecCceEEE
Q 002509 586 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG---KREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLV 660 (914)
Q Consensus 586 ~~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~---~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~LV 660 (914)
..|.+.+.||+|.||.||+++.+ +|+.+|+|++.+..... ...+.+|+++|+++. |||||.+.+.+......++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 34556689999999999999887 49999999998765443 358899999999998 99999999999999999999
Q ss_pred EEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCC----CcEEEeecccc
Q 002509 661 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH----MRAKVSDFGLS 736 (914)
Q Consensus 661 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~----~~~kl~DFGla 736 (914)
||++.+|.|.+.+... .+++.....++.|++.+++|||+. +|+||||||+|+|+... +.+|++|||++
T Consensus 115 mEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 9999999999999654 288999999999999999999998 99999999999999643 57999999999
Q ss_pred ccccCCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcc
Q 002509 737 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 816 (914)
Q Consensus 737 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 816 (914)
..... .......+||+.|+|||++....|+.++||||+||++|.|++|..||..+...+... .+..+++
T Consensus 187 ~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~--------~i~~~~~- 255 (382)
T KOG0032|consen 187 KFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL--------AILRGDF- 255 (382)
T ss_pred eEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH--------HHHcCCC-
Confidence 88765 445566789999999999999999999999999999999999999998765333222 1222222
Q ss_pred cccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 817 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 817 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+ ++..... ..-...-+++..|+..||.+|+++.+++++
T Consensus 256 ~-f~~~~w~----~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 D-FTSEPWD----DISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred C-CCCCCcc----ccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 0 1111111 122356788999999999999999999995
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=309.37 Aligned_cols=255 Identities=24% Similarity=0.338 Sum_probs=196.1
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC-cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
.+.+.||+|+||.||+++.. ++..+|+|.+.... .....++.+|++++.+++||||+++++++..++..++||||+++
T Consensus 4 ~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~ 83 (308)
T cd06615 4 EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 83 (308)
T ss_pred eEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCC
Confidence 34578999999999999876 67889999886542 22345688999999999999999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
++|.+++... ..+++..+..++.|+++||+|||+.+ +++||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (308)
T cd06615 84 GSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 154 (308)
T ss_pred CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence 9999998532 45788889999999999999999732 89999999999999999999999999986543321
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcc----------
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ---------- 816 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~---------- 816 (914)
.....|+..|+|||.+.+..++.++|||||||+++||++|+.||...... ....+...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK----ELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh----hHHHhhcCccccccccCCcccccCCC
Confidence 22346889999999998888999999999999999999999998643211 1111111000000000
Q ss_pred ----------ccc-------CCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 817 ----------GII-------DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 817 ----------~i~-------d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+.. .+.+.. ......+.+++.+|++.+|++||+++||+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPS---GAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcC---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 000000 0012357899999999999999999999986
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=302.28 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=198.3
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
.+.+.++||+|+||.||+|+.. +++.+++|++........+.+.+|++++++++|+||+++++.+..++..++||||++
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCP 92 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCC
Confidence 4556778999999999999886 589999999987655556778899999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+++|..++... ...+++..++.++.|+++||+|||+. +++||||||+||+++.++.+||+|||++....... .
T Consensus 93 ~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~ 165 (292)
T cd06644 93 GGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-Q 165 (292)
T ss_pred CCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-c
Confidence 99998887533 34588999999999999999999998 99999999999999999999999999986543221 1
Q ss_pred eeeccccCCcccCccccc-----cCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccC
Q 002509 746 VSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 820 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 820 (914)
......++..|+|||++. ...++.++|||||||++|||++|+.||...... ..+.+. ..........
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~~-----~~~~~~~~~~ 237 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVLLKI-----AKSEPPTLSQ 237 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH---HHHHHH-----hcCCCccCCC
Confidence 122345788999999985 344678999999999999999999998643211 111111 1111111100
Q ss_pred CccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 821 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 821 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+......+.+++.+|++.+|++||+++|++++
T Consensus 238 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 238 -------PSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -------CcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11122357889999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=304.28 Aligned_cols=253 Identities=24% Similarity=0.394 Sum_probs=199.0
Q ss_pred HhccccccCcEEEEEEEEC------CCcEEEEEEEecCCcc-cchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEE
Q 002509 590 LEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 662 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~------~g~~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 662 (914)
..+.||+|+||.||+|+.+ +.+.|++|.+...... ....+.+|++++++++|+||+++++++...+..++|||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 88 (275)
T cd05046 9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILE 88 (275)
T ss_pred eeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEE
Confidence 3468999999999999864 3467999988654333 34678999999999999999999999999999999999
Q ss_pred eccCCChHHHhhcccCc-----cccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccc
Q 002509 663 FMHNGTLKEHLYGTLTH-----EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 737 (914)
Q Consensus 663 ~~~~gsL~~~L~~~~~~-----~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 737 (914)
|+++|+|.+++...... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.++++|||+++
T Consensus 89 ~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~ 165 (275)
T cd05046 89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK 165 (275)
T ss_pred ecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccccccc
Confidence 99999999999654311 12689999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcc
Q 002509 738 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQ 816 (914)
Q Consensus 738 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 816 (914)
..............++..|+|||.+.+..++.++||||||++++||++ |..||..... ..+.... ..+...
T Consensus 166 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~----~~~~~~~----~~~~~~ 237 (275)
T cd05046 166 DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD----EEVLNRL----QAGKLE 237 (275)
T ss_pred ccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch----HHHHHHH----HcCCcC
Confidence 543322222233346778999999988888999999999999999999 7788854321 1222221 111111
Q ss_pred cccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002509 817 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861 (914)
Q Consensus 817 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 861 (914)
... .. .....+.+++.+|++.+|++||++.|+++.|+
T Consensus 238 ~~~----~~----~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 238 LPV----PE----GCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCC----CC----CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 100 11 12236889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=308.79 Aligned_cols=196 Identities=23% Similarity=0.378 Sum_probs=159.4
Q ss_pred hccccccCcEEEEEEEEC---CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeee--cCceEEEEEecc
Q 002509 591 EKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYEFMH 665 (914)
Q Consensus 591 ~~~lG~G~~G~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~LV~E~~~ 665 (914)
.++||+|+||.||+|+.+ +++.+|+|.+.... ....+.+|++++++++||||+++++++.. ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 358999999999999865 46789999986432 23457889999999999999999998854 356789999986
Q ss_pred CCChHHHhhccc-----CccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEe----CCCCcEEEeecccc
Q 002509 666 NGTLKEHLYGTL-----THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLS 736 (914)
Q Consensus 666 ~gsL~~~L~~~~-----~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DFGla 736 (914)
+ +|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 7877764321 1223588889999999999999999998 99999999999999 45678999999999
Q ss_pred ccccCCCCc--eeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCccc
Q 002509 737 KFAVDGASH--VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISN 792 (914)
Q Consensus 737 ~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~ 792 (914)
+........ ......||+.|+|||++.+ ..++.++||||+||+++||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 865433221 1233568999999999876 4588999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=314.35 Aligned_cols=252 Identities=22% Similarity=0.275 Sum_probs=190.8
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEec
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
.+.++||+|+||.||+++.+ +++.+|+|++.... ......+.+|+.++..++|+||+++++++.+.+..++||||+
T Consensus 4 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~ 83 (332)
T cd05623 4 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYY 83 (332)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEecc
Confidence 34578999999999999887 57889999986432 222345788999999999999999999999999999999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 744 (914)
++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 84 VGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred CCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 999999999642 34578888999999999999999998 999999999999999999999999999876543333
Q ss_pred ceeeccccCCcccCccccc-----cCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCccccc
Q 002509 745 HVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 819 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 819 (914)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||......+. ............ +
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~-------~~~i~~~~~~~~-~ 229 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-------YGKIMNHKERFQ-F 229 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH-------HHHHhCCCcccc-C
Confidence 3333456999999999986 34578899999999999999999999975432111 111111110000 0
Q ss_pred CCccCCccCHHHHHHHHHHHHHccCC--CCCCCCCHHHHHHH
Q 002509 820 DPSLLDEYDIQSMWKIEEKALMCVLP--HGHMRPSISEVLKD 859 (914)
Q Consensus 820 d~~l~~~~~~~~~~~l~~l~~~C~~~--~P~~RPsm~eVl~~ 859 (914)
+...... ...+.+++.+|+.. ++..||+++|++++
T Consensus 230 -p~~~~~~----s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 230 -PAQVTDV----SEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -CCccccC----CHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0000111 22355566666544 44457899999887
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=302.38 Aligned_cols=247 Identities=26% Similarity=0.385 Sum_probs=199.5
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC-cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
+.+.+.||.|++|.||+|+.. +++.||+|++.... ......+.+|++++++++|+||+++++++.+....++|+||++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG 82 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence 445678999999999999876 68899999987543 3334578899999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+++|.+++.. ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++.......
T Consensus 83 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 83 GGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred CCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence 9999999853 2688999999999999999999998 999999999999999999999999999977654322
Q ss_pred eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCC
Q 002509 746 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 825 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 825 (914)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...... .... ....... +.+..
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~----~~~~----~~~~~~~-----~~~~~ 220 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM----RVLF----LIPKNNP-----PSLEG 220 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH----HHHH----HhhhcCC-----CCCcc
Confidence 222345788999999999888999999999999999999999999643311 1111 1111111 11111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 826 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 826 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
. .....+.+++.+|+..+|++||++++++++
T Consensus 221 ~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 221 N---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred c---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1 022357789999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=301.35 Aligned_cols=246 Identities=27% Similarity=0.419 Sum_probs=195.4
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCCccc---------chhhhHHHHHHhhcccCceeEEEeeeeecCceEE
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG---------KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 659 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~---------~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~L 659 (914)
+.+.||+|++|.||+|... +++.+|+|.+....... .+.+.+|++++++++||||+++++++...+..++
T Consensus 4 ~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (267)
T cd06628 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNI 83 (267)
T ss_pred ccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEE
Confidence 4578999999999999875 68899999886543221 1457889999999999999999999999999999
Q ss_pred EEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccc
Q 002509 660 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 739 (914)
Q Consensus 660 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 739 (914)
|+||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 84 FLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred EEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 9999999999999853 24578888999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCc-----eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCC
Q 002509 740 VDGASH-----VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 814 (914)
Q Consensus 740 ~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 814 (914)
...... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ..+.. . ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~----~-~~-- 226 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL---QAIFK----I-GE-- 226 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH---HHHHH----H-hc--
Confidence 422111 112235788999999999888999999999999999999999999753211 11111 0 00
Q ss_pred cccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 815 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 815 ~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
...+.+.. .....+.+++.+|++.+|++||++.||+++
T Consensus 227 ---~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 227 ---NASPEIPS----NISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ---cCCCcCCc----ccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 01111111 223457889999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=310.61 Aligned_cols=252 Identities=25% Similarity=0.435 Sum_probs=196.4
Q ss_pred HhccccccCcEEEEEEEEC-CCc----EEEEEEEecCCc-ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEe
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 663 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~----~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~ 663 (914)
..+.||+|+||.||+|... +|. .+|+|.+..... .....+.+|+.++++++||||++++++|... ..++++||
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~ 89 (303)
T cd05110 11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL 89 (303)
T ss_pred eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence 3468999999999999865 444 478888765432 2234688999999999999999999998764 46799999
Q ss_pred ccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCC
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 743 (914)
Q Consensus 664 ~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 743 (914)
+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 90 ~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~ 163 (303)
T cd05110 90 MPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163 (303)
T ss_pred cCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCcc
Confidence 9999999998643 34578889999999999999999998 99999999999999999999999999998654332
Q ss_pred Cc-eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCC
Q 002509 744 SH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 821 (914)
Q Consensus 744 ~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 821 (914)
.. ......++..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+.++.. .+... ..+
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~----~~~~~~~~----~~~~~--~~~ 233 (303)
T cd05110 164 KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT----REIPDLLE----KGERL--PQP 233 (303)
T ss_pred cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHH----CCCCC--CCC
Confidence 21 1122345778999999998899999999999999999997 8899865331 22333222 11110 000
Q ss_pred ccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHh
Q 002509 822 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 822 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 865 (914)
. .....+.+++..|+..+|++||+|+|+++.|+++..
T Consensus 234 ---~----~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 234 ---P----ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred ---C----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1 112357889999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=306.96 Aligned_cols=265 Identities=21% Similarity=0.258 Sum_probs=199.4
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEec
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
+++.+.||+|++|.||+|..+ +++.||+|+++... ......+.+|++++++++|+||+++++++..++..++||||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 345678999999999999887 58899999986542 233467889999999999999999999999999999999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 744 (914)
+++.+..+... ...+++..+..++.|+++||+|||+. +++||||+|+||++++++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 83 ERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 98777665532 34478999999999999999999998 999999999999999999999999999877654433
Q ss_pred ceeeccccCCcccCccccccC-CCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhh--------hcCCc
Q 002509 745 HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI--------ESGDI 815 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~--------~~~~~ 815 (914)
.......++..|+|||++.+. .++.++||||||+++|||++|+.||......+....+........ .....
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 233345578899999999887 788999999999999999999999865432111111111000000 00000
Q ss_pred -----ccccCCcc-CCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 816 -----QGIIDPSL-LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 816 -----~~i~d~~l-~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.+..++.. ...++.....++.+++.+|++.+|++||++++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00000000 000111124568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=307.18 Aligned_cols=246 Identities=24% Similarity=0.371 Sum_probs=198.2
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCC
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 668 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gs 668 (914)
+.+.||.|++|.||+|... +++.|++|.+..........+.+|+++++.++||||+++++++...+..++|+||+++++
T Consensus 23 ~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 102 (296)
T cd06655 23 RYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGS 102 (296)
T ss_pred EEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCc
Confidence 4468999999999999864 789999999876655556678899999999999999999999999999999999999999
Q ss_pred hHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCceee
Q 002509 669 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 748 (914)
Q Consensus 669 L~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 748 (914)
|.+++. ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......... ..
T Consensus 103 L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~ 173 (296)
T cd06655 103 LTDVVT-----ETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-RS 173 (296)
T ss_pred HHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc-CC
Confidence 999884 23588999999999999999999998 9999999999999999999999999998765433221 22
Q ss_pred ccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccC
Q 002509 749 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 828 (914)
Q Consensus 749 ~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 828 (914)
...|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ..+.... . ........ .
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~---~~~~~~~----~-~~~~~~~~-------~ 238 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL---RALYLIA----T-NGTPELQN-------P 238 (296)
T ss_pred CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH----h-cCCcccCC-------c
Confidence 345889999999999888999999999999999999999999654321 1111110 0 00000000 1
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 829 IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 829 ~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
......+.+++.+|+..+|++||++.+++++
T Consensus 239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 1112357788999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=317.52 Aligned_cols=262 Identities=19% Similarity=0.255 Sum_probs=198.0
Q ss_pred HHHHHHHhccccccCcEEEEEEEEC---CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEE
Q 002509 584 EDATKMLEKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 660 (914)
Q Consensus 584 ~~~~~~~~~~lG~G~~G~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV 660 (914)
....+.+.+.||+|+||.||++... .++.||+|.+... ..+.+|++++++++||||+++++++......++|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 3445667789999999999999754 3578999987542 3456899999999999999999999999999999
Q ss_pred EEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccccc
Q 002509 661 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 740 (914)
Q Consensus 661 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 740 (914)
||++. ++|.+++. ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 165 ~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 165 MPKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred ehhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 99986 58888873 245689999999999999999999998 99999999999999999999999999997654
Q ss_pred CCCCc-eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcc--c
Q 002509 741 DGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ--G 817 (914)
Q Consensus 741 ~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~--~ 817 (914)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..... ........ .
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~-~~~~~~~~~~~ 315 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR-CMQVHPLEFPQ 315 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH-HhccCccccCC
Confidence 33222 22345699999999999999999999999999999999999999975543322222222111 11000000 0
Q ss_pred -----------ccCCccCCccCH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 818 -----------IIDPSLLDEYDI-------QSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 818 -----------i~d~~l~~~~~~-------~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.........+.. .....+.+++.+|+..+|++||++.|++.+
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000000 012356788999999999999999999986
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=302.94 Aligned_cols=252 Identities=25% Similarity=0.384 Sum_probs=194.4
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhc-ccCceeEEEeeee-----ecCceEEEE
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQ-----EEGRSVLVY 661 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~-----~~~~~~LV~ 661 (914)
.+.+.||+|+||.||++... +++.+|+|+++... .....+.+|+.+++++ +||||+++++++. .++..++||
T Consensus 21 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 99 (286)
T cd06638 21 EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVL 99 (286)
T ss_pred eeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEE
Confidence 34578999999999999876 68899999876432 2245678899999999 6999999999884 335689999
Q ss_pred EeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccC
Q 002509 662 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 741 (914)
Q Consensus 662 E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 741 (914)
||+++++|.++++........+++..+..++.|+++||.|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~ 176 (286)
T cd06638 100 ELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 176 (286)
T ss_pred eecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeeccc
Confidence 99999999998865444456788999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCceeeccccCCcccCcccccc-----CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcc
Q 002509 742 GASHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 816 (914)
Q Consensus 742 ~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 816 (914)
.. .......|+..|+|||++.. ..++.++|||||||++|||++|+.|+...... ..+... ......
T Consensus 177 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~---~~~~~~-----~~~~~~ 247 (286)
T cd06638 177 TR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM---RALFKI-----PRNPPP 247 (286)
T ss_pred CC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh---HHHhhc-----cccCCC
Confidence 22 12223458999999999853 44788999999999999999999998643311 111111 001101
Q ss_pred cccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002509 817 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 860 (914)
Q Consensus 817 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L 860 (914)
...++.. ....+.+++.+|++.+|++||++.||++++
T Consensus 248 ~~~~~~~-------~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 248 TLHQPEL-------WSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred cccCCCC-------cCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 1111111 113578899999999999999999999763
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=302.82 Aligned_cols=251 Identities=24% Similarity=0.348 Sum_probs=199.5
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
.+.+.+.||+|++|.||+++.. +++.+|+|+++.........+..|++++++++||||+++++.+..+...++||||++
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD 85 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccC
Confidence 3566788999999999999876 689999999876655555678899999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+++|.+++... ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++........
T Consensus 86 ~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 86 GGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred CCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 99999998543 34588999999999999999999998 999999999999999999999999999865433221
Q ss_pred eeeccccCCcccCccccc-----cCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccC
Q 002509 746 VSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 820 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 820 (914)
......|+..|+|||.+. ...++.++|||||||++|||++|+.||...... +.+..+ ..+.......
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~---~~~~~~-----~~~~~~~~~~ 230 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM---RVLLKI-----LKSEPPTLDQ 230 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH---HHHHHH-----hcCCCCCcCC
Confidence 223345889999999975 345677999999999999999999998654311 111111 1111110000
Q ss_pred CccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 821 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 821 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+ ......+.+++.+|++.+|.+||++.+|+++
T Consensus 231 ~-------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 231 P-------SKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred c-------ccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0 1112357789999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=290.10 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=200.5
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecC--CcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEe
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 663 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~ 663 (914)
.+.+.+.||+|+|+.||+.... +|+.+|+|++..+ +..+.+++.+|+.+-+.++|||||++.....+.+..++|+|+
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~ 91 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 91 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEec
Confidence 3456678999999999998655 7999999988644 444677889999999999999999999999999999999999
Q ss_pred ccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCC---CCcEEEeecccccccc
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAV 740 (914)
Q Consensus 664 ~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~ 740 (914)
|+|++|..-+-. +...++...-..+.||+++|.|+|.+ +|||||+||+|+||-. .--+||+|||+|....
T Consensus 92 m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 92 VTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999776632 24566777778899999999999999 9999999999999953 3469999999998776
Q ss_pred CCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccC
Q 002509 741 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 820 (914)
Q Consensus 741 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 820 (914)
.........||++|||||++...+|+..+|||+.||+|+-|+.|..||.++... .+.+.+ ..+.+. ++
T Consensus 165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~----rlye~I----~~g~yd--~~ 232 (355)
T KOG0033|consen 165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH----RLYEQI----KAGAYD--YP 232 (355)
T ss_pred --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH----HHHHHH----hccccC--CC
Confidence 344556678999999999999999999999999999999999999999875533 333321 112111 12
Q ss_pred CccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 821 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 821 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+.-.... -++..+|+.+|+..||.+|-|+.|.+++
T Consensus 233 ~~~w~~i----s~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 233 SPEWDTV----TPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred CcccCcC----CHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 2111111 2246688999999999999999998754
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=298.41 Aligned_cols=249 Identities=23% Similarity=0.383 Sum_probs=197.5
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeee-cCceEEEEEe
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSVLVYEF 663 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~LV~E~ 663 (914)
|.+.+.||+|++|.||+++.+ +++.+|+|.+.... ....+.+.+|++++++++|+|++++++.+.. ....+++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 345678999999999999876 57889999986543 2334568899999999999999999998764 4457899999
Q ss_pred ccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCC
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 743 (914)
Q Consensus 664 ~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 743 (914)
+++++|.+++... ....+++.+++.++.|++.||++||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 82 CEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred cCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999999998653 234589999999999999999999998 99999999999999999999999999987654322
Q ss_pred CceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCcc
Q 002509 744 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 823 (914)
Q Consensus 744 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 823 (914)
. ......|++.|+|||.+.+..++.++|||||||+++||++|+.||..... ....... ..+... .+
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-------~~~~~~~-~~~~~~-----~~ 222 (257)
T cd08223 157 D-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-------NSLVYRI-IEGKLP-----PM 222 (257)
T ss_pred C-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHH-HhcCCC-----CC
Confidence 2 22334588999999999998899999999999999999999999864321 1111111 111111 11
Q ss_pred CCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 824 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 824 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+......+.+++.+|++.+|++||++.|++++
T Consensus 223 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 223 ----PKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ----ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11222468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=301.79 Aligned_cols=263 Identities=22% Similarity=0.284 Sum_probs=197.0
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
++.+.||+|++|.||+|+.+ +++.||+|++.... ....+.+.+|++++++++|+|++++++++......++||||++
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~ 83 (286)
T cd07847 4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCD 83 (286)
T ss_pred eeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccC
Confidence 34568999999999999887 68999999986542 2234567899999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+++|...+.. ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 84 ~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 84 HTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred ccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence 9888877642 34589999999999999999999998 999999999999999999999999999976544321
Q ss_pred eeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhh-------cCC-cc
Q 002509 746 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE-------SGD-IQ 816 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~-------~~~-~~ 816 (914)
......++..|+|||.+.+ ..++.++|||||||+++||++|+.||......+....+......... ... ..
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 1222347889999999876 45788999999999999999999999754322211111111110000 000 00
Q ss_pred cccCCccCCccCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 817 GIIDPSLLDEYDI-----QSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 817 ~i~d~~l~~~~~~-----~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
....+......+. .....+.+++.+|++.+|++||++.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0001111100011 112457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=314.20 Aligned_cols=261 Identities=23% Similarity=0.307 Sum_probs=191.0
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecC--CcccchhhhHHHHHHhhcccCceeEEEeeeeecC------ce
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RS 657 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~------~~ 657 (914)
.+.+.+.||+|+||.||+++.. +|+.||||++... .......+.+|+.+++.++||||+++++++...+ ..
T Consensus 22 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 101 (359)
T cd07876 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDV 101 (359)
T ss_pred ceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccccee
Confidence 3445678999999999999875 6899999998643 2233456788999999999999999999886543 46
Q ss_pred EEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccc
Q 002509 658 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 737 (914)
Q Consensus 658 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 737 (914)
++||||+++ +|.+.++ ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 102 ~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 102 YLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred EEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 899999976 5666553 2367788889999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHH--------------
Q 002509 738 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV-------------- 803 (914)
Q Consensus 738 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~-------------- 803 (914)
..... .......||..|+|||.+.+..++.++|||||||++|||++|+.||......+....+.
T Consensus 172 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 172 TACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred ccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 54322 12233458999999999999999999999999999999999999997543111000000
Q ss_pred -HHHHHhhhc-CCc-----ccccCCccCC---ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 804 -QWAKLHIES-GDI-----QGIIDPSLLD---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 804 -~~~~~~~~~-~~~-----~~i~d~~l~~---~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
..+...... ... .+....-... .........+.+++.+|++.||++|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000000 000 0000000000 0001112357899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=318.93 Aligned_cols=198 Identities=26% Similarity=0.377 Sum_probs=169.8
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
+.+.||+|+||.||+++.+ +++.||+|+++... ......+..|+.++..++|+||+++++.+.+.+..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (360)
T cd05627 5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLP 84 (360)
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence 3478999999999999876 68999999997532 2234567889999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC-
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS- 744 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~- 744 (914)
+|+|.+++.. ...+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 85 GGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred CccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 9999999853 34588889999999999999999998 999999999999999999999999999864422100
Q ss_pred ---------------------------------ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcc
Q 002509 745 ---------------------------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS 791 (914)
Q Consensus 745 ---------------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~ 791 (914)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 00113469999999999999999999999999999999999999997
Q ss_pred ccc
Q 002509 792 NEK 794 (914)
Q Consensus 792 ~~~ 794 (914)
...
T Consensus 238 ~~~ 240 (360)
T cd05627 238 SET 240 (360)
T ss_pred CCC
Confidence 544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=303.87 Aligned_cols=255 Identities=25% Similarity=0.423 Sum_probs=201.3
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCc----EEEEEEEecCCc-ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEE
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 660 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~----~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV 660 (914)
.+.+.+.||+|+||.||+|..+ +|+ .+|+|.+..... .....+.+|++++++++||||++++++|.. ...++|
T Consensus 8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v 86 (279)
T cd05057 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLI 86 (279)
T ss_pred HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEE
Confidence 3455678999999999999875 333 589998865543 234678899999999999999999999987 788999
Q ss_pred EEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccccc
Q 002509 661 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 740 (914)
Q Consensus 661 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 740 (914)
+||+++|+|.+++... ...+++..++.++.|+++||+|||++ +++||||||+||+++.++.+||+|||+++...
T Consensus 87 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 87 TQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999998643 33588999999999999999999998 99999999999999999999999999998664
Q ss_pred CCCCcee-eccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccc
Q 002509 741 DGASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 818 (914)
Q Consensus 741 ~~~~~~~-~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i 818 (914)
....... ....++..|+|||.+....++.++|||||||+++|+++ |+.||..... ..+.+.+. .+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~----~~~~~-- 230 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA----VEIPDLLE----KGERL-- 230 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH----HHHHHHHh----CCCCC--
Confidence 3322221 12224568999999988889999999999999999998 9999875432 22222221 11110
Q ss_pred cCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHh
Q 002509 819 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 819 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 865 (914)
-.+. .....+.+++.+|+..+|++||++.++++.|+++..
T Consensus 231 ~~~~-------~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 231 PQPP-------ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCCC-------CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0011 112357788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=297.23 Aligned_cols=249 Identities=23% Similarity=0.319 Sum_probs=200.4
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecC--CcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
.+.+.||+|+||.||.++.. +++.+++|.+... .....+.+.+|++++++++|+||+++++++.+.+..+++|||++
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (256)
T cd08221 3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYAN 82 (256)
T ss_pred eEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecC
Confidence 34578999999999998765 6889999988654 23445678899999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+|+|.+++.... ...+++.++..++.|+++||+|||+. +++||||||+||++++++.+||+|||++........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 83 GGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred CCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 999999986442 35688999999999999999999998 999999999999999999999999999876544332
Q ss_pred eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCC
Q 002509 746 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 825 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 825 (914)
......|+..|+|||.+.+..++.++||||||++++||++|+.||...... +..... ..+.....
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-------~~~~~~-~~~~~~~~------- 221 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-------NLVVKI-VQGNYTPV------- 221 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHH-HcCCCCCC-------
Confidence 223345899999999998888899999999999999999999998643321 111111 11111111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002509 826 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 860 (914)
Q Consensus 826 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L 860 (914)
......++.+++.+|++.+|++||+++|+++++
T Consensus 222 --~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 --VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred --ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 011223578899999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=295.92 Aligned_cols=260 Identities=23% Similarity=0.351 Sum_probs=192.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEEec--CCcccchhhhHHHHHHhhcccCceeEEEeeeee-----cCceEEEEE
Q 002509 591 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTS--NSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-----EGRSVLVYE 662 (914)
Q Consensus 591 ~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~--~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~-----~~~~~LV~E 662 (914)
.+.||+|+||.|+.+..+ +|+.||+|.+.. ......+.-.+|+.+|+.++|+||+.+.+.+.. -+..++|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 357999999999999876 789999998863 233445667799999999999999999998865 246799999
Q ss_pred eccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCC
Q 002509 663 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 742 (914)
Q Consensus 663 ~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 742 (914)
+|+ -+|...++. ++.|+......+..|+++||.|+|+. +|+||||||+|+|++.+...||+|||+|+.....
T Consensus 107 lMe-tDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 107 LME-TDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred HHh-hHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeecccc
Confidence 995 488888753 34488888899999999999999998 9999999999999999999999999999977542
Q ss_pred -CCceeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccC
Q 002509 743 -ASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 820 (914)
Q Consensus 743 -~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 820 (914)
.....+..+.|.+|.|||.+.. ..|+.+.||||.|||+.||++|+.-|.+.+.-.-...+.+.. ....+..+..+-.
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~l-GtP~~e~l~~i~s 257 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELL-GTPSEEDLQKIRS 257 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhc-CCCCHHHHHHhcc
Confidence 1222345567999999999864 679999999999999999999999887644211111111100 0000000000000
Q ss_pred Cc-------c--CCccC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 821 PS-------L--LDEYD-----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 821 ~~-------l--~~~~~-----~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+. + ....+ ...-...++|..+|+..||.+|+|++|.+++
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00 0 00000 0112356788999999999999999999886
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=308.25 Aligned_cols=263 Identities=22% Similarity=0.312 Sum_probs=194.7
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc-ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
+.+.+.||+|+||.||+|+.+ +++.||+|.++.... .....+.+|++++++++||||+++++++..++..++||||++
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~ 87 (301)
T cd07873 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 87 (301)
T ss_pred eEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc
Confidence 344578999999999999876 688999999875432 234467789999999999999999999999999999999997
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
++|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 88 -~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 88 -KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred -cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 5898888543 34578889999999999999999998 999999999999999999999999999875432221
Q ss_pred eeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccC----
Q 002509 746 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID---- 820 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d---- 820 (914)
......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+...... ........+++
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 238 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGT-PTEETWPGILSNEEF 238 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC-CChhhchhhhccccc
Confidence 1122346889999999865 45788999999999999999999999754322111111111000 00000011100
Q ss_pred -----CccCCcc----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 821 -----PSLLDEY----DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 821 -----~~l~~~~----~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+...... .......+.+++.+|++.+|.+|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1100000 00112356789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=304.23 Aligned_cols=264 Identities=23% Similarity=0.260 Sum_probs=193.7
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc--ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
+.+.||+|++|.||+|+.. +++.||+|.++.... .....+.+|+.++++++||||+++++++..++..++||||++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (285)
T cd07861 4 KIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS- 82 (285)
T ss_pred EeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-
Confidence 4568999999999999876 689999999865422 224568899999999999999999999999999999999997
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
++|.+++.... ....+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++....... ..
T Consensus 83 ~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~ 157 (285)
T cd07861 83 MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RV 157 (285)
T ss_pred CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-cc
Confidence 68888875432 235689999999999999999999998 99999999999999999999999999987543221 11
Q ss_pred eeccccCCcccCccccccC-CCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhc--------CCccc
Q 002509 747 SSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES--------GDIQG 817 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~--------~~~~~ 817 (914)
.....+++.|+|||.+.+. .++.++|||||||+++||++|+.||...........+.+........ .....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 2223468899999988654 57889999999999999999999996543211111111100000000 00000
Q ss_pred ccCCccCC---ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 818 IIDPSLLD---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 818 i~d~~l~~---~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
..+..... ........++.+++.+|++.||++||+++||+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000 0000112356789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=297.86 Aligned_cols=247 Identities=26% Similarity=0.417 Sum_probs=195.7
Q ss_pred HhccccccCcEEEEEEEECCCcEEEEEEEecCCc------ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEe
Q 002509 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 663 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~------~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~ 663 (914)
..+.||+|+||.||+|...+++.+|+|.++.... .....+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 4 ~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (265)
T cd06631 4 KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEF 83 (265)
T ss_pred ccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEec
Confidence 4568999999999999988899999998864421 1124588899999999999999999999999999999999
Q ss_pred ccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCC
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 743 (914)
Q Consensus 664 ~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 743 (914)
+++++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++.......
T Consensus 84 ~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 84 VPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred CCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 9999999998532 3578888999999999999999998 89999999999999999999999999987543211
Q ss_pred -----CceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccc
Q 002509 744 -----SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 818 (914)
Q Consensus 744 -----~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i 818 (914)
........|+..|+|||++.+..++.++|||||||+++||++|+.||....... ..... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~~---~~~~~----- 225 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA---AMFYI---GAHRG----- 225 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH---HHHHh---hhccC-----
Confidence 111223458899999999998889999999999999999999999996432111 11110 00000
Q ss_pred cCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002509 819 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 858 (914)
Q Consensus 819 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 858 (914)
..+.+... ....+.+++.+|++.+|++||++.|+++
T Consensus 226 ~~~~~~~~----~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 LMPRLPDS----FSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCCCC----CCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 01112122 2235788999999999999999999976
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=303.76 Aligned_cols=264 Identities=23% Similarity=0.291 Sum_probs=198.6
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
.+.+.||+|++|.||+|+.. +|+.||+|++.... ......+.+|+.++++++||||+++++++..+...++|+||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~- 81 (286)
T cd07832 3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM- 81 (286)
T ss_pred eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-
Confidence 45678999999999999875 68999999987653 233467889999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+++|.+++... ...+++.+++.++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 82 PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 99999998643 25689999999999999999999998 9999999999999999999999999998766443322
Q ss_pred eeeccccCCcccCccccccC-CCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHH-------hhhc-CCcc
Q 002509 746 VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL-------HIES-GDIQ 816 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~-------~~~~-~~~~ 816 (914)
......|+..|+|||.+.+. .++.++||||+||+++||++|+.+|...........+...... ...+ .+..
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence 22334588999999998754 4688999999999999999998777543321111111110000 0000 0000
Q ss_pred cccCCccCC----ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 817 GIIDPSLLD----EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 817 ~i~d~~l~~----~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.+..+.-.. ....+....+.+++.+|++.+|++||++++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 0001123578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=299.75 Aligned_cols=253 Identities=24% Similarity=0.337 Sum_probs=199.9
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeee--cCceEEEEEe
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYEF 663 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~LV~E~ 663 (914)
++.+.||+|+||.||++... +++.+|+|++.... ....+.+..|++++++++|+||+++++++.. ....+++|||
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~ 82 (265)
T cd08217 3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEY 82 (265)
T ss_pred eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehh
Confidence 34578999999999999765 68899999987542 2334568889999999999999999998764 3457899999
Q ss_pred ccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCC--CCCccccCCCCCceEeCCCCcEEEeeccccccccC
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC--VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 741 (914)
Q Consensus 664 ~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~--~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 741 (914)
+++++|.+++.........+++..++.++.|+++||+|||..+ ..+++|+||||+||+++.++.+||+|||++.....
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~ 162 (265)
T cd08217 83 CEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH 162 (265)
T ss_pred ccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccC
Confidence 9999999999665444567899999999999999999999322 23999999999999999999999999999986644
Q ss_pred CCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCC
Q 002509 742 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 821 (914)
Q Consensus 742 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 821 (914)
.... .....|+..|+|||.+.+..++.++||||||+++++|++|+.||..... ..+.+.. ..+...
T Consensus 163 ~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~----~~~~~~----- 228 (265)
T cd08217 163 DSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ----LQLASKI----KEGKFR----- 228 (265)
T ss_pred Cccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH----HHHHHHH----hcCCCC-----
Confidence 3321 2234589999999999988899999999999999999999999875431 2222221 111111
Q ss_pred ccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 822 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 822 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
. .+......+.+++.+|++.+|++||+++||+++
T Consensus 229 ~----~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 R----IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred C----CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1 111223468899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=316.83 Aligned_cols=261 Identities=23% Similarity=0.306 Sum_probs=192.2
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeeec------Cce
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRS 657 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~------~~~ 657 (914)
.+.+.+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++||||+++++++... ...
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~ 104 (364)
T cd07875 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 104 (364)
T ss_pred ceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeE
Confidence 3455678999999999999865 68899999987532 23345678899999999999999999987543 356
Q ss_pred EEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccc
Q 002509 658 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 737 (914)
Q Consensus 658 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 737 (914)
++||||+++ +|.+.+. ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 105 ~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 105 YIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred EEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 999999975 6766663 2367888899999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHH------------
Q 002509 738 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW------------ 805 (914)
Q Consensus 738 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~------------ 805 (914)
..... .......||..|+|||++.+..++.++|||||||++|||++|+.||......+....+.+.
T Consensus 175 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 175 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred ccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 65332 1223345899999999999999999999999999999999999999754322111111110
Q ss_pred ---HHHhhhc-CCccc----ccCCccC----CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 806 ---AKLHIES-GDIQG----IIDPSLL----DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 806 ---~~~~~~~-~~~~~----i~d~~l~----~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
....... ..... .+.+... ..........+.+++.+|++.||++|||++|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 00000 0000000 00001112357899999999999999999999885
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=316.18 Aligned_cols=260 Identities=22% Similarity=0.303 Sum_probs=191.8
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeeec------CceE
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSV 658 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~------~~~~ 658 (914)
+.+.+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++||||+++++++... ...+
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 98 (355)
T cd07874 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVY 98 (355)
T ss_pred eeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeE
Confidence 445578999999999999865 68899999987542 22345677899999999999999999988643 3468
Q ss_pred EEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccc
Q 002509 659 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 738 (914)
Q Consensus 659 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 738 (914)
+||||+++ +|.+.+. ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 99 lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 99 LVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred EEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 99999975 5666653 2477888899999999999999998 999999999999999999999999999976
Q ss_pred ccCCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHH--------------
Q 002509 739 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ-------------- 804 (914)
Q Consensus 739 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~-------------- 804 (914)
.... .......||..|+|||.+.+..++.++|||||||++|||++|+.||......+....+.+
T Consensus 169 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 169 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred CCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 4322 222334689999999999988999999999999999999999999975432111111110
Q ss_pred -HHHHhhhc-CCcccccCCcc-----CC---ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 805 -WAKLHIES-GDIQGIIDPSL-----LD---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 805 -~~~~~~~~-~~~~~i~d~~l-----~~---~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
........ ........+.. .. .........+.+++.+|++.||++|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000 00000000000 00 0011123467899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=304.24 Aligned_cols=195 Identities=25% Similarity=0.387 Sum_probs=158.9
Q ss_pred ccccccCcEEEEEEEEC---CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeee--cCceEEEEEeccC
Q 002509 592 KKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYEFMHN 666 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~LV~E~~~~ 666 (914)
.+||+|+||.||+|+.+ ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 57999999999999875 45789999886542 23467889999999999999999998854 4567899999875
Q ss_pred CChHHHhhccc-----CccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEe----CCCCcEEEeeccccc
Q 002509 667 GTLKEHLYGTL-----THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSK 737 (914)
Q Consensus 667 gsL~~~L~~~~-----~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DFGla~ 737 (914)
+|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 7777764221 1233588899999999999999999998 99999999999999 566799999999998
Q ss_pred cccCCCCc--eeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCccc
Q 002509 738 FAVDGASH--VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISN 792 (914)
Q Consensus 738 ~~~~~~~~--~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~ 792 (914)
........ ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 65433221 1233458999999999876 4578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=297.52 Aligned_cols=248 Identities=25% Similarity=0.401 Sum_probs=198.5
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
.+.+.||+|+||.+|+++.. +|+.+|+|.+.... ....+++.+|++++++++||||+++++++...+..++|+||++
T Consensus 3 ~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08218 3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCE 82 (256)
T ss_pred eEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCC
Confidence 45578999999999999875 68999999987532 2334578899999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+++|.+++... ....+++.+++.++.|++.||+|||++ +++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 83 GGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 99999988643 233578889999999999999999998 999999999999999999999999999876543221
Q ss_pred eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCC
Q 002509 746 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 825 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 825 (914)
......|+..|+|||.+.+...+.++|||||||+++||++|+.||...... .+ +.... .+.... .
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~----~~---~~~~~-~~~~~~-----~-- 221 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK----NL---VLKII-RGSYPP-----V-- 221 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH----HH---HHHHh-cCCCCC-----C--
Confidence 122345788999999999888999999999999999999999998643211 11 11111 111110 1
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 826 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 826 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+......+.+++.+|++.+|++||+|+||+++
T Consensus 222 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 222 --SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred --cccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11123358899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=298.32 Aligned_cols=245 Identities=29% Similarity=0.488 Sum_probs=194.9
Q ss_pred HHHhccccccCcEEEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCC
Q 002509 588 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 667 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 667 (914)
+.+.+.||+|+||.||++.. .++.+|+|.++... ....+.+|+.++++++|||++++++++... ..++||||++++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~ 83 (254)
T cd05083 8 LTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKG 83 (254)
T ss_pred ceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCC
Confidence 45678999999999999975 57889999986532 345788999999999999999999998764 468999999999
Q ss_pred ChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCcee
Q 002509 668 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 747 (914)
Q Consensus 668 sL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 747 (914)
+|.+++... ....+++..++.++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 84 ~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 84 NLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 999999653 234578999999999999999999998 99999999999999999999999999987543221
Q ss_pred eccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCc
Q 002509 748 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826 (914)
Q Consensus 748 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 826 (914)
.....+..|+|||.+.+..++.++|||||||+++||++ |+.||...... .+.+. ...+... + ...
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----~~~~~----~~~~~~~---~--~~~- 220 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK----EVKEC----VEKGYRM---E--PPE- 220 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH----HHHHH----HhCCCCC---C--CCC-
Confidence 11224568999999988889999999999999999998 99998654321 11111 1111100 0 011
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002509 827 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862 (914)
Q Consensus 827 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 862 (914)
.....+.+++.+|++.+|++||+++++++.|++
T Consensus 221 ---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 221 ---GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 122457899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=306.15 Aligned_cols=244 Identities=25% Similarity=0.385 Sum_probs=196.0
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCChH
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK 670 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~ 670 (914)
..||+|+||.||++... +++.||||.+........+.+.+|+.++++++|+||+++++.+...+..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 46999999999999875 68899999987655455667889999999999999999999999999999999999999999
Q ss_pred HHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCceeecc
Q 002509 671 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 750 (914)
Q Consensus 671 ~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 750 (914)
+++. ...+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++........ .....
T Consensus 108 ~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~ 178 (292)
T cd06658 108 DIVT-----HTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSL 178 (292)
T ss_pred HHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCcee
Confidence 9874 23578899999999999999999998 999999999999999999999999999875433222 12234
Q ss_pred ccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccCHH
Q 002509 751 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQ 830 (914)
Q Consensus 751 ~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 830 (914)
.|+..|+|||.+.+..++.++||||||++++||++|+.||...... ....-... .+.+.+.... .
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~~~~~~~~---------~~~~~~~~~~--~ 243 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL----QAMRRIRD---------NLPPRVKDSH--K 243 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHh---------cCCCcccccc--c
Confidence 5889999999998888999999999999999999999998643311 11111111 1111111111 1
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 831 SMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 831 ~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
....+.+++..|+..+|++||+++|++++
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 12246788889999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=295.94 Aligned_cols=250 Identities=24% Similarity=0.369 Sum_probs=199.9
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCC
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 667 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 667 (914)
.+.+.||+|+||.||++... +++.+++|++........+.+.+|++++++++||||+++++++...+..+++|||++++
T Consensus 6 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~ 85 (262)
T cd06613 6 ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGG 85 (262)
T ss_pred EEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCC
Confidence 45578999999999999875 57889999998665555678899999999999999999999999999999999999999
Q ss_pred ChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCcee
Q 002509 668 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 747 (914)
Q Consensus 668 sL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 747 (914)
+|.+++... ...+++..+..++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++....... ...
T Consensus 86 ~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~ 158 (262)
T cd06613 86 SLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AKR 158 (262)
T ss_pred cHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh-hcc
Confidence 999988543 24688899999999999999999998 99999999999999999999999999987654321 112
Q ss_pred eccccCCcccCccccccC---CCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccC
Q 002509 748 SIVRGTVGYLDPEYYISQ---QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824 (914)
Q Consensus 748 ~~~~gt~~Y~aPE~~~~~---~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 824 (914)
....++..|+|||.+... .++.++|||||||+++||++|+.||...... ........ ... -.+.+.
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~---~~~~~~~~-----~~~---~~~~~~ 227 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM---RALFLISK-----SNF---PPPKLK 227 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh-----ccC---CCcccc
Confidence 234578899999999776 7889999999999999999999998653311 11111111 100 001111
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002509 825 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 858 (914)
Q Consensus 825 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 858 (914)
........+.+++.+|++.+|.+||+++||+.
T Consensus 228 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 --DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred --chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11223346889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=296.06 Aligned_cols=249 Identities=32% Similarity=0.509 Sum_probs=199.4
Q ss_pred HhccccccCcEEEEEEEECC-----CcEEEEEEEecCCcc-cchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEe
Q 002509 590 LEKKIGSGGFGVVYYGKLKD-----GKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 663 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~~-----g~~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~ 663 (914)
+.+.||+|+||.||+++..+ +..||+|+++..... ..+.+..|++.+..++|+||+++++++...+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 45689999999999998864 388999999765433 456889999999999999999999999999999999999
Q ss_pred ccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCC
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 743 (914)
Q Consensus 664 ~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 743 (914)
+++++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++......
T Consensus 83 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 83 MEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred cCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999999986432 22289999999999999999999998 99999999999999999999999999997665442
Q ss_pred CceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcccccCCc
Q 002509 744 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 822 (914)
Q Consensus 744 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 822 (914)
........++..|+|||.+.+..++.++||||+|++++||++ |+.||..... ..+.+... .+.....
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~----~~~~~~~~----~~~~~~~---- 225 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN----EEVLEYLK----KGYRLPK---- 225 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHh----cCCCCCC----
Confidence 222222336789999999988889999999999999999998 7888764321 22222221 1111110
Q ss_pred cCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002509 823 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 860 (914)
Q Consensus 823 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L 860 (914)
.. ....++.+++.+|+..+|++||++.|+++.|
T Consensus 226 -~~----~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 -PE----NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CC----cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 01 1233588899999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=305.33 Aligned_cols=244 Identities=23% Similarity=0.366 Sum_probs=196.3
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCChH
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK 670 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~ 670 (914)
..||+|+||.||++... +++.||+|++........+.+.+|+.++..++||||+++++++..++..++|+||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 47999999999999875 68999999987655455667889999999999999999999999999999999999999999
Q ss_pred HHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCceeecc
Q 002509 671 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 750 (914)
Q Consensus 671 ~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 750 (914)
+++. ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........ .....
T Consensus 107 ~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~ 177 (297)
T cd06659 107 DIVS-----QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSL 177 (297)
T ss_pred HHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccce
Confidence 8774 24578999999999999999999998 999999999999999999999999999865433221 22334
Q ss_pred ccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccCHH
Q 002509 751 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQ 830 (914)
Q Consensus 751 ~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 830 (914)
.|+..|+|||++.+..++.++|||||||+++||++|+.||...... ....... ....... .... .
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~~~----~~~~~~~---~~~~----~ 242 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV----QAMKRLR----DSPPPKL---KNAH----K 242 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHh----ccCCCCc---cccC----C
Confidence 5899999999999888999999999999999999999998643211 1111111 1000000 0001 1
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 831 SMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 831 ~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
....+.+++.+|++.+|++||+++|++++
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 12347789999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=312.29 Aligned_cols=241 Identities=26% Similarity=0.318 Sum_probs=185.4
Q ss_pred ccccCcEEEEEEEEC-CCcEEEEEEEecCCcc---cchhhhHHHHHHhhc---ccCceeEEEeeeeecCceEEEEEeccC
Q 002509 594 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRI---HHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 594 lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~---~~~~f~~E~~~l~~l---~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
||+|+||+||+|+.+ +++.||||++...... ....+..|..++.+. +||||+++++.+......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999876 6899999998653221 223345566666655 699999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
|+|.+++.. ...+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~ 152 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT 152 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence 999988853 45688899999999999999999998 99999999999999999999999999987543222 12
Q ss_pred eeccccCCcccCccccccC-CCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCC
Q 002509 747 SSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 825 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 825 (914)
.....||..|+|||.+.+. .++.++|||||||++|||++|+.||...... .+.+ ....+.. .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~----~~~~----~i~~~~~------~~~~ 218 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ----QMYR----NIAFGKV------RFPK 218 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH----HHHH----HHHcCCC------CCCC
Confidence 2345689999999998754 4789999999999999999999999654321 1111 1111111 1111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCC----CHHHHHHH
Q 002509 826 EYDIQSMWKIEEKALMCVLPHGHMRP----SISEVLKD 859 (914)
Q Consensus 826 ~~~~~~~~~l~~l~~~C~~~~P~~RP----sm~eVl~~ 859 (914)
. .....+.+++.+|++.+|++|| ++.|++++
T Consensus 219 ~---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 219 N---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred c---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 0 0112467889999999999998 56666653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=306.20 Aligned_cols=263 Identities=22% Similarity=0.321 Sum_probs=196.7
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc--ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
.+.++||+|+||.||+|..+ +++.||+|++..... ...+.+.+|++++++++||||+++++++..++..++|+||++
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 83 (286)
T cd07846 4 ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVD 83 (286)
T ss_pred eEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCC
Confidence 34578999999999999986 589999998765422 234568899999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+++|.++... ...++|..++.++.|+++||+|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 84 ~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07846 84 HTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE- 155 (286)
T ss_pred ccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-
Confidence 9998887642 23489999999999999999999998 999999999999999999999999999876543322
Q ss_pred eeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhc-------CCc-c
Q 002509 746 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES-------GDI-Q 816 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~-------~~~-~ 816 (914)
......++..|+|||++.+ ..++.++|||||||+++||++|+.||......+....+..+....... ... .
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 2223457889999999875 447789999999999999999999886443211111222111110000 000 0
Q ss_pred cccCCccCCcc-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 817 GIIDPSLLDEY-----DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 817 ~i~d~~l~~~~-----~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.+..+...... .......+.+++.+|++.+|++||+|+|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00001100000 01123468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=300.16 Aligned_cols=252 Identities=26% Similarity=0.383 Sum_probs=197.0
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecC-CcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
+++.+.||+|+||.||+++.+ +++.||+|.++.. .......+.+|++++++++|+||+++++.+...+..++||||++
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD 82 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence 456688999999999999887 7899999988754 22334678899999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+++|.+++.... ....+++..+..++.|+++||.|||+.+ +++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 157 (286)
T cd06622 83 AGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-- 157 (286)
T ss_pred CCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence 999999886431 2346899999999999999999999642 89999999999999999999999999987553221
Q ss_pred eeeccccCCcccCccccccCC------CCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCccccc
Q 002509 746 VSSIVRGTVGYLDPEYYISQQ------LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 819 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~~~------~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 819 (914)
.....++..|+|||.+.+.. ++.++|||||||++|||++|+.||...... ........ ...+..
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~~~~~~~~-~~~~~~---- 227 (286)
T cd06622 158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA----NIFAQLSA-IVDGDP---- 227 (286)
T ss_pred -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh----hHHHHHHH-HhhcCC----
Confidence 22234788999999986543 478999999999999999999999643321 11111111 111111
Q ss_pred CCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 820 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 820 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+.+ +......+.+++.+|++.+|++||++++++.+
T Consensus 228 -~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 228 -PTL----PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -CCC----CcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 111 11233457789999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=297.04 Aligned_cols=254 Identities=26% Similarity=0.405 Sum_probs=196.6
Q ss_pred HhccccccCcEEEEEEEEC----CCcEEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeeecC------ce
Q 002509 590 LEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RS 657 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~----~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~------~~ 657 (914)
+.+.||+|+||.||+|.+. .++.||||++.... ....+++.+|++++++++||||+++++++.... ..
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence 4578999999999999764 36889999987542 233456889999999999999999999886532 23
Q ss_pred EEEEEeccCCChHHHhhccc--CccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccc
Q 002509 658 VLVYEFMHNGTLKEHLYGTL--THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 735 (914)
Q Consensus 658 ~LV~E~~~~gsL~~~L~~~~--~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 735 (914)
++++||+.+|+|.+++.... .....+++...+.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccc
Confidence 78899999999998875332 1223578889999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCc-eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcC
Q 002509 736 SKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESG 813 (914)
Q Consensus 736 a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~ 813 (914)
++........ ......++..|++||.+....++.++|||||||++|||++ |+.||..... ..+..+... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~----~~~~~~~~~---~~ 232 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN----SEIYNYLIK---GN 232 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH----HHHHHHHHc---CC
Confidence 8765433211 1122335678999999988889999999999999999999 8888864331 222222211 11
Q ss_pred CcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 002509 814 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 863 (914)
Q Consensus 814 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 863 (914)
... . +......+.+++.+|++.+|++||++.|+++.|+++
T Consensus 233 ~~~------~----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 RLK------Q----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCC------C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 110 0 011234688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=294.76 Aligned_cols=254 Identities=26% Similarity=0.382 Sum_probs=201.3
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC-cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
.+.+.||.|++|+||+|... ++..+++|++.... ......+.+|+++++.++|+|++++++.+..++..++|+|++++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (267)
T cd06610 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSG 83 (267)
T ss_pred eeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCC
Confidence 45678999999999999865 68899999987543 23456789999999999999999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc-
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH- 745 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~- 745 (914)
++|.+++..... ...+++.....++.|++.||+|||+. +++||||||+||++++++.+||+|||++.........
T Consensus 84 ~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 84 GSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred CcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 999999965421 24688999999999999999999998 9999999999999999999999999998766543322
Q ss_pred --eeeccccCCcccCccccccC-CCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCc
Q 002509 746 --VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 822 (914)
Q Consensus 746 --~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 822 (914)
......|+..|+|||++... ..+.++|||||||+++||++|+.||......+ .+.+.... . .+.
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~~~~~~~----~------~~~ 226 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK---VLMLTLQN----D------PPS 226 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh---hHHHHhcC----C------CCC
Confidence 22334588999999999876 78899999999999999999999997543211 11121111 0 011
Q ss_pred cCCccC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 823 LLDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 823 l~~~~~-~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+..... ......+.+++.+|++.+|++||+++|++++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 111100 1223457899999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=300.17 Aligned_cols=250 Identities=28% Similarity=0.409 Sum_probs=194.5
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhc-ccCceeEEEeeeeec-----CceEEEEE
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE-----GRSVLVYE 662 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~-----~~~~LV~E 662 (914)
+.+.||+|+||.||++..+ +++.+|+|++.... .....+.+|+.++.++ +|||++++++++... +..++|+|
T Consensus 26 ~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~e 104 (291)
T cd06639 26 IIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLE 104 (291)
T ss_pred EEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEE
Confidence 4568999999999999875 68899999986532 2245677899999999 899999999998754 35799999
Q ss_pred eccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCC
Q 002509 663 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 742 (914)
Q Consensus 663 ~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 742 (914)
|+++|+|.++++........+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 105 y~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~ 181 (291)
T cd06639 105 LCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181 (291)
T ss_pred ECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhcccc
Confidence 9999999999865444456789999999999999999999998 9999999999999999999999999998765432
Q ss_pred CCceeeccccCCcccCccccccCC-----CCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCccc
Q 002509 743 ASHVSSIVRGTVGYLDPEYYISQQ-----LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 817 (914)
Q Consensus 743 ~~~~~~~~~gt~~Y~aPE~~~~~~-----~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 817 (914)
.. ......|+..|+|||.+.... ++.++|||||||++|||++|+.||...... ..+.++. .+....
T Consensus 182 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~---~~~~~~~-----~~~~~~ 252 (291)
T cd06639 182 RL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV---KTLFKIP-----RNPPPT 252 (291)
T ss_pred cc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH---HHHHHHh-----cCCCCC
Confidence 21 122345789999999986433 678999999999999999999998643311 1222211 111111
Q ss_pred ccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 818 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 818 i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+.++ .+....+.+++.+|++.+|++||++.|++++
T Consensus 253 ~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 253 LLHP-------EKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCcc-------cccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111 1122358899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=298.00 Aligned_cols=251 Identities=26% Similarity=0.376 Sum_probs=194.8
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcc----------cchhhhHHHHHHhhcccCceeEEEeeeeecCceE
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ----------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 658 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~----------~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 658 (914)
..+.||+|++|.||+|... +|+.+|+|.++..... ..+.+..|++++++++|+|++++++++...+..+
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (272)
T cd06629 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLS 84 (272)
T ss_pred ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceE
Confidence 4568999999999999765 6899999988642111 1235778999999999999999999999999999
Q ss_pred EEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccc
Q 002509 659 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 738 (914)
Q Consensus 659 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 738 (914)
+||||+++++|.++++.. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++.
T Consensus 85 lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 85 IFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred EEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 999999999999998643 4688889999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCc-eeeccccCCcccCccccccCC--CCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCc
Q 002509 739 AVDGASH-VSSIVRGTVGYLDPEYYISQQ--LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 815 (914)
Q Consensus 739 ~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~--~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 815 (914)
....... ......|+..|+|||.+.... ++.++||||||++++|+++|+.||...... ..+.+ ... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~----~~~-~~~ 229 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI---AAMFK----LGN-KRS 229 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH---HHHHH----hhc-ccc
Confidence 4332111 123345889999999987654 788999999999999999999998643211 11111 111 111
Q ss_pred ccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 816 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 816 ~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
...+++.... +....+.+++.+|++.+|++||+|+||+++
T Consensus 230 ~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 APPIPPDVSM----NLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCcCCccccc----cCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1111111111 223468889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=284.85 Aligned_cols=246 Identities=26% Similarity=0.388 Sum_probs=196.4
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEEecCCc----cc----chhhhHHHHHHhhc-ccCceeEEEeeeeecCceEEE
Q 002509 591 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY----QG----KREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLV 660 (914)
Q Consensus 591 ~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~----~~----~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV 660 (914)
.+.||+|..++|-+...+ .|++.|+|++..... .. .+.-..|+.+|+++ .||+|+++.++++.+...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 467999999999888665 789999999864321 11 12345689999998 799999999999999999999
Q ss_pred EEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccccc
Q 002509 661 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 740 (914)
Q Consensus 661 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 740 (914)
+|.|+.|.|.|+|. ..-.+++.+..+|+.|+.+|++|||.+ .||||||||+|||++++.++||+|||+++...
T Consensus 102 Fdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 102 FDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccC
Confidence 99999999999995 345688899999999999999999999 99999999999999999999999999998876
Q ss_pred CCCCceeeccccCCcccCcccccc------CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCC
Q 002509 741 DGASHVSSIVRGTVGYLDPEYYIS------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 814 (914)
Q Consensus 741 ~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 814 (914)
++. .-...+||++|+|||.+.. ..|+...|+|++||+||-|+.|.+||...+ +++. ...+.+|+
T Consensus 175 ~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk------QmlM--LR~ImeGk 244 (411)
T KOG0599|consen 175 PGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK------QMLM--LRMIMEGK 244 (411)
T ss_pred Cch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH------HHHH--HHHHHhcc
Confidence 653 3355789999999999974 257788999999999999999999997533 2221 11222232
Q ss_pred cccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 815 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 815 ~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+. .-.|. -.+......+|+.+|++.||.+|-|++|++++
T Consensus 245 yq-F~spe-----Wadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 245 YQ-FRSPE-----WADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred cc-cCCcc-----hhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 21 00000 01122357789999999999999999999976
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=297.37 Aligned_cols=247 Identities=24% Similarity=0.397 Sum_probs=198.2
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC-cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEec
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
.+.+.+.||+|+||.||+|... +++.+|+|++.... ......+.+|++++.+++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3445678999999999999875 68899999886443 223456889999999999999999999999999999999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 744 (914)
++++|.+++.. ..+++.....++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06641 85 GGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch-
Confidence 99999998853 3578999999999999999999998 99999999999999999999999999987654322
Q ss_pred ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccC
Q 002509 745 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 824 (914)
.......++..|+|||.+.+..++.++|||||||+++||++|..|+..... ....... ..+.. +.+.
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~~----~~~~~-----~~~~ 222 (277)
T cd06641 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP----MKVLFLI----PKNNP-----PTLE 222 (277)
T ss_pred hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch----HHHHHHH----hcCCC-----CCCC
Confidence 112234578899999999888889999999999999999999999864321 1111111 11111 1111
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 825 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 825 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
. .....+.+++.+|++.+|.+||+|.|++++
T Consensus 223 ~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 223 G----NYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred c----ccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1 123457889999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=313.49 Aligned_cols=262 Identities=22% Similarity=0.256 Sum_probs=200.0
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcc-c-----CceeEEEeeeeecCceEE
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-H-----RNLVQFLGYCQEEGRSVL 659 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-H-----pnIv~l~g~~~~~~~~~L 659 (914)
+|.+.+.||+|.||.|-++... +++.||||+++.... -..+-..|+.+|..++ | -|+|++++++..+++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 6667789999999999999655 799999999986532 2455678999999996 4 489999999999999999
Q ss_pred EEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCC--CcEEEeeccccc
Q 002509 660 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH--MRAKVSDFGLSK 737 (914)
Q Consensus 660 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~--~~~kl~DFGla~ 737 (914)
|+|.+.. +|.++|+.. ....++...+..|+.||+.||.+||+. +|||+||||+||||.+- ..+||+|||.|+
T Consensus 266 VfELL~~-NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eehhhhh-hHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccc
Confidence 9998865 999999765 345588899999999999999999998 99999999999999754 479999999998
Q ss_pred cccCCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHH----------
Q 002509 738 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK---------- 807 (914)
Q Consensus 738 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~---------- 807 (914)
+...... ...-+..|+|||++.+.+|+.+.||||||||+.||++|.+-|.++...+-...|++...
T Consensus 340 ~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 340 FESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred ccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 7643322 23357899999999999999999999999999999999887765443222222221110
Q ss_pred ----Hhhhc-CCc------cc----------------ccCCccCC--------ccCHHHHHHHHHHHHHccCCCCCCCCC
Q 002509 808 ----LHIES-GDI------QG----------------IIDPSLLD--------EYDIQSMWKIEEKALMCVLPHGHMRPS 852 (914)
Q Consensus 808 ----~~~~~-~~~------~~----------------i~d~~l~~--------~~~~~~~~~l~~l~~~C~~~~P~~RPs 852 (914)
..+.. ... .+ ..+..... ......-..+++++.+|+..||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 00000 000 00 00000000 011134467899999999999999999
Q ss_pred HHHHHHH
Q 002509 853 ISEVLKD 859 (914)
Q Consensus 853 m~eVl~~ 859 (914)
..|.+++
T Consensus 496 p~qal~H 502 (586)
T KOG0667|consen 496 PAQALNH 502 (586)
T ss_pred HHHHhcC
Confidence 9999986
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=301.52 Aligned_cols=263 Identities=21% Similarity=0.254 Sum_probs=192.1
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc--ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
.+.+.||+|+||.||+|+.. +|+.+|+|.++.... .....+.+|++++++++||||+++++++.+.+..++|+||++
T Consensus 3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (284)
T cd07839 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD 82 (284)
T ss_pred eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC
Confidence 34578999999999999886 689999999865422 224567889999999999999999999999999999999997
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
++|.+++... ...+++..++.++.|+++||.|||+. +++||||||+||+++.++.+||+|||+++........
T Consensus 83 -~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 155 (284)
T cd07839 83 -QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC 155 (284)
T ss_pred -CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence 4787777532 34589999999999999999999998 9999999999999999999999999998755332211
Q ss_pred eeeccccCCcccCccccccC-CCCccCceeehHHHHHHHHhCCCCccccc-ccccchhHHHHHHHhhhc--CCcccccCC
Q 002509 746 VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEK-FGANCRNIVQWAKLHIES--GDIQGIIDP 821 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~S~Gvvl~ElltG~~p~~~~~-~~~~~~~l~~~~~~~~~~--~~~~~i~d~ 821 (914)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.|+.... ..+....+.......... .......+.
T Consensus 156 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 156 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred -cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 1223468899999998764 46889999999999999999998864322 111111111000000000 000000000
Q ss_pred c----cCC-----ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 822 S----LLD-----EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 822 ~----l~~-----~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
. ... ........++.+++.+|++.+|.+|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0 000 0001123467789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=294.55 Aligned_cols=249 Identities=27% Similarity=0.413 Sum_probs=198.0
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcc--cchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
.+.+.||+|+||.||+|... +++.|++|.++..... ..+.+.+|++++++++|+||+++++++...+..++|+||++
T Consensus 3 ~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06626 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCS 82 (264)
T ss_pred eeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCC
Confidence 34578999999999999875 7899999998765442 45678999999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+++|.+++.. ...+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++.........
T Consensus 83 ~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 83 GGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999999853 33478889999999999999999998 9999999999999999999999999998766443332
Q ss_pred eee---ccccCCcccCccccccCC---CCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCccccc
Q 002509 746 VSS---IVRGTVGYLDPEYYISQQ---LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 819 (914)
Q Consensus 746 ~~~---~~~gt~~Y~aPE~~~~~~---~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 819 (914)
... ...++..|+|||++.+.. .+.++||||||++++|+++|+.||...... ..+..... .+.
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~---~~~~~~~~----~~~----- 223 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE---FQIMFHVG----AGH----- 223 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch---HHHHHHHh----cCC-----
Confidence 222 345788999999998766 889999999999999999999999643211 11111111 010
Q ss_pred CCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002509 820 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 858 (914)
Q Consensus 820 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 858 (914)
.+.+... ......+.+++.+|++.+|++||++.|+++
T Consensus 224 ~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 KPPIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111111 111335678999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=302.26 Aligned_cols=263 Identities=21% Similarity=0.258 Sum_probs=196.2
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcc-----cchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEE
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-----GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 662 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~-----~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 662 (914)
.+.+.||+|++|.||+|... +++.||||.++..... ....+..|++++++++|+||+++++++...+..++|||
T Consensus 3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (298)
T cd07841 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFE 82 (298)
T ss_pred eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEc
Confidence 34568999999999999876 6899999999765332 23456789999999999999999999999999999999
Q ss_pred eccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCC
Q 002509 663 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 742 (914)
Q Consensus 663 ~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 742 (914)
|+ +|+|.+++.... ..+++..++.++.|+++||+|||++ +++||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 83 FM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred cc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 99 899999986431 3689999999999999999999998 9999999999999999999999999999765443
Q ss_pred CCceeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhc-----CCcc
Q 002509 743 ASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES-----GDIQ 816 (914)
Q Consensus 743 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~-----~~~~ 816 (914)
.... ....++..|+|||.+.+ ..++.++|||||||+++||++|..+|......+....+.......... ....
T Consensus 156 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 156 NRKM-THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred Cccc-cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence 2211 22346788999998864 467889999999999999999987776433211111111110000000 0000
Q ss_pred cccCCccCCccC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 817 GIIDPSLLDEYD-----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 817 ~i~d~~l~~~~~-----~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
...........+ ......+.+++.+|++.+|++||+++||+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 001000001111 1123467899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=296.79 Aligned_cols=246 Identities=25% Similarity=0.397 Sum_probs=187.9
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc-----ccchhhhHHHHHHhhcccCceeEEEeeeeec--CceEEEE
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-----QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVY 661 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~-----~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~LV~ 661 (914)
..+.||+|+||.||+|... +++.|++|++..... .....+.+|++++++++||||+++++++... ...++++
T Consensus 6 ~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~ 85 (266)
T cd06651 6 RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFM 85 (266)
T ss_pred ccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEE
Confidence 4578999999999999875 689999998864321 1234678899999999999999999988753 5678999
Q ss_pred EeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccC
Q 002509 662 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 741 (914)
Q Consensus 662 E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 741 (914)
||+++++|.+++... ..+++...+.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 86 EYMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred eCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 999999999998532 3478888999999999999999998 999999999999999999999999999875432
Q ss_pred CCC--ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCccccc
Q 002509 742 GAS--HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 819 (914)
Q Consensus 742 ~~~--~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 819 (914)
... .......++..|+|||++.+..++.++|||||||++|||++|+.||...... ..+.+ ..... .
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~---~~~~~----~~~~~-----~ 226 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM---AAIFK----IATQP-----T 226 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH---HHHHH----HhcCC-----C
Confidence 111 1112245789999999999888999999999999999999999999643211 11111 11110 1
Q ss_pred CCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 820 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 820 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.+.+.. .....+.+++ +|+..+|++||+|+||+++
T Consensus 227 ~~~~~~----~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 227 NPQLPS----HISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CCCCch----hcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 111111 1112334444 7888999999999999763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=294.96 Aligned_cols=245 Identities=27% Similarity=0.416 Sum_probs=196.0
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc-----ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEe
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-----QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 663 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~-----~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~ 663 (914)
..+.||+|++|.||+|..+ +++.|++|.+..... ...+.+..|++++++++|+||+++++++......++++||
T Consensus 4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 83 (258)
T cd06632 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLEL 83 (258)
T ss_pred ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEe
Confidence 4468999999999999887 789999999865431 2345788999999999999999999999999999999999
Q ss_pred ccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCC
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 743 (914)
Q Consensus 664 ~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 743 (914)
+++++|.+++... ..+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 84 VPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 9999999998532 3578899999999999999999998 99999999999999999999999999987654332
Q ss_pred CceeeccccCCcccCccccccCC-CCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCc
Q 002509 744 SHVSSIVRGTVGYLDPEYYISQQ-LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 822 (914)
Q Consensus 744 ~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 822 (914)
......|+..|++||.+.... ++.++|+|||||++|||++|+.||..... ...+..+ ........ +
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~---~~~~~~~----~~~~~~~~-~--- 223 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG---VAAVFKI----GRSKELPP-I--- 223 (258)
T ss_pred --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH---HHHHHHH----HhcccCCC-c---
Confidence 223345889999999987766 89999999999999999999999864331 1111111 11111111 1
Q ss_pred cCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 823 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 823 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+......+.+++.+|++.+|++||++.|++++
T Consensus 224 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 224 -----PDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred -----CCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 11112357788999999999999999999863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=296.25 Aligned_cols=253 Identities=26% Similarity=0.405 Sum_probs=197.1
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhc-ccCceeEEEeeeeecC------ceE
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG------RSV 658 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~------~~~ 658 (914)
.+.+.+.||+|++|.||+|..+ +++.+++|++..... ....+.+|+++++++ +|+||+++++++.... ..+
T Consensus 7 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (275)
T cd06608 7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW 85 (275)
T ss_pred heeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence 3456689999999999999886 678899999875533 346789999999999 7999999999997654 479
Q ss_pred EEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccc
Q 002509 659 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 738 (914)
Q Consensus 659 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 738 (914)
+||||+++++|.+++.........+++..+..++.|+++||+|||+. +++||||+|+||++++++.+||+|||++..
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 162 (275)
T cd06608 86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcccee
Confidence 99999999999999865433356789999999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeeccccCCcccCcccccc-----CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcC
Q 002509 739 AVDGASHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 813 (914)
Q Consensus 739 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 813 (914)
...... ......|+..|+|||.+.. ..++.++|||||||+++||++|+.||...... ..+.+. ..+
T Consensus 163 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~-----~~~ 233 (275)
T cd06608 163 LDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM---RALFKI-----PRN 233 (275)
T ss_pred cccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH---HHHHHh-----hcc
Confidence 533221 1223458899999998753 34678999999999999999999999643211 111111 111
Q ss_pred CcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 814 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 814 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.. +.+.. .......+.+++.+|+..||++||+++|++++
T Consensus 234 ~~-----~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 234 PP-----PTLKS--PENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred CC-----CCCCc--hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11 11111 11123467899999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=295.26 Aligned_cols=251 Identities=28% Similarity=0.400 Sum_probs=200.1
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC-cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
.+.+.||+|++|.||++..+ +++.+|+|.+.... .....++.+|++++++++||||+++++.+..++..++++||+++
T Consensus 4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (265)
T cd06605 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG 83 (265)
T ss_pred hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCC
Confidence 35578999999999999887 68999999987653 23456788999999999999999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHh-CCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
++|.+++.... ..+++.....++.|+++||+|||+ . +++|+||||+||++++++.+||+|||.+.........
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 84 GSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred CcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 99999986432 567888889999999999999999 7 9999999999999999999999999998655332211
Q ss_pred eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCC
Q 002509 746 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 825 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 825 (914)
...++..|+|||.+.+..++.++||||||++++||++|+.||...... .....+......... .+.+..
T Consensus 158 ---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~------~~~~~~ 226 (265)
T cd06605 158 ---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP--PDGIFELLQYIVNEP------PPRLPS 226 (265)
T ss_pred ---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc--cccHHHHHHHHhcCC------CCCCCh
Confidence 155888999999999889999999999999999999999998654211 112222222221111 011111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 826 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 826 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
. .....+.+++.+|+..+|++||++.|++++
T Consensus 227 ~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 227 G---KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred h---hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1 123357899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=307.80 Aligned_cols=259 Identities=24% Similarity=0.317 Sum_probs=190.1
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeeec------Cce
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRS 657 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~------~~~ 657 (914)
.+.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07878 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV 95 (343)
T ss_pred hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcE
Confidence 3455678999999999999865 68899999986532 22345677899999999999999999987543 346
Q ss_pred EEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccc
Q 002509 658 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 737 (914)
Q Consensus 658 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 737 (914)
++++|++ +++|.+.+. ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 96 YLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred EEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccce
Confidence 8999987 678888774 34588999999999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCceeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHh-------
Q 002509 738 FAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH------- 809 (914)
Q Consensus 738 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~------- 809 (914)
..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||......+....+.......
T Consensus 167 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 167 QADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred ecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 65332 223458999999999876 568899999999999999999999996543211111111110000
Q ss_pred hhcCCcccccCCccCC--ccCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 810 IESGDIQGIIDPSLLD--EYDI-----QSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 810 ~~~~~~~~i~d~~l~~--~~~~-----~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.........+ ..+.. .... .....+.+++.+|++.||++|||++|++++
T Consensus 243 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 243 ISSEHARKYI-QSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred cchhhHHHHh-hccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 00000 0000 011246789999999999999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=295.66 Aligned_cols=256 Identities=25% Similarity=0.335 Sum_probs=199.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEEecCCc-ccchhhhHHHHHHhhcccCceeEEEeeeeec--CceEEEEEeccC
Q 002509 591 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVYEFMHN 666 (914)
Q Consensus 591 ~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~LV~E~~~~ 666 (914)
.+.||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||+++++++... +..++||||+++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 85 (287)
T cd06621 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEG 85 (287)
T ss_pred EEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCC
Confidence 468999999999999885 688999999875432 3456788999999999999999999998654 467999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
++|.+++.........+++.....++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 86 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-- 160 (287)
T cd06621 86 GSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA-- 160 (287)
T ss_pred CCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccccc--
Confidence 999998865444456688899999999999999999998 999999999999999999999999999865432211
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCccccccc-ccchhHHHHHHHhhhcCCcccccCCccCC
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG-ANCRNIVQWAKLHIESGDIQGIIDPSLLD 825 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~-~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 825 (914)
....++..|+|||.+.+..++.++|||||||++|||++|+.||...... .....+..+.... .... +......
T Consensus 161 -~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~-~~~~~~~ 234 (287)
T cd06621 161 -GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM----PNPE-LKDEPGN 234 (287)
T ss_pred -ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC----Cchh-hccCCCC
Confidence 2334788999999999889999999999999999999999999754321 1112233332211 1111 1101000
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 826 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 826 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.......+.+++.+|++.+|++||+|.||+++
T Consensus 235 --~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 235 --GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred --CCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 01123468899999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=293.04 Aligned_cols=247 Identities=27% Similarity=0.408 Sum_probs=197.1
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
.+.+.||+|++|.||++... +++.+|+|.+.... ......+.+|++++++++|||++++++.+..++..++||||++
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08220 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAP 82 (256)
T ss_pred eEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCC
Confidence 34578999999999999875 68899999986542 2335678899999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCC-CcEEEeeccccccccCCCC
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~~~~ 744 (914)
+++|.+++... ....+++..++.++.|+++||+|||++ +++||||||+||+++++ +.+||+|||++.......
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 83 GGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 99999999653 234578999999999999999999998 99999999999999865 468999999997654322
Q ss_pred ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccC
Q 002509 745 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 824 (914)
......|+..|+|||.+.+..++.++||||||++++||++|+.||...... ...... .. +....+.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~----~~~~~~---~~-~~~~~~~----- 222 (256)
T cd08220 157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP----ALVLKI---MS-GTFAPIS----- 222 (256)
T ss_pred -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH----HHHHHH---Hh-cCCCCCC-----
Confidence 122345789999999999888899999999999999999999998654321 112111 11 1111111
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 825 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 825 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
. .....+.+++.+|++.+|++||+++|++++
T Consensus 223 ~----~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 223 D----RYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred C----CcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1 122357899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=300.33 Aligned_cols=262 Identities=21% Similarity=0.271 Sum_probs=193.7
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
..+.||+|++|.||+|+.. +++.||||.++... ......+.+|++++++++||||+++++++.+.+..++||||+.
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (284)
T cd07860 4 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH- 82 (284)
T ss_pred eeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-
Confidence 3468999999999999876 68999999886543 2233568899999999999999999999999999999999996
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
++|.+++... ....+++..+..++.|+++||+|||+. +++||||+|+||+++.++.+||+|||+++........
T Consensus 83 ~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~- 156 (284)
T cd07860 83 QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT- 156 (284)
T ss_pred cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc-
Confidence 6898888643 245689999999999999999999998 9999999999999999999999999998755332211
Q ss_pred eeccccCCcccCccccccCC-CCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhc------------C
Q 002509 747 SSIVRGTVGYLDPEYYISQQ-LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES------------G 813 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~-~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~------------~ 813 (914)
.....++..|+|||.+.+.. ++.++|||||||++|||++|+.||...........+.++....... .
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 12234688999999887644 5888999999999999999999986543211111111111000000 0
Q ss_pred CcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 814 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 814 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.........+. .........+.+++.+|++.||++||+++|++++
T Consensus 237 ~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 237 SFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000000000 0000112346789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=298.68 Aligned_cols=264 Identities=21% Similarity=0.229 Sum_probs=196.0
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcc--cchhhhHHHHHHhhcccCceeEEEeeeeec--CceEEEEE
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVYE 662 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~LV~E 662 (914)
+.+.+.||+|+||.||+|+.+ +++.+++|.++..... ....+.+|++++.+++||||+++++++... ...++|+|
T Consensus 7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e 86 (293)
T cd07843 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVME 86 (293)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEeh
Confidence 455678999999999999887 6889999998754322 233567899999999999999999999877 88999999
Q ss_pred eccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCC
Q 002509 663 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 742 (914)
Q Consensus 663 ~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 742 (914)
|+++ +|.+.+... ...+++..++.++.|+++||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 87 ~~~~-~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 87 YVEH-DLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred hcCc-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 9974 898888543 23689999999999999999999998 9999999999999999999999999998765443
Q ss_pred CCceeeccccCCcccCccccccC-CCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHh-------h----
Q 002509 743 ASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH-------I---- 810 (914)
Q Consensus 743 ~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~-------~---- 810 (914)
... .....++..|+|||.+.+. .++.++|+||||++++||++|+.||...........+....... .
T Consensus 160 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 160 LKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred ccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 211 1223478899999998754 46889999999999999999999997543222112221111000 0
Q ss_pred --hcCCcccccCCccCCccCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 811 --ESGDIQGIIDPSLLDEYDIQ-SMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 811 --~~~~~~~i~d~~l~~~~~~~-~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
............+...+... ....+.+++.+|++.+|++||+++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000000011111111111 23457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=299.07 Aligned_cols=250 Identities=26% Similarity=0.398 Sum_probs=191.5
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc-ccchhhhHHHHH-HhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTL-LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~f~~E~~~-l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
+.+.||+|+||.||+++.+ +|+.||+|+++.... .....+..|+.. ++..+||||+++++++..++..+++|||++
T Consensus 5 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~- 83 (283)
T cd06617 5 VIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD- 83 (283)
T ss_pred EEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-
Confidence 4568999999999999876 699999999875432 233455556665 566789999999999999999999999997
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
|+|.+++.........+++..++.++.|++.||+|||+++ +++||||||+||+++.++.+||+|||++....... .
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~ 159 (283)
T cd06617 84 TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV--A 159 (283)
T ss_pred ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccccc--c
Confidence 6888888654444567899999999999999999999853 79999999999999999999999999987653321 1
Q ss_pred eeccccCCcccCcccccc----CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCc
Q 002509 747 SSIVRGTVGYLDPEYYIS----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 822 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~----~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 822 (914)
.....|+..|+|||.+.+ ..++.++|+|||||++|||++|+.||..... ....+.... . +. .+.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~----~-~~-----~~~ 227 (283)
T cd06617 160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--PFQQLKQVV----E-EP-----SPQ 227 (283)
T ss_pred cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--CHHHHHHHH----h-cC-----CCC
Confidence 222457889999998864 4568899999999999999999999864221 111221111 1 10 111
Q ss_pred cCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 823 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 823 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+... .....+.+++.+|++.+|++||+++|++++
T Consensus 228 ~~~~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 228 LPAE---KFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCcc---ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1110 112357889999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=333.76 Aligned_cols=254 Identities=24% Similarity=0.363 Sum_probs=194.9
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeeec--CceEEEE
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVY 661 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~LV~ 661 (914)
.+.+.+.||+|+||+||+++.. .+..+|+|++.... ......|..|+.++.+++|||||++++++... ...++||
T Consensus 14 ~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVM 93 (1021)
T PTZ00266 14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILM 93 (1021)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEE
Confidence 4556689999999999999876 57789999886542 22345788999999999999999999988543 5689999
Q ss_pred EeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCC----CCccccCCCCCceEeCC-------------
Q 002509 662 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV----PAIIHRDLKSSNILLDK------------- 724 (914)
Q Consensus 662 E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~----~~ivHrDlkp~NILl~~------------- 724 (914)
||+++|+|.++|.........+++..++.|+.||+.||+|||+.+. .+|+||||||+||||+.
T Consensus 94 EY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~ 173 (1021)
T PTZ00266 94 EFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQAN 173 (1021)
T ss_pred eCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccc
Confidence 9999999999997544444679999999999999999999998531 25999999999999964
Q ss_pred ----CCcEEEeeccccccccCCCCceeeccccCCcccCcccccc--CCCCccCceeehHHHHHHHHhCCCCccccccccc
Q 002509 725 ----HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGAN 798 (914)
Q Consensus 725 ----~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~ 798 (914)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||.....
T Consensus 174 n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~--- 248 (1021)
T PTZ00266 174 NLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN--- 248 (1021)
T ss_pred ccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc---
Confidence 2358999999997653321 2233468999999999864 4588999999999999999999999964321
Q ss_pred chhHHHHHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 799 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 799 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
...+.. .+..+. +..+ ... ...+.+++..|++.+|.+||++.|++++
T Consensus 249 ~~qli~----~lk~~p-----~lpi-~~~----S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 249 FSQLIS----ELKRGP-----DLPI-KGK----SKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred HHHHHH----HHhcCC-----CCCc-CCC----CHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 111111 111110 0000 111 2357889999999999999999999853
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=299.63 Aligned_cols=260 Identities=21% Similarity=0.315 Sum_probs=192.0
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc-ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
.+.+.||+|++|.||+|+.+ +++.||+|.+..... .....+.+|++++++++|+||+++++++...+..++||||+.+
T Consensus 8 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (291)
T cd07844 8 KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT 87 (291)
T ss_pred eEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC
Confidence 34578999999999999876 689999999875432 2234577899999999999999999999999999999999985
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
+|.+++... ...+++.....++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 88 -~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~ 159 (291)
T cd07844 88 -DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KT 159 (291)
T ss_pred -CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC-cc
Confidence 899888643 23678889999999999999999998 99999999999999999999999999986542211 11
Q ss_pred eeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhc---CCcccc----
Q 002509 747 SSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES---GDIQGI---- 818 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~---~~~~~i---- 818 (914)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ..+.. ....... .....+
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHK-IFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHH-HHHhcCCCChhhhhhhhhcc
Confidence 122346889999999875 457889999999999999999999986433110 01100 0000000 000000
Q ss_pred --c--------CCccCCcc-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 819 --I--------DPSLLDEY-DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 819 --~--------d~~l~~~~-~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
. ...+.... .......+.+++.+|++.+|++||++.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0 00000000 00112467789999999999999999998763
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=299.44 Aligned_cols=262 Identities=23% Similarity=0.276 Sum_probs=194.5
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc--ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
+.+.||+|++|.||+|..+ +|+.||+|++..... .....+.+|++++++++|||++++++++...+..+++|||++
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~- 81 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD- 81 (283)
T ss_pred hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-
Confidence 4578999999999999876 799999999875432 223568889999999999999999999999999999999995
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
++|.+++.... ...+++..++.++.|+++||+|||+. +++||||+|+||+++.++.++|+|||+++........
T Consensus 82 ~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 82 LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 68999885432 24689999999999999999999998 9999999999999999999999999998754322111
Q ss_pred eeccccCCcccCccccccC-CCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcC--------C---
Q 002509 747 SSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG--------D--- 814 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~--------~--- 814 (914)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||...........+.++........ +
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 1222468899999988654 568899999999999999999999865432111111111110000000 0
Q ss_pred -cccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 815 -IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 815 -~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
......... ..........+.+++.+|++.+|++||+++|++++
T Consensus 236 ~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 236 TFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000 00011112467899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=322.56 Aligned_cols=261 Identities=19% Similarity=0.266 Sum_probs=186.9
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcccC------ceeEEEeeeeec-CceE
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR------NLVQFLGYCQEE-GRSV 658 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~Hp------nIv~l~g~~~~~-~~~~ 658 (914)
.+.+.++||+|+||+||+|... .++.||||+++... ...+.+..|++++.+++|. +++++++++... ...+
T Consensus 130 ~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~ 208 (467)
T PTZ00284 130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC 208 (467)
T ss_pred cEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence 3455678999999999999875 57889999986432 2234556778888777654 588899988765 5678
Q ss_pred EEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCC------------
Q 002509 659 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM------------ 726 (914)
Q Consensus 659 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~------------ 726 (914)
+|||++ +++|.+++.. ...+++..+..|+.|++.||+|||++ .+|+||||||+|||++.++
T Consensus 209 iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 209 IVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred EEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccC
Confidence 999987 6688888753 34688999999999999999999973 1899999999999998765
Q ss_pred ----cEEEeeccccccccCCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhH
Q 002509 727 ----RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 802 (914)
Q Consensus 727 ----~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l 802 (914)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+
T Consensus 282 ~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 357 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357 (467)
T ss_pred CCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 499999998754321 223456899999999999999999999999999999999999999754321111111
Q ss_pred HH--------HHHHh--------hh-cCCcccccCCccC----Cc---cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002509 803 VQ--------WAKLH--------IE-SGDIQGIIDPSLL----DE---YDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 858 (914)
Q Consensus 803 ~~--------~~~~~--------~~-~~~~~~i~d~~l~----~~---~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 858 (914)
.+ |.... .. .+.+....++.-. .. ........+.+|+.+|++.||++|||++|+++
T Consensus 358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 11 11000 00 0000000010000 00 00011235779999999999999999999997
Q ss_pred H
Q 002509 859 D 859 (914)
Q Consensus 859 ~ 859 (914)
+
T Consensus 438 H 438 (467)
T PTZ00284 438 H 438 (467)
T ss_pred C
Confidence 5
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=290.69 Aligned_cols=250 Identities=25% Similarity=0.297 Sum_probs=204.6
Q ss_pred HHhccccccCcEEEEEEEECC-CcEEEEEEEecCCcc---cchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEec
Q 002509 589 MLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~~-g~~vAVK~l~~~~~~---~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
++.+.||.|.-|+||.+++++ +..+|+|++.+.... .....+.|-+||+.++||.+..|++.++.++..|++||||
T Consensus 80 ~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyC 159 (459)
T KOG0610|consen 80 RLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYC 159 (459)
T ss_pred HHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecC
Confidence 355789999999999999884 588999999766432 3345678999999999999999999999999999999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccC---
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD--- 741 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~--- 741 (914)
+||+|...++.+ ..+.++...+..++.+++-||+|||.. |||.|||||+||||.++|++.|+||.|+.....
T Consensus 160 pGGdL~~LrqkQ--p~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 160 PGGDLHSLRQKQ--PGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred CCccHHHHHhhC--CCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 999999988655 567899999999999999999999998 999999999999999999999999998743210
Q ss_pred ------------------------------CCC----------------------ceeeccccCCcccCccccccCCCCc
Q 002509 742 ------------------------------GAS----------------------HVSSIVRGTVGYLDPEYYISQQLTD 769 (914)
Q Consensus 742 ------------------------------~~~----------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ 769 (914)
... ..+..++||-.|+|||++.+...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 000 0112256999999999999999999
Q ss_pred cCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCC
Q 002509 770 KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHM 849 (914)
Q Consensus 770 ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~ 849 (914)
+.|-|+|||++|||+.|+.||.+....++..+++.. .+.-....+......+||.+.+..||++
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~----------------~l~Fp~~~~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ----------------PLKFPEEPEVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC----------------CCcCCCCCcchhHHHHHHHHHhccChhh
Confidence 999999999999999999999887766555555431 1111111133456789999999999999
Q ss_pred CCC----HHHHHHH
Q 002509 850 RPS----ISEVLKD 859 (914)
Q Consensus 850 RPs----m~eVl~~ 859 (914)
|-. +.||-++
T Consensus 379 Rlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 379 RLGSKRGAAEIKRH 392 (459)
T ss_pred hhccccchHHhhcC
Confidence 988 8888765
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=298.97 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=198.9
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
.+.+.+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++|||++++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 99 (293)
T cd06647 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLA 99 (293)
T ss_pred hceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCC
Confidence 3445678999999999999765 688999999875544455678899999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+++|.+++.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 100 ~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 100 GGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred CCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 9999999853 3478889999999999999999998 9999999999999999999999999998755433222
Q ss_pred eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCC
Q 002509 746 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 825 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 825 (914)
.....|++.|+|||.+....++.++|||||||++||+++|+.||....... .+... ...+. +...
T Consensus 172 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~---~~~~~----~~~~~------~~~~- 236 (293)
T cd06647 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---ALYLI----ATNGT------PELQ- 236 (293)
T ss_pred -cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh---heeeh----hcCCC------CCCC-
Confidence 223458889999999988889999999999999999999999996543211 11100 00000 0000
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 826 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 826 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
........+.+++.+|++.+|++||++.|++++
T Consensus 237 -~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 -NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011122357789999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=298.96 Aligned_cols=245 Identities=26% Similarity=0.395 Sum_probs=193.2
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc---ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEE
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 662 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 662 (914)
.+.+.+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|+++++.++||||+++.++|...+..++|+|
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e 95 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME 95 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence 3556688999999999999876 689999999864432 223568899999999999999999999999999999999
Q ss_pred eccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCC
Q 002509 663 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 742 (914)
Q Consensus 663 ~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 742 (914)
|++ |++.+.+... ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++......
T Consensus 96 ~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 96 YCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred hhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 997 5777766432 34589999999999999999999998 9999999999999999999999999998755332
Q ss_pred CCceeeccccCCcccCccccc---cCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCccccc
Q 002509 743 ASHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 819 (914)
Q Consensus 743 ~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 819 (914)
....++..|+|||.+. ...++.++||||||+++|||++|+.||....... .... ......
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~----~~~~----~~~~~~---- 231 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALYH----IAQNDS---- 231 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH----HHHH----HhcCCC----
Confidence 2235788999999884 4568889999999999999999999986433111 1110 011110
Q ss_pred CCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 820 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 820 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+.+. .......+.+++.+|++.+|++||+|.+|+++
T Consensus 232 -~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 -PTLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -CCCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 1111 11223468899999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=303.73 Aligned_cols=248 Identities=23% Similarity=0.285 Sum_probs=195.4
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcc---cchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~---~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
+.+.||+|++|.||++... +++.+|+|.+...... ..+.+..|++++++++|+||+++++.+......++||||+.
T Consensus 5 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (316)
T cd05574 5 KIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCP 84 (316)
T ss_pred EeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecC
Confidence 4568999999999999876 5899999998765322 34568899999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+++|.+++... ....+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||++.........
T Consensus 85 ~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 85 GGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred CCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence 99999998643 245688999999999999999999998 9999999999999999999999999998654322110
Q ss_pred ----------------------------eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccc
Q 002509 746 ----------------------------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA 797 (914)
Q Consensus 746 ----------------------------~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~ 797 (914)
......|+..|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 1112357889999999998889999999999999999999999997543211
Q ss_pred cchhHHHHHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCC----HHHHHH
Q 002509 798 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS----ISEVLK 858 (914)
Q Consensus 798 ~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPs----m~eVl~ 858 (914)
.+.. .. .... .... .......+.+++.+|++.+|++||+ ++|+++
T Consensus 240 ---~~~~----~~-~~~~------~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 240 ---TFSN----IL-KKEV------TFPG--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred ---HHHH----Hh-cCCc------cCCC--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 1111 00 0000 0000 0112346889999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=298.56 Aligned_cols=262 Identities=23% Similarity=0.305 Sum_probs=196.9
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeeec--CceEEEEEec
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVYEFM 664 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~LV~E~~ 664 (914)
+.+.||+|++|.||+|+.. +++.+|+|++.... ......+.+|++++++++|+|++++++++... +..++|+||+
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07840 3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM 82 (287)
T ss_pred eeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccc
Confidence 4568999999999999877 58899999998653 23345688999999999999999999999888 8899999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 744 (914)
++ +|.+++... ...+++..++.++.|+++||+|||+. +++|+||||+||++++++.+||+|||++........
T Consensus 83 ~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 83 DH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 85 888887543 24688999999999999999999998 999999999999999999999999999976654432
Q ss_pred ceeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccc-----
Q 002509 745 HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI----- 818 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i----- 818 (914)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.+..... ........
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 234 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSP-TDENWPGVSKLPW 234 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC-chhhccccccchh
Confidence 22233456889999998765 457899999999999999999999997544222111221111000 00000000
Q ss_pred ---------cCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 819 ---------IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 819 ---------~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
....+.......+...+.+++.+|++.+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000000000114568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=293.89 Aligned_cols=250 Identities=24% Similarity=0.399 Sum_probs=196.0
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc------ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEE
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 662 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~------~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 662 (914)
..+.||+|++|.||+++.. +++.+|+|+++.... ...+.+..|++++++++|+||+++++++.+.+..++|+|
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 83 (268)
T cd06630 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVE 83 (268)
T ss_pred ccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEe
Confidence 3568999999999999864 789999999864321 123568899999999999999999999999999999999
Q ss_pred eccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCC-cEEEeeccccccccC
Q 002509 663 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVD 741 (914)
Q Consensus 663 ~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~ 741 (914)
|+++++|.+++.. ...+++..+..++.|++.||+|||++ +++|+||||+||+++.++ .+||+|||++.....
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 84 WMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred ccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 9999999999853 24578899999999999999999998 999999999999998776 599999999876543
Q ss_pred CCC---ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccc
Q 002509 742 GAS---HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 818 (914)
Q Consensus 742 ~~~---~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i 818 (914)
... .......|+..|+|||.+.+..++.++||||+|++++||++|+.||......... ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~----- 227 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL----ALIFKIASAT----- 227 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH----HHHHHHhccC-----
Confidence 211 1122345789999999998888999999999999999999999998643322111 1111110000
Q ss_pred cCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 819 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 819 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
..+ ..+......+.+++.+|++.+|++||++.|++++
T Consensus 228 ~~~----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 228 TAP----SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred CCC----CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 001 1111223457889999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=296.28 Aligned_cols=244 Identities=25% Similarity=0.354 Sum_probs=196.6
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCChH
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK 670 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~ 670 (914)
+.||+|++|.||++... +++.+++|.+........+.+.+|+.++++++||||+++++++...+..++++||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~ 104 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence 58999999999999865 78899999987554444567889999999999999999999999999999999999999999
Q ss_pred HHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCceeecc
Q 002509 671 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 750 (914)
Q Consensus 671 ~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 750 (914)
+++.. .++++..+..++.|++.||+|||++ +++||||||+||+++.++.++|+|||++........ .....
T Consensus 105 ~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~ 175 (285)
T cd06648 105 DIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKSL 175 (285)
T ss_pred HHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccccc
Confidence 99853 4578899999999999999999998 999999999999999999999999998865433221 22234
Q ss_pred ccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccCHH
Q 002509 751 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQ 830 (914)
Q Consensus 751 ~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 830 (914)
.|+..|+|||.+.+..++.++|||||||+++||++|+.||...... ...... ..... +.+.. ...
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-------~~~~~~-~~~~~-----~~~~~--~~~ 240 (285)
T cd06648 176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-------QAMKRI-RDNLP-----PKLKN--LHK 240 (285)
T ss_pred cCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-------HHHHHH-HhcCC-----CCCcc--ccc
Confidence 5889999999998888999999999999999999999998643311 111111 11110 11110 001
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 831 SMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 831 ~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
....+.+++.+|++.+|++||++.|++++
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 241 VSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 22368899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=293.98 Aligned_cols=247 Identities=25% Similarity=0.386 Sum_probs=196.2
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC-cccchhhhHHHHHHhhcc---cCceeEEEeeeeecCceEEEEE
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIH---HRNLVQFLGYCQEEGRSVLVYE 662 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~---HpnIv~l~g~~~~~~~~~LV~E 662 (914)
+.+.+.||+|+||.||+|... +++.+|+|.++... ......+.+|++++++++ |||++++++++......++|||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 345578999999999999875 78999999987543 233456888999999997 9999999999999999999999
Q ss_pred eccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCC
Q 002509 663 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 742 (914)
Q Consensus 663 ~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 742 (914)
|+++++|.+++.. ..+++...+.++.|+++||.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 83 YAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred cCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 9999999998853 2688999999999999999999998 9999999999999999999999999998766543
Q ss_pred CCceeeccccCCcccCccccccC-CCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCC
Q 002509 743 ASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 821 (914)
Q Consensus 743 ~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 821 (914)
... .....|+..|+|||.+.++ .++.++|||||||++|||++|+.||...... .+.. ..... ..+
T Consensus 155 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-------~~~~-~~~~~-----~~~ 220 (277)
T cd06917 155 SSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-------RAMM-LIPKS-----KPP 220 (277)
T ss_pred ccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-------hhhh-ccccC-----CCC
Confidence 322 2234588999999998754 4688999999999999999999999653321 1110 00000 111
Q ss_pred ccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 822 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 822 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.+... .....+.+++.+|++.+|++||++.|++++
T Consensus 221 ~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 221 RLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 11111 123457889999999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-33 Score=307.84 Aligned_cols=240 Identities=26% Similarity=0.423 Sum_probs=194.5
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCCc---ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCC
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 667 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 667 (914)
+.||.|+||.||.|+.. +.+.||||.+.-... ..-.++..|+..|.+++|||++.+.|++..+...+||||||-|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG- 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG- 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc-
Confidence 46999999999999866 678899999865432 2345788999999999999999999999999999999999965
Q ss_pred ChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCcee
Q 002509 668 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 747 (914)
Q Consensus 668 sL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 747 (914)
+-.|.+.-. .+++-..++..|+.+.++||+|||+. +.||||||+.||||++.|.|||+|||.|.+..+.
T Consensus 111 SAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA----- 179 (948)
T KOG0577|consen 111 SASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA----- 179 (948)
T ss_pred cHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch-----
Confidence 666666322 45677888999999999999999998 9999999999999999999999999998776543
Q ss_pred eccccCCcccCccccc---cCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccC
Q 002509 748 SIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824 (914)
Q Consensus 748 ~~~~gt~~Y~aPE~~~---~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 824 (914)
..++||+.|||||++. .++|+-|+||||+|+...||.-.++|.-.++.-. +..++..++ .|.|.
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS--------ALYHIAQNe-----sPtLq 246 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNE-----SPTLQ 246 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH--------HHHHHHhcC-----CCCCC
Confidence 3456999999999986 5789999999999999999999999976544211 111222211 12222
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 825 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 825 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
..+-...+.+++..|++.-|.+|||.++++++
T Consensus 247 ---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 247 ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred ---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 22334468899999999999999999998865
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-33 Score=311.43 Aligned_cols=246 Identities=28% Similarity=0.436 Sum_probs=194.5
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEec----CCcccchhhhHHHHHHhhcccCceeEEEeeeeecCc--eEEEE
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTS----NSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR--SVLVY 661 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~----~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~--~~LV~ 661 (914)
.+..+||+|+|-+||||... +|.+||--.++. ......+.|..|+.+|+.|+||||++++.+..+... ..+|.
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 35568999999999999765 688887433321 123334789999999999999999999998877654 67899
Q ss_pred EeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCC-CcEEEeecccccccc
Q 002509 662 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAV 740 (914)
Q Consensus 662 E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~ 740 (914)
|.|..|+|..|+.. .++++......++.||++||.|||++ .|+|+|||||.+||+|+.+ |.|||+|.|||....
T Consensus 123 EL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 99999999999854 45677788999999999999999997 5799999999999999875 899999999998764
Q ss_pred CCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccC
Q 002509 741 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 820 (914)
Q Consensus 741 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 820 (914)
.. +. ..+.|||.|||||++. ..|.+..||||||+.|+||+|+..|+..... .-+|.+-+..-.+...+..+-|
T Consensus 198 ~s--~a-ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n---~AQIYKKV~SGiKP~sl~kV~d 270 (632)
T KOG0584|consen 198 KS--HA-KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN---PAQIYKKVTSGIKPAALSKVKD 270 (632)
T ss_pred cc--cc-ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC---HHHHHHHHHcCCCHHHhhccCC
Confidence 32 22 2367999999999986 7899999999999999999999999975432 1233333333322222222222
Q ss_pred CccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 821 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 821 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.++.+++.+|+.. .++||++.|++++
T Consensus 271 ------------Pevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 271 ------------PEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ------------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 2477899999999 8999999999874
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=285.37 Aligned_cols=247 Identities=31% Similarity=0.501 Sum_probs=201.0
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCC
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 668 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gs 668 (914)
..+.||+|++|.||++... +++.+++|++..........+.+|++++++++|+|++++++++......++++||+++++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 83 (253)
T cd05122 4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGS 83 (253)
T ss_pred eeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCc
Confidence 4568999999999999886 789999999977655456789999999999999999999999999999999999999999
Q ss_pred hHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCceee
Q 002509 669 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 748 (914)
Q Consensus 669 L~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 748 (914)
|.+++... ...+++..+..++.|+++||++||+. +++||||+|+||++++++.++|+|||.+........ ..
T Consensus 84 L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 155 (253)
T cd05122 84 LKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN 155 (253)
T ss_pred HHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence 99998643 25689999999999999999999998 999999999999999999999999999876654332 23
Q ss_pred ccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccC
Q 002509 749 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 828 (914)
Q Consensus 749 ~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 828 (914)
...++..|+|||.+.+..++.++||||||++++||++|+.|+...... ..+... . . .......++
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~-~---~-~~~~~~~~~------- 220 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM---KALFKI-A---T-NGPPGLRNP------- 220 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH---HHHHHH-H---h-cCCCCcCcc-------
Confidence 445889999999998888899999999999999999999998654211 111111 0 0 111111110
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 829 IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 829 ~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
......+.+++.+|++.+|++||++.|++++
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0012358889999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=292.81 Aligned_cols=246 Identities=25% Similarity=0.370 Sum_probs=188.8
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc-----ccchhhhHHHHHHhhcccCceeEEEeeeeec--CceEEEE
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-----QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVY 661 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~-----~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~LV~ 661 (914)
+.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|++++++++||||+++++++.+. ...+++|
T Consensus 6 ~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~ 85 (265)
T cd06652 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFM 85 (265)
T ss_pred EeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEE
Confidence 4578999999999999876 689999998864321 1234678899999999999999999988764 4577999
Q ss_pred EeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccC
Q 002509 662 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 741 (914)
Q Consensus 662 E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 741 (914)
||+++++|.+++... ..+++...+.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 86 EHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 999999999998532 3477888899999999999999998 999999999999999999999999999875432
Q ss_pred CCC--ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCccccc
Q 002509 742 GAS--HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 819 (914)
Q Consensus 742 ~~~--~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 819 (914)
... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ..+.+ ..... .
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~----~~~~~-----~ 226 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM---AAIFK----IATQP-----T 226 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH---HHHHH----HhcCC-----C
Confidence 111 1122345889999999998888999999999999999999999998643211 11111 11110 0
Q ss_pred CCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 820 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 820 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.+. .+......+.+++.+|+. +|++||+++||+++
T Consensus 227 ~~~----~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 NPV----LPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred CCC----CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 111 122223356677778884 89999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=299.28 Aligned_cols=252 Identities=21% Similarity=0.273 Sum_probs=195.9
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc---ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
+.+.||+|+||.||++... .++.|++|.+..... .....+.+|+++++.++||||+++++.+..++..++||||++
T Consensus 5 ~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (305)
T cd05609 5 TIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVE 84 (305)
T ss_pred EeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCC
Confidence 4578999999999999876 578999999875532 224567899999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCC--
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-- 743 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~-- 743 (914)
+++|.+++.. ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 85 g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 85 GGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 9999999853 24588899999999999999999998 99999999999999999999999999986421100
Q ss_pred ------------CceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhh
Q 002509 744 ------------SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE 811 (914)
Q Consensus 744 ------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~ 811 (914)
........|+..|+|||.+....++.++|+|||||++|||++|+.||.+.... .+.+ ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~----~~~~---~~~~ 230 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE----ELFG---QVIS 230 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHH---HHHh
Confidence 00111235788999999998888999999999999999999999998643321 1111 1111
Q ss_pred cCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 002509 812 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 863 (914)
Q Consensus 812 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 863 (914)
+.. ..+.... .....+.+++.+|++.+|++||++.++.+.|+..
T Consensus 231 -~~~---~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 231 -DDI---EWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred -ccc---CCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 110 1111111 1123478999999999999999976666666653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=290.18 Aligned_cols=249 Identities=29% Similarity=0.417 Sum_probs=202.0
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc-ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCC
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 667 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 667 (914)
+.+.||+|++|.||+++.. +++.|+||++..... .....+..|++.+.+++|+|++++++++...+..++|+||++++
T Consensus 5 ~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (264)
T cd06623 5 RVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGG 84 (264)
T ss_pred eeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCC
Confidence 4578999999999999887 599999999876543 34577999999999999999999999999999999999999999
Q ss_pred ChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHh-CCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 668 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 668 sL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
+|.+++... ..+++..++.++.|+++||+|||+ . +++||||+|+||+++.++.++|+|||++..........
T Consensus 85 ~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 157 (264)
T cd06623 85 SLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC 157 (264)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence 999998543 568889999999999999999999 8 99999999999999999999999999987654332221
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCc
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 826 (914)
....++..|+|||.+.+..++.++||||||+++|||++|+.||...... ....+.++.. .... +.+...
T Consensus 158 -~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~----~~~~-----~~~~~~ 226 (264)
T cd06623 158 -NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAIC----DGPP-----PSLPAE 226 (264)
T ss_pred -cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-CHHHHHHHHh----cCCC-----CCCCcc
Confidence 2345789999999999888999999999999999999999998654321 1122222221 1111 111111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 827 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 827 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.....+.+++.+|++.+|++||++.|++++
T Consensus 227 ---~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 227 ---EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ---cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 023468899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=294.40 Aligned_cols=249 Identities=25% Similarity=0.386 Sum_probs=191.6
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhc-ccCceeEEEeeeee------cCceE
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE------EGRSV 658 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~------~~~~~ 658 (914)
.+.+.+.||+|+||.||+|+.. +++.+|+|++.... .....+..|+.++.++ +|+||+++++++.. ....+
T Consensus 17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 95 (282)
T cd06636 17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW 95 (282)
T ss_pred hhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence 3455678999999999999875 68899999986543 2345678899999998 79999999999853 45679
Q ss_pred EEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccc
Q 002509 659 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 738 (914)
Q Consensus 659 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 738 (914)
++|||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+|+||||+||++++++.++|+|||++..
T Consensus 96 iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 96 LVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred EEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 9999999999999986432 34577888899999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeeccccCCcccCccccc-----cCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcC
Q 002509 739 AVDGASHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 813 (914)
Q Consensus 739 ~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 813 (914)
...... ......|+..|+|||.+. ...++.++|||||||++|||++|+.||....... .+.. ....
T Consensus 171 ~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~---~~~~-----~~~~ 241 (282)
T cd06636 171 LDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR---ALFL-----IPRN 241 (282)
T ss_pred hhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh---hhhh-----HhhC
Confidence 432211 122345889999999986 3457889999999999999999999996432111 1111 0000
Q ss_pred CcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002509 814 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 858 (914)
Q Consensus 814 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 858 (914)
..+.+.. ......+.+++.+|++.+|.+||++.|+++
T Consensus 242 -----~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 242 -----PPPKLKS---KKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -----CCCCCcc---cccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0111111 112235889999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=296.69 Aligned_cols=246 Identities=26% Similarity=0.408 Sum_probs=193.4
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc---ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEE
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 662 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 662 (914)
.+...+.||+|+||.||+++.. ++..+|+|++..... .....+..|++++++++|||++++++++..++..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3455678999999999999875 688999999875422 223468889999999999999999999999999999999
Q ss_pred eccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCC
Q 002509 663 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 742 (914)
Q Consensus 663 ~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 742 (914)
|+. |+|.+.+... ...++|.++..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~-g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 106 YCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred CCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 997 4787776432 34589999999999999999999998 9999999999999999999999999998654322
Q ss_pred CCceeeccccCCcccCccccc---cCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCccccc
Q 002509 743 ASHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 819 (914)
Q Consensus 743 ~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 819 (914)
....|+..|+|||++. .+.++.++|||||||++|||++|+.||...... ..+..+.. .+ .
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~~~~~----~~-~---- 241 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHIAQ----NE-S---- 241 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHHh----cc-C----
Confidence 2235788999999974 456889999999999999999999998643211 11111111 10 0
Q ss_pred CCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002509 820 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 860 (914)
Q Consensus 820 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L 860 (914)
+... .......+.+++.+|++.+|++||++.||++++
T Consensus 242 -~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 242 -PTLQ---SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred -CCCC---CccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 0000 111223578899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=294.79 Aligned_cols=260 Identities=20% Similarity=0.232 Sum_probs=191.2
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCC-cccchhhhHHHHHHhhcc-cCceeEEEeeeeec--CceEEEEEec
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEE--GRSVLVYEFM 664 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~--~~~~LV~E~~ 664 (914)
+.+.||+|+||.||+|+.. +++.||+|+++... .........|+..+.++. |+|++++++++.+. +..++|+||+
T Consensus 3 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (282)
T cd07831 3 ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM 82 (282)
T ss_pred eEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecC
Confidence 4568999999999999876 68999999987542 222334457888898885 99999999999987 8899999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 744 (914)
+ |+|.+.+... ...++|.+++.++.|+++||+|||+. +++||||||+||+++. +.+||+|||+++.......
T Consensus 83 ~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 83 D-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred C-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 7 5888877543 24689999999999999999999998 9999999999999999 9999999999976543222
Q ss_pred ceeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHH-------HHhhhcCCcc
Q 002509 745 HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA-------KLHIESGDIQ 816 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~-------~~~~~~~~~~ 816 (914)
. ....++..|+|||.+.. ..++.++|||||||++|||++|+.||......+....+.... ..........
T Consensus 155 ~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 155 Y--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred c--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence 1 22347889999997654 557889999999999999999999996543211111111100 0000000000
Q ss_pred cccCCccCC----ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 817 GIIDPSLLD----EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 817 ~i~d~~l~~----~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
....+.... .........+.+++.+|++.+|++||+++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000000 0011224578999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=295.38 Aligned_cols=263 Identities=22% Similarity=0.316 Sum_probs=196.3
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc-ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCC
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 667 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 667 (914)
+.++||+|++|.||+|+.. +|+.||||+++.... .....+.+|++++++++|+||+++++++...+..++||||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~- 82 (284)
T cd07836 4 QLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK- 82 (284)
T ss_pred EeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-
Confidence 4578999999999999986 688999999876533 2345677899999999999999999999999999999999985
Q ss_pred ChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCcee
Q 002509 668 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 747 (914)
Q Consensus 668 sL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 747 (914)
+|.+++.... ....+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||++........ ..
T Consensus 83 ~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (284)
T cd07836 83 DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TF 157 (284)
T ss_pred cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-cc
Confidence 8888875432 234689999999999999999999998 999999999999999999999999999875433211 11
Q ss_pred eccccCCcccCccccccC-CCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccc-----cCC
Q 002509 748 SIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI-----IDP 821 (914)
Q Consensus 748 ~~~~gt~~Y~aPE~~~~~-~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i-----~d~ 821 (914)
....++..|++||.+.+. .++.++|||||||++|||++|+.||......+....+.+....... .....+ ...
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTE-STWPGISQLPEYKP 236 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh-hhHHHHhcCchhcc
Confidence 223468899999998654 4688999999999999999999999754432222222221100000 000000 000
Q ss_pred ccC-------CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 822 SLL-------DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 822 ~l~-------~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
... ..........+.+++.+|++.+|.+||+++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000 00001123457799999999999999999999863
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=293.27 Aligned_cols=260 Identities=21% Similarity=0.300 Sum_probs=190.8
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcc-cchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
.+.+.||+|+||.||+|... +++.||+|++...... ....+.+|+++++.++|+||+++.+++..++..++|+||+.
T Consensus 8 ~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~- 86 (291)
T cd07870 8 LNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH- 86 (291)
T ss_pred EEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-
Confidence 34578999999999999865 6899999998755332 23467789999999999999999999999999999999996
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
++|.+.+... ...+.+..+..++.|+++||+|||+. +|+|+||||+||+++.++++||+|||+++....... .
T Consensus 87 ~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~ 159 (291)
T cd07870 87 TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-T 159 (291)
T ss_pred CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC-C
Confidence 6777766432 23467888889999999999999998 999999999999999999999999999875432211 1
Q ss_pred eeccccCCcccCccccccC-CCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhc------------C
Q 002509 747 SSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES------------G 813 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~------------~ 813 (914)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.||...... ...+.+. ...... .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKI-WTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHH-HHHcCCCChhhhhhhhhcc
Confidence 2233478899999998754 5788999999999999999999999643311 1111110 000000 0
Q ss_pred Cc-ccccCCccCCcc-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 814 DI-QGIIDPSLLDEY-----DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 814 ~~-~~i~d~~l~~~~-----~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+. .+.......... .......+.+++.+|++.+|++|||++|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00 000000000000 00113457789999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=292.97 Aligned_cols=249 Identities=27% Similarity=0.416 Sum_probs=199.6
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
+.+.+.||+|++|.||+|..+ +++.+++|++..... ....+.+|++++++++|+|++++++++...+..++|+||+++
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 99 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDG 99 (286)
T ss_pred chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCC
Confidence 344568999999999999887 789999999976544 456788999999999999999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
++|.+++.... ..+++..+..++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++........ .
T Consensus 100 ~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 172 (286)
T cd06614 100 GSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-K 172 (286)
T ss_pred CcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-h
Confidence 99999996432 4789999999999999999999998 999999999999999999999999999865433221 1
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCc
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 826 (914)
.....++..|++||.+.+..++.++|||||||++|||++|+.|+...... ....... ........++
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~---~~~~~~~-----~~~~~~~~~~----- 239 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL---RALFLIT-----TKGIPPLKNP----- 239 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH-----hcCCCCCcch-----
Confidence 12334788999999998888999999999999999999999998643311 1111111 1111111110
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 827 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 827 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
......+.+++.+|++.+|.+||++.+|+++
T Consensus 240 --~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 240 --EKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred --hhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0122357889999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=299.93 Aligned_cols=267 Identities=21% Similarity=0.265 Sum_probs=194.6
Q ss_pred HHhccccccCcEEEEEEEECC---CcEEEEEEEecCC---cccchhhhHHHHHHhhcccCceeEEEeeeeec--CceEEE
Q 002509 589 MLEKKIGSGGFGVVYYGKLKD---GKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLV 660 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~~---g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~LV 660 (914)
.+.++||+|++|.||+|.... ++.||+|.+.... ......+.+|++++.+++||||+++++++... ...++|
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 82 (316)
T cd07842 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLL 82 (316)
T ss_pred eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEE
Confidence 345789999999999998754 7899999997643 23345678899999999999999999999988 789999
Q ss_pred EEeccCCChHHHhhcccCc-cccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCC----CCcEEEeeccc
Q 002509 661 YEFMHNGTLKEHLYGTLTH-EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK----HMRAKVSDFGL 735 (914)
Q Consensus 661 ~E~~~~gsL~~~L~~~~~~-~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~----~~~~kl~DFGl 735 (914)
|||+++ +|.+.+...... ...++...+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 83 FDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 999985 676666433222 23688899999999999999999998 9999999999999999 89999999999
Q ss_pred cccccCCCC--ceeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCccccccccc------chhHHHHH
Q 002509 736 SKFAVDGAS--HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGAN------CRNIVQWA 806 (914)
Q Consensus 736 a~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~------~~~l~~~~ 806 (914)
++....... .......++..|+|||.+.+ ..++.++|||||||+++||++|+.||........ ...+...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 976543322 11233457889999998876 4578899999999999999999999975442210 00111110
Q ss_pred HHh-----------hhcCCcccccCCccCCccC---------H--HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 807 KLH-----------IESGDIQGIIDPSLLDEYD---------I--QSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 807 ~~~-----------~~~~~~~~i~d~~l~~~~~---------~--~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
... .+........+......++ . ....++.+++.+|++.+|++||++.|++++
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000 0000000000000000000 0 122468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=291.89 Aligned_cols=248 Identities=28% Similarity=0.423 Sum_probs=197.6
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
.+.+.||+|+||.||++..+ +|..+|+|.+.... ....+.+.+|++++++++|+||+++++.+......++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (257)
T cd08225 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCD 82 (257)
T ss_pred eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCC
Confidence 34578999999999999887 68899999986542 2334578899999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCC-cEEEeeccccccccCCCC
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~ 744 (914)
+++|.+++... ....+++..+..++.|+++||+|||+. +++|+||||+||++++++ .+||+|||.+........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 83 GGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999998643 234578999999999999999999998 999999999999999886 569999999876543222
Q ss_pred ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccC
Q 002509 745 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 824 (914)
......|+..|+|||+..+..++.++||||||++++||++|+.||..... .++...... +.... ..
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~-~~~~~-~~---- 223 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-------HQLVLKICQ-GYFAP-IS---- 223 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHhc-ccCCC-CC----
Confidence 22234588999999999888899999999999999999999999864321 122221111 11111 11
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 825 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 825 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
. .....+.+++.+|++.+|++||++.|++++
T Consensus 224 ~----~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 224 P----NFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred C----CCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1 112358889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-32 Score=295.08 Aligned_cols=242 Identities=26% Similarity=0.374 Sum_probs=195.8
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEec
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
.+.+.||+|++|.||++... +++.+|+|++.... ......+.+|++++++++||||+++++++..++..++||||+
T Consensus 4 ~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (290)
T cd05580 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYV 83 (290)
T ss_pred EEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecC
Confidence 35578999999999999876 68999999987542 223456888999999999999999999999999999999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 744 (914)
++++|.+++.. ...+++..+..++.|+++||+|||+. +++||||+|+||+++.++.+||+|||+++.....
T Consensus 84 ~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 84 PGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 99999999854 35688899999999999999999998 9999999999999999999999999998765443
Q ss_pred ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccC
Q 002509 745 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 824 (914)
.....|++.|+|||.+.+...+.++||||||++++||++|+.||...... ...+. ...+.. .+.
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~----~~~~~~------~~~ 218 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI----QIYEK----ILEGKV------RFP 218 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH----HHHHH----HhcCCc------cCC
Confidence 22345889999999998888899999999999999999999998654311 11111 111111 111
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002509 825 DEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 859 (914)
Q Consensus 825 ~~~~~~~~~~l~~l~~~C~~~~P~~RP-----sm~eVl~~ 859 (914)
... ...+.+++.+|++.+|.+|| +++|++++
T Consensus 219 ~~~----~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 219 SFF----SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ccC----CHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 111 23577899999999999999 77777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=299.68 Aligned_cols=260 Identities=21% Similarity=0.270 Sum_probs=192.4
Q ss_pred cccccc--CcEEEEEEEEC-CCcEEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 592 KKIGSG--GFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 592 ~~lG~G--~~G~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
..||+| +||+||+++.. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999875 79999999987542 22346788899999999999999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
|+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+|||++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999986542 33588889999999999999999998 99999999999999999999999998653322111100
Q ss_pred ------eeccccCCcccCccccccC--CCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhh--------
Q 002509 747 ------SSIVRGTVGYLDPEYYISQ--QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI-------- 810 (914)
Q Consensus 747 ------~~~~~gt~~Y~aPE~~~~~--~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~-------- 810 (914)
.....++..|+|||++.+. .++.++|||||||+++||++|+.||....... .+........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ---MLLQKLKGPPYSPLDITT 235 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH---HHHHHhcCCCCCCccccc
Confidence 1112346679999999763 47889999999999999999999996533111 1111100000
Q ss_pred ------------------------hcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 811 ------------------------ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 811 ------------------------~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
..+....+.+..+...........+.+++.+|++.+|++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0000001111112222222345678999999999999999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=295.94 Aligned_cols=265 Identities=21% Similarity=0.210 Sum_probs=192.6
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc--ccchhhhHHHHHHhhcc-cCceeEEEeeeeecCc-----eEE
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGR-----SVL 659 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~-----~~L 659 (914)
.+.+.||+|+||.||+|... +++.||+|.++.... .....+.+|++++++++ ||||+++++++...+. .++
T Consensus 4 ~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~l 83 (295)
T cd07837 4 EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYL 83 (295)
T ss_pred eEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEE
Confidence 34578999999999999876 689999998765422 22456888999999995 6999999999987665 799
Q ss_pred EEEeccCCChHHHhhcccCc-cccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCC-CCcEEEeeccccc
Q 002509 660 VYEFMHNGTLKEHLYGTLTH-EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSK 737 (914)
Q Consensus 660 V~E~~~~gsL~~~L~~~~~~-~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~ 737 (914)
||||+++ +|.+++...... ...+++..++.++.|+++||+|||+. +++||||||+||+++. ++.+||+|||+++
T Consensus 84 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 84 VFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccce
Confidence 9999986 888888644322 35689999999999999999999998 9999999999999998 8899999999987
Q ss_pred cccCCCCceeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcc
Q 002509 738 FAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 816 (914)
Q Consensus 738 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 816 (914)
........ .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.+..... ......
T Consensus 160 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 237 (295)
T cd07837 160 AFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTP-TEQVWP 237 (295)
T ss_pred ecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCC-ChhhCc
Confidence 54322111 122246789999998865 457899999999999999999999986543221111111111000 000000
Q ss_pred cccC-------CccCC----ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 817 GIID-------PSLLD----EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 817 ~i~d-------~~l~~----~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
...+ +.... ........++.+++.+|++.+|++||+++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 00000 0001123457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=290.83 Aligned_cols=241 Identities=26% Similarity=0.346 Sum_probs=189.1
Q ss_pred ccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCCh
Q 002509 594 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 669 (914)
Q Consensus 594 lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 669 (914)
||+|+||+||++..+ +|+.+|+|.+.... ......+..|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999765 68999999987542 22344567899999999999999999999999999999999999999
Q ss_pred HHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCceeec
Q 002509 670 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 749 (914)
Q Consensus 670 ~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 749 (914)
.+++.... ...+++..++.++.|++.||.|||+. +++||||+|+||++++++.+||+|||++....... ....
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~ 153 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKG 153 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccc
Confidence 99986542 24688999999999999999999998 99999999999999999999999999987654321 1223
Q ss_pred cccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccCH
Q 002509 750 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 829 (914)
Q Consensus 750 ~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 829 (914)
..++..|+|||.+.+..++.++|||||||+++||++|+.||...........+.+. ... .......
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~------~~~~~~~---- 219 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR----TLE------MAVEYPD---- 219 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc----ccc------ccccCCc----
Confidence 45788999999998888999999999999999999999999654321111111110 000 0001111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHH
Q 002509 830 QSMWKIEEKALMCVLPHGHMRPSISE 855 (914)
Q Consensus 830 ~~~~~l~~l~~~C~~~~P~~RPsm~e 855 (914)
.....+.+++.+|++.+|++||+.+|
T Consensus 220 ~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 220 KFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred cCCHHHHHHHHHHccCChhHccCCCc
Confidence 11235788999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=287.42 Aligned_cols=249 Identities=27% Similarity=0.444 Sum_probs=202.4
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc--ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
+.+.||+|++|.||++... +++.+++|++..... .....+.+|++++++++|+|++++++.+...+..++|+||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~ 83 (258)
T cd08215 4 IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG 83 (258)
T ss_pred EEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCC
Confidence 4568999999999999876 689999999876533 4456788999999999999999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
++|.+++.........+++..+..++.++++||+|||+. +++|+||+|+||++++++.++|+|||++....... ..
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 159 (258)
T cd08215 84 GDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-DL 159 (258)
T ss_pred CcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc-ce
Confidence 999999976543457789999999999999999999998 99999999999999999999999999987654432 12
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCc
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 826 (914)
.....|++.|+|||...+..++.++||||+|+++++|++|+.||...... .+.. .... ..... +..
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~~~---~~~~-~~~~~-----~~~- 225 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL----ELAL---KILK-GQYPP-----IPS- 225 (258)
T ss_pred ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH----HHHH---HHhc-CCCCC-----CCC-
Confidence 23345888999999998888999999999999999999999998644311 1111 1111 11111 111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 827 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 827 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.....+.+++.+|+..+|++||++.|++++
T Consensus 226 ---~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 226 ---QYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ---CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 122357889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=293.27 Aligned_cols=253 Identities=26% Similarity=0.350 Sum_probs=192.1
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCC-cccchhhhHHHHHHhhcc-cCceeEEEeeeeecCceEEEEEeccC
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
..+.||+|+||.||+++.. +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++|||+..
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~ 87 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI 87 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC
Confidence 3468999999999999876 68999999987543 234557889999999996 99999999999999999999999874
Q ss_pred CChHHHhhcc-cCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 667 GTLKEHLYGT-LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 667 gsL~~~L~~~-~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
++.++.... ......+++.....++.|+++||+|||+.. +++||||||+||+++.++.+||+|||+++.......
T Consensus 88 -~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 163 (288)
T cd06616 88 -SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA- 163 (288)
T ss_pred -CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc-
Confidence 554433211 112356889999999999999999999742 899999999999999999999999999876543221
Q ss_pred eeeccccCCcccCccccccC---CCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCc
Q 002509 746 VSSIVRGTVGYLDPEYYISQ---QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 822 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~~---~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 822 (914)
.....|+..|+|||.+.+. .++.++|||||||++|||++|+.||.... ...+....... +. .+.
T Consensus 164 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~-~~-----~~~ 230 (288)
T cd06616 164 -KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN------SVFDQLTQVVK-GD-----PPI 230 (288)
T ss_pred -cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc------hHHHHHhhhcC-CC-----CCc
Confidence 1223578999999999765 68899999999999999999999986432 11111111111 11 111
Q ss_pred cCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 823 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 823 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+..........++.+++.+|++.+|++||+++||+++
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2111111233468899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-32 Score=290.25 Aligned_cols=248 Identities=23% Similarity=0.358 Sum_probs=201.4
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
.+.++||+|++|.||+++.+ +++.+++|.+.... ......+.+|++++++++|+||+++++++......++|+||++
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd08530 3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAP 82 (256)
T ss_pred eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcC
Confidence 34578999999999999766 68899999987542 2334567889999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+++|.+++.........+++..++.++.|+++||+|||+. +++|+||+|+||++++++.+||+|||+++.....
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 83 FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred CCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999865443456789999999999999999999998 9999999999999999999999999999766543
Q ss_pred eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCC
Q 002509 746 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 825 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 825 (914)
......++..|++||.+.+..++.++|+||||++++||++|+.||...... .+... ...+....
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~----~~~~~----~~~~~~~~-------- 220 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ----DLRYK----VQRGKYPP-------- 220 (256)
T ss_pred CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHH----HhcCCCCC--------
Confidence 222244788999999999888999999999999999999999999654321 11111 11111111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 826 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 826 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
........+.+++.+|++.+|++||++.|++++
T Consensus 221 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 221 -IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 111233458899999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=292.24 Aligned_cols=246 Identities=24% Similarity=0.345 Sum_probs=204.6
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc--ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEe
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 663 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~ 663 (914)
.|++++.||+|.|+.|-.|++- .|..||||++.+... .....+.+|+..|+.++|||||+|+.+...+...+||+|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 3566789999999999999765 899999999976533 3356788999999999999999999999999999999999
Q ss_pred ccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeC-CCCcEEEeeccccccccCC
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDG 742 (914)
Q Consensus 664 ~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~ 742 (914)
-++|+|.|++-.. ...+.+....+++.||..|+.|+|.. .+|||||||+||.+- +-|-+||.|||++..+.++
T Consensus 99 GD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 99 GDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred cCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999543 55688888899999999999999998 899999999998765 5678999999999777665
Q ss_pred CCceeeccccCCcccCccccccCCCCc-cCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCC
Q 002509 743 ASHVSSIVRGTVGYLDPEYYISQQLTD-KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 821 (914)
Q Consensus 743 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~-ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 821 (914)
.. -+..+|+..|.|||.+.+..|.. +.||||||||||.|++|+.||...+..+.. ..++|-
T Consensus 173 ~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL----------------TmImDC 234 (864)
T KOG4717|consen 173 KK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL----------------TMIMDC 234 (864)
T ss_pred ch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh----------------hhhhcc
Confidence 43 34568999999999999998875 679999999999999999999876644332 223332
Q ss_pred ccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002509 822 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 858 (914)
Q Consensus 822 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 858 (914)
... .+...-.+..+|+..|+..||++|.+.+||+.
T Consensus 235 KYt--vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 235 KYT--VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ccc--CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 221 12334456889999999999999999999875
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=288.36 Aligned_cols=242 Identities=22% Similarity=0.305 Sum_probs=192.9
Q ss_pred ccccCcEEEEEEEEC-CCcEEEEEEEecCCc---ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCCh
Q 002509 594 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 669 (914)
Q Consensus 594 lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 669 (914)
||+|++|.||+++.. +++.+|+|++..... ...+.+.+|++++++++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999886 589999999875432 2346788999999999999999999999999999999999999999
Q ss_pred HHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCceeec
Q 002509 670 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 749 (914)
Q Consensus 670 ~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 749 (914)
.+++... ..+++..+..++.|+++||+|||++ +++|+||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 9999643 3478889999999999999999998 99999999999999999999999999997664432 1223
Q ss_pred cccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccCH
Q 002509 750 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 829 (914)
Q Consensus 750 ~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 829 (914)
..|+..|++||.+....++.++|+||||+++|||++|+.||..... +..+.......... ...++.
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~---------~~~~~~ 217 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-----DPMEIYNDILKGNG---------KLEFPN 217 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-----CHHHHHHHHhccCC---------CCCCCc
Confidence 4578999999999888899999999999999999999999965431 11111111111000 001111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 002509 830 QSMWKIEEKALMCVLPHGHMRPS-----ISEVLK 858 (914)
Q Consensus 830 ~~~~~l~~l~~~C~~~~P~~RPs-----m~eVl~ 858 (914)
.....+.+++.+|++.+|++||+ ++|+++
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 11346889999999999999999 555554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-32 Score=317.81 Aligned_cols=271 Identities=19% Similarity=0.257 Sum_probs=186.7
Q ss_pred HHHHHHhccccccCcEEEEEEEECC--CcEEEEEEEe--------------c---CCcccchhhhHHHHHHhhcccCcee
Q 002509 585 DATKMLEKKIGSGGFGVVYYGKLKD--GKEIAVKVLT--------------S---NSYQGKREFTNEVTLLSRIHHRNLV 645 (914)
Q Consensus 585 ~~~~~~~~~lG~G~~G~Vy~~~~~~--g~~vAVK~l~--------------~---~~~~~~~~f~~E~~~l~~l~HpnIv 645 (914)
...|.+.++||+|+||.||++..+. +...+.|.+. . ........+.+|+++|++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 3456667899999999999987642 2222222110 0 0111234578999999999999999
Q ss_pred EEEeeeeecCceEEEEEeccCCChHHHhhccc-CccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCC
Q 002509 646 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTL-THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 724 (914)
Q Consensus 646 ~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~-~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~ 724 (914)
++++++...+..++|+|++. ++|.+++.... .............++.|++.||+|||++ +|+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence 99999999999999999985 47777764322 1122334556778999999999999998 9999999999999999
Q ss_pred CCcEEEeeccccccccCCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHH
Q 002509 725 HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 804 (914)
Q Consensus 725 ~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~ 804 (914)
++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..++...........+.+
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 99999999999987654433333445699999999999999999999999999999999998754322221111122222
Q ss_pred HHHHhh-hcCCc-------ccccCCccC----CccC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 805 WAKLHI-ESGDI-------QGIIDPSLL----DEYD-----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 805 ~~~~~~-~~~~~-------~~i~d~~l~----~~~~-----~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
...... ..... .+.++.... .... ......+.+++.+|++.||++||++.|++++
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 111100 00000 000000000 0000 0011246677889999999999999999975
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=294.31 Aligned_cols=244 Identities=25% Similarity=0.366 Sum_probs=195.4
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCChH
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK 670 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~ 670 (914)
.+||+|+||.||++..+ +++.||+|.+..........+.+|+.++++++|+|++++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999875 78999999986554445667889999999999999999999999999999999999999999
Q ss_pred HHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCceeecc
Q 002509 671 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 750 (914)
Q Consensus 671 ~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 750 (914)
+++. ...+++.....++.|++.||+|||+. +++||||||+||++++++.++|+|||++....... ......
T Consensus 106 ~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 176 (292)
T cd06657 106 DIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSL 176 (292)
T ss_pred HHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc-cccccc
Confidence 9874 23578899999999999999999998 99999999999999999999999999986553322 112334
Q ss_pred ccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccCHH
Q 002509 751 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQ 830 (914)
Q Consensus 751 ~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 830 (914)
.|+..|+|||.+.+..++.++||||||++++||++|+.||...... .......... .+.+... ..
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~----~~~~~~~~~~---------~~~~~~~--~~ 241 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL----KAMKMIRDNL---------PPKLKNL--HK 241 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhhC---------CcccCCc--cc
Confidence 5889999999998888899999999999999999999998643211 1111111111 1111000 01
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 831 SMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 831 ~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
....+.+++.+|++.+|.+||++.|++++
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 12346788999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=294.12 Aligned_cols=264 Identities=23% Similarity=0.284 Sum_probs=194.9
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc--ccchhhhHHHHHHhhcccCceeEEEeeeeecC--------
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-------- 655 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~-------- 655 (914)
.+.+.+.||+|+||.||+|..+ +|+.||+|+++.... .....+.+|++++++++||||+++++++.+..
T Consensus 8 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~ 87 (302)
T cd07864 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKD 87 (302)
T ss_pred hhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcccc
Confidence 4456689999999999999986 689999999875432 23356778999999999999999999987654
Q ss_pred --ceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeec
Q 002509 656 --RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 733 (914)
Q Consensus 656 --~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 733 (914)
..++|+||+++ ++.+.+... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 88 ~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 88 KGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred CCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCcc
Confidence 78999999986 676666432 34689999999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCCceeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhc
Q 002509 734 GLSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES 812 (914)
Q Consensus 734 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 812 (914)
|++...............++..|+|||.+.+ ..++.++|||||||+++||++|+.||......+....+.+.......
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~- 239 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP- 239 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh-
Confidence 9997664433222223346788999998865 45688999999999999999999999754322211122221111000
Q ss_pred CCcccc--------cCC------ccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 813 GDIQGI--------IDP------SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 813 ~~~~~i--------~d~------~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.....+ .++ ....... .....+.+++.+|++.+|.+||++++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000 000 0000000 113468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=282.43 Aligned_cols=248 Identities=25% Similarity=0.377 Sum_probs=199.7
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc--ccchhhhHHHHHHhhcccCceeEEEeeeeec--CceEEEEEec
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVYEFM 664 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~LV~E~~ 664 (914)
..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++|+||+++++.+... ...++++||+
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 83 (260)
T cd06606 4 RGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYV 83 (260)
T ss_pred eeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEec
Confidence 3468999999999999887 789999999876542 3456788999999999999999999999988 8899999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 744 (914)
++++|.+++... ..+++..++.++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 84 ~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 84 SGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 999999998643 2789999999999999999999998 999999999999999999999999999876654332
Q ss_pred c-eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCcc
Q 002509 745 H-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 823 (914)
Q Consensus 745 ~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 823 (914)
. ......++..|+|||.+.+...+.++||||||++++||++|+.||.... . ..............
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~----~~~~~~~~~~~~~~-------- 222 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG--N----PMAALYKIGSSGEP-------- 222 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--c----hHHHHHhccccCCC--------
Confidence 1 1233458899999999988889999999999999999999999986543 1 11111111100000
Q ss_pred CCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 824 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 824 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
...+......+.+++.+|++.+|++||++.|++++
T Consensus 223 -~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 223 -PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred -cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 11111123468889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=294.65 Aligned_cols=264 Identities=22% Similarity=0.262 Sum_probs=191.1
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc--ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
.+.+.||+|++|.||+|+.+ +++.||+|.+..... .....+.+|++++++++||||+++++++......++||||++
T Consensus 5 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (294)
T PLN00009 5 EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD 84 (294)
T ss_pred EEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc
Confidence 34578999999999999876 789999999865422 234568899999999999999999999999999999999996
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCC-CCcEEEeeccccccccCCCC
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~ 744 (914)
++|.+++... ....+++.....++.|++.||+|||++ +++||||||+||+++. ++.+||+|||++.......
T Consensus 85 -~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~- 157 (294)
T PLN00009 85 -LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV- 157 (294)
T ss_pred -ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-
Confidence 5788877433 223457788889999999999999998 9999999999999985 5679999999987543221
Q ss_pred ceeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcC-----Ccccc
Q 002509 745 HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG-----DIQGI 818 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~-----~~~~i 818 (914)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+....+..+........ .+...
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY 237 (294)
T ss_pred cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence 11122346889999998865 4578899999999999999999999965432211111111110000000 00000
Q ss_pred --cCCccCC----ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 819 --IDPSLLD----EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 819 --~d~~l~~----~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.-+.... ........++.+++.+|++.+|++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 0001112357889999999999999999999874
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=302.68 Aligned_cols=260 Identities=22% Similarity=0.299 Sum_probs=192.1
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecC--CcccchhhhHHHHHHhhcccCceeEEEeeeeec------CceE
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSV 658 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~------~~~~ 658 (914)
+...+.||+|+||.||+++.. +++.||+|.+... .......+.+|+.++++++|+||+++++++... ...+
T Consensus 18 y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 97 (353)
T cd07850 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVY 97 (353)
T ss_pred eEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEE
Confidence 444578999999999999876 7899999998643 222345677899999999999999999988643 3468
Q ss_pred EEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccc
Q 002509 659 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 738 (914)
Q Consensus 659 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 738 (914)
+||||+.+ +|.+.+.. .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 98 lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 98 LVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred EEEeccCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 99999964 88887742 277888899999999999999998 999999999999999999999999999976
Q ss_pred ccCCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHH--------------
Q 002509 739 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ-------------- 804 (914)
Q Consensus 739 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~-------------- 804 (914)
...... .....++..|+|||.+.+..++.++|||||||++++|++|+.||...........+..
T Consensus 168 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 168 AGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred CCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 533221 2234578899999999999999999999999999999999999964432111111110
Q ss_pred -HHHHhhhcC------CcccccCCcc----CCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 805 -WAKLHIESG------DIQGIIDPSL----LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 805 -~~~~~~~~~------~~~~i~d~~l----~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
......... ...+.....+ ...........+.+++.+|++.||++||++.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 0001111111 001111234467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=290.83 Aligned_cols=242 Identities=25% Similarity=0.314 Sum_probs=185.5
Q ss_pred cccccCcEEEEEEEEC-CCcEEEEEEEecCCcc---cchhhhHHHHHHhh---cccCceeEEEeeeeecCceEEEEEecc
Q 002509 593 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSR---IHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 593 ~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~---~~~~f~~E~~~l~~---l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
.||+|+||.||++... +++.+|+|.+...... ....+.+|..++.. .+||||+.+.+++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 6899999998654221 12234445444433 479999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 9999998853 34589999999999999999999998 99999999999999999999999999986543221
Q ss_pred eeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccC
Q 002509 746 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 824 (914)
.....|+..|+|||.+.. ..++.++|||||||+++||++|+.||....... ...+.+. . . ..+..+.
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~---~-~------~~~~~~~ 219 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRM---T-L------TVNVELP 219 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC-HHHHHHH---h-h------cCCcCCc
Confidence 122358999999999864 567899999999999999999999996433211 1111111 0 0 0111111
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002509 825 DEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 859 (914)
Q Consensus 825 ~~~~~~~~~~l~~l~~~C~~~~P~~RP-----sm~eVl~~ 859 (914)
.. ...++.+++.+|++.+|++|| +++|++++
T Consensus 220 ~~----~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 220 DS----FSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cc----cCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 11 223577889999999999999 59999876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-33 Score=283.58 Aligned_cols=248 Identities=22% Similarity=0.363 Sum_probs=202.8
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
.++..+||+|+||.|||+.++ .|..+|+|.+... .+.+++..|+.++++++.|++|+++|.+.....+++|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 345578999999999999776 7999999988654 3467888999999999999999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
|++.+.++.+ .+.|++.++..++...++||+|||.. .-+|||||+.||||+.+|.+||+|||.|-.+.+....
T Consensus 113 GSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK- 185 (502)
T KOG0574|consen 113 GSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK- 185 (502)
T ss_pred CcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHh-
Confidence 9999999754 67799999999999999999999997 7899999999999999999999999999766543322
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCc
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 826 (914)
...+.||+-|||||++..-.|..++||||+|+...||..|++|+.+-..- +.+.. +..+ -.|....
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---RAIFM-----IPT~-----PPPTF~K- 251 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---RAIFM-----IPTK-----PPPTFKK- 251 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc---ceeEe-----ccCC-----CCCCCCC-
Confidence 23456999999999999999999999999999999999999998642210 00000 0100 0111111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 827 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 827 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+.+-..++.+++..|+-..|++|-|+-+++++
T Consensus 252 -PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 252 -PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred -hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 12223468899999999999999999999876
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=288.99 Aligned_cols=245 Identities=26% Similarity=0.359 Sum_probs=195.2
Q ss_pred ccccCcEEEEEEEEC-CCcEEEEEEEecCCc---ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCCh
Q 002509 594 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 669 (914)
Q Consensus 594 lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 669 (914)
||+|+||.||+++.. +|+.+++|++..... .....+.+|++++++++||||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 499999999875533 3355788899999999999999999999999999999999999999
Q ss_pred HHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC-----
Q 002509 670 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS----- 744 (914)
Q Consensus 670 ~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~----- 744 (914)
.+++... ..+++..+..++.|+++||+|||+. +++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9998643 3688999999999999999999998 999999999999999999999999999875433211
Q ss_pred --ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCc
Q 002509 745 --HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 822 (914)
Q Consensus 745 --~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 822 (914)
.......++..|+|||.......+.++||||||++++|+++|+.||..... ..+.... ..+...
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~----~~~~~~~----~~~~~~------ 219 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP----EEIFQNI----LNGKIE------ 219 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH----hcCCcC------
Confidence 122334578899999999888889999999999999999999999865432 1111111 111110
Q ss_pred cCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002509 823 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861 (914)
Q Consensus 823 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 861 (914)
..... .....+.+++.+|++.+|++||++.+|.+.|+
T Consensus 220 ~~~~~--~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 220 WPEDV--EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CCccc--cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00000 01346789999999999999999977766655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=298.78 Aligned_cols=262 Identities=21% Similarity=0.219 Sum_probs=193.1
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCccc--------------chhhhHHHHHHhhcccCceeEEEeeeee
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG--------------KREFTNEVTLLSRIHHRNLVQFLGYCQE 653 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~--------------~~~f~~E~~~l~~l~HpnIv~l~g~~~~ 653 (914)
.+.+.||+|+||.||+|..+ +++.||||.++...... ...+.+|++++++++|+||+++++++..
T Consensus 12 ~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 91 (335)
T PTZ00024 12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE 91 (335)
T ss_pred hhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec
Confidence 34578999999999999876 68999999986542221 1246789999999999999999999999
Q ss_pred cCceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeec
Q 002509 654 EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 733 (914)
Q Consensus 654 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 733 (914)
++..++||||+. |+|.+++.. ...+++.....++.|++.||+|||+. +++||||||+||+++.++.+||+||
T Consensus 92 ~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 92 GDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred CCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCc
Confidence 999999999997 589888843 34588889999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCC-------------CceeeccccCCcccCccccccC-CCCccCceeehHHHHHHHHhCCCCcccccccccc
Q 002509 734 GLSKFAVDGA-------------SHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANC 799 (914)
Q Consensus 734 Gla~~~~~~~-------------~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~ 799 (914)
|+++...... ........++..|+|||.+.+. .++.++|||||||+++||++|+.||......+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9987654110 0111223467889999998764 4688999999999999999999999754422211
Q ss_pred hhHHHHHHHhhhcCCcccc--------cCCccCCc---cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 800 RNIVQWAKLHIESGDIQGI--------IDPSLLDE---YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 800 ~~l~~~~~~~~~~~~~~~i--------~d~~l~~~---~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
..+.......... ..... ........ ........+.+++.+|++.+|++||+++|++.+
T Consensus 244 ~~i~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 244 GRIFELLGTPNED-NWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHhCCCchh-hCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 1222211110000 00000 00000000 001113457899999999999999999999863
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=287.93 Aligned_cols=245 Identities=24% Similarity=0.322 Sum_probs=196.6
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc---ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEec
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
.+.+.||+|+||.||+++.. +++.+|+|++..... ...+.+.+|++++++++||||+++++++.+....++|+||+
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (258)
T cd05578 3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLL 82 (258)
T ss_pred eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCC
Confidence 35578999999999999886 689999999975432 33567889999999999999999999999999999999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 744 (914)
.+++|.+++... ..+++.....++.|+++||.|||++ +++|+||||+||++++++.++|+|||++.......
T Consensus 83 ~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 83 LGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 999999998532 4678889999999999999999998 99999999999999999999999999987654332
Q ss_pred ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccC
Q 002509 745 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 824 (914)
......|+..|+|||.+....++.++|+||||+++|+|++|+.||...... ...+....... ....
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~--~~~~------ 220 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-----IRDQIRAKQET--ADVL------ 220 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-----HHHHHHHHhcc--cccc------
Confidence 223345888999999998888999999999999999999999999754421 11111111110 0000
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCH--HHHH
Q 002509 825 DEYDIQSMWKIEEKALMCVLPHGHMRPSI--SEVL 857 (914)
Q Consensus 825 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm--~eVl 857 (914)
.+......+.+++.+|++.+|.+||++ +|++
T Consensus 221 --~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 221 --YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred --CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 111122467889999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=289.22 Aligned_cols=262 Identities=22% Similarity=0.283 Sum_probs=193.6
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcc--cchhhhHHHHHHhhc---ccCceeEEEeeeeecCc-----eE
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRI---HHRNLVQFLGYCQEEGR-----SV 658 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~f~~E~~~l~~l---~HpnIv~l~g~~~~~~~-----~~ 658 (914)
+.+.||+|+||.||+|+.+ +++.+|+|+++..... ....+.+|+++++++ +|+|++++++++...+. .+
T Consensus 3 ~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 82 (287)
T cd07838 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT 82 (287)
T ss_pred EEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeE
Confidence 4568999999999999987 4899999998754222 234566788777666 59999999999988776 89
Q ss_pred EEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccc
Q 002509 659 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 738 (914)
Q Consensus 659 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 738 (914)
++|||+.+ +|.+++.... ...+++..++.++.|+++||+|||+. +++|+||+|+||+++.++.+||+|||++..
T Consensus 83 l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 83 LVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred EEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence 99999975 8988885432 23589999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCc---
Q 002509 739 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI--- 815 (914)
Q Consensus 739 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~--- 815 (914)
...... .....++..|+|||.+.+..++.++|||||||+++||++|+.||......+....+.+...........
T Consensus 157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 533221 122347889999999998889999999999999999999999987544322222222211000000000
Q ss_pred ---ccccCCccCC---ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 816 ---QGIIDPSLLD---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 816 ---~~i~d~~l~~---~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.......... ....+....+.+++.+|++.+|++||+++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000000000 0011223567789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=296.78 Aligned_cols=264 Identities=24% Similarity=0.343 Sum_probs=193.3
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecC--CcccchhhhHHHHHHhhc-ccCceeEEEeeeeec--CceEEE
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE--GRSVLV 660 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~--~~~~LV 660 (914)
.+.+.+.||+|+||.||+|... +++.+|+|++... .......+..|+.++.++ +||||+++++++... ...++|
T Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv 87 (337)
T cd07852 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLV 87 (337)
T ss_pred HHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEE
Confidence 4556789999999999999876 6889999988542 223345677899999999 999999999998654 357999
Q ss_pred EEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccccc
Q 002509 661 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 740 (914)
Q Consensus 661 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 740 (914)
|||++ ++|.+++.. ..++|..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 88 ~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 88 FEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred ecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 99997 589888743 2678889999999999999999998 99999999999999999999999999997654
Q ss_pred CCCCc----eeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHH-------
Q 002509 741 DGASH----VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL------- 808 (914)
Q Consensus 741 ~~~~~----~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~------- 808 (914)
..... ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 33221 2223458899999998865 45788999999999999999999998653322111111111000
Q ss_pred hhhcCCcccccCC----ccC--CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 809 HIESGDIQGIIDP----SLL--DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 809 ~~~~~~~~~i~d~----~l~--~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.........+++. ... .........++.+++.+|++.+|++||++.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000001100 000 00000123468899999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=280.94 Aligned_cols=245 Identities=25% Similarity=0.432 Sum_probs=198.5
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc--ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
.+.+.||+|++|.||+++.. +++.+++|.+..... .....+.+|++++.+++|+|++++++++..++..++++||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (254)
T cd06627 3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAE 82 (254)
T ss_pred eeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCC
Confidence 34578999999999999876 688999999976543 345678999999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 83 NGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 99999998533 5689999999999999999999998 9999999999999999999999999999766543322
Q ss_pred eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCC
Q 002509 746 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 825 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 825 (914)
.....++..|+|||...+...+.++||||+|++++||++|+.||...... ... |... .... +.+..
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~---~~~--~~~~---~~~~-----~~~~~ 221 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM---AAL--FRIV---QDDH-----PPLPE 221 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH---HHH--HHHh---ccCC-----CCCCC
Confidence 23345789999999998888889999999999999999999998643310 111 1110 1111 11111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002509 826 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 858 (914)
Q Consensus 826 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 858 (914)
.....+.+++.+|+..+|++||++.|++.
T Consensus 222 ----~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 222 ----GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ----CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 11235788999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=292.59 Aligned_cols=264 Identities=22% Similarity=0.255 Sum_probs=192.5
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcc--cchhhhHHHHHHhhcccCceeEEEeeeeec--CceEEEEE
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVYE 662 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~LV~E 662 (914)
+.+.+.||+|+||.||+|... +|+.||+|.++..... ....+.+|++++++++|+||+++++++... +..++|||
T Consensus 9 y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (309)
T cd07845 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVME 88 (309)
T ss_pred eeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEe
Confidence 345578999999999999876 6899999998754322 233567899999999999999999998765 46799999
Q ss_pred eccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCC
Q 002509 663 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 742 (914)
Q Consensus 663 ~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 742 (914)
|+++ +|.+++... ...+++.++..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 89 ~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 89 YCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred cCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9975 788887543 25689999999999999999999998 9999999999999999999999999999765433
Q ss_pred CCceeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHh-------hhcCC
Q 002509 743 ASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH-------IESGD 814 (914)
Q Consensus 743 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~-------~~~~~ 814 (914)
... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+.+..... .....
T Consensus 162 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 162 AKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred cCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 211 122235788999999875 457889999999999999999999997543222222222211000 00000
Q ss_pred ccccc--CCccCCccC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 815 IQGII--DPSLLDEYD---IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 815 ~~~i~--d~~l~~~~~---~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
..... ......... ......+.+++.+|++.||++||+++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000 000000000 0113456789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=320.48 Aligned_cols=265 Identities=26% Similarity=0.429 Sum_probs=209.7
Q ss_pred HHHHHHHHHhccccccCcEEEEEEEEC----C----CcEEEEEEEecCCc-ccchhhhHHHHHHhhc-ccCceeEEEeee
Q 002509 582 DIEDATKMLEKKIGSGGFGVVYYGKLK----D----GKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYC 651 (914)
Q Consensus 582 ei~~~~~~~~~~lG~G~~G~Vy~~~~~----~----g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l-~HpnIv~l~g~~ 651 (914)
|+......+.+.||+|.||.|++|... . ...||||+++.... ...+.+..|+++|+.+ +|+||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 333333356679999999999999754 1 45699999986533 4567899999999999 699999999999
Q ss_pred eecCceEEEEEeccCCChHHHhhccc----------Ccc--ccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCc
Q 002509 652 QEEGRSVLVYEFMHNGTLKEHLYGTL----------THE--QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN 719 (914)
Q Consensus 652 ~~~~~~~LV~E~~~~gsL~~~L~~~~----------~~~--~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~N 719 (914)
.+++..++|.||+..|+|.++|+... ... ..+.....+.++.|||.|++||++. +++||||.++|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhhh
Confidence 99999999999999999999997654 011 2388899999999999999999998 99999999999
Q ss_pred eEeCCCCcEEEeeccccccccCCCCceeecccc--CCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCccccccc
Q 002509 720 ILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--TVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFG 796 (914)
Q Consensus 720 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~g--t~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~ 796 (914)
||+.++..+||+|||+++...+..........| ...|||||.+....++.|+|||||||+||||+| |..|+.+...
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~- 527 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP- 527 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-
Confidence 999999999999999998765544443332223 456999999999999999999999999999999 7788764221
Q ss_pred ccchhHHHHHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHh
Q 002509 797 ANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 797 ~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 865 (914)
...+.++ +++|...+ .+..+..++.+++..|++.+|++||+..|+++.|+..+.
T Consensus 528 --~~~l~~~----l~~G~r~~---------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 528 --TEELLEF----LKEGNRME---------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred --HHHHHHH----HhcCCCCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 1233332 33332211 122223467899999999999999999999999998543
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=298.54 Aligned_cols=247 Identities=24% Similarity=0.369 Sum_probs=198.6
Q ss_pred hccccccCcEEEEEEEECCCcE-EEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCCh
Q 002509 591 EKKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 669 (914)
Q Consensus 591 ~~~lG~G~~G~Vy~~~~~~g~~-vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 669 (914)
.-.||.|+||.||+|..++... .|-|++...+......|.-|+++|..+.||+||+|++.+.-++.++++.|||.||-+
T Consensus 37 iGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAV 116 (1187)
T KOG0579|consen 37 IGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAV 116 (1187)
T ss_pred HhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchH
Confidence 3468999999999998875443 467888777777788899999999999999999999999999999999999999998
Q ss_pred HHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCceeec
Q 002509 670 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 749 (914)
Q Consensus 670 ~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 749 (914)
...+-. -+..|...++.-+++|++.||.|||++ .|||||||+.|||++-+|.++|+|||.+...... ......
T Consensus 117 DaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qkRDs 189 (1187)
T KOG0579|consen 117 DAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQKRDS 189 (1187)
T ss_pred hHHHHH---hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH-Hhhhcc
Confidence 887743 366789999999999999999999999 9999999999999999999999999997543221 222345
Q ss_pred cccCCcccCcccccc-----CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccC
Q 002509 750 VRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824 (914)
Q Consensus 750 ~~gt~~Y~aPE~~~~-----~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 824 (914)
+.||+.|||||+..+ .+|..++||||||+.|.||..+.+|-..... .+.++..++ .+...++.|.
T Consensus 190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp---MRVllKiaK-----SePPTLlqPS-- 259 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIAK-----SEPPTLLQPS-- 259 (1187)
T ss_pred ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch---HHHHHHHhh-----cCCCcccCcc--
Confidence 679999999999864 5799999999999999999999998654331 122333222 1122222222
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 825 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 825 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.-...+-++..+|+..+|..||++.+++++
T Consensus 260 -----~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 260 -----HWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -----hhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 222357788999999999999999999865
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=302.62 Aligned_cols=259 Identities=23% Similarity=0.313 Sum_probs=191.2
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC-cccchhhhHHHHHHhhcccCceeEEEeeeeecC-----ceEEE
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-----RSVLV 660 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~-----~~~LV 660 (914)
+.+.++||+|+||.||+|+.. +|+.||+|.+.... ......+.+|++++++++|+||+++++++.... ..++|
T Consensus 7 y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 86 (336)
T cd07849 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIV 86 (336)
T ss_pred eEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEE
Confidence 345678999999999999865 78999999986432 223456788999999999999999999876543 47899
Q ss_pred EEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccccc
Q 002509 661 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 740 (914)
Q Consensus 661 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 740 (914)
+||+++ +|.+.+. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 87 ~e~~~~-~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 87 QELMET-DLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred ehhccc-CHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 999975 7877764 34588999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCc--eeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcC---C
Q 002509 741 DGASH--VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG---D 814 (914)
Q Consensus 741 ~~~~~--~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~---~ 814 (914)
..... ......|+..|+|||.+.+ ..++.++|||||||+++||++|+.||....... ............ .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~----~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH----QLNLILGVLGTPSQED 233 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHcCCCCHHH
Confidence 32221 1123458899999998754 568899999999999999999999996533211 111111101000 0
Q ss_pred cccccCCcc---------CCccC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 815 IQGIIDPSL---------LDEYD-----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 815 ~~~i~d~~l---------~~~~~-----~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
...+.+... ....+ .....++.+++.+|++.+|++||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000010000 00000 0113457899999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=285.24 Aligned_cols=244 Identities=23% Similarity=0.284 Sum_probs=187.1
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCCcc---cchhhhHHHHHH-hhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLL-SRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~---~~~~f~~E~~~l-~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
+.||+|+||.||+|+.. +++.||+|+++..... ....+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999875 6899999998654321 122344454444 445899999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
++|.+++... ..+++..+..++.|+++||.|||+. +++||||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 9999998532 3578888999999999999999998 999999999999999999999999999875432
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCc
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 826 (914)
.....|+..|+|||.+.+..++.++||||||++++||++|..||...... .+..- ...+... .......
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~----~~~~~~~--~~~~~~~- 218 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD----AVFDN----ILSRRIN--WPEEVKE- 218 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH----HHHHH----HHhcccC--CCCcccc-
Confidence 22335788999999998888899999999999999999999999643321 11111 1111110 0001111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002509 827 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861 (914)
Q Consensus 827 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 861 (914)
.....+.+++.+|++.+|++||++.++.+.|+
T Consensus 219 ---~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 219 ---FCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ---cCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 12245889999999999999998876655444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=288.05 Aligned_cols=262 Identities=21% Similarity=0.276 Sum_probs=194.7
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc-ccchhhhHHHHHHhhcc-cCceeEEEeeeeecCceEEEEEeccC
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
+.+.||+|++|.||+|+.. +++.|++|.+..... .......+|+..+.+++ |+|++++++++..++..++||||+ +
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 81 (283)
T cd07830 3 VIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-E 81 (283)
T ss_pred eheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-C
Confidence 4578999999999999986 578899999865432 22334567899999998 999999999999999999999999 8
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
|+|.+++.... ...+++..++.++.|++.+|.|||++ +++|+||+|+||+++.++.++|+|||+++........
T Consensus 82 ~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (283)
T cd07830 82 GNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY- 155 (283)
T ss_pred CCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc-
Confidence 89999886542 35689999999999999999999998 9999999999999999999999999998765432221
Q ss_pred eeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHH---------HHHHhhhcCCcc
Q 002509 747 SSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ---------WAKLHIESGDIQ 816 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~---------~~~~~~~~~~~~ 816 (914)
....++..|+|||.+.. ..++.++|+||||++++||++|+.||......+....+.. |...........
T Consensus 156 -~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 156 -TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred -CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 22347889999998854 4578999999999999999999999865432211111111 111000000000
Q ss_pred cccCCccC---CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 817 GIIDPSLL---DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 817 ~i~d~~l~---~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
..+..... ..........+.+++.+|++.+|++||+++|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000 00000113468899999999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=291.52 Aligned_cols=264 Identities=20% Similarity=0.252 Sum_probs=190.0
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcc--cchhhhHHHHHHhhcccCceeEEEeeeeecC--------c
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEG--------R 656 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~--------~ 656 (914)
+.+.++||+|+||.||+|+.. +++.||||.+...... ....+.+|++++++++||||++++++|.... .
T Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 93 (310)
T cd07865 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS 93 (310)
T ss_pred eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence 445678999999999999876 6899999998654322 2335678999999999999999999987654 3
Q ss_pred eEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccc
Q 002509 657 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 736 (914)
Q Consensus 657 ~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 736 (914)
.++||||+.+ +|.+.+... ...+++.+.+.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++
T Consensus 94 ~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 94 FYLVFEFCEH-DLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred EEEEEcCCCc-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 4999999975 787777432 33689999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCc---eeeccccCCcccCccccccC-CCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhc
Q 002509 737 KFAVDGASH---VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES 812 (914)
Q Consensus 737 ~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 812 (914)
......... ......++..|+|||.+.+. .++.++||||||++++||++|+.||......... ............
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~-~~~~~~~~~~~~ 245 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQL-TLISQLCGSITP 245 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCh
Confidence 765432211 11233478899999988764 4688999999999999999999998654321111 111111100000
Q ss_pred CCccc-----ccCC-ccCCcc---CH------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 813 GDIQG-----IIDP-SLLDEY---DI------QSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 813 ~~~~~-----i~d~-~l~~~~---~~------~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
..... ..+. .+.... .. .....+.+++.+|++.+|++||+++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00000 0000 000000 00 011346789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=291.24 Aligned_cols=248 Identities=25% Similarity=0.384 Sum_probs=193.1
Q ss_pred HHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEE
Q 002509 585 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 660 (914)
Q Consensus 585 ~~~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV 660 (914)
..++...+.||+|++|.||+|+.. +++.+|+|.+.... ......+.+|+++++.++|+|++++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 344555678999999999999876 67889999886432 22235678899999999999999999999999999999
Q ss_pred EEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccccc
Q 002509 661 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 740 (914)
Q Consensus 661 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 740 (914)
|||+. |++.+.+... ...+++.++..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 94 ~e~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 94 MEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EEccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 99997 6887776432 34578899999999999999999998 99999999999999999999999999987653
Q ss_pred CCCCceeeccccCCcccCccccc---cCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCccc
Q 002509 741 DGASHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 817 (914)
Q Consensus 741 ~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 817 (914)
.. ....|+..|+|||.+. ...++.++|||||||++|||++|+.|+...... ..+..+. .+..
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~-----~~~~-- 231 (308)
T cd06634 167 PA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHIA-----QNES-- 231 (308)
T ss_pred Cc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH---HHHHHHh-----hcCC--
Confidence 32 2235788999999975 356788999999999999999999998643211 1111111 1111
Q ss_pred ccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002509 818 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 860 (914)
Q Consensus 818 i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L 860 (914)
+... .......+.+++.+|++.+|++||++++|+++-
T Consensus 232 ---~~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 232 ---PALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred ---CCcC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 1111 111223578899999999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=290.06 Aligned_cols=261 Identities=21% Similarity=0.266 Sum_probs=196.6
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc--ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
+.+.||+|++|.||++... +++.+++|.++.... .....+..|++++++++|+||+++++++..+...++|+||+++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 82 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT 82 (283)
T ss_pred cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC
Confidence 3467999999999999876 788999999875432 2346788899999999999999999999999999999999975
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
+|.+++... ...+++..++.++.|+++||+|||+. +++|+||||+||+++.++.+||+|||.+....... ..
T Consensus 83 -~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 83 -DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred -CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 888887543 25689999999999999999999998 99999999999999999999999999987664433 11
Q ss_pred eeccccCCcccCccccccC-CCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccC-----
Q 002509 747 SSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID----- 820 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d----- 820 (914)
.....++..|+|||.+.+. .++.++||||||+++++|++|+.||......+....+.+..... .........+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 233 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTP-DPEVWPKFTSLARNY 233 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC-chHhcccchhhhhhh
Confidence 2223478899999998876 78899999999999999999999986543211111111100000 0000000000
Q ss_pred -CccC-------CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 821 -PSLL-------DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 821 -~~l~-------~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.... .........++.+++..|++.+|.+||+++|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000 00111234578899999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=292.03 Aligned_cols=253 Identities=27% Similarity=0.364 Sum_probs=200.5
Q ss_pred HHHHHHHhccccccCcEEEEEEEECCCcEEEEEEEecC--CcccchhhhHHHHHHhhc-ccCceeEEEeeeeecCceEEE
Q 002509 584 EDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSN--SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLV 660 (914)
Q Consensus 584 ~~~~~~~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV 660 (914)
....|.+.++||+||.+.||++...+.+.+|+|.+... +......|.+|++.|.++ .|.+||+|++|-..++..++|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 44556777899999999999999988888888876543 334456799999999999 599999999999999999999
Q ss_pred EEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccccc
Q 002509 661 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 740 (914)
Q Consensus 661 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 740 (914)
|||-+ .+|...|.... .....| .+..+..|++.++.++|.+ +|||.||||.|+|+-. |.+||+|||+|..+.
T Consensus 439 mE~Gd-~DL~kiL~k~~--~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 439 MECGD-IDLNKILKKKK--SIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred eeccc-ccHHHHHHhcc--CCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 99754 48999986542 222335 6778999999999999999 9999999999999854 689999999998776
Q ss_pred CCCCc-eeeccccCCcccCccccccC-----------CCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHH
Q 002509 741 DGASH-VSSIVRGTVGYLDPEYYISQ-----------QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL 808 (914)
Q Consensus 741 ~~~~~-~~~~~~gt~~Y~aPE~~~~~-----------~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~ 808 (914)
..... .....+||+.||+||.+... +.+.++||||+|||||+|+.|+.||..-. -.|.
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--------n~~a-- 580 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--------NQIA-- 580 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--------HHHH--
Confidence 54443 34556899999999999643 25678999999999999999999985311 1232
Q ss_pred hhhcCCcccccCCccCCccC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 809 HIESGDIQGIIDPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 809 ~~~~~~~~~i~d~~l~~~~~-~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
++..+.||.-.-+++ ....+++++++..|++.||++||+..|++++
T Consensus 581 -----Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 -----KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -----HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 244556664322222 2233448999999999999999999999986
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=292.00 Aligned_cols=261 Identities=19% Similarity=0.264 Sum_probs=191.9
Q ss_pred HhccccccCcEEEEEEEECCCcEEEEEEEecC--CcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCC
Q 002509 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 667 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 667 (914)
+.+.+|.|+++.||+++. +++.||||+++.. .......+..|++++++++|+||+++++++...+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 444556666666666655 6899999998754 2334567899999999999999999999999999999999999999
Q ss_pred ChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC---
Q 002509 668 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS--- 744 (914)
Q Consensus 668 sL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~--- 744 (914)
+|.+++.... ...+++.....++.|+++||+|||++ +|+||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 85 SCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 9999996542 33578888899999999999999998 999999999999999999999999998865432211
Q ss_pred ---ceeeccccCCcccCcccccc--CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhh----hcC--
Q 002509 745 ---HVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI----ESG-- 813 (914)
Q Consensus 745 ---~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~----~~~-- 813 (914)
.......++..|+|||.+.. ..++.++|||||||++|||++|+.||...... ..+.+...... ...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT---QMLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhccCccccccCch
Confidence 11122346788999999875 35788999999999999999999999753311 11111111000 000
Q ss_pred -----Cccc----ccCCccCC----ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 814 -----DIQG----IIDPSLLD----EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 814 -----~~~~----i~d~~l~~----~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.... ..++.... .........+.+++.+|++.+|++||+++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 00111100 0111223467889999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=289.40 Aligned_cols=253 Identities=22% Similarity=0.289 Sum_probs=196.6
Q ss_pred HhccccccCcEEEEEEEEC----CCcEEEEEEEecCC----cccchhhhHHHHHHhhc-ccCceeEEEeeeeecCceEEE
Q 002509 590 LEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS----YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLV 660 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~----~g~~vAVK~l~~~~----~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV 660 (914)
+.+.||+|++|.||+++.. +++.||||+++... ......+.+|++++.++ +||||+++++.+......++|
T Consensus 4 ~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 83 (288)
T cd05583 4 LLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLI 83 (288)
T ss_pred EEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEE
Confidence 4578999999999998743 57889999987532 12345678899999999 599999999999988999999
Q ss_pred EEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccccc
Q 002509 661 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 740 (914)
Q Consensus 661 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 740 (914)
|||+++|+|.+++.. ...+++.....++.|+++||+|||+. +++||||||+||+++.++.++|+|||+++...
T Consensus 84 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 84 LDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 999999999998853 34578889999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCceeeccccCCcccCccccccCC--CCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccc
Q 002509 741 DGASHVSSIVRGTVGYLDPEYYISQQ--LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 818 (914)
Q Consensus 741 ~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i 818 (914)
...........|+..|+|||.+.+.. .+.++||||||++++||++|..||....... ............
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~------ 227 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN---SQSEISRRILKS------ 227 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc---hHHHHHHHHHcc------
Confidence 43332233345889999999987654 7889999999999999999999986432111 111111111111
Q ss_pred cCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 002509 819 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 863 (914)
Q Consensus 819 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 863 (914)
++...... ...+.+++.+|++.+|++|||+++|.+.|+..
T Consensus 228 -~~~~~~~~----~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 -KPPFPKTM----SAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred -CCCCCccc----CHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 01111111 23477889999999999999999998877654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=288.56 Aligned_cols=249 Identities=24% Similarity=0.326 Sum_probs=192.6
Q ss_pred HhccccccCcEEEEEEEE----CCCcEEEEEEEecCCc----ccchhhhHHHHHHhhc-ccCceeEEEeeeeecCceEEE
Q 002509 590 LEKKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNSY----QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLV 660 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~----~~g~~vAVK~l~~~~~----~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV 660 (914)
+.+.||+|+||.||+++. .+|+.||+|+++.... ...+.+.+|++++.++ +|+||+++++++..+...++|
T Consensus 4 ~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (290)
T cd05613 4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLI 83 (290)
T ss_pred eeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEE
Confidence 457899999999999976 3689999999875422 2245678899999999 699999999999998899999
Q ss_pred EEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccccc
Q 002509 661 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 740 (914)
Q Consensus 661 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 740 (914)
+||+++++|.+++.. ...+++.....++.|+++||+|||+. +++||||||+|||+++++.+||+|||+++...
T Consensus 84 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 84 LDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 999999999999853 34577888889999999999999998 99999999999999999999999999987654
Q ss_pred CCCCceeeccccCCcccCccccccC--CCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccc
Q 002509 741 DGASHVSSIVRGTVGYLDPEYYISQ--QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 818 (914)
Q Consensus 741 ~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i 818 (914)
...........|+..|+|||.+... .++.++||||||+++|||++|+.||...........+.+ ......
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~---~~~~~~----- 228 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR---RILKSE----- 228 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH---HhhccC-----
Confidence 3322222334588999999998753 467899999999999999999999864322111112211 111110
Q ss_pred cCCccCCccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002509 819 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 859 (914)
Q Consensus 819 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----sm~eVl~~ 859 (914)
+.. +......+.+++.+|++.+|++|| ++++++++
T Consensus 229 --~~~----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 --PPY----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred --CCC----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 111 111223577899999999999997 67777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=289.36 Aligned_cols=247 Identities=27% Similarity=0.375 Sum_probs=197.2
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCC
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 667 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 667 (914)
++||+|+||.||..+.+ +|+-+|.|.+.+.. ..++....+|-++|.+++.+.||.+--.++.++.+|||+..|.||
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG 270 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG 270 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence 68999999999999776 69999999886553 334556788999999999999999999999999999999999999
Q ss_pred ChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCcee
Q 002509 668 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 747 (914)
Q Consensus 668 sL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 747 (914)
+|.-||+... ...+++.....++.+|+.||+|||+. +||.||+||+|||||++|+++|+|.|||..+..+.....
T Consensus 271 DLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~ 345 (591)
T KOG0986|consen 271 DLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRG 345 (591)
T ss_pred ceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCcccc
Confidence 9999997653 46789999999999999999999999 999999999999999999999999999998876655443
Q ss_pred eccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCcc
Q 002509 748 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 827 (914)
Q Consensus 748 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 827 (914)
.+||.+|||||++....|+...|-||+||+||||+.|+.||...+.......+-+.+.. |+ .++
T Consensus 346 --rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~-----------~~---~ey 409 (591)
T KOG0986|consen 346 --RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE-----------DP---EEY 409 (591)
T ss_pred --ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc-----------ch---hhc
Confidence 47999999999999999999999999999999999999999654422111111111110 00 112
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002509 828 DIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 859 (914)
Q Consensus 828 ~~~~~~~l~~l~~~C~~~~P~~RP-----sm~eVl~~ 859 (914)
+....++...+....++.||++|- .+++|.++
T Consensus 410 ~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 410 SDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred ccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 222223455666677888998885 35566544
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=297.62 Aligned_cols=263 Identities=24% Similarity=0.309 Sum_probs=198.0
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeeecC-----ceEEE
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-----RSVLV 660 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~-----~~~LV 660 (914)
.+.+.||+|++|.||+|+.. +++.+|+|++.... ....+.+.+|+++++.++|+||+++++++.... ..++|
T Consensus 3 ~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 82 (330)
T cd07834 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIV 82 (330)
T ss_pred eeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEE
Confidence 45678999999999999876 58999999987643 334567889999999999999999999988765 78999
Q ss_pred EEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccccc
Q 002509 661 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 740 (914)
Q Consensus 661 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 740 (914)
|||+++ +|.+++.. ...+++..++.++.|+++||+|||+. +|+||||||+|||++.++.++|+|||++....
T Consensus 83 ~e~~~~-~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 83 TELMET-DLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred ecchhh-hHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 999984 78888753 23789999999999999999999998 99999999999999999999999999998665
Q ss_pred CCCC--ceeeccccCCcccCccccccC-CCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhh------
Q 002509 741 DGAS--HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE------ 811 (914)
Q Consensus 741 ~~~~--~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~------ 811 (914)
.... .......++..|+|||.+.+. .++.++||||||+++++|++|+.||......+....+.........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 4321 112234578899999999887 7899999999999999999999999754422211111111100000
Q ss_pred -cCCcccccCC-ccCCc-----cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 812 -SGDIQGIIDP-SLLDE-----YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 812 -~~~~~~i~d~-~l~~~-----~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.....+.+.. ..... ........+.+++.+|++.+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000000000 00000 001123457899999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=285.89 Aligned_cols=250 Identities=27% Similarity=0.402 Sum_probs=194.5
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC-----cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEE
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-----YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 661 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~-----~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 661 (914)
+.+.+.||+|+||.||+++.. .+..+++|+++... ......+..|+.++++++||||+++++++.+....++||
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 345678999999999999876 34556677665422 122345677899999999999999999999999999999
Q ss_pred EeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccC
Q 002509 662 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 741 (914)
Q Consensus 662 E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 741 (914)
||+++++|.+++.........+++..++.++.|+++||.|||+. +++|+||||+||+++. +.+||+|||+++....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999999999865444456799999999999999999999998 9999999999999975 5699999999876543
Q ss_pred CCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCC
Q 002509 742 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 821 (914)
Q Consensus 742 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 821 (914)
... ......|+..|+|||...+..++.++|+||||+++|+|++|..||..... ........ .+. .+
T Consensus 158 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-------~~~~~~~~-~~~-----~~ 223 (260)
T cd08222 158 SCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-------LSVVLRIV-EGP-----TP 223 (260)
T ss_pred Ccc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHH-cCC-----CC
Confidence 322 22234578899999999888889999999999999999999999864321 11111111 111 11
Q ss_pred ccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 822 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 822 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.+ +......+.+++.+|++.+|++||++.|++++
T Consensus 224 ~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 224 SL----PETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CC----cchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 11 11223467889999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=287.15 Aligned_cols=261 Identities=24% Similarity=0.273 Sum_probs=196.3
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCC
Q 002509 591 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 667 (914)
Q Consensus 591 ~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 667 (914)
.+.||+|++|.||+|+.. +++.+|+|++.... ....+.+..|++++++++|+|++++++++...+..++|+||++ +
T Consensus 4 ~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~ 82 (282)
T cd07829 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-M 82 (282)
T ss_pred ehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-c
Confidence 467999999999999887 58999999987653 2334567889999999999999999999999999999999998 5
Q ss_pred ChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCcee
Q 002509 668 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 747 (914)
Q Consensus 668 sL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 747 (914)
+|.+++.... ..+++..++.++.|+++||+|||+. +|+||||+|+||++++++.+||+|||+++........ .
T Consensus 83 ~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~ 155 (282)
T cd07829 83 DLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-Y 155 (282)
T ss_pred CHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc-c
Confidence 8999986431 4688999999999999999999998 9999999999999999999999999998765433221 1
Q ss_pred eccccCCcccCccccccC-CCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhc-----CCc---ccc
Q 002509 748 SIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES-----GDI---QGI 818 (914)
Q Consensus 748 ~~~~gt~~Y~aPE~~~~~-~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~-----~~~---~~i 818 (914)
....++..|+|||.+.+. .++.++|||||||+++||++|+.||......+....+.+........ ... ...
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT 235 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence 223357789999998766 78899999999999999999999986544222111221111100000 000 000
Q ss_pred cCCccCC---ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 819 IDPSLLD---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 819 ~d~~l~~---~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
....... .........+.+++.+|++.+|++||+++||+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000000 0000113468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=287.80 Aligned_cols=241 Identities=25% Similarity=0.409 Sum_probs=189.4
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEEecCCcc---cchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 591 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 591 ~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~---~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
.+.||+|+||.||+|+.. +++.|++|++...... ....+.+|++++++++|||++++++++.+....++||||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 457999999999999875 6889999998754322 23467889999999999999999999999999999999996
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
|++.+.+... ...+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 105 ~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 105 GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 5777776432 34588999999999999999999998 999999999999999999999999999864322
Q ss_pred eeccccCCcccCccccc---cCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCcc
Q 002509 747 SSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 823 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~---~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 823 (914)
.....|+..|+|||++. ...++.++|||||||++|||++|..|+...... ...... .. ........
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~----~~~~~~---~~-~~~~~~~~--- 242 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYHI---AQ-NDSPTLQS--- 242 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHH---Hh-cCCCCCCc---
Confidence 12345889999999984 456888999999999999999999998654311 111111 11 11111111
Q ss_pred CCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 824 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 824 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
. .....+.+++.+|++.+|++||++.+++++
T Consensus 243 -~----~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 243 -N----EWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -c----ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 112347789999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=297.92 Aligned_cols=262 Identities=21% Similarity=0.298 Sum_probs=192.6
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecC--CcccchhhhHHHHHHhhcccCceeEEEeeeeec-----CceEE
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSVL 659 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~-----~~~~L 659 (914)
+.+.+.||+|+||+||+++.. +++.||||.++.. .......+.+|+.++++++|+||+++++++... ...++
T Consensus 7 y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 86 (337)
T cd07858 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYI 86 (337)
T ss_pred eeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEE
Confidence 334568999999999999875 6899999998753 222345677899999999999999999988654 34799
Q ss_pred EEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccc
Q 002509 660 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 739 (914)
Q Consensus 660 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 739 (914)
|+||+. ++|.+++.. ...+++.....++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 87 v~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 87 VYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 999996 688888743 34688999999999999999999998 9999999999999999999999999999765
Q ss_pred cCCCCceeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhh-------h
Q 002509 740 VDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI-------E 811 (914)
Q Consensus 740 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~-------~ 811 (914)
.... .......++..|+|||.+.. ..++.++|||||||+++||++|+.||...........+.+...... .
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 159 SEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred CCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 4322 12223457889999998865 4688999999999999999999999965432111111111100000 0
Q ss_pred cCCccc-------ccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 812 SGDIQG-------IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 812 ~~~~~~-------i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
...... ..++.... .......++.+++.+|++.+|++||+++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred chhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000000 00000000 001123457899999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=289.92 Aligned_cols=256 Identities=19% Similarity=0.237 Sum_probs=179.4
Q ss_pred HHHHHhccccccCcEEEEEEEECC----CcEEEEEEEecCCcccc-----------hhhhHHHHHHhhcccCceeEEEee
Q 002509 586 ATKMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSYQGK-----------REFTNEVTLLSRIHHRNLVQFLGY 650 (914)
Q Consensus 586 ~~~~~~~~lG~G~~G~Vy~~~~~~----g~~vAVK~l~~~~~~~~-----------~~f~~E~~~l~~l~HpnIv~l~g~ 650 (914)
..+.+.++||+|+||.||+|...+ +..+|+|+......... .....+...+..+.|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 445677899999999999998764 34566665432221110 011223344556689999999997
Q ss_pred eeecC----ceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCC
Q 002509 651 CQEEG----RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 726 (914)
Q Consensus 651 ~~~~~----~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~ 726 (914)
+.... ..++++|++.. ++.+.+.. ....++..+..++.|+++||+|||+. +|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence 76543 23567776543 55555532 12346777889999999999999998 999999999999999999
Q ss_pred cEEEeeccccccccCCCCc------eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccch
Q 002509 727 RAKVSDFGLSKFAVDGASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR 800 (914)
Q Consensus 727 ~~kl~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~ 800 (914)
.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||+++||++|+.||..........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 9999999999765432211 1123469999999999999999999999999999999999999997653211111
Q ss_pred hH--HHHHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002509 801 NI--VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861 (914)
Q Consensus 801 ~l--~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 861 (914)
.. .++.. .+..+... . . .....+.+++..|++.+|++||++.++++.|+
T Consensus 244 ~~~~~~~~~-~~~~~~~~------~-~----~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 244 HAAKCDFIK-RLHEGKIK------I-K----NANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHhHHHHHH-Hhhhhhhc------c-C----CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11 11111 11111110 0 0 11245888999999999999999999998763
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=292.00 Aligned_cols=265 Identities=20% Similarity=0.270 Sum_probs=190.4
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcc--cchhhhHHHHHHhhcccCceeEEEeeeeecC--------c
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEG--------R 656 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~--------~ 656 (914)
+.+.++||+|++|.||+|+.+ +++.+|+|++...... ....+.+|++++++++||||+++++++.... .
T Consensus 10 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 89 (311)
T cd07866 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGS 89 (311)
T ss_pred EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCce
Confidence 345578999999999999876 6899999998654322 2345778999999999999999999875433 4
Q ss_pred eEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccc
Q 002509 657 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 736 (914)
Q Consensus 657 ~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 736 (914)
.++|+||+.. +|.+.+... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 90 ~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 90 VYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred EEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccc
Confidence 5899999975 676666432 34689999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCc----------eeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHH
Q 002509 737 KFAVDGASH----------VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW 805 (914)
Q Consensus 737 ~~~~~~~~~----------~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~ 805 (914)
+........ ......++..|+|||.+.+ ..++.++|||||||+++||++|+.||...........+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 754332111 1122356888999998865 45789999999999999999999998654322111111111
Q ss_pred HHHhhhc-----CCcccccCCccCCccC-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 806 AKLHIES-----GDIQGIIDPSLLDEYD-------IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 806 ~~~~~~~-----~~~~~i~d~~l~~~~~-------~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
....... ..+....+.......+ ......+.+++.+|++.+|++||++.|++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 1000000 0000000000000000 0112467899999999999999999998763
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=299.58 Aligned_cols=197 Identities=29% Similarity=0.505 Sum_probs=169.8
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEEecCCc-ccchhhhHHHHHHhhcccCceeEEEeeeeecC------ceEEEEE
Q 002509 591 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RSVLVYE 662 (914)
Q Consensus 591 ~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~------~~~LV~E 662 (914)
.+.||+|+||.||+|+.+ .|+.||||.++.... ...+....|+++|++++|+|||++++.-.+.. ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 357999999999999965 799999999987543 33456778999999999999999999765543 5689999
Q ss_pred eccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeC--CCC--cEEEeecccccc
Q 002509 663 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD--KHM--RAKVSDFGLSKF 738 (914)
Q Consensus 663 ~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~--~~~--~~kl~DFGla~~ 738 (914)
||.+|+|...|.... ....|++.+.+.+..+++.||.|||++ +|+||||||.||++- ++| .-||+|||.|+.
T Consensus 98 yC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred ecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 999999999997653 456799999999999999999999998 999999999999984 334 479999999998
Q ss_pred ccCCCCceeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccc
Q 002509 739 AVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNE 793 (914)
Q Consensus 739 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~ 793 (914)
..++. ....++||..|++||++.. +.|+..+|.|||||++||+.||..||...
T Consensus 174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 76554 5566789999999999984 88999999999999999999999999643
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=282.07 Aligned_cols=247 Identities=24% Similarity=0.361 Sum_probs=190.9
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC-----cccchhhhHHHHHHhhcccCceeEEEeeeeec--CceEEE
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-----YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLV 660 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~-----~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~LV 660 (914)
.+.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++|+||+++++++... ...+++
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (264)
T cd06653 5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIF 84 (264)
T ss_pred eeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEE
Confidence 45678999999999999875 68999999875321 12235688899999999999999999998664 457899
Q ss_pred EEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccccc
Q 002509 661 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 740 (914)
Q Consensus 661 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 740 (914)
+||+++++|.+++... ..+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++...
T Consensus 85 ~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 85 VEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEeCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 9999999999998532 3478888999999999999999998 99999999999999999999999999987543
Q ss_pred CCC--CceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccc
Q 002509 741 DGA--SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 818 (914)
Q Consensus 741 ~~~--~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i 818 (914)
... ........|+..|+|||++.+..++.++|||||||+++||++|+.||..... ...+.+. ...+ ..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~----~~~~-~~-- 227 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA---MAAIFKI----ATQP-TK-- 227 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH---HHHHHHH----HcCC-CC--
Confidence 211 1111234588999999999988889999999999999999999999964321 1111111 1111 11
Q ss_pred cCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 819 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 819 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+.+ +......+.+++.+|++ +|.+||+..+++.+
T Consensus 228 --~~~----p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 228 --PML----PDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred --CCC----CcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 111 11222457888999999 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=282.98 Aligned_cols=242 Identities=25% Similarity=0.327 Sum_probs=185.9
Q ss_pred cccccCcEEEEEEEEC-CCcEEEEEEEecCCcc---cchhhhHHHHH---HhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 593 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTL---LSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 593 ~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~---~~~~f~~E~~~---l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
.||+|+||.||++... +++.||+|.+...... ....+..|..+ ++...||||+++.+++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 6889999998754322 12234444443 444579999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+|+|.+++.. ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~- 152 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence 9999988853 34689999999999999999999998 999999999999999999999999999875533221
Q ss_pred eeeccccCCcccCccccccC-CCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccC
Q 002509 746 VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~~-~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 824 (914)
....|+..|+|||.+.++ .++.++||||+||+++||++|+.||........ ..+ .. .... .++.+.
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-~~~-~~---~~~~------~~~~~~ 219 (278)
T cd05606 153 --HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEI-DR---MTLT------MAVELP 219 (278)
T ss_pred --cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-HHH-HH---Hhhc------cCCCCC
Confidence 234589999999999754 688999999999999999999999975432111 011 00 0000 111111
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002509 825 DEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 859 (914)
Q Consensus 825 ~~~~~~~~~~l~~l~~~C~~~~P~~RP-----sm~eVl~~ 859 (914)
... ...+.+++.+|+..+|.+|| ++.|++++
T Consensus 220 ~~~----s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 220 DSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CcC----CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 111 23588889999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=295.93 Aligned_cols=263 Identities=19% Similarity=0.287 Sum_probs=192.4
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeee----cCceEEEE
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVLVY 661 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~----~~~~~LV~ 661 (914)
.+.+.||+|++|.||+|+.+ +|+.||+|++.... ......+.+|+.++++++||||+++++++.. ....++||
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 87 (334)
T cd07855 8 KPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVM 87 (334)
T ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEE
Confidence 34578999999999999876 69999999987542 2334567789999999999999999998753 34679999
Q ss_pred EeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccC
Q 002509 662 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 741 (914)
Q Consensus 662 E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 741 (914)
||+. |+|.+++.. ...+++.....++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 88 e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 88 DLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred ehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 9996 588888753 34489999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCc---eeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHH-------HHhh
Q 002509 742 GASH---VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA-------KLHI 810 (914)
Q Consensus 742 ~~~~---~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~-------~~~~ 810 (914)
.... ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+..-. ....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 2211 1123468899999999865 468899999999999999999999996543211000000000 0000
Q ss_pred hcCCcccccCC-ccCCccC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 811 ESGDIQGIIDP-SLLDEYD-----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 811 ~~~~~~~i~d~-~l~~~~~-----~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
..+.+.+..+. ....... ......+.+++.+|++.+|++||+++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000000 0000000 1123568899999999999999999998875
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=285.88 Aligned_cols=249 Identities=25% Similarity=0.352 Sum_probs=189.4
Q ss_pred HHhccccccCcEEEEEEEECC-CcEEEEEEEecCCc-ccchhhhHHHHHHhhcc-cCceeEEEeeeeecCceEEEEEecc
Q 002509 589 MLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~~-g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
.+.+.||+|++|.||+|+.++ ++.||||.++.... .....+..|+.++.+.. ||||++++++|......+++|||+.
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 97 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS 97 (296)
T ss_pred eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence 456799999999999999874 89999999875432 23455667777777775 9999999999999999999999985
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+ +|.+.+... ...+++..+..++.|+++||+|||+. .+|+||||+|+||++++++.+||+|||++.........
T Consensus 98 ~-~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~ 171 (296)
T cd06618 98 T-CLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK 171 (296)
T ss_pred c-CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc
Confidence 4 676665432 33688999999999999999999973 28999999999999999999999999998765432221
Q ss_pred eeeccccCCcccCccccccCC----CCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCC
Q 002509 746 VSSIVRGTVGYLDPEYYISQQ----LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 821 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~~~----~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 821 (914)
....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... ...+.. ..... ...
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~----~~~~~-~~~---- 238 (296)
T cd06618 172 --TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTK----ILQEE-PPS---- 238 (296)
T ss_pred --cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHH----HhcCC-CCC----
Confidence 2234788999999987553 788999999999999999999998642210 111111 11111 000
Q ss_pred ccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 822 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 822 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+.. ......++.+++.+|++.+|++||++++++++
T Consensus 239 -~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 -LPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -CCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 00123458899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=279.00 Aligned_cols=234 Identities=20% Similarity=0.303 Sum_probs=181.9
Q ss_pred ccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhc-ccCceeEEEeeeeecCceEEEEEeccCCChHH
Q 002509 594 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKE 671 (914)
Q Consensus 594 lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~ 671 (914)
||+|+||.||+++.+ ++..+|+|++...... . .|+.....+ +||||+++++.+...+..++||||+++|+|.+
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~--~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~ 98 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN---A--IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD 98 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcc---h--hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence 599999999999875 6888999998653221 1 123222222 79999999999999999999999999999999
Q ss_pred HhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCC-cEEEeeccccccccCCCCceeecc
Q 002509 672 HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIV 750 (914)
Q Consensus 672 ~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~~~~~~ 750 (914)
++... ..+++.++..++.|+++||+|||+. +++||||||+||+++.++ .++|+|||+++...... ..
T Consensus 99 ~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-----~~ 166 (267)
T PHA03390 99 LLKKE----GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS-----CY 166 (267)
T ss_pred HHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-----cC
Confidence 98533 3789999999999999999999998 899999999999999998 99999999987553221 23
Q ss_pred ccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccCHH
Q 002509 751 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQ 830 (914)
Q Consensus 751 ~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 830 (914)
.|+..|+|||++.+..++.++|||||||+++||++|+.||....... .....+.... ... . .... .
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~--~~~-~-----~~~~----~ 232 (267)
T PHA03390 167 DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE--LDLESLLKRQ--QKK-L-----PFIK----N 232 (267)
T ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch--hhHHHHHHhh--ccc-C-----Cccc----c
Confidence 57899999999998889999999999999999999999997433211 1222222211 000 0 0011 1
Q ss_pred HHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 002509 831 SMWKIEEKALMCVLPHGHMRPS-ISEVLK 858 (914)
Q Consensus 831 ~~~~l~~l~~~C~~~~P~~RPs-m~eVl~ 858 (914)
....+.+++.+|++.+|.+||+ ++|+++
T Consensus 233 ~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 233 VSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred cCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 2235788899999999999995 688875
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=289.24 Aligned_cols=259 Identities=21% Similarity=0.300 Sum_probs=188.1
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeeecC------ceEEE
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RSVLV 660 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~------~~~LV 660 (914)
+.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++.... ..++|
T Consensus 19 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 98 (342)
T cd07879 19 SLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLV 98 (342)
T ss_pred EEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEE
Confidence 3468999999999999875 68999999986532 222356789999999999999999999886542 45899
Q ss_pred EEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccccc
Q 002509 661 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 740 (914)
Q Consensus 661 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 740 (914)
+||+.. +|...+ ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 99 ~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 99 MPYMQT-DLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred eccccc-CHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 999974 666654 23578889999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCceeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHH-------Hhhhc
Q 002509 741 DGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK-------LHIES 812 (914)
Q Consensus 741 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~-------~~~~~ 812 (914)
.. .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+..... .....
T Consensus 169 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 169 AE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred CC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 21 122357889999999876 4688999999999999999999999975432111111111000 00000
Q ss_pred CCc-------ccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--Hhhh
Q 002509 813 GDI-------QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQDA 863 (914)
Q Consensus 813 ~~~-------~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~--L~~~ 863 (914)
... .......+.... ......+.+++.+|++.+|++||+++|++++ ++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred cchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 000 000000000000 0112357799999999999999999999976 6554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=285.73 Aligned_cols=245 Identities=26% Similarity=0.340 Sum_probs=196.1
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC---cccchhhhHHHHHHhhcc-cCceeEEEeeeeecCceEEEEEe
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEF 663 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~LV~E~ 663 (914)
.+.+.||+|++|.||+++.. +++.||+|++.... ....+.+..|++++++++ |+||+++++++...+..++||||
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd05581 4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEY 83 (280)
T ss_pred eEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcC
Confidence 35578999999999999876 79999999986532 223456888999999998 99999999999999999999999
Q ss_pred ccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCC
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 743 (914)
Q Consensus 664 ~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 743 (914)
+++++|.+++.. ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++++|||++.......
T Consensus 84 ~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 84 APNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 999999999853 23689999999999999999999998 99999999999999999999999999987654322
Q ss_pred C-------------------ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHH
Q 002509 744 S-------------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 804 (914)
Q Consensus 744 ~-------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~ 804 (914)
. .......++..|+|||......++.++||||||++++|+++|+.||..... ....+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~ 232 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE----YLTFQ 232 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH----HHHHH
Confidence 1 112234578899999999888899999999999999999999999875431 11111
Q ss_pred HHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCH----HHHHH
Q 002509 805 WAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSI----SEVLK 858 (914)
Q Consensus 805 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm----~eVl~ 858 (914)
... . . ...+ +......+.+++.+|++.+|++||++ +|+++
T Consensus 233 ~~~---~-~------~~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 233 KIL---K-L------EYSF----PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHH---h-c------CCCC----CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111 0 0 0011 11113457899999999999999999 77665
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=291.95 Aligned_cols=244 Identities=24% Similarity=0.418 Sum_probs=198.8
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc--ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
.+.+.||+|.|+.|..|+.. .+.+||+|.+.+..- ...+.+.+|+++|+.++|||||+++.+...+...++||||+.
T Consensus 59 ~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~ 138 (596)
T KOG0586|consen 59 VIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYAS 138 (596)
T ss_pred eeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEecc
Confidence 35578999999999999876 799999999876532 223458899999999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+|.+.+++.. ..++.......+..|+.+|++|||++ .|+|||||++||||+.+.++||+|||++.++.. ..
T Consensus 139 ~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~--~~ 209 (596)
T KOG0586|consen 139 GGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY--GL 209 (596)
T ss_pred CchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc--cc
Confidence 9999999954 34455577788999999999999999 999999999999999999999999999988753 34
Q ss_pred eeeccccCCcccCccccccCCC-CccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccC
Q 002509 746 VSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~~~~-s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 824 (914)
.....+|++.|.|||++.+.++ .+++|+||+|++||-|+.|..||++....+.....+ -.+++
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl----------------~gk~r 273 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVL----------------RGKYR 273 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhe----------------eeeec
Confidence 4566789999999999998775 578999999999999999999998654332211111 01111
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 825 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 825 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
-.+. .-....+++.+++-.+|.+|++++++.++
T Consensus 274 Ip~~--ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 274 IPFY--MSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ccce--eechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1111 11135677888999999999999999876
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=290.28 Aligned_cols=262 Identities=20% Similarity=0.264 Sum_probs=189.1
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeec------------
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------------ 654 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~------------ 654 (914)
+.+.+.||+|+||.||+|... +|+.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 7 y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 86 (342)
T cd07854 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLT 86 (342)
T ss_pred eEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccccc
Confidence 345578999999999999876 6899999998766555567788999999999999999999776543
Q ss_pred --CceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCC-CCcEEEe
Q 002509 655 --GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVS 731 (914)
Q Consensus 655 --~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~ 731 (914)
...++|+||++ ++|.+++. ...+++.....++.|+++||+|||+. +++||||||+||+++. ++.+|++
T Consensus 87 ~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 87 ELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEEC
Confidence 34689999997 58888774 23578899999999999999999998 9999999999999984 5678999
Q ss_pred eccccccccCCCCce--eeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHH
Q 002509 732 DFGLSKFAVDGASHV--SSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL 808 (914)
Q Consensus 732 DFGla~~~~~~~~~~--~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~ 808 (914)
|||+++......... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+..-. .
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~-~ 236 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV-P 236 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc-C
Confidence 999987653221111 122347889999998754 567889999999999999999999996443211111110000 0
Q ss_pred hhhc---CCcccccCCcc-----CCccC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 809 HIES---GDIQGIIDPSL-----LDEYD-----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 809 ~~~~---~~~~~i~d~~l-----~~~~~-----~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.... ......+...+ ....+ .....++.+++.+|++.+|++||+++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000 00000000000 00000 0112457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=285.58 Aligned_cols=259 Identities=19% Similarity=0.267 Sum_probs=189.8
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeee-cCceEEEEEe
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSVLVYEF 663 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~LV~E~ 663 (914)
+.+.+.||+|+||.||++... +++.||+|++.... ....+.+..|++++.+++||||+++.+++.. ....++|+||
T Consensus 12 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~ 91 (328)
T cd07856 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL 91 (328)
T ss_pred eEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeeh
Confidence 334578999999999999866 79999999886432 2234667889999999999999999998865 4578899999
Q ss_pred ccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCC
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 743 (914)
Q Consensus 664 ~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 743 (914)
+ +++|.+.+.. ..+++.....++.|+++||+|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 92 ~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~- 161 (328)
T cd07856 92 L-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ- 161 (328)
T ss_pred h-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCC-
Confidence 8 4688888742 3467778888999999999999998 9999999999999999999999999998754221
Q ss_pred CceeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHH--------HHHhhhcCC
Q 002509 744 SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW--------AKLHIESGD 814 (914)
Q Consensus 744 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~--------~~~~~~~~~ 814 (914)
.....++..|+|||.+.+ ..++.++|||||||+++||++|+.||...........+.++ .........
T Consensus 162 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd07856 162 ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT 238 (328)
T ss_pred ---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence 122346889999998765 56889999999999999999999998643321111111111 110000000
Q ss_pred cccccCCccCCccCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 815 IQGIIDPSLLDEYDI-----QSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 815 ~~~i~d~~l~~~~~~-----~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
..-...-......+. .....+.+++.+|++.+|++||++++++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000001111 112468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=274.69 Aligned_cols=236 Identities=28% Similarity=0.355 Sum_probs=190.8
Q ss_pred ccccCcEEEEEEEEC-CCcEEEEEEEecCCcc---cchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCCh
Q 002509 594 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 669 (914)
Q Consensus 594 lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~---~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 669 (914)
||+|+||.||++... +++.+|+|+++..... ....+..|++++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999876 5899999998765332 345788999999999999999999999999999999999999999
Q ss_pred HHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCceeec
Q 002509 670 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 749 (914)
Q Consensus 670 ~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 749 (914)
.+++... ..+++.....++.|+++||.|||+. +++|+||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 9998533 3588999999999999999999998 99999999999999999999999999987654332 12233
Q ss_pred cccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccCH
Q 002509 750 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 829 (914)
Q Consensus 750 ~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 829 (914)
..++..|++||...+...+.++|+||||++++|+++|+.||..... ..+.+.+. . +.. .+..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~---~-~~~------~~~~---- 214 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEIYEKIL---K-DPL------RFPE---- 214 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHh---c-CCC------CCCC----
Confidence 4578899999999888889999999999999999999999964332 12222111 1 110 1111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHH
Q 002509 830 QSMWKIEEKALMCVLPHGHMRPSISE 855 (914)
Q Consensus 830 ~~~~~l~~l~~~C~~~~P~~RPsm~e 855 (914)
.....+.+++.+|+..+|++||++.+
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 11235788999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=288.16 Aligned_cols=263 Identities=22% Similarity=0.270 Sum_probs=188.2
Q ss_pred HHhccccccCcEEEEEEEEC-C--CcEEEEEEEecCC--cccchhhhHHHHHHhhc-ccCceeEEEeeeeec----CceE
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-D--GKEIAVKVLTSNS--YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE----GRSV 658 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~--g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~----~~~~ 658 (914)
.+.+.||+|+||.||+++.. . ++.||+|.+.... ....+.+.+|+++++++ +||||+++++.+... ...+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 82 (332)
T cd07857 3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY 82 (332)
T ss_pred eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence 34578999999999999876 3 7889999986432 22245678899999999 599999999976432 4567
Q ss_pred EEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccc
Q 002509 659 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 738 (914)
Q Consensus 659 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 738 (914)
+++||+. ++|.+.+.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 83 ~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 83 LYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 8888886 588888743 34688999999999999999999998 999999999999999999999999999976
Q ss_pred ccCCCCc---eeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHh-----
Q 002509 739 AVDGASH---VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH----- 809 (914)
Q Consensus 739 ~~~~~~~---~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~----- 809 (914)
....... ......|+..|+|||.+.+ ..++.++|||||||+++||++|+.||...........+.......
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 5432211 1123458999999998765 468899999999999999999999986543211111111110000
Q ss_pred --hhcCCcccc---cCCc--c-CCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 810 --IESGDIQGI---IDPS--L-LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 810 --~~~~~~~~i---~d~~--l-~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
......... .+.. . ...........+.+++.+|++.+|++||+++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000 0000 0 000000112468899999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=315.52 Aligned_cols=244 Identities=25% Similarity=0.382 Sum_probs=189.0
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecC--CcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCC
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 668 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gs 668 (914)
.+||.|.||.||-|... +|+-.|||-++.. .....+...+|+.++..++|||+|+.+|+-...+..+|.||||++|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 47999999999999755 6888999987644 23345678899999999999999999999999999999999999999
Q ss_pred hHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc---
Q 002509 669 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH--- 745 (914)
Q Consensus 669 L~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~--- 745 (914)
|.+.+.. ++..++.....+..|++.|++|||++ +||||||||.||+|+.+|-+|++|||.|.........
T Consensus 1321 La~ll~~----gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1321 LASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred HHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence 9999842 33345555566789999999999999 9999999999999999999999999999776544211
Q ss_pred eeeccccCCcccCccccccC---CCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHH-HhhhcCCcccccCC
Q 002509 746 VSSIVRGTVGYLDPEYYISQ---QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK-LHIESGDIQGIIDP 821 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~~---~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~-~~~~~~~~~~i~d~ 821 (914)
.-....||+.|||||++.+. .-.-++||||+|||++||+||++||...+. +|+. .++..|....+
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn--------e~aIMy~V~~gh~Pq~--- 1462 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN--------EWAIMYHVAAGHKPQI--- 1462 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc--------hhHHHhHHhccCCCCC---
Confidence 12345699999999999753 345688999999999999999999975431 1221 11222222111
Q ss_pred ccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 822 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 822 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+...-.+=.+++.+|++.||++|.++.|++++
T Consensus 1463 ------P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1463 ------PERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ------chhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 11112234577889999999999888876653
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=286.67 Aligned_cols=258 Identities=22% Similarity=0.302 Sum_probs=188.7
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeeecC------ceE
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RSV 658 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~------~~~ 658 (914)
+.+.+.||+|+||.||++... +++.||||++.... ......+.+|++++++++||||+++++++.... ..+
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07880 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFY 96 (343)
T ss_pred eEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEE
Confidence 334578999999999999765 78999999986432 222346789999999999999999999886543 458
Q ss_pred EEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccc
Q 002509 659 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 738 (914)
Q Consensus 659 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 738 (914)
+||||+ +++|.+++. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 97 lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 97 LVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred EEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 999998 678888774 24588999999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHH--------HHHHh
Q 002509 739 AVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ--------WAKLH 809 (914)
Q Consensus 739 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~--------~~~~~ 809 (914)
.... .....++..|+|||.+.+ ..++.++|+|||||+++++++|+.||...........+.. +....
T Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 168 TDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred cccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 4322 122357889999999876 4578899999999999999999999975432111111111 00000
Q ss_pred hhcCCcccccC--CccCC----ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 810 IESGDIQGIID--PSLLD----EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 810 ~~~~~~~~i~d--~~l~~----~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.......... +.... .........+.+++.+|++.+|++||++.+++++
T Consensus 244 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 244 -QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred -cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 00000 0001112347799999999999999999999864
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=268.88 Aligned_cols=201 Identities=25% Similarity=0.368 Sum_probs=166.4
Q ss_pred HHHhccccccCcEEEEEEEEC---C--CcEEEEEEEecCCcc--cchhhhHHHHHHhhcccCceeEEEeeeee-cCceEE
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK---D--GKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSVL 659 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~---~--g~~vAVK~l~~~~~~--~~~~f~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~L 659 (914)
++....||+|.||.||+|..+ + .+.+|+|.++..... -.....+|+.+++.++||||+.+..++.+ +...++
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l 105 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL 105 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence 445568999999999999544 2 346899999765332 23567899999999999999999998877 778899
Q ss_pred EEEeccCCChHHHhhccc-CccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCC----CcEEEeecc
Q 002509 660 VYEFMHNGTLKEHLYGTL-THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH----MRAKVSDFG 734 (914)
Q Consensus 660 V~E~~~~gsL~~~L~~~~-~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~----~~~kl~DFG 734 (914)
++||.+. +|.+.++-.. ...+.++-....+|+.||+.|+.|||++ =|+||||||.|||+..+ |.+||+|+|
T Consensus 106 ~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 106 LFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred Eehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeeccc
Confidence 9999987 7888774322 2345788889999999999999999999 78999999999999877 899999999
Q ss_pred ccccccCCCCce--eeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCccc
Q 002509 735 LSKFAVDGASHV--SSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISN 792 (914)
Q Consensus 735 la~~~~~~~~~~--~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~ 792 (914)
+++.+.+.-... ...++-|.+|+|||.+.+ ..||.+.|||+.|||+.||++-++-|.+
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 999876543332 244567999999999987 5689999999999999999999887754
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=289.01 Aligned_cols=256 Identities=22% Similarity=0.297 Sum_probs=186.8
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeeec------CceEEE
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSVLV 660 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~------~~~~LV 660 (914)
+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++.+++||||+++++++... ...+++
T Consensus 21 ~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 100 (345)
T cd07877 21 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 100 (345)
T ss_pred EEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEE
Confidence 3468999999999999764 78999999986532 22345678899999999999999999988643 345778
Q ss_pred EEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccccc
Q 002509 661 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 740 (914)
Q Consensus 661 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 740 (914)
++++ +++|.+.+. ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 101 ~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 101 THLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred ehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 8876 778988774 23588999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCceeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHH-------Hhhhc
Q 002509 741 DGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK-------LHIES 812 (914)
Q Consensus 741 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~-------~~~~~ 812 (914)
.. .....++..|+|||.+.+ ..++.++|||||||+++||++|+.||...........+.+... .....
T Consensus 172 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 172 DE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247 (345)
T ss_pred cc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence 22 223457889999999866 5678899999999999999999999864332111111111110 00000
Q ss_pred CC-------cccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 813 GD-------IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 813 ~~-------~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.. +......... .........+.+++.+|++.+|.+||++.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 248 ESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00 0000000000 0000112357899999999999999999999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=274.41 Aligned_cols=254 Identities=24% Similarity=0.342 Sum_probs=202.2
Q ss_pred hccccccCcEEEEEEEEC------CCcEEEEEEEecCCc-ccchhhhHHHHHHhhcccCceeEEEeeeeec-CceEEEEE
Q 002509 591 EKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-GRSVLVYE 662 (914)
Q Consensus 591 ~~~lG~G~~G~Vy~~~~~------~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~LV~E 662 (914)
...+-+|.||.||+|.|. +.+.|.||.++.... -....+..|.-++..+.|||+.++.+.+.+. ...+.+|.
T Consensus 289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~ 368 (563)
T KOG1024|consen 289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP 368 (563)
T ss_pred hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence 456899999999999654 455678887765532 3345678888889999999999999999776 45688899
Q ss_pred eccCCChHHHhhccc----CccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccc
Q 002509 663 FMHNGTLKEHLYGTL----THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 738 (914)
Q Consensus 663 ~~~~gsL~~~L~~~~----~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 738 (914)
++.-|+|..+|.... ...+.++..+...++.|++.|++|||++ ++||.||.++|++||+..++||+|=.+++.
T Consensus 369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSRD 445 (563)
T KOG1024|consen 369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSRD 445 (563)
T ss_pred ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhccc
Confidence 999999999996221 2345678888999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCce-eeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHhhhcCCcc
Q 002509 739 AVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQ 816 (914)
Q Consensus 739 ~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 816 (914)
..+.+.+. ......+..||+||.+....++.++|||||||+||||+| |+.|+..-+..+ +..+ +++|
T Consensus 446 LFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE----m~~y----lkdG--- 514 (563)
T KOG1024|consen 446 LFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE----MEHY----LKDG--- 514 (563)
T ss_pred cCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH----HHHH----Hhcc---
Confidence 87766553 344456889999999999999999999999999999998 888875433211 1111 1222
Q ss_pred cccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhH
Q 002509 817 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 864 (914)
Q Consensus 817 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 864 (914)
.++.. +..+..++..++.-||...|++||+.+|++.-|.+.-
T Consensus 515 ----yRlaQ--P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 515 ----YRLAQ--PFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred ----ceecC--CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 11211 2344557889999999999999999999999998763
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=291.17 Aligned_cols=258 Identities=22% Similarity=0.320 Sum_probs=190.2
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecC--CcccchhhhHHHHHHhhcccCceeEEEeeeeecCc------eEE
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR------SVL 659 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~------~~L 659 (914)
.+.+.||+|++|.||+|+.. +++.||+|++... .......+.+|+.++++++|+|++++++++...+. .++
T Consensus 18 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 97 (343)
T cd07851 18 QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYL 97 (343)
T ss_pred EEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEE
Confidence 34578999999999999886 6889999998643 22233567789999999999999999988766554 899
Q ss_pred EEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccc
Q 002509 660 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 739 (914)
Q Consensus 660 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 739 (914)
|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 98 v~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 98 VTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred EEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 99998 5699988853 4689999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCceeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHH-------hhh
Q 002509 740 VDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL-------HIE 811 (914)
Q Consensus 740 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~-------~~~ 811 (914)
... .....++..|+|||.+.+ ..++.++|||||||+++|+++|+.||......+....+.+.... ...
T Consensus 169 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 169 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred ccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 332 223357889999999865 46788999999999999999999999644321111111111000 000
Q ss_pred cCCcccccC---CccCCccC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 812 SGDIQGIID---PSLLDEYD---IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 812 ~~~~~~i~d---~~l~~~~~---~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.......+. ..-...+. .....++.+++.+|++.+|++|||+.||+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000000000 00000000 0113468899999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-30 Score=262.50 Aligned_cols=264 Identities=24% Similarity=0.375 Sum_probs=196.7
Q ss_pred CHHHHHHHHHHHhccccccCcEEEEEEE-ECCCcEEEEEEEecCCcccchhhhHHHHHHhhc-ccCceeEEEeeeeecCc
Q 002509 579 TLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGR 656 (914)
Q Consensus 579 ~~~ei~~~~~~~~~~lG~G~~G~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~ 656 (914)
++.|.-+.| ++.||+|+|+.|-.+. ..+|.++|||++.+..........+|++++..+ .|+||++|+++++++..
T Consensus 74 ~F~d~YkLt---~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 74 KFEDMYKLT---SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred hHHHHHHhH---HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 345554444 4589999999998875 458999999999888666677888999999999 59999999999999999
Q ss_pred eEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCC---cEEEeec
Q 002509 657 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDF 733 (914)
Q Consensus 657 ~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DF 733 (914)
.+||||-|.||+|..+++. ..-+++.+.-++..+||.||.+||.+ +|.|||+||+|||-.+.. -+||+||
T Consensus 151 FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred EEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecc
Confidence 9999999999999999964 44578889999999999999999999 999999999999986543 4899999
Q ss_pred ccccccc------CCCCceeeccccCCcccCccccc-----cCCCCccCceeehHHHHHHHHhCCCCcccc-------cc
Q 002509 734 GLSKFAV------DGASHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNE-------KF 795 (914)
Q Consensus 734 Gla~~~~------~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~-------~~ 795 (914)
.+..-.. +.....-...+|+..|||||+.. ...|..++|.||||||||-|++|..||.+. +.
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 9874321 11111223356889999999974 235778999999999999999999999642 33
Q ss_pred cccchhHHHHHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002509 796 GANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 858 (914)
Q Consensus 796 ~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 858 (914)
++.|+.-.+-.-.-+.+|.+. .-|+.. ...-.+.-+++-..+..++.+|-++.+++.
T Consensus 304 Ge~Cr~CQ~~LFesIQEGkYe-FPdkdW-----ahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 304 GEVCRVCQNKLFESIQEGKYE-FPDKDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCccHHHHHHHHHHHhccCCc-CChhhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 444443333333333333321 111110 001112335555566688888888888876
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-30 Score=302.71 Aligned_cols=245 Identities=26% Similarity=0.381 Sum_probs=181.4
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCC-cccchhhhHHHHHHhhcccCceeEEEeeeee----------------
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE---------------- 653 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~---------------- 653 (914)
+.||+||||.|||++.+ ||+.+|||++.... ........+|+..|.+|+|||||+++....+
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~ 564 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE 564 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence 47999999999999988 99999999997653 3334567889999999999999998732000
Q ss_pred --------------------------------------------------------------------------------
Q 002509 654 -------------------------------------------------------------------------------- 653 (914)
Q Consensus 654 -------------------------------------------------------------------------------- 653 (914)
T Consensus 565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~ 644 (1351)
T KOG1035|consen 565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD 644 (1351)
T ss_pred hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence
Q ss_pred ---------------c--------CceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 002509 654 ---------------E--------GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 710 (914)
Q Consensus 654 ---------------~--------~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~i 710 (914)
+ ..+|+=||||+.-+|.+.++...-.. .-...++++.+|++||+|+|+. +|
T Consensus 645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaYIH~~---gi 718 (1351)
T KOG1035|consen 645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAYIHDQ---GI 718 (1351)
T ss_pred chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHHHHhC---ce
Confidence 0 11356788888877777775432111 2456788999999999999999 99
Q ss_pred cccCCCCCceEeCCCCcEEEeecccccccc------C-----------CCCceeeccccCCcccCccccccC---CCCcc
Q 002509 711 IHRDLKSSNILLDKHMRAKVSDFGLSKFAV------D-----------GASHVSSIVRGTVGYLDPEYYISQ---QLTDK 770 (914)
Q Consensus 711 vHrDlkp~NILl~~~~~~kl~DFGla~~~~------~-----------~~~~~~~~~~gt~~Y~aPE~~~~~---~~s~k 770 (914)
|||||||.||+|+++..|||+|||+|+... + ......+...||.-|+|||++.+. .|+.|
T Consensus 719 IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K 798 (1351)
T KOG1035|consen 719 IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK 798 (1351)
T ss_pred eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence 999999999999999999999999997621 0 011123456799999999999764 59999
Q ss_pred CceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCC
Q 002509 771 SDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMR 850 (914)
Q Consensus 771 sDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~R 850 (914)
+|+||+|||++||+. ||..... ...+ ...++.+.+..- ..+...++..=..++.++++.||.+|
T Consensus 799 iDmYSLGIVlFEM~y---PF~TsME---Ra~i----L~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kR 862 (1351)
T KOG1035|consen 799 IDMYSLGIVLFEMLY---PFGTSME---RASI----LTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKR 862 (1351)
T ss_pred hhhHHHHHHHHHHhc---cCCchHH---HHHH----HHhcccCCCCCC------cccccccchHHHHHHHHHhcCCCccC
Confidence 999999999999995 4543210 0111 123334443322 11222334445678899999999999
Q ss_pred CCHHHHHH
Q 002509 851 PSISEVLK 858 (914)
Q Consensus 851 Psm~eVl~ 858 (914)
||+.|++.
T Consensus 863 PtA~eLL~ 870 (1351)
T KOG1035|consen 863 PTATELLN 870 (1351)
T ss_pred CCHHHHhh
Confidence 99999985
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-30 Score=277.90 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=194.2
Q ss_pred HHHHHHHH-hccccccCcEEEEEEEEC-CCcEEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeeecCceE
Q 002509 583 IEDATKML-EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 658 (914)
Q Consensus 583 i~~~~~~~-~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 658 (914)
+...+.-| +++||+|.||+||-|+++ +|+.||||++.+.. .....++.+|+.+|++++||.||.+---|+..++.+
T Consensus 560 ~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervF 639 (888)
T KOG4236|consen 560 ISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVF 639 (888)
T ss_pred HHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEE
Confidence 33334444 378999999999999766 79999999997653 334567899999999999999999999999999999
Q ss_pred EEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCC---CcEEEeeccc
Q 002509 659 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDFGL 735 (914)
Q Consensus 659 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGl 735 (914)
+|||-+.+ +..+.+... +..+|+...-..++.||+.||.|||.+ +|+|+||||+||||... .++||+|||+
T Consensus 640 VVMEKl~G-DMLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGf 713 (888)
T KOG4236|consen 640 VVMEKLHG-DMLEMILSS--EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGF 713 (888)
T ss_pred EEehhhcc-hHHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccc
Confidence 99999965 655555433 466788888888999999999999998 99999999999999754 4899999999
Q ss_pred cccccCCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCc
Q 002509 736 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 815 (914)
Q Consensus 736 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 815 (914)
|++... ......++||+.|+|||++..+.|...-|+||.||++|.-++|..||.... +|-+.+.. .
T Consensus 714 ARiIgE--ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE------dIndQIQN------A 779 (888)
T KOG4236|consen 714 ARIIGE--KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE------DINDQIQN------A 779 (888)
T ss_pred eeecch--hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc------chhHHhhc------c
Confidence 998754 334456789999999999999999999999999999999999999997432 22221110 0
Q ss_pred ccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 816 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 816 ~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.-+..+.-..+.+ ...++++-..++..-.+|-+.+.-+.+
T Consensus 780 aFMyPp~PW~eis----~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 780 AFMYPPNPWSEIS----PEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred ccccCCCchhhcC----HHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 1111222122222 234566666677766777777665543
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-30 Score=257.27 Aligned_cols=246 Identities=25% Similarity=0.369 Sum_probs=188.9
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCC-cccchhhhHHHHHHhhcc-cCceeEEEeeeeecCceEEEEEeccCCC
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHNGT 668 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~LV~E~~~~gs 668 (914)
..||.|..|.|++.+.+ .|..+|||.+.... .+..+.+...+.++.+.+ +|.||+.+|||.......+.||.|.- .
T Consensus 98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C 176 (391)
T KOG0983|consen 98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-C 176 (391)
T ss_pred HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-H
Confidence 46999999999999887 58899999987653 344556667777776664 89999999999999998999998854 3
Q ss_pred hHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCceee
Q 002509 669 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 748 (914)
Q Consensus 669 L~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 748 (914)
++.++... .+.+++.-.-++...+.+||.||.+++ +|+|||+||+|||+|+.|++|++|||++-.+.+...+ +
T Consensus 177 ~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh--t 249 (391)
T KOG0983|consen 177 AEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH--T 249 (391)
T ss_pred HHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc--c
Confidence 44444332 344777777788999999999999874 9999999999999999999999999999877665444 3
Q ss_pred ccccCCcccCcccccc---CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCC
Q 002509 749 IVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 825 (914)
Q Consensus 749 ~~~gt~~Y~aPE~~~~---~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 825 (914)
..+|-+.|||||.+.- ..|.-++||||||+.|+||.||+.||...+.+ .....-+ .. +.. |.|..
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td---Fe~ltkv---ln--~eP----P~L~~ 317 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD---FEVLTKV---LN--EEP----PLLPG 317 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc---HHHHHHH---Hh--cCC----CCCCc
Confidence 3468899999999964 36888999999999999999999999764421 1111111 11 111 22221
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 826 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 826 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.. ..-..+.+++..|+..|+.+||...+++++
T Consensus 318 ~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 318 HM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred cc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11 022357889999999999999999999976
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=240.25 Aligned_cols=196 Identities=23% Similarity=0.377 Sum_probs=163.0
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCC--cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCC
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 668 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gs 668 (914)
++||+|.||+|+||+.. .++-||+|.++.+. ........+|+-+|+.++|+|||++++....+....+|+|||.. +
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-d 86 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-D 86 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-H
Confidence 58999999999999876 57889999987553 23346788999999999999999999999999999999999976 6
Q ss_pred hHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCceee
Q 002509 669 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 748 (914)
Q Consensus 669 L~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 748 (914)
|..+.... ...++.....+++.|+++||.++|++ .+.|||+||.|.|++.+|+.|++|||+++-+.-.....+
T Consensus 87 lkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrcys- 159 (292)
T KOG0662|consen 87 LKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS- 159 (292)
T ss_pred HHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee-
Confidence 76665432 44577788889999999999999999 999999999999999999999999999987654332222
Q ss_pred ccccCCcccCccccccC-CCCccCceeehHHHHHHHHh-CCCCcccccc
Q 002509 749 IVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELIS-GQEAISNEKF 795 (914)
Q Consensus 749 ~~~gt~~Y~aPE~~~~~-~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~ 795 (914)
...-|.+|.+|+++.+. -|+...|+||-||++.|+.. |++-|.+...
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv 208 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH
Confidence 23358999999999875 47788999999999999987 5555655443
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=304.77 Aligned_cols=142 Identities=31% Similarity=0.424 Sum_probs=126.0
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcc---cchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEec
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~---~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
.+.++||+|+||.||+|... +++.||||+++..... ....+..|+.++..++||||+++++++......++||||+
T Consensus 7 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~ 86 (669)
T cd05610 7 VIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYL 86 (669)
T ss_pred EEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCC
Confidence 34578999999999999887 6899999998754322 2356888999999999999999999999999999999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccc
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 737 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 737 (914)
.+++|.+++.. ...+++...+.++.||+.||+|||.+ +|+||||||+|||++.++.+||+|||+++
T Consensus 87 ~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 87 IGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999853 23578888999999999999999998 99999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-30 Score=262.73 Aligned_cols=197 Identities=29% Similarity=0.413 Sum_probs=171.8
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccch---hhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKR---EFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~---~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
+.++||+|.||.|-.++-+ .++.+|+|++++.-.-.+. .-..|-++|+..+||.+..+.-.++..++.|+||||..
T Consensus 172 fLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyan 251 (516)
T KOG0690|consen 172 FLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYAN 251 (516)
T ss_pred HHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEcc
Confidence 6689999999999999876 7899999999876433332 23568889999999999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
||.|.-+|. ..+.+++.....+...|..||.|||++ +||.||||.+|.|||.||++||+|||+++.-.. ...
T Consensus 252 GGeLf~HLs----rer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~-~g~ 323 (516)
T KOG0690|consen 252 GGELFFHLS----RERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK-YGD 323 (516)
T ss_pred CceEeeehh----hhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc-ccc
Confidence 999998884 355677777778899999999999998 999999999999999999999999999975322 233
Q ss_pred eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCccccc
Q 002509 746 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 794 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~ 794 (914)
....++||+.|+|||++....|..+.|-|.+|||+|||++|+.||....
T Consensus 324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d 372 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD 372 (516)
T ss_pred eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc
Confidence 4566899999999999999999999999999999999999999997644
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=266.44 Aligned_cols=221 Identities=21% Similarity=0.179 Sum_probs=174.9
Q ss_pred cCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCChHHHhhc
Q 002509 597 GGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG 675 (914)
Q Consensus 597 G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~ 675 (914)
|.+|.||+++.. +++.+|+|+++... .+..|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999876 78999999987542 234455555666799999999999999999999999999999999853
Q ss_pred ccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCceeeccccCCc
Q 002509 676 TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 755 (914)
Q Consensus 676 ~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~ 755 (914)
. ..+++.....++.|+++||+|||+. +++||||||+||+++.++.++++|||.+...... .....++..
T Consensus 79 ~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~ 147 (237)
T cd05576 79 F----LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENM 147 (237)
T ss_pred h----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcc
Confidence 2 3588999999999999999999998 9999999999999999999999999987654322 122345778
Q ss_pred ccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccCHHHHHHH
Q 002509 756 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKI 835 (914)
Q Consensus 756 Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l 835 (914)
|+|||......++.++||||+||+++||++|+.|+...... + .. .....+... ....+
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~--------~~-----~~~~~~~~~----~~~~~ 205 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I--------NT-----HTTLNIPEW----VSEEA 205 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c--------cc-----ccccCCccc----CCHHH
Confidence 99999998888899999999999999999999876532110 0 00 000011111 12357
Q ss_pred HHHHHHccCCCCCCCCCHHH
Q 002509 836 EEKALMCVLPHGHMRPSISE 855 (914)
Q Consensus 836 ~~l~~~C~~~~P~~RPsm~e 855 (914)
.+++.+|++.||++||++.+
T Consensus 206 ~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 206 RSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHHHHccCCHHHhcCCCc
Confidence 78999999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=261.50 Aligned_cols=262 Identities=27% Similarity=0.376 Sum_probs=195.5
Q ss_pred cccCHHHHHHHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCc-ccchhhhHHHHHHhhc-ccCceeEEEeeee
Q 002509 576 HCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQ 652 (914)
Q Consensus 576 ~~~~~~ei~~~~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~ 652 (914)
+.|+-.++++. ..||.|+||+|+|-.++ .|+..|||+++.... ...+++..|.+...+- +.||||+++|.+.
T Consensus 59 ~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F 133 (361)
T KOG1006|consen 59 HTFTSDNLQDL-----GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF 133 (361)
T ss_pred cccccchHHHH-----HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh
Confidence 44555555432 36999999999999877 799999999987654 4566788888765544 7999999999999
Q ss_pred ecCceEEEEEeccCCChHHHhh-cccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEe
Q 002509 653 EEGRSVLVYEFMHNGTLKEHLY-GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 731 (914)
Q Consensus 653 ~~~~~~LV~E~~~~gsL~~~L~-~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 731 (914)
.++..++.||.|.- +|..+-. -.......+++.-.-.|+.....||.||... ..|+|||+||+||||+..|.+||+
T Consensus 134 ~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLC 210 (361)
T KOG1006|consen 134 SEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLC 210 (361)
T ss_pred cCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeee
Confidence 99999999999964 4443321 1112455677777778888899999999987 489999999999999999999999
Q ss_pred eccccccccCCCCceeeccccCCcccCcccccc--CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHh
Q 002509 732 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH 809 (914)
Q Consensus 732 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~ 809 (914)
|||++-.+.++ ...+.-+|-..|||||.+.. ..|.-++||||||+.|+|+.||+.|+.... ++.+.+...
T Consensus 211 DFGIcGqLv~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~------svfeql~~V 282 (361)
T KOG1006|consen 211 DFGICGQLVDS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD------SVFEQLCQV 282 (361)
T ss_pred cccchHhHHHH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH------HHHHHHHHH
Confidence 99998655432 23344568899999999964 358889999999999999999999986533 222222222
Q ss_pred hhcCCcccccCCccCCcc-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 810 IESGDIQGIIDPSLLDEY-DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 810 ~~~~~~~~i~d~~l~~~~-~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+. |+.. .+.... ..+....+..++-.|+..|-..||...++.++
T Consensus 283 v~-gdpp-----~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 283 VI-GDPP-----ILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred Hc-CCCC-----eecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 22 2211 111111 12334568888899999999999999998764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=262.08 Aligned_cols=238 Identities=27% Similarity=0.420 Sum_probs=192.7
Q ss_pred CcEEEEEEEEC-CCcEEEEEEEecCCccc-chhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCChHHHhhc
Q 002509 598 GFGVVYYGKLK-DGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG 675 (914)
Q Consensus 598 ~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~-~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~ 675 (914)
+||.||+|+.. +++.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999987 48999999997665444 67899999999999999999999999999999999999999999999854
Q ss_pred ccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCceeeccccCCc
Q 002509 676 TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 755 (914)
Q Consensus 676 ~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~ 755 (914)
. ..+++..++.++.++++++.|||+. +++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus 81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 3 2278899999999999999999998 99999999999999999999999999987664432 2233457889
Q ss_pred ccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccCHHHHHHH
Q 002509 756 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKI 835 (914)
Q Consensus 756 Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l 835 (914)
|++||.+....++.++||||||++++|+++|..||.... ....+.++... +..... . .......++
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~---~~~~~~~~~~~----~~~~~~-~------~~~~~~~~~ 217 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD---QLLELFKKIGK----PKPPFP-P------PEWKISPEA 217 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHhc----cCCCCc-c------ccccCCHHH
Confidence 999999988888999999999999999999999986421 11223332211 111000 0 000022468
Q ss_pred HHHHHHccCCCCCCCCCHHHHHH
Q 002509 836 EEKALMCVLPHGHMRPSISEVLK 858 (914)
Q Consensus 836 ~~l~~~C~~~~P~~RPsm~eVl~ 858 (914)
.+++.+|+..+|++||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 89999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=285.02 Aligned_cols=249 Identities=25% Similarity=0.395 Sum_probs=200.8
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhc-ccCceeEEEeeeee-----cCceEEEE
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE-----EGRSVLVY 661 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~-----~~~~~LV~ 661 (914)
+|.+.||+|.+|.||+++.. +++..|+|++.... ....+.+.|.++|+.. .|||++.++|++.. +++++|||
T Consensus 22 ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVM 100 (953)
T KOG0587|consen 22 EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVM 100 (953)
T ss_pred EEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEe
Confidence 35678999999999999765 68889999987654 3456778889999887 79999999999864 46889999
Q ss_pred EeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccC
Q 002509 662 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 741 (914)
Q Consensus 662 E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 741 (914)
|||.+||..|++.+.+ ..++.|..+.-|+..++.||.|||.+ .++|||||-.|||++.++.+|+.|||++.....
T Consensus 101 EfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 101 EFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS 175 (953)
T ss_pred eccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence 9999999999998876 78899999999999999999999999 999999999999999999999999999976644
Q ss_pred CCCceeeccccCCcccCccccccC-----CCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcc
Q 002509 742 GASHVSSIVRGTVGYLDPEYYISQ-----QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 816 (914)
Q Consensus 742 ~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 816 (914)
... ......||+.|||||++... .|+..+|+||||++..||--|.+|+.++..-. .+.. +...
T Consensus 176 T~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr---aLF~-----IpRN--- 243 (953)
T KOG0587|consen 176 TVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR---ALFL-----IPRN--- 243 (953)
T ss_pred ccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh---hhcc-----CCCC---
Confidence 322 23445699999999999754 36678999999999999999999986543211 1111 0111
Q ss_pred cccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 817 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 817 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
-.|.+. .+..--.++.+++..|+..|-++||++.+++++
T Consensus 244 --PPPkLk--rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 244 --PPPKLK--RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred --CCcccc--chhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 112221 123344579999999999999999999999865
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-30 Score=257.71 Aligned_cols=262 Identities=21% Similarity=0.307 Sum_probs=189.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEEec-C-CcccchhhhHHHHHHhhcccCceeEEEeeeeec--------CceEE
Q 002509 591 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTS-N-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--------GRSVL 659 (914)
Q Consensus 591 ~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~-~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--------~~~~L 659 (914)
..+||+|.||.||+|+.+ .|+.||+|++-- + ...-.....+|+.+|..++|+|++.++..|... ...++
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl 101 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL 101 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence 458999999999999876 578889876432 2 222234567899999999999999999988542 34789
Q ss_pred EEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccc
Q 002509 660 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 739 (914)
Q Consensus 660 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 739 (914)
|+++|+. +|...|... ..+++..++.+++.++..||.|+|.. .|+|||+|+.|+||+.++.+||+|||+++.+
T Consensus 102 Vf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 102 VFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred eHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccce
Confidence 9999987 787777433 46788889999999999999999999 9999999999999999999999999999766
Q ss_pred cCCCC---ceeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHH-------HHH
Q 002509 740 VDGAS---HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW-------AKL 808 (914)
Q Consensus 740 ~~~~~---~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~-------~~~ 808 (914)
..... ...+..+-|.+|++||.+.+ +.++.+.|||+.|||+.||++|.+-+.+........-|.+. +++
T Consensus 175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP 254 (376)
T KOG0669|consen 175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWP 254 (376)
T ss_pred ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCC
Confidence 43322 22344556999999999986 57899999999999999999999887654422111111111 111
Q ss_pred hhhcCCccccc--CCccCCccC--HHHHH------HHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 809 HIESGDIQGII--DPSLLDEYD--IQSMW------KIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 809 ~~~~~~~~~i~--d~~l~~~~~--~~~~~------~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.+..-.+.+.+ .|--.+.+. .+.+. +.+++...++..||.+|+++++++.+
T Consensus 255 ~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 255 NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 11100111111 100000000 01111 46678888999999999999999865
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=281.46 Aligned_cols=258 Identities=22% Similarity=0.341 Sum_probs=176.5
Q ss_pred HHhccccccCcEEEEEEEE-----------------CCCcEEEEEEEecCCcccc--------------hhhhHHHHHHh
Q 002509 589 MLEKKIGSGGFGVVYYGKL-----------------KDGKEIAVKVLTSNSYQGK--------------REFTNEVTLLS 637 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~-----------------~~g~~vAVK~l~~~~~~~~--------------~~f~~E~~~l~ 637 (914)
.+.++||+|+||.||+|.+ .+++.||||++........ +.+..|+.++.
T Consensus 148 ~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~ 227 (507)
T PLN03224 148 QLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCA 227 (507)
T ss_pred eEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHH
Confidence 3557999999999999964 2456899999865432222 23345777778
Q ss_pred hcccCce-----eEEEeeeee--------cCceEEEEEeccCCChHHHhhcccC--------------------cccccc
Q 002509 638 RIHHRNL-----VQFLGYCQE--------EGRSVLVYEFMHNGTLKEHLYGTLT--------------------HEQRIN 684 (914)
Q Consensus 638 ~l~HpnI-----v~l~g~~~~--------~~~~~LV~E~~~~gsL~~~L~~~~~--------------------~~~~l~ 684 (914)
+++|.++ ++++++|.. ++..+|||||+++|+|.++++.... ....++
T Consensus 228 ~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~ 307 (507)
T PLN03224 228 KIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRD 307 (507)
T ss_pred HhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCC
Confidence 8877654 677888753 3567999999999999999875321 112356
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCceeeccccCCcccCcccccc
Q 002509 685 WIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 764 (914)
Q Consensus 685 ~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 764 (914)
|..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++..............+|+.|+|||.+..
T Consensus 308 ~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~ 384 (507)
T PLN03224 308 INVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVM 384 (507)
T ss_pred HHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcC
Confidence 788899999999999999998 99999999999999999999999999997654332222222235789999998854
Q ss_pred CCC----------------------CccCceeehHHHHHHHHhCCC-Ccccccc-----cccchhHHHHHHHhhhcCCcc
Q 002509 765 QQL----------------------TDKSDVYSFGVILLELISGQE-AISNEKF-----GANCRNIVQWAKLHIESGDIQ 816 (914)
Q Consensus 765 ~~~----------------------s~ksDV~S~Gvvl~ElltG~~-p~~~~~~-----~~~~~~l~~~~~~~~~~~~~~ 816 (914)
... ..+.||||+||+++||++|.. |+..... ......+..|.. ......
T Consensus 385 ~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~~~~~~- 461 (507)
T PLN03224 385 PQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--YKGQKY- 461 (507)
T ss_pred CCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--hcccCC-
Confidence 221 134699999999999999875 6643211 111112222321 111111
Q ss_pred cccCCccCCccCHHHHHHHHHHHHHccCCCC---CCCCCHHHHHHH
Q 002509 817 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHG---HMRPSISEVLKD 859 (914)
Q Consensus 817 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P---~~RPsm~eVl~~ 859 (914)
+-..... .-....+++.+++..+| .+|+|++|+++|
T Consensus 462 ---~~~~~d~----~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 462 ---DFSLLDR----NKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ---Ccccccc----cChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 1111111 12245667777887655 789999999875
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=291.37 Aligned_cols=259 Identities=24% Similarity=0.278 Sum_probs=166.5
Q ss_pred HHHhccccccCcEEEEEEEEC-C----CcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEee------eeecCc
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-D----GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY------CQEEGR 656 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~----g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~------~~~~~~ 656 (914)
+.+.+.||+|+||.||+|++. + +..||||++..... .+....| .+....+.++..++.. +.....
T Consensus 134 y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred eEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCc
Confidence 345679999999999999886 4 68999998754321 1111111 1222222222222211 245668
Q ss_pred eEEEEEeccCCChHHHhhcccC----------------ccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCce
Q 002509 657 SVLVYEFMHNGTLKEHLYGTLT----------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 720 (914)
Q Consensus 657 ~~LV~E~~~~gsL~~~L~~~~~----------------~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NI 720 (914)
.++||||+++++|.+++..... .........+..++.|+++||+|||+. +|+||||||+||
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NI 286 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNI 286 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHE
Confidence 8999999999999998864310 001112334567999999999999998 999999999999
Q ss_pred EeCC-CCcEEEeeccccccccCCCCceeeccccCCcccCccccccC----------------------CCCccCceeehH
Q 002509 721 LLDK-HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ----------------------QLTDKSDVYSFG 777 (914)
Q Consensus 721 Ll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----------------------~~s~ksDV~S~G 777 (914)
|+++ ++.+||+|||+++..............+++.|+|||.+... .+..++||||||
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 9986 57999999999986654444444456789999999965322 234567999999
Q ss_pred HHHHHHHhCCCCcccccc------cccchhHHHHHHHhhhcCCcccccCCccCCccCH--HHHHHHHHHHHHccCCCCCC
Q 002509 778 VILLELISGQEAISNEKF------GANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI--QSMWKIEEKALMCVLPHGHM 849 (914)
Q Consensus 778 vvl~ElltG~~p~~~~~~------~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~--~~~~~l~~l~~~C~~~~P~~ 849 (914)
|+||||+++..+.+.... ......+..|....... ..+.+...++. .......+++.+|++.||++
T Consensus 367 viL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 367 LIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred HHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 999999998766432110 00011122232111100 00000000000 01123457999999999999
Q ss_pred CCCHHHHHHH
Q 002509 850 RPSISEVLKD 859 (914)
Q Consensus 850 RPsm~eVl~~ 859 (914)
|||++|++++
T Consensus 441 R~ta~e~L~H 450 (566)
T PLN03225 441 RISAKAALAH 450 (566)
T ss_pred CCCHHHHhCC
Confidence 9999999986
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=279.28 Aligned_cols=238 Identities=21% Similarity=0.322 Sum_probs=188.5
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhc-ccCceeEEEeeeeecCceEEEEEec
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
.+.+...+|.|+|+.|-++... +++..+||++... ..+-.+|+.++.+. +||||+++.+.+.+..+.++|||.+
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l 398 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL 398 (612)
T ss_pred hhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence 4456677999999999988765 6889999998755 23345677666666 7999999999999999999999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEe-CCCCcEEEeeccccccccCCC
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL-DKHMRAKVSDFGLSKFAVDGA 743 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl-~~~~~~kl~DFGla~~~~~~~ 743 (914)
.++-+.+.+.... ....++..|+.+|+.|+.|||++ ++|||||||+|||+ ++.++++|+|||.++.....
T Consensus 399 ~g~ell~ri~~~~-----~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 399 DGGELLRRIRSKP-----EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred cccHHHHHHHhcc-----hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9998888775331 22256677999999999999998 99999999999999 58899999999999876543
Q ss_pred CceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCcc
Q 002509 744 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 823 (914)
Q Consensus 744 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 823 (914)
....+-|..|.|||++....+++++|+||||++||||++|+.||.....+ ..+.. .+..++..
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~----~i~~~~~s------- 532 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHT----RIQMPKFS------- 532 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHH----hhcCCccc-------
Confidence 12224588999999999999999999999999999999999999765532 12222 22222111
Q ss_pred CCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 824 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 824 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
...-....+|+.+|++.||.+||+|.|+..+
T Consensus 533 -----~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 533 -----ECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred -----cccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 1122346688889999999999999999763
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-29 Score=292.59 Aligned_cols=208 Identities=26% Similarity=0.323 Sum_probs=177.0
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecC---CcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEe
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 663 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~ 663 (914)
+.+.++||+|+||.|...+++ .++.+|+|++++. ......-|.+|-.+|..-+.+=|+.++-.|++...+|+||||
T Consensus 77 feilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY 156 (1317)
T KOG0612|consen 77 FEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDY 156 (1317)
T ss_pred hHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEec
Confidence 345689999999999999987 6788999999863 233345688899999988899999999999999999999999
Q ss_pred ccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCC
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 743 (914)
Q Consensus 664 ~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 743 (914)
|+||+|..++... .+++..-...++..|.-||.-||+. |+|||||||+|||||..|++||+|||.+-.+....
T Consensus 157 ~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 157 MPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG 229 (1317)
T ss_pred ccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence 9999999998543 3678777888999999999999998 99999999999999999999999999886665444
Q ss_pred CceeeccccCCcccCcccccc-----CCCCccCceeehHHHHHHHHhCCCCcccccccccchhH
Q 002509 744 SHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 802 (914)
Q Consensus 744 ~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l 802 (914)
...+...+|||.|++||++.. +.|...+|-||+||++|||+.|..||..+..-++...|
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KI 293 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKI 293 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHH
Confidence 555667789999999999962 57889999999999999999999999765543333333
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=260.70 Aligned_cols=259 Identities=24% Similarity=0.333 Sum_probs=196.5
Q ss_pred HHHHHHHHhccccccCcEEEEEEEE-CCCcEEEEEEEecCCccc-------chhhhHHHHHHhhcccCceeEEEeeee-e
Q 002509 583 IEDATKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQG-------KREFTNEVTLLSRIHHRNLVQFLGYCQ-E 653 (914)
Q Consensus 583 i~~~~~~~~~~lG~G~~G~Vy~~~~-~~g~~vAVK~l~~~~~~~-------~~~f~~E~~~l~~l~HpnIv~l~g~~~-~ 653 (914)
....+|-+.++||+|||+.||||.. ...+.||||+-..+..+. .+...+|..+.+.+.||.||++++|+. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 4455677788999999999999954 467889999865443221 134568999999999999999999986 4
Q ss_pred cCceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCC---CCcEEE
Q 002509 654 EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKV 730 (914)
Q Consensus 654 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl 730 (914)
.+..|-|+|||+|.+|.-+|. ..+.+++.+...|+.||..||.||.+. .++|||-||||.||||-. -|.+||
T Consensus 540 tdsFCTVLEYceGNDLDFYLK----QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLK----QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred cccceeeeeecCCCchhHHHH----hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEe
Confidence 567899999999999999985 345688999999999999999999986 579999999999999954 478999
Q ss_pred eeccccccccCCCCc------eeeccccCCcccCccccccC----CCCccCceeehHHHHHHHHhCCCCcccccccccch
Q 002509 731 SDFGLSKFAVDGASH------VSSIVRGTVGYLDPEYYISQ----QLTDKSDVYSFGVILLELISGQEAISNEKFGANCR 800 (914)
Q Consensus 731 ~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~----~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~ 800 (914)
.|||+++++.+.... .+....||.+|++||++.-+ +++.|.||||.|||+|.++.|+.||..... .+
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs---QQ 691 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS---QQ 691 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh---HH
Confidence 999999988654322 34556799999999998633 578899999999999999999999975332 23
Q ss_pred hHHHHHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002509 801 NIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 858 (914)
Q Consensus 801 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 858 (914)
+|++.- .+...-+-.+.. -+....+...++.+|++..-++|-...++..
T Consensus 692 dILqeN-------TIlkAtEVqFP~--KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 692 DILQEN-------TILKATEVQFPP--KPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred HHHhhh-------chhcceeccCCC--CCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 444321 111111101100 0111234567889999999999977666654
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-29 Score=263.98 Aligned_cols=238 Identities=25% Similarity=0.314 Sum_probs=188.4
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcc---cchhhhHHHHHHhhc-ccCceeEEEeeeeecCceEEEEE
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 662 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~---~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E 662 (914)
.+|..+||+|+||.|-.|..+ ..+.+|||+++++-.- +.+--+.|-++|... +-|.+++++.+++.-+++++|||
T Consensus 351 FnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVME 430 (683)
T KOG0696|consen 351 FNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVME 430 (683)
T ss_pred cceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEE
Confidence 467789999999999999777 4567899999876322 122234566666655 67899999999999999999999
Q ss_pred eccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCC
Q 002509 663 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 742 (914)
Q Consensus 663 ~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 742 (914)
|+.+|+|.-++. +-.++.+..+..+|.+||-||-+||++ +|+.||||.+|||||.+|++||+|||+++.-.-
T Consensus 431 yvnGGDLMyhiQ----Q~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~- 502 (683)
T KOG0696|consen 431 YVNGGDLMYHIQ----QVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF- 502 (683)
T ss_pred EecCchhhhHHH----HhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccccc-
Confidence 999999988885 345677778888999999999999999 999999999999999999999999999975322
Q ss_pred CCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCc
Q 002509 743 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 822 (914)
Q Consensus 743 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 822 (914)
....+...+||+.|+|||.+...+|....|-|||||+||||+.|+.||+++...+..+.|.+ ..
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~e----------------hn 566 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIME----------------HN 566 (683)
T ss_pred CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH----------------cc
Confidence 23345668899999999999999999999999999999999999999997764433333322 11
Q ss_pred cCCccCHHHHHHHHHHHHHccCCCCCCCC
Q 002509 823 LLDEYDIQSMWKIEEKALMCVLPHGHMRP 851 (914)
Q Consensus 823 l~~~~~~~~~~~l~~l~~~C~~~~P~~RP 851 (914)
. .++.....+...+...-+...|.+|-
T Consensus 567 v--syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 567 V--SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred C--cCcccccHHHHHHHHHHhhcCCcccc
Confidence 1 12222233456677777888888883
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=251.82 Aligned_cols=242 Identities=24% Similarity=0.282 Sum_probs=190.7
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhc-ccCceeEEEeeeee----cCceEEEEEecc
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE----EGRSVLVYEFMH 665 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~----~~~~~LV~E~~~ 665 (914)
++||-|-.|.|-....+ +|+.+|+|++... ....+|+++.-.. .|||||.+++++.. ...+++|||.|+
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me 142 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME 142 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence 68999999999988766 7899999998642 3456788876655 69999999998754 456789999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCC---CCcEEEeeccccccccCC
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVDG 742 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~~~ 742 (914)
||.|...+.++ ..+.+++.+.-.|+.||+.|+.|||+. .|.||||||+|+|... |..+||+|||+|+.....
T Consensus 143 GGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~ 217 (400)
T KOG0604|consen 143 GGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP 217 (400)
T ss_pred chHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCCC
Confidence 99999999655 355689999999999999999999998 9999999999999974 457999999999865432
Q ss_pred CCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCc
Q 002509 743 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 822 (914)
Q Consensus 743 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 822 (914)
......+-|+.|.|||++...+|...+|+||+||++|-|++|.+||..... ..+.--.+..++.+.+.
T Consensus 218 --~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg----~aispgMk~rI~~gqy~------ 285 (400)
T KOG0604|consen 218 --GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG----LAISPGMKRRIRTGQYE------ 285 (400)
T ss_pred --ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC----ccCChhHHhHhhccCcc------
Confidence 223344579999999999999999999999999999999999999965432 22222233333333221
Q ss_pred cCCccCHH----HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 823 LLDEYDIQ----SMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 823 l~~~~~~~----~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
++.+ ..+...+++...+..+|.+|-|+.|++.+
T Consensus 286 ----FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 286 ----FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ----CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 2222 22345678888889999999999999865
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-29 Score=264.29 Aligned_cols=273 Identities=20% Similarity=0.256 Sum_probs=204.4
Q ss_pred cccCHHHHHHHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhccc--C----ceeEEE
Q 002509 576 HCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH--R----NLVQFL 648 (914)
Q Consensus 576 ~~~~~~ei~~~~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H--p----nIv~l~ 648 (914)
-.+...|....++.+...+|+|.||.|-..-.. .+..||||+++.-... .+..+-|+++|+++.+ | -+|.+.
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 456777888888889999999999999988654 4788999998765332 4456779999999943 2 278888
Q ss_pred eeeeecCceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeC-----
Q 002509 649 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD----- 723 (914)
Q Consensus 649 g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~----- 723 (914)
+|+.-.++.|+|+|.+ |.|+.++|... ...+++...+..|+.|+++++++||+. +++|-||||+|||+.
T Consensus 158 ~wFdyrghiCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred hhhhccCceEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceE
Confidence 9999999999999988 44899999654 456788889999999999999999999 999999999999983
Q ss_pred ---------------CCCcEEEeeccccccccCCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCC
Q 002509 724 ---------------KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 788 (914)
Q Consensus 724 ---------------~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~ 788 (914)
++..+||+|||.|++..... ...+.|..|.|||++.+..++.++||||+||||.|+++|..
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~ 307 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGET 307 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccce
Confidence 13459999999997643322 34457999999999999999999999999999999999999
Q ss_pred Ccccccccc-----------cchhHHHH--HHHhhhcCCc-----------ccccCCcc----CCccCHHHHHHHHHHHH
Q 002509 789 AISNEKFGA-----------NCRNIVQW--AKLHIESGDI-----------QGIIDPSL----LDEYDIQSMWKIEEKAL 840 (914)
Q Consensus 789 p~~~~~~~~-----------~~~~l~~~--~~~~~~~~~~-----------~~i~d~~l----~~~~~~~~~~~l~~l~~ 840 (914)
-|......+ ....+.+- ....+..+++ ..+.++.. .-.....+..++.+|+.
T Consensus 308 LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 308 LFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred ecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 886433111 11111111 1111111111 00111100 00112345667999999
Q ss_pred HccCCCCCCCCCHHHHHHH
Q 002509 841 MCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 841 ~C~~~~P~~RPsm~eVl~~ 859 (914)
.++..||.+|+|+.|++++
T Consensus 388 ~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHccCccccccHHHHhcC
Confidence 9999999999999999874
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=282.11 Aligned_cols=243 Identities=28% Similarity=0.382 Sum_probs=185.5
Q ss_pred ccccccCcE-EEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhhc-ccCceeEEEeeeeecCceEEEEEeccCCCh
Q 002509 592 KKIGSGGFG-VVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 669 (914)
Q Consensus 592 ~~lG~G~~G-~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 669 (914)
+++|.|+.| .||+|... |++||||++-.. ...-..+|+..|+.- .|||||++++.-.+++..++..|.|.. +|
T Consensus 515 eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL 589 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SL 589 (903)
T ss_pred HHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hH
Confidence 578999998 67999997 889999987533 233457899999988 699999999888888999999999976 99
Q ss_pred HHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCC---C--CcEEEeeccccccccCCCC
Q 002509 670 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---H--MRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 670 ~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~--~~~kl~DFGla~~~~~~~~ 744 (914)
.+++.....+.....-...+.+..|++.||+|||+. +||||||||.||||+. + .+++|+|||+++....+..
T Consensus 590 ~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 590 QDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred HHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 999976311111111144567889999999999997 9999999999999976 3 5799999999988766554
Q ss_pred cee--eccccCCcccCccccccCCCCccCceeehHHHHHHHHhC-CCCcccccccccchhHHHHHHHhhhcCCcccccCC
Q 002509 745 HVS--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG-QEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 821 (914)
Q Consensus 745 ~~~--~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG-~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 821 (914)
... ....||-||+|||.+....-+.+.||||+|||+|..++| ..||......+ .+|+. .......
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~-------~~~~L~~--- 734 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILT-------GNYTLVH--- 734 (903)
T ss_pred hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhc-------Cccceee---
Confidence 433 345699999999999988888899999999999999996 89996432111 11111 0000000
Q ss_pred ccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 822 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 822 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+.. ..++ +..+|+.+|++++|..||++.+|+.+
T Consensus 735 -L~~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 735 -LEP--LPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred -ecc--CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 111 1111 67789999999999999999999955
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=232.63 Aligned_cols=197 Identities=27% Similarity=0.412 Sum_probs=165.3
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecC-CcccchhhhHHHHHHhhc-ccCceeEEEeeeeecCceEEEEEeccCCC
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGT 668 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~gs 668 (914)
..||+|++|.|=+-++. +|+..|||.++.. ..+..+....|+.+..+. .+|.+|.++|........++.||.|.- |
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-S 130 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-S 130 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-h
Confidence 46999999999888765 7999999998754 233455667777776554 799999999999999999999999975 7
Q ss_pred hHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCceee
Q 002509 669 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 748 (914)
Q Consensus 669 L~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 748 (914)
|..+-......+..+++.-.-+||..+.+||.|||++ ..++|||+||+|||++.+|++|++|||.+-.+.++. ..+
T Consensus 131 ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi--Akt 206 (282)
T KOG0984|consen 131 LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI--AKT 206 (282)
T ss_pred HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhh--HHH
Confidence 7776655556678899999999999999999999998 489999999999999999999999999997765432 223
Q ss_pred ccccCCcccCcccccc----CCCCccCceeehHHHHHHHHhCCCCcccc
Q 002509 749 IVRGTVGYLDPEYYIS----QQLTDKSDVYSFGVILLELISGQEAISNE 793 (914)
Q Consensus 749 ~~~gt~~Y~aPE~~~~----~~~s~ksDV~S~Gvvl~ElltG~~p~~~~ 793 (914)
...|-..|||||.+.. ..|+-|+||||||+.+.||.+++.|++..
T Consensus 207 ~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 207 MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 3457889999999863 46889999999999999999999998653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-26 Score=234.27 Aligned_cols=211 Identities=35% Similarity=0.609 Sum_probs=182.9
Q ss_pred ccccCcEEEEEEEECC-CcEEEEEEEecCCcc-cchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCChHH
Q 002509 594 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKE 671 (914)
Q Consensus 594 lG~G~~G~Vy~~~~~~-g~~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~ 671 (914)
||+|.+|.||+++... ++.+++|++...... ....+.+|++.+++++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998874 899999998765432 34678999999999999999999999999999999999999999999
Q ss_pred HhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCC-CCcEEEeeccccccccCCCCceeecc
Q 002509 672 HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGASHVSSIV 750 (914)
Q Consensus 672 ~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~ 750 (914)
++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. +++++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 985431 4688899999999999999999998 9999999999999999 89999999999876544321 12224
Q ss_pred ccCCcccCccccccC-CCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccCH
Q 002509 751 RGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 829 (914)
Q Consensus 751 ~gt~~Y~aPE~~~~~-~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 829 (914)
.+...|++||..... ..+.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 478899999999877 788999999999999999
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002509 830 QSMWKIEEKALMCVLPHGHMRPSISEVLKDI 860 (914)
Q Consensus 830 ~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L 860 (914)
..+.+++..|++.+|++||++.++++.+
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3578899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-27 Score=242.75 Aligned_cols=244 Identities=23% Similarity=0.324 Sum_probs=190.3
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEEecC---CcccchhhhHHHHHHhhc-ccCceeEEEeeeeecCceEEEEEec
Q 002509 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
+.++||+|+|+.|-.++++ ..+-+|+|++++. ..++....+.|-.+.... +||.+|.++.+++.+.++++|.||+
T Consensus 254 ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv 333 (593)
T KOG0695|consen 254 LLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYV 333 (593)
T ss_pred eeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEe
Confidence 3478999999999999877 5677899998764 233344456666666665 7999999999999999999999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCC
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 744 (914)
++|+|.-++. ..+++++.....+...|.-||.|||+. +|+.||||..|||+|..|++||.|+|+++.-. ...
T Consensus 334 ~ggdlmfhmq----rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l-~~g 405 (593)
T KOG0695|consen 334 NGGDLMFHMQ----RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-GPG 405 (593)
T ss_pred cCcceeeehh----hhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC-CCC
Confidence 9999987774 356788888888999999999999999 99999999999999999999999999987543 234
Q ss_pred ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccC
Q 002509 745 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 824 (914)
..+..++||+.|+|||.+.+..|....|-|++||+++||+.|+.||+.........+-.++.-..+-+..+. +...+
T Consensus 406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir--iprsl- 482 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR--IPRSL- 482 (593)
T ss_pred cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc--cccee-
Confidence 456678999999999999999999999999999999999999999975433333333333433333322221 00111
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCC
Q 002509 825 DEYDIQSMWKIEEKALMCVLPHGHMRP 851 (914)
Q Consensus 825 ~~~~~~~~~~l~~l~~~C~~~~P~~RP 851 (914)
..+...+...-+..||++|-
T Consensus 483 -------svkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 483 -------SVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred -------ehhhHHHHHHhhcCCcHHhc
Confidence 11344556677889999884
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=259.09 Aligned_cols=243 Identities=22% Similarity=0.283 Sum_probs=195.3
Q ss_pred ccccccCcEEEEEEEECCCcE-EEEEEEecCCcc---cchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCC
Q 002509 592 KKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 667 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~~g~~-vAVK~l~~~~~~---~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 667 (914)
..||-|+||.|=..+.+.... +|+|++++.... ..+....|-.+|..++.|.||+++-.+.+....++.||-|-||
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG 505 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG 505 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence 369999999999998875443 899998765332 2345678999999999999999999999999999999999999
Q ss_pred ChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCcee
Q 002509 668 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 747 (914)
Q Consensus 668 sL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 747 (914)
.|...|+. ++.++......++..+.+|++|||++ +||.|||||+|.+|+.+|-+||.|||+|+....+ ..+
T Consensus 506 ElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g--~KT 576 (732)
T KOG0614|consen 506 ELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG--RKT 576 (732)
T ss_pred hhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC--Cce
Confidence 99999964 45677778888999999999999999 9999999999999999999999999999987554 334
Q ss_pred eccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCcc
Q 002509 748 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 827 (914)
Q Consensus 748 ~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 827 (914)
-.++||+.|.|||.+..+....++|.||||++++||++|.+||...+.-.....|+..+... ++
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i----------------~~ 640 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI----------------EF 640 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh----------------hc
Confidence 55789999999999999999999999999999999999999998755333333333221110 11
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 002509 828 DIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 859 (914)
Q Consensus 828 ~~~~~~~l~~l~~~C~~~~P~~RPs-----m~eVl~~ 859 (914)
+........+++.+.+..+|.+|-. +.||-++
T Consensus 641 Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 641 PRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred ccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 2222334667888888999999965 5555554
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-28 Score=244.06 Aligned_cols=262 Identities=23% Similarity=0.290 Sum_probs=187.1
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecC--CcccchhhhHHHHHHhhcccCceeEEEeeeeecC-----ceEEEEEe
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-----RSVLVYEF 663 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~-----~~~LV~E~ 663 (914)
+-||.|+||.||..+.. +|+.||.|++..- +-...+.+.+|+++|...+|.|++..++...-.+ +.+++.|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 57999999999998765 8999999988643 2233567889999999999999999988776543 45667777
Q ss_pred ccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCC
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 743 (914)
Q Consensus 664 ~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 743 (914)
|.. +|+..+ ...+.++-..+.-+..||++||.|||+. +|.||||||.|.|++.+...||+|||+++......
T Consensus 139 mQS-DLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 139 MQS-DLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHh-hhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhh
Confidence 654 555444 4567788888888999999999999998 99999999999999999999999999998766555
Q ss_pred CceeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhH---------------HHHHH
Q 002509 744 SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI---------------VQWAK 807 (914)
Q Consensus 744 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l---------------~~~~~ 807 (914)
....+...-|..|+|||.+++ +.|+.+.||||.||++.|++..+.-|.....-+-.+-| .+.++
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 555555557899999999987 57999999999999999999888777533221111111 11111
Q ss_pred HhhhcCCcccccCCccCCccC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002509 808 LHIESGDIQGIIDPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861 (914)
Q Consensus 808 ~~~~~~~~~~i~d~~l~~~~~-~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 861 (914)
..+-.+....---+.+..-.+ ...--+-+.+.+.++..||.+|-+-.+.+.++-
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 111111111000011111000 011123456667788999999999888877643
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=254.47 Aligned_cols=209 Identities=25% Similarity=0.369 Sum_probs=172.2
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCCccc---chhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCC
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 667 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~---~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 667 (914)
+.||-|+||.|..++-. +...+|+|.+++.+... ......|-.||.....+=||+|+-.|++++.+++||||++||
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 45999999999999654 45668999987654322 234567889999999999999999999999999999999999
Q ss_pred ChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccc--------
Q 002509 668 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA-------- 739 (914)
Q Consensus 668 sL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~-------- 739 (914)
++..+|-.. +.+.+.....++.++..|+++.|.. |+|||||||+|||||.+|++||.||||+.-+
T Consensus 715 DmMSLLIrm----gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 715 DMMSLLIRM----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred cHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 999988532 3456666677888999999999998 9999999999999999999999999997421
Q ss_pred -cCCCCc--------------------------------eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhC
Q 002509 740 -VDGASH--------------------------------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 786 (914)
Q Consensus 740 -~~~~~~--------------------------------~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG 786 (914)
..+.-+ .....+||+.|+|||++....++.-+|-||.||||+||+.|
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence 111000 01124599999999999999999999999999999999999
Q ss_pred CCCcccccccccchhHHHHHH
Q 002509 787 QEAISNEKFGANCRNIVQWAK 807 (914)
Q Consensus 787 ~~p~~~~~~~~~~~~l~~~~~ 807 (914)
+.||.....++....+..|-.
T Consensus 868 ~~pf~~~tp~~tq~kv~nw~~ 888 (1034)
T KOG0608|consen 868 QPPFLADTPGETQYKVINWRN 888 (1034)
T ss_pred CCCccCCCCCcceeeeeehhh
Confidence 999988777777777777743
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-25 Score=230.97 Aligned_cols=197 Identities=35% Similarity=0.543 Sum_probs=170.4
Q ss_pred HhccccccCcEEEEEEEECC-CcEEEEEEEecCCcc-cchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCC
Q 002509 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 667 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~~-g~~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 667 (914)
+.+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++|+++++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 82 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG 82 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence 45689999999999999875 899999999866544 5678889999999999999999999999999999999999999
Q ss_pred ChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCcee
Q 002509 668 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 747 (914)
Q Consensus 668 sL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 747 (914)
+|.+++..... .+++.....++.++++++.+||+. +++|+||+|+||+++.++.++|+|||.+...........
T Consensus 83 ~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 83 DLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 99999864321 178899999999999999999998 999999999999999999999999999887654321122
Q ss_pred eccccCCcccCcccc-ccCCCCccCceeehHHHHHHHHhCCCCccc
Q 002509 748 SIVRGTVGYLDPEYY-ISQQLTDKSDVYSFGVILLELISGQEAISN 792 (914)
Q Consensus 748 ~~~~gt~~Y~aPE~~-~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~ 792 (914)
....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 334578899999998 666778899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.8e-25 Score=237.41 Aligned_cols=275 Identities=21% Similarity=0.326 Sum_probs=198.4
Q ss_pred ccccCHHHHHH-HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcc-----c---Cce
Q 002509 575 AHCFTLSDIED-ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-----H---RNL 644 (914)
Q Consensus 575 ~~~~~~~ei~~-~~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-----H---pnI 644 (914)
.+.....|... .+|.+.++||-|.|++||.+-.. ..+.||+|+.+..... .+....|+++|++++ | ..|
T Consensus 66 YHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY-tEaAlDEIklL~~v~~~Dp~~~~~~~V 144 (590)
T KOG1290|consen 66 YHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY-TEAALDEIKLLQQVREGDPNDPGKKCV 144 (590)
T ss_pred CceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH-HHHHHHHHHHHHHHHhcCCCCCCCcee
Confidence 34455666665 78888899999999999999654 6788999998765322 455678999999994 3 469
Q ss_pred eEEEeeeee----cCceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCce
Q 002509 645 VQFLGYCQE----EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 720 (914)
Q Consensus 645 v~l~g~~~~----~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NI 720 (914)
|+|+++|.. +.+.|+|+|++.. +|..+|... ..+.++...+.+|+.||+.||.|||..| +|||-||||+||
T Consensus 145 V~LlD~FkhsGpNG~HVCMVfEvLGd-nLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENv 219 (590)
T KOG1290|consen 145 VQLLDHFKHSGPNGQHVCMVFEVLGD-NLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENV 219 (590)
T ss_pred eeeeccceecCCCCcEEEEEehhhhh-HHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCccee
Confidence 999999965 3578999999854 777777543 4667889999999999999999999998 999999999999
Q ss_pred EeCCC---------------------------------------------------------------------------
Q 002509 721 LLDKH--------------------------------------------------------------------------- 725 (914)
Q Consensus 721 Ll~~~--------------------------------------------------------------------------- 725 (914)
|+..+
T Consensus 220 Ll~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~ 299 (590)
T KOG1290|consen 220 LLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPN 299 (590)
T ss_pred eeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccc
Confidence 98100
Q ss_pred --------------------------------------------------------------------------------
Q 002509 726 -------------------------------------------------------------------------------- 725 (914)
Q Consensus 726 -------------------------------------------------------------------------------- 725 (914)
T Consensus 300 ~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~ 379 (590)
T KOG1290|consen 300 QESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPL 379 (590)
T ss_pred ccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccc
Confidence
Q ss_pred -----------CcEEEeeccccccccCCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCccc--
Q 002509 726 -----------MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN-- 792 (914)
Q Consensus 726 -----------~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~-- 792 (914)
.++||+|||-|+.... ..+.-.-|..|+|||++.+..|++.+||||++|+++||+||...|+.
T Consensus 380 v~p~~~~~~~di~vKIaDlGNACW~~k----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhs 455 (590)
T KOG1290|consen 380 VNPDIPLPECDIRVKIADLGNACWVHK----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHS 455 (590)
T ss_pred cCCCCCCCccceeEEEeeccchhhhhh----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCC
Confidence 0134444444443211 11111247789999999999999999999999999999999988753
Q ss_pred -ccccccchhHHHHHH-------HhhhcCCc-ccccCCcc----------C-------C--ccCHHHHHHHHHHHHHccC
Q 002509 793 -EKFGANCRNIVQWAK-------LHIESGDI-QGIIDPSL----------L-------D--EYDIQSMWKIEEKALMCVL 844 (914)
Q Consensus 793 -~~~~~~~~~l~~~~~-------~~~~~~~~-~~i~d~~l----------~-------~--~~~~~~~~~l~~l~~~C~~ 844 (914)
........+|...+. .....|+. .+.++.+- . . +++.++..++.++..-|++
T Consensus 456 G~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLe 535 (590)
T KOG1290|consen 456 GENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLE 535 (590)
T ss_pred CCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHh
Confidence 223333344433221 11112221 12222211 1 1 2346777889999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 002509 845 PHGHMRPSISEVLKD 859 (914)
Q Consensus 845 ~~P~~RPsm~eVl~~ 859 (914)
.+|++|||+.+.+++
T Consensus 536 f~PeKR~tA~~cl~h 550 (590)
T KOG1290|consen 536 FDPEKRPTAAQCLKH 550 (590)
T ss_pred cCccccccHHHHhcC
Confidence 999999999999875
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-25 Score=217.93 Aligned_cols=256 Identities=20% Similarity=0.324 Sum_probs=191.9
Q ss_pred HHHHhccccccCcEEEEEEEE-CCCcEEEEEEEecCCcccchhhhHHHHHHhhcc-cCceeEEEeeeeec--CceEEEEE
Q 002509 587 TKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEE--GRSVLVYE 662 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~--~~~~LV~E 662 (914)
.+++.+++|+|.++.|+.|.. .+.+.++||+++.. .++.+.+|+.+|..++ ||||+++++...++ ....||+|
T Consensus 39 dYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 39 DYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred hHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 356778999999999999964 47889999999753 4567889999999997 99999999998765 45679999
Q ss_pred eccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCC-CcEEEeeccccccccC
Q 002509 663 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVD 741 (914)
Q Consensus 663 ~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~ 741 (914)
|+.+-+.... -+.++-..+.....+++.||.|+|+. ||.|||+||+|+++|.. -..+|+|+|+|.++.+
T Consensus 116 ~v~n~Dfk~l-------y~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 116 YVNNTDFKQL-------YPTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhccccHHHH-------hhhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 9999776543 23466667788999999999999998 99999999999999975 4799999999998766
Q ss_pred CCCceeeccccCCcccCcccccc-CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhc------CC
Q 002509 742 GASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES------GD 814 (914)
Q Consensus 742 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~------~~ 814 (914)
+... ...+.+..|.-||.+.. ..|...-|+|||||++.+|+..+.||-... +...+++..++-.-.+ ++
T Consensus 186 ~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~--dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 186 GKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH--DNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred Ccee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC--CCHHHHHHHHHHhChHHHHHHHHH
Confidence 5433 23446778899999976 456778899999999999999999984321 2234555443311110 01
Q ss_pred cccccCCccCC---ccC------------H-HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 815 IQGIIDPSLLD---EYD------------I-QSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 815 ~~~i~d~~l~~---~~~------------~-~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
..-.+||+..+ ..+ . -...+.+++....+..|-.+|||++|.+.+
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 11123333221 000 0 012457788889999999999999999876
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-25 Score=245.89 Aligned_cols=191 Identities=22% Similarity=0.415 Sum_probs=163.6
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEEecCCcc--------cchhhhHHHHHHhhcc---cCceeEEEeeeeecCceE
Q 002509 591 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--------GKREFTNEVTLLSRIH---HRNLVQFLGYCQEEGRSV 658 (914)
Q Consensus 591 ~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~--------~~~~f~~E~~~l~~l~---HpnIv~l~g~~~~~~~~~ 658 (914)
.+.+|+|+||.|+.+.++ +..+|+||++.+...- .......|+++|..++ |+||++++++|++++.++
T Consensus 566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy 645 (772)
T KOG1152|consen 566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY 645 (772)
T ss_pred eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence 367999999999999887 5678999998764221 1234667999999997 999999999999999999
Q ss_pred EEEEecc-CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccc
Q 002509 659 LVYEFMH-NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 737 (914)
Q Consensus 659 LV~E~~~-~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 737 (914)
|++|-.. +-+|.+++. ...++++.+...|..|++.|++|||+. +|||||||-+||.++.+|-+||+|||.+.
T Consensus 646 l~te~hg~gIDLFd~IE----~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 646 LETEVHGEGIDLFDFIE----FKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred EEecCCCCCcchhhhhh----ccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchh
Confidence 9999754 458888884 456789999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCceeeccccCCcccCccccccCCCCc-cCceeehHHHHHHHHhCCCCcc
Q 002509 738 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-KSDVYSFGVILLELISGQEAIS 791 (914)
Q Consensus 738 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~-ksDV~S~Gvvl~ElltG~~p~~ 791 (914)
....+ ....++||.+|.|||++.+.+|-- .-|||++|++||-++....|+.
T Consensus 719 ~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 719 YTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 65443 345578999999999999888765 4699999999999999888874
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-25 Score=241.68 Aligned_cols=217 Identities=21% Similarity=0.293 Sum_probs=180.0
Q ss_pred CCCCcccccccCHHHHHHHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhccc-----
Q 002509 568 NDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH----- 641 (914)
Q Consensus 568 ~~~~~~~~~~~~~~ei~~~~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H----- 641 (914)
+...++..-.+.+.|+....|.+.-..|+|-|++|.+|... .|..||||+++.+.... +.=..|+++|++|+.
T Consensus 414 NWdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~-KtGl~EleiLkKL~~AD~Ed 492 (752)
T KOG0670|consen 414 NWDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH-KTGLKELEILKKLNDADPED 492 (752)
T ss_pred CcccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh-hhhhHHHHHHHHhhccCchh
Confidence 44456667778899999999998889999999999999765 58899999998775443 334679999999952
Q ss_pred -CceeEEEeeeeecCceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCce
Q 002509 642 -RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 720 (914)
Q Consensus 642 -pnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NI 720 (914)
-+.++++-.|...+++|||+|-+. .+|.+.|... .....|....+..++.|+.-||..|..+ +|+|.||||.||
T Consensus 493 k~Hclrl~r~F~hknHLClVFE~Ls-lNLRevLKKy-G~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNi 567 (752)
T KOG0670|consen 493 KFHCLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKY-GRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNI 567 (752)
T ss_pred hhHHHHHHHHhhhcceeEEEehhhh-chHHHHHHHh-CcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccce
Confidence 478888889999999999999764 5899988654 3455678888899999999999999998 999999999999
Q ss_pred EeCCC-CcEEEeeccccccccCCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccc
Q 002509 721 LLDKH-MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 793 (914)
Q Consensus 721 Ll~~~-~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~ 793 (914)
|+++. ...||||||.|.......- +...-+.-|.|||++.+.+|....|+||.||.||||.||+..|.+.
T Consensus 568 LVNE~k~iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 568 LVNESKNILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred EeccCcceeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 99986 4689999999876544321 1122356799999999999999999999999999999999988653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-25 Score=247.77 Aligned_cols=250 Identities=23% Similarity=0.342 Sum_probs=196.4
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCC
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 667 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 667 (914)
++..++|.|.+|.|||++.. .++..|||+++........-..+|+-+++.++|||||.++|-+...+..++.||||.+|
T Consensus 18 ellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycggg 97 (829)
T KOG0576|consen 18 ELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGG 97 (829)
T ss_pred hheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCC
Confidence 34568999999999999876 78999999999887777788889999999999999999999999999999999999999
Q ss_pred ChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCcee
Q 002509 668 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 747 (914)
Q Consensus 668 sL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 747 (914)
+|++.-+. ...+++.++..+++...+||+|||+. +=+|||||-.|||+++.+.+|++|||.+..+...- ...
T Consensus 98 slQdiy~~----TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~Kr 169 (829)
T KOG0576|consen 98 SLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-AKR 169 (829)
T ss_pred cccceeee----cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh-hhh
Confidence 99987653 45688888889999999999999998 77999999999999999999999999986543221 122
Q ss_pred eccccCCcccCccccc---cCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccC
Q 002509 748 SIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824 (914)
Q Consensus 748 ~~~~gt~~Y~aPE~~~---~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 824 (914)
..+.||+.|||||+.. .+.|..++|||+.|+...|+---+.|....... +.+.---+..+.. |.+.
T Consensus 170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm---r~l~LmTkS~~qp--------p~lk 238 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM---RALFLMTKSGFQP--------PTLK 238 (829)
T ss_pred hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH---HHHHHhhccCCCC--------Cccc
Confidence 3456999999999984 567899999999999999998777775322210 1111111111111 1121
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 825 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 825 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+. ..--..+-+++..|+..+|++||+++.++++
T Consensus 239 Dk--~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 239 DK--TKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred CC--ccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 11 1112347789999999999999999988764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=224.87 Aligned_cols=248 Identities=25% Similarity=0.337 Sum_probs=182.2
Q ss_pred cccccCcEEEEEEEEC-CCcEEEEEEEecC--CcccchhhhHHHHHHhhcccCceeEEEeeeeec------CceEEEEEe
Q 002509 593 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSVLVYEF 663 (914)
Q Consensus 593 ~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~------~~~~LV~E~ 663 (914)
.+|.|.- .|..+... .+++||+|.+... .....+...+|..++..+.|+||++++.++.-. .+.++|||+
T Consensus 24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~ 102 (369)
T KOG0665|consen 24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL 102 (369)
T ss_pred ccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence 5677776 55555433 5889999987543 233456677899999999999999999988643 356899999
Q ss_pred ccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCC
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 743 (914)
Q Consensus 664 ~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 743 (914)
|.. +|...++ ..++-.....|..|++.|+.|||+. +|+||||||+||++..+..+||.|||+|+.....
T Consensus 103 m~~-nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~- 171 (369)
T KOG0665|consen 103 MDA-NLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD- 171 (369)
T ss_pred hhh-HHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc-
Confidence 965 8888775 2355567778999999999999999 9999999999999999999999999999754322
Q ss_pred CceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCC---------
Q 002509 744 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD--------- 814 (914)
Q Consensus 744 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~--------- 814 (914)
...+....|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+.. .+-+|.+..-.-|.
T Consensus 172 -~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d------~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 172 -FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD------HIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred -cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch------HHHHHHHHHHHhcCCCHHHHHHh
Confidence 33455567899999999999889999999999999999999998876432 33333321111110
Q ss_pred ------------------cccccCCcc-CC--ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 815 ------------------IQGIIDPSL-LD--EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 815 ------------------~~~i~d~~l-~~--~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
..+.+...+ .. +.+.-......+++.+|+-.+|++|-+.++++++
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000000000 00 0111122345688999999999999999999987
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=211.56 Aligned_cols=251 Identities=20% Similarity=0.314 Sum_probs=179.5
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhc-ccCceeEEEee-eeecCceEEEEEe
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGY-CQEEGRSVLVYEF 663 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~-~~~~~~~~LV~E~ 663 (914)
.+++.+.+|+|.||.+-.++++ ..+.+++|-+... ....++|.+|..---.| .|.||+.-++. ++..+.+.+++||
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 4567789999999999999887 5778899987643 23467788887654444 68999987764 5667788999999
Q ss_pred ccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeC-C-CCcEEEeeccccccccC
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-K-HMRAKVSDFGLSKFAVD 741 (914)
Q Consensus 664 ~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~-~-~~~~kl~DFGla~~~~~ 741 (914)
++.|+|.+.+. ...+.+....+++.|++.|+.|||++ .+||||||.+||||- . ..++||+|||+++....
T Consensus 104 aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 104 APRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred CccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 99999998873 24466677788999999999999999 999999999999994 3 35899999999865422
Q ss_pred CCCceeeccccCCcccCccccccC-----CCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcc
Q 002509 742 GASHVSSIVRGTVGYLDPEYYISQ-----QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 816 (914)
Q Consensus 742 ~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 816 (914)
......-+..|.+||..... ...+.+|||.||++++.++||+.||...... +....+|.... .+...
T Consensus 176 ----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~--d~~Y~~~~~w~--~rk~~ 247 (378)
T KOG1345|consen 176 ----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM--DKPYWEWEQWL--KRKNP 247 (378)
T ss_pred ----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc--CchHHHHHHHh--cccCc
Confidence 11222346689999988643 3556789999999999999999999844322 23444443222 11111
Q ss_pred cccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002509 817 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 860 (914)
Q Consensus 817 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L 860 (914)
--|+....+.. +.+++-.+-+.+++++|=...++.++-
T Consensus 248 --~~P~~F~~fs~----~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 248 --ALPKKFNPFSE----KALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred --cCchhhcccCH----HHHHHHHHhcCCcccccchhHHHHHHH
Confidence 11222222222 355566677889999996666655543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-24 Score=268.68 Aligned_cols=196 Identities=18% Similarity=0.272 Sum_probs=138.6
Q ss_pred hccc-CceeEEEeee-------eecCceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCC
Q 002509 638 RIHH-RNLVQFLGYC-------QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 709 (914)
Q Consensus 638 ~l~H-pnIv~l~g~~-------~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ 709 (914)
.++| +||++++++| .+....++++|++ +++|.++|... ...+++.+++.++.||++||+|||++ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 4456 6888888877 2234567788887 55999999632 35589999999999999999999998 9
Q ss_pred ccccCCCCCceEeCC-------------------CCcEEEeeccccccccCCC---------------CceeeccccCCc
Q 002509 710 IIHRDLKSSNILLDK-------------------HMRAKVSDFGLSKFAVDGA---------------SHVSSIVRGTVG 755 (914)
Q Consensus 710 ivHrDlkp~NILl~~-------------------~~~~kl~DFGla~~~~~~~---------------~~~~~~~~gt~~ 755 (914)
|+||||||+||||+. ++.+|++|||+++...... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999965 4456666666665321100 000111357889
Q ss_pred ccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccCHHHHHHH
Q 002509 756 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKI 835 (914)
Q Consensus 756 Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l 835 (914)
|+|||++.+..++.++|||||||+||||++|..|+.... ..+...... .+.+.. .....+.
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~~~~~~---------~~~~~~-----~~~~~~~ 241 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMSSLRHR---------VLPPQI-----LLNWPKE 241 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHHHHHHh---------hcChhh-----hhcCHHH
Confidence 999999999999999999999999999999988764211 011111100 011111 1112345
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHH
Q 002509 836 EEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 836 ~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
..++.+|++.+|.+||+|.||+++
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhhc
Confidence 678889999999999999999753
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.7e-23 Score=206.41 Aligned_cols=169 Identities=20% Similarity=0.188 Sum_probs=126.5
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 746 (914)
|+|.++++.. ...++|.+++.++.|+++||+|||+. + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 6899998643 44699999999999999999999997 4 999999999999999 99987654322
Q ss_pred eeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCC-
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD- 825 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~- 825 (914)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+..+.... ... ++....
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~-~~~------~~~~~~~ 131 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGM-PAD------DPRDRSN 131 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHh-ccC------Ccccccc
Confidence 25899999999999999999999999999999999999998643211 11111211111 110 000000
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhH
Q 002509 826 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 864 (914)
Q Consensus 826 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 864 (914)
........++.+++.+|++.+|++||++.|+++++....
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 001111125889999999999999999999999987654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=217.67 Aligned_cols=192 Identities=26% Similarity=0.423 Sum_probs=157.5
Q ss_pred HhccccccCcEEEEEEEEC----CCcEEEEEEEecCCcccchhhhHHHHHHhhc-ccCceeEEEeeeeecCceEEEEEec
Q 002509 590 LEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~----~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
..++||+|.|++||++.+. ..+.||+|.+...+ ......+|+++|..+ .+.||+++.+++...+..++|+||+
T Consensus 40 ~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~ 117 (418)
T KOG1167|consen 40 VVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYF 117 (418)
T ss_pred hhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEeccc
Confidence 4578999999999999754 36789999886543 234578999999999 5899999999999999999999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCC-CcEEEeecccccccc---
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAV--- 740 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~--- 740 (914)
++-.-.++... ++..++..++..+..||+++|.+ |||||||||+|+|.+.. ++-.|.|||+|....
T Consensus 118 ~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~ 187 (418)
T KOG1167|consen 118 EHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ 187 (418)
T ss_pred CccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence 99888887642 45777888999999999999999 99999999999999864 678999999986110
Q ss_pred --------------C--C--------------CCc----------eeeccccCCcccCcccccc-CCCCccCceeehHHH
Q 002509 741 --------------D--G--------------ASH----------VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVI 779 (914)
Q Consensus 741 --------------~--~--------------~~~----------~~~~~~gt~~Y~aPE~~~~-~~~s~ksDV~S~Gvv 779 (914)
. + ... .....+||+||.|||++.. ...+.++||||.|||
T Consensus 188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence 0 0 000 0112459999999999975 456889999999999
Q ss_pred HHHHHhCCCCcccc
Q 002509 780 LLELISGQEAISNE 793 (914)
Q Consensus 780 l~ElltG~~p~~~~ 793 (914)
++.+++++.||-..
T Consensus 268 ~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 268 LLSLLSRRYPFFKA 281 (418)
T ss_pred eehhhccccccccC
Confidence 99999999998543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-22 Score=204.48 Aligned_cols=247 Identities=20% Similarity=0.325 Sum_probs=186.4
Q ss_pred HHhccccccCcEEEEEEEECCCcEEEEEEEecC--CcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccC
Q 002509 589 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 666 (914)
++..+|.+...|..|+|++. |..+++|++... .....+.|.+|.-.|+-..||||++++|.|.......++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 34457899999999999998 677888887644 333457899999999999999999999999999999999999999
Q ss_pred CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEe--eccccccccCCCC
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS--DFGLSKFAVDGAS 744 (914)
Q Consensus 667 gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~--DFGla~~~~~~~~ 744 (914)
|+|...||+. ..-..+-.+..+++.++|+|++|||+.. +-|..--|.++.|++|++.+++|+ |--++. ..
T Consensus 272 gslynvlhe~--t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf---qe-- 343 (448)
T KOG0195|consen 272 GSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF---QE-- 343 (448)
T ss_pred hHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee---ec--
Confidence 9999999875 3455677889999999999999999963 334455789999999999988874 322221 11
Q ss_pred ceeeccccCCcccCccccccCCCC---ccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCC
Q 002509 745 HVSSIVRGTVGYLDPEYYISQQLT---DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 821 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~~~~~s---~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 821 (914)
....-.+.||+||.++..+-. .++|+|||.+++||+.|.+.||.+...-+....+. + + . +..
T Consensus 344 ---~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia------l-e-g----lrv 408 (448)
T KOG0195|consen 344 ---VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA------L-E-G----LRV 408 (448)
T ss_pred ---cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh------h-c-c----ccc
Confidence 111236889999999876543 47899999999999999999997654322111110 0 0 1 111
Q ss_pred ccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 002509 822 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 863 (914)
Q Consensus 822 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 863 (914)
.+ ++.....+.+++.-|+..||.+||.++.|+-.||.+
T Consensus 409 ~i----ppgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 409 HI----PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cC----CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 11 222222466677779999999999999999999865
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.7e-21 Score=214.08 Aligned_cols=161 Identities=19% Similarity=0.162 Sum_probs=124.2
Q ss_pred HHHhccccccCcEEEEEEEEC--CCcEEEEEEEecCC-----cccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEE
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNS-----YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 660 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~--~g~~vAVK~l~~~~-----~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV 660 (914)
|.+.+.||+|+||+||+|+.+ +++.+|||++.... ....+.|.+|+++|++++|+|+++.+.. .+..++|
T Consensus 20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LV 96 (365)
T PRK09188 20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLV 96 (365)
T ss_pred ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEE
Confidence 455678999999999999875 57778999875331 1124568999999999999999853322 2467999
Q ss_pred EEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCC-CCCceEeCCCCcEEEeeccccccc
Q 002509 661 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDL-KSSNILLDKHMRAKVSDFGLSKFA 739 (914)
Q Consensus 661 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDl-kp~NILl~~~~~~kl~DFGla~~~ 739 (914)
|||+++++|... . . .. ...++.++++||+|||+. +|+|||| ||+|||++.++++||+|||+|+..
T Consensus 97 mE~~~G~~L~~~-~-~---~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 97 RGWTEGVPLHLA-R-P---HG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred EEccCCCCHHHh-C-c---cc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 999999999632 1 1 11 135788999999999998 9999999 999999999999999999999876
Q ss_pred cCCCCce-------eeccccCCcccCccccccC
Q 002509 740 VDGASHV-------SSIVRGTVGYLDPEYYISQ 765 (914)
Q Consensus 740 ~~~~~~~-------~~~~~gt~~Y~aPE~~~~~ 765 (914)
....... -....+++.|+|||++...
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 4432111 1345688899999999754
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.8e-20 Score=206.01 Aligned_cols=262 Identities=21% Similarity=0.261 Sum_probs=194.3
Q ss_pred HHHHhccccccCcEEEEEEEECCC--cEEEEEEEecCCcccchhhhHHHHHHhhccc----CceeEEEeee-eecCceEE
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLKDG--KEIAVKVLTSNSYQGKREFTNEVTLLSRIHH----RNLVQFLGYC-QEEGRSVL 659 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~~~g--~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H----pnIv~l~g~~-~~~~~~~L 659 (914)
.+.+.++||+|+||.||.+..... ..+|+|.-..........+..|..++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 455678999999999999987653 4789998766543333378889999999873 5888888888 47778899
Q ss_pred EEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCC-----CcEEEeecc
Q 002509 660 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-----MRAKVSDFG 734 (914)
Q Consensus 660 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-----~~~kl~DFG 734 (914)
||+.+ +.+|.++..... .+.++..+.+.|+.|++.+|++||+. +++||||||.|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99976 568998765442 57899999999999999999999998 99999999999999865 469999999
Q ss_pred ccc--cccCCCC----ce---eeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHH
Q 002509 735 LSK--FAVDGAS----HV---SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW 805 (914)
Q Consensus 735 la~--~~~~~~~----~~---~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~ 805 (914)
+++ ....... .. .....||..|.+++...+...+.+.|+||++.++.|++.|..||...........+.+.
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998 3222111 11 23456999999999999999999999999999999999999998654432221111111
Q ss_pred HHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHhHh
Q 002509 806 AKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 867 (914)
Q Consensus 806 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~~ 867 (914)
.... .... ..... ...+.++...+-..+..++|....+...|++.....
T Consensus 253 ~~~~--------~~~~--~~~~~---~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 253 PRKL--------LTDR--FGDLK---PEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhhh--------cccc--ccCCC---hHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 1111 1110 11112 223555555566689999999999999988876543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.2e-19 Score=194.46 Aligned_cols=259 Identities=29% Similarity=0.420 Sum_probs=194.6
Q ss_pred HhccccccCcEEEEEEEECCCcEEEEEEEecCCcc---cchhhhHHHHHHhhcccC-ceeEEEeeeeecCceEEEEEecc
Q 002509 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHR-NLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~---~~~~f~~E~~~l~~l~Hp-nIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +++++.+.+......+++++++.
T Consensus 4 ~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 81 (384)
T COG0515 4 ILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD 81 (384)
T ss_pred eEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence 4567999999999999887 88999998765333 366789999999999988 79999999977777899999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCC-cEEEeeccccccccCCCC
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~ 744 (914)
++++.+.+...... ..+.......+..|++.++.|+|.. +++|||+||+||+++... .++++|||.++.......
T Consensus 82 ~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 82 GGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 99999766433111 3678888899999999999999998 899999999999999988 799999999975544332
Q ss_pred c-----eeeccccCCcccCcccccc---CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcc
Q 002509 745 H-----VSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 816 (914)
Q Consensus 745 ~-----~~~~~~gt~~Y~aPE~~~~---~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 816 (914)
. ......|+..|+|||.+.+ .......|+||+|++++++++|..|+......................
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---- 233 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP---- 233 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc----
Confidence 2 2355679999999999987 578889999999999999999999965433110011222222111110
Q ss_pred cccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 817 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 817 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
.................+.+++..|+..+|..|.++.+....
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000011110001223457788889999999999999988765
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2e-19 Score=203.54 Aligned_cols=217 Identities=24% Similarity=0.386 Sum_probs=167.7
Q ss_pred HhhcccCceeEEEeeeeecCceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCc-cccC
Q 002509 636 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI-IHRD 714 (914)
Q Consensus 636 l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~i-vHrD 714 (914)
|+.+.|.|+.+++|.+..+...+.|.+||..|+|.|.+.. ....++|.....+..+++.||+|||+. +| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence 3568899999999999999999999999999999999965 467899999999999999999999997 44 8999
Q ss_pred CCCCceEeCCCCcEEEeeccccccccCC-CCceeeccccCCcccCccccccC-------CCCccCceeehHHHHHHHHhC
Q 002509 715 LKSSNILLDKHMRAKVSDFGLSKFAVDG-ASHVSSIVRGTVGYLDPEYYISQ-------QLTDKSDVYSFGVILLELISG 786 (914)
Q Consensus 715 lkp~NILl~~~~~~kl~DFGla~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~-------~~s~ksDV~S~Gvvl~ElltG 786 (914)
++++|+++|....+||+|||+....... .........-..-|.|||.+... ..+.++||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999998765421 01111112234579999999763 146789999999999999999
Q ss_pred CCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHh
Q 002509 787 QEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 787 ~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 865 (914)
+.||+..........++.++.. .....+.|.+.... +....+..++..|+..+|++||++++|-..++.+..
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9999875544333445554333 11222333332211 333368999999999999999999999988776543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5e-19 Score=176.88 Aligned_cols=260 Identities=22% Similarity=0.284 Sum_probs=191.4
Q ss_pred HHHHhccccccCcEEEEEEEE-CCCcEEEEEEEecCCcccchhhhHHHHHHhhccc-CceeEEEeeeeecCceEEEEEec
Q 002509 587 TKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 587 ~~~~~~~lG~G~~G~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H-pnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
.+.+.++||.|+||.+|.|.. .+|++||+|+-+.. ....++..|..+...++| ..|..+.-|..++..-.+||+.+
T Consensus 16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL 93 (341)
T KOG1163|consen 16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL 93 (341)
T ss_pred ceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc
Confidence 455678999999999999964 58999999986543 234567889999999975 66777777888888899999987
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCC---CCcEEEeeccccccccC
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVD 741 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~~ 741 (914)
+-+|++...-. .++++..+.+.+|.|+..-++|+|.+ +++||||||+|.|..- ..++.++|||+|+.+.+
T Consensus 94 -GPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 94 -GPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred -CccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 45888876322 45688889999999999999999999 8999999999999964 34799999999987654
Q ss_pred CCCc------eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCc
Q 002509 742 GASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 815 (914)
Q Consensus 742 ~~~~------~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 815 (914)
..+. ......||.+|.+-....+...+.+.|+-|+|.+|..+-.|..||.+.....-.+.. +.+.+.++
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy-----EkI~EkK~ 241 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY-----EKISEKKM 241 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH-----HHHHHhhc
Confidence 3321 123456999999988888878888999999999999999999999865422111111 11111111
Q ss_pred ccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHh
Q 002509 816 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 816 ~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 865 (914)
...+ ..+...++. ++.....-|-...-++-|...-+.+.++-+..
T Consensus 242 s~~i-e~LC~G~P~----EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 242 STPI-EVLCKGFPA----EFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred CCCH-HHHhCCCcH----HHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 1111 011222333 45666667888888888988877777665543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.2e-19 Score=180.56 Aligned_cols=138 Identities=20% Similarity=0.201 Sum_probs=107.3
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEEecCCcc--c-------chhh-----------------hHHHHHHhhcccCcee
Q 002509 592 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ--G-------KREF-----------------TNEVTLLSRIHHRNLV 645 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~--~-------~~~f-----------------~~E~~~l~~l~HpnIv 645 (914)
..||+|++|.||+|...+|+.||||+++..... . ...| ..|++.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 579999999999999888999999999754221 1 1122 3499999999887764
Q ss_pred EEEeeeeecCceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHH-HhCCCCCccccCCCCCceEeCC
Q 002509 646 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL-HTGCVPAIIHRDLKSSNILLDK 724 (914)
Q Consensus 646 ~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yL-H~~~~~~ivHrDlkp~NILl~~ 724 (914)
....+. ....++||||++++++...+. ....+++.+...++.|++.+|.+| |+. +|+||||||+|||++
T Consensus 83 ~p~~~~--~~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~- 152 (190)
T cd05147 83 CPEPIL--LKSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH- 152 (190)
T ss_pred CCcEEE--ecCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence 333222 223489999999987765432 234578888999999999999999 677 999999999999998
Q ss_pred CCcEEEeeccccccc
Q 002509 725 HMRAKVSDFGLSKFA 739 (914)
Q Consensus 725 ~~~~kl~DFGla~~~ 739 (914)
++.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=6e-19 Score=183.12 Aligned_cols=173 Identities=14% Similarity=0.171 Sum_probs=132.3
Q ss_pred HHHHHHHHHhccccccCcEEEEEEEECCCcEEEEEEEecCCcccchh---------hhHHHHHHhhcccCceeEEEeeee
Q 002509 582 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE---------FTNEVTLLSRIHHRNLVQFLGYCQ 652 (914)
Q Consensus 582 ei~~~~~~~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~---------f~~E~~~l~~l~HpnIv~l~g~~~ 652 (914)
++....+...+.+|+|+||.||.... ++..+|+|+++......... +.+|+..+.+++|++|..+..++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 44455556668999999999999766 57789999997654333222 678999999999999999988865
Q ss_pred ec--------CceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCC
Q 002509 653 EE--------GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 724 (914)
Q Consensus 653 ~~--------~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~ 724 (914)
.. +..++||||++|.+|.+... ++. ....+++.+|..+|.. +++|||+||+||+++.
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSK 170 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeC
Confidence 33 35789999999999987631 111 2456999999999999 9999999999999999
Q ss_pred CCcEEEeeccccccccCCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHH
Q 002509 725 HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELI 784 (914)
Q Consensus 725 ~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ell 784 (914)
++ ++|+|||........... ..+.....+..++|+|+||+.+.-+.
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 88 999999987654221111 01344556778999999999887554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-19 Score=214.86 Aligned_cols=251 Identities=22% Similarity=0.238 Sum_probs=181.6
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEEe----cC-Cccc-chhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEe
Q 002509 591 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLT----SN-SYQG-KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 663 (914)
Q Consensus 591 ~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~----~~-~~~~-~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~ 663 (914)
.+.+|.|++|.|+..... ..+..+.|..+ .. .... ...+..|+.+-..++|+|++..+..+.+.....-+|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 468999999977777543 34444554432 11 1111 11256677778888999999888888777766667999
Q ss_pred ccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCC
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 743 (914)
Q Consensus 664 ~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 743 (914)
|+. +|...+.. ...+...++..+..|+..|+.|||+. +|.|||+|++|++++.++.+||+|||.+..+..+.
T Consensus 403 ~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 403 CPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred ccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 999 99998843 23677788889999999999999998 99999999999999999999999999986554332
Q ss_pred -C--ceeeccccCCcccCccccccCCCCcc-CceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCccccc
Q 002509 744 -S--HVSSIVRGTVGYLDPEYYISQQLTDK-SDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 819 (914)
Q Consensus 744 -~--~~~~~~~gt~~Y~aPE~~~~~~~s~k-sDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 819 (914)
. .......|+..|+|||.+.+..|... .||||.|+++..|.+|+.||......+... .+ ... ....-
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--~~-----~~~--~~~~~ 545 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--KT-----NNY--SDQRN 545 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--hh-----hcc--ccccc
Confidence 2 55667789999999999999999875 699999999999999999986544222110 00 000 00000
Q ss_pred CCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002509 820 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 858 (914)
Q Consensus 820 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 858 (914)
+..-..........+...++.++++.+|.+|-+|++|++
T Consensus 546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 000000111223345667888999999999999999986
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.6e-18 Score=176.58 Aligned_cols=260 Identities=20% Similarity=0.264 Sum_probs=190.6
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhc-ccCceeEEEeeeeecCceEEEEEecc
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
+.++++||+|.||.++.|+.- +++.||||.-... ....++..|....+.| ..++|...+-|-.++.+-.||+|.+
T Consensus 30 yrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 30 YRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred ceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 456789999999999999744 7999999974432 2356788899998888 4689988888888888889999987
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCC-----CcEEEeecccccccc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-----MRAKVSDFGLSKFAV 740 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-----~~~kl~DFGla~~~~ 740 (914)
|-+|+|+..-. .++++..+.+.+|.|+..-++|+|++ .+|.|||||+|.||..- ..+.++|||+|+.+.
T Consensus 107 GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 107 GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 45888876322 56789999999999999999999999 99999999999999643 358999999999886
Q ss_pred CCCCce------eeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCC
Q 002509 741 DGASHV------SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 814 (914)
Q Consensus 741 ~~~~~~------~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 814 (914)
+..+.. .....||.+||+-....++..+.+.|+-|+|-++...+.|..||.+.+.....+.... +.+.+
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK-----IGe~K 255 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK-----IGETK 255 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH-----hcccc
Confidence 654321 2335699999999999999999999999999999999999999987654322211111 11110
Q ss_pred cccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHhH
Q 002509 815 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 866 (914)
Q Consensus 815 ~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 866 (914)
-..-++ .|... -+++....++.+. ..+-.+-|..+-+...+.+++..
T Consensus 256 r~T~i~-~Lc~g-~P~efa~Yl~yvR---~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 256 RSTPIE-VLCEG-FPEEFATYLRYVR---RLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred ccCCHH-HHHhc-CHHHHHHHHHHHH---hcCcccCCCHHHHHHHHHHHHHh
Confidence 000000 01111 1233334444443 34556678888887777766643
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.2e-18 Score=174.10 Aligned_cols=140 Identities=20% Similarity=0.203 Sum_probs=109.8
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEEecCCccc--------------------------chhhhHHHHHHhhcccCce
Q 002509 591 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--------------------------KREFTNEVTLLSRIHHRNL 644 (914)
Q Consensus 591 ~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~--------------------------~~~f~~E~~~l~~l~HpnI 644 (914)
...||+|++|.||+|+..+|+.||||+++...... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 35799999999999998889999999998652210 0113578899999999987
Q ss_pred eEEEeeeeecCceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHh-CCCCCccccCCCCCceEeC
Q 002509 645 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLD 723 (914)
Q Consensus 645 v~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~-~~~~~ivHrDlkp~NILl~ 723 (914)
.....+... ..++||||++++++..... ....++......++.|++.++.+||+ . +|+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence 554444333 3489999999886543321 12346677889999999999999999 7 999999999999999
Q ss_pred CCCcEEEeecccccccc
Q 002509 724 KHMRAKVSDFGLSKFAV 740 (914)
Q Consensus 724 ~~~~~kl~DFGla~~~~ 740 (914)
+++++|+|||++....
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 8899999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.7e-18 Score=203.62 Aligned_cols=245 Identities=21% Similarity=0.264 Sum_probs=176.2
Q ss_pred HHhccccccCcEEEEEEEECCCcEEEEEEEecCC-cccchhhhHHHHH--HhhcccCceeEEEeeeeecCceEEEEEecc
Q 002509 589 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS-YQGKREFTNEVTL--LSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 589 ~~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~-~~~~~~f~~E~~~--l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
.+.+.||++.|=.|.+|+.+.|. |+||++-+.. .-..+.|.++++- ...++|||.+++.-......-.+||-+|..
T Consensus 26 ~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvk 104 (1431)
T KOG1240|consen 26 HYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVK 104 (1431)
T ss_pred eeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHh
Confidence 34578999999999999998877 9999986553 3344555554443 444589999999877666666778888876
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+ +|.|.|. .+.-+...+..-|+.|++.||..+|.. +|+|||||.+||||+.-.-+.|+||..-+...-....
T Consensus 105 h-nLyDRlS----TRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 105 H-NLYDRLS----TRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred h-hhhhhhc----cchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 5 7777763 345567777888999999999999998 9999999999999999999999999876543221111
Q ss_pred ------eeeccccCCcccCccccccC----------C-CCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHH
Q 002509 746 ------VSSIVRGTVGYLDPEYYISQ----------Q-LTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAK 807 (914)
Q Consensus 746 ------~~~~~~gt~~Y~aPE~~~~~----------~-~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~ 807 (914)
.......-.+|+|||.+... . .+++-||||+||++.||++ |+++|.- .++..+..
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-------SQL~aYr~ 249 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-------SQLLAYRS 249 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-------HHHHhHhc
Confidence 11222344689999998541 1 5678899999999999998 6777752 23333322
Q ss_pred Hh--hhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002509 808 LH--IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861 (914)
Q Consensus 808 ~~--~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 861 (914)
.. ..+.-++.+-| ..+.++++.|++.||++|-++++.++.-+
T Consensus 250 ~~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 250 GNADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred cCccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 10 00000111111 14678899999999999999999998843
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.2e-17 Score=165.09 Aligned_cols=184 Identities=14% Similarity=0.137 Sum_probs=137.3
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEEecCCcccc----hhhhHHHHHHhhcc-cCceeEEEeeeeecCceEEEEEecc
Q 002509 591 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK----REFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 591 ~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~~----~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
...|++|+||+||.+.. ++.+++.+.+........ ..|.+|+++|+++. |+++.+++++ +..+++|||++
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 35799999999997766 578888787765543222 25789999999995 5889999886 45699999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCC-CCCceEeCCCCcEEEeeccccccccCCCC
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDL-KSSNILLDKHMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDl-kp~NILl~~~~~~kl~DFGla~~~~~~~~ 744 (914)
+.+|...+. . ....++.|++++|+++|++ +|+|||| ||+|||++.++.++|+|||++........
T Consensus 82 G~~L~~~~~-----~------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 82 GAAMYQRPP-----R------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred CccHHhhhh-----h------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 998865431 1 1134678999999999999 9999999 79999999999999999999985443221
Q ss_pred c----e--------eeccccCCcccCccccccC-CCC-ccCceeehHHHHHHHHhCCCCcccc
Q 002509 745 H----V--------SSIVRGTVGYLDPEYYISQ-QLT-DKSDVYSFGVILLELISGQEAISNE 793 (914)
Q Consensus 745 ~----~--------~~~~~gt~~Y~aPE~~~~~-~~s-~ksDV~S~Gvvl~ElltG~~p~~~~ 793 (914)
. . ......++.|++|+...-. ..+ ...+-++-|+-+|.++|+..+....
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 0 1112357778888765322 222 3558889999999999998876443
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=5.3e-16 Score=186.55 Aligned_cols=313 Identities=19% Similarity=0.235 Sum_probs=183.0
Q ss_pred cEEEecCCCCC-----cc-cCC--CeEEecCCccccCcc------eeeecCcc-----ccccccccccccCCCCCceeee
Q 002509 32 FVSLNCGGNEN-----FT-DEI--GLQWIADDHLIYGEI------SNISVANE-----TRKQYMTLRHFPADSRKYCYKL 92 (914)
Q Consensus 32 ~~~idCG~~~~-----~~-~~~--~~~~~~D~~~~~g~~------~~~~~~~~-----~~~~~~tlR~Fp~~~~~~cY~~ 92 (914)
...||||+... |- |.- .|.|.+|..|..+.. ..|..+.. ....|+|.|.+-....+-.|.+
T Consensus 193 ~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~~~~~~~st~~~I~~~~~~~~~~P~~VyqTA~~~~~~~~~lty~~ 272 (623)
T PLN03150 193 AKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSGSDQAISTENVIKKASNAPNFYPESLYQSALVSTDTQPDLSYTM 272 (623)
T ss_pred EEEEEecCcccccccCCCCCcccCccccCcCcccCCCcccccccccccccccCCCccChHHHhhhhccccCCCCceEEEe
Confidence 45799997422 21 222 799999988753322 22221111 1137899999876434579999
Q ss_pred eccCCceEEEEEEeecccCCC-CCCCCceeEEeCCcccc-eeee---c-CCCceEEEEEEEecCCCCeeEEEecCCCCCc
Q 002509 93 DVITRTRYLIRATFLYGNFDN-NNVYPKFDISLGPTHWS-TIVI---S-DAATIEVRELIFLASSPKIDVCLSNATTGQP 166 (914)
Q Consensus 93 ~~~~~~~ylvR~~f~ygnyd~-~~~~p~Fd~~~~~~~w~-~v~~---~-~~~~~~~~e~i~~~~~~~~~vcl~~~~~~~p 166 (914)
++.++++|+||++|.-=.... ....-+||++++|..+. .++. + ....+.+.+..+.+.++.+.|.|+++....|
T Consensus 273 ~v~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~~~~di~~~~g~~~~~~~~~~~v~~~~g~l~isl~p~~~s~p 352 (623)
T PLN03150 273 DVDPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVKMSGERYTALVLNKTVAVSGRTLTIVLQPKKGTHA 352 (623)
T ss_pred ecCCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEeecccChhhhcCCcccceEEEeEEeecCCeEEEEEeeCCCCcc
Confidence 999999999999995432211 22234799999997543 2222 1 1234566777777777789999999776679
Q ss_pred eeeeeeeeecCCccccccccCceeEEEEeeeccCCCCCCCccCCCCCCCCcccCCccccccccccccCCccccccccccC
Q 002509 167 FISTLELRQFNGSVYLTPFEDRYYLSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPID 246 (914)
Q Consensus 167 fis~lEl~~l~~~~y~~~~~~~~~l~~~~R~~~G~~~~~~~rypdD~~dR~W~~~~~~~~~~~~~~~~~~~~~st~~~~~ 246 (914)
||||||+..+-..-..+....-.+|..++ .+++. +..--|..| ..
T Consensus 353 ilNaiEI~~~~~~~~~t~~~~~~aL~~~k-~~~~~-----------~~~~~W~g~--~C--------------------- 397 (623)
T PLN03150 353 IINAIEVFEIITAESKTLLEEVSALQTLK-SSLGL-----------PLRFGWNGD--PC--------------------- 397 (623)
T ss_pred eeeeeeeeeccccccccCchHHHHHHHHH-HhcCC-----------cccCCCCCC--CC---------------------
Confidence 99999999876521100000000111110 01110 000012110 00
Q ss_pred CCCCCCChHHHHhhceeccCCCeeEEEecCCCCCccceeeeehhcccCCCCcceEEEEEeCCCCCcccceeccccccCCc
Q 002509 247 LRSDELPPQKVMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGK 326 (914)
Q Consensus 247 ~~~~~~~P~~v~~tA~t~~~~~~~~~~~~~~~~~~~~v~lhFae~~~~~~~~~R~F~i~ing~~~~~~~~~~~~~~~~~~ 326 (914)
. |.. ..|... . |..... ....
T Consensus 398 -----~-p~~----------------~~w~Gv------~---C~~~~~-~~~~--------------------------- 418 (623)
T PLN03150 398 -----V-PQQ----------------HPWSGA------D---CQFDST-KGKW--------------------------- 418 (623)
T ss_pred -----C-Ccc----------------cccccc------e---eeccCC-CCce---------------------------
Confidence 0 000 011110 0 100000 0000
Q ss_pred eeeecccccccccceEEEEEEeecCCC-CCCcchhhhhhhhhccCCCCCccHHHHHHHHhhcCCCCCcCCCCCCCCCCCC
Q 002509 327 YRVYEPGYTNLSLPFVLSFKFGKTYDS-SRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPW 405 (914)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~l~l~~~~~s-~lpp~ln~le~l~~l~~~~~~~d~~al~~l~~~~~~~~~~~~~~dpc~~~~w 405 (914)
....|.|..|.++ .+|+.|..+..|+.|+++.+.... .-|. .+
T Consensus 419 --------------~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g-------------------~iP~---~~ 462 (623)
T PLN03150 419 --------------FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRG-------------------NIPP---SL 462 (623)
T ss_pred --------------EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccC-------------------cCCh---HH
Confidence 0133455555554 567777777778877776332110 0010 00
Q ss_pred ceEEeCCCCCCCeEEEEccCCCCcccCCchhhccccccccCCCCCcEEEcCCCcCCCCCCccCcCC-CCCceeeecCccc
Q 002509 406 SWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNL-PNLRELYVQNNML 484 (914)
Q Consensus 406 ~gv~c~~~~~~~l~~L~L~~n~l~G~ip~~~~~l~~L~~l~l~~L~~L~Ls~N~l~G~iP~~l~~l-~~L~~l~l~~N~l 484 (914)
+..++|+.|+|++|+|+|.+|+.+++|++|+ .|+|++|+|+|.+|..++.+ .++..+++.+|..
T Consensus 463 -------~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~--------~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~ 527 (623)
T PLN03150 463 -------GSITSLEVLDLSYNSFNGSIPESLGQLTSLR--------ILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAG 527 (623)
T ss_pred -------hCCCCCCEEECCCCCCCCCCchHHhcCCCCC--------EEECcCCcccccCChHHhhccccCceEEecCCcc
Confidence 1245899999999999999999999998887 99999999999999999874 4678899999986
Q ss_pred cCCCC
Q 002509 485 SGTVP 489 (914)
Q Consensus 485 ~G~iP 489 (914)
.+.+|
T Consensus 528 lc~~p 532 (623)
T PLN03150 528 LCGIP 532 (623)
T ss_pred ccCCC
Confidence 54455
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.6e-16 Score=191.68 Aligned_cols=252 Identities=19% Similarity=0.220 Sum_probs=181.2
Q ss_pred HHHHHHHHHHhccccccCcEEEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhhcc---cCceeEEEeeeeecCce
Q 002509 581 SDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH---HRNLVQFLGYCQEEGRS 657 (914)
Q Consensus 581 ~ei~~~~~~~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~---HpnIv~l~g~~~~~~~~ 657 (914)
.++....+.+.+.||+|+||.||+|...+|+.||+|+=+....+. |---.+++.||+ -+-|..+...+.-.+..
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 344444556678899999999999999889999999977655543 333334555555 23344444445566778
Q ss_pred EEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCC-------CCcEEE
Q 002509 658 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-------HMRAKV 730 (914)
Q Consensus 658 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~-------~~~~kl 730 (914)
+||+||.+.|+|.+++. ..+.++|.-.+.++.|+++-+++||.. +||||||||+|.||.. ...++|
T Consensus 770 ~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred eeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEE
Confidence 99999999999999996 456789999999999999999999998 9999999999999942 346999
Q ss_pred eeccccccccCC-CCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHh
Q 002509 731 SDFGLSKFAVDG-ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH 809 (914)
Q Consensus 731 ~DFGla~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~ 809 (914)
+|||.+-.+..- +.......++|-.+-.+|+..++.++.++|.|.+.-+++-|+.|+..=
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------------------- 903 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------------------- 903 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-------------------
Confidence 999998543221 123445567899999999999999999999999999999999996321
Q ss_pred hhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhHh
Q 002509 810 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 810 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 865 (914)
... .....++..+..-...+.+.++..+.+. .+-..=|...++...+++++.
T Consensus 904 ~~~-g~~~~~~~~~~Ry~~~~~W~~~F~~lLN---~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 904 VKN-GSSWMVKTNFPRYWKRDMWNKFFDLLLN---PDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred hcC-CcceeccccchhhhhHHHHHHHHHHHhC---cCcccchhHHHHHHHHHHHHH
Confidence 111 1111222222222223334455565544 444445777777777777664
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.9e-16 Score=163.86 Aligned_cols=133 Identities=19% Similarity=0.274 Sum_probs=103.7
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhhc-----ccCceeEEEeeeeecC---c-eEEEEE
Q 002509 592 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-----HHRNLVQFLGYCQEEG---R-SVLVYE 662 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-----~HpnIv~l~g~~~~~~---~-~~LV~E 662 (914)
+.||+|+||.||. .-.++.. +||++........+.+.+|+.+++.+ .||||++++|++.++. . ..+|+|
T Consensus 8 ~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 5799999999996 2234444 79988765444567899999999999 5799999999998864 3 337899
Q ss_pred e--ccCCChHHHhhcccCccccccHHHHHHHHHHHHHHH-HHHHhCCCCCccccCCCCCceEeCC----CCcEEEeeccc
Q 002509 663 F--MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI-EYLHTGCVPAIIHRDLKSSNILLDK----HMRAKVSDFGL 735 (914)
Q Consensus 663 ~--~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL-~yLH~~~~~~ivHrDlkp~NILl~~----~~~~kl~DFGl 735 (914)
| +.+|+|.+++... .+++. ..++.+++.++ +|||++ +|+||||||+|||++. +.+++|+||+-
T Consensus 86 ~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 86 FDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred CCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 9 5589999999532 24444 35577888777 999999 9999999999999974 34899999543
Q ss_pred c
Q 002509 736 S 736 (914)
Q Consensus 736 a 736 (914)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 3
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.8e-16 Score=169.45 Aligned_cols=230 Identities=19% Similarity=0.216 Sum_probs=144.1
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEEecCCc---ccchhhhHHHHHHhhcc----------cCceeEEEeee-----
Q 002509 591 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIH----------HRNLVQFLGYC----- 651 (914)
Q Consensus 591 ~~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~~l~~l~----------HpnIv~l~g~~----- 651 (914)
.+.||.|+++.||.++.. +++++|||++..... ...+++.+|.-....+. |-.++..++..
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 357999999999999887 589999999864432 22345555554444422 21222222211
Q ss_pred ----eec---C-----ceEEEEEeccCCChHHHhh---cccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCC
Q 002509 652 ----QEE---G-----RSVLVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK 716 (914)
Q Consensus 652 ----~~~---~-----~~~LV~E~~~~gsL~~~L~---~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlk 716 (914)
... . ..+++|+-+ .++|.+.+. ........+....++.+..|+.+.+++||+. +++|+|||
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-S
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccc
Confidence 111 1 225677766 458877753 2222234566777888999999999999999 99999999
Q ss_pred CCceEeCCCCcEEEeeccccccccCCCCceeeccccCCcccCccccccC--------CCCccCceeehHHHHHHHHhCCC
Q 002509 717 SSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ--------QLTDKSDVYSFGVILLELISGQE 788 (914)
Q Consensus 717 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--------~~s~ksDV~S~Gvvl~ElltG~~ 788 (914)
|+|++++++|.++|+||+....... .... ...+..|.+||..... .++.+.|.|++|+++|.|++|..
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~--~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGT--RYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTE--EEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred eeeEEEcCCCCEEEcChHHHeecCc--eeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 9999999999999999987643321 1111 2346789999987542 47888999999999999999999
Q ss_pred CcccccccccchhHHHHHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCC
Q 002509 789 AISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMR 850 (914)
Q Consensus 789 p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~R 850 (914)
||........... .+. .+. +..+.+..|+..+++.+|.+|
T Consensus 249 Pf~~~~~~~~~~~--------------------~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPEW--------------------DFS-RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSGG--------------------GGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccccc--------------------cch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence 9975432211100 111 122 445568889999999999987
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.9e-17 Score=185.62 Aligned_cols=186 Identities=29% Similarity=0.406 Sum_probs=155.6
Q ss_pred cccccCcEEEEEEE----ECCCcEEEEEEEecCCcc--cchhhhHHHHHHhhcc-cCceeEEEeeeeecCceEEEEEecc
Q 002509 593 KIGSGGFGVVYYGK----LKDGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 593 ~lG~G~~G~Vy~~~----~~~g~~vAVK~l~~~~~~--~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
.+|+|.||.|+..+ .+.|.-+|+|++++.... .+.....|..++..++ ||.+|++.-.++.+...+++.++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999998653 345777899988765322 1224556788888886 9999999999999999999999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCc
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 745 (914)
+|.|...+. ....++..........++-+++++|.. +|+|||+|++||+++.+|++|+.|||+++...+....
T Consensus 81 gg~lft~l~----~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLS----KEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhccc----cCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 999988874 334556666677788899999999998 9999999999999999999999999999877554332
Q ss_pred eeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCccc
Q 002509 746 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 792 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~ 792 (914)
+||..|||||++. .....+|-||||++++||+||..||..
T Consensus 154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 7999999999997 567889999999999999999999865
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=8e-16 Score=160.46 Aligned_cols=134 Identities=25% Similarity=0.426 Sum_probs=113.4
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEEecCCccc--------chhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEe
Q 002509 592 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--------KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 663 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~--------~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~ 663 (914)
+.||+|++|.||+|+. .|..+++|+........ ...+.+|++++..++|+++.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4789999999999988 57889999876432211 23577899999999999998888887778888999999
Q ss_pred ccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccc
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 738 (914)
Q Consensus 664 ~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 738 (914)
+++++|.+.+... .+ .+..++.+++.+|.+||+. +++|||++|+|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988432 11 7788999999999999998 999999999999999 78999999998764
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.4e-15 Score=161.28 Aligned_cols=140 Identities=22% Similarity=0.252 Sum_probs=107.9
Q ss_pred HHHhccccccCcEEEEEEE--ECCCcEEEEEEEecCCcc------------------------cchhhhHHHHHHhhccc
Q 002509 588 KMLEKKIGSGGFGVVYYGK--LKDGKEIAVKVLTSNSYQ------------------------GKREFTNEVTLLSRIHH 641 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~--~~~g~~vAVK~l~~~~~~------------------------~~~~f~~E~~~l~~l~H 641 (914)
+.+.+.||+|++|.||+|. ..+|+.||+|+++..... ....+..|++.+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 3466889999999999998 568999999998754211 01235679999999976
Q ss_pred Cc--eeEEEeeeeecCceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCC-ccccCCCCC
Q 002509 642 RN--LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA-IIHRDLKSS 718 (914)
Q Consensus 642 pn--Iv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~-ivHrDlkp~ 718 (914)
.. +.+++++ ...++||||+++++|...... ...+...+...++.|++.++++||+. + ++||||||+
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~ 178 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEY 178 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChh
Confidence 33 3444443 235899999999888765421 22344556678999999999999998 8 999999999
Q ss_pred ceEeCCCCcEEEeeccccccc
Q 002509 719 NILLDKHMRAKVSDFGLSKFA 739 (914)
Q Consensus 719 NILl~~~~~~kl~DFGla~~~ 739 (914)
||+++ +++++|+|||.+...
T Consensus 179 NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hEEEE-CCCEEEEEChhhhcc
Confidence 99999 889999999998654
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.7e-15 Score=156.48 Aligned_cols=130 Identities=26% Similarity=0.427 Sum_probs=107.1
Q ss_pred cccccCcEEEEEEEECCCcEEEEEEEecCCcc--------cchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEec
Q 002509 593 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ--------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 593 ~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~--------~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
.||+|++|.||+|.+ ++..+++|+....... ....+.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999986 4788999986543211 1245678999999999988766666666777789999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccc
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 738 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 738 (914)
++++|.+.+.... . .++.+++++|.+||+. +++|||++|+||+++ +++++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN-----D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH-----H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998874321 0 7899999999999998 999999999999999 88999999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.6e-15 Score=155.12 Aligned_cols=135 Identities=21% Similarity=0.217 Sum_probs=107.0
Q ss_pred HHHhccccccCcEEEEEEEECCCcEEEEEEEecCCcc----------------------cchhhhHHHHHHhhcccCc--
Q 002509 588 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ----------------------GKREFTNEVTLLSRIHHRN-- 643 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~----------------------~~~~f~~E~~~l~~l~Hpn-- 643 (914)
+.+.+.||+|+||.||++..++|+.||||+++..... ....+..|..++.++.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 5566889999999999999888999999987643210 0113567888999998874
Q ss_pred eeEEEeeeeecCceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeC
Q 002509 644 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 723 (914)
Q Consensus 644 Iv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~ 723 (914)
+...++ ....++||||+++++|.+.... .....++.++++++.++|+. +|+||||||+||+++
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~ 159 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVD 159 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEc
Confidence 444443 2455899999999998765420 23456889999999999998 999999999999999
Q ss_pred CCCcEEEeeccccccc
Q 002509 724 KHMRAKVSDFGLSKFA 739 (914)
Q Consensus 724 ~~~~~kl~DFGla~~~ 739 (914)
++++++|+|||++...
T Consensus 160 ~~~~~~liDfg~~~~~ 175 (198)
T cd05144 160 DDEKIYIIDWPQMVST 175 (198)
T ss_pred CCCcEEEEECCccccC
Confidence 9999999999998544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.7e-15 Score=176.40 Aligned_cols=132 Identities=23% Similarity=0.331 Sum_probs=108.6
Q ss_pred HhccccccCcEEEEEEEECCCcEEEEEEEecCC--c------ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEE
Q 002509 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--Y------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 661 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~--~------~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 661 (914)
..+.||+|+||+||+|.+... .+++|+..... . .....+.+|++++.+++|++++....++......++||
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 415 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM 415 (535)
T ss_pred ccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence 357899999999999988644 44444432211 1 11245788999999999999999888888878889999
Q ss_pred EeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccc
Q 002509 662 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 738 (914)
Q Consensus 662 E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 738 (914)
||+++++|.+++. ....++.+++++|.+||+. +++||||||+|||+ .++.++|+|||+++.
T Consensus 416 E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 416 EYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999998874 3467899999999999998 99999999999999 678999999999865
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.1e-14 Score=155.27 Aligned_cols=197 Identities=20% Similarity=0.238 Sum_probs=133.5
Q ss_pred ccCceeEEEeeeee---------------------------cCceEEEEEeccCCChHHHhhcccCccccccHHHHHHHH
Q 002509 640 HHRNLVQFLGYCQE---------------------------EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA 692 (914)
Q Consensus 640 ~HpnIv~l~g~~~~---------------------------~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia 692 (914)
+|||||++.++|.+ ....++||.-.+. +|.+++.. +..+...+.-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-----CCCchHHHHHHH
Confidence 69999999887632 2245788876654 88888843 234555666788
Q ss_pred HHHHHHHHHHHhCCCCCccccCCCCCceEe--CCC--CcEEEeeccccccccC-C--CCcee--eccccCCcccCccccc
Q 002509 693 EDAAKGIEYLHTGCVPAIIHRDLKSSNILL--DKH--MRAKVSDFGLSKFAVD-G--ASHVS--SIVRGTVGYLDPEYYI 763 (914)
Q Consensus 693 ~~ia~gL~yLH~~~~~~ivHrDlkp~NILl--~~~--~~~kl~DFGla~~~~~-~--~~~~~--~~~~gt~~Y~aPE~~~ 763 (914)
.|+++|+.|||.+ +|.|||+|++|||+ |+| ....|+|||++--... + -...+ -..-|.-.-||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 99999999999999 333 3678999998632111 0 00111 1123677889999986
Q ss_pred cCC------CCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccCHHHHHHHHH
Q 002509 764 SQQ------LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEE 837 (914)
Q Consensus 764 ~~~------~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~ 837 (914)
..+ -..|+|.|+.|-+-||++....||.... +..-+... .++.++ |.+.. .+...+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG--em~L~~r~-----Yqe~qL-----Palp~----~vpp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG--EMLLDTRT-----YQESQL-----PALPS----RVPPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc--hheechhh-----hhhhhC-----CCCcc----cCChHHHH
Confidence 532 2358999999999999999999996421 11001111 111122 12222 23335778
Q ss_pred HHHHccCCCCCCCCCHHHHHHHHh
Q 002509 838 KALMCVLPHGHMRPSISEVLKDIQ 861 (914)
Q Consensus 838 l~~~C~~~~P~~RPsm~eVl~~L~ 861 (914)
++...++.||.+||+..-....|+
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHH
Confidence 889999999999999876666655
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.2e-15 Score=167.56 Aligned_cols=173 Identities=28% Similarity=0.392 Sum_probs=127.8
Q ss_pred ceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccc
Q 002509 656 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 735 (914)
Q Consensus 656 ~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 735 (914)
..++.|++|...+|.++|.+.. .....+|...+.++.|++.|++| + +.+|+|+||.||+...+.++||+|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 4689999999999999997553 34567888999999999999999 4 899999999999999999999999999
Q ss_pred cccccCCC-----CceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh-CCCCcccccccccchhHHHHHHHh
Q 002509 736 SKFAVDGA-----SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH 809 (914)
Q Consensus 736 a~~~~~~~-----~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 809 (914)
........ ....+...||..||+||.+.+.+|+.|+||||||++|+|++. =..++.... ....
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~-----------t~~d 471 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA-----------TLTD 471 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH-----------hhhh
Confidence 86554333 112234569999999999999999999999999999999997 222221100 0111
Q ss_pred hhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 002509 810 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISE 855 (914)
Q Consensus 810 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~e 855 (914)
++.+ +++|....+++. =..+..+++.+.|.+||+..+
T Consensus 472 ~r~g----~ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 472 IRDG----IIPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred hhcC----CCChHHhhcCcH-----HHHHHHHhcCCCcccCchHHH
Confidence 2222 222222223332 235677899999999994433
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=6.2e-14 Score=143.27 Aligned_cols=135 Identities=22% Similarity=0.281 Sum_probs=97.6
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEEecCCcc--cchh----------------------hhHHHHHHhhcccCc--e
Q 002509 591 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ--GKRE----------------------FTNEVTLLSRIHHRN--L 644 (914)
Q Consensus 591 ~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~--~~~~----------------------f~~E~~~l~~l~Hpn--I 644 (914)
.+.||+|+||.||+|...+++.||||+++..... .... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 3579999999999999888999999998754221 1111 134566666664443 3
Q ss_pred eEEEeeeeecCceEEEEEeccCCChHHH-hhcccCccccccHHHHHHHHHHHHHHHHHHHh-CCCCCccccCCCCCceEe
Q 002509 645 VQFLGYCQEEGRSVLVYEFMHNGTLKEH-LYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILL 722 (914)
Q Consensus 645 v~l~g~~~~~~~~~LV~E~~~~gsL~~~-L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~-~~~~~ivHrDlkp~NILl 722 (914)
.+.+++ ...++||||++++.+... +.... .. .+...++.+++.++.++|. . +|+||||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 444433 245899999999654321 11110 01 4567889999999999999 6 99999999999999
Q ss_pred CCCCcEEEeeccccccc
Q 002509 723 DKHMRAKVSDFGLSKFA 739 (914)
Q Consensus 723 ~~~~~~kl~DFGla~~~ 739 (914)
+ ++.++|+|||.+...
T Consensus 149 ~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 149 D-DGKVYIIDVPQAVEI 164 (187)
T ss_pred E-CCcEEEEECcccccc
Confidence 9 899999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.52 E-value=8.9e-14 Score=135.60 Aligned_cols=133 Identities=25% Similarity=0.305 Sum_probs=113.3
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhhccc--CceeEEEeeeeecCceEEEEEeccCCCh
Q 002509 592 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH--RNLVQFLGYCQEEGRSVLVYEFMHNGTL 669 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H--pnIv~l~g~~~~~~~~~LV~E~~~~gsL 669 (914)
+.||+|.++.||+++..+ ..+++|....... ...+..|+.++..++| .++.+++++...++..++++||++++.+
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 579999999999999864 7899999865433 4678999999999977 5899999988888889999999998776
Q ss_pred HHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccc
Q 002509 670 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 738 (914)
Q Consensus 670 ~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 738 (914)
... +......++.+++++|++||.....+++|+|++|+||++++++.+++.|||.++.
T Consensus 81 ~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 81 DEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 543 4456677899999999999986445799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.6e-14 Score=170.81 Aligned_cols=200 Identities=25% Similarity=0.331 Sum_probs=133.6
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCChH
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK 670 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~ 670 (914)
+.|..|++|.||..+++ ..+++|+|+=+.+. +.+- ++.....|.+| |+-.
T Consensus 89 klisngAygavylvrh~~trqrfa~kiNkq~l------ilRn--ilt~a~npfvv---------------------gDc~ 139 (1205)
T KOG0606|consen 89 KLISNGAYGAVYLVRHKETRQRFAMKINKQNL------ILRN--ILTFAGNPFVV---------------------GDCA 139 (1205)
T ss_pred EeeccCCCCceeeeeccccccchhhcccccch------hhhc--cccccCCccee---------------------chhh
Confidence 67999999999999887 46678885422211 0000 22222333333 3433
Q ss_pred HHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCC-------
Q 002509 671 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA------- 743 (914)
Q Consensus 671 ~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~------- 743 (914)
..+... ..++ .+++.+++|||+. +|+|||+||+|.+|+.-|++|+.|||+++......
T Consensus 140 tllk~~----g~lP--------vdmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg 204 (1205)
T KOG0606|consen 140 TLLKNI----GPLP--------VDMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEG 204 (1205)
T ss_pred hhcccC----CCCc--------chhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhc
Confidence 334221 1222 1237789999998 99999999999999999999999999987532110
Q ss_pred -------CceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcc
Q 002509 744 -------SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 816 (914)
Q Consensus 744 -------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 816 (914)
......++||+.|+|||++....|....|.|++|+|+||.+-|+.||.++..++...+++...... .
T Consensus 205 ~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w------p 278 (1205)
T KOG0606|consen 205 HIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW------P 278 (1205)
T ss_pred chHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc------c
Confidence 111344689999999999999999999999999999999999999998765444333333211111 1
Q ss_pred cccCCccCCccCHHHHHHHHHHHHHccCCCCCCC
Q 002509 817 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMR 850 (914)
Q Consensus 817 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~R 850 (914)
|- |..+ ..+..+++.+.++.+|..|
T Consensus 279 E~-dea~--------p~Ea~dli~~LL~qnp~~R 303 (1205)
T KOG0606|consen 279 EE-DEAL--------PPEAQDLIEQLLRQNPLCR 303 (1205)
T ss_pred cc-CcCC--------CHHHHHHHHHHHHhChHhh
Confidence 11 2111 2245666777788888888
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.7e-13 Score=142.97 Aligned_cols=135 Identities=19% Similarity=0.240 Sum_probs=105.0
Q ss_pred cccc-ccCcEEEEEEEECCCcEEEEEEEecCC-------------cccchhhhHHHHHHhhcccCce--eEEEeeeeecC
Q 002509 592 KKIG-SGGFGVVYYGKLKDGKEIAVKVLTSNS-------------YQGKREFTNEVTLLSRIHHRNL--VQFLGYCQEEG 655 (914)
Q Consensus 592 ~~lG-~G~~G~Vy~~~~~~g~~vAVK~l~~~~-------------~~~~~~f~~E~~~l~~l~HpnI--v~l~g~~~~~~ 655 (914)
..|| .|+.|+||+.... +..++||++.... ......+.+|++++.+++|+++ +..+++...+.
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5788 8999999999886 7889999875321 1123457789999999998875 67777654432
Q ss_pred ----ceEEEEEeccC-CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEE
Q 002509 656 ----RSVLVYEFMHN-GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 730 (914)
Q Consensus 656 ----~~~LV~E~~~~-gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl 730 (914)
..++|+|++++ .+|.+++... .++. ..+.+++++|.+||+. +|+||||||+|||++.++.++|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~----~~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA-----PLSE----EQWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC-----CCCH----HHHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence 23599999997 6898887432 2332 2357899999999998 9999999999999999999999
Q ss_pred eeccccccc
Q 002509 731 SDFGLSKFA 739 (914)
Q Consensus 731 ~DFGla~~~ 739 (914)
+|||.+...
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999988653
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=8.2e-13 Score=138.26 Aligned_cols=204 Identities=23% Similarity=0.336 Sum_probs=143.0
Q ss_pred HHHhhcccCceeEEEeeeeec-----CceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCC
Q 002509 634 TLLSRIHHRNLVQFLGYCQEE-----GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 708 (914)
Q Consensus 634 ~~l~~l~HpnIv~l~g~~~~~-----~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~ 708 (914)
.-|-.+-|-|||+++.|..+. .+..++.|||..|++..+|+........+......+++.||..||.|||+ |.|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 345556799999999987543 45789999999999999998876667778888888999999999999998 578
Q ss_pred CccccCCCCCceEeCCCCcEEEeeccccccc---cCCCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHh
Q 002509 709 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFA---VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785 (914)
Q Consensus 709 ~ivHrDlkp~NILl~~~~~~kl~DFGla~~~---~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~Ellt 785 (914)
+|+|+++..+-|++..++-+|++----.... ............+-++|.+||+-.....+.++|||+||+..+||.-
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 9999999999999999998887532111100 0001111122346789999999887888889999999999999988
Q ss_pred CCCC-cccccccccchhHHHHHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002509 786 GQEA-ISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 786 G~~p-~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 859 (914)
+..- -.....-.....+..- +... .+..+ ...+..|++..|..||+|++++.+
T Consensus 278 lEiq~tnseS~~~~ee~ia~~---------i~~l-----en~lq-------r~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANV---------IIGL-----ENGLQ-------RGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred heeccCCCcceeehhhhhhhh---------eeec-----cCccc-------cCcCcccccCCCCCCcchhhhhcC
Confidence 7643 2222111111111110 0000 00000 123457999999999999998865
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.5e-13 Score=163.25 Aligned_cols=250 Identities=20% Similarity=0.256 Sum_probs=178.2
Q ss_pred HhccccccCcEEEEEEEECC--CcEEEEEEEecCC--cccchhhhHHHHHHhhcc-cCceeEEEeeeeecCceEEEEEec
Q 002509 590 LEKKIGSGGFGVVYYGKLKD--GKEIAVKVLTSNS--YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~~--g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
+.+.||+|+|+.|-...... ...+|+|.+.... .........|..+-..+. |+|++.+++.....+..+++.+|.
T Consensus 24 ~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s 103 (601)
T KOG0590|consen 24 LSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYS 103 (601)
T ss_pred ccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcc
Confidence 34569999999998776543 4446666654432 122233445677766775 999999999999999999999999
Q ss_pred cCCChHHHh-hcccCccccccHHHHHHHHHHHHHHHHHHH-hCCCCCccccCCCCCceEeCCCC-cEEEeeccccccccC
Q 002509 665 HNGTLKEHL-YGTLTHEQRINWIKRLEIAEDAAKGIEYLH-TGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVD 741 (914)
Q Consensus 665 ~~gsL~~~L-~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH-~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~ 741 (914)
.++++.+.+ +.. ....+-...-....|+..++.|+| .. ++.|+||||+|.+++..+ ..|++|||+|..+..
T Consensus 104 ~g~~~f~~i~~~~---~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 104 DGGSLFSKISHPD---STGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccccccccccCC---ccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999998877 322 113344455678899999999999 76 999999999999999999 999999999987655
Q ss_pred --CCCceeecccc-CCcccCccccccC-CCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCccc
Q 002509 742 --GASHVSSIVRG-TVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 817 (914)
Q Consensus 742 --~~~~~~~~~~g-t~~Y~aPE~~~~~-~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 817 (914)
+........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++...... .....|......
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~--~~~~~~~~~~~~------ 249 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD--GRYSSWKSNKGR------ 249 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc--ccceeecccccc------
Confidence 33444455678 9999999999885 44567899999999999999999986543221 122222211100
Q ss_pred ccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002509 818 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 858 (914)
Q Consensus 818 i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 858 (914)
........ -.....++...++..+|..|.+.+++..
T Consensus 250 -~~~~~~~~----~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 250 -FTQLPWNS----ISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred -cccCcccc----CChhhhhcccccccCCchhccccccccc
Confidence 00001111 1123556667788899999999888865
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.5e-12 Score=147.08 Aligned_cols=140 Identities=23% Similarity=0.263 Sum_probs=99.8
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEEecCCccc----------------------------------------chhhhH
Q 002509 592 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG----------------------------------------KREFTN 631 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~----------------------------------------~~~f~~ 631 (914)
+.||.|++|.||+|++++|+.||||+.+...... +-.|..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 4699999999999999999999999986542110 013455
Q ss_pred HHHHHhhcc----cCceeEEEeee-eecCceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHH-HHHHHHhC
Q 002509 632 EVTLLSRIH----HRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-GIEYLHTG 705 (914)
Q Consensus 632 E~~~l~~l~----HpnIv~l~g~~-~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~-gL~yLH~~ 705 (914)
|++.+.+++ |.+-+.+-..+ ...+..+|||||++|++|.+...... ... .+..++..+++ .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHHhC
Confidence 666666553 22223322222 23456799999999999988764211 111 23456666666 47888987
Q ss_pred CCCCccccCCCCCceEeCCCCcEEEeecccccccc
Q 002509 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 740 (914)
Q Consensus 706 ~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 740 (914)
+++|+|+||.||+++.+++++++|||++....
T Consensus 277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.19 E-value=1e-10 Score=117.37 Aligned_cols=129 Identities=20% Similarity=0.160 Sum_probs=96.5
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeE-EEeeeeecCceEEEEEeccCCChH
Q 002509 592 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ-FLGYCQEEGRSVLVYEFMHNGTLK 670 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~-l~g~~~~~~~~~LV~E~~~~gsL~ 670 (914)
+.|+.|.++.||+++.. ++.+++|+...... ....+..|++++..+.+.++++ ++.+. ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 46889999999999876 78899998754432 2345788999999997666554 44332 33458999999998875
Q ss_pred HHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCC--CCCccccCCCCCceEeCCCCcEEEeeccccc
Q 002509 671 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC--VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 737 (914)
Q Consensus 671 ~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~--~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 737 (914)
+.. .....++.+++++|+.||... ...++|||++|.||+++ ++.++++|||.+.
T Consensus 80 ~~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 80 TED------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccc------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 420 011245678999999999973 12369999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.3e-10 Score=133.54 Aligned_cols=140 Identities=19% Similarity=0.240 Sum_probs=91.8
Q ss_pred ccccccCcEEEEEEEECC-CcEEEEEEEecCCcc----------------------------------------cchhhh
Q 002509 592 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQ----------------------------------------GKREFT 630 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~~-g~~vAVK~l~~~~~~----------------------------------------~~~~f~ 630 (914)
+.||+|++|.||+|++++ |++||||+.+..-.. .+-+|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 479999999999999987 999999999754110 001244
Q ss_pred HHHHHHhhcc----cCceeEEEeeeee-cCceEEEEEeccCCChHHHh--hcccCccccccHHHHHHHHHHHHHHHHHHH
Q 002509 631 NEVTLLSRIH----HRNLVQFLGYCQE-EGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 703 (914)
Q Consensus 631 ~E~~~l~~l~----HpnIv~l~g~~~~-~~~~~LV~E~~~~gsL~~~L--~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH 703 (914)
.|+..+.+++ +.+.+.+-..+.+ ....+|||||++|+.+.+.- .........+.......++.|+ +
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence 5555555553 3333433333322 45678999999999998742 2111111123322223333333 3
Q ss_pred hCCCCCccccCCCCCceEeCCCC----cEEEeeccccccccC
Q 002509 704 TGCVPAIIHRDLKSSNILLDKHM----RAKVSDFGLSKFAVD 741 (914)
Q Consensus 704 ~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFGla~~~~~ 741 (914)
.. +++|+|+||.||+++.++ ++++.|||++.....
T Consensus 278 ~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 45 999999999999999988 999999999876543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.2e-09 Score=125.55 Aligned_cols=166 Identities=19% Similarity=0.230 Sum_probs=123.5
Q ss_pred ECCCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCChHHHhhcccCccccccHH
Q 002509 607 LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI 686 (914)
Q Consensus 607 ~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~ 686 (914)
..++.+|.|+..+...........+-++.|+.+|||||++++.....++..+||.|-+.. |..++... .-.
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~l-------~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKEL-------GKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHHh-------HHH
Confidence 347889999888765543345567778899999999999999999999999999998754 55555322 233
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCceeeccccCCcccCccccccCC
Q 002509 687 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 766 (914)
Q Consensus 687 ~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~ 766 (914)
...--+.||+.||.|||+.| +++|++|....|++++.|+.||++|.++........ ......--..|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence 44456789999999999776 899999999999999999999999998754322111 111111223466676553322
Q ss_pred CCccCceeehHHHHHHHHhC
Q 002509 767 LTDKSDVYSFGVILLELISG 786 (914)
Q Consensus 767 ~s~ksDV~S~Gvvl~ElltG 786 (914)
-..|.|.|||+++|++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.4e-10 Score=132.13 Aligned_cols=252 Identities=21% Similarity=0.210 Sum_probs=174.5
Q ss_pred HHHHHHHHHhccccc--cCcEEEEEEEE--C-CCcEEEEEEEecC--CcccchhhhHHHHHHhhc-ccCceeEEEeeeee
Q 002509 582 DIEDATKMLEKKIGS--GGFGVVYYGKL--K-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE 653 (914)
Q Consensus 582 ei~~~~~~~~~~lG~--G~~G~Vy~~~~--~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~ 653 (914)
+..+....+.+.+|. |.+|.||+++. . ++..+|+|.-+.. .......=.+|+....++ .|+|.++......+
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence 344445556678999 99999999987 3 6888999874322 222222334566666666 59999998888888
Q ss_pred cCceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHH----HHHHHHhCCCCCccccCCCCCceEeCCC-CcE
Q 002509 654 EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK----GIEYLHTGCVPAIIHRDLKSSNILLDKH-MRA 728 (914)
Q Consensus 654 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~----gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~ 728 (914)
.+..++-.|++. .+|.++.+... ..++....+....+..+ ||.++|+. .++|-|+||.||++..+ ...
T Consensus 190 ~~~lfiqtE~~~-~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~ 262 (524)
T KOG0601|consen 190 SGILFIQTELCG-ESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSC 262 (524)
T ss_pred CCcceeeecccc-chhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheeccccccee
Confidence 899999999886 57887776442 22444455566666667 99999998 99999999999999999 889
Q ss_pred EEeeccccccccCCCCce----eeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHH
Q 002509 729 KVSDFGLSKFAVDGASHV----SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 804 (914)
Q Consensus 729 kl~DFGla~~~~~~~~~~----~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~ 804 (914)
+++|||+...+.++.-.. .....|...|++||...+ -++.++|+|++|.+.+|..++......... ..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-------~~ 334 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN-------SS 334 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC-------CC
Confidence 999999987766544221 122257889999998754 568899999999999999988765432210 11
Q ss_pred HHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002509 805 WAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 858 (914)
Q Consensus 805 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 858 (914)
|. ..+.+- +..++...--.++......+++.+|..|++.+++..
T Consensus 335 W~--~~r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 335 WS--QLRQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cc--cccccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 21 111110 111111111123444788899999999998877754
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.04 E-value=4.5e-10 Score=143.95 Aligned_cols=127 Identities=31% Similarity=0.573 Sum_probs=95.9
Q ss_pred CCCccHHHHHHHHhhc-----CCCCCcCCCCCCCCCCCCceEEeCCCCCCCeEEEEccCCCCcccCCchhhcccccccc-
Q 002509 372 DGSIDGVAIVSVISLY-----SSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEF- 445 (914)
Q Consensus 372 ~~~~d~~al~~l~~~~-----~~~~~~~~~~dpc~~~~w~gv~c~~~~~~~l~~L~L~~n~l~G~ip~~~~~l~~L~~l- 445 (914)
..+.|..||+++|+.. ...+|.. ..|+| .|.||+|+. ..+++.|+|++|+++|.+|+.+..|++|+.|
T Consensus 26 ~~~~~~~~l~~~~~~~~~~~~~~~~w~~-~~~~c---~w~gv~c~~--~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~ 99 (968)
T PLN00113 26 LHAEELELLLSFKSSINDPLKYLSNWNS-SADVC---LWQGITCNN--SSRVVSIDLSGKNISGKISSAIFRLPYIQTIN 99 (968)
T ss_pred CCHHHHHHHHHHHHhCCCCcccCCCCCC-CCCCC---cCcceecCC--CCcEEEEEecCCCccccCChHHhCCCCCCEEE
Confidence 5678999999998832 2346754 46889 899999974 3589999999999999999999999988865
Q ss_pred ----------------CCCCCcEEEcCCCcCCCCCCccCcCCCCCceeeecCccccCCCCccc--cccccccccccCCC
Q 002509 446 ----------------GCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNIN 506 (914)
Q Consensus 446 ----------------~l~~L~~L~Ls~N~l~G~iP~~l~~l~~L~~l~l~~N~l~G~iP~~~--~~~~~~l~~~~N~~ 506 (914)
++++|++|+|++|+++|.+|. +.+++|+.|+|++|+++|.+|..+ +..++.|++++|..
T Consensus 100 Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l 176 (968)
T PLN00113 100 LSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVL 176 (968)
T ss_pred CCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcc
Confidence 345677777777777777764 456777777777777777777655 45567777777753
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.9e-11 Score=116.99 Aligned_cols=152 Identities=20% Similarity=0.294 Sum_probs=110.6
Q ss_pred EEEEEEeecCCCCCCcchhhhhhhhhccCC-----CCCccHHHHHHHHhhcCCCCCcCCCCCCCCCCCCceEEeCCCCCC
Q 002509 342 VLSFKFGKTYDSSRGPLLNAMEINKYLERN-----DGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 416 (914)
Q Consensus 342 ~~~l~l~~~~~s~lpp~ln~le~l~~l~~~-----~~~~d~~al~~l~~~~~~~~~~~~~~dpc~~~~w~gv~c~~~~~~ 416 (914)
.+.+.|++|.++.+||.|..+.+|++|++. .+|.....|..++.+.-..+... .-|- | -+..|
T Consensus 35 ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~--~lpr------g----fgs~p 102 (264)
T KOG0617|consen 35 ITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN--ILPR------G----FGSFP 102 (264)
T ss_pred hhhhhcccCceeecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh--cCcc------c----cCCCc
Confidence 378899999999999999999999999988 56777888888876544333221 2222 1 14567
Q ss_pred CeEEEEccCCCCcc-cCCchhhcccccccc---------------CCCCCcEEEcCCCcCCCCCCccCcCCCCCceeeec
Q 002509 417 SITVIHLSSKNLTG-NIPSDLTKLSSLVEF---------------GCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 480 (914)
Q Consensus 417 ~l~~L~L~~n~l~G-~ip~~~~~l~~L~~l---------------~l~~L~~L~Ls~N~l~G~iP~~l~~l~~L~~l~l~ 480 (914)
.|++|||+.|+|+- .+|..|.-|+.|+.| .|++|+.|.|.+|.|- ++|.+++.|+.|++|.++
T Consensus 103 ~levldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiq 181 (264)
T KOG0617|consen 103 ALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQ 181 (264)
T ss_pred hhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcc
Confidence 89999999999874 578778777777754 4566778888888777 788888888888888888
Q ss_pred CccccCCCCcccc-----ccccccccccCCCc
Q 002509 481 NNMLSGTVPSSLL-----SKNVVLNYAGNINL 507 (914)
Q Consensus 481 ~N~l~G~iP~~~~-----~~~~~l~~~~N~~~ 507 (914)
+|+|+ -+|+++. ...+.+.++.||+.
T Consensus 182 gnrl~-vlppel~~l~l~~~k~v~r~E~NPwv 212 (264)
T KOG0617|consen 182 GNRLT-VLPPELANLDLVGNKQVMRMEENPWV 212 (264)
T ss_pred cceee-ecChhhhhhhhhhhHHHHhhhhCCCC
Confidence 88887 6777652 22344556667664
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.8e-09 Score=108.64 Aligned_cols=135 Identities=19% Similarity=0.193 Sum_probs=95.9
Q ss_pred ccccccCcEEEEEEEECC-------CcEEEEEEEecCCc--c--------c------------chhh----hHHHHHHhh
Q 002509 592 KKIGSGGFGVVYYGKLKD-------GKEIAVKVLTSNSY--Q--------G------------KREF----TNEVTLLSR 638 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~~-------g~~vAVK~l~~~~~--~--------~------------~~~f----~~E~~~l~~ 638 (914)
..||.|.-+.||.|...+ +..+|||+.+.... + . .+.+ .+|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997653 47999998753210 0 0 1122 279999999
Q ss_pred ccc--CceeEEEeeeeecCceEEEEEeccCCChHH-HhhcccCccccccHHHHHHHHHHHHHHHHHH-HhCCCCCccccC
Q 002509 639 IHH--RNLVQFLGYCQEEGRSVLVYEFMHNGTLKE-HLYGTLTHEQRINWIKRLEIAEDAAKGIEYL-HTGCVPAIIHRD 714 (914)
Q Consensus 639 l~H--pnIv~l~g~~~~~~~~~LV~E~~~~gsL~~-~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yL-H~~~~~~ivHrD 714 (914)
+.. -++..++++ ...+|||||+.+..+.. .+.. ..++..+...+..+++.+|..| |.. +|+|||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 854 345555553 56789999998754321 1211 1233345567789999999999 777 999999
Q ss_pred CCCCceEeCCCCcEEEeeccccccc
Q 002509 715 LKSSNILLDKHMRAKVSDFGLSKFA 739 (914)
Q Consensus 715 lkp~NILl~~~~~~kl~DFGla~~~ 739 (914)
|++.|||++ ++.+.|+|||.+...
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeC
Confidence 999999997 468999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.00 E-value=3e-09 Score=111.37 Aligned_cols=142 Identities=17% Similarity=0.325 Sum_probs=108.8
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEEecCCc-ccchhhhHHHHHHhhcccC--ceeEEEeeeeecC---ceEEEEEecc
Q 002509 592 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHR--NLVQFLGYCQEEG---RSVLVYEFMH 665 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~Hp--nIv~l~g~~~~~~---~~~LV~E~~~ 665 (914)
+.|+.|..+.||+++..+|+.+++|+...... .....+..|+++++.+++. ++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999887778999999765432 2356788999999999763 4566777776542 5689999999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC--------------------------------------- 706 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~--------------------------------------- 706 (914)
+.++.+.+.. ..++..++..++.+++++|..||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9888765421 23566667778888888888888521
Q ss_pred --------------CCCccccCCCCCceEeCC--CCcEEEeecccccc
Q 002509 707 --------------VPAIIHRDLKSSNILLDK--HMRAKVSDFGLSKF 738 (914)
Q Consensus 707 --------------~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~ 738 (914)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 66789999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=4.4e-09 Score=103.64 Aligned_cols=130 Identities=24% Similarity=0.405 Sum_probs=102.8
Q ss_pred cccccCcEEEEEEEECCCcEEEEEEEecCCccc--------chhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEec
Q 002509 593 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--------KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 593 ~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~--------~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 664 (914)
.+++|+-+.+|.+.+. |.++.+|.-..+.... ...-.+|+.++.+++--.|....-+..+.....++|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999876 4557777644332211 233567999999998777766666777888889999999
Q ss_pred cCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccc
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 738 (914)
Q Consensus 665 ~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 738 (914)
++-.|.+.+... +..++..+-+-+.-||.. +|+|+||.++||++..+. +.++||||+.+
T Consensus 82 ~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999888432 256777888889999999 999999999999998765 99999999864
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=9.6e-09 Score=100.63 Aligned_cols=141 Identities=26% Similarity=0.303 Sum_probs=105.9
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEEecCCc--------ccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEe
Q 002509 592 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 663 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~--------~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~ 663 (914)
..|-+|+-+.|+++.+. |+...||.-..... -..+...+|+.+|.+++--.|.-..-++.+...-.|+|||
T Consensus 13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 46889999999999987 77777775432211 1235567899999999876766666677777788999999
Q ss_pred ccC-CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCC---cEEEeecccccc
Q 002509 664 MHN-GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDFGLSKF 738 (914)
Q Consensus 664 ~~~-gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~ 738 (914)
+++ .++.+++....... ..-.....++..+-+.+.-||.+ .|+||||..+||+|..++ .+.++|||++..
T Consensus 92 ~~g~~~vk~~i~~~~~~~--~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMEDE--SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred ccchhHHHHHHHHHccCc--ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 987 47888886543211 11222257888999999999999 999999999999997665 458999999753
|
|
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=98.83 E-value=7.1e-09 Score=104.40 Aligned_cols=134 Identities=24% Similarity=0.424 Sum_probs=76.5
Q ss_pred EEEecCCCCCcccCCCeEEecCCccccCcce--------------eeecC-ccccccccccccccCCCCCceeeeeccCC
Q 002509 33 VSLNCGGNENFTDEIGLQWIADDHLIYGEIS--------------NISVA-NETRKQYMTLRHFPADSRKYCYKLDVITR 97 (914)
Q Consensus 33 ~~idCG~~~~~~~~~~~~~~~D~~~~~g~~~--------------~~~~~-~~~~~~~~tlR~Fp~~~~~~cY~~~~~~~ 97 (914)
+.||||+... +|..|+.|.+|..|..|... ..+.. ....+.|+|-|+=|. ...|.+|+.+.
T Consensus 3 ~~IN~Gg~~~-~~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~---~f~Y~ip~~~~ 78 (174)
T PF11721_consen 3 LRINAGGPAY-TDSSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGPS---SFSYDIPVVPN 78 (174)
T ss_dssp EEEEETSSSE-EETTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----SS---SEEEEEE--S-
T ss_pred EEEECCCCcc-cCCCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCCC---ceEEEEecCCC
Confidence 5799998666 88899999999999855440 01111 111258899999543 48999998899
Q ss_pred ceEEEEEEe---ecccCCCCCCCC---ceeEEeCCc-ccceeeec---CCCc-eEEEEE-EEecCCCCeeEEEec-----
Q 002509 98 TRYLIRATF---LYGNFDNNNVYP---KFDISLGPT-HWSTIVIS---DAAT-IEVREL-IFLASSPKIDVCLSN----- 160 (914)
Q Consensus 98 ~~ylvR~~f---~ygnyd~~~~~p---~Fd~~~~~~-~w~~v~~~---~~~~-~~~~e~-i~~~~~~~~~vcl~~----- 160 (914)
|.|-||++| +++. ++....| +||+.++|. ....+++. .... +...+. -+.+.++.+.|+|..
T Consensus 79 G~Y~V~L~FaE~~~~~-~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg~L~i~f~~~~~~~ 157 (174)
T PF11721_consen 79 GTYTVRLHFAELYFGA-SGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDGTLNIQFVWAGKGT 157 (174)
T ss_dssp EEEEEEEEEE-SSS---------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETTEEETTEEEE--SE
T ss_pred cEEEEEEEeccccccc-cccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCCcEEEEEEecCCCc
Confidence 999999999 4444 3222233 799999995 44444432 1212 233333 234477789999996
Q ss_pred ------CCCCCceeeee
Q 002509 161 ------ATTGQPFISTL 171 (914)
Q Consensus 161 ------~~~~~pfis~l 171 (914)
...|.|.||||
T Consensus 158 ~~i~~~~~~~~p~IsaI 174 (174)
T PF11721_consen 158 LCIPFIGSYGNPLISAI 174 (174)
T ss_dssp EEEEEESSSSSSSEEEE
T ss_pred EEeeccccCCCcEEeeC
Confidence 44556888876
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.80 E-value=5.2e-10 Score=125.36 Aligned_cols=179 Identities=20% Similarity=0.282 Sum_probs=126.9
Q ss_pred cccccccccceEEEEEEeecCCCCCCcchhhhhhhhhccCCCCCccHHHHHHHHhhcCCCCCcCCCCC---CCCCCCCce
Q 002509 331 EPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGD---PCLPVPWSW 407 (914)
Q Consensus 331 ~~~~~~~~~~~~~~l~l~~~~~s~lpp~ln~le~l~~l~~~~~~~d~~al~~l~~~~~~~~~~~~~~d---pc~~~~w~g 407 (914)
.|+...+.++-++-|+|++|++..|||.+-.+..|+.|.++.+|..--.|-+|-.+....-..-+++. --.|.+-++
T Consensus 141 IPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~ 220 (1255)
T KOG0444|consen 141 IPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDD 220 (1255)
T ss_pred CCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhh
Confidence 34445556666688999999999999999999999999999877665444333221111000000000 000001111
Q ss_pred --------EEeCC---------------------CC----------CCCeEEEEccCCCCcccCCchhhcccccccc---
Q 002509 408 --------LQCNS---------------------DP----------QPSITVIHLSSKNLTGNIPSDLTKLSSLVEF--- 445 (914)
Q Consensus 408 --------v~c~~---------------------~~----------~~~l~~L~L~~n~l~G~ip~~~~~l~~L~~l--- 445 (914)
++|++ +. =.+|++|+||.|+|+ .+|+.+++|+.|+.|
T Consensus 221 l~NL~dvDlS~N~Lp~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n 299 (1255)
T KOG0444|consen 221 LHNLRDVDLSENNLPIVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYAN 299 (1255)
T ss_pred hhhhhhccccccCCCcchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhc
Confidence 22222 11 124578888999999 899999999999877
Q ss_pred --------------CCCCCcEEEcCCCcCCCCCCccCcCCCCCceeeecCccccCCCCccc--cccccccccccCCCccC
Q 002509 446 --------------GCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHE 509 (914)
Q Consensus 446 --------------~l~~L~~L~Ls~N~l~G~iP~~l~~l~~L~~l~l~~N~l~G~iP~~~--~~~~~~l~~~~N~~~~~ 509 (914)
.|.+|+++.+++|+|. -+|+.+..|.+|+.|.|+.|+|- ++|+.+ +..+..|++..||++--
T Consensus 300 ~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVM 377 (1255)
T KOG0444|consen 300 NNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVM 377 (1255)
T ss_pred cCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccC
Confidence 4667999999999999 89999999999999999999998 899886 77788999999999976
Q ss_pred CCc
Q 002509 510 GGR 512 (914)
Q Consensus 510 ~~~ 512 (914)
++.
T Consensus 378 PPK 380 (1255)
T KOG0444|consen 378 PPK 380 (1255)
T ss_pred CCC
Confidence 654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.76 E-value=5.4e-08 Score=108.57 Aligned_cols=170 Identities=21% Similarity=0.301 Sum_probs=131.4
Q ss_pred cEEEEEEEEC-CCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeee----cCceEEEEEeccC-CChHHH
Q 002509 599 FGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVLVYEFMHN-GTLKEH 672 (914)
Q Consensus 599 ~G~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~----~~~~~LV~E~~~~-gsL~~~ 672 (914)
..+.||+..+ ||..+++|+++.+..........-+++++++.|.|+|++...+.. +...++||+|.++ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3588999766 899999999966544444344566889999999999999998863 4567999999986 577776
Q ss_pred hhccc-----------CccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccC
Q 002509 673 LYGTL-----------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 741 (914)
Q Consensus 673 L~~~~-----------~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 741 (914)
-.... ..+..+++...|.++.|+..||.++|+. |+.-+-|.+++||++.+.+++|+.+|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 54322 1234567889999999999999999998 899999999999999999999999988765533
Q ss_pred CCCceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCC
Q 002509 742 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEA 789 (914)
Q Consensus 742 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p 789 (914)
... |.+.+ ..+-|.-.||.+++.|.||..-
T Consensus 446 d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 220 11111 2356888899999999999543
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.75 E-value=3e-09 Score=119.38 Aligned_cols=145 Identities=21% Similarity=0.274 Sum_probs=107.5
Q ss_pred EEEEEEeecCCCCCCcchhhhhhhhhccCC-----CCCccHHHHHHHHhhc-CCCCCcCCCCCCCCCCCCceEEeCCCCC
Q 002509 342 VLSFKFGKTYDSSRGPLLNAMEINKYLERN-----DGSIDGVAIVSVISLY-SSADWAQEGGDPCLPVPWSWLQCNSDPQ 415 (914)
Q Consensus 342 ~~~l~l~~~~~s~lpp~ln~le~l~~l~~~-----~~~~d~~al~~l~~~~-~~~~~~~~~~dpc~~~~w~gv~c~~~~~ 415 (914)
..=|.|..+.+..+|..|.++..|+-|.++ +.--+...|-.|+... ...+... +|-|- +--..
T Consensus 34 ~~WLkLnrt~L~~vPeEL~~lqkLEHLs~~HN~L~~vhGELs~Lp~LRsv~~R~N~LKn-sGiP~----------diF~l 102 (1255)
T KOG0444|consen 34 MTWLKLNRTKLEQVPEELSRLQKLEHLSMAHNQLISVHGELSDLPRLRSVIVRDNNLKN-SGIPT----------DIFRL 102 (1255)
T ss_pred eeEEEechhhhhhChHHHHHHhhhhhhhhhhhhhHhhhhhhccchhhHHHhhhcccccc-CCCCc----------hhccc
Confidence 366888999999999999999999998888 2333444555555422 2222222 23332 11234
Q ss_pred CCeEEEEccCCCCcccCCchhhccccccccCCCCCcEEEcCCCcCCCCCCccC-cCCCCCceeeecCccccCCCCccc--
Q 002509 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSL-MNLPNLRELYVQNNMLSGTVPSSL-- 492 (914)
Q Consensus 416 ~~l~~L~L~~n~l~G~ip~~~~~l~~L~~l~l~~L~~L~Ls~N~l~G~iP~~l-~~l~~L~~l~l~~N~l~G~iP~~~-- 492 (914)
..|+.||||+|+|+ ..|..+-.-+++. +|+||+|++. +||.++ .+|+.|-+||||+|+|. .+|+.+
T Consensus 103 ~dLt~lDLShNqL~-EvP~~LE~AKn~i--------VLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RR 171 (1255)
T KOG0444|consen 103 KDLTILDLSHNQLR-EVPTNLEYAKNSI--------VLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRR 171 (1255)
T ss_pred ccceeeecchhhhh-hcchhhhhhcCcE--------EEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHH
Confidence 57899999999999 9999888777666 8999999998 899776 58889999999999998 888876
Q ss_pred cccccccccccCCCcc
Q 002509 493 LSKNVVLNYAGNINLH 508 (914)
Q Consensus 493 ~~~~~~l~~~~N~~~~ 508 (914)
+..++.|.+++||..+
T Consensus 172 L~~LqtL~Ls~NPL~h 187 (1255)
T KOG0444|consen 172 LSMLQTLKLSNNPLNH 187 (1255)
T ss_pred HhhhhhhhcCCChhhH
Confidence 5667888888888654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.4e-08 Score=115.92 Aligned_cols=240 Identities=21% Similarity=0.204 Sum_probs=163.5
Q ss_pred hccccccCcEEEEEEEEC--CCcEEEEEEEecCCccc--chhhhHHHHHHhhc-ccCceeEEEeeeeecCceEEEEEecc
Q 002509 591 EKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNSYQG--KREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 591 ~~~lG~G~~G~Vy~~~~~--~g~~vAVK~l~~~~~~~--~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~ 665 (914)
...||.|.|+.|++...+ ++..+++|.+....... +..-..|+.+...+ .|.+++........-...++=-||++
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE 349 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence 357999999999987543 67889999876553322 22224566666555 58888877666666666678889999
Q ss_pred CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCC-CcEEEeeccccccccCCCC
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 666 ~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~~~~ 744 (914)
++++...+. -...++...++++..|++.++.++|+. .++|+|+||+||++..+ +..+++|||++..+.-.
T Consensus 350 ~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~-- 420 (524)
T KOG0601|consen 350 GGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS-- 420 (524)
T ss_pred CcchhhhhH----HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccccccee--
Confidence 998876651 244567778889999999999999987 99999999999999886 78899999998532110
Q ss_pred ceeeccccCCccc--CccccccCCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCc
Q 002509 745 HVSSIVRGTVGYL--DPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 822 (914)
Q Consensus 745 ~~~~~~~gt~~Y~--aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 822 (914)
.......-++. +++......+..+.|++|||.-+.|.+++..--. ...+|.. +..+.+. .
T Consensus 421 --~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~---------~~~~~~~--i~~~~~p-----~ 482 (524)
T KOG0601|consen 421 --SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE---------SGVQSLT--IRSGDTP-----N 482 (524)
T ss_pred --cccccccccccccchhhccccccccccccccccccccccccCcccCc---------cccccee--eeccccc-----C
Confidence 01111223333 5555556778889999999999999999864221 1112211 1111111 1
Q ss_pred cCCccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002509 823 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862 (914)
Q Consensus 823 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 862 (914)
+.. .- ..+..++..+..+++..||.+.+...+.+.
T Consensus 483 ~~~----~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 483 LPG----LK-LQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred CCc----hH-HhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 111 11 345566777889999999999888766554
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.67 E-value=4.5e-09 Score=113.12 Aligned_cols=147 Identities=21% Similarity=0.204 Sum_probs=102.0
Q ss_pred EEEEeecCCCCCCcchhhhhhhhhccCC-----CCCccHHHHHHHHhhcCCCCCcCCCCCCCCCCCCceEEeCCCCCCCe
Q 002509 344 SFKFGKTYDSSRGPLLNAMEINKYLERN-----DGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (914)
Q Consensus 344 ~l~l~~~~~s~lpp~ln~le~l~~l~~~-----~~~~d~~al~~l~~~~~~~~~~~~~~dpc~~~~w~gv~c~~~~~~~l 418 (914)
.++.++|+.+++|+.+..+-.+..+++. ..+++..+|..+|++ |+|.-. .+-+.-..+...+|
T Consensus 141 dl~~~~N~i~slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~l-----------d~~~N~-L~tlP~~lg~l~~L 208 (565)
T KOG0472|consen 141 DLDATNNQISSLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHL-----------DCNSNL-LETLPPELGGLESL 208 (565)
T ss_pred hhhccccccccCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhc-----------ccchhh-hhcCChhhcchhhh
Confidence 3444566666666666666555555554 455555555555442 222100 00000001334567
Q ss_pred EEEEccCCCCcccCCchhhcccccccc----------------CCCCCcEEEcCCCcCCCCCCccCcCCCCCceeeecCc
Q 002509 419 TVIHLSSKNLTGNIPSDLTKLSSLVEF----------------GCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 482 (914)
Q Consensus 419 ~~L~L~~n~l~G~ip~~~~~l~~L~~l----------------~l~~L~~L~Ls~N~l~G~iP~~l~~l~~L~~l~l~~N 482 (914)
+.|+|..|++. .+| +|..++.|++| +|.+|.+|||.+|+|. ++|.++..|.+|..||||+|
T Consensus 209 ~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN 285 (565)
T KOG0472|consen 209 ELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNN 285 (565)
T ss_pred HHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCC
Confidence 78888999988 888 88888888876 6788999999999999 99999999999999999999
Q ss_pred cccCCCCccccc-cccccccccCCC
Q 002509 483 MLSGTVPSSLLS-KNVVLNYAGNIN 506 (914)
Q Consensus 483 ~l~G~iP~~~~~-~~~~l~~~~N~~ 506 (914)
.++ .+|.++.. .+..|.+.|||.
T Consensus 286 ~is-~Lp~sLgnlhL~~L~leGNPl 309 (565)
T KOG0472|consen 286 DIS-SLPYSLGNLHLKFLALEGNPL 309 (565)
T ss_pred ccc-cCCcccccceeeehhhcCCch
Confidence 999 67877743 467788999985
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.8e-07 Score=95.20 Aligned_cols=125 Identities=26% Similarity=0.332 Sum_probs=81.0
Q ss_pred EEEEEEECCCcEEEEEEEecCCcc---------------------c-----chhhhHHHHHHhhcccC--ceeEEEeeee
Q 002509 601 VVYYGKLKDGKEIAVKVLTSNSYQ---------------------G-----KREFTNEVTLLSRIHHR--NLVQFLGYCQ 652 (914)
Q Consensus 601 ~Vy~~~~~~g~~vAVK~l~~~~~~---------------------~-----~~~f~~E~~~l~~l~Hp--nIv~l~g~~~ 652 (914)
.||.|...+|..+|||+.+..... . .....+|++.|.++... ++.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 489999999999999987542100 0 12345799999999765 34555543
Q ss_pred ecCceEEEEEecc--CCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHH-HhCCCCCccccCCCCCceEeCCCCcEE
Q 002509 653 EEGRSVLVYEFMH--NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL-HTGCVPAIIHRDLKSSNILLDKHMRAK 729 (914)
Q Consensus 653 ~~~~~~LV~E~~~--~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yL-H~~~~~~ivHrDlkp~NILl~~~~~~k 729 (914)
...+|||||++ +..+....... ++......++.++++.+..+ |.. +|+||||.+.|||++++ .+.
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred --eCCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 24589999999 54454433211 11334456777888866664 676 99999999999999988 999
Q ss_pred Eeeccccccc
Q 002509 730 VSDFGLSKFA 739 (914)
Q Consensus 730 l~DFGla~~~ 739 (914)
|+|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999987544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.64 E-value=3.8e-07 Score=98.24 Aligned_cols=141 Identities=14% Similarity=0.109 Sum_probs=100.0
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEEecCCcc-----------cchhhhHHHHHHhhcccCce--eEEEeeeee-----
Q 002509 592 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ-----------GKREFTNEVTLLSRIHHRNL--VQFLGYCQE----- 653 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~-----------~~~~f~~E~~~l~~l~HpnI--v~l~g~~~~----- 653 (914)
+.+-+-....|.+..+ +|+.+.||........ ....+.+|...+.++...+| ..++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444455777766 4788999976433211 11147789999988854443 344555543
Q ss_pred cCceEEEEEeccCC-ChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCC-------C
Q 002509 654 EGRSVLVYEFMHNG-TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-------H 725 (914)
Q Consensus 654 ~~~~~LV~E~~~~g-sL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~-------~ 725 (914)
....+||+|++++- +|.+++.... ....+...+..++.++++.+.-||.. +|+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23578999999986 8988874321 12334556678999999999999999 9999999999999975 4
Q ss_pred CcEEEeecccccc
Q 002509 726 MRAKVSDFGLSKF 738 (914)
Q Consensus 726 ~~~kl~DFGla~~ 738 (914)
+.+.++||+.++.
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6899999998753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=3.5e-08 Score=118.08 Aligned_cols=198 Identities=20% Similarity=0.235 Sum_probs=133.4
Q ss_pred cccccCcEEEEEEEEC-CCcEEEEEEEecC---CcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCC
Q 002509 593 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 668 (914)
Q Consensus 593 ~lG~G~~G~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gs 668 (914)
-+-+|.++.+..++-. .|.-.+.|+.... .....+....+-.++-..+||-++...--+.......|+++|..+++
T Consensus 811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~ 890 (1205)
T KOG0606|consen 811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD 890 (1205)
T ss_pred cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence 5677888888766433 2323333332211 11112223333333333456666655544455667889999999999
Q ss_pred hHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeecccccccc------C-
Q 002509 669 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV------D- 741 (914)
Q Consensus 669 L~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~------~- 741 (914)
|...|+... ..+..-.......+.+++++||.. .+.|+|++|.|+|...+++.+++|||...... +
T Consensus 891 ~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~ 963 (1205)
T KOG0606|consen 891 LPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDL 963 (1205)
T ss_pred chhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcCCc
Confidence 999987542 222222233455677899999997 68999999999999999999999998432110 0
Q ss_pred --------------CC--C-------ceeeccccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCcccccccc
Q 002509 742 --------------GA--S-------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA 797 (914)
Q Consensus 742 --------------~~--~-------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~ 797 (914)
.. . .......||+.|.+||...+......+|.|+.|++++|.++|..||.......
T Consensus 964 sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen 964 SGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ 1042 (1205)
T ss_pred ccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh
Confidence 00 0 00122458999999999999999999999999999999999999998665433
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.4e-06 Score=91.14 Aligned_cols=135 Identities=21% Similarity=0.241 Sum_probs=96.9
Q ss_pred HHHhccccccCcEEEEEEEECCCcEEEEEEEecCCc----------c------------cchhhhHHHHHHhhcccC--c
Q 002509 588 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY----------Q------------GKREFTNEVTLLSRIHHR--N 643 (914)
Q Consensus 588 ~~~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~----------~------------~~~~f~~E~~~l~~l~Hp--n 643 (914)
+.+++.||-|.-+.||.|....|.++|||.=+.... . .....++|.++|.++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 346689999999999999999999999996432110 0 123456899999998644 5
Q ss_pred eeEEEeeeeecCceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeC
Q 002509 644 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 723 (914)
Q Consensus 644 Iv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~ 723 (914)
+.+.+++ ++.++|||++++-.|...- ++....-.++..|++-+..+-.. |+||||+.+-||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence 5555543 5678999999986554321 12222334555556655555555 999999999999999
Q ss_pred CCCcEEEeecccccc
Q 002509 724 KHMRAKVSDFGLSKF 738 (914)
Q Consensus 724 ~~~~~kl~DFGla~~ 738 (914)
+||.+.++||--+..
T Consensus 237 ~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 237 EDGDIVVIDWPQAVP 251 (304)
T ss_pred cCCCEEEEeCccccc
Confidence 999999999986643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=9.5e-06 Score=88.79 Aligned_cols=262 Identities=12% Similarity=0.113 Sum_probs=150.5
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhhc-ccCceeEEEee----eee--c-CceEEEEE
Q 002509 591 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGY----CQE--E-GRSVLVYE 662 (914)
Q Consensus 591 ~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~----~~~--~-~~~~LV~E 662 (914)
++-||+|+-+.+|-.-- -..-+-|+..........+. ++.|.+. .||-+-.-+.+ ... + ...-+.|.
T Consensus 16 gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecch--hhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 35799999999985421 12234577665433322222 2223333 45533221111 111 1 12446666
Q ss_pred eccCCC-hHHHhhc--ccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccc
Q 002509 663 FMHNGT-LKEHLYG--TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 739 (914)
Q Consensus 663 ~~~~gs-L~~~L~~--~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 739 (914)
.+.+.- +..+... ........+|...++.+..+|.+.+-||+. |.+-||+.++|+|+++++.+.|.|-..-...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeec
Confidence 666542 2222211 111233478999999999999999999998 8899999999999999999999986543333
Q ss_pred cCCCCceeeccccCCcccCccccc-----cCCCCccCceeehHHHHHHHHhC-CCCccccccccc-----chhHHHHHHH
Q 002509 740 VDGASHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISG-QEAISNEKFGAN-----CRNIVQWAKL 808 (914)
Q Consensus 740 ~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDV~S~Gvvl~ElltG-~~p~~~~~~~~~-----~~~l~~~~~~ 808 (914)
..+..+ .-.+|...|.+||... +-.-+...|.|.+|+++++++.| ++||.+-..... +..|....-.
T Consensus 168 ~ng~~~--~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ 245 (637)
T COG4248 168 ANGTLH--LCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA 245 (637)
T ss_pred cCCceE--ecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence 222222 2235889999999875 33456789999999999999886 899975332111 1122110000
Q ss_pred hhhcCCcccccCCccCCccCHHH-HHHHHHHHHHccCC--CCCCCCCHHHHHHHHhhhHh
Q 002509 809 HIESGDIQGIIDPSLLDEYDIQS-MWKIEEKALMCVLP--HGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 809 ~~~~~~~~~i~d~~l~~~~~~~~-~~~l~~l~~~C~~~--~P~~RPsm~eVl~~L~~~~~ 865 (914)
...+....-.-.| .+.+.+. ...+.-+-.+|+.. ++.-||+++..+..|.++..
T Consensus 246 ya~~~~~g~~p~P---~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 246 YASDQRRGLKPPP---RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred echhccCCCCCCC---CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 0000000000000 0111111 12344455567754 36789999999988876643
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.9e-07 Score=103.52 Aligned_cols=60 Identities=23% Similarity=0.200 Sum_probs=38.6
Q ss_pred CCCCCcEEEcCCCcCCCCCCccCcCCCCCceeeecCccccCCCCccc---cccccccccccCCC
Q 002509 446 GCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGNIN 506 (914)
Q Consensus 446 ~l~~L~~L~Ls~N~l~G~iP~~l~~l~~L~~l~l~~N~l~G~iP~~~---~~~~~~l~~~~N~~ 506 (914)
+|+.|+.||||+|.+..--+.++...++|+.|+|++|+++ .+|++- ++.+..|+++.|..
T Consensus 291 gLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~-~l~~~sf~~L~~Le~LnLs~Nsi 353 (873)
T KOG4194|consen 291 GLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRIT-RLDEGSFRVLSQLEELNLSHNSI 353 (873)
T ss_pred ccchhhhhccchhhhheeecchhhhcccceeEeccccccc-cCChhHHHHHHHhhhhcccccch
Confidence 4566677777777776555666777777777777777777 555543 34455666666643
|
|
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.2e-07 Score=93.60 Aligned_cols=122 Identities=20% Similarity=0.209 Sum_probs=65.7
Q ss_pred EeeeccCCCCCCCccCCCCCCCCcccCCccccccccccccCCcccccc-ccccCCCCCCCChHHHHhhceeccCCCeeEE
Q 002509 194 SARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVST-KLPIDLRSDELPPQKVMQTAVVGTNGSLTYR 272 (914)
Q Consensus 194 ~~R~~~G~~~~~~~rypdD~~dR~W~~~~~~~~~~~~~~~~~~~~~st-~~~~~~~~~~~~P~~v~~tA~t~~~~~~~~~ 272 (914)
+.|+|+|+.. | +|..++.|++|..+....+ +.... ..-.. .........+..+..+|||+-...+ +..|.
T Consensus 2 ~~~IN~Gg~~-----~-~~~~g~~w~~D~~~~~g~~-~y~~~-~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~-~f~Y~ 72 (174)
T PF11721_consen 2 VLRINAGGPA-----Y-TDSSGIVWEADQYYTGGSW-GYYVS-SDNNGSTSSTNSSIPGTTDDPLYQTERYGPS-SFSYD 72 (174)
T ss_dssp EEEEEETSSS-----E-EETTTEEE-SSSSSTTSS-------------SSTTS--TTS-HHHHHTTT-----SS-SEEEE
T ss_pred EEEEECCCCc-----c-cCCCCCEEcCCCCCCCCCc-ccccc-cccccccccccccccCCCchhhhHhhcCCCC-ceEEE
Confidence 5799999843 3 8999999999998876553 00000 00000 0011112225567899999988443 44444
Q ss_pred EecCCCCCccceeeeehhcccCC-----CCcceEEEEEeCCCCCcccceeccccccCCce
Q 002509 273 LNLDGFPGFGWAVTYFAEIEDLD-----PDESRKFRLVLPGQPDVSKAIVNIQENAQGKY 327 (914)
Q Consensus 273 ~~~~~~~~~~~v~lhFae~~~~~-----~~~~R~F~i~ing~~~~~~~~~~~~~~~~~~~ 327 (914)
+.. .....+-|.|||||+..-. ..++|+|||+|||+...++ +|++...++..
T Consensus 73 ip~-~~~G~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~--~Di~~~~G~~~ 129 (174)
T PF11721_consen 73 IPV-VPNGTYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKN--FDIYAEAGGFN 129 (174)
T ss_dssp EE---S-EEEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEE--E-HHHHHSSSS
T ss_pred Eec-CCCcEEEEEEEeccccccccccccCCCceEEEEEecceEEEec--cCHHHHcCCCc
Confidence 432 2222336999999996532 3789999999999988665 67777766643
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.34 E-value=4e-06 Score=87.14 Aligned_cols=107 Identities=26% Similarity=0.321 Sum_probs=83.1
Q ss_pred chhhhHHHHHHhhcccCc--eeEEEeeeeecC----ceEEEEEeccCC-ChHHHhhcccCccccccHHHHHHHHHHHHHH
Q 002509 626 KREFTNEVTLLSRIHHRN--LVQFLGYCQEEG----RSVLVYEFMHNG-TLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 698 (914)
Q Consensus 626 ~~~f~~E~~~l~~l~Hpn--Iv~l~g~~~~~~----~~~LV~E~~~~g-sL~~~L~~~~~~~~~l~~~~~l~ia~~ia~g 698 (914)
.....+|...+.+++... ..+.+++..... ..++|+|++++. +|.+++.... ..+......++.++++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHH
Confidence 446778888888885433 455666665532 458999999984 7998885421 14455667899999999
Q ss_pred HHHHHhCCCCCccccCCCCCceEeCCCC---cEEEeeccccccc
Q 002509 699 IEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDFGLSKFA 739 (914)
Q Consensus 699 L~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~~ 739 (914)
++-||.. +|+|+|++++|||++.+. .+.++||+-++..
T Consensus 131 i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 131 IAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999 999999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.32 E-value=2e-06 Score=100.26 Aligned_cols=147 Identities=23% Similarity=0.268 Sum_probs=94.7
Q ss_pred HHHHHh-ccccccCcEEEEEEEECCCcEEEEEEEecCCccc---------------------------------------
Q 002509 586 ATKMLE-KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--------------------------------------- 625 (914)
Q Consensus 586 ~~~~~~-~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~--------------------------------------- 625 (914)
...+|. +-|+.++-|.||+|++++|+.||||+.+.+-...
T Consensus 124 ~F~eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~ 203 (517)
T COG0661 124 LFSEFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR 203 (517)
T ss_pred HHHHcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence 334454 5689999999999999999999999987531110
Q ss_pred -chhhhHHHHHHhhcc-----cCceeEEEeeeeecCceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHH-
Q 002509 626 -KREFTNEVTLLSRIH-----HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG- 698 (914)
Q Consensus 626 -~~~f~~E~~~l~~l~-----HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~g- 698 (914)
+-++..|+..+.+++ .+++.-..-|..-.+...|+|||++|-.+.+...-. ...++ +..++..++++
T Consensus 204 ~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~---~~g~d---~k~ia~~~~~~f 277 (517)
T COG0661 204 EELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK---SAGID---RKELAELLVRAF 277 (517)
T ss_pred HHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH---hcCCC---HHHHHHHHHHHH
Confidence 011334554444442 233322222223356779999999998888774211 12233 22333333333
Q ss_pred HHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccC
Q 002509 699 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 741 (914)
Q Consensus 699 L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 741 (914)
+..+-.. +++|.|.+|.||+++.++++.+.|||+.....+
T Consensus 278 ~~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 278 LRQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHhc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 3333334 899999999999999999999999999865543
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.3e-07 Score=106.26 Aligned_cols=135 Identities=21% Similarity=0.188 Sum_probs=85.7
Q ss_pred cceEEEEEEeecCCCCCCcchhh-hhhhhhccCCCCCccHH------HHHHHHhhcCCC-CCcCCCCCCCCCCCCceEEe
Q 002509 339 LPFVLSFKFGKTYDSSRGPLLNA-MEINKYLERNDGSIDGV------AIVSVISLYSSA-DWAQEGGDPCLPVPWSWLQC 410 (914)
Q Consensus 339 ~~~~~~l~l~~~~~s~lpp~ln~-le~l~~l~~~~~~~d~~------al~~l~~~~~~~-~~~~~~~dpc~~~~w~gv~c 410 (914)
+..++.+.|++|++++||+-... +..|+.|++.-+..... .|-++++++... +... -.|- .+.|.
T Consensus 196 lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~k-L~DG----~Fy~l-- 268 (873)
T KOG4194|consen 196 LNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISK-LDDG----AFYGL-- 268 (873)
T ss_pred cchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCccc-ccCc----ceeee--
Confidence 33458899999999999998665 88999999884433221 222332222111 1111 0111 22222
Q ss_pred CCCCCCCeEEEEccCCCCcccCCchhhcccccccc----------------CCCCCcEEEcCCCcCCCCCCccCcCCCCC
Q 002509 411 NSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEF----------------GCPDLRIIHLEDNQLTGPLPSSLMNLPNL 474 (914)
Q Consensus 411 ~~~~~~~l~~L~L~~n~l~G~ip~~~~~l~~L~~l----------------~l~~L~~L~Ls~N~l~G~iP~~l~~l~~L 474 (914)
..++.|+|+.|+++.---.++.+|++|+.| -+++|+.||||+|+++---|.++.-|..|
T Consensus 269 -----~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~L 343 (873)
T KOG4194|consen 269 -----EKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQL 343 (873)
T ss_pred -----cccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHh
Confidence 367888888888884445567788888887 34678888888888884444566666666
Q ss_pred ceeeecCcccc
Q 002509 475 RELYVQNNMLS 485 (914)
Q Consensus 475 ~~l~l~~N~l~ 485 (914)
+.|+|++|.++
T Consensus 344 e~LnLs~Nsi~ 354 (873)
T KOG4194|consen 344 EELNLSHNSID 354 (873)
T ss_pred hhhcccccchH
Confidence 66666666665
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.31 E-value=4.1e-07 Score=74.80 Aligned_cols=60 Identities=40% Similarity=0.650 Sum_probs=52.1
Q ss_pred CCeEEEEccCCCCcccCC-chhhccccccccCCCCCcEEEcCCCcCCCCCCccCcCCCCCceeeecCccc
Q 002509 416 PSITVIHLSSKNLTGNIP-SDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML 484 (914)
Q Consensus 416 ~~l~~L~L~~n~l~G~ip-~~~~~l~~L~~l~l~~L~~L~Ls~N~l~G~iP~~l~~l~~L~~l~l~~N~l 484 (914)
|+|+.|+|++|+|+ .|| ..|..+++|+ +|+|++|+++.--|..+..+++|+.|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~-~i~~~~f~~l~~L~--------~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLT-EIPPDSFSNLPNLE--------TLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTES-EECTTTTTTGTTES--------EEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCC-ccCHHHHcCCCCCC--------EeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 57999999999999 666 4677888776 999999999965556889999999999999986
|
... |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.4e-05 Score=81.87 Aligned_cols=138 Identities=17% Similarity=0.157 Sum_probs=102.1
Q ss_pred ccccCcEEEEEEEECCCcEEEEEEEecC-----C-cccchhhhHHHHHHhhcccC--ceeEEEeeee-ec----CceEEE
Q 002509 594 IGSGGFGVVYYGKLKDGKEIAVKVLTSN-----S-YQGKREFTNEVTLLSRIHHR--NLVQFLGYCQ-EE----GRSVLV 660 (914)
Q Consensus 594 lG~G~~G~Vy~~~~~~g~~vAVK~l~~~-----~-~~~~~~f~~E~~~l~~l~Hp--nIv~l~g~~~-~~----~~~~LV 660 (914)
-|+||-+.|++-.+. |+.+-+|.-... . +.....|.+|...|.++... .+.+.+ ++. .. .+.+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 367888899988776 457888875421 1 34567899999999999543 244444 332 21 245899
Q ss_pred EEeccC-CChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCc--EEEeeccccc
Q 002509 661 YEFMHN-GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR--AKVSDFGLSK 737 (914)
Q Consensus 661 ~E~~~~-gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~--~kl~DFGla~ 737 (914)
.|-+++ -+|.+++... ...+.+...+..+..++++.++-||.. ++.|+|+.+.|||++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 998775 4888887432 123456667788999999999999999 9999999999999986666 9999998765
Q ss_pred c
Q 002509 738 F 738 (914)
Q Consensus 738 ~ 738 (914)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 3
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.31 E-value=2.8e-07 Score=106.72 Aligned_cols=152 Identities=18% Similarity=0.304 Sum_probs=101.2
Q ss_pred HHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCce--------eeccccCCcccCcccccc
Q 002509 693 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV--------SSIVRGTVGYLDPEYYIS 764 (914)
Q Consensus 693 ~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~--------~~~~~gt~~Y~aPE~~~~ 764 (914)
.+++.||.|+|.. .++||++|.|++|.++..+..||+.|+.+.......... .....-...|.|||++..
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3556899999987 599999999999999999999999999875443322111 111223567999999999
Q ss_pred CCCCccCceeehHHHHHHHHhCCCCcccccccccchhHHHHHHHhhhcCCcccccCCccCCccCHHHHHHHHHHHHHccC
Q 002509 765 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVL 844 (914)
Q Consensus 765 ~~~s~ksDV~S~Gvvl~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~ 844 (914)
...+.++|+||+||+++-+..|..+.-............. . .+..-...+......++.+=..+.+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~---~----------~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR---N----------LLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh---c----------ccccccccccccCcHHHHHHHHHHhc
Confidence 8889999999999999999955444322111111001100 0 00000111222334456677778899
Q ss_pred CCCCCCCCHHHHHHH
Q 002509 845 PHGHMRPSISEVLKD 859 (914)
Q Consensus 845 ~~P~~RPsm~eVl~~ 859 (914)
.++..||++.++...
T Consensus 251 ~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLSI 265 (700)
T ss_pred CCcccCcchhhhhcc
Confidence 999999988877643
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.26 E-value=2.4e-07 Score=100.14 Aligned_cols=140 Identities=24% Similarity=0.228 Sum_probs=99.1
Q ss_pred EEEEEeecCCCCCCcchhhhhhhhhccCC-----CCCccHHHHHHHHhhcC---CCCCcCCCCCCCCCC--CCceEEe--
Q 002509 343 LSFKFGKTYDSSRGPLLNAMEINKYLERN-----DGSIDGVAIVSVISLYS---SADWAQEGGDPCLPV--PWSWLQC-- 410 (914)
Q Consensus 343 ~~l~l~~~~~s~lpp~ln~le~l~~l~~~-----~~~~d~~al~~l~~~~~---~~~~~~~~~dpc~~~--~w~gv~c-- 410 (914)
..+.+..|....+||.+.++..|+.++.. +.|+|...|.++.-+.- ....-+. -.-|.-. -.-|.+-
T Consensus 163 ~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~tlP~~lg~l~~L~~LyL~~Nki~~lPe-f~gcs~L~Elh~g~N~i~ 241 (565)
T KOG0472|consen 163 SKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLETLPPELGGLESLELLYLRRNKIRFLPE-FPGCSLLKELHVGENQIE 241 (565)
T ss_pred HHhhccccchhhCCHHHHHHHHHHhcccchhhhhcCChhhcchhhhHHHHhhhcccccCCC-CCccHHHHHHHhcccHHH
Confidence 56677788888888887778888888766 77888777666643221 1111111 1112110 0001000
Q ss_pred -----CCCCCCCeEEEEccCCCCcccCCchhhccccccccCCCCCcEEEcCCCcCCCCCCccCcCCCCCceeeecCcccc
Q 002509 411 -----NSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 485 (914)
Q Consensus 411 -----~~~~~~~l~~L~L~~n~l~G~ip~~~~~l~~L~~l~l~~L~~L~Ls~N~l~G~iP~~l~~l~~L~~l~l~~N~l~ 485 (914)
...+.++|.+|||..|+|+ +.|++++.|.+|. +||||+|.++ .+|.++|+| .|++|.|.+|-|.
T Consensus 242 ~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~--------rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlr 310 (565)
T KOG0472|consen 242 MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLE--------RLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLR 310 (565)
T ss_pred hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhh--------hhcccCCccc-cCCcccccc-eeeehhhcCCchH
Confidence 0036789999999999999 9999999998887 9999999999 799999999 9999999999997
Q ss_pred CCCCcccccc
Q 002509 486 GTVPSSLLSK 495 (914)
Q Consensus 486 G~iP~~~~~~ 495 (914)
+|-.++.++
T Consensus 311 -TiRr~ii~~ 319 (565)
T KOG0472|consen 311 -TIRREIISK 319 (565)
T ss_pred -HHHHHHHcc
Confidence 665555433
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.20 E-value=8.2e-07 Score=105.16 Aligned_cols=152 Identities=25% Similarity=0.307 Sum_probs=100.4
Q ss_pred cceEEEEEEeecCCCCCCcchh----h-hhhhhh--ccCCCC---Ccc-HHHHHHHHhhcCCCCCcCCCCCCCCCCCCce
Q 002509 339 LPFVLSFKFGKTYDSSRGPLLN----A-MEINKY--LERNDG---SID-GVAIVSVISLYSSADWAQEGGDPCLPVPWSW 407 (914)
Q Consensus 339 ~~~~~~l~l~~~~~s~lpp~ln----~-le~l~~--l~~~~~---~~d-~~al~~l~~~~~~~~~~~~~~dpc~~~~w~g 407 (914)
...+-+|+|.+|.+..+|+..- + ++.|.. ..+++. ... ..+|+.|. ...+. -+|-| |.-
T Consensus 309 ~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~Ly---lanN~---Ltd~c----~p~ 378 (1081)
T KOG0618|consen 309 LKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELY---LANNH---LTDSC----FPV 378 (1081)
T ss_pred cceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHH---HhcCc---ccccc----hhh
Confidence 3345788999999999988422 2 222222 122222 222 23333331 11111 36777 444
Q ss_pred EEeCCCCCCCeEEEEccCCCCcccCCch-hhcccccccc---------------CCCCCcEEEcCCCcCCCCCCccCcCC
Q 002509 408 LQCNSDPQPSITVIHLSSKNLTGNIPSD-LTKLSSLVEF---------------GCPDLRIIHLEDNQLTGPLPSSLMNL 471 (914)
Q Consensus 408 v~c~~~~~~~l~~L~L~~n~l~G~ip~~-~~~l~~L~~l---------------~l~~L~~L~Ls~N~l~G~iP~~l~~l 471 (914)
+.|- .+|++|+|++|.|. ++|++ +.+|..|++| +|..|++|..-+|+|. .+| ++.++
T Consensus 379 l~~~----~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l 451 (1081)
T KOG0618|consen 379 LVNF----KHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQL 451 (1081)
T ss_pred hccc----cceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCcee-ech-hhhhc
Confidence 4443 47999999999998 88876 5677777766 4566788888888888 788 88888
Q ss_pred CCCceeeecCcccc-CCCCcccc-ccccccccccCCCc
Q 002509 472 PNLRELYVQNNMLS-GTVPSSLL-SKNVVLNYAGNINL 507 (914)
Q Consensus 472 ~~L~~l~l~~N~l~-G~iP~~~~-~~~~~l~~~~N~~~ 507 (914)
+.|+.+|||.|+|+ +.+|..+- ..++.|+++||..+
T Consensus 452 ~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 452 PQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred CcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 99999999999987 34555554 56889999999864
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.7e-07 Score=88.94 Aligned_cols=80 Identities=34% Similarity=0.524 Sum_probs=69.3
Q ss_pred CCeEEEEccCCCCcccCCchhhccccccccCCCCCcEEEcCCCcCCCCCCccCcCCCCCceeeecCccccCCCCccc--c
Q 002509 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--L 493 (914)
Q Consensus 416 ~~l~~L~L~~n~l~G~ip~~~~~l~~L~~l~l~~L~~L~Ls~N~l~G~iP~~l~~l~~L~~l~l~~N~l~G~iP~~~--~ 493 (914)
..++.|.||+|+|+ .+|+.|..|.+|+ .|++++|+++ .+|.+++.|++|+.|+++-|+|. .+|..+ +
T Consensus 33 s~ITrLtLSHNKl~-~vppnia~l~nle--------vln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~ 101 (264)
T KOG0617|consen 33 SNITRLTLSHNKLT-VVPPNIAELKNLE--------VLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSF 101 (264)
T ss_pred hhhhhhhcccCcee-ecCCcHHHhhhhh--------hhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCC
Confidence 46788999999999 9999999998887 9999999999 89999999999999999999998 788776 3
Q ss_pred ccccccccccCCC
Q 002509 494 SKNVVLNYAGNIN 506 (914)
Q Consensus 494 ~~~~~l~~~~N~~ 506 (914)
..+..|++..|..
T Consensus 102 p~levldltynnl 114 (264)
T KOG0617|consen 102 PALEVLDLTYNNL 114 (264)
T ss_pred chhhhhhcccccc
Confidence 4566777777643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.08 E-value=3.6e-05 Score=81.18 Aligned_cols=140 Identities=15% Similarity=0.245 Sum_probs=84.4
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhhcccCce--eEEEeeeeecCceEEEEEeccCCC-
Q 002509 592 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL--VQFLGYCQEEGRSVLVYEFMHNGT- 668 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnI--v~l~g~~~~~~~~~LV~E~~~~gs- 668 (914)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-.+ .+.++++...+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 47899999999984 25567888876432 33456889999999864433 567777777777889999999863
Q ss_pred hHHHh---------------------hcccCccccccH-HHHH----H----HHHHHHH-HHHHHHhC-CCCCccccCCC
Q 002509 669 LKEHL---------------------YGTLTHEQRINW-IKRL----E----IAEDAAK-GIEYLHTG-CVPAIIHRDLK 716 (914)
Q Consensus 669 L~~~L---------------------~~~~~~~~~l~~-~~~l----~----ia~~ia~-gL~yLH~~-~~~~ivHrDlk 716 (914)
+...+ |........+.. ..++ . ....+.+ ...+|... ..+.++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 21111 111000000000 0000 0 0000111 12222211 12467899999
Q ss_pred CCceEeCCCCcEEEeeccccc
Q 002509 717 SSNILLDKHMRAKVSDFGLSK 737 (914)
Q Consensus 717 p~NILl~~~~~~kl~DFGla~ 737 (914)
|.||++++++ +.|+||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999888 9999999774
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.03 E-value=1e-06 Score=104.28 Aligned_cols=152 Identities=23% Similarity=0.271 Sum_probs=105.1
Q ss_pred EEEEEeecCCCCCCcchhhhhhhhhccCC-----CCCccHHHHHHHHhhcCCCCCcCCCCCCCCCCCCceEEeCCCCCCC
Q 002509 343 LSFKFGKTYDSSRGPLLNAMEINKYLERN-----DGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (914)
Q Consensus 343 ~~l~l~~~~~s~lpp~ln~le~l~~l~~~-----~~~~d~~al~~l~~~~~~~~~~~~~~dpc~~~~w~gv~c~~~~~~~ 417 (914)
..+++++|..+.+|..+.++-+++.++.. .++....++.+++.+....+-.. ..+| .-+| ...
T Consensus 244 ~~~dis~n~l~~lp~wi~~~~nle~l~~n~N~l~~lp~ri~~~~~L~~l~~~~nel~-yip~----~le~-------~~s 311 (1081)
T KOG0618|consen 244 QYLDISHNNLSNLPEWIGACANLEALNANHNRLVALPLRISRITSLVSLSAAYNELE-YIPP----FLEG-------LKS 311 (1081)
T ss_pred eeeecchhhhhcchHHHHhcccceEecccchhHHhhHHHHhhhhhHHHHHhhhhhhh-hCCC----cccc-------cce
Confidence 67899999999999999999999999888 44555566666655332221111 0111 1122 346
Q ss_pred eEEEEccCCCCcccCCchhhcccc--cccc----------------------------------------CCCCCcEEEc
Q 002509 418 ITVIHLSSKNLTGNIPSDLTKLSS--LVEF----------------------------------------GCPDLRIIHL 455 (914)
Q Consensus 418 l~~L~L~~n~l~G~ip~~~~~l~~--L~~l----------------------------------------~l~~L~~L~L 455 (914)
|++|+|..|+|. .+|+.+-.-.. |..| +.+.|++|+|
T Consensus 312 L~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhL 390 (1081)
T KOG0618|consen 312 LRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHL 390 (1081)
T ss_pred eeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeee
Confidence 899999999997 88875432111 1111 4578999999
Q ss_pred CCCcCCCCCCc-cCcCCCCCceeeecCccccCCCCccc--cccccccccccCCCccC
Q 002509 456 EDNQLTGPLPS-SLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHE 509 (914)
Q Consensus 456 s~N~l~G~iP~-~l~~l~~L~~l~l~~N~l~G~iP~~~--~~~~~~l~~~~N~~~~~ 509 (914)
++|+|+ ++|. .+.++..|++|+||+|+|+ .||..+ +..+..|...+|...|-
T Consensus 391 syNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~f 445 (1081)
T KOG0618|consen 391 SYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSF 445 (1081)
T ss_pred cccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeec
Confidence 999998 8886 4678999999999999999 888776 33455566666655543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.95 E-value=8.9e-05 Score=79.16 Aligned_cols=140 Identities=18% Similarity=0.161 Sum_probs=85.5
Q ss_pred ccccCc-EEEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhhcc-cCceeEEEeeeeecCceEEEEEeccCCChHH
Q 002509 594 IGSGGF-GVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKE 671 (914)
Q Consensus 594 lG~G~~-G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~ 671 (914)
|-.|.. ..||+.... +..+.||+..... ...+..|+++++.+. +--+.+++++....+..++|||+++|.+|.+
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 445555 689999765 4788889875443 345778999998884 4445577777766667899999999877764
Q ss_pred Hh-------------------hcccCcccccc--HHHHHHHHH--------------------HHHHHHHHHHh----CC
Q 002509 672 HL-------------------YGTLTHEQRIN--WIKRLEIAE--------------------DAAKGIEYLHT----GC 706 (914)
Q Consensus 672 ~L-------------------~~~~~~~~~l~--~~~~l~ia~--------------------~ia~gL~yLH~----~~ 706 (914)
.. |.......... ...++.-.. .+...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 32 11100000000 000000000 01111222211 12
Q ss_pred CCCccccCCCCCceEeCCCCcEEEeeccccc
Q 002509 707 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 737 (914)
Q Consensus 707 ~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 737 (914)
.+.++|+|+.|.|||++++....|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 3579999999999999998778999999764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.95 E-value=5e-06 Score=63.21 Aligned_cols=40 Identities=43% Similarity=0.672 Sum_probs=29.5
Q ss_pred CCCcEEEcCCCcCCCCCCccCcCCCCCceeeecCccccCCCC
Q 002509 448 PDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVP 489 (914)
Q Consensus 448 ~~L~~L~Ls~N~l~G~iP~~l~~l~~L~~l~l~~N~l~G~iP 489 (914)
++|++|+|++|+|+ .||..+++|++|+.|+|++|+++ .+|
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~-~i~ 40 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS-DIS 40 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS-BEG
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC-CCc
Confidence 35668888888888 78877888888888888888887 443
|
... |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.92 E-value=3e-06 Score=95.66 Aligned_cols=147 Identities=20% Similarity=0.189 Sum_probs=85.9
Q ss_pred EEEEEeecCCCCCCcchhhhhhhhhccCC-----CCCccHHHHHHHHhhcCCCCCcCCCCC-CCCCCCCceEEeCCCCCC
Q 002509 343 LSFKFGKTYDSSRGPLLNAMEINKYLERN-----DGSIDGVAIVSVISLYSSADWAQEGGD-PCLPVPWSWLQCNSDPQP 416 (914)
Q Consensus 343 ~~l~l~~~~~s~lpp~ln~le~l~~l~~~-----~~~~d~~al~~l~~~~~~~~~~~~~~d-pc~~~~w~gv~c~~~~~~ 416 (914)
...+|+.|+.+.+|...+++..|..+-+. +.+.-+..|.++.-+.-..+-.....+ -| ..
T Consensus 78 ~~aDlsrNR~~elp~~~~~f~~Le~liLy~n~~r~ip~~i~~L~~lt~l~ls~NqlS~lp~~lC----------~l---- 143 (722)
T KOG0532|consen 78 VFADLSRNRFSELPEEACAFVSLESLILYHNCIRTIPEAICNLEALTFLDLSSNQLSHLPDGLC----------DL---- 143 (722)
T ss_pred hhhhccccccccCchHHHHHHHHHHHHHHhccceecchhhhhhhHHHHhhhccchhhcCChhhh----------cC----
Confidence 45788899999999988888877766555 334333333333111111110000111 23 21
Q ss_pred CeEEEEccCCCCcccCCchhhcccccccc---------------CCCCCcEEEcCCCcCCCCCCccCcCCCCCceeeecC
Q 002509 417 SITVIHLSSKNLTGNIPSDLTKLSSLVEF---------------GCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 481 (914)
Q Consensus 417 ~l~~L~L~~n~l~G~ip~~~~~l~~L~~l---------------~l~~L~~L~Ls~N~l~G~iP~~l~~l~~L~~l~l~~ 481 (914)
-|+.|-+++|+|+ .+|+.|+.+..|..| +|.+|+.|.+..|++. .+|+++..| .|..||+|.
T Consensus 144 pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfSc 220 (722)
T KOG0532|consen 144 PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSC 220 (722)
T ss_pred cceeEEEecCccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeeccc
Confidence 3666777777776 777777755555544 3455566666666666 666666654 366677777
Q ss_pred ccccCCCCccc--cccccccccccCCCc
Q 002509 482 NMLSGTVPSSL--LSKNVVLNYAGNINL 507 (914)
Q Consensus 482 N~l~G~iP~~~--~~~~~~l~~~~N~~~ 507 (914)
|+++ .||-.+ +..++.|.|++||..
T Consensus 221 Nkis-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 221 NKIS-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred Ccee-ecchhhhhhhhheeeeeccCCCC
Confidence 7776 667665 445666777777654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.92 E-value=8.3e-05 Score=78.15 Aligned_cols=144 Identities=19% Similarity=0.251 Sum_probs=84.7
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhhcccCc--eeEEEeeeee---cCceEEEEEeccC
Q 002509 592 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN--LVQFLGYCQE---EGRSVLVYEFMHN 666 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~Hpn--Iv~l~g~~~~---~~~~~LV~E~~~~ 666 (914)
+.|+.|..+.||+....+ ..+++|..... .....+..|..+++.+.... +.+++.++.. ....+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 468999999999999987 69999997544 34567788999988885443 4566664432 2346899999999
Q ss_pred CChHH----------------Hh---hcccCccccccHHH---------HHH------------HHHHHHH-HHHHHHh-
Q 002509 667 GTLKE----------------HL---YGTLTHEQRINWIK---------RLE------------IAEDAAK-GIEYLHT- 704 (914)
Q Consensus 667 gsL~~----------------~L---~~~~~~~~~l~~~~---------~l~------------ia~~ia~-gL~yLH~- 704 (914)
..+.. .+ +..........+.. ... ....+.+ .++.++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 87777 11 11100000011000 000 0112222 3333332
Q ss_pred ---CCCCCccccCCCCCceEeC-CCCcEEEeecccccc
Q 002509 705 ---GCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKF 738 (914)
Q Consensus 705 ---~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~ 738 (914)
.....++|+|+.++|||++ +++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1234799999999999999 666678999997643
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.90 E-value=5.7e-05 Score=87.90 Aligned_cols=142 Identities=20% Similarity=0.208 Sum_probs=88.5
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEEecCCccc-------------------------------------chhhhHHHH
Q 002509 592 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-------------------------------------KREFTNEVT 634 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~-------------------------------------~~~f~~E~~ 634 (914)
+.||.-+.|.||+|++++|+.||||+-+..-... +-+|..|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5799999999999999999999999865431110 012444554
Q ss_pred HHhhc----ccCce---eEEEeee-eecCceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCC
Q 002509 635 LLSRI----HHRNL---VQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 706 (914)
Q Consensus 635 ~l~~l----~HpnI---v~l~g~~-~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~ 706 (914)
-..++ +|-+. |.+=.++ .-.....|+||||+|..+.|.-.- ....++-. .++..+.++... .-.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~---~i~~~l~~~~~~--qIf 318 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI---DKRGISPH---DILNKLVEAYLE--QIF 318 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH---HHcCCCHH---HHHHHHHHHHHH--HHH
Confidence 44443 34441 1111122 223467999999999877665321 12233333 333333333221 111
Q ss_pred CCCccccCCCCCceEeCC----CCcEEEeeccccccccC
Q 002509 707 VPAIIHRDLKSSNILLDK----HMRAKVSDFGLSKFAVD 741 (914)
Q Consensus 707 ~~~ivHrDlkp~NILl~~----~~~~kl~DFGla~~~~~ 741 (914)
..|++|+|=+|.||+++. ++++.+-|||+......
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 228999999999999984 67899999999866543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00012 Score=76.24 Aligned_cols=135 Identities=21% Similarity=0.246 Sum_probs=90.2
Q ss_pred cccccCcEEEEEEEECCCcEEEEEEEecCCccc---------ch---------------hhhHHHHHHhhcc--cCceeE
Q 002509 593 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG---------KR---------------EFTNEVTLLSRIH--HRNLVQ 646 (914)
Q Consensus 593 ~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~---------~~---------------~f~~E~~~l~~l~--HpnIv~ 646 (914)
.|+.|.-+.||+|...++..+|||+.+...... .. ...+|+.-|.++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 577888889999998889999999987542211 11 1235777777763 233333
Q ss_pred EEeeeeecCceEEEEEeccCCC-hHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCC
Q 002509 647 FLGYCQEEGRSVLVYEFMHNGT-LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH 725 (914)
Q Consensus 647 l~g~~~~~~~~~LV~E~~~~gs-L~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~ 725 (914)
.+++. ...|||||+...- -.-.|. .-.+...+...+..++.+.+.-|-..+ ++||+||..=|||+. +
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~Lk-----Dv~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRLK-----DVPLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-D 202 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCcc-----cCCcCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-C
Confidence 44332 3479999997641 111111 111222245566778888888887732 999999999999999 8
Q ss_pred CcEEEeeccccccc
Q 002509 726 MRAKVSDFGLSKFA 739 (914)
Q Consensus 726 ~~~kl~DFGla~~~ 739 (914)
+.+.|+|||-|...
T Consensus 203 ~~p~iID~~QaV~~ 216 (268)
T COG1718 203 GEPYIIDVSQAVTI 216 (268)
T ss_pred CeEEEEECcccccc
Confidence 89999999987544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.86 E-value=5.5e-06 Score=95.02 Aligned_cols=181 Identities=17% Similarity=0.177 Sum_probs=132.5
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhhcccCc-eeEEEeeeeecCceEEEEEeccCC-Ch
Q 002509 592 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN-LVQFLGYCQEEGRSVLVYEFMHNG-TL 669 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~Hpn-Iv~l~g~~~~~~~~~LV~E~~~~g-sL 669 (914)
+-+++|+++.+||.+-...+....+.+... ....-++++|.+++||| .+..++-+..+....++++++..| +.
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 457899999999987654444445554332 34556889999999999 777777777778889999999887 22
Q ss_pred HHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccccccCCCCceeec
Q 002509 670 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 749 (914)
Q Consensus 670 ~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 749 (914)
.... ......+...+...+...-+++|++||+. .=+|+| ||+..+ ...|.+||+....+.... ....
T Consensus 323 ~~~~---~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t 389 (829)
T KOG0576|consen 323 ALEM---TVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRT 389 (829)
T ss_pred cccC---ChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--cccc
Confidence 2111 11233444555566677778899999986 447888 777766 679999999887654433 2334
Q ss_pred cccCCcccCccccccCCCCccCceeehHHHHHHHHhCCCCc
Q 002509 750 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI 790 (914)
Q Consensus 750 ~~gt~~Y~aPE~~~~~~~s~ksDV~S~Gvvl~ElltG~~p~ 790 (914)
..+++.++|||+.....+..+.|+|+.|+--.++--|-+|-
T Consensus 390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 55899999999999999999999999998777777776654
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=97.84 E-value=1.6e-05 Score=96.77 Aligned_cols=69 Identities=26% Similarity=0.423 Sum_probs=38.6
Q ss_pred CCeEEEEccCCCCcccCCchhhcccccccc---------CCCCCcEEEcCCCcCCCCCCccCcCCCCCceeeecCccccC
Q 002509 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEF---------GCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 486 (914)
Q Consensus 416 ~~l~~L~L~~n~l~G~ip~~~~~l~~L~~l---------~l~~L~~L~Ls~N~l~G~iP~~l~~l~~L~~l~l~~N~l~G 486 (914)
..|+.|+|++|+|+ .||....+|..|..- ..++|+.|+|++|+|+ .+|... ++|+.|+|++|+|+
T Consensus 342 ~~Lq~LdLS~N~Ls-~LP~lp~~L~~L~Ls~N~L~~LP~l~~~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Ls- 415 (788)
T PRK15387 342 SGLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLT- 415 (788)
T ss_pred cccceEecCCCccC-CCCCCCcccceehhhccccccCcccccccceEEecCCccc-CCCCcc---cCCCEEEccCCcCC-
Confidence 36778888888888 566544443333110 1235666666666666 355432 34555666666665
Q ss_pred CCCc
Q 002509 487 TVPS 490 (914)
Q Consensus 487 ~iP~ 490 (914)
.||.
T Consensus 416 sIP~ 419 (788)
T PRK15387 416 SLPM 419 (788)
T ss_pred CCCc
Confidence 3543
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=97.80 E-value=3.1e-05 Score=94.73 Aligned_cols=83 Identities=25% Similarity=0.457 Sum_probs=47.5
Q ss_pred CCeEEEEccCCCCcccCCchhhcccccccc-------------CCCCCcEEEcCCCcCCCCCCccCcCCCCCceeeecCc
Q 002509 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEF-------------GCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 482 (914)
Q Consensus 416 ~~l~~L~L~~n~l~G~ip~~~~~l~~L~~l-------------~l~~L~~L~Ls~N~l~G~iP~~l~~l~~L~~l~l~~N 482 (914)
+.|+.|+|++|+|+ .+|..+. ++|+.| -.++|+.|+|++|+|+ .||..+. ++|+.|+|++|
T Consensus 283 ~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~LP~~l~~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N 356 (754)
T PRK15370 283 EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTALPETLPPGLKTLEAGENALT-SLPASLP--PELQVLDVSKN 356 (754)
T ss_pred CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccccCCccccccceeccccCCccc-cCChhhc--CcccEEECCCC
Confidence 36778888888877 4665443 122222 1135666666666666 3665543 46666666666
Q ss_pred cccCCCCccccccccccccccCC
Q 002509 483 MLSGTVPSSLLSKNVVLNYAGNI 505 (914)
Q Consensus 483 ~l~G~iP~~~~~~~~~l~~~~N~ 505 (914)
+|+ .+|..+...+..|++++|.
T Consensus 357 ~L~-~LP~~lp~~L~~LdLs~N~ 378 (754)
T PRK15370 357 QIT-VLPETLPPTITTLDVSRNA 378 (754)
T ss_pred CCC-cCChhhcCCcCEEECCCCc
Confidence 665 4555554555556666554
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00022 Score=73.52 Aligned_cols=113 Identities=19% Similarity=0.277 Sum_probs=73.1
Q ss_pred CCcEEEEEEEecCCcccchhh---------hHHHHHHhhcccC---ceeEEEeeeee-----cCceEEEEEeccCCChHH
Q 002509 609 DGKEIAVKVLTSNSYQGKREF---------TNEVTLLSRIHHR---NLVQFLGYCQE-----EGRSVLVYEFMHNGTLKE 671 (914)
Q Consensus 609 ~g~~vAVK~l~~~~~~~~~~f---------~~E~~~l~~l~Hp---nIv~l~g~~~~-----~~~~~LV~E~~~~gsL~~ 671 (914)
+|+.+.+|..+......++.| .+++..+.+++.. ....++..+.. ....+++|||++|..|.+
T Consensus 53 ~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d 132 (229)
T PF06176_consen 53 DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELND 132 (229)
T ss_pred CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEecCeeccc
Confidence 478888888765433222222 2344444444322 22232222222 234578999999988766
Q ss_pred HhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeCCCCcEEEeeccccc
Q 002509 672 HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 737 (914)
Q Consensus 672 ~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 737 (914)
... ++. .++..+.+++.-||.. |++|+|.+|+|+++++++ ++++||+..+
T Consensus 133 ~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 133 IED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred chh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-EEEEECcccc
Confidence 531 111 2556778889999999 999999999999998654 9999998764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=97.75 E-value=1.6e-05 Score=79.66 Aligned_cols=80 Identities=35% Similarity=0.561 Sum_probs=36.1
Q ss_pred CCeEEEEccCCCCcccCCchhhccccccccCCCCCcEEEcCCCcCCCCCCccC-cCCCCCceeeecCccccCCCCc----
Q 002509 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSL-MNLPNLRELYVQNNMLSGTVPS---- 490 (914)
Q Consensus 416 ~~l~~L~L~~n~l~G~ip~~~~~l~~L~~l~l~~L~~L~Ls~N~l~G~iP~~l-~~l~~L~~l~l~~N~l~G~iP~---- 490 (914)
.+|+.|||++|+++ .|+ .+..|+ .|+.|+|++|+++ .|+..+ ..+++|+.|+|++|++.. +-+
T Consensus 42 ~~L~~L~Ls~N~I~-~l~-~l~~L~--------~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~-l~~l~~L 109 (175)
T PF14580_consen 42 DKLEVLDLSNNQIT-KLE-GLPGLP--------RLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISD-LNELEPL 109 (175)
T ss_dssp TT--EEE-TTS--S---T-T----T--------T--EEE--SS----S-CHHHHHH-TT--EEE-TTS---S-CCCCGGG
T ss_pred cCCCEEECCCCCCc-ccc-CccChh--------hhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCC-hHHhHHH
Confidence 47999999999998 554 244444 5569999999999 787655 468999999999999973 322
Q ss_pred cccccccccccccCCCc
Q 002509 491 SLLSKNVVLNYAGNINL 507 (914)
Q Consensus 491 ~~~~~~~~l~~~~N~~~ 507 (914)
.-+.++..|++.|||..
T Consensus 110 ~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 110 SSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp GG-TT--EEE-TT-GGG
T ss_pred HcCCCcceeeccCCccc
Confidence 12556788999999864
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=97.74 E-value=1.3e-05 Score=97.63 Aligned_cols=38 Identities=32% Similarity=0.391 Sum_probs=19.2
Q ss_pred EEEcCCCcCCCCCCccCcCCCCCceeeecCccccCCCCc
Q 002509 452 IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPS 490 (914)
Q Consensus 452 ~L~Ls~N~l~G~iP~~l~~l~~L~~l~l~~N~l~G~iP~ 490 (914)
.|+|++|+|+ .||.+++++++|+.|+|++|.|+|.+|.
T Consensus 426 ~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 426 SLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred hhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 4455555554 4555555555555555555555544443
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.71 E-value=5.9e-06 Score=93.33 Aligned_cols=136 Identities=20% Similarity=0.284 Sum_probs=99.4
Q ss_pred EEEEEeecCCCCCCcchhhhhhhhhccCC----CCCccHHHHHHHHhhcCCCCCcCCCCCCCCCCCCceEEeCCCCCCCe
Q 002509 343 LSFKFGKTYDSSRGPLLNAMEINKYLERN----DGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (914)
Q Consensus 343 ~~l~l~~~~~s~lpp~ln~le~l~~l~~~----~~~~d~~al~~l~~~~~~~~~~~~~~dpc~~~~w~gv~c~~~~~~~l 418 (914)
..+.|..|.+-.+|+-+..++.|.+++++ ..-++..-.+-||-+....+ .--|.|..- +..+.|
T Consensus 101 e~liLy~n~~r~ip~~i~~L~~lt~l~ls~NqlS~lp~~lC~lpLkvli~sNN-----kl~~lp~~i-------g~~~tl 168 (722)
T KOG0532|consen 101 ESLILYHNCIRTIPEAICNLEALTFLDLSSNQLSHLPDGLCDLPLKVLIVSNN-----KLTSLPEEI-------GLLPTL 168 (722)
T ss_pred HHHHHHhccceecchhhhhhhHHHHhhhccchhhcCChhhhcCcceeEEEecC-----ccccCCccc-------ccchhH
Confidence 35667788899999999999999999988 22223333333322111111 122333211 234678
Q ss_pred EEEEccCCCCcccCCchhhccccccccC--------------CCCCcEEEcCCCcCCCCCCccCcCCCCCceeeecCccc
Q 002509 419 TVIHLSSKNLTGNIPSDLTKLSSLVEFG--------------CPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML 484 (914)
Q Consensus 419 ~~L~L~~n~l~G~ip~~~~~l~~L~~l~--------------l~~L~~L~Ls~N~l~G~iP~~l~~l~~L~~l~l~~N~l 484 (914)
..||.+.|++. ++|+.++.|++|+.|+ .=.|..||+|.|+++ .||..|-+|+.|++|.|.+|-|
T Consensus 169 ~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~lp~El~~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPL 246 (722)
T KOG0532|consen 169 AHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELCSLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPL 246 (722)
T ss_pred HHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHhCCceeeeecccCcee-ecchhhhhhhhheeeeeccCCC
Confidence 89999999998 9999999999998872 225889999999999 9999999999999999999999
Q ss_pred cCCCCcccc
Q 002509 485 SGTVPSSLL 493 (914)
Q Consensus 485 ~G~iP~~~~ 493 (914)
. +-|..+.
T Consensus 247 q-SPPAqIC 254 (722)
T KOG0532|consen 247 Q-SPPAQIC 254 (722)
T ss_pred C-CChHHHH
Confidence 8 6666653
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00016 Score=73.95 Aligned_cols=104 Identities=24% Similarity=0.313 Sum_probs=82.0
Q ss_pred hHHHHHHhhccc-CceeEEEeeeeecCceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCC
Q 002509 630 TNEVTLLSRIHH-RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 708 (914)
Q Consensus 630 ~~E~~~l~~l~H-pnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~ 708 (914)
..|.-+++.+++ +++.+++|+|- .++|.||...+++.+. +.....-...+|..|.+||.++++.+.+|++....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~-~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGI-YRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccc-ccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 357888888876 69999999993 3789999988766432 11111223468999999999999999999985444
Q ss_pred CccccCCCCCceEeCCCCcEEEeecccccc
Q 002509 709 AIIHRDLKSSNILLDKHMRAKVSDFGLSKF 738 (914)
Q Consensus 709 ~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 738 (914)
.+.-.|++++|+-+++++++|+.|......
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 677899999999999999999999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00044 Score=86.88 Aligned_cols=147 Identities=17% Similarity=0.365 Sum_probs=91.6
Q ss_pred ccccccCcEEEEEEEECCC---cEEEEEEEecCC-cccchhhhHHHHHHhhcc-cCce--eEEEeeeeec---CceEEEE
Q 002509 592 KKIGSGGFGVVYYGKLKDG---KEIAVKVLTSNS-YQGKREFTNEVTLLSRIH-HRNL--VQFLGYCQEE---GRSVLVY 661 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~~g---~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~-HpnI--v~l~g~~~~~---~~~~LV~ 661 (914)
+.++.|.+..+|+....++ ..+++|+..... ......+.+|+++|+.+. |.++ .+++++|.+. +..++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 4688999999999887654 467777754332 123356889999999995 6665 7788888764 4678999
Q ss_pred EeccCCChHH--------------------H---hhcccCc-------ccc-------c-cHHHHHHH---------HHH
Q 002509 662 EFMHNGTLKE--------------------H---LYGTLTH-------EQR-------I-NWIKRLEI---------AED 694 (914)
Q Consensus 662 E~~~~gsL~~--------------------~---L~~~~~~-------~~~-------l-~~~~~l~i---------a~~ 694 (914)
||+++..+.+ . ||..... ... + .|.....- .-.
T Consensus 124 E~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~ 203 (822)
T PLN02876 124 EYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPK 203 (822)
T ss_pred EecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChh
Confidence 9998764321 1 1211000 000 1 11111110 112
Q ss_pred HHHHHHHHHhCCC--------CCccccCCCCCceEeCCC-Cc-EEEeecccccc
Q 002509 695 AAKGIEYLHTGCV--------PAIIHRDLKSSNILLDKH-MR-AKVSDFGLSKF 738 (914)
Q Consensus 695 ia~gL~yLH~~~~--------~~ivHrDlkp~NILl~~~-~~-~kl~DFGla~~ 738 (914)
+.+.+++|..+.. +.+||+|+++.||+++.+ .+ +-|.||+++..
T Consensus 204 ~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 204 MLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred HHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 3344667754322 359999999999999853 33 57999998754
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=97.62 E-value=8e-05 Score=91.13 Aligned_cols=76 Identities=26% Similarity=0.507 Sum_probs=47.7
Q ss_pred CCeEEEEccCCCCcccCCchhhccccccccCCCCCcEEEcCCCcCCCCCCccCcCCCCCceeeecCccccCCCCcccccc
Q 002509 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 495 (914)
Q Consensus 416 ~~l~~L~L~~n~l~G~ip~~~~~l~~L~~l~l~~L~~L~Ls~N~l~G~iP~~l~~l~~L~~l~l~~N~l~G~iP~~~~~~ 495 (914)
++|+.|+|++|+|+ .||..+. + +|+.|+|++|+|+ .||..+. ++|+.|+|++|+|+ .+|..+...
T Consensus 325 ~sL~~L~Ls~N~Lt-~LP~~l~--~--------sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~~s 389 (754)
T PRK15370 325 PGLKTLEAGENALT-SLPASLP--P--------ELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLPAA 389 (754)
T ss_pred ccceeccccCCccc-cCChhhc--C--------cccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHHHH
Confidence 46777777777777 4665542 2 3447777777776 5665553 46777777777776 566665555
Q ss_pred ccccccccCCC
Q 002509 496 NVVLNYAGNIN 506 (914)
Q Consensus 496 ~~~l~~~~N~~ 506 (914)
+..|++++|..
T Consensus 390 L~~LdLs~N~L 400 (754)
T PRK15370 390 LQIMQASRNNL 400 (754)
T ss_pred HHHHhhccCCc
Confidence 55666666643
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.61 E-value=3.2e-05 Score=58.84 Aligned_cols=40 Identities=23% Similarity=0.566 Sum_probs=33.6
Q ss_pred CCeEEEEccCCCCcccCCchhhccccccccCCCCCcEEEcCCCcCCCCCC
Q 002509 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLP 465 (914)
Q Consensus 416 ~~l~~L~L~~n~l~G~ip~~~~~l~~L~~l~l~~L~~L~Ls~N~l~G~iP 465 (914)
++|+.|+|++|+++ .||++|++|++|+ +|+|++|+|+ .||
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~--------~L~l~~N~i~-~i~ 40 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLE--------TLNLSNNPIS-DIS 40 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSS--------EEEETSSCCS-BEG
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCC--------EEEecCCCCC-CCc
Confidence 47899999999999 8999999988877 9999999999 454
|
... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00064 Score=67.17 Aligned_cols=129 Identities=22% Similarity=0.325 Sum_probs=87.5
Q ss_pred HhccccccCcEEEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhhcccCceeEEEeeeeecCceEEEEEeccCCCh
Q 002509 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 669 (914)
Q Consensus 590 ~~~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 669 (914)
..+.||+|.+|.||.|.+. |.++|+|+-+.++ ....+..|+++|..+.-.++.+=+-++ ++-.+.|||++|-.|
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~y---g~~~i~me~i~G~~L 99 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFY---GEDFIRMEYIDGRPL 99 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEe---chhhhhhhhhcCcch
Confidence 3467999999999999998 6699999876553 357789999999999876665433222 122455999999888
Q ss_pred HHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCC-CCceEeCCCCcEEEeecccccc
Q 002509 670 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK-SSNILLDKHMRAKVSDFGLSKF 738 (914)
Q Consensus 670 ~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlk-p~NILl~~~~~~kl~DFGla~~ 738 (914)
.+.-... +- +-...+++.---|-.. +|-|+.|. |...+|-.+..+.|+||.-|++
T Consensus 100 ~~~~~~~-------~r----k~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 100 GKLEIGG-------DR----KHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhcc-------cH----HHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 7765321 11 1223444543333333 89999986 4444444555999999998864
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00089 Score=73.74 Aligned_cols=75 Identities=15% Similarity=0.139 Sum_probs=56.0
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhhccc---CceeEEEeeeee---cCceEEEEEecc
Q 002509 592 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH---RNLVQFLGYCQE---EGRSVLVYEFMH 665 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H---pnIv~l~g~~~~---~~~~~LV~E~~~ 665 (914)
+.||+|..+.||+....++ .+.+|..+. ......|..|++.|+.+.. -.+.+++++|.. .+..++|||+++
T Consensus 20 ~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 20 ECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 4699999999999987655 466777433 1134578999999998853 357788887754 366899999999
Q ss_pred CCCh
Q 002509 666 NGTL 669 (914)
Q Consensus 666 ~gsL 669 (914)
++++
T Consensus 97 G~~~ 100 (297)
T PRK10593 97 GVSV 100 (297)
T ss_pred CEec
Confidence 8765
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=97.53 E-value=8.8e-05 Score=96.47 Aligned_cols=91 Identities=30% Similarity=0.433 Sum_probs=73.6
Q ss_pred CCCeEEEEccCCCCcccCCchhhccccccccC-----------------------CCCCcEEEcCCCcCCCCCCccCcCC
Q 002509 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVEFG-----------------------CPDLRIIHLEDNQLTGPLPSSLMNL 471 (914)
Q Consensus 415 ~~~l~~L~L~~n~l~G~ip~~~~~l~~L~~l~-----------------------l~~L~~L~Ls~N~l~G~iP~~l~~l 471 (914)
.++|+.|+|++|.+. .+|..+ .+.+|+.|. +++|+.|+|++|...+.||.++++|
T Consensus 724 ~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L 801 (1153)
T PLN03210 724 STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNL 801 (1153)
T ss_pred cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCC
Confidence 457889999999987 888775 456666552 2579999999999888999999999
Q ss_pred CCCceeeecCccccCCCCccc-cccccccccccCCCc
Q 002509 472 PNLRELYVQNNMLSGTVPSSL-LSKNVVLNYAGNINL 507 (914)
Q Consensus 472 ~~L~~l~l~~N~l~G~iP~~~-~~~~~~l~~~~N~~~ 507 (914)
++|+.|+|++|..-+.+|..+ +..+..|+++++..+
T Consensus 802 ~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c~~L 838 (1153)
T PLN03210 802 HKLEHLEIENCINLETLPTGINLESLESLDLSGCSRL 838 (1153)
T ss_pred CCCCEEECCCCCCcCeeCCCCCccccCEEECCCCCcc
Confidence 999999999987666899876 556778888887654
|
syringae 6; Provisional |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0012 Score=67.77 Aligned_cols=127 Identities=23% Similarity=0.355 Sum_probs=90.1
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEEecCC----------------cccchhhhHHHHHHhhcc------cCceeEEEe
Q 002509 592 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS----------------YQGKREFTNEVTLLSRIH------HRNLVQFLG 649 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~~g~~vAVK~l~~~~----------------~~~~~~f~~E~~~l~~l~------HpnIv~l~g 649 (914)
..||+|+.-.||.- .+.....||+..... ....++..+|+.-...+. +..|.+++|
T Consensus 7 ~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 47999999999853 345667888887654 122456677777766666 788999999
Q ss_pred eeeecCceEEEEEeccC--C----ChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCceEeC
Q 002509 650 YCQEEGRSVLVYEFMHN--G----TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 723 (914)
Q Consensus 650 ~~~~~~~~~LV~E~~~~--g----sL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~ 723 (914)
+..+....-+|+|.+.+ | +|.+++. ...++. . +...+-+-..||-.+ .|+.+|++|+||++.
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~---~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLK-----EGGLTE-E---LRQALDEFKRYLLDH---HIVIRDLNPHNIVVQ 152 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHH-----cCCccH-H---HHHHHHHHHHHHHHc---CCeecCCCcccEEEE
Confidence 99999999999998764 2 5777773 223443 2 333334445677776 899999999999996
Q ss_pred CCC----cEEEee
Q 002509 724 KHM----RAKVSD 732 (914)
Q Consensus 724 ~~~----~~kl~D 732 (914)
... .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 432 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.51 E-value=5.4e-06 Score=95.72 Aligned_cols=111 Identities=30% Similarity=0.432 Sum_probs=78.0
Q ss_pred CCCCCCCCCCce---EEeCCC----------CCCCeEEEEccCCCCcccCCchhhcccccccc----------------C
Q 002509 396 GGDPCLPVPWSW---LQCNSD----------PQPSITVIHLSSKNLTGNIPSDLTKLSSLVEF----------------G 446 (914)
Q Consensus 396 ~~dpc~~~~w~g---v~c~~~----------~~~~l~~L~L~~n~l~G~ip~~~~~l~~L~~l----------------~ 446 (914)
+||.|....|.- ++|+++ ..+.|+.|||++|+++ ..- .|-.|.+|++| +
T Consensus 154 ggd~~ns~~Wn~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~-~v~-~Lr~l~~LkhLDlsyN~L~~vp~l~~~g 231 (1096)
T KOG1859|consen 154 GGDISNSPVWNKLATASFSYNRLVLMDESLQLLPALESLNLSHNKFT-KVD-NLRRLPKLKHLDLSYNCLRHVPQLSMVG 231 (1096)
T ss_pred ccccccchhhhhHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhh-hhH-HHHhcccccccccccchhccccccchhh
Confidence 688887777864 456553 3467899999999998 443 66666777655 1
Q ss_pred CCCCcEEEcCCCcCCCCCCccCcCCCCCceeeecCccccCCC---CccccccccccccccCCCccCCC
Q 002509 447 CPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTV---PSSLLSKNVVLNYAGNINLHEGG 511 (914)
Q Consensus 447 l~~L~~L~Ls~N~l~G~iP~~l~~l~~L~~l~l~~N~l~G~i---P~~~~~~~~~l~~~~N~~~~~~~ 511 (914)
|. |+.|.|+||-++ ++- .+.+|.+|+.|||++|-|+|.- |-..+..+..|++.|||..|.+-
T Consensus 232 c~-L~~L~lrnN~l~-tL~-gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p~ 296 (1096)
T KOG1859|consen 232 CK-LQLLNLRNNALT-TLR-GIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAPW 296 (1096)
T ss_pred hh-heeeeecccHHH-hhh-hHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCHH
Confidence 22 666666666665 332 4667888889999999888753 44446678889999999999753
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0014 Score=69.31 Aligned_cols=73 Identities=19% Similarity=0.234 Sum_probs=48.4
Q ss_pred ccccccCcEEEEEEEECC--CcEEEEEEEecCCcccchhhhHHHHHHhhcccCcee-EEEeeeeecCceEEEEEeccCCC
Q 002509 592 KKIGSGGFGVVYYGKLKD--GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV-QFLGYCQEEGRSVLVYEFMHNGT 668 (914)
Q Consensus 592 ~~lG~G~~G~Vy~~~~~~--g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~HpnIv-~l~g~~~~~~~~~LV~E~~~~gs 668 (914)
+.|..|-...+|+....+ ++.+++|+...... .......|+.++..+...+++ ++++.+. ..++|||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 357778888999998764 67899997654322 123345788889888544443 3433322 247999999876
Q ss_pred h
Q 002509 669 L 669 (914)
Q Consensus 669 L 669 (914)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=97.47 E-value=5.7e-05 Score=61.96 Aligned_cols=56 Identities=38% Similarity=0.621 Sum_probs=46.6
Q ss_pred CCCcEEEcCCCcCCCCCC-ccCcCCCCCceeeecCccccCCCCccc---cccccccccccCC
Q 002509 448 PDLRIIHLEDNQLTGPLP-SSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGNI 505 (914)
Q Consensus 448 ~~L~~L~Ls~N~l~G~iP-~~l~~l~~L~~l~l~~N~l~G~iP~~~---~~~~~~l~~~~N~ 505 (914)
++|++|+|++|+|+ .|| ..+..+++|+.|+|++|+++ .+|+.. +..+..|++++|.
T Consensus 1 p~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~-~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 1 PNLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLT-SIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TTESEEEETSSTES-EECTTTTTTGTTESEEEETSSSES-EEETTTTTTSTTESEEEETSSS
T ss_pred CcCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccC-ccCHHHHcCCCCCCEEeCcCCc
Confidence 46779999999999 666 57789999999999999998 666655 4457788898885
|
... |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=97.39 E-value=9.3e-05 Score=74.25 Aligned_cols=77 Identities=29% Similarity=0.463 Sum_probs=26.1
Q ss_pred CeEEEEccCCCCcccCCchhh-ccccccccCCCCCcEEEcCCCcCCCCCCccCcCCCCCceeeecCccccCCCCccc---
Q 002509 417 SITVIHLSSKNLTGNIPSDLT-KLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--- 492 (914)
Q Consensus 417 ~l~~L~L~~n~l~G~ip~~~~-~l~~L~~l~l~~L~~L~Ls~N~l~G~iP~~l~~l~~L~~l~l~~N~l~G~iP~~~--- 492 (914)
+++.|+|++|+++ .|. .++ .|.+| +.||||+|+++ .|+ .+..|++|+.|+|++|+++ .++..+
T Consensus 20 ~~~~L~L~~n~I~-~Ie-~L~~~l~~L--------~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~ 86 (175)
T PF14580_consen 20 KLRELNLRGNQIS-TIE-NLGATLDKL--------EVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKN 86 (175)
T ss_dssp ------------------S--TT-TT----------EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH
T ss_pred ccccccccccccc-ccc-chhhhhcCC--------CEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHh
Confidence 7899999999998 553 454 34444 59999999999 676 5888999999999999999 676543
Q ss_pred cccccccccccCCC
Q 002509 493 LSKNVVLNYAGNIN 506 (914)
Q Consensus 493 ~~~~~~l~~~~N~~ 506 (914)
+..+..|.+++|.-
T Consensus 87 lp~L~~L~L~~N~I 100 (175)
T PF14580_consen 87 LPNLQELYLSNNKI 100 (175)
T ss_dssp -TT--EEE-TTS--
T ss_pred CCcCCEEECcCCcC
Confidence 56788899998854
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0012 Score=70.04 Aligned_cols=72 Identities=18% Similarity=0.279 Sum_probs=44.2
Q ss_pred cccccCcE-EEEEEEECCCcEEEEEEEecCCcccchhhhHHHHHHhhcccC---ceeEEEeeeeec---CceEEEEEecc
Q 002509 593 KIGSGGFG-VVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR---NLVQFLGYCQEE---GRSVLVYEFMH 665 (914)
Q Consensus 593 ~lG~G~~G-~Vy~~~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~Hp---nIv~l~g~~~~~---~~~~LV~E~~~ 665 (914)
.|+.|+.. .||+. +..+++|..+.. .....+..|++++..+... .+.+.++..... ...+++|++++
T Consensus 4 ~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 4 PVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 46766666 58875 245777765432 2244788899999888532 233444443332 23478999999
Q ss_pred CCChH
Q 002509 666 NGTLK 670 (914)
Q Consensus 666 ~gsL~ 670 (914)
|.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 87664
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.002 Score=65.85 Aligned_cols=122 Identities=22% Similarity=0.343 Sum_probs=87.5
Q ss_pred HHhccccccCc-EEEEEEEECCCcEEEEEEEecC---Cc------------------ccchhhhHHHHHHhhcc---cCc
Q 002509 589 MLEKKIGSGGF-GVVYYGKLKDGKEIAVKVLTSN---SY------------------QGKREFTNEVTLLSRIH---HRN 643 (914)
Q Consensus 589 ~~~~~lG~G~~-G~Vy~~~~~~g~~vAVK~l~~~---~~------------------~~~~~f~~E~~~l~~l~---Hpn 643 (914)
++.+.||.|.- |.||+++.. |+.+|+|+++.- .. .....|..|.+...+++ +.+
T Consensus 40 ~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~ 118 (207)
T PF13095_consen 40 EFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREG 118 (207)
T ss_pred eeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccC
Confidence 35578999999 999999997 789999994321 00 11235788999888885 445
Q ss_pred e--eEEEeeeeec------------------CceEEEEEeccCCChHHHhhcccCccccccHHHHHHHHHHHHHHHHHHH
Q 002509 644 L--VQFLGYCQEE------------------GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 703 (914)
Q Consensus 644 I--v~l~g~~~~~------------------~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~l~ia~~ia~gL~yLH 703 (914)
+ |+.+||..-. ....||.||++... .+ ..+-+.++.+-|..+|
T Consensus 119 ~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~----~~~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 119 LWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PL----QIRDIPQMLRDLKILH 181 (207)
T ss_pred ceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------cc----chhHHHHHHHHHHHHH
Confidence 6 8999987322 12357888776533 11 1223456778888999
Q ss_pred hCCCCCccccCCCCCceEeCCCCcEEEeecccc
Q 002509 704 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 736 (914)
Q Consensus 704 ~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 736 (914)
.. +|+-+|+|+.|.. .-||+|||.+
T Consensus 182 k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HC---CeeeccCcccccc-----CCEEEecccC
Confidence 98 9999999999986 5789999864
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 914 | ||||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-57 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-56 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-49 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-48 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-33 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-33 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-33 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-32 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-31 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-31 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-26 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-26 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-26 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-26 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-26 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-26 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-26 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-26 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-26 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-26 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-26 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-25 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-25 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-25 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-25 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-25 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-25 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-25 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-25 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-25 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-24 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-24 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-24 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-24 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-24 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-24 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-24 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-24 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-23 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-23 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-23 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-23 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-23 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-23 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-23 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-23 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-23 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-23 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-23 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-23 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-23 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-23 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-23 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-23 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-23 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-23 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-22 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-21 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-21 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-21 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-21 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-21 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-21 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-21 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-21 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-21 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-21 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-21 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-21 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-21 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-21 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-21 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-21 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-21 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-21 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-21 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-21 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-21 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-21 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-21 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-21 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-20 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-20 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-20 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-20 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-20 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-20 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-20 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-20 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-17 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-16 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-16 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-16 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-15 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-15 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-13 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-13 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-13 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-12 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-12 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-12 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-12 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-12 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-12 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-12 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-12 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-12 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-12 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-11 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-11 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-11 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 9e-11 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 9e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-10 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 7e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 8e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 3e-06 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-06 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-06 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 4e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 5e-06 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 5e-06 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 5e-06 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 5e-06 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 5e-06 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 5e-06 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 6e-06 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 6e-06 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 6e-06 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 6e-06 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 6e-06 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 6e-06 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 6e-06 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 6e-06 |
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 448 bits (1154), Expect = e-151
Identities = 122/312 (39%), Positives = 187/312 (59%), Gaps = 7/312 (2%)
Query: 562 RPVSSLNDAPAEAAHCFTLSDIEDATKMLEKK--IGSGGFGVVYYGKLKDGKEIAVKVLT 619
S + ++ L D+E+AT + K IG G FG VY G L+DG ++A+K T
Sbjct: 13 NDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRT 72
Query: 620 SNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH 679
S QG EF E+ LS H +LV +G+C E +L+Y++M NG LK HLYG+
Sbjct: 73 PESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLP 132
Query: 680 EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-F 738
++W +RLEI AA+G+ YLHT IIHRD+KS NILLD++ K++DFG+SK
Sbjct: 133 TMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG 189
Query: 739 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN 798
+H+S++V+GT+GY+DPEY+I +LT+KSDVYSFGV+L E++ + AI +
Sbjct: 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI-VQSLPRE 248
Query: 799 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 858
N+ +WA +G ++ I+DP+L D+ +S+ K + A+ C+ RPS+ +VL
Sbjct: 249 MVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLW 308
Query: 859 DIQDAIVIEREA 870
++ A+ ++
Sbjct: 309 KLEYALRLQESV 320
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 376 bits (969), Expect = e-124
Identities = 103/288 (35%), Positives = 168/288 (58%), Gaps = 4/288 (1%)
Query: 575 AHCFTLSDIEDATKM--LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-KREFTN 631
F+L +++ A+ + +G GGFG VY G+L DG +AVK L QG + +F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 632 EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI 691
EV ++S HRNL++ G+C +LVY +M NG++ L + ++W KR I
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 692 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 751
A +A+G+ YLH C P IIHRD+K++NILLD+ A V DFGL+K +HV++ VR
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196
Query: 752 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF-GANCRNIVQWAKLHI 810
GT+G++ PEY + + ++K+DV+ +GV+LLELI+GQ A + + ++ W K +
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
Query: 811 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 858
+ ++ ++D L Y + + ++ + AL+C RP +SEV++
Sbjct: 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 356 bits (917), Expect = e-116
Identities = 97/305 (31%), Positives = 166/305 (54%), Gaps = 27/305 (8%)
Query: 576 HCFTLSDIEDATK--------MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTS----NSY 623
H F+ ++++ T + K+G GGFGVVY G + + +AVK L + +
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 624 QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI 683
+ K++F E+ ++++ H NLV+ LG+ + LVY +M NG+L + L L +
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-LDGTPPL 130
Query: 684 NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDG 742
+W R +IA+ AA GI +LH IHRD+KS+NILLD+ AK+SDFGL++
Sbjct: 131 SWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 743 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 802
+ ++S + GT Y+ PE + ++T KSD+YSFGV+LLE+I+G A+ + + +
Sbjct: 188 QTVMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR---EPQLL 243
Query: 803 VQWAK-LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEV---LK 858
+ + + E I+ ID +++ D S+ + A C+ + RP I +V L+
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
Query: 859 DIQDA 863
++ +
Sbjct: 303 EMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 1e-75
Identities = 77/310 (24%), Positives = 124/310 (40%), Gaps = 33/310 (10%)
Query: 578 FTLSDIEDATKMLE--KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTL 635
++ + L+ + G FG V+ +L + +AVK+ Q + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSW-QNEYEVYS 71
Query: 636 LSRIHHRNLVQFLGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI 691
L + H N++QF+G + L+ F G+L + L ++W + I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCHI 126
Query: 692 AEDAAKGIEYLHT-------GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744
AE A+G+ YLH G PAI HRD+KS N+LL ++ A ++DFGL+ G S
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 745 HVSSIVR-GTVGYLDPEY-----YISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN 798
+ + GT Y+ PE + + D+Y+ G++L EL S A
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP-VDEY 245
Query: 799 CRNIVQWAKLHIESGDIQGII-----DPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPS 852
+ H D+Q ++ P L D + M + E C R S
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 853 ISEVLKDIQD 862
V + I
Sbjct: 306 AGCVGERITQ 315
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 3e-70
Identities = 82/240 (34%), Positives = 125/240 (52%), Gaps = 6/240 (2%)
Query: 551 KEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDG 610
K H H + + + + A DI +++KIG+G FG V+ + G
Sbjct: 2 KHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-G 60
Query: 611 KEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 668
++AVK+L + + EF EV ++ R+ H N+V F+G + +V E++ G+
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 669 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA 728
L L+ + EQ ++ +RL +A D AKG+ YLH P I+HR+LKS N+L+DK
Sbjct: 121 LYRLLHKSGAREQ-LDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTV 178
Query: 729 KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 788
KV DFGLS+ S GT ++ PE + +KSDVYSFGVIL EL + Q+
Sbjct: 179 KVCDFGLSRLKASTFLSSKS-AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 8e-63
Identities = 68/211 (32%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLV 645
LE+ IG GGFG VY G E+AVK + + E L + + H N++
Sbjct: 11 LEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 646 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 705
G C +E LV EF G L L +RI + A A+G+ YLH
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHDE 124
Query: 706 CVPAIIHRDLKSSNILLDK--------HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 757
+ IIHRDLKSSNIL+ + + K++DFGL++ + S G ++
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR--TTKMSAA-GAYAWM 181
Query: 758 DPEYYISQQLTDKSDVYSFGVILLELISGQE 788
PE + + SDV+S+GV+L EL++G+
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEV 212
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 1e-62
Identities = 80/338 (23%), Positives = 141/338 (41%), Gaps = 59/338 (17%)
Query: 580 LSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI 639
+IE +E+ +G G FGVV K + K++A+K + S S ++ F E+ LSR+
Sbjct: 7 YKEIE-----VEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESE--RKAFIVELRQLSRV 58
Query: 640 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 699
+H N+V+ G C LV E+ G+L L+G + ++G+
Sbjct: 59 NHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGV 115
Query: 700 EYLHTGCVPAIIHRDLKSSNILLDKHMR-AKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 758
YLH+ A+IHRDLK N+LL K+ DFG + + +G+ ++
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMA 171
Query: 759 PEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 818
PE + ++K DV+S+G+IL E+I+ ++ + ++ + I
Sbjct: 172 PEVFEGSNYSEKCDVFSWGIILWEVITRRKP---------------FDEIGGPAFRIMWA 216
Query: 819 ID----PSLLDEYD------IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIER 868
+ P L+ + W + P RPS+ E++K + + R
Sbjct: 217 VHNGTRPPLIKNLPKPIESLMTRCWSKD--------P--SQRPSMEEIVKIMTH---LMR 263
Query: 869 EAAAARDGNSDDMSRNSLHSSLNVGSFGGTENFLSLDE 906
+D+ + SL G G E ++ E
Sbjct: 264 YFP-----GADEPLQYPCQHSLPPGEDGRVEPYVDFAE 296
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 2e-62
Identities = 85/291 (29%), Positives = 137/291 (47%), Gaps = 45/291 (15%)
Query: 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK-------REFTNEVTLLSRIHH 641
EK+IG GGFG+V+ G+L D +A+K L +G+ +EF EV ++S ++H
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 642 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 701
N+V+ G +V EF+ G L L I W +L + D A GIEY
Sbjct: 83 PNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEY 137
Query: 702 LHTGCVPAIIHRDLKSSNILLDK-----HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 756
+ P I+HRDL+S NI L + AKV+DFGLS+ + H S + G +
Sbjct: 138 MQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQW 192
Query: 757 LDPEYYISQQL--TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG- 813
+ PE +++ T+K+D YSF +IL +++G+ +G +++ + E G
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINMIREEGL 247
Query: 814 --DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862
I P L + I+ W + P RP S ++K++ +
Sbjct: 248 RPTIPEDCPPRLRNV--IELCWSGD--------P--KKRPHFSYIVKELSE 286
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 210 bits (538), Expect = 3e-62
Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 23/209 (11%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQF 647
K+ G ++ G+ + G +I VKVL + + R+F E L H N++
Sbjct: 14 FLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 648 LGYCQE--EGRSVLVYEFMHNGTLKEHLYGTLTHEQR---INWIKRLEIAEDAAKGIEYL 702
LG CQ L+ +M G+L L HE ++ + ++ A D A+G+ +L
Sbjct: 73 LGACQSPPAPHPTLITHWMPYGSLYNVL-----HEGTNFVVDQSQAVKFALDMARGMAFL 127
Query: 703 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 762
HT P I L S ++++D+ M A++S + ++ PE
Sbjct: 128 HT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPG------RMYAPAWVAPEAL 180
Query: 763 ISQQL---TDKSDVYSFGVILLELISGQE 788
+ +D++SF V+L EL++ +
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREV 209
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 2e-61
Identities = 71/322 (22%), Positives = 122/322 (37%), Gaps = 46/322 (14%)
Query: 578 FTLSDIEDATKMLE--KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNE--V 633
S+ L+ + IG G +G VY G L D + +AVKV + + Q F NE +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 634 TLLSRIHHRNLVQFLGYCQEEGRSV-----LVYEFMHNGTLKEHLYGTLTHEQRINWIKR 688
+ + H N+ +F+ + LV E+ NG+L ++L +W+
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSS 113
Query: 689 LEIAEDAAKGIEYLHT------GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF---- 738
+A +G+ YLHT PAI HRDL S N+L+ +SDFGLS
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 739 ---AVDGASHVSSIVRGTVGYLDPEY-------YISQQLTDKSDVYSFGVILLELISGQE 788
+ + GT+ Y+ PE + + D+Y+ G+I E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 789 AISNEKFGANCRNIVQW-AKLHIESGDIQGIID-----PSLLDEYDIQSMWKIEEKALM- 841
+ + + Q H D+Q ++ P + + S+ K +
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 842 -CVLPHGHMRPSISEVLKDIQD 862
C R + + + +
Sbjct: 294 DCWDQDAEARLTAQXAEERMAE 315
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 3e-60
Identities = 70/205 (34%), Positives = 114/205 (55%), Gaps = 15/205 (7%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQF 647
+ ++IGSG FG VY GK ++AVK+L + + + F NEV +L + H N++ F
Sbjct: 28 VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
+GY ++ V ++ +L HL+ E + K ++IA A+G++YLH
Sbjct: 86 MGYSTAPQLAI-VTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHA--- 138
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPE---YYI 763
+IIHRDLKS+NI L + K+ DFGL+ + SH + G++ ++ PE
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 764 SQQLTDKSDVYSFGVILLELISGQE 788
S + +SDVY+FG++L EL++GQ
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQL 223
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 6e-60
Identities = 61/290 (21%), Positives = 111/290 (38%), Gaps = 44/290 (15%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQF 647
+ + IG G FG VY+G+ E+A++++ + F EV + H N+V F
Sbjct: 37 IGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
+G C ++ TL + + ++ K +IA++ KG+ YLH
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHA--- 148
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKF----AVDGASHVSSIVRGTVGYLDPEYYI 763
I+H+DLKS N+ D + ++DFGL I G + +L PE
Sbjct: 149 KGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207
Query: 764 SQQL---------TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 814
+ SDV++ G I EL + + + A + W + +G
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-----IIWQ---MGTGM 259
Query: 815 IQGIIDPSLLDEYD--IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862
+ + E + W E RP+ ++++ ++
Sbjct: 260 KPNLSQIGMGKEISDILLFCWAFE--------Q--EERPTFTKLMDMLEK 299
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 2e-59
Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 20/214 (9%)
Query: 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
+ +G G FG ++ G+ + +K L + +R F EV ++ + H N+++F+
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 649 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 708
G ++ R + E++ GTL+ + + + + W +R+ A+D A G+ YLH+
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGII---KSMDSQYPWSQRVSFAKDIASGMAYLHS---M 127
Query: 709 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-------------VRGTVG 755
IIHRDL S N L+ ++ V+DFGL++ VD + + V G
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 756 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEA 789
++ PE + +K DV+SFG++L E+I A
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 2e-55
Identities = 69/303 (22%), Positives = 126/303 (41%), Gaps = 45/303 (14%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNE--VTLLSRIHHRNLVQF 647
+ K+IG G +G V+ GK + G+++AVKV + + + E + + H N++ F
Sbjct: 41 MVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGF 96
Query: 648 LGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 703
+ + S L+ ++ NG+L ++L ++ L++A + G+ +LH
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHLH 151
Query: 704 T-----GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV---SSIVRGTVG 755
T PAI HRDLKS NIL+ K+ ++D GL+ + + V + GT
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 756 YLDPE------YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH 809
Y+ PE Q +D+YSFG+IL E+ + + + + +
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271
Query: 810 IESGDIQGIID--------PSLLDEYDIQSMWK--IEEKALMCVLPHGHMRPSISEVLKD 859
E D++ I+ P+ + + E C + R + V K
Sbjct: 272 YE--DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE----CWAHNPASRLTALRVKKT 325
Query: 860 IQD 862
+
Sbjct: 326 LAK 328
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 1e-54
Identities = 52/217 (23%), Positives = 96/217 (44%), Gaps = 29/217 (13%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNE--VTLLSRIHHRNLVQF 647
L + +G G +G V+ G + G+ +AVK+ +S + ++ + E + + H N++ F
Sbjct: 12 LLECVGKGRYGEVWRGSWQ-GENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGF 67
Query: 648 LGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 703
+ S L+ + G+L ++L ++ + L I A G+ +LH
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLH 122
Query: 704 T-----GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG--- 755
PAI HRDLKS NIL+ K+ + ++D GL+ + + VG
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 756 YLDPE------YYISQQLTDKSDVYSFGVILLELISG 786
Y+ PE + D+++FG++L E+
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 2e-52
Identities = 65/303 (21%), Positives = 128/303 (42%), Gaps = 45/303 (14%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNE--VTLLSRIHHRNLVQF 647
L++ IG G FG V+ GK + G+E+AVK+ +S + +R + E + + H N++ F
Sbjct: 46 LQESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGF 101
Query: 648 LGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 703
+ ++ + LV ++ +G+L ++L + + +++A A G+ +LH
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLH 156
Query: 704 -----TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV---SSIVRGTVG 755
T PAI HRDLKS NIL+ K+ ++D GL+ + + GT
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 756 YLDPE------YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH 809
Y+ PE + ++D+Y+ G++ E+ + + +
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276
Query: 810 IESGDIQGI---------IDPSLLDEYDIQSMWK-IEEKALMCVLPHGHMRPSISEVLKD 859
+E +++ + I ++ M K + E C +G R + + K
Sbjct: 277 VE--EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRE----CWYANGAARLTALRIKKT 330
Query: 860 IQD 862
+
Sbjct: 331 LSQ 333
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 5e-42
Identities = 73/282 (25%), Positives = 124/282 (43%), Gaps = 40/282 (14%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQ 646
+ +IG G F VY G + E+A + ++ F E +L + H N+V+
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 647 FLGY----CQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 700
F + + VLV E M +GTLK +L + + + +W + +I + G++
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR--QILK----GLQ 143
Query: 701 YLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 759
+LHT P IIHRDLK NI + K+ D GL+ + AS +++ GT ++ P
Sbjct: 144 FLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT--LKRASFAKAVI-GTPEFMAP 199
Query: 760 EYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 819
E Y ++ + DVY+FG+ +LE+ + E + C+N Q + + SG
Sbjct: 200 EMY-EEKYDESVDVYAFGMCMLEMATS------EYPYSECQNAAQIYRR-VTSGVKPASF 251
Query: 820 DPSLLDEYDIQSMWKIEEKA--LMCVLPHGHMRPSISEVLKD 859
+ E K C+ + R SI ++L
Sbjct: 252 -DKVAIP---------EVKEIIEGCIRQNKDERYSIKDLLNH 283
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 6e-40
Identities = 65/203 (32%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGK-EIAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 647
L ++IG G FG V+ G+L+ +AVK + K +F E +L + H N+V+
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
+G C ++ +V E + G L T R+ L++ DAA G+EYL + C
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-----VRGTVGYLDPEYY 762
IHRDL + N L+ + K+SDFG+S+ DG S V+ T PE
Sbjct: 235 ---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTA----PEAL 287
Query: 763 ISQQLTDKSDVYSFGVILLELIS 785
+ + +SDV+SFG++L E S
Sbjct: 288 NYGRYSSESDVWSFGILLWETFS 310
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 6e-38
Identities = 66/280 (23%), Positives = 121/280 (43%), Gaps = 46/280 (16%)
Query: 592 KKIGSGGFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
+KIG G FG K +DG++ +K ++ S + + E EV +L+ + H N+VQ+
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 649 GYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHT 704
+E G +V ++ G L + + G L E +I +W ++ ++++H
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI------CLALKHVHD 143
Query: 705 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 764
I+HRD+KS NI L K ++ DFG+++ + + GT YL PE +
Sbjct: 144 ---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICEN 199
Query: 765 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824
+ +KSD+++ G +L EL + + A I+ G P +
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS--------GSF-----PPVS 246
Query: 825 DEYD------IQSMWKIEEKALMCVLPHGHMRPSISEVLK 858
Y + ++K RPS++ +L+
Sbjct: 247 LHYSYDLRSLVSQLFKRNP----------RDRPSVNSILE 276
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 8e-38
Identities = 73/262 (27%), Positives = 114/262 (43%), Gaps = 52/262 (19%)
Query: 553 QHRHSLPVQRPVSSLNDAPAEAAHCFTLSD---IEDATKMLEKKIGSGGFGVVYYGKL-- 607
H H P + F D E+ +++G G FG V +
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDP 64
Query: 608 ---KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV--LVYE 662
G+ +AVK L ++ + R+F E+ +L + H N+V++ G C GR L+ E
Sbjct: 65 LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 124
Query: 663 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNIL 721
++ G+L+++L H++RI+ IK L+ KG+EYL T IHRDL + NIL
Sbjct: 125 YLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTKRY----IHRDLATRNIL 177
Query: 722 LDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL-------------- 767
++ R K+ DFGL+K D EYY ++
Sbjct: 178 VENENRVKIGDFGLTKVLPQ----------------DKEYYKVKEPGESPIFWYAPESLT 221
Query: 768 ----TDKSDVYSFGVILLELIS 785
+ SDV+SFGV+L EL +
Sbjct: 222 ESKFSVASDVWSFGVVLYELFT 243
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 9e-38
Identities = 65/315 (20%), Positives = 118/315 (37%), Gaps = 40/315 (12%)
Query: 556 HSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIA 614
S +Q P + + + KKIG G F VY L DG +A
Sbjct: 4 QSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIE--KKIGRGQFSEVYRAACLLDGVPVA 61
Query: 615 VK---VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKE 671
+K + + + + E+ LL +++H N++++ E+ +V E G L
Sbjct: 62 LKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSR 121
Query: 672 HL-----YGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH 725
+ L E+ + + +L +E++H+ ++HRD+K +N+ +
Sbjct: 122 MIKHFKKQKRLIPERTVWKYFVQL------CSALEHMHS---RRVMHRDIKPANVFITAT 172
Query: 726 MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
K+ D GL +F + S+V GT Y+ PE KSD++S G +L E+ +
Sbjct: 173 GVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 231
Query: 786 GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD--IQSMWKIEEKALMCV 843
Q F + N+ IE D + +E + +
Sbjct: 232 LQSP-----FYGDKMNLYS-LCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDP------ 279
Query: 844 LPHGHMRPSISEVLK 858
RP ++ V
Sbjct: 280 ----EKRPDVTYVYD 290
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 66/286 (23%), Positives = 111/286 (38%), Gaps = 47/286 (16%)
Query: 592 KKIGSGGFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
IG+G +G + DGK + K S + K+ +EV LL + H N+V++
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 649 GYCQEEGRSVL--VYEFMHNGTLKEHL-----YGTLTHEQRINWIKRLEIAEDAAKGIEY 701
+ + L V E+ G L + E+ + L + ++
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV-----LRVMTQLTLALKE 126
Query: 702 LHTGCVPA--IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 759
H ++HRDLK +N+ LD K+ DFGL++ S + V GT Y+ P
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSP 185
Query: 760 EYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 819
E +KSD++S G +L EL + F A + + A I G
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPP-----FTAF--SQKELAGK-IREGKF---- 233
Query: 820 DPSLLDEYD------IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859
+ Y I M +++ + RPS+ E+L++
Sbjct: 234 -RRIPYRYSDELNEIITRMLNLKD----------YHRPSVEEILEN 268
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 49/222 (22%)
Query: 590 LEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL 644
+++G G FG V + G+ +AVK L ++ + R+F E+ +L + H N+
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 645 VQFLGYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 702
V++ G C GR L+ E++ G+L+++L H++RI+ IK L+ KG+EYL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 703 HT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 761
T IHRDL + NIL++ R K+ DFGL+K D E+
Sbjct: 131 GTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQ----------------DKEF 170
Query: 762 YISQQ------------------LTDKSDVYSFGVILLELIS 785
+ ++ + SDV+SFGV+L EL +
Sbjct: 171 FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-37
Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 649
LE K+G G FG V+ G +A+K L + F E ++ ++ H LVQ
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE-QRINWIKRLEIAEDAAKGIEYLHTGCVP 708
EE +V E+M G+L + L + + + +++A A G+ Y+
Sbjct: 247 VVSEEPI-YIVTEYMSKGSLLDFLK---GETGKYLRLPQLVDMAAQIASGMAYVERMN-- 300
Query: 709 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 768
+HRDL+++NIL+ +++ KV+DFGL++ D + + + PE + + T
Sbjct: 301 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 769 DKSDVYSFGVILLELIS 785
KSDV+SFG++L EL +
Sbjct: 360 IKSDVWSFGILLTELTT 376
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 64/200 (32%), Positives = 105/200 (52%), Gaps = 15/200 (7%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 649
++IGSG FG+V+ G + ++A+K + + + +F E ++ ++ H LVQ G
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 709
C E+ LV EFM +G L ++L T L + D +G+ YL CV
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEACV-- 125
Query: 710 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSI-VRGTVGYLDPEYYISQ 765
IHRDL + N L+ ++ KVSDFG+++F +D +S + V+ PE +
Sbjct: 126 -IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS----PEVFSFS 180
Query: 766 QLTDKSDVYSFGVILLELIS 785
+ + KSDV+SFGV++ E+ S
Sbjct: 181 RYSSKSDVWSFGVLMWEVFS 200
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-37
Identities = 60/293 (20%), Positives = 108/293 (36%), Gaps = 44/293 (15%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
+K+G GGF V + L DG A+K + + Q + E E + +H N+++ +
Sbjct: 33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 649 GYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 704
YC E + L+ F GTL + + + L + +G+E +H
Sbjct: 93 AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA 152
Query: 705 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--------GTVGY 756
HRDLK +NILL + + D G A + T+ Y
Sbjct: 153 ---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 757 LDPE---YYISQQLTDKSDVYSFGVILLELISGQ-----EAISNEKFGANCRNIVQWAKL 808
PE + +++DV+S G +L ++ G+ + +N + +
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQS 269
Query: 809 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861
S + ++ ++M V P H RP I +L ++
Sbjct: 270 PRHSSALWQLL------------------NSMMTVDP--HQRPHIPLLLSQLE 302
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 9e-37
Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 15/200 (7%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 649
K++G+G FGVV YGK + ++A+K++ S + EF E ++ + H LVQ G
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 709
C ++ ++ E+M NG L +L R + LE+ +D + +EYL +
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESKQF-- 141
Query: 710 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSI-VRGTVGYLDPEYYISQ 765
+HRDL + N L++ KVSDFGLS++ +D +S S VR + PE +
Sbjct: 142 -LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP----PEVLMYS 196
Query: 766 QLTDKSDVYSFGVILLELIS 785
+ + KSD+++FGV++ E+ S
Sbjct: 197 KFSSKSDIWAFGVLMWEIYS 216
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-36
Identities = 65/298 (21%), Positives = 106/298 (35%), Gaps = 58/298 (19%)
Query: 592 KKIGSGGFGVVYYGKLK-DGKEIAVK-VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 649
+ +G GGFGVV+ K K D A+K + N + + EV L+++ H +V++
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 650 YCQEEG---------RSVLVY---EFMHNGTLKEHL----YGTLTHEQRINWIKRLEIAE 693
E+ V +Y + LK+ + L I
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC-----LHIFL 125
Query: 694 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-----------FAVDG 742
A+ +E+LH+ ++HRDLK SNI KV DFGL
Sbjct: 126 QIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 743 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 802
A + GT Y+ PE + K D++S G+IL EL+ F +
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--------PFSTQMERV 234
Query: 803 VQWAKLHIESGDIQGIIDPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859
+ + + EY +Q M + P RP ++++
Sbjct: 235 RTLTD--VRNLKFPPLFTQKYPCEYVMVQDM--------LSPSP--MERPEAINIIEN 280
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-36
Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 649
LE K+G G FG V+ G +A+K L + F E ++ ++ H LVQ
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE-QRINWIKRLEIAEDAAKGIEYLHTGCVP 708
EE +V E+M G+L + L + + + +++A A G+ Y+
Sbjct: 330 VVSEEPI-YIVTEYMSKGSLLDFLK---GETGKYLRLPQLVDMAAQIASGMAYVERMN-- 383
Query: 709 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 768
+HRDL+++NIL+ +++ KV+DFGL++ D + + + PE + + T
Sbjct: 384 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 769 DKSDVYSFGVILLELIS 785
KSDV+SFG++L EL +
Sbjct: 443 IKSDVWSFGILLTELTT 459
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 22/226 (9%)
Query: 569 DAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE-----IAVKVL-TSNS 622
+AP +A +++ K +GSG FG VY G E +A+K L + S
Sbjct: 2 EAPNQALLRI----LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 57
Query: 623 YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR 682
+ +E +E +++ + + ++ + LG C L+ + M G L +++ H+
Sbjct: 58 PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYV---REHKDN 113
Query: 683 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 742
I L AKG+ YL ++HRDL + N+L+ K++DFGL+K
Sbjct: 114 IGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 743 ASHVSSIVRGT---VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
+ G + ++ E + + T +SDV+S+GV + EL++
Sbjct: 171 EKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 65/200 (32%), Positives = 112/200 (56%), Gaps = 15/200 (7%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 649
L K++GSG FGVV GK K ++AVK++ S + EF E + ++ H LV+F G
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 709
C +E +V E++ NG L +L +H + + + LE+ D +G+ +L +
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFLESHQF-- 125
Query: 710 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSI-VRGTVGYLDPEYYISQ 765
IHRDL + N L+D+ + KVSDFG++++ +D +S + V+ + PE +
Sbjct: 126 -IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSA----PEVFHYF 180
Query: 766 QLTDKSDVYSFGVILLELIS 785
+ + KSDV++FG+++ E+ S
Sbjct: 181 KYSSKSDVWAFGILMWEVFS 200
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 50/223 (22%)
Query: 590 LEKKIGSGGFGVVYYGKLK-----DGKEIAVKVL-TSNSYQGKREFTNEVTLLSRIHHRN 643
+ +G G FG V + G+++AVK L + + E+ +L ++H N
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84
Query: 644 LVQFLGYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 701
+V++ G C E+G + L+ EF+ +G+LKE+L ++ +IN ++L+ A KG++Y
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDY 141
Query: 702 LHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 760
L + +HRDL + N+L++ + K+ DFGL+K D E
Sbjct: 142 LGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAI----------------ETDKE 181
Query: 761 YYISQQL------------------TDKSDVYSFGVILLELIS 785
YY + SDV+SFGV L EL++
Sbjct: 182 YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 584 EDATKMLEKKIGSGGFGVVYYGKLKDGKE---IAVKVLTSN-SYQGKREFTNEVTLLSRI 639
D + + ++G G FG V G + K+ +A+KVL E E ++ ++
Sbjct: 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 67
Query: 640 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 699
+ +V+ +G CQ E +LV E G L + L + + I E+ + G+
Sbjct: 68 DNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGM 123
Query: 700 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYL 757
+YL +HRDL + N+LL AK+SDFGLSK S+ ++ G + +
Sbjct: 124 KYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 180
Query: 758 DPEYYISQQLTDKSDVYSFGVILLELIS 785
PE ++ + +SDV+S+GV + E +S
Sbjct: 181 APECINFRKFSSRSDVWSYGVTMWEALS 208
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-36
Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 49/222 (22%)
Query: 590 LEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL 644
++G G FG V + G +AVK L + +R+F E+ +L +H +
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 645 VQFLGYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 702
V++ G GR LV E++ +G L++ L H R++ + L + KG+EYL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYL 143
Query: 703 HT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 761
+ C +HRDL + NIL++ K++DFGL+K D +Y
Sbjct: 144 GSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPL----------------DKDY 183
Query: 762 YISQQL------------------TDKSDVYSFGVILLELIS 785
Y+ ++ + +SDV+SFGV+L EL +
Sbjct: 184 YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-36
Identities = 61/198 (30%), Positives = 99/198 (50%), Gaps = 9/198 (4%)
Query: 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
++ K+G G +G VY G K +AVK L ++ + EF E ++ I H NLVQ L
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 282
Query: 649 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE-QRINWIKRLEIAEDAAKGIEYLHTGCV 707
G C E ++ EFM G L ++L Q ++ + L +A + +EYL
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKKN- 338
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 767
IHR+L + N L+ ++ KV+DFGLS+ + + + + PE +
Sbjct: 339 --FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 396
Query: 768 TDKSDVYSFGVILLELIS 785
+ KSDV++FGV+L E+ +
Sbjct: 397 SIKSDVWAFGVLLWEIAT 414
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 7e-36
Identities = 72/341 (21%), Positives = 126/341 (36%), Gaps = 24/341 (7%)
Query: 451 RIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEG 510
I + + P + L L V+ L L + + A N +
Sbjct: 212 LISQDKAGKYCIPEGTKFDTLWQL----VEYLKLKADGLIYCLKEACPNSSASNASGAAA 267
Query: 511 GRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDA 570
H + + L +P+ V +
Sbjct: 268 PTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSP-------DKPRPMPMDTSVFESPFS 320
Query: 571 PAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE---IAVKVLTSN-SYQGK 626
E L D + + ++G G FG V G + K+ +A+KVL
Sbjct: 321 DPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT 380
Query: 627 REFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI 686
E E ++ ++ + +V+ +G CQ E +LV E G L + L + + I
Sbjct: 381 EEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFL---VGKREEIPVS 436
Query: 687 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746
E+ + G++YL +HR+L + N+LL AK+SDFGLSK S+
Sbjct: 437 NVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493
Query: 747 SSIVRGT--VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
++ G + + PE ++ + +SDV+S+GV + E +S
Sbjct: 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-35
Identities = 63/199 (31%), Positives = 105/199 (52%), Gaps = 15/199 (7%)
Query: 589 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
L + IG G FG V G + G ++AVK + +++ + F E ++++++ H NLVQ L
Sbjct: 196 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLL 252
Query: 649 GYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
G +E+G +V E+M G+L ++L + L+ + D + +EYL
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN- 309
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-VRGTVGYLDPEYYISQQ 766
+HRDL + N+L+ + AKVSDFGL+K + V+ T PE ++
Sbjct: 310 --FVHRDLAARNVLVSEDNVAKVSDFGLTKE-ASSTQDTGKLPVKWTA----PEALREKK 362
Query: 767 LTDKSDVYSFGVILLELIS 785
+ KSDV+SFG++L E+ S
Sbjct: 363 FSTKSDVWSFGILLWEIYS 381
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 63/261 (24%), Positives = 101/261 (38%), Gaps = 58/261 (22%)
Query: 552 EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK--- 608
H H + L P + + + +G G FG V
Sbjct: 3 HHHHHHHHHHGALEVLFQGPGDP------TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTN 56
Query: 609 DGKEI--AVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV--LVYEF 663
DG AVK L Q + + E+ +L ++H +++++ G C++ G + LV E+
Sbjct: 57 DGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEY 116
Query: 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILL 722
+ G+L+++L I + L A+ +G+ YLH IHRDL + N+LL
Sbjct: 117 VPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLHAQHY----IHRDLAARNVLL 167
Query: 723 DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL--------------- 767
D K+ DFGL+K EYY ++
Sbjct: 168 DNDRLVKIGDFGLAKAV----------------PEGHEYYRVREDGDSPVFWYAPECLKE 211
Query: 768 ---TDKSDVYSFGVILLELIS 785
SDV+SFGV L EL++
Sbjct: 212 YKFYYASDVWSFGVTLYELLT 232
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 56/221 (25%), Positives = 85/221 (38%), Gaps = 46/221 (20%)
Query: 589 MLEKKIGSGGFGVVYYGKLK--DGKEI--AVKVL---TSNSYQGKREFTNEVTLLSRIHH 641
L +K+G G FGVV G+ GK + AVK L + + +F EV + + H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 642 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 701
RNL++ G +V E G+L + L H+ A A+G+ Y
Sbjct: 81 RNLIRLYGVVLTP-PMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGY 136
Query: 702 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 761
L + IHRDL + N+LL K+ DFGL + + D Y
Sbjct: 137 LESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA---------------LPQNDDHY 178
Query: 762 YISQ-----------------QLTDKSDVYSFGVILLELIS 785
+ + + SD + FGV L E+ +
Sbjct: 179 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 66/254 (25%), Positives = 120/254 (47%), Gaps = 29/254 (11%)
Query: 549 YDKEQHRHS-LPVQR---PVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYY 604
Y H +P ++ P +A FT ++I + +K IG+G FG VY
Sbjct: 4 YHHHHHHDYDIPTTENLYFQGAMGSDPNQAVLKFT-TEIHPSCVTRQKVIGAGEFGEVYK 62
Query: 605 GKLKDGKE-----IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 658
G LK +A+K L + + + + +F E ++ + H N+++ G + +
Sbjct: 63 GMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122
Query: 659 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKS 717
++ E+M NG L + L + + ++ + + A G++YL +HRDL +
Sbjct: 123 IITEYMENGALDKFL---REKDGEFSVLQLVGMLRGIAAGMKYLANMNY----VHRDLAA 175
Query: 718 SNILLDKHMRAKVSDFGLSKFAVDG-----ASHVSSI-VRGTVGYLDPEYYISQQLTDKS 771
NIL++ ++ KVSDFGLS+ D + I +R T PE ++ T S
Sbjct: 176 RNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA----PEAISYRKFTSAS 231
Query: 772 DVYSFGVILLELIS 785
DV+SFG+++ E+++
Sbjct: 232 DVWSFGIVMWEVMT 245
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 15/205 (7%)
Query: 588 KMLEKKIGSGGFGVVYYGKLKDGK---EIAVKVL--TSNSYQGKREFTNEVTLLSRIHHR 642
+ +K++GSG FG V G + K +AVK+L +N K E E ++ ++ +
Sbjct: 19 TLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 78
Query: 643 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 702
+V+ +G C+ E +LV E G L ++L + + +E+ + G++YL
Sbjct: 79 YIVRMIGICEAESW-MLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYL 133
Query: 703 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPE 760
+HRDL + N+LL AK+SDFGLSK ++ + G V + PE
Sbjct: 134 EESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 190
Query: 761 YYISQQLTDKSDVYSFGVILLELIS 785
+ + KSDV+SFGV++ E S
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 74/289 (25%), Positives = 119/289 (41%), Gaps = 58/289 (20%)
Query: 592 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 650
+ IGSGGFG V+ K DGK +K + N + EV L+++ H N+V + G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVHYNGC 72
Query: 651 CQEEGRSVLVYEFMHNGTLKEHLY--------GTLTHEQRINWIKR-----------LEI 691
+ + + L+ GTL WI++ LE+
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQ-----WIEKRRGEKLDKVLALEL 127
Query: 692 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 751
E KG++Y+H+ +I+RDLK SNI L + K+ DFGL + S
Sbjct: 128 FEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK-- 182
Query: 752 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE-AISNEKFGANCRNIVQWAKLHI 810
GT+ Y+ PE SQ + D+Y+ G+IL EL+ + A KF + R+ +
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIF-- 240
Query: 811 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859
+ ++ + L+ P RP+ SE+L+
Sbjct: 241 -DKKEKTLL------------------QKLLSKKP--EDRPNTSEILRT 268
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 67/269 (24%), Positives = 122/269 (45%), Gaps = 48/269 (17%)
Query: 542 HKGKKNNYDKEQHRHSLPVQRPV--SSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGF 599
H + + + LP + + P A FT +IE + +EK IGSG
Sbjct: 4 HHHHSSGRENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFT-REIEASRIHIEKIIGSGDS 62
Query: 600 GVVYYGKLK--DGKEI--AVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE 654
G V YG+L+ +++ A+K L + + + +R+F +E +++ + H N+++ G
Sbjct: 63 GEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122
Query: 655 GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRD 714
+++V E+M NG+L L TH+ + ++ + + G+ YL +HRD
Sbjct: 123 RLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY---VHRD 176
Query: 715 LKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ-------- 766
L + N+L+D ++ KVSDFGLS+ D DP+ +
Sbjct: 177 LAARNVLVDSNLVCKVSDFGLSRVLED----------------DPDAAYTTTGGKIPIRW 220
Query: 767 ----------LTDKSDVYSFGVILLELIS 785
+ SDV+SFGV++ E+++
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-35
Identities = 53/196 (27%), Positives = 95/196 (48%), Gaps = 7/196 (3%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 649
LEKK+G+G FG V+ ++AVK + F E ++ + H LV+
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHA 250
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 709
+E + + EFM G+L + L + K ++ + A+G+ ++
Sbjct: 251 VVTKEPIYI-ITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN--- 304
Query: 710 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 769
IHRDL+++NIL+ + K++DFGL++ D + + + PE T
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 364
Query: 770 KSDVYSFGVILLELIS 785
KSDV+SFG++L+E+++
Sbjct: 365 KSDVWSFGILLMEIVT 380
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-35
Identities = 70/250 (28%), Positives = 126/250 (50%), Gaps = 22/250 (8%)
Query: 550 DKEQHRHSLPVQRP-VSSLND-----APAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVY 603
+K H + ++ P + + D P + H F +++ ++K +G+G FG V
Sbjct: 4 EKRLHFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFA-KELDATNISIDKVVGAGEFGEVC 62
Query: 604 YGKLK--DGKEI--AVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 658
G+LK KEI A+K L + + +R+F E +++ + H N+++ G + +
Sbjct: 63 SGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122
Query: 659 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKS 717
+V E+M NG+L L H+ + I+ + + A G++YL G V HRDL +
Sbjct: 123 IVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV----HRDLAA 175
Query: 718 SNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPEYYISQQLTDKSDVYS 775
NIL++ ++ KVSDFGL + D + G + + PE ++ T SDV+S
Sbjct: 176 RNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWS 235
Query: 776 FGVILLELIS 785
+G++L E++S
Sbjct: 236 YGIVLWEVMS 245
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-35
Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 24/207 (11%)
Query: 590 LEKKIGSGGFGVVYYGKLK--DGKEI--AVKVLTSN-SYQGKREFTNEVTLLSRIHHRNL 644
L + +G G FG VY G G++I AVK + + K +F +E ++ + H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 645 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 704
V+ +G +EE + ++ E G L +L ++ + + + + K + YL +
Sbjct: 76 VKLIGIIEEE-PTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYLES 131
Query: 705 -GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL-----D 758
C +HRD+ NIL+ K+ DFGLS++ D + +V L
Sbjct: 132 INC----VHRDIAVRNILVASPECVKLGDFGLSRYIED-----EDYYKASVTRLPIKWMS 182
Query: 759 PEYYISQQLTDKSDVYSFGVILLELIS 785
PE ++ T SDV+ F V + E++S
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILS 209
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-35
Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 649
L +++G+G FG V+ G ++AVK L S F E L+ ++ H+ LV+
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 709
+E + + E+M NG+L + L ++ K L++A A+G+ ++
Sbjct: 76 VVTQEPIYI-ITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERNY-- 130
Query: 710 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSI-VRGTVGYLDPEYYISQ 765
IHRDL+++NIL+ + K++DFGL++ D A + ++ T PE
Sbjct: 131 -IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEAINYG 185
Query: 766 QLTDKSDVYSFGVILLELIS 785
T KSDV+SFG++L E+++
Sbjct: 186 TFTIKSDVWSFGILLTEIVT 205
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 62/197 (31%), Positives = 100/197 (50%), Gaps = 7/197 (3%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGK-EIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
++ K+G G +G VY G K +AVK L ++ + EF E ++ I H NLVQ L
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 75
Query: 649 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 708
G C E ++ EFM G L ++L + Q ++ + L +A + +EYL
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKNF- 132
Query: 709 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 768
IHRDL + N L+ ++ KV+DFGLS+ + + + + PE + +
Sbjct: 133 --IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 769 DKSDVYSFGVILLELIS 785
KSDV++FGV+L E+ +
Sbjct: 191 IKSDVWAFGVLLWEIAT 207
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 47/202 (23%), Positives = 92/202 (45%), Gaps = 14/202 (6%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNL 644
L + IG G FG V+ G + +A+K + S + +F E + + H ++
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 645 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 704
V+ +G E ++ E G L+ L + ++ + A + + YL +
Sbjct: 79 VKLIGVITEN-PVWIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYLES 134
Query: 705 -GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 763
+HRD+ + N+L+ + K+ DFGLS++ D + +S + + ++ PE
Sbjct: 135 KRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 190
Query: 764 SQQLTDKSDVYSFGVILLELIS 785
++ T SDV+ FGV + E++
Sbjct: 191 FRRFTSASDVWMFGVCMWEILM 212
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 60/275 (21%), Positives = 105/275 (38%), Gaps = 41/275 (14%)
Query: 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRI-HHRNLVQF 647
++G G +G V+ + K DG+ AVK S + + EV ++ H V+
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 705
+E G L E +L++H +G E ++ D + +LH+
Sbjct: 123 EQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQV-----WGYLRDTLLALAHLHS- 175
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 765
++H D+K +NI L R K+ DFGL + A G Y+ PE +
Sbjct: 176 --QGLVHLDVKPANIFLGPRGRCKLGDFGLLV-ELGTAGAGEVQE-GDPRYMAPE-LLQG 230
Query: 766 QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 825
+DV+S G+ +LE+ E + W +L QG + P
Sbjct: 231 SYGTAADVFSLGLTILEVACNMELPHGGE---------GWQQL------RQGYLPPEFTA 275
Query: 826 EY--DIQSMWKIEEKALMCVLPHGHMRPSISEVLK 858
+++S+ M + P +R + +L
Sbjct: 276 GLSSELRSVLV------MMLEPDPKLRATAEALLA 304
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 64/199 (32%), Positives = 106/199 (53%), Gaps = 17/199 (8%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 649
L + IG G FG V G + G ++AVK + +++ + F E ++++++ H NLVQ LG
Sbjct: 25 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLG 81
Query: 650 YC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL-HTGCV 707
+E+G +V E+M G+L ++L + L+ + D + +EYL
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNNF- 138
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-VRGTVGYLDPEYYISQQ 766
+HRDL + N+L+ + AKVSDFGL+K A + V+ T PE ++
Sbjct: 139 ---VHRDLAARNVLVSEDNVAKVSDFGLTKEASS-TQDTGKLPVKWTA----PEALREKK 190
Query: 767 LTDKSDVYSFGVILLELIS 785
+ KSDV+SFG++L E+ S
Sbjct: 191 FSTKSDVWSFGILLWEIYS 209
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-34
Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 22/226 (9%)
Query: 569 DAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE-----IAVKVL-TSNS 622
+AP +A +++ K +GSG FG VY G E +A+K L + S
Sbjct: 2 EAPNQALLRI----LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 57
Query: 623 YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR 682
+ +E +E +++ + + ++ + LG C L+ + M G L +++ H+
Sbjct: 58 PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYV---REHKDN 113
Query: 683 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 742
I L AKG+ YL ++HRDL + N+L+ K++DFGL+K
Sbjct: 114 IGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 743 ASHVSSIVRGT---VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
+ G + ++ E + + T +SDV+S+GV + EL++
Sbjct: 171 EKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-34
Identities = 74/284 (26%), Positives = 121/284 (42%), Gaps = 26/284 (9%)
Query: 514 AKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAE 573
A + + GS + + + + L+ G +N Y + + + + S+LN +
Sbjct: 22 AAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDL----SALNPELVQ 77
Query: 574 AAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSN-SYQGKRE 628
A + + IG G FG VY+G L D AVK L +
Sbjct: 78 AVQHVVI-GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ 136
Query: 629 FTNEVTLLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK 687
F E ++ H N++ LG C + EG ++V +M +G L+ +
Sbjct: 137 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKD 193
Query: 688 RLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746
+ AKG+++L + V HRDL + N +LD+ KV+DFGL++ D
Sbjct: 194 LIGFGLQVAKGMKFLASKKFV----HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD- 248
Query: 747 SSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 785
S+ T L E +Q+ T KSDV+SFGV+L EL++
Sbjct: 249 -SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-34
Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 18/231 (7%)
Query: 565 SSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTS 620
S+LN +A + + IG G FG VY+G L D AVK L
Sbjct: 5 SALNPELVQAVQHVVI-GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 63
Query: 621 N-SYQGKREFTNEVTLLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLT 678
+F E ++ H N++ LG C + EG ++V +M +G L+ +
Sbjct: 64 ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RN 120
Query: 679 HEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 737
+ AKG++YL + V HRDL + N +LD+ KV+DFGL++
Sbjct: 121 ETHNPTVKDLIGFGLQVAKGMKYLASKKFV----HRDLAARNCMLDEKFTVKVADFGLAR 176
Query: 738 FAVDG---ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
D + H + + V ++ E +Q+ T KSDV+SFGV+L EL++
Sbjct: 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 13/203 (6%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNL 644
+ K+G GG VY + ++A+K + + K E F EV S++ H+N+
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIP-PREKEETLKRFEREVHNSSQLSHQNI 73
Query: 645 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 704
V + +E+ LV E++ TL E++ ++ + GI++ H
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYI----ESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 705 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 764
I+HRD+K NIL+D + K+ DFG++K + + ++ V GTV Y PE
Sbjct: 130 M---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 765 QQLTDKSDVYSFGVILLELISGQ 787
+ + +D+YS G++L E++ G+
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGE 209
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 8e-34
Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 18/206 (8%)
Query: 589 MLEKKIGSGGFGVVYYGKLKDGKE-----IAVKVL-TSNSYQGKREFTNEVTLLSRIHHR 642
K +GSG FG V+ G E + +KV+ + Q + T+ + + + H
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 75
Query: 643 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 702
++V+ LG C LV +++ G+L +H+ H + L AKG+ YL
Sbjct: 76 HIVRLLGLCPGS-SLQLVTQYLPLGSLLDHV---RQHRGALGPQLLLNWGVQIAKGMYYL 131
Query: 703 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT---VGYLDP 759
++HR+L + N+LL + +V+DFG++ + + ++
Sbjct: 132 EEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SEAKTPIKWMAL 186
Query: 760 EYYISQQLTDKSDVYSFGVILLELIS 785
E + T +SDV+S+GV + EL++
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 51/216 (23%), Positives = 97/216 (44%), Gaps = 32/216 (14%)
Query: 589 MLEKKIGSGGFGVVYYGKLKDGK--------EIAVKVLTSNSYQGKREFTNEVTLLSRIH 640
+ + +G G F ++ G ++ E+ +KVL F +++S++
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70
Query: 641 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 700
H++LV G C ++LV EF+ G+L +L ++ IN + +LE+A+ A +
Sbjct: 71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL---KKNKNCINILWKLEVAKQLAAAMH 127
Query: 701 YLHTGCVPAIIHRDLKSSNILLDKHMR--------AKVSDFGLSKFAVDGASHVSSIVRG 752
+L + IH ++ + NILL + K+SD G+S + I++
Sbjct: 128 FLEENTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP-----KDILQE 179
Query: 753 TVGYLDPE---YYISQQLTDKSDVYSFGVILLELIS 785
+ ++ PE + L +D +SFG L E+ S
Sbjct: 180 RIPWVPPECIENP--KNLNLATDKWSFGTTLWEICS 213
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNL 644
++ IG G FGVVY+G+ D + A+K L+ Q F E L+ ++H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 645 VQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 703
+ +G EG ++ +M +G L + + + ++ + A+G+EYL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFI---RSPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 704 T-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT---VGYLDP 759
+HRDL + N +LD+ KV+DFGL++ +D + R V +
Sbjct: 142 EQKF----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197
Query: 760 EYYISQQLTDKSDVYSFGVILLELIS 785
E + + T KSDV+SFGV+L EL++
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-33
Identities = 59/257 (22%), Positives = 110/257 (42%), Gaps = 43/257 (16%)
Query: 563 PVSSLNDAPAEAAHCFTLS-DIEDATKMLE-----KKIGSGGFGVVYYGKLKDGKEIAVK 616
P+ S+ D + ++ L+ +++ K + + + G F + + KD K A+K
Sbjct: 2 PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALK 60
Query: 617 VLTSNSYQGKREFT-----------------NEVTLLSRIHHRNLVQFLGYCQEEGRSVL 659
+ + KR+FT NE+ +++ I + + G +
Sbjct: 61 KYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYI 120
Query: 660 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIEYLHTGCVPAII 711
+YE+M N ++ + + ++ I K Y+H I
Sbjct: 121 IYEYMENDSILKFD----EYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK--NIC 174
Query: 712 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-- 769
HRD+K SNIL+DK+ R K+SDFG S++ VD S RGT ++ PE++ ++ +
Sbjct: 175 HRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS---RGTYEFMPPEFFSNESSYNGA 231
Query: 770 KSDVYSFGVILLELISG 786
K D++S G+ L +
Sbjct: 232 KVDIWSLGICLYVMFYN 248
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 8e-33
Identities = 63/299 (21%), Positives = 103/299 (34%), Gaps = 53/299 (17%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQF 647
+ + + GGF VY + + G+E A+K L SN + R EV + ++ H N+VQF
Sbjct: 32 VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91
Query: 648 LGYC-------QEEGRSVLVYEFMHNGTLKEHLYGTLTH----EQRINWIKRLEIAEDAA 696
L+ + G L E L + + L+I
Sbjct: 92 CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV-----LKIFYQTC 146
Query: 697 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI------- 749
+ ++++H P IIHRDLK N+LL K+ DFG + + S
Sbjct: 147 RAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 750 ----VRGTVGYLDPE---YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 802
T Y PE Y + + +K D+++ G IL L Q +
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK 265
Query: 803 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861
+ +I + + R SI+EV+ +Q
Sbjct: 266 YSIPPHDTQYTVFHSLIR--------------------AMLQVNPEERLSIAEVVHQLQ 304
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNL 644
L + +G GG V+ + L+D +++AVKVL ++ F E + ++H +
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRAD-LARDPSFYLRFRREAQNAAALNHPAI 74
Query: 645 VQFLGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 700
V + E + +V E++ TL++ + E + + +E+ DA + +
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALN 130
Query: 701 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV--SSIVRGTVGYLD 758
+ H IIHRD+K +NI++ KV DFG+++ D + V ++ V GT YL
Sbjct: 131 FSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 759 PEYYISQQLTDKSDVYSFGVILLELISGQ 787
PE + +SDVYS G +L E+++G+
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 67/306 (21%), Positives = 113/306 (36%), Gaps = 67/306 (21%)
Query: 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
+G G FG V + D + A+K + ++ + +EV LL+ ++H+ +V++
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 649 GYCQEEGRSV-------------LVYEFMHNGTLKEHL--YGTLTHEQRI-NWIKRLEIA 692
E V + E+ NGTL + + + +I
Sbjct: 69 AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR--QIL 126
Query: 693 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR- 751
E + Y+H+ IIHRDLK NI +D+ K+ DFGL+K + +
Sbjct: 127 E----ALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 752 ------------GTVGYLDPE------YYISQQLTDKSDVYSFGVILLELISGQEAISNE 793
GT Y+ E +Y +K D+YS G+I E+I
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHY-----NEKIDMYSLGIIFFEMIYP------- 227
Query: 794 KFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSI 853
R + K + S I+ P D+ ++ KI L+ P + RP
Sbjct: 228 FSTGMERVNI-LKK--LRSVSIE---FPPDFDDNKMKVEKKIIRL-LIDHDP--NKRPGA 278
Query: 854 SEVLKD 859
+L
Sbjct: 279 RTLLNS 284
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 60/232 (25%), Positives = 98/232 (42%), Gaps = 60/232 (25%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKE---IAVKVLTSN-SYQGKREFTNEVTLLSRI-HHRNL 644
+ IG G FG V ++K A+K + S R+F E+ +L ++ HH N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 645 VQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIKRLEIA 692
+ LG C+ G L E+ +G L + L + ++ + L A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 693 EDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 751
D A+G++YL IHRDL + NIL+ ++ AK++DFGLS+
Sbjct: 149 ADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR-------------- 190
Query: 752 GTVGYLDPEYYISQQL------------------TDKSDVYSFGVILLELIS 785
E Y+ + + T SDV+S+GV+L E++S
Sbjct: 191 ------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 3e-32
Identities = 51/229 (22%), Positives = 97/229 (42%), Gaps = 19/229 (8%)
Query: 563 PVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE----IAVKVL 618
P+ + IE L + IG G FG V+ G + +A+K
Sbjct: 372 DEEDTYTMPSTRDYEIQRERIE-----LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC 426
Query: 619 TSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTL 677
+ S + +F E + + H ++V+ +G E ++ E G L+ L
Sbjct: 427 KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFL---Q 482
Query: 678 THEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 736
+ ++ + A + + YL + V HRD+ + N+L+ + K+ DFGLS
Sbjct: 483 VRKFSLDLASLILYAYQLSTALAYLESKRFV----HRDIAARNVLVSSNDCVKLGDFGLS 538
Query: 737 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 785
++ D + +S + + ++ PE ++ T SDV+ FGV + E++
Sbjct: 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-32
Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 29/218 (13%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSNSYQGKREFTNEVTLLSRIHHRN 643
L+ ++G G FG V+ + + +AVK L S +++F E LL+ + H++
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 644 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL-----------YGTLTHEQRINWIKRLEIA 692
+V+F G C E ++V+E+M +G L L G + + L +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 693 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG 752
A G+ YL +HRDL + N L+ + + K+ DFG+S+ + G
Sbjct: 165 SQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY----RVG 217
Query: 753 TVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 785
L PE + ++ T +SDV+SFGV+L E+ +
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 27/217 (12%)
Query: 578 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVL---TSNSYQGKREFTNEV 633
+ L D E + + +G G FG VY + K +A+KVL + + EV
Sbjct: 6 WALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 634 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 693
+ S + H N+++ GY + R L+ E+ GT+ Y L + + +
Sbjct: 61 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYIT 116
Query: 694 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR-- 751
+ A + Y H+ +IHRD+K N+LL K++DFG S H S R
Sbjct: 117 ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV-------HAPSSRRTD 166
Query: 752 --GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 786
GT+ YL PE + +K D++S GV+ E + G
Sbjct: 167 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 25/214 (11%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRIHHR 642
+ +++G G FG+VY G K + +A+K + S + + EF NE +++ +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 643 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------YGTLTHEQRINWIKRLEIAEDAA 696
++V+ LG + ++++ E M G LK +L + K +++A + A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 697 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 756
G+ YL+ +HRDL + N ++ + K+ DFG+++ + +G G
Sbjct: 149 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET----DYYRKGGKGL 201
Query: 757 L-----DPEYYISQQLTDKSDVYSFGVILLELIS 785
L PE T SDV+SFGV+L E+ +
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 30/219 (13%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSNSYQGKREFTNEVTLLSRIHHRN 643
L++++G G FG V+ + + +AVK L + +++F E LL+ + H +
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 644 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIKRLEI 691
+V+F G C + ++V+E+M +G L + L + + + L I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 692 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 751
A A G+ YL + +HRDL + N L+ ++ K+ DFG+S+ +
Sbjct: 139 ASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY----RV 191
Query: 752 GTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 785
G L PE + ++ T +SDV+SFGVIL E+ +
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 62/232 (26%), Positives = 107/232 (46%), Gaps = 19/232 (8%)
Query: 565 SSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY 623
S + + D E +G G +G+VY G+ L + IA+K +
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60
Query: 624 QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK---EHLYGTL-TH 679
+ + E+ L + H+N+VQ+LG E G + E + G+L +G L +
Sbjct: 61 RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN 120
Query: 680 EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKF 738
EQ I + + +I E G++YLH I+HRD+K N+L++ + K+SDFG SK
Sbjct: 121 EQTIGFYTK-QILE----GLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKR 172
Query: 739 AVDGASHVSSIVRGTVGYLDPEYYISQQLTD---KSDVYSFGVILLELISGQ 787
+ GT+ Y+ PE I + +D++S G ++E+ +G+
Sbjct: 173 LAGINPCTET-FTGTLQYMAPE-IIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 25/214 (11%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVL--TSNSYQGKREFTNEVTLLSRIHHRN 643
L K +G G FG V G LK +AVK + ++S + EF +E + H N
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 644 LVQFLGYCQEEG-----RSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAA 696
+++ LG C E + +++ FM G L +L T + I L+ D A
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 697 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 756
G+EYL +HRDL + N +L M V+DFGLSK G + +G +
Sbjct: 158 LGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAK 210
Query: 757 L-----DPEYYISQQLTDKSDVYSFGVILLELIS 785
+ E + T KSDV++FGV + E+ +
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 29/216 (13%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNL--V 645
+ K+IGSGG V+ + + A+K L Q + NE+ L+++ + +
Sbjct: 32 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 91
Query: 646 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 703
+ Y + +V E N L L ++ +R ++ K + E + +H
Sbjct: 92 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK--NMLE----AVHTIH 144
Query: 704 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPE-- 760
I+H DLK +N L+ M K+ DFG++ D S V GTV Y+ PE
Sbjct: 145 QH---GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 761 ---------YYISQQLTDKSDVYSFGVILLELISGQ 787
+++ KSDV+S G IL + G+
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 54/215 (25%), Positives = 88/215 (40%), Gaps = 26/215 (12%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSN--SYQGKREFTNEVTLLSRIHHRN 643
L + +G G FG V +LK +AVK+L ++ + EF E + H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 644 LVQFLGYCQEEGRSV------LVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDA 695
+ + +G ++ FM +G L L + + + D
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 696 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 755
A G+EYL + IHRDL + N +L + M V+DFGLS+ G + +G
Sbjct: 147 ACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQGCAS 199
Query: 756 YL-----DPEYYISQQLTDKSDVYSFGVILLELIS 785
L E T SDV++FGV + E+++
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGK------EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHR 642
L + +G G FG VY G++ ++AVK L S Q + +F E ++S+ +H+
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 643 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIAEDAAKGI 699
N+V+ +G + ++ E M G LK L + + + L +A D A G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 700 EYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 756
+YL IHRD+ + N LL AK+ DFG+++ S +G
Sbjct: 154 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----SYYRKGGCAM 206
Query: 757 L-----DPEYYISQQLTDKSDVYSFGVILLELIS 785
L PE ++ T K+D +SFGV+L E+ S
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 35/221 (15%)
Query: 578 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVL---TSNSYQGKREFTNEV 633
FT+ D + + + +G G FG VY + K +A+KVL + + E+
Sbjct: 11 FTIDDFD-----IGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREI 65
Query: 634 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 693
+ S + H N+++ Y + R L+ EF G L Y L R + E
Sbjct: 66 EIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFD--------E 113
Query: 694 DAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745
+ + Y H V IHRD+K N+L+ K++DFG S A
Sbjct: 114 QRSATFMEELADALHYCHERKV---IHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR 170
Query: 746 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 786
GT+ YL PE + +K D++ GV+ E + G
Sbjct: 171 TMC---GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 5e-31
Identities = 70/292 (23%), Positives = 117/292 (40%), Gaps = 52/292 (17%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRI--HHRNLV 645
+ K+IGSGG V+ + + A+K L Q + NE+ L+++ H ++
Sbjct: 13 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 72
Query: 646 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 703
+ Y + +V E N L L ++ +R ++ K + + + +H
Sbjct: 73 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNM------LEAVHTIH 125
Query: 704 T-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPE- 760
G I+H DLK +N L+ M K+ DFG++ D S V GTV Y+ PE
Sbjct: 126 QHG----IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 761 ----------YYISQQLTDKSDVYSFGVILLELISGQ---EAISNEKFGANCRNIVQWAK 807
+++ KSDV+S G IL + G+ + I N+ + I+
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--SKLHAIID-PN 237
Query: 808 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859
IE I + L D ++ K + K R SI E+L
Sbjct: 238 HEIE---FPDIPEKDLQDV--LKCCLKRDPK----------QRISIPELLAH 274
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-31
Identities = 67/267 (25%), Positives = 109/267 (40%), Gaps = 28/267 (10%)
Query: 540 FMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSD---IEDATKMLEKKIGS 596
F E L ++ N A ++SD + L + +G
Sbjct: 22 FQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGH 81
Query: 597 GGFGVVYYGKLKDGK------EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLG 649
G FG VY G++ ++AVK L S Q + +F E ++S+ +H+N+V+ +G
Sbjct: 82 GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG 141
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 706
+ ++ E M G LK L + + + L +A D A G +YL
Sbjct: 142 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 201
Query: 707 VPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL-----D 758
IHRD+ + N LL AK+ DFG+++ +G L
Sbjct: 202 ---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----GYYRKGGCAMLPVKWMP 254
Query: 759 PEYYISQQLTDKSDVYSFGVILLELIS 785
PE ++ T K+D +SFGV+L E+ S
Sbjct: 255 PEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 51/234 (21%), Positives = 88/234 (37%), Gaps = 59/234 (25%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRIHHR 642
+++G FG VY G L +A+K L + EF +E L +R+ H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 643 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIKRLE 690
N+V LG ++ +++ + +G L E L T + + +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 691 IAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 749
+ A G+EYL + V H+DL + N+L+ + K+SD GL +
Sbjct: 133 LVAQIAAGMEYLSSHHVV----HKDLATRNVLVYDKLNVKISDLGLFREVYAA------- 181
Query: 750 VRGTVGYLDPEYYISQQL------------------TDKSDVYSFGVILLELIS 785
+YY + SD++S+GV+L E+ S
Sbjct: 182 ----------DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 60/262 (22%), Positives = 105/262 (40%), Gaps = 34/262 (12%)
Query: 545 KKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYY 604
K+ K + +H + A + A C + ++ + K+IGSGG V+
Sbjct: 18 KETAAAKFERQHMDSPDLGTDDDDKASSSANECIS---VKGRIYSILKQIGSGGSSKVFQ 74
Query: 605 GKLKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNL--VQFLGYCQEEGRSVLV 660
+ + A+K L Q + NE+ L+++ + ++ Y + +V
Sbjct: 75 VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134
Query: 661 YEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKS 717
E N L L ++ +R ++ K + E + +H G I+H DLK
Sbjct: 135 MEC-GNIDLNSWLKKKKSIDPWERKSYWK--NMLE----AVHTIHQHG----IVHSDLKP 183
Query: 718 SNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPE-----------YYISQ 765
+N L+ M K+ DFG++ D S V G V Y+ PE
Sbjct: 184 ANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKS 242
Query: 766 QLTDKSDVYSFGVILLELISGQ 787
+++ KSDV+S G IL + G+
Sbjct: 243 KISPKSDVWSLGCILYYMTYGK 264
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-30
Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 27/211 (12%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFL 648
+ +G G G + Y + D +++AVK + + EV LL H N++++
Sbjct: 28 PKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD---REVQLLRESDEHPNVIRY- 83
Query: 649 GYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-G 705
+C E+ R + E TL+E++ + ++ + + + G+ +LH+
Sbjct: 84 -FCTEKDRQFQYIAIELC-AATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLHSLN 138
Query: 706 CVPAIIHRDLKSSNILL-----DKHMRAKVSDFGLSKFAVDGAS--HVSSIVRGTVGYLD 758
I+HRDLK NIL+ ++A +SDFGL K G S V GT G++
Sbjct: 139 ----IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 759 PEYY---ISQQLTDKSDVYSFGVILLELISG 786
PE + T D++S G + +IS
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 56/223 (25%), Positives = 105/223 (47%), Gaps = 34/223 (15%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKE--------IAVKVLTSN-SYQGKREFTNEVTLLSRI- 639
L K +G G FG V + + +AVK+L + + + + +E+ ++ I
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 640 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIK 687
H+N++ LG C ++G ++ E+ G L+E+L E+++ +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 688 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 747
+ A+G+EYL + IHRDL + N+L+ ++ K++DFGL++ +
Sbjct: 159 LVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNI----D 211
Query: 748 SIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 785
+ T G L PE + T +SDV+SFGV++ E+ +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 43/208 (20%), Positives = 86/208 (41%), Gaps = 23/208 (11%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSN-----SYQGKREFTNEVTLLSRIHHRN 643
L + +G GG G VY + + +A+K+++ ++ + E R+ +
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTR--MQREARTAGRLQEPH 95
Query: 644 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEY 701
+V + + +G+ + ++ L L G L + + I ++
Sbjct: 96 VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRA------VAIVRQIGSALDA 149
Query: 702 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS--HVSSIVRGTVGYLDP 759
H HRD+K NIL+ A + DFG++ A + + V GT+ Y+ P
Sbjct: 150 AHAA---GATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLTQLGNTV-GTLYYMAP 204
Query: 760 EYYISQQLTDKSDVYSFGVILLELISGQ 787
E + T ++D+Y+ +L E ++G
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGS 232
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-30
Identities = 64/222 (28%), Positives = 96/222 (43%), Gaps = 33/222 (14%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRI-HH 641
L K +G G FG V + +AVK+L ++ R +E+ +L I HH
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 642 RNLVQFLGYCQEEGRSVLV-YEFMHNGTLKEHL------------YGTLTHEQRINWIKR 688
N+V LG C + G ++V EF G L +L ++ +
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 689 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 748
+ + AKG+E+L + IHRDL + NILL + K+ DFGL++
Sbjct: 151 ICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD----PD 203
Query: 749 IVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 785
VR L PE + T +SDV+SFGV+L E+ S
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-30
Identities = 70/300 (23%), Positives = 117/300 (39%), Gaps = 54/300 (18%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFL 648
EK +G G G V + G+ +AVK + + E+ LL+ H N++++
Sbjct: 19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIAL---MEIKLLTESDDHPNVIRY- 74
Query: 649 GYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE---DAAKGIEYLH 703
YC E + E N L++ + ++ + K A G+ +LH
Sbjct: 75 -YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 704 TGCVPAIIHRDLKSSNILLD-------------KHMRAKVSDFGLSKFAVDGASHVSSIV 750
+ IIHRDLK NIL+ +++R +SDFGL K G S + +
Sbjct: 133 SLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 751 R---GTVGYLDPE-------YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR 800
GT G+ PE ++LT D++S G + ++S FG
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK----GKHPFGDKYS 245
Query: 801 NIVQWAKLHIESGDIQGIIDPSLLDE-YD-IQSMWKIEEKALMCVLPHGHMRPSISEVLK 858
+ +++ + D SL+ E D I M + P RP+ +VL+
Sbjct: 246 RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQM--------IDHDP--LKRPTAMKVLR 295
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-30
Identities = 60/224 (26%), Positives = 94/224 (41%), Gaps = 36/224 (16%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRI-HH 641
K +G+G FG V + +AVK+L + + +E+ +LS + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 642 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--------------YGTLTHEQRINWIK 687
N+V LG C G ++++ E+ G L L E ++
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 688 RLEIAEDAAKGIEYLH-TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746
L + AKG+ +L C IHRDL + NILL K+ DFGL++ +
Sbjct: 147 LLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKND---- 198
Query: 747 SSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 785
S+ V L PE + T +SDV+S+G+ L EL S
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-30
Identities = 62/249 (24%), Positives = 108/249 (43%), Gaps = 13/249 (5%)
Query: 541 MHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFG 600
MH ++ + +L Q V + A D K IG G G
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVK-IGEGSTG 59
Query: 601 VVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 659
+V + G+++AVK++ Q + NEV ++ H N+V+ +
Sbjct: 60 IVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWV 119
Query: 660 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN 719
+ EF+ G L + + +E++I + + + YLH +IHRD+KS +
Sbjct: 120 LMEFLQGGALTDIVSQVRLNEEQIATVCE-----AVLQALAYLHA---QGVIHRDIKSDS 171
Query: 720 ILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-KSDVYSFGV 778
ILL R K+SDFG S+V GT ++ PE IS+ L + D++S G+
Sbjct: 172 ILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPE-VISRSLYATEVDIWSLGI 229
Query: 779 ILLELISGQ 787
+++E++ G+
Sbjct: 230 MVIEMVDGE 238
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-30
Identities = 59/231 (25%), Positives = 104/231 (45%), Gaps = 45/231 (19%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRIHHR 642
L K +G G FG V K +AVK+L N S R+ +E +L +++H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 643 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--------------------YGTLTHEQR 682
++++ G C ++G +L+ E+ G+L+ L E+
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 683 INWIKRLEIAEDAAKGIEYL---HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 739
+ + A ++G++YL ++HRDL + NIL+ + + K+SDFGLS+
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMK------LVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 740 VDGASHVSSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 785
+ S V+ + G + E T +SDV+SFGV+L E+++
Sbjct: 201 YEE----DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 28/217 (12%)
Query: 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 647
L +G G V+ G+ K G A+KV + S+ + E +L +++H+N+V+
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 648 LGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE---DAAKGIEYL 702
+E VL+ EF G+L L + E D G+ +L
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVL----EEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 703 HTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 758
I+HR++K NI+ D K++DFG ++ D VS GT YL
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLH 183
Query: 759 PEYY--------ISQQLTDKSDVYSFGVILLELISGQ 787
P+ Y ++ D++S GV +G
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKR---EFTNEVTLLSRIHHRNLV 645
+ +G GGF + + A K++ + + + E+++ + H+++V
Sbjct: 19 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 78
Query: 646 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 703
F G+ ++ +V E +L E LT + +++++ G +YLH
Sbjct: 79 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI------VLGCQYLH 132
Query: 704 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLDPEYY 762
V IHRDLK N+ L++ + K+ DFGL+ K DG GT Y+ PE
Sbjct: 133 RNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPE-V 186
Query: 763 ISQQLTD-KSDVYSFGVILLELISG 786
+S++ + DV+S G I+ L+ G
Sbjct: 187 LSKKGHSFEVDVWSIGCIMYTLLVG 211
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-29
Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 34/223 (15%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGK--------EIAVKVLTSN-SYQGKREFTNEVTLLSRI- 639
L K +G G FG V + ++AVK+L S+ + + + +E+ ++ I
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 640 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIK 687
H+N++ LG C ++G ++ E+ G L+E+L + E++++
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 688 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 747
+ A A+G+EYL + IHRDL + N+L+ + K++DFGL++
Sbjct: 193 LVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI----D 245
Query: 748 SIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 785
+ T G L PE + T +SDV+SFGV+L E+ +
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-29
Identities = 45/207 (21%), Positives = 84/207 (40%), Gaps = 26/207 (12%)
Query: 590 LEKKIGSGGFGVVYYGK--LKDGKEIAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQ 646
++ I GG G +Y +G+ + +K L S + + E L+ + H ++VQ
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 647 FLGYCQEEGRSV-----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 701
+ + R +V E++ +LK L + I + + Y
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAI------AYLLEILPALSY 197
Query: 702 LHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 760
LH+ G +++ DLK NI+L + + K+ D G ++ ++ GT G+ PE
Sbjct: 198 LHSIG----LVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGYLY----GTPGFQAPE 247
Query: 761 YYISQQLTDKSDVYSFGVILLELISGQ 787
+ T +D+Y+ G L L
Sbjct: 248 I-VRTGPTVATDIYTVGRTLAALTLDL 273
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKR---EFTNEVTLLSRIHHRNLV 645
+ +G GGF + + A K++ + + + E+++ + H+++V
Sbjct: 45 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 104
Query: 646 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 703
F G+ ++ +V E +L E LT + +++++ G +YLH
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI------VLGCQYLH 158
Query: 704 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLDPEYY 762
V IHRDLK N+ L++ + K+ DFGL+ K DG GT Y+ PE
Sbjct: 159 RNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPE-V 212
Query: 763 ISQQLTD-KSDVYSFGVILLELISG 786
+S++ + DV+S G I+ L+ G
Sbjct: 213 LSKKGHSFEVDVWSIGCIMYTLLVG 237
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 32/220 (14%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRI-HH 641
K +G+G FG V + +AVK+L S K +E+ ++S + H
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 642 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL----------YGTLTHEQRINWIKRLEI 691
N+V LG C G +++ E+ G L L + L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 692 AEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 750
+ A+G+ +L + C IHRD+ + N+LL AK+ DFGL++ ++ S+ +
Sbjct: 170 SSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMND----SNYI 221
Query: 751 RGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 785
L PE T +SDV+S+G++L E+ S
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 19/205 (9%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLV 645
+ +G G F VY + + G E+A+K++ + + NEV + ++ H +++
Sbjct: 15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSIL 74
Query: 646 QFLGYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIAEDAAKGIEYL 702
+ Y ++ LV E HNG + +L + + +++ ++ G+ YL
Sbjct: 75 ELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI------ITGMLYL 128
Query: 703 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLDPEY 761
H+ + +HRDL SN+LL ++M K++DFGL+ + + H + GT Y+ PE
Sbjct: 129 HSHGI---LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--GTPNYISPEI 183
Query: 762 YISQQLTDKSDVYSFGVILLELISG 786
+SDV+S G + L+ G
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIG 208
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-29
Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 28/217 (12%)
Query: 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 647
L +G G V+ G+ K G A+KV + S+ + E +L +++H+N+V+
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 648 LGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE---DAAKGIEYL 702
+E VL+ EF G+L L + E D G+ +L
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVL----EEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 703 HTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 758
I+HR++K NI+ D K++DFG ++ D VS GT YL
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLH 183
Query: 759 PEYY--------ISQQLTDKSDVYSFGVILLELISGQ 787
P+ Y ++ D++S GV +G
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-29
Identities = 56/226 (24%), Positives = 104/226 (46%), Gaps = 40/226 (17%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKE--------IAVKVLTSN-SYQGKREFTNEVTLLSRI- 639
L K +G G FG V + + +AVK+L + + + + +E+ ++ I
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 640 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIK 687
H+N++ LG C ++G ++ E+ G L+E+L E+++ +
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 688 RLEIAEDAAKGIEYL---HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744
+ A+G+EYL IHRDL + N+L+ ++ K++DFGL++ +
Sbjct: 205 LVSCTYQLARGMEYLASQK------CIHRDLAARNVLVTENNVMKIADFGLARDINNI-- 256
Query: 745 HVSSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 785
+ T G L PE + T +SDV+SFGV++ E+ +
Sbjct: 257 --DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 50/204 (24%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 592 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 650
++G G FG V+ K + G + AVK + ++ E+ + + +V G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118
Query: 651 CQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 708
+E + E + G+L + + G L E R + A +G+EYLHT
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLP-EDRALYYLG-----QALEGLEYLHTRR-- 170
Query: 709 AIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVSSI----VRGTVGYLDPEYYI 763
I+H D+K+ N+LL RA + DFG + S + + GT ++ PE +
Sbjct: 171 -ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229
Query: 764 SQQLTDKSDVYSFGVILLELISGQ 787
+ K D++S ++L +++G
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-29
Identities = 58/228 (25%), Positives = 93/228 (40%), Gaps = 39/228 (17%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRI-HH 641
K +GSG FG V + +AVK+L + +E+ +++++ H
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 642 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL-------------YGTLTHEQRINWIKR 688
N+V LG C G L++E+ G L +L Y + +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 689 L------EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 742
L A AKG+E+L +HRDL + N+L+ K+ DFGL++ +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 743 ASHVSSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 785
S+ V L PE T KSDV+S+G++L E+ S
Sbjct: 226 ----SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 27/271 (9%), Positives = 67/271 (24%), Gaps = 41/271 (15%)
Query: 551 KEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD- 609
+E + + V++ +L + L + + G VV+ + +
Sbjct: 27 EEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVER 86
Query: 610 GKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQFLGYCQEEGRS--------- 657
++ A+KV T + + E +R+ + + + S
Sbjct: 87 LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146
Query: 658 -----------------VLVYEFMH--NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 698
+L+ L L + + +
Sbjct: 147 PFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRL 206
Query: 699 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 758
L + ++H N+ + R + D V Y
Sbjct: 207 AANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW----KVGTRGPASSVPVTYAP 259
Query: 759 PEYYISQ--QLTDKSDVYSFGVILLELISGQ 787
E+ + T + + G+ + +
Sbjct: 260 REFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 58/229 (25%), Positives = 94/229 (41%), Gaps = 41/229 (17%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRIHHR 642
+ IG G FG V+ + +AVK+L S + +F E L++ +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 643 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--------------------YGTLTHEQR 682
N+V+ LG C L++E+M G L E L +
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 683 INWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 741
++ ++L IA A G+ YL V HRDL + N L+ ++M K++DFGLS+
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERKFV----HRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 742 GASHVSSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 785
+ PE + T +SDV+++GV+L E+ S
Sbjct: 227 A----DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 12/212 (5%)
Query: 579 TLSDIEDATKMLEK--KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTL 635
++ + D K + KIG G G VY + G+E+A++ + K NE+ +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 636 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 695
+ + N+V +L +V E++ G+L + + T E +I + R +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----EC 125
Query: 696 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 755
+ +E+LH+ +IHRD+KS NILL K++DFG S S++V GT
Sbjct: 126 LQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPY 181
Query: 756 YLDPEYYISQQLTDKSDVYSFGVILLELISGQ 787
++ PE + K D++S G++ +E+I G+
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-28
Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 23/212 (10%)
Query: 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 647
+++++G+GGFG V +D G+++A+K RE + E+ ++ +++H N+V
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 648 L------GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE---DAAKG 698
+L E+ G L+++L + +K I D +
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL----NQFENCCGLKEGPIRTLLSDISSA 133
Query: 699 IEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 755
+ YLH IIHRDLK NI+L + + K+ D G +K G + V GT+
Sbjct: 134 LRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFV-GTLQ 188
Query: 756 YLDPEYYISQQLTDKSDVYSFGVILLELISGQ 787
YL PE ++ T D +SFG + E I+G
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 63/338 (18%), Positives = 111/338 (32%), Gaps = 91/338 (26%)
Query: 591 EKKIGSGGFGVVYYGKLK-DGKEIAVK-VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
+ +G GGFGVV+ K K D A+K + N + + EV L+++ H +V++
Sbjct: 11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYF 70
Query: 649 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI------------------------- 683
E E E L+ +
Sbjct: 71 NAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPS 130
Query: 684 -------------------NWIKR------------LEIAEDAAKGIEYLHTGCVPAIIH 712
+W+ R L I A+ +E+LH+ ++H
Sbjct: 131 SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS---KGLMH 187
Query: 713 RDLKSSNILLDKHMRAKVSDFGLSK---FAVDGASHVSSIVR--------GTVGYLDPEY 761
RDLK SNI KV DFGL + + ++ + GT Y+ PE
Sbjct: 188 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ 247
Query: 762 YISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 821
+ K D++S G+IL EL+ F + +
Sbjct: 248 IHGNNYSHKVDIFSLGLILFELLYS--------FSTQMERVRIITDVR------NLKFPL 293
Query: 822 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859
+Y + M + + ++ P RP ++++++
Sbjct: 294 LFTQKYPQEHMM-V--QDMLSPSP--TERPEATDIIEN 326
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-28
Identities = 67/212 (31%), Positives = 96/212 (45%), Gaps = 33/212 (15%)
Query: 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLV 645
++ +G G FG V K K G+E AVKV++ + K + EV LL ++ H N++
Sbjct: 30 GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 89
Query: 646 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-------- 697
+ + +++G LV E G L + I I R +E A
Sbjct: 90 KLYEFFEDKGYFYLVGEVYTGGELFD----------EI--ISRKRFSEVDAARIIRQVLS 137
Query: 698 GIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 754
GI Y+H I+HRDLK N+LL K ++ DFGLS I GT
Sbjct: 138 GITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTA 192
Query: 755 GYLDPEYYISQQLTDKSDVYSFGVILLELISG 786
Y+ PE + +K DV+S GVIL L+SG
Sbjct: 193 YYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 4e-28
Identities = 40/217 (18%), Positives = 69/217 (31%), Gaps = 22/217 (10%)
Query: 590 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN 643
+ +G G F VY D ++ +KV + T + L
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128
Query: 644 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL-YGTLTHEQRINWIKRLEIAEDAAKGIEYL 702
++F + SVLV E GTL + T E+ + + A IE +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188
Query: 703 HTGCVPAIIHRDLKSSNILLDKHMRA-----------KVSDFGLSKFA-VDGASHVSSIV 750
H IIH D+K N +L + D G S + + +
Sbjct: 189 HDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245
Query: 751 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 787
T G+ E ++ + D + + ++ G
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 61/295 (20%), Positives = 116/295 (39%), Gaps = 56/295 (18%)
Query: 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 647
++K+GSG FG V+ + + G E +K + + Q E E+ +L + H N+++
Sbjct: 26 FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 648 LGYCQEEGRSVLVYEFMHNGTL------KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 701
++ +V E G L + L+ +K++ + Y
Sbjct: 86 FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM------MNALAY 139
Query: 702 LHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 757
H+ ++H+DLK NIL H K+ DFGL++ H ++ GT Y+
Sbjct: 140 FHSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAA-GTALYM 193
Query: 758 DPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 817
PE + +T K D++S GV++ L++G F ++
Sbjct: 194 APE-VFKRDVTFKCDIWSAGVVMYFLLTGCLP-----F---------TGT------SLEE 232
Query: 818 IIDPSLLDEYDIQSMWK-IEEKA------LMCVLPHGHMRPSISEVLKD--IQDA 863
+ + E + + + +A ++ P RPS ++VL + A
Sbjct: 233 VQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDP--ERRPSAAQVLHHEWFKQA 285
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 7e-28
Identities = 68/250 (27%), Positives = 103/250 (41%), Gaps = 34/250 (13%)
Query: 553 QHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKM--LEKKIGSGGFGVVYYGKLK-D 609
H H R F S ++M KK+GSG +G V + K
Sbjct: 2 HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61
Query: 610 GKEIAVKVLTSNSYQGKRE--FTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 667
E A+K++ S EV +L + H N+++ + +++ LV E G
Sbjct: 62 HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121
Query: 668 TLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIEYLHTGCVPAIIHRDLKSSN 719
L + I I R++ E A G+ YLH I+HRDLK N
Sbjct: 122 ELFD----------EI--IHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPEN 166
Query: 720 ILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSF 776
+LL +K K+ DFGLS + + GT Y+ PE + ++ +K DV+S
Sbjct: 167 LLLESKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIAPE-VLRKKYDEKCDVWSI 223
Query: 777 GVILLELISG 786
GVIL L++G
Sbjct: 224 GVILFILLAG 233
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 8e-28
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
+ +GSG F V+ K + GK A+K + + NE+ +L +I H N+V
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 649 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK-------GIE 700
+ LV + + G L + RI ++R E DA+ ++
Sbjct: 73 DIYESTTHYYLVMQLVSGGELFD----------RI--LERGVYTEKDASLVIQQVLSAVK 120
Query: 701 YLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 756
YLH G I+HRDLK N+L +++ + ++DFGLSK +G +S+ GT GY
Sbjct: 121 YLHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTAC-GTPGY 173
Query: 757 LDPEYYISQQLTDKSDVYSFGVILLELISG 786
+ PE + + D +S GVI L+ G
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 58/226 (25%), Positives = 107/226 (47%), Gaps = 20/226 (8%)
Query: 571 PAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREF 629
E H D + +++ + +G G FG VY K + G A KV+ + S + ++
Sbjct: 5 SREYEHVRRDLDPNEVWEIVGE-LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY 63
Query: 630 TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK---EHLYGTLTHEQRINWI 686
E+ +L+ H +V+ LG +G+ ++ EF G + L LT E +I +
Sbjct: 64 IVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT-EPQIQVV 122
Query: 687 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746
R + + +LH+ IIHRDLK+ N+L+ +++DFG+S +
Sbjct: 123 CR-----QMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR 174
Query: 747 SSIVRGTVGYLDPEYYISQQLTD-----KSDVYSFGVILLELISGQ 787
S + GT ++ PE + + + D K+D++S G+ L+E+ +
Sbjct: 175 DSFI-GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 27/213 (12%)
Query: 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKV-----LTSNSYQGKREFTNEVTLLSRIHHRN 643
L + IG G F VV ++ G++ AVK+ TS+ + E ++ + H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 644 LVQFLGYCQEEGRSVLVYEFMHNGTL------KEHLYGTLTHEQRINWIKRLEIAEDAAK 697
+V+ L +G +V+EFM L + + ++++++ +
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI------LE 141
Query: 698 GIEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 753
+ Y H IIHRD+K +LL + K+ FG++ + V GT
Sbjct: 142 ALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GT 196
Query: 754 VGYLDPEYYISQQLTDKSDVYSFGVILLELISG 786
++ PE + DV+ GVIL L+SG
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 68/212 (32%), Positives = 97/212 (45%), Gaps = 34/212 (16%)
Query: 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQ 646
+ +G G FG V K + +E AVKV+ S + K EV LL ++ H N+++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 647 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK-------G 698
++ +V E G L + I IKR +E DAA+ G
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFD----------EI--IKRKRFSEHDAARIIKQVFSG 133
Query: 699 IEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 754
I Y+H I+HRDLK NILL +K K+ DFGLS + + + GT
Sbjct: 134 ITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTA 187
Query: 755 GYLDPEYYISQQLTDKSDVYSFGVILLELISG 786
Y+ PE + +K DV+S GVIL L+SG
Sbjct: 188 YYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 4e-27
Identities = 43/308 (13%), Positives = 86/308 (27%), Gaps = 61/308 (19%)
Query: 552 EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDG 610
VS+ + + T + +G + G
Sbjct: 39 TSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETG 98
Query: 611 KEIAVKVLTSNSYQG-------KRE---------------------FTNEVTLLSRIHHR 642
+ V V K E F L+ +
Sbjct: 99 ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 158
Query: 643 NLVQFLGYCQEEGRS--VLVYEFMH--NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 698
+++ ++ +Y M T E L + + + RL++ +
Sbjct: 159 KMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRL 218
Query: 699 IEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 757
+ LH G ++H L+ +I+LD+ ++ F DGA VS + G+
Sbjct: 219 LASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVR--DGARVVS---SVSRGFE 269
Query: 758 DPEYYISQQL-----------TDKSDVYSFGVILLELISGQ-------EAISNEKFGANC 799
PE + T D ++ G+++ + +E +C
Sbjct: 270 PPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSC 329
Query: 800 RNIVQWAK 807
+NI Q +
Sbjct: 330 KNIPQPVR 337
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 56/246 (22%), Positives = 99/246 (40%), Gaps = 37/246 (15%)
Query: 557 SLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AV 615
+ P S + P D + K +G G F V + A+
Sbjct: 6 AEPRPGAGSLQHAQPPPQPRKKRPEDFK-----FGKILGEGSFSTVVLARELATSREYAI 60
Query: 616 KVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEH 672
K+L + + E ++SR+ H V+ Q++ + + NG L ++
Sbjct: 61 KILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKY 120
Query: 673 LYGTLTHEQRINWIKRLEIAEDAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDK 724
+ + E + +EYLH IIHRDLK NILL++
Sbjct: 121 IR----KIGSFD--------ETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNE 165
Query: 725 HMRAKVSDFGLSKFAVDGASHV--SSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILL 781
M +++DFG +K + +S V GT Y+ PE ++++ KS D+++ G I+
Sbjct: 166 DMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVSPE-LLTEKSACKSSDLWALGCIIY 223
Query: 782 ELISGQ 787
+L++G
Sbjct: 224 QLVAGL 229
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 55/220 (25%), Positives = 102/220 (46%), Gaps = 23/220 (10%)
Query: 578 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE-FTNEVT- 634
D+E ++G G +GVV + G+ +AVK + + +++ ++
Sbjct: 4 VKADDLEP-----IMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDI 58
Query: 635 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI--NWIKRLEIA 692
+ + V F G EG + E M + +L + + Q I + + + IA
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IA 115
Query: 693 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG 752
K +E+LH+ ++IHRD+K SN+L++ + K+ DFG+S + VD + G
Sbjct: 116 VSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA--G 171
Query: 753 TVGYLDPEYYISQQLTD-----KSDVYSFGVILLELISGQ 787
Y+ PE I+ +L KSD++S G+ ++EL +
Sbjct: 172 CKPYMAPE-RINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-26
Identities = 67/223 (30%), Positives = 99/223 (44%), Gaps = 45/223 (20%)
Query: 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL-------------TSNSYQGKREFTNEVTL 635
+K+GSG +G V K K E A+KV+ N + E NE++L
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 636 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 695
L + H N+++ +++ LV EF G L E +I I R + E
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFE----------QI--INRHKFDECD 147
Query: 696 AK--------GIEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGA 743
A GI YLH I+HRD+K NILL + + K+ DFGLS F
Sbjct: 148 AANIMKQILSGICYLHKHN----IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD- 202
Query: 744 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 786
+ + GT Y+ PE + ++ +K DV+S GVI+ L+ G
Sbjct: 203 YKLRDRL-GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 49/210 (23%), Positives = 78/210 (37%), Gaps = 32/210 (15%)
Query: 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
LE IG G +G V K A K + + F E+ ++ + H N+++
Sbjct: 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 72
Query: 649 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 700
++ LV E G L E R+ + + E A +
Sbjct: 73 ETFEDNTDIYLVMELCTGGELFE----------RV--VHKRVFRESDAARIMKDVLSAVA 120
Query: 701 YLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 756
Y H + HRDLK N L K+ DFGL+ G + + V GT Y
Sbjct: 121 YCHKLN----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKV-GTPYY 174
Query: 757 LDPEYYISQQLTDKSDVYSFGVILLELISG 786
+ P+ + + D +S GV++ L+ G
Sbjct: 175 VSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-26
Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 26/207 (12%)
Query: 594 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 649
+G GGFG V+ ++K ++ A K L + ++ + E +L+++H R +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS-LA 251
Query: 650 YC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 700
Y + + LV M+ G ++ H+Y E A G+E
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ--------EPRAIFYTAQIVSGLE 303
Query: 701 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 760
+LH II+RDLK N+LLD ++SD GL+ G + GT G++ PE
Sbjct: 304 HLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPE 359
Query: 761 YYISQQLTDKSDVYSFGVILLELISGQ 787
+ ++ D ++ GV L E+I+ +
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 60/230 (26%), Positives = 98/230 (42%), Gaps = 18/230 (7%)
Query: 561 QRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLT 619
QR + D E ++G+G GVV+ K + A K++
Sbjct: 13 QRKRLEAFLTQKQKVGELKDDDFE-----KISELGAGNGGVVFKVSHKPSGLVMARKLIH 67
Query: 620 SNSYQGKREF-TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL-YGTL 677
R E+ +L + +V F G +G + E M G+L + L
Sbjct: 68 LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR 127
Query: 678 THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 737
EQ + +++ KG+ YL I+HRD+K SNIL++ K+ DFG+S
Sbjct: 128 IPEQILG-----KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 180
Query: 738 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 787
+D S +S V GT Y+ PE + +SD++S G+ L+E+ G+
Sbjct: 181 QLID--SMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-26
Identities = 47/206 (22%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
+ +++GSG FGVV+ K G+ K + + K NE+++++++HH L+
Sbjct: 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 114
Query: 649 GYCQEEGRSVLVYEFMHNGTL------KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 702
+++ VL+ EF+ G L +++ + + IN+++ + E G++++
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKM---SEAEVINYMR--QACE----GLKHM 165
Query: 703 HTGCVPAIIHRDLKSSNILLDKHMRA--KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 760
H +I+H D+K NI+ + + K+ DFGL+ + + T + PE
Sbjct: 166 HEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPE 220
Query: 761 YYISQQLTDKSDVYSFGVILLELISG 786
+ + +D+++ GV+ L+SG
Sbjct: 221 IVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 44/223 (19%)
Query: 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKV--------LTSNSYQGKRE-FTNEVTLLSRI 639
++ +G G VV K KE AVK+ ++ Q RE EV +L ++
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 640 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK- 697
H N++Q + LV++ M G L + + +++ ++E +
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFD----------YL--TEKVTLSEKETRK 128
Query: 698 -------GIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 749
I LH I+HRDLK NILLD M K++DFG S +D + +
Sbjct: 129 IMRALLEVICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQ-LDPGEKLREV 183
Query: 750 VRGTVGYLDPE------YYISQQLTDKSDVYSFGVILLELISG 786
GT YL PE + D++S GVI+ L++G
Sbjct: 184 C-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 66/212 (31%), Positives = 94/212 (44%), Gaps = 34/212 (16%)
Query: 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--FTNEVTLLSRIHHRNLVQ 646
+ +G G FG V K + +E AVKV+ S + K EV LL ++ H N+++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 647 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------G 698
++ +V E G L + I IKR +E A G
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFD----------EI--IKRKRFSEHDAARIIKQVFSG 133
Query: 699 IEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 754
I Y+H I+HRDLK NILL +K K+ DFGLS + + + GT
Sbjct: 134 ITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTA 187
Query: 755 GYLDPEYYISQQLTDKSDVYSFGVILLELISG 786
Y+ PE + +K DV+S GVIL L+SG
Sbjct: 188 YYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 58/201 (28%), Positives = 106/201 (52%), Gaps = 13/201 (6%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 647
+KIG G FG V+ G + K +A+K++ + + E E+T+LS+ + ++
Sbjct: 26 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 85
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
G ++ + ++ E++ G+ + L E +I I R + KG++YLH+
Sbjct: 86 YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGLDYLHSE-- 138
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 767
IHRD+K++N+LL +H K++DFG++ D ++ V GT ++ PE I Q
Sbjct: 139 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPE-VIKQSA 195
Query: 768 TD-KSDVYSFGVILLELISGQ 787
D K+D++S G+ +EL G+
Sbjct: 196 YDSKADIWSLGITAIELARGE 216
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 71/310 (22%), Positives = 114/310 (36%), Gaps = 54/310 (17%)
Query: 581 SDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRI 639
ED ++ E +G G V +E AVK++ + EV +L +
Sbjct: 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQC 67
Query: 640 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK 697
HRN+++ + + +EE R LV+E M G++ I KR E +A+
Sbjct: 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILS----------HI--HKRRHFNELEASV 115
Query: 698 -------GIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVS 747
+++LH I HRDLK NIL ++ K+ DF L
Sbjct: 116 VVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172
Query: 748 SIVR------GTVGYLDPE----YYISQQLTDKS-DVYSFGVILLELISGQEAISNEKFG 796
G+ Y+ PE + + DK D++S GVIL L+SG F
Sbjct: 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP-----FV 227
Query: 797 ANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQS-MWK-IEEKA------LMCVLPHGH 848
C + W + + + +Y+ W I A L+
Sbjct: 228 GRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDA--K 285
Query: 849 MRPSISEVLK 858
R S ++VL+
Sbjct: 286 QRLSAAQVLQ 295
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-26
Identities = 56/258 (21%), Positives = 112/258 (43%), Gaps = 24/258 (9%)
Query: 542 HKGKKNNYDKEQHRHSLPVQRPVSSLNDAP-AEAAHCFTLSDIEDATK------MLEKKI 594
+ ++ YD ++ + + VSS D + + +E + +++
Sbjct: 106 ERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEEL 165
Query: 595 GSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE 653
G+G FGVV+ + G A K + + K E+ +S + H LV ++
Sbjct: 166 GTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED 225
Query: 654 EGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 710
+ V++YEFM G L E + + ++ ++ + +++ ++ + G+ ++H
Sbjct: 226 DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR--QVCK----GLCHMHEN---NY 276
Query: 711 IHRDLKSSNILLDKHMRA--KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 768
+H DLK NI+ K+ DFGL+ +D V GT + PE + +
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAH-LDPKQSVKVTT-GTAEFAAPEVAEGKPVG 334
Query: 769 DKSDVYSFGVILLELISG 786
+D++S GV+ L+SG
Sbjct: 335 YYTDMWSVGVLSYILLSG 352
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 22/225 (9%)
Query: 573 EAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKV--LTSNSYQGKREF 629
E FT D++ +IG G +G V K G+ +AVK T + + K+
Sbjct: 14 EQHWDFTAEDLK-----DLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLL 68
Query: 630 TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI--NWIK 687
+ ++ +VQF G EG + E M K + Y + I +
Sbjct: 69 MDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG 128
Query: 688 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 747
+ I K + +L IIHRD+K SNILLD+ K+ DFG+S VD +
Sbjct: 129 K--ITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTR 184
Query: 748 SIVRGTVGYLDPEYYISQQLTD-----KSDVYSFGVILLELISGQ 787
G Y+ PE I + +SDV+S G+ L EL +G+
Sbjct: 185 DA--GCRPYMAPE-RIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 52/296 (17%), Positives = 109/296 (36%), Gaps = 62/296 (20%)
Query: 592 KKIGSGGFGVVYYG-KLKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRI-HHRNLVQF 647
+KIGSG FG V+ K DG A+K ++ EV + + H ++V++
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
E+ ++ E+ + G+L + + + ++ +G+ Y+H+
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS--- 133
Query: 708 PAIIHRDLKSSNILLDKH-------------------MRAKVSDFGLSKFAVDGASHVSS 748
+++H D+K SNI + + + K+ D G + +SS
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH-------VTRISS 186
Query: 749 --IVRGTVGYLDPEYYISQQL--TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 804
+ G +L E + + K+D+++ + ++ + N Q
Sbjct: 187 PQVEEGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---------Q 236
Query: 805 WAKLHIESGDIQGIIDPSLLDEY--DIQSMWKIEEKALMCVLPHGHMRPSISEVLK 858
W + I G + P + + + K + + P RPS ++K
Sbjct: 237 WHE--IRQGRL-----PRIPQVLSQEFTELLK------VMIHPDPERRPSAMALVK 279
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 55/247 (22%), Positives = 83/247 (33%), Gaps = 54/247 (21%)
Query: 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKV-----LTSNSYQGKREFTNEVTLLSRIHHRN 643
L+ IG G +GVV A+K+ + + + EV L+ ++HH N
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 644 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL----------------------------YG 675
+ + ++E LV E H G L + L
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 676 TLTHEQRINWIKRLEIAEDAAK--------GIEYLHT-GCVPAIIHRDLKSSNILL--DK 724
E + YLH G I HRD+K N L +K
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG----ICHRDIKPENFLFSTNK 205
Query: 725 HMRAKVSDFGLSKFAVDGASHVSSIVR---GTVGYLDPE--YYISQQLTDKSDVYSFGVI 779
K+ DFGLSK + + GT ++ PE ++ K D +S GV+
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 780 LLELISG 786
L L+ G
Sbjct: 266 LHLLLMG 272
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 67/239 (28%), Positives = 116/239 (48%), Gaps = 30/239 (12%)
Query: 568 NDAPAEAAHCFTLSDIEDATKM--LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQ 624
+D+PA + LS + D + L + +G+G +G VY G+ +K G+ A+KV+
Sbjct: 4 SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-D 62
Query: 625 GKREFTNEVTLLSRI-HHRNLVQFLG-YCQEEGRSV-----LVYEFMHNGT----LKEHL 673
+ E E+ +L + HHRN+ + G + ++ + LV EF G+ +K
Sbjct: 63 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 122
Query: 674 YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 733
TL E+ I +I R + +G+ +LH V IHRD+K N+LL ++ K+ DF
Sbjct: 123 GNTLK-EEWIAYICR-----EILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDF 173
Query: 734 GLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-----KSDVYSFGVILLELISGQ 787
G+S ++ + GT ++ PE + D KSD++S G+ +E+ G
Sbjct: 174 GVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 63/219 (28%), Positives = 108/219 (49%), Gaps = 25/219 (11%)
Query: 581 SDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVL------TSNSYQGKREFTNEV 633
S +ED + + +++GSG F +V + K GKE A K + +S + E EV
Sbjct: 1 SMVEDHYE-MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREV 59
Query: 634 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEI 691
+L I H N++ + + VL+ E + G L + L +LT ++ ++K +I
Sbjct: 60 NILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK--QI 117
Query: 692 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVS 747
+ G+ YLH+ I H DLK NI+L + R K+ DFG++ ++ +
Sbjct: 118 LD----GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK-IEAGNEFK 169
Query: 748 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 786
+I GT ++ PE + L ++D++S GVI L+SG
Sbjct: 170 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVL------TSNSYQGKREFTNEVTLLSRIHHR 642
+ +++GSG F +V + K G E A K + S + E EV++L ++ H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 643 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 700
N++ + VL+ E + G L + L +L+ E+ ++IK +I + G+
Sbjct: 76 NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK--QILD----GVN 129
Query: 701 YLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 756
YLHT I H DLK NI+L K+ DFGL+ ++ +I GT +
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKNIF-GTPEF 184
Query: 757 LDPEYYISQQLTDKSDVYSFGVILLELISG 786
+ PE + L ++D++S GVI L+SG
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-25
Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 594 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 649
+G GGFG V +++ ++ A K L + ++ NE +L +++ R +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS-LA 250
Query: 650 YC-QEEGRSVLVYEFMHNGTLKEHLYGTLTH---EQRINWIKRLEIAEDAAKGIEYLHTG 705
Y + + LV M+ G LK H+Y E R AE G+E LH
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA----VFYAAE-ICCGLEDLHRE 305
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 765
I++RDLK NILLD H ++SD GL+ +G + + V GTVGY+ PE ++
Sbjct: 306 ---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNE 360
Query: 766 QLTDKSDVYSFGVILLELISGQ 787
+ T D ++ G +L E+I+GQ
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQ 382
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-25
Identities = 28/235 (11%), Positives = 59/235 (25%), Gaps = 43/235 (18%)
Query: 592 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQG-------KREFTNEVTLLSRIH--- 640
+G + G+ V V K E L +
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 641 ---------------HRNLVQFLGYCQEEGRSVLVYEF-------MHNGTLKEHLYGTLT 678
+ + +E ++ F + T E L +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 679 HEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 737
+ + RL++ + + LH G ++H L+ +I+LD+ ++ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 738 FAVDGASHVSSIVRGTVGYLDPEYYISQQ-----LTDKSDVYSFGVILLELISGQ 787
A Q +T D ++ G+ + +
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 24/218 (11%)
Query: 581 SDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVL--TSNSYQGKREFTNEVTLLS 637
+ + + K++G G F VV K G+E A K L + E +E+ +L
Sbjct: 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLE 83
Query: 638 RI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGTL----KEHLYGTLTHEQRINWIKRLEIA 692
++ + +L+ E+ G + L ++ I IK +I
Sbjct: 84 LAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK--QIL 141
Query: 693 EDAAKGIEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSS 748
E G+ YLH I+H DLK NILL K+ DFG+S+ + A +
Sbjct: 142 E----GVYYLHQNN----IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK-IGHACELRE 192
Query: 749 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 786
I+ GT YL PE +T +D+++ G+I L++
Sbjct: 193 IM-GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 52/203 (25%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 589 MLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQF 647
+ +K+G G +G VY + G+ +A+K + +E E++++ + ++V++
Sbjct: 32 DVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKY 89
Query: 648 LGYCQEEGRSVLVYEFMHNGTLK---EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 704
G + +V E+ G++ TLT E I I + KG+EYLH
Sbjct: 90 YGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLT-EDEIATILQ-----STLKGLEYLHF 143
Query: 705 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 764
IHRD+K+ NILL+ AK++DFG++ D + ++++ GT ++ PE
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQE 199
Query: 765 QQLTDKSDVYSFGVILLELISGQ 787
+D++S G+ +E+ G+
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGK 222
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-25
Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVL------TSNSYQGKREFTNEVTLLSRIHHR 642
+ +++GSG F +V + K G E A K + S + E EV++L ++ H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75
Query: 643 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 700
N++ + VL+ E + G L + L +L+ E+ ++IK +I + G+
Sbjct: 76 NIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK--QILD----GVN 129
Query: 701 YLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 756
YLHT I H DLK NI+L K+ DFGL+ ++ +I GT +
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKNIF-GTPEF 184
Query: 757 LDPEYYISQQLTDKSDVYSFGVILLELISG 786
+ PE + L ++D++S GVI L+SG
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-25
Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 592 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEVTLLSRIH---HRNL 644
+ IG GGFG VY + D ++ A+K L + K+ T NE +LS + +
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 645 VQFLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEY 701
V + Y + + + M+ G L HL G + E + R AE G+E+
Sbjct: 255 VC-MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-EADM----RFYAAE-IILGLEH 307
Query: 702 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 761
+H +++RDLK +NILLD+H ++SD GL+ H + V GT GY+ PE
Sbjct: 308 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEV 361
Query: 762 YISQQLTDKS-DVYSFGVILLELISGQ 787
D S D +S G +L +L+ G
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 21/218 (9%)
Query: 578 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE-FTNEV-T 634
++D+E ++GSG G V+ + + + AVK + + + + + ++
Sbjct: 22 AEINDLE-----NLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDV 76
Query: 635 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 694
+L +VQ G + E M K L + + + +
Sbjct: 77 VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEK--LKKRMQGPIPERILGK--MTVA 132
Query: 695 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 754
K + YL +IHRD+K SNILLD+ + K+ DFG+S VD + S G
Sbjct: 133 IVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA--GCA 188
Query: 755 GYLDPEYYISQQLTD-----KSDVYSFGVILLELISGQ 787
Y+ PE T ++DV+S G+ L+EL +GQ
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 30/217 (13%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 647
L++ IGSG VV +++A+K + Q + E+ +S+ HH N+V +
Sbjct: 19 LQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSY 78
Query: 648 LGYCQEEGRSVLVYEFMHNGTL----------KEHLYGTLTHEQRINWIKRLEIAEDAAK 697
+ LV + + G++ EH G L E I I R + +
Sbjct: 79 YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD-ESTIATILR-----EVLE 132
Query: 698 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT-VG- 755
G+EYLH IHRD+K+ NILL + +++DFG+S F G + VR T VG
Sbjct: 133 GLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 756 --YLDPEYYISQQLTD---KSDVYSFGVILLELISGQ 787
++ PE + +Q+ K+D++SFG+ +EL +G
Sbjct: 190 PCWMAPE--VMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-25
Identities = 63/252 (25%), Positives = 111/252 (44%), Gaps = 30/252 (11%)
Query: 551 KEQHRHSLPVQRPVSSLNDAPAEAA---HCFTLS---DIEDATKMLEKK-IGSGGFGVVY 603
R + +R + D PA A H + + + + + +G G FG V+
Sbjct: 47 DLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVH 106
Query: 604 YGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 662
+ G ++A K++ + + K E NE+++++++ H NL+Q + + VLV E
Sbjct: 107 KCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166
Query: 663 FMHNGTL------KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK 716
++ G L + + T I ++K +I E GI ++H I+H DLK
Sbjct: 167 YVDGGELFDRIIDESYNL---TELDTILFMK--QICE----GIRHMHQM---YILHLDLK 214
Query: 717 SSNILLDKHMRA--KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVY 774
NIL K+ DFGL++ + GT +L PE ++ +D++
Sbjct: 215 PENILCVNRDAKQIKIIDFGLARR-YKPREKLKVNF-GTPEFLAPEVVNYDFVSFPTDMW 272
Query: 775 SFGVILLELISG 786
S GVI L+SG
Sbjct: 273 SVGVIAYMLLSG 284
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 31/211 (14%)
Query: 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--FTNEVTLLSRIHHRNLVQ 646
+++++G G F VV K G E A K++ + + E + ++ H N+V+
Sbjct: 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 69
Query: 647 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KG 698
QEE LV++ + G L E I + R +E A +
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGELFE----------DI--VAREFYSEADASHCIQQILES 117
Query: 699 IEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 755
I Y H+ I+HR+LK N+LL K K++DFGL+ D GT G
Sbjct: 118 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFA-GTPG 172
Query: 756 YLDPEYYISQQLTDKSDVYSFGVILLELISG 786
YL PE + D+++ GVIL L+ G
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-25
Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 43/222 (19%)
Query: 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--------FTNEVTLLSRIH 640
+ IG G VV + G E AVK++ + + E E +L ++
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157
Query: 641 -HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 697
H +++ + + LV++ M G L + + +++ ++E +
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFD----------YL--TEKVALSEKETRSI 205
Query: 698 ------GIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 750
+ +LH I+HRDLK NILLD +M+ ++SDFG S G + +
Sbjct: 206 MRSLLEAVSFLHANN----IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-EKLRELC 260
Query: 751 RGTVGYLDPE------YYISQQLTDKSDVYSFGVILLELISG 786
GT GYL PE + D+++ GVIL L++G
Sbjct: 261 -GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-25
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLV 645
+ + IG G FG V + D K++ A+K + + E N E+ ++ + H LV
Sbjct: 19 ILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLV 78
Query: 646 QFLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYL 702
L Y Q+E +V + + G L+ HL E+ + +L I E ++YL
Sbjct: 79 N-LWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK-EETV----KLFICE-LVMALDYL 131
Query: 703 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 762
IIHRD+K NILLD+H ++DF ++ + + GT Y+ PE +
Sbjct: 132 QNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMF 186
Query: 763 ISQQLT--DKS-DVYSFGVILLELISGQ 787
S++ + D +S GV EL+ G+
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 62/291 (21%), Positives = 110/291 (37%), Gaps = 55/291 (18%)
Query: 552 EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKM-----LEKKIGSGGFGVVYYGK 606
H H + AP H L+ ++ + + +GSGGFG VY G
Sbjct: 4 SHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGI 63
Query: 607 -LKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIHHR--NLVQFLGYCQEEGRS 657
+ D +A+K + + E N EV LL ++ +++ L + +
Sbjct: 64 RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 123
Query: 658 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIEYLHTGCVPA 709
VL+ E ++ L+ +T + E+ A+ + + H V
Sbjct: 124 VLILERPEPV--QD-LFDFITERGALQ--------EELARSFFWQVLEAVRHCHNCGV-- 170
Query: 710 IIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 768
+HRD+K NIL+D K+ DFG D GT Y PE +I
Sbjct: 171 -LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSPPE-WIRYHRY 225
Query: 769 D--KSDVYSFGVILLELISG------QEAISNEKFG------ANCRNIVQW 805
+ V+S G++L +++ G E I + + C+++++W
Sbjct: 226 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRW 276
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 40/219 (18%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIH-- 640
L +G GGFG V+ G L D ++A+KV+ N G ++ EV LL ++
Sbjct: 35 LGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAG 94
Query: 641 --HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK- 697
H +++ L + + + +LV E + L+ +T + + E ++
Sbjct: 95 GGHPGVIRLLDWFETQEGFMLVLERPLPA---QDLFDYITEKGPLG--------EGPSRC 143
Query: 698 -------GIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSI 749
I++ H+ V +HRD+K NIL+D AK+ DFG D
Sbjct: 144 FFGQVVAAIQHCHSRGV---VHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD- 199
Query: 750 VRGTVGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 786
GT Y PE +IS+ + V+S G++L +++ G
Sbjct: 200 --GTRVYSPPE-WISRHQYHALPATVWSLGILLYDMVCG 235
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 37/214 (17%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-----TSNSYQGKREFTNEVTLLSRIHHRN 643
L + +G G +G V + +AVK++ K+E + + ++H N
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHEN 66
Query: 644 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK------ 697
+V+F G+ +E L E+ G L + + + + E A+
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRI------------EPDIGMPEPDAQRFFHQL 114
Query: 698 --GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTV 754
G+ YLH I HRD+K N+LLD+ K+SDFGL+ + + + GT+
Sbjct: 115 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 755 GYLDPEYYISQQLTD--KSDVYSFGVILLELISG 786
Y+ PE + ++ DV+S G++L +++G
Sbjct: 172 PYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVL------TSNSYQGKREFTNEVTLLSRIHHR 642
+++GSG F VV + K G + A K + +S + + EV++L I H
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 643 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 700
N++ + + +L+ E + G L + L +LT E+ ++K +I G+
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK--QILN----GVY 128
Query: 701 YLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 756
YLH+ I H DLK NI+L R K+ DFGL+ +D + +I GT +
Sbjct: 129 YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK-IDFGNEFKNIF-GTPEF 183
Query: 757 LDPEYYISQQLTDKSDVYSFGVILLELISG 786
+ PE + L ++D++S GVI L+SG
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-24
Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 43/221 (19%)
Query: 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--------FTNEVTLLSRIH 640
+ K +GSG G V + K++A+++++ + E+ +L +++
Sbjct: 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198
Query: 641 HRNLVQFLGYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 697
H +++ + E +V E M G L + ++ + + E K
Sbjct: 199 HPCIIKIKNFFDAE--DYYIVLELMEGGELFD----------KV--VGNKRLKEATCKLY 244
Query: 698 ------GIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSS 748
++YLH IIHRDLK N+LL ++ K++DFG SK + S + +
Sbjct: 245 FYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRT 300
Query: 749 IVRGTVGYLDPE---YYISQQLTDKSDVYSFGVILLELISG 786
+ GT YL PE + D +S GVIL +SG
Sbjct: 301 LC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 37/203 (18%), Positives = 88/203 (43%), Gaps = 18/203 (8%)
Query: 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
+ + +G G FG+V+ K K + + E+++L+ HRN++
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLH 67
Query: 649 GYCQEEGRSVLVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 705
+ V+++EF+ + E + L + ++++ ++ E +++LH+
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH--QVCE----ALQFLHSH 121
Query: 706 CVPAIIHRDLKSSNILL--DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 763
I H D++ NI+ + K+ +FG ++ + + + Y PE +
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ-LKPGDNFRLLF-TAPEYYAPEVHQ 176
Query: 764 SQQLTDKSDVYSFGVILLELISG 786
++ +D++S G ++ L+SG
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSG 199
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 31/211 (14%)
Query: 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--FTNEVTLLSRIHHRNLVQ 646
+++++G G F VV K G E A K++ + + E + ++ H N+V+
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 647 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KG 698
QEE LV++ + G L E I + R +E A +
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELFE----------DI--VAREFYSEADASHCIQQILES 140
Query: 699 IEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 755
I Y H+ I+HR+LK N+LL K K++DFGL+ V+ + GT G
Sbjct: 141 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSEAWHGFA-GTPG 195
Query: 756 YLDPEYYISQQLTDKSDVYSFGVILLELISG 786
YL PE + D+++ GVIL L+ G
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 45/216 (20%), Positives = 82/216 (37%), Gaps = 28/216 (12%)
Query: 590 LEKKIGSG--GFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNL 644
L IG G V + G+ + V+ L + S + E+ + +H N+
Sbjct: 29 LLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNI 88
Query: 645 VQFLGYCQEEGRSVLVYEFMHNGT----LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 700
V + + +V FM G+ + H + E I +I + K ++
Sbjct: 89 VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN-ELAIAYILQ-----GVLKALD 142
Query: 701 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR------GTV 754
Y+H +HR +K+S+IL+ + +S + + + +
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 755 GYLDPEYYISQQL---TDKSDVYSFGVILLELISGQ 787
+L PE + Q L KSD+YS G+ EL +G
Sbjct: 200 PWLSPE-VLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-24
Identities = 54/212 (25%), Positives = 86/212 (40%), Gaps = 32/212 (15%)
Query: 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--FTNEVTLLSRIHHRNLVQ 646
L +++G G F VV G+E A ++ + + E + + H N+V+
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 647 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK-------G 698
EEG L+++ + G L E I + R +E DA+
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFE----------DI--VAREYYSEADASHCIQQILEA 122
Query: 699 IEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 754
+ + H G ++HR+LK N+LL K K++DFGL+ GT
Sbjct: 123 VLHCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTP 177
Query: 755 GYLDPEYYISQQLTDKSDVYSFGVILLELISG 786
GYL PE D+++ GVIL L+ G
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 66/240 (27%), Positives = 106/240 (44%), Gaps = 26/240 (10%)
Query: 557 SLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAV 615
+P SL D + A F D E L + IG G FG VY+ + +++ + +A+
Sbjct: 28 PMPAGGRAGSLKDP--DVAELFFKDDPEKLFSDLRE-IGHGSFGAVYFARDVRNSEVVAI 84
Query: 616 KVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG--TLK 670
K ++ + Q ++ EV L ++ H N +Q+ G E + LV E+ L
Sbjct: 85 KKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLL 144
Query: 671 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 730
E L E I + A +G+ YLH+ +IHRD+K+ NILL + K+
Sbjct: 145 EVHKKPLQ-EVEIAAVTH-----GALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKL 195
Query: 731 SDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD---KSDVYSFGVILLELISGQ 787
DFG + S V GT ++ PE ++ K DV+S G+ +EL +
Sbjct: 196 GDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 37/214 (17%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-----TSNSYQGKREFTNEVTLLSRIHHRN 643
L + +G G +G V + +AVK++ K+E + + ++H N
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHEN 66
Query: 644 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK------ 697
+V+F G+ +E L E+ G L + + + + E A+
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRI------------EPDIGMPEPDAQRFFHQL 114
Query: 698 --GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTV 754
G+ YLH I HRD+K N+LLD+ K+SDFGL+ + + + GT+
Sbjct: 115 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 755 GYLDPEYYISQQLTD--KSDVYSFGVILLELISG 786
Y+ PE + ++ DV+S G++L +++G
Sbjct: 172 PYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 69/267 (25%), Positives = 108/267 (40%), Gaps = 42/267 (15%)
Query: 541 MHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCF--------TLSDIEDATKMLEK 592
MH ++ + +L Q S A A + D + +E
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFE-VES 59
Query: 593 KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 651
++G G +VY K K K A+KVL K+ E+ +L R+ H N+++
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 652 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK-------GIEYLH 703
+ LV E + G L + RI +++ +E DAA + YLH
Sbjct: 118 ETPTEISLVLELVTGGELFD----------RI--VEKGYYSERDAADAVKQILEAVAYLH 165
Query: 704 T-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 759
G I+HRDLK N+L K++DFGLSK V+ + ++ GT GY P
Sbjct: 166 ENG----IVHRDLKPENLLYATPAPDAPLKIADFGLSKI-VEHQVLMKTVC-GTPGYCAP 219
Query: 760 EYYISQQLTDKSDVYSFGVILLELISG 786
E + D++S G+I L+ G
Sbjct: 220 EILRGCAYGPEVDMWSVGIITYILLCG 246
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 52/217 (23%), Positives = 87/217 (40%), Gaps = 38/217 (17%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--------TSNSYQGKREFTNEVTLLSRIH 640
+GSG FG V+ + KE+ VK + + T E+ +LSR+
Sbjct: 28 TMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE 87
Query: 641 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--- 697
H N+++ L + +G LV E +G L+ + R++ E A
Sbjct: 88 HANIIKVLDIFENQGFFQLVMEKHGSGL---DLFAFIDRHPRLD--------EPLASYIF 136
Query: 698 -----GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVR 751
+ YL IIHRD+K NI++ + K+ DFG + + G +
Sbjct: 137 RQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC--- 190
Query: 752 GTVGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 786
GT+ Y PE + + +++S GV L L+
Sbjct: 191 GTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 43/221 (19%)
Query: 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--------FTNEVTLLSRIH 640
+ K +GSG G V + K++A+K+++ + E+ +L +++
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 641 HRNLVQFLGYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 697
H +++ + E +V E M G L + ++ + + E K
Sbjct: 74 HPCIIKIKNFFDAE--DYYIVLELMEGGELFD----------KV--VGNKRLKEATCKLY 119
Query: 698 ------GIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSS 748
++YLH IIHRDLK N+LL ++ K++DFG SK + S + +
Sbjct: 120 FYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRT 175
Query: 749 IVRGTVGYLDPE---YYISQQLTDKSDVYSFGVILLELISG 786
+ GT YL PE + D +S GVIL +SG
Sbjct: 176 LC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 8e-23
Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 38/223 (17%)
Query: 581 SDIEDATKM--LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLS 637
S + +K +G G F + K + AVK+++ + E+T L
Sbjct: 4 SPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ---KEITALK 60
Query: 638 RI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DA 695
H N+V+ ++ + LV E ++ G L E RI K+ +E +A
Sbjct: 61 LCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFE----------RI--KKKKHFSETEA 108
Query: 696 AK-------GIEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGAS 744
+ + ++H G ++HRDLK N+L + ++ K+ DFG ++
Sbjct: 109 SYIMRKLVSAVSHMHDVG----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164
Query: 745 HVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISG 786
+ + T+ Y PE ++Q D+S D++S GVIL ++SG
Sbjct: 165 PLKTPC-FTLHYAAPE-LLNQNGYDESCDLWSLGVILYTMLSG 205
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-23
Identities = 53/222 (23%), Positives = 89/222 (40%), Gaps = 46/222 (20%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--------TSNSYQGKREFTNEVTLLSRIH 640
+ +G G +G V + AVK+L + K+E + LL R+
Sbjct: 9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKE----IQLLRRLR 64
Query: 641 HRNLVQFLGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK- 697
H+N++Q + E + +V E+ G ++E + ++ KR A
Sbjct: 65 HKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQE-MLDSVPE-------KRFP--VCQAHG 113
Query: 698 -------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS----KFAVDGASHV 746
G+EYLH+ I+H+D+K N+LL K+S G++ FA D
Sbjct: 114 YFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 747 SSIVRGTVGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 786
S G+ + PE K D++S GV L + +G
Sbjct: 171 SQ---GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 51/213 (23%), Positives = 91/213 (42%), Gaps = 38/213 (17%)
Query: 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSR-IHHRNLVQF 647
+++ IG G + V K E AVK++ + E + +L R H N++
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----IEILLRYGQHPNIITL 81
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK-------GI 699
+ +V E M G L + +I +++ +E +A+ +
Sbjct: 82 KDVYDDGKYVYVVTELMKGGELLD----------KI--LRQKFFSEREASAVLFTITKTV 129
Query: 700 EYLHT-GCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 754
EYLH G ++HRDLK SNIL ++ DFG +K + + T
Sbjct: 130 EYLHAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTA 184
Query: 755 GYLDPEYYISQQLTDKS-DVYSFGVILLELISG 786
++ PE + +Q D + D++S GV+L +++G
Sbjct: 185 NFVAPE-VLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-22
Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 38/213 (17%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL---TSNSYQGKREFTNEVTLLSRIHHRNLV 645
K IGSG FGV + + +AVK + + +RE + + H N+V
Sbjct: 24 FVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQRE----IINHRSLRHPNIV 79
Query: 646 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-------- 697
+F ++ E+ G L E + +ED A+
Sbjct: 80 RFKEVILTPTHLAIIMEYASGGELYERI------------CNAGRFSEDEARFFFQQLLS 127
Query: 698 GIEYLHTGCVPAIIHRDLKSSNILLDKH--MRAKVSDFGLSKFAVDGASHVSSIVRGTVG 755
G+ Y H+ + HRDLK N LLD R K+ DFG SK +V + S++ GT
Sbjct: 128 GVSYCHSMQI---CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPA 182
Query: 756 YLDPEYYISQQLTD--KSDVYSFGVILLELISG 786
Y+ PE + +Q D +DV+S GV L ++ G
Sbjct: 183 YIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVG 214
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 4e-22
Identities = 58/211 (27%), Positives = 85/211 (40%), Gaps = 25/211 (11%)
Query: 592 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 647
K IG G F V K+K ++ A+K++ + E F E +L R + Q
Sbjct: 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ- 125
Query: 648 LGYC-QEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 704
L + Q+E LV E+ G L L +G + R +AE I+ +H
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA----RFYLAE-IVMAIDSVHR 180
Query: 705 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 763
+HRD+K NILLD+ +++DFG DG V GT YL PE
Sbjct: 181 L---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQ 236
Query: 764 SQQLTDKSDVY-------SFGVILLELISGQ 787
+ + Y + GV E+ GQ
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 6e-22
Identities = 62/215 (28%), Positives = 95/215 (44%), Gaps = 40/215 (18%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-------TSNSYQGKREFTNEVTLLSRIHH 641
L +G G FG V G+ G ++AVK+L + KRE + L H
Sbjct: 15 LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE----IQNLKLFRH 70
Query: 642 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK---- 697
++++ +V E++ G L +++ K + E A+
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSGGELFDYI------------CKHGRVEEMEARRLFQ 118
Query: 698 ----GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 753
++Y H ++HRDLK N+LLD HM AK++DFGLS DG +S G+
Sbjct: 119 QILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--GS 173
Query: 754 VGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 786
Y PE IS +L + D++S GVIL L+ G
Sbjct: 174 PNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCG 207
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-21
Identities = 66/243 (27%), Positives = 104/243 (42%), Gaps = 30/243 (12%)
Query: 559 PVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVK-V 617
P+ N A + + K IG+G FGVV+ KL + E+A+K V
Sbjct: 13 VKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV 72
Query: 618 LTSNSYQGKREFTN-EVTLLSRIHHRNLVQFLGYCQEEGRSV------LVYEFMHNGTLK 670
L Q KR F N E+ ++ + H N+V + G LV E++ T+
Sbjct: 73 L-----QDKR-FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVY 125
Query: 671 EHLYGTLTHEQRI--NWIKRL--EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 726
+Q + IK ++ + + Y+H+ I HRD+K N+LLD
Sbjct: 126 RASRHYAKLKQTMPMLLIKLYMYQL----LRSLAYIHSI---GICHRDIKPQNLLLDPPS 178
Query: 727 RA-KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELI 784
K+ DFG +K + G +VS I + Y PE + T D++S G ++ EL+
Sbjct: 179 GVLKLIDFGSAKILIAGEPNVSYIC--SRYYRAPELIFGATNYTTNIDIWSTGCVMAELM 236
Query: 785 SGQ 787
GQ
Sbjct: 237 QGQ 239
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 1e-21
Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 33/214 (15%)
Query: 592 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 647
K IG G FG V KLK+ ++ A+K+L + E F E +L + +
Sbjct: 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT- 138
Query: 648 LGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------G 698
L Y Q++ LV ++ G L L E R+ E+ A+
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLS---KFEDRLP--------EEMARFYLAEMVIA 187
Query: 699 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 758
I+ +H +HRD+K NIL+D + +++DFG ++ + SS+ GT Y+
Sbjct: 188 IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244
Query: 759 PEYYISQQLTDKS-----DVYSFGVILLELISGQ 787
PE + + D +S GV + E++ G+
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 39/214 (18%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL------TSNSYQGKREFTNEVTLLSRIHHR 642
L K IG G F V + + G+E+A+K++ ++ + RE V ++ ++H
Sbjct: 19 LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFRE----VRIMKILNHP 74
Query: 643 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK----- 697
N+V+ + E L+ E+ G + ++L + + E A+
Sbjct: 75 NIVKLFEVIETEKTLYLIMEYASGGEVFDYL------------VAHGRMKEKEARSKFRQ 122
Query: 698 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 754
++Y H I+HRDLK+ N+LLD M K++DFG S G + + G
Sbjct: 123 IVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFC-GAP 177
Query: 755 GYLDPEYYISQQLTD--KSDVYSFGVILLELISG 786
Y PE + D + DV+S GVIL L+SG
Sbjct: 178 PYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSG 210
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 62/307 (20%), Positives = 111/307 (36%), Gaps = 70/307 (22%)
Query: 581 SDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSR 638
+ D ++ ++ +G G G V + G++ A+K+L EV +
Sbjct: 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY------DSPKARQEVDHHWQ 77
Query: 639 I-HHRNLVQFLGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA- 692
++V L + ++ E M G L RI +R + A
Sbjct: 78 ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFS----------RI--QERGDQAF 125
Query: 693 --EDAAK-------GIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAV 740
+AA+ I++LH+ I HRD+K N+L +K K++DFG +K
Sbjct: 126 TEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182
Query: 741 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR 800
A + + T Y+ PE ++ D++S GVI+ L+ G F +N
Sbjct: 183 QNA--LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP-----FYSNTG 234
Query: 801 NIVQWAKLH-IESGDIQGIIDPSLLDEYDIQSMW-KIEEKA------LMCVLPHGHMRPS 852
+ I G + W ++ E A L+ P R +
Sbjct: 235 QAISPGMKRRIRLGQY------GFPNPE-----WSEVSEDAKQLIRLLLKTDP--TERLT 281
Query: 853 ISEVLKD 859
I++ +
Sbjct: 282 ITQFMNH 288
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 3e-21
Identities = 58/255 (22%), Positives = 99/255 (38%), Gaps = 47/255 (18%)
Query: 554 HRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKE 612
H + P P ++ + I D K+ + +G G G V K ++
Sbjct: 30 HPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEK 89
Query: 613 IAVKVLTSNSYQGKRE-FTNEVTLLSRI-HHRNLVQFLGYCQEEGRSV----LVYEFMHN 666
A+K+L EV L R ++V+ + + +V E +
Sbjct: 90 FALKMLQ------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 143
Query: 667 GTLKEHLYGTLTHEQRINWIKRLEIA---EDAA-------KGIEYLHT-GCVPAIIHRDL 715
G L RI R + A +A+ + I+YLH+ I HRD+
Sbjct: 144 GELFS----------RI--QDRGDQAFTEREASEIMKSIGEAIQYLHSIN----IAHRDV 187
Query: 716 KSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS- 771
K N+L + K++DFG +K + +++ T Y+ PE + + DKS
Sbjct: 188 KPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPC-YTPYYVAPE-VLGPEKYDKSC 244
Query: 772 DVYSFGVILLELISG 786
D++S GVI+ L+ G
Sbjct: 245 DMWSLGVIMYILLCG 259
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 5e-21
Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 38/223 (17%)
Query: 578 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEV 633
L + K +G+G FG V K K+ A+K+L ++ NE
Sbjct: 38 AQLDQFD-----RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 634 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 693
+L ++ LV+ ++ +V E++ G + HL R + E
Sbjct: 93 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFS--------E 140
Query: 694 DAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745
A+ EYLH+ +I+RDLK N+L+D+ +V+DFG +K
Sbjct: 141 PHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193
Query: 746 VSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 787
+ + GT L PE I + +K+ D ++ GV++ E+ +G
Sbjct: 194 RTWTLCGTPEALAPE-IILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 5e-21
Identities = 60/223 (26%), Positives = 106/223 (47%), Gaps = 38/223 (17%)
Query: 578 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEV 633
++L D + + + +G+G FG V+ + + A+KVL ++ +E
Sbjct: 3 YSLQDFQ-----ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDER 57
Query: 634 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 693
+LS + H +++ G Q+ + ++ +++ G L L QR
Sbjct: 58 LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR----KSQRFP--------N 105
Query: 694 DAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745
AK +EYLH+ II+RDLK NILLDK+ K++DFG +K+ D
Sbjct: 106 PVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-- 160
Query: 746 VSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 787
+ GT Y+ PE +S + +KS D +SFG+++ E+++G
Sbjct: 161 --YTLCGTPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 6e-21
Identities = 68/251 (27%), Positives = 103/251 (41%), Gaps = 23/251 (9%)
Query: 545 KKNNYDKEQHRHSLPVQRP-VSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVY 603
KK + R P + + A+ H T+++ E K +G G FG V
Sbjct: 111 KKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFE-----YLKLLGKGTFGKVI 165
Query: 604 YGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQFLGYC-QEEGRSV 658
K K A+K+L K E + E +L H L L Y Q R
Sbjct: 166 LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA-LKYSFQTHDRLC 224
Query: 659 LVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK 716
V E+ + G L HL + E R R AE ++YLH+ +++RDLK
Sbjct: 225 FVMEYANGGELFFHLSRERVFS-EDRA----RFYGAE-IVSALDYLHSEK--NVVYRDLK 276
Query: 717 SSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSF 776
N++LDK K++DFGL K + + + + GT YL PE D +
Sbjct: 277 LENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDNDYGRAVDWWGL 335
Query: 777 GVILLELISGQ 787
GV++ E++ G+
Sbjct: 336 GVVMYEMMCGR 346
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 7e-21
Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 40/215 (18%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-------TSNSYQGKREFTNEVTLLSRIHH 641
L +G G FG V GK G ++AVK+L + +RE + L H
Sbjct: 20 LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRRE----IQNLKLFRH 75
Query: 642 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK---- 697
++++ +V E++ G L +++ K + E ++
Sbjct: 76 PHIIKLYQVISTPSDIFMVMEYVSGGELFDYI------------CKNGRLDEKESRRLFQ 123
Query: 698 ----GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 753
G++Y H V +HRDLK N+LLD HM AK++DFGLS DG +S G+
Sbjct: 124 QILSGVDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--GS 178
Query: 754 VGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 786
Y PE IS +L + D++S GVIL L+ G
Sbjct: 179 PNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCG 212
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 9e-21
Identities = 61/245 (24%), Positives = 100/245 (40%), Gaps = 71/245 (28%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-------------------TSNSYQGKREF 629
L+ +IG G +GVV D A+KVL T + G +
Sbjct: 17 LKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQP 76
Query: 630 TN-------EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY-------- 674
E+ +L ++ H N+V+ + E + + ++HLY
Sbjct: 77 RGPIEQVYQEIAILKKLDHPNVVK-------------LVEVLDDPN-EDHLYMVFELVNQ 122
Query: 675 GTLTHEQRINWIKRLEIAEDAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHM 726
G + + ++ED A+ GIEYLH IIHRD+K SN+L+ +
Sbjct: 123 GPV-----MEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDG 174
Query: 727 RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD----KSDVYSFGVILLE 782
K++DFG+S + +S+ V GT ++ PE +S+ DV++ GV L
Sbjct: 175 HIKIADFGVSNEFKGSDALLSNTV-GTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYC 232
Query: 783 LISGQ 787
+ GQ
Sbjct: 233 FVFGQ 237
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-20
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 589 MLEKKIGSGGFGVVYYGKLKD-GKEIAVK-VLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 646
+E+ G G FG V GK K G +A+K V+ ++ RE + L+ +HH N+VQ
Sbjct: 26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-NRELQ-IMQDLAVLHHPNIVQ 83
Query: 647 ----FLGYCQEEGRSV---LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 697
F + + R + +V E++ TL R + +++ K
Sbjct: 84 LQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCC--------RNYYRRQVAPPPILIKVF 134
Query: 698 ------GIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIV 750
I LH V + HRD+K N+L+++ K+ DFG +K +V+ I
Sbjct: 135 LFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC 193
Query: 751 RGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 787
+ Y PE +Q T D++S G I E++ G+
Sbjct: 194 --SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-20
Identities = 73/247 (29%), Positives = 109/247 (44%), Gaps = 27/247 (10%)
Query: 550 DKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD 609
+ + + P P +N P+ H SD K IG G FG V + K
Sbjct: 8 PELMNANPAPPPAPSQQINLGPSSNPH-AKPSDFH-----FLKVIGKGSFGKVLLARHKA 61
Query: 610 GKEI-AVKVLTSNSYQGKREFTNEVT----LLSRIHHRNLVQFLGYC-QEEGRSVLVYEF 663
+ AVKVL + K+E + ++ LL + H LV L + Q + V ++
Sbjct: 62 EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG-LHFSFQTADKLYFVLDY 120
Query: 664 MHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 721
++ G L HL E R R AE A + YLH+ I++RDLK NIL
Sbjct: 121 INGGELFYHLQRERCFL-EPRA----RFYAAE-IASALGYLHSL---NIVYRDLKPENIL 171
Query: 722 LDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVIL 780
LD ++DFGL K ++ S S+ GT YL PE + +Q D++ D + G +L
Sbjct: 172 LDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLAPE-VLHKQPYDRTVDWWCLGAVL 229
Query: 781 LELISGQ 787
E++ G
Sbjct: 230 YEMLYGL 236
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 5e-20
Identities = 68/218 (31%), Positives = 98/218 (44%), Gaps = 39/218 (17%)
Query: 589 MLEKKIGSGGFGVVYYGKLKD-GKEIAVK-VLTSNSYQGKREFTN-EVTLLSRIHHRNLV 645
K IG+G FGVVY KL D G+ +A+K VL Q KR F N E+ ++ ++ H N+V
Sbjct: 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKR-FKNRELQIMRKLDHCNIV 110
Query: 646 QFLGYCQEEGRSV------LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 697
+ + G LV +++ E +Y H R + K
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAK----QTLPVIYVKLY 161
Query: 698 ------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIV 750
+ Y+H+ I HRD+K N+LLD K+ DFG +K V G +VS I
Sbjct: 162 MYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 218
Query: 751 RGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 787
+ Y PE + T DV+S G +L EL+ GQ
Sbjct: 219 --SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 5e-20
Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 34/213 (15%)
Query: 592 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 647
K IG G FG V + K +++ A+K+L+ + + F E +++ + +VQ
Sbjct: 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ- 133
Query: 648 LGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------G 698
L Y Q++ +V E+M G L + ++ E A+
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVNLM-------------SNYDVPEKWARFYTAEVVLA 180
Query: 699 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 758
++ +H+ IHRD+K N+LLDK K++DFG GT Y+
Sbjct: 181 LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 237
Query: 759 PEYYISQQLT---DKS-DVYSFGVILLELISGQ 787
PE SQ + D +S GV L E++ G
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-20
Identities = 54/216 (25%), Positives = 97/216 (44%), Gaps = 43/216 (19%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-------TSNSYQGKREFTNEVTLLSRIHH 641
+ + +G G FG V K +++A+K + + + +RE ++ L + H
Sbjct: 13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVERE----ISYLKLLRH 68
Query: 642 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK---- 697
++++ V+V E+ G L +++ +++ + ED +
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEYA-GGELFDYI------------VEKKRMTEDEGRRFFQ 115
Query: 698 ----GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRG 752
IEY H I+HRDLK N+LLD ++ K++DFGLS DG S G
Sbjct: 116 QIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---G 169
Query: 753 TVGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 786
+ Y PE I+ +L + DV+S G++L ++ G
Sbjct: 170 SPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVG 204
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 7e-20
Identities = 24/203 (11%), Positives = 56/203 (27%), Gaps = 43/203 (21%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLV 645
L G + +++A+ + +E + LSRI +
Sbjct: 35 LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 646 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH-T 704
+ L ++V E++ G+L+E + + + + A + H
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGA------IRAMQSLAAAADAAHRA 148
Query: 705 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 764
G + S + + ++ T+ +P+
Sbjct: 149 G----VALSIDHPSRVRVSIDGDVVLAYP------------------ATMPDANPQ---- 182
Query: 765 QQLTDKSDVYSFGVILLELISGQ 787
D+ G L L+ +
Sbjct: 183 ------DDIRGIGASLYALLVNR 199
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 1e-19
Identities = 70/232 (30%), Positives = 116/232 (50%), Gaps = 27/232 (11%)
Query: 566 SLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVY---YGKLKDGKEI-AVKVLTSN 621
++ E S E L K +G G FG V+ D +++ A+KVL
Sbjct: 9 AITHHVKEGHEKADPSQFE-----LLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKA 63
Query: 622 SYQGKREF--TNEVTLLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GT 676
+ + + E +L ++H +V+ L Y Q EG+ L+ +F+ G L L
Sbjct: 64 TLKVRDRVRTKMERDILVEVNHPFIVK-LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM 122
Query: 677 LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 736
T E+ + + +AE A +++LH+ II+RDLK NILLD+ K++DFGLS
Sbjct: 123 FT-EEDV----KFYLAE-LALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLS 173
Query: 737 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 787
K ++D S GTV Y+ PE ++++ +S D +SFGV++ E+++G
Sbjct: 174 KESIDHEKKAYSFC-GTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-19
Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 32/210 (15%)
Query: 592 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQF 647
K +G G FG V + K A+K+L K E + E +L H L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA- 69
Query: 648 LGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------G 698
L Y Q R V E+ + G L HL E+ E+ A+
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFT--------EERARFYGAEIVSA 117
Query: 699 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 758
+EYLH+ +++RD+K N++LDK K++DFGL K + + + + GT YL
Sbjct: 118 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLA 173
Query: 759 PEYYISQQLTDKS-DVYSFGVILLELISGQ 787
PE + ++ D + GV++ E++ G+
Sbjct: 174 PE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 6e-19
Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 36/214 (16%)
Query: 592 KKIGSGGFGVVY---YGKLKDGKEI-AVKVLTSNSYQGKREFT----NEVTLLSRIHHRN 643
+ +G GG+G V+ + +I A+KVL + T E +L + H
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 644 LVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK----- 697
+V L Y Q G+ L+ E++ G L L E ED A
Sbjct: 83 IVD-LIYAFQTGGKLYLILEYLSGGELFMQLE----REGIFM--------EDTACFYLAE 129
Query: 698 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 754
+ +LH II+RDLK NI+L+ K++DFGL K ++ + + GT+
Sbjct: 130 ISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTI 185
Query: 755 GYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 787
Y+ PE + + +++ D +S G ++ ++++G
Sbjct: 186 EYMAPE-ILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 9e-19
Identities = 48/205 (23%), Positives = 95/205 (46%), Gaps = 21/205 (10%)
Query: 592 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLG 649
+K+G G + V+ + + +++ VK+L K++ E+ +L + N++
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLAD 98
Query: 650 --YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
LV+E ++N K LY TLT ++ + K ++Y H+
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFK-QLYQTLTDYDIRFYMYEI------LKALDYCHSM-- 149
Query: 708 PAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 766
I+HRD+K N+++D R ++ D+GL++F G + + + + PE + Q
Sbjct: 150 -GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA--SRYFKGPELLVDYQ 206
Query: 767 LTDKS-DVYSFGVILLELISGQEAI 790
+ D S D++S G +L +I +E
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 1e-18
Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 23/205 (11%)
Query: 592 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLVQ 646
+K+G G +GVVY K G+ +A+K + ++ + E T E++LL +HH N+V
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDA---EDEGIPSTAIREISLLKELHHPNIVS 83
Query: 647 FLGYCQEEGRSVLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 704
+ E LV+EFM + + L Q ++ +L +G+ + H
Sbjct: 84 LIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL------LRGVAHCHQ 137
Query: 705 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 763
I+HRDLK N+L++ K++DFGL++ F + S+ +V T+ Y P+ +
Sbjct: 138 HR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPDVLM 192
Query: 764 -SQQLTDKSDVYSFGVILLELISGQ 787
S++ + D++S G I E+I+G+
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 25/212 (11%)
Query: 589 MLEK-----KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTN--EVTLLSRIH 640
M+EK KIG G +GVV+ + +D G+ +A+K + + E+ +L ++
Sbjct: 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK 60
Query: 641 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRI-NWIKRLEIAEDAAK 697
H NLV L + + R LV+E+ + T+ L Y E + + + +
Sbjct: 61 HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQT------LQ 113
Query: 698 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGY 756
+ + H IHRD+K NIL+ KH K+ DFG ++ + + T Y
Sbjct: 114 AVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA--TRWY 168
Query: 757 LDPEYYISQQLTDKS-DVYSFGVILLELISGQ 787
PE + DV++ G + EL+SG
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 3e-18
Identities = 63/243 (25%), Positives = 103/243 (42%), Gaps = 40/243 (16%)
Query: 561 QRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLT 619
+ N +++ + + E + +G G FG V ++K+ ++ AVKVL
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDNFE-----FIRVLGKGSFGKVMLARVKETGDLYAVKVL- 56
Query: 620 SNSYQGKREF---TNEVT--------LLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMHNG 667
K++ ++V L +H L Q L C Q R V EF++ G
Sbjct: 57 ------KKDVILQDDDVECTMTEKRILSLARNHPFLTQ-LFCCFQTPDRLFFVMEFVNGG 109
Query: 668 TLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH 725
L H+ E R R AE + +LH II+RDLK N+LLD
Sbjct: 110 DLMFHIQKSRRFD-EARA----RFYAAE-IISALMFLHDK---GIIYRDLKLDNVLLDHE 160
Query: 726 MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELI 784
K++DFG+ K + ++ GT Y+ PE + + L + D ++ GV+L E++
Sbjct: 161 GHCKLADFGMCKEGICNGVTTATFC-GTPDYIAPE-ILQEMLYGPAVDWWAMGVLLYEML 218
Query: 785 SGQ 787
G
Sbjct: 219 CGH 221
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 4e-18
Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 592 KKIGSGGFGVVYYGKLKDGKEI-AVK-VLTSNSYQGKREFTN--EVTLLSRIHHRNLVQF 647
+G G +G+V + KD I A+K L S+ + + E+ LL ++ H NLV
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK-KIAMREIKLLKQLRHENLVNL 89
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHT 704
L C+++ R LV+EF+ + T+ + L + Q + ++ ++ GI + H+
Sbjct: 90 LEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQI------INGIGFCHS 142
Query: 705 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 763
IIHRD+K NIL+ + K+ DFG ++ A G + + T Y PE +
Sbjct: 143 HN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA--TRWYRAPELLV 197
Query: 764 -SQQLTDKSDVYSFGVILLELISGQ 787
+ DV++ G ++ E+ G+
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 63/230 (27%), Positives = 101/230 (43%), Gaps = 41/230 (17%)
Query: 578 FTLSDIEDATKMLEKKIGSGGFGVVY---YGKLKDGKEI-AVKVLTSNSYQGKREFT--- 630
+ + E L K +G+G +G V+ D ++ A+KVL + K + T
Sbjct: 51 VGIENFE-----LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT 105
Query: 631 -NEVTLLSRI-HHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK 687
E +L I LV L Y Q E + L+ ++++ G L HL +R
Sbjct: 106 RTERQVLEHIRQSPFLVT-LHYAFQTETKLHLILDYINGGELFTHLS----QRERFT--- 157
Query: 688 RLEIAEDAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 739
E + +E+LH II+RD+K NILLD + ++DFGLSK
Sbjct: 158 -----EHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209
Query: 740 VDGASHVSSIVRGTVGYLDPE-YYISQQLTDKS-DVYSFGVILLELISGQ 787
V + + GT+ Y+ P+ DK+ D +S GV++ EL++G
Sbjct: 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 7e-18
Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 23/204 (11%)
Query: 593 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLVQF 647
KIG G +GVVY + G+ A+K + + E T E+++L + H N+V+
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEK---EDEGIPSTTIREISILKELKHSNIVKL 65
Query: 648 LGYCQEEGRSVLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 705
+ R VLV+E + L + G L +++ +L GI Y H
Sbjct: 66 YDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL------LNGIAYCHDR 119
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI- 763
++HRDLK N+L+++ K++DFGL++ F + + IV T+ Y P+ +
Sbjct: 120 R---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPDVLMG 174
Query: 764 SQQLTDKSDVYSFGVILLELISGQ 787
S++ + D++S G I E+++G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 7e-18
Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 592 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVT----LLSRIHHRNLVQ 646
+ IG G + V +LK I A+KV+ + T +H LV
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 647 FLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLH 703
L C Q E R V E+++ G L H+ L E+ R AE + + YLH
Sbjct: 75 -LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP-EEHA----RFYSAE-ISLALNYLH 127
Query: 704 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 763
II+RDLK N+LLD K++D+G+ K + S+ GT Y+ PE +
Sbjct: 128 ER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPE-IL 182
Query: 764 SQQLTDKS-DVYSFGVILLELISGQ 787
+ S D ++ GV++ E+++G+
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 8e-18
Identities = 58/210 (27%), Positives = 102/210 (48%), Gaps = 30/210 (14%)
Query: 593 KIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGK-----REFTNEVTLLSRIHHRNLVQ 646
K+G+G + VY G K A+K + +S +G RE ++L+ + H N+V+
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISLMKELKHENIVR 67
Query: 647 FLGYCQEEGRSVLVYEFMHNGTLKEH-LYGTLTHEQRINWIKRLEIAEDAA------KGI 699
E + LV+EFM ++ L + N + LE+ +G+
Sbjct: 68 LYDVIHTENKLTLVFEFM------DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 700 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLD 758
+ H I+HRDLK N+L++K + K+ DFGL++ F + + S +V T+ Y
Sbjct: 122 AFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLWYRA 176
Query: 759 PEYYI-SQQLTDKSDVYSFGVILLELISGQ 787
P+ + S+ + D++S G IL E+I+G+
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 87.0 bits (215), Expect = 9e-18
Identities = 60/204 (29%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 592 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVT----LLSRIHHRNLVQ 646
+G G FG V + K E+ AVK+L + + + L L Q
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 647 FLGYC-QEEGRSVLVYEFMHNGTLKEHLYGT-LTHEQRINWIKRLEIAEDAAKGIEYLHT 704
L C Q R V E+++ G L H+ E AE A G+ +L +
Sbjct: 407 -LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA----VFYAAE-IAIGLFFLQS 460
Query: 705 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 764
II+RDLK N++LD K++DFG+ K + + GT Y+ PE I+
Sbjct: 461 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPE-IIA 515
Query: 765 QQLTDKS-DVYSFGVILLELISGQ 787
Q KS D ++FGV+L E+++GQ
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 57/235 (24%), Positives = 98/235 (41%), Gaps = 49/235 (20%)
Query: 583 IEDATKMLEKKIGSGGFGVVYYGKLKD---GKEIAVKVLTSNSYQGKREFTN--EVTLLS 637
+ED + K+G G +G VY K KD K+ A+K + + E+ LL
Sbjct: 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLR 73
Query: 638 RIHHRNLVQFLGYCQEEG-RSV-LVYEFMHNGTLKEH-LYGTL-THEQRINWIKRLEIAE 693
+ H N++ R V L++++ EH L+ + H K +++
Sbjct: 74 ELKHPNVISLQKVFLSHADRKVWLLFDYA------EHDLWHIIKFHRASKANKKPVQLPR 127
Query: 694 DAAK--------GIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKF--- 738
K GI YLH ++HRDLK +NIL+ + R K++D G ++
Sbjct: 128 GMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 739 AVDGASHVSSIVRGTVGYLDPE------YYISQQLTDKSDVYSFGVILLELISGQ 787
+ + + +V T Y PE +Y T D+++ G I EL++ +
Sbjct: 185 PLKPLADLDPVVV-TFWYRAPELLLGARHY-----TKAIDIWAIGCIFAELLTSE 233
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 61/236 (25%), Positives = 100/236 (42%), Gaps = 26/236 (11%)
Query: 561 QRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLT 619
+ + +A+ L D + L + IG G + V +LK I A++V+
Sbjct: 32 EEKEAMNTRESGKASSSLGLQDFD-----LLRVIGRGSYAKVLLVRLKKTDRIYAMRVVK 86
Query: 620 SNSYQGKREFTNEVT----LLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLY 674
+ T +H LV L C Q E R V E+++ G L H+
Sbjct: 87 KELVNDDEDIDWVQTEKHVFEQASNHPFLVG-LHSCFQTESRLFFVIEYVNGGDLMFHMQ 145
Query: 675 --GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 732
L E+ R AE + + YLH II+RDLK N+LLD K++D
Sbjct: 146 RQRKLP-EEHA----RFYSAE-ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTD 196
Query: 733 FGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 787
+G+ K + S+ GT Y+ PE + + S D ++ GV++ E+++G+
Sbjct: 197 YGMCKEGLRPGDTTSTFC-GTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-17
Identities = 21/116 (18%), Positives = 42/116 (36%), Gaps = 15/116 (12%)
Query: 402 PVPWSWLQCNSDPQPSITVIHLSSKNLTGNIP-SDLTKLSSLV-----------EFG-CP 448
W+ + + + +S ++G++ S L L G C
Sbjct: 166 ANVVGWVLSDGCG--ELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPFLGDCS 223
Query: 449 DLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 504
L+ + + N+L+G ++ L+ L + +N G +P L L+ A N
Sbjct: 224 ALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAEN 279
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-16
Identities = 33/111 (29%), Positives = 47/111 (42%), Gaps = 19/111 (17%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLV---------------EFG-CPDLRIIHLEDNQ 459
+ +HLS L+G IPS L LS L E L + L+ N
Sbjct: 418 SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND 477
Query: 460 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLH 508
LTG +PS L N NL + + NN L+G +P + L +L + N +
Sbjct: 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNN-SFS 527
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-16
Identities = 30/91 (32%), Positives = 46/91 (50%), Gaps = 11/91 (12%)
Query: 402 PVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLT 461
P+ + Q P+ ++ ++L + TG IP L+ S L +HL N L+
Sbjct: 383 PILPNLCQN---PKNTLQELYLQNNGFTGKIPPTLSNCSEL--------VSLHLSFNYLS 431
Query: 462 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 492
G +PSSL +L LR+L + NML G +P L
Sbjct: 432 GTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL 462
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-15
Identities = 26/126 (20%), Positives = 51/126 (40%), Gaps = 15/126 (11%)
Query: 402 PVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLT 461
+P C ++ I LS+ LTG IP + +L +L I+ L +N +
Sbjct: 481 EIPSGLSNC-----TNLNWISLSNNRLTGEIPKWIGRLENL--------AILKLSNNSFS 527
Query: 462 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHEGGRGAKHLNI 519
G +P+ L + +L L + N+ +GT+P+++ S + N+
Sbjct: 528 GNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKEC 587
Query: 520 IIGSSV 525
++
Sbjct: 588 HGAGNL 593
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-15
Identities = 24/94 (25%), Positives = 35/94 (37%), Gaps = 14/94 (14%)
Query: 402 PVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLT 461
P+P L S+ + L+ TG IP L+ C L + L N
Sbjct: 262 PIPPLPL-------KSLQYLSLAENKFTGEIPDFLSGA-------CDTLTGLDLSGNHFY 307
Query: 462 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 495
G +P + L L + +N SG +P L K
Sbjct: 308 GAVPPFFGSCSLLESLALSSNNFSGELPMDTLLK 341
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-14
Identities = 25/93 (26%), Positives = 42/93 (45%), Gaps = 12/93 (12%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLP-SSLMNLPNL 474
++T + LS + G +P S L + L N +G LP +L+ + L
Sbjct: 294 DTLTGLDLSGNHFYGAVPPFFGSCSLL--------ESLALSSNNFSGELPMDTLLKMRGL 345
Query: 475 RELYVQNNMLSGTVPSSL--LSKN-VVLNYAGN 504
+ L + N SG +P SL LS + + L+ + N
Sbjct: 346 KVLDLSFNEFSGELPESLTNLSASLLTLDLSSN 378
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-14
Identities = 17/86 (19%), Positives = 37/86 (43%), Gaps = 10/86 (11%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
++ + +S L+G+ ++ + L +++++ NQ GP+P L +L+
Sbjct: 223 SALQHLDISGNKLSGDFSRAISTCTEL--------KLLNISSNQFVGPIPPL--PLKSLQ 272
Query: 476 ELYVQNNMLSGTVPSSLLSKNVVLNY 501
L + N +G +P L L
Sbjct: 273 YLSLAENKFTGEIPDFLSGACDTLTG 298
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 8e-14
Identities = 27/93 (29%), Positives = 41/93 (44%), Gaps = 13/93 (13%)
Query: 402 PVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLT 461
+P L + V+ LS +G +P LT LS L + L N +
Sbjct: 333 ELPMDTLL----KMRGLKVLDLSFNEFSGELPESLTNLS-------ASLLTLDLSSNNFS 381
Query: 462 GPLPSSLMN--LPNLRELYVQNNMLSGTVPSSL 492
GP+ +L L+ELY+QNN +G +P +L
Sbjct: 382 GPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-13
Identities = 21/90 (23%), Positives = 44/90 (48%), Gaps = 10/90 (11%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 476
S+ + +S L+G IP ++ + L I++L N ++G +P + +L L
Sbjct: 633 SMMFLDMSYNMLSGYIPKEIGSMPYL--------FILNLGHNDISGSIPDEVGDLRGLNI 684
Query: 477 LYVQNNMLSGTVPSSL--LSKNVVLNYAGN 504
L + +N L G +P ++ L+ ++ + N
Sbjct: 685 LDLSSNKLDGRIPQAMSALTMLTEIDLSNN 714
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-12
Identities = 20/90 (22%), Positives = 38/90 (42%), Gaps = 8/90 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
S+ V+ LS+ +++G +L+ + + N+++G + S NL
Sbjct: 151 NSLEVLDLSANSISGANVVGWVLSDGC-----GELKHLAISGNKISGDVDVS--RCVNLE 203
Query: 476 ELYVQNNMLSGTVPS-SLLSKNVVLNYAGN 504
L V +N S +P S L+ +GN
Sbjct: 204 FLDVSSNNFSTGIPFLGDCSALQHLDISGN 233
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-12
Identities = 21/111 (18%), Positives = 38/111 (34%), Gaps = 22/111 (19%)
Query: 416 PSITVIHLSSKNLTGNIPSD-----LTKLSSL--------------VEFGCPDLRIIHLE 456
S+T + LS +L+G + + + L L L ++ L
Sbjct: 100 ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS 159
Query: 457 DNQLTGPLPSSLM---NLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 504
N ++G + L+ L + N +SG V S L+ + N
Sbjct: 160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSN 210
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-11
Identities = 14/77 (18%), Positives = 35/77 (45%), Gaps = 8/77 (10%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
+ +++S+ G+ S++ + + N L+G +P + ++P L
Sbjct: 608 STRNPCNITSRVYGGHTSPTFDNNGSMM--------FLDMSYNMLSGYIPKEIGSMPYLF 659
Query: 476 ELYVQNNMLSGTVPSSL 492
L + +N +SG++P +
Sbjct: 660 ILNLGHNDISGSIPDEV 676
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 7e-10
Identities = 23/92 (25%), Positives = 41/92 (44%), Gaps = 9/92 (9%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 476
+ +++L +++G+IP ++ L L DL N+L G +P ++ L L E
Sbjct: 657 YLFILNLGHNDISGSIPDEVGDLRGLNIL---DL-----SSNKLDGRIPQAMSALTMLTE 708
Query: 477 LYVQNNMLSGTVPSS-LLSKNVVLNYAGNINL 507
+ + NN LSG +P + N L
Sbjct: 709 IDLSNNNLSGPIPEMGQFETFPPAKFLNNPGL 740
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-09
Identities = 30/124 (24%), Positives = 45/124 (36%), Gaps = 27/124 (21%)
Query: 390 ADWAQEGGDPCLPVPWSWL--QCNSDPQPSITVIHLSSKNLT---GNIPSDLTKLSSLVE 444
DW +PC ++ C D +T I LSSK L + S L L+ L
Sbjct: 31 PDW-SSNKNPC-----TFDGVTCRDD---KVTSIDLSSKPLNVGFSAVSSSLLSLTGL-- 79
Query: 445 FGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL----LSKNVVLN 500
+ L ++ + G + +L L + N LSG V + S LN
Sbjct: 80 ------ESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLN 132
Query: 501 YAGN 504
+ N
Sbjct: 133 VSSN 136
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 4e-08
Identities = 17/95 (17%), Positives = 31/95 (32%), Gaps = 10/95 (10%)
Query: 412 SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNL 471
+D + G L +LS+ ++ G + N
Sbjct: 580 NDGMKKECHGAGNLLEFQGIRSEQLNRLSTR--------NPCNITSRVYGGHTSPTFDNN 631
Query: 472 PNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 504
++ L + NMLSG +P + + +LN N
Sbjct: 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHN 666
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 63/212 (29%), Positives = 94/212 (44%), Gaps = 35/212 (16%)
Query: 592 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREF---TNEVT--------LLSRI 639
+G G FG V + K E+ AVK+L K++ ++V L
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKIL-------KKDVVIQDDDVECTMVEKRVLALPG 78
Query: 640 HHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAA 696
L Q L C Q R V E+++ G L H+ G E AE A
Sbjct: 79 KPPFLTQ-LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK-EPHA----VFYAAE-IA 131
Query: 697 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 756
G+ +L + II+RDLK N++LD K++DFG+ K + + GT Y
Sbjct: 132 IGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDY 187
Query: 757 LDPEYYISQQLTDKS-DVYSFGVILLELISGQ 787
+ PE I+ Q KS D ++FGV+L E+++GQ
Sbjct: 188 IAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 51/208 (24%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 593 KIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLVQ 646
KIG G +G V+ K ++ EI A+K + + E + E+ LL + H+N+V+
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKELKHKNIVR 65
Query: 647 FLGYCQEEGRSVLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 704
+ + LV+EF + G L E +++ +L KG+ + H+
Sbjct: 66 LHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL------LKGLGFCHS 119
Query: 705 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 763
++HRDLK N+L++++ K+++FGL++ F + + + +V T+ Y P+
Sbjct: 120 RN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLF 174
Query: 764 -SQQLTDKSDVYSFGVILLELISGQEAI 790
++ + D++S G I EL + +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 592 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVT----LLSRIHHRNLVQ 646
K +G G FG V+ + K + A+K L + + + L H L
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 647 FLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLH 703
+ Q + V E+++ G L H+ + AE G+++LH
Sbjct: 83 -MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA-----TFYAAE-IILGLQFLH 135
Query: 704 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 763
+ I++RDLK NILLDK K++DFG+ K + G + ++ GT Y+ PE +
Sbjct: 136 SK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPE-IL 190
Query: 764 SQQLTDKS-DVYSFGVILLELISGQ 787
Q + S D +SFGV+L E++ GQ
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 4e-17
Identities = 25/92 (27%), Positives = 42/92 (45%), Gaps = 11/92 (11%)
Query: 416 PSITVIHLSSKN-LTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNL 474
P + +++ N L G IP + KL+ L +++ ++G +P L + L
Sbjct: 76 PYLNFLYIGGINNLVGPIPPAIAKLTQL--------HYLYITHTNVSGAIPDFLSQIKTL 127
Query: 475 RELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 504
L N LSGT+P S+ L V + + GN
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 21/77 (27%), Positives = 39/77 (50%), Gaps = 8/77 (10%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
+ ++++ N++G IP L+++ +L + N L+G LP S+ +LPNL
Sbjct: 101 TQLHYLYITHTNVSGAIPDFLSQIKTL--------VTLDFSYNALSGTLPPSISSLPNLV 152
Query: 476 ELYVQNNMLSGTVPSSL 492
+ N +SG +P S
Sbjct: 153 GITFDGNRISGAIPDSY 169
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-15
Identities = 26/107 (24%), Positives = 39/107 (36%), Gaps = 16/107 (14%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLV--------------EFG-CPDLRIIHLEDNQLT 461
++ + LS L G+ + + G +L + L +N++
Sbjct: 198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIY 257
Query: 462 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSL-LSKNVVLNYAGNINL 507
G LP L L L L V N L G +P L + V YA N L
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 32/129 (24%), Positives = 55/129 (42%), Gaps = 16/129 (12%)
Query: 382 SVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP-SITVIHLSSKNLTG--NIPSDLTK 438
+ + + + W C W + C++D Q + + LS NL IPS L
Sbjct: 17 DLGNPTTLSSWL--PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLAN 74
Query: 439 LSSLVEFGCPDLRIIHLED-NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSK 495
L L +++ N L GP+P ++ L L LY+ + +SG +P L +
Sbjct: 75 LPY--------LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKT 126
Query: 496 NVVLNYAGN 504
V L+++ N
Sbjct: 127 LVTLDFSYN 135
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 5e-15
Identities = 19/92 (20%), Positives = 39/92 (42%), Gaps = 19/92 (20%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 476
++ + S L+G +P ++ L +L I + N+++G +P S + L
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNL--------VGITFDGNRISGAIPDSYGSFSKLFT 177
Query: 477 -LYVQNNMLSGTVPSSLLSKNVVLNYAGNINL 507
+ + N L+G +P + N+NL
Sbjct: 178 SMTISRNRLTGKIPPTF----------ANLNL 199
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 22/91 (24%), Positives = 35/91 (38%), Gaps = 10/91 (10%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
P++ I ++G IP S L + + N+LTG +P + NL NL
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTS-------MTISRNRLTGKIPPTFANL-NLA 200
Query: 476 ELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 504
+ + NML G ++ A N
Sbjct: 201 FVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 2e-12
Identities = 18/89 (20%), Positives = 33/89 (37%), Gaps = 13/89 (14%)
Query: 402 PVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLT 461
+P S+ + T + +S LTG IP L+ L + L N L
Sbjct: 164 AIPDSYGSFSK----LFTSMTISRNRLTGKIPPTFANLN---------LAFVDLSRNMLE 210
Query: 462 GPLPSSLMNLPNLRELYVQNNMLSGTVPS 490
G + N +++++ N L+ +
Sbjct: 211 GDASVLFGSDKNTQKIHLAKNSLAFDLGK 239
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 6e-07
Identities = 16/72 (22%), Positives = 26/72 (36%), Gaps = 10/72 (13%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
++ + L + + G +P LT+L L ++ N L G +P NL
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSL--------NVSFNNLCGEIPQGG-NLQRFD 294
Query: 476 ELYVQ-NNMLSG 486
N L G
Sbjct: 295 VSAYANNKCLCG 306
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 7e-17
Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 592 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLV 645
+G G F VY + + +A+K + ++ T E+ LL + H N++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 646 QFLGYCQEEGRSVLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 703
L + LV++FM + + LT ++ +G+EYLH
Sbjct: 76 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT------LQGLEYLH 129
Query: 704 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEY- 761
I+HRDLK +N+LLD++ K++DFGL+K F ++ +V T Y PE
Sbjct: 130 QHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV--TRWYRAPELL 184
Query: 762 YISQQLTDKSDVYSFGVILLELISGQ 787
+ ++ D+++ G IL EL+
Sbjct: 185 FGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 24/157 (15%)
Query: 593 KIGSGGFGVVYYGKLKDGKEI-AVK-VLTSNSYQGKREFTN--EVTLLSRIHHRNLVQFL 648
KIG G FG V+ + + + A+K VL N +G T E+ +L + H N+V +
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP-ITALREIKILQLLKHENVVNLI 82
Query: 649 GYCQEEGRSV--------LVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 698
C+ + LV++F + L ++ T + ++ L G
Sbjct: 83 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML------LNG 136
Query: 699 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 735
+ Y+H I+HRD+K++N+L+ + K++DFGL
Sbjct: 137 LYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 49/206 (23%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 592 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGK-----REFTNEVTLLSRIHHRNLV 645
K+G G + VY GK K +A+K + +G RE V+LL + H N+V
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDLKHANIV 63
Query: 646 QFLGYCQEEGRSVLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 703
E LV+E++ + + ++ +L +G+ Y H
Sbjct: 64 TLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQL------LRGLAYCH 117
Query: 704 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYY 762
++HRDLK N+L+++ K++DFGL++ ++ ++ + +V T+ Y P+
Sbjct: 118 RQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDIL 172
Query: 763 I-SQQLTDKSDVYSFGVILLELISGQ 787
+ S + + D++ G I E+ +G+
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 2e-16
Identities = 60/272 (22%), Positives = 95/272 (34%), Gaps = 83/272 (30%)
Query: 590 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQG-KREFTNEVTLLSRI-HH 641
L K +G G FG V + +AVK+L + R +E+ +L I HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 642 RN--------------------------LVQFL-------------GYCQEEGRSVLVYE 662
N L +L G +G+ +
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 663 FMH----------------NGTLKEHLYGTLTHEQRINWIKR--------LEIAEDAAKG 698
+ +G ++E + E+ + + + + AKG
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205
Query: 699 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 758
+E+L + IHRDL + NILL + K+ DFGL++ VR L
Sbjct: 206 MEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD----PDYVRKGDARLP 258
Query: 759 -----PEYYISQQLTDKSDVYSFGVILLELIS 785
PE + T +SDV+SFGV+L E+ S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 51/227 (22%), Positives = 82/227 (36%), Gaps = 66/227 (29%)
Query: 581 SDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSR 638
+ I D K+ + +G G G V K ++ A+K+L EV L R
Sbjct: 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ------DCPKARREVELHWR 66
Query: 639 I-HHRNLVQFLGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA- 692
++V+ + + +V E + G L RI R + A
Sbjct: 67 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFS----------RI--QDRGDQAF 114
Query: 693 --EDAA-------KGIEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFA 739
+A+ + I+YLH+ I HRD+K N+L + K++DFG +K
Sbjct: 115 TEREASEIMKSIGEAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-- 168
Query: 740 VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 786
G Y D D++S GVI+ L+ G
Sbjct: 169 ---------ETTGE-KY-DKS----------CDMWSLGVIMYILLCG 194
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 5e-16
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 592 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 647
K IGSG G+V + +A+K L+ N KR + E+ L+ ++H+N++
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGL 89
Query: 648 L-----GYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 701
L EE + V +V E M L + + L HE+ + ++ GI++
Sbjct: 90 LNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQM------LCGIKH 142
Query: 702 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 761
LH+ + IHRDLK SNI++ K+ DFGL++ A +V T Y PE
Sbjct: 143 LHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEV 197
Query: 762 YISQQLTDKSDVYSFGVILLELISGQ 787
+ + D++S G I+ E+I G
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 6e-16
Identities = 47/254 (18%), Positives = 94/254 (37%), Gaps = 65/254 (25%)
Query: 582 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTN-EVTLLSRI 639
+ L K +G+G FG+V + GK A+K + + + N E+ ++ +
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVL 57
Query: 640 HHRNLVQFLGYCQEEGRSV--------------------------------------LVY 661
H N+++ + Y G ++
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 662 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE------DAAKGIEYLHTGCVPAIIHRDL 715
E++ + L+ L R + + + + + ++H+ I HRD+
Sbjct: 118 EYV-----PDTLHKVLKSFIRSG--RSIPMNLISIYIYQLFRAVGFIHSL---GICHRDI 167
Query: 716 KSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI-SQQLTDKSDV 773
K N+L++ K+ DFG +K + V+ I + Y PE + + + T D+
Sbjct: 168 KPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDL 225
Query: 774 YSFGVILLELISGQ 787
+S G + ELI G+
Sbjct: 226 WSIGCVFGELILGK 239
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 50/210 (23%), Positives = 94/210 (44%), Gaps = 30/210 (14%)
Query: 593 KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLVQ 646
K+G G +G VY + +A+K + + + E T EV+LL + HRN+++
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIKRI---RLEHEEEGVPGTAIREVSLLKELQHRNIIE 97
Query: 647 FLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 704
R L++E+ N LK+++ ++ +++ +L G+ + H+
Sbjct: 98 LKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQL------INGVNFCHS 150
Query: 705 GCVPAIIHRDLKSSNILLDKHMRA-----KVSDFGLSK-FAVDGASHVSSIVRGTVGYLD 758
+HRDLK N+LL + K+ DFGL++ F + I+ T+ Y
Sbjct: 151 ---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII--TLWYRP 205
Query: 759 PEYYI-SQQLTDKSDVYSFGVILLELISGQ 787
PE + S+ + D++S I E++
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 4e-15
Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 592 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 647
K IGSG G+V + +A+K L+ N KR + E+ L+ ++H+N++
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISL 126
Query: 648 L-----GYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 701
L EE + V LV E M L + + L HE+ + ++ GI++
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQM------LCGIKH 179
Query: 702 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 761
LH+ + IHRDLK SNI++ K+ DFGL++ + ++ V T Y PE
Sbjct: 180 LHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYV-VTRYYRAPEV 234
Query: 762 YISQQLTDKSDVYSFGVILLELISGQ 787
+ + D++S G I+ E++ +
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 48/233 (20%), Positives = 87/233 (37%), Gaps = 62/233 (26%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVK--VLTSNSYQGKREFTN---------EVTLLSR 638
+++ I SG +G V G +G +A+K T + + ++ E+ LL+
Sbjct: 26 VQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNH 85
Query: 639 IHHRNLVQ----FLGYCQEEGRSV-LVYEFM----------HNGTLKEH-----LYGTLT 678
HH N++ F+ + + + LV E M + +Y L
Sbjct: 86 FHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHIL- 144
Query: 679 HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 738
G+ LH V +HRDL NILL + + DF L++
Sbjct: 145 ------------------LGLHVLHEAGV---VHRDLHPGNILLADNNDITICDFNLARE 183
Query: 739 AVDGAS---HVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 787
A+ +V+ Y PE + + K D++S G ++ E+ + +
Sbjct: 184 DTADANKTHYVT-----HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 32/214 (14%)
Query: 593 KIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQGKREFTN----EVTLLSRIH---HRN 643
+IG G +G VY + G +A+K V N G EV LL R+ H N
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 644 LVQFL-----GYCQEEGRSVLVYEFMHN---GTLKEHLYGTLTHEQRINWIKRLEIAEDA 695
+V+ + E + LV+E + L + L E + +++
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF------ 129
Query: 696 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGA-SHVSSIVRGT 753
+G+++LH C I+HRDLK NIL+ K++DFGL++ ++ A + V +V T
Sbjct: 130 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV--VV--T 182
Query: 754 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 787
+ Y PE + D++S G I E+ +
Sbjct: 183 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 52/210 (24%), Positives = 98/210 (46%), Gaps = 32/210 (15%)
Query: 592 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 647
+GSG +G V + G+++A+K L+ + KR + E+ LL + H N++
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY-RELLLLKHMQHENVIGL 88
Query: 648 L-----GYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 701
L LV FM L++ + + E+ + ++ KG++Y
Sbjct: 89 LDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQML------KGLKY 141
Query: 702 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG---YLD 758
+H+ ++HRDLK N+ +++ K+ DFGL A H + + G V Y
Sbjct: 142 IHSA---GVVHRDLKPGNLAVNEDCELKILDFGL-------ARHADAEMTGYVVTRWYRA 191
Query: 759 PEYYISQQLTDKS-DVYSFGVILLELISGQ 787
PE +S +++ D++S G I+ E+++G+
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 53/252 (21%), Positives = 92/252 (36%), Gaps = 68/252 (26%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLV 645
++ IG G +G VY K +A+K + + KR E+T+L+R+ ++
Sbjct: 30 IKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL-REITILNRLKSDYII 88
Query: 646 Q----FLGYCQEEGRSV-LVYEFM---------HNGTLK-EH----LYGTLTHEQRINWI 686
+ + + + +V E L EH LY L
Sbjct: 89 RLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLL--------- 139
Query: 687 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASH 745
G ++H IIHRDLK +N LL++ KV DFGL+ + ++
Sbjct: 140 ----------LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186
Query: 746 VSSIVRGTVGYLDPEYYISQQLTD--------------------KS-DVYSFGVILLELI 784
+ + + + +QLT KS D++S G I EL+
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246
Query: 785 SGQEAISNEKFG 796
+ ++ N+
Sbjct: 247 NMLQSHINDPTN 258
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 55/229 (24%), Positives = 87/229 (37%), Gaps = 54/229 (23%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLVQ 646
L+ +G G +GVV G+ +A+K + R E+ +L H N++
Sbjct: 15 LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKILKHFKHENIIT 73
Query: 647 ----FLGYCQEEGRSV-LVYEFM--------HNGTLK-EH----LYGTLTHEQRINWIKR 688
E V ++ E M L +H +Y TL
Sbjct: 74 IFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL----------- 122
Query: 689 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 748
+ ++ LH V IHRDLK SN+L++ + KV DFGL++ + A+ S
Sbjct: 123 --------RAVKVLHGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 749 IVRGTVG---------YLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 787
G Y PE ++ ++ DV+S G IL EL +
Sbjct: 172 PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 1e-13
Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 38/216 (17%)
Query: 593 KIGSGGFGVVYYGK-LKDGKEI-AVK-VLTSNSYQGK-----REFTNEVTLL---SRIHH 641
+IG G +G V+ + LK+G A+K V +G RE V +L H
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE----VAVLRHLETFEH 73
Query: 642 RNLVQFL-----GYCQEEGRSVLVYEFMHN---GTLKEHLYGTLTHEQRINWIKRLEIAE 693
N+V+ E + LV+E + L + + E + + +L
Sbjct: 74 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL---- 129
Query: 694 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGA-SHVSSIVR 751
+G+++LH+ ++HRDLK NIL+ + K++DFGL++ ++ A + V +V
Sbjct: 130 --LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV--VV- 181
Query: 752 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 787
T+ Y PE + D++S G I E+ +
Sbjct: 182 -TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-13
Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 49/221 (22%)
Query: 592 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLVQ-- 646
IG G +G+V + +A+K ++ + +R E+ +L R H N++
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGIN 91
Query: 647 --FLGYCQEEGRSV-LVYEFM--------HNGTL-KEH----LYGTLTHEQRINWIKRLE 690
E+ + V +V + M L +H LY L
Sbjct: 92 DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL------------- 138
Query: 691 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI- 749
+G++Y+H+ V +HRDLK SN+LL+ K+ DFGL++ A H +
Sbjct: 139 ------RGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 750 --VRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 787
V T Y PE ++ + KS D++S G IL E++S +
Sbjct: 190 EYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 63/239 (26%), Positives = 102/239 (42%), Gaps = 64/239 (26%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIH-HRNL 644
L KK+G G +G+V+ + G+ +AVK + NS +R F E+ +L+ + H N+
Sbjct: 13 LVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF-REIMILTELSGHENI 71
Query: 645 VQFLGYCQ-EEGRSV-LVYEFM--------HNGTLK-EH----LYGTLTHEQRINWIKRL 689
V L + + R V LV+++M L+ H +Y +
Sbjct: 72 VNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLI------------ 119
Query: 690 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 749
K I+YLH+G + +HRD+K SNILL+ KV+DFGLS+ V+ ++I
Sbjct: 120 -------KVIKYLHSGGL---LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 750 VRGTVGYLDPEYYISQQLTD---------------------KSDVYSFGVILLELISGQ 787
+ LTD D++S G IL E++ G+
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 51/271 (18%), Positives = 109/271 (40%), Gaps = 64/271 (23%)
Query: 592 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIH------- 640
+K+G G F V+ K + + +A+K++ + + E + LL R++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDE----IKLLQRVNDADNTKE 80
Query: 641 ----HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEH-----------LYGTL--THEQRI 683
++++ L + F H G H L + + I
Sbjct: 81 DSMGANHILKLLDH------------FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI 128
Query: 684 N--WIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA------KVSDFGL 735
++K+ I++ G++Y+H C IIH D+K N+L++ K++D G
Sbjct: 129 PLIYVKQ--ISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGN 184
Query: 736 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF 795
+ + + H ++ ++ T Y PE + +D++S ++ ELI+G ++
Sbjct: 185 ACWYDE---HYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 240
Query: 796 GANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826
+ ++ A+ I ++ G + LL
Sbjct: 241 HSYTKDDDHIAQ--II--ELLGELPSYLLRN 267
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 3e-13
Identities = 48/250 (19%), Positives = 90/250 (36%), Gaps = 73/250 (29%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLV 645
+ IG+G +G V + + +A+K + + KR E+ +L+R++H ++V
Sbjct: 57 IRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL-REIAILNRLNHDHVV 115
Query: 646 Q----FLGYCQEEGRSV-LVYEFMH---------NGTLK-EH----LYGTLTHEQRINWI 686
+ + E+ + +V E L H LY L
Sbjct: 116 KVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLL--------- 166
Query: 687 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS------KFAV 740
G++Y+H+ + +HRDLK +N L+++ KV DFGL+ +
Sbjct: 167 ----------VGVKYVHSAGI---LHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGN 213
Query: 741 DGASHVSSIVRGTVGYLDPEYYISQQLTD--------------------KS-DVYSFGVI 779
+ + +QLT ++ DV+S G I
Sbjct: 214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCI 273
Query: 780 LLELISGQEA 789
EL++ +
Sbjct: 274 FAELLNMIKE 283
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 55/223 (24%), Positives = 92/223 (41%), Gaps = 57/223 (25%)
Query: 592 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 647
+ +GSG +G V + G ++A+K L + KR + E+ LL + H N++
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMRHENVIGL 89
Query: 648 L-----GYCQEEGRSV-LVYEFM--------HNGTL-KEH----LYGTLTHEQRINWIKR 688
L ++ LV FM + L ++ +Y L
Sbjct: 90 LDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML----------- 138
Query: 689 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 748
KG+ Y+H IIHRDLK N+ +++ K+ DFGL A S
Sbjct: 139 --------KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL-------ARQADS 180
Query: 749 IVRGTVG---YLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 787
+ G V Y PE ++ ++ D++S G I+ E+I+G+
Sbjct: 181 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 57/223 (25%)
Query: 592 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 647
+GSG +G V K G +AVK L+ + KR + E+ LL + H N++
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGL 93
Query: 648 L-----GYCQEEGRSV-LVYEFM--------HNGTLK-EH----LYGTLTHEQRINWIKR 688
L EE V LV M L +H +Y L
Sbjct: 94 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----------- 142
Query: 689 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 748
+G++Y+H+ IIHRDLK SN+ +++ K+ DFGL A H +
Sbjct: 143 --------RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL-------ARHTAD 184
Query: 749 IVRGTVG---YLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 787
+ G V Y PE ++ +++ D++S G I+ EL++G+
Sbjct: 185 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 38/170 (22%), Positives = 65/170 (38%), Gaps = 30/170 (17%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQF 647
+ KKIG G FG + GK L + +A+K+ S + E ++ + Q
Sbjct: 13 VGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQV 70
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR-------LEIAEDAAKGIE 700
+ + +V E + G E L+ + R L IA +E
Sbjct: 71 YYFGPCGKYNAMVLELL--GPSLEDLF---------DLCDRTFSLKTVLMIAIQLISRME 119
Query: 701 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVS-----DFGLSKFAVDGASH 745
Y+H+ +I+RD+K N L+ + DF L+K +D +
Sbjct: 120 YVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 54/232 (23%), Positives = 97/232 (41%), Gaps = 58/232 (25%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT-SNSYQGKREFTNEVTLLSRIHHRNLVQF 647
K +G GG G+V+ K +A+K + ++ K E+ ++ R+ H N+V+
Sbjct: 15 DLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL-REIKIIRRLDHDNIVKV 73
Query: 648 L-------------GYCQEEGRSV-LVYEFM--------HNGTL-KEH----LYGTLTHE 680
E SV +V E+M G L +EH +Y L
Sbjct: 74 FEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLL--- 130
Query: 681 QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFA 739
+G++Y+H+ V +HRDLK +N+ ++ + + K+ DFGL++
Sbjct: 131 ----------------RGLKYIHSANV---LHRDLKPANLFINTEDLVLKIGDFGLARIM 171
Query: 740 VDGASHVSSI---VRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQ 787
SH + + T Y P +S T D+++ G I E+++G+
Sbjct: 172 DPHYSHKGHLSEGL-VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 25/188 (13%), Positives = 59/188 (31%), Gaps = 46/188 (24%)
Query: 590 LEKKIGSGGFGVVYYGK---------LKDGKEIAVKVLTSNS----------YQGKREFT 630
L+ G++Y ++ ++K+ + K
Sbjct: 46 LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQV 105
Query: 631 NEVTLLSRIHHRNLVQFLGYCQEEGR-SVLVYEFMHNGTLKEHLYGT-LTHEQRINWIKR 688
N+ L + +G+ + + LV G L + ++ +
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLP----------SLGRSL--QSALDVSPK 153
Query: 689 --------LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV--SDFGLSKF 738
L++A +E+LH +H ++ + NI +D +++V + +G +
Sbjct: 154 HVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
Query: 739 AVDGASHV 746
HV
Sbjct: 211 YCPSGKHV 218
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 42/224 (18%), Positives = 84/224 (37%), Gaps = 48/224 (21%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQF 647
+ ++IG G FGV++ G L + +++A+K S + +E + +
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR-------LEIAEDAAKGIE 700
+ QE +VLV + + G E L + R A+ ++
Sbjct: 72 YYFGQEGLHNVLVIDLL--GPSLEDLL---------DLCGRKFSVKTVAMAAKQMLARVQ 120
Query: 701 YLHTGCVPAIIHRDLKSSNILLDKHMRAK-----VSDFGLSKFAVDGASHV------SSI 749
+H +++RD+K N L+ + V DFG+ KF D +
Sbjct: 121 SIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 177
Query: 750 VRGTVGYLDPEYYIS------QQLTDKSDVYSFGVILLELISGQ 787
+ GT Y+S ++ + + D+ + G + + + G
Sbjct: 178 LSGTA------RYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-12
Identities = 20/93 (21%), Positives = 36/93 (38%), Gaps = 4/93 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
P + I LS + + P+ S+L FG + N+ P + P+L
Sbjct: 513 PYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGI--RNQRDAQGNRTLREWPEGITLCPSLT 569
Query: 476 ELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 508
+L + +N + V + VL+ N N+
Sbjct: 570 QLQIGSNDIR-KVNEKITPNISVLDIKDNPNIS 601
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-11
Identities = 21/110 (19%), Positives = 37/110 (33%), Gaps = 26/110 (23%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVEF------------------------GCPDLRI 452
+T + + + +P+ L L + ++I
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI 309
Query: 453 IHLEDNQL-TGPLPSSLMNLPNLRELYVQNNMLSGTVPS-SLLSKNVVLN 500
I++ N L T P+ +SL + L L N L G +P+ K LN
Sbjct: 310 IYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLN 359
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 22/101 (21%), Positives = 37/101 (36%), Gaps = 14/101 (13%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVEF-----------GCPDLRIIHLEDNQLTGPLP 465
T I S N+T + + +L+ L +F C + E Q
Sbjct: 184 KDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTED 242
Query: 466 SSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 504
NL +L ++ V N +P+ L L + ++N A N
Sbjct: 243 LKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACN 283
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-09
Identities = 15/84 (17%), Positives = 30/84 (35%), Gaps = 1/84 (1%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
++ I S + + L F ++ I+L +NQ++ L
Sbjct: 402 SVMSAIDFSYNEIGSVDGKNFDPLDPTP-FKGINVSSINLSNNQISKFPKELFSTGSPLS 460
Query: 476 ELYVQNNMLSGTVPSSLLSKNVVL 499
+ + NML+ +SL +N
Sbjct: 461 SINLMGNMLTEIPKNSLKDENENF 484
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-09
Identities = 14/88 (15%), Positives = 30/88 (34%), Gaps = 16/88 (18%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTG-------PLPSSL 468
+++ I+LS+ ++ + S L I+L N LT +
Sbjct: 433 INVSSINLSNNQISKFPKELFSTGSPL--------SSINLMGNMLTEIPKNSLKDENENF 484
Query: 469 MNLPNLRELYVQNNMLSGTVPSSLLSKN 496
N L + ++ N L+ + +
Sbjct: 485 KNTYLLTSIDLRFNKLTK-LSDDFRATT 511
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-09
Identities = 20/96 (20%), Positives = 36/96 (37%), Gaps = 17/96 (17%)
Query: 417 SITVIHLSSKNL-TGNIPSDLTKLSSLV--------------EFG-CPDLRIIHLEDNQL 460
I +I++ NL T + + L K+ L FG L ++L NQ+
Sbjct: 306 KIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQI 365
Query: 461 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 496
T + + L +N L +P+ +K+
Sbjct: 366 TEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKS 400
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-08
Identities = 14/90 (15%), Positives = 27/90 (30%), Gaps = 10/90 (11%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 476
+ ++S +I + I N +T + ++M L LR+
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQ--------IGQLSNNITF-VSKAVMRLTKLRQ 210
Query: 477 LYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 506
Y+ N+ +N YA
Sbjct: 211 FYMGNSPFVAENICEAW-ENENSEYAQQYK 239
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 6e-08
Identities = 9/96 (9%), Positives = 22/96 (22%), Gaps = 9/96 (9%)
Query: 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPN 473
+ + L L + + + + LP+ L LP
Sbjct: 223 ICEAWENENSEYAQQYKTEDLKWDNLKDLTD--------VEVYNCPNLTKLPTFLKALPE 274
Query: 474 LRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 509
++ + V N + + +
Sbjct: 275 MQLINVACNRGIS-GEQLKDDWQALADAPVGEKIQI 309
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 4e-06
Identities = 16/122 (13%), Positives = 40/122 (32%), Gaps = 26/122 (21%)
Query: 376 DGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQ--CNSDPQPSITVIHLSSKNLTGNIP 433
D +A+ + + +W+Q+G W++ + QP +++
Sbjct: 31 DYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSL------------- 77
Query: 434 SDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL 493
+ +++ L LE +G +P ++ L L L + ++
Sbjct: 78 NSNGRVTGL-----------SLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGP 126
Query: 494 SK 495
Sbjct: 127 KG 128
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 7/86 (8%), Positives = 21/86 (24%), Gaps = 9/86 (10%)
Query: 421 IHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 480
+ + DL + + + S ++
Sbjct: 138 KQKMRMHYQKTFVDYDPREDFS------DLIKDCINSDPQQKSIKKSSRITLKDTQIGQL 191
Query: 481 NNMLSGTVPSSL--LSKNVVLNYAGN 504
+N ++ V ++ L+K +
Sbjct: 192 SNNITF-VSKAVMRLTKLRQFYMGNS 216
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 20/209 (9%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQF 647
L +KIGSG FG +Y G + G+E+A+K+ + + E + + +
Sbjct: 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTI 70
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
E +V+V E + G E L+ + + + + L +A+ IEY+H+
Sbjct: 71 RWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTV--LLLADQMISRIEYIHSKN- 125
Query: 708 PAIIHRDLKSSNILLDKHMRAK---VSDFGLSKFAVDGASHV------SSIVRGTVGYLD 758
IHRD+K N L+ + + DFGL+K D +H + + GT Y
Sbjct: 126 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183
Query: 759 PEYYISQQLTDKSDVYSFGVILLELISGQ 787
++ + + + D+ S G +L+ G
Sbjct: 184 INTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-11
Identities = 19/108 (17%), Positives = 35/108 (32%), Gaps = 19/108 (17%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEF-----------------GCPDLRIIHLEDN 458
++ + +S + LSSL +L + L
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480
Query: 459 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN--VVLNYAGN 504
QL P++ +L +L+ L + +N N VL+Y+ N
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 528
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-10
Identities = 19/103 (18%), Positives = 34/103 (33%), Gaps = 11/103 (10%)
Query: 405 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPL 464
++L ++T + LS L P+ LSSL +++++ N
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL--------QVLNMSHNNFFSLD 510
Query: 465 PSSLMNLPNLRELYVQNNMLSGTVPSS---LLSKNVVLNYAGN 504
L +L+ L N + + S LN N
Sbjct: 511 TFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 6e-10
Identities = 7/80 (8%), Positives = 18/80 (22%), Gaps = 7/80 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
+ + NL + +L + + L +L
Sbjct: 396 EQLEHLDFQHSNLKQMSEFSVFL-------SLRNLIYLDISHTHTRVAFNGIFNGLSSLE 448
Query: 476 ELYVQNNMLSGTVPSSLLSK 495
L + N + ++
Sbjct: 449 VLKMAGNSFQENFLPDIFTE 468
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 4e-09
Identities = 17/96 (17%), Positives = 29/96 (30%), Gaps = 16/96 (16%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVE----------------FGCPDLRIIHLEDNQ 459
P + V+ LS + LS L G L+ + +
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 460 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 495
L + +L L+EL V +N++ S
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 8e-09
Identities = 10/77 (12%), Positives = 22/77 (28%), Gaps = 8/77 (10%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
S + LS L L +++ L ++ + +L +L
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPEL--------QVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 476 ELYVQNNMLSGTVPSSL 492
L + N + +
Sbjct: 80 TLILTGNPIQSLALGAF 96
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 9e-08
Identities = 16/86 (18%), Positives = 31/86 (36%), Gaps = 5/86 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
++ + LSS + +DL L + + L N + P + + L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLL----NLSLDLSLNPMNFIQPGAFKEI-RLH 203
Query: 476 ELYVQNNMLSGTVPSSLLSKNVVLNY 501
+L ++NN S V + + L
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEV 229
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 16/111 (14%), Positives = 30/111 (27%), Gaps = 22/111 (19%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVE-----------------FGCPDLRIIHLEDN 458
S+ + NL + L +L E +L + L N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 459 QLTGPLPSSLMNLPNLR----ELYVQNNMLSGTVPSSLLSKN-VVLNYAGN 504
++ + L L + L + N ++ P + L N
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 3e-07
Identities = 19/88 (21%), Positives = 32/88 (36%), Gaps = 11/88 (12%)
Query: 416 PSITVIHLSSKNLT--GNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPN 473
PS+ + LS L+ G +SL + + L N + + S+ + L
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSL--------KYLDLSFNGVIT-MSSNFLGLEQ 397
Query: 474 LRELYVQNNMLSGTVPSSLLSKNVVLNY 501
L L Q++ L S+ L Y
Sbjct: 398 LEHLDFQHSNLKQMSEFSVFLSLRNLIY 425
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 5e-05
Identities = 10/89 (11%), Positives = 21/89 (23%), Gaps = 6/89 (6%)
Query: 422 HLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLT------GPLPSSLMNLPNLR 475
L L + L + L + +E+ +L + L N+
Sbjct: 226 GLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVS 285
Query: 476 ELYVQNNMLSGTVPSSLLSKNVVLNYAGN 504
+ + + S L
Sbjct: 286 SFSLVSVTIERVKDFSYNFGWQHLELVNC 314
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 33/179 (18%), Positives = 64/179 (35%), Gaps = 28/179 (15%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEI------AVKVLTSNSYQGKREFTNEVTLLSRIHHRN 643
+ IG GGFG +Y + + + VKV S++ E ++
Sbjct: 39 VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTEL-KFYQRAAKPEQIQ 97
Query: 644 LVQFLGYCQEEGRSVLVYEFMHNGTLKEH------LYGT-LTHEQRINWIKR-------L 689
+ G +H+ K + +G+ L ++ + L
Sbjct: 98 KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDL--QKIYEANAKRFSRKTVL 155
Query: 690 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV--SDFGLSKFAVDGASHV 746
+++ +EY+H +H D+K+SN+LL+ +V D+GL+ H
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 66.6 bits (162), Expect = 2e-11
Identities = 50/216 (23%), Positives = 93/216 (43%), Gaps = 34/216 (15%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV-QF 647
L +KIGSG FG +Y G ++ +E+A+K+ + + E + + +
Sbjct: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNV 68
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR-------LEIAEDAAKGIE 700
+ E +VLV + + G E L+ N+ R L +A+ +E
Sbjct: 69 RWFGVEGDYNVLVMDLL--GPSLEDLF---------NFCSRKLSLKTVLMLADQMINRVE 117
Query: 701 YLHTGCVPAIIHRDLKSSNILLDKHMRAK---VSDFGLSKFAVDGASHV------SSIVR 751
++H+ +HRD+K N L+ RA + DFGL+K D ++H + +
Sbjct: 118 FVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
Query: 752 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 787
GT Y ++ + + + D+ S G +L+ + G
Sbjct: 175 GTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 65.3 bits (158), Expect = 2e-11
Identities = 38/268 (14%), Positives = 73/268 (27%), Gaps = 68/268 (25%)
Query: 575 AHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVL--------TSNSYQGK 626
+HC ++ +KIG G FG V+ +A+K++ + +
Sbjct: 14 SHCLPTEKLQRC-----EKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTF 67
Query: 627 REFTNEVTLLSRIH---------HRNLVQFLGYCQEEGRS-------------------- 657
E E+ + + + +G
Sbjct: 68 EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAND 127
Query: 658 ----------VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
+V EF G E + + + I +
Sbjct: 128 RPDFFKDDQLFIVLEFEFGGIDLEQM-----RTKLSSLATAKSILHQLTASLAVAEA--S 180
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 767
HRDL N+LL K K+ K + + + V +D Y +S+
Sbjct: 181 LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGL------QVSIID--YTLSRLE 232
Query: 768 TDKSDVYSFGVILLELISGQEAISNEKF 795
D V+ + +L +G + +
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDGDYQFDIY 260
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 2e-11
Identities = 20/93 (21%), Positives = 39/93 (41%), Gaps = 4/93 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
P ++ + +S + P+ S L FG E N++ P+ + P+L
Sbjct: 753 PYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGI--RHQRDAEGNRILRQWPTGITTCPSLI 809
Query: 476 ELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 508
+L + +N + V L + +L+ A N N+
Sbjct: 810 QLQIGSNDIR-KVDEKLTPQLYILDIADNPNIS 841
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 4e-09
Identities = 17/95 (17%), Positives = 30/95 (31%), Gaps = 17/95 (17%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGP---------LPS 466
+T + L + +P L L L + +++ N+ L
Sbjct: 491 KDLTDVELYNCPNMTQLPDFLYDLPEL--------QSLNIACNRGISAAQLKADWTRLAD 542
Query: 467 SLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 501
P ++ Y+ N L S+ L K V L
Sbjct: 543 DEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGL 577
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 23/97 (23%), Positives = 34/97 (35%), Gaps = 7/97 (7%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLM--NLPN 473
I+ I LS+ +T +IP + K L I L N+LT L LP
Sbjct: 697 SPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPY 754
Query: 474 LRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLH 508
L + V N S + P+ S+ +
Sbjct: 755 LSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAE 790
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 8e-08
Identities = 12/83 (14%), Positives = 19/83 (22%), Gaps = 8/83 (9%)
Query: 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPN 473
+ N + L L + L + LP L +LP
Sbjct: 465 IAVDWEDANSDYAKQYENEELSWSNLKDL--------TDVELYNCPNMTQLPDFLYDLPE 516
Query: 474 LRELYVQNNMLSGTVPSSLLSKN 496
L+ L + N
Sbjct: 517 LQSLNIACNRGISAAQLKADWTR 539
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 4e-07
Identities = 8/79 (10%), Positives = 29/79 (36%), Gaps = 4/79 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
+ + S + ++ S+ ++ + + L N++ +
Sbjct: 644 YVMGSVDFSYNKIGS-EGRNI--SCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPIS 700
Query: 476 ELYVQNNMLSGTVPSSLLS 494
+ + NN+++ ++P + L
Sbjct: 701 TIILSNNLMT-SIPENSLK 718
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 6e-07
Identities = 17/123 (13%), Positives = 34/123 (27%), Gaps = 16/123 (13%)
Query: 390 ADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFG-CP 448
A W G W + + N N D+ V+
Sbjct: 276 AIWEALDGKN-----WRYYSGTINNTIHSL-------NWNFNKELDMWGDQPGVDLDNNG 323
Query: 449 DLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSS---LLSKNVVLNYAGNI 505
+ + L G +P ++ L L+ L + + + L+ ++ I
Sbjct: 324 RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRI 383
Query: 506 NLH 508
+H
Sbjct: 384 RMH 386
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 1e-06
Identities = 12/87 (13%), Positives = 27/87 (31%), Gaps = 16/87 (18%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLT-------GPLPSSLM 469
+ + + LS + S + I L +N +T P +
Sbjct: 674 NASTVTLSYNEIQKFPTELFATGSPI--------STIILSNNLMTSIPENSLKPKDGNYK 725
Query: 470 NLPNLRELYVQNNMLSGTVPSSLLSKN 496
N L + ++ N L+ ++ +
Sbjct: 726 NTYLLTTIDLRFNKLT-SLSDDFRATT 751
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 10/103 (9%), Positives = 30/103 (29%), Gaps = 10/103 (9%)
Query: 398 DPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLED 457
+ + + ++ +T + L+ G +P + +L+ L +++
Sbjct: 307 ELDMWGDQPGVDLDN--NGRVTGLSLAGFGAKGRVPDAIGQLTEL--------KVLSFGT 356
Query: 458 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 500
+ T + + + L + LN
Sbjct: 357 HSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLN 399
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 4e-06
Identities = 17/97 (17%), Positives = 32/97 (32%), Gaps = 18/97 (18%)
Query: 416 PSITVIHLSSKNLTG-NIPSDLTKLSSLVEF--------------GCPDLRIIHLEDNQL 460
P I + ++ NL + L K+ L L + L+ NQ+
Sbjct: 548 PKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHLEAFGTNVKLTDLKLDYNQI 607
Query: 461 TGPLPSSLM-NLPNLRELYVQNNMLSGTVPSSLLSKN 496
+P + L +N L +P+ +K+
Sbjct: 608 EE-IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKS 642
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 4e-06
Identities = 15/102 (14%), Positives = 38/102 (37%), Gaps = 5/102 (4%)
Query: 409 QCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSL 468
+ D + + L + N ++ + D +I +L N++T + ++
Sbjct: 389 KMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQIGNLT-NRITF-ISKAI 444
Query: 469 MNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEG 510
L L+ +Y N+ + ++ ++ +YA E
Sbjct: 445 QRLTKLQIIYFANSPFTY-DNIAVDWEDANSDYAKQYENEEL 485
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 9e-05
Identities = 12/114 (10%), Positives = 25/114 (21%), Gaps = 26/114 (22%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEF------------------GCPDLRIIHLED 457
+T + L + IP D + VE + +
Sbjct: 595 VKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSY 653
Query: 458 NQLTG-----PLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 504
N++ N + + N + S + + N
Sbjct: 654 NKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNN 707
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 36/185 (19%), Positives = 64/185 (34%), Gaps = 43/185 (23%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLL--SRIHHRNLVQ 646
L KKIGSGGFG++Y ++ A V+ K E+ L + + R
Sbjct: 41 LGKKIGSGGFGLIYLAFPTNKPEKDARHVV-------KVEYQENGPLFSELKFYQR---- 89
Query: 647 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR-----------------INWIKR- 688
+ + + + + G + G + R
Sbjct: 90 -VAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTF 148
Query: 689 -----LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV--SDFGLSKFAVD 741
L++ +EY+H +H D+K++N+LL +V +D+GLS
Sbjct: 149 KKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCP 205
Query: 742 GASHV 746
+H
Sbjct: 206 NGNHK 210
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 51/262 (19%), Positives = 92/262 (35%), Gaps = 80/262 (30%)
Query: 592 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 650
+K+G G F V+ ++ K +A+KV+ S + + +E+ LL + + +
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDP------ 95
Query: 651 CQEEGRSVLVY---EFMHNGTLKEH-------LYGTLTHEQRINWIKRL------EIAED 694
+ R ++V +F +G H L L + + L +I +
Sbjct: 96 -NDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQ 154
Query: 695 AAKGIEYLHTGCVPAIIHRDLKSSNILL-------------------------------- 722
+G++YLHT C IIH D+K NILL
Sbjct: 155 VLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 723 -----------------DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 765
+ ++ K++D G A H + ++ T Y E I
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGN---ACWVHKHFTEDIQ-TRQYRSLEVLIGS 268
Query: 766 QLTDKSDVYSFGVILLELISGQ 787
+D++S + EL +G
Sbjct: 269 GYNTPADIWSTACMAFELATGD 290
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-09
Identities = 17/97 (17%), Positives = 31/97 (31%), Gaps = 18/97 (18%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVE------------------FGCPDLRIIHLED 457
++ + LS L+ +L +L E F L+ + L
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 458 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 494
NQ+ P + L L++ N L ++ L
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCL 217
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-09
Identities = 18/93 (19%), Positives = 38/93 (40%), Gaps = 16/93 (17%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEF----------------GCPDLRIIHLEDNQ 459
+ITV++L+ L ++ T+ S L P L++++L+ N+
Sbjct: 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84
Query: 460 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 492
L+ + NL EL++ +N + +
Sbjct: 85 LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPF 117
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-09
Identities = 12/106 (11%), Positives = 31/106 (29%), Gaps = 20/106 (18%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEF--------------------GCPDLRIIHL 455
+ +++ ++ G + T L +L L I++L
Sbjct: 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNL 388
Query: 456 EDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 501
N+++ + L +L L + N + + +
Sbjct: 389 TKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFE 434
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 6e-09
Identities = 17/92 (18%), Positives = 29/92 (31%), Gaps = 11/92 (11%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
+ +++L S L L +II L N L S N +L+
Sbjct: 536 SHLHILNLESNGFDEIPVEVFKDLFEL--------KIIDLGLNNLNTLPASVFNNQVSLK 587
Query: 476 ELYVQNNMLSGTVPSSL---LSKNVVLNYAGN 504
L +Q N+++ L+ N
Sbjct: 588 SLNLQKNLITSVEKKVFGPAFRNLTELDMRFN 619
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 7e-09
Identities = 24/117 (20%), Positives = 37/117 (31%), Gaps = 10/117 (8%)
Query: 410 CNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLM 469
C SI + LS+ L+ + L +L ++ L N L S
Sbjct: 216 CLELANTSIRNLSLSNSQLSTTSNTTFLGLK------WTNLTMLDLSYNNLNVVGNDSFA 269
Query: 470 NLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHEGGRGAKHLNIIIGSS 524
LP L +++ N + SL L LN + + L I S
Sbjct: 270 WLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKR--SFTKQSISLASLPKIDDFS 324
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-08
Identities = 21/109 (19%), Positives = 36/109 (33%), Gaps = 20/109 (18%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEF----------------GCPDLRIIHLEDNQ 459
P + V++L L+ ++L E +L + L N
Sbjct: 73 PMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNG 132
Query: 460 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL----LSKNVVLNYAGN 504
L+ + + L NL+EL + NN + L S L + N
Sbjct: 133 LSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 4e-08
Identities = 13/94 (13%), Positives = 30/94 (31%), Gaps = 11/94 (11%)
Query: 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLP-SSLMNLP 472
+ +++L+ ++ + L L ++ L N++ L L
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGH--------LEVLDLGLNEIGQELTGQEWRGLE 430
Query: 473 NLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 504
N+ E+Y+ N +S + L
Sbjct: 431 NIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRV 464
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 6e-08
Identities = 20/112 (17%), Positives = 34/112 (30%), Gaps = 19/112 (16%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVE------------------FGCPDLRIIHLED 457
+I I+LS + + SL +L I+ L +
Sbjct: 430 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489
Query: 458 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 509
N + L L L L +Q+N L+ + + G +LH
Sbjct: 490 NNIANINDDMLEGLEKLEILDLQHNNLA-RLWKHANPGGPIYFLKGLSHLHI 540
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 7e-08
Identities = 21/115 (18%), Positives = 34/115 (29%), Gaps = 26/115 (22%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEF------------------------GCPDLR 451
++T++ LS+ N+ L L L G L
Sbjct: 480 RNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLH 539
Query: 452 IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 504
I++LE N +L L+ + + N L+ S LN N
Sbjct: 540 ILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKN 594
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 16/110 (14%), Positives = 33/110 (30%), Gaps = 25/110 (22%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEF-------------------------GCPDL 450
P + L N+ L L ++ L
Sbjct: 272 PQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCL 331
Query: 451 RIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 500
+++EDN + G + L NL+ L + N+ S ++ ++ +
Sbjct: 332 EHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHS 381
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 6e-07
Identities = 17/82 (20%), Positives = 30/82 (36%), Gaps = 11/82 (13%)
Query: 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSL---MN 470
S+ + LSS + P + L + L + QL L L +
Sbjct: 169 ANSSLKKLELSSNQIKEFSPGCFHAIGRL--------FGLFLNNVQLGPSLTEKLCLELA 220
Query: 471 LPNLRELYVQNNMLSGTVPSSL 492
++R L + N+ LS T ++
Sbjct: 221 NTSIRNLSLSNSQLSTTSNTTF 242
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-06
Identities = 14/79 (17%), Positives = 31/79 (39%), Gaps = 7/79 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNL--PN 473
+ + L++ L ++ L + +R + L ++QL+ ++ + L N
Sbjct: 195 GRLFGLFLNNVQLGPSLTEKLCLELAN-----TSIRNLSLSNSQLSTTSNTTFLGLKWTN 249
Query: 474 LRELYVQNNMLSGTVPSSL 492
L L + N L+ S
Sbjct: 250 LTMLDLSYNNLNVVGNDSF 268
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-05
Identities = 17/76 (22%), Positives = 26/76 (34%), Gaps = 9/76 (11%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLM-NLPNL 474
+ +I L NL S SL + ++L+ N +T NL
Sbjct: 560 FELKIIDLGLNNLNTLPASVFNNQVSL--------KSLNLQKNLITSVEKKVFGPAFRNL 611
Query: 475 RELYVQNNMLSGTVPS 490
EL ++ N T S
Sbjct: 612 TELDMRFNPFDCTCES 627
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 49/211 (23%), Positives = 89/211 (42%), Gaps = 32/211 (15%)
Query: 592 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHR----- 642
K IG G FG V K + +A+K++ + Q E+ +L + +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA----EEIRILEHLRKQDKDNT 158
Query: 643 -NLVQFLGYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAKG 698
N++ L + +E + +K++ + + + +++ A +
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFS----LPLVRK--FAHSILQC 212
Query: 699 IEYLHTGCVPAIIHRDLKSSNILLDKHMRA--KVSDFGLSKFAVDGASHVSSIVRGTVGY 756
++ LH IIH DLK NILL + R+ KV DFG S + V + ++ + Y
Sbjct: 213 LDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ---RVYTYIQ-SRFY 265
Query: 757 LDPEYYISQQLTDKSDVYSFGVILLELISGQ 787
PE + + D++S G IL EL++G
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 17/96 (17%), Positives = 29/96 (30%), Gaps = 15/96 (15%)
Query: 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVE---------------FGCPDLRIIHLEDN 458
+ S+ I+L + S L E G L+ + L N
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSAN 311
Query: 459 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 494
+ S N P+L L ++ N + + L
Sbjct: 312 KFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLE 347
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 9e-08
Identities = 16/107 (14%), Positives = 27/107 (25%), Gaps = 18/107 (16%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEF----------------GCPDLRIIHLEDNQ 459
S + S L + ++L +L L + L N
Sbjct: 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92
Query: 460 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 504
L ++L L+ L+ +S L L N
Sbjct: 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSN 139
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 19/109 (17%), Positives = 36/109 (33%), Gaps = 20/109 (18%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEF-------------------GCPDLRIIHLE 456
+ V++LS L + L +L L I+ L
Sbjct: 425 HLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLS 484
Query: 457 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL-LSKNVVLNYAGN 504
L+ + +L + + + +N L+ + +L K + LN A N
Sbjct: 485 FCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASN 533
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 15/93 (16%), Positives = 29/93 (31%), Gaps = 12/93 (12%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
++ + ++ L +L ++L N ++ L+
Sbjct: 105 KALKHLFFIQTGISSIDFIPLHNQKTL--------ESLYLGSNHISSIKLPKGFPTEKLK 156
Query: 476 ELYVQNNMLSGTVPSSLLS----KNVVLNYAGN 504
L QNN + + S N+ LN GN
Sbjct: 157 VLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGN 189
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-06
Identities = 17/72 (23%), Positives = 29/72 (40%), Gaps = 9/72 (12%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
+ + LS LT + L+ L + ++L N ++ LPS L L R
Sbjct: 500 KMMNHVDLSHNRLTSSSIEALSHLKGIY---------LNLASNHISIILPSLLPILSQQR 550
Query: 476 ELYVQNNMLSGT 487
+ ++ N L T
Sbjct: 551 TINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 16/105 (15%), Positives = 29/105 (27%), Gaps = 19/105 (18%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVE------------------FGCPDLRIIHLE 456
PS+T + + + + L L +L E L+ ++L
Sbjct: 325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLS 384
Query: 457 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 501
N+ + P L L + L S +L
Sbjct: 385 YNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKV 429
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 12/94 (12%), Positives = 23/94 (24%), Gaps = 17/94 (18%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEF-----------------GCPDLRIIHLEDN 458
+ ++LS + L L++++L +
Sbjct: 376 SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHS 435
Query: 459 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 492
L LP L+ L +Q N
Sbjct: 436 LLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKT 469
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 9e-06
Identities = 17/80 (21%), Positives = 28/80 (35%), Gaps = 5/80 (6%)
Query: 427 NLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 486
LT N L ++ G L+ + ++ L N L LY+ +N +S
Sbjct: 87 VLTAN---PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143
Query: 487 TVPSSL--LSKNVVLNYAGN 504
K VL++ N
Sbjct: 144 IKLPKGFPTEKLKVLDFQNN 163
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 48/211 (22%), Positives = 86/211 (40%), Gaps = 30/211 (14%)
Query: 592 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHR----- 642
IG G FG V + + +A+K++ + Q + EV LL ++
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELMNKHDTEMK 115
Query: 643 -NLVQFLGYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAKG 698
+V + LV+E + L+ + ++ +N ++ A+
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVS----LNLTRK--FAQQMCTA 169
Query: 699 IEYLHTGCVPAIIHRDLKSSNILL--DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 756
+ +L T + +IIH DLK NILL K K+ DFG S + ++ + Y
Sbjct: 170 LLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ---RIYQYIQ-SRFY 224
Query: 757 LDPEYYISQQLTDKSDVYSFGVILLELISGQ 787
PE + D++S G IL+E+ +G+
Sbjct: 225 RSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 12/97 (12%), Positives = 25/97 (25%), Gaps = 18/97 (18%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVE----------------F-GCPDLRIIHLEDN 458
S+ + LS + + S+ L L F +L + +
Sbjct: 373 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431
Query: 459 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 495
L +L L + N + ++
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 6e-07
Identities = 22/94 (23%), Positives = 40/94 (42%), Gaps = 13/94 (13%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNL 474
S+ V+ ++ + N D T+L +L + L QL P++ +L +L
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNL--------TFLDLSQCQLEQLSPTAFNSLSSL 496
Query: 475 RELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 508
+ L + +N L +VP + + L I LH
Sbjct: 497 QVLNMASNQLK-SVPDGIFDRLTSLQK---IWLH 526
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 8e-07
Identities = 15/94 (15%), Positives = 29/94 (30%), Gaps = 14/94 (14%)
Query: 419 TVIHLSSKNLT---GNIPSDLTKL-------SSLVE---FGCPDLRIIHLEDNQLTGPLP 465
N N+P L L F P+L+++ L ++
Sbjct: 10 ITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 466 SSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 499
+ +L +L L + N + ++ S L
Sbjct: 70 GAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSL 102
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 12/96 (12%), Positives = 25/96 (26%), Gaps = 17/96 (17%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVE---------------F-GCPDLRIIHLEDNQ 459
S + LS L L + L + L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 460 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 495
+ + L +L++L L+ ++ + +
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGH 122
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 7e-05
Identities = 14/59 (23%), Positives = 25/59 (42%), Gaps = 3/59 (5%)
Query: 427 NLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 485
LTGN + L+ G L+ + + L + +L L+EL V +N++
Sbjct: 82 ILTGN---PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 20/94 (21%), Positives = 34/94 (36%), Gaps = 16/94 (17%)
Query: 406 SWLQCNSDPQ---PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLT- 461
+ P S+ + +S N GN S++ P L + L N L+
Sbjct: 312 VNCKFGQFPTLKLKSLKRLTFTS-NKGGNAFSEV---------DLPSLEFLDLSRNGLSF 361
Query: 462 -GPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 494
G S +L+ L + N + T+ S+ L
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLG 394
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 16/83 (19%), Positives = 34/83 (40%), Gaps = 8/83 (9%)
Query: 405 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPL 464
++L ++T + LS L P+ LSS L+++++ NQL
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS--------LQVLNMASNQLKSVP 510
Query: 465 PSSLMNLPNLRELYVQNNMLSGT 487
L +L+++++ N +
Sbjct: 511 DGIFDRLTSLQKIWLHTNPWDCS 533
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 9e-08
Identities = 8/84 (9%), Positives = 18/84 (21%), Gaps = 7/84 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
+ + L L + + + L +L
Sbjct: 399 EELQHLDFQHSTLKRVTEFSAFL-------SLEKLLYLDISYTNTKIDFDGIFLGLTSLN 451
Query: 476 ELYVQNNMLSGTVPSSLLSKNVVL 499
L + N S++ + L
Sbjct: 452 TLKMAGNSFKDNTLSNVFANTTNL 475
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-07
Identities = 18/109 (16%), Positives = 33/109 (30%), Gaps = 21/109 (19%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEF-----------------GCPDLRIIHLEDN 458
+ + +S N + L+SL +L + L
Sbjct: 424 EKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKC 483
Query: 459 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNV---VLNYAGN 504
QL L L+ L + +N L + SS ++ L+ + N
Sbjct: 484 QLEQISWGVFDTLHRLQLLNMSHNNLLF-LDSSHYNQLYSLSTLDCSFN 531
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 15/91 (16%), Positives = 26/91 (28%), Gaps = 10/91 (10%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
++T + LS L L L +++++ N L S L +L
Sbjct: 473 TNLTFLDLSKCQLEQISWGVFDTLHRL--------QLLNMSHNNLLFLDSSHYNQLYSLS 524
Query: 476 ELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 504
L N + + N N
Sbjct: 525 TLDCSFNRIETSKGILQHFPKSLAFFNLTNN 555
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 3e-07
Identities = 15/96 (15%), Positives = 33/96 (34%), Gaps = 15/96 (15%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTG-PLPSSLMNLPNL 474
S+ + L + +L +L + +++ N + LP+ NL NL
Sbjct: 104 TSLENLVAVETKLASLESFPIGQLITL--------KKLNVAHNFIHSCKLPAYFSNLTNL 155
Query: 475 RELYVQNNMLSGTVPSS------LLSKNVVLNYAGN 504
+ + N + + N+ L+ + N
Sbjct: 156 VHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 3e-07
Identities = 17/93 (18%), Positives = 24/93 (25%), Gaps = 16/93 (17%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVE---------------F-GCPDLRIIHLEDNQ 459
S I LS L + S L + G L + L N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 460 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 492
+ P S L +L L L+ +
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPI 124
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 6e-07
Identities = 12/80 (15%), Positives = 28/80 (35%), Gaps = 8/80 (10%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
++ + L+ + P + L+SL + + +L + L L+
Sbjct: 80 HHLSNLILTGNPIQSFSPGSFSGLTSL--------ENLVAVETKLASLESFPIGQLITLK 131
Query: 476 ELYVQNNMLSGTVPSSLLSK 495
+L V +N + + S
Sbjct: 132 KLNVAHNFIHSCKLPAYFSN 151
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 9e-06
Identities = 18/79 (22%), Positives = 30/79 (37%), Gaps = 7/79 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
PS++ + LS L+ S + G LR + L N + ++ M L L+
Sbjct: 350 PSLSYLDLSRNALS-FSGCC-----SYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQ 402
Query: 476 ELYVQNNMLSGTVPSSLLS 494
L Q++ L S
Sbjct: 403 HLDFQHSTLKRVTEFSAFL 421
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 13/96 (13%), Positives = 27/96 (28%), Gaps = 8/96 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
++ + LS + +DL L + + N + + L
Sbjct: 153 TNLVHVDLSYNYIQTITVNDLQFLREN----PQVNLSLDMSLNPIDF-IQDQAFQGIKLH 207
Query: 476 ELYVQNNMLSGTVPSSL---LSKNVVLNYAGNINLH 508
EL ++ N S + + L+ V
Sbjct: 208 ELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKD 243
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 16/105 (15%), Positives = 32/105 (30%), Gaps = 17/105 (16%)
Query: 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVE--------------FGCPDLRIIHLEDNQ 459
+I L+ N + L+++ + + + Q
Sbjct: 259 CDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQ 318
Query: 460 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 504
L P+ +LP L+ L + N S + L L+ + N
Sbjct: 319 LKQ-FPTL--DLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRN 360
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 7e-04
Identities = 16/86 (18%), Positives = 29/86 (33%), Gaps = 12/86 (13%)
Query: 423 LSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 482
S ++ +L P L+ + L N+ + LP+L L + N
Sbjct: 309 WQSLSIIRC------QLKQFPTLDLPFLKSLTLTMNKGSISFKKV--ALPSLSYLDLSRN 360
Query: 483 MLSGTVPSSL----LSKNVVLNYAGN 504
LS + S + L+ + N
Sbjct: 361 ALSFSGCCSYSDLGTNSLRHLDLSFN 386
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.5 bits (130), Expect = 2e-07
Identities = 99/653 (15%), Positives = 202/653 (30%), Gaps = 172/653 (26%)
Query: 324 QGKYR----VYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVA 379
Q +Y+ V+E FV +F D + +L+ EI+ + D ++ G
Sbjct: 15 QYQYKDILSVFED-------AFVDNFDCKDVQDMPK-SILSKEEIDHIIMSKD-AVSGTL 65
Query: 380 IVSVISLYSSADWAQEGGDPCLPVPWSWL------QCNSDPQPS-ITVIHLSSKNLTGNI 432
+ L + Q+ + L + + +L + QPS +T +++ ++ N
Sbjct: 66 RLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQR---QPSMMTRMYIEQRDRLYND 122
Query: 433 PSDLTKLS----SLVEFGCPDLR--IIHLEDNQ---LTGPLPS--SLMNLPNLRELYVQN 481
K + LR ++ L + + G L S + + L VQ
Sbjct: 123 NQVFAKYNVSRLQPYL----KLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQC 178
Query: 482 NMLSG----TV-----PSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLL 532
M + P ++L L Y + N + ++ + I S +
Sbjct: 179 KMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHS--------I 230
Query: 533 ATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEK 592
+ L K + + L V V + A C K+L
Sbjct: 231 QAELRRLLKSK---------PYENCLLVLLNVQNAKAWNAFNLSC----------KIL-- 269
Query: 593 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ 652
+ T ++ T+ ++ + H +
Sbjct: 270 ------------------------LTTRF-----KQVTDFLSAATTTHISLDHHSMTLTP 300
Query: 653 EEGRSVLV-YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 711
+E +S+L+ Y L + T+ +R++ I I + A + H C +
Sbjct: 301 DEVKSLLLKYLDCRPQDLPREV--LTTNPRRLSIIAES-IRDGLATWDNWKHVNCDK--L 355
Query: 712 HRDLKSS-NILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 770
++SS N+L R + F +H+ +I+ + + D + +K
Sbjct: 356 TTIIESSLNVLEPAEYRKMFDRLSV--FPPS--AHIPTILLSLI-WFDVIKSDVMVVVNK 410
Query: 771 SDVYSFGVILLELISGQEAIS----NEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826
YS L+E + IS + N LH S++D
Sbjct: 411 LHKYS----LVEKQPKESTISIPSIYLELKVKLENEYA---LHR-----------SIVDH 452
Query: 827 YDIQSMWKIEEKALMCV-------LPHGHMRPS--------ISEVLKD---IQDAIVIER 868
Y+I + ++ + + H H++ V D ++ I +
Sbjct: 453 YNIPKTFDSDDLIPPYLDQYFYSHIGH-HLKNIEHPERMTLFRMVFLDFRFLEQKIRHDS 511
Query: 869 EAAAARDGNSDD----------MSRNSLHSSLNVGSFGGTENFL-SLDESIVR 910
A A + + N V + +FL ++E+++
Sbjct: 512 TAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAI---LDFLPKIEENLIC 561
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.6 bits (120), Expect = 2e-06
Identities = 73/613 (11%), Positives = 170/613 (27%), Gaps = 228/613 (37%)
Query: 22 LDSSSAQM------------PGFVS-LNCGGNENFTDEIGLQWIAD---DHLIYGEISNI 65
+D + + FV +C ++ I ++ DH I +
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSI----LSKEEIDH-IIMSKDAV 61
Query: 66 SVANETR--------KQYMTLRHFPADSRKYCY-----KLDVITRTRYLIRATFLYGN-- 110
+ T KQ ++ F + + Y + R ++ ++
Sbjct: 62 ---SGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDR 118
Query: 111 -FDNNNVYPKFDISLGPTHWSTIVISDAATIEVRE-LIFLASSPKI-------------- 154
+++N V+ K+++S + ++R+ L+ L + +
Sbjct: 119 LYNDNQVFAKYNVSRLQPYL-----------KLRQALLELRPAKNVLIDGVLGSGKTWVA 167
Query: 155 -DVCLSNATTGQPFISTLELRQFNGSVY-------------LTPFEDRYYL--------- 191
DVCLS + + ++ L + Y
Sbjct: 168 LDVCLSYKV----------QCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRS 217
Query: 192 --SVSARINFGADSEAPVR------YP------DDPFD-RIWES---------------- 220
S + ++ + R Y + + + W +
Sbjct: 218 DHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQV 277
Query: 221 -DSLKKANY----LVDVAAG-TEKVSTKL---PIDLRSDELPPQKV----MQTAVVGT-- 265
D L A L + T L +D R +LP + + + +++
Sbjct: 278 TDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESI 337
Query: 266 -NGSLTY----RLNLDGFPGFGWAVTYFAE--IEDLDPDESRK-FRL--VLPGQPDV--- 312
+G T+ +N D +T E + L+P E RK F V P P
Sbjct: 338 RDGLATWDNWKHVNCD-------KLTTIIESSLNVLEPAEYRKMFDRLSVFP--PSAHIP 388
Query: 313 ------------------------SKAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFG 348
++V ++ + + S+ L K
Sbjct: 389 TILLSLIWFDVIKSDVMVVVNKLHKYSLVE-KQPKESTISIP-------SIYLELKVKLE 440
Query: 349 KTYDSSRGPLLNAMEINKYLERNDGS---IDGVAIVSVISLY--SSADWAQEGGD-PCLP 402
Y R +++ I K + +D +D S I + + + + +
Sbjct: 441 NEYALHR-SIVDHYNIPKTFDSDDLIPPYLDQY-FYSHIG-HHLKNIEHPERMTLFRMVF 497
Query: 403 VPWSWLQ-----------CNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEF------ 445
+ + +L+ + ++ + + N P ++++++F
Sbjct: 498 LDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEE 557
Query: 446 ---GCPDLRIIHL 455
++ +
Sbjct: 558 NLICSKYTDLLRI 570
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 22/97 (22%), Positives = 35/97 (36%), Gaps = 13/97 (13%)
Query: 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNL 474
QP + L S L P +LS L ++ L LP ++ L
Sbjct: 80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHM--------TIDAAGLME-LPDTMQQFAGL 129
Query: 475 RELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHE 509
L + N L +P+S+ L++ L+ L E
Sbjct: 130 ETLTLARNPLR-ALPASIASLNRLRELSIRACPELTE 165
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 1e-05
Identities = 15/95 (15%), Positives = 36/95 (37%), Gaps = 12/95 (12%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 476
++ + L + ++P+ + L +L + + + ++ L+ L ++ +LP L E
Sbjct: 184 NLQSLRLEWTGIR-SLPASIANLQNL--------KSLKIRNSPLSA-LGPAIHHLPKLEE 233
Query: 477 LYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHE 509
L ++ P + L NL
Sbjct: 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT 268
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 13/94 (13%), Positives = 21/94 (22%), Gaps = 17/94 (18%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVEF----------------GCPDLRIIHLEDNQL 460
+ + L N P + L L + L
Sbjct: 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVN 289
Query: 461 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 494
LPS + LP + V + L +
Sbjct: 290 LSRLPSLIAQLPANCIILVPPH-LQAQLDQHRPV 322
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 15/81 (18%), Positives = 27/81 (33%), Gaps = 10/81 (12%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
+ + LSS L + + + + I L +N+L + +L NL
Sbjct: 191 AKLKTLDLSSNKLA-FMGPEFQSAAGV--------TWISLRNNKLVL-IEKALRFSQNLE 240
Query: 476 ELYVQNNMLSGTVPSSLLSKN 496
++ N SKN
Sbjct: 241 HFDLRGNGFHCGTLRDFFSKN 261
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 18/104 (17%), Positives = 38/104 (36%), Gaps = 16/104 (15%)
Query: 416 PSITVIHLSSKNLTGNIPSD--------------LTKLSSLVEFGCPDLRIIHLEDNQLT 461
PSI +H ++ N++ + +T L L E ++ + L+ N++
Sbjct: 99 PSIETLHAANNNIS-RVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
Query: 462 G-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 504
+ L L +Q N + + +K L+ + N
Sbjct: 158 TVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSN 201
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 7e-06
Identities = 15/89 (16%), Positives = 31/89 (34%), Gaps = 8/89 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
+ ++ +L + S ++ + + L N L+ + L L
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNV--------KELDLSGNPLSQISAADLAPFTKLE 61
Query: 476 ELYVQNNMLSGTVPSSLLSKNVVLNYAGN 504
L + +N+L T+ LS L+ N
Sbjct: 62 LLNLSSNVLYETLDLESLSTLRTLDLNNN 90
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 20/103 (19%), Positives = 35/103 (33%), Gaps = 20/103 (19%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVE--------------FGCPDLRIIHLEDNQLT 461
++ + LS L+ +DL + L LR + L +N +
Sbjct: 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ 93
Query: 462 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 504
L+ P++ L+ NN +S V S + A N
Sbjct: 94 -----ELLVGPSIETLHAANNNIS-RVSCSRGQGKKNIYLANN 130
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 15/86 (17%), Positives = 28/86 (32%), Gaps = 10/86 (11%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
+ + LSS L + + + + I L +N+L + +L NL
Sbjct: 191 AKLKTLDLSSNKLA-FMGPEFQSAAGV--------TWISLRNNKLVL-IEKALRFSQNLE 240
Query: 476 ELYVQNNMLSGTVPSSLLSKNVVLNY 501
++ N SKN +
Sbjct: 241 HFDLRGNGFHCGTLRDFFSKNQRVQT 266
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 15/89 (16%), Positives = 31/89 (34%), Gaps = 8/89 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
+ ++ +L + S ++ + + L N L+ + L L
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNV--------KELDLSGNPLSQISAADLAPFTKLE 61
Query: 476 ELYVQNNMLSGTVPSSLLSKNVVLNYAGN 504
L + +N+L T+ LS L+ N
Sbjct: 62 LLNLSSNVLYETLDLESLSTLRTLDLNNN 90
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 18/104 (17%), Positives = 38/104 (36%), Gaps = 16/104 (15%)
Query: 416 PSITVIHLSSKNLTGNIPSD--------------LTKLSSLVEFGCPDLRIIHLEDNQLT 461
PSI +H ++ N++ + +T L L E ++ + L+ N++
Sbjct: 99 PSIETLHAANNNIS-RVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
Query: 462 G-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 504
+ L L +Q N + + +K L+ + N
Sbjct: 158 TVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSN 201
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 20/103 (19%), Positives = 35/103 (33%), Gaps = 20/103 (19%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVE--------------FGCPDLRIIHLEDNQLT 461
++ + LS L+ +DL + L LR + L +N +
Sbjct: 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ 93
Query: 462 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 504
L+ P++ L+ NN +S V S + A N
Sbjct: 94 -----ELLVGPSIETLHAANNNIS-RVSCSRGQGKKNIYLANN 130
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 5e-07
Identities = 21/89 (23%), Positives = 38/89 (42%), Gaps = 3/89 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
PS+ + L L ++L V G L++++L N L P +L LR
Sbjct: 451 PSLEQLFLGENMLQLAWETEL---CWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALR 507
Query: 476 ELYVQNNMLSGTVPSSLLSKNVVLNYAGN 504
L + +N L+ + L + +L+ + N
Sbjct: 508 GLSLNSNRLTVLSHNDLPANLEILDISRN 536
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 14/82 (17%), Positives = 22/82 (26%), Gaps = 12/82 (14%)
Query: 420 VIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 479
+ NLT +P L + L N + SS L L+ L +
Sbjct: 8 IAFYRFCNLT-QVPQVL-----------NTTERLLLSFNYIRTVTASSFPFLEQLQLLEL 55
Query: 480 QNNMLSGTVPSSLLSKNVVLNY 501
+ T+ L
Sbjct: 56 GSQYTPLTIDKEAFRNLPNLRI 77
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 18/104 (17%), Positives = 30/104 (28%), Gaps = 18/104 (17%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEF-----------------GCPDLRIIHLEDN 458
+ + LS + S L L P+LRI+ L +
Sbjct: 24 NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83
Query: 459 QLTGPLPSSLMNLPNLRELYVQNNMLS-GTVPSSLLSKNVVLNY 501
++ P + L +L EL + LS + L
Sbjct: 84 KIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTR 127
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 52.3 bits (125), Expect = 6e-07
Identities = 17/103 (16%), Positives = 42/103 (40%), Gaps = 6/103 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
S+ + +S+ L ++P+ + E +N++T +P ++++L
Sbjct: 180 ESLEALDVSTNLLE-SLPAVPVRNHHSEE----TEIFFRCRENRITH-IPENILSLDPTC 233
Query: 476 ELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLN 518
+ +++N LS + SL + +Y G G ++
Sbjct: 234 TIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTL 276
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 7e-07
Identities = 23/103 (22%), Positives = 42/103 (40%), Gaps = 11/103 (10%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSL---------VEFGCPDLRIIHLEDNQLTGPLPS 466
+ + +S LT ++P ++L L + L + + NQLT LP
Sbjct: 221 SGLKELIVSGNRLT-SLPVLPSELKELMVSGNRLTSLPMLPSGLLSLSVYRNQLTR-LPE 278
Query: 467 SLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 509
SL++L + + ++ N LS +L Y+G I +
Sbjct: 279 SLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFD 321
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 22/83 (26%), Positives = 33/83 (39%), Gaps = 11/83 (13%)
Query: 419 TVIHLSSKNLT---GNIPSDLTKLS----SLVEF--GCPDLRIIHLEDNQLTGPLPSSLM 469
V+++ LT +P+ +T L +L P+LR + + NQLT LP
Sbjct: 43 AVLNVGESGLTTLPDCLPAHITTLVIPDNNLTSLPALPPELRTLEVSGNQLTS-LPVLPP 101
Query: 470 NLPNLRELYVQNNMLSGTVPSSL 492
L L L +PS L
Sbjct: 102 GLLELSIFSNPLTHLP-ALPSGL 123
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 8e-07
Identities = 23/102 (22%), Positives = 41/102 (40%), Gaps = 14/102 (13%)
Query: 416 PSITVIHLSSKNLTGNIP--SDLTKL----------SSLVEFG-CPDLRIIHLEDNQLTG 462
+T + + + ++ +I DLTKL S + L + L +NQL
Sbjct: 243 SQLTWLEIGTNQIS-DINAVKDLTKLKMLNVGSNQISDISVLNNLSQLNSLFLNNNQLGN 301
Query: 463 PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 504
+ L NL L++ N ++ P + LSK ++A
Sbjct: 302 EDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 4e-05
Identities = 29/105 (27%), Positives = 48/105 (45%), Gaps = 16/105 (15%)
Query: 416 PSITVIHLSSKNLTGNIP--SDLTKL----------SSLVEFG-CPDLRIIHLEDNQLTG 462
SIT + ++ + + +I LT L + + L +++ N++T
Sbjct: 44 ESITKLVVAGEKVA-SIQGIEYLTNLEYLNLNGNQITDISPLSNLVKLTNLYIGTNKITD 102
Query: 463 PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINL 507
S+L NL NLRELY+ + +S P + L+K LN N NL
Sbjct: 103 I--SALQNLTNLRELYLNEDNISDISPLANLTKMYSLNLGANHNL 145
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 4e-05
Identities = 10/70 (14%), Positives = 23/70 (32%), Gaps = 10/70 (14%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
+ + L++ L + L++L + L N +T L +L +
Sbjct: 287 SQLNSLFLNNNQLGNEDMEVIGGLTNL--------TTLFLSQNHITDI--RPLASLSKMD 336
Query: 476 ELYVQNNMLS 485
N ++
Sbjct: 337 SADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 1e-04
Identities = 20/90 (22%), Positives = 37/90 (41%), Gaps = 13/90 (14%)
Query: 416 PSITVIHLSSKNLTGNIP-SDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNL 474
++ ++L+ N++ P ++LTK+ SL +L N S L N+ L
Sbjct: 110 TNLRELYLNEDNISDISPLANLTKMYSL-----------NLGANHNLS-DLSPLSNMTGL 157
Query: 475 RELYVQNNMLSGTVPSSLLSKNVVLNYAGN 504
L V + + P + L+ L+ N
Sbjct: 158 NYLTVTESKVKDVTPIANLTDLYSLSLNYN 187
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 3e-04
Identities = 21/101 (20%), Positives = 37/101 (36%), Gaps = 14/101 (13%)
Query: 416 PSITVIHLSSKNLTGNIP-SDLTKL----------SSLVEFG-CPDLRIIHLEDNQLTGP 463
+ + L+ + P + LT L + + L + + +N++T
Sbjct: 177 TDLYSLSLNYNQIEDISPLASLTSLHYFTAYVNQITDITPVANMTRLNSLKIGNNKITDL 236
Query: 464 LPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 504
S L NL L L + N +S L+K +LN N
Sbjct: 237 --SPLANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVGSN 275
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 22/110 (20%), Positives = 40/110 (36%), Gaps = 15/110 (13%)
Query: 399 PCLPVPWSW-LQCNSDPQPSITVIHLSSKNLT---GNIPSDLTKL-------SSLVE--F 445
P +P C Q + V+ S L ++P D L + + + F
Sbjct: 13 PEVPEIEPMGPVCPFRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDF 72
Query: 446 -GCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 494
+L + L +N+++ P + L L LY+ N L +P +
Sbjct: 73 KNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK 121
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 7e-06
Identities = 22/87 (25%), Positives = 38/87 (43%), Gaps = 19/87 (21%)
Query: 416 PSITVIHLSSKNLTGNIPSD----LTKLSSL-------------VEFGCPDLRIIHLEDN 458
PS+T +HL +T + + L L+ L P LR +HL +N
Sbjct: 192 PSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN 250
Query: 459 QLTGPLPSSLMNLPNLRELYVQNNMLS 485
+L +P L + ++ +Y+ NN +S
Sbjct: 251 KLVK-VPGGLADHKYIQVVYLHNNNIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 25/90 (27%), Positives = 41/90 (45%), Gaps = 14/90 (15%)
Query: 416 PSITVIHLSSKNLTG---NIPSDLTKLS------SLVEFGC----PDLRIIHLEDNQLTG 462
++ I ++ N+T +P LT+L + V+ +L + L N ++
Sbjct: 171 KKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA 230
Query: 463 PLPSSLMNLPNLRELYVQNNMLSGTVPSSL 492
SL N P+LREL++ NN L VP L
Sbjct: 231 VDNGSLANTPHLRELHLNNNKLV-KVPGGL 259
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 11/99 (11%), Positives = 32/99 (32%), Gaps = 19/99 (19%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTG------PLPSSLM 469
P + +HL++ L +P L +++++L +N ++ P
Sbjct: 240 PHLRELHLNNNKLV-KVPGGL--------ADHKYIQVVYLHNNNISAIGSNDFCPPGYNT 290
Query: 470 NLPNLRELYVQNNMLSGT-VPSSL---LSKNVVLNYAGN 504
+ + + +N + + S + +
Sbjct: 291 KKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 8e-04
Identities = 20/88 (22%), Positives = 34/88 (38%), Gaps = 14/88 (15%)
Query: 416 PSITVIHLSSKNLT-GNIPSDLTKLSSLVEF-GCPDLRIIHLEDNQLTGPLPSSLMNLPN 473
+ V+ L + L I + F G L I + D +T +P L P+
Sbjct: 145 NQMIVVELGTNPLKSSGIENGA--------FQGMKKLSYIRIADTNITT-IPQGL--PPS 193
Query: 474 LRELYVQNNMLSGTVPSSLLSKNVVLNY 501
L EL++ N ++ V ++ L L
Sbjct: 194 LTELHLDGNKIT-KVDAASLKGLNNLAK 220
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-06
Identities = 19/103 (18%), Positives = 40/103 (38%), Gaps = 15/103 (14%)
Query: 416 PSITVIHLSSKNLTGNIP-SDLTKL----------SSLVEFG-CPDLRIIHLEDNQLTGP 463
++T + L N++ P S LTKL S + ++ + NQ++
Sbjct: 309 KNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDVSSLANLTNINWLSAGHNQISDL 368
Query: 464 LPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 506
+ L NL + +L + + + P + + + N N+
Sbjct: 369 --TPLANLTRITQLGLNDQAWT-NAPVNYKANVSIPNTVKNVT 408
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-06
Identities = 28/101 (27%), Positives = 44/101 (43%), Gaps = 14/101 (13%)
Query: 416 PSITVIHLSSKNLTGNIP-SDLTKL----------SSLVEFG-CPDLRIIHLEDNQLTGP 463
++T + L++ ++ P S LTKL S++ L + L +NQL
Sbjct: 243 TNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDI 302
Query: 464 LPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 504
S + NL NL L + N +S P S L+K L + N
Sbjct: 303 --SPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNN 341
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 5e-06
Identities = 22/103 (21%), Positives = 33/103 (32%), Gaps = 18/103 (17%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEF--------------GCPDLRIIHLEDNQLT 461
++ + L+ L L L++L + G L + L NQ++
Sbjct: 221 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQIS 278
Query: 462 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 504
S L L L L + N L P S L L N
Sbjct: 279 NI--SPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFN 319
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 7e-06
Identities = 19/101 (18%), Positives = 38/101 (37%), Gaps = 14/101 (13%)
Query: 416 PSITVIHLSSKNLTGNIP-SDLTKL----------SSLVEFG-CPDLRIIHLEDNQLTGP 463
+T + L + ++ P + LT L + +L + L N ++
Sbjct: 265 TKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDI 324
Query: 464 LPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 504
P + +L L+ L+ NN +S + L+ L+ N
Sbjct: 325 SP--VSSLTKLQRLFFYNNKVSDVSSLANLTNINWLSAGHN 363
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 22/101 (21%), Positives = 40/101 (39%), Gaps = 14/101 (13%)
Query: 416 PSITVIHLSSKNLTGNIP-SDLTKL----------SSLVEFG-CPDLRIIHLEDNQLTGP 463
++T + L+ L P S+L L S + L+ + +N+++
Sbjct: 287 TALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDV 346
Query: 464 LPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 504
SSL NL N+ L +N +S P + L++ L
Sbjct: 347 --SSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 385
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 24/102 (23%), Positives = 41/102 (40%), Gaps = 17/102 (16%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEF-------------GCPDLRIIHLEDNQLTG 462
++ + LSS ++ S L+ L+SL + L + + N+++
Sbjct: 134 TNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD 191
Query: 463 PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 504
S L L NL L NN +S P +L+ L+ GN
Sbjct: 192 I--SVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGN 231
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 21/82 (25%), Positives = 37/82 (45%), Gaps = 7/82 (8%)
Query: 423 LSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 482
L +++ N SD++ L+ L +L + +NQ++ + L L NL EL + N
Sbjct: 179 LERLDISSNKVSDISVLAKL-----TNLESLIATNNQISDI--TPLGILTNLDELSLNGN 231
Query: 483 MLSGTVPSSLLSKNVVLNYAGN 504
L + L+ L+ A N
Sbjct: 232 QLKDIGTLASLTNLTDLDLANN 253
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 26/102 (25%), Positives = 44/102 (43%), Gaps = 14/102 (13%)
Query: 416 PSITVIHLSSKNLTGNIP-SDLTKL----------SSLVEFG-CPDLRIIHLEDNQLTGP 463
++T I+ S+ LT P +LTKL + + +L + L +NQ+T
Sbjct: 68 NNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDI 127
Query: 464 LPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNI 505
L NL NL L + +N +S S L+ L++ +
Sbjct: 128 --DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQV 167
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 17/90 (18%), Positives = 32/90 (35%), Gaps = 14/90 (15%)
Query: 416 PSITVIHLSSKNLTGNIP-SDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNL 474
L N+T + +DL ++++L + + + L NL
Sbjct: 24 AEKMKTVLGKTNVTDTVSQTDLDQVTTL-----------QADRLGIKSI--DGVEYLNNL 70
Query: 475 RELYVQNNMLSGTVPSSLLSKNVVLNYAGN 504
++ NN L+ P L+K V + N
Sbjct: 71 TQINFSNNQLTDITPLKNLTKLVDILMNNN 100
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 12/97 (12%), Positives = 25/97 (25%), Gaps = 18/97 (18%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVE----------------F-GCPDLRIIHLEDN 458
S+ + LS + + S+ L L F +L + +
Sbjct: 78 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 136
Query: 459 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 495
L +L L + N + ++
Sbjct: 137 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 173
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 22/104 (21%), Positives = 34/104 (32%), Gaps = 19/104 (18%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVE------------------FGCPDLRIIHLED 457
S T + L S L KL+ L + FG L+ + L
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87
Query: 458 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 501
N + + S+ + L L L Q++ L S+ L Y
Sbjct: 88 NGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 130
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 13/79 (16%), Positives = 31/79 (39%), Gaps = 8/79 (10%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
S+ V+ ++ + N D+ +L + L QL P++ +L +L+
Sbjct: 150 SSLEVLKMAGNSFQENFLPDIFT-------ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 202
Query: 476 ELYVQNNMLSGTVPSSLLS 494
L + +N ++ +
Sbjct: 203 VLNMSHNNFF-SLDTFPYK 220
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 22/72 (30%), Positives = 28/72 (38%), Gaps = 17/72 (23%)
Query: 417 SITVIHLSSKNLT---GNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPN 473
S T I +SK LT IPS T+L LE N+L L
Sbjct: 8 SGTEIRCNSKGLTSVPTGIPSSATRL--------------ELESNKLQSLPHGVFDKLTQ 53
Query: 474 LRELYVQNNMLS 485
L +L + +N LS
Sbjct: 54 LTKLSLSSNGLS 65
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 14/89 (15%), Positives = 32/89 (35%), Gaps = 11/89 (12%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
+ +++S+ L + + +L +++ L N L + + L
Sbjct: 272 QRLERLYISNNRLV-ALNLYGQPIPTL--------KVLDLSHNHLLH-VERNQPQFDRLE 321
Query: 476 ELYVQNNMLSGTVPSSLLSKNVVLNYAGN 504
LY+ +N + T+ S L + N
Sbjct: 322 NLYLDHNSIV-TLKLSTHHTLKNLTLSHN 349
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 18/78 (23%), Positives = 31/78 (39%), Gaps = 4/78 (5%)
Query: 427 NLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 486
L N DL+ L + P L + + +N L + +L+ L + +N L+
Sbjct: 123 VLERN---DLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT- 178
Query: 487 TVPSSLLSKNVVLNYAGN 504
V SL+ N + N
Sbjct: 179 HVDLSLIPSLFHANVSYN 196
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 14/109 (12%), Positives = 36/109 (33%), Gaps = 22/109 (20%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVEF----------------GCPDLRIIHLEDN 458
+ ++ + + +P+ L + ++ +++ N
Sbjct: 45 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFN 103
Query: 459 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN---VVLNYAGN 504
+ P N+P L L ++ N LS ++P + L+ + N
Sbjct: 104 AIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNN 151
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 14/85 (16%), Positives = 28/85 (32%), Gaps = 13/85 (15%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSD-LTKLSSL-----------VEFGCPDLRIIHLEDNQL 460
++ + S ++ + +L+ L P L + L N+L
Sbjct: 202 AIPIAVEELDASHNSIN-VVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNEL 260
Query: 461 TGPLPSSLMNLPNLRELYVQNNMLS 485
+ + + L LY+ NN L
Sbjct: 261 EKIMYHPFVKMQRLERLYISNNRLV 285
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 20/109 (18%), Positives = 36/109 (33%), Gaps = 20/109 (18%)
Query: 399 PCLPVPWSWLQCNSDPQPSITVIHLSSKNLT---GNIPSDLTKL-------SSLVE---F 445
PC C +P +T + L IP+ ++ S +
Sbjct: 1 PCPGA------CVCYNEPKVTT-SCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFR 53
Query: 446 GCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 494
C +L I+ L N L ++ L L +L + +N +V +
Sbjct: 54 ACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFH 102
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 7e-05
Identities = 18/74 (24%), Positives = 28/74 (37%), Gaps = 3/74 (4%)
Query: 422 HLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 481
L +L+ N + L + G L +HL+ L P L L+ LY+Q+
Sbjct: 81 LLEQLDLSDN--AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQD 138
Query: 482 NMLSGTVPSSLLSK 495
N L +P
Sbjct: 139 NALQ-ALPDDTFRD 151
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 24/111 (21%), Positives = 42/111 (37%), Gaps = 22/111 (19%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVE---------------F-GCPDLRIIHLEDN 458
++ ++L L +P D L +L F G L + L N
Sbjct: 129 AALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN 187
Query: 459 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 509
++ P + +L L LY+ N LS +P+ L+ L Y + L++
Sbjct: 188 RVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQY---LRLND 234
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 11/83 (13%), Positives = 32/83 (38%), Gaps = 7/83 (8%)
Query: 427 NLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 486
+ ++ +S L +L + + +T +L L +L L + ++
Sbjct: 72 TINNIHATNYNPISGL-----SNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD 126
Query: 487 TVPSSL--LSKNVVLNYAGNINL 507
++ + + L K ++ + N +
Sbjct: 127 SILTKINTLPKVNSIDLSYNGAI 149
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 14/89 (15%), Positives = 32/89 (35%), Gaps = 11/89 (12%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
+ +++S+ L + + +L +++ L N L + + L
Sbjct: 278 QRLERLYISNNRLV-ALNLYGQPIPTL--------KVLDLSHNHLLH-VERNQPQFDRLE 327
Query: 476 ELYVQNNMLSGTVPSSLLSKNVVLNYAGN 504
LY+ +N + T+ S L + N
Sbjct: 328 NLYLDHNSIV-TLKLSTHHTLKNLTLSHN 355
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 18/78 (23%), Positives = 31/78 (39%), Gaps = 4/78 (5%)
Query: 427 NLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 486
L N DL+ L + P L + + +N L + +L+ L + +N L+
Sbjct: 129 VLERN---DLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT- 184
Query: 487 TVPSSLLSKNVVLNYAGN 504
V SL+ N + N
Sbjct: 185 HVDLSLIPSLFHANVSYN 202
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 7e-05
Identities = 13/101 (12%), Positives = 33/101 (32%), Gaps = 19/101 (18%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVEF----------------GCPDLRIIHLEDN 458
+ ++ + + +P+ L + ++ +++ N
Sbjct: 51 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFN 109
Query: 459 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 499
+ P N+P L L ++ N LS ++P + L
Sbjct: 110 AIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKL 149
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 20/85 (23%), Positives = 34/85 (40%), Gaps = 8/85 (9%)
Query: 422 HLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 481
L+ L N +LT + L+ P L + L N+L + + + L LY+ N
Sbjct: 233 ELTILKLQHN---NLTDTAWLL--NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN 287
Query: 482 NMLSGTVPSSL--LSKNVVLNYAGN 504
N L + + VL+ + N
Sbjct: 288 NRLV-ALNLYGQPIPTLKVLDLSHN 311
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 27/109 (24%), Positives = 41/109 (37%), Gaps = 14/109 (12%)
Query: 409 QCNSDPQPSITVIHLSSKNLT---GNIPSDLTKL-------SSLVE--F-GCPDLRIIHL 455
C + V+ S L I D T L S L + F G L + L
Sbjct: 26 MCPFGCHCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVL 85
Query: 456 EDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 504
+N+++ + L L++LY+ N L +P +L S V L N
Sbjct: 86 VNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPSSLVELRIHDN 133
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 20/87 (22%), Positives = 38/87 (43%), Gaps = 19/87 (21%)
Query: 416 PSITVIHLSSKNLTGNIPS-DLTKLSSLVE---------------F-GCPDLRIIHLEDN 458
++ +HL + I DL + S L P LR +HL++N
Sbjct: 193 ETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNN 251
Query: 459 QLTGPLPSSLMNLPNLRELYVQNNMLS 485
+L+ +P+ L +L L+ +Y+ N ++
Sbjct: 252 KLSR-VPAGLPDLKLLQVVYLHTNNIT 277
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 26/89 (29%), Positives = 39/89 (43%), Gaps = 14/89 (15%)
Query: 417 SITVIHLSSKNLTG---NIPSDLTKL-------SSLVEF---GCPDLRIIHLEDNQLTGP 463
+ + +S LTG ++P L +L ++ L + L NQ+
Sbjct: 173 KLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMI 232
Query: 464 LPSSLMNLPNLRELYVQNNMLSGTVPSSL 492
SL LP LREL++ NN LS VP+ L
Sbjct: 233 ENGSLSFLPTLRELHLDNNKLS-RVPAGL 260
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 5e-06
Identities = 17/112 (15%), Positives = 32/112 (28%), Gaps = 28/112 (25%)
Query: 398 DPCLPVPWSWLQCNSDPQPSITVIHLSSKNLT---GNIPSD----------LTKLSSLVE 444
+PC N N+P L L S
Sbjct: 1 EPC--------VEV----VPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSF 48
Query: 445 FGCPDLRIIHLEDNQLTGPLPSSL-MNLPNLRELYVQNNMLSGTVPSSLLSK 495
F P+L+++ L ++ + +L +L L + N + ++ S
Sbjct: 49 FSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSG 98
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 17/97 (17%), Positives = 34/97 (35%), Gaps = 18/97 (18%)
Query: 416 PSITVIHLSSKNLT---GNIPSDLTKLSSLVEFGC-------------PDLRIIHLEDNQ 459
++ + L+ + S L+ L LV L+ +++ N
Sbjct: 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135
Query: 460 LTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 495
+ LP NL NL L + +N + ++ + L
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRV 171
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 27/165 (16%), Positives = 48/165 (29%), Gaps = 28/165 (16%)
Query: 35 LNCGGNENFTDEIGLQWIADDHLI-------YGEISNISVANETRKQ-YMTLRHFPADSR 86
+N GG D G+ + D YG I +N + Y T R+
Sbjct: 10 VNAGGES-HVDVHGIHYRKDPLEGRVGRASDYGMKLPILRSNPEDQVLYQTERYNEDS-- 66
Query: 87 KYCYKLDVITRTRYLIRATFLYGNFDNNN------------VYPKFDISLGPTHWSTIVI 134
+ Y + + Y++ F F + V DI H +
Sbjct: 67 -FGYDIPIKEEGEYVLVLKFAEVYFAQSQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDE 125
Query: 135 SDAATIEVRELIF----LASSPKIDVCLSNATTGQPFISTLELRQ 175
+I+ +L + K+ V P + L + +
Sbjct: 126 IIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNPKVCALFIMK 170
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 20/102 (19%), Positives = 38/102 (37%), Gaps = 19/102 (18%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEF-------------GCPDLRIIHLEDNQLTG 462
++T + + ++T ++ + KL+ L + +L + + N+LT
Sbjct: 42 ATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNITTLDLSQNTNLTYLACDSNKLTN 99
Query: 463 PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 504
L + L L L N L+ + S LN A N
Sbjct: 100 -LD--VTPLTKLTYLNCDTNKLT-KLDVSQNPLLTYLNCARN 137
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 16/105 (15%), Positives = 34/105 (32%), Gaps = 16/105 (15%)
Query: 416 PSITVIHLSSKNLTGNIP-SDLTKLSSL---------VEFG-CPDLRIIHLEDNQLTGPL 464
+ ++ + N+T + + +L+ L ++ L N LT L
Sbjct: 191 KLLNRLNCDTNNIT-KLDLNQNIQLTFLDCSSNKLTEIDVTPLTQLTYFDCSVNPLT-EL 248
Query: 465 PSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 509
S L L L+ L + + ++ + G + E
Sbjct: 249 DVS--TLSKLTTLHCIQTDLL-EIDLTHNTQLIYFQAEGCRKIKE 290
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 7e-05
Identities = 14/100 (14%), Positives = 35/100 (35%), Gaps = 15/100 (15%)
Query: 416 PSITVIHLSSKNLTGNIP-SDLTKLSSL---------VEFG-CPDLRIIHLEDNQLTGPL 464
+T + + + T+L++L ++ L ++ + N +T
Sbjct: 148 TQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITELDVSQNKLLNRLNCDTNNITKL- 206
Query: 465 PSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 504
L L L +N L+ + + L++ + + N
Sbjct: 207 --DLNQNIQLTFLDCSSNKLT-EIDVTPLTQLTYFDCSVN 243
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 18/88 (20%), Positives = 30/88 (34%), Gaps = 5/88 (5%)
Query: 418 ITVIHLSS-KNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 476
+ I L+ L K+ L L ++ + +T L L P L
Sbjct: 266 LLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVY 322
Query: 477 LYVQNNMLSGTVPSSLLSKNVVLNYAGN 504
LY+ N L+ + S +K L+
Sbjct: 323 LYLNNTELT-ELDVSHNTKLKSLSCVNA 349
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 10/103 (9%), Positives = 33/103 (32%), Gaps = 18/103 (17%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEF-------------GCPDLRIIHLEDNQLTG 462
+ ++ + +T + DL++ LV L+ + + +
Sbjct: 297 TQLYLLDCQAAGIT-EL--DLSQNPKLVYLYLNNTELTELDVSHNTKLKSLSCVNAHIQD 353
Query: 463 PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNI 505
S + +P L + +L + ++ + + ++
Sbjct: 354 -FSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDL 394
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 7e-06
Identities = 18/95 (18%), Positives = 37/95 (38%), Gaps = 17/95 (17%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVE----------------FGCPDLRIIHLEDNQ 459
+ +++L + + L L G +L + L DN+
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123
Query: 460 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 494
LT + + L L+EL+++NN + ++PS +
Sbjct: 124 LTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFN 157
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 23/108 (21%), Positives = 44/108 (40%), Gaps = 22/108 (20%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVE----------------FGCPDLRIIHLEDNQ 459
++ ++L+ NL IP +LT L L E G L+ + + +Q
Sbjct: 185 SNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQ 242
Query: 460 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGN 504
+ ++ NL +L E+ + +N L+ +P L L ++ N
Sbjct: 243 IQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 6e-04
Identities = 22/96 (22%), Positives = 35/96 (36%), Gaps = 20/96 (20%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSD-LTKLSSLVE---------------F-GCPDLRIIHL 455
+ ++ + L LT IP+ LS L E F P LR + L
Sbjct: 109 NGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDL 167
Query: 456 ED-NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPS 490
+ +L+ + L NLR L + L +P+
Sbjct: 168 GELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN 202
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 19/101 (18%), Positives = 36/101 (35%), Gaps = 19/101 (18%)
Query: 409 QCNSDPQPSITVIHLSSKNLT---GNIPSD----------LTKLSSLVEF-GCPDLRIIH 454
+C + T + S++ L +IP T L + F P LR I+
Sbjct: 8 KCRCEG----TTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKIN 63
Query: 455 LEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 495
+N++T + + E+ + +N L V +
Sbjct: 64 FSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKG 103
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 9e-06
Identities = 14/99 (14%), Positives = 31/99 (31%), Gaps = 14/99 (14%)
Query: 419 TVIHLSSKNLT---GNIPSD----------LTKLSSLVEFGCPDLRIIHLEDNQLTGPLP 465
++ S L ++ +++L + LRI+ + N++
Sbjct: 3 FLVDRSKNGLIHVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDI 62
Query: 466 SSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 504
S L L + +N L + L+ + N
Sbjct: 63 SVFKFNQELEYLDLSHNKLV-KISCHPTVNLKHLDLSFN 100
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 22/88 (25%), Positives = 38/88 (43%), Gaps = 19/88 (21%)
Query: 402 PVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLT 461
SW S+ +++SS LT I L P ++++ L N++
Sbjct: 392 KGDCSWT-------KSLLSLNMSSNILTDTIFRCLP----------PRIKVLDLHSNKIK 434
Query: 462 GPLPSSLMNLPNLRELYVQNNMLSGTVP 489
+P ++ L L+EL V +N L +VP
Sbjct: 435 S-IPKQVVKLEALQELNVASNQLK-SVP 460
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 15/78 (19%), Positives = 31/78 (39%), Gaps = 12/78 (15%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSL-----------VEFGCPDLRIIHLEDNQLTGPL 464
++ V+ +S+ NL + L +L L P L ++ + NQL
Sbjct: 431 QTLEVLDVSNNNLD-SFSLFLPRLQELYISRNKLKTLPDASLFPVLLVMKISRNQLKSVP 489
Query: 465 PSSLMNLPNLRELYVQNN 482
L +L+++++ N
Sbjct: 490 DGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 17/94 (18%), Positives = 33/94 (35%), Gaps = 1/94 (1%)
Query: 408 LQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSS 467
L + + L PS+ +S L + +R +H+ L L +
Sbjct: 246 LLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTV 305
Query: 468 LMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 501
L ++ + V+N+ + VP S L +
Sbjct: 306 YSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEF 338
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 21/101 (20%), Positives = 37/101 (36%), Gaps = 15/101 (14%)
Query: 416 PSITVIHLSSKNLT---GNIPSDLTKLS------SLVEFGCPDLRIIHLEDNQLTGPLPS 466
+ ++LSS + IP L L P L+ +++ N+L LP
Sbjct: 410 EKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLKT-LPD 468
Query: 467 SLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGN 504
+ P L + + N L +VP + L+ + N
Sbjct: 469 A-SLFPVLLVMKISRNQLK-SVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 6e-05
Identities = 21/93 (22%), Positives = 33/93 (35%), Gaps = 10/93 (10%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLT--GPLPSSLMNLPN 473
S+ + LS N+ + +S + P L+ + L N L L+ L N
Sbjct: 334 KSLEFLDLS-----ENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKN 388
Query: 474 LRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 504
L L + N +P S K LN +
Sbjct: 389 LTSLDISRNTFH-PMPDSCQWPEKMRFLNLSST 420
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 12/94 (12%), Positives = 31/94 (32%), Gaps = 8/94 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
+ + + ++ L S V ++ I +E++++ S +L +L
Sbjct: 281 GKVETVTIRRLHIPQF---YLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLE 337
Query: 476 ELYVQNNMLSG-----TVPSSLLSKNVVLNYAGN 504
L + N++ + L + N
Sbjct: 338 FLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQN 371
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 18/96 (18%), Positives = 30/96 (31%), Gaps = 16/96 (16%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEF----------------GCPDLRIIHLEDNQ 459
++ + LS +T DL ++L L + L DN
Sbjct: 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNH 85
Query: 460 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 495
L+ S L +L+ L + N +SL
Sbjct: 86 LSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPN 121
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 20/103 (19%), Positives = 37/103 (35%), Gaps = 20/103 (19%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVE-----------FGC--PDLRIIHLEDNQLTG 462
++T + +S +P + C L ++ + +N L
Sbjct: 387 KNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDS 445
Query: 463 PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN-VVLNYAGN 504
LP L+ELY+ N L T+P + L +V+ + N
Sbjct: 446 -FSL---FLPRLQELYISRNKLK-TLPDASLFPVLLVMKISRN 483
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 9/78 (11%), Positives = 26/78 (33%), Gaps = 9/78 (11%)
Query: 416 PSITVIHLSSKNLTGNIP-SDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNL 474
++ + + + I D L+SL + ++ L SL ++ ++
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSL--------NELEIKALSLRNYQSQSLKSIRDI 174
Query: 475 RELYVQNNMLSGTVPSSL 492
L + + + +
Sbjct: 175 HHLTLHLSESAFLLEIFA 192
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 19/81 (23%), Positives = 30/81 (37%), Gaps = 4/81 (4%)
Query: 422 HLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTG-PLPSSLMNLPNLRELYVQ 480
L +L+ N L+ LSS L+ ++L N + S NL NL+ L +
Sbjct: 75 SLEHLDLSDN---HLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIG 131
Query: 481 NNMLSGTVPSSLLSKNVVLNY 501
N + + LN
Sbjct: 132 NVETFSEIRRIDFAGLTSLNE 152
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 18/79 (22%), Positives = 29/79 (36%), Gaps = 17/79 (21%)
Query: 410 CNSDPQPSITVIHLSSKNLT---GNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPS 466
C S ++ +NLT ++P D T L HL +N L +
Sbjct: 4 CEVSKVASHLEVNCDKRNLTALPPDLPKDTTIL--------------HLSENLLYTFSLA 49
Query: 467 SLMNLPNLRELYVQNNMLS 485
+LM L +L + L+
Sbjct: 50 TLMPYTRLTQLNLDRAELT 68
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 20/95 (21%), Positives = 33/95 (34%), Gaps = 17/95 (17%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVE----------------FGCPDLRIIHLEDNQ 459
+ ++L N+ L L G L + L DN
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134
Query: 460 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 494
LT + L LREL+++NN + ++PS +
Sbjct: 135 LTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFN 168
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 17/85 (20%), Positives = 27/85 (31%), Gaps = 15/85 (17%)
Query: 416 PSITVIHLSSKNLTGNIPSD----LTKLSSLV----------EF-GCPDLRIIHLEDNQL 460
PS+ + L I L L L L + + N
Sbjct: 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPNLTPLVGLEELEMSGNHF 230
Query: 461 TGPLPSSLMNLPNLRELYVQNNMLS 485
P S L +L++L+V N+ +S
Sbjct: 231 PEIRPGSFHGLSSLKKLWVMNSQVS 255
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 20/95 (21%), Positives = 43/95 (45%), Gaps = 19/95 (20%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVE----------------FGCPDLRIIHLEDNQ 459
++ ++L N+ ++P +LT L L E G L+ + + ++Q
Sbjct: 196 FNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQ 253
Query: 460 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 494
++ ++ L +L EL + +N LS ++P L +
Sbjct: 254 VSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFT 287
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 20/108 (18%), Positives = 36/108 (33%), Gaps = 20/108 (18%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEF----------------GCPDLRIIHLEDNQ 459
+ V+ +S + + +L LR ++L N
Sbjct: 200 YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNP 259
Query: 460 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGN 504
++ S L L L+E+ + L+ V L+ VLN +GN
Sbjct: 260 ISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGN 306
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 13/95 (13%), Positives = 25/95 (26%), Gaps = 17/95 (17%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEF----------------GCPDLRIIHLEDNQ 459
++ L + + L E +LR + L N+
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91
Query: 460 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 494
L L NL +L + N + + +
Sbjct: 92 LKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQ 125
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 14/96 (14%), Positives = 31/96 (32%), Gaps = 19/96 (19%)
Query: 416 PSITVIHLSSKNLTGNIPSDL-TKLSSLVE----------------FGCPDLRIIHLEDN 458
++T + +S + + + L +L G L + LE
Sbjct: 104 SNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKC 162
Query: 459 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 494
LT +L +L L L +++ ++ +
Sbjct: 163 NLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFK 197
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 17/79 (21%), Positives = 31/79 (39%), Gaps = 9/79 (11%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
++ + L S L IP + G +L + + +N++ L +L NL+
Sbjct: 80 FNLRTLGLRSNRLK-LIPLGVFT-------GLSNLTKLDISENKIVILLDYMFQDLYNLK 131
Query: 476 ELYVQNNMLSGTVPSSLLS 494
L V +N L + S
Sbjct: 132 SLEVGDNDLV-YISHRAFS 149
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 13/106 (12%), Positives = 29/106 (27%), Gaps = 26/106 (24%)
Query: 398 DPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTG--NIPSDLTKLSSLVEFGCPDLRIIHL 455
DP +C+ ++ L +P+ + + L
Sbjct: 2 DPGTS------ECSV----IGYNAICINRGLHQVPELPAHVNYV--------------DL 37
Query: 456 EDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 501
N + +S L +L+ L V+ + ++ L
Sbjct: 38 SLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLII 83
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 9e-05
Identities = 16/104 (15%), Positives = 26/104 (25%), Gaps = 17/104 (16%)
Query: 408 LQCNSDPQPSITVIHLSSKNLT---GNIPSDLTKLSSL-------------VEFGCPDLR 451
+ LS + ++ S T L L +G L
Sbjct: 267 FTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLL 326
Query: 452 IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 495
++L N L NL L L + N + +
Sbjct: 327 KLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLG 369
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 5e-05
Identities = 49/229 (21%), Positives = 83/229 (36%), Gaps = 50/229 (21%)
Query: 592 KKIGSGGFGVVY--YGKLKDGKEIAVKVLTSN-SY--QGKREFTNEVTLLSRIHHR---- 642
+G G FG V + ++A+K++ + Y + E + +L +I +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE----INVLKKIKEKDKEN 80
Query: 643 --NLVQFLGYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAK 697
V + G + +E + T LKE+ + ++ +A
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPH----VRH--MAYQLCH 134
Query: 698 GIEYLHTGCVPAIIHRDLKSSNILL-------------------DKHMRAKVSDFGLSKF 738
+ +LH + H DLK NIL K+ +V+DFG + F
Sbjct: 135 ALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF 191
Query: 739 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 787
+ H ++IV T Y PE + DV+S G IL E G
Sbjct: 192 DHE---HHTTIVA-TRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 19/97 (19%), Positives = 40/97 (41%), Gaps = 15/97 (15%)
Query: 405 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPL 464
S +++ +++ S++NLT ++P DL P + + L N ++
Sbjct: 23 GSMTPFSNE---LESMVDYSNRNLT-HVPKDLP----------PRTKALSLSQNSISELR 68
Query: 465 PSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 501
+ L LR L + +N + ++ + N L Y
Sbjct: 69 MPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEY 104
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 23/74 (31%), Positives = 40/74 (54%), Gaps = 12/74 (16%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
SI V++LSS LTG++ L P ++++ L +N++ +P + +L L+
Sbjct: 428 ESILVLNLSSNMLTGSVFRCLP----------PKVKVLDLHNNRIMS-IPKDVTHLQALQ 476
Query: 476 ELYVQNNMLSGTVP 489
EL V +N L +VP
Sbjct: 477 ELNVASNQLK-SVP 489
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 11/64 (17%), Positives = 22/64 (34%), Gaps = 3/64 (4%)
Query: 422 HLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 481
++ K L+ + D + + ++ N T + L L+ L +Q
Sbjct: 330 EMNIKMLSIS---DTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQR 386
Query: 482 NMLS 485
N L
Sbjct: 387 NGLK 390
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 16/79 (20%), Positives = 28/79 (35%), Gaps = 2/79 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
S+ + L +L S+L+ + R + + D L + L + L
Sbjct: 222 SSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLL 280
Query: 476 ELYVQNNMLSGTVPSSLLS 494
EL N L +VP +
Sbjct: 281 ELEFSRNQLK-SVPDGIFD 298
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 18/107 (16%), Positives = 34/107 (31%), Gaps = 19/107 (17%)
Query: 413 DPQPSITVIHLSSKNLT----GNIPSDLTKLSSLVEF--------------GCPDLRIIH 454
P S+T ++L ++ S LTKL L G L +
Sbjct: 121 KPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELE 180
Query: 455 LEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 501
++ + L P SL ++ N+ L + + + +
Sbjct: 181 IDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVEC 226
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 22/113 (19%), Positives = 37/113 (32%), Gaps = 19/113 (16%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVE---------------F-GCPDLRIIHLEDNQ 459
++ + LS+ +T SDL + +L F L + L N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY 111
Query: 460 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGNINLHE 509
L+ S L +L L + N +SL L+K +L +
Sbjct: 112 LSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTK 164
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 5e-05
Identities = 21/79 (26%), Positives = 31/79 (39%), Gaps = 15/79 (18%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
+ +I + + +L +P L + +NQL LP L NLP L
Sbjct: 153 SFLKIIDVDNNSLK-KLPDLPPSLEFI-----------AAGNNQLEE-LPE-LQNLPFLT 198
Query: 476 ELYVQNNMLSGTVPSSLLS 494
+Y NN L +P LS
Sbjct: 199 AIYADNNSLK-KLPDLPLS 216
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 5e-05
Identities = 19/87 (21%), Positives = 29/87 (33%), Gaps = 18/87 (20%)
Query: 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPN 473
+ L++ L+ ++P L SL N LT LP +L +
Sbjct: 69 LDRQAHELELNNLGLS-SLPELPPHLESL-----------VASCNSLT-ELPELPQSLKS 115
Query: 474 LRELYVQNNMLSGTVPSSL----LSKN 496
L LS +P L +S N
Sbjct: 116 LLVDNNNLKALSD-LPPLLEYLGVSNN 141
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 9e-04
Identities = 24/90 (26%), Positives = 38/90 (42%), Gaps = 17/90 (18%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLV----------EFG-CPDLRIIHLEDNQLTGPL 464
P +T I+ + +L +P L S+V E P L I+ ++N L L
Sbjct: 195 PFLTAIYADNNSLK-KLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKT-L 252
Query: 465 PSSLMNLPNLRELYVQNNMLSGTVPSSLLS 494
P P+L L V++N L+ +P S
Sbjct: 253 PDLP---PSLEALNVRDNYLT-DLPELPQS 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 7e-05
Identities = 22/80 (27%), Positives = 37/80 (46%), Gaps = 8/80 (10%)
Query: 427 NLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 486
N SD++ L+SL P+L +HL++NQ++ S L N NL + + N ++
Sbjct: 179 KADDNKISDISPLASL-----PNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTIT- 230
Query: 487 TVPSSLLSKNVVLNYAGNIN 506
P + VV N +
Sbjct: 231 NQPVFYNNNLVVPNVVKGPS 250
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 22/101 (21%), Positives = 42/101 (41%), Gaps = 14/101 (13%)
Query: 416 PSITVIHLSSKNLTGNIP-SDLTKLSSL---------VEF--GCPDLRIIHLEDNQLTGP 463
SI + L+S +T P + L+ L L + G +L+ + + + Q++
Sbjct: 107 QSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDL 166
Query: 464 LPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 504
+ L NL L L +N +S P + L + ++ N
Sbjct: 167 --TPLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNN 205
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 9e-04
Identities = 20/89 (22%), Positives = 43/89 (48%), Gaps = 12/89 (13%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
++ + + + ++ DLT L++L L + +DN+++ S L +LPNL
Sbjct: 151 TNLQYLSIGNAQVS-----DLTPLANL-----SKLTTLKADDNKISDI--SPLASLPNLI 198
Query: 476 ELYVQNNMLSGTVPSSLLSKNVVLNYAGN 504
E++++NN +S P + S ++
Sbjct: 199 EVHLKNNQISDVSPLANTSNLFIVTLTNQ 227
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 7e-05
Identities = 59/238 (24%), Positives = 90/238 (37%), Gaps = 64/238 (26%)
Query: 592 KKIGSGGFG-VVYYGKLKDGKEIAVKVLTSN-SY--QGKREFTNEVTLLSRI-----HHR 642
+K+G G FG V+ + + K AVKV+ + Y K E +L +I ++
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE----ADILKKIQNDDINNN 96
Query: 643 NLVQFLGYCQEEGRSVLV--------YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 694
N+V++ G L+ YE + + Y E IK +
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEPLGPSLYEI-----ITRNNYNGFHIED----IKL--YCIE 145
Query: 695 AAKGIEYLHTGCVPAIIHRDLKSSNILL-------------------------DKHMRAK 729
K + YL ++ H DLK NILL K K
Sbjct: 146 ILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202
Query: 730 VSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 787
+ DFG + F D + SI+ T Y PE ++ SD++SFG +L EL +G
Sbjct: 203 LIDFGCATFKSD---YHGSIIN-TRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 9e-05
Identities = 33/106 (31%), Positives = 49/106 (46%), Gaps = 20/106 (18%)
Query: 410 CNSDPQPSITVIHLSSKNLT---GNIPSD----------LTKLSSLVEFGCPDLRIIHLE 456
CN++ +V SSK LT NIP+D L+ L S LR+++L
Sbjct: 14 CNNNKN---SV-DCSSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLN 69
Query: 457 DNQLTGPLPSSL-MNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 501
DN+L LP+ + L NL L+V +N L +P + + V L
Sbjct: 70 DNKLQT-LPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAE 113
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 19/85 (22%), Positives = 31/85 (36%), Gaps = 14/85 (16%)
Query: 424 SSKNLT---GNIPSD----------LTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMN 470
K LT N+P + + LR I L +NQ++ P +
Sbjct: 19 RGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQG 78
Query: 471 LPNLRELYVQNNMLSGTVPSSLLSK 495
L +L L + N ++ +P SL
Sbjct: 79 LRSLNSLVLYGNKIT-ELPKSLFEG 102
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 20/82 (24%), Positives = 31/82 (37%), Gaps = 7/82 (8%)
Query: 423 LSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 482
LS L N D L L +L I+ + +N+L L L L L + N
Sbjct: 108 LSRLFLDNNELRDTDSLIHL-----KNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGN 160
Query: 483 MLSGTVPSSLLSKNVVLNYAGN 504
++ T + L K ++ G
Sbjct: 161 EITNTGGLTRLKKVNWIDLTGQ 182
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 2e-04
Identities = 19/107 (17%), Positives = 38/107 (35%), Gaps = 18/107 (16%)
Query: 398 DPCLPVPWSWLQCNSD----------PQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGC 447
D C P S L+C D ++T +++ ++ ++ L L
Sbjct: 3 DACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRD--LRGL----- 55
Query: 448 PDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 494
+LR + + + L P + P L L + N L ++ +
Sbjct: 56 GELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQ 101
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 23/78 (29%), Positives = 32/78 (41%), Gaps = 7/78 (8%)
Query: 427 NLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 486
L N +D+T LS L L + LEDNQ++ L L L+ LY+ N +S
Sbjct: 137 YLGNNKITDITVLSRL-----TKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHISD 189
Query: 487 TVPSSLLSKNVVLNYAGN 504
+ L VL
Sbjct: 190 LRALAGLKNLDVLELFSQ 207
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 3e-04
Identities = 23/78 (29%), Positives = 38/78 (48%), Gaps = 7/78 (8%)
Query: 427 NLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 486
+L N SD+ L L P L ++L +N++T + L L L L +++N +S
Sbjct: 115 SLEHNGISDINGLVHL-----PQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD 167
Query: 487 TVPSSLLSKNVVLNYAGN 504
VP + L+K L + N
Sbjct: 168 IVPLAGLTKLQNLYLSKN 185
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 14/59 (23%), Positives = 26/59 (44%), Gaps = 5/59 (8%)
Query: 427 NLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 485
+ LT +++L + L+ + L DN+++G L PNL L + N +
Sbjct: 48 STINV---GLTSIANLPK--LNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 16/89 (17%), Positives = 32/89 (35%), Gaps = 7/89 (7%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLT---GPLPSSLMNLP 472
P+++ + LS G +S+L P L+++ L + + G +
Sbjct: 173 PALSTLDLSDNPELGERGL----ISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV 228
Query: 473 NLRELYVQNNMLSGTVPSSLLSKNVVLNY 501
L+ L + +N L + LN
Sbjct: 229 QLQGLDLSHNSLRDAAGAPSCDWPSQLNS 257
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 13/88 (14%), Positives = 30/88 (34%), Gaps = 7/88 (7%)
Query: 402 PVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLT 461
P L+ P + +++L + + L+ L ++ P L+++ +
Sbjct: 110 TAPPPLLEATG---PDLNILNLRNVSWATRDAW----LAELQQWLKPGLKVLSIAQAHSL 162
Query: 462 GPLPSSLMNLPNLRELYVQNNMLSGTVP 489
+ P L L + +N G
Sbjct: 163 NFSCEQVRVFPALSTLDLSDNPELGERG 190
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 22/117 (18%), Positives = 37/117 (31%), Gaps = 25/117 (21%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVE-----------------FGCPDLRIIHLED 457
PS + L +L IPS + L ++ + + I + +
Sbjct: 31 PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 458 NQ-LTGPLPSSLMNLPNLRELYVQNNMLSGTVPS----SLLSKNVVLNYAGNINLHE 509
+ LT P +L LP L+ L + N L P +L N +
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTS 145
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 23/91 (25%), Positives = 36/91 (39%), Gaps = 19/91 (20%)
Query: 409 QCNSDPQPSITVIHLSSKNLT---GNIPSD----------LTKLSSLVEFGCPDLRIIHL 455
QC+ T + SK IP++ +TKL V +L+ ++L
Sbjct: 16 QCSCSG----TTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYL 71
Query: 456 EDNQLTGPLPSSLMN-LPNLRELYVQNNMLS 485
NQL LP + + L L L + N L+
Sbjct: 72 GSNQLGA-LPVGVFDSLTQLTVLDLGTNQLT 101
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Length = 130 | Back alignment and structure |
|---|
Score = 40.2 bits (94), Expect = 4e-04
Identities = 18/69 (26%), Positives = 24/69 (34%), Gaps = 19/69 (27%)
Query: 419 TVIHLSSKNLTG-----NIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPN 473
T++ + LT P D T+L L N LT P L LP
Sbjct: 11 TLVDCGRRGLTWASLPTAFPVDTTEL--------------VLTGNNLTALPPGLLDALPA 56
Query: 474 LRELYVQNN 482
LR ++ N
Sbjct: 57 LRTAHLGAN 65
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 6e-04
Identities = 17/85 (20%), Positives = 37/85 (43%), Gaps = 11/85 (12%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNL 474
P++ + LSS +L + + L +L ++ L +N + ++ ++ L
Sbjct: 88 PNLRYLDLSSNHLH-TLDEFLFSDLQAL--------EVLLLYNNHIVVVDRNAFEDMAQL 138
Query: 475 RELYVQNNMLSGTVPSSLLSKNVVL 499
++LY+ N +S P L+ L
Sbjct: 139 QKLYLSQNQIS-RFPVELIKDGNKL 162
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 7e-04
Identities = 13/87 (14%), Positives = 27/87 (31%), Gaps = 11/87 (12%)
Query: 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNL 474
S V +T IPSDL + + +L + +L
Sbjct: 8 HCSNRVFLCQESKVT-EIPSDLP----------RNAIELRFVLTKLRVIQKGAFSGFGDL 56
Query: 475 RELYVQNNMLSGTVPSSLLSKNVVLNY 501
++ + N + + + + S L+
Sbjct: 57 EKIEISQNDVLEVIEADVFSNLPKLHE 83
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 7e-04
Identities = 24/110 (21%), Positives = 37/110 (33%), Gaps = 9/110 (8%)
Query: 398 DPCLPVPWSWLQCNSDPQPSITVIHLSSK---NLTGNIPSDLTKLSSLVEFGCPDLRIIH 454
DP L+ + S+ + + +L DLT L L + +
Sbjct: 415 DPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHK---DLTVLCHL--EQLLLVTHLD 469
Query: 455 LEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 504
L N+L LP +L L L L +N L + L + L N
Sbjct: 470 LSHNRLRA-LPPALAALRCLEVLQASDNALENVDGVANLPRLQELLLCNN 518
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 9e-04
Identities = 21/90 (23%), Positives = 34/90 (37%), Gaps = 19/90 (21%)
Query: 409 QCNSDPQPSITVIHLSSKNLT---GNIPSD----------LTKLSSLVEFGCPDLRIIHL 455
+C+ T + S+ T IP+ L L + V L ++L
Sbjct: 4 RCSCSG----TTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYL 59
Query: 456 EDNQLTGPLPSSLMN-LPNLRELYVQNNML 484
N+L LP+ + N L +L L + N L
Sbjct: 60 GGNKLQS-LPNGVFNKLTSLTYLNLSTNQL 88
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 914 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-65 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-63 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-61 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-56 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-55 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-54 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-54 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-53 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-53 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-52 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-51 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-50 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-48 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-47 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-22 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-06 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (555), Expect = 3e-65
Identities = 80/276 (28%), Positives = 134/276 (48%), Gaps = 23/276 (8%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 649
+ ++IGSG FG VY GK + + +T+ + Q + F NEV +L + H N++ F+G
Sbjct: 12 VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 709
Y +V ++ +L HL+ E + IK ++IA A+G++YLH +
Sbjct: 72 YSTAPQL-AIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHA---KS 124
Query: 710 IIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYISQQ-- 766
IIHRDLKS+NI L + + K+ DFGL+ + SH + G++ ++ PE Q
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 767 -LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 825
+ +SDVY+FG++L EL++GQ SN N + +G + P L
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNI-------NNRDQIIFMVG----RGYLSPD-LS 232
Query: 826 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861
+ ++ C+ RP ++L I+
Sbjct: 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 5e-63
Identities = 75/274 (27%), Positives = 126/274 (45%), Gaps = 25/274 (9%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 649
K++G+G FGVV YGK + ++A+K++ + EF E ++ + H LVQ G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 709
C ++ ++ E+M NG L +L R + LE+ +D + +EYL +
Sbjct: 67 VCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESKQ--- 120
Query: 710 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 769
+HRDL + N L++ KVSDFGLS++ +D S + V + PE + + +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 770 KSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 828
KSD+++FGV++ E+ S G+ +I Q +L+ P L E
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY----------RPHLASE-- 228
Query: 829 IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862
K+ C RP+ +L +I D
Sbjct: 229 -----KVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 4e-62
Identities = 69/273 (25%), Positives = 123/273 (45%), Gaps = 23/273 (8%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 649
++IGSG FG+V+ G + ++A+K + + +F E ++ ++ H LVQ G
Sbjct: 9 FVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 709
C E+ LV+EFM +G L ++ T L + D +G+ YL C
Sbjct: 68 VCLEQAPICLVFEFMEHGCLSDY---LRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--- 121
Query: 710 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 769
+IHRDL + N L+ ++ KVSDFG+++F +D S+ + V + PE + + +
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 770 KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 829
KSDV+SFGV++ E+ S + + + + + P L
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR---------LYKPRLAST--- 229
Query: 830 QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862
+ + C RP+ S +L+ + +
Sbjct: 230 ----HVYQIMNHCWKERPEDRPAFSRLLRQLAE 258
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 2e-61
Identities = 65/273 (23%), Positives = 123/273 (45%), Gaps = 23/273 (8%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 649
L +++G+G FG V+ G ++AVK L F E L+ ++ H+ LV+
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 709
+E ++ E+M NG+L + L ++ K L++A A+G+ ++
Sbjct: 76 VVTQEPI-YIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN--- 129
Query: 710 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 769
IHRDL+++NIL+ + K++DFGL++ D + + + PE T
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 770 KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 829
KSDV+SFG++L E+++ G ++Q ++E G ++ P E
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYP---GMTNPEVIQ----NLERG--YRMVRPDNCPE--- 237
Query: 830 QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862
++ + +C RP+ + ++D
Sbjct: 238 ----ELYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 4e-60
Identities = 62/295 (21%), Positives = 126/295 (42%), Gaps = 29/295 (9%)
Query: 589 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
+L++ IG G FG V+ GK + G+E+AVK+ +S + E+ + H N++ F+
Sbjct: 6 VLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFI 63
Query: 649 GYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 704
++ + LV ++ +G+L ++L + + +++A A G+ +LH
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHM 118
Query: 705 GCV-----PAIIHRDLKSSNILLDKHMRAKVSDFGLSKF---AVDGASHVSSIVRGTVGY 756
V PAI HRDLKS NIL+ K+ ++D GL+ A D + GT Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 757 LDPEYYISQ------QLTDKSDVYSFGVILLELISGQEAISNEKFGANC---RNIVQWAK 807
+ PE + ++D+Y+ G++ E+ + +
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238
Query: 808 LHIESGDIQGIIDPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861
+ + + P++ + + +++ + + C +G R + + K +
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 1e-56
Identities = 62/273 (22%), Positives = 114/273 (41%), Gaps = 23/273 (8%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 649
LE K+G G FG V+ G +A+K L F E ++ ++ H LVQ
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 79
Query: 650 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 709
EE +V E+M G+L + L G + + + +++A A G+ Y+
Sbjct: 80 VVSEEPI-YIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN--- 133
Query: 710 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 769
+HRDL+++NIL+ +++ KV+DFGL++ D + + + PE + + T
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 193
Query: 770 KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 829
KSDV+SFG++L EL + + ++ ++
Sbjct: 194 KSDVWSFGILLTELTTKGRVPYPGM----------------VNREVLDQVERGYRMPCPP 237
Query: 830 QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862
+ + + C RP+ + ++D
Sbjct: 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 1e-56
Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 11/200 (5%)
Query: 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 647
++G+G GVV+ K G +A K++ R E+ +L + +V F
Sbjct: 10 KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF 69
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
G +G + E M G+L + L RI +++ KG+ YL
Sbjct: 70 YGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKH- 124
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 767
I+HRD+K SNIL++ K+ DFG+S +D +++ GT Y+ PE
Sbjct: 125 -KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPERLQGTHY 180
Query: 768 TDKSDVYSFGVILLELISGQ 787
+ +SD++S G+ L+E+ G+
Sbjct: 181 SVQSDIWSMGLSLVEMAVGR 200
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 5e-56
Identities = 63/277 (22%), Positives = 109/277 (39%), Gaps = 25/277 (9%)
Query: 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 646
+ IG+G +G + K DGK + K L S + K+ +EV LL + H N+V+
Sbjct: 8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 67
Query: 647 FLGYCQEE--GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH- 703
+ + +V E+ G L + Q ++ L + ++ H
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127
Query: 704 -TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 762
+ ++HRDLK +N+ LD K+ DFGL++ S + GT Y+ PE
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPEQM 186
Query: 763 ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 822
+KSD++S G +L EL + + I + I
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR-----YSDE 241
Query: 823 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859
L + I M +++ RPS+ E+L++
Sbjct: 242 LNE--IITRMLNLKDY----------HRPSVEEILEN 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 8e-56
Identities = 67/278 (24%), Positives = 115/278 (41%), Gaps = 32/278 (11%)
Query: 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 646
+ +IG G F VY G + E+A L + ++ F E +L + H N+V+
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 647 FLGYCQEEGRS----VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 702
F + + VLV E M +GTLK +L + + KG+++L
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFL 128
Query: 703 HTGCVPAIIHRDLKSSNILL-DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 761
HT P IIHRDLK NI + K+ D GL+ + + V GT ++ PE
Sbjct: 129 HTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEM 184
Query: 762 YISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 821
++ + DVY+FG+ +LE+ + + S + N I + ++ + P
Sbjct: 185 -YEEKYDESVDVYAFGMCMLEMATSEYPYSECQ---NAAQIYRRVTSGVKPASFDKVAIP 240
Query: 822 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859
+ + I+ + + R SI ++L
Sbjct: 241 EVKEI--IEGCIRQNKDE----------RYSIKDLLNH 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 192 bits (489), Expect = 8e-56
Identities = 70/274 (25%), Positives = 120/274 (43%), Gaps = 23/274 (8%)
Query: 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
++ K+G G +G VY G K +AVK L ++ + EF E ++ I H NLVQ L
Sbjct: 21 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 79
Query: 649 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 708
G C E ++ EFM G L ++L + Q ++ + L +A + +EYL
Sbjct: 80 GVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK---K 134
Query: 709 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 768
IHRDL + N L+ ++ KV+DFGLS+ + + + + PE + +
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 769 DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 828
KSDV++FGV+L E+ + + + + +++ E
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPYPGI----------------DLSQVYELLEKDYRMERP 238
Query: 829 IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862
K+ E C + RPS +E+ + +
Sbjct: 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (490), Expect = 8e-56
Identities = 72/307 (23%), Positives = 137/307 (44%), Gaps = 42/307 (13%)
Query: 578 FTLSDIEDATK-----------MLEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSN- 621
FT D +A + +E+ IG+G FG V G LK + +A+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 622 SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQ 681
+ + +R+F +E +++ + H N++ G + +++ EFM NG+L L ++
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR---QNDG 123
Query: 682 RINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 741
+ I+ + + A G++YL +HRDL + NIL++ ++ KVSDFGLS+F D
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 742 GASHVSSI----VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA 797
S + + + + PE ++ T SDV+S+G+++ E++S E +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD---- 236
Query: 798 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVL 857
+ + D+ I+ + + + L C + RP +++
Sbjct: 237 ------------MTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 858 KDIQDAI 864
+ I
Sbjct: 285 NTLDKMI 291
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (488), Expect = 2e-55
Identities = 66/285 (23%), Positives = 123/285 (43%), Gaps = 37/285 (12%)
Query: 584 EDATKMLE--KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGK---REFTNEVTLLS 637
+D K+ ++IG G FG VY+ + +++ + +A+K ++ + Q ++ EV L
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 638 RIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK 697
++ H N +Q+ G E + LV E+ H++ + ++ + A +
Sbjct: 71 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQ 126
Query: 698 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 757
G+ YLH+ +IHRD+K+ NILL + K+ DFG + S V GT ++
Sbjct: 127 GLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWM 178
Query: 758 DPEYYISQ---QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 814
PE ++ Q K DV+S G+ +EL + + N + +I Q ++SG
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238
Query: 815 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859
+ + S + + RP+ +LK
Sbjct: 239 ----WSEYFRNF--VDSCLQKIPQD----------RPTSEVLLKH 267
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 5e-55
Identities = 61/284 (21%), Positives = 114/284 (40%), Gaps = 29/284 (10%)
Query: 582 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 640
+ ED +++ ++G G FG VY + K+ A KV+ + S + ++ E+ +L+
Sbjct: 9 NPEDFWEII-GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD 67
Query: 641 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 700
H N+V+ L E ++ EF G + + E+ + + + + +
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALN 124
Query: 701 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 760
YLH IIHRDLK+ NIL K++DFG+S S + GT ++ PE
Sbjct: 125 YLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPE 180
Query: 761 YYISQQLTD-----KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 815
+ + D K+DV+S G+ L+E+ + I + +
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPS- 239
Query: 816 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859
+ D ++ + A R + S++L+
Sbjct: 240 --RWSSNFKDF--LKKCLEKNVDA----------RWTTSQLLQH 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 9e-55
Identities = 60/271 (22%), Positives = 115/271 (42%), Gaps = 25/271 (9%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
+KIG G G VY + G+E+A++ + K NE+ ++ + N+V +L
Sbjct: 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 649 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 708
+V E++ G+L + + E ++ + + + + +E+LH+
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSNQ-- 136
Query: 709 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 768
+IHRD+KS NILL K++DFG S S++V GT ++ PE +
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 194
Query: 769 DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 828
K D++S G++ +E+I G+ NE I +++ + + D
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE---KLSAIFRDF-- 249
Query: 829 IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859
+ ++ + R S E+L+
Sbjct: 250 LNRCLDMDVE----------KRGSAKELLQH 270
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 4e-54
Identities = 66/286 (23%), Positives = 111/286 (38%), Gaps = 37/286 (12%)
Query: 578 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK---REFTNEV 633
+ L D E + + +G G FG VY + K +A+KVL + + EV
Sbjct: 3 WALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 57
Query: 634 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 693
+ S + H N+++ GY + R L+ E+ GT+ L + + +
Sbjct: 58 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYIT 113
Query: 694 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 753
+ A + Y H+ +IHRD+K N+LL K++DFG S A + GT
Sbjct: 114 ELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGT 167
Query: 754 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 813
+ YL PE + +K D++S GV+ E + G+ + + I +
Sbjct: 168 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR------VEF 221
Query: 814 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859
+ D I + K RP + EVL+
Sbjct: 222 TFPDFVTEGARDL--ISRLLKHNPSQ----------RPMLREVLEH 255
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 5e-54
Identities = 74/286 (25%), Positives = 131/286 (45%), Gaps = 34/286 (11%)
Query: 578 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLS 637
+ +++ L + IG G FG V G + G ++AVK + +++ + F E ++++
Sbjct: 4 LNMKELK-----LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMT 55
Query: 638 RIHHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 696
++ H NLVQ LG +E+G +V E+M G+L ++L + L+ + D
Sbjct: 56 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVC 113
Query: 697 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 756
+ +EYL +HRDL + N+L+ + AKVSDFGL+K A S + V +
Sbjct: 114 EAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKW 166
Query: 757 LDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 816
PE ++ + KSDV+SFG++L E+ S +++V +E G
Sbjct: 167 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP---YPRIPLKDVVP----RVEKGYKM 219
Query: 817 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862
D Y++ C MRPS ++ + ++
Sbjct: 220 DAPDGCPPAVYEV---------MKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 8e-54
Identities = 79/308 (25%), Positives = 127/308 (41%), Gaps = 32/308 (10%)
Query: 564 VSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGK----EIAVKVLT 619
+S+LN +A + + IG G FG VY+G L D AVK L
Sbjct: 6 LSALNPELVQAVQHVVI-GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 64
Query: 620 SNSYQGK-REFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSVLVYEFMHNGTLKEHLYGTL 677
+ G+ +F E ++ H N++ LG C EG ++V +M +G L+ +
Sbjct: 65 RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR--- 121
Query: 678 THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 737
+ AKG + +HRDL + N +LD+ KV+DFGL++
Sbjct: 122 NETHNPTVKDLIGFGLQVAKG---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178
Query: 738 FAVDG---ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 794
D + H + + V ++ E +Q+ T KSDV+SFGV+L EL++ +
Sbjct: 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238
Query: 795 FGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSIS 854
N ++ L EY ++++ L C P MRPS S
Sbjct: 239 ------NTFDITVYLLQG-------RRLLQPEYCPDPLYEV---MLKCWHPKAEMRPSFS 282
Query: 855 EVLKDIQD 862
E++ I
Sbjct: 283 ELVSRISA 290
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 1e-53
Identities = 69/280 (24%), Positives = 123/280 (43%), Gaps = 33/280 (11%)
Query: 591 EKKIGSGGFGVVYYGKLKD---GKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLV 645
+K++GSG FG V G + K +AVK+L +N K E E ++ ++ + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 646 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 705
+ +G C+ E +LV E G L ++L + + +E+ + G++YL
Sbjct: 72 RMIGICEAESW-MLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES 126
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS--IVRGTVGYLDPEYYI 763
+HRDL + N+LL AK+SDFGLSK ++ + + V + PE
Sbjct: 127 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 764 SQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 822
+ + KSDV+SFGV++ E S GQ+ K + + ++ +G
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG-----CPRE 238
Query: 823 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862
+ D + W + + RP + V +++
Sbjct: 239 MYDL--MNLCWTYDVE----------NRPGFAAVELRLRN 266
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 186 bits (473), Expect = 1e-53
Identities = 67/300 (22%), Positives = 120/300 (40%), Gaps = 47/300 (15%)
Query: 590 LEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHR 642
+ IG G FG V+ + +AVK+L + + +F E L++ +
Sbjct: 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76
Query: 643 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH--------------------EQR 682
N+V+ LG C L++E+M G L E L H
Sbjct: 77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136
Query: 683 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 742
++ ++L IA A G+ YL +HRDL + N L+ ++M K++DFGLS+
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193
Query: 743 -ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRN 801
+ ++ PE + T +SDV+++GV+L E+ S +G
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY---YGMAHEE 250
Query: 802 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861
++ + + G+I + L+ Y++ +C RPS + + +Q
Sbjct: 251 VIYY----VRDGNILACPENCPLELYNL---------MRLCWSKLPADRPSFCSIHRILQ 297
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 2e-53
Identities = 59/274 (21%), Positives = 113/274 (41%), Gaps = 26/274 (9%)
Query: 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 647
L + +G G +G V + + +AVK++ + E+ + ++H N+V+F
Sbjct: 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 68
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
G+ +E L E+ G L + + + + G+ YLH
Sbjct: 69 YGHRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG--- 121
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 766
I HRD+K N+LLD+ K+SDFGL+ F + + + + GT+ Y+ PE ++
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 767 L-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 825
+ DV+S G++L +++G+ + + K ++ ID + L
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK---KIDSAPLA 238
Query: 826 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859
+ + A R +I ++ KD
Sbjct: 239 --LLHKILVENPSA----------RITIPDIKKD 260
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 3e-53
Identities = 66/283 (23%), Positives = 129/283 (45%), Gaps = 30/283 (10%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKE-----IAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRN 643
+K IG+G FG VY G LK +A+K L + + +R +F E ++ + H N
Sbjct: 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 70
Query: 644 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 703
+++ G + +++ E+M NG L + L + + ++ + + A G++YL
Sbjct: 71 IIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLA 127
Query: 704 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--ASHVSSIVRGTVGYLDPEY 761
+HRDL + NIL++ ++ KVSDFGLS+ D A++ +S + + + PE
Sbjct: 128 N---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 762 YISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 821
++ T SDV+SFG+++ E+++ E E + + ++ I+
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWE----------------LSNHEVMKAIND 228
Query: 822 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 864
+ I + + C RP ++++ + I
Sbjct: 229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 5e-53
Identities = 70/282 (24%), Positives = 118/282 (41%), Gaps = 31/282 (10%)
Query: 588 KMLEKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRN 643
+ + ++G G FG V G + ++A+KVL + + E E ++ ++ +
Sbjct: 11 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPY 70
Query: 644 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 703
+V+ +G CQ E +LV E G L + L G + I E+ + G++YL
Sbjct: 71 IVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLE 126
Query: 704 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF--AVDGASHVSSIVRGTVGYLDPEY 761
+HRDL + N+LL AK+SDFGLSK A D S + + + PE
Sbjct: 127 E---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183
Query: 762 YISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 820
++ + +SDV+S+GV + E +S GQ+ K I Q ++
Sbjct: 184 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE-----CP 238
Query: 821 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862
P L Y + C + RP V + ++
Sbjct: 239 PEL---YAL---------MSDCWIYKWEDRPDFLTVEQRMRA 268
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 7e-52
Identities = 67/298 (22%), Positives = 119/298 (39%), Gaps = 41/298 (13%)
Query: 590 LEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HH 641
K +G+G FG V +AVK+L +++ +RE +E+ +LS + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 642 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG--------------TLTHEQRINWIK 687
N+V LG C G ++++ E+ G L L E ++
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 688 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-V 746
L + AKG+ +L + IHRDL + NILL K+ DFGL++ + +++ V
Sbjct: 147 LLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA 806
R V ++ PE + T +SDV+S+G+ L EL S +
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS---------------PY 248
Query: 807 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 864
+I + ++ + C RP+ ++++ I+ I
Sbjct: 249 PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 5e-51
Identities = 65/297 (21%), Positives = 117/297 (39%), Gaps = 46/297 (15%)
Query: 590 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HH 641
K +GSG FG V ++AVK+L + +RE +E+ +++++ H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 642 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH-------------------EQR 682
N+V LG C G L++E+ G L +L
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 683 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 742
+ + L A AKG+E+L + +HRDL + N+L+ K+ DFGL++ +
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 743 ASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRN 801
+++V R V ++ PE T KSDV+S+G++L E+ S
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP----------- 266
Query: 802 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 858
+ + +++ + +I + + +I C RPS +
Sbjct: 267 ---YPGIPVDA-NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 2e-50
Identities = 59/285 (20%), Positives = 114/285 (40%), Gaps = 30/285 (10%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNL 644
L + IG G FG V+ G + +A+K + + RE F E + + H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 645 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 704
V+ +G E ++ E G L+ L + ++ + A + + YL +
Sbjct: 71 VKLIGVI-TENPVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLES 126
Query: 705 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 764
+HRD+ + N+L+ + K+ DFGLS++ D + +S + + ++ PE
Sbjct: 127 ---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 765 QQLTDKSDVYSFGVILLELI-SGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 823
++ T SDV+ FGV + E++ G + K I +L + P+L
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN-----CPPTL 238
Query: 824 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIER 868
+ W + RP +E+ + + E+
Sbjct: 239 YSL--MTKCWAYDPS----------RRPRFTELKAQLSTILEEEK 271
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (451), Expect = 7e-50
Identities = 60/273 (21%), Positives = 108/273 (39%), Gaps = 25/273 (9%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
+ +++G+G FGVV+ G A K + + K E+ +S + H LV
Sbjct: 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 89
Query: 649 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 708
+++ V++YEFM G L E + +++ + +E KG+ ++H
Sbjct: 90 DAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHENN-- 144
Query: 709 AIIHRDLKSSNILL--DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 766
+H DLK NI+ + K+ DFGL+ S GT + PE +
Sbjct: 145 -YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV--TTGTAEFAAPEVAEGKP 201
Query: 767 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826
+ +D++S GV+ L+SG E RN+ +++ G I D
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC-DWNMDDSAFSG-ISEDGKDF 259
Query: 827 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859
I+ + + R +I + L+
Sbjct: 260 --IRKLLLADPNT----------RMTIHQALEH 280
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 1e-49
Identities = 70/292 (23%), Positives = 121/292 (41%), Gaps = 38/292 (13%)
Query: 590 LEKKIGSGGFGVVYYGKLKDG---KEIAVKVL-TSNSYQGKREFTNEVTLLSRI-HHRNL 644
+ IG G FG V ++K + A+K + S R+F E+ +L ++ HH N+
Sbjct: 14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 73
Query: 645 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE------------QRINWIKRLEIA 692
+ LG C+ G L E+ +G L + L + E ++ + L A
Sbjct: 74 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 133
Query: 693 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG 752
D A+G++YL IHRDL + NIL+ ++ AK++DFGLS+ R
Sbjct: 134 ADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM--GRL 188
Query: 753 TVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES 812
V ++ E T SDV+S+GV+L E++S G C + +
Sbjct: 189 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC---GMTCAELYEK------- 238
Query: 813 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 864
+ E + ++ + C + RPS +++L + +
Sbjct: 239 ------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 2e-48
Identities = 64/283 (22%), Positives = 106/283 (37%), Gaps = 31/283 (10%)
Query: 590 LEKKIGSGGFGVVYYGKLK----DGKEIAVKVL---TSNSYQGKREFTNEVTLLSRIHHR 642
L +K+G G FGVV G+ +AVK L + + +F EV + + HR
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 643 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 702
NL++ G +V E G+L + L H+ A A+G+ YL
Sbjct: 72 NLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 703 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH--VSSIVRGTVGYLDPE 760
+ IHRDL + N+LL K+ DFGL + H + + + PE
Sbjct: 128 ESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 761 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 820
++ + SD + FGV L E+ + + N Q + G+ +
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG------LNGSQILHKIDKEGERLPRPE 238
Query: 821 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 863
D Y++ + C RP+ + + +A
Sbjct: 239 DCPQDIYNV---------MVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 173 bits (439), Expect = 3e-48
Identities = 55/273 (20%), Positives = 121/273 (44%), Gaps = 25/273 (9%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
+ +++GSG FGVV+ G+ K + + K NE+++++++HH L+
Sbjct: 33 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 92
Query: 649 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 708
+++ VL+ EF+ G L + + + +++ + + A +G++++H
Sbjct: 93 DAFEDKYEMVLILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHMHE---H 146
Query: 709 AIIHRDLKSSNILLD--KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 766
+I+H D+K NI+ + K K+ DFGL+ + + T + PE +
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDREP 204
Query: 767 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826
+ +D+++ GV+ L+SG + E +N+ + E D + P D
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE--DAFSSVSPEAKDF 262
Query: 827 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859
I+++ + E + R ++ + L+
Sbjct: 263 --IKNLLQKEPRK----------RLTVHDALEH 283
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 5e-48
Identities = 57/279 (20%), Positives = 116/279 (41%), Gaps = 30/279 (10%)
Query: 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL-----TSNSYQGKREFTNEVTLLSRIHHRN 643
K +GSG FG VY G +G+++ + V + S + +E +E +++ + + +
Sbjct: 13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 72
Query: 644 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 703
+ + LG C L+ + M G L +++ H+ I L AKG+ YL
Sbjct: 73 VCRLLGICLTSTV-QLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYL- 127
Query: 704 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYY 762
++HRDL + N+L+ K++DFGL+K + + + + + ++ E
Sbjct: 128 --EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 763 ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 822
+ + T +SDV+S+GV + EL++ + + +I I++
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI----------------PASEISSILEKG 229
Query: 823 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 861
+ + C + RP E++ +
Sbjct: 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-47
Identities = 57/274 (20%), Positives = 104/274 (37%), Gaps = 30/274 (10%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL---TSNSYQGKREFTNEVTLLSRIHHRNLV 645
K +G G F V + L +E A+K+L T E ++SR+ H V
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 646 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 705
+ Q++ + + NG L +++ + + +EYLH
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHG- 126
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYIS 764
IIHRDLK NILL++ M +++DFG +K + + ++ GT Y+ PE
Sbjct: 127 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 765 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824
+ SD+++ G I+ +L++G + I++ D P
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK------LEYDFPEKFFPKAR 238
Query: 825 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 858
D ++ + ++ R E+
Sbjct: 239 DL--VEKLLVLDATK----------RLGCEEMEG 260
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 3e-47
Identities = 63/289 (21%), Positives = 122/289 (42%), Gaps = 33/289 (11%)
Query: 590 LEKKIGSGGFGVVYYGKLK------DGKEIAVKVLT-SNSYQGKREFTNEVTLLSRIHHR 642
+ +++G G FG+VY G K +A+K + + S + + EF NE +++ +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 643 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY------GTLTHEQRINWIKRLEIAEDAA 696
++V+ LG + ++++ E M G LK +L + K +++A + A
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 697 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG-ASHVSSIVRGTVG 755
G+ YL+ +HRDL + N ++ + K+ DFG+++ + V
Sbjct: 144 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 756 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 815
++ PE T SDV+SFGV+L E+ + E + + G +
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-------NEQVLRFVMEGGL 253
Query: 816 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 864
D +++ MC + MRPS E++ I++ +
Sbjct: 254 LDKPDNCPDMLFEL---------MRMCWQYNPKMRPSFLEIISSIKEEM 293
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 6e-47
Identities = 72/297 (24%), Positives = 121/297 (40%), Gaps = 40/297 (13%)
Query: 590 LEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQG-KREFTNEVTLLSRI-HH 641
L K +G G FG V + +AVK+L + R +E+ +L I HH
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 642 RNLVQFLGYCQEEGRSV-LVYEFMHNGTLKEHLYG------------TLTHEQRINWIKR 688
N+V LG C + G + ++ EF G L +L ++ +
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 689 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-S 747
+ + AKG+E+L + IHRDL + NILL + K+ DFGL++ +V
Sbjct: 137 ICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 748 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK 807
R + ++ PE + T +SDV+SFGV+L E+ S + I +
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV------KIDEEFC 247
Query: 808 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 864
++ G D + + Y L C RP+ SE+++ + + +
Sbjct: 248 RRLKEGTRMRAPDYTTPEMYQT---------MLDCWHGEPSQRPTFSELVEHLGNLL 295
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 3e-45
Identities = 50/273 (18%), Positives = 107/273 (39%), Gaps = 26/273 (9%)
Query: 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
+ + +G G FG+V+ K K + + E+++L+ HRN++
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLH 67
Query: 649 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 708
+ V+++EF+ + E + T +N + + + +++LH+
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHS---H 121
Query: 709 AIIHRDLKSSNILLD--KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 766
I H D++ NI+ + K+ +FG ++ G + ++ Y PE +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQHDV 179
Query: 767 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826
++ +D++S G ++ L+SG E NI+ A+ + + I +D
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN-AEYTFDEEAFKE-ISIEAMDF 237
Query: 827 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859
+ + E K R + SE L+
Sbjct: 238 --VDRLLVKERK----------SRMTASEALQH 258
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (411), Expect = 5e-45
Identities = 68/283 (24%), Positives = 114/283 (40%), Gaps = 29/283 (10%)
Query: 582 DIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI 639
DI D +G+G F V + + K +A+K + + +GK NE+ +L +I
Sbjct: 6 DIRDIYD-FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI 64
Query: 640 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 699
H N+V + G L+ + + G L + + + + +
Sbjct: 65 KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAV 120
Query: 700 EYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 756
+YLH I+HRDLK N+L D+ + +SDFGLSK G V S GT GY
Sbjct: 121 KYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLSTACGTPGY 175
Query: 757 LDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 816
+ PE + + D +S GVI L+ G +E I++ A+ +S
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK-AEYEFDSPYWD 234
Query: 817 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859
I S D I+ + + + + R + + L+
Sbjct: 235 D-ISDSAKDF--IRHLMEKDPEK----------RFTCEQALQH 264
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 8e-45
Identities = 62/298 (20%), Positives = 127/298 (42%), Gaps = 42/298 (14%)
Query: 590 LEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRI- 639
L K +G G FG V + ++AVK+L S++ + + +E+ ++ I
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 640 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY------------GTLTHEQRINWIK 687
H+N++ LG C ++G ++ E+ G L+E+L + E++++
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 688 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 747
+ A A+G+EYL + IHRDL + N+L+ + K++DFGL++ +
Sbjct: 137 LVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 748 SIV-RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA 806
+ R V ++ PE + T +SDV+SFGV+L E+ + +
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV------------ 241
Query: 807 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 864
++ ++ + ++ C RP+ ++++D+ +
Sbjct: 242 ----PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 160 bits (405), Expect = 4e-44
Identities = 58/285 (20%), Positives = 118/285 (41%), Gaps = 33/285 (11%)
Query: 578 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVL---TSNSYQGKREFTNEV 633
++L D + + + +G+G FG V+ + + +G+ A+KVL + +E
Sbjct: 1 YSLQDFQ-----ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDER 55
Query: 634 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 693
+LS + H +++ G Q+ + ++ +++ G L L + + E+
Sbjct: 56 LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL 115
Query: 694 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 753
L II+RDLK NILLDK+ K++DFG +K+ D + GT
Sbjct: 116 -------ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT----LCGT 164
Query: 754 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 813
Y+ PE ++ D +SFG+++ E+++G + I+ A+L
Sbjct: 165 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN-AELRFPPF 223
Query: 814 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 858
+ + D + + + + G+++ +V
Sbjct: 224 -----FNEDVKDL--LSRLITRDLSQRL-----GNLQNGTEDVKN 256
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 156 bits (394), Expect = 5e-43
Identities = 57/225 (25%), Positives = 108/225 (48%), Gaps = 17/225 (7%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGK---REFTNEVTLLSRIHHRNLV 645
L + +G GG V+ + L+ +++AVKVL ++ + F E + ++H +V
Sbjct: 11 LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 70
Query: 646 QFLGYCQEE----GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 701
+ E +V E++ TL++ ++ E + + +E+ DA + + +
Sbjct: 71 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNF 126
Query: 702 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV--SSIVRGTVGYLDP 759
H IIHRD+K +NI++ KV DFG+++ D + V ++ V GT YL P
Sbjct: 127 SHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 760 EYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 804
E + +SDVYS G +L E+++G+ + + + V+
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 228
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 154 bits (390), Expect = 2e-42
Identities = 66/287 (22%), Positives = 108/287 (37%), Gaps = 40/287 (13%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL---------TSNSYQGKREFTNEVTLLSRI 639
++ +G G VV KE AVK++ + + EV +L ++
Sbjct: 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66
Query: 640 H-HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 698
H N++Q + LV++ M G L ++L T + ++ + +I +
Sbjct: 67 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEV 122
Query: 699 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 758
I LH I+HRDLK NILLD M K++DFG S G V GT YL
Sbjct: 123 ICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYLA 177
Query: 759 PEYYISQQL------TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES 812
PE + D++S GVI+ L++G + K R I+ S
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG-NYQFGS 236
Query: 813 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859
+ ++ D + ++ + R + E L
Sbjct: 237 PEWDD-YSDTVKDL--VSRFLVVQPQK----------RYTAEEALAH 270
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 2e-41
Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 13/203 (6%)
Query: 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNL 644
L K +G G FG V+ + K + A+K L + + + L H L
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 645 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 704
Q + V E+++ G L H+ + + + A + G+++LH+
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 705 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 764
I++RDLK NILLDK K++DFG+ K + G + ++ GT Y+ PE +
Sbjct: 122 KG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLG 177
Query: 765 QQLTDKSDVYSFGVILLELISGQ 787
Q+ D +SFGV+L E++ GQ
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 153 bits (388), Expect = 2e-41
Identities = 65/277 (23%), Positives = 108/277 (38%), Gaps = 28/277 (10%)
Query: 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSY---QGKREFTNEV---TLLSRIHHR 642
+ + IG GGFG VY + D GK A+K L QG+ NE +L+S
Sbjct: 8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 67
Query: 643 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 702
+V + + + M+ G L HL + + A + G+E++
Sbjct: 68 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGLEHM 123
Query: 703 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 762
H +++RDLK +NILLD+H ++SD GL+ H GT GY+ PE
Sbjct: 124 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVL 177
Query: 763 ISQQLTD-KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 821
D +D +S G +L +L+ G K + +E + P
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE---LPDSFSP 234
Query: 822 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 858
L ++ + + + + G + EV +
Sbjct: 235 ELRSL--LEGLLQRDVNRRL-----GCLGRGAQEVKE 264
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (377), Expect = 1e-40
Identities = 54/288 (18%), Positives = 104/288 (36%), Gaps = 34/288 (11%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
L +KIGSG FG +Y G + G+E+A+K+ + + E + + + +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTI 68
Query: 649 GYCQEEGRS-VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
+C EG V+V E + + ++ + L +A+ IEY+H+
Sbjct: 69 RWCGAEGDYNVMVMELLGPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHSKN- 123
Query: 708 PAIIHRDLKSSNIL---LDKHMRAKVSDFGLSKFAVDGASHV------SSIVRGTVGYLD 758
IHRD+K N L K + DFGL+K D +H + + GT Y
Sbjct: 124 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 759 PEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA--KLHIESGDIQ 816
++ + + + D+ S G +L+ G K + + + K+ +
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 817 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 864
+ + +P S + + ++
Sbjct: 242 KGYPSEFATY--LNFCRSLRFDD----------KPDYSYLRQLFRNLF 277
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 1e-40
Identities = 58/276 (21%), Positives = 104/276 (37%), Gaps = 27/276 (9%)
Query: 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE-----FTNEVTLLSRIHHRNLV 645
+G G F VY + K + +A+K + ++ E+ LL + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 646 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 705
L + LV++FM + + +G+EYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 706 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 765
I+HRDLK +N+LLD++ K++DFGL+K + V T Y PE
Sbjct: 120 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175
Query: 766 QLTD-KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824
++ D+++ G IL EL+ + + I + + P+
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI------------FETLGTPTEE 223
Query: 825 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 860
D+ S+ +P H+ + + L D+
Sbjct: 224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDL 259
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 148 bits (375), Expect = 2e-40
Identities = 52/283 (18%), Positives = 97/283 (34%), Gaps = 20/283 (7%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQF 647
+KIG G +GVVY + G+ A+K + E+++L + H N+V+
Sbjct: 6 GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
+ R VLV+E + K E + + GI Y H
Sbjct: 66 YDVIHTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDRR- 120
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 767
++HRDLK N+L+++ K++DFGL++ + + S++
Sbjct: 121 --VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 768 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ---------WAKLHIESGDIQGI 818
+ D++S G I E+++G I + W +
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 819 IDPSLLDEYDIQSMWKIEEKALM--CVLPHGHMRPSISEVLKD 859
L L+ + + R + + L+
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-40
Identities = 65/293 (22%), Positives = 115/293 (39%), Gaps = 35/293 (11%)
Query: 578 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVL------TSNSYQGKREFT 630
F +++D +++GSG F VV + K G + A K + +S + +
Sbjct: 3 FRQENVDDYYDTG-EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 61
Query: 631 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLE 690
EV++L I H N++ + + +L+ E + G L + L ++ + + E
Sbjct: 62 REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATE 117
Query: 691 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH----MRAKVSDFGLSKFAVDGASHV 746
+ G+ YLH+ I H DLK NI+L R K+ DFGL+ G
Sbjct: 118 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF- 173
Query: 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA 806
+ GT ++ PE + L ++D++S GVI L+SG + N+
Sbjct: 174 -KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV- 231
Query: 807 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859
E + D I+ + + K R +I + L+
Sbjct: 232 NYEFED-EYFSNTSALAKDF--IRRLLVKDPK----------KRMTIQDSLQH 271
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 6e-40
Identities = 54/284 (19%), Positives = 106/284 (37%), Gaps = 20/284 (7%)
Query: 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 646
+KIG G +GVVY + K G+ +A+K + + + E++LL ++H N+V+
Sbjct: 6 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 65
Query: 647 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 706
L E + LV+EF+H K + I +G+ + H+
Sbjct: 66 LLDVIHTENKLYLVFEFLHQDLKKFMD---ASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 707 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 766
++HRDLK N+L++ K++DFGL++ + V +
Sbjct: 123 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 767 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ---------WAKLHIESGDIQG 817
+ D++S G I E+++ + + I + W +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 818 IIDPSLLDEYDIQSMWKIEEKALM--CVLPHGHMRPSISEVLKD 859
+ D + + ++L+ + + R S L
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 6e-40
Identities = 57/291 (19%), Positives = 104/291 (35%), Gaps = 29/291 (9%)
Query: 590 LEKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNSYQGK--REFTNEVTLLSRI---HHR 642
+IG G +G V+ + G+ +A+K + + + EV +L + H
Sbjct: 11 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 70
Query: 643 NLVQFLGYC-----QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK 697
N+V+ C E + LV+E + E + ++ +
Sbjct: 71 NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLR 127
Query: 698 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 757
G+++LH+ ++HRDLK NIL+ + K++DFGL++ + S V T+ Y
Sbjct: 128 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VVVTLWYR 182
Query: 758 DPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 817
PE + D++S G I E+ + I+ L E +
Sbjct: 183 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242
Query: 818 IIDPSLLDEYDIQSMWKI-------EEKALM--CVLPHGHMRPSISEVLKD 859
+ P + K L+ C+ + R S L
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 7e-40
Identities = 55/288 (19%), Positives = 107/288 (37%), Gaps = 22/288 (7%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 647
IG G +G+V + +A+K ++ +Q + E+ +L R H N++
Sbjct: 12 NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI 71
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
+ + ++ L L Q ++ +G++Y+H+
Sbjct: 72 NDIIRAPTIEQMKDVYLVTH-LMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN- 129
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI--VRGTVGYLDPEYYISQ 765
++HRDLK SN+LL+ K+ DFGL++ A H + T Y PE ++
Sbjct: 130 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187
Query: 766 QLTDKS-DVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824
+ KS D++S G IL E++S + + + +I+ + I +
Sbjct: 188 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 247
Query: 825 DEYDIQSMWKIEEKALM-------------CVLPHGHMRPSISEVLKD 859
+ K+ L + + H R + + L
Sbjct: 248 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 8e-39
Identities = 55/284 (19%), Positives = 107/284 (37%), Gaps = 37/284 (13%)
Query: 588 KMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLV 645
K+ + +G G G V + ++ A+K+L Q + EV L R ++V
Sbjct: 14 KVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIV 68
Query: 646 QFLGYCQ----EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 701
+ + + ++V E + G L + +Q + EI + + I+Y
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQY 126
Query: 702 LHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 758
LH+ I HRD+K N+L K++DFG +K S + T Y+
Sbjct: 127 LHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVA 181
Query: 759 PEYYISQQLTDKSDVYSFGVILLELISGQ---EAISNEKFGANCRNIVQWAKLHIESGDI 815
PE ++ D++S GVI+ L+ G + + ++ + + +
Sbjct: 182 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241
Query: 816 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859
+ + I+++ K E R +I+E +
Sbjct: 242 SE-VSEEVKML--IRNLLKTEPT----------QRMTITEFMNH 272
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 9e-39
Identities = 62/289 (21%), Positives = 108/289 (37%), Gaps = 28/289 (9%)
Query: 590 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
K IG+G FGVVY KL D G+ +A+K + Q KR E+ ++ ++ H N+V+
Sbjct: 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLR 79
Query: 649 GYCQEEGRS------VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 702
+ G LV +++ + + +Q + I + + Y+
Sbjct: 80 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 703 HTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 761
H+ I HRD+K N+LLD K+ DFG +K V G S +
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELI 194
Query: 762 YISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ---------WAKLHIES 812
+ + T DV+S G +L EL+ GQ + I++ +++
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 813 GDIQGIIDPSLLDEYDIQSMWKIEEKALM--CVLPHGHMRPSISEVLKD 859
+ + + + E AL + R + E
Sbjct: 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 143 bits (361), Expect = 2e-38
Identities = 44/289 (15%), Positives = 105/289 (36%), Gaps = 34/289 (11%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 648
+ ++IG G FGV++ G L + +++A+K S + +E + + +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 649 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 708
Y +EG ++ + +L++ L ++ + A+ ++ +H
Sbjct: 67 YYFGQEGLHNVLVIDLLGPSLEDLL---DLCGRKFSVKTVAMAAKQMLARVQSIHEKS-- 121
Query: 709 AIIHRDLKSSNILLDKHMR-----AKVSDFGLSKFAVDGASHVSSI------VRGTVGYL 757
+++RD+K N L+ + V DFG+ KF D + + GT Y+
Sbjct: 122 -LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 758 DPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 817
++ ++ + + D+ + G + + + G K A + + +S ++
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK-AATNKQKYERIGEKKQSTPLRE 239
Query: 818 IID--PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 864
+ P +Y + + A P + +
Sbjct: 240 LCAGFPEEFYKY-MHYARNLAFDA----------TPDYDYLQGLFSKVL 277
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-38
Identities = 52/281 (18%), Positives = 98/281 (34%), Gaps = 44/281 (15%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE------FTNEVTLLSRIH-- 640
+ +GSGGFG VY G + D +A+K + + E EV LL ++
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 641 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 700
+++ L + + VL+ E +T + + +
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDF---ITERGALQEELARSFFWQVLEAVR 124
Query: 701 YLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 759
+ H ++HRD+K NIL+D + K+ DFG D V + GT Y P
Sbjct: 125 HCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPP 178
Query: 760 EYYISQQLTDKS-DVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 818
E+ + +S V+S G++L +++ G ++ + ++
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-------EEIIRGQVFFRQR----- 226
Query: 819 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859
+ I+ + RP+ E+
Sbjct: 227 VSSECQHL--IRWCLALRPSD----------RPTFEEIQNH 255
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 2e-38
Identities = 50/285 (17%), Positives = 104/285 (36%), Gaps = 22/285 (7%)
Query: 590 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 646
+KIG G +G V+ K + + +A+K + + E+ LL + H+N+V+
Sbjct: 6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVR 65
Query: 647 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 706
+ + LV+EF K ++ KG+ + H+
Sbjct: 66 LHDVLHSDKKLTLVFEFCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 707 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 766
++HRDLK N+L++++ K+++FGL++ S+ V + ++
Sbjct: 122 ---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 767 LTDKSDVYSFGVILLELISG----------QEAISNEKFGANCRNIVQWAKLHIESGDIQ 816
+ D++S G I EL + + + QW +
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 817 GIIDPSLLDEYDIQSMWKIEEKALM--CVLPHGHMRPSISEVLKD 859
+ P+ ++ + L+ + + R S E L+
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 3e-37
Identities = 54/213 (25%), Positives = 85/213 (39%), Gaps = 17/213 (7%)
Query: 579 TLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE---FTNEVT 634
T++D + K +G G FG V + K G+ A+K+L K E E
Sbjct: 3 TMNDFD-----YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 635 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 694
+L H L Q R V E+ + G L HL R
Sbjct: 58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-------SRERVFTEERARFY 110
Query: 695 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 754
A+ + L +++RD+K N++LDK K++DFGL K + + + + GT
Sbjct: 111 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTP 169
Query: 755 GYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 787
YL PE D + GV++ E++ G+
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 6e-36
Identities = 55/286 (19%), Positives = 103/286 (36%), Gaps = 22/286 (7%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 646
+ +GSG +G V + G ++A+K L S + E+ LL + H N++
Sbjct: 22 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIG 81
Query: 647 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 706
L + +F G L +++ + + KG+ Y+H
Sbjct: 82 LLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG 141
Query: 707 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 766
IIHRDLK N+ +++ K+ DFGL++ A S ++ V +
Sbjct: 142 ---IIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTGYVVTRWYRAPEVILNWMR 195
Query: 767 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ---------WAKLHIESGDIQG 817
T D++S G I+ E+I+G+ + I++ +L +
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255
Query: 818 IIDPSLLDEYDIQSMWKIEEKAL----MCVLPHGHMRPSISEVLKD 859
P L + + A+ ++ R + E L
Sbjct: 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 9e-36
Identities = 53/300 (17%), Positives = 110/300 (36%), Gaps = 38/300 (12%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQ 646
KIG G FG V+ + K G+++A+K + + + E+ +L + H N+V
Sbjct: 14 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVN 73
Query: 647 FLGYCQE--------EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 698
+ C+ +G LV++F + + EI
Sbjct: 74 LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-------NVLVKFTLSEIKRVMQML 126
Query: 699 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF---AVDGASHVSSIVRGTVG 755
+ L+ I+HRD+K++N+L+ + K++DFGL++ A + + + T+
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 756 YLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 814
Y PE + ++ D++ G I+ E+ + + I Q I
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ-LCGSITPEV 245
Query: 815 IQGIIDPSLLDEYDIQSMWKIEEKALM---------------CVLPHGHMRPSISEVLKD 859
+ + L ++ ++ K + K + ++ R + L
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 135 bits (341), Expect = 3e-35
Identities = 58/290 (20%), Positives = 113/290 (38%), Gaps = 33/290 (11%)
Query: 592 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 647
K +G+G FG V K + G A+K+L ++ NE +L ++ LV+
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 648 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 707
++ +V E++ G + HL R + A EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD- 161
Query: 708 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 767
+I+RDLK N+L+D+ +V+DFG +K + GT L PE +S+
Sbjct: 162 --LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----LCGTPEALAPEIILSKGY 215
Query: 768 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 827
D ++ GV++ E+ +G ++ IV L D
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG------KVRFPSHFSSDLKD-- 267
Query: 828 DIQSMWKIEEKALMCVLPHGHMRPSISEVL-----KDIQDAIVIEREAAA 872
++++ +++ G+++ ++++ + +R+ A
Sbjct: 268 LLRNLLQVDLTKRF-----GNLKNGVNDIKNHKWFATTDWIAIYQRKVEA 312
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 129 bits (326), Expect = 2e-33
Identities = 52/277 (18%), Positives = 114/277 (41%), Gaps = 23/277 (8%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQF 647
L +K+G G + V+ + + +++ VK+L K++ E+ +L + N++
Sbjct: 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITL 95
Query: 648 LGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 705
++ LV+E ++N K+ Q + + K ++Y H+
Sbjct: 96 ADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM 148
Query: 706 CVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 764
I+HRD+K N+++D +H + ++ D+GL++F G + + + + PE +
Sbjct: 149 G---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV--ASRYFKGPELLVD 203
Query: 765 QQLTD-KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 823
Q+ D D++S G +L +I +E + N +V+ AK+ I ++
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGH--DNYDQLVRIAKVLGTEDLYDYIDKYNI 261
Query: 824 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 860
+ + + H + +S D
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 1e-31
Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 18/209 (8%)
Query: 590 LEKKIGSGGFGVVYYGKL----KDGKEIAVKVL----TSNSYQGKREFTNEVTLLSRI-H 640
L K +G+G +G V+ + GK A+KVL + E +L I
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87
Query: 641 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 700
LV Q E + L+ ++++ G L HL + I EI
Sbjct: 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL------- 140
Query: 701 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 760
L II+RD+K NILLD + ++DFGLSK V + + GT+ Y+ P+
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 761 YYISQQ--LTDKSDVYSFGVILLELISGQ 787
D +S GV++ EL++G
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 3e-30
Identities = 56/276 (20%), Positives = 104/276 (37%), Gaps = 22/276 (7%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 646
+GSG +G V K G +AVK L S + E+ LL + H N++
Sbjct: 22 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 81
Query: 647 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 706
L + L + Q++ + +G++Y+H+
Sbjct: 82 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 707 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 766
IIHRDLK SN+ +++ K+ DFGL++ + T Y PE ++
Sbjct: 142 ---IIHRDLKPSNLAVNEDCELKILDFGLARH----TDDEMTGYVATRWYRAPEIMLNWM 194
Query: 767 LTD-KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 825
+ D++S G I+ EL++G+ + I++ + G LL
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR----------LVGTPGAELLK 244
Query: 826 EYDIQSMWK-IEEKALMCVLPHGHMRPSISEVLKDI 860
+ +S I+ M + ++ + + D+
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL 280
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 7e-30
Identities = 50/225 (22%), Positives = 92/225 (40%), Gaps = 21/225 (9%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 646
K IGSG G+V + +A+K L + + E+ L+ ++H+N++
Sbjct: 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80
Query: 647 FLGYC------QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 700
L +E LV E M + + ++ + + GI+
Sbjct: 81 LLNVFTPQKTLEEFQDVYLVMELMDANLCQ-------VIQMELDHERMSYLLYQMLCGIK 133
Query: 701 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 760
+LH+ IIHRDLK SNI++ K+ DFGL++ G S + + T Y PE
Sbjct: 134 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPE 188
Query: 761 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW 805
+ + D++S G I+ E++ + + +++
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (288), Expect = 2e-28
Identities = 42/241 (17%), Positives = 97/241 (40%), Gaps = 18/241 (7%)
Query: 590 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL---- 644
L +K+G G F V+ K + + +A+K++ +E+ LL R++ +
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKED 75
Query: 645 -------VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL-EIAEDAA 696
++ L + +G + + + + L +E R + + +I++
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135
Query: 697 KGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVS-SIVRGTV 754
G++Y+H C IIH D+K N+L++ + ++ + T
Sbjct: 136 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 755 GYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 814
Y PE + +D++S ++ ELI+G ++ + ++ A++ G+
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 253
Query: 815 I 815
+
Sbjct: 254 L 254
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 92.9 bits (230), Expect = 4e-22
Identities = 29/158 (18%), Positives = 48/158 (30%), Gaps = 21/158 (13%)
Query: 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVL----------TSNSYQGKREFTNEVTLLSRI 639
+ K +G G V+ + E VK G F+ +R
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 640 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 699
R L + G VY + N L E R+ E+ + + +
Sbjct: 64 EFRALQKLQGLAV-----PKVYAWEGNAVLME--LIDAKELYRVRVENPDEVLDMILEEV 116
Query: 700 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 737
+ I+H DL N+L+ + + DF S
Sbjct: 117 AKFYHRG---IVHGDLSQYNVLVSEEG-IWIIDFPQSV 150
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 60.9 bits (146), Expect = 2e-10
Identities = 21/62 (33%), Positives = 28/62 (45%), Gaps = 1/62 (1%)
Query: 447 CPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL-LSKNVVLNYAGNI 505
+L + L +N++ G LP L L L L V N L G +P L + V YA N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302
Query: 506 NL 507
L
Sbjct: 303 CL 304
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 58.6 bits (140), Expect = 1e-09
Identities = 17/83 (20%), Positives = 30/83 (36%), Gaps = 10/83 (12%)
Query: 405 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPL 464
++ ++ + L + + G +P LT+L L +++ N L G +
Sbjct: 233 LAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKF--------LHSLNVSFNNLCGEI 284
Query: 465 PSSLMNLPNLRELYVQNN-MLSG 486
P NL NN L G
Sbjct: 285 P-QGGNLQRFDVSAYANNKCLCG 306
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 42.8 bits (99), Expect = 1e-04
Identities = 25/98 (25%), Positives = 39/98 (39%), Gaps = 14/98 (14%)
Query: 390 ADWAQEGGDPCLPVPWSWLQCNSDPQPS-ITVIHLSSKNLTGN--IPSDLTKLSSLVEFG 446
+ W D C W + C++D Q + + LS NL IPS L L
Sbjct: 25 SSW-LPTTDCC-NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPY----- 77
Query: 447 CPDLRIIHLEDN-QLTGPLPSSLMNLPNLRELYVQNNM 483
L +++ L GP+P ++ L L LY+ +
Sbjct: 78 ---LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTN 112
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 57.7 bits (138), Expect = 3e-09
Identities = 21/100 (21%), Positives = 39/100 (39%), Gaps = 12/100 (12%)
Query: 405 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPL 464
++T + L N++ P +SSL L+ + +N+++
Sbjct: 296 QLEDISPISNLKNLTYLTLYFNNISDISP-----VSSL-----TKLQRLFFANNKVSDV- 344
Query: 465 PSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 504
SSL NL N+ L +N +S P + L++ L
Sbjct: 345 -SSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 6e-04
Identities = 16/81 (19%), Positives = 31/81 (38%), Gaps = 14/81 (17%)
Query: 422 HLSSKNLTGNIP-SDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 480
L N+T + +DL ++++L + + + L NL ++
Sbjct: 28 VLGKTNVTDTVSQTDLDQVTTL-----------QADRLGIKSI--DGVEYLNNLTQINFS 74
Query: 481 NNMLSGTVPSSLLSKNVVLNY 501
NN L+ P L+K V +
Sbjct: 75 NNQLTDITPLKNLTKLVDILM 95
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 38.4 bits (88), Expect = 0.003
Identities = 18/54 (33%), Positives = 26/54 (48%), Gaps = 2/54 (3%)
Query: 447 CPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 500
+L + L NQL +L +L NL +L + NN +S P S L+K L
Sbjct: 218 LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAPLSGLTKLTELK 269
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 8e-07
Identities = 16/82 (19%), Positives = 32/82 (39%), Gaps = 11/82 (13%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTG----PLPSSLMNLP 472
I + + + L+ ++L +++ L+D LT + S+L P
Sbjct: 3 DIQSLDIQCEELSDARWAELLP-------LLQQCQVVRLDDCGLTEARCKDISSALRVNP 55
Query: 473 NLRELYVQNNMLSGTVPSSLLS 494
L EL +++N L +L
Sbjct: 56 ALAELNLRSNELGDVGVHCVLQ 77
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 14/53 (26%), Positives = 24/53 (45%), Gaps = 4/53 (7%)
Query: 446 GCPDLRIIHLEDNQLTG----PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 494
LR++ L D ++ L ++L+ +LREL + NN L L+
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 49.3 bits (116), Expect = 1e-06
Identities = 24/90 (26%), Positives = 37/90 (41%), Gaps = 13/90 (14%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 476
+ V+ S L +P DL PD ++ L++N++T NL NL
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLP----------PDTALLDLQNNKITEIKDGDFKNLKNLHT 59
Query: 477 LYVQNNMLSGTVPSSL--LSKNVVLNYAGN 504
L + NN +S P + L K L + N
Sbjct: 60 LILINNKISKISPGAFAPLVKLERLYLSKN 89
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 48.9 bits (115), Expect = 1e-06
Identities = 18/89 (20%), Positives = 32/89 (35%), Gaps = 9/89 (10%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 475
P ++ L + +T D L +L + L +N+++ P + L L
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNL--------HTLILINNKISKISPGAFAPLVKLE 82
Query: 476 ELYVQNNMLSGTVPSSLLSKNVVLNYAGN 504
LY+ N L +P + L N
Sbjct: 83 RLYLSKNQLK-ELPEKMPKTLQELRVHEN 110
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (110), Expect = 4e-06
Identities = 19/74 (25%), Positives = 29/74 (39%), Gaps = 11/74 (14%)
Query: 410 CNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLM 469
C S ++ +NLT +P DL K D I+HL +N L ++LM
Sbjct: 4 CEVSKVASHLEVNCDKRNLT-ALPPDLPK----------DTTILHLSENLLYTFSLATLM 52
Query: 470 NLPNLRELYVQNNM 483
L +L +
Sbjct: 53 PYTRLTQLNLDRAE 66
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.0 bits (107), Expect = 1e-05
Identities = 19/90 (21%), Positives = 37/90 (41%), Gaps = 18/90 (20%)
Query: 405 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPL 464
+ ++ D PS+ +++S+ L +P+ +L L N L +
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL-----------IASFNHLAE-V 319
Query: 465 PSSLMNLPNLRELYVQNNMLSG--TVPSSL 492
P NL++L+V+ N L +P S+
Sbjct: 320 PELP---QNLKQLHVEYNPLREFPDIPESV 346
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 6e-05
Identities = 17/84 (20%), Positives = 35/84 (41%), Gaps = 3/84 (3%)
Query: 399 PCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFG-CPDLRIIHLED 457
L + + + L++ + + +D K+S + P+L +HL++
Sbjct: 145 SPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKN 204
Query: 458 NQLTGPLPSSLMNLPNLRELYVQN 481
NQ++ P L N NL + + N
Sbjct: 205 NQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 15/54 (27%), Positives = 29/54 (53%), Gaps = 2/54 (3%)
Query: 447 CPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 500
L + +DN+++ P L +LPNL E++++NN +S P + S ++
Sbjct: 172 LSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVT 223
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (96), Expect = 2e-04
Identities = 13/75 (17%), Positives = 27/75 (36%), Gaps = 12/75 (16%)
Query: 409 QCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSL 468
C +P +T + L +P + + I L N+++ +S
Sbjct: 5 ACVCYNEPKVTT-SCPQQGLQ-AVPVGIP----------AASQRIFLHGNRISHVPAASF 52
Query: 469 MNLPNLRELYVQNNM 483
NL L++ +N+
Sbjct: 53 RACRNLTILWLHSNV 67
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.2 bits (88), Expect = 7e-04
Identities = 11/40 (27%), Positives = 17/40 (42%), Gaps = 2/40 (5%)
Query: 451 RIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPS 490
R++HL LT L L + L + +N L P+
Sbjct: 1 RVLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPA 38
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.4 bits (86), Expect = 0.001
Identities = 20/86 (23%), Positives = 30/86 (34%), Gaps = 16/86 (18%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEF--------------GCPDLRIIHLEDNQLT 461
+T + LS L P+ L L L P L+ + L +N+L
Sbjct: 20 LLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDGVANLPRLQELLLCNNRLQ 78
Query: 462 G-PLPSSLMNLPNLRELYVQNNMLSG 486
L++ P L L +Q N L
Sbjct: 79 QSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.002
Identities = 14/86 (16%), Positives = 33/86 (38%), Gaps = 7/86 (8%)
Query: 405 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPL 464
S L P++ + L+ L+ + + + + + L+ + L+ N++
Sbjct: 232 SSALAIALKSWPNLRELGLNDCLLSARGAAAV--VDAFSKLENIGLQTLRLQYNEIELDA 289
Query: 465 PSSLM-----NLPNLRELYVQNNMLS 485
+L +P+L L + N S
Sbjct: 290 VRTLKTVIDEKMPDLLFLELNGNRFS 315
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.003
Identities = 9/45 (20%), Positives = 15/45 (33%), Gaps = 3/45 (6%)
Query: 446 GCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPS 490
G I+ + ++ L NL LR N +P+
Sbjct: 199 GASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (85), Expect = 0.004
Identities = 11/67 (16%), Positives = 20/67 (29%), Gaps = 11/67 (16%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 476
S V +T IPSDL + + +L + +L +
Sbjct: 9 SNRVFLCQESKVT-EIPSDL----------PRNAIELRFVLTKLRVIQKGAFSGFGDLEK 57
Query: 477 LYVQNNM 483
+ + N
Sbjct: 58 IEISQND 64
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 914 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.87 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.38 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.35 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.19 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.16 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.15 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.95 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 98.94 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 98.91 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.84 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 98.8 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.79 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.77 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 98.73 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 98.72 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 98.68 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.59 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.52 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.51 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.51 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.5 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 98.43 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.34 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.31 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 98.27 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.26 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.11 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.11 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.1 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.04 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 97.92 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.89 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 97.83 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.8 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 97.74 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.47 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.44 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.24 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.17 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.12 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 96.95 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 96.68 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 95.71 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 91.16 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 89.57 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=368.76 Aligned_cols=265 Identities=27% Similarity=0.464 Sum_probs=211.5
Q ss_pred CCHHHHHHHHHHH-----------HCCCCCCCCEEEEEEEECC-C---CEEEEEEEECC-CCCCCHHHHHHHHHHHHCCC
Q ss_conf 4888899999987-----------4111523867999999789-9---69999997047-84351014589999963246
Q 002509 578 FTLSDIEDATKML-----------EKKIGSGGFGVVYYGKLKD-G---KEIAVKVLTSN-SYQGKREFTNEVTLLSRIHH 641 (914)
Q Consensus 578 ~~~~el~~~~~~~-----------~~~LG~G~~G~Vy~~~~~~-~---~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H 641 (914)
++++|+..++.+| .+.||+|+||+||+|+++. + ..||||.+... .....+.|.+|++++++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHHHHCHHHCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCC
T ss_conf 88798999996046220800427856980278829999999579978899999997844598999999999999985799
Q ss_pred CCEEEEEEEEEECCCEEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEE
Q ss_conf 86027986555259148999954589767774135673222357888999999999999987089997114577877657
Q 002509 642 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 721 (914)
Q Consensus 642 pnIv~l~g~~~~~~~~~LV~e~~~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NIL 721 (914)
|||++++|+|...+..++||||+++|+|.+++... ...+++.+++.++.|+|+||+|||++ +++||||||+|||
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NIL 160 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNIL 160 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCCCCEEEEEEECCEEEEEEEECCCCCCEEEECCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEE
T ss_conf 88861899996288779999722798530021045---67999999999999999988988527---9835761504489
Q ss_pred ECCCCCEEEEECCCCCCCCCCCCC----EEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCC
Q ss_conf 679994999620566123489972----0001125776569532224877865753205899999881-99776634336
Q 002509 722 LDKHMRAKVSDFGLSKFAVDGASH----VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFG 796 (914)
Q Consensus 722 l~~~~~~kI~DFGla~~~~~~~~~----~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~Ellt-G~~p~~~~~~~ 796 (914)
++.++.+||+|||+|+........ ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+...
T Consensus 161 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~- 239 (299)
T d1jpaa_ 161 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN- 239 (299)
T ss_dssp ECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-
T ss_pred ECCCCCEEECCCCCCEECCCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH-
T ss_conf 8899919988844315756777765365025666883003878883699786121445357899998679999999999-
Q ss_pred CCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 631228899887530388331127766781078999999999988249999999979999999765475
Q 002509 797 ANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 797 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~L~~~~~ 865 (914)
..+...+.. +.. ...+.+....+.+++.+|++.+|++||+|.||++.|+++++
T Consensus 240 ---~~~~~~i~~----~~~---------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 240 ---QDVINAIEQ----DYR---------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp ---HHHHHHHHT----TCC---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHHHHC----CCC---------CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf ---999999973----788---------99974226999999999758797689299999999999841
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.45 Aligned_cols=253 Identities=28% Similarity=0.480 Sum_probs=208.4
Q ss_pred HHHCCCCCCCCEEEEEEEECCCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEECCCCC
Q ss_conf 87411152386799999978996999999704784351014589999963246860279865552591489999545897
Q 002509 589 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 668 (914)
Q Consensus 589 ~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~e~~~~gs 668 (914)
.+.+.||+|+||.||+|++.+++.||||+++... ...++|.+|++++.+++||||++++|+|...+..++||||+++|+
T Consensus 8 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~ 86 (263)
T d1sm2a_ 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 86 (263)
T ss_dssp EEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred EEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECCCCC
T ss_conf 8888982088829999998899999999987886-768999999999996689975653524315993379998369991
Q ss_pred HHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCEEE
Q ss_conf 67774135673222357888999999999999987089997114577877657679994999620566123489972000
Q 002509 669 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 748 (914)
Q Consensus 669 L~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~~~~~~~~~~ 748 (914)
|.+++... ...+++..++.++.|+|.||+|||++ +|+||||||+|||++.++.+||+|||+++...........
T Consensus 87 L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 87 LSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp HHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred HHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCHHHEEECCCCCEEECCCCHHEECCCCCCEEEC
T ss_conf 89975201---34788999999999999987765316---4310443153266668877686553210023688733504
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHC-CCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 11257765695322248778657532058999998819-97766343366312288998875303883311277667810
Q 002509 749 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG-QEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 827 (914)
Q Consensus 749 ~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ElltG-~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 827 (914)
...||..|+|||++.+..++.++|||||||++|||+|+ ++|+..... ..+.+.+.. +. ....+..
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~----~~~~~~i~~----~~--~~~~p~~---- 226 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----SEVVEDIST----GF--RLYKPRL---- 226 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH----HHHHHHHHH----TC--CCCCCTT----
T ss_pred CEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCH----HHHHHHHHH----CC--CCCCCCC----
T ss_conf 300176667857860799984033210599999998789888778999----999999980----68--8899543----
Q ss_pred CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 78999999999988249999999979999999765475
Q 002509 828 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 828 ~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~L~~~~~ 865 (914)
...++.+++.+|++.+|++||+|+||+++|+++.+
T Consensus 227 ---~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 227 ---ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ---67999999999765797689199999999999985
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.12 Aligned_cols=256 Identities=25% Similarity=0.398 Sum_probs=206.8
Q ss_pred HHHHHCCCCCCCCEEEEEEEECCCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEECCC
Q ss_conf 99874111523867999999789969999997047843510145899999632468602798655525914899995458
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 587 ~~~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~e~~~~ 666 (914)
.+.+.+.||+|+||.||+|.+++++.||||+++... ...+.|.+|++++.+++||||++++|++.+ +..++||||+++
T Consensus 14 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~ 91 (272)
T d1qpca_ 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 91 (272)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred HEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEEECCC
T ss_conf 938867981079828999999999999999986476-888999999999986799988578731045-976999995789
Q ss_pred CCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCE
Q ss_conf 97677741356732223578889999999999999870899971145778776576799949996205661234899720
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~~~~~~~~ 746 (914)
|+|.+++... ....+++..++.|+.|+++||.|||++ +|+||||||+|||+++++.+||+|||+|+.........
T Consensus 92 g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 92 GSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp CBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCHHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECCCCEEECCCCCEEECCCCCCCC
T ss_conf 8288887514--789887889999999999999999748---95467564225156202440423410147735886442
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 00112577656953222487786575320589999988199776634336631228899887530388331127766781
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 826 (914)
.....|++.|+|||++.++.++.++|||||||++|||+||..|+..... ...+.+.+. .+.. +.....
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~---~~~~~~~i~----~~~~-----~~~p~~ 234 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT---NPEVIQNLE----RGYR-----MVRPDN 234 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHHH----TTCC-----CCCCTT
T ss_pred CCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC---HHHHHHHHH----HCCC-----CCCCCC
T ss_conf 0356774444582898379998245645257999999968988888889---999999997----0688-----889655
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 078999999999988249999999979999999765475
Q 002509 827 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 827 ~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~L~~~~~ 865 (914)
.+ .++.+++.+|++.+|++||||.||++.|++...
T Consensus 235 ~~----~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 235 CP----EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CH----HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 71----999999999758897689399999998611321
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=367.65 Aligned_cols=258 Identities=27% Similarity=0.378 Sum_probs=210.5
Q ss_pred HHHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEEC
Q ss_conf 99987411152386799999978-99699999970478435101458999996324686027986555259148999954
Q 002509 586 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 586 ~~~~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~e~~ 664 (914)
..+.+.+.||+|+||+||+|+++ +++.||||+++... ...++|.+|++++++++||||++++|+|.+.+..++||||+
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEEECC
T ss_conf 99398659820888089999999999699999977761-03999999999998679998826775274578547876314
Q ss_pred CCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 58976777413567322235788899999999999998708999711457787765767999499962056612348997
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 665 ~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~~~~~~ 744 (914)
++|+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 96 ~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 96 TYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp TTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred CCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCEEECCCCCC
T ss_conf 676067775303--554157999999999999978889878---930576045768998999289832445465378872
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 20001125776569532224877865753205899999881997766343366312288998875303883311277667
Q 002509 745 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 824 (914)
.......|+..|+|||++.+..++.++|||||||++|||++|..|+..... ...+.+.+.. +.. +...
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~---~~~~~~~i~~----~~~-----~~~~ 238 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEK----DYR-----MERP 238 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHHHHHT----TCC-----CCCC
T ss_pred EEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHC----CCC-----CCCC
T ss_conf 210355665466692787279998104302178999999867998877425---9999999855----888-----8887
Q ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 81078999999999988249999999979999999765475
Q 002509 825 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 825 ~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~L~~~~~ 865 (914)
... ..++.+++.+|++.+|++||||.||++.|+.+.+
T Consensus 239 ~~~----~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 239 EGC----PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred CCC----HHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 433----0999999999757797689399999999999987
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.59 Aligned_cols=256 Identities=32% Similarity=0.514 Sum_probs=202.4
Q ss_pred HHHCCCCCCCCEEEEEEEECCCCEEEEEEEECCC--CCCCHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEECCC
Q ss_conf 8741115238679999997899699999970478--43510145899999632468602798655525914899995458
Q 002509 589 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 589 ~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~e~~~~ 666 (914)
.+.+.||+|+||+||+|+++ ..||||+++... ....+.|.+|++++.+++||||++++|++.+ ...++||||+++
T Consensus 11 ~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~ 87 (276)
T d1uwha_ 11 TVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEG 87 (276)
T ss_dssp CCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCE
T ss_pred EEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEEECCCC
T ss_conf 99889830788589999999--989999997346998999999999999984799878645679715-589999965899
Q ss_pred CCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCC-CC
Q ss_conf 97677741356732223578889999999999999870899971145778776576799949996205661234899-72
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-SH 745 (914)
Q Consensus 667 gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~~~~~-~~ 745 (914)
|+|.++++.. ...+++..++.++.|+|+||+|||++ +|+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 88 g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 88 SSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp EEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred CCHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCHHHEEECCCCCEEECCCCCEEECCCCCCCC
T ss_conf 8889998523---57899999999999999998887509---99516147899798189978875002213335567763
Q ss_pred EEECCCCCCCCCCCCCCCC---CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 0001125776569532224---8778657532058999998819977663433663122889988753038833112776
Q 002509 746 VSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 822 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~---~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 822 (914)
......||+.|+|||++.+ ..++.++|||||||++|||+||+.||.+..... .+...+.......... .
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~---~~~~~~~~~~~~p~~~-----~ 233 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIFMVGRGYLSPDLS-----K 233 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHHHHHTSCCCCGG-----G
T ss_pred CCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHCCCCCCCCH-----H
T ss_conf 1256655743179999950568999953151635999999997889989989699---9999996588898600-----0
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 6781078999999999988249999999979999999765475
Q 002509 823 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 823 l~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~L~~~~~ 865 (914)
... .....+.+++.+|++.+|++||||.||+++|+.+.+
T Consensus 234 ~~~----~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 234 VRS----NCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp SCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC----CCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 365----554999999999758897689299999999999997
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.73 Aligned_cols=258 Identities=26% Similarity=0.381 Sum_probs=207.1
Q ss_pred HHHHHHCCCCCCCCEEEEEEEECC-C-----CEEEEEEEECC-CCCCCHHHHHHHHHHHHC-CCCCEEEEEEEEEECCCE
Q ss_conf 999874111523867999999789-9-----69999997047-843510145899999632-468602798655525914
Q 002509 586 ATKMLEKKIGSGGFGVVYYGKLKD-G-----KEIAVKVLTSN-SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRS 657 (914)
Q Consensus 586 ~~~~~~~~LG~G~~G~Vy~~~~~~-~-----~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~ 657 (914)
..+.+.+.||+|+||.||+|++.. + ..||+|++... .......+.+|+.++.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEE
T ss_conf 99397019830788199999985788554204999999663358789999999999999715899686877888629958
Q ss_pred EEEEEECCCCCHHHHHHCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 899995458976777413567-------------------3222357888999999999999987089997114577877
Q 002509 658 VLVYEFMHNGTLKEHLYGTLT-------------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSS 718 (914)
Q Consensus 658 ~LV~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~ 718 (914)
++||||+++|+|.++++.... ....+++..++.++.|+++||+|||++ +|+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHH
T ss_conf 9999727999599999862577751022100001222001257789999999999999999999739---9050527032
Q ss_pred CEEECCCCCEEEEECCCCCCCCCCCCC-EEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCC
Q ss_conf 657679994999620566123489972-0001125776569532224877865753205899999881-99776634336
Q 002509 719 NILLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFG 796 (914)
Q Consensus 719 NILl~~~~~~kI~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~Ellt-G~~p~~~~~~~ 796 (914)
|||++.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred CCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCCHH
T ss_conf 14434598289851422220457786156234357876578388727999963303000399999983899999998989
Q ss_pred CCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 631228899887530388331127766781078999999999988249999999979999999765
Q 002509 797 ANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 862 (914)
Q Consensus 797 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~L~~ 862 (914)
. .+.+.+.. +.. +. .+.....++.+++.+|++.+|++||||+||+++|..
T Consensus 274 ~---~~~~~~~~----~~~-----~~----~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 274 A---NFYKLIQN----GFK-----MD----QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp H---HHHHHHHT----TCC-----CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H---HHHHHHHC----CCC-----CC----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 9---99999856----998-----99----887678999999999758896689399999999748
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.27 Aligned_cols=248 Identities=24% Similarity=0.352 Sum_probs=202.8
Q ss_pred HHHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEECCC
Q ss_conf 987411152386799999978-9969999997047843510145899999632468602798655525914899995458
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 588 ~~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~e~~~~ 666 (914)
|.+.+.||+|+||.||+|+.. +++.||+|+++.......+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g 101 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred CEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEECCC
T ss_conf 38878981285829999999899989999998430172799999999999867999880585779889998999970379
Q ss_pred CCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCE
Q ss_conf 97677741356732223578889999999999999870899971145778776576799949996205661234899720
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~~~~~~~~ 746 (914)
|+|.+++. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 102 g~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~ 172 (293)
T d1yhwa1 102 GSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK 172 (293)
T ss_dssp CBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CC
T ss_pred CCHHHHHH-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC-CC
T ss_conf 80898864-----15999999999999999999999987---97226776888688789968642515641321366-64
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 00112577656953222487786575320589999988199776634336631228899887530388331127766781
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 826 (914)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||.+..... .+.... ..+.. .. .....
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~~~----~~~~~-~~---~~~~~ 241 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---ALYLIA----TNGTP-EL---QNPEK 241 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHH----HHCSC-CC---SSGGG
T ss_pred CCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHH---HHHHHH----HCCCC-CC---CCCCC
T ss_conf 444444777368266447998801203137299999804889989979999---999998----57999-88---88553
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 078999999999988249999999979999999
Q 002509 827 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 827 ~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~ 859 (914)
.+ ..+.+++.+|++.+|++|||+.|++++
T Consensus 242 ~s----~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 242 LS----AIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp SC----HHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CC----HHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 79----999999999866996689099999649
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.20 Aligned_cols=250 Identities=29% Similarity=0.499 Sum_probs=208.8
Q ss_pred HHCCCCCCCCEEEEEEEECCCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEECCCCCH
Q ss_conf 74111523867999999789969999997047843510145899999632468602798655525914899995458976
Q 002509 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 669 (914)
Q Consensus 590 ~~~~LG~G~~G~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~e~~~~gsL 669 (914)
+.+.||+|+||+||+|++++++.||||+++... ....+|.+|+.++.+++||||++++|+|.+++..++||||+++|+|
T Consensus 8 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l 86 (258)
T d1k2pa_ 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 86 (258)
T ss_dssp CCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEH
T ss_pred EEEEEECCCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECCCCCCH
T ss_conf 968982078839999998899899999987475-7789999999999966898601588998507816999970489938
Q ss_pred HHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCEEEC
Q ss_conf 77741356732223578889999999999999870899971145778776576799949996205661234899720001
Q 002509 670 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 749 (914)
Q Consensus 670 ~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~ 749 (914)
.+++... ...+++..+.+++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++............
T Consensus 87 ~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (258)
T d1k2pa_ 87 LNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 160 (258)
T ss_dssp HHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCC
T ss_pred HHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCCEEECC
T ss_conf 8864102---46776899999999999999987546---84346654135887699847988614420235787225246
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCC
Q ss_conf 125776569532224877865753205899999881-9977663433663122889988753038833112776678107
Q 002509 750 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 828 (914)
Q Consensus 750 ~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 828 (914)
..||..|+|||.+....++.++||||||+++|||+| |+.||...... .+...+ ..+.. ...+.
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~----~~~~~i----~~~~~--~~~p~------ 224 (258)
T d1k2pa_ 161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS----ETAEHI----AQGLR--LYRPH------ 224 (258)
T ss_dssp SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH----HHHHHH----HTTCC--CCCCT------
T ss_pred CCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHH----HHHHHH----HHCCC--CCCCC------
T ss_conf 578877578078637998852103364324673975599998899999----999999----80797--89965------
Q ss_pred HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 89999999999882499999999799999997654
Q 002509 829 IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 863 (914)
Q Consensus 829 ~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~L~~~ 863 (914)
....++.+++.+|++.+|++||||++++++|.++
T Consensus 225 -~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 225 -LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp -TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred -CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf -4659999999997668976893999999874188
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.66 Aligned_cols=256 Identities=25% Similarity=0.402 Sum_probs=204.8
Q ss_pred HHHCCCCCCCCEEEEEEEECCC-----CEEEEEEEECCC-CCCCHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEE
Q ss_conf 8741115238679999997899-----699999970478-4351014589999963246860279865552591489999
Q 002509 589 MLEKKIGSGGFGVVYYGKLKDG-----KEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 662 (914)
Q Consensus 589 ~~~~~LG~G~~G~Vy~~~~~~~-----~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~e 662 (914)
.+++.||+|+||.||+|.++.. ..||||+++... ......|.+|+.++.+++||||++++|++.+....++|+|
T Consensus 10 ~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e 89 (283)
T d1mqba_ 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 89 (283)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEEE
T ss_conf 86159811779099999996899878799999998844596899999999999985689878323677833880389997
Q ss_pred ECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 54589767774135673222357888999999999999987089997114577877657679994999620566123489
Q 002509 663 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 742 (914)
Q Consensus 663 ~~~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~~~~ 742 (914)
|+.+|++.+.+... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 90 YMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp CCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred ECCCCCCHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHCCCC---CCCCCCCCCCEEEECCCCEEEECCCCHHHCCCCC
T ss_conf 21357402221023---45420899999999999854121212---3425765644278889984998455103003578
Q ss_pred CC--CEEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 97--2000112577656953222487786575320589999988199776634336631228899887530388331127
Q 002509 743 AS--HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 820 (914)
Q Consensus 743 ~~--~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 820 (914)
.. .......||..|+|||++.+..++.++|||||||++|||+++..|+..... ...+.+.+. .+..
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~---~~~~~~~i~----~~~~----- 231 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---NHEVMKAIN----DGFR----- 231 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHH----TTCC-----
T ss_pred CCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC---HHHHHHHHH----CCCC-----
T ss_conf 7652674267777343488887049999735563448989999967988655689---999999986----3578-----
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 7667810789999999999882499999999799999997654757
Q 002509 821 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 866 (914)
Q Consensus 821 ~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~L~~~~~~ 866 (914)
...+.+...++.+++.+|++.+|++||+|.||++.|+.+++.
T Consensus 232 ----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 232 ----LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ----CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----CCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf ----998504579999999997767976893999999999998669
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=353.82 Aligned_cols=251 Identities=23% Similarity=0.351 Sum_probs=204.8
Q ss_pred HHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEECC
Q ss_conf 9987411152386799999978-996999999704784351014589999963246860279865552591489999545
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 587 ~~~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~e~~~ 665 (914)
.|.+.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECCC
T ss_conf 75898898407681999999889998999999845243169999999999986799799929999998999999998579
Q ss_pred CCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECC--CCCEEEEECCCCCCCCCCC
Q ss_conf 89767774135673222357888999999999999987089997114577877657679--9949996205661234899
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK--HMRAKVSDFGLSKFAVDGA 743 (914)
Q Consensus 666 ~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~--~~~~kI~DFGla~~~~~~~ 743 (914)
+|+|.+++... ...+++..+..++.|++.||+|||++ +++||||||+|||++. ++.+||+|||+|+.....
T Consensus 107 gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~- 179 (350)
T d1koaa2 107 GGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 179 (350)
T ss_dssp SCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred CCCHHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCEEEEECHHHEEECCCCCCEEEEEECCHHEECCCC-
T ss_conf 98899999762---37899999999999999999999756---976000154673641688986999545210442565-
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 72000112577656953222487786575320589999988199776634336631228899887530388331127766
Q 002509 744 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 823 (914)
Q Consensus 744 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 823 (914)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... .+...... ... ..+...
T Consensus 180 -~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----~~~~~i~~----~~~--~~~~~~ 248 (350)
T d1koaa2 180 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD----ETLRNVKS----CDW--NMDDSA 248 (350)
T ss_dssp -SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHH----TCC--CSCCGG
T ss_pred -CCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHH----CCC--CCCCCC
T ss_conf -4320006862421889975899872676554659999998598998997999----99999984----788--989422
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 781078999999999988249999999979999999
Q 002509 824 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 824 ~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~ 859 (914)
....+ ..+.+++.+|++.||++|||+.|++++
T Consensus 249 ~~~~s----~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 249 FSGIS----EDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGGCC----HHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCCCC----HHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 35899----999999999756896679089998629
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.38 Aligned_cols=250 Identities=26% Similarity=0.411 Sum_probs=202.4
Q ss_pred CCCCCCCEEEEEEEEC---CCCEEEEEEEECCC-CCCCHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEECCCCC
Q ss_conf 1152386799999978---99699999970478-4351014589999963246860279865552591489999545897
Q 002509 593 KIGSGGFGVVYYGKLK---DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 668 (914)
Q Consensus 593 ~LG~G~~G~Vy~~~~~---~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~e~~~~gs 668 (914)
+||+|+||.||+|.++ ++..||||+++... ....+.|.+|++++.+++||||++++|+|.. +..++||||+++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEEEEEECCCCC
T ss_conf 87306080999999960897689999998820397899999999999986799888068656036-80799998078996
Q ss_pred HHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC--E
Q ss_conf 67774135673222357888999999999999987089997114577877657679994999620566123489972--0
Q 002509 669 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH--V 746 (914)
Q Consensus 669 L~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~~~~~~~--~ 746 (914)
|.+++... ...+++..++.++.|+|.||+|||++ +|+||||||+|||++.++.+||+|||+|+........ .
T Consensus 95 L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 168 (285)
T d1u59a_ 95 LHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 168 (285)
T ss_dssp HHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECC
T ss_pred HHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEECCCHHHHCCCCCCCCCCC
T ss_conf 89975212---56999999999999999987899868---8105767646604546885420331342115543432113
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 001125776569532224877865753205899999881-9977663433663122889988753038833112776678
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 825 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 825 (914)
.....||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .+...+ ..+...+ ...
T Consensus 169 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~----~~~~~i----~~~~~~~-----~p~ 235 (285)
T d1u59a_ 169 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EVMAFI----EQGKRME-----CPP 235 (285)
T ss_dssp CCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH----HHHHHH----HTTCCCC-----CCT
T ss_pred CCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHH----HHHHHH----HCCCCCC-----CCC
T ss_conf 562113743358688727999954123220178999993899999997999----999999----8189999-----997
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 10789999999999882499999999799999997654757
Q 002509 826 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 866 (914)
Q Consensus 826 ~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~L~~~~~~ 866 (914)
.. ..++.+++.+|++.+|++||+|.+|.+.|+.....
T Consensus 236 ~~----~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 236 EC----PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp TC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC----CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 67----89999999997577976890999999999999998
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.20 Aligned_cols=250 Identities=22% Similarity=0.357 Sum_probs=200.8
Q ss_pred HHHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCC-CCCCHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEECC
Q ss_conf 987411152386799999978-99699999970478-4351014589999963246860279865552591489999545
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 588 ~~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~e~~~ 665 (914)
|.+.+.||+|+||.||+|+.+ +++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 86 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEECCC
T ss_conf 08998972174809999999999979999998456641279999999999985799888469654046743679886458
Q ss_pred CCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCC-C
Q ss_conf 897677741356732223578889999999999999870899971145778776576799949996205661234899-7
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-S 744 (914)
Q Consensus 666 ~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~~~~~-~ 744 (914)
+|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+...... .
T Consensus 87 gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 87 GGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp TEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCCHHHHHH----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCCC
T ss_conf 980899975----379999999999999999999999975---9835754689978878998798323142240468865
Q ss_pred CEEECCCCCCCCCCCCCCCCCCC-CCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 20001125776569532224877-86575320589999988199776634336631228899887530388331127766
Q 002509 745 HVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 823 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 823 (914)
......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||....... .....+... .... ..
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~~~~~~~----~~~~-----~~ 228 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSDWKEK----KTYL-----NP 228 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS--HHHHHHHTT----CTTS-----TT
T ss_pred CCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHCC----CCCC-----CC
T ss_conf 311132557474287286189999971016173799999982997888898599--999998638----8878-----86
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 781078999999999988249999999979999999
Q 002509 824 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 824 ~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~ 859 (914)
....+ .++.+++.+|++.+|++|||++|++++
T Consensus 229 ~~~~s----~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 229 WKKID----SAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp GGGSC----HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCC----HHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 44699----999999999767996689099999619
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.64 Aligned_cols=250 Identities=22% Similarity=0.318 Sum_probs=201.8
Q ss_pred HHHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEECCC
Q ss_conf 987411152386799999978-9969999997047843510145899999632468602798655525914899995458
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 588 ~~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~e~~~~ 666 (914)
|.+.+.||+|+||.||+|+.. +++.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECCCC
T ss_conf 59847993077819999999999939999998728999999999999999867999988498898009958999962799
Q ss_pred CCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCE
Q ss_conf 97677741356732223578889999999999999870899971145778776576799949996205661234899720
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~~~~~~~~ 746 (914)
|+|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 94 g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~ 166 (288)
T d2jfla1 94 GAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 166 (288)
T ss_dssp EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred CCHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEECCHHHEEECCCCCEEEEECHHHHCCCCCC-CC
T ss_conf 8188999862---89999999999999999999999988---98871407003148789998997161230357786-41
Q ss_pred EECCCCCCCCCCCCCCC-----CCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 00112577656953222-----4877865753205899999881997766343366312288998875303883311277
Q 002509 747 SSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 821 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 821 (914)
.....||+.|+|||++. ...++.++||||+||++|||++|+.||......+ +..... .+.......
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~----~~~~i~----~~~~~~~~~- 237 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR----VLLKIA----KSEPPTLAQ- 237 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG----HHHHHH----HSCCCCCSS-
T ss_pred CCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHH----CCCCCCCCC-
T ss_conf 00102562647999983202578888806657878999999820889999989999----999997----079987776-
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 66781078999999999988249999999979999999
Q 002509 822 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 822 ~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~ 859 (914)
+.....++.+++.+|++.+|++|||+.|++++
T Consensus 238 ------~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 238 ------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp ------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ------56699999999999766996689199999629
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.93 Aligned_cols=262 Identities=23% Similarity=0.328 Sum_probs=201.3
Q ss_pred HHHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCC-CCCCHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEECC
Q ss_conf 987411152386799999978-99699999970478-4351014589999963246860279865552591489999545
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 588 ~~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~e~~~ 665 (914)
|.+.+.||+|+||+||+|+.. +++.||+|+++... ......+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 8 y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~ 87 (322)
T d1s9ja_ 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 87 (322)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred CEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECCC
T ss_conf 88978971277809999999899969999998754097899999999999986799999949999998999999997679
Q ss_pred CCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 897677741356732223578889999999999999870-8999711457787765767999499962056612348997
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 666 ~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~-~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~~~~~~ 744 (914)
+|+|.+++.. ...+++..+..++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||+|+...+.
T Consensus 88 gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 88 GGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp TEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred CCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEEEECCCCCCCCCC--
T ss_conf 9868998742----499999999999999999999999859---9971445779946878998999548776256788--
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHC--------CC--
Q ss_conf 20001125776569532224877865753205899999881997766343366312288998875303--------88--
Q 002509 745 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES--------GD-- 814 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~--------~~-- 814 (914)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||...................... ..
T Consensus 159 -~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp -TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred -CCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCC
T ss_conf -6211137714119468758998948889989999999998889989988789999998875177545774212333221
Q ss_pred ------------CCCC-------CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHH
Q ss_conf ------------3311-------27766781078999999999988249999999979999999--765
Q 002509 815 ------------IQGI-------IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQD 862 (914)
Q Consensus 815 ------------~~~~-------~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~--L~~ 862 (914)
..+. ..+.+... ....++.+++.+|++.||++|||++|++++ +++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSG---VFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCCBT---TBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHHCCCCCCCCCC---CCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCC
T ss_conf 1112223541347788766502687667644---48999999999986899467908999960986476
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.99 Aligned_cols=249 Identities=27% Similarity=0.410 Sum_probs=201.3
Q ss_pred CCCCCCCCEEEEEEEEC---CCCEEEEEEEECCC--CCCCHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEECCC
Q ss_conf 11152386799999978---99699999970478--43510145899999632468602798655525914899995458
Q 002509 592 KKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 592 ~~LG~G~~G~Vy~~~~~---~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~e~~~~ 666 (914)
++||+|+||.||+|.++ .++.||||+++... ....+.|.+|++++++++||||++++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf 7834587829999998169738599999988010898999999999999986799898527777505-977999974788
Q ss_pred CCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCE
Q ss_conf 97677741356732223578889999999999999870899971145778776576799949996205661234899720
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~~~~~~~~ 746 (914)
|+|.++++. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCC
T ss_conf 968999752----25789999999999999997668747---95567776113102356751234134533134323443
Q ss_pred --EECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf --001125776569532224877865753205899999881-99776634336631228899887530388331127766
Q 002509 747 --SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 823 (914)
Q Consensus 747 --~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 823 (914)
.....||+.|+|||.+.+..++.++|||||||++|||++ |+.||.+... ..+...+ ..+.... .
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~----~~~~~~i----~~~~~~~-----~ 231 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEVTAML----EKGERMG-----C 231 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHH----HTTCCCC-----C
T ss_pred CCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCH----HHHHHHH----HCCCCCC-----C
T ss_conf 2244567784203916653799984344303403132896589999999899----9999999----8289999-----9
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 781078999999999988249999999979999999765475
Q 002509 824 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 824 ~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~L~~~~~ 865 (914)
.... ..++.+++.+|++.+|++||+|.+|.+.|+....
T Consensus 232 p~~~----~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 232 PAGC----PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp CTTC----CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCC----CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHHH
T ss_conf 8656----7999999999758897689098999998528875
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=351.03 Aligned_cols=250 Identities=21% Similarity=0.343 Sum_probs=204.9
Q ss_pred HHHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEECCC
Q ss_conf 987411152386799999978-9969999997047843510145899999632468602798655525914899995458
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 588 ~~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~e~~~~ 666 (914)
|.+.+.||+|+||.||+|+.. +++.||+|+++.........+.+|++++++++||||+++++++.+++..++||||+++
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 110 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 110 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECCCC
T ss_conf 59989993177829999999899979999998872646799999999999867997989199999989999999982899
Q ss_pred CCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEEC--CCCCEEEEECCCCCCCCCCCC
Q ss_conf 976777413567322235788899999999999998708999711457787765767--999499962056612348997
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD--KHMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 667 gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~--~~~~~kI~DFGla~~~~~~~~ 744 (914)
|+|.+.+.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++ .++.+||+|||+|+.....
T Consensus 111 g~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-- 182 (352)
T d1koba_ 111 GELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 182 (352)
T ss_dssp CBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred CHHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCC--
T ss_conf 808888986---389989999999999999999999977---926513144553113467884899525630343788--
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 20001125776569532224877865753205899999881997766343366312288998875303883311277667
Q 002509 745 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 824 (914)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... .+...... +... ......
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----~~~~~i~~----~~~~--~~~~~~ 252 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL----ETLQNVKR----CDWE--FDEDAF 252 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH----HHHHHHHH----CCCC--CCSSTT
T ss_pred CCEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHH----CCCC--CCCCCC
T ss_conf 7201004764534899974799897633389899999999688998997999----99999984----7889--893002
Q ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 81078999999999988249999999979999999
Q 002509 825 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 825 ~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~ 859 (914)
...+ .++.+++.+|++.+|++|||+.|++++
T Consensus 253 ~~~s----~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 253 SSVS----PEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp TTSC----HHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCC----HHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 4799----999999999756996689189999609
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.94 Aligned_cols=256 Identities=25% Similarity=0.407 Sum_probs=208.2
Q ss_pred HHHHHCCCCCCCCEEEEEEEECCCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEECCC
Q ss_conf 99874111523867999999789969999997047843510145899999632468602798655525914899995458
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 587 ~~~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~e~~~~ 666 (914)
.+.+.+.||+|+||.||+|++++++.||||+++... ...+.|.+|+.++.+++||||++++|+|.+ +..++||||+++
T Consensus 18 ~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~ 95 (285)
T d1fmka3 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 95 (285)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEECCC
T ss_conf 979846993079809999999999999999988044-888999999999986666788689999823-975999994479
Q ss_pred CCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCE
Q ss_conf 97677741356732223578889999999999999870899971145778776576799949996205661234899720
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~~~~~~~~ 746 (914)
|+|...+... ....++|.+++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++.........
T Consensus 96 g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 96 GSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp CBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHHHH---HEECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCCEE
T ss_conf 9435420000--355305999999999999999987541---14335312307999899929984425554256887335
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 00112577656953222487786575320589999988199776634336631228899887530388331127766781
Q 002509 747 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 826 (914)
.....||+.|+|||++..+.++.++|||||||++|||++|..|+..... ...+...+.. +.. ......
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~---~~~~~~~i~~----~~~-----~~~~~~ 238 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NREVLDQVER----GYR-----MPCPPE 238 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHHHT----TCC-----CCCCTT
T ss_pred ECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCC---HHHHHHHHHH----CCC-----CCCCCC
T ss_conf 2454556654580898379989177413235899999868999998888---9999999982----689-----999832
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 078999999999988249999999979999999765475
Q 002509 827 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 827 ~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~L~~~~~ 865 (914)
...++.+++.+|++.+|++||+|++|++.|+....
T Consensus 239 ----~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 239 ----CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred ----CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf ----37999999999756697589199999998766623
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.11 Aligned_cols=244 Identities=25% Similarity=0.402 Sum_probs=201.4
Q ss_pred HHHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCC---CCCCHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf 987411152386799999978-99699999970478---43510145899999632468602798655525914899995
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 663 (914)
Q Consensus 588 ~~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~e~ 663 (914)
|.+.+.||+|+||.||+++.+ +++.||+|++.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEE
T ss_conf 69988985177858999999899949999998168856768999999999999856888888599999989998999850
Q ss_pred CCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 45897677741356732223578889999999999999870899971145778776576799949996205661234899
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 743 (914)
Q Consensus 664 ~~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~~~~~ 743 (914)
+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 88 ~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 88 APLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred CCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCCEECCCCCEEECCCCEEEECCCC-
T ss_conf 479858988750----48999999999999999999999988---9465220234414668998711555633544888-
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 72000112577656953222487786575320589999988199776634336631228899887530388331127766
Q 002509 744 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 823 (914)
Q Consensus 744 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 823 (914)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .+.+.. ..+.. .+
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----~~~~~i----~~~~~------~~ 223 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ----ETYKRI----SRVEF------TF 223 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHH----HTTCC------CC
T ss_pred --CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHH----HHHHHH----HCCCC------CC
T ss_conf --523557887634999975899893144046759999983299998889999----999999----71899------99
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 781078999999999988249999999979999999
Q 002509 824 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 824 ~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~ 859 (914)
....+ .++.+++.+|++.+|++|||++|++++
T Consensus 224 p~~~s----~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 224 PDFVT----EGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp CTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CCCCC----HHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 86689----999999999764797689099999719
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.32 Aligned_cols=254 Identities=24% Similarity=0.355 Sum_probs=203.4
Q ss_pred HHHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCCC--CCCHHHHHHHHHHHHCCCCCEEEEEEEEEE--CCCEEEEEE
Q ss_conf 987411152386799999978-996999999704784--351014589999963246860279865552--591489999
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYE 662 (914)
Q Consensus 588 ~~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~LV~e 662 (914)
|.+.+.||+|+||.||+++.+ +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+ .+..++|||
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE 85 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred CEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEE
T ss_conf 79967983088919999999999979999998746579799999999999999778999824899999178998999995
Q ss_pred ECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 54589767774135673222357888999999999999987089--9971145778776576799949996205661234
Q 002509 663 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC--VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 740 (914)
Q Consensus 663 ~~~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~--~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~~ 740 (914)
|+++|+|.+++.........+++..++.++.|++.||+|||+.. ..+|+||||||+|||++.++.+||+|||+|+...
T Consensus 86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 165 (269)
T d2java1 86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 165 (269)
T ss_dssp CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred CCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEEECC
T ss_conf 68999389999851545789999999999999999999999716778878858676542574788857980010003224
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 89972000112577656953222487786575320589999988199776634336631228899887530388331127
Q 002509 741 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 820 (914)
Q Consensus 741 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 820 (914)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+... +..+....
T Consensus 166 ~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~----~~~~~----i~~~~~~~--- 233 (269)
T d2java1 166 HDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK----ELAGK----IREGKFRR--- 233 (269)
T ss_dssp -----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHH----HHHTCCCC---
T ss_pred CCCC-CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHH----HHHHH----HHCCCCCC---
T ss_conf 5777-556677882327999983999993898875278999980188998998999----99999----97189988---
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 766781078999999999988249999999979999999
Q 002509 821 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 821 ~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~ 859 (914)
+...++ .++.+++.+|++.+|++|||+.|++++
T Consensus 234 --~~~~~s----~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 234 --IPYRYS----DELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp --CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CCCCCC----HHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf --974359----999999999767995579189999729
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=349.67 Aligned_cols=249 Identities=23% Similarity=0.362 Sum_probs=202.3
Q ss_pred HHHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCCC-CCCHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEECC
Q ss_conf 987411152386799999978-996999999704784-351014589999963246860279865552591489999545
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 588 ~~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~e~~~ 665 (914)
|.+.+.||+|+||.||+|+.+ +++.||||++..... .....+.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~ 90 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS 90 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECCC
T ss_conf 69988994065839999999999989999998157731289999999999986799899919899998998889885268
Q ss_pred CCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEEC---CCCCEEEEECCCCCCCCCC
Q ss_conf 8976777413567322235788899999999999998708999711457787765767---9994999620566123489
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFAVDG 742 (914)
Q Consensus 666 ~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~---~~~~~kI~DFGla~~~~~~ 742 (914)
+|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+. +++.+||+|||+|+.....
T Consensus 91 gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 91 GGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp SCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred CCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHC---EEEEEEECCCCEEECCCCCCCEEEEECCCEEEECCCC
T ss_conf 9848886530----36788789999999999998752413---0556870463001104688824998315435872589
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 97200011257765695322248778657532058999998819977663433663122889988753038833112776
Q 002509 743 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 822 (914)
Q Consensus 743 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 822 (914)
. .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... .+..... .+... ....
T Consensus 164 ~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~----~~~~~i~----~~~~~--~~~~ 231 (307)
T d1a06a_ 164 S--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA----KLFEQIL----KAEYE--FDSP 231 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHH----TTCCC--CCTT
T ss_pred C--EEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHH----CCCCC--CCCC
T ss_conf 7--044003284225918873799980787345159999998597999998999----9999986----16877--7876
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 6781078999999999988249999999979999999
Q 002509 823 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 823 l~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~ 859 (914)
.....+ ..+.+++.+|++.+|++|||+.|++++
T Consensus 232 ~~~~~s----~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 232 YWDDIS----DSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCCCC----HHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 666789----999999999760897579189998629
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.69 Aligned_cols=254 Identities=29% Similarity=0.457 Sum_probs=202.5
Q ss_pred HHCCCCCCCCEEEEEEEECCC----CEEEEEEEECC-CCCCCHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CCEEEEEEE
Q ss_conf 741115238679999997899----69999997047-843510145899999632468602798655525-914899995
Q 002509 590 LEKKIGSGGFGVVYYGKLKDG----KEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-GRSVLVYEF 663 (914)
Q Consensus 590 ~~~~LG~G~~G~Vy~~~~~~~----~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~LV~e~ 663 (914)
+.++||+|+||+||+|++.+. ..||||+++.. .......|.+|++++.+++||||++++|+|... +..++||||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred CCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEE
T ss_conf 66698136880999999977998799999999884369789999999999998678999867867898069943899987
Q ss_pred CCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 45897677741356732223578889999999999999870899971145778776576799949996205661234899
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 743 (914)
Q Consensus 664 ~~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~~~~~ 743 (914)
+++|+|.++++.. ...+++..++.++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 111 ~~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 111 MKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EECCCHHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCC
T ss_conf 4067414421013---45404899999999988765200336---76257766875767799988991065232255665
Q ss_pred CC---EEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 72---000112577656953222487786575320589999988199776634336631228899887530388331127
Q 002509 744 SH---VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 820 (914)
Q Consensus 744 ~~---~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 820 (914)
.. ......||..|+|||.+....++.++||||||+++|||++|+.|+...... .++..++. .+... ..
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~---~~~~~~i~----~g~~~--~~ 255 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVYLL----QGRRL--LQ 255 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------CHHHHH----TTCCC--CC
T ss_pred CCCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHHHH----CCCCC--CC
T ss_conf 55310025655564556768874379997457466199999999789999888999---99999998----08988--99
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 766781078999999999988249999999979999999765475
Q 002509 821 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 821 ~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~L~~~~~ 865 (914)
+. ....++.+++.+|++.+|++||+|.||+++|+.+..
T Consensus 256 p~-------~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 256 PE-------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp CT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC-------CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 64-------475999999999768897689399999999999997
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.25 Aligned_cols=254 Identities=23% Similarity=0.379 Sum_probs=203.4
Q ss_pred HHHHCCCCCCCCEEEEEEEEC-CCC----EEEEEEEECC-CCCCCHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEE
Q ss_conf 987411152386799999978-996----9999997047-8435101458999996324686027986555259148999
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 661 (914)
Q Consensus 588 ~~~~~~LG~G~~G~Vy~~~~~-~~~----~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 661 (914)
+.+.+.||+|+||+||+|.+. +++ .||+|+++.. .....+.|.+|+.++++++||||++++|+|.+. ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEEEE
T ss_conf 9783198208992999999958998898999999965134979999999999999867998881589999619-836999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 95458976777413567322235788899999999999998708999711457787765767999499962056612348
Q 002509 662 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 741 (914)
Q Consensus 662 e~~~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~~~ 741 (914)
|++.+|+|.+.+... ...+++..++.++.|+|.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 90 e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 90 QLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp ECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EECCCCCCCCCCCCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCHHHCCEECCCCCEEEECCCCCEECCC
T ss_conf 842687401011133---45799999999999999999999876---950476212031167998758602552223354
Q ss_pred CCCC-EEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCC
Q ss_conf 9972-0001125776569532224877865753205899999881-9977663433663122889988753038833112
Q 002509 742 GASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 819 (914)
Q Consensus 742 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 819 (914)
.... ......||..|+|||++.++.++.++|||||||++|||+| |+.||...... .+...+.. +...
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~----~~~~~i~~----~~~~--- 232 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSILEK----GERL--- 232 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG----GHHHHHHH----TCCC---
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH----HHHHHHHC----CCCC---
T ss_conf 445322365105864467088746999835654407999999997799999999989----99999975----9989---
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 7766781078999999999988249999999979999999765475
Q 002509 820 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 820 d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~L~~~~~ 865 (914)
..+......+.+++.+|++.+|++||||.||+++|+.+..
T Consensus 233 ------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 233 ------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp ------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ------9985568999999998478993469199999999999875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.48 Aligned_cols=245 Identities=28% Similarity=0.427 Sum_probs=193.6
Q ss_pred HHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCC--CCCCHHHHHHHHHHHHCCCCCEEEEEEEEEE----CCCEEEEE
Q ss_conf 87411152386799999978-99699999970478--4351014589999963246860279865552----59148999
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVLVY 661 (914)
Q Consensus 589 ~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~----~~~~~LV~ 661 (914)
.+.++||+|+||+||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.. ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf 85169700828499999999999599999985122798999999999999985799985069999840334588899999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCC--CCCCCCCCCCEEEC-CCCCEEEEECCCCCC
Q ss_conf 954589767774135673222357888999999999999987089997--11457787765767-999499962056612
Q 002509 662 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA--IIHRDLKSSNILLD-KHMRAKVSDFGLSKF 738 (914)
Q Consensus 662 e~~~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~--ivH~DIkp~NILl~-~~~~~kI~DFGla~~ 738 (914)
||+++|+|.+++.. ...+++..+..++.|+++||+|||++ + |+||||||+|||++ .++.+||+|||+|+.
T Consensus 92 E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred ECCCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEECCCCHHHCEEECCCCCEEEEECCCCEE
T ss_conf 57898948999751----35546999999999999999999978---997996876743511667999889800576542
Q ss_pred CCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCC
Q ss_conf 34899720001125776569532224877865753205899999881997766343366312288998875303883311
Q 002509 739 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 818 (914)
Q Consensus 739 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 818 (914)
.... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||...... ..+.+. +..+.....
T Consensus 165 ~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~---~~~~~~----i~~~~~~~~ 233 (270)
T d1t4ha_ 165 KRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA---AQIYRR----VTSGVKPAS 233 (270)
T ss_dssp CCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH---HHHHHH----HTTTCCCGG
T ss_pred CCCC---CCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHH----HHCCCCCCC
T ss_conf 3687---6677553813008988478-9998671100799999998788999876559---999999----973899865
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 27766781078999999999988249999999979999999
Q 002509 819 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 819 ~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~ 859 (914)
.+ ... ..++.+++.+|++.+|++|||+.|++++
T Consensus 234 ~~----~~~----~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 234 FD----KVA----IPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp GG----GCC----CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CC----CCC----CHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 67----557----8999999999763797589299999677
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=347.59 Aligned_cols=246 Identities=24% Similarity=0.373 Sum_probs=197.2
Q ss_pred HHHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCCCC---CCHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEE
Q ss_conf 99987411152386799999978-9969999997047843---5101458999996324686027986555259148999
Q 002509 586 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 661 (914)
Q Consensus 586 ~~~~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 661 (914)
..+...+.||+|+||.||+|+.. +++.||||+++..... ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 85676279701888099999998999399999984444358899999999999999778999823899999899889999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 95458976777413567322235788899999999999998708999711457787765767999499962056612348
Q 002509 662 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 741 (914)
Q Consensus 662 e~~~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~~~ 741 (914)
|||.+|+|..++. ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EECCCCCHHHHHH----HCCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCCCEEEECCCCCEEEEECCCCCCCCC
T ss_conf 8069994578997----379999999999999999999999868---976667884217987999789844365334677
Q ss_pred CCCCEEECCCCCCCCCCCCCCCC---CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCC
Q ss_conf 99720001125776569532224---877865753205899999881997766343366312288998875303883311
Q 002509 742 GASHVSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 818 (914)
Q Consensus 742 ~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 818 (914)
. ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.... ..... . ..+.....
T Consensus 168 ~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~----~~~~~---i-~~~~~~~~ 234 (309)
T d1u5ra_ 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYH---I-AQNESPAL 234 (309)
T ss_dssp B-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHH---H-HHSCCCCC
T ss_pred C-----CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH----HHHHH---H-HHCCCCCC
T ss_conf 8-----7313476636889983467888672145455899999998788999997999----99999---9-82899988
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 27766781078999999999988249999999979999999
Q 002509 819 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 819 ~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~ 859 (914)
.. ..++ ..+.+++.+|++.+|++|||+.|++++
T Consensus 235 ~~----~~~s----~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 235 QS----GHWS----EYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp SC----TTSC----HHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CC----CCCC----HHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf 87----8889----999999999773796579189999719
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.30 Aligned_cols=258 Identities=21% Similarity=0.341 Sum_probs=208.3
Q ss_pred HHHHHCCCCCCCCEEEEEEEECC----CCEEEEEEEECCC-CCCCHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEE
Q ss_conf 99874111523867999999789----9699999970478-435101458999996324686027986555259148999
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 661 (914)
Q Consensus 587 ~~~~~~~LG~G~~G~Vy~~~~~~----~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 661 (914)
.+.+.+.||+|+||.||+|++.. +..||||.++... ......+.+|++++++++||||++++|++. .+..++||
T Consensus 8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~ 86 (273)
T d1mp8a_ 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM 86 (273)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEEEE
T ss_conf 96987799307882999999936996449999999365668799999999999998689999856988995-37479999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 95458976777413567322235788899999999999998708999711457787765767999499962056612348
Q 002509 662 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 741 (914)
Q Consensus 662 e~~~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~~~ 741 (914)
||+++|+|.+++... ...+++..++.++.|+++||+|||++ +++||||||+||+++.++.+||+|||+|+....
T Consensus 87 E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp ECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EECCCCCHHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCHHHEEECCCCCEEECCCHHHEECCC
T ss_conf 840698077654224---78999999999999998775230226---744141026553206789678765034213367
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 99720001125776569532224877865753205899999881-99776634336631228899887530388331127
Q 002509 742 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 820 (914)
Q Consensus 742 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 820 (914)
..........||+.|+|||++.+..++.++|||||||++|||++ |..||...... .+...+. .+...
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~----~~~~~i~----~~~~~---- 228 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIGRIE----NGERL---- 228 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHHHHH----TTCCC----
T ss_pred CCCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH----HHHHHHH----CCCCC----
T ss_conf 76233054005831032667516998874524442478999982699998889999----9999998----18999----
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 766781078999999999988249999999979999999765475746
Q 002509 821 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIER 868 (914)
Q Consensus 821 ~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~L~~~~~~~~ 868 (914)
...... ..++.+++.+|++.+|++||||.||+++|+.++..++
T Consensus 229 -~~~~~~----~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k 271 (273)
T d1mp8a_ 229 -PMPPNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271 (273)
T ss_dssp -CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -CCCCCC----CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHH
T ss_conf -898777----9999999999768797689299999999999977861
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=346.82 Aligned_cols=257 Identities=25% Similarity=0.415 Sum_probs=206.5
Q ss_pred HHHHCCCCCCCCEEEEEEEEC------CCCEEEEEEEECCCC-CCCHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEE
Q ss_conf 987411152386799999978------996999999704784-3510145899999632468602798655525914899
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 660 (914)
Q Consensus 588 ~~~~~~LG~G~~G~Vy~~~~~------~~~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV 660 (914)
+.+.+.||+|+||.||+|+++ +++.||||+++.... ...+.|.+|++++++++||||++++++|......+++
T Consensus 15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v 94 (301)
T d1lufa_ 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 94 (301)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred CEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCCCCEEEE
T ss_conf 38867982078839999998887657788299999988210857999999999999966899765524666059803899
Q ss_pred EEECCCCCHHHHHHCCC--------------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCE
Q ss_conf 99545897677741356--------------------7322235788899999999999998708999711457787765
Q 002509 661 YEFMHNGTLKEHLYGTL--------------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 720 (914)
Q Consensus 661 ~e~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NI 720 (914)
+|++++|+|.++++... .....+++..++.|+.|++.||+|||+. +++||||||+||
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NI 171 (301)
T d1lufa_ 95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNC 171 (301)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred EEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCC---CEEEEEECCCCE
T ss_conf 98158992999998527554210000111001210346788989999999999999985541357---868548840116
Q ss_pred EECCCCCEEEEECCCCCCCCCCC-CCEEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCC-CCCCCCCCCCC
Q ss_conf 76799949996205661234899-72000112577656953222487786575320589999988199-77663433663
Q 002509 721 LLDKHMRAKVSDFGLSKFAVDGA-SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ-EAISNEKFGAN 798 (914)
Q Consensus 721 Ll~~~~~~kI~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ElltG~-~p~~~~~~~~~ 798 (914)
|++.++.+||+|||+|+...... ........|++.|+|||.+.+..++.++|||||||++|||++|. +||.....
T Consensus 172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~--- 248 (301)
T d1lufa_ 172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH--- 248 (301)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---
T ss_pred EECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCCCCCCCH---
T ss_conf 89899928983314421136776411157777676767989972688980563025236299998068999999899---
Q ss_pred CHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 122889988753038833112776678107899999999998824999999997999999976547
Q 002509 799 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 864 (914)
Q Consensus 799 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~L~~~~ 864 (914)
..+...+ ..+..... .... ..++.+++.+|++.+|++||||.||+++|+++.
T Consensus 249 -~e~~~~v----~~~~~~~~-----p~~~----~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 249 -EEVIYYV----RDGNILAC-----PENC----PLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp -HHHHHHH----HTTCCCCC-----CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -HHHHHHH----HCCCCCCC-----CCCC----HHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHC
T ss_conf -9999999----73997888-----7325----299999999974889657939999999999842
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.59 Aligned_cols=247 Identities=23% Similarity=0.313 Sum_probs=202.7
Q ss_pred HHHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCC---CCCCHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf 987411152386799999978-99699999970478---43510145899999632468602798655525914899995
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 663 (914)
Q Consensus 588 ~~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~e~ 663 (914)
|.+.+.||+|+||.||+|+.. +++.||||+++... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEC
T ss_conf 78988985087909999999899979999998657755777899999999999876888861799999989988999970
Q ss_pred CCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 45897677741356732223578889999999999999870899971145778776576799949996205661234899
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 743 (914)
Q Consensus 664 ~~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~~~~~ 743 (914)
+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 90 ~~gg~L~~~~~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 90 AKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred CCCCCHHHHHH----CCCCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCCCCCCCCCCCEEEECCCCCCEECCCCC
T ss_conf 48987777653----159999999999999999999762165---08847677412366888538860321024225677
Q ss_pred -CCEEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf -7200011257765695322248778657532058999998819977663433663122889988753038833112776
Q 002509 744 -SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 822 (914)
Q Consensus 744 -~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 822 (914)
........||+.|+|||++.+..++.++||||+||++|||++|+.||...... .+.+. +..+.. .
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~----~~~~~----i~~~~~------~ 228 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY----LIFQK----IIKLEY------D 228 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHH----HHTTCC------C
T ss_pred CCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHH----HHHHH----HHCCCC------C
T ss_conf 643335556775525844002689896662304569999980388998995999----99999----971899------9
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 6781078999999999988249999999979999999
Q 002509 823 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 823 l~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~ 859 (914)
+....+ .++.+++.+|++.+|++|||++|+.++
T Consensus 229 ~p~~~s----~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 229 FPEKFF----PKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp CCTTCC----HHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred CCCCCC----HHHHHHHHHHCCCCHHHCCCHHHHCCC
T ss_conf 985479----999999999855797689197897377
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.68 Aligned_cols=265 Identities=23% Similarity=0.363 Sum_probs=199.9
Q ss_pred HHHCCCCCCCCEEEEEEEECCCCEEEEEEEECCCCCCCHHHHH--HHHHHHHCCCCCEEEEEEEEEECC----CEEEEEE
Q ss_conf 8741115238679999997899699999970478435101458--999996324686027986555259----1489999
Q 002509 589 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTN--EVTLLSRIHHRNLVQFLGYCQEEG----RSVLVYE 662 (914)
Q Consensus 589 ~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~--E~~~l~~l~HpnIv~l~g~~~~~~----~~~LV~e 662 (914)
.+.+.||+|+||.||+|+++ |+.||||+++... ...+.. |+..+.+++||||++++|+|...+ ..++|||
T Consensus 6 ~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 6 VLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp EEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEECCCEEEEEEEEC-CEEEEEEEECCCC---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEEEE
T ss_conf 99889820788199999999-9899999987200---4679999999999627998683268899837986048999996
Q ss_pred ECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 54589767774135673222357888999999999999987089-----9971145778776576799949996205661
Q 002509 663 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC-----VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 737 (914)
Q Consensus 663 ~~~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~-----~~~ivH~DIkp~NILl~~~~~~kI~DFGla~ 737 (914)
|+++|+|.++++. ..++|..++.++.|+|.||+|||+.+ .++|+||||||+|||++.++.+||+|||+++
T Consensus 82 y~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 82 YHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp CCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CCCCCCHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCCC
T ss_conf 4669898999865-----89998999999999999999988766520468986615317313578688776887638662
Q ss_pred CCCCCCCC---EEECCCCCCCCCCCCCCCCC------CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCC-CH------H
Q ss_conf 23489972---00011257765695322248------778657532058999998819977663433663-12------2
Q 002509 738 FAVDGASH---VSSIVRGTVGYLDPEYYISQ------QLTDKSDVYSFGVILLELISGQEAISNEKFGAN-CR------N 801 (914)
Q Consensus 738 ~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~------~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~-~~------~ 801 (914)
........ ......||+.|+|||++.+. .++.++|||||||++|||+||..|+........ .. .
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred CCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCC
T ss_conf 34677762001355250354767822105654546777675012201599999996289988766311241012255643
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCC-CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 88998875303883311277667810-789999999999882499999999799999997654757
Q 002509 802 IVQWAKLHIESGDIQGIIDPSLLDEY-DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 866 (914)
Q Consensus 802 l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~L~~~~~~ 866 (914)
........... ...+|.+.... +.+....+.+++.+|++.+|++||||.||++.|+++...
T Consensus 237 ~~~~~~~~~~~----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 237 SVEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CHHHHHHHHTT----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHC----CCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 09999998750----246888776557768999999999997606985895999999999988886
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.90 Aligned_cols=250 Identities=24% Similarity=0.331 Sum_probs=200.8
Q ss_pred HHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCCCC------CCHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEE
Q ss_conf 9987411152386799999978-9969999997047843------51014589999963246860279865552591489
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 659 (914)
Q Consensus 587 ~~~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~~~------~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~L 659 (914)
.|.+.+.||+|+||.||+|+.+ +|+.||||+++..... ..+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEE
T ss_conf 77982798117895999999999998999999875663213406899999999999986799899938899997998999
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCC----CEEEEECCC
Q ss_conf 9995458976777413567322235788899999999999998708999711457787765767999----499962056
Q 002509 660 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM----RAKVSDFGL 735 (914)
Q Consensus 660 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~----~~kI~DFGl 735 (914)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+|++|||+
T Consensus 91 v~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 91 ILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEECCCCCCCCCHHCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEEECCCCCCCCEEECCHHH
T ss_conf 9986778643100103----56421557899999999998766625---4221133301279825898666469643344
Q ss_pred CCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCC
Q ss_conf 61234899720001125776569532224877865753205899999881997766343366312288998875303883
Q 002509 736 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 815 (914)
Q Consensus 736 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 815 (914)
|+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... ...... ..+..
T Consensus 164 a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~----~~~~~i----~~~~~ 233 (293)
T d1jksa_ 164 AHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----ETLANV----SAVNY 233 (293)
T ss_dssp CEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH----HTTCC
T ss_pred HHHCCCCC--CCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHH----HHHHHH----HHCCC
T ss_conf 21057776--312247777430999981899997665221409999997088998899999----999999----81688
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 31127766781078999999999988249999999979999999
Q 002509 816 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 816 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~ 859 (914)
.............+.+++.+|++.+|++|||++|++++
T Consensus 234 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 234 ------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp ------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------CCCCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ------88701047889999999999863896689199999619
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.07 Aligned_cols=262 Identities=27% Similarity=0.393 Sum_probs=204.2
Q ss_pred HHHHHHCCCCCCCCEEEEEEEEC------CCCEEEEEEEECCC-CCCCHHHHHHHHHHHHC-CCCCEEEEEEEEEEC-CC
Q ss_conf 99987411152386799999978------99699999970478-43510145899999632-468602798655525-91
Q 002509 586 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE-GR 656 (914)
Q Consensus 586 ~~~~~~~~LG~G~~G~Vy~~~~~------~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~-~~ 656 (914)
..+.+.+.||+|+||.||+|++. +++.||||+++... ....+.+..|...+.++ +|+||+.+++++.+. ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCE
T ss_conf 99798449841678399999986777555783999999860017178999999999988614998499741154047975
Q ss_pred EEEEEEECCCCCHHHHHHCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECC
Q ss_conf 4899995458976777413567------------3222357888999999999999987089997114577877657679
Q 002509 657 SVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 724 (914)
Q Consensus 657 ~~LV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~ 724 (914)
.++||||+++|+|.++++.... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECG
T ss_pred EEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECC
T ss_conf 7999984589929999985366666532220233214689999999999999999988737---9717867731065779
Q ss_pred CCCEEEEECCCCCCCCCCCCC-EEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCC-CCCCCCCCCCCCHHH
Q ss_conf 994999620566123489972-000112577656953222487786575320589999988199-776634336631228
Q 002509 725 HMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ-EAISNEKFGANCRNI 802 (914)
Q Consensus 725 ~~~~kI~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ElltG~-~p~~~~~~~~~~~~l 802 (914)
++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++|. .||...... ..+
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~---~~~ 246 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---EEF 246 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS---HHH
T ss_pred CCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHH---HHH
T ss_conf 98289845752001135665222475166721020368646889966322136789999986889999899989---999
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 8998875303883311277667810789999999999882499999999799999997654757
Q 002509 803 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 866 (914)
Q Consensus 803 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~L~~~~~~ 866 (914)
.... ..+... ......+ .++.+++.+|++.+|++||||.||+++|+++++.
T Consensus 247 ~~~~----~~~~~~-----~~~~~~~----~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 247 CRRL----KEGTRM-----RAPDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HHHH----HHTCCC-----CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHH----HCCCCC-----CCCCCCC----HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 9999----638988-----8886578----9999999997677966791999999999799867
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.91 Aligned_cols=246 Identities=23% Similarity=0.317 Sum_probs=201.7
Q ss_pred HHHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCC---CCCCHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf 987411152386799999978-99699999970478---43510145899999632468602798655525914899995
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 663 (914)
Q Consensus 588 ~~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~e~ 663 (914)
+.+.+.||+|+||.||+++.+ +++.||+|+++... ......+.+|+.++++++||||+++++++.+....++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCEEC
T ss_conf 28988983176849999999899989999998156544979999999999999867999887787640356421110003
Q ss_pred CCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 45897677741356732223578889999999999999870899971145778776576799949996205661234899
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 743 (914)
Q Consensus 664 ~~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~~~~~ 743 (914)
+++|+|.+++.. ...+++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 87 ~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 87 ANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp CTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred CCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEEEECCCCCCCCCCC
T ss_conf 579860555532----56775999999999996521134315---96224647778476589988882056520035678
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 72000112577656953222487786575320589999988199776634336631228899887530388331127766
Q 002509 744 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 823 (914)
Q Consensus 744 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 823 (914)
......+||+.|+|||++.+..++.++||||+||++|||++|+.||...... .+.+.. ..+.. .+
T Consensus 160 -~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~----~~~~~i----~~~~~------~~ 224 (337)
T d1o6la_ 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELI----LMEEI------RF 224 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH----HHCCC------CC
T ss_pred -CCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHH----HHHHHH----HCCCC------CC
T ss_conf -6205510088996666504898883331022306788998789999996999----999998----52899------89
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHH
Q ss_conf 78107899999999998824999999997-----9999999
Q 002509 824 LDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 859 (914)
Q Consensus 824 ~~~~~~~~~~~l~~li~~Cl~~~P~~RPt-----m~eV~~~ 859 (914)
....+. ++.+++.+|++.+|++||+ ++|++++
T Consensus 225 p~~~s~----~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 225 PRTLSP----EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CTTSCH----HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCH----HHHHHHHHHCCCCCHHHCCCCCCCHHHHHCC
T ss_conf 866899----9999998666389344225652349999729
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.03 Aligned_cols=262 Identities=25% Similarity=0.382 Sum_probs=208.7
Q ss_pred HHHHHHHCCCCCCCCEEEEEEEEC------CCCEEEEEEEECCC-CCCCHHHHHHHHHHHHC-CCCCEEEEEEEEEECCC
Q ss_conf 999987411152386799999978------99699999970478-43510145899999632-46860279865552591
Q 002509 585 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGR 656 (914)
Q Consensus 585 ~~~~~~~~~LG~G~~G~Vy~~~~~------~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~ 656 (914)
...+.+.+.||+|+||.||+|++. .++.||||+++... ......+.+|+.++.++ +||||++++|+|.+...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCE
T ss_conf 89969854982068829999998066447788699999987424877999999999998762699988789989831997
Q ss_pred EEEEEEECCCCCHHHHHHCCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEE
Q ss_conf 4899995458976777413567--------------32223578889999999999999870899971145778776576
Q 002509 657 SVLVYEFMHNGTLKEHLYGTLT--------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 722 (914)
Q Consensus 657 ~~LV~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl 722 (914)
.+++|||+++|+|.++++.... ....+++..++.++.|+++||+|||++ +++||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCCC
T ss_conf 899997379987999998535665444445332223345889999999999999999988757---92666241021000
Q ss_pred CCCCCEEEEECCCCCCCCCCCC-CEEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCCH
Q ss_conf 7999499962056612348997-20001125776569532224877865753205899999881-997766343366312
Q 002509 723 DKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCR 800 (914)
Q Consensus 723 ~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~Ellt-G~~p~~~~~~~~~~~ 800 (914)
+.++.+|++|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+| |++++......+
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~--- 255 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--- 255 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH---
T ss_pred CCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHH---
T ss_conf 02575210234010233678861586201359687677886179999740010258999999858998877899899---
Q ss_pred HHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 28899887530388331127766781078999999999988249999999979999999765475
Q 002509 801 NIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 801 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~L~~~~~ 865 (914)
.+.+.+....+ +. .+......+.+++.+|++.+|++||+|.||+++|++.+.
T Consensus 256 ~~~~~i~~~~~---------~~----~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 256 KFYKMIKEGFR---------ML----SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp HHHHHHHHTCC---------CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHCCCC---------CC----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf 99999866898---------89----854365999999999757796579299999999987653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.82 Aligned_cols=255 Identities=27% Similarity=0.421 Sum_probs=204.6
Q ss_pred HHHCCCCCCCCEEEEEEEEC-CCC--EEEEEEEECC-CCCCCHHHHHHHHHHHHC-CCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf 87411152386799999978-996--9999997047-843510145899999632-468602798655525914899995
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGK--EIAVKVLTSN-SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEF 663 (914)
Q Consensus 589 ~~~~~LG~G~~G~Vy~~~~~-~~~--~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~e~ 663 (914)
.+.+.||+|+||.||+|+++ ++. .||||+++.. .....+.|.+|++++.++ +||||++++|+|...+..++|+||
T Consensus 13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey 92 (309)
T d1fvra_ 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 92 (309)
T ss_dssp EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred EEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEEE
T ss_conf 88779820788289999998999699999999782338579999999999998622899883678888418736999980
Q ss_pred CCCCCHHHHHHCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEE
Q ss_conf 45897677741356------------732223578889999999999999870899971145778776576799949996
Q 002509 664 MHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 731 (914)
Q Consensus 664 ~~~gsL~~~l~~~~------------~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~ 731 (914)
+++|+|.++++... .....+++..++.++.|+|.||.|||+. +++||||||+|||++.++.+||+
T Consensus 93 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEEC
T ss_pred CCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCCEEEC
T ss_conf 289869999864035555512310123457899999999999999998766308---95455505204898688763874
Q ss_pred ECCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCC-CCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 205661234899720001125776569532224877865753205899999881997-7663433663122889988753
Q 002509 732 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE-AISNEKFGANCRNIVQWAKLHI 810 (914)
Q Consensus 732 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ElltG~~-p~~~~~~~~~~~~l~~~~~~~~ 810 (914)
|||+++...... ......||..|+|||.+....++.++|||||||++|||++|.. ||..... ..+.+.+.
T Consensus 170 DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~----~~~~~~i~--- 240 (309)
T d1fvra_ 170 DFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----AELYEKLP--- 240 (309)
T ss_dssp CTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHGG---
T ss_pred CCCCCCCCCCCC--CCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCH----HHHHHHHH---
T ss_conf 344322444223--455301377555538752699996221531388999998368999999999----99999998---
Q ss_pred HCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 0388331127766781078999999999988249999999979999999765475
Q 002509 811 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 811 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~L~~~~~ 865 (914)
.+.. +..... ...++.+++.+|++.+|++||+|+||+++|+.+++
T Consensus 241 -~~~~-----~~~~~~----~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 241 -QGYR-----LEKPLN----CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp -GTCC-----CCCCTT----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HCCC-----CCCCCC----CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf -2688-----888766----78999999999767896689499999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.64 Aligned_cols=248 Identities=29% Similarity=0.454 Sum_probs=203.5
Q ss_pred HHHCCCCCCCCEEEEEEEECCCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCCEEEEEEECCCC
Q ss_conf 87411152386799999978996999999704784351014589999963246860279865552-59148999954589
Q 002509 589 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSVLVYEFMHNG 667 (914)
Q Consensus 589 ~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~LV~e~~~~g 667 (914)
.+.+.||+|+||.||+|+++ ++.||||+++.. ...+.+.+|++++++++||||++++|+|.+ .+..++|+||+++|
T Consensus 10 ~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g 86 (262)
T d1byga_ 10 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86 (262)
T ss_dssp EEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred EEEEEEECCCCEEEEEEEEC-CEEEEEEEECCH--HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEECCCCC
T ss_conf 88579820798089999999-909999998857--779999999999986789898549878872389289999636999
Q ss_pred CHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCEE
Q ss_conf 76777413567322235788899999999999998708999711457787765767999499962056612348997200
Q 002509 668 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 747 (914)
Q Consensus 668 sL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~~~~~~~~~ 747 (914)
+|.++++.. ....++|..+++++.|++.||.|||+. +++||||||+|||++.++.+|++|||+++..... .
T Consensus 87 ~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----~ 157 (262)
T d1byga_ 87 SLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----Q 157 (262)
T ss_dssp EHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CHHHHHHHC--CCCCCCHHHHHHHHHHHHHHCCCCCCC---CEECCCCCHHHHEECCCCCEEECCCCCCEECCCC----C
T ss_conf 899998745--788889999999999998523211337---6553666567601468997763245600344787----7
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 01125776569532224877865753205899999881-99776634336631228899887530388331127766781
Q 002509 748 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 826 (914)
Q Consensus 748 ~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 826 (914)
....++..|+|||++.+..++.++||||||+++|||+| |+.|+..... .++..++.. +.. +.....
T Consensus 158 ~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~----~~~~~~i~~----~~~-----~~~~~~ 224 (262)
T d1byga_ 158 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPRVEK----GYK-----MDAPDG 224 (262)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG----GGHHHHHTT----TCC-----CCCCTT
T ss_pred CCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH----HHHHHHHHC----CCC-----CCCCCC
T ss_conf 6556664677817872798885887775799999999789999999999----999999980----899-----999765
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 078999999999988249999999979999999765475
Q 002509 827 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 865 (914)
Q Consensus 827 ~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~L~~~~~ 865 (914)
. ..++.+++.+|++.+|++||||.+++++|+++..
T Consensus 225 ~----~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 225 C----PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp C----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C----CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 7----9999999999756697689399999999999986
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=335.73 Aligned_cols=247 Identities=23% Similarity=0.375 Sum_probs=200.9
Q ss_pred HHHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCC---CCCCHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf 987411152386799999978-99699999970478---43510145899999632468602798655525914899995
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 663 (914)
Q Consensus 588 ~~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~e~ 663 (914)
|.+.+.||+|+||.||+|+.+ +|+.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEEEE
T ss_conf 08888972076808999999899979999998457754889999999999999863696753303568528800567650
Q ss_pred CCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 45897677741356732223578889999999999999870899971145778776576799949996205661234899
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 743 (914)
Q Consensus 664 ~~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~~~~~ 743 (914)
+++|+|...+.. ...+++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 ~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 86 IEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp CCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred CCCCCCCCCCCC----CCCCCCCHHHHHHHHHHHHHHHHCCC---CEECCCCCCHHEEECCCCCEEEECCCCCEEECCC-
T ss_conf 378632234322----22111007999999998765541247---6770556810503868998898317521671245-
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 72000112577656953222487786575320589999988199776634336631228899887530388331127766
Q 002509 744 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 823 (914)
Q Consensus 744 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 823 (914)
....+||+.|+|||++.+..++.++||||+||++|||++|+.||......+ +...+ ..+.. ..
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~~~i----~~~~~------~~ 220 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK----TYEKI----LNAEL------RF 220 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHH----HHCCC------CC
T ss_pred ---CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHH----HHHHH----HCCCC------CC
T ss_conf ---643457634359999838999804304653336899975989999969999----99999----70898------89
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHH--HHHH
Q ss_conf 7810789999999999882499999999-----79999999--7654
Q 002509 824 LDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD--IQDA 863 (914)
Q Consensus 824 ~~~~~~~~~~~l~~li~~Cl~~~P~~RP-----tm~eV~~~--L~~~ 863 (914)
....+ ..+.+++.+|++.+|++|+ ++++++++ ++++
T Consensus 221 p~~~s----~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 221 PPFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp CTTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred CCCCC----HHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCCCCCCCC
T ss_conf 97789----99999999995449976664310219999819351467
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.02 Aligned_cols=260 Identities=25% Similarity=0.432 Sum_probs=209.3
Q ss_pred HHHHHCCCCCCCCEEEEEEEECC--------CCEEEEEEEECCCC-CCCHHHHHHHHHHHHC-CCCCEEEEEEEEEECCC
Q ss_conf 99874111523867999999789--------96999999704784-3510145899999632-46860279865552591
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLKD--------GKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGR 656 (914)
Q Consensus 587 ~~~~~~~LG~G~~G~Vy~~~~~~--------~~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~ 656 (914)
.+.+.+.||+|+||.||+|+... +..||||+++.... ....++.+|...+.++ +||||++++++|.++..
T Consensus 14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~ 93 (299)
T d1fgka_ 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 93 (299)
T ss_dssp GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCCCE
T ss_conf 96970098516782899999857875556675499999988112868899999999999981399969734652201886
Q ss_pred EEEEEEECCCCCHHHHHHCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECC
Q ss_conf 4899995458976777413567------------3222357888999999999999987089997114577877657679
Q 002509 657 SVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 724 (914)
Q Consensus 657 ~~LV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~ 724 (914)
.++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +++||||||+|||++.
T Consensus 94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTE 170 (299)
T ss_dssp CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT
T ss_pred EEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCEEECC
T ss_conf 8999973699909999986067764322233457434679999999999999999876637---9786302210224547
Q ss_pred CCCEEEEECCCCCCCCCCCC-CEEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCCHHH
Q ss_conf 99499962056612348997-20001125776569532224877865753205899999881-99776634336631228
Q 002509 725 HMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNI 802 (914)
Q Consensus 725 ~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~Ellt-G~~p~~~~~~~~~~~~l 802 (914)
++.+||+|||+++....... .......|++.|+|||.+.++.++.++||||||+++|||++ |+.||..... ..+
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~----~~~ 246 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----EEL 246 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----HHH
T ss_pred CCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCH----HHH
T ss_conf 8976762211101135555543146678884663266751798882555477588888740179898999999----999
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 8998875303883311277667810789999999999882499999999799999997654757
Q 002509 803 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 866 (914)
Q Consensus 803 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~L~~~~~~ 866 (914)
.+.+ ..+.... .....+ ..+.+++.+|++.+|++||||.||++.|+++++.
T Consensus 247 ~~~i----~~~~~~~-----~p~~~~----~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 247 FKLL----KEGHRMD-----KPSNCT----NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHHH----HTTCCCC-----CCSSCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHH----HCCCCCC-----CCCCCH----HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 9999----7288889-----874352----9999999997667976793999999999888604
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=332.84 Aligned_cols=243 Identities=23% Similarity=0.308 Sum_probs=199.6
Q ss_pred HHHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCC---CCCCHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf 987411152386799999978-99699999970478---43510145899999632468602798655525914899995
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 663 (914)
Q Consensus 588 ~~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~e~ 663 (914)
+.+.+.||+|+||.||+|+.+ +|+.||||++.... ......+.+|+.+++.++||||+++++++......++|+|+
T Consensus 43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~ 122 (350)
T d1rdqe_ 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCCC
T ss_conf 08988961176808999999899989999998267745889999999999999974877274034444322222322223
Q ss_pred CCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 45897677741356732223578889999999999999870899971145778776576799949996205661234899
Q 002509 664 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 743 (914)
Q Consensus 664 ~~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~~~~~ 743 (914)
+.+|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 123 ~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 123 VAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp CTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred CCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHCCCCCCCCEEEEECEEEEECCCC-
T ss_conf 346622666751----58989999999999999989999859---9861767999936077897886101033322566-
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 72000112577656953222487786575320589999988199776634336631228899887530388331127766
Q 002509 744 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 823 (914)
Q Consensus 744 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 823 (914)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...... .+..... .+.. ..
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~----~~~~~i~----~~~~------~~ 257 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI----QIYEKIV----SGKV------RF 257 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH----HCCC------CC
T ss_pred ---CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHH----HHHHHHH----CCCC------CC
T ss_conf ---64336763567889971799885331145007899997588998995999----9999986----1798------89
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHH
Q ss_conf 7810789999999999882499999999-----79999999
Q 002509 824 LDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 859 (914)
Q Consensus 824 ~~~~~~~~~~~l~~li~~Cl~~~P~~RP-----tm~eV~~~ 859 (914)
....+ ..+.+++.+|++.||++|+ +++|++++
T Consensus 258 p~~~s----~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 258 PSHFS----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CTTCC----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCC----HHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCC
T ss_conf 76689----99999999983409986065534549999719
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.39 Aligned_cols=260 Identities=24% Similarity=0.406 Sum_probs=205.9
Q ss_pred HHHHHCCCCCCCCEEEEEEEEC------CCCEEEEEEEECCC-CCCCHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEE
Q ss_conf 9987411152386799999978------99699999970478-4351014589999963246860279865552591489
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 659 (914)
Q Consensus 587 ~~~~~~~LG~G~~G~Vy~~~~~------~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~L 659 (914)
.+.+.+.||+|+||.||+|.++ +++.||||+++... ......|.+|++++.+++||||++++|+|......++
T Consensus 21 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 100 (308)
T d1p4oa_ 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 100 (308)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred HEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEE
T ss_conf 91883598207881899999878644778968999998701286899999999999997699988412547842881067
Q ss_pred EEEECCCCCHHHHHHCCC------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEEC
Q ss_conf 999545897677741356------73222357888999999999999987089997114577877657679994999620
Q 002509 660 VYEFMHNGTLKEHLYGTL------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 733 (914)
Q Consensus 660 V~e~~~~gsL~~~l~~~~------~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DF 733 (914)
|+||+++|+|.++++... .....+++..+..++.|+|+||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 101 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DF 177 (308)
T d1p4oa_ 101 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF 177 (308)
T ss_dssp EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCT
T ss_pred EEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECEECCCCEEECCCCEEEEEEC
T ss_conf 7760489988999875033211344468879999999999999999987647---9654328677540359964999424
Q ss_pred CCCCCCCCCCCC-EEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCC-CCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 566123489972-000112577656953222487786575320589999988199-776634336631228899887530
Q 002509 734 GLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ-EAISNEKFGANCRNIVQWAKLHIE 811 (914)
Q Consensus 734 Gla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ElltG~-~p~~~~~~~~~~~~l~~~~~~~~~ 811 (914)
|+|+........ ......|++.|+|||.+.+..++.++||||||+++|||+||. .|+..... ..+...+ .
T Consensus 178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~----~~~~~~i----~ 249 (308)
T d1p4oa_ 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----EQVLRFV----M 249 (308)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH----HHHHHHH----H
T ss_pred CCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCH----HHHHHHH----H
T ss_conf 5420235776303134023163237888873699883334443789999999689999999899----9999999----8
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 3883311277667810789999999999882499999999799999997654757
Q 002509 812 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 866 (914)
Q Consensus 812 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~L~~~~~~ 866 (914)
.+..... .... ...+.+++.+|++.+|++||||.+|+++|++.++.
T Consensus 250 ~~~~~~~-----p~~~----~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 250 EGGLLDK-----PDNC----PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp TTCCCCC-----CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HCCCCCC-----CCCC----HHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCCC
T ss_conf 0888888-----6335----39999999997577965893999999997876177
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=331.09 Aligned_cols=247 Identities=25% Similarity=0.320 Sum_probs=193.9
Q ss_pred HHHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCCC---CCCHHHHHH---HHHHHHCCCCCEEEEEEEEEECCCEEEE
Q ss_conf 987411152386799999978-996999999704784---351014589---9999632468602798655525914899
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNE---VTLLSRIHHRNLVQFLGYCQEEGRSVLV 660 (914)
Q Consensus 588 ~~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E---~~~l~~l~HpnIv~l~g~~~~~~~~~LV 660 (914)
|.+.+.||+|+||.||+|+.. +|+.||+|++..... .....+.+| +.+++.++||||+++++++...+..++|
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred CEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEE
T ss_conf 85101884288909999999999979999998458754266799999999999998508998588999999989988999
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 99545897677741356732223578889999999999999870899971145778776576799949996205661234
Q 002509 661 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 740 (914)
Q Consensus 661 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~~ 740 (914)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||+|+...
T Consensus 86 mE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp ECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEECCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCEEECCCEEEECCCCCEEEEEECEEEECC
T ss_conf 991489838999873----25532789999999999999999977---96220444221678588967982201023337
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCC-CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCC
Q ss_conf 899720001125776569532224-8778657532058999998819977663433663122889988753038833112
Q 002509 741 DGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 819 (914)
Q Consensus 741 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 819 (914)
... .....||+.|+|||++.. ..++.++||||+||++|||++|+.||....... ........ ...
T Consensus 159 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~~~~~~~-~~~------ 224 (364)
T d1omwa3 159 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----KHEIDRMT-LTM------ 224 (364)
T ss_dssp SSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC----HHHHHHHS-SSC------
T ss_pred CCC---CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHHC-CCC------
T ss_conf 886---4331134554216876038999844104677899999985999888899899----99999860-468------
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHH
Q ss_conf 776678107899999999998824999999997-----9999999
Q 002509 820 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 859 (914)
Q Consensus 820 d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPt-----m~eV~~~ 859 (914)
........+ .++.+++.+|++.||++||+ ++|++++
T Consensus 225 ~~~~~~~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 225 AVELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp CCCCCSSSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CCCCCCCCC----HHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCC
T ss_conf 887887789----99999999985669888088743579999749
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=328.73 Aligned_cols=247 Identities=21% Similarity=0.252 Sum_probs=193.8
Q ss_pred HCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCCCCCCHHHHHHHHHHHHC-CCCCEEEEEEEEEE----CCCEEEEEEEC
Q ss_conf 411152386799999978-9969999997047843510145899999632-46860279865552----59148999954
Q 002509 591 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE----EGRSVLVYEFM 664 (914)
Q Consensus 591 ~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~----~~~~~LV~e~~ 664 (914)
.+.||+|+||.||+|+.. +++.||||+++. ...+.+|++++.++ +||||+++++++.. ....++|||||
T Consensus 17 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~ 91 (335)
T d2ozaa1 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 91 (335)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred EEEEEECCCEEEEEEEECCCCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEEEEEEECC
T ss_conf 0796545486999999889998999999897-----47799999999986699997829899950346897899999778
Q ss_pred CCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECC---CCCEEEEECCCCCCCCC
Q ss_conf 589767774135673222357888999999999999987089997114577877657679---99499962056612348
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVD 741 (914)
Q Consensus 665 ~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~---~~~~kI~DFGla~~~~~ 741 (914)
++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+|+....
T Consensus 92 ~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~ 166 (335)
T d2ozaa1 92 DGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 166 (335)
T ss_dssp CSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred CCCCHHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCC
T ss_conf 998499999862--787757999999999999999999976---986444100220113555566311354551233368
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 99720001125776569532224877865753205899999881997766343366312288998875303883311277
Q 002509 742 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 821 (914)
Q Consensus 742 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 821 (914)
.. ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.........+.. ....+..
T Consensus 167 ~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~----~i~~~~~------ 234 (335)
T d2ozaa1 167 HN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----RIRMGQY------ 234 (335)
T ss_dssp CC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCSCSS------
T ss_pred CC--CCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHH----HHHCCCC------
T ss_conf 88--64322677563792777489888888887645167788658899889887788999999----9853888------
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 66781078999999999988249999999979999999
Q 002509 822 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 822 ~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~ 859 (914)
............++.+++.+|++.+|++|||+.|++++
T Consensus 235 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 88985434699999999999756996579099999709
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=333.32 Aligned_cols=249 Identities=18% Similarity=0.309 Sum_probs=200.4
Q ss_pred HHHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEECCC
Q ss_conf 987411152386799999978-9969999997047843510145899999632468602798655525914899995458
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 588 ~~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~e~~~~ 666 (914)
|.+.+.||+|+||+||+|..+ +++.||+|+++... .....+.+|+++|.+++||||+++++++.+.+..++||||+++
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~g 85 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECCCC
T ss_conf 588789831778399999998999699999975786-6599999999999857997989098999889988999953899
Q ss_pred CCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCC--CCEEEEECCCCCCCCCCCC
Q ss_conf 97677741356732223578889999999999999870899971145778776576799--9499962056612348997
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH--MRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 667 gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~--~~~kI~DFGla~~~~~~~~ 744 (914)
|+|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+|||++.+ ..+||+|||+++.....
T Consensus 86 g~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-- 157 (321)
T d1tkia_ 86 LDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-- 157 (321)
T ss_dssp CBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred CCHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCC--
T ss_conf 8088998753---89999999999999999999999876---997513554443443788518997644111003467--
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 20001125776569532224877865753205899999881997766343366312288998875303883311277667
Q 002509 745 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 824 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 824 (914)
.......|++.|+|||...+..++.++||||+||++|||++|+.||...... .+..... . +... .+....
T Consensus 158 ~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~----~~~~~i~---~-~~~~--~~~~~~ 227 (321)
T d1tkia_ 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ----QIIENIM---N-AEYT--FDEEAF 227 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHH---H-TCCC--CCHHHH
T ss_pred CCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHH----HHHHHHH---H-CCCC--CCHHHC
T ss_conf 7532122332223402104877784011302799999998289999998999----9999998---3-8999--880223
Q ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 81078999999999988249999999979999999
Q 002509 825 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 825 ~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~ 859 (914)
...+ .++.+++.+|+..||++|||+.|++++
T Consensus 228 ~~~s----~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 228 KEIS----IEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp TTSC----HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCC----HHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 6789----999999999866996689099999639
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.90 Aligned_cols=253 Identities=26% Similarity=0.382 Sum_probs=201.2
Q ss_pred HHHHCCCCCCCCEEEEEEEEC--CC--CEEEEEEEECCC---CCCCHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEE
Q ss_conf 987411152386799999978--99--699999970478---43510145899999632468602798655525914899
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK--DG--KEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 660 (914)
Q Consensus 588 ~~~~~~LG~G~~G~Vy~~~~~--~~--~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV 660 (914)
+.+.+.||+|+||.||+|++. ++ ..||||+++... ....+.|.+|+.++.+++||||++++|+|.+ ...++|
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred EEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCHHEE
T ss_conf 1997898038883999999988999079999999983555798999999999999986899998789877740-100114
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 99545897677741356732223578889999999999999870899971145778776576799949996205661234
Q 002509 661 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 740 (914)
Q Consensus 661 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~~ 740 (914)
+||+++|++.+.+... ...+++..++.++.|+|.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEECCCCHHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECHHHHCCCCCCCEEECCCHHHHHCC
T ss_conf 6542386125444212---68999999999999999999875217---87520566888156556543325611555303
Q ss_pred CCCCC--EEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCC
Q ss_conf 89972--0001125776569532224877865753205899999881-99776634336631228899887530388331
Q 002509 741 DGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQG 817 (914)
Q Consensus 741 ~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~Ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 817 (914)
..... ......|+..|+|||++.+..++.++||||||+++|||+| |+.||...... .+..++ .+.+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~----~~~~~i---~~~~~~~- 234 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS----QILHKI---DKEGERL- 234 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHH---HTSCCCC-
T ss_pred CCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHH----HHHHHH---HHCCCCC-
T ss_conf 58875265476325731079999837999942156614899999996899999996999----999999---8479999-
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 1277667810789999999999882499999999799999997654
Q 002509 818 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 863 (914)
Q Consensus 818 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~L~~~ 863 (914)
......+ ..+.+++.+|++.+|++||||.||.+.|+++
T Consensus 235 ----~~~~~~~----~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 ----PRPEDCP----QDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ----CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCC----HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf ----9854453----9999999997688966792999999999964
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=326.92 Aligned_cols=259 Identities=22% Similarity=0.229 Sum_probs=195.7
Q ss_pred CCCCCCCCEEEEEEEEC-CCCEEEEEEEECCCCC-----CCHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEECC
Q ss_conf 11152386799999978-9969999997047843-----51014589999963246860279865552591489999545
Q 002509 592 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-----GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 592 ~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~e~~~ 665 (914)
+.||+|+||+||+|+.+ +++.||||+++..... ..+.+.+|+.++++++||||+++++++...+..++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred EEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHHHC
T ss_conf 38512728299999999999699999984202124567999999999999986799998689854225874022045534
Q ss_pred CCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 89767774135673222357888999999999999987089997114577877657679994999620566123489972
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~~~~~~~ 745 (914)
++++..... ....+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||+|+.......
T Consensus 84 ~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 84 TDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp EEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred CHHHHHHHH----CCCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCC-
T ss_conf 507765541----266778999999999999999886316---355035776258853778411465761000578755-
Q ss_pred EEECCCCCCCCCCCCCCCCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCC----
Q ss_conf 00011257765695322248-7786575320589999988199776634336631228899887530388331127----
Q 002509 746 VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID---- 820 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d---- 820 (914)
......||+.|+|||++... .++.++||||+||++|||++|+.||......+....+.+.......+ .......
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~-~~~~~~~~~~~ 234 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE-QWPDMCSLPDY 234 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT-TSSSTTSSTTC
T ss_pred CCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHH-HCCCHHCCCHH
T ss_conf 43302047333639997267788805643630428999985969999999999999999851899725-45210002134
Q ss_pred --CCCCCCCCHH-----HHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf --7667810789-----99999999988249999999979999999
Q 002509 821 --PSLLDEYDIQ-----SMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 821 --~~l~~~~~~~-----~~~~l~~li~~Cl~~~P~~RPtm~eV~~~ 859 (914)
.......+.. ....+.+++.+|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 4303478988678565689999999999763894569089999679
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=330.71 Aligned_cols=256 Identities=24% Similarity=0.370 Sum_probs=203.7
Q ss_pred HHHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCCCC---CCHHHHHHHHHHHHCCCCCEEEEEEEEEECCC----EEE
Q ss_conf 987411152386799999978-9969999997047843---51014589999963246860279865552591----489
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR----SVL 659 (914)
Q Consensus 588 ~~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~----~~L 659 (914)
|.+.+.||+|+||.||+|+.. +++.||+|+++..... ....+.+|++++++++||||+++++++..... .++
T Consensus 9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l 88 (277)
T d1o6ya_ 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred EEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCEEEE
T ss_conf 69868996089929999999999989999998556646989999999999999856999887311435432688766999
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 99954589767774135673222357888999999999999987089997114577877657679994999620566123
Q 002509 660 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 739 (914)
Q Consensus 660 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~ 739 (914)
||||+++|+|.+.+.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++..+++|||.++..
T Consensus 89 vmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 89 VMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEECCCCCEEHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCEEEHHHHHHHH
T ss_conf 9977889871011203----58999999999999999999999857---9527634675566575432010034443221
Q ss_pred CCCC--CCEEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCC
Q ss_conf 4899--72000112577656953222487786575320589999988199776634336631228899887530388331
Q 002509 740 VDGA--SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 817 (914)
Q Consensus 740 ~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 817 (914)
.... ........||+.|+|||++.+..++.++||||+||++|||++|+.||......+ + .......+....
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----~---~~~~~~~~~~~~ 234 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS----V---AYQHVREDPIPP 234 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----H---HHHHHHCCCCCG
T ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHH----H---HHHHHHCCCCCC
T ss_conf 235443333464257624369999839999966320265289999976979989969999----9---999984699997
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHHHHH
Q ss_conf 1277667810789999999999882499999999-7999999976547
Q 002509 818 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-SISEVLKDIQDAI 864 (914)
Q Consensus 818 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RP-tm~eV~~~L~~~~ 864 (914)
.......+ .++.+++.+|++.||++|| +++++.+.|.++.
T Consensus 235 ---~~~~~~~s----~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 235 ---SARHEGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ---GGTSSSCC----HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---CHHCCCCC----HHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHH
T ss_conf ---10034789----999999999866797677739999999999975
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.49 Aligned_cols=246 Identities=24% Similarity=0.390 Sum_probs=197.3
Q ss_pred HHHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCC---CCCCHHHHHHHHHHH-HCCCCCEEEEEEEEEECCCEEEEEE
Q ss_conf 987411152386799999978-99699999970478---435101458999996-3246860279865552591489999
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLS-RIHHRNLVQFLGYCQEEGRSVLVYE 662 (914)
Q Consensus 588 ~~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~-~l~HpnIv~l~g~~~~~~~~~LV~e 662 (914)
|.+.+.||+|+||+||+|+.+ +++.||||+++... ......+..|..++. .++||||+++++++.+++..++|||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred EEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEEEE
T ss_conf 18865894087828999999999989999998055533848999999999999984799968789889704983167775
Q ss_pred ECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 54589767774135673222357888999999999999987089997114577877657679994999620566123489
Q 002509 663 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 742 (914)
Q Consensus 663 ~~~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~~~~ 742 (914)
|+++|+|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++.....
T Consensus 84 y~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 84 YLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred ECCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCEEECCCCCEECCCCCHHHHCCCC
T ss_conf 0379808998640----47899999999999999999999868---9340347654044448996301555302323566
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 97200011257765695322248778657532058999998819977663433663122889988753038833112776
Q 002509 743 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 822 (914)
Q Consensus 743 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 822 (914)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... .+.... ..+. +.
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~----~~~~~i----~~~~------~~ 221 (320)
T d1xjda_ 157 D-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE----ELFHSI----RMDN------PF 221 (320)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH----HHCC------CC
T ss_pred C-CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHH----HCCC------CC
T ss_conf 5-3345457877768999982799883232011227898987388999998999----999999----7189------98
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHH-HHHHH
Q ss_conf 67810789999999999882499999999799-99999
Q 002509 823 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSIS-EVLKD 859 (914)
Q Consensus 823 l~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~-eV~~~ 859 (914)
.....+ .++.+++.+|++.+|++||++. |++++
T Consensus 222 ~p~~~s----~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 222 YPRWLE----KEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp CCTTSC----HHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred CCCCCC----HHHHHHHHHHCCCCCCCCCCHHHHHHHC
T ss_conf 975679----9999999996544898783889999809
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=326.99 Aligned_cols=249 Identities=27% Similarity=0.338 Sum_probs=198.9
Q ss_pred HHHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCCCCC---------CHHHHHHHHHHHHCC-CCCEEEEEEEEEECCC
Q ss_conf 987411152386799999978-99699999970478435---------101458999996324-6860279865552591
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG---------KREFTNEVTLLSRIH-HRNLVQFLGYCQEEGR 656 (914)
Q Consensus 588 ~~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~~~~---------~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~ 656 (914)
|.+.+.||+|+||+||+++.. +++.+|||+++...... ...+.+|+.++.+++ ||||+++++++.+.+.
T Consensus 5 y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 84 (277)
T d1phka_ 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 84 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCC
T ss_conf 88852884176849999999999989999999624464114788899999999999999985079974799762146760
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCC
Q ss_conf 48999954589767774135673222357888999999999999987089997114577877657679994999620566
Q 002509 657 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 736 (914)
Q Consensus 657 ~~LV~e~~~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla 736 (914)
.++||||+++|+|.+++.. ...+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 85 ~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 85 FFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEECCCCCHHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCHHE
T ss_conf 5999976898668999986----59999999999999999999999875---9943234625489868998387124031
Q ss_pred CCCCCCCCCEEECCCCCCCCCCCCCCCC------CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 1234899720001125776569532224------8778657532058999998819977663433663122889988753
Q 002509 737 KFAVDGASHVSSIVRGTVGYLDPEYYIS------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 810 (914)
Q Consensus 737 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~ 810 (914)
+...... ......||..|+|||.+.+ ..++.++||||+||+++||++|+.||...... .+.+..
T Consensus 158 ~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~----~~~~~i---- 227 (277)
T d1phka_ 158 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM----LMLRMI---- 227 (277)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH----
T ss_pred EECCCCC--CEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHH----HHHHHH----
T ss_conf 6726887--213452467888988860534456788992331856560231032288898899999----999999----
Q ss_pred HCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 0388331127766781078999999999988249999999979999999
Q 002509 811 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 811 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~ 859 (914)
..+... .........+ .++.+++.+|++.+|++||++.||+++
T Consensus 228 ~~~~~~--~~~~~~~~~s----~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 228 MSGNYQ--FGSPEWDDYS----DTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHTCCC--CCTTTGGGSC----HHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHCCCC--CCCCCCCCCC----HHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 818988--8985434689----999999999765896689199999739
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.42 Aligned_cols=263 Identities=22% Similarity=0.290 Sum_probs=196.3
Q ss_pred HHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCC--CCCCHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEECC
Q ss_conf 87411152386799999978-99699999970478--4351014589999963246860279865552591489999545
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 589 ~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~e~~~ 665 (914)
.+.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|++++++++||||+++++++.+.+..++||||+.
T Consensus 5 ~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~ 84 (298)
T d1gz8a_ 5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH 84 (298)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEEECC
T ss_conf 76517723768099999999999799999980222575899999999999986799838874453322432037886237
Q ss_pred CCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 89767774135673222357888999999999999987089997114577877657679994999620566123489972
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 745 (914)
Q Consensus 666 ~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~~~~~~~ 745 (914)
++ +.+.+... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+...... .
T Consensus 85 ~~-~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~ 157 (298)
T d1gz8a_ 85 QD-LKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R 157 (298)
T ss_dssp EE-HHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-B
T ss_pred CC-HHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCHHEEECCCCCCEECCCCCCEECCCCC-C
T ss_conf 74-45554420--256888899999999999999986528---89921357114011346762103578613436886-4
Q ss_pred EEECCCCCCCCCCCCCCCCCC-CCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCC-CCCC
Q ss_conf 000112577656953222487-78657532058999998819977663433663122889988753038833112-7766
Q 002509 746 VSSIVRGTVGYLDPEYYISQQ-LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII-DPSL 823 (914)
Q Consensus 746 ~~~~~~gt~~Y~aPE~~~~~~-~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-d~~l 823 (914)
......||+.|+|||...... .+.++||||+||++|||++|+.||......+....+...... ..+....... .+..
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT-PDEVVWPGVTSMPDY 236 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CCTTTSTTGGGSTTC
T ss_pred CCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCC-CCHHHCCCCCCCCCC
T ss_conf 1001036521541122136657774221033331342796687998988999999999983289-833314442224212
Q ss_pred C------CCCC-----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 7------8107-----8999999999988249999999979999999
Q 002509 824 L------DEYD-----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 824 ~------~~~~-----~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~ 859 (914)
. ...+ ......+.+++.+|++.+|++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 43454322220444166789999999999763995579189999678
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=320.59 Aligned_cols=264 Identities=21% Similarity=0.261 Sum_probs=193.9
Q ss_pred HHHHCCCCCCCCEEEEEEEEC-C-CCEEEEEEEECCC--CCCCHHHHHHHHHHHHC---CCCCEEEEEEEEEE-----CC
Q ss_conf 987411152386799999978-9-9699999970478--43510145899999632---46860279865552-----59
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-D-GKEIAVKVLTSNS--YQGKREFTNEVTLLSRI---HHRNLVQFLGYCQE-----EG 655 (914)
Q Consensus 588 ~~~~~~LG~G~~G~Vy~~~~~-~-~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l---~HpnIv~l~g~~~~-----~~ 655 (914)
|.+.+.||+|+||+||+|+.. + ++.||||+++... ......+.+|+.+++.+ +||||+++++++.. ..
T Consensus 9 Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~ 88 (305)
T d1blxa_ 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 88 (305)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred EEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 79888992155869999999888998999999802324516799999999999987425898802366322146666674
Q ss_pred CEEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCC
Q ss_conf 14899995458976777413567322235788899999999999998708999711457787765767999499962056
Q 002509 656 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 735 (914)
Q Consensus 656 ~~~LV~e~~~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGl 735 (914)
..++++|++.++.+...... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 89 ~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 89 KLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp EEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred EEEEEEEECCCCCHHHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEECCCCCEEECCHHH
T ss_conf 69999974058714444430---378999899999999999999999758---898357986278985899754210001
Q ss_pred CCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCC-
Q ss_conf 6123489972000112577656953222487786575320589999988199776634336631228899887530388-
Q 002509 736 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD- 814 (914)
Q Consensus 736 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~- 814 (914)
++.... ........||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+.+..........
T Consensus 163 ~~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 163 ARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred HHHHCC--CCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHCCC
T ss_conf 011002--345777654851148310017988811100032899999987879989989899999999840799611053
Q ss_pred ----CCCCCCCCC----CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf ----331127766----781078999999999988249999999979999999
Q 002509 815 ----IQGIIDPSL----LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 815 ----~~~~~d~~l----~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~ 859 (914)
......... ...........+.+++.+|++.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 21111033302234564544044589999999999874896679189999669
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=319.56 Aligned_cols=262 Identities=21% Similarity=0.283 Sum_probs=198.6
Q ss_pred HHHCCCCCCCCEEEEEEEECCCCEEEEEEEECCCC--CCCHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEECCC
Q ss_conf 87411152386799999978996999999704784--3510145899999632468602798655525914899995458
Q 002509 589 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 666 (914)
Q Consensus 589 ~~~~~LG~G~~G~Vy~~~~~~~~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~e~~~~ 666 (914)
.+.+.||+|+||+||+|+.++++.||||+++.... .....+.+|+.++++++||||+++++++...+..++++|++.+
T Consensus 5 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~ 84 (286)
T d1ob3a_ 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ 84 (286)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred EECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEEEHH
T ss_conf 34318722778189999968999999999812326858999999999999867998687660120467731589974004
Q ss_pred CCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCE
Q ss_conf 97677741356732223578889999999999999870899971145778776576799949996205661234899720
Q 002509 667 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 746 (914)
Q Consensus 667 gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~~~~~~~~ 746 (914)
+.+..... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++|||.+....... ..
T Consensus 85 ~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~ 156 (286)
T d1ob3a_ 85 DLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RK 156 (286)
T ss_dssp EHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred HHHHHHHH----HCCCCCHHHHHHHHHHHHHHHHHHCCC---CEEECCCCCCEEEECCCCCEEECCCCCCEECCCCC-CC
T ss_conf 56789986----047751445689999999999986057---48826787750568689978732366430114676-54
Q ss_pred EECCCCCCCCCCCCCCCC-CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCC-----CC
Q ss_conf 001125776569532224-877865753205899999881997766343366312288998875303883311-----27
Q 002509 747 SSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI-----ID 820 (914)
Q Consensus 747 ~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-----~d 820 (914)
.....|++.|+|||.+.. ..++.++||||+||+++||++|+.||......+....+...... ......... .+
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT-PNSKNWPNVTELPKYD 235 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CCTTTSTTGGGSTTCC
T ss_pred CCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCC-CCHHHCCCHHHHHHCC
T ss_conf 101024311013788717888884100211175899997797998988989999999986389-9711042123332214
Q ss_pred CCC-------CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 766-------781078999999999988249999999979999999
Q 002509 821 PSL-------LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 821 ~~l-------~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~ 859 (914)
... ...........+.+++.+|++.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 3333356764666512589999999999866896689099998569
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=316.26 Aligned_cols=265 Identities=23% Similarity=0.262 Sum_probs=191.6
Q ss_pred HHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCEEEEEEEEEECC------CEEEEE
Q ss_conf 87411152386799999978-99699999970478435101458999996324686027986555259------148999
Q 002509 589 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RSVLVY 661 (914)
Q Consensus 589 ~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~------~~~LV~ 661 (914)
...++||+|+||+||+|+.. +++.||||++... .....+|++++++++|+||+++++++.... ..++||
T Consensus 23 ~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred EEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC----CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEEEE
T ss_conf 7516982176839999999999979999998816----068999999998668989873878997447657731899998
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCC-CEEEEECCCCCCCC
Q ss_conf 95458976777413567322235788899999999999998708999711457787765767999-49996205661234
Q 002509 662 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAV 740 (914)
Q Consensus 662 e~~~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~-~~kI~DFGla~~~~ 740 (914)
||++++.+....+ .......+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++...
T Consensus 99 Ey~~~~~~~~l~~-~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 99 DYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp ECCSEEHHHHHHH-HHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred ECCCCCCHHHHHH-HHHCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEEECCCCCEEEECCCCHHHCC
T ss_conf 4168860788886-310368999999999999999999999866---876457886037873589711673366054404
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCC-CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHH--------HHHHH-
Q ss_conf 899720001125776569532224-87786575320589999988199776634336631228899--------88753-
Q 002509 741 DGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW--------AKLHI- 810 (914)
Q Consensus 741 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~--------~~~~~- 810 (914)
... ......|+..|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+... .....
T Consensus 175 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 252 (350)
T d1q5ka_ 175 RGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252 (350)
T ss_dssp TTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred CCC--CCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHHHHHCC
T ss_conf 776--532002555556827764046888210002465277855028799898799999999999748981776543062
Q ss_pred --HCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHH
Q ss_conf --0388331127766781078999999999988249999999979999999--7654
Q 002509 811 --ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQDA 863 (914)
Q Consensus 811 --~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~--L~~~ 863 (914)
........................+.+++.+|++.||++|||+.|++++ ++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred CHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 101103554456744443156899999999999765895579299999669845246
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=315.94 Aligned_cols=243 Identities=22% Similarity=0.381 Sum_probs=194.5
Q ss_pred HHHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCCC------CCCHHHHHHHHHHHHCC--CCCEEEEEEEEEECCCEE
Q ss_conf 987411152386799999978-996999999704784------35101458999996324--686027986555259148
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY------QGKREFTNEVTLLSRIH--HRNLVQFLGYCQEEGRSV 658 (914)
Q Consensus 588 ~~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~~------~~~~~~~~E~~~l~~l~--HpnIv~l~g~~~~~~~~~ 658 (914)
|.+.+.||+|+||.||+|+.. +++.||||+++.... .....+.+|+.++++++ ||||+++++++.+.+..+
T Consensus 6 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~ 85 (273)
T d1xwsa_ 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 85 (273)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred EEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEEE
T ss_conf 79967984087839999999999979999998568844334556799999999999974358988127999983099689
Q ss_pred EEEEECCC-CCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCC-CCEEEEECCCC
Q ss_conf 99995458-97677741356732223578889999999999999870899971145778776576799-94999620566
Q 002509 659 LVYEFMHN-GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLS 736 (914)
Q Consensus 659 LV~e~~~~-gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~-~~~kI~DFGla 736 (914)
+|+|++.+ +++.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+|
T Consensus 86 lv~e~~~~~~~l~~~~~----~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 86 LILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEECCCCCHHHHHHH----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEEECCCCEEEECCCCCC
T ss_conf 99983368622899986----158999999999999999999999877---97556676111477447884897754653
Q ss_pred CCCCCCCCCEEECCCCCCCCCCCCCCCCCCC-CCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCC
Q ss_conf 1234899720001125776569532224877-865753205899999881997766343366312288998875303883
Q 002509 737 KFAVDGASHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 815 (914)
Q Consensus 737 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 815 (914)
+..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... .+.. +..
T Consensus 159 ~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~--------~~~ 221 (273)
T d1xwsa_ 159 ALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR--------GQV 221 (273)
T ss_dssp EECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH--------CCC
T ss_pred EECCCC---CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH------HHHH--------CCC
T ss_conf 532444---55665658774799998489978865332554034536756889988736------7761--------544
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHHH
Q ss_conf 31127766781078999999999988249999999979999999--76547
Q 002509 816 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQDAI 864 (914)
Q Consensus 816 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~--L~~~~ 864 (914)
......+ .++.+++.+|++.+|++|||++|++++ ++++.
T Consensus 222 ------~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 222 ------FFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp ------CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ------CCCCCCC----HHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf ------7787799----9999999997608975893999985398667887
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=310.74 Aligned_cols=261 Identities=21% Similarity=0.270 Sum_probs=194.7
Q ss_pred HHHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCCC--CCCHHHHHHHHHHHHCCCCCEEEEEEEEEECC------CEE
Q ss_conf 987411152386799999978-996999999704784--35101458999996324686027986555259------148
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RSV 658 (914)
Q Consensus 588 ~~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~------~~~ 658 (914)
|.+.+.||+|+||+||+|... +++.||||+++.... ...+.+.+|+++|++++||||+++++++...+ ..+
T Consensus 20 Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 99 (346)
T d1cm8a_ 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 99 (346)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCCEEE
T ss_conf 89988980177819999999999989999998522259699999999999998668987547999863576555541599
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 99995458976777413567322235788899999999999998708999711457787765767999499962056612
Q 002509 659 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 738 (914)
Q Consensus 659 LV~e~~~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~ 738 (914)
+||||+ +.+|..... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||+|+.
T Consensus 100 lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 100 LVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp EEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEECC-CCCHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCHHHCCCCCCCCCCCCCCEEC
T ss_conf 998405-521899987-----40226999999999999999998737---876456685111121001221134310220
Q ss_pred CCCCCCCEEECCCCCCCCCCCCCCCCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHH--------
Q ss_conf 348997200011257765695322248-77865753205899999881997766343366312288998875--------
Q 002509 739 AVDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH-------- 809 (914)
Q Consensus 739 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~-------- 809 (914)
.... .....||+.|+|||++.+. .++.++||||+||+++||++|+.||...........+.......
T Consensus 171 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 171 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred CCCC----CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHHHHH
T ss_conf 6876----310245533358899817878996501030038999999786998889768999999850378848888653
Q ss_pred ---------HHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHHHH
Q ss_conf ---------30388331127766781078999999999988249999999979999999--765475
Q 002509 810 ---------IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQDAIV 865 (914)
Q Consensus 810 ---------~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~--L~~~~~ 865 (914)
..........-..+....+ ..+.+++.+|++.||++|||+.|++++ ++.+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s----~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDFASILTNAS----PLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCC----HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred CCHHHHHHHCCCCCCCCCCHHHHCCCCC----HHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf 0003443311578666556677556899----99999999977299557929999963962375877
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=309.05 Aligned_cols=264 Identities=18% Similarity=0.231 Sum_probs=195.1
Q ss_pred HHHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECC--CCCCCHHHHHHHHHHHHCCCCCEEEEEEEEEE--------CCC
Q ss_conf 987411152386799999978-9969999997047--84351014589999963246860279865552--------591
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--------EGR 656 (914)
Q Consensus 588 ~~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--------~~~ 656 (914)
|.+.+.||+|+||+||+|+.. +++.||||++... .......+.+|++++++++|||++++++.+.. ...
T Consensus 12 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~ 91 (318)
T d3blha1 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS 91 (318)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------C
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCCCCE
T ss_conf 88999972274829999999899979999998422246378999999999999835999660676540246544445763
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCC
Q ss_conf 48999954589767774135673222357888999999999999987089997114577877657679994999620566
Q 002509 657 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 736 (914)
Q Consensus 657 ~~LV~e~~~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla 736 (914)
.++++|++.++.+..... ....++......++.|++.||.|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 92 ~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 92 IYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp EEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEECCCCCCCCHHHH----CCCCCCCHHHHHHHHHHHHHHHHHCCC---CEEECCCCCHHEEECCCCCEEEEECCEE
T ss_conf 899985357874101222----034433089999999999999885229---9885676722203668996876313500
Q ss_pred CCCCCCC---CCEEECCCCCCCCCCCCCCCCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 1234899---7200011257765695322248-77865753205899999881997766343366312288998875303
Q 002509 737 KFAVDGA---SHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES 812 (914)
Q Consensus 737 ~~~~~~~---~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 812 (914)
+...... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.........+.+..... ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~-~~ 243 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI-TP 243 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC-CT
T ss_pred EECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHCCCC-CH
T ss_conf 22355444321135660249787428997079998917870067864661744879989989999999999841899-82
Q ss_pred CCCCCCCCC--------CCCCCCCHHH-------HHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 883311277--------6678107899-------9999999988249999999979999999
Q 002509 813 GDIQGIIDP--------SLLDEYDIQS-------MWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 813 ~~~~~~~d~--------~l~~~~~~~~-------~~~l~~li~~Cl~~~P~~RPtm~eV~~~ 859 (914)
......... .......... ...+.+++.+|++.||++|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 55344320344433201334455503340444599899999999873896589099999749
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=308.49 Aligned_cols=260 Identities=21% Similarity=0.283 Sum_probs=198.7
Q ss_pred HHHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCEEEE-EEEEEECCCEEEEEEECC
Q ss_conf 987411152386799999978-996999999704784351014589999963246860279-865552591489999545
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQF-LGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 588 ~~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l-~g~~~~~~~~~LV~e~~~ 665 (914)
|.+.+.||+|+||.||+|+.. +++.||||++.... ....+..|+++++.++|++++.. .++.......++|||++
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~- 85 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 85 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHC--CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEEEC-
T ss_conf 999689850788099999998899899999972100--58889999999997038996017999995198778999873-
Q ss_pred CCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECC---CCCEEEEECCCCCCCCCC
Q ss_conf 89767774135673222357888999999999999987089997114577877657679---994999620566123489
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVDG 742 (914)
Q Consensus 666 ~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~---~~~~kI~DFGla~~~~~~ 742 (914)
++++.+.+.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++. +..+|++|||+|+.....
T Consensus 86 ~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 86 GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred CCCHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCCC
T ss_conf 8713332443---068876899999999999999999979---9442667876606433577761565046751342554
Q ss_pred CCC------EEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCC
Q ss_conf 972------00011257765695322248778657532058999998819977663433663122889988753038833
Q 002509 743 ASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 816 (914)
Q Consensus 743 ~~~------~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 816 (914)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+..+........ .
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~-~- 237 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-I- 237 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC-H-
T ss_pred CCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCC-H-
T ss_conf 45541000135776787353299999189989832188617789999849876655305779999998523567898-3-
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 11277667810789999999999882499999999799999997654757
Q 002509 817 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 866 (914)
Q Consensus 817 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~L~~~~~~ 866 (914)
+.+...++ .++.+++..|++.+|++||++.++.+.|+.+...
T Consensus 238 ----~~~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 238 ----EVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp ----HHHTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ----HHHCCCCC----HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf ----57534788----9999999998439955791999999999999997
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=310.79 Aligned_cols=259 Identities=20% Similarity=0.286 Sum_probs=192.4
Q ss_pred HHHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCC-CCCCHHHHHHHHHHHHCCCCCEEEEEEEEEECC----CEEEEE
Q ss_conf 987411152386799999978-99699999970478-435101458999996324686027986555259----148999
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG----RSVLVY 661 (914)
Q Consensus 588 ~~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~----~~~LV~ 661 (914)
|.+.+.||+|+||+||+|+.+ +++.||||+++... ....+.+.+|+++|++++|||++++++++.... ..++++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred EEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 59978994064809999999999949999998031095899999999999997689898858889950564554149999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 95458976777413567322235788899999999999998708999711457787765767999499962056612348
Q 002509 662 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 741 (914)
Q Consensus 662 e~~~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~~~ 741 (914)
+++.+|+|.+++. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~~~~~g~L~~~l~-----~~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 90 THLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EECCCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEECCCCHHHHHH-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCEEECCC
T ss_conf 9625986566440-----58999999999999999999999978---986777876437887999778754570565047
Q ss_pred CCC--CEEECCCCCCCCCCCCCCCC-CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCC-
Q ss_conf 997--20001125776569532224-87786575320589999988199776634336631228899887530388331-
Q 002509 742 GAS--HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG- 817 (914)
Q Consensus 742 ~~~--~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~- 817 (914)
... .......||+.|+|||++.. ..++.++||||+||+++||++|+.||......+....... .........
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~----~~~~~~~~~~ 237 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG----ILGSPSQEDL 237 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH----HHCSCCHHHH
T ss_pred CCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHH----HCCCCCHHHH
T ss_conf 776410101102652000387860478887410100467013377669799788888999998765----2069975664
Q ss_pred -----------C-CCCCCCCCCCHH-----HHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf -----------1-277667810789-----99999999988249999999979999999
Q 002509 818 -----------I-IDPSLLDEYDIQ-----SMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 818 -----------~-~d~~l~~~~~~~-----~~~~l~~li~~Cl~~~P~~RPtm~eV~~~ 859 (914)
. ..+. ....+.. .-.++.+++.+|++.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPH-KNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HTCCCHHHHHHHHTSCC-CCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHCCCCCCCC-CCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 23433222202446775-57787778378999999999999764895679089998619
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=309.46 Aligned_cols=254 Identities=24% Similarity=0.313 Sum_probs=202.0
Q ss_pred HHHHCCCCCCCCEEEEEEEEC----CCCEEEEEEEECCC----CCCCHHHHHHHHHHHHCCC-CCEEEEEEEEEECCCEE
Q ss_conf 987411152386799999978----99699999970478----4351014589999963246-86027986555259148
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS----YQGKREFTNEVTLLSRIHH-RNLVQFLGYCQEEGRSV 658 (914)
Q Consensus 588 ~~~~~~LG~G~~G~Vy~~~~~----~~~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l~H-pnIv~l~g~~~~~~~~~ 658 (914)
|.+.+.||+|+||+||+|+.. +|+.||+|+++... ....+.+.+|++++.+++| |||+++++++......+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCEE
T ss_conf 59998983287839999998765887948999998367721016899999999999986467983999620002487300
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 99995458976777413567322235788899999999999998708999711457787765767999499962056612
Q 002509 659 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 738 (914)
Q Consensus 659 LV~e~~~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~ 738 (914)
+++||+.+|+|.+.+.. ...+.......++.|++.||+|+|+. +++||||||+|||++.++.+||+|||+++.
T Consensus 106 ~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred EEEECCCCCHHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCCCCEEECCCCCEEEEECCCHHH
T ss_conf 12312341179999873----04543788888899999999885149---989654773201246999888741320222
Q ss_pred CCCCCCCEEECCCCCCCCCCCCCCCCC--CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCC
Q ss_conf 348997200011257765695322248--778657532058999998819977663433663122889988753038833
Q 002509 739 AVDGASHVSSIVRGTVGYLDPEYYISQ--QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 816 (914)
Q Consensus 739 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 816 (914)
.............|++.|++||.+.+. .++.++||||+||+||||++|+.||...........+.......
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~------- 251 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS------- 251 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-------
T ss_pred HCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCC-------
T ss_conf 0344443221222333331068760577688713251777799999976899988887777999999833568-------
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHH--HHH
Q ss_conf 11277667810789999999999882499999999-----79999999--765
Q 002509 817 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD--IQD 862 (914)
Q Consensus 817 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RP-----tm~eV~~~--L~~ 862 (914)
.+...... ..++.+++.+|++.+|++|| +++|++++ ++.
T Consensus 252 ---~~~~~~~~----s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 252 ---EPPYPQEM----SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp ---CCCCCTTS----CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred ---CCCCCCCC----CHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCCHHHCC
T ss_conf ---99886547----99999999997445898819997450999974972348
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=304.77 Aligned_cols=261 Identities=16% Similarity=0.241 Sum_probs=203.8
Q ss_pred HHHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCC-CCEEEEEEEEEECCCEEEEEEECC
Q ss_conf 987411152386799999978-996999999704784351014589999963246-860279865552591489999545
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQFLGYCQEEGRSVLVYEFMH 665 (914)
Q Consensus 588 ~~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~g~~~~~~~~~LV~e~~~ 665 (914)
|.+.+.||+|+||.||+|+.. +++.||||+++.. .....+.+|++.+..++| +|++.+++++......++|||++
T Consensus 7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~- 83 (293)
T d1csna_ 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 83 (293)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC--CCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEEC-
T ss_conf 69979984178829999999889979999997502--582999999999999648999877999960188117999964-
Q ss_pred CCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECC-----CCCEEEEECCCCCCCC
Q ss_conf 89767774135673222357888999999999999987089997114577877657679-----9949996205661234
Q 002509 666 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-----HMRAKVSDFGLSKFAV 740 (914)
Q Consensus 666 ~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~-----~~~~kI~DFGla~~~~ 740 (914)
+++|.+.+... ...+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+|+...
T Consensus 84 ~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 84 GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred CCCHHHHHHHH---CCCHHHHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCCEEECCCCCCCCCCEEECCCCEEEECC
T ss_conf 88879999752---03110689999999999999999977---9662667713152347543447956872366057714
Q ss_pred CCCC------CEEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 8997------2000112577656953222487786575320589999988199776634336631228899887530388
Q 002509 741 DGAS------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 814 (914)
Q Consensus 741 ~~~~------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 814 (914)
.... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||................... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~-~~~~ 236 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK-QSTP 236 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH-HHSC
T ss_pred CCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCC-CCCC
T ss_conf 676654111024676277510267989648888869998983199999986987678853021999999997056-7999
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 33112776678107899999999998824999999997999999976547574
Q 002509 815 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 867 (914)
Q Consensus 815 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~L~~~~~~~ 867 (914)
..+ +....+ .++.+++..|+..+|++||+++.+.+.|++++...
T Consensus 237 ~~~-----l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 237 LRE-----LCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp HHH-----HTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHH-----HCCCCC----HHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHC
T ss_conf 589-----657998----99999999984399300859999999999999975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=305.06 Aligned_cols=260 Identities=21% Similarity=0.288 Sum_probs=195.3
Q ss_pred HHHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCC--CCCCHHHHHHHHHHHHCCCCCEEEEEEEEEEC------CCEE
Q ss_conf 987411152386799999978-99699999970478--43510145899999632468602798655525------9148
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSV 658 (914)
Q Consensus 588 ~~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~------~~~~ 658 (914)
|.+.+.||+|+||+||+|+.. +++.||||+++... ......+.+|+.++++++||||+++++++... ...+
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~ 98 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCEEE
T ss_conf 59988962175859999999999989999998823369799999999999998648987648998970256434576269
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 99995458976777413567322235788899999999999998708999711457787765767999499962056612
Q 002509 659 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 738 (914)
Q Consensus 659 LV~e~~~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~ 738 (914)
+||||+.++.+ +.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++|||+++.
T Consensus 99 iv~Ey~~~~l~-~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 99 LVMELMDANLC-QVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEECCSEEHH-HHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEECCCHHHH-HHHH------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCEEEECHHHHHC
T ss_conf 99841446778-7650------3899999999999999999886522---112456776321136544313201023211
Q ss_pred CCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHH------------
Q ss_conf 34899720001125776569532224877865753205899999881997766343366312288998------------
Q 002509 739 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA------------ 806 (914)
Q Consensus 739 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~------------ 806 (914)
.... .......+|+.|+|||++.+..++.++||||+||+++||++|+.||...........+....
T Consensus 169 ~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 169 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred CCCC--CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHH
T ss_conf 4666--55332214655558133147777877433356625789865989988897788999999720589879998765
Q ss_pred ---HHHHHCC-C-----CCCCCCCCCCC---CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf ---8753038-8-----33112776678---1078999999999988249999999979999999
Q 002509 807 ---KLHIESG-D-----IQGIIDPSLLD---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 807 ---~~~~~~~-~-----~~~~~d~~l~~---~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~ 859 (914)
....... . ........... .........+.+++.+|++.||++|||++|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 66777764175435666421264333543210133379999999999876994579089999669
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=298.90 Aligned_cols=258 Identities=18% Similarity=0.269 Sum_probs=190.6
Q ss_pred HHHHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCCCCCCHHHHHHHHHHHHCC-CCCEEEEEEEEEEC--CCEEEEEE
Q ss_conf 9987411152386799999978-99699999970478435101458999996324-68602798655525--91489999
Q 002509 587 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEE--GRSVLVYE 662 (914)
Q Consensus 587 ~~~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~--~~~~LV~e 662 (914)
.|.+.+.||+|+||+||+|+.. +++.||+|+++.. ..+.+.+|+++|.+++ ||||+++++++... ...++|||
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEEE
T ss_conf 718978983174819999998899979999998889---99999999999985157998767999998168771268886
Q ss_pred ECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCC-CEEEEECCCCCCCCC
Q ss_conf 5458976777413567322235788899999999999998708999711457787765767999-499962056612348
Q 002509 663 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVD 741 (914)
Q Consensus 663 ~~~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~-~~kI~DFGla~~~~~ 741 (914)
|+.+++|.... +.+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+|+....
T Consensus 113 ~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 113 HVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp CCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred ECCCCCHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEECCCCCCEECCC
T ss_conf 31798589974-------6899999999999999999887643---3443456441237748998366415654266468
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCC-CHHHHH---------HHHHHH
Q ss_conf 997200011257765695322248-778657532058999998819977663433663-122889---------988753
Q 002509 742 GASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGAN-CRNIVQ---------WAKLHI 810 (914)
Q Consensus 742 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~-~~~l~~---------~~~~~~ 810 (914)
.. ......+|..|+|||.+.+. .++.++||||+||+++||++|+.||........ ...+.. +.....
T Consensus 183 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 183 GQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp TC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHHCC
T ss_conf 87--4443224864247610268888884523233545558760488999887601899999999878841555554225
Q ss_pred HCC--CCCCCCCCCC--------CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 038--8331127766--------781078999999999988249999999979999999
Q 002509 811 ESG--DIQGIIDPSL--------LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 811 ~~~--~~~~~~d~~l--------~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~ 859 (914)
... .......... ..........++.+++.+|++.||++|||++|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 44474300000333433112115521124489999999999866995689089999649
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=301.81 Aligned_cols=263 Identities=19% Similarity=0.219 Sum_probs=196.1
Q ss_pred HHHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCCC--CCCHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEEC
Q ss_conf 987411152386799999978-996999999704784--35101458999996324686027986555259148999954
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 664 (914)
Q Consensus 588 ~~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~e~~ 664 (914)
|++.+.||+|+||+||+|+.. +++.||||+++.... .....+.+|+.++++++||||+++++++......+++++++
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~ 83 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEEEC
T ss_conf 78626971286819999999999969999998032178689999999999998567578882135444443115886302
Q ss_pred CCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 58976777413567322235788899999999999998708999711457787765767999499962056612348997
Q 002509 665 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 744 (914)
Q Consensus 665 ~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~~~~~~ 744 (914)
.+++|...+. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++.......
T Consensus 84 ~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 84 DQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp SEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred CCCCCCCCCC----CCCCCCHHHHHHHHHHHHHHHHHHHCC---CEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCCC
T ss_conf 3322211212----356540367899999999998774339---986001467612113378266520460110468875
Q ss_pred CEEECCCCCCCCCCCCCCCCCC-CCCCCCEEEHHHHHHHHHHCCCCCCCCCC-CCCCHHHHHHHHHHHHCCCCC---CCC
Q ss_conf 2000112577656953222487-78657532058999998819977663433-663122889988753038833---112
Q 002509 745 HVSSIVRGTVGYLDPEYYISQQ-LTDKSDVYSFGVILLELISGQEAISNEKF-GANCRNIVQWAKLHIESGDIQ---GII 819 (914)
Q Consensus 745 ~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDVwSlGviL~ElltG~~p~~~~~~-~~~~~~l~~~~~~~~~~~~~~---~~~ 819 (914)
......++..|+|||.+.... ++.++||||+||+++||++|+.||..... .+....+...... ....... ...
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 234 (292)
T d1unla_ 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT-PTEEQWPSMTKLP 234 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCC-CCTTTCTTGGGST
T ss_pred -CCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCC-CCHHHHHHHHHCC
T ss_conf -10010344310146675069888804440265418899851899998899999999999861189-9735513443222
Q ss_pred CCC---C------CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 776---6------781078999999999988249999999979999999
Q 002509 820 DPS---L------LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 820 d~~---l------~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~ 859 (914)
+.. . ........-..+.+++.+|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 1133444544310433065689999999999864996689099999649
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=301.80 Aligned_cols=259 Identities=20% Similarity=0.261 Sum_probs=191.7
Q ss_pred HHHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCC--CCCCHHHHHHHHHHHHCCCCCEEEEEEEEEEC-----CCEEE
Q ss_conf 987411152386799999978-99699999970478--43510145899999632468602798655525-----91489
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSVL 659 (914)
Q Consensus 588 ~~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----~~~~L 659 (914)
|.+.+.||+|+||+||+|+.. +++.||||+++... ......+.+|++++++++|||++++++++... ...++
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 99 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCCEEE
T ss_conf 18888983178839999999999979999998820028689999999999998668987425999996346456686499
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 99954589767774135673222357888999999999999987089997114577877657679994999620566123
Q 002509 660 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 739 (914)
Q Consensus 660 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~~ 739 (914)
+++++.+|+|.+++. .+++++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||++...
T Consensus 100 i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 100 LVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp EEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred EEEEECCCCHHHHCC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCHHCCC
T ss_conf 999625886232002-----24530999999999999999999738---8765166776334554322001321000125
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHH----HC--
Q ss_conf 48997200011257765695322248-778657532058999998819977663433663122889988753----03--
Q 002509 740 VDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI----ES-- 812 (914)
Q Consensus 740 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~~~l~~~~~~~~----~~-- 812 (914)
.. ......|+..|+|||...+. .++.++||||+||++|||++|+.||...........+........ ..
T Consensus 172 ~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (348)
T d2gfsa1 172 DD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247 (348)
T ss_dssp TG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred CC----CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHCC
T ss_conf 75----44443454355583553377567855124320589999976889978898899999999730799757732001
Q ss_pred --------CCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf --------88331127766781078999999999988249999999979999999
Q 002509 813 --------GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 859 (914)
Q Consensus 813 --------~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV~~~ 859 (914)
......-...+. .........+.+++.+|++.||++|||+.|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 248 SESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CHHHHHHHTTSCCCCCCCHH-HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHHHHCCCCCCCCHH-HHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 02445444303557875556-6267899999999999775883459389998559
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.4e-44 Score=276.13 Aligned_cols=268 Identities=19% Similarity=0.303 Sum_probs=189.8
Q ss_pred HHHHCCCCCCCCEEEEEEEEC-CCCEEEEEEEECCCCCCCHHHHHHHHHHHHCC-----------CCCEEEEEEEEEEC-
Q ss_conf 987411152386799999978-99699999970478435101458999996324-----------68602798655525-
Q 002509 588 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-----------HRNLVQFLGYCQEE- 654 (914)
Q Consensus 588 ~~~~~~LG~G~~G~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-----------HpnIv~l~g~~~~~- 654 (914)
|.+.+.||+|+||+||+|+.. +|+.||||+++.... ....+.+|+.+++.++ |+||+++++++...
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred EEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 7998997507781899999999997999999834313-368999999999984014555554227676478998763125
Q ss_pred -CCEEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCEEECCCC------
Q ss_conf -91489999545897677741356732223578889999999999999870-8999711457787765767999------
Q 002509 655 -GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHM------ 726 (914)
Q Consensus 655 -~~~~LV~e~~~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~-~~~~~ivH~DIkp~NILl~~~~------ 726 (914)
...+++++++..+......... .....+++..+..++.|++.||+|||+ . +|+||||||+|||++.++
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEE
T ss_pred CCCEEEEEEECCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECCCCCCCCC
T ss_conf 65202343200035420000012-23467868999999999999988876405---864656770570563057656443
Q ss_pred CEEEEECCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCC---HHHH
Q ss_conf 4999620566123489972000112577656953222487786575320589999988199776634336631---2288
Q 002509 727 RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANC---RNIV 803 (914)
Q Consensus 727 ~~kI~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ElltG~~p~~~~~~~~~~---~~l~ 803 (914)
.++++|||.+...... .....||+.|+|||.+....++.++||||+||+++||++|+.||......... ..+.
T Consensus 170 ~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred EEEEEECCCCCCCCCC----CCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHH
T ss_conf 0567531442123445----422366521057132146677764320123789999987889989875543210268999
Q ss_pred HHHHHH-------HHCCC-CCCCCC---------C-CC---------CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHH
Q ss_conf 998875-------30388-331127---------7-66---------781078999999999988249999999979999
Q 002509 804 QWAKLH-------IESGD-IQGIID---------P-SL---------LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEV 856 (914)
Q Consensus 804 ~~~~~~-------~~~~~-~~~~~d---------~-~l---------~~~~~~~~~~~l~~li~~Cl~~~P~~RPtm~eV 856 (914)
...... ..... .....+ . .. ..........++.+++.+|+..||++|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 99998379987886245322000132012202432357764442100015674358999999999877994579089999
Q ss_pred HHH--HHHHH
Q ss_conf 999--76547
Q 002509 857 LKD--IQDAI 864 (914)
Q Consensus 857 ~~~--L~~~~ 864 (914)
+++ +++..
T Consensus 326 L~Hp~f~~~~ 335 (362)
T d1q8ya_ 326 VNHPWLKDTL 335 (362)
T ss_dssp HTCGGGTTCT
T ss_pred HCCCCCCCCC
T ss_conf 6693407898
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=4.3e-24 Score=158.48 Aligned_cols=169 Identities=17% Similarity=0.165 Sum_probs=117.8
Q ss_pred HHCCCCCCCCEEEEEEEECCCCEEEEEEEECCCCC-----C-------------CHHHHHHHHHHHHCCCCCEEEEEEEE
Q ss_conf 74111523867999999789969999997047843-----5-------------10145899999632468602798655
Q 002509 590 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ-----G-------------KREFTNEVTLLSRIHHRNLVQFLGYC 651 (914)
Q Consensus 590 ~~~~LG~G~~G~Vy~~~~~~~~~vAvK~l~~~~~~-----~-------------~~~~~~E~~~l~~l~HpnIv~l~g~~ 651 (914)
++++||+|+||.||+|...+|+.||||+++..... . ......|...+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred HCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEC
T ss_conf 27780248565999999799999999998604434666556563000888999999778999999981699914499862
Q ss_pred EECCCEEEEEEECCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCEEECCCCCEEEE
Q ss_conf 52591489999545897677741356732223578889999999999999870899971145778776576799949996
Q 002509 652 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 731 (914)
Q Consensus 652 ~~~~~~~LV~e~~~~gsL~~~l~~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~~~~~~ivH~DIkp~NILl~~~~~~kI~ 731 (914)
..+++||++++..+.+ +.......++.|++++++|||.+ +++||||||+|||++++ .++|+
T Consensus 84 ----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp ----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred ----CCEEEEEEECCCCCCC-----------HHHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHEEEECC-CEEEE
T ss_conf ----8889999504565420-----------01578999999999999998268---88983689036114289-89998
Q ss_pred ECCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCEEEHHHHHH
Q ss_conf 20566123489972000112577656953222487786575320589999
Q 002509 732 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILL 781 (914)
Q Consensus 732 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ 781 (914)
|||+|+.......... ....... -.+. ..+.+..++|+||..--++
T Consensus 145 DFG~a~~~~~~~~~~~--l~rd~~~-~~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 145 DFPQSVEVGEEGWREI--LERDVRN-IITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCTTCEETTSTTHHHH--HHHHHHH-HHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred ECCCCCCCCCCCCHHH--HHHHHHH-HHHH-HCCCCCCCCCHHHHHHHHH
T ss_conf 7788430899870999--9877999-9999-7578998446899999874
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.87 E-value=1.3e-22 Score=149.58 Aligned_cols=126 Identities=27% Similarity=0.480 Sum_probs=102.5
Q ss_pred CCCCCHHHHHHHHHHCC----CCCCCCCCCCCCCCCCCCEEEECCC-CCCCEEEEECCCCCCCC--CCCCHHHCCCCCCC
Q ss_conf 99860899999995229----9997677999999999960880799-99986899935897840--07900112565432
Q 002509 372 DGSIDGVAIVSVISLYS----SADWAQEGGDPCLPVPWSWLQCNSD-PQPSITVIHLSSKNLTG--NIPSDLTKLSSLVE 444 (914)
Q Consensus 372 ~~~~d~~al~~l~~~~~----~~~~~~~~~dpc~~~~w~gv~c~~~-~~~~l~~L~l~~n~l~g--~ip~~~~~l~~L~~ 444 (914)
+.+.|+.||++||+... ..+|.. ++|||.. .|.||+|+.. ...+++.|+|++|+++| .||++|++|++|+
T Consensus 3 c~~~e~~aLl~~k~~~~~~~~l~sW~~-~~d~C~~-~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~- 79 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPTTLSSWLP-TTDCCNR-TWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN- 79 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCGGGTTCCT-TSCTTTT-CSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS-
T ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCC-CCCCCCC-CCCCEEEECCCCCEEEEEEECCCCCCCCCCCCCHHHHCCCCCC-
T ss_conf 898999999999997799986778899-9999889-4889697489994798899898998888887984784675335-
Q ss_pred CCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCC--CCCCCCCCCCCCCCC
Q ss_conf 5999972998579-72789999237699999604301742558778311--122320121267776
Q 002509 445 FGCPDLRIIHLED-NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINL 507 (914)
Q Consensus 445 L~l~~L~~L~ls~-N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~--~~~~~~l~~~~n~~~ 507 (914)
+|||++ |+++|.||.+++++++|++|+|++|++.|..|..+ ...+..+.+..|...
T Consensus 80 -------~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~ 138 (313)
T d1ogqa_ 80 -------FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALS 138 (313)
T ss_dssp -------EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEE
T ss_pred -------CCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCC
T ss_conf -------20202654333002431145420011020356434433222220111001111224555
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=9.2e-13 Score=90.71 Aligned_cols=132 Identities=20% Similarity=0.125 Sum_probs=96.0
Q ss_pred EEEEEEEECCCCCCCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCEEEE
Q ss_conf 78999730689887731125555110348999860899999995229999767799999999996088079999986899
Q 002509 342 VLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVI 421 (914)
Q Consensus 342 ~~~l~l~~~~~s~lpp~ln~~e~~~~l~~~~~~~d~~al~~l~~~~~~~~~~~~~~dpc~~~~w~gv~c~~~~~~~l~~L 421 (914)
+..+++..|.++..++.+..+..++.+.++...... ..++ .+ .....+..|
T Consensus 79 L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~-------------------~~~~---~~-------~~l~~l~~L 129 (266)
T d1p9ag_ 79 LGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS-------------------LPLG---AL-------RGLGELQEL 129 (266)
T ss_dssp CCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCC-------------------CCSS---TT-------TTCTTCCEE
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCE-------------------EECC---CC-------CCCCCCCCC
T ss_conf 211111222221111121222222222222231101-------------------1001---12-------222111122
Q ss_pred ECCCCCCCCCCCCHHHCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCC--CCCCCC
Q ss_conf 935897840079001125654325999972998579727899992376999996043017425587783111--223201
Q 002509 422 HLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL--SKNVVL 499 (914)
Q Consensus 422 ~l~~n~l~g~ip~~~~~l~~L~~L~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~--~~~~~l 499 (914)
++++|.+++..+..+..+..|+ .|++++|+|++..|..+..+++|+.|+|++|+|+ .||..+. ..+..+
T Consensus 130 ~l~~n~l~~l~~~~~~~l~~l~--------~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L 200 (266)
T d1p9ag_ 130 YLKGNELKTLPPGLLTPTPKLE--------KLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFA 200 (266)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCC--------EEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEE
T ss_pred CCCCCCCCEECCCCCCCCCCCH--------HCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCCCEE
T ss_conf 1243421022123332211100--------0000015652237200134212423430139785-568667778889999
Q ss_pred CCCCCCCCCCCC
Q ss_conf 212677766787
Q 002509 500 NYAGNINLHEGG 511 (914)
Q Consensus 500 ~~~~n~~~~~~~ 511 (914)
.+.|||+.|.+.
T Consensus 201 ~L~~Np~~CdC~ 212 (266)
T d1p9ag_ 201 FLHGNPWLCNCE 212 (266)
T ss_dssp ECCSCCBCCSGG
T ss_pred EECCCCCCCCCC
T ss_conf 836999878864
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.35 E-value=1.1e-12 Score=90.29 Aligned_cols=107 Identities=21% Similarity=0.247 Sum_probs=73.9
Q ss_pred CCCEEEECC--------CCCCCEEEEECCCCCCCCCCC-CHHHCCCCCCCC----------------CCCCCCEEECCCC
Q ss_conf 996088079--------999986899935897840079-001125654325----------------9999729985797
Q 002509 404 PWSWLQCNS--------DPQPSITVIHLSSKNLTGNIP-SDLTKLSSLVEF----------------GCPDLRIIHLEDN 458 (914)
Q Consensus 404 ~w~gv~c~~--------~~~~~l~~L~l~~n~l~g~ip-~~~~~l~~L~~L----------------~l~~L~~L~ls~N 458 (914)
.|..|.|+. +.++.++.|+|++|+|++.++ ..|+.+++|+.| .+++|+.|+|++|
T Consensus 9 ~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 9 EGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp ETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred CCCEEEEECCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCC
T ss_conf 69999970899670298989787889848987755302002578762721301363221212122211222210100355
Q ss_pred CCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCC---CCCCCCCCCCCCCCCCCCC
Q ss_conf 2789999237699999604301742558778311---1223201212677766787
Q 002509 459 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGNINLHEGG 511 (914)
Q Consensus 459 ~l~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~---~~~~~~l~~~~n~~~~~~~ 511 (914)
++++-.|..+.++++|+.|+|++|+|+ .+|... +..+..+.+.+|+..|...
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~-~i~~~~f~~l~~L~~l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCC-EECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CCCCCCHHHHHCCCCCCCCCCCCCCCC-CCCHHHHCCCCCCCCCCCCCCCCCCCCC
T ss_conf 344349799807974655245774535-3597785687533420003644343530
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.19 E-value=7.9e-12 Score=85.11 Aligned_cols=89 Identities=28% Similarity=0.357 Sum_probs=69.9
Q ss_pred CCCEEEEECCCCCCCCCCCCHHHCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCC-C
Q ss_conf 998689993589784007900112565432599997299857972789999237699999604301742558778311-1
Q 002509 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL-L 493 (914)
Q Consensus 415 ~~~l~~L~l~~n~l~g~ip~~~~~l~~L~~L~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~-~ 493 (914)
.+.++.|++++|.++|.+| .++.++ +|+.|+|++|+|+|.||..++++++|++|+|++|+|+|.||... +
T Consensus 220 ~~~l~~l~~~~~~l~~~~~-~~~~~~--------~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L 290 (313)
T d1ogqa_ 220 DKNTQKIHLAKNSLAFDLG-KVGLSK--------NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNL 290 (313)
T ss_dssp TSCCSEEECCSSEECCBGG-GCCCCT--------TCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTG
T ss_pred CCCCCCCCCCCCCCCCCCC-CCCCCC--------CCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCC
T ss_conf 2221112222222222222-222455--------4444447657066608768847999998979588351668986667
Q ss_pred CCCCCCCCCCCCCCCCCCC
Q ss_conf 2232012126777667876
Q 002509 494 SKNVVLNYAGNINLHEGGR 512 (914)
Q Consensus 494 ~~~~~l~~~~n~~~~~~~~ 512 (914)
+.+..+.+.+|+.+|+.+.
T Consensus 291 ~~L~~l~l~~N~~l~g~pl 309 (313)
T d1ogqa_ 291 QRFDVSAYANNKCLCGSPL 309 (313)
T ss_dssp GGSCGGGTCSSSEEESTTS
T ss_pred CCCCHHHHCCCCCCCCCCC
T ss_conf 9989788688950019898
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.16 E-value=1.1e-11 Score=84.24 Aligned_cols=90 Identities=21% Similarity=0.218 Sum_probs=71.3
Q ss_pred CCCEEEEECCCCCCCCCCCCHHHCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCC--
Q ss_conf 998689993589784007900112565432599997299857972789999237699999604301742558778311--
Q 002509 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL-- 492 (914)
Q Consensus 415 ~~~l~~L~l~~n~l~g~ip~~~~~l~~L~~L~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~-- 492 (914)
.+.++.|+|++|+|++..|..+..+++|+ .+++++|++++..|..+..+++|++|++++|++.+..|..+
T Consensus 152 ~~~L~~L~l~~N~l~~l~~~~f~~l~~L~--------~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~ 223 (284)
T d1ozna_ 152 LGNLTHLFLHGNRISSVPERAFRGLHSLD--------RLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAP 223 (284)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCC--------EEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTT
T ss_pred CCCHHHCCCCCCCCCCCCHHHHCCCCCCC--------HHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCC
T ss_conf 34050223141765662566654656341--------3142114346628167665320002333335221000002355
Q ss_pred CCCCCCCCCCCCCCCCCCCC
Q ss_conf 12232012126777667876
Q 002509 493 LSKNVVLNYAGNINLHEGGR 512 (914)
Q Consensus 493 ~~~~~~l~~~~n~~~~~~~~ 512 (914)
...+..+.+++|++.|.++.
T Consensus 224 ~~~L~~L~l~~N~l~C~C~~ 243 (284)
T d1ozna_ 224 LRALQYLRLNDNPWVCDCRA 243 (284)
T ss_dssp CTTCCEEECCSSCEECSGGG
T ss_pred CCCCCEEEECCCCCCCCCCC
T ss_conf 46568898119988787564
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.15 E-value=7.6e-11 Score=79.24 Aligned_cols=104 Identities=22% Similarity=0.280 Sum_probs=82.1
Q ss_pred CCCCCCCCCEEEECCC----------CCCCEEEEECCCCC-CCCCCC-CHHHCCCCCCCCCCCCCCEEECCCCCCCCCCC
Q ss_conf 9999999960880799----------99986899935897-840079-00112565432599997299857972789999
Q 002509 398 DPCLPVPWSWLQCNSD----------PQPSITVIHLSSKN-LTGNIP-SDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLP 465 (914)
Q Consensus 398 dpc~~~~w~gv~c~~~----------~~~~l~~L~l~~n~-l~g~ip-~~~~~l~~L~~L~l~~L~~L~ls~N~l~g~iP 465 (914)
+.|.+..+++|.|... ..++++.|+|++|+ |+ .|+ ..|..|++|+ .|+|++|+|+.--|
T Consensus 3 ~~C~c~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~-~i~~~~f~~l~~L~--------~L~Ls~N~l~~i~~ 73 (156)
T d2ifga3 3 DACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQ-HLELRDLRGLGELR--------NLTIVKSGLRFVAP 73 (156)
T ss_dssp SSSCCSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCC-EECGGGSCSCCCCS--------EEECCSSCCCEECT
T ss_pred CCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCC-CCCCHHHCCCCCCC--------CCEEECCCCCCCCC
T ss_conf 9788699996985289976586002576565743168986644-36921225666667--------21620212477420
Q ss_pred CCCCCCCCCCEEEECCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCC
Q ss_conf 23769999960430174255877831112--23201212677766787
Q 002509 466 SSLMNLPNLRELYVQNNMLSGTVPSSLLS--KNVVLNYAGNINLHEGG 511 (914)
Q Consensus 466 ~~l~~l~~L~~l~l~~N~l~g~ip~~~~~--~~~~l~~~~n~~~~~~~ 511 (914)
..+..+++|+.|+|++|+|+ .+|...+. .+..+.+++||+.|.+.
T Consensus 74 ~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~C~C~ 120 (156)
T d2ifga3 74 DAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCA 120 (156)
T ss_dssp TGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCCCCGG
T ss_pred CCCCCCCCCCCEECCCCCCC-CCCHHHHCCCCCCCCCCCCCCCCCCCH
T ss_conf 11124554333322678785-157456335321243357986338811
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.95 E-value=1.5e-09 Score=71.41 Aligned_cols=84 Identities=19% Similarity=0.245 Sum_probs=63.4
Q ss_pred CCCEEEEECCCCCCCCCCCCHHHCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCC--
Q ss_conf 998689993589784007900112565432599997299857972789999237699999604301742558778311--
Q 002509 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL-- 492 (914)
Q Consensus 415 ~~~l~~L~l~~n~l~g~ip~~~~~l~~L~~L~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~-- 492 (914)
.+.++.|++++|.+++..|..+..+++|+ .|+|++|.|+ .||..+.++++|+.|+|++|+|+ .|+...
T Consensus 194 ~~~l~~L~~s~n~l~~~~~~~~~~l~~L~--------~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~-~i~~~~f~ 263 (305)
T d1xkua_ 194 LNNLAKLGLSFNSISAVDNGSLANTPHLR--------ELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFC 263 (305)
T ss_dssp CTTCCEEECCSSCCCEECTTTGGGSTTCC--------EEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC-CCCTTSSS
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCE--------EEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCC-CCCHHHCC
T ss_conf 34133015445533222345433443322--------4302554002-46311033467898989898657-63810026
Q ss_pred -------CCCCCCCCCCCCCCCC
Q ss_conf -------1223201212677766
Q 002509 493 -------LSKNVVLNYAGNINLH 508 (914)
Q Consensus 493 -------~~~~~~l~~~~n~~~~ 508 (914)
...+..+.+.+||.-+
T Consensus 264 ~~~~~~~~~~L~~L~L~~N~~~~ 286 (305)
T d1xkua_ 264 PPGYNTKKASYSGVSLFSNPVQY 286 (305)
T ss_dssp CSSCCTTSCCCSEEECCSSSSCG
T ss_pred CCCHHCCCCCCCEEECCCCCCCC
T ss_conf 72100215888978898995766
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=98.94 E-value=2.2e-09 Score=70.55 Aligned_cols=131 Identities=14% Similarity=0.135 Sum_probs=86.4
Q ss_pred EEEEEEECCCCC-CCCC-HHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCEEE
Q ss_conf 899973068988-7731-12555511034899986089999999522999976779999999999608807999998689
Q 002509 343 LSFKFGKTYDSS-RGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITV 420 (914)
Q Consensus 343 ~~l~l~~~~~s~-lpp~-ln~~e~~~~l~~~~~~~d~~al~~l~~~~~~~~~~~~~~dpc~~~~w~gv~c~~~~~~~l~~ 420 (914)
..+.|..|.++. +++. +..+..++.|+++...... .. .+ .|. ..+.|+.
T Consensus 32 ~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~--------------~~---~~-----~~~-------~~~~L~~ 82 (192)
T d1w8aa_ 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG--------------IE---PN-----AFE-------GASHIQE 82 (192)
T ss_dssp SEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCC--------------BC---TT-----TTT-------TCTTCCE
T ss_pred CEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCC--------------CC---CC-----CCC-------CCCCCCE
T ss_conf 8898489877553020025787627213013632212--------------12---12-----221-------1222210
Q ss_pred EECCCCCCCCCCCCHHHCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCC-CCCCC
Q ss_conf 99358978400790011256543259999729985797278999923769999960430174255877831112-23201
Q 002509 421 IHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS-KNVVL 499 (914)
Q Consensus 421 L~l~~n~l~g~ip~~~~~l~~L~~L~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~~-~~~~l 499 (914)
|+|++|+|++..|..|.+|++|+ .|+|++|+|++-.|..+..+++|++|+|++|.+.+..+...+. .+..+
T Consensus 83 L~Ls~N~l~~l~~~~F~~l~~L~--------~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~ 154 (192)
T d1w8aa_ 83 LQLGENKIKEISNKMFLGLHQLK--------TLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKK 154 (192)
T ss_dssp EECCSCCCCEECSSSSTTCTTCC--------EEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHH
T ss_pred EEECCCCCCCCCHHHHHCCCCCC--------CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHH
T ss_conf 10035534434979980797465--------5245774535359778568753342000364434353027776423540
Q ss_pred CCCCCCCCCCC
Q ss_conf 21267776678
Q 002509 500 NYAGNINLHEG 510 (914)
Q Consensus 500 ~~~~n~~~~~~ 510 (914)
.+..|...|..
T Consensus 155 ~l~~~~~~c~~ 165 (192)
T d1w8aa_ 155 SLNGGAARCGA 165 (192)
T ss_dssp CCSGGGCBBCS
T ss_pred CCCCCCEEECC
T ss_conf 35689827689
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.91 E-value=3.3e-09 Score=69.45 Aligned_cols=61 Identities=23% Similarity=0.313 Sum_probs=34.7
Q ss_pred CCEEEEECCCCCCCCCCCCHHHCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCC
Q ss_conf 9868999358978400790011256543259999729985797278999923769999960430174255
Q 002509 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 485 (914)
Q Consensus 416 ~~l~~L~l~~n~l~g~ip~~~~~l~~L~~L~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~N~l~ 485 (914)
+.++.|++++|+|++..+..|+.+++|+ .|||++|+|+ .||..+..+++|+.|+|++|.+.
T Consensus 148 ~~l~~l~l~~N~l~~~~~~~~~~l~~L~--------~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 148 PKLEKLSLANNNLTELPAGLLNGLENLD--------TLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp TTCCEEECTTSCCSCCCTTTTTTCTTCC--------EEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred CCCHHCCCCCCCCCCCCCCCCCCCCCCC--------EEECCCCCCC-CCCHHHCCCCCCCEEEECCCCCC
T ss_conf 1100000001565223720013421242--------3430139785-56866777888999983699987
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.84 E-value=6e-09 Score=67.87 Aligned_cols=92 Identities=23% Similarity=0.376 Sum_probs=56.0
Q ss_pred CCCEEEECCC--------CCCCEEEEECCCCCCCCCCCC-HHHCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf 9960880799--------999868999358978400790-0112565432599997299857972789999237699999
Q 002509 404 PWSWLQCNSD--------PQPSITVIHLSSKNLTGNIPS-DLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNL 474 (914)
Q Consensus 404 ~w~gv~c~~~--------~~~~l~~L~l~~n~l~g~ip~-~~~~l~~L~~L~l~~L~~L~ls~N~l~g~iP~~l~~l~~L 474 (914)
.|..|.|+.. .++.++.|+|++|+++ .+|+ .|.+++.|+ .|++++|.++.-.|..+.++++|
T Consensus 11 ~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~--------~L~l~~n~~~~i~~~~f~~l~~L 81 (305)
T d1xkua_ 11 HLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLH--------TLILINNKISKISPGAFAPLVKL 81 (305)
T ss_dssp ETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCC-CBCTTTTTTCTTCC--------EEECCSSCCCCBCTTTTTTCTTC
T ss_pred CCCEEEECCCCCCCCCCCCCCCCCEEECCCCCCC-CCCHHHHHCCCCCC--------CCCCCCCCCCCCCHHHHHCCCCC
T ss_conf 5999985599988519888999798978499189-86965760465652--------31123443445235665279855
Q ss_pred CEEEECCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 6043017425587783111223201212677
Q 002509 475 RELYVQNNMLSGTVPSSLLSKNVVLNYAGNI 505 (914)
Q Consensus 475 ~~l~l~~N~l~g~ip~~~~~~~~~l~~~~n~ 505 (914)
+.|++++|+++ .+|......+..+....|.
T Consensus 82 ~~L~l~~n~l~-~l~~~~~~~l~~L~~~~n~ 111 (305)
T d1xkua_ 82 ERLYLSKNQLK-ELPEKMPKTLQELRVHENE 111 (305)
T ss_dssp CEEECCSSCCS-BCCSSCCTTCCEEECCSSC
T ss_pred CEECCCCCCCC-CCCCCHHHHHHHHHCCCCC
T ss_conf 78315687567-6764001113232102461
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.80 E-value=6.6e-09 Score=67.62 Aligned_cols=82 Identities=32% Similarity=0.456 Sum_probs=59.9
Q ss_pred CCCEEEEECCCCCCCCCCCCHHHCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCC--CC
Q ss_conf 9986899935897840079001125654325999972998579727899992376999996043017425587783--11
Q 002509 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPS--SL 492 (914)
Q Consensus 415 ~~~l~~L~l~~n~l~g~ip~~~~~l~~L~~L~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~--~~ 492 (914)
.+.++.|+|++|+|+ .+|+.++.+++|+ .|++++|+++ .+| .++++++|+.|++++|+++ .+|. .+
T Consensus 19 l~~L~~L~ls~N~l~-~lp~~~~~l~~L~--------~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i~-~~~~~~~l 86 (124)
T d1dcea3 19 LLLVTHLDLSHNRLR-ALPPALAALRCLE--------VLQASDNALE-NVD-GVANLPRLQELLLCNNRLQ-QSAAIQPL 86 (124)
T ss_dssp GTTCCEEECCSSCCC-CCCGGGGGCTTCC--------EEECCSSCCC-CCG-GGTTCSSCCEEECCSSCCC-SSSTTGGG
T ss_pred CCCCCEEECCCCCCC-CCHHHHHHHHCCC--------CCCCCCCCCC-CCC-CCCCCCCCCEEECCCCCCC-CCCCCHHH
T ss_conf 898898979787168-6521565543135--------4532432112-357-4123355576888898658-88882565
Q ss_pred --CCCCCCCCCCCCCCCC
Q ss_conf --1223201212677766
Q 002509 493 --LSKNVVLNYAGNINLH 508 (914)
Q Consensus 493 --~~~~~~l~~~~n~~~~ 508 (914)
+..+..+++.+|+...
T Consensus 87 ~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 87 VSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp GGCTTCCEEECTTSGGGG
T ss_pred CCCCCCCEEECCCCCCCC
T ss_conf 379999999897996886
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.79 E-value=4.9e-09 Score=68.44 Aligned_cols=140 Identities=16% Similarity=0.192 Sum_probs=85.2
Q ss_pred EEEEEEEECCCCCCCCCHHHHHHHHHCCCCCCC-CCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCEEE
Q ss_conf 789997306898877311255551103489998-6089999999522999976779999999999608807999998689
Q 002509 342 VLSFKFGKTYDSSRGPLLNAMEINKYLERNDGS-IDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITV 420 (914)
Q Consensus 342 ~~~l~l~~~~~s~lpp~ln~~e~~~~l~~~~~~-~d~~al~~l~~~~~~~~~~~~~~dpc~~~~w~gv~c~~~~~~~l~~ 420 (914)
+..+.+..+..+.+++ +..+..++.+.++... .+...+..+ ..+..-....| .-.++.+- ...+.++.
T Consensus 243 L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~~~l~~~~~~~~~------~~l~~l~~~~n---~l~~~~~~-~~~~~l~~ 311 (384)
T d2omza2 243 LTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNISPLAGL------TALTNLELNEN---QLEDISPI-SNLKNLTY 311 (384)
T ss_dssp CSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCCGGGTTC------TTCSEEECCSS---CCSCCGGG-GGCTTCSE
T ss_pred CCHHCCCCCCCCCCCC-CCCCCCCCEEECCCCCCCCCCCCCCC------CCCCCCCCCCC---CCCCCCCC-CHHCCCCE
T ss_conf 3410044674478775-35546687754567445787732356------52222332323---33332210-00024676
Q ss_pred EECCCCCCCCCCCCHHHCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99358978400790011256543259999729985797278999923769999960430174255877831112232012
Q 002509 421 IHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 500 (914)
Q Consensus 421 L~l~~n~l~g~ip~~~~~l~~L~~L~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~~~~l~ 500 (914)
|+|++|++++ ++ .+..+++|+ .|+|++|+++ .+| .++++++|+.|+|++|++++-.|-.-+++++.|.
T Consensus 312 L~ls~n~l~~-l~-~l~~l~~L~--------~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~l~~l~~L~~L~ 379 (384)
T d2omza2 312 LTLYFNNISD-IS-PVSSLTKLQ--------RLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDLTPLANLTRITQLG 379 (384)
T ss_dssp EECCSSCCSC-CG-GGGGCTTCC--------EEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGGGTTCTTCSEEE
T ss_pred EECCCCCCCC-CC-CCCCCCCCC--------EEECCCCCCC-CCH-HHCCCCCCCEEECCCCCCCCCHHHCCCCCCCEEE
T ss_conf 7777887789-84-536689889--------8989899899-974-6708999998989799589980000399999963
Q ss_pred CCCC
Q ss_conf 1267
Q 002509 501 YAGN 504 (914)
Q Consensus 501 ~~~n 504 (914)
+++|
T Consensus 380 L~~N 383 (384)
T d2omza2 380 LNDQ 383 (384)
T ss_dssp CCCE
T ss_pred CCCC
T ss_conf 9789
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.77 E-value=1.1e-07 Score=60.25 Aligned_cols=133 Identities=18% Similarity=0.126 Sum_probs=88.1
Q ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCCCHHHHHHHHHHHHCC-CCCEEEEEEEEEECCCEEEEEEECCCCCHHHHHH
Q ss_conf 238679999997899699999970478435101458999996324-6860279865552591489999545897677741
Q 002509 596 SGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY 674 (914)
Q Consensus 596 ~G~~G~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~LV~e~~~~gsL~~~l~ 674 (914)
.++...||+.... ++.+.+|+...........+.+|...+..+. +--+.+++.++...+..++||+++++.++.+...
T Consensus 24 G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~ 102 (263)
T d1j7la_ 24 GMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE 102 (263)
T ss_dssp CCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTT
T ss_pred CCCCCCEEEEEEC-CCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEEEEEECCCCCCCCCCC
T ss_conf 9987718999908-986999984887653255699999999987606998728999750896499998604334354334
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------------
Q ss_conf 356732223578889999999999999870--------------------------------------------------
Q 002509 675 GTLTHEQRINWIKRLEIAEDAAKGIEYLHT-------------------------------------------------- 704 (914)
Q Consensus 675 ~~~~~~~~l~~~~~l~ia~~ia~gL~~LH~-------------------------------------------------- 704 (914)
.. .....++.++++.++.||+
T Consensus 103 ~~---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (263)
T d1j7la_ 103 DE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDF 173 (263)
T ss_dssp TC---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHH
T ss_pred CC---------CCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHH
T ss_conf 40---------269999998999999985568421435764465655577899877655554303323200579999999
Q ss_pred ---C---CCCCCCCCCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf ---8---999711457787765767999499962056612
Q 002509 705 ---G---CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 738 (914)
Q Consensus 705 ---~---~~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~ 738 (914)
. ..+.++|+|+.+.|||++++...-|.||+.+..
T Consensus 174 l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 174 LKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 9844986781789860047642364996599960231441
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.73 E-value=9.1e-09 Score=66.81 Aligned_cols=78 Identities=22% Similarity=0.235 Sum_probs=37.7
Q ss_pred CCEEEEECCCCCCCCCCCCHHHCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCC---
Q ss_conf 98689993589784007900112565432599997299857972789999237699999604301742558778311---
Q 002509 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--- 492 (914)
Q Consensus 416 ~~l~~L~l~~n~l~g~ip~~~~~l~~L~~L~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~--- 492 (914)
..++.|+|++|+++ .||..+..++.|+ .|||++|+++ .++ .+..+++|+.|+|++|+++ .+|..+
T Consensus 18 ~~lr~L~L~~n~I~-~i~~~~~~l~~L~--------~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~-~l~~~~~~~ 85 (162)
T d1a9na_ 18 VRDRELDLRGYKIP-VIENLGATLDQFD--------AIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRIC-RIGEGLDQA 85 (162)
T ss_dssp TSCEEEECTTSCCC-SCCCGGGGTTCCS--------EEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCC-EECSCHHHH
T ss_pred CCCCEEECCCCCCC-CCCCCCCCCCCCC--------EEECCCCCCC-CCC-CCCCCCCHHHHHCCCCCCC-CCCCCCCCC
T ss_conf 74848978899788-6576200414599--------8989799787-647-7445761306431021345-777632233
Q ss_pred CCCCCCCCCCCCC
Q ss_conf 1223201212677
Q 002509 493 LSKNVVLNYAGNI 505 (914)
Q Consensus 493 ~~~~~~l~~~~n~ 505 (914)
+..+..+.+++|.
T Consensus 86 l~~L~~L~L~~N~ 98 (162)
T d1a9na_ 86 LPDLTELILTNNS 98 (162)
T ss_dssp CTTCCEEECCSCC
T ss_pred CCCCCCCEECCCC
T ss_conf 4534434203000
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.72 E-value=3.9e-08 Score=63.05 Aligned_cols=66 Identities=20% Similarity=0.216 Sum_probs=41.5
Q ss_pred CCEEEEECCCCCCCCCCCCHHHCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCC
Q ss_conf 98689993589784007900112565432599997299857972789999237699999604301742558778
Q 002509 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVP 489 (914)
Q Consensus 416 ~~l~~L~l~~n~l~g~ip~~~~~l~~L~~L~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~ip 489 (914)
+.|+.++|++|++++..|..|..+.+|+ .||+++|++++..|..++.+++|+.|+|++|.+.+.-+
T Consensus 177 ~~L~~l~l~~N~l~~i~~~~f~~l~~L~--------~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 177 HSLDRLLLHQNRVAHVHPHAFRDLGRLM--------TLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCC--------EEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred CCCCHHHHHHCCCCCCCHHHHHHHHHCC--------CCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCC
T ss_conf 6341314211434662816766532000--------23333352210000023554656889811998878756
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.68 E-value=2e-08 Score=64.74 Aligned_cols=75 Identities=31% Similarity=0.363 Sum_probs=46.6
Q ss_pred EEECCCCCCCCCCCCHHHCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCC-CCCCCCC
Q ss_conf 999358978400790011256543259999729985797278999923769999960430174255877831-1122320
Q 002509 420 VIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSS-LLSKNVV 498 (914)
Q Consensus 420 ~L~l~~n~l~g~ip~~~~~l~~L~~L~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~-~~~~~~~ 498 (914)
.|+|++|+++ .+| .++.++.|+ .||+++|+++ .+|..++.+++|+.|++++|+++ .+|.- -+..+..
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~--------~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~~~~~l~~L~~ 69 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVT--------HLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDGVANLPRLQE 69 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCC--------EEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCGGGTTCSSCCE
T ss_pred EEECCCCCCC-CCC-CCCCCCCCC--------EEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCC-CCCCCCCCCCCCE
T ss_conf 8986899898-871-010589889--------8979787168-65215655431354532432112-3574123355576
Q ss_pred CCCCCCCC
Q ss_conf 12126777
Q 002509 499 LNYAGNIN 506 (914)
Q Consensus 499 l~~~~n~~ 506 (914)
+.+++|..
T Consensus 70 L~l~~N~i 77 (124)
T d1dcea3 70 LLLCNNRL 77 (124)
T ss_dssp EECCSSCC
T ss_pred EECCCCCC
T ss_conf 88889865
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.59 E-value=2.8e-08 Score=63.92 Aligned_cols=75 Identities=23% Similarity=0.433 Sum_probs=53.7
Q ss_pred CCCEEEEECCCCCCCCCCCCHHHCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCC-CCC
Q ss_conf 9986899935897840079001125654325999972998579727899992376999996043017425587783-111
Q 002509 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPS-SLL 493 (914)
Q Consensus 415 ~~~l~~L~l~~n~l~g~ip~~~~~l~~L~~L~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~-~~~ 493 (914)
.+.++.|++++|.+++ ++ .++.+++|+ .|+|++|+++ .+|. +.++++|++|+|++|+++ .+|+ .-+
T Consensus 150 ~~~L~~L~l~~n~~~~-~~-~l~~l~~L~--------~L~Ls~n~l~-~l~~-l~~l~~L~~L~Ls~N~lt-~i~~l~~l 216 (227)
T d1h6ua2 150 LTNLQYLSIGNAQVSD-LT-PLANLSKLT--------TLKADDNKIS-DISP-LASLPNLIEVHLKNNQIS-DVSPLANT 216 (227)
T ss_dssp CTTCCEEECCSSCCCC-CG-GGTTCTTCC--------EEECCSSCCC-CCGG-GGGCTTCCEEECTTSCCC-BCGGGTTC
T ss_pred CCCCCCCCCCCCCCCC-CH-HHCCCCCCE--------ECCCCCCCCC-CCHH-HCCCCCCCEEECCCCCCC-CCCCCCCC
T ss_conf 2111002333333331-00-105646335--------6445888417-7853-447999998979599689-98020369
Q ss_pred CCCCCCCCC
Q ss_conf 223201212
Q 002509 494 SKNVVLNYA 502 (914)
Q Consensus 494 ~~~~~l~~~ 502 (914)
..+..++++
T Consensus 217 ~~L~~L~ls 225 (227)
T d1h6ua2 217 SNLFIVTLT 225 (227)
T ss_dssp TTCCEEEEE
T ss_pred CCCCEEEEE
T ss_conf 998989712
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.52 E-value=1e-07 Score=60.47 Aligned_cols=124 Identities=20% Similarity=0.226 Sum_probs=69.7
Q ss_pred EEEEEEEECCCCCCCCCHHHHHHHHHCCCCC-CCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCEEE
Q ss_conf 7899973068988773112555511034899-986089999999522999976779999999999608807999998689
Q 002509 342 VLSFKFGKTYDSSRGPLLNAMEINKYLERND-GSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITV 420 (914)
Q Consensus 342 ~~~l~l~~~~~s~lpp~ln~~e~~~~l~~~~-~~~d~~al~~l~~~~~~~~~~~~~~dpc~~~~w~gv~c~~~~~~~l~~ 420 (914)
+..+.+..|.++.++| +..+..++.+.++. .-.+..++..+ ....... -..|......++ ...++++.
T Consensus 64 L~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~~~~~l~~l---~~L~~L~---l~~~~~~~~~~~----~~l~~L~~ 132 (199)
T d2omxa2 64 LTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIADITPLANL---TNLTGLT---LFNNQITDIDPL----KNLTNLNR 132 (199)
T ss_dssp CCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGGGTTC---TTCSEEE---CCSSCCCCCGGG----TTCTTCSE
T ss_pred CCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCCCC---CCCCCCCCCCCC----CHHHHHHH
T ss_conf 6757545655667640-16775223111122222222111112---2322211---122222232100----01223677
Q ss_pred EECCCCCCCCCCCCHHHCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCC
Q ss_conf 993589784007900112565432599997299857972789999237699999604301742558778
Q 002509 421 IHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVP 489 (914)
Q Consensus 421 L~l~~n~l~g~ip~~~~~l~~L~~L~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~ip 489 (914)
|++++|++. .+| .+..+++|+ .|++++|+++ .++ .++++++|+.|++++|+++ .+|
T Consensus 133 L~l~~n~l~-~~~-~l~~~~~L~--------~L~l~~n~l~-~l~-~l~~l~~L~~L~ls~N~i~-~i~ 188 (199)
T d2omxa2 133 LELSSNTIS-DIS-ALSGLTSLQ--------QLNFSSNQVT-DLK-PLANLTTLERLDISSNKVS-DIS 188 (199)
T ss_dssp EECCSSCCC-CCG-GGTTCTTCS--------EEECCSSCCC-CCG-GGTTCTTCCEEECCSSCCC-CCG
T ss_pred HHHHHHHHC-CCC-CCCCCCCCC--------CCCCCCCCCC-CCC-CCCCCCCCCEEECCCCCCC-CCC
T ss_conf 643111100-234-333211111--------1223455556-770-1167998999978799799-881
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.51 E-value=1.1e-06 Score=54.34 Aligned_cols=143 Identities=18% Similarity=0.101 Sum_probs=83.6
Q ss_pred CCCCCCC-EEEEEEEECCCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCC--CCEEEEEEEEEECCCEEEEEEECCCCCH
Q ss_conf 1152386-799999978996999999704784351014589999963246--8602798655525914899995458976
Q 002509 593 KIGSGGF-GVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH--RNLVQFLGYCQEEGRSVLVYEFMHNGTL 669 (914)
Q Consensus 593 ~LG~G~~-G~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~g~~~~~~~~~LV~e~~~~gsL 669 (914)
.+..|.. +.||+....++..+.+|..... ....+..|...++.+.. -.+.++++++...+..+++++++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCC---CHHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf 767865477589999389878999958966---77689999999999986599988613222456615999874413554
Q ss_pred HHH-----------------HHCCCCCCCCCC--HHHHHH--------------------HHHHHHHHHHHHHHC----C
Q ss_conf 777-----------------413567322235--788899--------------------999999999998708----9
Q 002509 670 KEH-----------------LYGTLTHEQRIN--WIKRLE--------------------IAEDAAKGIEYLHTG----C 706 (914)
Q Consensus 670 ~~~-----------------l~~~~~~~~~l~--~~~~l~--------------------ia~~ia~gL~~LH~~----~ 706 (914)
.+. ||........+. +..... ........+..+... .
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCC
T ss_conf 32212689999999999998736885448875541246889999998754110113401121379999999987187657
Q ss_pred CCCCCCCCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 99711457787765767999499962056612
Q 002509 707 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 738 (914)
Q Consensus 707 ~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~ 738 (914)
.+.++|+|+.+.|||++++..+.|+||+.+..
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 95678678887635773796589998533265
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.51 E-value=2.2e-07 Score=58.50 Aligned_cols=74 Identities=30% Similarity=0.480 Sum_probs=44.5
Q ss_pred CCCEEEEECCCCCCCCCCCCHHHCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCC--
Q ss_conf 998689993589784007900112565432599997299857972789999237699999604301742558778311--
Q 002509 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL-- 492 (914)
Q Consensus 415 ~~~l~~L~l~~n~l~g~ip~~~~~l~~L~~L~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~-- 492 (914)
.+.++.++++.|.+++ +..++.+++|+ .+++++|++++ ++ .+.++++|+.|+|++|+++ .+|. +
T Consensus 133 l~~l~~l~~~~n~l~~--~~~~~~l~~L~--------~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~-~l~~-l~~ 198 (210)
T d1h6ta2 133 LPQLESLYLGNNKITD--ITVLSRLTKLD--------TLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHIS-DLRA-LAG 198 (210)
T ss_dssp CTTCCEEECCSSCCCC--CGGGGGCTTCS--------EEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-BCGG-GTT
T ss_pred CCCCCCCCCCCCCCCC--CCCCCCCCCCC--------CCCCCCCCCCC-CC-CCCCCCCCCEEECCCCCCC-CCHH-HCC
T ss_conf 1112221122233345--43100013321--------00134643025-64-5367898999989799899-8721-169
Q ss_pred CCCCCCCCCC
Q ss_conf 1223201212
Q 002509 493 LSKNVVLNYA 502 (914)
Q Consensus 493 ~~~~~~l~~~ 502 (914)
+.+++.|++.
T Consensus 199 l~~L~~L~Ls 208 (210)
T d1h6ta2 199 LKNLDVLELF 208 (210)
T ss_dssp CTTCSEEEEE
T ss_pred CCCCCEEECC
T ss_conf 9998999711
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.50 E-value=8.4e-08 Score=61.01 Aligned_cols=55 Identities=24% Similarity=0.367 Sum_probs=33.3
Q ss_pred CCCEEEEECCCCCCCCCCCCHHHCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECC
Q ss_conf 9986899935897840079001125654325999972998579727899992376999996043017
Q 002509 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 481 (914)
Q Consensus 415 ~~~l~~L~l~~n~l~g~ip~~~~~l~~L~~L~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~ 481 (914)
.+.|+.+++++|+++ .+++ ++++++|+ .|+|++|+++ .|| .+..+++|+.|+|++
T Consensus 155 l~~L~~l~l~~n~l~-~i~~-l~~l~~L~--------~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 155 LTKLDTLSLEDNQIS-DIVP-LAGLTKLQ--------NLYLSKNHIS-DLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp CTTCSEEECCSSCCC-CCGG-GTTCTTCC--------EEECCSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred CCCCCCCCCCCCCCC-CCCC-CCCCCCCC--------EEECCCCCCC-CCH-HHCCCCCCCEEECCC
T ss_conf 133210013464302-5645-36789899--------9989799899-872-116999989997118
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.43 E-value=2.9e-07 Score=57.78 Aligned_cols=102 Identities=15% Similarity=0.141 Sum_probs=48.3
Q ss_pred EEEEEEECCCCCCCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCEEEEE
Q ss_conf 89997306898877311255551103489998608999999952299997677999999999960880799999868999
Q 002509 343 LSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIH 422 (914)
Q Consensus 343 ~~l~l~~~~~s~lpp~ln~~e~~~~l~~~~~~~d~~al~~l~~~~~~~~~~~~~~dpc~~~~w~gv~c~~~~~~~l~~L~ 422 (914)
..++|..|.++.++.....+..++.++++.+.-.. +.++ ...++|+.|+
T Consensus 21 r~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~~---------------------------l~~~----~~l~~L~~L~ 69 (162)
T d1a9na_ 21 RELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRK---------------------------LDGF----PLLRRLKTLL 69 (162)
T ss_dssp EEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCE---------------------------ECCC----CCCSSCCEEE
T ss_pred CEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCC---------------------------CCCC----CCCCCHHHHH
T ss_conf 48978899788657620041459989897997876---------------------------4774----4576130643
Q ss_pred CCCCCCCCCCCCH-HHCCCCCCCCCCCCCCEEECCCCCCCCCCCC--CCCCCCCCCEEEECCCCCC
Q ss_conf 3589784007900-1125654325999972998579727899992--3769999960430174255
Q 002509 423 LSSKNLTGNIPSD-LTKLSSLVEFGCPDLRIIHLEDNQLTGPLPS--SLMNLPNLRELYVQNNMLS 485 (914)
Q Consensus 423 l~~n~l~g~ip~~-~~~l~~L~~L~l~~L~~L~ls~N~l~g~iP~--~l~~l~~L~~l~l~~N~l~ 485 (914)
|++|+++ .+|.. +..+++|+ .|+|++|+++ .++. .+..+++|+.|++++|.++
T Consensus 70 ls~N~i~-~l~~~~~~~l~~L~--------~L~L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 70 VNNNRIC-RIGEGLDQALPDLT--------ELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp CCSSCCC-EECSCHHHHCTTCC--------EEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred CCCCCCC-CCCCCCCCCCCCCC--------CCEECCCCCC-CCCCCCCCCCCCCCCHHHCCCCCCC
T ss_conf 1021345-77763223345344--------3420300016-6542110013653206640799634
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.34 E-value=2.2e-07 Score=58.52 Aligned_cols=57 Identities=21% Similarity=0.326 Sum_probs=29.8
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99972998579727899992376999996043017425587783111223201212677
Q 002509 447 CPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNI 505 (914)
Q Consensus 447 l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~~~~l~~~~n~ 505 (914)
+++|+.|++++|++. .+| .+..+++|+.|++.+|++++.-|-.-+..+..|++++|+
T Consensus 127 l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l~~l~~l~~L~~L~ls~N~ 183 (199)
T d2omxa2 127 LTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNK 183 (199)
T ss_dssp CTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSC
T ss_pred HHHHHHHHHHHHHHC-CCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCC
T ss_conf 223677643111100-234-333211111122345555677011679989999787997
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.31 E-value=7.7e-07 Score=55.28 Aligned_cols=52 Identities=29% Similarity=0.403 Sum_probs=22.8
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCC--CCCCCCCCCCCC
Q ss_conf 97299857972789999237699999604301742558778311--122320121267
Q 002509 449 DLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 504 (914)
Q Consensus 449 ~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~--~~~~~~l~~~~n 504 (914)
+|+.|+|++|++++ ++ .+..+++|+.|+|++|+++ .+| .+ +..++.+++++|
T Consensus 308 ~l~~L~ls~n~l~~-l~-~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N 361 (384)
T d2omza2 308 NLTYLTLYFNNISD-IS-PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHN 361 (384)
T ss_dssp TCSEEECCSSCCSC-CG-GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSS
T ss_pred CCCEEECCCCCCCC-CC-CCCCCCCCCEEECCCCCCC-CCH-HHCCCCCCCEEECCCC
T ss_conf 46767777887789-84-5366898898989899899-974-6708999998989799
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.27 E-value=1.1e-06 Score=54.36 Aligned_cols=62 Identities=19% Similarity=0.170 Sum_probs=51.7
Q ss_pred CCCEEEEECCCCCCCCCCCCHHHCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCC
Q ss_conf 99868999358978400790011256543259999729985797278999923769999960430174255
Q 002509 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 485 (914)
Q Consensus 415 ~~~l~~L~l~~n~l~g~ip~~~~~l~~L~~L~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~N~l~ 485 (914)
.+.|+.|+|++|+|+..-|..|..+++|+ .|+|++|+|+ .+|..+....+|+.|+|++|.+.
T Consensus 55 l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~--------~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 55 LGELRNLTIVKSGLRFVAPDAFHFTPRLS--------RLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CCCCSEEECCSSCCCEECTTGGGSCSCCC--------EEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred CCCCCCCEEECCCCCCCCCCCCCCCCCCC--------CEECCCCCCC-CCCHHHHCCCCCCCCCCCCCCCC
T ss_conf 66667216202124774201112455433--------3322678785-15745633532124335798633
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.26 E-value=5.8e-07 Score=56.02 Aligned_cols=77 Identities=22% Similarity=0.365 Sum_probs=42.8
Q ss_pred CCEEEEECCCCCCCCCCCCHHHCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCC-CCCC
Q ss_conf 986899935897840079001125654325999972998579727899992376999996043017425587783-1112
Q 002509 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPS-SLLS 494 (914)
Q Consensus 416 ~~l~~L~l~~n~l~g~ip~~~~~l~~L~~L~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~-~~~~ 494 (914)
+.+..+.++++.+.... .+..+.+| +.|++++|.+++ ++ .++++++|+.|+|++|++++ +|. .-+.
T Consensus 129 ~~~~~l~~~~~~~~~~~--~~~~~~~L--------~~L~l~~n~~~~-~~-~l~~l~~L~~L~Ls~n~l~~-l~~l~~l~ 195 (227)
T d1h6ua2 129 SNLQVLYLDLNQITNIS--PLAGLTNL--------QYLSIGNAQVSD-LT-PLANLSKLTTLKADDNKISD-ISPLASLP 195 (227)
T ss_dssp TTCCEEECCSSCCCCCG--GGGGCTTC--------CEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-CGGGGGCT
T ss_pred CCHHHHHCHHHHHCHHH--HHCCCCCC--------CCCCCCCCCCCC-CH-HHCCCCCCEECCCCCCCCCC-CHHHCCCC
T ss_conf 30122200000000000--00102111--------002333333331-00-10564633564458884177-85344799
Q ss_pred CCCCCCCCCCC
Q ss_conf 23201212677
Q 002509 495 KNVVLNYAGNI 505 (914)
Q Consensus 495 ~~~~l~~~~n~ 505 (914)
.+..|.+++|.
T Consensus 196 ~L~~L~Ls~N~ 206 (227)
T d1h6ua2 196 NLIEVHLKNNQ 206 (227)
T ss_dssp TCCEEECTTSC
T ss_pred CCCEEECCCCC
T ss_conf 99989795996
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.11 E-value=3.4e-05 Score=45.42 Aligned_cols=75 Identities=17% Similarity=0.135 Sum_probs=47.5
Q ss_pred CCCCCCCCEEEEEEEECC-CCEEEEEEEECC------C-CCCCHHHHHHHHHHHHCC-C-C-CEEEEEEEEEECCCEEEE
Q ss_conf 111523867999999789-969999997047------8-435101458999996324-6-8-602798655525914899
Q 002509 592 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSN------S-YQGKREFTNEVTLLSRIH-H-R-NLVQFLGYCQEEGRSVLV 660 (914)
Q Consensus 592 ~~LG~G~~G~Vy~~~~~~-~~~vAvK~l~~~------~-~~~~~~~~~E~~~l~~l~-H-p-nIv~l~g~~~~~~~~~LV 660 (914)
+.||.|....||+....+ ++.+.+|.-... . .........|.+.|..+. + | .+.+++.+ +....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEEE
T ss_conf 9807985276899995799848999617713034677788877899999999998650579885528998--59887798
Q ss_pred EEECCCCC
Q ss_conf 99545897
Q 002509 661 YEFMHNGT 668 (914)
Q Consensus 661 ~e~~~~gs 668 (914)
||++.+..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EECCCCCC
T ss_conf 71357765
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.11 E-value=4e-06 Score=50.97 Aligned_cols=62 Identities=27% Similarity=0.395 Sum_probs=48.4
Q ss_pred CCCCCEEEEECCCCCCCCCCCCHHHCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCC
Q ss_conf 9999868999358978400790011256543259999729985797278999923769999960430174255877831
Q 002509 413 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSS 491 (914)
Q Consensus 413 ~~~~~l~~L~l~~n~l~g~ip~~~~~l~~L~~L~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~ 491 (914)
...+.|+.|+|++|+|+ .+|..+ . +|+.|+|++|+|+ .||.. +++|+.|+|++|+++ .+|..
T Consensus 281 ~~~~~L~~L~Ls~N~l~-~lp~~~---~--------~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~ 342 (353)
T d1jl5a_ 281 DLPPSLEELNVSNNKLI-ELPALP---P--------RLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDI 342 (353)
T ss_dssp CCCTTCCEEECCSSCCS-CCCCCC---T--------TCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCC
T ss_pred CCCCCCCEEECCCCCCC-CCCCCC---C--------CCCEEECCCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCC
T ss_conf 66898898979799168-356654---8--------7998989999687-54532---288898987699189-77765
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.10 E-value=4.8e-06 Score=50.52 Aligned_cols=53 Identities=28% Similarity=0.348 Sum_probs=33.3
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99729985797278999923769999960430174255877831112232012126777
Q 002509 448 PDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 506 (914)
Q Consensus 448 ~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~~~~~~~~~l~~~~n~~ 506 (914)
++|+.|+|++|+|+ .||.. +++|+.|+|++|+|+ .+|.. ...++.|++++|+.
T Consensus 284 ~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~-~~~L~~L~L~~N~L 336 (353)
T d1jl5a_ 284 PSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL-PQNLKQLHVEYNPL 336 (353)
T ss_dssp TTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC-CTTCCEEECCSSCC
T ss_pred CCCCEEECCCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCC-CCCCCEEECCCCCC
T ss_conf 98898979799168-35665---487998989999687-54532-28889898769918
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.04 E-value=2.1e-08 Score=64.67 Aligned_cols=33 Identities=24% Similarity=0.411 Sum_probs=12.0
Q ss_pred EEECCCCCCCCCCC--CCCCCCCCCCEEEECCCCCC
Q ss_conf 99857972789999--23769999960430174255
Q 002509 452 IIHLEDNQLTGPLP--SSLMNLPNLRELYVQNNMLS 485 (914)
Q Consensus 452 ~L~ls~N~l~g~iP--~~l~~l~~L~~l~l~~N~l~ 485 (914)
.|+|++|+++ .++ ..+..+++|+.|+|++|.+.
T Consensus 119 ~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 119 VLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp EEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred CCCCCCCHHC-CCCCCCCCCCCCCCCEEECCCCCCC
T ss_conf 1123410212-5542212367776302342798434
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.92 E-value=1.2e-05 Score=48.04 Aligned_cols=76 Identities=16% Similarity=0.169 Sum_probs=56.5
Q ss_pred CCCEEEEECCCCCCCCCCCCHHHCCCCCCCCCCCCCCEEECCCCCCCCCCCCC-CCCCCCCCEEEECCCCCCCCCCCCCC
Q ss_conf 99868999358978400790011256543259999729985797278999923-76999996043017425587783111
Q 002509 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSS-LMNLPNLRELYVQNNMLSGTVPSSLL 493 (914)
Q Consensus 415 ~~~l~~L~l~~n~l~g~ip~~~~~l~~L~~L~l~~L~~L~ls~N~l~g~iP~~-l~~l~~L~~l~l~~N~l~g~ip~~~~ 493 (914)
...+..|++++|+++ .++....+...+. +.+++++|+++ .||.. +.++++|+.|+|++|+++ .+|...+
T Consensus 152 ~~~l~~L~l~~n~l~-~i~~~~~~~~~l~-------~~~~l~~n~l~-~l~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~ 221 (242)
T d1xwdc1 152 SFESVILWLNKNGIQ-EIHNCAFNGTQLD-------ELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGL 221 (242)
T ss_dssp BSSCEEEECCSSCCC-EECTTTTTTCCEE-------EEECTTCTTCC-CCCTTTTTTSCCCSEEECTTSCCC-CCCSSSC
T ss_pred CCCCEEEECCCCCCC-CCCCCCCCCHHHH-------CCCCCCCCCCC-CCCHHHHCCCCCCCEEECCCCCCC-CCCHHHH
T ss_conf 331001220012333-3222222201110-------12123543246-424788668999998989799289-4597797
Q ss_pred CCCCCCC
Q ss_conf 2232012
Q 002509 494 SKNVVLN 500 (914)
Q Consensus 494 ~~~~~l~ 500 (914)
..+..|.
T Consensus 222 ~~l~~L~ 228 (242)
T d1xwdc1 222 ENLKKLR 228 (242)
T ss_dssp TTCCEEE
T ss_pred CCCCCCC
T ss_conf 3771341
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.89 E-value=4.8e-05 Score=44.54 Aligned_cols=137 Identities=15% Similarity=0.177 Sum_probs=76.0
Q ss_pred CEEEEEEEECCCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCE-----EEEEE--EEEECCCEEEEEEECCCCCHH-
Q ss_conf 6799999978996999999704784351014589999963246860-----27986--555259148999954589767-
Q 002509 599 FGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL-----VQFLG--YCQEEGRSVLVYEFMHNGTLK- 670 (914)
Q Consensus 599 ~G~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~HpnI-----v~l~g--~~~~~~~~~LV~e~~~~gsL~- 670 (914)
--.||+....+|..+++|+.+.. .....++..|...+..+....+ +..-+ .....+..+.+++++.|..+.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred CCEEEEEECCCCCEEEEEEECCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCCCC
T ss_conf 20269998389997999984787-78899999999999999855998787520689805665347999986527768899
Q ss_pred ----H---------HHHC----C-CCCCCCCCHH----------------------HHHHHHHHHHHHHHHH-HHCCCCC
Q ss_conf ----7---------7413----5-6732223578----------------------8899999999999998-7089997
Q 002509 671 ----E---------HLYG----T-LTHEQRINWI----------------------KRLEIAEDAAKGIEYL-HTGCVPA 709 (914)
Q Consensus 671 ----~---------~l~~----~-~~~~~~l~~~----------------------~~l~ia~~ia~gL~~L-H~~~~~~ 709 (914)
. .+|. . ......+++. .....+..+...+... ......+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCE
T ss_conf 99999999899999988630357865567789788766568999874769988989999999999999998454568712
Q ss_pred CCCCCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 11457787765767999499962056612
Q 002509 710 IIHRDLKSSNILLDKHMRAKVSDFGLSKF 738 (914)
Q Consensus 710 ivH~DIkp~NILl~~~~~~kI~DFGla~~ 738 (914)
++|+|+.+.|||++++ ..+.||+-++.
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred EECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 0247888042878389--35886520146
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=97.83 E-value=2.4e-07 Score=58.24 Aligned_cols=78 Identities=27% Similarity=0.322 Sum_probs=37.4
Q ss_pred CEEEEECCCCCCCCCCCCHHHCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCC--CC--
Q ss_conf 86899935897840079001125654325999972998579727899992376999996043017425587783--11--
Q 002509 417 SITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPS--SL-- 492 (914)
Q Consensus 417 ~l~~L~l~~n~l~g~ip~~~~~l~~L~~L~l~~L~~L~ls~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~ip~--~~-- 492 (914)
.|+.|+|++|.++ .+|..+..+..|+ .|++++|+++ .++ .+..+++|+.|+|++|+++ .++. .+
T Consensus 71 ~L~~L~Ls~N~i~-~i~~~~~~~~~L~--------~L~l~~N~i~-~l~-~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~ 138 (198)
T d1m9la_ 71 NLRILSLGRNLIK-KIENLDAVADTLE--------ELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKIT-NWGEIDKLAA 138 (198)
T ss_dssp TCCEEECCEEEEC-SCSSHHHHHHHCC--------EEECSEEECC-CHH-HHHHHHHSSEEEESEEECC-CHHHHHHHTT
T ss_pred CCCCHHHCCCCCC-CCCCCCCCCCCCC--------CCCCCCCCCC-CCC-CCCCCCCCCCCCCCCCHHC-CCCCCCCCCC
T ss_conf 5357341353432-1000033221233--------3333332222-222-2222223411123410212-5542212367
Q ss_pred CCCCCCCCCCCCCC
Q ss_conf 12232012126777
Q 002509 493 LSKNVVLNYAGNIN 506 (914)
Q Consensus 493 ~~~~~~l~~~~n~~ 506 (914)
+..+..+.+.+|+.
T Consensus 139 l~~L~~L~L~~N~l 152 (198)
T d1m9la_ 139 LDKLEDLLLAGNPL 152 (198)
T ss_dssp TTTCSEEEECSSHH
T ss_pred CCCCCEEECCCCCC
T ss_conf 77630234279843
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.80 E-value=7.6e-06 Score=49.32 Aligned_cols=38 Identities=21% Similarity=0.294 Sum_probs=19.1
Q ss_pred CCCCEEECCCC-CCCCCCCCCCCCCCCCCEEEECC-CCCC
Q ss_conf 99729985797-27899992376999996043017-4255
Q 002509 448 PDLRIIHLEDN-QLTGPLPSSLMNLPNLRELYVQN-NMLS 485 (914)
Q Consensus 448 ~~L~~L~ls~N-~l~g~iP~~l~~l~~L~~l~l~~-N~l~ 485 (914)
++|+.|+|++| .+++..+..++++++|+.|+|++ +.++
T Consensus 175 ~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~ 214 (284)
T d2astb2 175 PNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDII 214 (284)
T ss_dssp TTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCC
T ss_pred CCCCCCCCCCCCCCCCHHHHHHCCCCCCCEEECCCCCCCC
T ss_conf 2212355322347783033332135768779899999787
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.74 E-value=3.8e-05 Score=45.17 Aligned_cols=48 Identities=31% Similarity=0.468 Sum_probs=21.3
Q ss_pred ECCCCCCCCCCCCH-HHCCCCCCCCCCCCCCEEECCCCCCCCCCCCC-CCCCCCCCEEEE
Q ss_conf 93589784007900-11256543259999729985797278999923-769999960430
Q 002509 422 HLSSKNLTGNIPSD-LTKLSSLVEFGCPDLRIIHLEDNQLTGPLPSS-LMNLPNLRELYV 479 (914)
Q Consensus 422 ~l~~n~l~g~ip~~-~~~l~~L~~L~l~~L~~L~ls~N~l~g~iP~~-l~~l~~L~~l~l 479 (914)
++++|+++ .||.. |..+++|+ .|+|++|+++ .+|.. +.++++|+.+++
T Consensus 183 ~l~~n~l~-~l~~~~f~~l~~L~--------~L~Ls~N~l~-~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 183 LSDNNNLE-ELPNDVFHGASGPV--------ILDISRTRIH-SLPSYGLENLKKLRARST 232 (242)
T ss_dssp CTTCTTCC-CCCTTTTTTSCCCS--------EEECTTSCCC-CCCSSSCTTCCEEESSSE
T ss_pred CCCCCCCC-CCCHHHHCCCCCCC--------EEECCCCCCC-CCCHHHHCCCCCCCCCCC
T ss_conf 23543246-42478866899999--------8989799289-459779737713414767
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.47 E-value=1.1e-05 Score=48.48 Aligned_cols=59 Identities=29% Similarity=0.290 Sum_probs=29.5
Q ss_pred CCCCCEEECCCCCCCCCC---CCCCCCCCCCCEEEECCCCCCCCCCCCC-C--CCCCCCCCCCCCCC
Q ss_conf 999729985797278999---9237699999604301742558778311-1--22320121267776
Q 002509 447 CPDLRIIHLEDNQLTGPL---PSSLMNLPNLRELYVQNNMLSGTVPSSL-L--SKNVVLNYAGNINL 507 (914)
Q Consensus 447 l~~L~~L~ls~N~l~g~i---P~~l~~l~~L~~l~l~~N~l~g~ip~~~-~--~~~~~l~~~~n~~~ 507 (914)
+++|+.|+|++|+++ .+ +..+..+++|+.|+|++|+++ .++.-. + ..+..+.+.|||..
T Consensus 64 ~~~L~~L~Ls~N~i~-~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~ 128 (162)
T d1koha1 64 IPELLSLNLSNNRLY-RLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLS 128 (162)
T ss_dssp CTTCCCCCCCSSCCC-CCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred CCCCCEEECCCCCCC-CCCHHHHHHHHCCCCCCCCCCCCCCC-CCHHHHHHHCCCCCEEECCCCCCC
T ss_conf 878788637776666-77315889865885610004357213-423442220331042664899767
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.44 E-value=0.0018 Score=35.10 Aligned_cols=72 Identities=14% Similarity=0.306 Sum_probs=44.9
Q ss_pred CCCCCCCCEEEEEEEECC--------CCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCE-EEEEEEEEECCCEEEEEE
Q ss_conf 111523867999999789--------96999999704784351014589999963246860-279865552591489999
Q 002509 592 KKIGSGGFGVVYYGKLKD--------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL-VQFLGYCQEEGRSVLVYE 662 (914)
Q Consensus 592 ~~LG~G~~G~Vy~~~~~~--------~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~g~~~~~~~~~LV~e 662 (914)
+.|+.|-.-.+|+....+ ...|.+++... ........+|..+++.+.-.++ .++++++.. ..|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCC--CCHHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEEE
T ss_conf 9917853343489996887754457898179996599--61165899999999999757999808998189----56999
Q ss_pred ECCCCCH
Q ss_conf 5458976
Q 002509 663 FMHNGTL 669 (914)
Q Consensus 663 ~~~~gsL 669 (914)
|+++..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EECCCCC
T ss_conf 7345548
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.24 E-value=2.9e-05 Score=45.81 Aligned_cols=66 Identities=27% Similarity=0.373 Sum_probs=49.8
Q ss_pred CCCEEEEECCCCCCCCCCC---CHHHCCCCCCCCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCCEEEECCCCCCCCCCC
Q ss_conf 9986899935897840079---001125654325999972998579727899992-376999996043017425587783
Q 002509 415 QPSITVIHLSSKNLTGNIP---SDLTKLSSLVEFGCPDLRIIHLEDNQLTGPLPS-SLMNLPNLRELYVQNNMLSGTVPS 490 (914)
Q Consensus 415 ~~~l~~L~l~~n~l~g~ip---~~~~~l~~L~~L~l~~L~~L~ls~N~l~g~iP~-~l~~l~~L~~l~l~~N~l~g~ip~ 490 (914)
.+.|+.|+|++|+++ .++ ..+..+++|+ .|||++|+++ .++. .......|+.|+|++|.++.....
T Consensus 64 ~~~L~~L~Ls~N~i~-~l~~~~~~~~~l~~L~--------~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~ 133 (162)
T d1koha1 64 IPELLSLNLSNNRLY-RLDDMSSIVQKAPNLK--------ILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRD 133 (162)
T ss_dssp CTTCCCCCCCSSCCC-CCSGGGTHHHHSTTCC--------CCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSS
T ss_pred CCCCCEEECCCCCCC-CCCHHHHHHHHCCCCC--------CCCCCCCCCC-CCHHHHHHHCCCCCEEECCCCCCCCCCCC
T ss_conf 878788637776666-7731588986588561--------0004357213-42344222033104266489976767666
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.17 E-value=3.6e-05 Score=45.29 Aligned_cols=117 Identities=21% Similarity=0.255 Sum_probs=73.3
Q ss_pred EEEEEEEECCCCCC--CCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCEE
Q ss_conf 78999730689887--7311255551103489998608999999952299997677999999999960880799999868
Q 002509 342 VLSFKFGKTYDSSR--GPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT 419 (914)
Q Consensus 342 ~~~l~l~~~~~s~l--pp~ln~~e~~~~l~~~~~~~d~~al~~l~~~~~~~~~~~~~~dpc~~~~w~gv~c~~~~~~~l~ 419 (914)
+..+++..+..+.. ..++..+..++.+.++...-....+..+.... ...+.|+
T Consensus 4 l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L-------------------------~~~~~L~ 58 (460)
T d1z7xw1 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSAL-------------------------RVNPALA 58 (460)
T ss_dssp EEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHH-------------------------HTCTTCC
T ss_pred CCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHH-------------------------HCCCCCC
T ss_conf 777982089588689999997677999998289999889999999998-------------------------5399988
Q ss_pred EEECCCCCCCCCCCCHHHCCCCCCCCCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEEECCCCCCC
Q ss_conf 99935897840079001125654325999972998579727899----99237699999604301742558
Q 002509 420 VIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGP----LPSSLMNLPNLRELYVQNNMLSG 486 (914)
Q Consensus 420 ~L~l~~n~l~g~ip~~~~~l~~L~~L~l~~L~~L~ls~N~l~g~----iP~~l~~l~~L~~l~l~~N~l~g 486 (914)
.|||++|+++..--..+... |+ ....+|+.|+|++|+++.. ++..+..+++|+.|+|++|.++.
T Consensus 59 ~LdLs~N~i~~~~~~~l~~~--l~-~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 59 ELNLRSNELGDVGVHCVLQG--LQ-TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp EEECTTCCCHHHHHHHHHHT--TC-STTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred EEECCCCCCCHHHHHHHHHH--HH-CCCCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCHH
T ss_conf 89795985972899999999--84-3788778877888775432210121100003432002444332023
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.12 E-value=0.003 Score=33.77 Aligned_cols=143 Identities=13% Similarity=0.101 Sum_probs=72.3
Q ss_pred CCCCCCCEEEEEEEECCCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCE-----EEEE-E--EEEECCCEEEEEEEC
Q ss_conf 1152386799999978996999999704784351014589999963246860-----2798-6--555259148999954
Q 002509 593 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL-----VQFL-G--YCQEEGRSVLVYEFM 664 (914)
Q Consensus 593 ~LG~G~~G~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~HpnI-----v~l~-g--~~~~~~~~~LV~e~~ 664 (914)
.|..|.--+.|+....++ .+++|+.... ....++..|++.+..+...++ +... | ..........++.+.
T Consensus 25 ~i~~G~~N~ny~v~t~~g-~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~ 101 (316)
T d2ppqa1 25 GIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 101 (316)
T ss_dssp EECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred CCCCCCCCCEEEEEECCC-CEEEEECCCC--CCHHHHHHHHHHHHHHHHCCCCCCCCCEECCCCCCEEEECCCCEEEEEC
T ss_conf 378885267389997897-2899980789--9988999999998754302555455641048976213412550245311
Q ss_pred CCCCHHH--------------HHHCC---CC---CCC-----------------CCCHHHHHHHHHHHHHHHHHHHH-CC
Q ss_conf 5897677--------------74135---67---322-----------------23578889999999999999870-89
Q 002509 665 HNGTLKE--------------HLYGT---LT---HEQ-----------------RINWIKRLEIAEDAAKGIEYLHT-GC 706 (914)
Q Consensus 665 ~~gsL~~--------------~l~~~---~~---~~~-----------------~l~~~~~l~ia~~ia~gL~~LH~-~~ 706 (914)
.+..... .++.. .. ... ..........+......+...+. ..
T Consensus 102 ~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L 181 (316)
T d2ppqa1 102 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 181 (316)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHHHHHHHHHHHHHHHCCCCCCC
T ss_conf 46553332046788888998764544432024531011101200245677776531141279999999876420485545
Q ss_pred CCCCCCCCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 99711457787765767999499962056612
Q 002509 707 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 738 (914)
Q Consensus 707 ~~~ivH~DIkp~NILl~~~~~~kI~DFGla~~ 738 (914)
..+++|+|+.+.||+++.+...-|.||+.+..
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf 45033378636564020454126742221236
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.95 E-value=0.00016 Score=41.44 Aligned_cols=59 Identities=27% Similarity=0.335 Sum_probs=27.2
Q ss_pred CCCCCCEEECCCCCCCC----CCCCCCC-CCCCCCEEEECCCCCCCC----CCCCC--CCCCCCCCCCCC
Q ss_conf 99997299857972789----9992376-999996043017425587----78311--122320121267
Q 002509 446 GCPDLRIIHLEDNQLTG----PLPSSLM-NLPNLRELYVQNNMLSGT----VPSSL--LSKNVVLNYAGN 504 (914)
Q Consensus 446 ~l~~L~~L~ls~N~l~g----~iP~~l~-~l~~L~~l~l~~N~l~g~----ip~~~--~~~~~~l~~~~n 504 (914)
.+++|+.|||++|.++. .+...+. ...+|+.|+|++|+++.. ++..+ ...++.+++.+|
T Consensus 53 ~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N 122 (460)
T d1z7xw1 53 VNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 122 (460)
T ss_dssp TCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSS
T ss_pred CCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCC
T ss_conf 3999888979598597289999999984378877887788877543221012110000343200244433
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.68 E-value=0.00087 Score=36.99 Aligned_cols=59 Identities=20% Similarity=0.265 Sum_probs=34.2
Q ss_pred CCEEEEECCCC-CCCCCCCCHHHCCCCCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCEEEECCC
Q ss_conf 98689993589-7840079001125654325999972998579-7278999923769999960430174
Q 002509 416 PSITVIHLSSK-NLTGNIPSDLTKLSSLVEFGCPDLRIIHLED-NQLTGPLPSSLMNLPNLRELYVQNN 482 (914)
Q Consensus 416 ~~l~~L~l~~n-~l~g~ip~~~~~l~~L~~L~l~~L~~L~ls~-N~l~g~iP~~l~~l~~L~~l~l~~N 482 (914)
|.|+.|+|+++ .+++.....++++++|+ +|+|++ +++++.....++++++|+.|++.++
T Consensus 175 ~~L~~L~L~~~~~itd~~~~~l~~~~~L~--------~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 175 PNLVHLDLSDSVMLKNDCFQEFFQLNYLQ--------HLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp TTCSEEECTTCTTCCGGGGGGGGGCTTCC--------EEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCCCCCCCCCCCCCCCHHHHHHCCCCCCC--------EEECCCCCCCCHHHHHHHHCCCCCCEEEEECC
T ss_conf 22123553223477830333321357687--------79899999787378999726999898964488
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=95.71 E-value=0.00075 Score=37.39 Aligned_cols=35 Identities=40% Similarity=0.629 Sum_probs=13.5
Q ss_pred CEEECCCCCCCCC----CCCCCCCCCCCCEEEECCCCCC
Q ss_conf 2998579727899----9923769999960430174255
Q 002509 451 RIIHLEDNQLTGP----LPSSLMNLPNLRELYVQNNMLS 485 (914)
Q Consensus 451 ~~L~ls~N~l~g~----iP~~l~~l~~L~~l~l~~N~l~ 485 (914)
+.|+|++|.++.. +...+...++|+.|+|++|.++
T Consensus 218 ~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~ 256 (344)
T d2ca6a1 218 KVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 256 (344)
T ss_dssp CEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCC
T ss_conf 122233332222222234443323221111030047567
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=91.16 E-value=0.044 Score=26.82 Aligned_cols=66 Identities=15% Similarity=0.317 Sum_probs=30.3
Q ss_pred CCEEEEECCCC-CCCCCCCCHHHCC-CCCCCCCCCCCCEEECCCCCCCC----CCCCCCCCCCCCCEEEECCCCCCC
Q ss_conf 98689993589-7840079001125-65432599997299857972789----999237699999604301742558
Q 002509 416 PSITVIHLSSK-NLTGNIPSDLTKL-SSLVEFGCPDLRIIHLEDNQLTG----PLPSSLMNLPNLRELYVQNNMLSG 486 (914)
Q Consensus 416 ~~l~~L~l~~n-~l~g~ip~~~~~l-~~L~~L~l~~L~~L~ls~N~l~g----~iP~~l~~l~~L~~l~l~~N~l~g 486 (914)
+.|+.|+|+++ .++.. .+..+ ..|. ..+.|+.|+|++|.+.. .+-..+...+.|+.|+|++|.++.
T Consensus 15 ~~L~~L~L~~~~~i~~~---~~~~l~~~L~--~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~ 86 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKE---RIRSLIEAAC--NSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP 86 (167)
T ss_dssp SSCCEEECTTCCSSCHH---HHHHHHHHHT--TCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred CCCCEEEECCCCCCCHH---HHHHHHHHHH--HCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCH
T ss_conf 99819782799998989---9999999976--377645401201562156798875310002343300330102145
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=89.57 E-value=0.065 Score=25.80 Aligned_cols=66 Identities=24% Similarity=0.334 Sum_probs=43.5
Q ss_pred CCEEEEECCCCCCCCCCCCHHHCCCCCCCCCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEEECCCCCC
Q ss_conf 986899935897840079001125654325999972998579727899----9923769999960430174255
Q 002509 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEFGCPDLRIIHLEDNQLTGP----LPSSLMNLPNLRELYVQNNMLS 485 (914)
Q Consensus 416 ~~l~~L~l~~n~l~g~ip~~~~~l~~L~~L~l~~L~~L~ls~N~l~g~----iP~~l~~l~~L~~l~l~~N~l~ 485 (914)
+.|+.|+|++|.+...-...++.+ |+ ..+.|+.|+|++|.++.. +-..+...++|+.|+|++|.+.
T Consensus 44 ~~L~~L~Ls~n~l~~~~~~~la~~--L~--~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 44 KHIEKFSLANTAISDSEARGLIEL--IE--TSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp SCCCEEECTTSCCBHHHHTTHHHH--HH--HCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSC
T ss_pred CCCCEEECCCCCCCHHHHHHHHHH--HH--HCCCCCCEEEEHHHCCHHHHHHHHHHHHHCCCCCEEECCCCCCC
T ss_conf 764540120156215679887531--00--02343300330102145999999999984893898778877688
|